<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083365</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1540-8167</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cardiovascular electrophysiology</Title>
          <ISOAbbreviation>J. Cardiovasc. Electrophysiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of Wearable Cardioverter-Defibrillator Compliance on Outcomes in the VEST Trial: As-Treated and Per-Protocol Analyses.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14404</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">VEST did not demonstrate a significant reduction in arrhythmic death with the wearable cardioverter-defibrillator (WCD), but compliance with the device may have substantially affected the results. The influence of WCD compliance on outcomes has not yet been fully evaluated.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Using linear and pooled logistic models, we performed as-treated analyses omitting person-time in the hospital and adjusted for correlates of WCD compliance. To assess the impact of early stopping of WCD, we performed a per-protocol Kaplan-Meier analysis, censoring after the last day the WCD was worn. Interactions of potential effect modifiers with treatment assignment and WCD compliance on outcomes were investigated. Lastly, we used linear models to identify predictors of WCD compliance.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A per-protocol analysis demonstrated a significant reduction in total (p&lt;0.001) and arrhythmic (p=0.001) mortality. Better WCD compliance was independently predicted by cardiac arrest during index MI, higher maximum Cr, diabetes, prior heart failure, EF≤25%, Polish enrolling center and number of WCD alarms, while worse compliance was predicted by being divorced, Asian race, higher BMI, prior PCI, or any WCD shock. Neither excluding time in hospital from the as-treated analysis nor adjustment for factors affecting WCD compliance materially changed the results. No variable demonstrated a significant interaction in either the intention-to-treat or as-treated analysis.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Robust sensitivity analyses of as-treated and per-protocol analyses suggest that the WCD is protective in compliant patients with EF≤35% during the first 3 months post-MI. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Olgin</LastName>
            <ForeName>Jeffrey E</ForeName>
            <Initials>JE</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-1684-9327</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology and the Cardiovascular Research Institute, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Byron K</ForeName>
            <Initials>BK</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology and the Cardiovascular Research Institute, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vittinghoff</LastName>
            <ForeName>Eric</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morin</LastName>
            <ForeName>Daniel P</ForeName>
            <Initials>DP</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-9637-9507</Identifier>
            <AffiliationInfo>
              <Affiliation>Ochsner Medical Center and Ochsner Clinical School, University of Queensland School of Medicine, New Orleans.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zweibel</LastName>
            <ForeName>Steven</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1967-6559</Identifier>
            <AffiliationInfo>
              <Affiliation>Hartford Healthcare Heart and Vascular Institute and University of Connecticut School of Medicine, Hartford.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rashba</LastName>
            <ForeName>Eric</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Stony Brook Medicine, Stony Brook, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chung</LastName>
            <ForeName>Eugene H</ForeName>
            <Initials>EH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, University of Michigan, Michigan Medicine, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borggrefe</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Medicine-Cardiology, University Medical Center Mannheim, Mannheim, and DZHK (German Center for Cardiovascular Re- search), Heidelberg.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hulley</LastName>
            <ForeName>Stephen</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Feng</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hue</LastName>
            <ForeName>Trisha F</ForeName>
            <Initials>TF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pletcher</LastName>
            <ForeName>Mark J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cardiovasc Electrophysiol</MedlineTA>
        <NlmUniqueID>9010756</NlmUniqueID>
        <ISSNLinking>1045-3873</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Defibrillator</Keyword>
        <Keyword MajorTopicYN="N">Heart failure</Keyword>
        <Keyword MajorTopicYN="N">Myocardial infarction</Keyword>
        <Keyword MajorTopicYN="N">Sudden death</Keyword>
        <Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword>
        <Keyword MajorTopicYN="N">Wearable cardioverter-defibrillator</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083365</ArticleId>
        <ArticleId IdType="doi">10.1111/jce.14404</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083366</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4998</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pest management science</Title>
          <ISOAbbreviation>Pest Manag. Sci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Safening activity and metabolism of the safener cyprosulfamide in maize and wheat.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ps.5801</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Safeners extend the application of existing herbicides by selectively enhancing tolerance in large-grained cereal crops. While their activity is linked to enhanced herbicide metabolism, their exact mode of action and reasons for their crop specificity have yet to be determined. In this study, we have investigated the selectivity of the recently developed sulfonamide safener cyprosulfamide (CSA), in maize (Zea mays L.) and wheat (Triticum aestivum), focussing on its uptake, distribution and metabolism in the two species.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">CSA protected maize, but not wheat, from injury by thiencarbazone-methyl (TCM). This correlated with the selective enhanced detoxification of the herbicide in maize, while CSA displayed increased mobility and translocation in wheat. CSA underwent more rapid metabolism in maize than in wheat, with the formation of a specific hydroxylated metabolite correlating with safening. Studies with the nsf1 mutant sweetcorn line showed that the hydroxylation of CSA was partly mediated by the cytochrome P450 CYP81A9. Primary metabolites of CSA were chemically synthesised and tested for their ability to safen TCM in maize. All metabolites tested were inactive as safeners.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study suggest that the protection against TCM injury by CSA is linked to enhanced herbicide metabolism. This selective activity is due to the specific recognition of parent CSA in maize but not in wheat. Subsequent rapid oxidative metabolism of CSA led to its inactivation, demonstrating that cytochrome P450s regulate the activity of safeners as well as herbicides. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Giannakopoulos</LastName>
            <ForeName>George</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9070-1473</Identifier>
            <AffiliationInfo>
              <Affiliation>Crop Protection group, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dittgen</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Weed Control Research, Bayer AG, Frankfurt, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schulte</LastName>
            <ForeName>Wolfgang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Weed Control Research, Bayer AG, Frankfurt, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zoellner</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Small Molecules Technologies, Bayer AG, Frankfurt, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Helmke</LastName>
            <ForeName>Hendrik</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Weed Control Research, Bayer AG, Frankfurt, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lagojda</LastName>
            <ForeName>Andreas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Structure Elucidation, Environmental Safety, Development, Bayer AG, Monheim, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edwards</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0809-5991</Identifier>
            <AffiliationInfo>
              <Affiliation>Crop Protection group, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pest Manag Sci</MedlineTA>
        <NlmUniqueID>100898744</NlmUniqueID>
        <ISSNLinking>1526-498X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CYP81A9</Keyword>
        <Keyword MajorTopicYN="N">cytochrome P450</Keyword>
        <Keyword MajorTopicYN="N">herbicide metabolism</Keyword>
        <Keyword MajorTopicYN="N">nsf1</Keyword>
        <Keyword MajorTopicYN="N">thiencarbazone-methyl</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083366</ArticleId>
        <ArticleId IdType="doi">10.1002/ps.5801</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083368</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1540-8167</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cardiovascular electrophysiology</Title>
          <ISOAbbreviation>J. Cardiovasc. Electrophysiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: a post hoc analysis of the EURIDIS and ADONIS trials.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14405</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The phase 3 EURIDIS and ADONIS studies evaluated dronedarone for atrial fibrillation (AF)/atrial flutter (AFL) recurrence in patients with non-permanent AF. Here we assessed whether patient characteristics and/or treatment outcomes in these studies differed based on need for cardioversion before randomization.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Time to adjudicated first AF/AFL recurrence, symptomatic recurrence, cardiovascular hospitalization/death, and AF hospitalization, and safety were assessed by cardioversion status.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1237 patients randomized (2:1 dronedarone:placebo), 364 required baseline cardioversion (dronedarone 243, placebo 121). Patients requiring cardioversion had a greater prevalence of cardiovascular comorbidities and shorter times to first AF/AFL recurrence compared with those not requiring cardioversion. Dronedarone was associated with longer median time to first AF/AFL recurrence vs placebo regardless of cardioversion status (cardioversion: 50 vs 15 days, hazard ratio [HR] 0.76; 95% confidence interval [CI], 0.59-0.97; P = 0.02; non-cardioversion: 150 vs 77 days, HR 0.76; 95% CI, 0.64-0.90; P &lt; 0.01). Dronedarone was similarly associated with prolonged median time to symptomatic recurrence vs placebo in the cardioversion (347 vs 87 days, HR 0.65; 95% CI, 0.49-0.87) and non-cardioversion (288 vs 120 days, HR 0.74; 95% CI, 0.62-0.90) populations. Risk of cardiovascular hospitalization/death and first AF hospitalization was lower with dronedarone vs placebo regardless of cardioversion status, but differences were not statistically significant. Safety of dronedarone was similar in both groups.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Patients requiring baseline cardioversion represent a distinct population, having more underlying cardiovascular disease and experiencing shorter time to AF/AFL recurrences. Dronedarone was associated with improved efficacy vs placebo regardless of cardioversion status. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thind</LastName>
            <ForeName>Munveer</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-9852-2867</Identifier>
            <AffiliationInfo>
              <Affiliation>Lankenau Heart Institute, Wynnewood, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crijns</LastName>
            <ForeName>Harry J</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Maastricht University Medical Center and CARIM, Maastricht, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naccarelli</LastName>
            <ForeName>Gerald V</ForeName>
            <Initials>GV</Initials>
            <AffiliationInfo>
              <Affiliation>Penn State University College of Medicine, Hershey, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reiffel</LastName>
            <ForeName>James A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Columbia University, NYC, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Corp Dit Genti</LastName>
            <ForeName>Valérie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Sanofi-Aventis, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wieloch</LastName>
            <ForeName>Mattias</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Sanofi-Aventis, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koren</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Sanofi US Inc, Bridgewater, NJ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kowey</LastName>
            <ForeName>Peter R</ForeName>
            <Initials>PR</Initials>
            <AffiliationInfo>
              <Affiliation>Lankenau Heart Institute, Wynnewood, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cardiovasc Electrophysiol</MedlineTA>
        <NlmUniqueID>9010756</NlmUniqueID>
        <ISSNLinking>1045-3873</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
        <Keyword MajorTopicYN="N">antiarrhythmic drug</Keyword>
        <Keyword MajorTopicYN="N">atrial flutter</Keyword>
        <Keyword MajorTopicYN="N">cardioversion</Keyword>
        <Keyword MajorTopicYN="N">dronedarone</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083368</ArticleId>
        <ArticleId IdType="doi">10.1111/jce.14405</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083369</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">1051-0761</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecological applications : a publication of the Ecological Society of America</Title>
          <ISOAbbreviation>Ecol Appl</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Understanding neighborhood effects to increase restoration success of woody plant communities.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/eap.2098</ELocationID>
        <Abstract>
          <AbstractText>Revegetation is the most common procedure in the restoration of disturbed areas; this practice usually aims at reconstructing plant communities that can last without further management. A low-cost strategy to assist these efforts is the application of ecological knowledge in the design of the restoration. Promoting ecological processes that enhance the functioning of the restored community could result in higher restoration success. Among these processes, plant-plant interactions, e.g., facilitation and competition, can play an important role, both facilitating or impeding the development of a self-sustaining plant community. Although these processes have been well-studied in nature, we rarely have sufficient knowledge about the whole plant community. To develop that knowledge, we leverage on a restoration experiment that took place after a mine toxic spill, where ~15,000 woody plants from 13 species were planted and geolocated. Species were planted in three mixtures mimicking natural communities found along soil moisture gradients (xerophyte, intermediate, and hydrophyte). Plantings also varied in density. ~2,600 plants were monitored for damage status, survival, and growth, for four years. We analyzed growth performance of six targeted species as a function of their damage status, planted mixture, and density. Growth was also assessed on the basis of neighboring plants, accounting for the species identity and distance to the focal plant. Results show that survival among planted species was relatively high and was mostly unaffected by mixture or density of the plantings. Only very damaged plants in one species experienced a decrease in survival with increasing density. Neighborhood effects on growth show positive, neutral, and negative interactions among the tested species; these also varied depending on the type of growth performance considered (height, crown area, diameter). The species-specific results ranged from positive to negative, varying between pair of species and growth performance metric. Results gathered from our neighborhood analyses on plant growth provide valuable information for the design of planting schemes that could enhance the performance of the target species. The methods developed can be applied to other systems and species. Given the potential impacts that facilitation and competition may have during revegetation, these interactions could be considered in restoration operations.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ibáñez</LastName>
            <ForeName>Inés</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1054-0727</Identifier>
            <AffiliationInfo>
              <Affiliation>School for Environment and Sustainability, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Conservation Biology, Estación Biológica de Doñana - CSIC, Sevilla, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecol Appl</MedlineTA>
        <NlmUniqueID>9889808</NlmUniqueID>
        <ISSNLinking>1051-0761</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Guadimar toxic spill
</Keyword>
        <Keyword MajorTopicYN="N">
Spain
</Keyword>
        <Keyword MajorTopicYN="N">
reclamation
</Keyword>
        <Keyword MajorTopicYN="N">Crataegus monogyna</Keyword>
        <Keyword MajorTopicYN="N">Myrtus communis</Keyword>
        <Keyword MajorTopicYN="N">Olea europaea</Keyword>
        <Keyword MajorTopicYN="N">Phillyrea angustifolia</Keyword>
        <Keyword MajorTopicYN="N">Pistacia lentiscus</Keyword>
        <Keyword MajorTopicYN="N">Tamarix Africana</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083369</ArticleId>
        <ArticleId IdType="doi">10.1002/eap.2098</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083367</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-2795</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular reproduction and development</Title>
          <ISOAbbreviation>Mol. Reprod. Dev.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of increased scrotal temperature on semen quality and seminal plasma proteins in Brahman bulls.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/mrd.23328</ELocationID>
        <Abstract>
          <AbstractText>Environmental temperature has effects on sperm quality with differences in susceptibility between cattle subspecies and breeds, but very little is known about the seminal plasma protein (SPP) changes resulting from testicular heat stress. Scrotal insulation (SI) for 48 hr was applied to Brahman (Bos indicus) bulls. Semen was collected at 3-day intervals from before, until 74 days post-SI. The changes in sperm morphology and motility following SI were comparable to previously reported and differences were detected in measures of sperm chromatin conformation as early as 8 days post-SI. New proteins spots, in the SPP two-dimensional (2-D) gels, were apparent when comparing pre-SI with 74 days post-SI, and SPP identified as associated with mechanisms of cellular repair and protection. Similar trends between 2-D gel and Sequential Window Acquisition of All Theoretical Mass Spectra (SWATH-MS) data was observed, with SWATH-MS able to quantify individual SPP that otherwise were not resolved on 2-D gel. The SPP assessment at peak sperm damage (21-24 days) showed a significant difference in 29 SPP (adjusted p &lt; .05), and identified six proteins with change in abundance in the SI group. In conclusion both spermatozoa and SPP composition of bulls are susceptible to temperature change incurred by SI, and SPP markers for testicular heat insults may be detected.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Boe-Hansen</LastName>
            <ForeName>Gry Brandt</ForeName>
            <Initials>GB</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2453-1992</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Veterinary Science, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rêgo</LastName>
            <ForeName>João Paulo A</ForeName>
            <Initials>JPA</Initials>
            <AffiliationInfo>
              <Affiliation>Federal Institute of Education, Science and Technology of Ceará, Boa Viagem Campus, Fortaleza, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Satake</LastName>
            <ForeName>Nana</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4895-7437</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Agriculture and Food Sciences, The University of Queensland, St. Lucia, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Venus</LastName>
            <ForeName>Bronwyn</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Agri-Science Department of Agriculture, Fisheries and Forestry, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sadowski</LastName>
            <ForeName>Pawel</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-1812-3490</Identifier>
            <AffiliationInfo>
              <Affiliation>Central Analytical Research Facility, Queensland University of Technology, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nouwens</LastName>
            <ForeName>Amanda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yutao</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>CSIRO Agriculture and Food, St. Lucia, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McGowan</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0783-4748</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Veterinary Science, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Brazilian Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>The University of Queensland</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Mol Reprod Dev</MedlineTA>
        <NlmUniqueID>8903333</NlmUniqueID>
        <ISSNLinking>1040-452X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MS-based proteomics</Keyword>
        <Keyword MajorTopicYN="N">chromatin structure</Keyword>
        <Keyword MajorTopicYN="N">scrotal insulation</Keyword>
        <Keyword MajorTopicYN="N">testicular stress</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083367</ArticleId>
        <ArticleId IdType="doi">10.1002/mrd.23328</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Alvarez-Gallardo, H., Kjelland, M. E., Moreno, J. F., Welsh, T. H., Jr., Randel, R. D., Lammoglia, M. A., … Romo, S. (2013). Gamete therapeutics: Recombinant protein adsorption by sperm for increasing fertility via artificial insemination. PLoS One, 8(6), e65083. https://doi.org/10.1371/journal.pone.0065083</Citation>
        </Reference>
        <Reference>
          <Citation>Amann, R. P., Kavanaugh, J. F., Griel, L. C., Jr., &amp; Voglmayr, J. K. (1974). Sperm production of Holstein bulls determined from testicular spermatid reserves, after cannulation of rete testis or vas deferens, and by daily ejaculation. Journal of Dairy Science, 57(1), 93-99. https://doi.org/10.3168/jds.S0022-0302(74)84836-8</Citation>
        </Reference>
        <Reference>
          <Citation>Assumpcao, T. I., Fontes, W., Sousa, M. V., &amp; Ricart, C. A. O. (2005). Proteome analysis of Nelore bull (Bos taurus indicus) seminal plasma. Protein and Peptide Letters, 12(8), 813-817. https://doi.org/10.2174/0929866054864292</Citation>
        </Reference>
        <Reference>
          <Citation>Azamar, Y., Uribe, S., &amp; Mújica, A. (2007). F-actin involvement in guinea pig sperm motility. Molecular Reproduction and Development, 74(3), 312-320.</Citation>
        </Reference>
        <Reference>
          <Citation>Barth, A. D., &amp; Bowman, P. A. (1994). The sequential appearance of sperm abnormalities after scrotal insulation or dexamethasone treatment in bulls. Canadian Veterinary Journal, 35(2), 93-102.</Citation>
        </Reference>
        <Reference>
          <Citation>Belleannee, C., Labas, V., Teixeira-Gomes, A.-P., Gatti, J. L., Dacheux, J.-L., &amp; Dacheux, F. (2011). Identification of luminal and secreted proteins in bull epididymis. Journal of Proteomics, 74(1), 59-78. https://doi.org/10.1016/j.jprot.2010.07.013</Citation>
        </Reference>
        <Reference>
          <Citation>Boe-Hansen, G. B., Rego, J. P., Crisp, J. M., Moura, A. A., Nouwens, A. S., Li, Y., … McGowan, M. R. (2015). Seminal plasma proteins and their relationship with percentage of morphologically normal sperm in 2-year-old Brahman (Bos indicus) bulls. Animal Reproduction Science, 162, 20-30. https://doi.org/10.1016/j.anireprosci.2015.09.003</Citation>
        </Reference>
        <Reference>
          <Citation>Bradford, M. M. (1976). Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Analytical Biochemistry, 72(1-2), 248-254. https://doi.org/10.1006/abio.1976.9999</Citation>
        </Reference>
        <Reference>
          <Citation>Breitbart, H., Cohen, G., &amp; Rubinstein, S. (2005). Role of actin cytoskeleton in mammalian sperm capacitation and the acrosome reaction. Reproduction (Cambridge, England), 129(3), 263-268.</Citation>
        </Reference>
        <Reference>
          <Citation>Brito, L. F. C., Silva, A. E. D. F., Barbosa, R. T., &amp; Kastelic, J. P. (2004). Testicular thermoregulation in Bos indicus, crossbred and Bos taurus bulls: Relationship with scrotal, testicular vascular cone and testicular morphology, and effects on semen quality and sperm production. Theriogenology, 61(2-3), 511-528. https://doi.org/10.1016/S0093-691x(03)00231-0</Citation>
        </Reference>
        <Reference>
          <Citation>Byrne, K., Leahy, T., McCulloch, R., Colgrave, M. L., &amp; Holland, M. K. (2012). Comprehensive mapping of the bull sperm surface proteome. Proteomics, 12(23-24), 3559-3579. https://doi.org/10.1002/pmic.201200133</Citation>
        </Reference>
        <Reference>
          <Citation>Champroux, A., Torres-Carreira, J., Gharagozloo, P., Drevet, J. R., &amp; Kocer, A. (2016). Mammalian sperm nuclear organization: Resiliencies and vulnerabilities. Basic and Clinical Andrology, 26, 17. https://doi.org/10.1186/s12610-016-0044-5</Citation>
        </Reference>
        <Reference>
          <Citation>Chowdhury, N. A., Kamada, M., Takikawa, M., Mori, H., Gima, H., &amp; Aono, T. (1996). Complement-inhibiting activity of human seminal plasma and semen quality. Archives of Andrology, 36(2), 109-118. https://doi.org/10.3109/01485019608987086</Citation>
        </Reference>
        <Reference>
          <Citation>Coulthard, M. G., Morgan, M., Woodruff, T. M., Arumugam, T. V., Taylor, S. M., Carpenter, T. C., … Boyd, A. W. (2012). Eph/Ephrin signaling in injury and inflammation. The American Journal of Pathology, 181(5), 1493-1503.</Citation>
        </Reference>
        <Reference>
          <Citation>Dostalova, Z., Calvete, J. J., Sanz, L., Hettel, C., Riedel, D., Schoneck, C., … Topfer-Petersen, E. (1994). Immunolocalization and quantitation of acidic seminal fluid protein (aSFP) in ejaculated, swim-up, and capacitated bull spermatozoa. Biological Chemistry Hoppe-Seyler, 375(7), 457-461.</Citation>
        </Reference>
        <Reference>
          <Citation>Eliyahu, E., Shtraizent, N., Martinuzzi, K., Barritt, J., He, X., Wei, H., … Schuchman, E. H. (2010). Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization. The FASEB Journal, 24(4), 1229-1238. https://doi.org/10.1096/fj.09-145508</Citation>
        </Reference>
        <Reference>
          <Citation>Evenson, D., &amp; Jost, L. (2000). Sperm chromatin structure assay is useful for fertility assessment. Methods in Cell Science, 22(2-3), 169-189.</Citation>
        </Reference>
        <Reference>
          <Citation>Evenson, D. P., Jost, L. K., Corzett, M., &amp; Balhorn, R. (2000). Characteristics of human sperm chromatin structure following an episode of influenza and high fever: A case study. Journal of Andrology, 21(5), 739-746.</Citation>
        </Reference>
        <Reference>
          <Citation>Felton-Taylor, J., Prosser, K. A., Hernandez-Medrano, J. H., Gentili, S., Copping, K. J., Macrossan, P. E., &amp; Perry, V. E. A. (2020). Effect of breed, age, season and region on sperm morphology in 11,387 bulls submitted to breeding soundness evaluation in Australia. Theriogenology, 142, 1-7. https://doi.org/10.1016/j.theriogenology.2019.09.001</Citation>
        </Reference>
        <Reference>
          <Citation>Fernandes, C. E., Dode, M. A., Pereira, D., &amp; Silva, A. E. (2008). Effects of scrotal insulation in Nellore bulls (Bos taurus indicus) on seminal quality and its relationship with in vitro fertilizing ability. Theriogenology, 70(9), 1560-1568. https://doi.org/10.1016/j.theriogenology.2008.07.005</Citation>
        </Reference>
        <Reference>
          <Citation>Fordyce, G., Entwistle, K., Norman, S., Perry, V., Gardiner, B., &amp; Fordyce, P. (2006). Standardising bull breeding soundness evaluations and reporting in Australia. Theriogenology, 66(5), 1140-1148. https://doi.org/10.1016/j.theriogenology.2006.03.009</Citation>
        </Reference>
        <Reference>
          <Citation>Fortes, M. R. S., Holroyd, R. G., Reverter, A., Venus, B. K., Satake, N., &amp; Boe-Hansen, G. B. (2012). The integrity of sperm chromatin in young tropical composite bulls. Theriogenology, 78(2), 326-333.</Citation>
        </Reference>
        <Reference>
          <Citation>Fortes, M. R. S., Satake, N., Corbet, D. H., Corbet, N. J., Burns, B. M., Moore, S. S., &amp; Boe-Hansen, G. B. (2014). Sperm protamine deficiency correlates with sperm DNA damage in Bos indicus bulls. Andrology, 2(3), 370-378. https://doi.org/10.1111/j.2047-2927.2014.00196.x</Citation>
        </Reference>
        <Reference>
          <Citation>Frenette, G., Lessard, C., &amp; Sullivan, R. (2004). Polyol pathway along the bovine epididymis. Molecular Reproduction and Development, 69(4), 448-456. https://doi.org/10.1002/mrd.20170</Citation>
        </Reference>
        <Reference>
          <Citation>Gillet, L. C., Navarro, P., Tate, S., Rost, H., Selevsek, N., Reiter, L., … Aebersold, R. (2012). Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Molecular &amp; Cellular Proteomics, 11(6), O111.016717. https://doi.org/10.1074/mcp.O111.016717.</Citation>
        </Reference>
        <Reference>
          <Citation>Girouard, J., Frenette, G., &amp; Sullivan, R. (2009). Compartmentalization of proteins in epididymosomes coordinates the association of epididymal proteins with the different functional structures of bovine spermatozoa. Biology of Reproduction, 80(5), 965-972. https://doi.org/10.1095/biolreprod.108.073551</Citation>
        </Reference>
        <Reference>
          <Citation>Hansen, P. J. (2009). Effects of heat stress on mammalian reproduction. Philosophical Transactions of the Royal Society B-Biological Sciences, 364(1534), 3341-3350. https://doi.org/10.1098/rstb.2009.0131</Citation>
        </Reference>
        <Reference>
          <Citation>Hering, D. M., Lecewicz, M., Kordan, W., Majewska, A., &amp; Kaminski, S. (2015). Missense mutation in glutathione-S-transferase M1 gene is associated with sperm motility and ATP content in frozen-thawed semen of Holstein-Friesian bulls. Animal Reproduction Science, 159, 94-97. https://doi.org/10.1016/j.anireprosci.2015.06.001</Citation>
        </Reference>
        <Reference>
          <Citation>Hough, S. R., &amp; Parks, J. E. (1994). Platelet-activating factor acetylhydrolase activity in seminal plasma from the bull, stallion, rabbit, and rooster. Biology of Reproduction, 50(4), 912-916.</Citation>
        </Reference>
        <Reference>
          <Citation>Hough, S. R., &amp; Parks, J. E. (1997). Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma. Journal of Andrology, 18(5), 540-548.</Citation>
        </Reference>
        <Reference>
          <Citation>Humphreys, D. T., Carver, J. A., Easterbrook-Smith, S. B., &amp; Wilson, M. R. (1999). Clusterin has chaperone-like activity similar to that of small heat shock proteins. Journal of Biological Chemistry, 274(11), 6875-6881. https://doi.org/10.1074/jbc.274.11.6875</Citation>
        </Reference>
        <Reference>
          <Citation>Ibrahim, N. M., Romano, J. E., Troedsson, M. H. T., &amp; Crabo, B. G. (2001). Effect of scrotal insulation on clusterin-positive cells in ram semen and their relationship to semen quality. Journal of Andrology, 22(5), 863-877.</Citation>
        </Reference>
        <Reference>
          <Citation>Ignotz, G. G., Cho, M. Y., &amp; Suarez, S. S. (2007). Annexins are candidate oviductal receptors for bovine sperm surface proteins and thus may serve to hold bovine sperm in the oviductal reservoir. Biology of Reproduction, 77(6), 906-913.</Citation>
        </Reference>
        <Reference>
          <Citation>Intasqui, P., Antoniassi, M. P., Camargo, M., Nichi, M., Carvalho, V. M., Cardozo, K. H. M., … Bertolla, R. P. (2015). Differences in the seminal plasma proteome are associated with oxidative stress levels in men with normal semen parameters. Fertility and Sterility, 104(2), 292-301. https://doi.org/10.1016/j.fertnstert.2015.04.037</Citation>
        </Reference>
        <Reference>
          <Citation>Ishitsuka, R., Kojima, K., Utsumi, H., Ogawa, H., &amp; Matsumoto, I. (1998). Glycosaminoglycan binding properties of annexin IV, V, and VI. Journal of Biological Chemistry, 273(16), 9935-9941.</Citation>
        </Reference>
        <Reference>
          <Citation>Jarvi, K., Langlais, J., Gagnon, C., &amp; Roberts, K. D. (1993). Platelet activating factor acetylhydrolase in the male reproductive tract-Origin and properties. International Journal of Andrology, 16(2), 121-127. https://doi.org/10.1111/j.1365-2605.1993.tb01164.x</Citation>
        </Reference>
        <Reference>
          <Citation>Junior, F. A. B., Junior, C. K., Fávaro, P. d C., Pereira, G. R., Morotti, F., Menegassi, S. R. O., … Seneda, M. M. (2018). Effect of breed on testicular blood flow dynamics in bulls. Theriogenology, 118, 16-21. https://doi.org/10.1016/j.theriogenology.2018.05.022</Citation>
        </Reference>
        <Reference>
          <Citation>Karabinus, D. S., Vogler, C. J., Saacke, R. G., &amp; Evenson, D. P. (1997). Chromatin structural changes in sperm after scrotal insulation of Holstein bulls. Journal of Andrology, 18(5), 549-555.</Citation>
        </Reference>
        <Reference>
          <Citation>Kelly, V. C., Kuy, S., Palmer, D. J., Xu, Z., Davis, S. R., &amp; Cooper, G. J. (2006). Characterization of bovine seminal plasma by proteomics. Proteomics, 6(21), 5826-5833.</Citation>
        </Reference>
        <Reference>
          <Citation>Kimura, K., Asami, K., &amp; Yamamoto, M. (1997). Effect of heat shock treatment on the production of variant testosterone-repressed prostate message-2 (TRPM-2) mRNA in culture cells. Cell Biochemistry and Function, 15(4), 251-257. https://doi.org/10.1002/(sici)1099-0844(199712)15:4&lt;251::aid-cbf748&gt;3.0.co;2-3</Citation>
        </Reference>
        <Reference>
          <Citation>Kirchhoff, C., Osterhoff, C., Pera, I., &amp; Schroter, S. (1998). Function of human epididymal proteins in sperm maturation. Andrologia, 30(4-5), 225-232.</Citation>
        </Reference>
        <Reference>
          <Citation>Koefoed-Johnson, H. H. (1960). Influence of ejaculation frequency on the time required for sperm formation and epididymal passage in the bull. Nature, 185, 49-50.</Citation>
        </Reference>
        <Reference>
          <Citation>Manjunath, P., Chandonnet, L., Leblond, E., &amp; Desnoyers, L. (1994). Major proteins of bovine seminal vesicles bind to spermatozoa. Biology of Reproduction, 50(1), 27-37.</Citation>
        </Reference>
        <Reference>
          <Citation>Manjunath, P., &amp; Sairam, M. R. (1987). Purification and biochemical characterization of 3 major acidic proteins (BSP-A1, BSP-A2 and BSP-A3) from bovine seminal plasma. Biochemical Journal, 241(3), 685-692.</Citation>
        </Reference>
        <Reference>
          <Citation>Martins, J. A. M., Souza, C. E. A., Silva, F. D. A., Cadavid, V. G., Nogueira, F. C., Domont, G. B., … Moura, A. A. (2013). Major heparin-binding proteins of the seminal plasma from Morada Nova rams. Small Ruminant Research, 113(1), 115-127. https://doi.org/10.1016/j.smallrumres.2013.01.005</Citation>
        </Reference>
        <Reference>
          <Citation>McCauley, T. C., Zhang, H. M., Bellin, M. E., &amp; Ax, R. L. (2001). Identification of a heparin-binding protein in bovine seminal fluid as tissue inhibitor of metalloproteinases-2. Molecular Reproduction and Development, 58(3), 336-341. https://doi.org/10.1002/1098-2795(200103)58:3&lt;336::aid-mrd12&gt;3.0.co;2-z</Citation>
        </Reference>
        <Reference>
          <Citation>Menezes, E. B., de Oliveira, R. V., van Tilburg, M. F., Barbosa, E. A., Nascimento, N. V., Velho, A. L. M. C. S., … Moura, A. A. (2017). Proteomic analysis of seminal plasma from locally-adapted “Curraleiro Pé-Duro bulls” (Bos taurus): Identifying biomarkers involved in sperm physiology in endangered animals for conservation of biodiversity. Animal Reproduction Science, 183, 86-101. https://doi.org/10.1016/j.anireprosci.2017.05.014</Citation>
        </Reference>
        <Reference>
          <Citation>Montanholi, Y. R., Fontoura, A. B. P., Diel de Amorim, M., Foster, R. A., Chenier, T., &amp; Miller, S. P. (2016). Seminal plasma protein concentrations vary with feed efficiency and fertility-related measures in young beef bulls. Reproductive Biology, 16(2), 147-156. https://doi.org/10.1016/j.repbio.2016.04.002</Citation>
        </Reference>
        <Reference>
          <Citation>Moura, A. A., Chapman, D. A., Koc, H., &amp; Killian, G. J. (2007). A comprehensive proteomic analysis of the accessory sex gland fluid from mature Holstein bulls. Animal Reproduction Science, 98(3-4), 169-188. https://doi.org/10.1016/j.anireprosci.2006.03.012</Citation>
        </Reference>
        <Reference>
          <Citation>Moura, A. A., Koc, H., Chapman, D. A., &amp; Killian, G. J. (2006). Identification of proteins in the accessory sex gland fluid associated with fertility indexes of dairy bulls: A proteomic approach. Journal of Andrology, 27(2), 201-211. https://doi.org/10.2164/jandrol.05089</Citation>
        </Reference>
        <Reference>
          <Citation>Moura, A. A., Souza, C. E., Stanley, B. A., Chapman, D. A., &amp; Killian, G. J. (2010). Proteomics of cauda epididymal fluid from mature Holstein bulls. Journal of Proteomics, 73(10), 2006-2020. https://doi.org/10.1016/j.jprot.2010.06.005</Citation>
        </Reference>
        <Reference>
          <Citation>Mukai, C., &amp; Okuno, M. (2004). Glycolysis plays a major role for adenosine triphosphate supplementation in mouse sperm flagellar movement. Biology of Reproduction, 71(2), 540-547.</Citation>
        </Reference>
        <Reference>
          <Citation>Niforou, K., Cheimonidou, C., &amp; Trougakos, I. P. (2014). Molecular chaperones and proteostasis regulation during redox imbalance. Redox Biology, 2, 323-332. https://doi.org/10.1016/j.redox.2014.01.017</Citation>
        </Reference>
        <Reference>
          <Citation>Park, H.-J., Lee, W.-Y., Park, C., Hong, K.-H., Kim, J.-H., &amp; Song, H. (2018). Species-specific expression of phosphoglycerate kinase 2 (PGK2) in the developing porcine testis. Theriogenology, 110, 158-167. https://doi.org/10.1016/j.theriogenology.2018.01.007</Citation>
        </Reference>
        <Reference>
          <Citation>Pei, Y., Wu, Y., &amp; Qin, Y. (2012). Effects of chronic heat stress on the expressions of heat shock proteins 60, 70, 90, A2, and HSC70 in the rabbit testis. Cell Stress and Chaperones, 17(1), 81-87. https://doi.org/10.1007/s12192-011-0287-1</Citation>
        </Reference>
        <Reference>
          <Citation>Rahman, M. B., Schellander, K., Luceño, N. L., &amp; Van Soom, A. (2018). Heat stress responses in spermatozoa: Mechanisms and consequences for cattle fertility. Theriogenology, 113, 102-112. https://doi.org/10.1016/j.theriogenology.2018.02.012</Citation>
        </Reference>
        <Reference>
          <Citation>Rahman, M. B., Vandaele, L., Rijsselaere, T., Maes, D., Hoogewijs, M., Frijters, A., … Van Soom, A. (2011). Scrotal insulation and its relationship to abnormal morphology, chromatin protamination and nuclear shape of spermatozoa in Holstein-Friesian and Belgian Blue bulls. Theriogenology, 76(7), 1246-1257. https://doi.org/10.1016/j.theriogenology.2011.05.031</Citation>
        </Reference>
        <Reference>
          <Citation>Rao, M., Ma, S., Hu, S., Lei, H., Wu, Y., Zhou, Y., … Zhu, C. (2017). Isobaric tags for relative and absolute quantification-based proteomic analysis of testis biopsies in rhesus monkeys treated with transient scrotal hyperthermia. Oncotarget, 8(49), 85909-85925. https://doi.org/10.18632/oncotarget.20719</Citation>
        </Reference>
        <Reference>
          <Citation>Rappsilber, J., Mann, M., &amp; Ishihama, Y. (2007). Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nature Protocols, 2(8), 1896-1906. https://doi.org/10.1038/nprot.2007.261</Citation>
        </Reference>
        <Reference>
          <Citation>Rego, J. P. A., Crisp, J. M., Moura, A. A., Nouwens, A. S., Li, Y., Venus, B., … McGowan, M. R. (2014). Seminal plasma proteome of electroejaculated Bos indicus bulls. Animal Reproduction Science, 148(1), 1-17. https://doi.org/10.1016/j.anireprosci.2014.04.016</Citation>
        </Reference>
        <Reference>
          <Citation>Rego, J. P. A., Martins, J. M., Wolf, C. A., van Tilburg, M., Moreno, F., Monteiro-Moreira, A. C., … Moura, A. A. (2016). Proteomic analysis of seminal plasma and sperm cells and their associations with semen freezability in Guzerat bulls. Journal of Animal Science, 94(12), 5308-5320. https://doi.org/10.2527/jas.2016-0811</Citation>
        </Reference>
        <Reference>
          <Citation>Rego, J. P. A., Moura, A. A., Nouwens, A. S., McGowan, M. R., &amp; Boe-Hansen, G. B. (2015). Seminal plasma protein profiles of ejaculates obtained by internal artificial vagina and electroejaculation in Brahman bulls. Animal Reproduction Science, 160, 126-137. https://doi.org/10.1016/j.anireprosci.2015.07.015</Citation>
        </Reference>
        <Reference>
          <Citation>Rescher, U., &amp; Gerke, V. (2004). Annexins--Unique membrane binding proteins with diverse functions. Journal of Cell Science, 117(Pt. 13), 2631-2639.</Citation>
        </Reference>
        <Reference>
          <Citation>Rhynes, W. E., &amp; Ewing, L. L. (1973). Testicular endocrine function in Hereford bulls exposed to high ambient temperature. Endocrinology, 92(2), 509-515. https://doi.org/10.1210/endo-92-2-509</Citation>
        </Reference>
        <Reference>
          <Citation>Rocha, D. R., Martins, J. A. M., van Tilburg, M. F., Oliveira, R. V., Moreno, F. B., Monteiro-Moreira, A. C. O., … Moura, A. A. (2015). Effect of increased testicular temperature on seminal plasma proteome of the ram. Theriogenology, 84(8), 1291-1305. https://doi.org/10.1016/j.theriogenology.2015.07.008</Citation>
        </Reference>
        <Reference>
          <Citation>Ronquist, K. G., Ek, B., Morrell, J., Stavreus-Evers, A., Ström Holst, B., Humblot, P., … Larsson, A. (2013). Prostasomes from four different species are able to produce extracellular adenosine triphosphate (ATP). Biochimica et Biophysica Acta (BBA)-General Subjects, 1830(10), 4604-4610. https://doi.org/10.1016/j.bbagen.2013.05.019</Citation>
        </Reference>
        <Reference>
          <Citation>Ross, A. D., &amp; Entwistle, K. W. (1979). The effect of scrotal insulation on spermatozoal morphology and the rates of spermatogenesis and epididymal passage of spermatozoa in the bull. Theriogenology, 11(2), 111-129. https://doi.org/10.1016/0093-691X(79)90064-5</Citation>
        </Reference>
        <Reference>
          <Citation>Sakaue, T., Takeuchi, K., Maeda, T., Yamamoto, Y., Nishi, K., &amp; Ohkubo, I. (2010). Factor H in porcine seminal plasma protects sperm against complement attack in genital tracts. The Journal of Biological Chemistry, 285(3), 2184-2192. https://doi.org/10.1074/jbc.M109.063495</Citation>
        </Reference>
        <Reference>
          <Citation>Setchell, B. P. (1998). The Parkes lecture-Heat and the testis. Journal of Reproduction and Fertility, 114(2), 179-194.</Citation>
        </Reference>
        <Reference>
          <Citation>Shojaei Saadi, H. A., van Riemsdijk, E., Dance, A. L., Rajamanickam, G. D., Kastelic, J. P., &amp; Thundathil, J. C. (2013). Proteins associated with critical sperm functions and sperm head shape are differentially expressed in morphologically abnormal bovine sperm induced by scrotal insulation. Journal of Proteomics, 82, 64-80. https://doi.org/10.1016/j.jprot.2013.02.027</Citation>
        </Reference>
        <Reference>
          <Citation>Silkensen, J. R., Schwochau, G. B., &amp; Rosenberg, M. E. (1994). The role of clusterin in tissue-injury. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire, 72(11-12), 483-488.</Citation>
        </Reference>
        <Reference>
          <Citation>Simoes, R., Feitosa, W. B., Mendes, C. M., Marques, M. G., Nicacio, A. C., de Barros, F. R. O., … Assumpcao, M. E. O. A. (2009). Use of chromomycin A3 staining in bovine sperm cells for detection of protamine deficiency. Biotechnic &amp; Histochemistry, 84(3), 79-83. https://doi.org/10.1080/10520290902843595</Citation>
        </Reference>
        <Reference>
          <Citation>Soleilhavoup, C., Tsikis, G., Labas, V., Harichaux, G., Kohnke, P. L., Dacheux, J. L., … Druart, X. (2014). Ram seminal plasma proteome and its impact on liquid preservation of spermatozoa. Journal of Proteomics, 109, 245-260. https://doi.org/10.1016/j.jprot.2014.07.007</Citation>
        </Reference>
        <Reference>
          <Citation>Souza, C. E. A., Rego, J. P. A., Lobo, C. H., Oliveira, J. T. A., Nogueira, F. C. S., Domont, G. B., … Moura, A. A. (2012). Proteomic analysis of the reproductive tract fluids from tropically-adapted Santa Ines rams. Journal of Proteomics, 75(14), 4436-4456. https://doi.org/10.1016/j.jprot.2012.05.039</Citation>
        </Reference>
        <Reference>
          <Citation>Srivastava, N., Srivastava, S. K., Ghosh, S. K., Singh, L. P., Prasad, J. K., Kumar, A., … Thamizharasan, A. (2012). Sequestration of PDC-109 protein improves freezability of crossbred bull spermatozoa. Animal Reproduction Science, 131(1), 54-62. https://doi.org/10.1016/j.anireprosci.2012.02.003</Citation>
        </Reference>
        <Reference>
          <Citation>Tarter, T. H., &amp; Alexander, N. J. (1984). Complement-inhibiting activity of seminal plasma. American Journal of Reproductive Immunology, 6(1), 28-32. https://doi.org/10.1111/j.1600-0897.1984.tb00105.x</Citation>
        </Reference>
        <Reference>
          <Citation>Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H. Y., Karlak, B., Daverman, R., … Narechania, A. (2003). PANTHER: A library of protein families and subfamilies indexed by function. Genome Research, 13(9), 2129-2141. https://doi.org/10.1101/gr.772403</Citation>
        </Reference>
        <Reference>
          <Citation>Thornton, P. K., van de Steeg, J., Notenbaert, A., &amp; Herrero, M. (2009). The impacts of climate change on livestock and livestock systems in developing countries: A review of what we know and what we need to know. Agricultural Systems, 101(3), 113-127. https://doi.org/10.1016/j.agsy.2009.05.002</Citation>
        </Reference>
        <Reference>
          <Citation>Vogler, C. J., Bame, J. H., DeJarnette, J. M., McGilliard, M. L., &amp; Saacke, R. G. (1993). Effects of elevated testicular temperature on morphology characteristics of ejaculated spermatozoa in the bovine. Theriogenology, 40(6), 1207-1219. https://doi.org/10.1016/0093-691X(93)90291-C</Citation>
        </Reference>
        <Reference>
          <Citation>Waites, G. M. (1962). The effect of heating the scrotum of the ram on respiration and body temperature. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences, 47, 314-323.</Citation>
        </Reference>
        <Reference>
          <Citation>Walters, A. H., Eyestone, W. E., Saacke, R. G., Pearson, R. E., &amp; Gwazdauskas, F. C. (2004). Sperm morphology and preparation method affect bovine embryonic development. Journal of Andrology, 25(4), 554-563. https://doi.org/10.1002/j.1939-4640.2004.tb02826.x</Citation>
        </Reference>
        <Reference>
          <Citation>Westfalewicz, B., Dietrich, M. A., Mostek, A., Partyka, A., Bielas, W., Niżański, W., &amp; Ciereszko, A. (2017a). Analysis of bull (Bos taurus) seminal vesicle fluid proteome in relation to seminal plasma proteome. Journal of Dairy Science, 100(3), 2282-2298. https://doi.org/10.3168/jds.2016-11866</Citation>
        </Reference>
        <Reference>
          <Citation>Westfalewicz, B., Dietrich, M. A., Mostek, A., Partyka, A., Bielas, W., Niżański, W., &amp; Ciereszko, A. (2017b). Identification and functional analysis of bull (Bos taurus) cauda epididymal fluid proteome. Journal of Dairy Science, 100(8), 6707-6719. https://doi.org/10.3168/jds.2016-12526</Citation>
        </Reference>
        <Reference>
          <Citation>Wildeus, S., &amp; Entwistle, K. W. (1986). Effects of scrotal insulation and unilateral vasoligation on ejaculate characteristics and sperm reserves in the bull. Animal Reproduction Science, 10(1), 11-21. https://doi.org/10.1016/0378-4320(86)90136-3</Citation>
        </Reference>
        <Reference>
          <Citation>Wisniewski, J. R., Zougman, A., Nagaraj, N., &amp; Mann, M. (2009). Universal sample preparation method for proteome analysis. Nature Methods, 6(5), 359-362. https://doi.org/10.1038/nmeth.1322</Citation>
        </Reference>
        <Reference>
          <Citation>Wolfe, D. F., Bradley, J. T., &amp; Riddell, M. G. (1993). Characterization of seminal plasma-proteins and sperm proteins in ejaculates from normospermic bulls and bulls with thermally-induced testicular degeneration. Theriogenology, 40(5), 1083-1091. https://doi.org/10.1016/0093-691x(93)90376-G</Citation>
        </Reference>
        <Reference>
          <Citation>Yoshida, H., Satoh, K., &amp; Imaizumi, T. (1992). Activity of platelet activating factor acetylhydrolase exists in red cell membrane. American Journal of Hematology, 40(1), 61-63. https://doi.org/10.1002/ajh.2830400113</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou, W., De Iuliis, G. N., Dun, M. D., &amp; Nixon, B. (2018). Characteristics of the epididymal luminal environment responsible for sperm maturation and storage. Frontiers in Endocrinology, 9, 59. https://doi.org/10.3389/fendo.2018.00059</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou, Z.-P., Xia, X.-Y., Guo, Q.-S., &amp; Xu, C. (2014). Bactericidal/permeability-increasing protein originates in both the testis and the epididymis and localizes in mouse spermatozoa. Asian Journal of Andrology, 16(2), 309-313. https://doi.org/10.4103/1008-682X.122583</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu, Z., Xu, W., Dai, J., Chen, X., Zhao, X., Fang, P., … Qaio, Z. (2013). The alteration of protein profile induced by cigarette smoking via oxidative stress in mice epididymis. The International Journal of Biochemistry &amp; Cell Biology, 45(3), 571-582. https://doi.org/10.1016/j.biocel.2012.12.007</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083370</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1540-8167</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cardiovascular electrophysiology</Title>
          <ISOAbbreviation>J. Cardiovasc. Electrophysiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Patient Selection for Wearable Cardioverter Defibrillator Therapy after Myocardial Infarction: How Can We Incorporate Compliance into Decision-Making?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14403</ELocationID>
        <Abstract>
          <AbstractText>Ventricular tachyarrhythmia leading to sudden cardiac death (SCD) within the first 3 months after myocardial infarction (MI) is a devastating complication in patients with ischemic heart disease.<sup>1</sup> Several studies have reported that the highest incidence of SCD (ranges between 1.4%-2.3%) is within the first 3 months after an acute MI, and that the risk is more pronounced among patients with low left ventricular ejection fraction (LVEF).<sup>2, 3</sup> However, randomized clinical trials have failed to demonstrate that prophylactic implantation of an implantable cardioverter defibrillator (ICD) during the high-risk early post-MI period is associated with long-term survival benefit, emphasizing the need to allow for LVEF recovery prior to a decision on the need for prophylactic ICD implantation.<sup>4, 5</sup> This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Younis</LastName>
            <ForeName>Arwa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goldenberg</LastName>
            <ForeName>Ilan</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-5806-3325</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cardiovasc Electrophysiol</MedlineTA>
        <NlmUniqueID>9010756</NlmUniqueID>
        <ISSNLinking>1045-3873</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">compliance</Keyword>
        <Keyword MajorTopicYN="N">sudden cardiac death</Keyword>
        <Keyword MajorTopicYN="N">wearable cardioverter defibrillator</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083370</ArticleId>
        <ArticleId IdType="doi">10.1111/jce.14403</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083371</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1542-474X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc</Title>
          <ISOAbbreviation>Ann Noninvasive Electrocardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>PR depression with multilead ST elevation and ST depression in aVR by left circumflex artery occlusion: How to differentiate from acute pericarditis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12752</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/anec.12752</ELocationID>
        <Abstract>
          <AbstractText>PR-segment depression with multilead ST-segment elevation and ST-segment depression in lead aVR are classic ECG manifestation of acute pericarditis. We present a patient, where the etiology of these ECG features was acute ST-elevation myocardial infarction due to left circumflex artery occlusion. To avoid misdiagnosis, unnecessary examinations, and inappropriate therapeutic decisions, the possibility of ST-segment elevation myocardial infarction should be kept in mind even when ECG changes typical for pericarditis are encountered in chest pain patients. Findings of QRS widening and QT interval shortening in leads with ST-segment elevation could help to differentiate acute ST-segment elevation myocardial infarction from acute pericarditis.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhan</LastName>
            <ForeName>Zhong-Qun</ForeName>
            <Initials>ZQ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0982-5194</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Shenzhen Hospital-University of Chinese Academy of Sciences, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nikus</LastName>
            <ForeName>Kjell</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Heart Center, Tampere and Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, Tampere, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Birnbaum</LastName>
            <ForeName>Yochai</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7653-6328</Identifier>
            <AffiliationInfo>
              <Affiliation>The Section of Cardiology, Baylor College of Medicine and Texas Heart Institute, Luke Medical Center, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ann Noninvasive Electrocardiol</MedlineTA>
        <NlmUniqueID>9607443</NlmUniqueID>
        <ISSNLinking>1082-720X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PR segment</Keyword>
        <Keyword MajorTopicYN="N">acute myocardial infarction</Keyword>
        <Keyword MajorTopicYN="N">left circumflex artery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083371</ArticleId>
        <ArticleId IdType="doi">10.1111/anec.12752</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Birnbaum, Y., Perez Riera, A. R., &amp; Nikus, K. (2019). PR depression with multi-lead ST elevation and ST depression in aVR: Is it always acute pericarditis. Journal of Electrocardiology, 54, 13-17. https://doi.org/10.1016/j.jelectrocard.2019.01.085</Citation>
        </Reference>
        <Reference>
          <Citation>Cushing, E. H., Feil, H. S., Stanton, E. J., &amp; Wartman, W. B. (1942). Infarction of the cardiac auricles (atria): Clinical, pathological, and experimental studies. British Heart Journal, 4(1-2), 17-34. https://doi.org/10.1136/hrt.4.1-2.17</Citation>
        </Reference>
        <Reference>
          <Citation>Jim, M. H., Siu, C. W., Chan, A. O., Chan, R. H., Lee, S. W., &amp; Lau, C. P. (2006). Prognostic implications of PR-segment depression in inferior leads in acute inferior myocardial infarction. Clinical Cardiology, 29(8), 363-368. https://doi.org/10.1002/clc.4960290809</Citation>
        </Reference>
        <Reference>
          <Citation>Kudenchuk, P. J., Maynard, C., Cobb, L. A. ., Wirkus, M., Martin, J. S., Kennedy, J. W., … Weaver, W. D. (1998). Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: The Myocardial Infarction Triage and Intervention (MITI) Project. Journal of the American College of Cardiology, 32(1), 17-27. https://doi.org/10.1016/S0735-1097(98)00175-2</Citation>
        </Reference>
        <Reference>
          <Citation>Lu, M. L., De Venecia, T., Patnaik, S., &amp; Figueredo, V. M. (2016). Atrial myocardial infarction: A tale of the forgotten chamber. International Journal of Cardiology, 202, 904-909. https://doi.org/10.1016/j.ijcard.2015.10.070</Citation>
        </Reference>
        <Reference>
          <Citation>McNamara, N., Ibrahim, A., Satti, Z., Ibrahim, M., &amp; Kiernan, T. J. (2019). Acute pericarditis: A review of current diagnostic and management guidelines. Future Cardiology. https://doi.org/10.2217/fca-2017-0102</Citation>
        </Reference>
        <Reference>
          <Citation>Porela, P., Kytö, V., Nikus, K., Eskola, M., &amp; Airaksinen, K. E. (2012). PR depression is useful in the differential diagnosis of myopericarditis and ST elevation myocardial infarction. Annals of Noninvasive Electrocardiology, 17(2), 141-145. https://doi.org/10.1111/j.1542-474X.2012.00489.x</Citation>
        </Reference>
        <Reference>
          <Citation>Rossello, X., Wiegerinck, R. F., Alguersuari, J., Bardají, A., Worner, F., Sutil, M., Ferrero, A., … Cinca, J. (2014). New electrocardiographic criteria to differentiate acute pericarditis and myocardial infarction. American Journal of Medicine, 127(3), 233-239. https://doi.org/10.1016/j.amjmed.2013.11.006</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083373</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4998</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pest management science</Title>
          <ISOAbbreviation>Pest Manag. Sci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification and expression of main genes involved in non-target site resistance mechanisms to fenoxaprop-p-ethyl in Beckmannia syzigachne.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ps.5800</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGRAOUD" NlmCategory="UNASSIGNED">Non-target-site resistance (NTSR) to herbicide is a serious threat to global agriculture. Though the metabolic resistance was the dominant mechanism of NTSR, the molecular mechanism is not yet well-characterized. This study aimed to uncover the likely metabolism-related genes in Beckmannia syzigachne (American sloughgrass) resistant to fenoxaprop-p-ethyl.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">UPLC-MS-MS experiment showed that the resistant American sloughgrass biotype (R, SD-04-SS) showed enhanced degradation of this herbicide compared to the susceptible biotype (S, SD-12). R and S biotype were harvested at the 24 hour after fenoxaprop-p-ethyl treatment to conduct RNA sequencing (RNA-Seq) analysis to investigate the likely fenoxaprop-p-ethyl metabolic genes. The RNA-Seq libraries yield 417,969,980 clean reads. The de novo assembly generated 115,112 unigenes, in which 57906 unigenes were annotated. Finally, we identified 273 cytochrome P450s, 178 oxidase, 47 GSTs, 166 GTs and 180 ABC transporter genes to determine the likely fenoxaprop-p-ethyl metabolism-related genes in R biotype. Twelve overlapping up-regulated genes in R biotype (fenoxaprop-p-ethyl-treated R/non-treated R, fenoxaprop-p-ethyl-treated R/fenoxaprop-p-ethyl-treated S) were identified by RNA-Seq and the results were validated using qRT-PCR. Ten were identified as fenoxaprop-p-ethyl metabolism-related genes including three P450s (homology to CYP71D7, CYP99A2, and CYP71D10), one GSTs (homology to GSTF1), two GTs (homology to UGT90A1 and UGT83A1) and four oxidase genes.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This work demonstrates that the NTSR mechanism by means of enhanced detoxification of fenoxaprop-p-ethyl in American sloughgrass is very likely driven by the herbicide metabolism related genes. The RNA-Seq data presented here provide a valuable resource for understanding the molecular mechanism of NTSR in American sloughgrass. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bai</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>College of Plant Health and Medicine, Qingdao Agricultural University, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Integrated Crop Pest Management of Shandong Province, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yanfang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Chemistry and Pharmacy, Qingdao Agricultural University, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yuanming</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Central Laboratory of Qingdao Agricultural University, Qingdao, 255109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Mingliang</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>College of Plant Health and Medicine, Qingdao Agricultural University, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Integrated Crop Pest Management of Shandong Province, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yihui</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Plant Health and Medicine, Qingdao Agricultural University, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Integrated Crop Pest Management of Shandong Province, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Xiaoyong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Plant Health and Medicine, Qingdao Agricultural University, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Integrated Crop Pest Management of Shandong Province, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Lingxu</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1436-0069</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Plant Health and Medicine, Qingdao Agricultural University, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Integrated Crop Pest Management of Shandong Province, Qingdao, 266109, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pest Manag Sci</MedlineTA>
        <NlmUniqueID>100898744</NlmUniqueID>
        <ISSNLinking>1526-498X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">American sloughgrass</Keyword>
        <Keyword MajorTopicYN="N">RNA-Seq</Keyword>
        <Keyword MajorTopicYN="N">detoxification</Keyword>
        <Keyword MajorTopicYN="N">fenoxaprop-p</Keyword>
        <Keyword MajorTopicYN="N">qRT-PCR</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083373</ArticleId>
        <ArticleId IdType="doi">10.1002/ps.5800</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083372</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1545-5017</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric blood &amp; cancer</Title>
          <ISOAbbreviation>Pediatr Blood Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Review of nutritional status, body composition, and effects of antineoplastic drug disposition.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e28207</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pbc.28207</ELocationID>
        <Abstract>
          <AbstractText>The overall survival for children with cancer in high income countries is excellent. However, there are many disparities that may negatively affect survival, which are particularly problematic in low income countries, such as nutritional status at diagnosis and throughout therapy. Nutritional status as well as concomitant foods, supplements, and medications may play a role in overall exposure and response to chemotherapy. Emerging science around the microbiome may also play a role and should be further explored as a contributor to disease progression and therapeutic response. This article highlights some of these issues and proposes additional areas of research relevant to nutritional status and pharmacology that are needed in pediatric oncology.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wiernikowski</LastName>
            <ForeName>John T</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Paediatric Haematology/Oncology, Department of Paediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bernhardt</LastName>
            <ForeName>Melanie Brooke</ForeName>
            <Initials>MB</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9612-3624</Identifier>
            <AffiliationInfo>
              <Affiliation>Section of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Blood Cancer</MedlineTA>
        <NlmUniqueID>101186624</NlmUniqueID>
        <ISSNLinking>1545-5009</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">chemotherapy</Keyword>
        <Keyword MajorTopicYN="N">nutrition</Keyword>
        <Keyword MajorTopicYN="N">pediatric oncology</Keyword>
        <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083372</ArticleId>
        <ArticleId IdType="doi">10.1002/pbc.28207</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2016. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2016/. Accessed February 11, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Zenatti PP, Azussa Migita N, Moreno Cury N, et al. Low bioavailability and high immunogenicity of a new brand of E. coli L-asparaginase with active host contaminating proteins. EBioMedicine. 2018;30:158-166.</Citation>
        </Reference>
        <Reference>
          <Citation>Friedrich P, Lam CG, Itriago E, et al. Magnitude of treatment abandonment in childhood cancer. PLoS One. 2015;10:e0135230.</Citation>
        </Reference>
        <Reference>
          <Citation>Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States 2015-2016. NCHS Data Brief, No 288. 2017. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.</Citation>
        </Reference>
        <Reference>
          <Citation>NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975-2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents and adults. Lancet 2017;390:2627-2642.</Citation>
        </Reference>
        <Reference>
          <Citation>Jinabhai CC, Taylor M, Sullivan KR. Changing patterns of under and over nutrition in South African children-future risks of non-communicable diseases. Ann Trop Pediatr. 2005;25:3-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Shoeps DO, de Abreu LC, Valenti VE, et al. Nutritional status of pre-school children from low income families. Nutr J. 2011;10:43.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.</Citation>
        </Reference>
        <Reference>
          <Citation>Tzioumis E, Adair LS. Childhood dual burden of under-and over-nutrition in low-and middle-income countries: a critical review. Food Nutr Bull. 2014;35:230-243.</Citation>
        </Reference>
        <Reference>
          <Citation>Obama M, Cangir A, van Eys J. Nutritional status and anthracycline cardiotoxicity in children. South Med J. 1983;76:577-578.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith M, Abrams J, Trimble EL, Ungerleider RS. Dose intensity of chemotherapy for childhood cancers. Oncologist. 1996;1:293-304.</Citation>
        </Reference>
        <Reference>
          <Citation>Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the children's oncology group. J Clin Oncol. 2012;30:4148-4154.</Citation>
        </Reference>
        <Reference>
          <Citation>Asselin BL, Devidas M, Wang C, et al. Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the children's oncology group (POG 9404). Blood. 2011;118:874-883.</Citation>
        </Reference>
        <Reference>
          <Citation>Larsen EC, Devidas M, Chen S, et al. Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from children's oncology group study AALL0232. J Clin Oncol. 2016;34:2380-2388.</Citation>
        </Reference>
        <Reference>
          <Citation>Hill CR, Cole M, Errington J, et al. Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer. Clin Pharmacokinet. 2014;53:741-751.</Citation>
        </Reference>
        <Reference>
          <Citation>Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157-1167.</Citation>
        </Reference>
        <Reference>
          <Citation>Boullata JI. Drug disposition in obesity and protein-energy malnutrition. Proc Nutr Soc. 2010;69:543-550.</Citation>
        </Reference>
        <Reference>
          <Citation>Sala A, Pencharz P, Barr RD. Children, cancer and nutrition-a dynamic triangle in review. Cancer. 2004;100:677-687.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Eys J. Malnutrition in children with cancer, incidence and consequence. Cancer. 1979;43:2030-2035.</Citation>
        </Reference>
        <Reference>
          <Citation>Wessels G, Hesseling PB, vanOmmeren KH, et al. Nutrition, morbidity and survival in South African children with Wilms tumor. J Pediatr Hematol Oncol. 1999;16:321-327.</Citation>
        </Reference>
        <Reference>
          <Citation>Sala A, Rossi E, Antillon F. Nutritional status at diagnosis in children and adolescents with cancer in the Asociacion de Hemato-Oncologia Pediatrica de Centro America (AHOPCA) countries: preliminary results from Guatemala. Pediatr Blood Cancer. 2008;50:499-501.</Citation>
        </Reference>
        <Reference>
          <Citation>Israels T, Chirambo C, Caron HN, Molyneus EM. Nutritional status at admission of children with cancer in Malawi. Pediatr Blood Cancer. 2008;51:626-628.</Citation>
        </Reference>
        <Reference>
          <Citation>Israels T, Borgstein E, Jamali M, et al. Acute malnutrition is common in Malawian patients with a Wilms tumor: a role for peanut butter. Pediatr Blood Cancer. 2009;53:1221-1226.</Citation>
        </Reference>
        <Reference>
          <Citation>Israels T, Damen CWN, Cole M, et al. Malnourished patients presenting with large Wilms tumors have a decreased vincristine clearance rate. Eur J Cancer. 2010;46:1841-1847.</Citation>
        </Reference>
        <Reference>
          <Citation>Oguz A, Karadeniz C, Pelit M. Arm anthropometry in evaluation of malnutrition in children with cancer. Ped Hematol Oncol. 1999;16:35-41.</Citation>
        </Reference>
        <Reference>
          <Citation>Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981;34:2540-2545.</Citation>
        </Reference>
        <Reference>
          <Citation>Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69:491-497.</Citation>
        </Reference>
        <Reference>
          <Citation>Elhasid R, Laor A, Lischinsky S, et al. Nutritional status of children with solid tumors. Cancer. 1999;86:119-125.</Citation>
        </Reference>
        <Reference>
          <Citation>Hamberg O, Ovesen L, Dorfeldt A, et al. The effect of dietary energy and protein deficiency on drug metabolism. Eur J Clin Pharmacol. 1990;38:567-570.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee JH, Suh OK, Lee MG. Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes. Arch Pharm Res. 2004;27:693-712.</Citation>
        </Reference>
        <Reference>
          <Citation>Cusack BJ, Young SP, Loseke VL, et al. Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit. Cancer Chemother Pharmacol. 1992;30:145-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Davis LE, Lenkinski RE, Shinkwin MA, et al. The effect of dietary protein depletion on hepatic 5-fluorouracil metabolism. Cancer. 1993;72:3715-3722.</Citation>
        </Reference>
        <Reference>
          <Citation>Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1998;11:48-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Mihranian MH, Wang YM, Daly JM. Effects of nutritional depletion and repletion on plasma methotrexate pharmacokinetics. Cancer. 1984;54:2268-2271.</Citation>
        </Reference>
        <Reference>
          <Citation>Dunki Jacobs PB, Ruevekamp M, Varossiau FJ, et al. Alterations in serum levels, anti-tumor activity and toxicity of methotrexate in rats after a short period of nutritional depletion. Eur J Cancer Clin Oncol. 1989;25:415-422.</Citation>
        </Reference>
        <Reference>
          <Citation>Charland SL, Bartlett D, Torosian MH. Effect of protein-calorie malnutrition on methotrexate pharmacokinetics. JPEN J Parenter Enteral Nutr. 1994;18:45-49.</Citation>
        </Reference>
        <Reference>
          <Citation>Israels T, van de Wetering MD, Hesseling P, et al. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer. 2009;53:47-52.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Obesity and overweight. 2018. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed February 11, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39:215-231.</Citation>
        </Reference>
        <Reference>
          <Citation>Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci. 1999;88:1-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30:1553-1561.</Citation>
        </Reference>
        <Reference>
          <Citation>Bastarrachea J, Hortobagyi GN, Smith TL, et al. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med. 1994;120:18-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Georgiadis MS, Steinberg SM, Hankins L, et al. Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Natl Cancer Inst. 1995;87:361-366.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484-495.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol. 2004;22:648-657.</Citation>
        </Reference>
        <Reference>
          <Citation>Krischer JP, Epstein S, Cuthbertson DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15:1544-1552.</Citation>
        </Reference>
        <Reference>
          <Citation>Maruyama S, Shibata R, Ohashi K, et al. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism. J Biol Chem. 2011;286:32790-32800.</Citation>
        </Reference>
        <Reference>
          <Citation>Mitra MS, Donthamsetty S, White B, Mehendale HM. High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol. 2008;23:413-422.</Citation>
        </Reference>
        <Reference>
          <Citation>Eksborg S, Palm C, Bjork O. A comparative pharmacokinetic study of doxorubicin and 4'-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure. Anticancer Drugs. 2000;11:129-136.</Citation>
        </Reference>
        <Reference>
          <Citation>Kontny NE, Würthwein G, Joachim B, et al. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years. Cancer Chemother Pharmacol. 2013;71:749-763.</Citation>
        </Reference>
        <Reference>
          <Citation>Thompson PA, Rosner GL, Matthay KK, et al. Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. Cancer Chemother Pharmacol. 2009;64:243-251.</Citation>
        </Reference>
        <Reference>
          <Citation>Butturini AM, Dorey FJ, Lange BJ, et al. Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2007;25:2063-2069.</Citation>
        </Reference>
        <Reference>
          <Citation>Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293:203-211.</Citation>
        </Reference>
        <Reference>
          <Citation>Haidar C, Jeha S. Drug interactions in childhood cancer. Lancet Oncol. 2011;12:92-99.</Citation>
        </Reference>
        <Reference>
          <Citation>Kelly KM. Bringing evidence to complementary and alternative medicine in children with cancer: focus on nutrition-related therapies. Pediatr Blood Cancer. 2008;50(2 Suppl):490-493. discussion 498.</Citation>
        </Reference>
        <Reference>
          <Citation>Ladas EJ, Kelly KM. Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer? J Altern Complement Med. 2003;9:411-416.</Citation>
        </Reference>
        <Reference>
          <Citation>Rocha V, Ladas EJ, Lin M, et al. Beliefs and determinants of use of traditional complementary/alternative medicine in pediatric patients who undergo treatment for cancer in South America. J Glob Oncol. 2017;3:701-710.</Citation>
        </Reference>
        <Reference>
          <Citation>Schutze T, Längler A, Zuzak TJ, et al. Use of complementary and alternative medicine by pediatric oncology patients during palliative care. Support Care Cancer. 2016;24:2869-2875.</Citation>
        </Reference>
        <Reference>
          <Citation>Ghiasuddin A, Wong J, Siu AM. Complementary and alternative medicine practices, traditional healing practices, and cultural competency in pediatric oncology in Hawai' i. J Integr Med. 2016;14:374-379.</Citation>
        </Reference>
        <Reference>
          <Citation>Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286:487-491.</Citation>
        </Reference>
        <Reference>
          <Citation>Cavallari LM, Ellingrod VL, Kolesar JM. Pharmaco-genomics Handbook. 2nd ed. Hudson, OH: Lexi-Comp; 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Beijnen JH, Schellens JHM. Drug interactions in oncology. Lancet Oncol. 2004;5:489-496.</Citation>
        </Reference>
        <Reference>
          <Citation>Gunes A, Dahl ML. Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics. 2008;9:625-637.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41:89-295.</Citation>
        </Reference>
        <Reference>
          <Citation>Scott SA, Jaremko M, Lubitz SA, et al. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing. Pharmacogenomics J. 2009;10:1243-1255.</Citation>
        </Reference>
        <Reference>
          <Citation>Speed WC, Kang SP, Tuck DP, et al. Global variation in CYP2C8-CYP2C9 functional haplotypes. Pharmacogenomics J. 2009;9:283-290.</Citation>
        </Reference>
        <Reference>
          <Citation>Bergmann TK, Brasch-Andersen C, Green H, et al. Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. Pharmacogenomics J. 2011;11:113-120.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaspera R, Naraharisetti SB, Evangelista EA, et al. Drug metabolism by CYP2C8*3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. Biochem Pharmacol. 2011;82:681-691.</Citation>
        </Reference>
        <Reference>
          <Citation>Garcia-Martin E, Martinez C, Ladero JM, et al. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. Mol Diagn Ther. 2006;10:29-40.</Citation>
        </Reference>
        <Reference>
          <Citation>McGraw J, Waller D. Cytochrome P450 variations in different ethnic populations. Expert Opin Drug Metab Toxicol. 2012;8:371-382.</Citation>
        </Reference>
        <Reference>
          <Citation>Sistonen J, Fuselli S, Palo JU, et al. Pharmacogenetic variation in CUP2C9. CYP2C19 and CYP2d6 at global and microgeographic scales. Pharmacogenet Genomics. 2009;19:170-179.</Citation>
        </Reference>
        <Reference>
          <Citation>Xie HG, Kim RB, Wood AJ, et al. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol. 2001;41:815-850.</Citation>
        </Reference>
        <Reference>
          <Citation>Cai WM, Nikoloff DM, Pan RM, et al. CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing. Pharmacogenomics J. 2006;6:343-350.</Citation>
        </Reference>
        <Reference>
          <Citation>Neafsey P, Ginsberg G, Hattis D, et al. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): population distribution of CYP2D6 activity. J Toxicol Environ Health B Crit Rev. 2009;12:334-361.</Citation>
        </Reference>
        <Reference>
          <Citation>Hart SN, Li Y, Nakamoro K, et al. Novel SNPs in cytochrome P450 oxidoreductase. Drug Metab Pharmacokinet. 2007;22:322-326.</Citation>
        </Reference>
        <Reference>
          <Citation>Xie HG, Wood AJ, Kim RB, et al. Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics. 2004;4:243-272.</Citation>
        </Reference>
        <Reference>
          <Citation>Liui YT, Hao HP, Liu CX, et al. Drugs as CYP3A probes, inducers and inhibitors. Drug Metab Rev. 2007;39:699-721.</Citation>
        </Reference>
        <Reference>
          <Citation>Lakhman SS, Ma Q, Morse GD. Pharmacogenomics of CYP3A: considerations for HIV treatment. Pharmacogenomics. 2009;10:1323-1339.</Citation>
        </Reference>
        <Reference>
          <Citation>de Lemos ML, Hamata L, Jenninfs S, Leduc T. Interaction between mercaptopurine and milk. J Oncol Pharm Pract. 2007;13:237-240.</Citation>
        </Reference>
        <Reference>
          <Citation>Riccardi R, Balis FM, Ferrara P, et al. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986;3:319-324.</Citation>
        </Reference>
        <Reference>
          <Citation>Landier W, Hageman L, Chen Y, et al. Mercaptopurine ingestion habits, red cell thioguanine levels, and relapse risk in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group Study AALL03N1. J Clin Oncol. 2017;35:1730-1736.</Citation>
        </Reference>
        <Reference>
          <Citation>Brunner LJ, Pai KS, Munar MY, et al. Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant. 2000;4:313-321.</Citation>
        </Reference>
        <Reference>
          <Citation>Reif S, Nicolson MC, Bisset D, et al. Effect of grapefruit juice intake on etoposide bioavailability. Eur J Clin Pharmacol. 2002;58:491-494.</Citation>
        </Reference>
        <Reference>
          <Citation>Collado-Borrell R, Escudero-Vilaplana V, Romero-Jimenez R, et al. Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account. J Cancer Res Clin Oncol. 2016;142:2319-2330.</Citation>
        </Reference>
        <Reference>
          <Citation>Ladas EJ, Marjerrison S, Arora B, et al. Traditional and complementary medicine in pediatric oncology and low-middle income countries: recommendations from the International Society of Pediatric Oncology (SIOP), T&amp;CM Collaborative. J Natl Cancer Inst Monogr. 2017;52:15-18.</Citation>
        </Reference>
        <Reference>
          <Citation>Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med. 2012;78:1458-1477.</Citation>
        </Reference>
        <Reference>
          <Citation>Zadoyan G, Fuhr U. Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome P450 enzymes. Planta Med. 2012;78:1428-1457.</Citation>
        </Reference>
        <Reference>
          <Citation>Wanwimolruk S, Prachayasittikul V. Cytochrome P450 enzyme mediated herbal drug interactions (Part 1). EXCLI J. 2014;13:347-391.</Citation>
        </Reference>
        <Reference>
          <Citation>Wanwimolruk S, Phopin K, Prachayasittikul V. Cytochrome P450 enzyme mediated herbal drug interactions (Part 2). EXCLI J. 2014;13:869-896.</Citation>
        </Reference>
        <Reference>
          <Citation>Asher GN, Corbett AH, Hawke RL. Common herbal dietary supplement-drug interactions. Am Fam Physician. 2017;96:101-107.</Citation>
        </Reference>
        <Reference>
          <Citation>Ardekani AM, Jabbari S. Nutrigenomics and cancer. Avicenna J Med Biotechnol. 2009;1:9-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Hua X, Yu L, You R, et al. Association among dietary flavonoids, flavonoid subclasses and ovarian cancer risk: a meta-analysis. PLoS One. 2016;11:e0151134.</Citation>
        </Reference>
        <Reference>
          <Citation>Hui C, Qi X, Qianyong Z, Xiaoli P, et al. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One. 2013;8:e54318.</Citation>
        </Reference>
        <Reference>
          <Citation>Cui L, Lui X, Tian Y, et al. Flavonoids, flavonoid subclasses and esophageal cancer risk: a metal-analysis of epidemiologic studies. Nutrients;2016:8.</Citation>
        </Reference>
        <Reference>
          <Citation>Braicu C, Mehterov N, Vladimirow B, et al. Nutrigenomics in cancer: revisiting the effects of natural compounds. Semin Cancer Biol. 2017;46:84-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Thiesen S, Yin P, Jorgensen AL, et al. TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenet Genomics. 2017;27(6):213-222.</Citation>
        </Reference>
        <Reference>
          <Citation>Mukherjea D, Rybak LP. Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics. 2011;12:1039-1050.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang VY, Wang JJ. Pharmacogenetics of chemotherapy-induced cardiotoxicity. Curr Oncol Rep. 2018;20:52.</Citation>
        </Reference>
        <Reference>
          <Citation>Tripaydonis A, Conyers R, Elliott DA. Pediatric anthracycline-induced cardiotoxicity: mechanisms, pharmacogenomics, and pluripotent stem-cell modeling. Clin Pharmacol Ther. 2019;105:614-624.</Citation>
        </Reference>
        <Reference>
          <Citation>Chaudhari U, Nemade H, Wagh V, et al. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol. 2016;90:2763-2777.</Citation>
        </Reference>
        <Reference>
          <Citation>Huttenhower C, Gevers D, Knight R, et al. Human microbiome project consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207-214.</Citation>
        </Reference>
        <Reference>
          <Citation>Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887-894.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial eneterotypes. Science. 2001;334:105-108.</Citation>
        </Reference>
        <Reference>
          <Citation>Moeller AH, Li Y, Mpoudi Ngole E, et al. Rapid changes in the gut microbiome during human evolution. Proc Natl Acad Sci USA. 2014;111:16431-16435.</Citation>
        </Reference>
        <Reference>
          <Citation>Fulbright LE, Ellermann M, Arthur JC. The microbiome and the hallmarks of cancer. PLoS Pathog. 2017;13(9):e1006480.</Citation>
        </Reference>
        <Reference>
          <Citation>Rajagopala SV, Vashee S, Oldfield LM, et al. The human microbiome and cancer. Cancer Prev Res. 2017;10:226-234.</Citation>
        </Reference>
        <Reference>
          <Citation>Dapito DH, Mencin A, Gwak GY, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21:504-516.</Citation>
        </Reference>
        <Reference>
          <Citation>Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.</Citation>
        </Reference>
        <Reference>
          <Citation>Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120-123.</Citation>
        </Reference>
        <Reference>
          <Citation>Rajagopala SV, Yooseph S, Harkins DM, et al. Gastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosis. BMC Genomics. 2016;17:635.</Citation>
        </Reference>
        <Reference>
          <Citation>Han L, Jin H, Zhoui L, et al. Intestinal microbiota at engraftment influence acute graft-versus-host disease via the Treg/Th17 balance in ALL-HSCT recipients. Front Immunol. 2018;9:669.</Citation>
        </Reference>
        <Reference>
          <Citation>Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330:831-835.</Citation>
        </Reference>
        <Reference>
          <Citation>Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967-970.</Citation>
        </Reference>
        <Reference>
          <Citation>Vetizou M, Pitt JM, Daillere R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079-1084.</Citation>
        </Reference>
        <Reference>
          <Citation>Pitt JM, Vetizou M, Waldschmitt N, et al. Fine-tuning cancer immunotherapy: optimizing the gut microbiome. Cancer Res. 2016;76:4602-4607.</Citation>
        </Reference>
        <Reference>
          <Citation>Zimmerman M, Zimmerman-Kogadeeva M, Wegmann R, Goodman AL. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science. 2019;363. https://doi.org/10.1126/science.aat9931.</Citation>
        </Reference>
        <Reference>
          <Citation>Zimmerman M, Zimmerman-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacterai and their genes. Nature. 2019;570:462-467.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">32083374</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>31</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Carrying Ions Lucky Choices: The Story of My Life in Science by Jens Christian Skou Denmark University Press, Copenhagen, Denmark, 2016.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1260-1262</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201601351</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Franzini-Armstrong</LastName>
            <ForeName>Clara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cell and Developmental Biology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083374</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.201601351</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Libet, B. (1948) Adenosinetriphosphatase in nerve. Fed. Proc. 7, 72</Citation>
        </Reference>
        <Reference>
          <Citation>Post, R. L. (1974) A reminiscence about sodium, potassium-ATPase. Ann. N. Y. Acad. Sci. 242, 6-11</Citation>
        </Reference>
        <Reference>
          <Citation>Charnock, J. S., and Post, R. L. (1963) Evidence of the mechanism of ouabain inhibition of cation activated adenosine triphosphatase. Nature 199, 910-911</Citation>
        </Reference>
        <Reference>
          <Citation>Albers, R. W., Fahn, S., and Koval, G. J. (1963) The role of sodium ions in the activation of Electrophorus electric organ adenosine triphosphatase. Proc. Natl. Acad. Sci. USA 50, 474-481</Citation>
        </Reference>
        <Reference>
          <Citation>Post, R. L., Hegyvary, C., and Kume, S. (1972) Activation by adenine trisphosphate in the phosphorylation kinetics of sodium and potassium ion transport adenosine triphosphatase. J. Biol. Chem. 247, 6530-6540</Citation>
        </Reference>
        <Reference>
          <Citation>Glynn, I. M., Hara, Y., and Richards, D. E. (1984) The occlusion of sodium ions within the mammalian sodium-potassium pump: its role in sodium transport. J. Physiol. 351, 531-547</Citation>
        </Reference>
        <Reference>
          <Citation>Kielley, W. W., and Meyerhof, O. (1948) Studies on adenosinetriphosphatase of muscle; a new magnesium-activated a denosinetriphosphatase. J. Biol. Chem. 176, 591-601</Citation>
        </Reference>
        <Reference>
          <Citation>Hasselbach, W., and Makinose, M. (1961) Die Calciumpumpe der erschlaffungsgrana des Muskels und ihre Abhängigkeit von der ATP-Spalting. Biochem. Z. 333, 518-528</Citation>
        </Reference>
        <Reference>
          <Citation>Ebashi, S., and Lipmann, F. (1962) Adenosine triphosphate-linked concentration of calcium ions in a particulate fraction of rabbit muscle. J. Cell Biol. 14, 389-400</Citation>
        </Reference>
        <Reference>
          <Citation>Barton, K. N., and MacLennan, D. H. (2004) The proteins of the sarcotubular system. In Myology (Engel, A. G., and Franzini-Armstrong, C., eds.), pp. 307-324, McGraw Hill, New York</Citation>
        </Reference>
        <Reference>
          <Citation>Toyoshima, C., and Inesi, G. (2004) Structural basis of ion pumping by Ca2+-ATPase of the sarcoplasmic reticulum. Annu. Rev. Biochem. 73, 269-292</Citation>
        </Reference>
        <Reference>
          <Citation>Ogawa, H., Cornelius, F., Hirata, A., and Toyoshima, C. (2015) Sequential substitution of K(+) bound to Na(+), K(+)-ATPase visualized by X-ray crystallography. Nat. Commun. 6, 8004</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083375</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4876</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part C, Seminars in medical genetics</Title>
          <ISOAbbreviation>Am J Med Genet C Semin Med Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The state of congenital heart disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.c.31776</ELocationID>
        <Abstract>
          <AbstractText>In this special issue of the American Journal of Medical Genetics Part C, we focus on the "State of Congenital Heart Disease." We anticipate that after viewing this journal, the reader will be up-to-date on the epidemiology of congenital heart disease (CHD), the genetic basis of CHD, ethical concerns, and the global impact of CHD. And most importantly, we are confident that this special issue conveys the message that CHD is complex and that much work is still needed in genetic and genomic research.</AbstractText>
          <CopyrightInformation>Published 2020. This article is a U.S. Government work and is in the public domain in the USA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kruszka</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4949-0875</Identifier>
            <AffiliationInfo>
              <Affiliation>Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beaton</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4963-355X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, Ohio.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Cincinnati School of Medicine, Cincinnati, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet C Semin Med Genet</MedlineTA>
        <NlmUniqueID>101235745</NlmUniqueID>
        <ISSNLinking>1552-4868</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">congenital heart disease</Keyword>
        <Keyword MajorTopicYN="N">genetic syndromes</Keyword>
        <Keyword MajorTopicYN="N">genomics</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083375</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.c.31776</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Botto, L. (2020). From cause to care: How can better data improve global outcomes in congenital heart disease? American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Ekure, E. (2020). Congenital heart disease in school children in Lagos, Nigeria: Prevalence and the diagnostic gap. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Gabriel, G. C., &amp; Lo, C. W. (2020). Left-right patterning in congenital heart disease beyond heterotaxy. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Jerves, T., Beaton, A., &amp; Kruszka, P. (2019). The genetic workup for structural congenital heart disease. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Lalani, S. R. (2020). Other genomic disorders and congenital heart disease. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Lin, A. E., Santoro, S., High, F. A., Goldenberg, P., &amp; Gutmark-Little, I. (2019). Congenital heart defects associated with aneuploidy syndromes: New insights into familiar associations. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Linglart, L., &amp; Gelb, B.D. (2020). Congenital heart defe cts in Noonan syndrome: Diagnosis,management, and treatment. Am J Med Genet C Semin Med Genet, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Meisner, J. K., &amp; Martin, D. M. (2019). Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Nees, S. N., &amp; Chung, W. K. (2019). The genetics of isolated congenital heart disease. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Neubauer, K., &amp; Boss, R. D. (2020). Ethical considerations for cardiac surgical interventions in children with trisomy 13 and trisomy 18. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Zimmerman, M., &amp; Sable, C. (2020). Congenital heart disease in low-and-middle-income countries. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 184(1), [Epub ahead of print].</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083376</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1551-3793</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Integrated environmental assessment and management</Title>
          <ISOAbbreviation>Integr Environ Assess Manag</ISOAbbreviation>
        </Journal>
        <ArticleTitle>China's complex urban air pollution: an improved understanding with ground operational measurements.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ieam.4254</ELocationID>
        <Abstract>
          <AbstractText>Complex urban air quality has long been assessed by a single (or major) contaminant, e.g., fine particulate matter (PM<sub>2.5</sub> ), but scant attention has been given to multicontaminant air pollution, especially in countries with severe air pollution, e.g., China. We thus proposed an improved method for quantifying both single- and multicontaminant air pollution. Our approach uses China's major cities as an example, as they have an operational national urban air quality monitoring network. We found that our proposed method could remove the duplicated consideration under both single- and multicontaminant conditions, thus proving to be an improved and more accurate way to understand complex urban air pollution conditions. Our method involved monitoring three contaminants (PM<sub>2.5</sub> , PM<sub>10</sub> , and SO<sub>2</sub> ) in cities in Shanxi, Shandong, Henan, and Hebei Provinces and two contaminants (PM<sub>2.5</sub> and PM<sub>10</sub> ) in the cities between the Yellow River and the Yangtze River, and these pollutants were the major contributors to multicontaminant air pollution. We argue that both the research community and the government should pay increased attention to multicontaminant air pollution beyond the current single major pollutant-based air pollution method when building a sustainable city. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Lijian</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Weiqi</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weifeng</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qian</LastName>
            <ForeName>Yuguo</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Integr Environ Assess Manag</MedlineTA>
        <NlmUniqueID>101234521</NlmUniqueID>
        <ISSNLinking>1551-3777</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Air pollution</Keyword>
        <Keyword MajorTopicYN="N">Population exposure</Keyword>
        <Keyword MajorTopicYN="N">Trade-off</Keyword>
        <Keyword MajorTopicYN="N">Urbanization</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083376</ArticleId>
        <ArticleId IdType="doi">10.1002/ieam.4254</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083377</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1439-7641</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemphyschem : a European journal of chemical physics and physical chemistry</Title>
          <ISOAbbreviation>Chemphyschem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Anisotropic Dynamics of Binary Particles in Confined Geometries.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cphc.201901163</ELocationID>
        <Abstract>
          <AbstractText>The diffusion dynamics of colloidal particles in a good solvent confined between two parallel quartz walls have been studied within the framework of dynamical density functional theory. The highly ordered density layers induced by interfacial effects give rise to the oscillating dynamics, resulting in position-dependent structural relaxations and diffusivities. Further investigation reveals that particle size, particle-wall interaction, and slitpore width play different roles in affecting the oscillating behaviors along different directions. As a result, the theory yields the local mean square displacements in perpendicular and parallel directions, which agree remarkably well with prior experimental measurements. The results indicate that the mean square displacements can be quantitatively predicted based on the knowledge of inhomogeneous thermodynamics and dynamics. The local and averaged free energy evolution of the binary particles has been described and presented to understand their dynamic mechanism in confined geometry.</AbstractText>
          <CopyrightInformation>© 2020 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Kun</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Changzhou Institute of Advanced Materials, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yue</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Du</LastName>
            <ForeName>Zhongjie</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Changzhou Institute of Advanced Materials, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Chen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Changzhou Institute of Advanced Materials, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mi</LastName>
            <ForeName>Jianguo</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-6355-783X</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>BK20181160</GrantID>
            <Agency>Natural Science Foundation of Jiangsu Province</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chemphyschem</MedlineTA>
        <NlmUniqueID>100954211</NlmUniqueID>
        <ISSNLinking>1439-4235</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anisotropic dynamics</Keyword>
        <Keyword MajorTopicYN="N">confined geometries</Keyword>
        <Keyword MajorTopicYN="N">dynamic density functional theory</Keyword>
        <Keyword MajorTopicYN="N">mean square displacements</Keyword>
        <Keyword MajorTopicYN="N">structural relaxations</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083377</ArticleId>
        <ArticleId IdType="doi">10.1002/cphc.201901163</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>V. Turlo, O. Politano, F. Baras, Acta Mater. 2015, 99, 363-372.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Fathi, A. Raoof, S. H. Mansouri, J. Power Sources 2017, 349, 57-67.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Hu, K. Gopinadhan, A. Rakowski, M. Neek-Amal, T. Heine, I. V. Grigorieva, S. J. Haigh, A. K. Geim, Nat. Nanotechnol. 2018, 13, 468-472.</Citation>
        </Reference>
        <Reference>
          <Citation>R. B. Schoch, J. Han, P. Renaud, Rev. Mod. Phys. 2008, 80, 839.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Nygård, Phys. Chem. Chem. Phys. 2017, 19, 23632-23641.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Tang, J. Wu, Phys. Rev. E 2004, 70, 011201.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Zeng, J. Mi, C. Zhong, J. Phys. Chem. B 2010, 114, 3894-3901.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. X. Yu, A. W. Tian, G. H. Gao, Phys. Chem. Chem. Phys. 2005, 7, 2423-2428.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Köddermann, R. Ludwig, D. Paschek, ChemPhysChem 2008, 9, 1851-1858.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Ye, H. Qin, M. Tian, J. Mi, Chin. J. Polym. Sci. 2019, 37, 719-728.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Liu, E. Harder, B. J. Berne, J. Phys. Chem. B 2004, 108, 6595-6602.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Waichman, F. Roder, C. P. Richter, O. Birkholz, J. Piehler, Small 2013, 9, 570-577.</Citation>
        </Reference>
        <Reference>
          <Citation>J. H. Ortony, C. Y. Cheng, J. M. Franck, R. Kausik, A. Pavlova, J. Hunt, S. Han, New J. Phys. 2011, 13, 015006.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Kruk, P. Rochowski, E. Masiewicz, S. Wilczynski, M. Wojciechowski, L. M. Broche, D. J. Lurie, ChemPhysChem 2019, 20, 1-8.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Nygård, J. Buitenhuis, M. Kagias, K. Jefimovs, F. Zontone, Y. Chushkin, Phys. Rev. Lett. 2016, 116, 167801.</Citation>
        </Reference>
        <Reference>
          <Citation>J. A. Bollinger, A. Jain, T. M. Truskett, J. Phys. Chem. B 2014, 119, 9103-9113.</Citation>
        </Reference>
        <Reference>
          <Citation>L. B. Krott, M. C. Barbosa, Phys. Rev. E 2014, 89, 012110.</Citation>
        </Reference>
        <Reference>
          <Citation>B. J. Borah, P. K. Maiti, C. Chakravarty, S. Yashonath, J. Chem. Phys. 2012, 136, 174510.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Mittal, T. M. Truskett, J. R. Errington, Phys. Rev. Lett. 2008, 100, 145901.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Pal, M. Vogel, ChemPhysChem 2017, 18, 2233-2242.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Inui, Phys. Rev. E 2019, 99, 022102.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Berthier, G. Biroli, Rev. Mod. Phys. 2011, 83, 587.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Lang, V. Bota̧n, M. Oettel, D. Hajnal, T. Franosch, R. Schilling, Phys. Rev. Lett. 2010, 105, 125701.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Pastore, M. P. Ciamarra, A. de Candia, A. Coniglio, Phys. Rev. Lett. 2011, 107, 065703.</Citation>
        </Reference>
        <Reference>
          <Citation>P. S. Burada, P. Hänggi, F. Marchesoni, G. Schmid, P. Talkner, ChemPhysChem 2009, 10, 45-54.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Nayar, C. Chakravarty, Phys. Chem. Chem. Phys. 2013, 15, 14162-14177.</Citation>
        </Reference>
        <Reference>
          <Citation>J. C. Dyre, J. Phys. Chem. B 2014, 118, 10007-10024.</Citation>
        </Reference>
        <Reference>
          <Citation>M. J. Pond, J. R. Errington, T. M. Truskett, J. Chem. Phys. 2011, 134, 081101.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Varnik, T. Franosch, J. Phys. Condens. Matter 2016, 28, 133001.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Juárez-Maldonado, M. Medina-Noyola, Phys. Rev. E 2008, 77, 051503.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Hernandez-Contreras, M. Medina-Noyola, A. Vizcarra-Rendón, Physica A 1996, 234, 271-310.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Lang, R. Schilling, V. Krakoviack, T. Franosch, Phys. Rev. E 2012, 86, 021502.</Citation>
        </Reference>
        <Reference>
          <Citation>V. Krakoviack, Phys. Rev. Lett. 2005, 94, 065703.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Lang, R. Schilling, T. Franosch, Phys. Rev. E 2014, 90, 062126.</Citation>
        </Reference>
        <Reference>
          <Citation>S. König, T. M. Bayerl, G. Coddens, D. Richter, E. Sackmann, Biophys. J. 1995, 68, 1871-1880.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Rex, H. Löwen, Phys. Rev. Lett. 2008, 101, 148302.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Español, H. Löwen, J. Chem. Phys. 2009, 131, 244101.</Citation>
        </Reference>
        <Reference>
          <Citation>C. R. Nugent, K. V. Edmond, H. N. Patel, E. R. Weeks, Phys. Rev. Lett. 2007, 99, 025702.</Citation>
        </Reference>
        <Reference>
          <Citation>J. F. M. Lodge, D. M. Heyes, Mol. Simul. 1999, 23, 203-241.</Citation>
        </Reference>
        <Reference>
          <Citation>W. A. Steele, Surface Sci. 1973, 36, 317-352.</Citation>
        </Reference>
        <Reference>
          <Citation>I. K. Nook, W. van Megen, J. Chem. Phys. 1980, 72, 2907-2913.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Svaneborg, H. A. Karimi-Varzaneh, N. Hojdis, F. Fleck, R. Everaers, arXiv preprint arXiv: 1808.03509, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>O. G. Jepps, S. K. Bhatia, D. J. Searles, Phys. Rev. Lett. 2003, 91, 126102.</Citation>
        </Reference>
        <Reference>
          <Citation>F. F. Abraham, J. Chem. Phys. 1978, 68, 3713-3716.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Evans, Adv. Phys. 1979, 28, 143-200.</Citation>
        </Reference>
        <Reference>
          <Citation>U. M. B. Marconi, P. Tarazona, J. Phys. Condens. Matter 2000, 12, A413.</Citation>
        </Reference>
        <Reference>
          <Citation>A. J. Archer, R. Evans, J. Chem. Phys. 2004, 121, 4246-4254.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Ye, N. Ning, M. Tian, L. Zhang, J. Mi, J. Phys. Chem. C 2019, 123, 22529-22538.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Rosenfeld, Phys. Rev. Lett. 1989, 63, 980.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. X. Yu, J. Z. Wu, Y. X. Xin, G. H. Gao, J. Chem. Phys. 2004, 121, 1535-1541.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. X. Yu, J. Wu, J. Chem. Phys. 2002, 117, 10156-10164.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Leidl, H. Wagner, J. Chem. Phys. 1993, 98, 4142-4148.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Mi, Y. Tang, C. Zhong, J. Chem. Phys. 2008, 128, 054503.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Tang, Mol. Phys. 2002, 100, 1033-1047.</Citation>
        </Reference>
        <Reference>
          <Citation>J. P. Hansen, I. R. McDonald, Academic Press 1986.</Citation>
        </Reference>
        <Reference>
          <Citation>A. J. Archer, J. Phys. Condens. Matter 2006, 18, 5617.</Citation>
        </Reference>
        <Reference>
          <Citation>J. K. Percus, Phys. Rev. Lett. 1962, 8, 462.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Stopper, K. Marolt, R. Roth, H. Hansen-Goos, Phys. Rev. E 2015, 92, 022151.</Citation>
        </Reference>
        <Reference>
          <Citation>P. M. Reis, R. A. Ingale, M. D. Shattuck, Phys. Rev. Lett. 2007, 98, 188301.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Morineau, Y. Xia, C. Alba-Simionesco, J. Chem. Phys. 2002, 117, 8966-8972.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Shin, A. G. Cherstvy, R. Metzler, New J. Phys. 2015, 17, 113028.</Citation>
        </Reference>
        <Reference>
          <Citation>H. B. Eral, D. van den Ende, F. Mugele, M. H. G. Duits, Phys. Rev. E 2009, 80, 061403.</Citation>
        </Reference>
        <Reference>
          <Citation>K. V. Edmond, C. R. Nugent, E. R. Weeks, Euro. Phys. J. - Spec. Top. 2010, 189, 83-93.</Citation>
        </Reference>
        <Reference>
          <Citation>C. A. Angell, J. Phys. Condens. Matter 2000, 12, 6463.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083378</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-5224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Veterinary ophthalmology</Title>
          <ISOAbbreviation>Vet Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of partial tarsal plate excision using a transconjunctival approach for the treatment of distichiasis in dogs.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/vop.12748</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the clinical outcome, possible complications, and recurrence rate of distichiasis in dogs treated with partial tarsal plate excision (PTPE) technique using a transconjunctival approach.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective study including 17 client-owned canine patients affected with distichiasis and presenting with associated clinical signs (ie, blepharospasm, epiphora, chronic keratoconjunctivitis, or corneal ulceration) that underwent surgical removal of the aberrant lashes using a PTPE technique between January 2018 and February 2019. Data collected included breed, age, sex, affected eyelid(s), number of distichia, and tear film breakup time (TBUT). Resected cilia-bearing tarsoconjunctival strips were submitted for histopathological analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty eyes (52 eyelids) from 17 dogs were included in the study. The median age was 688 days (range 118-4243 days). A successful outcome, defined as complete resolution of clinical signs attributable to the distichia, occurred in all eyes after a single procedure, with a mean follow-up time of 239 days (range 69-480 days). Appearance of new distichia occurred in 14/30 eyes (46.3%), and of these, three eyes needed a new PTPE procedure. Recurrence of the distichia only occurred in one eye (3.3%) which was asymptomatic. Following surgery, TBUT decreased below the normal value in 7/24 eyes (29.1%) although none developed clinical signs of qualitative tear film deficiency. Post-operative complications included trichiasis and cicatricial entropion, which developed in two eyes (6.6%), and these were successfully managed with corrective eyelid surgery.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Partial tarsal plate excision, using a transconjunctival approach, had an excellent clinical outcome with a low incidence of complications.</AbstractText>
          <CopyrightInformation>© 2020 American College of Veterinary Ophthalmologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Palella Gómez</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7909-481X</Identifier>
            <AffiliationInfo>
              <Affiliation>Willows Veterinary Centre &amp; Referral Service, Solihull, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazzucchelli</LastName>
            <ForeName>Samuela</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Willows Veterinary Centre &amp; Referral Service, Solihull, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scurrell</LastName>
            <ForeName>Emma</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Cytopath Ltd, Ledbury, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Kinley</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Willows Veterinary Centre &amp; Referral Service, Solihull, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pinheiro de Lacerda</LastName>
            <ForeName>Rodrigo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Willows Veterinary Centre &amp; Referral Service, Solihull, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Vet Ophthalmol</MedlineTA>
        <NlmUniqueID>100887377</NlmUniqueID>
        <ISSNLinking>1463-5216</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">distichia</Keyword>
        <Keyword MajorTopicYN="N">dog</Keyword>
        <Keyword MajorTopicYN="N">eyelid</Keyword>
        <Keyword MajorTopicYN="N">meibomian gland</Keyword>
        <Keyword MajorTopicYN="N">tarsal plate excision</Keyword>
        <Keyword MajorTopicYN="N">transconjunctival</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083378</ArticleId>
        <ArticleId IdType="doi">10.1111/vop.12748</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Lawson DD. Canine distichiasis. J Small Anim Pract. 1973;14(8):469-478.</Citation>
        </Reference>
        <Reference>
          <Citation>Bedford PG. Eyelashes and adventitious cilia as causes of corneal irritation. J Small Anim Pract. 1971 Jan;12(1):11-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Bedford P. Conditions of the eyelids in the dog. J Small Anim Pract. 1988;29(7):416-428.</Citation>
        </Reference>
        <Reference>
          <Citation>Grahn BHWJ. Diagnostic ophthalmology. Distichiasis and uveal cysts. Canine. Vet J. 1997;38(6):38-39.</Citation>
        </Reference>
        <Reference>
          <Citation>Raymond-Letron I, Bourges-Abella N, Rousseau T, Douet JY, de Geyer G. Histopathologic features of canine distichiasis. Vet Ophthalmol. 2012;15(2):92-97.</Citation>
        </Reference>
        <Reference>
          <Citation>D´Anna N, Sapienza JS, Guandalini A. Use of a dermal biopsy punch for removal of ectopic cilia in dogs: 19 Cases. Vet Ophthalmol. 2007;10(1):65-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Verboven CA, Djajadiningrat-Laanen SC, Kitslaar WJ, Grinwis GC, Schoemaker NJ. Distichiasis in a ferret (Mustela putorius furo). Vet Ophthalmol. 2014;17(4):290-293.</Citation>
        </Reference>
        <Reference>
          <Citation>Utter ME, Wotman KL. Distichiasis causing recurrent corneal ulceration in two Friesian horses. Equine Vet Educ. 2012;24(11):556-560.</Citation>
        </Reference>
        <Reference>
          <Citation>Hermans H, Ensink JM. Treatment and long-term follow-up of distichiasis, with special reference to the Friesian horse: A case series. Equine Vet J. 2014;46(4):458-462.</Citation>
        </Reference>
        <Reference>
          <Citation>Reinstein SL, Gross SL, Komáromy AM. Successful treatment of distichiasis in a cat using transconjunctival electrocautery. Vet Ophthalmol. 2011;14(Suppl. 1):130-134.</Citation>
        </Reference>
        <Reference>
          <Citation>Krecny M, Tichy A, Rushton J, Nell B. A retrospective survey of ocular abnormalities in pugs: 130 cases. J Small Anim Pract. 2015;56(2):96-102.</Citation>
        </Reference>
        <Reference>
          <Citation>Petersen T, Proschowsky HF, Hardon T, Rasch SN, Fredholm M. Prevalence and heritability of distichiasis in the English Cocker spaniel. Canine Genet Epidemiol. 2015;2(1):11.</Citation>
        </Reference>
        <Reference>
          <Citation>Zimmerman KL, Reinstein SL. Evaluation of transconjunctival thermal electrocautery for treatment of canine distichiasis: 88 eyelids (2013-2016). Vet Ophthalmol. 2019;22(1):50-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Chambers ED, Slatter DH. Cryotherapy (N2O) of canine distichiasis and trichiasis: an experimental and clinical report. J Small Anim Pract. 1984;25(11):647-659.</Citation>
        </Reference>
        <Reference>
          <Citation>Bedford P. Distichiasis and its treatment by the method of partial tarsal plate excision. J Small Anim Pract. 1973;14(1):1-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Long RD. Treatment of distichiasis by conjunctival resection. J Small Anim Pract. 1991;32(3):146-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Labelle AL, Dresser CB, Hamor RE, Allender MC, Disney JL. Characteristics of, prevalence of, and risk factors for corneal pigmentation (pigmentary keratopathy) in Pugs. J Am Vet Med Assoc. 2013;243(5):667-674.</Citation>
        </Reference>
        <Reference>
          <Citation>Wheeler CA, Severin GA. Cryosurgical epilation for the treatment of distichiasis in the dog and cat. J Am Anim Hosp Assoc. 1984;20:877-884.</Citation>
        </Reference>
        <Reference>
          <Citation>Stades F, Van der Woerdt A. Diseases and surgery of the Canine Eyelid. In: Gelatt KN, Gilger BC, Kern TJ, eds. Veterinry Ophthalmology, 5th edn. Ames, Iowa: Blackwell Publishing; 2013:840-843.</Citation>
        </Reference>
        <Reference>
          <Citation>Moore CP. Qualitative Tear Film Disease. Vet Clin North Am Small Anim Pract. 1990;20(3):565-581.</Citation>
        </Reference>
        <Reference>
          <Citation>Isreb MA, Greiner JV, Korb DR, Glonek T, Mody SS. Finnemore VM Reddy CV. Correlation of lipid layer thickness measurements with fluorescein tear film break-up time and Schirmer's test. Eye J. 2003;17(1):79-83.</Citation>
        </Reference>
        <Reference>
          <Citation>Ofri R, Orgad K, Kass PH, Dikstein S. Canine meibometry: Establishing baseline values for meibomian gland secretions in dogs. Vet J. 2007;174(3):536-540.</Citation>
        </Reference>
        <Reference>
          <Citation>Benz P, Tichy A, Nell B. Review of the measuring precision of the new Meibometer ® MB550 through repeated measurements in dogs. Vet Ophthalmol. 2008;11(6):368-374.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083380</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1542-2011</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of midwifery &amp; women's health</Title>
          <ISOAbbreviation>J Midwifery Womens Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Refining Trauma-Informed Perinatal Care for Urban Prenatal Care Patients with Multiple Lifetime Traumatic Exposures: A Qualitative Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jmwh.13063</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Because lifetime trauma exposure has been linked to multiple adverse pregnancy outcomes, there is a need for all perinatal care providers to be versed in trauma-informed care practices. However, there are few data to guide trauma-informed practice during the perinatal period. The objective of this study was to refine ongoing development of a trauma-informed care framework for perinatal care by conducting a qualitative study of all trauma experiences and preferred screening practices of pregnant patients at an urban prenatal clinic.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this qualitative study, we conducted semistructured interviews with 30 women receiving prenatal care at an urban clinic. Participants also completed a trauma history questionnaire. Inductive coding was used to generate themes and subthemes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants described multiple lifetime traumatic exposures as well as background exposure to community violence. Not all participants desired routine trauma screening; factors limiting disclosure included fear of retraumatization and belief that prior trauma is unrelated to the current pregnancy. Strong therapeutic relationships were identified as critical to any trauma history discussion.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This study supports a trauma-informed care approach to caring for pregnant women with prior traumatic exposures, including trauma screening without retraumatization and trusting patient-provider relationships.</AbstractText>
          <CopyrightInformation>© 2020 by the American College of Nurse-Midwives.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gokhale</LastName>
            <ForeName>Priyanka</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1981-3656</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Young</LastName>
            <ForeName>Maria R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>Makayla N</ForeName>
            <Initials>MN</Initials>
            <AffiliationInfo>
              <Affiliation>Saint Louis University School of Medicine, Saint Louis, Missouri.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reid</LastName>
            <ForeName>Shayla N</ForeName>
            <Initials>SN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tom</LastName>
            <ForeName>Laura S</ForeName>
            <Initials>LS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Brian</LastName>
            <ForeName>Catherine A</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simon</LastName>
            <ForeName>Melissa A</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9021-7315</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>UL1TR001422</GrantID>
            <Agency>National Institutes of Health's National Center for Advancing Translational Sciences</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Midwifery Womens Health</MedlineTA>
        <NlmUniqueID>100909407</NlmUniqueID>
        <ISSNLinking>1526-9523</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adult survivors of child adverse events</Keyword>
        <Keyword MajorTopicYN="N">exposure to violence</Keyword>
        <Keyword MajorTopicYN="N">midwifery</Keyword>
        <Keyword MajorTopicYN="N">obstetrics</Keyword>
        <Keyword MajorTopicYN="N">psychological trauma</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083380</ArticleId>
        <ArticleId IdType="doi">10.1111/jmwh.13063</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Forman-Hoffman VL, Bose J, Batts KR, et al. Correlates of lifetime exposure to one or more potentially traumatic events and subsequent posttraumatic stress among adults in the United States: results from the Mental Health Surveillance Study, 2008-2012. In: CBHSQ Data Review. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2012:1-49.</Citation>
        </Reference>
        <Reference>
          <Citation>McFarlane AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry. 2010;9(1):3-10.</Citation>
        </Reference>
        <Reference>
          <Citation>White A, Danis M, Gillece J. Abuse survivor perspectives on trauma inquiry in obstetrical practice. Arch Womens Ment Health. 2016;19(2):423-427.</Citation>
        </Reference>
        <Reference>
          <Citation>Alhusen JL, Ray E, Sharps P, Bullock L. Intimate partner violence during pregnancy: maternal and neonatal outcomes. J Womens Health. 2015;24(1):100-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Silverman JG, Decker MR, Reed E, Raj A. Intimate partner violence victimization prior to and during pregnancy among women residing in 26 U.S. states: associations with maternal and neonatal health. Am J Obstet Gynecol. 2006;195(1):140-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Collins JW, Jr., David RJ. Urban violence and African-American pregnancy outcome: an ecologic study. Ethn Dis. 1997;7(3):184-190.</Citation>
        </Reference>
        <Reference>
          <Citation>Masi CM, Hawkley LC, Piotrowski ZH, Pickett KE. Neighborhood economic disadvantage, violent crime, group density, and pregnancy outcomes in a diverse, urban population. Soc Sci Med. 2007;65(12):2440-2457.</Citation>
        </Reference>
        <Reference>
          <Citation>Messer LC, Kaufman JS, Dole N, Savitz DA, Laraia BA. Neighborhood crime, deprivation, and preterm birth. Ann Epidemiol. 2006;16(6):455-462.</Citation>
        </Reference>
        <Reference>
          <Citation>Messer LC, Kaufman JS, Dole N, Herring A, Laraia BA. Violent crime exposure classification and adverse birth outcomes: a geographically-defined cohort study. Int J Health Geogr. 2006;5:22.</Citation>
        </Reference>
        <Reference>
          <Citation>Shaw JG, Asch SM, Kimerling R, Frayne SM, Shaw KA, Phibbs CS. Posttraumatic stress disorder and risk of spontaneous preterm birth. Obstet Gynecol. 2014;124(6):1111-1119.</Citation>
        </Reference>
        <Reference>
          <Citation>Yonkers KA, Smith MV, Forray A, et al. Pregnant women with posttraumatic stress disorder and risk of preterm birth. JAMA Psychiatry. 2014;71(8):897-904.</Citation>
        </Reference>
        <Reference>
          <Citation>Seng JS, Low LK, Sperlich M, Ronis DL, Liberzon I. Post-traumatic stress disorder, child abuse history, birthweight and gestational age: a prospective cohort study. BJOG. 2011;118(11):1329-1339.</Citation>
        </Reference>
        <Reference>
          <Citation>Nijenhuis ER, van der Hart O. Dissociation in trauma: a new definition and comparison with previous formulations. J Trauma Dissociation. 2011;12(4):416-445.</Citation>
        </Reference>
        <Reference>
          <Citation>Substance Abuse and Mental Health Services Administration. SAMHSA's Concept of Trauma and Guidance for a Trauma-Informed Approach. HHS Publication No. (SMA) 14-4884. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Bloom T, Glass N, Curry MA, Hernandez R, Houck G. Maternal stress exposures, reactions, and priorities for stress reduction among low-income, urban women. J Midwifery Womens Health. 2013;58(2):167-174.</Citation>
        </Reference>
        <Reference>
          <Citation>Sperlich M, Seng JS, Li Y, Taylor J, Bradbury-Jones C. Integrating trauma-informed care into maternity care practice: conceptual and practical issues. J Midwifery Womens Health. 2017;62(6):661-672.</Citation>
        </Reference>
        <Reference>
          <Citation>Hooper LM, Stockton P, Krupnick JL, Green BL. Development, use, and psychometric properties of the trauma history questionnaire. J Loss Trauma. 2010;16(3):258-283.</Citation>
        </Reference>
        <Reference>
          <Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.</Citation>
        </Reference>
        <Reference>
          <Citation>Corbin J, Strauss A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. 4th ed. Thousand Oaks, CA: Sage Publications; 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Intl J Qual Methods. 2006;5(1):80-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Chicago Police Department. CLEARMAP: Citizen Law Enforcement Analysis and Protection; 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Muzik M, Ads M, Bonham C, Rosenblum KL, Broderick A, Kirk R. Perspectives on trauma-informed care from mothers with a history of childhood maltreatment: a qualitative study. Child Abuse Negl. 2013;37(12):1215-1224.</Citation>
        </Reference>
        <Reference>
          <Citation>Seng JS, Sparbel, KJ, Low, LK, Killion, C. Abuse-related posttraumatic stress and desired maternity care practices: women's perspectives. J Midwifery Womens Health. 2002;47(5):360-370.</Citation>
        </Reference>
        <Reference>
          <Citation>ACOG committee opinion no. 518: intimate partner violence. Obstet Gynecol 2012;119(2 Pt 1):412-417.</Citation>
        </Reference>
        <Reference>
          <Citation>ACOG committee opinion no. 777: sexual assault. Obstet Gynecol 2019;133(4):e296-e302.</Citation>
        </Reference>
        <Reference>
          <Citation>American College of Obstetricians and Gynecologists. Committee opinion no. 554: reproductive and sexual coercion. Obstet Gynecol 2013;121(2 Pt 1):411-415.</Citation>
        </Reference>
        <Reference>
          <Citation>Namey E, Guest G, McKenna K, Chen M. Evaluating bang for the buck: a cost-effectiveness comparison between individual interviews and focus groups based on thematic saturation levels. Am J Eval. 2016;37(3):425-440.</Citation>
        </Reference>
        <Reference>
          <Citation>Keeling J, Mason T. Postnatal disclosure of domestic violence: comparison with disclosure in the first trimester of pregnancy. J Clin Nurs. 2011;20(1-2):103-110.</Citation>
        </Reference>
        <Reference>
          <Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083379</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0193</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human brain mapping</Title>
          <ISOAbbreviation>Hum Brain Mapp</ISOAbbreviation>
        </Journal>
        <ArticleTitle>White matter extension of the Melbourne Children's Regional Infant Brain atlas: M-CRIB-WM.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hbm.24948</ELocationID>
        <Abstract>
          <AbstractText>Brain atlases providing standardised identification of neonatal brain regions are key in investigating neurological disorders of early childhood. Our previously developed Melbourne Children's Regional Infant Brain (M-CRIB) and M-CRIB 2.0 neonatal brain atlases provide standardised parcellation of 100 brain regions including cortical, subcortical, and cerebellar regions. The aim of this study was to extend M-CRIB atlas coverage to include 54 white matter (WM) regions. Participants were 10 healthy term-born neonates that were used to create the initial M-CRIB atlas. WM regions were manually segmented based on T<sub>2</sub> images and co-registered diffusion tensor imaging-based, direction-encoded colour maps. Our labelled regions imitate the Johns Hopkins University neonatal atlas, with minor anatomical modifications. All segmentations were reviewed and approved by a paediatric radiologist and a neurosurgery research fellow for anatomical accuracy. The resulting neonatal WM atlas comprises 54 WM regions: 24 paired regions, and six unpaired regions comprising five corpus callosum subdivisions, and one pontine crossing tract. Detailed protocols for manual WM parcellations are provided, and the M-CRIB-WM atlas is presented together with the existing M-CRIB cortical, subcortical, and cerebellar parcellations in 10 individual neonatal MRI data sets. The novel M-CRIB-WM atlas, along with the M-CRIB cortical and subcortical atlases, provide neonatal whole brain MRI coverage in the first multi-subject manually parcellated neonatal atlas compatible with atlases commonly used at older time points. The M-CRIB-WM atlas is publicly available, providing a valuable tool that will help facilitate neuroimaging research into neonatal brain development in both healthy and diseased states.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Alexander</LastName>
            <ForeName>Bonnie</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1108-5890</Identifier>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Joseph Yuan-Mou</ForeName>
            <Initials>JY</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4081-7157</Identifier>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yao</LastName>
            <ForeName>Sarah Hui Wen</ForeName>
            <Initials>SHW</Initials>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Monash School of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Michelle Hao</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Imaging, Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kelly</LastName>
            <ForeName>Claire E</ForeName>
            <Initials>CE</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6564-0872</Identifier>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ball</LastName>
            <ForeName>Gareth</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3509-1435</Identifier>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matthews</LastName>
            <ForeName>Lillian G</ForeName>
            <Initials>LG</Initials>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seal</LastName>
            <ForeName>Marc L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anderson</LastName>
            <ForeName>Peter J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doyle</LastName>
            <ForeName>Lex W</ForeName>
            <Initials>LW</Initials>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Newborn research, Royal Women's Hospital, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheong</LastName>
            <ForeName>Jeanie L Y</ForeName>
            <Initials>JLY</Initials>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Newborn research, Royal Women's Hospital, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spittle</LastName>
            <ForeName>Alicia J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Newborn research, Royal Women's Hospital, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiotherapy, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thompson</LastName>
            <ForeName>Deanne K</ForeName>
            <Initials>DK</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8017-5756</Identifier>
            <AffiliationInfo>
              <Affiliation>Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Victorian Infant Brain Studies, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>University of Melbourne</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Royal Children's Hospital Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1024516</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1028822</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1153176</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1060733</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>546519</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1081288</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1053787</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1053767</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1012236</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1108714</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1085754</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>1160003</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hum Brain Mapp</MedlineTA>
        <NlmUniqueID>9419065</NlmUniqueID>
        <ISSNLinking>1065-9471</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MRI</Keyword>
        <Keyword MajorTopicYN="N">atlas</Keyword>
        <Keyword MajorTopicYN="N">neonatal</Keyword>
        <Keyword MajorTopicYN="N">parcellation</Keyword>
        <Keyword MajorTopicYN="N">white matter</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083379</ArticleId>
        <ArticleId IdType="doi">10.1002/hbm.24948</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Akhondi-Asl, A., Hoyte, L., Lockhart, M. E., &amp; Warfield, S. K. (2014). A logarithmic opinion pool based STAPLE algorithm for the fusion of segmentations with associated reliability weights. IEEE Transactions on Medical Imaging, 33(10), 1997-2009. https://doi.org/10.1109/TMI.2014.2329603</Citation>
        </Reference>
        <Reference>
          <Citation>Akhondi-Asl, A., &amp; Warfield, S. K. (2013). Simultaneous truth and performance level estimation through fusion of probabilistic segmentations. IEEE Transactions on Medical Imaging, 32(10), 1840-1852.</Citation>
        </Reference>
        <Reference>
          <Citation>Alexander, B., Kelly, C. E., Adamson, C., Beare, R., Zannino, D., Chen, J., … Thompson, D. K. (2019). Changes in neonatal regional brain volume associated with preterm birth and perinatal factors. NeuroImage, 185, 654-663. https://doi.org/10.1016/j.neuroimage.2018.07.021</Citation>
        </Reference>
        <Reference>
          <Citation>Alexander, B., Murray, A. L., Loh, W. Y., Matthews, L. G., Adamson, C., Beare, R., … Thompson, D. K. (2017). A new neonatal cortical and subcortical brain atlas: The Melbourne Children's regional infant brain (M-CRIB) atlas. NeuroImage, 147, 841-851. https://doi.org/10.1016/j.neuroimage.2016.09.068</Citation>
        </Reference>
        <Reference>
          <Citation>Anderson, P. J., Cheong, J. L., &amp; Thompson, D. K. (2015). The predictive validity of neonatal MRI for neurodevelopmental outcome in very preterm children. Seminars in Perinatology, 39(2), 147-158 WB Saunders.</Citation>
        </Reference>
        <Reference>
          <Citation>Avants, B. B., Epstein, C. L., Grossman, M., &amp; Gee, J. C. (2008). Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Medical Image Analysis, 12(1), 26-41. https://doi.org/10.1016/j.media.2007.06.004</Citation>
        </Reference>
        <Reference>
          <Citation>Avants, B. B., Tustison, N. J., Song, G., Cook, P. A., Klein, A., &amp; Gee, J. C. (2011). A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage, 54(3), 2033-2044. https://doi.org/10.1016/j.neuroimage.2010.09.025</Citation>
        </Reference>
        <Reference>
          <Citation>Beare, R., Chen, J., Alexopoulos, D., Kelly, C. E., Smyser, C., Rogers, C., … Thompson, D. K. (2016). Neonatal brain tissue classification with morphological adaptation and unified segmentation. Frontiers in Neuroinformatics, 10, 12. https://doi.org/10.3389/fninf.2016.00012</Citation>
        </Reference>
        <Reference>
          <Citation>Blesa, M., Serag, A., Wilkinson, A. G., Anblagan, D., Telford, E. J., Pataky, R., … Boardman, J. P. (2016). Parcellation of the healthy neonatal brain into 107 regions using atlas propagation through intermediate time points in childhood. Frontiers in Neuroscience, 10, 220. https://doi.org/10.3389/fnins.2016.00220</Citation>
        </Reference>
        <Reference>
          <Citation>Chang, L., Oishi, K., Skranes, J., Buchthal, S., Cunningham, E., Yamakawa, R., … Cloak, C. (2016). Sex-specific alterations of white matter developmental trajectories in infants with prenatal exposure to methamphetamine and tobacco. JAMA Psychiatry, 73(12), 1217-1227.</Citation>
        </Reference>
        <Reference>
          <Citation>Choi, C. Y., Han, S. R., Yee, G. T., &amp; Lee, C. H. (2010). An understanding of the temporal stem. Journal of Korean Neurosurgical Association, 47(5), 365-369. https://doi.org/10.3340/jkns.2010.47.5.365</Citation>
        </Reference>
        <Reference>
          <Citation>Croxson, P. L., Forkel, S. J., Cerliani, L., &amp; Thiebaut de Schotten, M. (2018). Structural variability across the primate brain: A cross-species comparison. Cerebral Cortex, 28(11), 3829-3841.</Citation>
        </Reference>
        <Reference>
          <Citation>de Macedo Rodrigues, K., Ben-Avi, E., Sliva, D. D., Choe, M. S., Drottar, M., Wang, R., … Zollei, L. (2015). A FreeSurfer-compliant consistent manual segmentation of infant brains spanning the 0-2 year age range. Frontiers in Human Neuroscience, 9, 21. https://doi.org/10.3389/fnhum.2015.00021</Citation>
        </Reference>
        <Reference>
          <Citation>Desikan, R. S., Segonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., … Killiany, R. J. (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage, 31(3), 968-980. https://doi.org/10.1016/j.neuroimage.2006.01.021</Citation>
        </Reference>
        <Reference>
          <Citation>Dickie, D. A., Shenkin, S. D., Anblagan, D., Lee, J., Blesa Cabez, M., Rodriguez, D., … Wardlaw, J. M. (2017). Whole brain magnetic resonance image atlases: A systematic review of existing atlases and caveats for use in population imaging. Frontiers in Neuroinformatics, 11, 1. https://doi.org/10.3389/fninf.2017.00001</Citation>
        </Reference>
        <Reference>
          <Citation>Dubois, J., Dehaene-Lambertz, G., Kulikova, S., Poupon, C., Huppi, P. S., &amp; Hertz-Pannier, L. (2014). The early development of brain white matter: A review of imaging studies in fetuses, newborns and infants. Neuroscience, 276, 48-71. https://doi.org/10.1016/j.neuroscience.2013.12.044</Citation>
        </Reference>
        <Reference>
          <Citation>Ebeling, U., &amp; von Cramon, D. (1992). Topography of the uncinate fascicle and adjacent temporal fiber tracts. Acta Neurochirurgica, 115(3-4), 143-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Feng, L., Li, H., Oishi, K., Mishra, V., Song, L., Peng, Q., … Lee, L. (2019). Age-specific gray and white matter DTI atlas for human brain at 33, 36 and 39 postmenstrual weeks. NeuroImage, 185, 685-698.</Citation>
        </Reference>
        <Reference>
          <Citation>Fillmore, P. T., Richards, J. E., Phillips-Meek, M. C., Cryer, A., &amp; Stevens, M. (2015). Stereotaxic magnetic resonance imaging brain atlases for infants from 3 to 12 months. Developmental Neuroscience, 37(6), 515-532. https://doi.org/10.1159/000438749</Citation>
        </Reference>
        <Reference>
          <Citation>Forkel, S. J., Thiebaut de Schotten, M., Kawadler, J. M., Dell'Acqua, F., Danek, A., &amp; Catani, M. (2014). The anatomy of fronto-occipital connections from early blunt dissections to contemporary tractography. Cortex, 56, 73-84. https://doi.org/10.1016/j.cortex.2012.09.005</Citation>
        </Reference>
        <Reference>
          <Citation>Gousias, I. S., Edwards, A. D., Rutherford, M. A., Counsell, S. J., Hajnal, J. V., Rueckert, D., &amp; Hammers, A. (2012). Magnetic resonance imaging of the newborn brain: Manual segmentation of labelled atlases in term-born and preterm infants. NeuroImage, 62(3), 1499-1509. https://doi.org/10.1016/j.neuroimage.2012.05.083</Citation>
        </Reference>
        <Reference>
          <Citation>Greve, D. N., &amp; Fischl, B. (2009). Accurate and robust brain image alignment using boundary-based registration. NeuroImage, 48(1), 63-72. https://doi.org/10.1016/j.neuroimage.2009.06.060</Citation>
        </Reference>
        <Reference>
          <Citation>Heckemann, R. A., Hajnal, J. V., Aljabar, P., Rueckert, D., &amp; Hammers, A. (2006). Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. NeuroImage, 33(1), 115-126. https://doi.org/10.1016/j.neuroimage.2006.05.061</Citation>
        </Reference>
        <Reference>
          <Citation>Heemskerk, A. M., Leemans, A., Plaisier, A., Pieterman, K., Lequin, M. H., &amp; Dudink, J. (2013). Acquisition guidelines and quality assessment tools for analyzing neonatal diffusion tensor MRI data. AJNR American Journal of Neuroradiology, 34(8), 1496-1505. https://doi.org/10.3174/ajnr.A3465</Citation>
        </Reference>
        <Reference>
          <Citation>Hirsch, W. L., Kemp, S. S., Martinez, A. J., Curtin, H., Latchaw, R. E., &amp; Wolf, G. (1989). Anatomy of the brainstem: Correlation of in vitro MR images with histologic sections. AJNR American Journal of Neuroradiology, 10(5), 923-928.</Citation>
        </Reference>
        <Reference>
          <Citation>Hofer, S., &amp; Frahm, J. (2006). Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. NeuroImage, 32(3), 989-994. https://doi.org/10.1016/j.neuroimage.2006.05.044</Citation>
        </Reference>
        <Reference>
          <Citation>Jellison, B. J., Field, A. S., Medow, J., Lazar, M., Salamat, M. S., &amp; Alexander, A. L. (2004). Diffusion tensor imaging of cerebral white matter: A pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR American Journal of Neuroradiology, 25(3), 356-369.</Citation>
        </Reference>
        <Reference>
          <Citation>Jenkinson, M., Bannister, P., Brady, M., &amp; Smith, S. (2002). Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage, 17(2), 825-841.</Citation>
        </Reference>
        <Reference>
          <Citation>Jenkinson, M., Beckmann, C. F., Behrens, T. E., Woolrich, M. W., &amp; Smith, S. M. (2012). FSL. NeuroImage, 62(2), 782-790.</Citation>
        </Reference>
        <Reference>
          <Citation>Jenkinson, M., &amp; Smith, S. (2001). A global optimisation method for robust affine registration of brain images. Medical Image Analysis, 5(2), 143-156.</Citation>
        </Reference>
        <Reference>
          <Citation>Kazemi, K., Moghaddam, H. A., Grebe, R., Gondry-Jouet, C., &amp; Wallois, F. (2007). A neonatal atlas template for spatial normalization of whole-brain magnetic resonance images of newborns: Preliminary results. NeuroImage, 37(2), 463-473. https://doi.org/10.1016/j.neuroimage.2007.05.004</Citation>
        </Reference>
        <Reference>
          <Citation>Kier, E. L., Staib, L. H., Davis, L. M., &amp; Bronen, R. A. (2004). MR imaging of the temporal stem: Anatomic dissection tractography of the uncinate fasciculus, inferior occipitofrontal fasciculus, and Meyer's loop of the optic radiation. AJNR American Journal of Neuroradiology, 25(5), 677-691.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuklisova-Murgasova, M., Aljabar, P., Srinivasan, L., Counsell, S. J., Doria, V., Serag, A., … Rueckert, D. (2011). A dynamic 4D probabilistic atlas of the developing brain. NeuroImage, 54(4), 2750-2763. https://doi.org/10.1016/j.neuroimage.2010.10.019</Citation>
        </Reference>
        <Reference>
          <Citation>Leemans, A., &amp; Jones, D. K. (2009). The B-matrix must be rotated when correcting for subject motion in DTI data. Magnetic Resonance in Medicine, 61(6), 1336-1349. https://doi.org/10.1002/mrm.21890</Citation>
        </Reference>
        <Reference>
          <Citation>Lin, X., &amp; Li, X. (2019). Image based brain segmentation: From multi-atlas fusion to deep learning. Current Medical Imaging Reviews, 15(5), 443-452.</Citation>
        </Reference>
        <Reference>
          <Citation>Loh, W. Y., Connelly, A., Cheong, J. L., Spittle, A. J., Chen, J., Adamson, C., … Doyle, L. W. (2016). A new MRI-based pediatric subcortical segmentation technique (PSST). Neuroinformatics, 14(1), 69-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Makropoulos, A., Aljabar, P., Wright, R., Huning, B., Merchant, N., Arichi, T., … Rueckert, D. (2016). Regional growth and atlasing of the developing human brain. NeuroImage, 125, 456-478. https://doi.org/10.1016/j.neuroimage.2015.10.047</Citation>
        </Reference>
        <Reference>
          <Citation>Makropoulos, A., Counsell, S. J., &amp; Rueckert, D. (2018). A review on automatic fetal and neonatal brain MRI segmentation. NeuroImage, 170, 231-248.</Citation>
        </Reference>
        <Reference>
          <Citation>Makropoulos, A., Robinson, E. C., Schuh, A., Wright, R., Fitzgibbon, S., Bozek, J., … Passerat-Palmbach, J. (2018). The developing human connectome project: A minimal processing pipeline for neonatal cortical surface reconstruction. NeuroImage, 173, 88-112.</Citation>
        </Reference>
        <Reference>
          <Citation>Martino, J., Brogna, C., Robles, S. G., Vergani, F., &amp; Duffau, H. (2010). Anatomic dissection of the inferior fronto-occipital fasciculus revisited in the lights of brain stimulation data. Cortex, 46(5), 691-699. https://doi.org/10.1016/j.cortex.2009.07.015</Citation>
        </Reference>
        <Reference>
          <Citation>Martino, J., De Witt Hamer, P. C., Berger, M. S., Lawton, M. T., Arnold, C. M., de Lucas, E. M., &amp; Duffau, H. (2013). Analysis of the subcomponents and cortical terminations of the perisylvian superior longitudinal fasciculus: A fiber dissection and DTI tractography study. Brain Structure &amp; Function, 218(1), 105-121. https://doi.org/10.1007/s00429-012-0386-5</Citation>
        </Reference>
        <Reference>
          <Citation>Mori, S., Oishi, K., &amp; Faria, A. V. (2009). White matter atlases based on diffusion tensor imaging. Current Opinion in Neurology, 22(4), 362.</Citation>
        </Reference>
        <Reference>
          <Citation>Mori, S., Oishi, K., Jiang, H., Jiang, L., Li, X., Akhter, K., … Mazziotta, J. (2008). Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. NeuroImage, 40(2), 570-582. https://doi.org/10.1016/j.neuroimage.2007.12.035</Citation>
        </Reference>
        <Reference>
          <Citation>Mori, S., &amp; van Zijl, P. (2007). Human white matter atlas. The American Journal of Psychiatry, 164(7), 1005. https://doi.org/10.1176/ajp.2007.164.7.1005</Citation>
        </Reference>
        <Reference>
          <Citation>Mori, S., W., S., Nagae-Poetscher, L. M., &amp; van Zijl, P. C. (2005). MRI atlas of human white matter. Amsterdam, The Netherlands: Elsevier.</Citation>
        </Reference>
        <Reference>
          <Citation>Nieuwenhuys, R., Voogd, J., &amp; Van Hujizen, C. (2008). The human central nervous system (4th ed.). Heidelberg/Berlin: Steinkopff-Verlag.</Citation>
        </Reference>
        <Reference>
          <Citation>Oishi, K., Faria, A., Jiang, H., Li, X., Akhter, K., Zhang, J., … Mori, S. (2009). Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: Application to normal elderly and Alzheimer's disease participants. NeuroImage, 46(2), 486-499.</Citation>
        </Reference>
        <Reference>
          <Citation>Oishi, K., Mori, S., Donohue, P. K., Ernst, T., Anderson, L., Buchthal, S., … Chang, L. (2011). Multi-contrast human neonatal brain atlas: Application to normal neonate development analysis. NeuroImage, 56(1), 8-20. https://doi.org/10.1016/j.neuroimage.2011.01.051</Citation>
        </Reference>
        <Reference>
          <Citation>Otsuka, Y., Chang, L., Kawasaki, Y., Wu, D., Ceritoglu, C., Oishi, K., … Oishi, K. (2019). A multi-atlas label fusion tool for neonatal brain MRI Parcellation and quantification. Journal of Neuroimaging, 29(4), 431-439.</Citation>
        </Reference>
        <Reference>
          <Citation>Pannek, K., Hatzigeorgiou, X., Colditz, P. B., &amp; Rose, S. (2013). Assessment of structural connectivity in the preterm brain at term equivalent age using diffusion MRI and T2 relaxometry: A network-based analysis. PLoS One, 8(8), e68593.</Citation>
        </Reference>
        <Reference>
          <Citation>Richards, J. E., Sanchez, C., Phillips-Meek, M., &amp; Xie, W. (2016). A database of age-appropriate average MRI templates. NeuroImage, 124(Pt B), 1254-1259. https://doi.org/10.1016/j.neuroimage.2015.04.055</Citation>
        </Reference>
        <Reference>
          <Citation>Sanchez, C. E., Richards, J. E., &amp; Almli, C. R. (2012). Neurodevelopmental MRI brain templates for children from 2 weeks to 4 years of age. Developmental Psychobiology, 54(1), 77-91. https://doi.org/10.1002/dev.20579</Citation>
        </Reference>
        <Reference>
          <Citation>Shah, A., Jhawar, S. S., &amp; Goel, A. (2012). Analysis of the anatomy of the Papez circuit and adjoining limbic system by fiber dissection techniques. Journal of Clinical Neuroscience, 19(2), 289-298. https://doi.org/10.1016/j.jocn.2011.04.039</Citation>
        </Reference>
        <Reference>
          <Citation>Shi, F., Yap, P. T., Fan, Y., Gilmore, J. H., Lin, W., &amp; Shen, D. (2010). Construction of multi-region-multi-reference atlases for neonatal brain MRI segmentation. NeuroImage, 51(2), 684-693. https://doi.org/10.1016/j.neuroimage.2010.02.025</Citation>
        </Reference>
        <Reference>
          <Citation>Shi, F., Yap, P. T., Wu, G., Jia, H., Gilmore, J. H., Lin, W., &amp; Shen, D. (2011). Infant brain atlases from neonates to 1- and 2-year-olds. PLoS One, 6(4), e18746. https://doi.org/10.1371/journal.pone.0018746</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, S. M. (2002). Fast robust automated brain extraction. Human Brain Mapping, 17(3), 143-155.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E., Johansen-Berg, H., … Flitney, D. E. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23, S208-S219. https://doi.org/10.1016/j.neuroimage.2004.07.051</Citation>
        </Reference>
        <Reference>
          <Citation>Spittle, A. J., Thompson, D. K., Brown, N. C., Treyvaud, K., Cheong, J. L., Lee, K. J., … Anderson, P. J. (2014). Neurobehaviour between birth and 40 weeks’ gestation in infants born &lt;30 weeks' gestation and parental psychological wellbeing: Predictors of brain development and child outcomes. BMC Pediatrics, 14, 111. https://doi.org/10.1186/1471-2431-14-111</Citation>
        </Reference>
        <Reference>
          <Citation>Thompson, D. K., Inder, T. E., Faggian, N., Johnston, L., Warfield, S. K., Anderson, P. J., … Egan, G. F. (2011). Characterization of the corpus callosum in very preterm and full-term infants utilizing MRI. NeuroImage, 55(2), 479-490. https://doi.org/10.1016/j.neuroimage.2010.12.025</Citation>
        </Reference>
        <Reference>
          <Citation>Thompson, D. K., Inder, T. E., Faggian, N., Warfield, S. K., Anderson, P. J., Doyle, L. W., &amp; Egan, G. F. (2012). Corpus callosum alterations in very preterm infants: Perinatal correlates and 2 year neurodevelopmental outcomes. NeuroImage, 59(4), 3571-3581.</Citation>
        </Reference>
        <Reference>
          <Citation>Thompson, D. K., Kelly, C. E., Chen, J., Beare, R., Alexander, B., Seal, M. L., … Spittle, A. J. (2018). Characterisation of brain volume and microstructure at term-equivalent age in infants born across the gestational age spectrum. Neuroimage Clinical, 21, 101630. https://doi.org/10.1016/j.nicl.2018.101630</Citation>
        </Reference>
        <Reference>
          <Citation>Ture, U., Yasargil, M. G., Friedman, A. H., &amp; Al-Mefty, O. (2000). Fiber dissection technique: Lateral aspect of the brain. Neurosurgery, 47(2), 417-426 discussion 426-417.</Citation>
        </Reference>
        <Reference>
          <Citation>Tustison, N. J., Avants, B. B., Cook, P. A., Zheng, Y., Egan, A., Yushkevich, P. A., &amp; Gee, J. C. (2010). N4ITK: Improved N3 bias correction. IEEE Transactions on Medical Imaging, 29(6), 1310-1320. https://doi.org/10.1109/TMI.2010.2046908</Citation>
        </Reference>
        <Reference>
          <Citation>Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., … Joliot, M. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1), 273-289. https://doi.org/10.1006/nimg.2001.0978</Citation>
        </Reference>
        <Reference>
          <Citation>Walsh, J. M., Doyle, L. W., Anderson, P. J., Lee, K. J., &amp; Cheong, J. L. (2014). Moderate and late preterm birth: Effect on brain size and maturation at term-equivalent age. Radiology, 273(1), 232-240. https://doi.org/10.1148/radiol.14132410</Citation>
        </Reference>
        <Reference>
          <Citation>Warfield, S. K., Zou, K. H., &amp; Wells, W. M. (2004). Simultaneous truth and performance level estimation (STAPLE): An algorithm for the validation of image segmentation. IEEE Transactions on Medical Imaging, 23(7), 903-921. https://doi.org/10.1109/TMI.2004.828354</Citation>
        </Reference>
        <Reference>
          <Citation>Yasargil, M. G., Ture, U., &amp; Yasargil, D. C. (2004). Impact of temporal lobe surgery. Journal of Neurosurgery, 101(5), 725-738. https://doi.org/10.3171/jns.2004.101.5.0725</Citation>
        </Reference>
        <Reference>
          <Citation>Yushkevich, P. A., Piven, J., Hazlett, H. C., Smith, R. G., Ho, S., Gee, J. C., &amp; Gerig, G. (2006). User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage, 31(3), 1116-1128. https://doi.org/10.1016/j.neuroimage.2006.01.015</Citation>
        </Reference>
        <Reference>
          <Citation>Zollei, L., Ou, Y., Iglesias, J., Grant, P. E., &amp; Fischl, B. (2017). FreeSurfer image processing pipeline for infant clinical MRI images. Paper presented at the Human Brain Mapping, Vancouver, Canada.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083381</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part A</Title>
          <ISOAbbreviation>Am. J. Med. Genet. A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Behavioral phenotype of 49,XXXXY syndrome: Presence of anxiety-related symptoms and intact social awareness.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.61507</ELocationID>
        <Abstract>
          <AbstractText>49,XXXXY is a rare X and Y chromosome variation that occurs in 1:85,000 to 1:100,000 live male births and is notable for variable motor, speech, and behavioral deficits. Case studies have described boys with this disorder as shy, impulsive, and aggressive with low frustration tolerances; however, previous studies have been limited due to cohort size. This study reports on the largest cohort of boys with 49,XXXXY to date with an emphasis on the prevalence of anxiety-related symptoms and sociability from preschool to adolescence. The Child Behavior Checklist, Behavior Rating Inventory of Executive Function, 2nd edition, and Social Responsiveness Scale, 2nd edition were completed by parents on a cohort of 69. The cohort demonstrated deficits in social cognition and communication beginning in preschool, however, presented with consistent social awareness and motivation for social activities not previously appreciated in this disorder. In addition, signs of anxiety presented during preschool years and increased in severity with age, particularly in internalizing problems. Boys with 49,XXXXY presented with wide behavioral variability across all ages and domains. Further research into the potential influences of culture, birth order, biological treatment, and frequency of services is needed to better define the behavioral phenotype of children with this disorder.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lasutschinkow</LastName>
            <ForeName>Patricia C</ForeName>
            <Initials>PC</Initials>
            <AffiliationInfo>
              <Affiliation>Research Department, The Focus Foundation, Davidsonville, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gropman</LastName>
            <ForeName>Andrea L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Neurogenetics and Developmental Pediatrics, Children's National Health System, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porter</LastName>
            <ForeName>Grace F</ForeName>
            <Initials>GF</Initials>
            <AffiliationInfo>
              <Affiliation>Research Department, The Focus Foundation, Davidsonville, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sadeghin</LastName>
            <ForeName>Teresa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Research Department, The Focus Foundation, Davidsonville, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samango-Sprouse</LastName>
            <ForeName>Carole A</ForeName>
            <Initials>CA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9941-0568</Identifier>
            <AffiliationInfo>
              <Affiliation>Research Department, The Focus Foundation, Davidsonville, Maryland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Human and Molecular Genetics, Florida International University, Miami, Florida.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet A</MedlineTA>
        <NlmUniqueID>101235741</NlmUniqueID>
        <ISSNLinking>1552-4825</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">49,XXXXY</Keyword>
        <Keyword MajorTopicYN="N">X and Y chromosomal variations</Keyword>
        <Keyword MajorTopicYN="N">anxiety disorders</Keyword>
        <Keyword MajorTopicYN="N">behavioral dysfunction</Keyword>
        <Keyword MajorTopicYN="N">communication deficits</Keyword>
        <Keyword MajorTopicYN="N">sex chromosome abnormalities and aneuploidies</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083381</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.a.61507</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Achenbach, T. M. (1999). The child behavior checklist and related instruments. In M. E. Maruish (Ed.), The use of psychological testing for treatment planning and outcomes assessment (pp. 429-466). Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers.</Citation>
        </Reference>
        <Reference>
          <Citation>Blumenthal, J. D., Baker, E. H., Lee, N. R., Wade, B., Clasen, L. S., Lenroot, R. K., &amp; Geidd, J. N. (2013). Brain morphological abnormalities in 49,XXXXY syndrome: A pediatric magnetic resonance imaging study. Neuroimage Clin, 2, 197-203.</Citation>
        </Reference>
        <Reference>
          <Citation>Borghgraef, M., Fryns, J. P., Smeet, E., Marien, J., &amp; van den Berghe, H. (1988). The 49,XXXXY syndrome. Clinical and psychological follow-up data. Clinical Genetics, 33(6), 429-434.</Citation>
        </Reference>
        <Reference>
          <Citation>Burgemeister, S., Gronwald, S., Maurer, M., &amp; Zirn, B. (2018). Clinical report of 8 patients with 49,XXXXY: Delineation of the facial gestalt and depiction of the clinical spectrum. European Journal of Medical Genetics, 62(3), 210-216.</Citation>
        </Reference>
        <Reference>
          <Citation>Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., … Splinter, R. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427-433.</Citation>
        </Reference>
        <Reference>
          <Citation>Curfs, L. M., Schreppers-Tijdink, G., Wiegers, A., Borghgraef, M., &amp; Fryns, J. P. (1990). The 49,XXXXY syndrome: Clinical and psychological findings in five patients. Journal of Mental Deficiency Research, 34(3), 277-282.</Citation>
        </Reference>
        <Reference>
          <Citation>Galasso, C., Arpino, C., Fabbri, F., &amp; Curatolo, P. (2003). Neurologic aspects of 49,XXXXY syndrome. Journal of Child Neurology, 18(7), 501-504.</Citation>
        </Reference>
        <Reference>
          <Citation>Gioia, G., Isquith, P. K., Guy, S. C., &amp; Kenworthy, L. (2000). Reviewed by Baron, I.S. "Test review: Behavior rating inventory of executive function". Child Neuropsychology, 6(3), 235-238.</Citation>
        </Reference>
        <Reference>
          <Citation>Gropman, A. L., Rogol, A., Fennoy, I., Sadeghin, T., Sinn, S., Jameson, R., … Samango-Sprouse, C. A. (2010). Clinical variability and novel neurodevelopmental findings in 49,XXXXY syndrome. Am J Med Genet Pt A, 152A, 1523-1530.</Citation>
        </Reference>
        <Reference>
          <Citation>Halls, G., Cooper, P., &amp; Creswell, C. (2015). Social communication deficits: Specific associations with social anxiety disorder. Journal of Affective Disorders, 172, 38-42.</Citation>
        </Reference>
        <Reference>
          <Citation>Kleczkowska, A., Fryns, J. P., &amp; van den Berghe, H. (1988). X chromosome polysomy in the male. The Leuven experience 1966-1987. Human Genetics, 80(1), 16-22.</Citation>
        </Reference>
        <Reference>
          <Citation>Linden, M., Gender, B., &amp; Robinson, A. (1995). Sex chromosome tetrasomy and pentasomy. Pediatrics, 96(4), 672-682.</Citation>
        </Reference>
        <Reference>
          <Citation>Lomelino, C. A., &amp; Reiss, A. L. (1991). 49,XXXXY syndrome: Behavioural and developmental profiles. Journal of Medical Genetics, 28(9), 609-612.</Citation>
        </Reference>
        <Reference>
          <Citation>Mazefsky, C. A., Anderson, R., Conner, C. M., &amp; Minchew, N. (2011). Child behavior checklist scores for school-aged children with autism: Preliminary evidence of patterns suggesting the need for referral. Journal of Psychopathology and Behavioral Assessment, 33(1), 31-37.</Citation>
        </Reference>
        <Reference>
          <Citation>Pickard, H., Rijsdijk, F., Happe, F., &amp; Mandy, W. (2017). Are social and communication difficulties a risk factor for the development of social anxiety? Journal of the American Academy of Child and Adolescent Psychiatry, 56(4), 344-351.e3.</Citation>
        </Reference>
        <Reference>
          <Citation>Samango-Sprouse, C., Lasutschinkow, P., Powell, S., Sadeghin, T., &amp; Gropman, A. (2019). The incidence of anxiety symptoms in boys with 47,XXY (Klinefelter syndrome) and the possible impact of timing of diagnosis and hormonal replacement therapy. American Journal of Medical Genetics - Part A, 179A, 423-428.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheridan, M. K., Radlinkski, S. S., &amp; Kennedy, M. D. (1990). Developmental outcome in 49,XXXXY klinefelter syndrome. Developmental Medicine and Child Neurology, 32(6), 532-539.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083382</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-3148</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Transfusion medicine (Oxford, England)</Title>
          <ISOAbbreviation>Transfus Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Do red cell alloantibodies continue to challenge breast fed babies?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/tme.12672</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Newborns have limited specific immune capability at birth, owing to delayed and constrained development of adaptive immunity. To supplement this period the mother passively transfers antibodies to the child either transplacentally or through breast milk. When maternal alloimmunisation occurs through foreign or fetal red cell surface antigens, stimulating the production of immunoglobulin G (IgG) antibodies, these IgG antibodies can cross the placenta and cause haemolytic disease of the fetus and the newborn.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We present two case reports of a neonate and an infant in whom IgG red cell alloantibodies were transferred through maternal breast milk.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Maternal serum, baby's serum and expressed breast milk samples were tested for the presence of red cell alloantibodies using gel card. Antibody screening, antibody identifications and titres alongside monospecific direct antiglobulin test, IgG subtypes were performed using the standard methods.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the first case, a 6-month-old child was incidentally found to have positive antibody screen. Anti-KELL1 was identified, which was also present in maternal serum and breast milk. The second neonate was evaluated for haemolysis and was found to have anti-D. Anti-D was also detected in the maternal serum and breast milk. Both babies did not have any sensitising events. The first baby was asymptomatic, but the second baby had ongoing haemolysis until 1 month.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We report that maternal anti-KELL1 and anti-D antibodies were present in breast milk and were capable of being transferred to a feeding child. Our case report also raises interesting and unanswered immunologic fundamentals that should be considered in neonates with unexplained anaemia or delayed and persistent haemolysis.</AbstractText>
          <CopyrightInformation>© 2020 British Blood Transfusion Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rasalam</LastName>
            <ForeName>Jess E</ForeName>
            <Initials>JE</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8612-6864</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kumar</LastName>
            <ForeName>Snehil</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amalraj</LastName>
            <ForeName>Pushpanathan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bal</LastName>
            <ForeName>Harshjeet S</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatric Surgery, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mathai</LastName>
            <ForeName>John</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatric Surgery, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kumar</LastName>
            <ForeName>Manish</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neonatology, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sridhar</LastName>
            <ForeName>Santhanam</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neonatology, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daniel</LastName>
            <ForeName>Dolly</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Transfus Med</MedlineTA>
        <NlmUniqueID>9301182</NlmUniqueID>
        <ISSNLinking>0958-7578</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HDFN</Keyword>
        <Keyword MajorTopicYN="N">KELL1</Keyword>
        <Keyword MajorTopicYN="N">anti-D</Keyword>
        <Keyword MajorTopicYN="N">breast milk</Keyword>
        <Keyword MajorTopicYN="N">haemolytic disease of fetus and newborn</Keyword>
        <Keyword MajorTopicYN="N">neonate</Keyword>
        <Keyword MajorTopicYN="N">red cell alloimunisation</Keyword>
        <Keyword MajorTopicYN="N">red cell antibody</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083382</ArticleId>
        <ArticleId IdType="doi">10.1111/tme.12672</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Vaccine responses in newborns. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711983/. Accessed October 7, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Macchiaverni P, Arslanian C, Frazão JB, et al. Mother to child transfer of IgG and IgA antibodies against dermatophagoides pteronyssinus: maternal transfer of anti-Der p IgG and IgA. Scand J Immunol. 2011;74(6):619-627. https://doi.org/10.1111/j.1365-3083.2011.02615.x.</Citation>
        </Reference>
        <Reference>
          <Citation>Santhanakrishnan M, Tormey CA, Natarajan P, Liu J, Hendrickson JE. Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model. Vox Sang. 2016;111(1):79-87. https://doi.org/10.1111/vox.12387.</Citation>
        </Reference>
        <Reference>
          <Citation>Neal-Kluever A, Fisher J, Grylack L, Kakiuchi-Kiyota S, Halpern W. Physiology of the neonatal gastrointestinal system relevant to the disposition of orally administered medications. Drug Metab Dispos. 2019;47(3):296-313. https://doi.org/10.1124/dmd.118.084418.</Citation>
        </Reference>
        <Reference>
          <Citation>Li M, Blaustein JC. Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk. Transfusion. 2017;57(9):2121-2124. https://doi.org/10.1111/trf.14171.</Citation>
        </Reference>
        <Reference>
          <Citation>Hurley WL, Theil PK. Perspectives on immunoglobulins in colostrum and milk. Nutrients. 2011;3(4):442-474. https://doi.org/10.3390/nu3040442.</Citation>
        </Reference>
        <Reference>
          <Citation>Palmeira P, Costa-Carvalho B, Arslanian C, Pontes G, Nagao dias A, Carneiro-Sampaio M. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin. Pediatr Allergy Immunol. 2009;20:528-535. https://doi.org/10.1111/j.1399-3038.2008.00828.x.</Citation>
        </Reference>
        <Reference>
          <Citation>Hamilton RG. Asthma and Allergy Center Johns Hopkins University School of Medicine Baltimore, MD 21224.:64.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones EA, Waldmann TA. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest. 1972;51(11):2916-2927.</Citation>
        </Reference>
        <Reference>
          <Citation>Demers-Mathieu V, Underwood MA, Beverly RL, Nielsen SD, Dallas DC. Comparison of human milk immunoglobulin survival during gastric digestion between preterm and term infants. Nutrients. 2018;10(5):631. https://doi.org/10.3390/nu10050631.</Citation>
        </Reference>
        <Reference>
          <Citation>DeMoss P, Asfour M, Hersey K. Anti-K1 (Kell) antibody expressed in maternal breastmilk: a case report of a neonate with multiple intrauterine transfusions and postnatal exposure to Kell antibody in maternal breastmilk. Case Rep Pediatr. 2017;2017:1-4. https://doi.org/10.1155/2017/6927813.</Citation>
        </Reference>
        <Reference>
          <Citation>Leonard A, Boal LH, Pary P, et al. Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn. Transfusion. 2019;59(4):1183-1189. https://doi.org/10.1111/trf.15154.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083383</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2472-1727</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Birth defects research</Title>
          <ISOAbbreviation>Birth Defects Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Introduction to the special issue on "Genetic Screening and Testing".</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/bdr2.1637</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mitchell</LastName>
            <ForeName>Anna L</ForeName>
            <Initials>AL</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7856-2949</Identifier>
            <AffiliationInfo>
              <Affiliation>Genetics and Genome Sciences, Case Western Reserve University, School of Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Birth Defects Res</MedlineTA>
        <NlmUniqueID>101701004</NlmUniqueID>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083383</ArticleId>
        <ArticleId IdType="doi">10.1002/bdr2.1637</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Ormond, K. E., Laurino, M. Y., Barlow-Stewart, K., Wessels, T.-M., Macaulay, S., Austin, J., &amp; Middleton, A. (2018). Commentary, genetic counseling globally: Where are we now? American Journal of Medical Genetics, 178C, 98-107. https://doi.org/10.1002/ajmg.c.31607</Citation>
        </Reference>
        <Reference>
          <Citation>Brosco JP and Paul DP (2013) The political history of PKU: Reflections on 50 years of newborn screening. Pediatrics 132(6): 987-989. PMCID: PMC3838532, PMID: 24276841, DOI: https://doi.org/10.1542/peds.2013-1441</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083384</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1545-5017</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric blood &amp; cancer</Title>
          <ISOAbbreviation>Pediatr Blood Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A pilot study to screen for poor academic performance in children with sickle cell disease in the outpatient setting.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e28196</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pbc.28196</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Children with sickle cell disease (SCD) are at risk for neurocognitive deficits, which can lead to effects on academic performance and later job attainment. However, screening in children at high risk for poor academic performance (PAP) in a clinic setting has been limited. The goal was to identify young children with SCD at high risk for PAP via administration of a standardized screening tool at the clinic visit.</AbstractText>
          <AbstractText Label="PROCEDURE" NlmCategory="METHODS">Parents of 20 patients were asked to complete the Behavior Assessment System for Children, 3rd edition (BASC-3) Parent Rating Scale. Children ages six to nine years and all SCD genotypes were included. Those patients who scored at least 1 standard deviation below the mean were considered high risk. Statistics was used to associate demographic, academic, and laboratory data with risk status (RS).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Four of 20 patients (20%) were found to be at risk by the BASC-3. A significant association was found between those with a history of PAP and RS (P = 0.001). A trend toward association was found between baseline hemoglobin, reticulocyte count, and RS. Children not at risk had a higher hemoglobin level and lower reticulocyte count (P = 0.37 and P = 0.20, respectively). Those on hydroxyurea were significantly less likely to score as at risk (P = 0.014), whereas those with siblings may be at greater risk (P = 0.037).</AbstractText>
          <AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">A parent-directed screening tool may identify children with SCD in need of additional school support. Further prospective studies are necessary to understand correlations found between hemoglobin, reticulocyte count, and hydroxyurea treatment and risk for PAP.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Karkoska</LastName>
            <ForeName>Kristine</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0990-399X</Identifier>
            <AffiliationInfo>
              <Affiliation>Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaheer</LastName>
            <ForeName>Sibgha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Cohen Children's Medical Center of New York, New Hyde Park, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Victoria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Developmental-Behavioral Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fishbein</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Feinstein Institute for Medical Research, Biostatistics, Manhasset, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Appiah-Kubi</LastName>
            <ForeName>Abena</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Cohen Children's Medical Center of New York, New Hyde Park, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aygun</LastName>
            <ForeName>Banu</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9934-5161</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Cohen Children's Medical Center of New York, New Hyde Park, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Blood Cancer</MedlineTA>
        <NlmUniqueID>101186624</NlmUniqueID>
        <ISSNLinking>1545-5009</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">academic performance</Keyword>
        <Keyword MajorTopicYN="N">hydroxyurea</Keyword>
        <Keyword MajorTopicYN="N">neurocognition</Keyword>
        <Keyword MajorTopicYN="N">sickle cell disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083384</ArticleId>
        <ArticleId IdType="doi">10.1002/pbc.28196</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Hassell K. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38:S512-521.</Citation>
        </Reference>
        <Reference>
          <Citation>Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle disease: rate and risk factors. Blood. 1998;91:288-294.</Citation>
        </Reference>
        <Reference>
          <Citation>Armstrong FD Jr, Thompson RJ, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97:864-870.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang W, Enos L, Gallagher D, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139:391-397.</Citation>
        </Reference>
        <Reference>
          <Citation>Kawadler JM, Clayden JD, Clark CA, Kirkham FJ. Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis. Dev Med Child Neurol. 2016;58:672-679.</Citation>
        </Reference>
        <Reference>
          <Citation>Hijmans CT, Grootenhuis MA, Oosterlaan J, Heijboer H, Peters M, Fijnvandraat K. Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia. Pediatr Blood Cancer. 2011;57:297-302.</Citation>
        </Reference>
        <Reference>
          <Citation>Hogan AM, Pit-ten IM, Vargha-Khadem F, Prengler M, Kirkham FJ. Physiological correlates of intellectual function in children with sickle cell disease: hypoxemia, hyperemia, and brain function. Dev Sci. 2006;9:379-387.</Citation>
        </Reference>
        <Reference>
          <Citation>Fields ME, Guilliams KP, Ragan DK, et al. Regional oxygen extraction predicts border zone vulnerability to stroke in sickle cell disease. Neurology. 2018;90:e1134-e1142.</Citation>
        </Reference>
        <Reference>
          <Citation>Herron S, Bacak S, King A, DeBaun M. Inadequate recognition of education resources required for high-risk students with sickle cell disease. Arch Pediatr Adolesc Med. 2003;157:104.</Citation>
        </Reference>
        <Reference>
          <Citation>Armstrong FD, Elkin TD, Brown RC, et al. Developmental function in toddlers with sickle cell anemia. Pediatrics. 2013;131:e406-414.</Citation>
        </Reference>
        <Reference>
          <Citation>Fields ME, Hoyt-Drazen C, Abel R, et al. A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease. Pediatr Blood Cancer. 2016;63:2131-2138.</Citation>
        </Reference>
        <Reference>
          <Citation>National Heart, Lung and Blood institute. NHLBI Evidence-based management of sickle cell disease. Expert Panel Rep 2014. https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle-cell-disease-report%20020816_0.pdf. Accessed: January 21, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Schatz J, Schlenz AM, Smith KE, Roberts CW. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow up study. Dev Med Child Neurol. 2018;60:520-526.</Citation>
        </Reference>
        <Reference>
          <Citation>Reynolds C, Kamphaus R. Behavior Assessment System for Children. 3rd ed. Bloomington, MN: Pearson; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Jimenez ME, Martinez Alcaraz E, Williams J, Strom BL. Access to developmental pediatrics evaluations for at-risk children. J Dev Behav Pediatr. 2017;38:228-232.</Citation>
        </Reference>
        <Reference>
          <Citation>Schatz J, Schlenz A, Reinman L, Smith K, Roberts CW. Developmental screening in pediatric sickle cell disease: disease-related risk and screening outcomes in 4 year olds. J Dev Behav Pediatr. 2017;38:654-662.</Citation>
        </Reference>
        <Reference>
          <Citation>Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146:300-305.</Citation>
        </Reference>
        <Reference>
          <Citation>Nottage KA, Ware RE, Aygun B, et al. Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia. Br J Haematol. 2016;175:331-338.</Citation>
        </Reference>
        <Reference>
          <Citation>Calvet D, Tuilier T, Mele N, et al. Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease. Blood Adv. 2017;1:2503-2509.</Citation>
        </Reference>
        <Reference>
          <Citation>DeBaun MR, Gordon M, McKinstry RC, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371:699-710.</Citation>
        </Reference>
        <Reference>
          <Citation>King A, Rodeghier MJ, Panepinto JA, et al. Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. Am J Hematol. 2014;89:E188-92.</Citation>
        </Reference>
        <Reference>
          <Citation>King AA, Strouse JJ, Rodeghier MJ, et al. Parent education and biologic factors influence on cognition in sickle cell anemia. Am J Hematol. 2014;89:162-167.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">32083385</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>31</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Junk DNA: A Journey through the Dark Matter of the Genome by Nessa Carey Columbia University Press, New York, 2015.</ArticleTitle>
        <Pagination>
          <MedlinePgn>4663-4664</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201700951</ELocationID>
        <Abstract>
          <AbstractText>The term "junk DNA" came into widespread use in 2001, when the near completion of the Human Genome Project revealed that only a small fraction of the DNA sequences in the human genome encodes amino acid sequences in proteins. Was the rest merely junk? A great deal has been learned since then about functions of the noncoding sequences, and in this entertaining volume, Nessa Carey describes what we know about these sequences, with information complete through approximately 2014. This book follows her earlier and well-received book, The Epigenetics Revolution.</AbstractText>
          <CopyrightInformation>© FASEB.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mathews</LastName>
            <ForeName>Christopher K</ForeName>
            <Initials>CK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083385</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.201700951</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">32083386</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>31</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5049-5067</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201700254R</ELocationID>
        <Abstract>
          <AbstractText>Tumor cell metastasis to the brain involves cell migration through biochemically and physically complex microenvironments at the blood-brain barrier (BBB). The current understanding of tumor cell migration across the BBB is limited. We hypothesize that an interplay between biochemical cues and physical cues at the BBB affects the mechanisms of brain metastasis. We found that astrocyte conditioned medium(ACM) applied directly to tumor cells increased tumor cell velocity, induced elongation, and promoted actin stress fiber organization. Notably, treatment of the extracellular matrix with ACM led to even more significant increases in tumor cell velocity in comparison with ACM treatment of cells directly. Furthermore, inhibiting matrix metalloproteinases in ACM reversed ACM's effect on tumor cells. The effects of ACM on tumor cell morphology and migration also depended on astrocytes' activation state. Finally, using a microfluidic device, we found that the effects of ACM were abrogated in confinement. Overall, our work demonstrates that astrocyte-secreted factors alter migration and morphology of metastatic breast tumor cells, and this effect depends on the cells' mechanical microenvironment.-Shumakovich, M. A., Mencio, C. P., Siglin, J. S., Moriarty, R. A., Geller, H. M., Stroka, K. M. Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells. FASEB J. 31, 5049-5067 (2017). www.fasebj.org.</AbstractText>
          <CopyrightInformation>© FASEB.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shumakovich</LastName>
            <ForeName>Marina A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mencio</LastName>
            <ForeName>Caitlin P</ForeName>
            <Initials>CP</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Developmental Neurobiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siglin</LastName>
            <ForeName>Jonathan S</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moriarty</LastName>
            <ForeName>Rebecca A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Geller</LastName>
            <ForeName>Herbert M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Developmental Neurobiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stroka</LastName>
            <ForeName>Kimberly M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Stem Cell Biology and Regenerative Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Marlene and Stewart Greenbaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Burroughs Wellcome Career Award at the Scientific Interface (to K.M.S.)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Fischell Department of Bioengineering (University of Maryland)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>U.S. National Institutes of Health</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>National Heart Lung and Blood Institute (NHLBI)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Intramural Research Program (to C.P.M. and H.M.G.)</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">actin cytoskeleton</Keyword>
        <Keyword MajorTopicYN="N">blood-brain barrier</Keyword>
        <Keyword MajorTopicYN="N">extracellular matrix</Keyword>
        <Keyword MajorTopicYN="N">matrix metalloproteinases</Keyword>
        <Keyword MajorTopicYN="N">tumor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>07</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>03</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083386</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.201700254R</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Witzel, I., Oliveira-Ferrer, L., Pantel, K., Müller, V., and Wikman, H. (2016) Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res. 18, 8-17</Citation>
        </Reference>
        <Reference>
          <Citation>Balkwill, F. R., Capasso, M., and Hagemann, T. (2012) The tumor microenvironment at a glance. J. Cell Sci. 125, 5591-5596</Citation>
        </Reference>
        <Reference>
          <Citation>Fokas, E., Engenhart-Cabillic, R., Daniilidis, K., Rose, F., and An, H. X. (2007) Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev. 26, 705-715</Citation>
        </Reference>
        <Reference>
          <Citation>Valiente, M., Obenauf, A. C., Jin, X., Chen, Q., Zhang, X. H. F., Lee, D. J., Chaft, J. E., Kris, M. G., Huse, J. T., Brogi, E., and Massagué, J. (2014) Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002-1016</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, L., Cossette, S. M., Rarick, K. R., Gershan, J., Dwinell, M. B., Harder, D. R., and Ramchandran, R. (2013) Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS One 8, e80933</Citation>
        </Reference>
        <Reference>
          <Citation>Hohensee, I., Chuang, H., Grottke, A., Werner, S., Horn, S., Lamszus, K., Bartkowiak, K., Witzel, I., Matschke, J., Glatzel, M., Jücker, M., Pukrop, T., Pantel, K., and Wikman, H. (2017) PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression. Oncotarget 8, 6155-6168</Citation>
        </Reference>
        <Reference>
          <Citation>Xing, F., Kobayashi, A., Okuda, H., Watabe, M., Pai, S. K., Pandey, P. R., Hirota, S., Wilber, A., Mo, Y. Y., Moore, B. E., Liu, W., Fukuda, K., Iiizumi, M., Sharma, S., Liu, Y., Wu, K., Peralta, E., and Watabe, K. (2013) Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating notch signalling in brain. EMBO Mol. Med. 5, 384-396</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, Q., Boire, A., Jin, X., Valiente, M., Er, E. E., Lopez-Soto, A., Jacob, L. S., Patwa, R., Shah, H., Xu, K., Cross, J. R., and Massagué, J. (2016) Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533, 493-498</Citation>
        </Reference>
        <Reference>
          <Citation>Abbott, N. J., Rönnbäck, L., and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53</Citation>
        </Reference>
        <Reference>
          <Citation>Abbott, N. J. (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200, 629-638</Citation>
        </Reference>
        <Reference>
          <Citation>Proia, P., Schiera, G., Mineo, M., Ingrassia, A. M. R., Santoro, G., Savettieri, G., and Di Liegro, I. (2008) Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int. J. Mol. Med. 21, 63-67</Citation>
        </Reference>
        <Reference>
          <Citation>Liang, Y., Brekken, R. A., and Hyder, S. M. (2006) Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones. Endocr. Relat. Cancer 13, 905-919</Citation>
        </Reference>
        <Reference>
          <Citation>Löffek, S., Schilling, O., and Franzke, C. W. (2011) Series “matrix metalloproteinases in lung health and disease”: biological role of matrix metalloproteinases: a critical balance. Eur. Respir. J. 38, 191-208</Citation>
        </Reference>
        <Reference>
          <Citation>Schachtrup, C., Ryu, J. K., Helmrick, M. J., Vagena, E., Galanakis, D. K., Degen, J. L., Margolis, R. U., and Akassoglou, K. (2010) Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-β after vascular damage. J. Neurosci. 30, 5843-5854</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, H., Katagiri, Y., McCann, T. E., Unsworth, E., Goldsmith, P., Yu, Z.-X., Tan, F., Santiago, L., Mills, E. M., Wang, Y., Symes, A. J., and Geller, H. M. (2008) Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J. Cell Sci. 121, 3083-3091</Citation>
        </Reference>
        <Reference>
          <Citation>Sochocka, M., Diniz, B. S., and Leszek, J. (2016) Inflammatory response in the CNS: friend or foe? [E-pub ahead of print] Mol. Neurobiol. 10.1007/212035-016-0297-1</Citation>
        </Reference>
        <Reference>
          <Citation>Kuzet, S.-E., and Gaggioli, C. (2016) Fibroblast activation in cancer: when seed fertilizes soil. Cell Tissue Res. 365, 607-619</Citation>
        </Reference>
        <Reference>
          <Citation>Preston, S. D., Steart, P. V., Wilkinson, A., Nicoll, J. A., and Weller, R. O. (2003) Capillary and arterial cerebral amyloid angiopathy in Alzheimer’s disease: defining the perivascular route for the elimination of amyloid β from the human brain. Neuropathol. Appl. Neurobiol. 29, 106-117</Citation>
        </Reference>
        <Reference>
          <Citation>Friedl, P., and Alexander, S. (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009</Citation>
        </Reference>
        <Reference>
          <Citation>Stroka, K. M., Jiang, H., Chen, S. H., Tong, Z., Wirtz, D., Sun, S. X., and Konstantopoulos, K. (2014) Water permeation drives tumor cell migration in confined microenvironments. Cell 157, 611-623</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, Z., Yu, P., Chen, H., and Geller, H. M. (2014) Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway. J. Neurochem. 130, 41-49</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor, A. R., Robinson, M. B., and Milligan, C.E. (2007) In vitro methods to prepare astrocyte and motoneuron cultures for the investigation of potential in vivo interactions. Nat. Protoc. 2, 1499-1507</Citation>
        </Reference>
        <Reference>
          <Citation>Miller, M. A., Meyer, A. S., Beste, M. T., Lasisi, Z., Reddy, S., Jeng, K. W., Chen, C.-H., Han, J., Isaacson, K., Griffith, L. G., and Lauffenburger, D. A. (2013) ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc. Natl. Acad. Sci. USA 110, e2074-E2083</Citation>
        </Reference>
        <Reference>
          <Citation>Nosoudi, N., Nahar-Gohad, P., Sinha, A., Chowdhury, A., Gerard, P., Carsten, C. G., Gray, B. H., and Vyavahare, N. R. (2015) Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles. Circ. Res. 117, e80-e89</Citation>
        </Reference>
        <Reference>
          <Citation>Rolli, M., Fransvea, E., Pilch, J., Saven, A., and Felding-Habermann, B. (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 9482-9487</Citation>
        </Reference>
        <Reference>
          <Citation>Isaksen, B., and Fagerhol, M. K. (2001) Calprotectin inhibits matrix metalloproteinases by sequestration of zinc. Mol. Pathol. 54, 289-292</Citation>
        </Reference>
        <Reference>
          <Citation>Balzer, E. M., Tong, Z., Paul, C. D., Hung, W. C., Stroka, K. M., Boggs, A. E., Martin, S. S., and Konstantopoulos, K. (2012) Physical confinement alters tumor cell adhesion and migration phenotypes. FASEB J. 26, 4045-4056</Citation>
        </Reference>
        <Reference>
          <Citation>Tong, Z., Balzer, E. M., Dallas, M. R., Hung, W.-C., Stebe, K. J., and Konstantopoulos, K. (2012) Chemotaxis of cell populations through confined spaces at single-cell resolution. PLoS One 7, e29211</Citation>
        </Reference>
        <Reference>
          <Citation>Stroka, K. M., Wong, B. S., Shriver, M., Phillip, J. M., Wirtz, D., Kontrogianni-Konstantopoulos, A., and Konstantopoulos, K. (2016) Loss of giant obscurins alters breast epithelial cell mechanosensing of matrix stiffness. Oncotarget 8, 54004-54020</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, L. A.,Aranda-Espinoza, H., Haun, J. B., and Hammer, D.A. (2007) Interplay between shear stress and adhesion on neutrophil locomotion. Biophys. J. 92, 632-640</Citation>
        </Reference>
        <Reference>
          <Citation>Kapoor, A., and Sen, S. (2012) Synergistic modulation of cellular contractility by mixed extracellular matrices. Int. J. Cell Biol. 2012, 471591</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, J. A., Kim, H. N., Im, S.-K., Chung, S., Kang, J. Y., and Choi, N. (2015) Collagen-based brain microvasculature model in vitro using three-dimensional printed template. Biomicrofluidics 9, 024115</Citation>
        </Reference>
        <Reference>
          <Citation>Wolf, K., Alexander, S., Schacht, V., Coussens, L. M., von Andrian, U. H., van Rheenen, J., Deryugina, E., and Friedl, P. (2009) Collagen-based cell migration models in vitro and in vivo. Semin. Cell Dev. Biol. 20, 931-941</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, X., Wang, Y., Chen, Z., Sternlicht, M. D., Hidalgo, M., and Steffensen, B. (2005) Matrix metalloproteinase-2 contributes to cancer cell migration on collagen. Cancer Res. 65, 130-136</Citation>
        </Reference>
        <Reference>
          <Citation>Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., Wilton, D. K., Frouin, A., Napier, B. A., Panicker, N., Kumar, M., Buckwalter, M. S., Rowitch, D. H., Dawson, V. L., Dawson, T. M., Stevens, B., and Barres, B. A. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481-487</Citation>
        </Reference>
        <Reference>
          <Citation>Flanders, K. C., Ren, R. F., and Lippa, C. F. (1998) Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54, 71-85</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, G. M., and Strunz, C. (2005) Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52, 209-218</Citation>
        </Reference>
        <Reference>
          <Citation>McAndrews, K. M., McGrail, D. J., Ravikumar, N., and Dawson, M. R. (2015) Mesenchymal stem cells induce directional migration of invasive breast cancer cells through TGF-β. Sci. Rep. 5, 16941</Citation>
        </Reference>
        <Reference>
          <Citation>Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174</Citation>
        </Reference>
        <Reference>
          <Citation>Yin, K.-J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.-F., Turk, J., Xu, J., Hsu, C. Y., Mills, J. C., Holtzman, D. M., and Lee, J.-M. (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26, 10939-10948</Citation>
        </Reference>
        <Reference>
          <Citation>Bigg, H. F., Rowan, A. D., Barker, M. D., and Cawston, T.E. (2007) Activity of matrix metalloproteinase-9 against native collagen types I and III. FEBS J. 274, 1246-1255</Citation>
        </Reference>
        <Reference>
          <Citation>Aimes, R. T., and Quigley, J. P. (1995) Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J. Biol. Chem. 270, 5872-5876</Citation>
        </Reference>
        <Reference>
          <Citation>Petrie, R. J., Koo, H., and Yamada, K. M. (2014) Generation of compartmentalized pressure by a nuclear piston governs cell motility in a 3D matrix. Science 345, 1062-1065</Citation>
        </Reference>
        <Reference>
          <Citation>Skau, C. T., Fischer, R. S., Gurel, P., Thiam, H. R., Tubbs, A., Baird, M. A., Davidson, M. W., Piel, M., Alushin, G. M., Nussenzweig, A., Steeg, P. S., and Waterman, C. M. (2016) FMN2 makes perinuclear actin to protect nuclei during confined migration and promote metastasis. Cell 167, 1571-1585.e18</Citation>
        </Reference>
        <Reference>
          <Citation>Lyons, S. M., Alizadeh, E., Mannheimer, J., Schuamberg, K., Castle, J., Schroder, B., Turk, P., Thamm, D., and Prasad, A. (2016) Changes in cell shape are correlated with metastatic potential in murine and human osteosarcomas. Biol. Open 5, 289-299</Citation>
        </Reference>
        <Reference>
          <Citation>Deakin, N. O., and Turner, C. E. (2011) Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol. Biol. Cell 22, 327-341</Citation>
        </Reference>
        <Reference>
          <Citation>Dowell, J. A., Johnson, J. A., and Li, L. (2009) Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. J. Proteome Res. 8, 4135-4143</Citation>
        </Reference>
        <Reference>
          <Citation>Hsieh, H. L., Wang, H. H., Wu, W. B., Chu, P. J., and Yang, C.M. (2010) Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK-and JNK-NF-κB pathways. J. Neuroinflammation 7, 88</Citation>
        </Reference>
        <Reference>
          <Citation>Seike, T., Fujita, K., Yamakawa, Y., Kido, M. A., Takiguchi, S., Teramoto, N., Iguchi, H., and Noda, M. (2011) Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin. Exp. Metastasis 28, 13-25</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083387</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1440-1827</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pathology international</Title>
          <ISOAbbreviation>Pathol. Int.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lung proliferative lesion-promoting effects of left pulmonary ligation in A/J female mice.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/pin.12915</ELocationID>
        <Abstract>
          <AbstractText>This present study was conducted in an attempt to examine proliferative lesion-promoting effect in the lung by compensatory lung growth after left pulmonary ligation. To examine a strong proliferative lesion-promoting effect in the lung, the effects of left pulmonary ligation on lung proliferative lesions induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were examined for 12 weeks. The number of proliferative lesions induced by NNK in the right lung after left pulmonary ligation increased significantly after 12 weeks, indicated by an increase in the weight of the right lung. In addition, several messenger RNA (mRNA) markers, including insulin growth factor 1, were highly expressed in the right lung on the seventh day after left ligation. These experiments demonstrated the clear proliferative lesion-promoting effects of pulmonary ligation on the induction of the expression of mRNAs related to the cell cycle, cell division and mitosis. However, the proliferative lesion-promoting effects were not strong enough to allow a shortened experimental period for the establishment of the lung bioassay model. The results also indicated the necessity to pay attention to the possibility of a recurrence of lung cancer in the residual lung after resection in humans.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yokohira</LastName>
            <ForeName>Masanao</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-8117-0495</Identifier>
            <AffiliationInfo>
              <Affiliation>Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hashimoto</LastName>
            <ForeName>Nozomi</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamakawa</LastName>
            <ForeName>Keiko</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakano-Narusawa</LastName>
            <ForeName>Yuko</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsuda</LastName>
            <ForeName>Yoko</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imaida</LastName>
            <ForeName>Katsumi</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>20-8</GrantID>
            <Agency>Grants-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Pathol Int</MedlineTA>
        <NlmUniqueID>9431380</NlmUniqueID>
        <ISSNLinking>1320-5463</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">A/J mouse</Keyword>
        <Keyword MajorTopicYN="N">IGF-1</Keyword>
        <Keyword MajorTopicYN="N">NNK</Keyword>
        <Keyword MajorTopicYN="N">ligation</Keyword>
        <Keyword MajorTopicYN="N">lung proliferative lesion</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083387</ArticleId>
        <ArticleId IdType="doi">10.1111/pin.12915</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Takeuchi H, Saoo K, Matsuda Y et al. Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett 2006; 234: 232-38.</Citation>
        </Reference>
        <Reference>
          <Citation>Mitchell E, Sanders J. Tobacco control in NSW: Evidence supporting improved strategies to reduce exposure to environmental tobacco smoke. NSW Public Health Bull 2002; 13: 215-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol 2000; 38: 637-46.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokohira M, Takeuchi H, Saoo K et al. Establishment of a bioassay model for lung cancer chemoprevention initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice. Exp Toxicol Pathol 2008; 60: 469-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Belinsky SA, Devereux TR, Foley JF, Maronpot RR, Anderson MW. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res 1992; 52: 3164-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Kushida H, Fujita K, Suzuki A, Yamada M, Nohmi T, Kamataki T. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108. Mutat Res 2000; 471: 135-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Imaida K, Yokohira M, Hashimoto N, Kuno T. Risk analysis of environmental chemicals on lung carcinogenesis. Asian Pac J Cancer Prev 2010; 11: 9-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Takeuchi H, Saoo K, Matsuda Y et al. 8-Methoxypsoralen, a potent human CYP2A6 inhibitor, inhibits lung adenocarcinoma development induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Mol Med Rep 2009; 2: 585-88.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuno T, Yokohira M, Matsuda Y et al. Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice. Oncol Rep 2008; 20: 767-72.</Citation>
        </Reference>
        <Reference>
          <Citation>Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010; 176: 2-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Hasegawa R, Ito N. Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. Food Chem Toxicol 1992; 30: 979-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Ito N, Tamano S, Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 2003; 94: 3-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokohira M, Hosokawa K, Yamakawa K et al. Potential inhibitory effects of D-allose, a rare sugar, on liver preneoplastic lesion development in F344 rat medium-term bioassay. J Biosci Bioeng 2008; 105: 545-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokohira M, Yamakawa K, Saoo K et al. Antioxidant effects of flavonoids used as food additives (purple corn color, enzymatically modified isoquercitrin, and isoquercitrin) on liver carcinogenesis in a rat medium-term bioassay. J Food Sci 2008; 73: C561-68.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsuda H, Futakuchi M, Fukamachi K et al. A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol Pathol 2010; 38: 182-87.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokohira M, Hashimoto N, Yamakawa K, Saoo K, Kuno T, Imaida K. Lack of promoting effects from physical pulmonary collapse in a female A/J mouse lung tumor initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) with remarkable mesothelial cell reactions in the thoracic cavity by the polymer. Exp Toxicol Pathol 2011; 63: 181-85.</Citation>
        </Reference>
        <Reference>
          <Citation>Hsia CC, Herazo LF, Fryder-Doffey F, Weibel ER. Compensatory lung growth occurs in adult dogs after right pneumonectomy. J Clin Invest 1994; 94: 405-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Cagle PT, Langston C, Thurlbeck WM. The effect of age on postpneumonectomy growth in rabbits. Pediatr Pulmonol 1988; 5: 92-95.</Citation>
        </Reference>
        <Reference>
          <Citation>Dungworth DL, Rittinghausen S, Schwartz L et al. Respiratory system and mesothelium. In: Mohr U, ed. International Classificatiosn of Rodent Tumors:The Mouse. New York: WHO. International Agency for Research on Cancer, 2001; 87-137.</Citation>
        </Reference>
        <Reference>
          <Citation>Boguszewski CL, Boguszewski MC, Kopchick JJ. Growth hormone, insulin-like growth factor system and carcinogenesis. Endokrynol Pol 2016; 67: 414-26.</Citation>
        </Reference>
        <Reference>
          <Citation>Brown LM, Malkinson AM, Rannels DE, Rannels SR. Compensatory lung growth after partial pneumonectomy enhances lung tumorigenesis induced by 3-methylcholanthrene. Cancer Res 1999; 59: 5089-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Rannels DE, Rannels SR. Compensatory growth of the lung following partial pneumonectomy. Exp Lung Res 1988; 14: 157-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Kumar V, Abbas A. Robbins and Cotran Pathologic Basis of Disease. New York: Saunders, 2004; 6-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokohira M, Nakano-Narusawa Y, Yamakawa K et al. Validating the use of napsin A as a marker for identifying tumorigenic potential of lung bronchiolo-alveolar hyperplasia in rodents. Exp Toxicol Pathol 2017; 69: 637-42.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokohira M, Kishi S, Yamakawa K et al. Napsin A is possibly useful marker to predict the tumorigenic potential of lung bronchiolo-alveolar hyperplasia in F344 rats. Exp Toxicol Pathol 2014; 66: 117-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Boguszewski CL. Molecular heterogeneity of human GH: From basic research to clinical implications. J Endocrinol Invest 2003; 26: 274-88.</Citation>
        </Reference>
        <Reference>
          <Citation>Bergman D, Halje M, Nordin M, Engstrom W. Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology 2013; 59: 240-49.</Citation>
        </Reference>
        <Reference>
          <Citation>Fajka-Boja R, Marton A, Tóth A et al. Increased insulin-like growth factor 1 production by polyploid adipose stem cells promotes growth of breast cancer cells. BMC Cancer 2018; 18: 872.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083388</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4998</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pest management science</Title>
          <ISOAbbreviation>Pest Manag. Sci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Odorant binding proteins and chemosensory proteins potentially involved in host plant recognition in the Asian citrus psyllid, Diaphorina citri.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ps.5799</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Odorant-binding proteins (OBPs) and chemosensory proteins (CSPs) are two families of small water-soluble proteins, which are involved in odor detection and subsequent signal transmission. Determination of their binding mechanisms and specificity towards different odorants are important for developing OBPs/CSPs as targets in pest control management.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We re-annotated genes encoding putative OBPs and CSPs in the Asian citrus psyllid (Diaphorina citri) draft genome using various bioinformatic tools. Genes encoding nine OBPs (seven Classic and two Plus-C OBPs) and 12 CSPs were identified, consistent with our previous transcriptomic results. Tissue-specific and developmental expression analyses suggested that genes encoding six OBPs and four CSPs were predominantly expressed in antennae, and displayed various expression patterns in different development stages, suggesting potential involvement in olfactory perception. Competitive fluorescence binding assays with 13 candidate ligands, including known host plant volatiles, sex pheromone components and repellents, showed that DcitOBP3 could bind to various odorants, whereas DcitOBP6, 8 and 9 bound specifically to host plant terpenoids. DcitCSP1 and 12 could also bind to certain terpenoids with high binding specificity.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">OBP- and CSP-encoding genes were systematically identified by annotating the draft D. citri genome and those potentially involved in odorant detection and signal transmission were identified by analyzing their tissue-expression profiles and odorant-binding affinities, particularly to the peripheral molecular perception of host plant terpenoids. The identified genes may provide potential targets for efficient pest control. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>He</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Guangzhou City Key Laboratory of Subtropical Fruit Tree Outbreak Control, Zhongkai University of Agriculture and Engineering, Guangzhou, 510225, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jun-Long</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Guangzhou City Key Laboratory of Subtropical Fruit Tree Outbreak Control, Zhongkai University of Agriculture and Engineering, Guangzhou, 510225, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Jia-Hao</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Guangzhou City Key Laboratory of Subtropical Fruit Tree Outbreak Control, Zhongkai University of Agriculture and Engineering, Guangzhou, 510225, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Jin-Tian</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Guangzhou City Key Laboratory of Subtropical Fruit Tree Outbreak Control, Zhongkai University of Agriculture and Engineering, Guangzhou, 510225, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Zhong-Zhen</ForeName>
            <Initials>ZZ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1761-1740</Identifier>
            <AffiliationInfo>
              <Affiliation>Guangzhou City Key Laboratory of Subtropical Fruit Tree Outbreak Control, Zhongkai University of Agriculture and Engineering, Guangzhou, 510225, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pest Manag Sci</MedlineTA>
        <NlmUniqueID>100898744</NlmUniqueID>
        <ISSNLinking>1526-498X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chemosensory protein</Keyword>
        <Keyword MajorTopicYN="N">Competitive fluorescence binding assays</Keyword>
        <Keyword MajorTopicYN="N">Diaphorina citri</Keyword>
        <Keyword MajorTopicYN="N">Molecular docking</Keyword>
        <Keyword MajorTopicYN="N">Odorant-binding protein</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083388</ArticleId>
        <ArticleId IdType="doi">10.1002/ps.5799</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083389</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3773</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Angewandte Chemie (International ed. in English)</Title>
          <ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genomic encryption of digital data stored in synthetic DNA.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.202001162</ELocationID>
        <Abstract>
          <AbstractText>Today, we can read human genomes and store digital data robustly in synthetic DNA. Here we report a strategy to intertwine these two technologies to enable the secure storage of valuable information in synthetic DNA, protected with personalized keys. We show that genetic short tandem repeats (STRs) contain sufficient entropy to generate strong encryption keys, and that only one technology, DNA sequencing, is required to simultaneously read key and data. Using this approach, we experimentally generated 80 bit strong keys from human DNA, and used such a key to encrypt 17kB of digital information stored in synthetic DNA. Finally, the decrypted information was recovered perfectly from a single massively parallel sequencing run.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Grass</LastName>
            <ForeName>Robert N</ForeName>
            <Initials>RN</Initials>
            <AffiliationInfo>
              <Affiliation>ETH Zurich, Institute for Chemical and Bioengineering, Vladimir-Prelog-Weg 1, HCI E 111, 8093, Zürich, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Heckel</LastName>
            <ForeName>Reinhard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Rice University, Department of Electrical Engineergin, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dessimoz</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>University of Lausanne, Department of Computational Biology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stark</LastName>
            <ForeName>Wendelin J</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>ETH Zurich, Department of Chemistry and Applied Biosciences, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
        <NlmUniqueID>0370543</NlmUniqueID>
        <ISSNLinking>1433-7851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Next Generation Sequencing</Keyword>
        <Keyword MajorTopicYN="N">STR profiles</Keyword>
        <Keyword MajorTopicYN="N">Synthetic DNA</Keyword>
        <Keyword MajorTopicYN="N">biometrics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083389</ArticleId>
        <ArticleId IdType="doi">10.1002/anie.202001162</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083390</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-1241</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of clinical practice</Title>
          <ISOAbbreviation>Int. J. Clin. Pract.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of High-Intensity Interval Training and Continuous Endurance Training on Peak Oxygen Uptake Among Seniors Aged 65 or Older: A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13490</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13490</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Aging is intrinsically associated with a progressive decline in cardiorespiratory fitness (CRF) as measured by peak oxygen uptake (VO<sub>2peak</sub> ). Improving CRF through physical activity contribute to better and healthy ageing. High-intensity interval training (HIIT) is a potent method of improving CRF among seniors, yet comparisons between this type of training and traditional endurance training (ET) are equivocal especially among older adults.</AbstractText>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To analyze the effects of HIIT and ET on the VO<sub>2peak</sub> of seniors aged 65 years or older when compared with controls and also when the two types of training were compared with one another.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive, systematic database search for manuscripts was performed in Embase, Medline, PubMed Central, ScienceDirect, Scopus, and Web of Science using key words. Two reviewers independently assessed interventional studies for potential inclusion. Fifteen randomized controlled trials (RCTs) were included totaling 480 seniors aged 65 years or over. Across the trials, no high risk of bias was measured.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In pooled analysis of the RCTs, the VO<sub>2peak</sub> was significantly higher after ET sessions compared to controls (mean difference - MD = 1.35; 95% confidence interval - CI: 0.73 - 1.96). Furthermore, VO<sub>2peak</sub> was found significantly higher not only when compared HIIT with controls (MD = 4.61; 95% CI: 3.21 - 6.01), but also when compared HIIT with ET (MD = 3.76; 95% CI: 2.96 - 4.56).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">HIIT and ET both elicit large improvements in the VO<sub>2peak</sub> of older adults aged 65 or over. When compared with ET, the gain in VO<sub>2peak</sub> was greater following HIIT. Nevertheless, further RCTs are therefore needed to confirm our results in senior's population.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bouaziz</LastName>
            <ForeName>Walid</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5710-1342</Identifier>
            <AffiliationInfo>
              <Affiliation>French Armed Biomedical Research Institute, Unit of Physiology of Exercise and Activities in Extreme Conditions, Brétigny sur Orge, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>LBEPS, University of Évry, IRBA, University of Paris-Saclay, Évry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malgoyre</LastName>
            <ForeName>Alexandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>French Armed Biomedical Research Institute, Unit of Physiology of Exercise and Activities in Extreme Conditions, Brétigny sur Orge, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>LBEPS, University of Évry, IRBA, University of Paris-Saclay, Évry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmitt</LastName>
            <ForeName>Elise</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Department, Medical School and University Hospitals of Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lang</LastName>
            <ForeName>Pierre-Olivier</ForeName>
            <Initials>PO</Initials>
            <AffiliationInfo>
              <Affiliation>Montchoisi Clinic, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vogel</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Department, Medical School and University Hospitals of Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanagaratnam</LastName>
            <ForeName>Lukshe</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Research and Public health, University Hospitals of Reims, Reims, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Clin Pract</MedlineTA>
        <NlmUniqueID>9712381</NlmUniqueID>
        <ISSNLinking>1368-5031</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HIIT</Keyword>
        <Keyword MajorTopicYN="N">VO2peak</Keyword>
        <Keyword MajorTopicYN="N">aerobic training</Keyword>
        <Keyword MajorTopicYN="N">cardiorespiratory fitness</Keyword>
        <Keyword MajorTopicYN="N">endurance training</Keyword>
        <Keyword MajorTopicYN="N">older adults</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083390</ArticleId>
        <ArticleId IdType="doi">10.1111/ijcp.13490</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083391</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4957</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cytometry. Part B, Clinical cytometry</Title>
          <ISOAbbreviation>Cytometry B Clin Cytom</ISOAbbreviation>
        </Journal>
        <ArticleTitle>It is time to adopt a multicolor immunophenotyping approach to evaluate blood for Sézary syndrome and mycosis fungoides.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cyto.b.21872</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Craig</LastName>
            <ForeName>Fiona E</ForeName>
            <Initials>FE</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1743-3454</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cytometry B Clin Cytom</MedlineTA>
        <NlmUniqueID>101235690</NlmUniqueID>
        <ISSNLinking>1552-4949</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083391</ArticleId>
        <ArticleId IdType="doi">10.1002/cyto.b.21872</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Bernengo, M. G., Novelli, M., Quaglino, P., Lisa, F., De Matteis, A., Savoia, P., … Fierro, M. T. (2001). The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. The British Journal of Dermatology, 144(1), 125-135.</Citation>
        </Reference>
        <Reference>
          <Citation>Bogen, S. A., Pelley, D., Charif, M., McCusker, M., Koh, H., Foss, F., … Zucker-Franklin, D. (1996). Immunophenotypic identification of Sezary cells in peripheral blood. American Journal of Clinical Pathology, 106(6), 739-748.</Citation>
        </Reference>
        <Reference>
          <Citation>Boumsell, L., Bernard, A., Reinherz, E. L., Nadler, L. M., Ritz, J., Coppin, H., … Schlossman, S. F. (1981). Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood, 57(3), 526-530.</Citation>
        </Reference>
        <Reference>
          <Citation>Clinical Laboratory Standards Institute. Validation of assays performed by flow cytometry (H62).</Citation>
        </Reference>
        <Reference>
          <Citation>DiGiuseppe, J. A., &amp; Wood, B. L. (2019). Applications of flow cytometric immunophenotyping in the diagnosis and posttreatment monitoring of B and T lymphoblastic leukemia/lymphoma. Cytometry. Part B, Clinical Cytometry, 96(4), 256-265.</Citation>
        </Reference>
        <Reference>
          <Citation>Guitart, J. Sézary syndrome and mycosis fungoides flow cytometric evaluation: The clinicians' perspective. Cytometry. Part B, Clinical Cytometry.</Citation>
        </Reference>
        <Reference>
          <Citation>Haynes, B. F., Bunn, P., Mann, D., Thomas, C., Eisenbarth, G. S., Minna, J., &amp; Fauci, A. S. (1981). Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. The Journal of Clinical Investigation, 67(2), 523-530.</Citation>
        </Reference>
        <Reference>
          <Citation>Horna, P., Deaver, D. M., Qin, D., Moscinski, L. C., Sotomayor, E. M., Glass, L. F., &amp; Sokol, L. (2014). Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis. Journal of Clinical Pathology, 67(5), 431-436.</Citation>
        </Reference>
        <Reference>
          <Citation>Horna, P., Wang, S. A., Wolniak, K. L., Psarra, K., Almeida, J., Illingworth, A. J., … Torres, R. Flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: International guidelines for assay design. Cytometry. Part B, Clinical Cytometry.</Citation>
        </Reference>
        <Reference>
          <Citation>Illingworth, A. J., Johansson, U., Huang, S., Horna, P., Almeida, J., Torres, R., &amp; Craig, F. E. International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: Assay optimization, validation and ongoing quality monitors. Cytometry. Part B, Clinical Cytometry.</Citation>
        </Reference>
        <Reference>
          <Citation>Jevremovic, D., &amp; Olteanu, H. (2019). Flow Cytometry applications in the diagnosis of T/NK-cell Lymphoproliferative disorders. Cytometry. Part B, Clinical Cytometry, 96(2), 99-115.</Citation>
        </Reference>
        <Reference>
          <Citation>Kelemen, K., Guitart, J., Kuzel, T. M., Goolsby, C. L., &amp; Peterson, L. C. (2008). The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. American Journal of Clinical Pathology, 129(1), 146-156.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., &amp; Hoppe, R. T. (2003). Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: Clinical prognostic factors and risk for disease progression. Archives of Dermatology, 139(7), 857-866.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuchnio, M., Sausville, E. A., Jaffe, E. S., Greiner, T., Foss, F. M., McClanahan, J., … Stetler-Stevenson, M. A. (1994). Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression. American Journal of Clinical Pathology, 102(6), 856-860.</Citation>
        </Reference>
        <Reference>
          <Citation>Lamberg, S. I., &amp; Bunn, P. A., Jr. (1979). Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Archives of Dermatology, 115(9), 1103-1105.</Citation>
        </Reference>
        <Reference>
          <Citation>Main, R. A., Goodall, H. B., &amp; Swanson, W. C. (1959). Sezary's syndrome. The British Journal of Dermatology, 71, 335-343.</Citation>
        </Reference>
        <Reference>
          <Citation>Moll, M., Reinhold, U., Kukel, S., Abken, H., Müller, R., Oltermann, I., &amp; Kreysel, H. W. (1994). CD7-negative helper T cells accumulate in inflammatory skin lesions. The Journal of Investigative Dermatology, 102(3), 328-332.</Citation>
        </Reference>
        <Reference>
          <Citation>Novelli, M., Fava, P., Sarda, C., Ponti, R., Osella-Abate, S., Savoia, P., … Quaglino, P. (2015). Blood flow cytometry in Sézary syndrome: New insights on prognostic relevance and immunophenotypic changes during follow-up. American Journal of Clinical Pathology, 143(1), 57-69.</Citation>
        </Reference>
        <Reference>
          <Citation>Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., … Whittaker, S. (2007). ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of cancer (EORTC). Blood, 110(6), 1713-1722.</Citation>
        </Reference>
        <Reference>
          <Citation>Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., … Cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. (2011). Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. Journal of Clinical Oncology, 29(18), 2598-2607.</Citation>
        </Reference>
        <Reference>
          <Citation>Pulitzer, M. P., Horna, P., &amp; Almeida, J. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping. Cytometry. Part B, Clinical Cytometry.</Citation>
        </Reference>
        <Reference>
          <Citation>Scarisbrick, J. J., Hodak, E., Bagot, M., Stranzenbach, R., Stadler, R., Ortiz-Romero, P. L., … Vermeer, M. H. (2018). Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: Recommendations from the EORTC cutaneous lymphoma task force. European Journal of Cancer, 93, 47-56.</Citation>
        </Reference>
        <Reference>
          <Citation>Sezary, A., &amp; Bouvrain, Y. (1938). Erythrodermie avec presence de cellules monstrueuses dans le derme et le sang circulant. Bulletin Society French Dermatology and Syphilology, 45, 254-260.</Citation>
        </Reference>
        <Reference>
          <Citation>Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., … ISCL. (2002). Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas. Journal of the American Academy of Dermatology, 46(1), 95-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Waldmann, T. A., Greene, W. C., Sarin, P. S., Saxinger, C., Blayney, D. W., Blattner, W. A., et al. (1984). Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. The Journal of Clinical Investigation, 73(6), 1711-1718.</Citation>
        </Reference>
        <Reference>
          <Citation>Washington, L. T., Huh, Y. O., Powers, L. C., Duvic, M., &amp; Jones, D. (2002). A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clinical Pathology, 2(1), 5.</Citation>
        </Reference>
        <Reference>
          <Citation>Willemze, R., van Vloten, W. A., Hermans, J., Damsteeg, M. J., &amp; Meijer, C. J. (1983). Diagnostic criteria in Sézary's syndrome: A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. The Journal of Investigative Dermatology, 81(5), 392-397.</Citation>
        </Reference>
        <Reference>
          <Citation>Wood, G. S., Hong, S. R., Sasaki, D. T., Abel, E. A., Hoppe, R. T., Warnke, R. A., &amp; Morhenn, V. B. (1990). Leu-8/CD7 antigen expression by CD3+ T cells: Comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. Journal of the American Academy of Dermatology, 22(4), 602-607.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083392</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3765</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Chemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Polar organofluorine substituents: Multivicinal fluorines on alkyl chains and alicyclic rings.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chem.202000178</ELocationID>
        <Abstract>
          <AbstractText>This Review outlines the progression, primarily of our own work, but with important contributions from other labs, on the synthesis and properties of multiple vicinally fluorinated alkyl chains and rings. Chain conformations of individual diastereoisomers with -CHF- at adjacent carbons are influenced by stereoelectronic factors associated with the polar C-F bond and the polarised geminal hydrogens. Generally the chain will prefer a conformation which acts to minimise overall molecular polarity, and where the C-F bonds orient away from each other. However when vicinal fluorines are positioned on a ring then conformations are more constrained. The ring will adopt optimal conformations such as a chair in cyclohexane and then C-F bonds can be introduced with a stereochemistry that forces parallel (axial) orientations. In the case of cyclohexane, 1,3-diaxial arrangements of C-F bonds impart considerable polarity to the ring, resulting in an electronegative 'fluorine face' and an electropositive 'hydrogen face'. For all- syn 1,2,3,4,5,6-hexafluorocyclohexane, this arrangement generates an unusually polar aliphatic ring system. Most recently the concept has been extended to the preparation of all- syn 1,2,3-trifluorocyclopropanes, a rigid ring system with fluorines on one face and hydrogens on the other. Log Ps of such compounds indicate that they are significantly more polar than their parent alicyclic hydrocarbons and give some positive indication for a future role of such substituents in medicinal chemistry. Expanding to such a role will require access to improved synthesis methods to these motifs and consequently access to a broader a range of building blocks, however some exciting new methods have emerged recently and these are briefly reviewed.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>O'Hagan</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University of St Andrews, Department of Chemistry, North Haugh, KY16 9ST, St. Andrews, UNITED KINGDOM.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chemistry</MedlineTA>
        <NlmUniqueID>9513783</NlmUniqueID>
        <ISSNLinking>0947-6539</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Organofluorine chemistry</Keyword>
        <Keyword MajorTopicYN="N">alicyclic chemistry</Keyword>
        <Keyword MajorTopicYN="N">aliphatic conformation</Keyword>
        <Keyword MajorTopicYN="N">cyclopropanes</Keyword>
        <Keyword MajorTopicYN="N">selective fluorination</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083392</ArticleId>
        <ArticleId IdType="doi">10.1002/chem.202000178</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083393</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-1241</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of clinical practice</Title>
          <ISOAbbreviation>Int. J. Clin. Pract.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Baseline plasma lipid levels in patients with Acute Coronary Syndrome: Association with 20-year mortality. The ABC-5a Study on Heart Disease.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13492</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13492</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The relationship between baseline plasma lipid levels during acute coronary syndrome and the outcome has clinical relevance.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">To evaluate their long-term prognostic value we examined 589 patients admitted with acute coronary syndrome at three hospitals. Baseline plasma lipids were assessed on days 1 and 7. Patients were followed for 20 years or until death.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Virtually all patients completed follow-up; 437 (74%) had died: 24% due to coronary artery disease/heart failure (CAD/HF), 21% sudden cardiac death (SCD), 16% due to other cardiovascular causes, and 39% due to non-cardiac death. The incidence rate (IR) of all-cause mortality was not different among patients with baseline plasma lipids less or greater than the median value. The IR of CAD/HF mortality was not significantly higher among patients with greater than median LDL and triglyceride levels. The IR of non-cardiac death tended to be lower among patients with greater than median TC and LDL levels. Using three levels of adjusted Cox survival models, baseline plasma lipids had no consistent independent or inverse association with all-cause mortality, even after excluding patients who received statins. Competitive risk survival models for each cause of death revealed that the only hazard of non-cardiac death was consistently higher among patients with less than or equal to median TC and LDL levels.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In the present prospective long term study, after acute coronary syndrome, baseline plasma lipid levels seem not to be associated with long-term global mortality. Only an independent inverse association between TC and LDL and non-cardiac death has been observed.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berton</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9965-0932</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Conegliano General Hospital, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The ABC Heart Disease Foundation-ONLUS, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cordiano</LastName>
            <ForeName>Rocco</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine and Cardiology, Adria General Hospital, Adria, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The ABC Heart Disease Foundation-ONLUS, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahmoud</LastName>
            <ForeName>Heba T</ForeName>
            <Initials>HT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Conegliano General Hospital, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The ABC Heart Disease Foundation-ONLUS, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palmieri</LastName>
            <ForeName>Rosa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine and Cardiology, Adria General Hospital, Adria, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The ABC Heart Disease Foundation-ONLUS, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cavuto</LastName>
            <ForeName>Fiorella</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Bassano del Grappa General Hospital, Bassano del Grappa, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The ABC Heart Disease Foundation-ONLUS, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pasquinucci</LastName>
            <ForeName>Mattia</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Conegliano General Hospital, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The ABC Heart Disease Foundation-ONLUS, Conegliano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Clin Pract</MedlineTA>
        <NlmUniqueID>9712381</NlmUniqueID>
        <ISSNLinking>1368-5031</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acute coronary syndrome</Keyword>
        <Keyword MajorTopicYN="N">Competitive risks</Keyword>
        <Keyword MajorTopicYN="N">LDL</Keyword>
        <Keyword MajorTopicYN="N">Long-term follow up</Keyword>
        <Keyword MajorTopicYN="N">Plasma lipids</Keyword>
        <Keyword MajorTopicYN="N">Survival analysis</Keyword>
        <Keyword MajorTopicYN="N">cholesterol</Keyword>
        <Keyword MajorTopicYN="N">non-cardiac death</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083393</ArticleId>
        <ArticleId IdType="doi">10.1111/ijcp.13492</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083394</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-7909</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of integrative plant biology</Title>
          <ISOAbbreviation>J Integr Plant Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>QTL pyramiding for producing nutritious and safe rice grains.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jipb.12920</ELocationID>
        <Abstract>
          <AbstractText>Breeding of rice varieties that are enriched with essential micronutrients and simultaneously have reduced levels of toxic elements in grains is largely unexplored in rice breeding practice. In this issue of JIPB, Liu et al. (2020) developed two rice lines with low level of cadmium and simultaneously high levels of zinc or selenium accumulation in the grains, thus providing elite genetic materials for breeding rice varieties important for addressing mineral malnutrition and ensuring food safety. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xin-Yuan</ForeName>
            <Initials>XY</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Crop Genetics and Germplasm Enhancement, College of Resources and Environmental Sciences, Nanjing Agricultural University, Nanjing, 210095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Fang-Jie</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Crop Genetics and Germplasm Enhancement, College of Resources and Environmental Sciences, Nanjing Agricultural University, Nanjing, 210095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>China (Republic : 1949- )</Country>
        <MedlineTA>J Integr Plant Biol</MedlineTA>
        <NlmUniqueID>101250502</NlmUniqueID>
        <ISSNLinking>1672-9072</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083394</ArticleId>
        <ArticleId IdType="doi">10.1111/jipb.12920</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083395</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4876</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part C, Seminars in medical genetics</Title>
          <ISOAbbreviation>Am J Med Genet C Semin Med Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genetic variants in rheumatic fever and rheumatic heart disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.c.31773</ELocationID>
        <Abstract>
          <AbstractText>Genetic association studies in rheumatic heart disease (RHD) have the potential to contribute toward our understanding of the pathogenetic mechanism, and may shed light on controversies about RHD etiology. Furthermore, genetic association studies may uncover biomarkers that can be used to identify susceptible individuals, and contribute toward developing vaccine and novel therapeutic targets. Genetic predisposition to rheumatic fever and RHD has been hypothesized by findings from familial studies and observed associations between genes located in the human leukocyte antigens on chromosome 6p21.3 and elsewhere in the genome. We sought to summarize, from published Genetic association studies in RHD, evidence on genetic variants implicated in RHD susceptibility. Using HuGENet™ systematic review methods, we evaluated 66 studies reporting on 42 genes. Existing meta-analyses of candidate gene studies suggest that TGF-β1 [rs1800469], and IL-1β [rs2853550] single nucleotide polymorphisms (SNPs) contribute to susceptibility to RHD, whereas the TNF-α [rs1800629 and rs361525], TGF-β1 [rs1800470 and rs4803457], IL-6 [rs1800795], IL-10 [rs1800896] were not associated with RHD. However, candidate gene studies in RF/RHD are relatively small, thus lacking statistical power to identify reliable and reproducible findings, emphasizing the need for large-scale multicenter studies with different populations.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Muhamed</LastName>
            <ForeName>Babu</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4832-0671</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Cape Town, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hatter Institute for Cardiovascular Diseases Research in Africa, Observatory, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Children's National Health System, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaboodien</LastName>
            <ForeName>Gasnat</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Cape Town, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hatter Institute for Cardiovascular Diseases Research in Africa, Observatory, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Engel</LastName>
            <ForeName>Mark E</ForeName>
            <Initials>ME</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1334-8829</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Cape Town, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>American Heart Association</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>116287</GrantID>
            <Agency>National Research Foundation of South Africa</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>94044</GrantID>
            <Agency>National Research Foundation of South Africa</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Medical Research Council of South Africa (MRC-SA)</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet C Semin Med Genet</MedlineTA>
        <NlmUniqueID>101235745</NlmUniqueID>
        <ISSNLinking>1552-4868</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">genetics</Keyword>
        <Keyword MajorTopicYN="N">polymorphisms</Keyword>
        <Keyword MajorTopicYN="N">rheumatic fever</Keyword>
        <Keyword MajorTopicYN="N">rheumatic heart disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083395</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.c.31773</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Abdallah, A. M., Al-Mazroea, A. H., Al-Harbi, W. N., Al-Harbi, N. A., Eldardear, A. E., Almohammadi, Y., &amp; Al-Harbi, K. M. (2016). Impact of MIF gene promoter variations on risk of rheumatic heart disease and its age of onset in Saudi Arabian patients. Frontiers in Immunology, 7, 98. https://doi.org/10.3389/fimmu.2016.00098</Citation>
        </Reference>
        <Reference>
          <Citation>Abdallah, A. M., Alnuzha, A., Al-Mazroea, A. H., Eldardear, A. E., AlSamman, A. Y., Almohammadi, Y., &amp; Al-Harbi, K. M. (2016). IL10 promoter polymorphisms are associated with rheumatic heart disease in Saudi Arabian patients. Pediatric Cardiology, 37(1), 99-105. https://doi.org/10.1007/s00246-015-1245-y</Citation>
        </Reference>
        <Reference>
          <Citation>Aksoy, R., Duman, T., Keskin, O., &amp; Duzgun, N. (2011). No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Molecular Biology Reports, 38(8), 5,393-5,396. https://doi.org/10.1007/s11033-011-0692-7</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Harbi, K. M., Almuzaini, I. S., Morsy, M. M., Abdelaziz, N. A., Al-Balawi, A. M., &amp; Abdallah, A. M. (2015). Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease. Saudi Medical Journal, 36(2), 176-180. https://doi.org/10.15537/smj.2015.2.10267</Citation>
        </Reference>
        <Reference>
          <Citation>Atalar, E., Tokgozoglu, S. L., Alikasifoglu, M., Ovunc, K., Aksoyek, S., Kes, S., &amp; Tuncbilek, E. (2003). Angiotensin-converting enzyme genotype predicts valve damage in acute rheumatic fever. The Journal of Heart Valve Disease, 12(1), 7-10 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=12578328</Citation>
        </Reference>
        <Reference>
          <Citation>Azad, N., Rojanasakul, Y., &amp; Vallyathan, V. (2008). Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. Journal of Toxicology and Environmental Health. Part B, Critical Reviews, 11(1), 1-15. https://doi.org/10.1080/10937400701436460</Citation>
        </Reference>
        <Reference>
          <Citation>Azevedo, P. M., Bauer, R., Caparbo Vde, F., Silva, C. A., Bonfa, E., &amp; Pereira, R. M. (2010). Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine, 49(1), 109-113. https://doi.org/10.1016/j.cyto.2009.09.003</Citation>
        </Reference>
        <Reference>
          <Citation>Azevedo, P. M., Merriman, T. R., Topless, R. K., Wilson, N. J., Crengle, S., &amp; Lennon, D. R. (2016). Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Maori and Pacific ancestry. Cytokine, 85, 201-206. https://doi.org/10.1016/j.cyto.2016.06.029</Citation>
        </Reference>
        <Reference>
          <Citation>Berdeli, A., Celik, H. A., Ozyurek, R., &amp; Aydin, H. H. (2004). Involvement of immunoglobulin FcgammaRIIA and FcgammaRIIIB gene polymorphisms in susceptibility to rheumatic fever. Clinical Biochemistry, 37(10), 925-929. https://doi.org/10.1016/j.clinbiochem.2004.06.007</Citation>
        </Reference>
        <Reference>
          <Citation>Berdeli, A., Celik, H. A., Ozyurek, R., Dogrusoz, B., &amp; Aydin, H. H. (2005). TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. Journal of Molecular Medicine (Berlin, Germany), 83(7), 535-541. https://doi.org/10.1007/s00109-005-0677-x</Citation>
        </Reference>
        <Reference>
          <Citation>Berdeli, A., Tabel, Y., Celik, H. A., Ozyurek, R., Dogrusoz, B., &amp; Aydin, H. H. (2006). Lack of association between TNFalpha gene polymorphism at position -308 and risk of acute rheumatic fever in Turkish patients. Scandinavian Journal of Rheumatology, 35(1), 44-47. https://doi.org/10.1080/03009740510026760</Citation>
        </Reference>
        <Reference>
          <Citation>Bhatt, M., Kumar, S., Garg, N., Siddiqui, M. H., &amp; Mittal, B. (2019). Influence of IL-1β STAT3 &amp; 5 and TLR-5 gene polymorphisms on rheumatic heart disease susceptibility in north Indian population. International Journal of Cardiology. 15, 89-95. https://doi.org/10.1016/j.ijcard.2019.03.035</Citation>
        </Reference>
        <Reference>
          <Citation>Bhatt, M., Kumar, S., Siddiqui, M. H., Garg, N., &amp; Mittal, B. (2018). Influence of cytokine gene polymorphism on the risk of rheumatic heart disease-A meta-analysis. Immunology Letters, 194, 69-78. https://doi.org/10.1016/j.imlet.2018.01.001</Citation>
        </Reference>
        <Reference>
          <Citation>Bright, P. D., Mayosi, B. M., &amp; Martin, W. J. (2016). An immunological perspective on rheumatic heart disease pathogenesis: More questions than answers. Heart, 102(19), 1527-1532. https://doi.org/10.1136/heartjnl-2015-309188</Citation>
        </Reference>
        <Reference>
          <Citation>Bryant, P. A., Robins-Browne, R., Carapetis, J. R., &amp; Curtis, N. (2009). Some of the people, some of the time: Susceptibility to acute rheumatic fever. Circulation, 119(5), 742-753. https://doi.org/10.1161/circulationaha.108.792135</Citation>
        </Reference>
        <Reference>
          <Citation>Carlus, S. J., Abdallah, A. M., Bhaskar, L. V., Morsy, M. M., Al-Harbi, G. S., Al-Mazroea, A. H., &amp; Al-Harbi, K. M. (2016). The MTHFR C677T polymorphism is associated with mitral valve rheumatic heart disease. European Review for Medical and Pharmacological Sciences, 20(1), 109-114.</Citation>
        </Reference>
        <Reference>
          <Citation>Catarino, S. J., Andrade, F. A., Boldt, A. B. W., Guilherme, L., &amp; Messias-Reason, I. J. (2018). Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever. Frontiers in Immunology, 9, 3009. https://doi.org/10.3389/fimmu.2018.03009</Citation>
        </Reference>
        <Reference>
          <Citation>Catarino, S. J., Boldt, A. B., Beltrame, M. H., Nisihara, R. M., Schafranski, M. D., &amp; de Messias-Reason, I. J. (2014). Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease. Human Immunology, 75(12), 1197-1202. https://doi.org/10.1016/j.humimm.2014.10.003</Citation>
        </Reference>
        <Reference>
          <Citation>Cheadle, W. (1889). Harveian lectures on the various manifestation of the rheumatic state as exemplified in childhood and early life. Lancet, 133, 821-827.</Citation>
        </Reference>
        <Reference>
          <Citation>Chou, H. T., Chen, C. H., Tsai, C. H., &amp; Tsai, F. J. (2004). Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. American Heart Journal, 148(1), 181-186. https://doi.org/10.1016/j.ahj.2004.03.032</Citation>
        </Reference>
        <Reference>
          <Citation>Chou, H. T., Tsai, C. H., Chen, W. C., &amp; Tsai, F. J. (2005). Lack of association of genetic polymorphisms in the interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese. International Heart Journal, 46(3), 397-406.</Citation>
        </Reference>
        <Reference>
          <Citation>Chou, H. T., Tsai, C. H., &amp; Tsai, F. J. (2004). Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Japanese Heart Journal, 45(6), 949-957.</Citation>
        </Reference>
        <Reference>
          <Citation>Chou, H. T., &amp; Tsai, F. J. (2006). Tumor necrosis factor-α gene G-308A and G-238A polymorphisms are not associated with rheumatic heart disease in Taiwan. Mid-Taiwan Journal of Medicine, 11(3), 149-154 Retrieved from https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749610183&amp;partnerID=40&amp;md5=681622b9b100277f1563cf76232abd80</Citation>
        </Reference>
        <Reference>
          <Citation>Col-Araz, N., Pehlivan, S., Baspinar, O., Oguzkan-Balci, S., Sever, T., &amp; Balat, A. (2012). Role of cytokine gene (IFN-gamma, TNF-alpha, TGF-beta1, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children. European Journal of Pediatrics, 171(7), 1103-1108. https://doi.org/10.1007/s00431-012-1689-5</Citation>
        </Reference>
        <Reference>
          <Citation>Col-Araz, N., Pehlivan, S., Baspinar, O., Sever, T., Oguzkan-Balci, S., &amp; Balat, A. (2013). Association of macrophage migration inhibitory factor and mannose-binding lectin-2 gene polymorphisms in acute rheumatic fever. Cardiology in the Young, 23(4), 486-490. https://doi.org/10.1017/s1047951112000972</Citation>
        </Reference>
        <Reference>
          <Citation>Cosan, F., Oku, B., Cakiris, A., Duymaz-Tozkir, J., Mercanoglu, F., Saruhan-Direskeneli, G., … Gul, A. (2009). No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet's disease. Clinical Rheumatology, 28(12), 1385-1388. https://doi.org/10.1007/s10067-009-1,252-6</Citation>
        </Reference>
        <Reference>
          <Citation>Dai, W., Ye, Z., Lu, H., Su, Q., Li, H., &amp; Li, L. (2018). Meta-analysis of the relationship between single nucleotide polymorphism of IL-10-1082G/A and rheumatic heart disease. Oncotarget, 9(15), 12343-12350. https://doi.org/10.18632/oncotarget.23901</Citation>
        </Reference>
        <Reference>
          <Citation>Davutoglu, V., &amp; Nacak, M. (2005). Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. The Journal of Heart Valve Disease, 14(3), 277-281.</Citation>
        </Reference>
        <Reference>
          <Citation>Di Battista, C., Stuppia, L., Ferrante, R., Lucantoni, M., Marsili, M., Breda, L., &amp; Chiarelli, F. (2015). MBL2 and the FCN2 polymorphisms in a group of pediatric subjects with rheumatic fever: A case control study (preliminary data). Annals of the Rheumatic Diseases, 74(2), 840-840.</Citation>
        </Reference>
        <Reference>
          <Citation>Dobson, J., Steer, A. C., Colquhoun, S., &amp; Kado, J. (2012). Environmental factors and rheumatic heart disease in Fiji. Pediatric Cardiology, 33(2), 332-336. https://doi.org/10.1007/s00246-011-0139-x</Citation>
        </Reference>
        <Reference>
          <Citation>Duzgun, N., Duman, T., Haydardedeoglu, F. E., &amp; Tutkak, H. (2007). The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clinical Rheumatology, 26(6), 915-919. https://doi.org/10.1007/s10067-006-0432-x</Citation>
        </Reference>
        <Reference>
          <Citation>Duzgun, N., Duman, T., Haydardedeoglu, F. E., &amp; Tutkak, H. (2009). Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens, 74(6), 539-542. https://doi.org/10.1111/j.1399-0039.2009.01347.x</Citation>
        </Reference>
        <Reference>
          <Citation>Elshamaa, M. F., Hamza, H., El Rahman, N. A., Emam, S., Elghoroury, E. A., Farid, T. M., … El-Aziz, D. A. (2018). Association of ficolin-2 (FCN2) functional polymorphisms and protein levels with rheumatic fever and rheumatic heart disease: relationship with cardiac function. Archives of Medical Science - Atherosclerotic Disease, 3, e142-e155. https://doi.org/10.5114/amsad.2018.80999</Citation>
        </Reference>
        <Reference>
          <Citation>Engel, M. E., Stander, R., Vogel, J., Adeyemo, A. A., &amp; Mayosi, B. M. (2011). Genetic susceptibility to acute rheumatic fever: A systematic review and meta-analysis of twin studies. PLoS One, 6(9), e25326. https://doi.org/10.1371/journal.pone.0025326</Citation>
        </Reference>
        <Reference>
          <Citation>Fonseca, J. E., Santos, M. J., Canhao, H., &amp; Choy, E. (2009). Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmunity Reviews, 8(7), 538-542. https://doi.org/10.1016/j.autrev.2009.01.012</Citation>
        </Reference>
        <Reference>
          <Citation>Gomaa, M. H., Ali, S. S., Fattouh, A. M., Hamza, H. S., &amp; Badr, M. M. (2018). MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: An Egyptian pilot study. Pediatric Rheumatology Online Journal, 16(1), 24. https://doi.org/10.1186/s12969-018-0245-x</Citation>
        </Reference>
        <Reference>
          <Citation>Gray, L. A., D'Antoine, H. A., Tong, S. Y. C., McKinnon, M., Bessarab, D., Brown, N., … Carapetis, J. R. (2017). Genome-wide analysis of genetic risk factors for rheumatic heart disease in aboriginal Australians provides support for pathogenic molecular mimicry. The Journal of Infectious Diseases, 216(11), 1460-1470. https://doi.org/10.1093/infdis/jix497</Citation>
        </Reference>
        <Reference>
          <Citation>Guilherme, L., Cury, P., Demarchi, L. M., Coelho, V., Abel, L., Lopez, A. P., … Kalil, J. (2004). Rheumatic heart disease: Proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. The American Journal of Pathology, 165(5), 1583-1591 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=15509528</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, U., Mir, S. S., Chauhan, T., Garg, N., Agarwal, S. K., Pande, S., &amp; Mittal, B. (2014). Influence of protein tyrosine phosphatase gene (PTPN22) polymorphisms on rheumatic heart disease susceptibility in North Indian population. Tissue Antigens, 84(5), 492-496. https://doi.org/10.1111/tan.12440</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, U., Mir, S. S., Garg, N., Agarwal, S. K., Pande, S., &amp; Mittal, B. (2016). Association study of inflammatory genes with rheumatic heart disease in North Indian population: A multi-analytical approach. Immunology Letters, 174, 53-62. https://doi.org/10.1016/j.imlet.2016.04.012</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, U., Mir, S. S., Srivastava, A., Garg, N., Agarwal, S. K., Pande, S., &amp; Mittal, B. (2014). Signal transducers and activators of transcription (STATs) gene polymorphisms related with susceptibility to rheumatic heart disease in north Indian population. Immunology Letters, 161(1), 100-105. https://doi.org/10.1016/j.imlet.2014.04.015</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, U., Mishra, A., Rathore, S. S., Agarwal, S. K., Pande, S., Garg, N., &amp; Mittal, B. (2013). Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease in Indian population and meta-analysis. Molecular and Cellular Biochemistry, 382(1-2), 75-82. https://doi.org/10.1007/s11010-013-1719-2</Citation>
        </Reference>
        <Reference>
          <Citation>Gwinn, M., Ioannidis, J. P., Little, J., &amp; Khoury, M. J. (2014). Editorial: Updated guidance on human genome epidemiology (HuGE) reviews and meta-analyses of genetic associations. American Journal of Epidemiology, 180(6), 559-561. https://doi.org/10.1093/aje/kwu196</Citation>
        </Reference>
        <Reference>
          <Citation>Hernandez-Pacheco, G., Flores-Dominguez, C., Rodriguez-Perez, J. M., Perez-Hernandez, N., Fragoso, J. M., Saul, A., … Vargas-Alarcon, G. (2003). Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. Journal of Autoimmunity, 21(1), 59-63.</Citation>
        </Reference>
        <Reference>
          <Citation>Higgins, J. P., &amp; Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539-1558 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=12111919</Citation>
        </Reference>
        <Reference>
          <Citation>Hu, W., Ye, Y., Yin, Y., Sang, P., Li, L., Wang, J., … Meng, Z. (2018). Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population. BMC Medical Genetics, 19(1), 27. https://doi.org/10.1186/s12881-018-0538-4</Citation>
        </Reference>
        <Reference>
          <Citation>Hua, R., Xu, J. B., Wang, J. C., Zhu, L., Li, B., Liu, Y., … Wang, X. F. (2009). Association of TNFAIP3 polymorphism with rheumatic heart disease in Chinese Han population. Immunogenetics, 61(11-12), 739-744. https://doi.org/10.1007/s00251-009-0405-8</Citation>
        </Reference>
        <Reference>
          <Citation>Ioannidis, J. P., Gwinn, M., Little, J., Higgins, J. P., Bernstein, J. L., Boffetta, P., … the Network of Investigator. (2006). A road map for efficient and reliable human genome epidemiology. Nature Genetics, 38(1), 3-5 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16468121</Citation>
        </Reference>
        <Reference>
          <Citation>Jian, B., Narula, N., Li, Q. Y., Mohler, E. R., &amp; Levy, R. J. (2003). Progression of aortic valve stenosis: TGF-beta 1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Annals of Thoracic Surgery, 75(2), 457-465. https://doi.org/10.1016/S0003-4975(02)04312-6</Citation>
        </Reference>
        <Reference>
          <Citation>Jin, Z., Ji, Z., &amp; Hu, J. (2001). Mannose-binding lectin gene site mutations and the susceptibility of rheumatic heart disease. Zhonghua Yi Xue Za Zhi, 81(21), 1,284-1,286 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16200716</Citation>
        </Reference>
        <Reference>
          <Citation>Kamal, H., Hussein, G., Hassoba, H., Mosaad, N., Gad, A., &amp; Ismail, M. (2010). Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt. Acta Cardiologica, 65(2), 177-183. https://doi.org/10.2143/ac.65.2.2047051</Citation>
        </Reference>
        <Reference>
          <Citation>Khoury, M. J., &amp; Dorman, J. S. (1998). The human genome epidemiology network. American Journal of Epidemiology, 148(1), 1-3 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9663396</Citation>
        </Reference>
        <Reference>
          <Citation>Kumar, R. K., &amp; Tandon, R. (2013). Rheumatic fever &amp; rheumatic heart disease: The last 50 years. The Indian Journal of Medical Research, 137(4), 643-658.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Y., Zhang, S., Xu, W., Guo, X., Xu, Q., &amp; Chen, Y. (2015). A normal polymorphism site of TLR2 3′ untranslated region is related to rheumatic heart disease by up-regulating TLR2 expression. Annals of Clinical Biochemistry, 52(Pt 4), 470-475. https://doi.org/10.1177/0004563214564581</Citation>
        </Reference>
        <Reference>
          <Citation>Maheshkumar, P., Sivakumar, E., Sambath, S., Rajalingam, R., &amp; Jayalakshmi, M. (2017). KIR genotypes that encode activating NK cell receptor repertoire are associated with the sever form of rheumatic heart disease among South Indian population. Human Immunology, 78, 155-155. https://doi.org/10.1016/j.humimm.2017.06.198</Citation>
        </Reference>
        <Reference>
          <Citation>Marzetti, V., Di Battista, C., Ferrante, R., Carlucci, L., Balsamo, M., Stuppia, L., … Breda, L. (2017). MBL2 and FCN2 gene polymorphisms in a cohort of Italian children with rheumatic fever: A case-control study. Seminars in Arthritis and Rheumatism, 47(2), 264-268. https://doi.org/10.1016/j.semarthrit.2017.04.006</Citation>
        </Reference>
        <Reference>
          <Citation>Messias Reason, I. J., Schafranski, M. D., Jensenius, J. C., &amp; Steffensen, R. (2006). The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Human Immunology, 67(12), 991-998. https://doi.org/10.1016/j.humimm.2006.08.296</Citation>
        </Reference>
        <Reference>
          <Citation>Messias-Reason, I. J., Schafranski, M. D., Kremsner, P. G., &amp; Kun, J. F. (2009). Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clinical and Experimental Immunology, 157(3), 395-399. https://doi.org/10.1111/j.1365-2,249.2009.03975.x</Citation>
        </Reference>
        <Reference>
          <Citation>Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian, A., &amp; Attia, J. (2005). The choice of a genetic model in the meta-analysis of molecular association studies. International Journal of Epidemiology, 34(6), 1319-1328. https://doi.org/10.1093/ije/dyi169</Citation>
        </Reference>
        <Reference>
          <Citation>Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian, A., &amp; Attia, J. (2009). The quality of meta-analyses of genetic association studies: A review with recommendations. American Journal of Epidemiology, 170(11), 1333-1343. https://doi.org/10.1093/aje/kwp350</Citation>
        </Reference>
        <Reference>
          <Citation>Mohamed, A. A., Rashed, L. A., Shaker, S. M., &amp; Ammar, R. I. (2010). Association of tumor necrosis factor-alpha polymorphisms with susceptibility and clinical outcomes of rheumatic heart disease. Saudi Medical Journal, 31(6), 644-649.</Citation>
        </Reference>
        <Reference>
          <Citation>Morsy, M. M., Abdelaziz, N. A., Boghdady, A. M., Ahmed, H., Abu Elfadl, E. M., &amp; Ismail, M. A. (2011). Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children. Rheumatology International, 31(1), 17-21. https://doi.org/10.1007/s00296-009-1,208-9</Citation>
        </Reference>
        <Reference>
          <Citation>Morsy, M. M., Abdelaziz, N. A., Boghdady, A. M., Ahmed, H., Fadl, E. M., &amp; Ismail, M. A. (2009). Lack of association between endothelial constitutive nitric oxide synthase (ecNOS 4 b/a) gene polymorphism and rheumatic heart disease. Modern Rheumatology, 19(6), 670-674. https://doi.org/10.1007/s10165-009-0225-6</Citation>
        </Reference>
        <Reference>
          <Citation>Muhamed, B., Engel, M. E., Shaboodien, G., Pare, G., &amp; Mayosi B. M. (2018). Genetics of rheumatic fevr and rheumatic heart disease in Africans (Doctor of Philosophy). University of Cape Town.</Citation>
        </Reference>
        <Reference>
          <Citation>Muhamed, B., Parks, T., &amp; Sliwa, K. (2019). Genetics of rheumatic fever and rheumatic heart disease. Nature Reviews. Cardiology. https://doi.org/10.1038/s41569-019-0258-2</Citation>
        </Reference>
        <Reference>
          <Citation>Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., &amp; Erlich, H. (1986). Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. Cold Spring Harbor Symposia on Quantitative Biology, 51(Pt 1), 263-273 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3472723</Citation>
        </Reference>
        <Reference>
          <Citation>Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., &amp; Erlich, H. (1992). Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. 1986. Biotechnology, 24, 17-27 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1422010</Citation>
        </Reference>
        <Reference>
          <Citation>Nascimento, B. R., Santos, J. P. A., Beaton, A. Z., Rocha, L. P. C., Pinto, C. H. R., Diamantino, A., … Dutra, W. (2019). IL2 and IL4 gene polymorphisms are associated with latent and clinical rheumatic heart disease: Data from the provar study. Journal of the American College of Cardiology, 73(9), 1964-1964. https://doi.org/10.1016/s0735-1,097(19)32570-7</Citation>
        </Reference>
        <Reference>
          <Citation>Okello, E., Kakande, B., Sebatta, E., Kayima, J., Kuteesa, M., Mutatina, B., … Juergen, F. (2012). Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda. PLoS One, 7(8), e43917. https://doi.org/10.1371/journal.pone.0043917</Citation>
        </Reference>
        <Reference>
          <Citation>Olgu Hallioglu, S. B., Eras-Erdogan, N., &amp; Akbas, E. (2014). Relationship of TNF-A-308, IL-10-1082 gene polymorphisms with the severity and susceptibility of rheumatic heart disease in Turkish children. Russian Kardiological Journal, 111(S7), 42-46.</Citation>
        </Reference>
        <Reference>
          <Citation>Ordunez, P., Martinez, R., Soliz, P., Giraldo, G., Mujica, O. J., &amp; Nordet, P. (2019). Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990-2017: A population-based study. The Lancet Global Health, 7(10), e1388-e1397. https://doi.org/10.1016/s2214-109x(19)30360-2</Citation>
        </Reference>
        <Reference>
          <Citation>Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., &amp; Hymowitz, S. G. (2011). Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology, 29, 71-109. https://doi.org/10.1146/annurev-immunol-031210-101312</Citation>
        </Reference>
        <Reference>
          <Citation>Ozisik, K., Emir, M., Ulus, A. T., Kaplan, S., Misirlioglu, M., Tuncer, A. S., &amp; Katircioglu, S. F. (2004). The renin-angiotensin system genetic polymorphisms and rheumatic mitral valve disease. The Journal of Heart Valve Disease, 13(1), 33-37 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=14765837</Citation>
        </Reference>
        <Reference>
          <Citation>Parks, T., Mirabel, M. M., Kado, J., Auckland, K., Nowak, J., Rautanen, A., … Pacific Islands Rheumatic Heart Disease Genetics Network. (2017). Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania. Nature Communications, 8, 14946. https://doi.org/10.1038/ncomms14946</Citation>
        </Reference>
        <Reference>
          <Citation>Poomarimuthu, M., Elango, S., Solomon, P. R., Soundarapandian, S., &amp; Mariakuttikan, J. (2018a). Lack of association between TNF-alpha, IFN-gamma, IL-10 gene polymorphisms and rheumatic heart disease in south Indian population. Fetal and Pediatric Pathology, 37(5), 309-318. https://doi.org/10.1080/15513815.2018.1494232</Citation>
        </Reference>
        <Reference>
          <Citation>Poomarimuthu, M., Elango, S., Solomon, P. R., Soundrapandian, S., &amp; Mariakuttikan, J. (2018b). Association of IL17 and IL23R gene polymorphisms with rheumatic heart disease in South Indian population. Immunological Investigations, 47(7), 754-764. https://doi.org/10.1080/08820139.2018.1493053</Citation>
        </Reference>
        <Reference>
          <Citation>Poomarimuthu, M., Elango, S., Soundrapandian, S., &amp; Mariakuttikan, J. (2017). HLA-G 3'UTR gene polymorphisms and rheumatic heart disease: A familial study among South Indian population. Pediatric Rheumatology Online Journal, 15(1), 10. https://doi.org/10.1186/s12969-017-0140-x</Citation>
        </Reference>
        <Reference>
          <Citation>Ramasawmy, R., Fae, K. C., Spina, G., Victora, G. D., Tanaka, A. C., Palacios, S. A., … Guilherme, L. (2007). Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Molecular Immunology, 44(8), 1873-1878. https://doi.org/10.1016/j.molimm.2006.10.001</Citation>
        </Reference>
        <Reference>
          <Citation>Ramasawmy, R., Spina, G. S., Fae, K. C., Pereira, A. C., Nisihara, R., Messias Reason, I. J., … Guilherme, L. (2008). Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clinical and Vaccine Immunology, 15(6), 932-936. https://doi.org/10.1128/cvi.00324-07</Citation>
        </Reference>
        <Reference>
          <Citation>Rehman, S., Akhtar, N., Saba, N., Munir, S., Ahmed, W., Mohyuddin, A., &amp; Khanum, A. (2013). A study on the association of TNF-alpha(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients. Cytokine, 61(2), 527-531. https://doi.org/10.1016/j.cyto.2012.10.020</Citation>
        </Reference>
        <Reference>
          <Citation>Rehman, S., Saba, N., Akhtar, N., Munir, S., Ahmed, W., &amp; Khanum, A. (2015). Angiotensin converting enzyme gene I/D polymorphism in pakistani rheumatic heart disease patients and healthy controls. International Cardiovascular Research Journal, 9(3), 169-172 Retrieved from https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938581021&amp;partnerID=40&amp;md5=d225f26c45baced9db33ae4807d60d22</Citation>
        </Reference>
        <Reference>
          <Citation>Reményi, B. et al. (2012). World Heart Federation criteria forechocardiographic diagnosis of rheumatic heartdisease-an evidence-based guideline. Nat. Rev. Cardiol. 9, 297-309.</Citation>
        </Reference>
        <Reference>
          <Citation>Sagoo, G. S., Little, J., &amp; Higgins, J. P. (2009). Systematic reviews of genetic association studies. Human genome epidemiology network. PLoS Medicine, 6(3), e28. https://doi.org/10.1371/journal.pmed.1000028</Citation>
        </Reference>
        <Reference>
          <Citation>Sallakci, N., Akcurin, G., Koksoy, S., Kardelen, F., Uguz, A., Coskun, M., … Yegin, O. (2005). TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. Journal of Autoimmunity, 25(2), 150-154. https://doi.org/10.1016/j.jaut.2005.05.005</Citation>
        </Reference>
        <Reference>
          <Citation>Saraswathy, R., Abilash, V. G., Manivannan, G., George, A., &amp; Babu, K. T. (2010). Four novel mutations detected in the exon 1 of MBL2 gene associated with rheumatic heart disease in south indian patients. International Journal of Genetics and Molecular Biology, 2(8), 165-170.</Citation>
        </Reference>
        <Reference>
          <Citation>Schafranski, M. D., Pereira Ferrari, L., Scherner, D., Torres, R., Jensenius, J. C., &amp; de Messias-Reason, I. J. (2008). High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Molecular Immunology, 45(14), 3827-3831. https://doi.org/10.1016/j.molimm.2008.05.013</Citation>
        </Reference>
        <Reference>
          <Citation>Schafranski, M. D., Pereira Ferrari, L., Scherner, D., Torres, R., &amp; de Messias-Reason, I. J. (2008). Functional MASP2 gene polymorphism in patients with history of rheumatic fever. Human Immunology, 69(1), 41-44. https://doi.org/10.1016/j.humimm.2007.11.003</Citation>
        </Reference>
        <Reference>
          <Citation>Schwarzer, G. (2007). Meta: An R package for meta-analysis. R News, 7(3), 40-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Settin, A., Abdel-Hady, H., El-Baz, R., &amp; Saber, I. (2007). Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatric Cardiology, 28(5), 363-371. https://doi.org/10.1007/s00246-006-0002-7</Citation>
        </Reference>
        <Reference>
          <Citation>Shang, J. J., Zhou, Q., Weng, C. M., Gong, J. H., Chen, G. L., &amp; Zhou, X. J. (2016). Association between the insertion/deletion polymorphism of angiotensin converting enzyme gene and rheumatic heart disease: A comprehensive meta-analysis. International Journal of Clinical and Experimental Medicine, 9(3), 5539-5551.</Citation>
        </Reference>
        <Reference>
          <Citation>Shen, Y.-c., Yang, T., Wan, C., Wang, T., Chen, L., &amp; Wen, F.-Q. (2013). Tumor necrosis factor-alpha polymorphisms and rheumatic heart disease risk: A meta-analysis. International Journal of Cardiology, 168(3), 2878-2880. https://doi.org/10.1016/j.ijcard.2013.03.129</Citation>
        </Reference>
        <Reference>
          <Citation>Sika-Paotonu, D., Beaton, A., Raghu, A., Steer, A., &amp; Carapetis, J. Acute Rheumatic Fever and Rheumatic Heart Disease. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Simsek, I., Koz, C., Basar, N., Sari, I., Erdem, H., Pay, S., … Dinc, A. (2011). Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease. Clinical Rheumatology, 30(4), 491-495. https://doi.org/10.1007/s10067-010-1,537-9</Citation>
        </Reference>
        <Reference>
          <Citation>Sreekanth, M. S., Esdan Basha, S. K., Arun Kumar, G., Govindaraju, S., Pradeep Nayar, N., &amp; Pitchappan, R. M. (2016). Association of IL-1beta +3,953 C and HLA-DRB1*15 with Coronary Artery and Rheumatic Heart Diseases in South India. Human Immunology, 77(12), 1275-1279. https://doi.org/10.1016/j.humimm.2016.08.003</Citation>
        </Reference>
        <Reference>
          <Citation>Stanevica, V., Nikitina-Zake, L., Zepa, L., Davidsone, Z., Santere, R., &amp; Scegolevs, A. (2016). Cytokine gene polymorphisms (IL10, IL6, TNF alpha) in children with rheumatic fever in Latvia. Annals of the Rheumatic Diseases, 75, 769-769, 76769. https://doi.org/10.1136/annrheumdis-2016-eular.4007</Citation>
        </Reference>
        <Reference>
          <Citation>Tawfik Enas, M. A. E.-S., ulkarem, A. A., &amp; Yosseri, M. (2010). Gene polymorphisms of TNF-α and IL-10 related to rheumatic heart disease. Egyptian Journal of Human Genetics, 11, 33-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Teker, E., Akadam-Teker, A. B., Ozturk, O., Eronat, A. P., Yalin, K., Golcuk, S. E., &amp; Bugra, Z. (2018). Association between the interferon gamma 874T/A polymorphism and the severity of valvular damage in patients with rheumatic heart disease. Biochemical Genetics, 56(3), 225-234. https://doi.org/10.1007/s10528-017-9,839-0</Citation>
        </Reference>
        <Reference>
          <Citation>Tian, Y., Ge, Z., Xing, Y., Sun, Y., &amp; Ying, J. (2016). Correlation of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease: A meta-analysis. Bioscience Reports, 36(6), pii: e00412. https://doi.org/10.1042/bsr20160151</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, L., Fu, C., Wang, X., &amp; Zeng, C. (2014). A meta analysis of the relation between TNF-α G308A gene polymorphism and heart disease. Life Science Journal, 11(4), 204-206 Retrieved from https://www2.scopus.com/inward/record.uri?eid=2-s2.0-84897836207&amp;partnerID=40&amp;md5=f4192cd5dd335de979b60574a256bbf4</Citation>
        </Reference>
        <Reference>
          <Citation>Yousry, S. M., Sedky, Y., &amp; Sobieh, A. (2016). Association of IL-4 (intron 3) and IL-10 (-1082) gene polymorphisms with risk of mitral valve disease in children with rheumatic heart disease. Cardiology in the Young, 26(7), 1290-1296. https://doi.org/10.1017/s1047951115002413</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, Y. F., Cheng, Q., Tang, N. L., Chu, T. T., Tomlinson, B., Liu, F., &amp; Kwok, T. C. (2014). Gender difference of serum angiotensin-converting enzyme (ACE) activity in DD genotype of ACE insertion/deletion polymorphism in elderly Chinese. Journal of the Renin-Angiotensin-Aldosterone System, 15(4), 547-552. https://doi.org/10.1177/1470320313475906</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng, R.-l., Zhang, H., &amp; Jiang, W.-l. (2014). Tumor necrosis factor-alpha 308G &gt; A polymorphism and risk of rheumatic heart disease: A meta-analysis. Scientific Reports, 4, 4731. https://doi.org/10.1038/srep04731</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu, L., Zou, L. J., Hua, R., &amp; Li, B. (2010). Association of single-nucleotide polymorphisms in toll-like receptor 5 gene with rheumatic heart disease in Chinese Han population. International Journal of Cardiology, 145(1), 129-130. https://doi.org/10.1016/j.ijcard.2009.06.046</Citation>
        </Reference>
        <Reference>
          <Citation>Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F., &amp; Haugen, A. (2004). Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. International Journal of Cancer, 109(3), 353-356. https://doi.org/10.1002/ijc.11695</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083396</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1545-5017</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric blood &amp; cancer</Title>
          <ISOAbbreviation>Pediatr Blood Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Kidney-sparing whole abdominal irradiation in Wilms tumor: Potential advantages of VMAT technique.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e28223</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pbc.28223</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To present a preliminary clinical experience and a dosimetric comparison of kidney-sparing volumetric modulated arc therapy (VMAT) with three-dimensional conformal radiotherapy (3D-CRT) for whole abdominal irradiation (WAI), in the setting of Wilms tumor (WT) treatment.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">From a total of 20 consecutive WT cases treated with adjuvant irradiation, seven were submitted to WAI with VMAT. Renal function and survival rates were evaluated, and, for comparison purposes, similar VMAT and 3D-CRT treatment plans were performed for WAI patients, and differences were dosimetrically evaluated regarding doses to the remaining kidney and other organs at risk and the planning target volume (PTV).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">After a median follow-up time of 40.8 months (35.3-52.2), no acute significant intestinal toxicity was observed, and median creatinine clearance was 110.1 and 103.3 mL/min/1.73 m², respectively, before treatment and at last follow-up for WAI patients (P = 0.128). For comparative plans, maximum and median doses were lower for the remaining kidney with VMAT than with 3D-CRT. VMAT was associated with better PTV coverage as compared with 3D-CRT, with superior results for all the evaluated parameters (D95, D2, V100%, V98%, V95%; P = 0.018).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of VMAT technique is associated with lower radiation doses to the remaining kidney and better coverage to the PTV than 3D-CRT technique for WAI, with preliminary clinical experience showing a favorable toxicity profile. Long-term results from prospective studies might prove the ability of VMAT to spare renal function in the setting of WT treatment.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Michael Jenwei</ForeName>
            <Initials>MJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3936-8956</Identifier>
            <AffiliationInfo>
              <Affiliation>Grupo de Apoio ao Adolescente e a Criança com Cancer, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>A.C. Camargo Cancer Center, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leao</LastName>
            <ForeName>Caio Raposo</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>A.C. Camargo Cancer Center, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simoes</LastName>
            <ForeName>Roberto Campos Pereira</ForeName>
            <Initials>RCP</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Apoio ao Adolescente e a Criança com Cancer, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Belletti</LastName>
            <ForeName>Fernanda Salheb</ForeName>
            <Initials>FS</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Apoio ao Adolescente e a Criança com Cancer, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Figueiredo</LastName>
            <ForeName>Maria Luisa Sucharski</ForeName>
            <Initials>MLS</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Apoio ao Adolescente e a Criança com Cancer, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cypriano</LastName>
            <ForeName>Monica Santos</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Apoio ao Adolescente e a Criança com Cancer, Radiation Oncology, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Blood Cancer</MedlineTA>
        <NlmUniqueID>101186624</NlmUniqueID>
        <ISSNLinking>1545-5009</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">VMAT</Keyword>
        <Keyword MajorTopicYN="N">Wilms tumor</Keyword>
        <Keyword MajorTopicYN="N">radiotherapy</Keyword>
        <Keyword MajorTopicYN="N">renal function</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083396</ArticleId>
        <ArticleId IdType="doi">10.1002/pbc.28223</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys. 2000;46(5):1239-1246.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor RE. Morbidity from abdominal radiotherapy in the First United Kingdom Children's Cancer Study Group Wilms’ Tumour Study. United Kingdom Children's Cancer Study Group. Clin Oncol (R Coll Radiol). 1997;9(6):381-384.</Citation>
        </Reference>
        <Reference>
          <Citation>Pritchard-Jones K, Bergeron C, de Camargo B, et al, SIOP Renal Tumours Study Group. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomized controlled trial. Lancet. 2015;386(9999):1156-1164.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629-637.</Citation>
        </Reference>
        <Reference>
          <Citation>National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.</Citation>
        </Reference>
        <Reference>
          <Citation>Arians N, Kieser M, Benner L, et al. Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer (International Federation of Gynecology and Obstetrics Stage III): first results of a prospective phase 2 study. Int J Radiat Oncol Biol Phys. 2017;99(4):912-920.</Citation>
        </Reference>
        <Reference>
          <Citation>Osborne EM, Briere TM, Hayes-Jordan A, et al. Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor. Radiother Oncol. 2016;119(1):40-44.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalapurakal JA, Lee B, Bautista J, Rigsby C, Helenowski I, Gopalakrishnan M. Cardiac-sparing whole lung intensity modulated radiation therapy in children with wilms tumor: final report on technique and abdominal field matching to maximize normal tissue protection. Pract Radiat Oncol. 2018;9(1):e62-e73. pii: S1879-8500(18)30243-1.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalapurakal JA, Pokhrel D, Gopalakrishnan M, Zhang Y. Advantages of whole-liver intensity modulated radiation therapy in children with Wilms tumor and liver metastasis. Int J Radiat Oncol Biol Phys. 2013;85(3):754-760.</Citation>
        </Reference>
        <Reference>
          <Citation>Bölling T, Ernst I, Pape H, et al. Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium. Int J Radiat Oncol Biol Phys. 2011;80(3):840-844.</Citation>
        </Reference>
        <Reference>
          <Citation>Dawson LA, Kavanagh BD, Paulino AC, et al. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S108-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Termuhlen AM, Tersak JM, Liu Q, et al. Twenty-five-year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57(7):1210-1216.</Citation>
        </Reference>
        <Reference>
          <Citation>Berger M, Fernandez-Pineda I, Cabello R, et al. The relationship between the site of metastases and outcome in children with stage IV Wilms tumor: data from 3 European Pediatric Cancer Institutions. J Pediatr Hematol Oncol. 2013;35(7):518-524.</Citation>
        </Reference>
        <Reference>
          <Citation>Malogolowkin M, Spreafico F, Dome JS, et al, COG Renal Tumors Committee and the SIOP Renal Tumor Study Group. Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer. 2013;60(10):1612-1615.</Citation>
        </Reference>
        <Reference>
          <Citation>Neu MA, Russo A, Wingerter A, et al. Prospective analysis of long-term renal function in survivors of childhood Wilms tumor. Pediatr Nephrol. 2017;32(10):1915-1925.</Citation>
        </Reference>
        <Reference>
          <Citation>Knijnenburg SL, Mulder RL, Schouten-Van Meeteren AY, et al. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev. 2013(10):CD008944.</Citation>
        </Reference>
        <Reference>
          <Citation>van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al, International Society of Paediatric Oncology - Renal Tumour Study Group (SIOP-RTSG). Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017;14(12):743-752.</Citation>
        </Reference>
        <Reference>
          <Citation>Fogliata A, Nicolini G, Alber M, et al. On the performances of different IMRT treatment planning systems for selected paediatric cases. Radiat Oncol. 2007;2:7.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen MJ, Santos Ada S, Sakuraba RK, et al. Intensity-modulated and 3D-conformal radiotherapy for whole-ventricular irradiation as compared with conventional whole-brain irradiation in the management of localized central nervous system germ cell tumors. Int J Radiat Oncol Biol Phys. 2010;76(2):608-614.</Citation>
        </Reference>
        <Reference>
          <Citation>Vogel J, Lin H, Both S, Tochner Z, Balis F, Hill-Kayser C. Pencil beam scanning proton therapy for treatment of the retroperitoneum after nephrectomy for Wilms tumor: a dosimetric comparison study. Pediatr Blood Cancer. 2017;64(1):39-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalapurakal JA, Green DM, Haase G, Anderson JR, Dome JS, Grundy PE. Outcomes of children with favorable histology Wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5. Int J Radiat Oncol Biol Phys. 2010;77(2):554-558.</Citation>
        </Reference>
        <Reference>
          <Citation>Dzierma Y, Mikulla K, Richter P, et al. Imaging dose and secondary cancer risk in image-guided radiotherapy of pediatric patients. Radiat Oncol. 2018;13(1):168.</Citation>
        </Reference>
        <Reference>
          <Citation>Godzinski J. The current status of treatment of Wilms' tumor as per the SIOP trials. J Indian Assoc Pediatr Surg. 2015;20(1):16-20.</Citation>
        </Reference>
        <Reference>
          <Citation>Neville HL, Ritchey ML. Wilms' tumor. Overview of National Wilms' Tumor Study Group results. Urol Clin North Am. 2000;27(3):435-442.</Citation>
        </Reference>
        <Reference>
          <Citation>Romao RL, Lorenzo AJ. Renal function in patients with Wilms tumor. Urol Oncol. 2016;34(1):33-41.</Citation>
        </Reference>
        <Reference>
          <Citation>Ritchey ML, Green DM, Thomas PR, et al. Renal failure in Wilms' tumor patients: a report from the National Wilms' Tumor Study Group. Med Pediatr Oncol. 1996;26(2):75-80.</Citation>
        </Reference>
        <Reference>
          <Citation>Cozzi DA, Ceccanti S, Cozzi F. Renal function up to the 5th decade of life after nephrectomy in childhood: a literature review. Nephrology (Carlton). 2018;23(5):397-404.</Citation>
        </Reference>
        <Reference>
          <Citation>Kishore SS, Oberoi S, Bhattacharya A, et al. Function and size of the residual kidney after treatment of Wilms tumor. Pediatr Hematol Oncol. 2015;32(1):11-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Rochet N, Kieser M, Sterzing F, et al. Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III-the OVAR-IMRT-02 study. BMC Cancer. 2011;11:41.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang JC, Wexler LH, Meyers PA, Happersett L, La Quaglia MP, Wolden SL. Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases. Pediatr Blood Cancer. 2013;60(10):1616-1620.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsai YC, Tsai CL, Hsu FM, Jian-Kuen W, Chien-Jang W, Cheng JC. Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study. Med Dosim. 2013;38(4):366-371.</Citation>
        </Reference>
        <Reference>
          <Citation>Ludwig R, Weirich A, Abel U, Hofmann W, Graf N, Tournade MF. Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol. 1999;33(5):462-469.</Citation>
        </Reference>
        <Reference>
          <Citation>Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Anghelescu DL, Burgoyne LL, Liu W, et al. Safe anesthesia for radiotherapy in pediatric oncology: St. Jude Children's Research Hospital Experience, 2004-2006. Int J Radiat Oncol Biol Phys. 2008;71(2):491-497.</Citation>
        </Reference>
        <Reference>
          <Citation>Hess CB, Thompson HM, Benedict SH, et al. Exposure risks among children undergoing radiation therapy: considerations in the era of image guided radiation therapy. Int J Radiat Oncol Biol Phys. 2016;94(5):978-992.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083397</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-3806</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Autism research : official journal of the International Society for Autism Research</Title>
          <ISOAbbreviation>Autism Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Vitamin D Receptor Polymorphisms Associated with Autism Spectrum Disorder.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/aur.2279</ELocationID>
        <Abstract>
          <AbstractText>Vitamin D is endowed with a number of biological properties, including down-regulation of inflammation, and might contribute to the pathogenesis of autism spectrum disorders (ASD). Vitamin D binds to the vitamin D Receptor (VDR); the biological activity of the ensuing complex depends on VDR FokI, BsmI, ApaI, and TaqI gene polymorphisms. We evaluated such Single Nucletoide Polymorphismsm (SNPs) in a cohort of 100 Italian families with ASD children. FokI genotype distribution was skewed in ASD children compared with their healthy sibs (P<sub>c</sub> = 0.03 2 df) and to a group of 170 Italian healthy women (HC) (P<sub>c</sub> = 0.04 2 df). FokI genotype and allelic distribution skewing were also observed in mothers of ASD children compared to HC (P<sub>c</sub> = 0.04 2 df). Both Transmission Disequilibrium Test for single loci and haplotype analysis distribution revealed a major FokI (C) allele-mediated protective effect, which was more frequently transmitted (73%) than not transmitted to healthy sibs (P = 0.02). A protective FokI-, BsmI-, ApaI-, and TaqI (CCAG) haplotype was more frequently carried by healthy sibs than by ASD children (P = 1 × 10<sup>-4</sup> ; OR: 0.1, 95% CI: 0.03-0.4) too. Finally, a strong gene-dose association of FokI (T) allele with both higher Childhood Autism Rating Scale score (P<sub>c</sub> = 0.01) and, particularly, with hyperactivity behavior (P<sub>c</sub> = 0.006) emerged in ASD children. Because the protein produced by the FokI (T) allele is transcriptionally less active than that produced by the FokI (C) allele, the reduced biological activity of the vitamin D/VDR complex prevalent in ASD could favor ASD- and maternal immune activation- associated inflammation. Vitamin D supplementation might be useful in preventative and rehabilitation protocols for ASD. LAY SUMMARY: Vitamin D deficiency and Vitamin D receptor (VDR) polymorphisms are associated with structural and functional brain abnormalities and behavioral disorders. We analyzed the association of VDR gene polymorphisms in a cohort of 100 Italian families with ASD children. A strong correlation between one of the VDR polymorphisms and hyperactivity behavior was evidenced in ASD children. In healthy mothers, the same VDR polymorphism was also correlated with an increased risk of giving birth to children with ASD. © 2020 International Society for Autism Research, Wiley Periodicals, Inc.</AbstractText>
          <CopyrightInformation>© 2020 International Society for Autism Research, Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guerini</LastName>
            <ForeName>Franca Rosa</ForeName>
            <Initials>FR</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9461-5927</Identifier>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bolognesi</LastName>
            <ForeName>Elisabetta</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chiappedi</LastName>
            <ForeName>Matteo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mensi</LastName>
            <ForeName>Maria Martina</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fumagalli</LastName>
            <ForeName>Oscar</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rogantini</LastName>
            <ForeName>Chiara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zanzottera</LastName>
            <ForeName>Milena</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghezzo</LastName>
            <ForeName>Alessandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zanette</LastName>
            <ForeName>Michela</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agliardi</LastName>
            <ForeName>Cristina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Costa</LastName>
            <ForeName>Andrea Saul</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sotgiu</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Child Neuropsychiatry, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carta</LastName>
            <ForeName>Alessandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Child Neuropsychiatry, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Child Psychiatry Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Daghri</LastName>
            <ForeName>Nasser</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clerici</LastName>
            <ForeName>Mario</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>RF-2013-02358607</GrantID>
            <Agency>Ministero della Salute</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>ISPP-118</GrantID>
            <Agency>King Saud University</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>International Scientific Partnership Program (ISPP)</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Autism Res</MedlineTA>
        <NlmUniqueID>101461858</NlmUniqueID>
        <ISSNLinking>1939-3806</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Autistic Spectrum Disorder</Keyword>
        <Keyword MajorTopicYN="N">Immune system, VDR FokI</Keyword>
        <Keyword MajorTopicYN="N">VDR polymorphisms</Keyword>
        <Keyword MajorTopicYN="N">Vitamin D</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083397</ArticleId>
        <ArticleId IdType="doi">10.1002/aur.2279</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Abouzid, M., Karazniewicz-Lada, M., &amp; Glowka, F. (2018). Genetic determinants of vitamin D-related disorders; focus on vitamin D receptor. Current Drug Metabolism, 19, 1042-1052. https://doi.org/10.2174/1389200219666180723143552</Citation>
        </Reference>
        <Reference>
          <Citation>Alabdali, A., Al-Ayadhi, L., &amp; El-Ansary, A. (2014). Association of social and cognitive impairment and biomarkers in autism spectrum disorders. Journal of Neuroinflammation, 8(11), 4. https://doi.org/10.1186/1742-2094-11-4</Citation>
        </Reference>
        <Reference>
          <Citation>Altevogt, B. M., Hanson, S. L., &amp; Leshner, A. I. (2008). Autism and the environment: challenges and opportunities for research. Pediatrics, 121, 1225-1229.</Citation>
        </Reference>
        <Reference>
          <Citation>American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Association.</Citation>
        </Reference>
        <Reference>
          <Citation>Atladóttir, H. O., Pedersen, M. G., Thorsen, P., Mortensen, P. B., Deleuran, B., Eaton, W. W., &amp; Parner, E. T. (2009). Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics, 124, 687-694.</Citation>
        </Reference>
        <Reference>
          <Citation>Barchitta, M., Maugeri, A., La Rosa, M. C., San Lio, R. M., Favara, G., Panella, M., … Agodi, A. (2018). Single nucleotide polymorphisms in vitamin D receptor gene affect birth weight and the risk of preterm birth: Results from the "Mamma &amp;Bambino" cohort and a meta-analysis. Nutrients, 27, 10. https://doi.org/10.3390/nu10091172</Citation>
        </Reference>
        <Reference>
          <Citation>Biswas, S., Kanwal, B., Jeet, C., &amp; Seminara, R. S. (2018). Fok-I, Bsm-I, and Taq-I variants of vitamin D receptor polymorphism in the development of autism spectrum disorder: A literature review. Cureus, 10, e3228. https://doi.org/10.7759/cureus.3228.Review</Citation>
        </Reference>
        <Reference>
          <Citation>Busse, M., Campe, K. J., Nowak, D., Schumacher, A., Plenagl, S., Langwisch, S., … Zenclussen, A. C. (2019). IL-10 producing B cells rescue mouse fetuses from inflammation-driven fetal death and are able to modulate T cell immune responses. Scientific Reports, 9, 9335. https://doi.org/10.1038/s41598-019-45860-2</Citation>
        </Reference>
        <Reference>
          <Citation>Cannell, J. J. (2008). Autism and vitamin D. Medical Hypotheses, 70, 750-759.</Citation>
        </Reference>
        <Reference>
          <Citation>Chiappedi, M., Rossi, G., Rossi, M., Bejor, M., &amp; Balottin, U. (2010). Autism and classification systems: A study of 84 children. Italian Journal of Pediatrics, 36, 10. https://doi.org/10.1186/1824-7288-36-10</Citation>
        </Reference>
        <Reference>
          <Citation>Cieślińska, A., Kostyra, E., Chwała, B., Moszyńska-Dumar, A. M., Fiedorowicz, E., Teodorowicz, M., &amp; Savelkoul, H. F. J. (2017). Vitamin D receptor gene polymorphisms associated with childhood autism. Brain Sciences, 7(9). pii: E115. https://doi.org/10.3390/brainsci7090115</Citation>
        </Reference>
        <Reference>
          <Citation>Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., &amp; Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology., 14, 388-394.</Citation>
        </Reference>
        <Reference>
          <Citation>Coşkun, S., Şimşek, Ş., Camkurt, M. A., Çim, A., &amp; Çelik, S. B. (2016). Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder. Gene, 588(2), 109-114. https://doi.org/10.1016/j.gene.2016.05.004</Citation>
        </Reference>
        <Reference>
          <Citation>Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., &amp; van de Water, J. V. (2005). Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Archives of Pediatrics &amp; Adolescent Medicine, 159, 151-157.</Citation>
        </Reference>
        <Reference>
          <Citation>Eyles, D. W., Burne, T. H., &amp; McGrath, J. J. (2013). Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34, 47-64.</Citation>
        </Reference>
        <Reference>
          <Citation>Faraco, J. H., Morrison, N. A., Baker, A., Shine, J., &amp; Frossard, P. M. (1989). ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Research, 17, 2150. https://doi.org/10.1093/nar/17.5.2150</Citation>
        </Reference>
        <Reference>
          <Citation>Funderburk, S. J., Carter, J., Tanguay, P., Freeman, B. J., &amp; Westlake, J. R. (1983). Parental reproductive problems and gestational hormonal exposure in autistic and schizophrenic children. Journal of Autism and Developmental Disorders, 13, 325-332.</Citation>
        </Reference>
        <Reference>
          <Citation>García-Serna, A. M., &amp; Morales, E. (2019). Neurodevelopmental effects of prenatal vitamin D in humans: Systematic review and meta-analysis. Molecular Psychiatry. https://doi.org/10.1038/s41380-019-0357-9</Citation>
        </Reference>
        <Reference>
          <Citation>Gross, C., Eccleshall, T. R., Malloy, P. J., Villa, M. L., Marcus, R., &amp; Feldman, D. (1996). The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. Journal of Bone and Mineral Research, 11, 1850-1855. https://doi.org/10.1002/jbmr.5650111204</Citation>
        </Reference>
        <Reference>
          <Citation>Guerini, F. R., Bolognesi, E., Chiappedi, M., Ghezzo, A., Canevini, M. P., Mensi, M. M., … Clerici, M. (2015). An HLA-G(*)14bp insertion/deletionpolymorphism associates with the development of autistic spectrum disorders. Brain, Behavior, and Immunity, 44, 207-212. https://doi.org/10.1016/j.bbi.2014.10.002</Citation>
        </Reference>
        <Reference>
          <Citation>Guerini, F. R., Bolognesi, E., Chiappedi, M., Manca, S., Ghezzo, A., Agliardi, C., … Clerici, M. (2014). Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers. Brain, Behavior, and Immunity, 36, 54-60. https://doi.org/10.1016/j.bbi.2013.10.006</Citation>
        </Reference>
        <Reference>
          <Citation>Guerini, F. R., Bolognesi, E., Chiappedi, M., Ripamonti, E., Ghezzo, A., Zanette, M., … Clerici, M. (2018). HLA-G coding region polymorphism is skewed in autistic spectrum disorders. Brain, Behavior, and Immunity, 67, 308-313. https://doi.org/10.1016/j.bbi.2017.09.007</Citation>
        </Reference>
        <Reference>
          <Citation>Harvey, N. C., Holroyd, C., Ntani, G., Javaid, K., Cooper, P., Moon, R., … Cooper, C. (2014). Vitamin D supplementation in pregnancy: A systematic review. Health Technology Assessment, 18, 1-190. https://doi.org/10.3310/hta18450</Citation>
        </Reference>
        <Reference>
          <Citation>Hawes, J. E., Tesic, D., Whitehouse, A. J., Zosky, G. R., Smith, J. T., &amp; Wyrwoll, C. S. (2015). Maternal vitamin D deficiency alters fetal brain development in the BALB/c mouse. Behavioural Brain Research, 286, 192-200. https://doi.org/10.1016/j.bbr.2015.03.008</Citation>
        </Reference>
        <Reference>
          <Citation>He, B., Giedraitis, V., Ligers, A., Binzer, M., Andersen, P. M., Forsgren, L., … Hillert, J. (2002). Sharing of a conserved haplotype suggests a susceptibility gene for multiple sclerosis at chromosome 17p11. European Journal of Human Genetics, 10, 271-275.</Citation>
        </Reference>
        <Reference>
          <Citation>Ito, M., Nakashima, A., Hidaka, T., Okabe, M., Bac, N. D., Ina, S., … Saito, S. (2010). A role for IL-17 in induction of aninflammation at the fetomaternal interface in preterm labour. Journal of Reproductive Immunology, 84(1), 75-85. https://doi.org/10.1016/j.jri.2009.09.005</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, P., Zhu, W. Y., He, X., Tang, M. M., Dang, R. L., Li, H. D., et al., 2015. Association between vitamin D receptor gene polymorphisms with childhood temporal lobe epilepsy. Int. J. Environ. Res. Public Health, 12(11), 13913-13922.</Citation>
        </Reference>
        <Reference>
          <Citation>Ji, J., Zhai, H., Zhou, H., Song, S., Mor, G., &amp; Liao, A. (2019). The role and mechanism of vitamin D-mediated regulation of Treg/Th17 balance in recurrent pregnancy loss. American Journal of Reproductive Immunology, 81(6), e13112. https://doi.org/10.1111/aji.13112</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, Y. H., Kim, J. H., Song, G. G., 2014. Vitamin D receptor polymorphisms and susceptibility to Parkinson's disease and Alzheimer's disease: a meta-analysis. Neurol. Sci., 35(12), 1947-1953.</Citation>
        </Reference>
        <Reference>
          <Citation>Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., &amp; Bishop, S. (2012). Autism diagnostic observation schedule-Second edition (ADOS-2). Los Angeles: Western Psychological Services Italian edition Colombi C., Tancredi R., Persico A., &amp; Faggioli A. (eds.) Firenze: Hogrefe Editor.</Citation>
        </Reference>
        <Reference>
          <Citation>Lord, C., Rutter, M., &amp; Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659-685.</Citation>
        </Reference>
        <Reference>
          <Citation>Makhseed, M., Raghupathy, R., El-Shazly, S., Azizieh, F., Al-Harmi, J. A., &amp; Al-Azemi, M. M. (2003). Pro-inflammatory maternal cytokine profile in preterm delivery. American Journal of Reproductive Immunology, 49(5), 308-318.</Citation>
        </Reference>
        <Reference>
          <Citation>Marzi, M., Vigano', A., Trabattoni, D., Villa, M. L., Clerici, E., &amp; Clerici, M. (1996). Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clinical and Experimental Immunology, 106, 127-133.</Citation>
        </Reference>
        <Reference>
          <Citation>Mobasheri, L., Moossavi, S. Z., Esmaeili, A., Mohammadoo-Khorasani, M., Sarab, G. A. 2020. Association between vitamin D receptor geneFokI and TaqI variants with autismspectrumdisorder predisposition in Iranian population. Gene, 723, 144133. https://doi.org/10.1016/j.gene.2019.144133</Citation>
        </Reference>
        <Reference>
          <Citation>Morrison, N. A., Qi, J. C., Tokita, A., Kelly, P. J., Crofts, L., Nguyen, T. V., … Eisman, J. (1994). Prediction of bone density from vitamin D receptor alleles. Nature, 367, 284-287. https://doi.org/10.1038/367284a0</Citation>
        </Reference>
        <Reference>
          <Citation>Morrison, N. A., Yeoman, R., Kelly, P. J., &amp; Eisman, J. A. (1992). Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphism and circulating osteocalcin. Proceedings of the National Academy of Sciences of the United States of America, 89, 6665-6669. https://doi.org/10.1073/pnas.89.15.6665</Citation>
        </Reference>
        <Reference>
          <Citation>Onore, C., Careaga, M., &amp; Ashwood, P. (2012). The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity, 26, 383-392. https://doi.org/10.1016/j.bbi.2011.08.007</Citation>
        </Reference>
        <Reference>
          <Citation>Piccinni, M. P., Beloni, L., Livi, C., Maggi, E., Scarselli, G., &amp; Romagnani, S. (1998). Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature Medicine, 4(9), 1020-1024.</Citation>
        </Reference>
        <Reference>
          <Citation>Raven, J. C., Court, J. H., &amp; Raven, J. (1984). Manual for Raven's progressive matrices and vocabulary scales. Section 2: Coloured progressive matrices. London: H. K. Lewis Italian edition Belacchi C., Scalisi T. G., Cannoni E., &amp; Cornoldi C. (eds.) Firenze: Giunti Organizzazioni Speciali.</Citation>
        </Reference>
        <Reference>
          <Citation>Roid, G. H., Miller, L. J., Pomplun, M., &amp; Koch, C. (2013). Leiter international performance scale (3rs ed.). (Leiter-3). Los Angeles: Western Psychological Services Italian edition Cornoldi C., Giofrè D., &amp; Belacchi C. (eds.) Firenze: Giunti Organizzazioni Speciali.</Citation>
        </Reference>
        <Reference>
          <Citation>Saijo, T., Ito, M., Takeda, E., Huq, A. H., Naito, E., Yokota, I., … Kuroda, Y. (1991). A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. American Journal of Human Genetics, 49, 668-673.</Citation>
        </Reference>
        <Reference>
          <Citation>Saito, S., Nakashima, A., Shima, T., &amp; Ito, M. (2010). Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. American Journal of Reproductive Immunology, 63(6), 601-610. https://doi.org/10.1111/j.1600-0897.2010.00852.x</Citation>
        </Reference>
        <Reference>
          <Citation>Saresella, M., Marventano, I., Guerini, F. R., Mancuso, R., Ceresa, L., Zanzottera, M., … Clerici, M. (2009). An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biological Psychiatry, 15(66), 978-984. https://doi.org/10.1016/j.biopsych.2009.06.020</Citation>
        </Reference>
        <Reference>
          <Citation>Saresella, M., Piancone, F., Marventano, I., Zoppis, M., Hernis, A., Zanette, M., … Clerici, M. (2016). Multiple inflammasome complexes are activated in autistic spectrum disorders. Brain, Behavior, and Immunity, 57, 125-133. https://doi.org/10.1016/j.bbi.2016.03.009</Citation>
        </Reference>
        <Reference>
          <Citation>Schendel, D., &amp; Bhasin, T. K. (2008). Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics, 121, 1155-1564. https://doi.org/10.1542/peds.2007-1049</Citation>
        </Reference>
        <Reference>
          <Citation>Schopler, E., Reichler, R. J., DeVellis, R. F., &amp; Daly, K. (1980). Toward objective classification of childhood autism: Childhood autism rating scale (CARS). Journal of Autism and Developmental Disorders, 10, 91-103.</Citation>
        </Reference>
        <Reference>
          <Citation>Sharif, K., Sharif, Y., Watad, A., Yavne, Y., Lichtbroun, B., Bragazzi, N. L., … Shoenfeld, Y. (2018). Vitamin D, autoimmunity and recurrent pregnancy loss: More than an association. American Journal of Reproductive Immunology, 80(3), e12991. https://doi.org/10.1111/aji.12991</Citation>
        </Reference>
        <Reference>
          <Citation>Shi, Y. Y., &amp; He, L. (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research, 15, 97-98.</Citation>
        </Reference>
        <Reference>
          <Citation>Spielman, R. S., McGinnis, R. E., &amp; Ewens, W. J. (1993). Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics, 52, 506.</Citation>
        </Reference>
        <Reference>
          <Citation>Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., … Mori, N. (2011). Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One, 6(5), e20470. https://doi.org/10.1371/journal.pone.0020470</Citation>
        </Reference>
        <Reference>
          <Citation>Sweeten, T. L., Posey, D. J., &amp; McDougle, C. J. (2003). High blood monocyte counts and neopterin levels in children with autistic disorder. The American Journal of Psychiatry, 160, 1691-1693.</Citation>
        </Reference>
        <Reference>
          <Citation>Uitterlinden, A. G., Fang, Y., Van Meurs, J. B., Pols, H. A., &amp; Van Leeuwen, J. P. (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-156. https://doi.org/10.1016/j.gene.2004.05.014</Citation>
        </Reference>
        <Reference>
          <Citation>Valdivielso, J. M., &amp; Fernandez, E. (2006). Vitamin D receptor polymorphisms and diseases. Clinica Chimica Acta, 2, 1-12. https://doi.org/10.1016/j.cca.2006.02.016</Citation>
        </Reference>
        <Reference>
          <Citation>Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., &amp; Pardo, C. A. (2005). Neuroglialactivation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, L. Q., Yan, X. T., Yan, C. F., Zhang, X. W., Hui, L. Y., Xue, M., &amp; Yu, X. W. (2016). Women with recurrent miscarriage have decreased expression of 25-hydroxyvitamin D3-1α-hydroxylase by the fetal-maternal interface. PLoS One, 11, e0165589. https://doi.org/10.1371/journal.pone.0165589</Citation>
        </Reference>
        <Reference>
          <Citation>Wechsler, D. (2003). Wechsler Intelligence Scale for Children (4th ed.). San Antonio, TX: Harcourt Assessment.</Citation>
        </Reference>
        <Reference>
          <Citation>Yan, J., Feng, J., Craddock, N., Jones, I. R., Cook, E. H. Jr, Goldman, D., Heston, L. L., Chen, J., Burkhart, P., Li, W., Shibayama, A., Sommer, S. S. 2005. Vitamin Dreceptor variants in 192 patients with schizophrenia and other psychiatric diseases. Neurosci Lett. 20-27, 380, 37-41.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, Z., Li, S., Yu, L., &amp; Liu, J. (2018). Polymorphisms in vitamin D receptor genes in association with childhood autism spectrum disorder. Disease Markers, 2018, 7862892. https://doi.org/10.1155/2018/7862892</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083398</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2160-7648</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical pharmacology in drug development</Title>
          <ISOAbbreviation>Clin Pharmacol Drug Dev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Absolute Bioavailability of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation-Positive Malignancies.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cpdd.773</ELocationID>
        <Abstract>
          <AbstractText>Vemurafenib is a BRAF kinase inhibitor indicated for the treatment of patients with BRAF<sup>V600</sup> mutation-positive unresectable or metastatic melanoma and Erdheim-Chester disease. This phase 1, open-label, single-arm study was designed to estimate absolute bioavailability of oral vemurafenib at steady state and to characterize the pharmacokinetics of a single intravenous microdose of <sup>14</sup> C-labeled vemurafenib in patients with BRAF<sup>V600</sup> mutation-positive malignancies. Patients received oral vemurafenib 960 mg twice daily on days 1 through 28, with a single intravenous infusion of <sup>14</sup> C-labeled vemurafenib solution (3 mL, corresponding to a radioactive dose of 18.5 kBq and a vemurafenib dose of 20 µg) given on the morning of day 21, immediately following the morning dose of oral vemurafenib. A total of 6 patients were enrolled. Four patients who received <sup>14</sup> C-labeled vemurafenib infusion were included in the pharmacokinetic and bioavailability analyses. Geometric mean absolute bioavailability of oral vemurafenib at steady state, calculated as the ratio of dose-normalized area under the curve during the dosing interval (AUC<sub>τ</sub> ) following oral vemurafenib dose to dose-normalized AUC from time 0 extrapolated to infinity (AUC<sub>0-inf</sub> ) following vemurafenib intravenous dose, was 57.8%. The majority of radioactivity (geometric mean 41%) was recovered in feces, and a small proportion (geometric mean 1.4%) was recovered in urine. Treatment-emergent adverse events occurred in 5 of 6 (83%) patients and were all grade 1/2 in severity, except for 1 grade-4 anaphylactic reaction occurring during infusion of <sup>14</sup> C-labeled vemurafenib, which was thought to be related to the excipient polysorbate 80 in the intravenous formulation.</AbstractText>
          <CopyrightInformation>© 2020, The American College of Clinical Pharmacology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Weijiang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Roche Innovation Center New York, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colburn</LastName>
            <ForeName>Dawn</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Genentech, Inc, South San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simmons</LastName>
            <ForeName>Brian</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Genentech, Inc, South San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Papai</LastName>
            <ForeName>Zsuzsanna</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>PRA Magyarország Kft Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bertran</LastName>
            <ForeName>Enric</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schadt</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Husser</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Forbes</LastName>
            <ForeName>Harper</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roethlisberger</LastName>
            <ForeName>Dieter</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hartung</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>F. Hoffmann-La Roche, Ltd.</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Pharmacol Drug Dev</MedlineTA>
        <NlmUniqueID>101572899</NlmUniqueID>
        <ISSNLinking>2160-763X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">bioavailability</Keyword>
        <Keyword MajorTopicYN="N">melanoma</Keyword>
        <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>
        <Keyword MajorTopicYN="N">vemurafenib</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083398</ArticleId>
        <ArticleId IdType="doi">10.1002/cpdd.773</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507-2516.</Citation>
        </Reference>
        <Reference>
          <Citation>McArthur GA, Chapman PB, Robert C, et al. Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study. Lancet Oncol. 2014;15(3):323-332.</Citation>
        </Reference>
        <Reference>
          <Citation>Diamond EL, Subbiah V, Lockhart AC, et al. Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study. JAMA Oncol. 2018;4(3):384-388.</Citation>
        </Reference>
        <Reference>
          <Citation>Larkin J, Ascierto PA, Dreno B, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014;371(20):1867-1876.</Citation>
        </Reference>
        <Reference>
          <Citation>Ascierto PA, McArthur GA, Dreno B, et al. Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. Lancet Oncol. 2016;17(9):1248-1260.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang W, McIntyre C, Forbes H, et al. Effect of rifampicin on the pharmacokinetics of a single dose of vemurafenib in patients with BRAFV600 mutation-positive metastatic malignancy. Clinical Pharmacol Drug Dev. 2019;8(6):837-843.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang W, McIntyre C, Kuhn M, et al. Effect of vemurafenib on the pharmacokinetics of a single dose of digoxin in patients with BRAFV600 mutation-positive metastatic malignancy. J Clin Pharmacol. 2018;58(8):1067-1073.</Citation>
        </Reference>
        <Reference>
          <Citation>Grippo JF, Zhang W, Heinzmann D, et al. A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAFV600E mutation-positive metastatic melanoma. Cancer Chemother Pharmacol. 2014;73(1):103-111.</Citation>
        </Reference>
        <Reference>
          <Citation>Ribas A, Zhang W, Chang I, et al. The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics. J Clin Pharmacol. 2014;54(4):368-374.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang W, Heinzmann D, Grippo JF. Clinical pharmacokinetics of vemurafenib. Clin Pharmacokinet. 2017;56(9):1033-1043.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldinger SM, Rinderknecht J, Dummer R, et al. A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma. Pharmacol Res Perspect. 2015;3(2):e00113.</Citation>
        </Reference>
        <Reference>
          <Citation>Shah N, Iyer RM, Mair HJ, et al. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process. J Pharm Sci. 2013;102(3):967-981.</Citation>
        </Reference>
        <Reference>
          <Citation>Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809-819.</Citation>
        </Reference>
        <Reference>
          <Citation>Boulton DW, Kasichayanula S, Keung CFA, et al. Simultaneous oral therapeutic and intravenous 14C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin. Br J Clin Pharmacol. 2013;75(3):763-768.</Citation>
        </Reference>
        <Reference>
          <Citation>Williams HD, Trevaskis NL, Charman SA, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65(1):315-499.</Citation>
        </Reference>
        <Reference>
          <Citation>Sarapa N, Hsyu PH, Lappin G, Garner RC. The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers. J Clin Pharmacol. 2005;45(10):1198-1205.</Citation>
        </Reference>
        <Reference>
          <Citation>Kishore RS, Kiese S, Fischer S, Pappenberger A, Grauschopf U, Mahler HC. The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics. Pharm Res. 2011;28(5):1194-1210.</Citation>
        </Reference>
        <Reference>
          <Citation>Swart P, Lozac'h F, Simon M, van Duijn E, Vaes WH. The impact of early human data on clinical development: there is time to win. Drug Discov Today. 2016;21(6):873-879.</Citation>
        </Reference>
        <Reference>
          <Citation>Steele RH, Limaye S, Cleland B, Chow J, Suranyi MG. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin. Nephrology. 2005;10(3):317-320.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwartzberg LS, Navari RM. Safety of polysorbate 80 in the oncology setting. Adv Ther. 2018;35(6):754-767.</Citation>
        </Reference>
        <Reference>
          <Citation>Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol. 2005;95(6): 593-599.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083399</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1542-474X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc</Title>
          <ISOAbbreviation>Ann Noninvasive Electrocardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12749</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/anec.12749</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac amyloidosis (CA) is characterized by left ventricular hypertrophy (LVH) and autonomic nervous imbalance due to amyloid infiltration. However, autonomic dysfunction is often seen in heart failure (HF) with LVH from other etiologies. We aimed to characterize autonomic dysfunction in CA from other etiologies of LVH.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-five HF patients with LVH (35 males, mean age 65 ± 16 years) were enrolled. LVH was defined as left ventricular mass index measured by echocardiography &gt;95 g/m<sup>2</sup> in women and 115 g/m<sup>2</sup> in men. The etiology was as follows: amyloid light chain (AL)-CA, n = 14; hypertrophic cardiomyopathy, n = 21; and aortic stenosis (AS), n = 20. With the patient in a clinically stable condition, heart rate variability (HRV) and heart rate turbulence (HRT), which reflect autonomic dysfunction, were measured using Holter monitoring and compared among the three groups.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Brain natriuretic peptide levels, LVH severity, left ventricular ejection fraction, and tissue Doppler index E/e' did not differ among the three groups. However, severe abnormalities of HRV and HRT were obtained in AL-CA. In the ROC analysis to identify AL-CA in HF with LVH, the best cutoff value for standard deviation of all R-R intervals, standard deviation of the 5-min mean R-R intervals, turbulence onset, and turbulence slope were 68.5 ms (AUC: 0.865), 58.5 ms (AUC: 0.834), 0.25% (AUC: 0.813), and 1.00 ms/RR (AUC 0.736), respectively.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Autonomic dysfunction is a hallmark of AL-CA, and its noninvasive assessment by Holter monitoring may be a useful tool for differential diagnosis of HF with LVH.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yamada</LastName>
            <ForeName>Shinya</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5726-3926</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoshihisa</LastName>
            <ForeName>Akiomi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Advanced Cardiac Therapeutics, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hijioka</LastName>
            <ForeName>Naoko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamioka</LastName>
            <ForeName>Masashi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaneshiro</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Arrhythmia and Cardiac Pacing, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yokokawa</LastName>
            <ForeName>Tetsuro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Misaka</LastName>
            <ForeName>Tomofumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Advanced Cardiac Therapeutics, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishida</LastName>
            <ForeName>Takafumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takeishi</LastName>
            <ForeName>Yasuchika</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ann Noninvasive Electrocardiol</MedlineTA>
        <NlmUniqueID>9607443</NlmUniqueID>
        <ISSNLinking>1082-720X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">autonomic dysfunction</Keyword>
        <Keyword MajorTopicYN="N">cardiac amyloidosis</Keyword>
        <Keyword MajorTopicYN="N">heart rate turbulence</Keyword>
        <Keyword MajorTopicYN="N">heart rate variability</Keyword>
        <Keyword MajorTopicYN="N">left ventricular hypertrophy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083399</ArticleId>
        <ArticleId IdType="doi">10.1111/anec.12749</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Ajiki, K., Murakawa, Y., Yanagisawa-Miwa, A., Usui, M., Yamashita, T., Oikawa, N., &amp; Inoue, H. (1993). Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. American Journal of Cardiology, 71, 1316-1320. https://doi.org/10.1016/0002-9149(93)90547-P</Citation>
        </Reference>
        <Reference>
          <Citation>Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., … Watkins, H. (2014). ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal, 2014(35), 2733-2779.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauer, A., Malik, M., Schmidt, G., Barthel, P., Bonnemeier, H., Cygankiewicz, I., … Zareba, W. (2008). Heart rate turbulence: Standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. Journal of the American College of Cardiology, 52, 1353-1365. https://doi.org/10.1016/j.jacc.2008.07.041</Citation>
        </Reference>
        <Reference>
          <Citation>Bazett, H. (1920). An analysis of the time-relations of electrocardiograms. Heart, 7, 353-370.</Citation>
        </Reference>
        <Reference>
          <Citation>Bély, M., &amp; Apáthy, A. (2000). Histochemical and immunohistochemical differential diagnosis of amyloidosis-a brief illustrated essay and personal experience with Romhányi's method. Amyloid, 7, 212-217. https://doi.org/10.3109/13506120009146836</Citation>
        </Reference>
        <Reference>
          <Citation>Cueto-Garcia, L., Reeder, G. S., Kyle, R. A., Wood, D. L., Seward, J. B., Naessens, J., … Tajik, A. J. (1985). Echocardiographic findings in systemic amyloidosis: Spectrum of cardiac involvement and relation to survival. Journal of the American College of Cardiology, 6, 737-743. https://doi.org/10.1016/S0735-1097(85)80475-7</Citation>
        </Reference>
        <Reference>
          <Citation>Di Bella, G., Minutoli, F., Piaggi, P., Casale, M., Mazzeo, A., Zito, C., … Carerj, S. (2015). Usefulness of combining electrocardiographic and echocardiographic findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation. American Journal of Cardiology, 116, 1122-1127.</Citation>
        </Reference>
        <Reference>
          <Citation>Fei, L., Slade, A. K., Prasad, K., Malik, M., McKenna, W. J., &amp; Camm, A. J. (1995). Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy? Journal of the American College of Cardiology, 26, 472-480. https://doi.org/10.1016/0735-1097(95)80025-C</Citation>
        </Reference>
        <Reference>
          <Citation>Getz, M. A. (2004). The classification and typing of amyloid deposits. American Journal of Clinical Pathology, 121, 787-789. https://doi.org/10.1309/TR4LGLVRJKAMV5QT</Citation>
        </Reference>
        <Reference>
          <Citation>Grogan, M., &amp; Dispenzieri, A. (2015). Natural history and therapy of AL cardiac amyloidosis. Heart Failure Reviews, 20, 155-162. https://doi.org/10.1007/s10741-014-9464-5</Citation>
        </Reference>
        <Reference>
          <Citation>Ho, K. K., Anderson, K. M., Kannel, W. B., Grossman, W., &amp; Levy, D. (1993). Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation, 88, 107-115. https://doi.org/10.1161/01.CIR.88.1.107</Citation>
        </Reference>
        <Reference>
          <Citation>Hongo, M., Yamamoto, H., Kohda, T., Takeda, M., Kinoshita, O., Uchikawa, S., … Kubo, K. (2000). Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings. American Journal of Cardiology, 85, 849-853. https://doi.org/10.1016/S0002-9149(99)00879-6</Citation>
        </Reference>
        <Reference>
          <Citation>Karcz, M., Chojnowska, L., Zareba, W., &amp; Ruzyłło, W. (2003). Prognostic significance of heart rate variability in dilated cardiomyopathy. International Journal of Cardiology, 87, 75-81. https://doi.org/10.1016/S0167-5273(02)00207-3</Citation>
        </Reference>
        <Reference>
          <Citation>Kimishima, Y., Yoshihisa, A., Kiko, T., Yokokawa, T., Miyata-Tatsumi, M., Misaka, T., … Takeishi, Y. (2019) Utility of B-type natriuretic peptide for detecting cardiac involvement in immunoglobulin amyloidosis. International Heart Journal, 60(5), 1106-1112.</Citation>
        </Reference>
        <Reference>
          <Citation>Kleiger, R. E., Miller, J. P., Bigger, J. T. Jr, &amp; Moss, A. J. (1987). Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology, 59, 256-262. https://doi.org/10.1016/0002-9149(87)90795-8</Citation>
        </Reference>
        <Reference>
          <Citation>Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., … Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 28, 1-39. https://doi.org/10.1016/j.echo.2014.10.003</Citation>
        </Reference>
        <Reference>
          <Citation>Leung, N., Nasr, S. H., &amp; Sethi, S. (2012). How I treat amyloidosis: The importance of accurate diagnosis and amyloid typing. Blood, 120, 3206-3213. https://doi.org/10.1182/blood-2012-03-413682</Citation>
        </Reference>
        <Reference>
          <Citation>Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. L., Hendriksen, S., … Van Lente, F. (2006). Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annals of Internal Medicine, 145, 247-254. https://doi.org/10.7326/0003-4819-145-4-200608150-00004</Citation>
        </Reference>
        <Reference>
          <Citation>Mathew, J., Sleight, P., Lonn, E., Johnstone, D., Pogue, J., Yi, Q., … Yusuf, S. (2001). Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation, 104, 1615-1621. https://doi.org/10.1161/hc3901.096700</Citation>
        </Reference>
        <Reference>
          <Citation>McMurray, J. J., Adamopoulos, S., Anker, S. D., Auricchio, A., Bohm, M., Dickstein, K., … ESC Committee for Practice Guidelines. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 14, 803-869.</Citation>
        </Reference>
        <Reference>
          <Citation>Miwa, Y., Ikeda, T., Sakaki, K., Miyakoshi, M., Ishiguro, H., Tsukada, T., … Yoshino, H. (2009). Heart rate turbulence as a predictor of cardiac mortality and arrhythmic events in patients with dilated cardiomyopathy: A prospective study. Journal of Cardiovascular Electrophysiology, 20, 788-795. https://doi.org/10.1111/j.1540-8167.2009.01438.x</Citation>
        </Reference>
        <Reference>
          <Citation>Montano, N., Ruscone, T. G., Porta, A., Lombardi, F., Pagani, M., &amp; Malliani, A. (1994). Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation, 90, 1826-1831. https://doi.org/10.1161/01.CIR.90.4.1826</Citation>
        </Reference>
        <Reference>
          <Citation>Nearing, B. D., &amp; Verrier, R. L. (2002). Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. Journal of Applied Physiology, 92, 541-549. https://doi.org/10.1152/japplphysiol.00592.2001</Citation>
        </Reference>
        <Reference>
          <Citation>Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P. 3rd, &amp; Guyton, R. A. … American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014). AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63, 57-185. https://doi.org/10.1161/CIR.0000000000000031</Citation>
        </Reference>
        <Reference>
          <Citation>Nolan, J., Batin, P. D., Andrews, R., Lindsay, S. J., Brooksby, P., Mullen, M., … Fox, K. A. (1998). Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation, 98, 1510-1516. https://doi.org/10.1161/01.CIR.98.15.1510</Citation>
        </Reference>
        <Reference>
          <Citation>Reyners, A. K., Hazenberg, B. P., Reitsma, W. D., &amp; Smit, A. J. (2002). Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. European Heart Journal, 23, 157-161. https://doi.org/10.1053/euhj.2001.2972</Citation>
        </Reference>
        <Reference>
          <Citation>Schmidt, G., Malik, M., Barthel, P., Schneider, R., Ulm, K., Rolnitzky, L., … Schömig, A. (1999). Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet, 353, 1390-1396. https://doi.org/10.1016/S0140-6736(98)08428-1</Citation>
        </Reference>
        <Reference>
          <Citation>Schonland, S. O., Hegenbart, U., Bochtler, T., Mangatter, A., Hansberg, M., Ho, A. D., … Röcken, C. (2012). Immunohistochemistry in the classification of systemic forms of amyloidosis: A systematic investigation of 117 patients. Blood, 119, 488-493. https://doi.org/10.1182/blood-2011-06-358507</Citation>
        </Reference>
        <Reference>
          <Citation>Sokolow, M., &amp; Lyon, T. P. (1949). The ventricular complex in left ventricular hypertrophy as obtained by unipolar and limb leads. American Heart Journal, 37, 161-186.</Citation>
        </Reference>
        <Reference>
          <Citation>Surawicz, B., Childers, R., Deal, B. J., Gettes, L. S., Bailey, J. J., &amp; Gorgels, A. … Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation, 119, e235-e240.</Citation>
        </Reference>
        <Reference>
          <Citation>Takeda, M., Amano, Y., Tachi, M., Tani, H., Mizuno, K., &amp; Kumita, S. (2013). MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: Differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease. Japanese Journal of Radiology, 31, 693-700. https://doi.org/10.1007/s11604-013-0238-0</Citation>
        </Reference>
        <Reference>
          <Citation>Umetani, K., Singer, D. H., McCraty, R., &amp; Atkinson, M. (1998). Twenty-four hour time domain heart rate variability and heart rate: Relations to age and gender over nine decades. Journal of the American College of Cardiology, 31, 593-601. https://doi.org/10.1016/S0735-1097(97)00554-8</Citation>
        </Reference>
        <Reference>
          <Citation>Yamada, S., Suzuki, H., Kamioka, M., Suzuki, S., Kamiyama, Y., Yoshihisa, A., … Takeishi, Y. (2013). Sleep-disordered breathing increases risk for fatal ventricular arrhythmias in patients with chronic heart failure. Circulation Journal, 77, 1466-1473. https://doi.org/10.1253/circj.CJ-12-0836</Citation>
        </Reference>
        <Reference>
          <Citation>Yamada, S., Yoshihisa, A., Sato, Y., Sato, T., Kamioka, M., Kaneshiro, T., … Takeishi, Y. (2018). Utility of heart rate turbulence and T-wave alternans to assess risk for readmission and cardiac death in hospitalized heart failure patients. Journal of Cardiovascular Electrophysiology, 29, 1257-1264. https://doi.org/10.1111/jce.13639</Citation>
        </Reference>
        <Reference>
          <Citation>Yusuf, S. W., Solhpour, A., Banchs, J., Lopez-Mattei, J. C., Durand, J. B., Iliescu, C., … Qazilbash, M. H. (2014). Cardiac amyloidosis. Expert Review of Cardiovascular Therapy, 12, 265-277. https://doi.org/10.1586/14779072.2014.876363</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083400</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4930</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cytometry. Part A : the journal of the International Society for Analytical Cytology</Title>
          <ISOAbbreviation>Cytometry A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development of Automated Microscopy-Assisted High-Content Multiparametric Assays for Cell Cycle Staging and Foci Quantitation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cyto.a.23988</ELocationID>
        <Abstract>
          <AbstractText>The investigation of cell cycle stage-dependent processes in a population of cells is often performed using flow cytometry. While this approach is high-throughput, it is relatively low in resolution and unable to measure phenotypic changes or processes occurring in subcellular compartments. We integrated automated microscopy with newly developed informatics workflow that enabled the quantitation of multiple fluorescent markers from specific subnuclear regions throughout a population of cells. Telomeres protect chromosome termini and prevent cellular aging. Cancer cells lengthen telomeres by synthesizing new TTAGGG repeats by the enzyme telomerase, while others activate recombination-dependent alternative lengthening of telomeres (ALT). A key feature of the ALT pathway is the specific clustering of promyelocytic leukemia (PML) nuclear bodies at telomeres. These ALT-associated PML bodies (APBs) common in tumors of mesenchymal origin have gained in diagnostic use in the past decade. Here we applied recent improvements in automated microscopy and developed novel informatics workflows for quantitation of multiple fluorescent markers from specific subnuclear regions at the single cell level. Key to this workflow are customized machine learning algorithms within HCS Studio™ Cell Analysis which automatically identify and segment cells into defined regions of interest based on fluorescent markers, measure marker intensities and compute marker colocalizations in specific segmented regions. These multiparametric cellular assays assess cell cycle dynamics as well as the interactome of APBs, are amenable to adherent cells and histological sections, and are adaptable for use with additional markers. In the future we anticipate exploiting these algorithms for a wide range of research questions related to telomere biology with potential to facilitate clinical development of ALT detection assays to benefit patients with these often-poor prognosis tumors. © 2020 International Society for Advancement of Cytometry.</AbstractText>
          <CopyrightInformation>© 2020 International Society for Advancement of Cytometry.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Frölich</LastName>
            <ForeName>Sonja</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8673-3437</Identifier>
            <AffiliationInfo>
              <Affiliation>Robinson Research Institute, School of Medicine, The University of Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robker</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Robinson Research Institute, School of Medicine, The University of Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Russell</LastName>
            <ForeName>Darryl</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4930-7658</Identifier>
            <AffiliationInfo>
              <Affiliation>Robinson Research Institute, School of Medicine, The University of Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cytometry A</MedlineTA>
        <NlmUniqueID>101235694</NlmUniqueID>
        <ISSNLinking>1552-4922</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ALT-associated PML bodies</Keyword>
        <Keyword MajorTopicYN="N">cell cycle profiling</Keyword>
        <Keyword MajorTopicYN="N">fluorescence in situ hybridization</Keyword>
        <Keyword MajorTopicYN="N">image analysis</Keyword>
        <Keyword MajorTopicYN="N">phenotyping</Keyword>
        <Keyword MajorTopicYN="N">telomeres</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083400</ArticleId>
        <ArticleId IdType="doi">10.1002/cyto.a.23988</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Literature Cited</Title>
        <Reference>
          <Citation>Ma HT, Poon RY. Synchronization of HeLa cells. Methods Mol Biol 2017;1524:189-201.</Citation>
        </Reference>
        <Reference>
          <Citation>Baranovskiy AG, Babayeva ND, Suwa Y, Gu J, Pavlov YI, Tahirov TH. Structural basis for inhibition of DNA replication by aphidicolin. Nucleic Acids Res 2014;42(22):14013-14021.</Citation>
        </Reference>
        <Reference>
          <Citation>Koc A, Wheeler LJ, Mathews CK, Merrill GF. Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools. J Biol Chem 2004;279(1):223-230.</Citation>
        </Reference>
        <Reference>
          <Citation>Jemaa M, Manic G, Vitale I. Synchronization and desynchronization of cells by interventions on the spindle assembly checkpoint. Methods Mol Biol 2017;1524:77-95.</Citation>
        </Reference>
        <Reference>
          <Citation>Harper JV. Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol 2005;296:157-166.</Citation>
        </Reference>
        <Reference>
          <Citation>Cesare AJ, Heaphy CM, O'Sullivan RJ. Visualization of telomere integrity and function in vitro and in vivo using immunofluorescence techniques. Curr Protoc Cytom 2015;73: 12 40 1-31.</Citation>
        </Reference>
        <Reference>
          <Citation>Fay FS, Taneja KL, Shenoy S, Lifshitz L, Singer RH. Quantitative digital analysis of diffuse and concentrated nuclear distributions of nascent transcripts, SC35 and poly(A). Exp Cell Res 1997;231(1):27-37.</Citation>
        </Reference>
        <Reference>
          <Citation>Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA. Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci 1992;103(Pt 3):857-862.</Citation>
        </Reference>
        <Reference>
          <Citation>Ponten J, Saksela E. Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 1967;2(5):434-447.</Citation>
        </Reference>
        <Reference>
          <Citation>Storchova Z, Kuffer C. The consequences of tetraploidy and aneuploidy. J Cell Sci 2008;121(Pt 23):3859-3866.</Citation>
        </Reference>
        <Reference>
          <Citation>Gisselsson D, Jin Y, Lindgren D, Persson J, Gisselsson L, Hanks S, Sehic D, Mengelbier LH, Ora I, Rahman N, et al. Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis. Proc Natl Acad Sci U S A 2010;107(47):20489-20,493.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin RM, Cardoso MC. Chromatin condensation modulates access and binding of nuclear proteins. FASEB J 2010;24(4):1066-1072.</Citation>
        </Reference>
        <Reference>
          <Citation>Dean PN, Jett JH. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974;60(2):523-527.</Citation>
        </Reference>
        <Reference>
          <Citation>Crosio C, Fimia GM, Loury R, Kimura M, Okano Y, Zhou H, Sen S, Allis CD, Sassone-Corsi P. Mitotic phosphorylation of histone H3: Spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol 2002;22(3):874-885.</Citation>
        </Reference>
        <Reference>
          <Citation>Juan G, Traganos F, Darzynkiewicz Z. Methods to identify mitotic cells by flow cytometry. Methods Cell Biol 2001;63:343-354.</Citation>
        </Reference>
        <Reference>
          <Citation>Cappella P, Gasparri F, Pulici M, Moll J. A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A 2008;73(7):626-636.</Citation>
        </Reference>
        <Reference>
          <Citation>Salic A, Mitchison TJ. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci U S A 2008;105(7):2415-2420.</Citation>
        </Reference>
        <Reference>
          <Citation>Geuens G, de Brabander M, Nuydens R, De Mey J. The interaction between microtubules and intermediate filaments in cultured cells treated with taxol and nocodazole. Cell Biol Int Rep 1983;7(1):35-47.</Citation>
        </Reference>
        <Reference>
          <Citation>Manfredi JJ, Horwitz SB. Taxol: An antimitotic agent with a new mechanism of action. Pharmacol Ther 1984;25(1):83-125.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh A, Xu YJ. The cell killing mechanisms of hydroxyurea. Genes (Basel) 2016;7(11):99.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheaff R, Ilsley D, Kuchta R. Mechanism of DNA polymerase alpha inhibition by aphidicolin. Biochemistry 1991;30(35):8590-8597.</Citation>
        </Reference>
        <Reference>
          <Citation>Everett RD. Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 2006;8(3):365-374.</Citation>
        </Reference>
        <Reference>
          <Citation>Villagra NT, Navascues J, Casafont I, Val-Bernal JF, Lafarga M, Berciano MT. The PML-nuclear inclusion of human supraoptic neurons: A new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Neurobiol Dis 2006;21(1):181-193.</Citation>
        </Reference>
        <Reference>
          <Citation>Fasching CL, Neumann AA, Muntoni A, Yeager TR, Reddel RR. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res 2007;67(15):7072-7077.</Citation>
        </Reference>
        <Reference>
          <Citation>Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 2004;96(4):269-279.</Citation>
        </Reference>
        <Reference>
          <Citation>Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 1994;13(5):1073-1083.</Citation>
        </Reference>
        <Reference>
          <Citation>Marciniak RA, Cavazos D, Montellano R, Chen Q, Guarente L, Johnson FB. A novel telomere structure in a human alternative lengthening of telomeres cell line. Cancer Res 2005;65(7):2730-2737.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim J, Daniel J, Espejo A, Lake A, Krishna M, Xia L, Zhang Y, Bedford MT. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep 2006;7(4):397-403.</Citation>
        </Reference>
        <Reference>
          <Citation>Eidet JR, Pasovic L, Maria R, Jackson CJ, Utheim TP. Objective assessment of changes in nuclear morphology and cell distribution following induction of apoptosis. Diagn Pathol 2014;9:92.</Citation>
        </Reference>
        <Reference>
          <Citation>Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, et al. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 2005;11(1):217-225.</Citation>
        </Reference>
        <Reference>
          <Citation>Slatter T, Gifford-Garner J, Wiles A, Tan X, Chen YJ, MacFarlane M, Sullivan M, Royds J, Hung N. Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres. Am J Pathol 2010;177(6):2694-2700.</Citation>
        </Reference>
        <Reference>
          <Citation>Onitake Y, Hiyama E, Kamei N, Yamaoka H, Sueda T, Hiyama K. Telomere biology in neuroblastoma: Telomere binding proteins and alternative strengthening of telomeres. J Pediatr Surg 2009;44(12):2258-2266.</Citation>
        </Reference>
        <Reference>
          <Citation>Costa A, Daidone MG, Daprai L, Villa R, Cantu S, Pilotti S, Mariani L, Gronchi A, Henson JD, Reddel RR, et al. Telomere maintenance mechanisms in liposarcomas: Association with histologic subtypes and disease progression. Cancer Res 2006;66(17):8918-8924.</Citation>
        </Reference>
        <Reference>
          <Citation>Cairney CJ, Hoare SF, Daidone MG, Zaffaroni N, Keith WN. High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma. Br J Cancer 2008;98(8):1467-1474.</Citation>
        </Reference>
        <Reference>
          <Citation>Gunkel M, Chung I, Worz S, Deeg KI, Simon R, Sauter G, Jones DTW, Korshunov A, Rohr K, Erfle H, et al. Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow. Methods 2017;114:60-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Han M, Napier CE, Frolich S, Teber E, Wong T, Noble JR, Choi EHY, Everett RD, Cesare AJ, Reddel RR. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency. J Cell Sci 2019;132(5):jcs222349.</Citation>
        </Reference>
        <Reference>
          <Citation>Henson JD, Reddel RR. Assaying and investigating alternative lengthening of telomeres activity in human cells and cancers. FEBS Lett 2010;584(17):3800-3811.</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen SB, Reddel RR. A sensitive direct human telomerase activity assay. Nat Methods 2008;5(4):355-360.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083401</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part A</Title>
          <ISOAbbreviation>Am. J. Med. Genet. A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.61518</ELocationID>
        <Abstract>
          <AbstractText>Pathogenic variants in KMT2D, which encodes lysine specific methyltransferase 2D, cause autosomal dominant Kabuki syndrome, associated with distinctive dysmorphic features including arched eyebrows, long palpebral fissures with eversion of the lower lid, large protuberant ears, and fetal finger pads. Most disease-causing variants identified to date are putative loss-of-function alleles, although 15-20% of cases are attributed to missense variants. We describe here four patients (including one previously published patient) with de novo KMT2D missense variants and with shared but unusual clinical findings not typically seen in Kabuki syndrome, including athelia (absent nipples), choanal atresia, hypoparathyroidism, delayed or absent pubertal development, and extreme short stature. These individuals also lack the typical dysmorphic facial features found in Kabuki syndrome. Two of the four patients had severe interstitial lung disease. All of these variants cluster within a 40-amino-acid region of the protein that is located just N-terminal of an annotated coiled coil domain. These findings significantly expand the phenotypic spectrum of features associated with variants in KMT2D beyond those seen in Kabuki syndrome and suggest a possible new underlying disease mechanism for these patients.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baldridge</LastName>
            <ForeName>Dustin</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6027-6020</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spillmann</LastName>
            <ForeName>Rebecca C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wegner</LastName>
            <ForeName>Daniel J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wambach</LastName>
            <ForeName>Jennifer A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>White</LastName>
            <ForeName>Frances V</ForeName>
            <Initials>FV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sisco</LastName>
            <ForeName>Kathleen</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Toler</LastName>
            <ForeName>Tomi L</ForeName>
            <Initials>TL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dickson</LastName>
            <ForeName>Patricia I</ForeName>
            <Initials>PI</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cole</LastName>
            <ForeName>F Sessions</ForeName>
            <Initials>FS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shashi</LastName>
            <ForeName>Vandana</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grange</LastName>
            <ForeName>Dorothy K</ForeName>
            <Initials>DK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Duke University Health system and UCB Celltech</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Children's Discovery Institute</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>K08HG010154</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K12HL120002</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U01HG010215</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Acronym>HG</Acronym>
            <Agency>NHGRI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>Office of the NIH Director</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Office of Strategic Coordination</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet A</MedlineTA>
        <NlmUniqueID>101235741</NlmUniqueID>
        <ISSNLinking>1552-4825</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">KMT2D</Keyword>
        <Keyword MajorTopicYN="N">Kabuki syndrome</Keyword>
        <Keyword MajorTopicYN="N">athelia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083401</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.a.61518</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Adam, M. P., Banka, S., Bjornsson, H. T., Bodamer, O., Chudley, A. E., Harris, J., … Kabuki Syndrome Medical Advisory, B. (2019). Kabuki syndrome: international consensus diagnostic criteria. Journal of Medical Genetics, 56(2), 89-95. https://doi.org/10.1136/jmedgenet-2018-105625</Citation>
        </Reference>
        <Reference>
          <Citation>Adam, M. P., Hudgins, L., &amp; Hannibal, M. (1993-2019). Kabuki Syndrome. 2011 Sep 1 [Updated 2019 Oct 21]. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. Stephens, &amp; A. Amemiya (Eds.), GeneReviews(R)Seattle, WA.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Gazali, L. I., Hamid, Z., Hertecant, J., Bakir, M., Nath, D., &amp; Kakadekar, A. (2002). An autosomal recessive syndrome of choanal atresia, hypothelia/athelia and thyroid gland anomalies overlapping bamforth syndrome, ANOTHER syndrome and methimazole embryopathy. Clinical Dysmorphology, 11(2), 79-85.</Citation>
        </Reference>
        <Reference>
          <Citation>Ausavarat, S., Tongkobpetch, S., Praphanphoj, V., Mahatumarat, C., Rojvachiranonda, N., Snabboon, T., … Shotelersuk, V. (2011). PTPRF is disrupted in a patient with syndromic amastia. BMC Medical Genetics, 12, 46. https://doi.org/10.1186/1471-2350-12-46</Citation>
        </Reference>
        <Reference>
          <Citation>Badalato, L., Farhan, S. M., Dilliott, A. A., Care4Rare Canada Consortium, Bulman, D. E., Hegele, R. A., &amp; Goobie, S. L. (2017). KMT2D p.Gln3575His segregating in a family with autosomal dominant choanal atresia strengthens the Kabuki/CHARGE connection. American Journal of Medical Genetics. Part A, 173(1), 183-189. https://doi.org/10.1002/ajmg.a.38010</Citation>
        </Reference>
        <Reference>
          <Citation>Bamshad, M., Lin, R. C., Law, D. J., Watkins, W. C., Krakowiak, P. A., Moore, M. E., … Jorde, L. B. (1997). Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nature Genetics, 16(3), 311-315. https://doi.org/10.1038/ng0797-311</Citation>
        </Reference>
        <Reference>
          <Citation>Bamshad, M. J. (2016). Epstein's Inborn Errors of Development. The Molecular Basis of Clinical Disorders of Morphogenesis TP63 and the Ectodermal Dysplasia, Ectrodactyly, and Cleft Lip and/or Palate (EEC), Limb-Mammary (LMS), Ankyloblepharon, Ectrodactyly, and Cleft Lip/Palate (AEC, Hay-Wells), Acro-Dermato-Ungual-Lacrimal-Digit (ADULT), and Rapp-Hodgkin Syndromes and Ectrodactyly (Split Hand/Foot Malformation). Oxford, England: Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Bienert, S., Waterhouse, A., de Beer, T. A., Tauriello, G., Studer, G., Bordoli, L., &amp; Schwede, T. (2017). The SWISS-MODEL Repository-new features and functionality. Nucleic Acids Research, 45(D1), D313-D319. https://doi.org/10.1093/nar/gkw1132</Citation>
        </Reference>
        <Reference>
          <Citation>Bjornsson, H. T., Benjamin, J. S., Zhang, L., Weissman, J., Gerber, E. E., Chen, Y. C., … Dietz, H. C. (2014). Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med, 6(256), 256ra135. doi:https://doi.org/10.1126/scitranslmed.3009278</Citation>
        </Reference>
        <Reference>
          <Citation>Blake, K. D., Davenport, S. L., Hall, B. D., Hefner, M. A., Pagon, R. A., Williams, M. S., … Graham, J. M., Jr. (1998). CHARGE association: an update and review for the primary pediatrician. Clinical Pediatrics (Phila), 37(3), 159-173. https://doi.org/10.1177/000992289803700302</Citation>
        </Reference>
        <Reference>
          <Citation>Bogershausen, N., Gatinois, V., Riehmer, V., Kayserili, H., Becker, J., Thoenes, M., … Wollnik, B. (2016). Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2. Human Mutation, 37(9), 847-864. https://doi.org/10.1002/humu.23026</Citation>
        </Reference>
        <Reference>
          <Citation>Bogershausen, N., &amp; Wollnik, B. (2018). Mutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability Disorders. Frontiers in Molecular Neuroscience, 11, 252. https://doi.org/10.3389/fnmol.2018.00252</Citation>
        </Reference>
        <Reference>
          <Citation>Borck, G., de Vries, L., Wu, H. J., Smirin-Yosef, P., Nurnberg, G., Lagovsky, I., … Basel-Vanagaite, L. (2014). Homozygous truncating PTPRF mutation causes athelia. Human Genetics, 133(8), 1041-1047. https://doi.org/10.1007/s00439-014-1445-1</Citation>
        </Reference>
        <Reference>
          <Citation>Butcher, D. T., Cytrynbaum, C., Turinsky, A. L., Siu, M. T., Inbar-Feigenberg, M., Mendoza-Londono, R., … Weksberg, R. (2017). CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions. American Journal of Human Genetics, 100(5), 773-788. https://doi.org/10.1016/j.ajhg.2017.04.004</Citation>
        </Reference>
        <Reference>
          <Citation>Campeau, P. M., Lenk, G. M., Lu, J. T., Bae, Y., Burrage, L., Turnpenny, P., … Lee, B. H. (2013). Yunis-Varon syndrome is caused by mutations in FIG 4, encoding a phosphoinositide phosphatase. American Journal of Human Genetics, 92(5), 781-791. https://doi.org/10.1016/j.ajhg.2013.03.020</Citation>
        </Reference>
        <Reference>
          <Citation>Chang, K. T., Guo, J., di Ronza, A., &amp; Sardiello, M. (2018). Aminode: Identification of Evolutionary Constraints in the Human Proteome. Scientific Reports, 8(1), 1357. https://doi.org/10.1038/s41598-018-19744-w</Citation>
        </Reference>
        <Reference>
          <Citation>Cocciadiferro, D., Augello, B., De Nittis, P., Zhang, J., Mandriani, B., Malerba, N., … Merla, G. (2018). Dissecting KMT2D missense mutations in Kabuki syndrome patients. Human Molecular Genetics, 27(21), 3651-3668. https://doi.org/10.1093/hmg/ddy241</Citation>
        </Reference>
        <Reference>
          <Citation>Cuvertino, S., Hartill, V., Colyer, A., Garner, T., Nair, N., Al-Gazali, L., … Banka, S. (2020). A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome. Genetics in Medicine. https://doi.org/10.1038/s41436-019-0743-3</Citation>
        </Reference>
        <Reference>
          <Citation>Dumic, M., Cvitanovic, M., Saric, B., Spehar, A., &amp; Batinica, S. (2002). Choanal stenosis, hypothelia, deafness, recurrent dacryocystitis, neck fistulas, short stature, and microcephaly: report of a case. American Journal of Medical Genetics, 113(3), 295-297. https://doi.org/10.1002/ajmg.10783</Citation>
        </Reference>
        <Reference>
          <Citation>Faundes, V., Malone, G., Newman, W. G., &amp; Banka, S. (2019). A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population. Journal of Human Genetics, 64(2), 161-170. https://doi.org/10.1038/s10038-018-0536-6</Citation>
        </Reference>
        <Reference>
          <Citation>Foulds, N., Walpole, I., Elmslie, F., &amp; Mansour, S. (2005). Carbimazole embryopathy: an emerging phenotype. American Journal of Medical Genetics. Part A, 132A(2), 130-135. https://doi.org/10.1002/ajmg.a.30418</Citation>
        </Reference>
        <Reference>
          <Citation>Greenberg, F. (1987). Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? American Journal of Medical Genetics, 28(4), 931-934. https://doi.org/10.1002/ajmg.1320280419</Citation>
        </Reference>
        <Reference>
          <Citation>Haghighi, A., Nikuei, P., Haghighi-Kakhki, H., Saleh-Gohari, N., Baghestani, S., Krawitz, P. M., … Mundlos, S. (2013). Whole-exome sequencing identifies a novel missense mutation in EDAR causing autosomal recessive hypohidrotic ectodermal dysplasia with bilateral amastia and palmoplantar hyperkeratosis. The British Journal of Dermatology, 168(6), 1353-1356. https://doi.org/10.1111/bjd.12151</Citation>
        </Reference>
        <Reference>
          <Citation>Hisama, F. M., Reyes-Mugica, M., Wargowski, D. S., Thompson, K. J., &amp; Mahoney, M. J. (1998). Renal tubular dysgenesis, absent nipples, and multiple malformations in three brothers: a new, lethal syndrome. American Journal of Medical Genetics, 80(4), 335-342.</Citation>
        </Reference>
        <Reference>
          <Citation>Horvath, G. A., &amp; Armstrong, L. (2007). Report of a fourth individual with a lethal syndrome of choanal atresia, athelia, evidence of renal tubulopathy, and family history of neck cysts. American Journal of Medical Genetics. Part A, 143A(11), 1231-1235. https://doi.org/10.1002/ajmg.a.31734</Citation>
        </Reference>
        <Reference>
          <Citation>Ishida, L. H., Alves, H. R., Munhoz, A. M., Kaimoto, C., Ishida, L. C., Saito, F. L., … Ferreira, M. C. (2005). Athelia: case report and review of the literature. British Journal of Plastic Surgery, 58(6), 833-837. https://doi.org/10.1016/j.bjps.2005.01.018</Citation>
        </Reference>
        <Reference>
          <Citation>Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., … Ding, L. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339. https://doi.org/10.1038/nature12634</Citation>
        </Reference>
        <Reference>
          <Citation>Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., … MacArthur, D. G. (2019). Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv, 531210. doi:https://doi.org/10.1101/531210</Citation>
        </Reference>
        <Reference>
          <Citation>Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., … Maglott, D. R. (2018). ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Research, 46(D1), D1062-D1067. https://doi.org/10.1093/nar/gkx1153</Citation>
        </Reference>
        <Reference>
          <Citation>Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., … Exome Aggregation, C. (2016). Analysis of protein-coding genetic variation in 60,706 humans. Nature, 536(7616), 285-291. https://doi.org/10.1038/nature19057</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, W., Xie, Y., Ma, J., Luo, X., Nie, P., Zuo, Z., … Ren, J. (2015). IBS: an illustrator for the presentation and visualization of biological sequences. Bioinformatics, 31(20), 3359-3361. https://doi.org/10.1093/bioinformatics/btv362</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, X., Wu, C., Li, C., &amp; Boerwinkle, E. (2016). dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs. Human Mutation, 37(3), 235-241. https://doi.org/10.1002/humu.22932</Citation>
        </Reference>
        <Reference>
          <Citation>Lupas, A., Van Dyke, M., &amp; Stock, J. (1991). Predicting coiled coils from protein sequences. Science, 252(5009), 1162-1164. https://doi.org/10.1126/science.252.5009.1162</Citation>
        </Reference>
        <Reference>
          <Citation>Marneros, A. G., Beck, A. E., Turner, E. H., McMillin, M. J., Edwards, M. J., Field, M., … University of Washington Center for Mendelian. (2013). Mutations in KCTD1 cause scalp-ear-nipple syndrome. American Journal of Human Genetics, 92(4), 621-626. https://doi.org/10.1016/j.ajhg.2013.03.002</Citation>
        </Reference>
        <Reference>
          <Citation>Ming, J. E., Russell, K. L., Bason, L., McDonald-McGinn, D. M., &amp; Zackai, E. H. (2003). Coloboma and other ophthalmologic anomalies in Kabuki syndrome: distinction from charge association. American Journal of Medical Genetics. Part A, 123A(3), 249-252. https://doi.org/10.1002/ajmg.a.20277</Citation>
        </Reference>
        <Reference>
          <Citation>Mitchell, A. L., Attwood, T. K., Babbitt, P. C., Blum, M., Bork, P., Bridge, A., … Finn, R. D. (2019). InterPro in 2019: improving coverage, classification and access to protein sequence annotations. Nucleic Acids Research, 47(D1), D351-D360. https://doi.org/10.1093/nar/gky1100</Citation>
        </Reference>
        <Reference>
          <Citation>Ng, S. B., Bigham, A. W., Buckingham, K. J., Hannibal, M. C., McMillin, M. J., Gildersleeve, H. I., … Shendure, J. (2010). Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nature Genetics, 42(9), 790-793. https://doi.org/10.1038/ng.646</Citation>
        </Reference>
        <Reference>
          <Citation>Papadimitriou, A., Karapanou, O., Papadopoulou, A., Nicolaidou, P., &amp; Fretzayas, A. (2009). Congenital bilateral amazia associated with bilateral choanal atresia. American Journal of Medical Genetics. Part A, 149A(7), 1529-1531. https://doi.org/10.1002/ajmg.a.32935</Citation>
        </Reference>
        <Reference>
          <Citation>Patel, N., &amp; Alkuraya, F. S. (2015). Overlap between CHARGE and Kabuki syndromes: more than an interesting clinical observation? American Journal of Medical Genetics. Part A, 167A(1), 259-260. https://doi.org/10.1002/ajmg.a.36804</Citation>
        </Reference>
        <Reference>
          <Citation>Qazi, Q. H., Kanchanapoomi, R., Beller, E., &amp; Collins, R. (1982). Inheritance of posterior choanal atresia. American Journal of Medical Genetics, 13(4), 413-416. https://doi.org/10.1002/ajmg.1320130409</Citation>
        </Reference>
        <Reference>
          <Citation>Rao, R. C., &amp; Dou, Y. (2015). Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nature Reviews. Cancer, 15(6), 334-346. https://doi.org/10.1038/nrc3929</Citation>
        </Reference>
        <Reference>
          <Citation>Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., &amp; Kircher, M. (2019). CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47(D1), D886-D894. https://doi.org/10.1093/nar/gky1016</Citation>
        </Reference>
        <Reference>
          <Citation>Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., … Committee, A. L. Q. A. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30</Citation>
        </Reference>
        <Reference>
          <Citation>Rinne, T., Hamel, B., van Bokhoven, H., &amp; Brunner, H. G. (2006). Pattern of p63 mutations and their phenotypes-update. American Journal of Medical Genetics. Part A, 140(13), 1396-1406. https://doi.org/10.1002/ajmg.a.31271</Citation>
        </Reference>
        <Reference>
          <Citation>Sakata, S., Okada, S., Aoyama, K., Hara, K., Tani, C., Kagawa, R., … Kobayashi, M. (2017). Individual Clinically Diagnosed with CHARGE Syndrome but with a Mutation in KMT2D, a Gene Associated with Kabuki Syndrome: A Case Report. Frontiers in Genetics, 8, 210. https://doi.org/10.3389/fgene.2017.00210</Citation>
        </Reference>
        <Reference>
          <Citation>Samocha, K. E., Kosmicki, J. A., Karczewski, K. J., O'Donnell-Luria, A. H., Pierce-Hoffman, E., MacArthur, D. G., … Daly, M. J. (2017). Regional missense constraint improves variant deleteriousness prediction. bioRxiv, 148353.</Citation>
        </Reference>
        <Reference>
          <Citation>Schulz, Y., Freese, L., Manz, J., Zoll, B., Volter, C., Brockmann, K., … Pauli, S. (2014). CHARGE and Kabuki syndromes: a phenotypic and molecular link. Human Molecular Genetics, 23(16), 4396-4405. https://doi.org/10.1093/hmg/ddu156</Citation>
        </Reference>
        <Reference>
          <Citation>Seiwert, T. Y., Zuo, Z., Keck, M. K., Khattri, A., Pedamallu, C. S., Stricker, T., … Hammerman, P. S. (2015). Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clinical Cancer Research, 21(3), 632-641. https://doi.org/10.1158/1078-0432.CCR-13-3310</Citation>
        </Reference>
        <Reference>
          <Citation>Shilatifard, A. (2012). The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annual Review of Biochemistry, 81, 65-95. https://doi.org/10.1146/annurev-biochem-051710-134100</Citation>
        </Reference>
        <Reference>
          <Citation>Sobreira, N., Brucato, M., Zhang, L., Ladd-Acosta, C., Ongaco, C., Romm, J., … Bjornsson, H. T. (2017). Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities. European Journal of Human Genetics, 25(12), 1335-1344. https://doi.org/10.1038/s41431-017-0023-0</Citation>
        </Reference>
        <Reference>
          <Citation>Sweet, S., de la Morena, M., Schuler, P., Huddleston, C., &amp; Mendeloff, E. (2004). Association of growth hormone therapy with the development of bronchiolitis obliterans syndrome in pediatric lung transplant recipients. The Journal of Heart and Lung Transplantation, 23(2), S127.</Citation>
        </Reference>
        <Reference>
          <Citation>Tanaka, A. J., Cho, M. T., Millan, F., Juusola, J., Retterer, K., Joshi, C., … Chung, W. K. (2015). Mutations in SPATA5 Are Associated with Microcephaly, Intellectual Disability, Seizures, and Hearing Loss. American Journal of Human Genetics, 97(3), 457-464. https://doi.org/10.1016/j.ajhg.2015.07.014</Citation>
        </Reference>
        <Reference>
          <Citation>Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., … Forbes, S. A. (2019). COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Research, 47(D1), D941-D947. https://doi.org/10.1093/nar/gky1015</Citation>
        </Reference>
        <Reference>
          <Citation>Uchida, K., Konishi, N., Inoue, M., Otake, K., &amp; Kusunoki, M. (2006). A case of congenital jejunal atresia associated with bilateral athelia and choanal atresia: new syndrome spectrum. Clinical Dysmorphology, 15(1), 37-38.</Citation>
        </Reference>
        <Reference>
          <Citation>Verhagen, J. M., Oostdijk, W., Terwisscha van Scheltinga, C. E., Schalij-Delfos, N. E., &amp; van Bever, Y. (2014). An unusual presentation of Kabuki syndrome: clinical overlap with CHARGE syndrome. European Journal of Medical Genetics, 57(9), 510-512. https://doi.org/10.1016/j.ejmg.2014.05.005</Citation>
        </Reference>
        <Reference>
          <Citation>Verloes, A. (2005). Updated diagnostic criteria for CHARGE syndrome: a proposal. American Journal of Medical Genetics. Part A, 133A(3), 306-308. https://doi.org/10.1002/ajmg.a.30559</Citation>
        </Reference>
        <Reference>
          <Citation>Wahlbuhl-Becker, M., Faschingbauer, F., Beckmann, M. W., &amp; Schneider, H. (2017). Hypohidrotic Ectodermal Dysplasia: Breastfeeding Complications Due to Impaired Breast Development. Geburtshilfe und Frauenheilkunde, 77(4), 377-382. https://doi.org/10.1055/s-0043-100106</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, K., Li, M., &amp; Hakonarson, H. (2010). ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research, 38(16), e164. https://doi.org/10.1093/nar/gkq603</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson, L. C., Kerr, B. A., Wilkinson, R., Fossard, C., &amp; Donnai, D. (1998). Choanal atresia and hypothelia following methimazole exposure in utero: a second report. American Journal of Medical Genetics, 75(2), 220-222.</Citation>
        </Reference>
        <Reference>
          <Citation>Zenker, M., Mayerle, J., Lerch, M. M., Tagariello, A., Zerres, K., Durie, P. R., … Reis, A. (2005). Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nature Genetics, 37(12), 1345-1350. https://doi.org/10.1038/ng1681</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu, X., Petrovski, S., Xie, P., Ruzzo, E. K., Lu, Y. F., McSweeney, K. M., … Goldstein, D. B. (2015). Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genetics in Medicine, 17(10), 774-781. https://doi.org/10.1038/gim.2014.191</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083403</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1748-3743</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of older people nursing</Title>
          <ISOAbbreviation>Int J Older People Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Risk for physical dependence in community-dwelling older adults: The role of fear of falling, falls and fall-related injuries.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12310</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/opn.12310</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Falls and fall-related injuries along with fear of falling (FoF) seem to restrict activities of daily living (ADL), resulting in physical dependence. However, it is still unclear how falls and related injuries or FoF by themselves explain general and specific ADL dependence.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate the relationships between falls and related injuries, FoF and physical dependence on ADL in community-dwelling older adults, controlling for age, gender, physical activity and physical fitness as confounders.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional descriptive study assessed 588 community-dwelling older adults. Falls and fall-related injuries, ADL dependence on basic, instrumental and advanced activities, FoF, demographic characteristics and health conditions were assessed through a questionnaire. Physical activity was measured through the International Physical Activity Questionnaire. Physical fitness was assessed by the Senior Fitness Test and the Fullerton Advanced Balance Scale. Body composition was measured through bioimpedance.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Severe injuries occurrence increased the likelihood of moderate and high physical dependence by 3 and 6 times, while FoF increased this likelihood by 3 and 7 times, respectively. Also, the occurrence of previous falls, resulting in severe injuries, increased the likelihood of dependence in two instrumental ADL (3 and 4 times), while FoF increased this likelihood in numerous basic, instrumental and advanced ADL (2-3 times). The FoF was shown to explain overall physical functioning dependence, by itself, representing a constraint on the performance of most basic, instrumental and advanced ADL.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The FoF showed to be a greater threat to ADL dependence than falls and related injuries. Assessment guidelines for older adults living in the community should include the FoF in clinical evaluation.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">Understand the isolated interplay of FoF and previous falls and injuries on ADL dependence among older adults allows healthcare professionals to perform more accurate clinical evaluations and develop more successful interventions to prevent further dependence.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pereira</LastName>
            <ForeName>Catarina</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8111-1455</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Desporto e Saúde, Escola de Ciências e Tecnologia, Universidade de Évora, Évora, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Health Research Center (CHRC), Évora, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bravo</LastName>
            <ForeName>Jorge</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9009-5693</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Desporto e Saúde, Escola de Ciências e Tecnologia, Universidade de Évora, Évora, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Health Research Center (CHRC), Évora, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raimundo</LastName>
            <ForeName>Armando</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9753-8381</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Desporto e Saúde, Escola de Ciências e Tecnologia, Universidade de Évora, Évora, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Health Research Center (CHRC), Évora, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomas-Carus</LastName>
            <ForeName>Pablo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7780-3942</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Desporto e Saúde, Escola de Ciências e Tecnologia, Universidade de Évora, Évora, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Health Research Center (CHRC), Évora, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mendes</LastName>
            <ForeName>Felismina</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9518-2289</Identifier>
            <AffiliationInfo>
              <Affiliation>Comprehensive Health Research Center (CHRC), Évora, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Escola Superior de Enfermagem S. João de Deus, Universidade de Évora, Évora, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baptista</LastName>
            <ForeName>Fátima</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0214-5401</Identifier>
            <AffiliationInfo>
              <Affiliation>Exercise and Health Laboratory, Interdisciplinary Center for the Study of Human Performance, Faculty of Human Kinetics, Technical University of Lisbon, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>ALT20-03-0145-FEDER-000007</GrantID>
            <Agency>Horizon 2020-Portugal 2020-Programa Operacional Regional do Alentejo</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Older People Nurs</MedlineTA>
        <NlmUniqueID>101267281</NlmUniqueID>
        <ISSNLinking>1748-3735</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">accidental falls</Keyword>
        <Keyword MajorTopicYN="N">activities of daily living</Keyword>
        <Keyword MajorTopicYN="N">ageing</Keyword>
        <Keyword MajorTopicYN="N">fear</Keyword>
        <Keyword MajorTopicYN="N">independent living</Keyword>
        <Keyword MajorTopicYN="N">physical fitness</Keyword>
        <Keyword MajorTopicYN="N">practice guidelines</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083403</ArticleId>
        <ArticleId IdType="doi">10.1111/opn.12310</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Auais, M., Alvarado, B. E., Curcio, C. L., Garcia, A., Ylli, A., &amp; Deshpande, N. (2016). Fear of falling as a risk factor of mobility disability in older people at five diverse sites of the IMIAS study. Archives of Gerontology and Geriatrics, 66, 147-153. https://doi.org/10.1016/j.archger.2016.05.012</Citation>
        </Reference>
        <Reference>
          <Citation>Auais, M., French, S., Alvarado, B., Pirkle, C., Belanger, E., &amp; Guralnik, J. (2018). Fear of falling predicts incidence of functional disability 2 years later: a perspective from an international cohort study. The Journals of Gerontology Series A Biological Sciences and Medical Sciences, 73(9), 1212-1215. https://doi.org/10.1093/gerona/glx237</Citation>
        </Reference>
        <Reference>
          <Citation>Bowling, A., &amp; Iliffe, S. (2006). Which model of successful ageing should be used? Baseline findings from a British longitudinal survey of ageing. Age and Ageing, 35(6), 607-614. https://doi.org/10.1093/ageing/afl100</Citation>
        </Reference>
        <Reference>
          <Citation>Carral, J. C., &amp; Pérez, C. A. (2007). Effects of high-intensity combined training on women over 65. Gerontology, 53(6), 340-346. https://doi.org/10.1159/000104098</Citation>
        </Reference>
        <Reference>
          <Citation>Chodzko-Zajko, W., Proctor, D., Fiatarone Singh, M., Minson, C., Nigg, C., Salem, G., &amp; Skinner, J. (2009). American College of Sports Medicine Position Stand. Exercise and physical activity for older adults. Medicine &amp; Science in Sports &amp; Exercise, 41(7), 1510-1530. https://doi.org/10.1249/MSS.0b013e3181a0c95c</Citation>
        </Reference>
        <Reference>
          <Citation>Choi, K., &amp; Ko, Y. (2015). Characteristics associated with fear of falling and activity restriction in South Korean older adults. Journal of Aging and Health, 27(6), 1066-1083. https://doi.org/10.1177/0898264315573519</Citation>
        </Reference>
        <Reference>
          <Citation>Chu, C.-L., Liang, C.-K., Chow, P. C., Lin, Y.-T., Tang, K.-Y., Chou, M.-Y., … Pan, C.-C. (2011). Fear of falling (FF): Psychosocial and physical factors among institutionalized older Chinese men in Taiwan. Archives of Gerontology and Geriatrics, 53(2), 232-236. https://doi.org/10.1016/j.archger.2010.12.018</Citation>
        </Reference>
        <Reference>
          <Citation>Craig, C. L., Marshall, A. L., Sjöström, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., … Oja, P. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine &amp; Science in Sports &amp; Exercise, 35(8), 1381-1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB</Citation>
        </Reference>
        <Reference>
          <Citation>Curcio, C. L., Gomez, F., &amp; Reyes-Ortiz, C. A. (2009). Activity restriction related to fear of falling among older people in the Colombian Andes mountains: Are functional or psychosocial risk factors more important? Journal of Aging and Health, 21(3), 460-479. https://doi.org/10.1177/0898264308329024</Citation>
        </Reference>
        <Reference>
          <Citation>Dean, A., Sullivan, K., &amp; Soe, M. (2014). OpenEpi: Open source epidemiologic statistics for public health (version 2.3.1.). Retrieved from www.OpenEpi.com</Citation>
        </Reference>
        <Reference>
          <Citation>den Ouden, M. E., Schuurmans, M. J., Arts, I. E., &amp; van der Schouw, Y. T. (2016). Association between physical performance characteristics and independence in activities of daily living in middle-aged and elderly men. Geriatrics &amp; Gerontology International, 13(2), 274-280. https://doi.org/10.1111/j.1447-0594.2012.00890.x</Citation>
        </Reference>
        <Reference>
          <Citation>Denkinger, M., Lukas, A., Nikolaus, T., &amp; Hauer, K. (2015). Factors associated with fear of falling and associated activity restriction in community-dwelling older adults: A systematic review. The American Journal of Geriatric Psychiatry, 23(1), 72-86. https://doi.org/10.1016/j.jagp.2014.03.002</Citation>
        </Reference>
        <Reference>
          <Citation>Deshpande, N., Metter, E. J., Bandinelli, S., Lauretani, F., Windham, B. G., &amp; Ferrucci, L. (2008). Psychological, physical, and sensory correlates of fear of falling and consequent activity restriction in the elderly: The InCHIANTI study. American Journal of Physical Medicine &amp; Rehabilitation/Association of Academic Physiatrists, 87(5), 354-362. https://doi.org/10.1097/PHM.0b013e31815e6e9b</Citation>
        </Reference>
        <Reference>
          <Citation>Folstein, M. F., Folstein, S. E., &amp; McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198. http://doi.org/10.0022-3956(75)90026-6</Citation>
        </Reference>
        <Reference>
          <Citation>Fujiwara, Y., Yoshida, H., Amano, H., Fukaya, T., Liang, J., Uchida, H., &amp; Shinkai, S. (2008). Predictors of improvement or decline in instrumental activities of daily living among community-dwelling older Japanese. Gerontology, 54(6), 373-380. https://doi.org/10.1159/000151221</Citation>
        </Reference>
        <Reference>
          <Citation>Gill, T. M., Allore, H. G., Gahbauer, E. A., &amp; Murphy, T. E. (2012). Change in disability after hospitalization or restricted activity in older persons. Journal of the American Medical Association, 304(17), 1919-1928. https://doi.org/10.1001/jama.2010.1568</Citation>
        </Reference>
        <Reference>
          <Citation>Gómez, F., Wu, Y. Y., Auais, M., Vafaei, A., &amp; Zunzunegui, M.-V. (2017). A simple algorithm to predict falls in primary care patients aged 65 to 74 years: The International Mobility in Aging Study. Journal of the American Medical Directors Association, 18(9), 774-779.</Citation>
        </Reference>
        <Reference>
          <Citation>Himes, C. L., &amp; Reynolds, S. L. (2012). Effect of obesity on falls, injury, and disability. Journal of the American Geriatrics Society, 60(1), 124-129. https://doi.org/10.1111/j.1532-5415.2011.03767.x</Citation>
        </Reference>
        <Reference>
          <Citation>Hoang, O. T., Jullamate, P., Piphatvanitcha, N., &amp; Rosenberg, E. (2017). Factors related to fear of falling among community-dwelling older adults. Journal of Clinical Nursing, 26(1-2), 68-76. https://doi.org/10.1111/jocn.13337</Citation>
        </Reference>
        <Reference>
          <Citation>INE (2019). Census 2011: Resident population (No.) by place of residence, sex and age group (by life cycles). Retrieved from http://www.ine.pt</Citation>
        </Reference>
        <Reference>
          <Citation>Lavedan, A., Viladrosa, M., Jurschik, P., Botigue, T., Nuin, C., Masot, O., &amp; Lavedan, R. (2018). Correction: Fear of falling in community-dwelling older adults: A cause of falls, a consequence, or both? PLoS ONE, 13(5), e0197792. https://doi.org/10.1371/journal.pone.0197792</Citation>
        </Reference>
        <Reference>
          <Citation>Neri, S. G. R., Gadelha, A. B., de David, A. C., Ferreira, A. P., Safons, M. P., Tiedemann, A., &amp; Lima, R. M. (2017). The association between body adiposity measures, postural balance, fear of falling, and fall risk in older community-dwelling women. Journal of Geriatric Physical Therapy, 42(3), E94-E100. https://doi.org/10.1519/JPT.0000000000000165</Citation>
        </Reference>
        <Reference>
          <Citation>Paterson, D. H., &amp; Warburton, D. E. (2010). Physical activity and functional limitations in older adults: A systematic review related to Canada's Physical Activity Guidelines. International Journal of Behavioral Nutrition and Physical Activity, 7, 38. https://doi.org/10.1186/1479-5868-7-38</Citation>
        </Reference>
        <Reference>
          <Citation>Pereira, C., Baptista, F., &amp; Cruz-Ferreira, A. (2016). Role of physical activity, physical fitness, and chronic health conditions on the physical independence of community-dwelling older adults over a 5-year period. Archives of Gerontology and Geriatrics, 65, 45-53. https://doi.org/10.1016/j.archger.2016.02.004</Citation>
        </Reference>
        <Reference>
          <Citation>Pereira, C., Baptista, F., &amp; Infante, P. (2014). Role of physical activity in the occurrence of falls and fall-related injuries in community-dwelling adults over 50 years old. Disability and Rehabilitation, 36(2), 117-124. https://doi.org/10.3109/09638288.2013.782355</Citation>
        </Reference>
        <Reference>
          <Citation>Pluijm, S. M., Smit, J. H., Tromp, E. A., Stel, V. S., Deeg, D. J., Bouter, L. M., &amp; Lips, P. (2006). A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling: Results of a 3-year prospective study. Osteoporosis International, 17(3), 417-425. https://doi.org/10.1007/s00198-005-0002-0</Citation>
        </Reference>
        <Reference>
          <Citation>Rikli, R., &amp; Jones, C. (1998). The reliability and validity of a 6-minute walk test as a measure of physical endurance in older adults. Journal of Aging and Physical Activity, 6, 363-375. https://doi.org/10.1123/japa.6.4.363</Citation>
        </Reference>
        <Reference>
          <Citation>Rikli, R., &amp; Jones, C. (2013). Development and validation of criterion-referenced clinically relevant fitness standards for maintaining physical independence in later years. Gerontologist, 53(2), 255-267. https://doi.org/10.1093/geront/gns071</Citation>
        </Reference>
        <Reference>
          <Citation>Rose, D. J., Lucchese, N., &amp; Wiersma, L. D. (2006). Development of a multidimensional balance scale for use with functionally independent older adults. Archives of Physical Medicine and Rehabilitation, 87(11), 1478-1485. https://doi.org/10.1016/j.apmr.2006.07.263</Citation>
        </Reference>
        <Reference>
          <Citation>Rubio, E., Lazaro, A., &amp; Sanchez-Sanchez, A. (2009). Social participation and independence in activities of daily living: A cross sectional study. BMC Geriatrics, 9, 26. https://doi.org/10.1186/1471-2318-9-26</Citation>
        </Reference>
        <Reference>
          <Citation>Ruthig, J. C., Chipperfield, J. G., Newall, N. E., Perry, R. P., &amp; Hall, N. C. (2007). Detrimental effects of falling on health and well-being in later life: The mediating roles of perceived control and optimism. Journal of Health Psychology, 12(2), 231-248. https://doi.org/10.1177/1359105307074250</Citation>
        </Reference>
        <Reference>
          <Citation>Sato, D., Kaneda, K., Wakabayashi, H., Shimoyama, Y., Baba, Y., &amp; Nomura, T. (2011). Comparison of once and twice weekly water exercise on various bodily functions in community-dwelling frail elderly requiring nursing care. Archives of Gerontology and Geriatrics, 52(3), 331-335. https://doi.org/10.1016/j.archger.2010.05.002</Citation>
        </Reference>
        <Reference>
          <Citation>Scheffer, A. C., Schuurmans, M. J., Van Dijk, N., Van Der Hooft, T., &amp; De Rooij, S. E. (2008). Fear of falling: Measurement strategy, prevalence, risk factors and consequences among older persons. Age and Ageing, 37(1), 19-24. https://doi.org/10.1093/ageing/afm169</Citation>
        </Reference>
        <Reference>
          <Citation>Tinetti, M., &amp; Kumar, C. (2010). The patient who falls: "It's always a trade-off". Journal of the American Medical Association, 303(3), 258-266. https://doi.org/10.1001/jama.2009.2024</Citation>
        </Reference>
        <Reference>
          <Citation>Tinetti, M., Mendes de Leon, C., Doucette, J., &amp; Baker, D. (1994). Fear of falling and fall-related efficacy in relationship to functioning among community-living elders. Journal of Gerontology, 49(3), M140-M147. https://doi.org/10.1093/geronj/49.3.M140</Citation>
        </Reference>
        <Reference>
          <Citation>Tinetti, M., Richman, D., &amp; Powell, L. (1990). Falls efficacy as a measure of fear of falling. Journal of Gerontology, 45(6), P239-P243. https://doi.org/10.1093/geronj/45.6.P239</Citation>
        </Reference>
        <Reference>
          <Citation>Zaluska, W., Malecka, T., Mozul, S., &amp; Ksiazek, A. (2004). Whole body versus segmental bioimpedance measurements (BIS) of electrical resistance (Re) and extracellular volume (ECV) for assessment of dry weight in end-stage renal patients treated by hemodialysis. Przeglad Lekarski, 61(2), 70-73.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083404</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4876</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part C, Seminars in medical genetics</Title>
          <ISOAbbreviation>Am J Med Genet C Semin Med Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>From cause to care: Can a triple approach to better population data improve the global outlook of congenital heart disease?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.c.31775</ELocationID>
        <Abstract>
          <AbstractText>Congenital heart disease (CHD) is common, costly, and critical. Approximately half of all infant deaths due to congenital anomalies are associated with CHD or neural tube defects. As infant mortality improves due to better infection control and peripartum care, congenital anomalies are becoming a key driver of pediatric survival and health. Improving CHD prevention and care globally will play a significant role toward key goals such as United Nation's sustainable development goals (SDGs) of good health and well-being (SDG 3) and reduced inequalities (SDG 10). This review addresses two questions: how can we reinterpret and reframe available data on CHD to spur action in prevention and care? How can we re-engineer how we currently track CHD in populations to efficiently generate new data to assess successes and detect gaps in prevention and care? Answering these questions requires understanding the causal chain of disease, from cause to CHD occurrence to health outcomes. This perspective provides a logical basis for two innovations. First, develop a data-driven message that reframes epidemiologic and clinical data in terms of incentives for action, evidence for change, and strategies for population-wide impact. Second, through partnerships between clinical and public health systems, implement an integrated "triple surveillance," which, in the same population, concurrently tracks the three elements of the causal chain-causes, disease occurrence, health outcomes. By streamlining activities and minimizing operational waste, such systems can have a vital role in improving prevention and care on a population level, including in many low and middle-income countries.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Botto</LastName>
            <ForeName>Lorenzo D</ForeName>
            <Initials>LD</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5322-7116</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet C Semin Med Genet</MedlineTA>
        <NlmUniqueID>101235745</NlmUniqueID>
        <ISSNLinking>1552-4868</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">congenital heart disease</Keyword>
        <Keyword MajorTopicYN="N">genetics</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
        <Keyword MajorTopicYN="N">public health</Keyword>
        <Keyword MajorTopicYN="N">surveillance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083404</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.c.31775</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Al Turki, S., Manickaraj, A. K., Mercer, C. L., Gerety, S. S., Hitz, M. P., Lindsay, S., … Hurles, M. E. (2014). Rare variants in NR2F2 cause congenital heart defects in humans. American Journal of Human Genetics, 94(4), 574-585.</Citation>
        </Reference>
        <Reference>
          <Citation>Boneva, R. S., Botto, L. D., Moore, C. A., Yang, Q., Correa, A., &amp; Erickson, J. D. (2001). Mortality associated with congenital heart defects in the United States: Trends and racial disparities, 1979-1997. Circulation, 103(19), 2376-2381.</Citation>
        </Reference>
        <Reference>
          <Citation>Botto, L. D. (2013). Epidemiology and prevention of congenital heart defects. In H. D. Allen, D. J. Driscoll, R. E. Shaddy, &amp; T. F. Feltes (Eds.), Moss and Adams' heart disease in infants, children, and adolescents, including the Fetus and young adult (8th ed.). Philadelphia: Lippincott.</Citation>
        </Reference>
        <Reference>
          <Citation>Botto, L. D. (2015). Epidemiology and prevention of congenital heart defects. In K. Muenke &amp; B. Sable (Eds.), Congenital heart disease: Molecular genetics, principles of diagnosis and treatment. Basel (Switzerland): Karger.</Citation>
        </Reference>
        <Reference>
          <Citation>Botto, L. D., &amp; Mastroiacovo, P. (2018a). From cause to care: Triple surveillance for better outcomes in birth defects and rare diseases. European Journal of Medical Genetics, 61(9), 551-555.</Citation>
        </Reference>
        <Reference>
          <Citation>Botto, L. D., &amp; Mastroiacovo, P. (2018b). Triple surveillance: A proposal for an integrated strategy to support and accelerate birth defect prevention. Annals of the New York Academy of Sciences, 1414(1), 126-136.</Citation>
        </Reference>
        <Reference>
          <Citation>Boulet, S., Grosse, S. C., Riehle-Colarusso, T., &amp; Correa-Villasenor, A. (2010). Health care costs of congenital heart defects. In D. F. Wyszynski, A. Correa-Villasenor, &amp; T. P. Graham (Eds.), Congenital heart defects: From origin to treatment (pp. 493-501). New York: Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. PRAMS: Pregnancy Risk Assessment Monitoring System.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (CDC). (2010). Racial differences by gestational age in neonatal deaths attributable to congenital heart defects - United States, 2003-2006. MMWR. Morbidity and Mortality Weekly Report, 59(37), 1208-1211.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention, Waitzman, N. J., Romano, P. S., Scheffler, R. M., &amp; Harris, J. A. (1995). Economic costs of birth defects and cerebral palsy - United States, 1992. MMWR. Morbidity and Mortality Weekly Report, 44(37), 694-699.</Citation>
        </Reference>
        <Reference>
          <Citation>Christianson, A., Howson, C. P., &amp; Modell, B. (2006). March of Dimes global report on birth defects: The hidden toll of dying and disabled children. White Plains, New York: March of Dimes Birth Defects Foundation.</Citation>
        </Reference>
        <Reference>
          <Citation>Correa, A., Gilboa, S. M., Besser, L. M., Botto, L. D., Moore, C. A., Hobbs, C. A., … Reece, E. A. (2008). Diabetes mellitus and birth defects. American Journal of Obstetrics and Gynecology, 199(3), 237 e231-237 e239.</Citation>
        </Reference>
        <Reference>
          <Citation>D'Angelo, D., Willians, L., Morrow, B., Cox, S., Harris, N., Harrison, L., … Zapata, L. (2007). Preconception and Interconception health status of women who recently gave birth to a live-born infant - pregnancy risk assessment monitoring system (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveillance Summaries, 56(10), 1-35.</Citation>
        </Reference>
        <Reference>
          <Citation>Dolk, H., Loane, M., &amp; Garne, E. (2011). Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005. Circulation, 123(8), 841-849.</Citation>
        </Reference>
        <Reference>
          <Citation>Frieden, T. R. (2010). A framework for public health action: The health impact pyramid. American Journal of Public Health, 100(4), 590-595.</Citation>
        </Reference>
        <Reference>
          <Citation>G. B. D. Congenital Heart Disease Collaborators. (2020). Global, regional, and national burden of congenital heart disease, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet Child Adolesc Health pii: S2352-4642(2319)30402-X.</Citation>
        </Reference>
        <Reference>
          <Citation>Gilboa, S. M., Salemi, J. L., Nembhard, W. N., Fixler, D. E., &amp; Correa, A. (2010). Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation, 122(22), 2254-2263.</Citation>
        </Reference>
        <Reference>
          <Citation>Gittenberger-de Groot, A. C., Bartelings, M. M., Poelmann, R. E., Haak, M. C., &amp; Jongbloed, M. R. (2013). Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Seminars in Fetal &amp; Neonatal Medicine, 18(5), 237-244.</Citation>
        </Reference>
        <Reference>
          <Citation>Hartman, R. J., Rasmussen, S. A., Botto, L. D., Riehle-Colarusso, T., Martin, C. L., Cragan, J. D., … Correa, A. (2011). The contribution of chromosomal abnormalities to congenital heart defects: A population-based study. Pediatric Cardiology, 32(8), 1147-1157.</Citation>
        </Reference>
        <Reference>
          <Citation>Inkster, M. E., Fahey, T. P., Donnan, P. T., Leese, G. P., Mires, G. J., &amp; Murphy, D. J. (2006). Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: Systematic review of observational studies. BMC Pregnancy and Childbirth, 6, 30.</Citation>
        </Reference>
        <Reference>
          <Citation>Jack, B. W., Atrash, H., Coonrod, D. V., Moos, M. K., O'Donnell, J., &amp; Johnson, K. (2008). The clinical content of preconception care: An overview and preparation of this supplement. American Journal of Obstetrics and Gynecology, 199(6 Suppl 2), S266-S279.</Citation>
        </Reference>
        <Reference>
          <Citation>Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., … Webb, C. L. (2007). Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on cardiovascular disease in the young: Endorsed by the American Academy of Pediatrics. Circulation, 115(23), 2995-3014.</Citation>
        </Reference>
        <Reference>
          <Citation>Keren, R., Luan, X., Localio, R., Hall, M., McLeod, L., Dai, D., … Pediatric Research in Inpatient Settings N. (2012). Prioritization of comparative effectiveness research topics in hospital pediatrics. Archives of Pediatrics &amp; Adolescent Medicine, 166(12), 1155-1164.</Citation>
        </Reference>
        <Reference>
          <Citation>Kruszka, P., Sable, C. A., Belmont, J. W., &amp; Muenke, M. (2015). The genetic workup for congenital structural heart disease: From clinical to genetic evaluation. In M. Muenke, P. Kruszka, C. A. Sable, &amp; J. W. Belmont (Eds.), Congenital heart disease: Molecular genetics, principles of diagnosis and treatment (pp. 238-268). Basel (Switzerland): Karger.</Citation>
        </Reference>
        <Reference>
          <Citation>Lisowski, L. A., Verheijen, P. M., Copel, J. A., Kleinman, C. S., Wassink, S., Visser, G. H., &amp; Meijboom, E. J. (2010). Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz, 35(1), 19-26.</Citation>
        </Reference>
        <Reference>
          <Citation>Lopez, A. D., &amp; Mathers, C. D. (2006). Measuring the global burden of disease and epidemiological transitions: 2002-2030. Annals of Tropical Medicine and Parasitology, 100(5), 481-499.</Citation>
        </Reference>
        <Reference>
          <Citation>Marelli, A. J., Mackie, A. S., Ionescu-Ittu, R., Rahme, E., &amp; Pilote, L. (2007). Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation, 115(2), 163-172.</Citation>
        </Reference>
        <Reference>
          <Citation>Muenke, M., Kruszka, P., Sable, C. A., &amp; Belmont, J. W. (2015). Congenital heart disease: Molecular genetics, principles of diagnosis and treatment. Karger.</Citation>
        </Reference>
        <Reference>
          <Citation>Olsen, M., Christensen, T. D., Pedersen, L., Johnsen, S. P., &amp; Hjortdal, V. E. (2010). Late mortality among Danish patients with congenital heart defect. The American Journal of Cardiology, 106(9), 1322-1326.</Citation>
        </Reference>
        <Reference>
          <Citation>Riehle-Colarusso T, Patel SS. 2014. Nongenetic risk factors for congenital heart defects. Congenital Heart Disease: Molecular Genetics, Principles of Diagnosis and Treatment.</Citation>
        </Reference>
        <Reference>
          <Citation>Robbins, J. M., Bird, T. M., Tilford, J. M., Cleves, M. A., Hobbs, C. A., Grosse, S. D., &amp; Correa, A. (2007). Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects-United States, 2003. MMWR. Morbidity and Mortality Weekly Report, 56(2), 25-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosano, A., Botto, L. D., Botting, B., &amp; Mastroiacovo, P. (2000). Infant mortality and congenital anomalies from 1950 to 1994: An international perspective. Journal of Epidemiology and Community Health, 54(9), 660-666.</Citation>
        </Reference>
        <Reference>
          <Citation>Wahabi, H. A., Alzeidan, R. A., Bawazeer, G. A., Alansari, L. A., &amp; Esmaeil, S. A. (2010). Preconception care for diabetic women for improving maternal and fetal outcomes: A systematic review and meta-analysis. BMC Pregnancy and Childbirth, 10, 63.</Citation>
        </Reference>
        <Reference>
          <Citation>Wahabi, H. A., Alzeidan, R. A., &amp; Esmaeil, S. A. (2012). Pre-pregnancy care for women with pre-gestational diabetes mellitus: A systematic review and meta-analysis. BMC Public Health, 12, 792.</Citation>
        </Reference>
        <Reference>
          <Citation>Waitzman, N. J., Romano, P. S., &amp; Scheffler, R. M. (1996). The cost of birth defects (p. 276). Lanham (Maryland, USA): University Press of America.</Citation>
        </Reference>
        <Reference>
          <Citation>Warburton, D., Ronemus, M., Kline, J., Jobanputra, V., Williams, I., Anyane-Yeboa, K., … Levy, D. (2014). The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Human Genetics, 133(1), 11-27.</Citation>
        </Reference>
        <Reference>
          <Citation>Warnes, C. A., Liberthson, R., Danielson, G. K., Dore, A., Harris, L., Hoffman, J. I., … Webb, G. D. (2001). Task force 1: The changing profile of congenital heart disease in adult life. Journal of the American College of Cardiology, 37(5), 1170-1175.</Citation>
        </Reference>
        <Reference>
          <Citation>Williamson, D. F. (2010). The population attributable fraction and confounding: Buyer beware. International Journal of Clinical Practice, 64(8), 1019-1023.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. 2020. Sustainable Developmental Goals.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. STEPwise approach to surveillance (STEPS).</Citation>
        </Reference>
        <Reference>
          <Citation>Zaidi, S., Choi, M., Wakimoto, H., Ma, L., Jiang, J., Overton, J. D., … Lifton, R. P. (2013). De novo mutations in histone-modifying genes in congenital heart disease. Nature, 498(7453), 220-223.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083402</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-3806</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Autism research : official journal of the International Society for Autism Research</Title>
          <ISOAbbreviation>Autism Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Conceptual Framework for Understanding the Cultural and Contextual Factors on Autism Across the Globe.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/aur.2276</ELocationID>
        <Abstract>
          <AbstractText>Autism research is heavily skewed toward western high-income countries. Culturally appropriate screening and diagnostic instruments for autism are lacking in most low- and middle-income settings where the majority of the global autism population lives. To date, a clear overview of the possible cultural and contextual factors that may affect the process of identifying and diagnosing individuals with autism spectrum disorders (ASD) is missing. This study aims to outline these factors by proposing a conceptual framework. A multidisciplinary review approach was applied to inform the development of the conceptual framework, combining a systematic review of the relevant autism research literature with a wider literature search spanning key texts in global mental health, cultural psychiatry, cross-cultural psychology, and intellectual disability research. The resulting conceptual framework considers the identification, help-seeking, and diagnostic process at four interrelated levels: (a) the expression; (b) recognition; (c) interpretation; and (d) reporting of autism symptoms, and describes the cultural and contextual factors associated with each of these levels, including cultural norms of typical and atypical behavior, culture-specific approaches to parenting, mental health literacy, cultural beliefs, attitudes and stigma, as well as the affordability, availability, accessibility, and acceptability of services. This framework, mapping out the cultural and contextual factors that can affect the identification, help-seeking, and diagnosis of ASD may function as a springboard for the development of culturally appropriate autism screening and diagnostic instruments, and inform future cross-cultural autism research directions. The framework also has relevance for clinicians and policy makers aiming to improve support for underserved autism populations worldwide. LAY SUMMARY: The vast majority of autism research is conducted in western high-income settings. We therefore know relatively little of how culture and context can affect the identification, help-seeking, and diagnosis of autism across the globe. This study synthesizes what is known from the autism research literature and a broader literature and maps out how culture and context may affect (a) the expression, (b) recognition, (c) interpretation, and (d) reporting of autism symptoms. © 2020 International Society for Autism Research, Wiley Periodicals, Inc.</AbstractText>
          <CopyrightInformation>© 2020 International Society for Autism Research, Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>de Leeuw</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Amsterdam University Medical Centre, location VUmc, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Happé</LastName>
            <ForeName>Francesca</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoekstra</LastName>
            <ForeName>Rosa A</ForeName>
            <Initials>RA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1333-9762</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>#9817</GrantID>
            <Acronym>AS</Acronym>
            <Agency>Autism Speaks</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>Erasmus+ exchange program grant</GrantID>
            <Agency>European Commission</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>#MR/P020844/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <Agency>National Institute for Health Research</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <Agency>DFID</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Erasmus+ exchange program</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Autism Res</MedlineTA>
        <NlmUniqueID>101461858</NlmUniqueID>
        <ISSNLinking>1939-3806</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">autism</Keyword>
        <Keyword MajorTopicYN="N">culture</Keyword>
        <Keyword MajorTopicYN="N">diagnosis</Keyword>
        <Keyword MajorTopicYN="N">low- and middle-income countries</Keyword>
        <Keyword MajorTopicYN="N">screening</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083402</ArticleId>
        <ArticleId IdType="doi">10.1002/aur.2276</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Abubakar, A., Ssewanyana, D., de Vries, P. J., &amp; Newton, C. R. (2016). Autism spectrum disorders in sub-Saharan Africa. The Lancet Psychiatry, 3(9), 800-802.</Citation>
        </Reference>
        <Reference>
          <Citation>Abubakar, A., Ssewanyana, D., &amp; Newton, C. R. (2016). A systematic review of research on autism spectrum disorders in Sub-Saharan Africa. Behavioural Neurology, 2, 1-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Adnams, C. M. (2010). Perspectives of intellectual disability in South Africa: Epidemiology, policy, services for children and adults. Current Opinion in Psychiatry, 23(5), 436-440. https://doi.org/10.1097/YCO.0b013e32833cfc2d</Citation>
        </Reference>
        <Reference>
          <Citation>Al Maskari, T. S., Melville, C. A., &amp; Willis, D. S. (2018). Systematic review: Cultural adaptation and feasibility of screening for autism in non-English speaking countries. International Journal of Mental Health Systems, 12, 22. https://doi.org/10.1186/s13033-018-0200-8</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Dababneh, K. A., Al-Zboon, E. K., &amp; Baibers, H. (2016). Jordanian parents' beliefs about the causes of disability and the progress of their children with disabilities: Insights on mainstream schools and segregated centres. European Journal of Special Needs Education, 32(3), 362-376. https://doi.org/10.1080/08856257.2016.1240341</Citation>
        </Reference>
        <Reference>
          <Citation>Alegría, M., Alvarez, K., &amp; Falgas-Bague, I. (2017). Clinical Care Across Cultures: What Helps, What Hinders, What to Do. JAMA Psychiatry, 74(9), 865-866. https://doi.org/10.1001/jamapsychiatry.2017.1994</Citation>
        </Reference>
        <Reference>
          <Citation>Alnemary, F. M., Aldhalaan, H. M., Simon-Cereijido, G., &amp; Alnemary, F. M. (2017). Services for children with autism in the Kingdom of Saudi Arabia. Autism: The International Journal of Research and Practice, 21(5), 592-602. https://doi.org/10.1177/1362361316664868</Citation>
        </Reference>
        <Reference>
          <Citation>American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed., pp. 50-51). Arlington, VA: Author.</Citation>
        </Reference>
        <Reference>
          <Citation>Angermeyer, M. C., Holzinger, A., Carta, M. G., &amp; Schomerus, G. (2011). Biogenetic explanations and public acceptance of mental illness: Systematic review of population studies. The British Journal of Psychiatry, 199(5), 367-372. https://doi.org/10.1192/bjp.bp.110.085563</Citation>
        </Reference>
        <Reference>
          <Citation>Ashton-James, C. E., Kushlev, K., &amp; Dunn, E. W. (2013). Parents reap what they sow: Child-centrism and parental well-being. Social Psychological and Personality Science, 4(6), 635-642. https://doi.org/10.1177/1948550613479804</Citation>
        </Reference>
        <Reference>
          <Citation>Baghdadli, A., Picot, M. C., Pascal, C., Pry, R., &amp; Aussilloux, C. (2003). Relationship between age of recognition of first disturbances and severity in young children with autism. European Child &amp; Adolescent Psychiatry, 12(3), 122-127. https://doi.org/10.1007/s00787-003-0314-6</Citation>
        </Reference>
        <Reference>
          <Citation>Bakare, M. O., &amp; Munir, K. M. (2011). Excess of non-verbal cases of autism spectrum disorders presenting to orthodox clinical practice in Africa-A trend possibly resulting from late diagnosis and intervention. The South African Journal of Psychiatry, 17(4), 118-120.</Citation>
        </Reference>
        <Reference>
          <Citation>Barbaro, J., &amp; Halder, S. (2016). Early identification of autism spectrum disorder: Current challenges and future global directions. Current Developmental Disorders Reports, 3(1), 67-74. https://doi.org/10.1007/s40474-016-0078-6</Citation>
        </Reference>
        <Reference>
          <Citation>Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., &amp; Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Bazzano, A., Zeldin, A., Schuster, E., Barrett, C., &amp; Lehrer, D. (2012). Vaccine-related beliefs and practices of parents of children with autism spectrum disorders. American Journal on Intellectual and Developmental Disabilities, 117(3), 233-242. https://doi.org/10.1352/1944-7558-117.3.233</Citation>
        </Reference>
        <Reference>
          <Citation>Bello-Mojeed, M. A., Omigbodun, O. O., Bakare, M. O., &amp; Adewuya, A. O. (2017). Pattern of impairments and late diagnosis of autism spectrum disorder among a sub-Saharan African clinical population of children in Nigeria. Global Mental Health (Cambridge, England), 4, e5. https://doi.org/10.1017/gmh.2016.30</Citation>
        </Reference>
        <Reference>
          <Citation>Bernier, R., Mao, A., &amp; Yen, J. (2010). Psychopathology, families, and culture: Autism. Child and Adolescent Psychiatric Clinics of North America, 19(4), 855-867. https://doi.org/10.1016/j.chc.2010.07.005</Citation>
        </Reference>
        <Reference>
          <Citation>Berry, J. W. (1969). On cross-cultural comparability. International Journal of Psychology, 4(2), 119-128. https://doi.org/10.1080/00207596908247261</Citation>
        </Reference>
        <Reference>
          <Citation>Bishop-Fitzpatrick, L., &amp; Kind, A. J. H. (2017). A scoping review of health disparities in autism spectrum disorder. Journal of Autism and Developmental Disorders, 47(11), 3380-3391. https://doi.org/10.1007/s10803-017-3251-9</Citation>
        </Reference>
        <Reference>
          <Citation>Blacher, J., Cohen, S. R., &amp; Azad, G. (2014). In the eye of the beholder: Reports of autism symptoms by Anglo and Latino mothers. Research in Autism Spectrum Disorders, 8(12), 1648-1656. https://doi.org/10.1016/j.rasd.2014.08.017</Citation>
        </Reference>
        <Reference>
          <Citation>Bornstein, M. H. (2005). Handbook of parenting. Volume 4: Social conditions and applied parenting. Psychology Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Bornstein, M. H. (2012). Cultural approaches to parenting. Parenting, Science and Practice, 12(2-3), 212-221. https://doi.org/10.1080/15295192.2012.683359</Citation>
        </Reference>
        <Reference>
          <Citation>Bornstein, M. H. (2013). Parenting and child mental health: A cross-cultural perspective. World Psychiatry, 12(3), 258-265. https://doi.org/10.1002/wps.20071</Citation>
        </Reference>
        <Reference>
          <Citation>Brohan, E., Slade, M., Clement, S., &amp; Thornicroft, G. (2010). Experiences of mental illness stigma, prejudice and discrimination: A review of measures. BMC Health Services Research, 10, 80. https://doi.org/10.1186/1472-6963-10-80</Citation>
        </Reference>
        <Reference>
          <Citation>Bruckner, T. A., Scheffler, R. M., Shen, G., Yoon, J., Chisholm, D., Morris, J., … Saxena, S. (2011). The mental health workforce gap in low- and middle-income countries: A needs-based approach. Bulletin of the World Health Organization, 89(3), 184-194. https://doi.org/10.2471/BLT.10.082784</Citation>
        </Reference>
        <Reference>
          <Citation>Buehning, L. J., &amp; Peddecord, K. M. (2017). Vaccination attitudes and practices of integrative medicine physicians. Alternative Therapies in Health and Medicine, 23(1), 46-54.</Citation>
        </Reference>
        <Reference>
          <Citation>Carruthers, S., Kinnaird, E., Rudra, A., Smith, P., Allison, C., Auyeung, B., … Hoekstra, R. A. (2018). A cross-cultural study of autistic traits across India, Japan and the UK. Molecular Autism, 9, 52. https://doi.org/10.1186/s13229-018-0235-3</Citation>
        </Reference>
        <Reference>
          <Citation>Cauce, A. M., Domenech-Rodríguez, M., Paradise, M., Cochran, B. N., Shea, J. M., Srebnik, D., &amp; Baydar, N. (2002). Cultural and contextual influences in mental health help seeking: A focus on ethnic minority youth. Journal of Consulting and Clinical Psychology, 70(1), 44-55.</Citation>
        </Reference>
        <Reference>
          <Citation>Chaidez, V., Fernandez, Y., Garcia, E., Wang, L. W., Angkustsiri, K., Krakowiak, P., … Hansen, R. L. (2018). Comparison of maternal beliefs about causes of autism spectrum disorder and association with utilization of services and treatments. Child: Care, Health and Development, 44(6), 916-925. https://doi.org/10.1111/cch.12612</Citation>
        </Reference>
        <Reference>
          <Citation>Chao, R. (1995). Chinese and European-American cultural models of the self reflected in mothers' child-rearing beliefs. Ethos, 23, 328-354.</Citation>
        </Reference>
        <Reference>
          <Citation>Chawarska, K., Paul, R., Klin, A., Hannigen, S., Dichtel, L. E., &amp; Volkmar, F. (2006). Parental recognition of developmental problems in toddlers with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37(1), 62-72. https://doi.org/10.1007/s10803-006-0330-8</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, Y.-W., Bundy, A. C., Cordier, R., Chien, Y.-L., &amp; Einfeld, S. L. (2017). A cross-cultural exploration of the everyday social participation of individuals with autism spectrum disorders in Australia and Taiwan: An experience sampling study. Autism: The International Journal of Research and Practice, 2, 231-241. https://doi.org/10.1177/1362361316636756</Citation>
        </Reference>
        <Reference>
          <Citation>Chua, A. (2011). Battle hymn of the tiger mom. New York, NY: Penguin Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Colbert, A. M., Webber, J., &amp; Graham, R. (2017). Factors that influence autism knowledge in Hispanic cultures: A pilot study. Journal of Racial and Ethnic Health Disparities, 4(2), 156-164. https://doi.org/10.1007/s40615-016-0213-4</Citation>
        </Reference>
        <Reference>
          <Citation>Daley, T. C. (2004). From symptom recognition to diagnosis: Children with autism in urban India. Social Science &amp; Medicine, 58(7), 1323-1335. https://doi.org/10.1016/S0277-9536(03)00330-7</Citation>
        </Reference>
        <Reference>
          <Citation>Daley, T. C., Singhal, N., &amp; Krishnamurthy, V. (2013). Ethical considerations in conducting research on autism spectrum disorders in low and middle income countries. Journal of Autism and Developmental Disorders, 43(9), 2002-2014. https://doi.org/10.1007/s10803-012-1750-2</Citation>
        </Reference>
        <Reference>
          <Citation>de Vries, P. J. (2016). Thinking globally to meet local needs. Current Opinion in Neurology, 29(0), 130-136.</Citation>
        </Reference>
        <Reference>
          <Citation>Decoteau, C. L. (2017). The “Western disease”: Autism and Somali parents' embodied health movements. Social Science &amp; Medicine (1982, 177, 169-176. https://doi.org/10.1016/j.socscimed.2017.01.064</Citation>
        </Reference>
        <Reference>
          <Citation>Dickerson, A. S., Rahbar, M. H., Pearson, D. A., Kirby, R. S., Bakian, A. V., Bilder, D. A., … Slay Wingate, M. (2017). Autism spectrum disorder reporting in lower socioeconomic neighborhoods. Autism: The International Journal of Research and Practice, 21(4), 470-480. https://doi.org/10.1177/1362361316650091</Citation>
        </Reference>
        <Reference>
          <Citation>Divan, G., Vajaratkar, V., Desai, M. U., Strik-Lievers, L., &amp; Patel, V. (2012). Challenges, coping strategies, and unmet needs of families with a child with autism spectrum disorder in Goa, India. Autism Research, 5(3), 190-200. https://doi.org/10.1002/aur.1225</Citation>
        </Reference>
        <Reference>
          <Citation>Donohue, M. R., Childs, A. W., Richards, M., &amp; Robins, D. L. (2017). Race influences parent report of concerns about symptoms of autism spectrum disorder. In Race influences parent report of concerns about symptoms of autism spectrum disorder. Autism: The International Journal of Research and Practice. https://doi.org/10.1177/1362361317722030</Citation>
        </Reference>
        <Reference>
          <Citation>Durkin, M. S., Elsabbagh, M., Barbaro, J., Gladstone, M., Happe, F., Hoekstra, R. A., … Shih, A. (2015). Autism screening and diagnosis in low resource settings: Challenges and opportunities to enhance research and services worldwide. Autism Research: Official Journal of the International Society for Autism Research, 8(5), 473-476. https://doi.org/10.1002/aur.1575</Citation>
        </Reference>
        <Reference>
          <Citation>Eaton, J., McCay, L., Semrau, M., Chatterjee, S., Baingana, F., Araya, R., … Saxena, S. (2011). Scale up of services for mental health in low-income and middle-income countries. The Lancet, 378(9802), 1592-1603. https://doi.org/10.1016/S0140-6736(11)60891-X</Citation>
        </Reference>
        <Reference>
          <Citation>Edwards, C. P. (2000). Children's play in cross-cultural perspective: A new look at the six cultures study. Cross-Cultural Research, 34(4), 318-338. https://doi.org/10.1177/106939710003400402</Citation>
        </Reference>
        <Reference>
          <Citation>Eggertson, L. (2010). Lancet retracts 12-year-old article linking autism to MMR vaccines. Canadian Medical Association Journal, 182(4), E199-E200. https://doi.org/10.1503/cmaj.109-3179</Citation>
        </Reference>
        <Reference>
          <Citation>Elsabbagh, M., Divan, G., Koh, Y.-J., Kim, Y. S., Kauchali, S., Marcín, C., … Fombonne, E. (2012). Global prevalence of autism and other pervasive developmental disorders. Autism Research, 5(3), 160-179. https://doi.org/10.1002/aur.239</Citation>
        </Reference>
        <Reference>
          <Citation>Engle, P. L., Fernald, L. C., Alderman, H., Behrman, J., O'Gara, C., Yousafzai, A., … Iltus, S. (2011). Strategies for reducing inequalities and improving developmental outcomes for young children in low-income and middle-income countries. The Lancet, 378(9799), 1339-1353. https://doi.org/10.1016/S0140-6736(11)60889-1</Citation>
        </Reference>
        <Reference>
          <Citation>Ertem, I. O., Krishnamurthy, V., Mulaudzi, M. C., Sguassero, Y., Balta, H., Gulumser, O., … Forsyth, B. W. C. (2018). Similarities and differences in child development from birth to age 3 years by sex and across four countries: A cross-sectional, observational study. The Lancet Global Health, 6(3), e279-e291. https://doi.org/10.1016/S2214-109X(18)30003-2</Citation>
        </Reference>
        <Reference>
          <Citation>Eseigbe, E. E., Nuhu, F. T., Sheikh, T. L., Eseigbe, P., Sanni, K. A., &amp; Olisah, V. O. (2015). Knowledge of childhood autism and challenges of management among medical doctors in Kaduna State, Northwest Nigeria. Autism Research and Treatment, 2015, 1-6. https://doi.org/10.1155/2015/892301</Citation>
        </Reference>
        <Reference>
          <Citation>Farrugia, D. (2009). Exploring stigma: Medical knowledge and the stigmatisation of parents of children diagnosed with autism spectrum disorder. Sociology of Health &amp; Illness, 31(7), 1011-1027. https://doi.org/10.1111/j.1467-9566.2009.01174.x</Citation>
        </Reference>
        <Reference>
          <Citation>Farver, J. A., &amp; Shin, Y. L. (1997). Social pretend play in Korean- and Anglo-American preschoolers. Child Development, 68(3), 544-556.</Citation>
        </Reference>
        <Reference>
          <Citation>Flaherty, J. A., Gaviria, F. M., Pathak, D., Mitchell, T., Wintrob, R., Richman, J. A, &amp; Birz, S. (1988). Developing instruments for cross-cultural psychiatric research. The Journal of Nervous and Mental Disease, 176(5), 257-263.</Citation>
        </Reference>
        <Reference>
          <Citation>Fox, F., Aabe, N., Turner, K., Redwood, S., &amp; Rai, D. (2016). “It was like walking without knowing where I was going”: A qualitative study of autism in a UKSomali migrant community. Journal of Autism and Developmental Disorders, 47(2), 305-315. https://doi.org/10.1007/s10803-016-2952-9</Citation>
        </Reference>
        <Reference>
          <Citation>Franz, L., Chambers, N., von Isenburg, M., &amp; de Vries, P. J. (2017). Autism spectrum disorder in sub-Saharan Africa: A comprehensive scoping review. Autism Research: Official Journal of the International Society for Autism Research, 10(5), 723-749. https://doi.org/10.1002/aur.1766</Citation>
        </Reference>
        <Reference>
          <Citation>Freeth, M., Sheppard, E., Ramachandran, R., &amp; Milne, E. (2013). A cross-cultural comparison of autistic traits in the UK, India and Malaysia. Journal of Autism and Developmental Disorders, 43(11), 2569-2583. https://doi.org/10.1007/s10803-013-1808-9</Citation>
        </Reference>
        <Reference>
          <Citation>Furnham, A., &amp; Hamid, A. (2014). Mental health literacy in non-western countries: A review of the recent literature. Mental Health Review Journal, 19(2), 84-98. https://doi.org/10.1108/MHRJ-01-2013-0004</Citation>
        </Reference>
        <Reference>
          <Citation>Gaebel, W., Roessler, W., &amp; Sartorius, N. (2017). The stigma of mental illness-End of the story? Springer.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganasen, K. A., Parker, S., Hugo, C. J., Stein, D. J., Emsley, R. A., &amp; Seedat, S. (2008). Mental health literacy: Focus on developing countries. African Journal of Psychiatry, 11(1), 23-28.</Citation>
        </Reference>
        <Reference>
          <Citation>Gielen, U. P., &amp; Roopnarine, J. L. (2016). Childhood and adolescence: cross-cultural perspectives and applications. Cross-cultural perspectives and applications (2nd ed.), Santa Barbara, California: ABC-CLIO. https://www.abc-clio.com/ABC-CLIOCorporate/product.aspx?pc=A4391C</Citation>
        </Reference>
        <Reference>
          <Citation>Goin-Kochel, R. P., Mire, S. S., Dempsey, A. G., Fein, R. H., Guffey, D., Minard, C. G., … Boom, J. A. (2016). Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine, 34(11), 1335-1342. https://doi.org/10.1016/j.vaccine.2016.02.008</Citation>
        </Reference>
        <Reference>
          <Citation>Gona, J. K., Newton, C. R., Rimba, K. K., Mapenzi, R., Kihara, M., Vijver, F. V., &amp; Abubakar, A. (2016). Challenges and coping strategies of parents of children with autism on the Kenyan coast, Rural and Remote Health, 16(2), 3517.</Citation>
        </Reference>
        <Reference>
          <Citation>Gona, J. K., Newton, C. R., Rimba, K., Mapenzi, R., Kihara, M., de Vijver, F. J. R. V., &amp; Abubakar, A. (2015). Parents' and professionals' perceptions on causes and treatment options for autism spectrum disorders (ASD) in a multicultural context on the Kenyan Coast. PLoS One, 10(8), e0132729. https://doi.org/10.1371/journal.pone.0132729</Citation>
        </Reference>
        <Reference>
          <Citation>Greenhalgh, T., &amp; Peacock, R. (2005). Effectiveness and efficiency of search methods in systematic reviews of complex evidence: Audit of primary sources. BMJ (Clinical Research Ed.), 331(7524), 1064-1065. https://doi.org/10.1136/bmj.38636.593461.68</Citation>
        </Reference>
        <Reference>
          <Citation>Grinker, R. R., Chambers, N., Njongwe, N., Lagman, A., Guthrie, S., … Wetherby, A. M. (2012). “Communities” in Community engagement: Lessons learned from autism research in South Korea and South Africa. Autism Research, 5(3), 201-210. https://doi.org/10.1002/aur.1229</Citation>
        </Reference>
        <Reference>
          <Citation>Grinker, R. R., &amp; Cho, K. (2013). Border children: Interpreting autism spectrum disorder in South Korea. Ethos, 41(1), 46-74. https://doi.org/10.1111/etho.12002</Citation>
        </Reference>
        <Reference>
          <Citation>Grinker, R. R., Kang-Yi, C. D., Ahmann, C., Beidas, R. S., Lagman, A., &amp; Mandell, D. S. (2015). Cultural adaptation and translation of outreach materials on autism spectrum disorder. Journal of Autism and Developmental Disorders, 45(8), 2329-2336. https://doi.org/10.1007/s10803-015-2397-6</Citation>
        </Reference>
        <Reference>
          <Citation>Guler, J., de Vries, P. J., Seris, N., Shabalala, N., &amp; Franz, L. (2017). The importance of context in early autism intervention: A qualitative South African study. Autism: The International Journal of Research and Practice, https://doi.org/10.1177/1362361317716604 22(8):1005-1017</Citation>
        </Reference>
        <Reference>
          <Citation>Gureje, O., Nortje, G., Makanjuola, V., Oladeji, B. D., Seedat, S., &amp; Jenkins, R. (2015). The role of global traditional and complementary systems of medicine in the treatment of mental health disorders. Lancet Psychiatry, 2, 168-177.</Citation>
        </Reference>
        <Reference>
          <Citation>Guthrie, W., Wallis, K., Bennett, A., Brooks, E., Dudley, J., Gerdes, M., … Miller, J. S. (2019). Accuracy of autism screening in a large pediatric network. Pediatrics, 144(4), e20183963. https://doi.org/10.1542/peds.2018-3963</Citation>
        </Reference>
        <Reference>
          <Citation>Ha, V. S., Whittaker, A., Whittaker, M., &amp; Rodger, S. (2014). Living with autism spectrum disorder in Hanoi, Vietnam. Social Science &amp; Medicine, 120, 278-285. https://doi.org/10.1016/j.socscimed.2014.09.038</Citation>
        </Reference>
        <Reference>
          <Citation>Hadidi, M. S., &amp; Khateeb, J. M. A. (2015). Special education in Arab countries: Current challenges. International Journal of Disability, Development and Education, 62(5), 518-530. https://doi.org/10.1080/1034912X.2015.1049127</Citation>
        </Reference>
        <Reference>
          <Citation>Hahler, E.-M., &amp; Elsabbagh, M. (2014). Autism: A global perspective. Current Developmental Disorders Reports, 2(1), 58-64. https://doi.org/10.1007/s40474-014-0033-3</Citation>
        </Reference>
        <Reference>
          <Citation>Hailemichael, Y., Hailemariam, D., Tirfessa, K., Docrat, S., Alem, A., Medhin, G., … Hanlon, C. (2019). Catastrophic out-of-pocket payments for households of people with severe mental disorder: A comparative study in rural Ethiopia. International Journal of Mental Health Systems, 13, 39. https://doi.org/10.1186/s13033-019-0294-7</Citation>
        </Reference>
        <Reference>
          <Citation>Hamdani, S. U., Akhtar, P., Zill-E-Huma, N., Nazir, H., Minhas, F. A., Sikander, S., … Rahman, A. (2017). WHO Parents Skills Training (PST) programme for children with developmental disorders and delays delivered by family volunteers in rural Pakistan: Study protocol for effectiveness implementation hybrid cluster randomized controlled trial. Global Mental Health, 4, e11. https://doi.org/10.1017/gmh.2017.7</Citation>
        </Reference>
        <Reference>
          <Citation>Hamdani, S. U., Minhas, F. A., Iqbal, Z., &amp; Rahman, A. (2015). Model for service delivery for developmental disorders in low-income countries. Pediatrics, 136(6), 1166-1172. https://doi.org/10.1542/peds.2015-0861</Citation>
        </Reference>
        <Reference>
          <Citation>Harrison, A. J., Long, K. A., Tommet, D. C., &amp; Jones, R. N. (2017). Examining the role of race, ethnicity, and gender on social and behavioral ratings within the autism diagnostic observation schedule. Journal of Autism and Developmental Disorders, 47(9), 2770-2782. https://doi.org/10.1007/s10803-017-3176-3</Citation>
        </Reference>
        <Reference>
          <Citation>Heys, M., Alexander, A., Medeiros, E., Tumbahangphe, K. M., Gibbons, F., Shrestha, R., … Pellicano, E. (2017). Understanding parents' and professionals' knowledge and awareness of autism in Nepal. Autism: The International Journal of Research and Practice, 21(4), 436-449. https://doi.org/10.1177/1362361316646558</Citation>
        </Reference>
        <Reference>
          <Citation>Hoekstra, R. A., Bayouh, F. G., Gebru, B. T., Kinfe, M., Mihretu, A., Adamu, W., … Hanlon, C. (2018). The face of autism in Ethiopia: The expression, recognition, reporting and interpretation of autism symptoms in the Ethiopian context. In International Society for Autism Research (INSAR) meeting, Rotterdam. https://insar.confex.com/insar/2018/webprogram/Paper29303.html</Citation>
        </Reference>
        <Reference>
          <Citation>Hoekstra, R. A., Girma, F., Tekola, B., &amp; Yenus, Z. (2018). Nothing about us without us: The importance of local collaboration and engagement in the global study of autism. BJPsych International, 15(2), 40-43. https://doi.org/10.1192/bji.2017.26</Citation>
        </Reference>
        <Reference>
          <Citation>Hoven, C. W., Doan, T., Musa, G. J., Jaliashvili, T., Duarte, C. S., Ovuga, E., … Force, W. A. T. (2008). Worldwide child and adolescent mental health begins with awareness: A preliminary assessment in nine countries. International Review of Psychiatry, 20(3), 261-270. https://doi.org/10.1080/09540260801995950</Citation>
        </Reference>
        <Reference>
          <Citation>Hsu, Y., Tsai, S., Hsieh, M., Jenks, M. S., Tsai, C., &amp; Hsu, M. (2017). On my own: A qualitative phenomenological study of mothers of young children with autism spectrum disorder in Taiwan. Journal of Applied Research in Intellectual Disabilities, 30(1), 147-156. https://doi.org/10.1111/jar.12229</Citation>
        </Reference>
        <Reference>
          <Citation>Ilias, K., Liaw, J. H. J., Cornish, K., Park, M. S.-A., &amp; Golden, K. J. (2017). Wellbeing of mothers of children with “A-U-T-I-S-M” in Malaysia: An interpretative phenomenological analysis study. Journal of Intellectual and Developmental Disability, 42(1), 74-89. https://doi.org/10.3109/13668250.2016.1196657</Citation>
        </Reference>
        <Reference>
          <Citation>Irarrazaval, M., García, R., Riesle, S., Moyano, A., Cabezas, M., Rattazzi, A., … Rosoli, A. (2017). 5.17 Access to services, priorities, and challenges in caregivers of persons with autism. Journal of the American Academy of Child &amp; Adolescent Psychiatry, 56(10), S259. https://doi.org/10.1016/j.jaac.2017.09.300</Citation>
        </Reference>
        <Reference>
          <Citation>Jacobs, B., Ir, P., Bigdeli, M., Annear, P. L., &amp; Van Damme, W. (2012). Addressing access barriers to health services: An analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy and Planning, 27(4), 288-300. https://doi.org/10.1093/heapol/czr038</Citation>
        </Reference>
        <Reference>
          <Citation>Jorm, A. F., Korten, A. E., Jacomb, P. A., Christensen, H., Rodgers, B., &amp; Pollitt, P. (1997). “Mental health literacy”: A survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. The Medical Journal of Australia, 166(4), 182-186.</Citation>
        </Reference>
        <Reference>
          <Citation>Kakooza-Mwesige, A., Ssebyala, K., Karamagi, C., Kiguli, S., &amp; al, e. (2014). Adaptation of the “ten questions” to screen for autism and other neurodevelopmental disorders in Uganda. Autism, 18(4), 447-457.</Citation>
        </Reference>
        <Reference>
          <Citation>Kamio, Y., Inada, N., Koyama, T., Inokuchi, E., Tsuchiya, K., &amp; Kuroda, M. (2014). Effectiveness of using the modified checklist for autism in toddlers in two-stage screening of autism spectrum disorder at the 18-month health check-up in Japan. Journal of Autism and Developmental Disorders, 44(1), 194-203. https://doi.org/10.1007/s10803-013-1864-1</Citation>
        </Reference>
        <Reference>
          <Citation>Kang-Yi, C. D., Grinker, R. R., Beidas, R., Agha, A., Russell, R., Shah, S. B., … Mandell, D. S. (2018). Influence of community-level cultural beliefs about autism on families' and professionals' care for children. Transcultural Psychiatry, 1363461518779831, 623-647. https://doi.org/10.1177/1363461518779831</Citation>
        </Reference>
        <Reference>
          <Citation>Kawa, R., Saemundsen, E., Lóa Jónsdóttir, S., Hellendoorn, A., Lemcke, S., Canal-Bedia, R., … Moilanen, I. (2016). European studies on prevalence and risk of autism spectrum disorders according to immigrant status-A review. European Journal of Public Health, 27(1), 101-110. https://doi.org/10.1093/eurpub/ckw206</Citation>
        </Reference>
        <Reference>
          <Citation>Khowaja, M. K., Hazzard, A. P., &amp; Robins, D. L. (2015). Sociodemographic barriers to early detection of autism: screening and evaluation using the M-CHAT, M-CHAT-R, and follow-up. Journal of Autism and Developmental Disorders, 45(6), 1797-1808. https://doi.org/10.1007/s10803-014-2339-8</Citation>
        </Reference>
        <Reference>
          <Citation>Kieling, C., Baker-Henningham, H., Belfer, M., Conti, G., Ertem, I., Omigbodun, O., … Rahman, A. (2011). Child and adolescent mental health worldwide: Evidence for action. Lancet (London, England), 378(9801), 1515-1525. https://doi.org/10.1016/S0140-6736(11)60827-1</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, S. H., Kim, Y. S., Koh, Y.-J., Lim, E.-C., Kim, S.-J., &amp; Leventhal, B. L. (2016). Often asked but rarely answered: Can asians meet DSM-5/ICD-10 autism spectrum disorder criteria? Journal of Child and Adolescent Psychopharmacology, 26(9), 835-842. https://doi.org/10.1089/cap.2016.0021</Citation>
        </Reference>
        <Reference>
          <Citation>Kirmayer, L. J., &amp; Swartz, L. (2014). Culture and global mental health (Chapter 3). In V. Patel, H. Minas, A. Cohen, &amp; M. J. Prince (Eds.), Global mental health principles and practice. Oxford, UK: Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Kishore, M. T., &amp; Basu, A. (2011). Early concerns of mothers of children later diagnosed with autism: Implications for early identification. Research in Autism Spectrum Disorders, 5(1), 157-163. https://doi.org/10.1016/j.rasd.2010.03.005</Citation>
        </Reference>
        <Reference>
          <Citation>Klasen, H., &amp; Goodman, R. (2000). Parents and GPs at cross-purposes over hyperactivity: A qualitative study of possible barriers to treatment. The British Journal of General Practice, 50(452), 199-202.</Citation>
        </Reference>
        <Reference>
          <Citation>Kleinman, A. (1978). Concepts and a model for the comparison of medical systems as cultural systems. Social Science &amp; Medicine, 12(2B), 85-95.</Citation>
        </Reference>
        <Reference>
          <Citation>Kleinman, A. (1987). Anthropology and psychiatry. The role of culture in cross-cultural research on illness. The British Journal of Psychiatry: the Journal of Mental Science, 151, 447-454.</Citation>
        </Reference>
        <Reference>
          <Citation>Kutcher, S., Wei, Y., &amp; Coniglio, C. (2016). Mental health literacy. Canadian Journal of Psychiatry, 61(3), 154-158. https://doi.org/10.1177/0706743715616609</Citation>
        </Reference>
        <Reference>
          <Citation>La Roche, M. J., Bush, H. H., &amp; D'Angelo, E. (2018). The assessment and treatment of autism spectrum disorder: A cultural examination. Practice Innovations, 3(2), 107-122. https://doi.org/10.1037/pri0000067</Citation>
        </Reference>
        <Reference>
          <Citation>Lai, M.-C., Lombardo, M. V., Auyeung, B., Chakrabarti, B., &amp; Baron-Cohen, S. (2015). Sex/gender differences and autism: Setting the scene for future research. Journal of the American Academy of Child and Adolescent Psychiatry, 54(1), 11-24. https://doi.org/10.1016/j.jaac.2014.10.003</Citation>
        </Reference>
        <Reference>
          <Citation>Lai, M.-C., Lombardo, M. V., &amp; Baron-Cohen, S. (2014). Autism. Lancet (London, England), 383(9920), 896-910. https://doi.org/10.1016/S0140-6736(13)61539-1</Citation>
        </Reference>
        <Reference>
          <Citation>Lai, M.-C., Lombardo, M. V., Chakrabarti, B., &amp; Baron-Cohen, S. (2013). Subgrouping the autism “spectrum”: Reflections on DSM-5. PLoS Biology, 11(4), e1001544. https://doi.org/10.1371/journal.pbio.1001544</Citation>
        </Reference>
        <Reference>
          <Citation>Lambert, M. C., Weisz, J. R., Knight, F., Desrosiers, M. F., Overly, K., &amp; Thesiger, C. (1992). Jamaican and American adult perspectives on child psychopathology: Further exploration of the threshold model. Journal of Consulting and Clinical Psychology, 60(1), 146-149.</Citation>
        </Reference>
        <Reference>
          <Citation>Lau, W. Y.-P., Gau, S. S.-F., Chiu, Y.-N., Wu, Y.-Y., Chou, W.-J., Liu, S.-K., &amp; Chou, M.-C. (2013). Psychometric properties of the Chinese version of the Autism Spectrum Quotient (AQ). Research in Developmental Disabilities, 34(1), 294-305. https://doi.org/10.1016/j.ridd.2012.08.005</Citation>
        </Reference>
        <Reference>
          <Citation>Le Roux, J. (2002). Effective educators are culturally competent communicators. Intercultural Education.13, 37-48</Citation>
        </Reference>
        <Reference>
          <Citation>Leijten, P., Raaijmakers, M. A. J., Orobio de Castro, B., &amp; Matthys, W. (2016). Ethnic differences in problem perception: Immigrant mothers in a parenting intervention to reduce disruptive child behavior. The American Journal of Orthopsychiatry, 86(3), 323-331. https://doi.org/10.1037/ort0000142</Citation>
        </Reference>
        <Reference>
          <Citation>Lillard, A., &amp; Pinkham, A. (2011). Pretend play and cognitive development. In U. Goswami (Ed.), Blackwell handbook of childhood cognitive development (2nd ed., pp. 285-311). Chichester, UK: Blackwell Publishing Ltd, John Wiley &amp; Sons Ltd</Citation>
        </Reference>
        <Reference>
          <Citation>Lofthouse, N., Hendren, R., Hurt, E., Arnold, L. E., &amp; Butter, E. (2012). A review of complementary and alternative treatments for autism spectrum disorders. Autism Research and Treatment, 87039, 1-21. https://doi.org/10.1155/2012/870391</Citation>
        </Reference>
        <Reference>
          <Citation>Lotter, V. (1978). Childhood autism in Africa. Journal of Child Psychology and Psychiatry, 19(3), 231-244. https://doi.org/10.1111/j.1469-7610.1978.tb00466.x</Citation>
        </Reference>
        <Reference>
          <Citation>Magaña, S., Parish, S. L., &amp; Son, E. (2015). Have racial and ethnic disparities in the quality of health care relationships changed for children with developmental disabilities and ASD? American Journal on Intellectual and Developmental Disabilities, 120(6), 504-513. https://doi.org/10.1352/1944-7558-120.6.504</Citation>
        </Reference>
        <Reference>
          <Citation>Magaña, S., &amp; Smith, L. E. (2013). The use of the autism diagnostic interview-revised with a latino population of adolescents and adults with autism. Journal of Autism and Developmental Disorders, 43(5), 1098-1105. https://doi.org/10.1007/s10803-012-1652-3</Citation>
        </Reference>
        <Reference>
          <Citation>Magaña, S., &amp; Vanegas, S. B. (2017). Diagnostic utility of the ADI-R and DSM-5 in the assessment of latino children and adolescents. Journal of Autism and Developmental Disorders, 47(5), 1278-1287. https://doi.org/10.1007/s10803-017-3043-2</Citation>
        </Reference>
        <Reference>
          <Citation>Magnusson, D. M., Minkovitz, C. S., Kuhlthau, K. A., Caballero, T. M., &amp; Mistry, K. B. (2017). Beliefs regarding development and early intervention among low-income African American and Hispanic mothers. Pediatrics, 140(5), e20172059. https://doi.org/10.1542/peds.2017-2059</Citation>
        </Reference>
        <Reference>
          <Citation>Mandell, D. S., &amp; Novak, M. (2005). The role of culture in families' treatment decisions for children with autism spectrum disorders. Mental Retardation and Developmental Disabilities Research Reviews, 11(2), 110-115. https://doi.org/10.1002/mrdd.20061</Citation>
        </Reference>
        <Reference>
          <Citation>Manor-Binyamini, I., &amp; Shoshana, A. (2018). Listening to Bedouin mothers of children with autism. Culture, Medicine, and Psychiatry: An International Journal of Cross-Cultural Health Research, 42(2), 401-418. https://doi.org/10.1007/s11013-018-9567-x</Citation>
        </Reference>
        <Reference>
          <Citation>Marlow, M., Servili, C., &amp; Tomlinson, M. (2019). A review of screening tools for the identification of autism spectrum disorders and developmental delay in infants and young children: Recommendations for use in low- and middle-income countries. Autism Research, 12(2), 176-199. https://doi.org/10.1002/aur.2033</Citation>
        </Reference>
        <Reference>
          <Citation>Masri, A. T., Al Suluh, N., &amp; Nasir, R. (2013). Diagnostic delay of autism in Jordan: Review of 84 cases. The Libyan Journal of Medicine, 8, 21725.</Citation>
        </Reference>
        <Reference>
          <Citation>Matheis, M., Matson, J. L., Burns, C. O., Jiang, X., Peters, W. J., Moore, M., … Estabillo, J. (2017). Factors related to parental age of first concern in toddlers with autism spectrum disorder. Developmental Neurorehabilitation, 20(4), 228-235. https://doi.org/10.1080/17518423.2016.1211186</Citation>
        </Reference>
        <Reference>
          <Citation>Matson, J., Worley, J., Fodstad, J., Chung, K. M., Suh, D., Jhin, H. K., … Furniss, F. (2011). A multinational study examining the cross cultural differences in reported symptoms of autism spectrum disorders: Israel, South Korea, the United Kingdom, and the United States of America. Research in Autism Spectrum Disorders, 5(4), 1598-1604. https://doi.org/10.1016/j.rasd.2011.03.007</Citation>
        </Reference>
        <Reference>
          <Citation>Matson, J. L., Matheis, M., Burns, C. O., Esposito, G., Venuti, P., Pisula, E., … Goldin, R. L. (2017). Examining cross-cultural differences in autism spectrum disorder: A multinational comparison from Greece, Italy, Japan, Poland, and the United States. European Psychiatry, 42, 70-76. https://doi.org/10.1016/j.eurpsy.2016.10.007</Citation>
        </Reference>
        <Reference>
          <Citation>Milačić-Vidojević, I., Gligorović, M., &amp; Dragojević, N. (2014). Tendency towards stigmatization of families of a person with autistic spectrum disorders. The International Journal of Social Psychiatry, 60(1), 63-70. https://doi.org/10.1177/0020764012463298</Citation>
        </Reference>
        <Reference>
          <Citation>Minhas, A., Vajaratkar, V., Divan, G., Hamdani, S. U., Leadbitter, K., Taylor, C., … Rahman, A. (2015). Parents' perspectives on care of children with autistic spectrum disorder in South Asia-Views from Pakistan and India. International Review of Psychiatry, 27(3), 247-256. https://doi.org/10.3109/09540261.2015.1049128</Citation>
        </Reference>
        <Reference>
          <Citation>Mirza, I., Tareen, A., Davidson, L. L., &amp; Rahman, A. (2009). Community management of intellectual disabilities in Pakistan: A mixed methods study. Journal of Intellectual Disability Research, 53(6), 559-570.</Citation>
        </Reference>
        <Reference>
          <Citation>Mitchell, C., &amp; Holdt, N. (2014). The search for a timely diagnosis: Parents' experiences of their child being diagnosed with an Autistic Spectrum Disorder. Journal of Child &amp; Adolescent Mental Health, 26(1), 49-62. https://doi.org/10.2989/17280583.2013.849606</Citation>
        </Reference>
        <Reference>
          <Citation>Mitter, N., Ali, A., &amp; Scior, K. (2019). Stigma experienced by families of individuals with intellectual disabilities and autism: A systematic review. Research in Developmental Disabilities, 89, 10-21. https://doi.org/10.1016/j.ridd.2019.03.001</Citation>
        </Reference>
        <Reference>
          <Citation>Montiel-Nava, C., Chacín, J. A., &amp; González-Ávila, Z. (2017). Age of diagnosis of autism spectrum disorder in Latino children: The case of Venezuelan children. Autism, 21(5), 573-580. https://doi.org/10.1177/1362361317701267</Citation>
        </Reference>
        <Reference>
          <Citation>Munir, K., Lavelle, T. A., Helm, D. T., Thompson, D., Prestt, J., &amp; Azeem, M. W. (2016) Autism: A global framework for action. Doha, Qatar: World Innovation Summit for Health, Report of the WISH Autism Forum.</Citation>
        </Reference>
        <Reference>
          <Citation>Nichter, M. (2010). Idioms of distress revisited. Culture, Medicine, and Psychiatry, 34(2), 401-416. https://doi.org/10.1007/s11013-010-9179-6</Citation>
        </Reference>
        <Reference>
          <Citation>Norbury, C. E., &amp; Sparks, A. (2013). Difference or disorder? Cultural issues in understanding neurodevelopmental disorders. Developmental Psychology, 49(1), 45-58.</Citation>
        </Reference>
        <Reference>
          <Citation>Obeid, R., Daou, N., DeNigris, D., Shane-Simpson, C., Brooks, P. J., &amp; Gillespie-Lynch, K. (2015). A cross-cultural comparison of knowledge and stigma associated with autism spectrum disorder among college students in Lebanon and the United States. Journal of Autism and Developmental Disorders, 45(11), 3520-3536. https://doi.org/10.1007/s10803-015-2499-1</Citation>
        </Reference>
        <Reference>
          <Citation>Ooi, K. L., Ong, Y. S., Jacob, S. A., &amp; Khan, T. M. (2016). A meta-synthesis on parenting a child with autism. Neuropsychiatric Disease and Treatment, 12, 745-762. https://doi.org/10.2147/NDT.S100634</Citation>
        </Reference>
        <Reference>
          <Citation>Papadopoulos, C., Lodder, A., Constantinou, G., &amp; Randhawa, G. (2019). Systematic review of the relationship between autism stigma and informal caregiver mental health. Journal of Autism and Developmental Disorders, 49(4), 1665-1685. https://doi.org/10.1007/s10803-018-3835-z</Citation>
        </Reference>
        <Reference>
          <Citation>Park, S., Lee, Y., &amp; Kim, C. E. (2018). Korean adults' beliefs about and social distance toward attention-deficit hyperactivity disorder, Tourette syndrome, and autism spectrum disorder. Psychiatry Research, 269, 633-639. https://doi.org/10.1016/j.psychres.2018.08.023</Citation>
        </Reference>
        <Reference>
          <Citation>Patel, M. (Ed.). (2003). Cultural issues in measurement and research. In Practical Psychiatric Epidemiology. M. Prince, R. Stewart, T. Ford, M. Hotopf (pp.43-64). Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Patel, V., &amp; Mann, A. (1997). Etic and emic criteria for non-psychotic mental disorder: A study of the CISR and care provider assessment in Harare. Social Psychiatry and Psychiatric Epidemiology, 32(2), 84-89.</Citation>
        </Reference>
        <Reference>
          <Citation>Perera, H., Wijewardena, K., &amp; Aluthwelage, R. (2009). Screening of 18-24-month-old children for autism in a semi-urban community in Sri Lanka. Journal of Tropical Pediatrics, 55(6), 402-405. https://doi.org/10.1093/tropej/fmp031</Citation>
        </Reference>
        <Reference>
          <Citation>Peters, D. H., Garg, A., Bloom, G., Walker, D. G., Brieger, W. R., &amp; Hafizur Rahman, M. (2008). Poverty and access to health care in developing countries. Annals of the New York Academy of Sciences, 1136(1), 161-171. https://doi.org/10.1196/annals.1425.011</Citation>
        </Reference>
        <Reference>
          <Citation>Phelan, J. C. (2005). Geneticization of deviant behavior and consequences for stigma: The case of mental illness. Journal of Health and Social Behavior, 46(4), 307-322. https://doi.org/10.1177/002214650504600401</Citation>
        </Reference>
        <Reference>
          <Citation>Phelan, J. C., Yang, L. H., &amp; Cruz-Rojas, R. (2006). Effects of attributing serious mental illnesses to genetic causes on orientations to treatment. Psychiatric Services (Washington, D.C.), 57(3), 382-387. https://doi.org/10.1176/appi.ps.57.3.382</Citation>
        </Reference>
        <Reference>
          <Citation>Pippins, J. R., Alegría, M., &amp; Haas, J. S. (2007). Association between language proficiency and the quality of primary care among a national sample of insured Latinos. Medical Care, 45(11), 1020-1025. https://doi.org/10.1097/MLR.0b013e31814847be</Citation>
        </Reference>
        <Reference>
          <Citation>Preeti, K., Srinath, D. S., Seshadri, D. S. P., Girimaji, D. S. C., &amp; Kommu, D. J. V. S. (2017). Lost time-need for more awareness in early intervention of autism spectrum disorder. Asian Journal of Psychiatry, 25, 13-15. https://www.researchgate.net/publication/308831655_Lost_time_-_Need_for_more_awareness_in_early_intervention_of_Autism_Spectrum_DisorderPreetiKanda</Citation>
        </Reference>
        <Reference>
          <Citation>Prince, R. (1960). The “brain fag” syndrome in Nigerian students. The Journal of Mental Science, 106, 559-570.</Citation>
        </Reference>
        <Reference>
          <Citation>Prince, R. (1985). The concept of culture-bound syndromes: anorexia nervosa and brain-fag. Social Science &amp; Medicine(1982), 21(2), 197-203.</Citation>
        </Reference>
        <Reference>
          <Citation>Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., &amp; Rahman, A. (2007). No health without mental health. Lancet (London, England), 370(9590), 859-877. https://doi.org/10.1016/S0140-6736(07)61238-0</Citation>
        </Reference>
        <Reference>
          <Citation>Ravindran, N., &amp; Myers, B. J. (2013). Beliefs and practices regarding autism in indian families now settled abroad an internet survey. Focus on Autism and Other Developmental Disabilities, 28(1), 44-53. https://doi.org/10.1177/1088357612458970</Citation>
        </Reference>
        <Reference>
          <Citation>Reardon, T., Harvey, K., Baranowska, M., O'Brien, D., Smith, L., &amp; Creswell, C. (2017). What do parents perceive are the barriers and facilitators to accessing psychological treatment for mental health problems in children and adolescents? A systematic review of qualitative and quantitative studies. European Child &amp; Adolescent Psychiatry, 26(6), 623-647. https://doi.org/10.1007/s00787-016-0930-6</Citation>
        </Reference>
        <Reference>
          <Citation>Rice, C. E., &amp; Lee, L.-C. (2017). Expanding the global reach of research in autism. Autism: The International Journal of Research and Practice, 21(5), 515-517. https://doi.org/10.1177/1362361317704603</Citation>
        </Reference>
        <Reference>
          <Citation>Rogler, L. H. (1993). Culturally sensitizing psychiatric diagnosis. A framework for research. The Journal of Nervous and Mental Disease, 181(7), 401-408.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosenberg, R. E., Landa, R., Law, J. K., Stuart, E. A., &amp; Law, P. A. (2011). Factors affecting age at initial autism spectrum disorder diagnosis in a national survey. Autism Research and Treatment, 2011, 874619. https://doi.org/10.1155/2011/874619, 1, 11</Citation>
        </Reference>
        <Reference>
          <Citation>Ruparelia, K., Abubakar, A., Badoe, E., Bakare, M., Visser, K., Chugani, D. C., … Newton, C. R. (2016). Autism spectrum disorders in Africa: Current challenges in identification, assessment, and treatment. Journal of Child Neurology, 31(8), 1018-1026. https://doi.org/10.1177/0883073816635748</Citation>
        </Reference>
        <Reference>
          <Citation>Samadi, S. A., &amp; McConkey, R. (2015). Screening for autism in iranian preschoolers: Contrasting M-CHAT and a scale developed in Iran. Journal of Autism and Developmental Disorders, 45(9), 2908-2916. https://doi.org/10.1007/s10803-015-2454-1</Citation>
        </Reference>
        <Reference>
          <Citation>Saraceno, B., Ommeren, M. van, Batniji, R., Cohen, A., Gureje, O., Mahoney, J., … Underhill, C. (2007). Barriers to improvement of mental health services in low-income and middle-income countries. The Lancet, 370(9593), 1164-1174. https://doi.org/10.1016/S0140-6736(07)61263-X</Citation>
        </Reference>
        <Reference>
          <Citation>Saxena, S., Thornicroft, G., Knapp, M., &amp; Whiteford, H. (2007). Resources for mental health: Scarcity, inequity, and inefficiency. Lancet (London, England), 370(9590), 878-889. https://doi.org/10.1016/S0140-6736(07)61239-2</Citation>
        </Reference>
        <Reference>
          <Citation>Scarpa, A., Reyes, N. M., Patriquin, M. A., Lorenzi, J., Hassenfeldt, T. A., Desai, V. J., &amp; Kerkering, K. W. (2013). The modified checklist for autism in toddlers: Reliability in a diverse rural American sample. Journal of Autism and Developmental Disorders, 43(10), 2269-2279. https://doi.org/10.1007/s10803-013-1779-x</Citation>
        </Reference>
        <Reference>
          <Citation>Sell, N. K., Giarelli, E., Blum, N., Hanlon, A. L., &amp; Levy, S. E. (2012). A comparison of autism spectrum disorder DSM-IV criteria and associated features among African American and white children in Philadelphia County. Disability and Health Journal, 5(1), 9-17. https://doi.org/10.1016/j.dhjo.2011.08.002</Citation>
        </Reference>
        <Reference>
          <Citation>Shaked, M. (2005). The social trajectory of illness: Autism in the ultraorthodox community in Israel. Social Science &amp; Medicine, 61(10), 2190-2200. https://doi.org/10.1016/j.socscimed.2005.04.022</Citation>
        </Reference>
        <Reference>
          <Citation>Shaked, M., &amp; Bilu, Y. (2006). Grappling with affliction: Autism in the Jewish ultraorthodox community in Israel. Culture, Medicine and Psychiatry, 30(1), 1-27. https://doi.org/10.1007/s11013-006-9006-2</Citation>
        </Reference>
        <Reference>
          <Citation>Shuster, J., Perry, A., Bebko, J., &amp; Toplak, M. E. (2014). Review of factor analytic studies examining symptoms of autism spectrum disorders. Journal of Autism and Developmental Disorders, 44(1), 90-110. https://doi.org/10.1007/s10803-013-1854-3</Citation>
        </Reference>
        <Reference>
          <Citation>Shyu, Y.-I. L., Tsai, J.-L., &amp; Tsai, W.-C. (2010). Explaining and selecting treatments for autism: Parental explanatory models in Taiwan. Journal of Autism and Developmental Disorders, 40(11), 1323-1331. https://doi.org/10.1007/s10803-010-0991-1</Citation>
        </Reference>
        <Reference>
          <Citation>Smeeth, L., Cook, C., Fombonne, E., Heavey, L., Rodrigues, L. C., Smith, P. G., &amp; Hall, A. J. (2004). MMR vaccination and pervasive developmental disorders: A case-control study. Lancet (London, England), 364(9438), 963-969. https://doi.org/10.1016/S0140-6736(04)17020-7</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, L., Malcolm-Smith, S., &amp; Vries, P. J. d. (2017). Translation and cultural appropriateness of the autism diagnostic observation schedule-2 in Afrikaans. Autism, 21(5), 552-563. https://doi.org/10.1177/1362361316648469</Citation>
        </Reference>
        <Reference>
          <Citation>Someki, F., Torii, M., Brooks, P. J., Koeda, T., &amp; Gillespie-Lynch, K. (2018). Stigma associated with autism among college students in Japan and the United States: An online training study. Research in Developmental Disabilities, 76, 88-98. https://doi.org/10.1016/j.ridd.2018.02.016</Citation>
        </Reference>
        <Reference>
          <Citation>Song, J., Leventhal, B. L., Koh, Y. J., Cheon, K. A., Hong, H. J., Kim, Y. K., … Kim, Y. S. (2017). Cross-cultural aspect of behavior assessment system for children-2, parent rating scale-child: Standardization in Korean children. Yonsei Medical Journal, 58(2), 439-448. https://doi.org/10.3349/ymj.2017.58.2.439</Citation>
        </Reference>
        <Reference>
          <Citation>Soto, S., Linas, K., Jacobstein, D., Biel, M., Migdal, T., &amp; Anthony, B. J. (2015). A review of cultural adaptations of screening tools for autism spectrum disorders. Autism: The International Journal of Research and Practice, 19(6), 646-661. https://doi.org/10.1177/1362361314541012</Citation>
        </Reference>
        <Reference>
          <Citation>Stewart, L. A., &amp; Lee, L.-C. (2017). Screening for autism spectrum disorder in low- and middle-income countries: A systematic review. Autism, 1362361316677025, 527-539. https://doi.org/10.1177/1362361316677025</Citation>
        </Reference>
        <Reference>
          <Citation>Street, R. L., O'Malley, K. J., Cooper, L. A., &amp; Haidet, P. (2008). Understanding concordance in patient-physician relationships: Personal and ethnic dimensions of shared identity. Annals of Family Medicine, 6(3), 198-205. https://doi.org/10.1370/afm.821</Citation>
        </Reference>
        <Reference>
          <Citation>Sun, X., Allison, C., Auyeung, B., Matthews, F. E., Baron-Cohen, S., &amp; Brayne, C. (2013). Service provision for autism in mainland China: Preliminary mapping of service pathways. Social Science &amp; Medicine, 98, 87-94. https://doi.org/10.1016/j.socscimed.2013.08.016</Citation>
        </Reference>
        <Reference>
          <Citation>Tait, K., Fung, F., Hu, A., Sweller, N., &amp; Wang, W. (2016). Understanding Hong Kong Chinese families' experiences of an autism/ASD diagnosis. Journal of Autism and Developmental Disorders, 46(4), 1164-1183. https://doi.org/10.1007/s10803-015-2650-z</Citation>
        </Reference>
        <Reference>
          <Citation>Tekola, B., Baheretibeb, Y., Roth, I., Tilahun, D., Fekadu, A., Hanlon, C., &amp; Hoekstra, R. A. (2016). Challenges and opportunities to improve autism services in low-income countries: Lessons from a situational analysis in Ethiopia. Global Mental Health, 1(3), e21.</Citation>
        </Reference>
        <Reference>
          <Citation>Tekola, B., Girma, F., Kinfe, M., Abdurahman, R., Tesfaye, M., Yenus, Z., WHO CST Team, Salomone, E., Pacione, L., Fekadu, A., Servili, C., Hanlon, C., Hoekstra, R.A.(2020). Adapting and pre-testing the World Health Organization's Caregiver Skills Training programme for autism and other developmental disorders in a very low-resource setting: Findings from Ethiopia. Autism 24(1):51-63. https://doi.org/10.1177/1362361319848532.</Citation>
        </Reference>
        <Reference>
          <Citation>Thornicroft, G., Mehta, N., Clement, S., Evans-Lacko, S., Doherty, M., Rose, D., … Henderson, C. (2016). Evidence for effective interventions to reduce mental-health-related stigma and discrimination. The Lancet, 387(10023), 1123-1132. https://doi.org/10.1016/S0140-6736(15)00298-6</Citation>
        </Reference>
        <Reference>
          <Citation>Tilahun, D., Fekadu, A., Tekola, B., Araya, M., Roth, I., Davey, B., … Hoekstra, R. A. (2019). Ethiopian community health workers' beliefs and attitudes towards children with autism: Impact of a brief training intervention. Autism: The International Journal of Research and Practice, 23(1), 39-49. https://doi.org/10.1177/1362361317730298</Citation>
        </Reference>
        <Reference>
          <Citation>Tilahun, D., Hanlon, C., Fekadu, A., Tekola, B., Baheretibeb, Y., &amp; Hoekstra, R. A. (2016). Stigma, explanatory models and unmet needs of caregivers of children with developmental disorders in a low-income African country: A cross-sectional facility-based survey. BMC Health Services Research, 16, 152. https://doi.org/10.1186/s12913-016-1383-9</Citation>
        </Reference>
        <Reference>
          <Citation>UNESCO Institute for Statistics. (2017). Literacy rates continue to rise from one generation to the next. Factsheet no. 45.Montreal, Canada: UNESCO Institute for Statistics.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations, Department of Economic and Social Affairs. (2015). Trends in international migrant stock: migrants by destination and origin (United Nations database, POP/DB/MIG/Stock/Rev). New York, USA, Department of Economic and Social Affairs, United Nations.</Citation>
        </Reference>
        <Reference>
          <Citation>Vanegas, S. B., Magaña, S., Morales, M., &amp; McNamara, E. (2016). Clinical validity of the ADI-R in a US-based Latino population. Journal of Autism and Developmental Disorders, 46(5), 1623-1635. https://doi.org/10.1007/s10803-015-2690-4</Citation>
        </Reference>
        <Reference>
          <Citation>Wakabayashi, A., Baron-Cohen, S., Wheelwright, S., &amp; Tojo, Y. (2006). The Autism-Spectrum Quotient (AQ) in Japan: A cross-cultural comparison. Journal of Autism and Developmental Disorders, 36(2), 263-270. https://doi.org/10.1007/s10803-005-0061-2</Citation>
        </Reference>
        <Reference>
          <Citation>Weisberg, D. S. (2015). Pretend play. Wiley Interdisciplinary Reviews: Cognitive Science, 6(3), 249-261. https://doi.org/10.1002/wcs.1341</Citation>
        </Reference>
        <Reference>
          <Citation>Weisz, J. R., Suwanlert, S., Chaiyasit, W., Weiss, B., Walter, B. R., &amp; Anderson, W. W. (1988). Thai and American perspectives on over- and undercontrolled child behavior problems: Exploring the threshold model among parents, teachers, and psychologists. Journal of Consulting and Clinical Psychology, 56(4), 601-609.</Citation>
        </Reference>
        <Reference>
          <Citation>Werner, S., &amp; Shulman, C. (2015). Does type of disability make a difference in affiliate stigma among family caregivers of individuals with autism, intellectual disability or physical disability? Journal of Intellectual Disability Research, 59(3), 272-283. https://doi.org/10.1111/jir.12136</Citation>
        </Reference>
        <Reference>
          <Citation>West, E. A., Travers, J. C., Kemper, T. D., Liberty, L. M., Cote, D. L., McCollow, M. M., &amp; Brusnahan, L. L. S. (2016). Racial and ethnic diversity of participants in research supporting evidence-based practices for learners with autism spectrum disorder. The Journal of Special Education, 50(3), 151-163. https://doi.org/10.1177/0022466916632495</Citation>
        </Reference>
        <Reference>
          <Citation>Wolff, E. R., &amp; Madlon-Kay, D. J. (2014). Childhood vaccine beliefs reported by Somali and non-Somali parents. Journal of the American Board of Family Medicine, 27(4), 458-464. https://doi.org/10.3122/jabfm.2014.04.130275</Citation>
        </Reference>
        <Reference>
          <Citation>World Bank. (2015). World development indicators. Washington, DC: Author.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization [WHO]. (2005). Technical briefs for policy-makers: Designing health financing systems to reduce catastrophic health expenditure. Number 2.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization [WHO]. (2008). mhGAP: Mental health gap action programme: Scaling up care for mental, neurological and substance use disorders. Geneva: WHO Guidelines Approved by the Guidelines Review Committee.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization [WHO]. (2012). Developmental difficulties in early childhood: Prevention, early identification, assessment and intervention in low- and middle-income countries: a review. Geneva, Switzerland: Author.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization [WHO]. (2013). Meeting report: Autism spectrum disorders and other developmental disorders. From raising awareness to building capacity. Geneva, Switzerland: Author.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization [WHO]. (2018). ICD-11 international classification of diseases for mortality and morbidity statistics, Eleventh Revision. Author. Geneva, Switzerland: World Health Organization.</Citation>
        </Reference>
        <Reference>
          <Citation>Yeh, M., Hough, R. L., McCabe, K., Lau, A., &amp; Garland, A. (2004). Parental beliefs about the causes of child problems: Exploring racial/ethnic patterns. Journal of the American Academy of Child &amp; Adolescent Psychiatry, 43(5), 605-612. https://doi.org/10.1097/00004583-200405000-00014</Citation>
        </Reference>
        <Reference>
          <Citation>Zager, D., Cihak, D. F., &amp; Stone-MacDonald, A. (2016). Autism spectrum disorders: Identification, education, and treatment. Chapter 5: Global perspectives. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, J., Wheeler, J., &amp; Richey, D. (2006). Cultural validity in assessment instruments for children with autism from a Chinese cultural perspective. International Journal of Special Education, 21, 109-114.</Citation>
        </Reference>
        <Reference>
          <Citation>Zuckerman, K. E., Chavez, A. E., Murillo, C. R., Lindly, O. J., &amp; Reeder, J. A. (2018). Disparities in familiarity with developmental disabilities among low-income parents. Academic Pediatrics, 18(8), 944-951.</Citation>
        </Reference>
        <Reference>
          <Citation>Zuckerman, K. E., Lindly, O. J., &amp; Sinche, B. (2016). Parent beliefs about the causes of learning and developmental problems among children with autism spectrum disorder: Results from a national survey. American Journal on Intellectual and Developmental Disabilities, 121(5), 432-447. https://doi.org/10.1352/1944-7558-121.5.432</Citation>
        </Reference>
        <Reference>
          <Citation>Zuckerman, K. E., Sinche, B., Mejia, A., Cobian, M., Becker, T., &amp; Nicolaidis, C. (2014). Latino parents' perspectives of barriers to autism diagnosis. Academic Pediatrics, 14(3), 301-308. https://doi.org/10.1016/j.acap.2013.12.004</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083405</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4981</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomedical materials research. Part B, Applied biomaterials</Title>
          <ISOAbbreviation>J. Biomed. Mater. Res. Part B Appl. Biomater.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Optimization of the interaction of graphene quantum dots with lipase for biological applications.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbm.b.34579</ELocationID>
        <Abstract>
          <AbstractText>Graphene quantum dots (GQDs) are known as emerging sub-10 nm nanoparticles (NPs), which are in fact few-layered pieces of graphene, capable of emitting blue fluorescence, when exposed to 360 nm UV light. Understanding the details of the interaction between GQDs and lipase can serve as a critical step for improving the biological outcome of GQD-derived drug-delivery and diagnosis systems. The interaction occurs in the form of surface adsorption, which can subsequently influence the physicochemical properties of both the NP and the protein. Hence, a systematic approach was taken here to optimize the GQDs' synthesis conditions in order to achieve the highest possible quantum yield (QY). Furthermore, to understands the influence of the interaction of GQDs and lipase, on both the activity of lipase and the emission intensity of GQDs, various incubation conditions were tested to achieve optimized conditions over central composite design algorithm by Design-Expert®, using response surface methodology. The results show that the GQDs fabricated by thermal decomposition of citric acid at 160°C, with a heating duration of 55 min, obtain almost three times higher QY than the highest values reported previously. The best enzymatic activity after the formation of the hard corona, as well as the highest fluorescent emission, were achieved at GQD-to-enzyme ratios within the rage of 23-25%, at temperatures between 41 and 42°C, for 6-8 min. In the aforementioned condition, the enzyme retains 91-95% of its activity and the NP preserves about 80-82% of its fluorescence intensity after incubation.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mohammadi</LastName>
            <ForeName>Asra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Protein Research Center, Shahid Beheshti University G.C, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rahmandoust</LastName>
            <ForeName>Moones</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0354-5095</Identifier>
            <AffiliationInfo>
              <Affiliation>Protein Research Center, Shahid Beheshti University G.C, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirzajani</LastName>
            <ForeName>Fateme</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Protein Research Center, Shahid Beheshti University G.C, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azadkhah Shalmani</LastName>
            <ForeName>Armin</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raoufi</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Physical Chemistry I and Research Center of Micro- and Nanochemistry and Engineering (Cμ), University of Siegen, Siegen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Biomed Mater Res B Appl Biomater</MedlineTA>
        <NlmUniqueID>101234238</NlmUniqueID>
        <ISSNLinking>1552-4973</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">carbon dot</Keyword>
        <Keyword MajorTopicYN="N">fluorescence</Keyword>
        <Keyword MajorTopicYN="N">lipase</Keyword>
        <Keyword MajorTopicYN="N">nanoparticle enzyme interaction</Keyword>
        <Keyword MajorTopicYN="N">protein corona</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083405</ArticleId>
        <ArticleId IdType="doi">10.1002/jbm.b.34579</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Amiri, H., Bordonali, L., Lascialfari, A., Wan, S., Monopoli, M. P., Lynch, I., … Mahmoudi, M. (2013). Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale, 5(18), 8656-8665.</Citation>
        </Reference>
        <Reference>
          <Citation>Amjadi, M., Manzoori, J. L., &amp; Hallaj, T. (2014). Chemiluminescence of graphene quantum dots and its application to the determination of uric acid. Journal of Luminescence, 153, 73-78.</Citation>
        </Reference>
        <Reference>
          <Citation>Asfaram, A., &amp; Ghaedi, M. (2016). Simultaneous determination of cationic dyes in water samples with dispersive liquid-liquid microextraction followed by spectrophotometry: Experimental design methodology. New Journal of Chemistry, 40(5), 4793-4802.</Citation>
        </Reference>
        <Reference>
          <Citation>Bagheri, Z., Ehtesabi, H., Rahmandoust, M., Ahadian, M. M., Hallaji, Z., Eskandari, F., &amp; Jokar, E. (2017). New insight into the concept of carbonization degree in synthesis of carbon dots to achieve facile smartphone based sensing platform. Scientific Reports, 7(1), 11013.</Citation>
        </Reference>
        <Reference>
          <Citation>Beloqui, A., Solinís, M. Á., Gascón, A. R., del Pozo-Rodríguez, A., des Rieux, A., &amp; Préat, V. (2013). Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. Journal of Controlled Release, 166(2), 115-123.</Citation>
        </Reference>
        <Reference>
          <Citation>Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., … Linse, S. (2007). Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proceedings of the National Academy of Sciences, 104(7), 2050-2055.</Citation>
        </Reference>
        <Reference>
          <Citation>Christophersen, P. C., Zhang, L., Müllertz, A., Nielsen, H. M., Yang, M., &amp; Mu, H. (2014). Solid lipid particles for oral delivery of peptide and protein drugs II-the digestion of trilaurin protects desmopressin from proteolytic degradation. Pharmaceutical Research, 31(9), 2420-2428.</Citation>
        </Reference>
        <Reference>
          <Citation>Del Pino, P., Pelaz, B., Zhang, Q., Maffre, P., Nienhaus, G. U., &amp; Parak, W. J. (2014). Protein corona formation around nanoparticles-from the past to the future. Materials Horizons, 1(3), 301-313.</Citation>
        </Reference>
        <Reference>
          <Citation>Docter, D., Westmeier, D., Markiewicz, M., Stolte, S., Knauer, S., &amp; Stauber, R. (2015). The nanoparticle biomolecule corona: Lessons learned-challenge accepted? Chemical Society Reviews, 44(17), 6094-6121.</Citation>
        </Reference>
        <Reference>
          <Citation>Dominguez-Medina, S., Kisley, L., Tauzin, L. J., Hoggard, A., Shuang, B., AS, D. S. I., … Liopo, A. (2016). Adsorption and unfolding of a single protein triggers nanoparticle aggregation. ACS Nano, 10(2), 2103-2112.</Citation>
        </Reference>
        <Reference>
          <Citation>Dong, Y., Shao, J., Chen, C., Li, H., Wang, R., Chi, Y., … Chen, G. (2012). Blue luminescent graphene quantum dots and graphene oxide prepared by tuning the carbonization degree of citric acid. Carbon, 50, 4738-4743. https://doi.org/10.1016/j.carbon.2012.06.002</Citation>
        </Reference>
        <Reference>
          <Citation>Eisazadeh, B., Fateme, M., &amp; Sefidbakht, Y. (2020). How is the effect of silver nanoparticles and lipase/Cellulase enzymes on each other? Iranian Journal of Science and Technology, Transactions A: Science (in press)2020, 1-9. https://doi.org/10.1007/s40995-020-00820-8</Citation>
        </Reference>
        <Reference>
          <Citation>Entressangles, B., &amp; Desnuelle, P. (1968). Action of pancreatic lipase on aggregated glyceride molecules in an isotropic system. Biochimica et Biophysica Acta (BBA)-Enzymology, 159(2), 285-295.</Citation>
        </Reference>
        <Reference>
          <Citation>Fu, Z., Xu, W., Chen, G., Wang, Z., Lu, D., Wu, J., &amp; Liu, Z. (2019). Molecular dynamics simulations reveal how graphene oxide stabilizes and activates lipase in an anhydrous gas. Physical Chemistry Chemical Physics, 21(45), 25425-25430. https://doi.org/10.1039/C9CP05271B</Citation>
        </Reference>
        <Reference>
          <Citation>Gao, F., Ma, S., Li, J., Dai, K., Xiao, X., Zhao, D., &amp; Gong, W. (2017). Rational design of high quality citric acid-derived carbon dots by selecting efficient chemical structure motifs. Carbon, 112, 131-141.</Citation>
        </Reference>
        <Reference>
          <Citation>Ge, J., Lan, M., Zhou, B., Liu, W., Guo, L., Wang, H., … Han, X. (2014). A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nature Communications, 5, 4596. https://doi.org/10.1038/ncomms5596</Citation>
        </Reference>
        <Reference>
          <Citation>Greenfield, N. J. (2006). Using circular dichroism spectra to estimate protein secondary structure. Nature Protocols, 1(6), 2876-2890.</Citation>
        </Reference>
        <Reference>
          <Citation>Habiba, K., Makarov, V. I., Avalos, J., Guinel, M. J. F., Weiner, B. R., &amp; Morell, G. C. (2013). Luminescent graphene quantum dots fabricated by pulsed laser synthesis. Carbon, 64, 341-350.</Citation>
        </Reference>
        <Reference>
          <Citation>Hasan, F., Shah, A. A., &amp; Hameed, A. (2006). Industrial applications of microbial lipases. Enzyme and Microbial Technology, 39(2), 235-251.</Citation>
        </Reference>
        <Reference>
          <Citation>Hassan, M., Gomes, V. G., Dehghani, A., &amp; Ardekani, S. M. (2018). Engineering carbon quantum dots for photomediated theranostics. Nano Research, 11(1), 1-41.</Citation>
        </Reference>
        <Reference>
          <Citation>Horcas, I., Fernández, R., Gomez-Rodriguez, J., Colchero, J., Gómez-Herrero, J., &amp; Baro, A. (2007). WSXM: A software for scanning probe microscopy and a tool for nanotechnology. Review of Scientific Instruments, 78(1), 013705.</Citation>
        </Reference>
        <Reference>
          <Citation>Iannazzo, D., Pistone, A., Salamò, M., Galvagno, S., Romeo, R., Giofré, S. V., … Di Pietro, A. (2017). Graphene quantum dots for cancer targeted drug delivery. International Journal of Pharmaceutics, 518(1), 185-192.</Citation>
        </Reference>
        <Reference>
          <Citation>Jenness, R., Herreid, E. O., Caulfield, W., Burgwald, L., Jack, E., &amp; Tuckey, S. (1942). The density of milk fat: Its relation to the accuracy of the Babcock test. Journal of Dairy Science, 25(11), 949-960.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, W., Kim, B. Y., Rutka, J. T., &amp; Chan, W. C. (2008). Nanoparticle-mediated cellular response is size-dependent. Nature Nanotechnology, 3(3), 145-150.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, R., Eun, J. S., &amp; Lee, M.-K. (2011). Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration. Archives of Pharmacal Research, 34(2), 331-337.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, X., Zhu, S., Xu, B., Ma, K., Zhang, J., Yang, B., &amp; Tian, W. (2013). Self-assembled graphene quantum dots induced by cytochrome c: A novel biosensor for trypsin with remarkable fluorescence enhancement. Nanoscale, 5(17), 7776-7779. https://doi.org/10.1039/C3NR00006K</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, J., Sun, W., Wei, D., Song, X., Jiao, T., He, S., … Du, C. (2015). Direct growth of graphene nanowalls on the crystalline silicon for solar cells. Applied Physics Letters, 106(4), 043904.</Citation>
        </Reference>
        <Reference>
          <Citation>Lynch, I., &amp; Dawson, K. A. (2008). Protein-nanoparticle interactions. Nano Today, 3(1), 40-47.</Citation>
        </Reference>
        <Reference>
          <Citation>Ma, L., Kohli, M., &amp; Smith, A. (2013). Nanoparticles for combination drug therapy. ACS Nano, 7(11), 9518-9525.</Citation>
        </Reference>
        <Reference>
          <Citation>Moosavi-Movahedi, Z., Gharibi, H., Hadi-Alijanvand, H., Akbarzadeh, M., Esmaili, M., Atri, M. S., … Javadian, S. (2015). Caseoperoxidase, mixed β-casein-SDS-hemin-imidazole complex: A nano artificial enzyme. Journal of Biomolecular Structure and Dynamics, 33(12), 2619-2632.</Citation>
        </Reference>
        <Reference>
          <Citation>Pan, D., Zhang, J., Li, Z., &amp; Wu, M. (2010). Hydrothermal route for cutting graphene sheets into blue-luminescent graphene quantum dots. Advanced Materials, 22(6), 734-738.</Citation>
        </Reference>
        <Reference>
          <Citation>Peng, Z., Han, X., Li, S., Al-Youbi, A. O., Bashammakh, A. S., El-Shahawi, M. S., &amp; Leblanc, R. M. (2017). Carbon dots: Biomacromolecule interaction, bioimaging and nanomedicine. Coordination Chemistry Reviews, 343, 256-277.</Citation>
        </Reference>
        <Reference>
          <Citation>Salarian, A.-A., Hami, Z., Mirzaei, N., Mohseni, S. M., Asadi, A., Bahrami, H., … Zare, M.-R. (2016). N-doped TiO 2 nanosheets for photocatalytic degradation and mineralization of diazinon under simulated solar irradiation: Optimization and modeling using a response surface methodology. Journal of Molecular Liquids, 220, 183-191.</Citation>
        </Reference>
        <Reference>
          <Citation>Segura, R. L., Betancor, L., Palomo, J. M., Hidalgo, A., Fernández-Lorente, G., Terreni, M., … Guisán, J. M. (2006). Purification and identification of different lipases contained in PPL commercial extracts: A minor contaminant is the main responsible of most esterasic activity. Enzyme and Microbial Technology, 39(4), 817-823.</Citation>
        </Reference>
        <Reference>
          <Citation>Segura, R. L., Palomo, J. M., Mateo, C., Cortes, A., Terreni, M., Fernández-Lafuente, R., &amp; Guisan, J. M. (2004). Different properties of the lipases contained in porcine pancreatic lipase extracts as enantioselective biocatalysts. Biotechnology Progress, 20(3), 825-829.</Citation>
        </Reference>
        <Reference>
          <Citation>Shang, L., &amp; Nienhaus, G. U. (2013). Small fluorescent nanoparticles at the nano-bio interface. Materials Today, 16(3), 58-66.</Citation>
        </Reference>
        <Reference>
          <Citation>Shu, Z.-Y., Jiang, H., Lin, R.-F., Jiang, Y.-M., Lin, L., &amp; Huang, J.-Z. (2010). Technical methods to improve yield, activity and stability in the development of microbial lipases. Journal of Molecular Catalysis B: Enzymatic, 62(1), 1-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Šinko, G., Vrček, I. V., Goessler, W., Leitinger, G., Dijanošić, A., &amp; Miljanić, S. (2014). Alteration of cholinesterase activity as possible mechanism of silver nanoparticle toxicity. Environmental Science and Pollution Research, 21(2), 1391-1400.</Citation>
        </Reference>
        <Reference>
          <Citation>Stergiou, P.-Y., Foukis, A., Filippou, M., Koukouritaki, M., Parapouli, M., Theodorou, L. G., … Papamichael, E. M. (2013). Advances in lipase-catalyzed esterification reactions. Biotechnology Advances, 31(8), 1846-1859.</Citation>
        </Reference>
        <Reference>
          <Citation>Suplatov, D., Besenmatter, W., Švedas, V., &amp; Svendsen, A. (2012). Bioinformatic analysis of alpha/beta-hydrolase fold enzymes reveals subfamily-specific positions responsible for discrimination of amidase and lipase activities. Protein Engineering, Design &amp; Selection, 25(11), 689-697.</Citation>
        </Reference>
        <Reference>
          <Citation>Treichel, H., de Oliveira, D., Mazutti, M. A., Di Luccio, M., &amp; Oliveira, J. V. (2010). A review on microbial lipases production. Food and Bioprocess Technology, 3(2), 182-196.</Citation>
        </Reference>
        <Reference>
          <Citation>Vakhlu, J. (2006). Yeast lipases: Enzyme purification, biochemical properties and gene cloning. Electronic Journal of Biotechnology, 9(1), 69-85.</Citation>
        </Reference>
        <Reference>
          <Citation>Venyaminov, S. Y., &amp; Vassilenko, K. S. (1994). Determination of protein tertiary structure class from circular dichroism spectra. Analytical Biochemistry, 222(1), 176-184.</Citation>
        </Reference>
        <Reference>
          <Citation>Vertegel, A. A., Siegel, R. W., &amp; Dordick, J. S. (2004). Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir, 20(16), 6800-6807. https://doi.org/10.1021/la0497200</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, F., Gu, Z., Lei, W., Wang, W., Xia, X., &amp; Hao, Q. (2014). Graphene quantum dots as a fluorescent sensing platform for highly efficient detection of copper (II) ions. Sensors and Actuators B: Chemical, 190, 516-522.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, S., Chen, Z.-G., Cole, I., &amp; Li, Q. (2015). Structural evolution of graphene quantum dots during thermal decomposition of citric acid and the corresponding photoluminescence. Carbon, 82, 304-313.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, S., Cole, I. S., Zhao, D., &amp; Li, Q. (2016). The dual roles of functional groups in the photoluminescence of graphene quantum dots. Nanoscale, 8(14), 7449-7458.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, W. (2005). Protein aggregation and its inhibition in biopharmaceutics. International Journal of Pharmaceutics, 289(1), 1-30. https://doi.org/10.1016/j.ijpharm.2004.11.014</Citation>
        </Reference>
        <Reference>
          <Citation>Wen, Z.-H., &amp; Yin, X.-B. (2016). Excitation-independent carbon dots, from photoluminescence mechanism to single-color application. RSC Advances, 6(33), 27829-27835. https://doi.org/10.1039/C5RA27172J</Citation>
        </Reference>
        <Reference>
          <Citation>Wray, W., Boulikas, T., Wray, V. P., &amp; Hancock, R. (1981). Silver staining of proteins in polyacrylamide gels. Analytical Biochemistry, 118(1), 197-203.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu, X., Tian, F., Wang, W., Chen, J., Wu, M., &amp; Zhao, J. X. (2013). Fabrication of highly fluorescent graphene quantum dots using L-glutamic acid for in vitro/in vivo imaging and sensing. Journal of Materials Chemistry C, 1(31), 4676-4684.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhong, Z., Li, G., Wu, Y., Luo, Z., &amp; Zhu, B. (2012). Ultrasound-assisted matrix solid-phase dispersive liquid extraction for the determination of intermediates in hair dyes with ion chromatography. Analytica Chimica Acta, 752, 53-61.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu, S., Song, Y., Zhao, X., Shao, J., Zhang, J., &amp; Yang, B. (2015). The photoluminescence mechanism in carbon dots (graphene quantum dots, carbon nanodots, and polymer dots): Current state and future perspective. Nano Research, 8(2), 355-381.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">32083406</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1421-9778</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>22</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</Title>
          <ISOAbbreviation>Cell. Physiol. Biochem.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.</ArticleTitle>
        <Pagination>
          <MedlinePgn>195-210</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.33594/000000214</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND/AIMS" NlmCategory="OBJECTIVE">Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive and chronic interstitial lung disease of unknown cause. IPF is characterized by excessive deposition of extracellular matrix (ECM) and destructive pathological remodeling due to epithelial-to-mesenchymal transition (EMT). Eventually, lung interstitium thickens and stiffens and breathing becomes difficult. It has been well established that the transforming growth factor-β1 (TGF-β1)/Smad signaling pathway plays a critical role in the pathogenesis of pulmonary fibrosis. TGF-β1-mediated activation of mitogen activated protein kinase (MAPK) family affects Smad signaling. p90RSK is a serine/threonine kinase and is activated by the extracellular signal-regulated kinase (ERK) signaling pathway. However, the roles played by p90RSK in TGF-β1 signaling and the pathogenesis of pulmonary fibrosis remain unknown.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We investigated whether p90RSK regulates the pathogenesis of pulmonary fibrosis using in vitro and in vivo systems and Western blotting, real-time quantitative PCR, transcriptional activity assays and immunofluorescence studies.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Pharmacological inhibition of p90RSK by FMK or inhibition of p90RSK with adenoviral vector encoding a dominant negative form of p90RSK suppressed TGF-β1-induced ECM accumulation and EMT in lung epithelial cells and fibroblasts. Interestingly, FMK significantly inhibited TGF-β1-induced Smad3 nuclear translocation and smad binding element-dependent transcriptional activity, but not Smad3 phosphorylation. Furthermore, in a mouse model of bleomycin-induced lung fibrosis, FMK ameliorated pulmonary fibrosis.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings indicate that p90RSK plays critical roles in pulmonary fibrosis, which suggests it be viewed as a novel therapeutic target for the treatment of lung fibrosis.</AbstractText>
          <CopyrightInformation>© Copyright by the Author(s). Published by Cell Physiol Biochem Press.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Suji</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Smart-Ageing Convergence Research Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Jung-Hwa</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Smart-Ageing Convergence Research Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Sujin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Smart-Ageing Convergence Research Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Heejung</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Smart-Ageing Convergence Research Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Jae-Ryong</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Smart-Ageing Convergence Research Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lim</LastName>
            <ForeName>Jae Hyang</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Ewha Womans University College of Medicine, Seoul, Republic of Korea, jlim19@ewha.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woo</LastName>
            <ForeName>Chang-Hoon</ForeName>
            <Initials>CH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Yeungnam University College of Medicine, Daegu, Republic of Korea, changhoon_woo@yu.ac.kr.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Smart-Ageing Convergence Research Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2015R1A5A2009124, 2018R1A2B6004664, 2019R1I1A1A01060129</GrantID>
            <Agency>NRF (Korean National Research Foundation)</Agency>
            <Country>Republic of Korea</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Cell Physiol Biochem</MedlineTA>
        <NlmUniqueID>9113221</NlmUniqueID>
        <ISSNLinking>1015-8987</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Pulmonary fibrosis; p90RSK; TGF-β1; ECM; EMT</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no conflict of interests to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083406</ArticleId>
        <ArticleId IdType="doi">10.33594/000000214</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">32083407</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1758-7247</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>ahead-of-print</Volume>
            <Issue>ahead-of-print</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of health organization and management</Title>
          <ISOAbbreviation>J Health Organ Manag</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fiddling while Rome burns? Conducting research with healthcare staff when the NHS is in crisis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1108/JHOM-04-2019-0105</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Health research in the UK is being impeded by a stretched NHS system. The purpose of this paper is to use the Great Fire of Rome as an allegory to understand the difficulties encountered by health researchers when attempting to conduct research within a healthcare system that is currently in crisis.</AbstractText>
          <AbstractText Label="DESIGN/METHODOLOGY/APPROACH" NlmCategory="METHODS">The paper draws on both the authors' own and other research teams' experiences from the published literature in order to demonstrate that this difficulty is a widespread problem for the health research community in the UK.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">Recruitment and engagement issues across different research studies and clinical environments are often ascribed as being related to individual contexts or settings. Rather, the authors propose that these problems are actually writ large across nearly the entire NHS. The authors offer ideas for what can be done to alleviate the worst of this situation - a change in culture and ways of working alongside employing more pragmatic, rapid methods to engage exceptionally busy healthcare staff.</AbstractText>
          <AbstractText Label="ORIGINALITY/VALUE" NlmCategory="CONCLUSIONS">The paper offers a provocative viewpoint that instead of seeking to individualise recruitment and engagement issues in relation to the local context, the research community should publicly acknowledge the universality of this problem in order to bring about meaningful change.</AbstractText>
          <CopyrightInformation>© Emerald Publishing Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sheard</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Bradford Institute for Health Research, Bradford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peacock</LastName>
            <ForeName>Rosemary</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>University of Leeds, Leeds, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Health Organ Manag</MedlineTA>
        <NlmUniqueID>101179473</NlmUniqueID>
        <ISSNLinking>1477-7266</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>H</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Austerity</Keyword>
        <Keyword MajorTopicYN="N">Health research</Keyword>
        <Keyword MajorTopicYN="N">Healthcare staff</Keyword>
        <Keyword MajorTopicYN="N">National Health Service</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083407</ArticleId>
        <ArticleId IdType="doi">10.1108/JHOM-04-2019-0105</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Adams, A. (2017), “Nursing degree applications slump after NHS bursaries abolished”, Guardian Newspaper, 2 February, available at: www.theguardian.com/education/2017/feb/02/nursing-degree-applications-slump-after-nhs-bursaries-abolished</Citation>
        </Reference>
        <Reference>
          <Citation>Boaz, A., Hanney, S., Jones, T. and Soper, B. (2015), “Does the engagement of clinicians and organisations in research improve healthcare performance: a three stage review”, BMJ Open, Vol. 5 No. 12, doi: 10.1136/bmjopen-2015-009415.</Citation>
        </Reference>
        <Reference>
          <Citation>Campbell, D., Morris, S. and Marsh, S. (2017), “NHS faces ‘humanitarian crisis’ as demand rises, British Red Cross warns”, Guardian Newspaper, 6 January, available at: www.theguardian.com/society/2017/jan/06/nhs-faces-humanitarian-crisis-rising-demand-british-red-cross</Citation>
        </Reference>
        <Reference>
          <Citation>Clarke, D.J., Hawkins, R., Sadler, E., Harding, G., McKevitt, C., Godfrey, M., Dickerson, J., Farrin, A., Kalra, L., Smithard, D. and Forster, A. (2014), “Introducing structured caregiver training in stroke care: findings from the TRACS process evaluation study”, BMJ Open, Vol. 4 No. 4, doi: 10.1136/bmjopen-2013-004473.</Citation>
        </Reference>
        <Reference>
          <Citation>Ham, C. (2017), “Political crisis in the NHS”, BMJ, Vol. 356, p. j218.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaffash, J. (2016), “GP vacancy rate at highest recorded with one in eight positions unfilled”, Pulse Magazine, 1 June, available at: www.pulsetoday.co.uk/your-practice/practice-topics/employment/gp-vacancy-rates-at-highest-recorded-with-one-in-eight-positions-unfilled/20031836.article</Citation>
        </Reference>
        <Reference>
          <Citation>Karanikolos, M., Mladovsky, P. and Cylus, J. (2013), “Financial crisis, austerity and health in Europe”, Lancet, Vol. 381 No. 9874, pp. 1323-1331.</Citation>
        </Reference>
        <Reference>
          <Citation>Kislov, R., Wilson, P., Knowles, S. and Boaden, R. (2018), “Learning from the emergency of the NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRCs): a systematic review of evaluations”, Implementation Science, Vol. 13, p. 111.</Citation>
        </Reference>
        <Reference>
          <Citation>Krzyanowska, M., Kaplan, R. and Sullivan, R. (2011), “How may clinical research improve healthcare outcomes?”, Annals of Oncology, Vol. 22 No. S7, pp. 10-15.</Citation>
        </Reference>
        <Reference>
          <Citation>McMullen, H., Griffiths, C., Leber, W. and Greenhalgh, T. (2015), “Explaining high and low performers in complex intervention trials: a new model based on diffusion of innovations theory”, Trials, Vol. 16.</Citation>
        </Reference>
        <Reference>
          <Citation>Maguire, D., Dunn, P. and McKenna, H. (2017), “How hospital activity in the NHS in England has changed over time”, King’s Fund report, 20 December 2016, London, available at: www.kingsfund.org.uk/publications/hospital-activity-funding-changes</Citation>
        </Reference>
        <Reference>
          <Citation>Marshall, M., Pagel, C., French, C., Utley, M., Allwood, D., Fulop, N., Pope, C., Banks, V. and Goldmann, A. (2014), “Moving improvement research closer to practice: the Researcher-in-Residence model”, BMJ Quality &amp; Safety, Vol. 23, pp. 801-805.</Citation>
        </Reference>
        <Reference>
          <Citation>Moberly, T. (2017), “Specialty training vacancies increase by 30% in a year”, BMJ Careers, 19 July, available at: http://careers.bmj.com/careers/advice/Specialty_training_vacancies_increase_by_30%2525_in_a_year (accessed 26 February 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Morgan, M. and Cole, J. (2018), “Research matters”, BMJ Blog, 27 March, available at: http://blogs.bmj.com/bmj/2018/03/27/matt-morgan-and-jade-cole-research-matters/ (accessed 2 April 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Murray, R. (2017), “Falling number of nurses in the NHS paints a worrying picture”, King’s Fund report, 12 October, London, available at: www.kingsfund.org.uk/blog/2017/10/falling-number-nurses-nhs-paints-worrying-picture</Citation>
        </Reference>
        <Reference>
          <Citation>O’Hara, J., Lawton, R. and Armitage, G. (2016), “The patient reporting and action for a safe environment (PRASE) intervention: a feasibility study”, BMC Health Services Research, Vol. 16, p. 676.</Citation>
        </Reference>
        <Reference>
          <Citation>Power, M., Brewster, L., Parry, G., Brotheron, A., Minion, J., Ozieranski, P., McNicol, S., Harrison, A. and Dixon-Woods, M. (2016), “Multimethod study of a large scale programme to improve patient safety using a harm free care approach”, BMJ Open, Vol. 6 No. 9.</Citation>
        </Reference>
        <Reference>
          <Citation>Reeves, R., West, E. and Barron, D. (2013), “Facilitating patient experience feedback can improve nursing care: a pilot study for a phase three cluster randomised controlled trial”, BMC Health Services Research, Vol. 13, p. 259.</Citation>
        </Reference>
        <Reference>
          <Citation>Roland, M. (2016), “Tackling the crisis in general practice”, BMJ, Vol. 352, p. i942.</Citation>
        </Reference>
        <Reference>
          <Citation>Scobie, S. and Castle-Clarke, S. (2019), What Can the NHS Learn From Learning Health Systems?, Nuffield Trust, London.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheard, L., Peacock, R., Marsh, C. and Lawton, R. (2019), “What’s the problem with patient experience feedback? A macro and micro understanding based on findings from a three site UK study”, Health Expectations, Vol. 22 No. 1, pp. 46-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheard, L., Marsh, C., O’Hara, J., Armitage, G., Wright, J. and Lawton, R. (2017), “Exploring how ward staff engage with the implementation of a patient safety intervention: a UK-based qualitative process evaluation”, BMJ Open, Vol. 7 No. 7, doi: 10.1136/bmjopen-2016-014558.</Citation>
        </Reference>
        <Reference>
          <Citation>Skea, Z.C., Treweek, S. and Gillies, K. (2017), “‘It’s trying to manage the work’: a qualitative evaluation of recruitment processes within a UK multicentre trial”, BMJ Open, Vol. 7, doi: 10.1136/bmjopen-2017-016475.</Citation>
        </Reference>
        <Reference>
          <Citation>Stephens, T., Peden, C., Pearse, R., Shaw, S., Abbott, T., Jones, E., Kocman, D. and Martin, G. (2018), “Improving care at scale: Process evaluation of a multi-component quality improvement intervention to reduce mortality after emergency abdominal surgery (EPOCH trial)”, Implementation Science, Vol. 13.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor, S.L., Dy, S., Foy, R., Hempel, S., McDonald, K., Ovretveit, J., Pronovost, P., Rubenstein, V., Wachter, R. and Shekelle, P. (2011), “What context features might be important determinants of the effectiveness of patient safety practice interventions?”, BMJ Q&amp;S, Vol. 20, pp. 611-617.</Citation>
        </Reference>
        <Reference>
          <Citation>The Healthcare Improvement Studies Institute (2019), “Involving NHS staff in research”, THIS Institute, Cambridge.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">32083408</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0952-6862</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>ahead-of-print</Volume>
            <Issue>ahead-of-print</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of health care quality assurance</Title>
          <ISOAbbreviation>Int J Health Care Qual Assur</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Measuring the continuous quality improvement orientation of medical education programs.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1108/IJHCQA-06-2019-0102</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">There is a growing interest in applying continuous quality improvement (CQI) methodologies and tools to medical education contexts. One such tool, the "Are We Making Progress" questionnaire from the Malcolm Baldrige National Quality Award framework, adequately captures the dimensions critical for performance excellence and allows organizations to assess their performance and identify areas for improvement. Its results have been widely validated in business, education, and health care and might be applicable in medical education contexts. The measurement properties of the questionnaire data were analyzed using Rasch modeling to determine if validity evidence, based on Messick's framework, supports the interpretation of results in medical education contexts. Rasch modeling was performed since the questionnaire uses Likert-type scales whose estimates might not be amenable to parametric statistical analyses.</AbstractText>
          <AbstractText Label="DESIGN/METHODOLOGY/APPROACH" NlmCategory="METHODS">Leaders and teachers at 16 of the 17 Canadian medical schools were invited in 2015-2016 to complete the 40-item questionnaire. Data were analyzed using the ConQuest Rasch calibration program, rating scale model.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">491 faculty members from 11 (69 percent) schools participated. A seven-dimensional, four-point response scale model better fit the data. Overall data fit to model requirements supported the use of person measures with parametric statistics. The structural, content, generalizability, and substantive validity evidence supported the interpretation of results in medical education contexts.</AbstractText>
          <AbstractText Label="ORIGINALITY/VALUE" NlmCategory="CONCLUSIONS">For the first time, the Baldrige questionnaire results were validated in medical education contexts. Medical education leaders are encouraged to serially use this questionnaire to measure progress on their school's CQI focus.</AbstractText>
          <CopyrightInformation>© Emerald Publishing Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Blouin</LastName>
            <ForeName>Danielle</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Everett V</ForeName>
            <Initials>EV</Initials>
            <AffiliationInfo>
              <Affiliation>University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Health Care Qual Assur</MedlineTA>
        <NlmUniqueID>8916799</NlmUniqueID>
        <ISSNLinking>0952-6862</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>H</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Continuous quality improvement</Keyword>
        <Keyword MajorTopicYN="N">Medicine</Keyword>
        <Keyword MajorTopicYN="N">Organizational performance</Keyword>
        <Keyword MajorTopicYN="N">Performance measurement</Keyword>
        <Keyword MajorTopicYN="N">Psychometrics</Keyword>
        <Keyword MajorTopicYN="N">Quality frameworks</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083408</ArticleId>
        <ArticleId IdType="doi">10.1108/IJHCQA-06-2019-0102</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Abdulla Badri, M., Selim, H., Alshare, K., Grandon, E.E., Younis, H. and Abdulla, M. (2005), “The Baldrige education criteria for performance excellence framework: empirical test and validation”, International Journal of Quality and Reliability Management, Vol. 23, pp. 1118-1157.</Citation>
        </Reference>
        <Reference>
          <Citation>Akaike, H. (1981), “Likelihood of a model and information criteria”, Journal of Econometrics, Vol. 16, pp. 3-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Barzansky, B., Hunt, D., Moineau, G., Ahn, D., Lai, C.W., Humphrey, H. and Peterson, L. (2015), “Continuous quality improvement in an accreditation system for undergraduate medical education: benefits and challenges”, Medical Teacher, Vol. 37, pp. 1032-1038.</Citation>
        </Reference>
        <Reference>
          <Citation>Bing-You, R.G. (1997), “T2QM (teaching and total quality management) for medical teachers”, Medical Teacher, Vol. 19, pp. 205-207.</Citation>
        </Reference>
        <Reference>
          <Citation>Blouin, D. (2019), “Quality improvement in medical schools: vision meets culture”, Medical Education, Vol. 53, pp. 1100-1110.</Citation>
        </Reference>
        <Reference>
          <Citation>Blouin, D. and Tekian, A. (2017), “Accreditation of medical education programs: moving from student outcomes to continuous quality improvement measures”, Academic Medicine: Journal of the Association of American Medical Colleges, Vol. 93, pp. 377-383.</Citation>
        </Reference>
        <Reference>
          <Citation>Brandrud, A.S., Schreiner, A., Hjortdahl, P., Helljesen, G.S., Nyen, B. and Nelson, E.C. (2011), “Three success factors for continual improvement in healthcare: an analysis of the reports of improvement team members”, BMJ Quality and Safety, Vol. 20, pp. 251-259.</Citation>
        </Reference>
        <Reference>
          <Citation>Carman, J.M., Shortell, S.M., Foster, R.W., Hughes, E.F., Boerstler, H., JL, O.B. and O'Connor, E.J. (2010), “Keys for successful implementation of total quality management in hospitals”, Health Care Management Review, Vol. 35, pp. 283-293.</Citation>
        </Reference>
        <Reference>
          <Citation>Curkovic, S., Melnyk, S., Calantone, R. and Handfield, R. (2000), “Validating the Malcolm Baldrige national quality award framework through structural equation modelling”, International Journal of Production, Vol. 38, pp. 765-791.</Citation>
        </Reference>
        <Reference>
          <Citation>Ettorchi-Tardy, A., Levif, M. and Michel, P. (2012), “Benchmarking: a method for continuous quality improvement in health”, Healthcare Policy, Vol. 7, pp. e101-e119.</Citation>
        </Reference>
        <Reference>
          <Citation>Frary, R.B. (2002), A Brief Guide to Questionnaire Development, available at: http://ericae.net/ft/tamu/vpiques3.htm (accessed 24 June 2019).</Citation>
        </Reference>
        <Reference>
          <Citation>Hinkle, D.E., Wiersma, W. and Jurs, S.G. (1988), Applied Statistics for the Behavioral Sciences, Houghton Mifflin, Boston.</Citation>
        </Reference>
        <Reference>
          <Citation>Hinton, P.R., Bronlow, C., McMurray, I. and Cozens, B. (2004), “Using SPSS to analyze questionnaires: Reliability”, SPSS Explained, Routledge, New York, NY, p. 364.</Citation>
        </Reference>
        <Reference>
          <Citation>Jayamaha, N.P., Grigg, N.P. and Mann, R.S. (2008), “Empirical validity of Baldrige criteria: New Zealand evidence”, International Journal of Quality and Reliability Management, Vol. 25 No. 5, pp. 477-493.</Citation>
        </Reference>
        <Reference>
          <Citation>Kass, R.E. and Raftery, A.E. (1995), “Bayes factors”, Journal of the American Statistical Association, Vol. 90, pp. 773-795.</Citation>
        </Reference>
        <Reference>
          <Citation>Kulas, J.T. and Stachowski, A.A. (2009), “Middle category endorsemet in odd-numbered Likert response scales: associated item characteristics, cognitive demands, and preferred meanings”, Journal of Research in Personality, Vol. 43, pp. 489-493.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, S., Choi, K.S., Kang, H.Y., Cho, W. and Chae, Y.M. (2002), “Assessing the factors influencing continuous quality improvement implementation: experience in Korean hospitals”, International Journal for Quality in Health Care, Vol. 14, pp. 383-391.</Citation>
        </Reference>
        <Reference>
          <Citation>Linacre, J.M. (2004a), “Estimation methods for Rasch measures”, in Smith, E.V. and Smith, R.M. (Eds), Introduction to Rasch Measurement, JAM Press, Maple Grove, Minnesota, MN, pp. 25-47.</Citation>
        </Reference>
        <Reference>
          <Citation>Linacre, J.M. (2004b), “Optimizing rating scale category effectiveness”, in Smith, E.V. and Smith, R.M. (Eds), Introduction to Rasch Measurement, JAM Press, Maple Grove, Minnesota, MN, pp. 258-278.</Citation>
        </Reference>
        <Reference>
          <Citation>Linacre, J.M. (2004c), “Rasch model estimation: further topics”, in Smith, E.V. and Smith, R.M. (Eds), Introduction to Rasch Measurement, JAM Press, Maple Grove, Minnesota, MN, pp. 48-72.</Citation>
        </Reference>
        <Reference>
          <Citation>Merbitz, C., Morris, J. and Grip, J.C. (1989), “Ordinal scales and foundations of misinference”, Archives of Physical Medicine and Rehabilitation, Vol. 70, p. 308.</Citation>
        </Reference>
        <Reference>
          <Citation>Messick, S. (1995), “Validity of psychological assessment: validation of inferences from persons' responses and performances as scientific inquiry into score meaning”, The American Psychologist, Vol. 50, pp. 741-749.</Citation>
        </Reference>
        <Reference>
          <Citation>NIST (2011), Are We Making Progress?, US Department of Commerce, Gaithersburg, MD, available at: http://www.nist.gov/baldrige/publications/upload/AWMP.pdf (accessed 28 February 2015).</Citation>
        </Reference>
        <Reference>
          <Citation>NIST (2015), About the Baldrige Excellence Framework (Education), US Department of Commerce, Gaithersburg, MD, available at: http://nist.gov/baldrige/publications/ed_about.cfm (accessed 10 April 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>Peng, X. and Prybutok, V. (2015), “Relative effectiveness of the Malcolm Baldrige national quality award categories”, International Journal of Production Research, Vol. 53, pp. 629-647.</Citation>
        </Reference>
        <Reference>
          <Citation>Raftery, A.E. (1995), “Bayesian model selection in social research”, Sociol Methodol, Vol. 25, pp. 111-163.</Citation>
        </Reference>
        <Reference>
          <Citation>Rondeau, K.V. and Wagar, T.H. (2004), “Implementing CQI while reducing the work force: how does it influence hospital performance?”, Healthcare Management Forum Gestion des soins de santé, Vol. 17, pp. 22-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Rubenstein, L., Khodyakov, D., Hempel, S., Danz, M., Salem-Schatz, S., Foy, R., O'Neill, S., Dalal, S. and Shekelle, P. (2014), “How can we recognize continuous quality improvement?”, International Journal for Quality in Health Care, Vol. 26, pp. 6-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwarz, G. (1978), “Estimating the dimension of a model”, Annals of Statistics, Vol. 6, pp. 461-464.</Citation>
        </Reference>
        <Reference>
          <Citation>Shields, J.A. and Jennings, J.L. (2013), “Using the Malcolm Baldrige “are we making progress” survey for organizational self-assessment and performance improvement”, Journal for Healthcare Quality, Vol. 35, pp. 5-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Shortell, S.M., O'Brien, J.L., Carman, J.M., Foster, R.W., Hughes, E.F., Boerstler, H. and O'Connor, E.J. (1995), “Assessing the impact of continuous quality improvement/total quality management: concept versus implementation”, Health Services Research, Vol. 30, pp. 377-401.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, J.E.V. (2001), “Evidence for the reliability of measures and validity of measure interpretation: a Rasch measurement perspective”, Journal of Applied Measurement, Vol. 2, p. 281.</Citation>
        </Reference>
        <Reference>
          <Citation>Tennant, A. and Conaghan, P.G. (2007), “The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?”, Arthritis and Rheumatism, Vol. 57, pp. 1358-1362.</Citation>
        </Reference>
        <Reference>
          <Citation>Wakefield, B.J., Blegen, M.A., Uden-Holman, T., Vaughn, T., Chrischilles, E. and Wakefield, D.S. (2001), “Organizational culture, continuous quality improvement, and medication administration error reporting”, American Journal of Medical Quality, Vol. 16, pp. 128-134.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolfe, E.W. and Smith, E.V. Jr, (2007a), “Instrument development tools and activities for measure validation using Rasch models: part I - instrument development tools”, Journal of Applied Measurement, Vol. 8, p. 97.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolfe, E.W. and Smith, E.V. Jr, (2007b), “Instrument development tools and activities for measure validation using Rasch models: part II - validation activities”, Journal of Applied Measurement, Vol. 8, p. 97.</Citation>
        </Reference>
        <Reference>
          <Citation>Wright, B.D. and Linacre, J.M. (1989), “Observations are always ordinal; measurements, however, must be interval”, Archives of Physical Medicine and Rehabilitation, Vol. 70, p. 857.</Citation>
        </Reference>
        <Reference>
          <Citation>Wright, B.D. and Linacre, J.M. (1994), “Reasonable mean-square fit values”, Rasch Measurement Transactions, Vol. 8, p. 370.</Citation>
        </Reference>
        <Reference>
          <Citation>Wright, B.D. and Mok, M.M.C. (2004), “An overview of the family of Rasch measurement models”, in Smith, E.V.J. and Smith, R.M. (Eds), Introduction to Rasch Measurement, JAM Press, Maple Grove, Minnesota, MN, pp. 1-24.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu, M.L., Adams, R. and Wilson, M. (1998), ConQuest, 3rd ed., Australian Council for Educational Research, Melbourne, Australia.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083409</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0253-9624</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>54</Volume>
            <Issue>0</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
          <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Risk assessment of exported risk of novel coronavirus pneumonia from Hubei Province].</ArticleTitle>
        <Pagination>
          <MedlinePgn>E017</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112150-20200219-00142</ELocationID>
        <Abstract>
          <AbstractText><b>Objective:</b> To evaluate the exported risk of novel coronavirus pneumonia (NCP) from Hubei Province and the imported risk in various provinces across China. <b>Methods:</b> Data of reported NCP cases and Baidu Migration Indexin all provinces of the country as of February 14, 2020 were collected. The correlation analysis between cumulative number of reported cases and the migration index from Hubei was performed, and the imported risks from Hubei to different provinces across China were further evaluated. <b>Results:</b> A total of 49 970 confirmed cases were reported nationwide, of which 37 884 were in Hubei Province. The average daily migration index from Hubei to other provinces was 312.09, Wuhan and other cities in Hubei were 117.95 and 194.16, respectively. The cumulative NCP cases of provinces was positively correlated with the migration index derived from Hubei province, also in Wuhan and other cities in Hubei, with correlation coefficients of 0.84, 0.84, and 0.81. In linear model, population migration from Hubei Province, Wuhan and other cities in Hubei account for 71.2%, 70.1%, and 66.3% of the variation, respectively. The period of high exported risk from Hubei occurred before January 27, of which the risks before January 23 mainly came from Wuhan, and then mainly from other cities in Hubei. Hunan Province, Henan Province and Guangdong Province ranked the top three in terms of cumulative imported risk (the cumulative risk indices were 58.61, 54.75 and 49.62 respectively). <b>Conclusion:</b> The epidemic in each province was mainly caused by the importation of Hubei Province. Taking measures such as restricting the migration of population in Hubei Province and strengthening quarantine measures for immigrants from Hubei Province may greatly reduce the risk of continued spread of the epidemic.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>J X</ForeName>
            <Initials>JX</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>G H</ForeName>
            <Initials>GH</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>J P</ForeName>
            <Initials>JP</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rong</LastName>
            <ForeName>Z H</ForeName>
            <Initials>ZH</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>L C</ForeName>
            <Initials>LC</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>W L</ForeName>
            <Initials>WL</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Z H</ForeName>
            <Initials>ZH</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>D X</ForeName>
            <Initials>DX</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>L H</ForeName>
            <Initials>LH</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wan</LastName>
            <ForeName>D H</ForeName>
            <Initials>DH</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>L L</ForeName>
            <Initials>LL</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>W J</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>chi</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2018B020207006, 2019B020208005, 2019B111103001</GrantID>
            <Agency>Science and Technology Program of Guangdong Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>201804010383</GrantID>
            <Agency>Guangzhou Science and technology Plan Project</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>A2018462</GrantID>
            <Agency>Guangdong medical research foundation</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>China</Country>
        <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
        <NlmUniqueID>7904962</NlmUniqueID>
        <ISSNLinking>0253-9624</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText><b>目的：</b>评估湖北新型冠状病毒肺炎的疫情输出风险及其他各省从湖北输入疫情的风险。 <b>方法：</b>获取截至2020年2月14日我国各省报告病例数（不含临床诊断病例；不含中国香港、澳门和台湾数据）和百度迁徙指数，对各省累计报告病例数和湖北迁出指数进行相关分析，评估湖北疫情输出风险和其他省疫情输入风险。 <b>结果：</b>全国累计报告确诊病例49 970例，其中湖北37 884例。湖北平均每天迁出至其他省的指数为312.09，武汉和湖北其他市分别为117.95和194.16。各省累计报告病例数与湖北、武汉及湖北其他市迁出至各省的人口迁徙指数均成正相关，相关系数分别为0.84、 0.84和0.81；湖北、武汉及湖北其他市人口迁出分别可解释线性模型71.2%、70.1％和66.3％的变异。湖北高输出风险时间集中在1月27日前，其中1月23日前的疫情输出风险主要来源于武汉，之后主要来源于湖北其他市。疫情输入风险排前3位的是湖南、河南和广东，累计风险指数分别为58.61, 54.75和49.62。 <b>结论：</b>我国各省疫情主要由湖北输入引起，湖北限制人口流出、各省加强对湖北省迁入人员的检疫，可以较大程度降低各省（除湖北）疫情持续传播风险。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Novel coronavirus pneumonia</Keyword>
        <Keyword MajorTopicYN="N">Population migration</Keyword>
        <Keyword MajorTopicYN="N">Risk assessment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083409</ArticleId>
        <ArticleId IdType="doi">10.3760/cma.j.cn112150-20200219-00142</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083410</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1626</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva chirurgica</Title>
          <ISOAbbreviation>Minerva Chir</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Adjuvant radiotherapy in urothelial neuroendocrine carcinoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4733.20.08259-0</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rossi</LastName>
            <ForeName>Roberta E</ForeName>
            <Initials>RE</Initials>
            <AffiliationInfo>
              <Affiliation>Gastrointestinal and Hepato-Pancreatic Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale Tumori (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy - robertaelisa.rossi@gmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Università degli Studi di Milano, Milan, Italy - robertaelisa.rossi@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Monteleone</LastName>
            <ForeName>Michela</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Gastrointestinal and Hepato-Pancreatic Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale Tumori (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Altomare</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Gastrointestinal and Hepato-Pancreatic Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale Tumori (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cattaneo</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, Fondazione IRCCS (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Torchio</LastName>
            <ForeName>Martina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Coppa</LastName>
            <ForeName>Jorgelina</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Gastrointestinal and Hepato-Pancreatic Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale Tumori (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazzaferro</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Gastrointestinal and Hepato-Pancreatic Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale Tumori (INT, National Cancer Institute), Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Università degli Studi di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Chir</MedlineTA>
        <NlmUniqueID>0400726</NlmUniqueID>
        <ISSNLinking>0026-4733</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083410</ArticleId>
        <ArticleId IdType="pii">S0026-4733.20.08259-0</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4733.20.08259-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083411</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1626</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva chirurgica</Title>
          <ISOAbbreviation>Minerva Chir</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Transanal endoscopic operation (TEO) for rectal lesion: a rapid initial experience.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4733.20.08260-7</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In recent decades, transanal surgery for rectal lesions has become a valid alternative treatment for the treatment of small lesions of the rectum. Significant benefits in terms of morbidity and mortality are confirmes. There are multiple platforms for transanal surgery but the TEO system® is one of the best known.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Between November 2017 and July 2019, 25 patients with rectal lesions suitable to transanal treatment came to our observation. In all reported cases, full-thickness rectum resections were performed.Demographic,histopathological, surgical morbidity/mortality and clinical outcome in all patients who underwent TEO were retrospectively evaluated from a prospectively collected database.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">For a period of less than 2 years, 25 rectal lesions were excised by TEO. 16 lesions (64%) were low (&lt; 4 cm), 7 (28%)were mid-rectal (4-8 cm) and 2 (8%) were in the proximal rectum (&gt; 8 cm). Postoperative complications included: 3 (12%) bleedings, and 8 (32%) post-polipectomy syndrome.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our initial experience suggests TEO is safe and feasible. Full-thickness resection guarantees adequate deep margins. Moreover, the limited number of cases requires the development of adequate reference centers.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Coratti</LastName>
            <ForeName>Francesco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Careggi University Hospital, Digestive Surgery, Florence, Italy - corattif@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bisogni</LastName>
            <ForeName>Damiano</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Careggi University Hospital, Digestive Surgery, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montanelli</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Careggi University Hospital, Digestive Surgery, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cianchi</LastName>
            <ForeName>Fabio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Careggi University Hospital, Digestive Surgery, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Chir</MedlineTA>
        <NlmUniqueID>0400726</NlmUniqueID>
        <ISSNLinking>0026-4733</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083411</ArticleId>
        <ArticleId IdType="pii">S0026-4733.20.08260-7</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4733.20.08260-7</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083412</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1626</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva chirurgica</Title>
          <ISOAbbreviation>Minerva Chir</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Enhanced Recovery after Surgery (ERAS) is safe, feasible and effective in elderly patients undergoing laparoscopic colorectal surgery: results of a prospective single center study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4733.20.08275-9</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It remains largely unknown if ERAS program is safe, feasible and effective in elderly patients undergoing laparoscopic colorectal surgery. In addition, the definition of the "old patient"in terms of age varies across the studies and different age cut-off, such as 65, 70, and 75 years have been used worldwide.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">All adult patients undergoing primary, elective colorectal laparoscopic surgery between January 2017 and December 2018 were considered eligible to follow the ERAS protocol according to the Enhanced Recovery After Surgery (ERAS) Society guidelines. Elderly were defined according three different cut-off: &lt;65 and ≥65 years, &lt;70 and ≥70 years, &lt;75 and ≥75 years.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and eight patients were included in the study. Adherence to protocol did not differ significantly between younger and older patients, for most of the items. 30- day mortality was absent. The frequency of postoperative complications globally considered and the frequency of the various single complications did not differ significantly between younger and older patients, independently of the cutoff considered to define the older age. Similarly, the frequency of re-intervention and readmission was similar in younger and older patients. Time to flatus and time to stool were similar in young and older patients, independently of the age cut-off used. Time to oral liquid diet was similar in patients with age &lt;65 and ≥65 years while it was moderately longer in patients ≥70 years (1.5±1.1 days;) than in those &lt;70 years (1.1±0.4 days; P=0.030) as well as in patients ≥75 years with respect to the younger ones (1.2±0.5 vs 1.6±1.2 days; P=0.045). The time to oral solid feeding was similar in young and old patients, independently of the age cut-off used. Time to bladder catheter removal was significantly longer in older patients, independently of the age cut-off used, although the differences do not seem to be clinically relevant. The length of stay was significantly higher in older patients, when the cutoff of 70 years or 75 years was used, but did not differ significantly when the cut-off of 65 years was used.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present study shows that the ERAS protocol is safe, feasible, and effective in elderly patients as in the young ones, undergoing laparoscopic elective colorectal surgery. This suggests that the ERAS program can be applied usefully to elderly patients in the routine clinical practice.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Crucitti</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>General and Minimally Invasive Surgery Unit, Cristo Re Hospital, Rome, Italy - antonio.crucitti@unicatt.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazzari</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>General and Minimally Invasive Surgery Unit, Cristo Re Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Toniuolo</LastName>
            <ForeName>Pasquina M</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>General and Minimally Invasive Surgery Unit, Cristo Re Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dionisi</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Human Nutrition Research Unit, Department of Experimental Medicine, Sapienza University, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Diamanti</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Cristo Re Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Flumeri</LastName>
            <ForeName>Giada</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>General and Minimally Invasive Surgery Unit, Cristo Re Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Donini</LastName>
            <ForeName>Lorenzo M</ForeName>
            <Initials>LM</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Human Nutrition Research Unit, Department of Experimental Medicine, Sapienza University, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bossola</LastName>
            <ForeName>Maurizio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Clinical Surgery, Hemodialysis Unit, Fondazione Policlinico Universitario &amp;quot;Agostino Gemelli&amp;quot; IRCSS, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Chir</MedlineTA>
        <NlmUniqueID>0400726</NlmUniqueID>
        <ISSNLinking>0026-4733</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083412</ArticleId>
        <ArticleId IdType="pii">S0026-4733.20.08275-9</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4733.20.08275-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083413</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy and post cystectomy complications.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03616-4</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sarcopenia is suspected to influence the complication rates in patients undergoing radical cystectomy (RC). The aim of our study was to assess variations in sarcopenia in patients scheduled for neoadjuvant cisplatin-based chemotherapy (NAC) and RC for muscle invasive bladder cancer (MIBC) and to explore the impact of sarcopenia on complications linked to NAC or surgery.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Between 2012 and 2017, 82 consecutive patients who underwent NAC and RC for cT2-T4 N0 MIBC were retrospectively selected. Using CT scan before and after NAC, Lumbar Skeletal Muscle Index (SMI) was assessed by two observers. We defined severe sarcopenia as SMI &lt;50 cm2/m2 for men and SMI &lt;35 cm2/m2 for women. We evaluated pre- and post-NAC cisplatin-based chemotherapy renal function and post-operative complication rates after cystectomy using the Clavien-Dindo classification. We explored risk factors of complications by logistic regression models.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">According to the SMI, 47 patients (57.3%) were classified as sarcopenic and 35 patients (42.7%) non-sarcopenic. Patients' characteristics between sarcopenic and non- sarcopenic patients were not significantly different except for BMI (p&lt;0.001). Among patients non-sarcopenic before NAC, 9 (25.7%) became sarcopenic after NAC. In multivariate analysis, sarcopenia was an independent significant predictor of renal impairment after NAC (p=0.02). Moreover, sarcopenia and ASA score were independent significant predictors of postoperative early complications (p=0.01 and p=0.03 respectively).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We observed significant changes in sarcopenic status during NAC. Sarcopenia, estimated by the lumbar SMI measurement, was an independent predictor associated with the risk of renal impairment during NAC and early postoperative complications after RC.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Regnier</LastName>
            <ForeName>Pierre</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, CHU de Nice, University of Nice Sophia Antipolis, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Luca</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brunelle</LastName>
            <ForeName>Serge</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sfumato</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistic, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walz</LastName>
            <ForeName>Jochen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rybikowski</LastName>
            <ForeName>Stanislas</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maubon</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Branger</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fakhfakh</LastName>
            <ForeName>Sami</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Durand</LastName>
            <ForeName>Matthieu</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, CHU de Nice, University of Nice Sophia Antipolis, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gravis</LastName>
            <ForeName>Gwenaelle</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pignot</LastName>
            <ForeName>Geraldine</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France - pignotg@ipc.unicancer.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083413</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03616-4</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03616-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083414</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Percutaneous cryoablation vs SoC in small kidney cancers: the Italian experience.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03625-5</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The objective of the present work was to analyse the economic impact of PCA (per- cutaneous cryoablation) vs OPN (open partial nephrectomy), as it represents the most common standard of care for SRMs (Small Renal Masses), namely T1a renal cancers (&lt;4 cm), in Italy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A cost analysis was performed to compare the difference of the total perioperative costs between PCA and OPN, both from the perspective of the National Healthcare System and the hospital. Clinical and resources consumption inputs were retrieved by a non-systematic literature search on scientific databases, complemented by a grey literature research, and validated by expert opinion. Costs calculation for the NHS perspective were based on reference tariffs published by the National Ministry of Health, while for the hospital perspective, unit costs published in the grey literature were used to compare the two alternatives.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Assuming the NHS perspective, the cost analysis shows there is an economic advantage in using PCA vs OPN (€4,080 vs €7,541) for the treatment of SRMs. Hospitalization time is the driver of the total costs, while the costs of complications are quite negligible in both groups. From the hospital perspective the costs of PCA is slightly higher (+€737) than OPN, with cryoprobes contributing as the greatest cost component. However, this increase is quite restrained and is offset by an inferior use of healthcare resources (surgery room, healthcare personnel, length of stay in the hospital).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">According to our analysis, PCA results in an advantageous technique compared to OPN respectively in terms of costs and resource consumption from both the NHS and the hospital perspective.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Celia</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>S.C. di Urologia, Ospedale San Bassiano, Bassano del Grappa, Vicenza, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pusceddu</LastName>
            <ForeName>Claudio</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncological and Interventional Radiology, Oncological Hospital A. Businco, AO Brotzu, Cagliari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silvestri</LastName>
            <ForeName>Tommaso</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>S.C. di Urologia, Ospedale San Bassiano, Bassano del Grappa, Vicenza, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gidaro</LastName>
            <ForeName>Giovanni B</ForeName>
            <Initials>GB</Initials>
            <AffiliationInfo>
              <Affiliation>HTA Consultant at BTG, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iannello</LastName>
            <ForeName>Fabrizio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>MA Provider, Milan, Italy - iannello@maprovider.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lanati</LastName>
            <ForeName>Elena P</ForeName>
            <Initials>EP</Initials>
            <AffiliationInfo>
              <Affiliation>MA Provider, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D'ausilio</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>MA Provider, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083414</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03625-5</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03625-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083415</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>All you must know about "Aquablation" procedure for treatment of benign prostatic obstruction: a systematic review of comparative outcomes and critical review of current literature.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03654-1</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In recent years, technological advances and new approaches have been developed for the treatment of Benign prostatic obstruction (BPO) in order to reduce complications like bleeding, retrograde ejaculation and risk of infection while obtaining an adequate disobstruction. The most recent surgical approach introduced is the Aquablation system (PROCEPT BioRobotics, Redwood Shores, CA, USA). This intervention is a robotically guided system that uses high-velocity water jets in order to ablate prostatic tissue, with real-time ultrasound guidance. The aim of this review is to summarize the current evidence on Aquablation and its results, compared to the reported outcomes of the gold standard treatment, the transurethral resection of the prostate (TURP).</AbstractText>
          <AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">A systematic review of the Literature was performed in June 2019 using Medline (via PubMed), Embase (via Ovid), and Cochrane databases. The studies that compared the Aquablation to the standard TURP were included. Moreover, a critical review of the single arm studies was conducted.</AbstractText>
          <AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">The results of this systematic review, based on a single RCT that compared Aquablation vs. TURP in prostates 30-80 cc in size, confirmed that Aquablation has at least a similar efficacy as TURP, but has a better safety profile, allows shorter resection times, and has a lower risk of retrograde ejaculation. Moreover, in some subcategories of patients (e.g., when prostate volume is &gt;50 cc) functional outcomes of Aquablation are better than those of TURP. Evidence from non-comparative clinical studies and from real life scenarios have confirmed that Aquablation may be used effectively for prostate volumes up to 150 cc.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The Aquablation procedure for the treatment of BPO allows high clinical efficacy with an excellent safety profile. For prostate volume 30-80 cc, comparative studies demonstrated that this procedure offers clinical results at least comparable to those of conventional TURP. Latest evidence showed that Aquablation may be used effectively for prostate volumes up to 150 cc. The major strengths are its high-speed resection time, low complication rate, and potential for sexual function preservation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fiori</LastName>
            <ForeName>Cristian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy - Cristian.fiori@unito.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Checcucci</LastName>
            <ForeName>Enrico</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gilling</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Tauranga Urology Research, Tauranga, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amparore</LastName>
            <ForeName>Daniele</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Volpi</LastName>
            <ForeName>Gabriele</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Cillis</LastName>
            <ForeName>Sabrina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aimar</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sica</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cattaneo</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alleva</LastName>
            <ForeName>Giorgio</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manfredi</LastName>
            <ForeName>Matteo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porpiglia</LastName>
            <ForeName>Francesco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>ESUT Lower Tract Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083415</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03654-1</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03654-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083416</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03662-0</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To examine the predictive value of neutrophil-to-lymphocyte ratio in localized prostate cancer for surgical pathology and recurrence in patients treated by radical prostatectomy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated 1 258 patients treated by radical prostatectomy at San Raffaele Hospital between 2011 and 2017 and assessed the association between preoperative neutrophil-to-lymphocyte ratio and surgical pathology (advanced stage, grade group ≥4, nodal involvement, grade discordance between biopsy and surgical pathology) and biochemical recurrence.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The preoperative neutrophil-to-lymphocyte ratio was not significantly associated with advanced stage (≥T3), International Society of Urological Pathology (ISUP) grade (≥4) or discordance. At multivariable analysis, patients with higher neutrophil-to-lymphocyte ratio had lower risk of nodal involvement at final pathology (odds ratio [OR]: 0.77; 95% confidence interval [CI]: 0.64, 0.92; P=0.005). The preoperative level of neutrophil-to-lymphocyte ratio was associated with biochemical recurrence on univariate analysis (OR: 0.81, 95% CI: 0.68, 0.96; P=0.017). Such a relationship was not significant at multivariable analysis adjusting for tumor severity (OR: 0.93, 95% CI: 0.79, 1.09; P=0.4).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Neutrophil-to-lymphocyte ratio does not have clinical utility for the prediction of adverse pathology and biochemical recurrence. Further research should focus on its value for predicting regional lymph node metastasis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bravi</LastName>
            <ForeName>Carlo A</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy - bravi.carloandrea@hsr.it.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA - bravi.carloandrea@hsr.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosiello</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fallara</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vertosick</LastName>
            <ForeName>Emily</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tin</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sjoberg</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bianchi</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazzone</LastName>
            <ForeName>Elio</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martini</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dell'oglio</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stabile</LastName>
            <ForeName>Armando</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gandaglia</LastName>
            <ForeName>Giorgio</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fossati</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Briganti</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montorsi</LastName>
            <ForeName>Francesco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vickers</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083416</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03662-0</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03662-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083417</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A systematic review on imaging-guided metastasis directed therapy for oligorecurrent prostate cancer: revolution or devolution?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03675-9</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Metastasis directed therapy (MDT) is increasingly being implemented in recurring prostate cancer (PCa), although its role in PCa management has yet been fully defined. Aim of the current systematic review is to analyze current knowledge of MDT in the setting of recurrent PCa and highlight future trials which will continue to shed a light on a controversial aspect of current PCa management.</AbstractText>
          <AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">The National Library of Medicine Database was searched for relevant articles published between January 2014 and August 2019. A wide search was performed including the combination of following words: ((metastasis AND directed AND therapy) AND prostate AND cancer). The selection procedure followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) principles.</AbstractText>
          <AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Biologic studies support the use of MDT in oligometastatic PCa. Modern imaging techniques as PSMA PET/CT, Fuciclovine PET/CT and whole body MRI are fundamental to implement such an approach given the high diagnostic yield at low PSA values. The majority of data available on MDT concerns retrospective trials, although three prospective randomized trials (STOMP, ORIOLE and POPSTAR) have assessed the safety and feasibility of MDT. Overall, it appears that MDT delays significantly PCa progression and time to systemic therapy.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MDT is highly appealing given its potential to delay disease progression and adverse events of systemic therapy. Nonetheless, data remains immature to recommend MDT on a large scale and the selection criteria for patients have yet been defined. Today, MDT should be administered within a clinical trial and results of future research are eagerly awaited.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Albisinni</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium - simone.albisinni@erasme.ulb.ac.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Damme</LastName>
            <ForeName>Julien</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aoun</LastName>
            <ForeName>Fouad</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Urology Department, Hôtel Dieu de France, Université Saint Joseph, Beyrouth, Liban.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bou Kheir</LastName>
            <ForeName>George</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roumeguère</LastName>
            <ForeName>Thierry</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Nunzio</LastName>
            <ForeName>Cosimo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, Sant'Andrea Hospital, Università degli Studi di Roma La Sapienza, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083417</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03675-9</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03675-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083418</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03680-2</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Our aim is to compare feasibility and safety of open radical cystectomy (ORC), laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy (RARC) for the treatment of bladder cancer through network meta-analysis.</AbstractText>
          <AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">Eligible articles were identified from electronic databases including PubMed/Medline, Embase, the Cochrane Library and Web of Science up to August 2019 with no language limitations. Studies selection, quality assessment, data extraction and analysis were accomplished by two independent reviewers (DCF and AL) using Cochrane Collaboration's tools.</AbstractText>
          <AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">After screening 2528 articles, 27 studies were included in the final meta-analysis. In the network meta-analysis, both RARC (MD:83.09, 95%CI: 61.06 to 105.11) and LRC (MD: 49.68, 95%CI: 21.75 to 77.62) showed a longer operative time compared with ORC. Besides, RARC had a longer operative time than LRC (MD: 33.40, 95%CI: 1.35 to 65.45). RARC (MD:-591.86, 95%CI: -879.46 to - 304.27) and LRC (MD: -435.28, 95%CI: -854.98 to -15.58) showed a less estimated blood loss (EBL) than ORC; however, the difference in EBL for RARC versus LRC was not significant. RARC (OR: 0.26, 95%CI: 0.14 to 0.50) and LRC (OR: 0.23, 95%CI: 0.13 to 0.43) had a higher blood transfusion rate than ORC; however, the OR between RARC and LRC was not significant. RARC (MD: -1.34, 95%CI: -2.55 to -0.12) and LRC (MD: -1.35, 95%CI: -2.38 to -0.32) took a shorter time to regular diet compared with ORC; however, there was no significant difference between RARC and LRC. Compared with ORC, RARC (MD: -2.37, 95%CI: -3.57 to -1.17) and LRC (MD: -2.22, 95%CI: -4.04 to -0.40) showed a shorter length of stay (LOS); however, the difference in LOS for RARC versus LRC was not significant. RARC, LRC and ORC were comparable with regard to minor complications, major complications, positive surgical margin and lymph node yields.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Current evidence indicates that minimally invasive approaches could be considered as a feasible and safe alternative to ORC when performed by experienced surgeons in selected patients. Notably, RARC may be more suitable for RC with extracorporeal urinary diversion. Larger well-designed trials are still needed to confirm these findings due to the observational nature of most studies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Dechao</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ao</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Xiao</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Tianhai</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Yin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Ping</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China - hanpingwch@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083418</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03680-2</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03680-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083419</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Adverse events related to Radium 223 treatment: "real life" data from Eudra-Vigilance database.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03690-5</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Aim of our study was to analyze adverse events (AEs) associated with Radium 223 using real life data from Eudra-Vigilance (EV) database.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">EV database is the system for managing and analyzing information on suspected adverse reactions to medicines which have been authorized or being studied in clinical trials in the European Economic Area (EEA). We recorded number of AEs for Radium 223 per category and severity from 2013 to May 2019. We recorded AEs per age group (&lt;65 years old; between 65 and 85 years; &gt;85 years old) Pooled Relative Risk (PRR) were used to compare groups. The number of individual cases identified in EV database was 4339.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">According to the registry study the most frequent AEs in patients treated with Radium 223 were hematological, general and gastrointestinal disorders and they were confirmed as the most frequent AEs in the EV database. In the EV database over 90% of the reported AEs were defined as serious and 8% were fatal. Older patients (&gt;85 years) treated with Radium 223 were at increased risk of cardiac, infectious, and metabolism disorders when compared to younger patients (&lt;65). However, we have no information on the number of patients under treatment in the EV database.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">EV database highlights several AEs which are not reported in registry studies as well as different AEs profiles according to age. Clinicians should consider these data when treating patients with Radium 223.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tema</LastName>
            <ForeName>Giorgia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lombardo</LastName>
            <ForeName>Riccardo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Voglino</LastName>
            <ForeName>Olivia</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sica</LastName>
            <ForeName>Angela</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baldassarri</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nacchia</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iacovelli</LastName>
            <ForeName>Roberto</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Oncologia Medica, Fondazione Policlinico Universitario &amp;quot;A. Gemelli&amp;quot; IRCCS, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tubaro</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Nunzio</LastName>
            <ForeName>Cosimo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Rome, Italy - cosimodenunzio@virgilio.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083419</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03690-5</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03690-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083420</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hyperbaric Oxygen Therapy reduces mortality in patients with Fournier's gangrene. Results from a multi-institutional observational study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03696-6</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evidence about the clinical benefits of Hyperbaric Oxygen Therapy (HBOT) in patients with Fournier's Gangrene (FG) is controversial and inconclusive. We aimed to compare the mortality related to FG between patients undergoing surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective multi-institutional observational case-control study. All patients admitted with diagnosis of FG from June 2009 to June 2019 were included into the study. Patients received surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT. Factors associated with FG related mortality were assessed with uni- and multivariate analyses. The main outcome measure was FG related mortality.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 161 patients with diagnosis of FG were identified. Mean FG Severity Index was 8.6 ± 4.5. All patients had broad-spectrum parenteral antibiotic therapy. An aggressive debridement was performed in 139 (86.3%) patients. A total of 72 patients (44.7%) underwent HBOT. Mortality due to FG was observed in 32 (36.0%) of patients who do not underwent HBOT and in 14 (19.4%) of patients who underwent HBOT (p=0.01). At the multivariate analysis, surgical debridement and HBOT were independent predictors of lower mortality while higher FG Severity Index was independent predictor of higher mortality.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HBOT and surgical debridement are independent predictors of reduced FG related mortality.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Creta</LastName>
            <ForeName>Massimiliano</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Longo</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arcaniolo</LastName>
            <ForeName>Davide</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Unit, Luigi Vanvitelli University, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giannella</LastName>
            <ForeName>Riccardo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, A. Cardarelli Hospital, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cai</LastName>
            <ForeName>Tommaso</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Santa Chiara Regional Hospital, Trento, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cicalese</LastName>
            <ForeName>Annarita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, A.O.R.N.&amp;quot;S.G. Moscati&amp;quot;, Avellino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Nunzio</LastName>
            <ForeName>Cosimo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Ospedale Sant'Andrea, Sapienza University of Rome, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grimaldi</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Uro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS, Fondazione &amp;quot;G. Pascale&amp;quot;, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cicalese</LastName>
            <ForeName>Virgilio</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, A.O.R.N.&amp;quot;S.G. Moscati&amp;quot;, Avellino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Sio</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Unit, Luigi Vanvitelli University, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Autorino</LastName>
            <ForeName>Riccardo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Unit, Luigi Vanvitelli University, Naples, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Urology, Department of Surgery, VCU Health, Richmond, VA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Urology, McGuire VA Medical Center, Richmond, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lima</LastName>
            <ForeName>Estevao</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Department, Braga Hospital, Braga, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fedelini</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, A. Cardarelli Hospital, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marmo</LastName>
            <ForeName>Mariano</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Intensive Care and HBOT Unit, Department of Anesthesia, A. Cardarelli Hospital, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Capece</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>La Rocca</LastName>
            <ForeName>Roberto</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tubaro</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imbimbo</LastName>
            <ForeName>Ciro</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirone</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fusco</LastName>
            <ForeName>Ferdinando</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy - ferdinando-fusco@libero.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083420</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03696-6</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03696-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083421</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The effect of additional drug therapy as metaphylaxis in patients with cystinuria: a systematic review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03704-2</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">To systematically review the effect of additional drug therapy as metaphylaxis in patients with cystinuria.</AbstractText>
          <AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">A literature search of three databases (MEDLINE, Embase and the Cochrane Library) was performed according to the PRISMA-guidelines enclosing articles published up to May 2019. A total of 1117 articles were screened. Thirty-four publications met the inclusion criteria for this review.</AbstractText>
          <AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Male-female ratio in the studied cohorts was 49,9% - 50.1%. The majority of studies showed a positive effect in reducing stone events and/or urinary cystine excretion. D-Penicillamine showed success in 13/14 (92%) studies, whereas Tiopronin-treatment showed a reduction in all (8/8; 100%) studies. All studies on Captopril (4/4) showed a decrease, however not all significant. The same is true for studies on Thiols in combination with Captopril (2/2). Furthermore, Tiopronin showed less side effects compared to D-penicillamine, respectively 30% and 37%. Captopril showed the least adverse events, with one event in nine patients.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The evidence on benefit of additional drug therapy in patients with cystinuria is scarce. All studied medications showed an effect on stone event and urinary cystine excretion, when used in addition to hyperhydration, alkalization and a diet low on methionine. Based on this systematic review, no drug can be preferred over another. An important aspect in the choice of drug is the risk of side effects. Therefore, the choice￼ of additional drug should be personalized for every patient where the risk of side effects should be taken into consideration.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Melessen</LastName>
            <ForeName>Indra M</ForeName>
            <Initials>IM</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine (AMC), University of Amsterdam, Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Henderickx</LastName>
            <ForeName>Michaël M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Amsterdam UMC, Amsterdam, the Netherlands - m.m.henderickx@amsterdamumc.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Merkx</LastName>
            <ForeName>Maria M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Amsterdam UMC, Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Etten-Jamaludin</LastName>
            <ForeName>Faridi S</ForeName>
            <Initials>FS</Initials>
            <AffiliationInfo>
              <Affiliation>Research Support, Medical Library, Amsterdam UMC, Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Homan van der Heide</LastName>
            <ForeName>Jaap J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Amsterdam UMC, Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamphuis</LastName>
            <ForeName>Guido M</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Amsterdam UMC, Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083421</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03704-2</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03704-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083422</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Conservative treatment of upper urinary tract carcinoma in patients with imperative indications.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03710-8</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To report our experience for endoscopic treatment of upper urinary tract carcinoma (UTUC) in patients with imperative indications for management.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective data were collected for all patients who underwent endoscopic management of UTUC for imperative situations, from September 2013 to January 2019. Comorbidity was determined by using the age-adjusted Charlson comorbidity index (CCI). The primary endpoint of the study was overall survival (OS). Secondary outcomes were recurrence- free survival (RFS) rates, complication rates and global renal function.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 29 patients were enrolled in the study. The median age was 69.0 (IQR 63.0- 79.0) years and the median CCI was 6 (IQR 4-8). Overall, 137 endoscopic procedures were performed; 117 (85.4%) had no complication. Clavien-Dindo grade III and IV complications were 3 (2.2%) and 1 (0.7%) respectively. The median follow-up of 23 months (IQR 14-35). During the follow-up, 2 (6.9%) patients died for cause not related to cancer. Recurrence of UTUC occurred in 18 patients (61.1%). The 24-month OS was 96.4 ± 3.5% and the 24-month RFS was 31.7 ± 9.4%. Lower RFS rates were found in high grade tumor patients (22.2 ± 13.9%) compared to low grade tumor patients (35.6 ± 12.3%) (p=0.237). There was statistical difference in creatinine and eGFR values when comparing baseline to last follow-up (p=0.018 and p=0.005, respectively).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Endoscopic management of UTUC in patients with imperative indications appears to be a reasonable alternative to nephroureterectomy. However, stringent endoscopic follow- up is necessary due to the high risk of disease recurrence.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Proietti</LastName>
            <ForeName>Silvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, IRCCS San Raffaele Hospital, Ville Turro, Milan, Italy - proiettisil@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marchioni</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Unit, Department of Medical, Oral and Biotechnological Sciences, &amp;quot;G. D'Annunzio&amp;quot; University of Chieti, Chieti, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eisner</LastName>
            <ForeName>Brian H</ForeName>
            <Initials>BH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lucianò</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Pathology Unit, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saitta</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, IRCCS San Raffaele Hospital, Ville Turro, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez-Socarrás</LastName>
            <ForeName>Moises E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, IRCCS San Raffaele Hospital, Ville Turro, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D'orta</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Unit, Department of Medical, Oral and Biotechnological Sciences, &amp;quot;G. D'Annunzio&amp;quot; University of Chieti, Chieti, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bellinzoni</LastName>
            <ForeName>Piera</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, IRCCS San Raffaele Hospital, Ville Turro, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schips</LastName>
            <ForeName>Luigi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Urology Unit, Department of Medical, Oral and Biotechnological Sciences, &amp;quot;G. D'Annunzio&amp;quot; University of Chieti, Chieti, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gaboardi</LastName>
            <ForeName>Franco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, IRCCS San Raffaele Hospital, Ville Turro, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giusti</LastName>
            <ForeName>Guido</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, IRCCS San Raffaele Hospital, Ville Turro, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083422</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03710-8</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03710-8</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083423</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1758</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva urologica e nefrologica = The Italian journal of urology and nephrology</Title>
          <ISOAbbreviation>Minerva Urol Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Retrograde Intra Renal Surgery (RIRS) versus Percutaneous Nephrolithotomy (PCNL) for renal stones &gt;2cm. A systematic review and meta-analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0393-2249.20.03721-2</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The recent advances in technology and miniaturization of endoscopic devices have permitted the use of RIRS to treat large and complicated kidney stones as first line therapy in alternative to PCNL.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Systematically review the efficacy and safety of RIRS for large renal stones over 2 cm versus the current gold standard, the percutaneous nephrolithotomy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A large search was effected in PubMed, Cochrane Library, Embase, Ovid and Scopus regarding the treatment of renal stones over 2cm with RIRS versus PCNL. Articles not in English and not regarding adult population were excluded. The retrieval time included a time span from 2000 to 2019. All clinical trials were further evaluated about quality and references. The eligible studies were included and analyzed with RevMan 5.2 Software.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Two randomized and nine non-randomized studies were included for a total of 1618 patients involved. Our meta-analysis showed no difference in SFR (RR = 0.92, 95% CI 0.86- 0.99, p = 0.03) and in mean operation time (WMD = 6.34 min, 95% CI -4.98 - 17.65, p = 0.27) while shorter hospital stay was reported for RIRS (WMD = -2.15 days,95% CI -3.04 - -1.25, = &lt;0.00001). We reported moreover lower Hb drop (WMD = -0.83 g/dl, 95% CI -1.20 - -0.45, p= &lt;0.00001) and complications rate in favours of RIRS (RR = 0.88, 95% CI 0.71 - 1.09, p=0.23).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RIRS is challenging PCNL for the treatment of large renal stones over 2cm, becoming a safe and effective alternative with a comparable stone free rate, lower complication rate and lower hospitalization time. It is, however, of the uttermost importance to share the treatment decision with the patient due to the possibility of requiring multiple RIRS session to completely clear larger stone burdens.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Barone</LastName>
            <ForeName>Biagio</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy - biagio.barone@unina.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crocetto</LastName>
            <ForeName>Felice</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vitale</LastName>
            <ForeName>Raffaele</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Domenico</LastName>
            <ForeName>Dante</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caputo</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Romano</LastName>
            <ForeName>Francesco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Luca</LastName>
            <ForeName>Luigi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bada</LastName>
            <ForeName>Maida</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, San Bassiano Hospital, Bassano del Grappa, Vicenza, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imbimbo</LastName>
            <ForeName>Ciro</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prezioso</LastName>
            <ForeName>Domenico</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Urol Nefrol</MedlineTA>
        <NlmUniqueID>8503649</NlmUniqueID>
        <ISSNLinking>0393-2249</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083423</ArticleId>
        <ArticleId IdType="pii">S0393-2249.20.03721-2</ArticleId>
        <ArticleId IdType="doi">10.23736/S0393-2249.20.03721-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083424</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva cardioangiologica</Title>
          <ISOAbbreviation>Minerva Cardioangiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Long-term ischemic mitral regurgitation. Which parameters predict decrease or increase in the degree after 5-years?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4725.20.05021-5</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ischemic mitral regurgitation (IMR) is a frequent valvular heart disease and is related to worse prognosis. The aim of this study was to investigate the dynamics in the degree of IMR from the acute phase of inferoposterior myocardial infarction (MI) to 5-years follow-up and to identify the predictors of change in the degree of mitral regurgitation (MR).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We included patients with first ever acute inferoposterior MI and examined them in two phases: at the time of acute MI then 5-years later. Based on two-dimensional transthoracic echocardiography, the patients were divided into the non-significant MR (NMR) group and IMR group. The parameters of left ventricle (LV), mitral apparatus and clinical data were assessed in both phases. The predictors of a decrease or an increase in the degree of mitral regurgitation after 5-years were identified.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The values of the parameters of mitral apparatus and LV chambers increased with higher degrees of IMR. The tenting height, systolic blood pressure and posteromedial papillary muscle (PMPM) displacement during the acute phase were the most important in predicting the change in the degree of MR after 5-years.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The assessment of mitral apparatus in acute phase of MI can be most useful to determine the change of the degree of MR long-term post MI. Although LV remodelling itself contributes to IMR, this influence is directly dependent on alterations in mitral geometry.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mėlinytė</LastName>
            <ForeName>Karolina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Lithuanian University of Health Sciences, Eiveniu 2, Kaunas, Lithuania - karolina.mlinyt652@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mizarienė</LastName>
            <ForeName>Vaida</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Lithuanian University of Health Sciences, Eiveniu 2, Kaunas, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jurkevičius</LastName>
            <ForeName>Renaldas</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Lithuanian University of Health Sciences, Eiveniu 2, Kaunas, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Cardioangiol</MedlineTA>
        <NlmUniqueID>0400725</NlmUniqueID>
        <ISSNLinking>0026-4725</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083424</ArticleId>
        <ArticleId IdType="pii">S0026-4725.20.05021-5</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4725.20.05021-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083425</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva cardioangiologica</Title>
          <ISOAbbreviation>Minerva Cardioangiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Interventional procedures versus medical therapy alone: outcome of cardiac patient management. A systematic review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4725.20.05069-0</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac patients are managed medically or with an intervention. This review aims to explore the survival benefit of each approach in the management of cardiac patients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed updated evidence of survival benefit from the most recent trials and guidelines.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with ST-segment-elevation myocardial infarction (STEMI) have a mortality benefit when a Primary Cardiac Intervention is implemented. No similar benefit has been shown in chronic stable coronary artery disease. Heart failure patients show a mortality benefit using medication and similarly, mild or moderate valve disease patients do not require an intervention. In atrial fibrillation, the CABANA trial using ablation therapy, had no mortality benefit. Hypertension drug therapy showed a significant mortality benefit, a similar benefit was noted with drug therapy for the treatment of dyslipidemia, when achieving the target lipid goal.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Not all interventional procedures result in a mortality benefit. Medical therapy alone increases survival in many cardiac diseases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abuosa</LastName>
            <ForeName>Ahmed</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Ministry of National Guard Health Affair, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elshiekh</LastName>
            <ForeName>Ayman</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Ministry of National Guard Health Affair, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kinsara</LastName>
            <ForeName>Abdulhalim J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Ministry of National Guard Health Affair, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia - kinsaraaj@ngha.med.sa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Cardioangiol</MedlineTA>
        <NlmUniqueID>0400725</NlmUniqueID>
        <ISSNLinking>0026-4725</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083425</ArticleId>
        <ArticleId IdType="pii">S0026-4725.20.05069-0</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4725.20.05069-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083426</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva cardioangiologica</Title>
          <ISOAbbreviation>Minerva Cardioangiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Coronary microvascular dysfunction: an overview.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4725.20.05070-7</ELocationID>
        <Abstract>
          <AbstractText>Patients with coronary microvascular dysfunction (CMVD) represent a widespread population and despite the good prognosis, many of them have a poor quality of life with strong limitations in their daily activities because of the angina symptoms. This work summarizes the most frequent clinical presentation pictures like stable and unstable microvascular angina. Main risk factors are discussed, followed by the last updates on the subject about different pathogenic hypotheses, diagnosis and treatment. Not very well understood microvascular alterations, like slow flow phenomenon and no reflow are discussed and both prognosis and the impact of the disease in the quality of life are analized.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sucato</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE) &amp;quot;G. D'Alessandro&amp;quot;, University Hospital Paolo Giaccone, University of Palermo, Palermo, Italy - odisseos86@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Novo</LastName>
            <ForeName>Giuseppina</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE) &amp;quot;G. D'Alessandro&amp;quot;, University Hospital Paolo Giaccone, University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saladino</LastName>
            <ForeName>Antonino</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE) &amp;quot;G. D'Alessandro&amp;quot;, University Hospital Paolo Giaccone, University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evola</LastName>
            <ForeName>Salvatore</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE) &amp;quot;G. D'Alessandro&amp;quot;, University Hospital Paolo Giaccone, University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galassi</LastName>
            <ForeName>Alfredo R</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE) &amp;quot;G. D'Alessandro&amp;quot;, University Hospital Paolo Giaccone, University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Cardioangiol</MedlineTA>
        <NlmUniqueID>0400725</NlmUniqueID>
        <ISSNLinking>0026-4725</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083426</ArticleId>
        <ArticleId IdType="pii">S0026-4725.20.05070-7</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4725.20.05070-7</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083427</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva cardioangiologica</Title>
          <ISOAbbreviation>Minerva Cardioangiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of a restricted water intake on various clinical and laboratory outcomes in patients with heart failure: a meta-analysis of randomized controlled trials.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4725.20.05072-0</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The guidelines of the Scientific Societies of Cardiology suggest limiting water intake in the diet as one of the non-pharmacological measures for the management of chronic heart failure. However, many patients with heart failure may suffer from severe thirst, even irrespective of a possible restricted fluid intake, and this has received relatively little attention in clinical studies. Moreover, definitive and irrefutable evidence that documents the efficacy of the limitation in water consumption on major cardiovascular outcomes is lacking. Therefore, we decided to perform a meta-analysis of studies that evaluated the efficacy and safety of the strategy of restricting water intake in the diet of patients with chronic heart failure.</AbstractText>
          <AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">The studies included in the meta-analysis had to have the characteristics of randomized controlled trials that compared patients with heart failure undergoing limitation in water consumption with patients who had free access to water intake. Primary outcomes of interest were heart failure hospitalizations and all-cause mortality. Secondary outcomes of interest were the sensation of thirst as measured by a visual analog scale, the duration of therapy with intravenous diuretics, and the serum levels of creatinine, sodium and B-type natriuretic peptide(BNP). The effect size was expressed as pooled odds ratio(OR) in the case of binary variables, and as weighted mean difference (WMD) in the case of continuous variables.</AbstractText>
          <AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Six studies were judged to comply with the inclusion criteria and incorporated into the meta-analysis. Significant heterogeneity was detected for the majority of investigated outcomes. Patients subjected to restricted fluid intake compared with patients admitted to free intake of beverages showed a similar rehospitalization rate (5 studies, pooled OR=1.52; 95%CI: 0.67 to 3.43; p = 0.32) and a similar mortality rate(5 studies, pooled OR= 1.55; 95% CI:0.87 to 2.75; p = 0.14). Likewise, there were no differences in regards to patients' sense of thirst (4 studies, WMD =-0.7; 95% CI: -2.58 to 1.17; p = 0.46),the duration of intravenous diuretictreatment(2 studies, WMD=0.17 days; 95% CI: -1.26 to 1.6 days; p =0.81), the serum creatinine levels(5 studies, WMD=0.05 mg/dl; 95% CI: -0.16 to 0.26 mg/dl; p=0.12), and serum sodium levels(5 studies, WMD= -0.86 mmol/L;95% CI:-2.92 to 1.2 mmol/L; p=0.41). By contrast, serum BNP levels were significantly higher in the group with free water intake(4 studies, WMD=223.76 pg/ml ; 95% CI: 158.8 to 288.72 pg/ml; p&lt;0.001).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with heart failure, liberal fluid consumption does not seem to exert an unfavorable impact on heart failure rehospitalizations or all-cause mortality. Considering the heterogeneity of the included studies and their quite exiguous sample sizes, larger randomized controlled trials would be warranted in the future in order to achieve definitive confirmation of the present findings. These findings substantially disavow any useful role of water intake restriction as a non-pharmacological measure to be adopted in heart failure management.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De Vecchis</LastName>
            <ForeName>Renato</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Medical and Polyspecialist Centre, DSB 29 &amp;quot;S. Gennaro dei Poveri Hospital&amp;quot;, Naples, Italy - devecchis.erre@virgilio.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paccone</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, University of Bari &amp;quot;Aldo Moro&amp;quot;, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Maio</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, University of Campania &amp;quot;Luigi Vanvitelli&amp;quot;, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Cardioangiol</MedlineTA>
        <NlmUniqueID>0400725</NlmUniqueID>
        <ISSNLinking>0026-4725</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083427</ArticleId>
        <ArticleId IdType="pii">S0026-4725.20.05072-0</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4725.20.05072-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083428</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva cardioangiologica</Title>
          <ISOAbbreviation>Minerva Cardioangiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Health-related quality of life and unscheduled re-hospitalizations after coronary revascularization: significant predictive role of the MacNew questionnaire.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4725.20.05074-4</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The MacNew questionnaire in its original version is a diagnostic tool which consists of a number of questions answered on a seven-point scale. Among the multiple possible choices, each marked by a box, the examined patient will have to tick only one. In fact, more than one answer for each proposed question is not allowed, for the formulation of the final score. Global and subscale( physical, social and emotional subscales) scores are computed by dividing the sum of the scores achieved for each individual item by the number of items listed in the questionnaire.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The study consisted of a retrospective analysis that involved patients followed up for 3 years after a procedure of revascularization (coronary angioplasty with stent or coronary artery bypass graft). According to customary practice conducted at the two institutes for cardiovascular rehabilitation involved in the study, all of the patients underwent an evaluation using the MacNew questionnaire, in the context of the practices of psychological and psychosomatic assessment that are routinely implemented in patients who are treated in order to recover from recent interventions of coronary percutaneous or surgical revascularization.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the total study population of 210 patients retrospectively enrolled, the mean MacNew health - related quality of life (HRQL) scores were 4.38 ± 1.56 on the global scale, 4.46 ± 1.1 on the physical, 4.54 ± 1.1 on the social and 4.384 ± 1.5 on the emotional subscale. After adjustment for several variables, namely age, gender, history of myocardial infarction, left ventricular ejection fraction and diabetes, using a multivariate Cox proportional hazards regression model, the protection exerted by a high MacNew score against the risk of hospitalizations resulted to be significant ( hazard ratio [ HR] 0.2856, 95% IC: 0,1670 to 0,4884; p &lt;0.0001).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with low scores on the MacNew questionnaire, the unplanned hospitalizations should be considered more likely and therefore the clinicians should activate all precautions to avoid them, such as critically reviewing and reconsidering the medication dosages or changing the type of molecules that had been originally prescribed. In these cases, a low MacNew global score would serve as a wake-up call that would be able to direct the doctor's attention on the possibility of concealed procedure-related complications or of greater disease severity or of non-procedural complications.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De Vecchis</LastName>
            <ForeName>Renato</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Medical and Polyspecialist Centre, DSB 29 &amp;quot;S. Gennaro dei Poveri Hospital&amp;quot;, Napoli, Italy - devecchis.erre@virgilio.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paccone</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, University of Bari &amp;quot;Aldo Moro&amp;quot;, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Maio</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, University of Campania &amp;quot;Luigi Vanvitelli&amp;quot;, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Cardioangiol</MedlineTA>
        <NlmUniqueID>0400725</NlmUniqueID>
        <ISSNLinking>0026-4725</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083428</ArticleId>
        <ArticleId IdType="pii">S0026-4725.20.05074-4</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4725.20.05074-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083429</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Minerva cardioangiologica</Title>
          <ISOAbbreviation>Minerva Cardioangiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Glifozines and cardio-renal outcomes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0026-4725.20.05078-1</ELocationID>
        <Abstract>
          <AbstractText>Diabetes mellitus, with its complications, is one of the major health problems in economically developed countries and its prevalence is constantly increasing. Kidneys and heart involvement represent main comorbidities in diabetic patients often leading to organ's failure. The treatments available until a few years ago are often associated with hypoglycemia, weight gain, gastro-intestinal disorders and other side effects together with serious averse effects on renal function. The new frontiers of diabetic cardionephropathy treatment are mainly focused on delay of heart and renal failure both on diabetic and non - diabetic patients ad it was shown by last data reports. In the following review, we'll focus on Gliflozins, one of the newest classes of hypoglycemic drugs that have shown to hold peculiar pharmacological properties in managing cardiac and renal complications.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Di Lullo</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology and Dialysis, L. Parodi, Delfino Hospital, Colleferro, Roma, Italy - dilulloluca69@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bellasi</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Research, Innovation, Brand Reputation, Bergamo Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guastamacchia</LastName>
            <ForeName>Edoardo</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Interdisciplinar Department of Medicine, University of Bari, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Triggiani</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Interdisciplinar Department of Medicine, University of Bari, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ronco</LastName>
            <ForeName>Claudio</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>International Renal Research Institute, S. Bortolo Hospital, Vicenza, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lavalle</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Disease, Policlinico Umberto I Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Iorio</LastName>
            <ForeName>Biagio R</ForeName>
            <Initials>BR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology and Dialysis, &amp;quot;Antonio Cardarelli&amp;quot; Hospital, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Russo</LastName>
            <ForeName>Domenico</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cianciolo</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Nephrology, Dialysis and Transplantation, Department of Experimental Diagnostic and Specialty Medicine, S.Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>La Manna</LastName>
            <ForeName>Gaetano</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Nephrology, Dialysis and Transplantation, Department of Experimental Diagnostic and Specialty Medicine, S.Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Settembrini</LastName>
            <ForeName>Silvio</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Diabetology and Metabolic Disease, Pellegrini Hospital, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Minerva Cardioangiol</MedlineTA>
        <NlmUniqueID>0400725</NlmUniqueID>
        <ISSNLinking>0026-4725</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083429</ArticleId>
        <ArticleId IdType="pii">S0026-4725.20.05078-1</ArticleId>
        <ArticleId IdType="doi">10.23736/S0026-4725.20.05078-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083430</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1827-1839</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>International angiology : a journal of the International Union of Angiology</Title>
          <ISOAbbreviation>Int Angiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Influence of reimbursement policies on phlebological surgical practice in Belgium between 2007 and 2017.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.23736/S0392-9590.20.04305-9</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To date, it is unclear how treatment of patients with chronic venous disease (CVD) is influenced by national reimbursement systems. In Belgium, catheters or fibers used for endovenous thermal ablation (EVTA) are reimbursed only once in a lifetime. The potential impact of the Belgian public health insurance reimbursement policy on surgical practice in phlebology needs to be investigated.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Billing data available from the Belgian National Institute for Health and Disability Insurance (NIHDI) were used for analysing the distribution of specific surgical procedures for treating varicose veins and their relative use from 2007 to 2017. The potential influence of age, sex, social status and geographical origin of insured patients on surgical practice in Belgium were studied.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The annual intervention rate was 343 per 100,000 insured individuals for 2017 with a slight annual increase over the period 2007-2017 (+ 0.83% per year). Patients with limited resources, benefiting from a preferential reimbursement system, had a significantly lower intervention rate than those having the usual system (p&lt;0.001). There was a large geographical variation in the use of care, ranging from 172 to 549 per 100.000 insured in 2017. The number of classic surgical procedures decreased (-6.17% per year) in the period 2015-2017) while EVTA, newly reimbursed in Belgium since 2012, increased during the same period (+ 3.6% per year). This evolution was more pronounced in the north (Flanders) than in the south (Wallonia) of the country. Bilateral treatment increased considerably from 2012 and stabilized at 33% of all surgical interventions in 2016 and 2017.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Available data of the NIHDI in Belgium highlight remarkable differences in the use of care for CVD, depending on social status and geographical origin of insured patients. The introduction of EVTA techniques has been adopted more rapidly in the north of the country and has led to an increased percentage of bilateral procedures.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guillaume</LastName>
            <ForeName>Geneviève M</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular and Thoracic Surgery, Belgium President of the Phlebology Working Group of the Belgian Society of Vascular Surgery Surgery CHU-UCL-Namur, Dinant, Belgium - genevieve.guillaume@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vuylsteke</LastName>
            <ForeName>Marc E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Vascular Surgery, Sint-Andries Ziekenhuis, Tielt, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dalcq</LastName>
            <ForeName>Virginie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health and Disability Insurance, Federal Government, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Van der Borght</LastName>
            <ForeName>Lisbeth</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health and Disability Insurance, Federal Government, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meeus</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health and Disability Insurance, Federal Government, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Maeseneer</LastName>
            <ForeName>Marianne G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Erasmus Medical Centre, Rotterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Int Angiol</MedlineTA>
        <NlmUniqueID>8402693</NlmUniqueID>
        <ISSNLinking>0392-9590</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083430</ArticleId>
        <ArticleId IdType="pii">S0392-9590.20.04305-9</ArticleId>
        <ArticleId IdType="doi">10.23736/S0392-9590.20.04305-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083432</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>One Voice.</ArticleTitle>
        <Pagination>
          <MedlinePgn>9-10</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pryor</LastName>
            <ForeName>Lillian A</ForeName>
            <Initials>LA</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083432</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083431</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>2020: A New Decade Begins.</ArticleTitle>
        <Pagination>
          <MedlinePgn>7</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ulrich</LastName>
            <ForeName>Beth</ForeName>
            <Initials>B</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083431</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083433</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Perfect Storm: Stakeholder Perspectives on Factors Contributing to Hospital Admissions for Patients Undergoing Maintenance Hemodialysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>11-20</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Patients living with end stage renal disease (ESRD) who are undergoing hemodialysis experience frequent hospitalizations associated with complications of care and exacerbations of illness. Efforts to reduce hospitalizations have had limited success. The purpose of this study was to explore why hospitalizations occur from the perspectives of patients undergoing hemodialysis treatment, their caregivers, and health care providers. Semi-structured interviews and focus groups were conducted with 21 patients living with ESRD, 10 caregivers, and three focus groups with health care professionals. Findings are discussed under four main themes: Graft site/Catheter/Access issues, "My resistance is low," "I could not breathe,"" and "The perfect storm." Results highlight the complexity of care and vulnerability of patients with ESRD. Further interprofessional research is needed to improve transitional care and care delivery for patient populations receiving hemodialysis.</AbstractText>
          <CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Clark-Cutaia</LastName>
            <ForeName>Maya N</ForeName>
            <Initials>MN</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor. New York University, Rory Meyers College of Nursing, New York, NY.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>member of ANNA's New York Chapter.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jarrín</LastName>
            <ForeName>Olga F</ForeName>
            <Initials>OF</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, Rutgers, The State University of New Jersey School of Nursing, Division of Nursing Science and Institute for Health, Health Care Policy, and Aging Research, New Brunswick, NJ.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas-Hawkins</LastName>
            <ForeName>Charlotte</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Associate Professor, Interim Associate Dean, Nursing Science Division and Director, Center for Health Services Research and Policy at Rutgers, The State University of New Jersey, Newark, NJ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>member of ANNA's New Jersey Chapter.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirschman</LastName>
            <ForeName>Karen B</ForeName>
            <Initials>KB</Initials>
            <AffiliationInfo>
              <Affiliation>Research Associate Professor and the NewCourtland Term Chair in Health Transitions Research, the University of Pennsylvania School of Nursing, Philadelphia, PA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dialysis</Keyword>
        <Keyword MajorTopicYN="N">end stage renal disease</Keyword>
        <Keyword MajorTopicYN="N">hemodialysis</Keyword>
        <Keyword MajorTopicYN="N">hospitalization</Keyword>
        <Keyword MajorTopicYN="N">kidney failure (chronic)</Keyword>
      </KeywordList>
      <CoiStatement>This study was supported through a pilot grant from the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. Maya Clark-Cutaia was supported in part by a NIH-NINR K23 Mentored Patient-Oriented Research Career Development Award Recipient (NR015058-01). Olga Jarrín was supported in part by an AHRQ/PCOR K99/R00 award (HS022406).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083433</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083434</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Experiences of Caregivers Caring for a Family Member Who Is Using Hemodialysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>23-34</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>In this qualitative phenomenological study using a purposive sample, six caregivers of patients on hemodialysis were interviewed about their experiences of caring for a family member who uses hemodialysis. Six major themes and 12 subthemes were identified. Perceptions of caregivers are that caregiving is hard work and stressful; however, caregivers found the experience to be meaningful, even though the stress may interfere with their own health status. Study limitations include a small sample that may not represent the entirety of caregivers' perspectives. Implications for practice include developing informal and formal support systems and exercise programs that help this population manage the stress associated with caregiving for family members using hemodialysis.</AbstractText>
          <CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Turner</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Professor, the Bon Secours Memorial College of Nursing, Richmond, VA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>member of ANNA's XYZ Chapter.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finch-Guthrie</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor and the Co-Director for Interprofessional Education, Research, and Practice, St. Catherine University, St. Paul, MN.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dissertation Advisor, the School of Advanced Studies, the University of Phoenix.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">caregiver</Keyword>
        <Keyword MajorTopicYN="N">caregiver strain</Keyword>
        <Keyword MajorTopicYN="N">family caregivers</Keyword>
        <Keyword MajorTopicYN="N">hemodialysis</Keyword>
        <Keyword MajorTopicYN="N">nurses</Keyword>
        <Keyword MajorTopicYN="N">nursing</Keyword>
      </KeywordList>
      <CoiStatement>The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083434</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083435</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Experiences of Nephrology Nurses in Assessing and Managing Pain in Patients Receiving Maintenance Hemodialysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>37-44</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Chronic kidney disease (CKD) is a major health problem. The purpose of this qualitative study was to describe nephrology nurses' experiences in assessing and managing pain in patients who were receiving maintenance hemodialysis at outpatient units within a tertiary care institution. Semi-structured interviews were conducted with seven nurses, and a thematic analysis was used to analyze data. Themes emerged related to the complexity of pain assessment and management in these patients, who were often elderly. Nurses had to ascertain whether the pain was related to hemodialysis treatment, renal failure, or comorbidities. Nurses described managing pain within the context of the hemodialysis unit, and this required working as a team. Nurses also described the need for a palliative approach in patient care.</AbstractText>
          <CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bourbonnais</LastName>
            <ForeName>Frances Fothergill</ForeName>
            <Initials>FF</Initials>
            <AffiliationInfo>
              <Affiliation>Professor Emeritus, School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tousignant</LastName>
            <ForeName>Kelley Ford</ForeName>
            <Initials>KF</Initials>
            <AffiliationInfo>
              <Affiliation>Teaching Associate, School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">assessment</Keyword>
        <Keyword MajorTopicYN="N">hemodialysis</Keyword>
        <Keyword MajorTopicYN="N">management</Keyword>
        <Keyword MajorTopicYN="N">nephrology nurses</Keyword>
        <Keyword MajorTopicYN="N">pain</Keyword>
      </KeywordList>
      <CoiStatement>The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083435</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083436</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Feasibility Study for Teaching Older Kidney Transplant Recipients How to Wear and Use an Activity Tracker to Promote Daily Physical Activity.</ArticleTitle>
        <Pagination>
          <MedlinePgn>47-51</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Activity trackers have demonstrated promise in promoting physical activity in chronic disease populations, but few studies describe how participants were educated to use the activity tracker. The purpose of this study was to describe the teach-back method used to instruct older kidney transplant recipients to use an activity tracker/app and to describe the facilitators/challenges of wearing the activity tracker. A feasibility design was used for implementing the use of the tracker. A four-week follow-up questionnaire was administered to obtain participants' opinions on wear ing the tracker. The leading facilitator was the desire to track daily steps. The main challenge was securing the band. Reports of challenges were minimal, suggesting the teach-back method is feasible for teaching this population how to use an activity tracker.</AbstractText>
          <CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>O'Brien</LastName>
            <ForeName>Tara</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, The Ohio State University College of Nursing, Columbus, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meyer</LastName>
            <ForeName>Tess</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Registered Nurse, Nationwide Chidren's Hospital, Columbus, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">activity tracker</Keyword>
        <Keyword MajorTopicYN="N">kidney transplant</Keyword>
        <Keyword MajorTopicYN="N">physical activity</Keyword>
        <Keyword MajorTopicYN="N">teach-back method</Keyword>
      </KeywordList>
      <CoiStatement>The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083436</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083437</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Perspectives of African-American Family Members about Kidney Failure Treatment.</ArticleTitle>
        <Pagination>
          <MedlinePgn>53-65</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Understanding African-American families' experiences with treatment for kidney failure is necessary for informing the delivery of family-centered care and the design of appropriate interventions. This qualitative study explored treatment-related questions, concerns, and family impacts among African-American family members of patients with pre-kidney failure and kidney failure. Thirty-five family members participated in focus groups stratified by patients' treatment experiences (pre-kidney failure, in-center hemodialysis, peritoneal dialysis, awaiting living-donor kidney transplantation, or post-transplantation). Family members raised questions and concerns about the psychological, lifestyle, and practical aspects of treatment. Similarly, discussions about family impacts emphasized psychosocial effects, lifestyle consequences, and the provision and receipt of support. Efforts to address these questions, concerns, and perceived family impacts through additional research, early and tailored education, and supportive interventions are needed.</AbstractText>
          <CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>DePasquale</LastName>
            <ForeName>Nicole</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, Division of General Internal Medicine, Duke University School of Medicine, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cabacungan</LastName>
            <ForeName>Ashley</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Research Specialist, Division of General Internal Medicine, Duke University School of Medicine, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ephraim</LastName>
            <ForeName>Patti L</ForeName>
            <Initials>PL</Initials>
            <AffiliationInfo>
              <Affiliation>Research Associate, Welch Center for Prevention, Epidemiology and Clinical Research, and Associate Faculty, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewis-Boyér</LastName>
            <ForeName>LaPricia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Senior Research Program Coordinator, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Powe</LastName>
            <ForeName>Neil R</ForeName>
            <Initials>NR</Initials>
            <AffiliationInfo>
              <Affiliation>Chief of Medicine, the Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, the Constance B. Wofsy Distinguished Professor and Vice-Chair of Medicine, the University of California at San Francisco, San Francisco, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boulware</LastName>
            <ForeName>L Ebony</ForeName>
            <Initials>LE</Initials>
            <AffiliationInfo>
              <Affiliation>Eleanor Easley Chair and Professor of Medicine, the School of Medicine; Chief of the Division of General Internal Medicine, Department of Medicine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vice Dean for Translational Science.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Associate Vice Chancellor for Translational Research, Duke University, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dialysis</Keyword>
        <Keyword MajorTopicYN="N">living-donor kidney transplantation</Keyword>
        <Keyword MajorTopicYN="N">positive and negative treatment impacts</Keyword>
        <Keyword MajorTopicYN="N">treatment concerns</Keyword>
        <Keyword MajorTopicYN="N">treatment questions</Keyword>
      </KeywordList>
      <CoiStatement>The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083437</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083438</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1526-744X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <MedlineDate>2020 Jan-Feb</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title>
          <ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Exploring Patients' Experiences After Chronic Kidney Disease Diagnosis: A Qualitative Study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>67-98</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Chronic kidney disease (CKD) diagnosis is often associated with stress, depression, and major lifestyle changes. The aim of this qualitative study was to explore patients' experiences of living with CKD. A non-random purposeful sampling strategy was used to recruit 10 patients with CKD undergoing hemodialysis, from a tertiary care hospital in Crete, Greece. Semi-structured, face-to-face interviews were conducted with open-ended questions aiming to assess different aspects of their life after CKD diagnosis. Four main themes were revealed portraying participants' experience, including facing a new reality, 2) confronting changes, 3) finding ways to cope, and 4) continuing life.</AbstractText>
          <CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stavropoulou</LastName>
            <ForeName>Areti</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Lecturer in Nursing Management and Education, Department of Nursing, University of West Attica, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rovithis</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, Laboratory of Interdisciplinary Approaches for the Enhancement of Quality of Life, Hellenic Mediterranean University, Heraklion, Crete, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grammatikopoulou</LastName>
            <ForeName>Maria G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Senior Lecturer, Department of Nutritional Sciences and Dietetics, International Hellenic University, Alexander Campus, Sindos,Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kyriakidi</LastName>
            <ForeName>Konstantina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Student, Department of Nutrition and Dietetics Sciences, Hellenic Mediterranean University, Sitia, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pylarinou</LastName>
            <ForeName>Andriani</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Student, Department of Nutrition and Dietetics Sciences, Hellenic Mediterranean University, Sitia, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Markaki</LastName>
            <ForeName>Anastasia G</ForeName>
            <Initials>AG</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor in Clinical Nutrition, Department of Nutrition and Dietetics Sciences, Hellenic Mediterranean University, Sitia, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nephrol Nurs J</MedlineTA>
        <NlmUniqueID>100909377</NlmUniqueID>
        <ISSNLinking>1526-744X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CKD diagnosis</Keyword>
        <Keyword MajorTopicYN="N">chronic kidney disease (CKD)</Keyword>
        <Keyword MajorTopicYN="N">hemodialysis</Keyword>
        <Keyword MajorTopicYN="N">patients' experiences</Keyword>
        <Keyword MajorTopicYN="N">qualitative study</Keyword>
      </KeywordList>
      <CoiStatement>The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083438</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083439</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1437-4331</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical chemistry and laboratory medicine</Title>
          <ISOAbbreviation>Clin. Chem. Lab. Med.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>IgE cross-reactivity measurement of cashew nut, hazelnut and peanut using a novel IMMULITE inhibition method.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2019-1083</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/cclm.ahead-of-print/cclm-2019-1083/cclm-2019-1083.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Tree nut-allergic individuals are often sensitised towards multiple nuts and seeds. The underlying cause behind a multi-sensitisation for cashew nut, hazelnut, peanut and birch pollen is not always clear. We investigated whether immunoglobulin E antibody (IgE) cross-reactivity between cashew nut, hazelnut and peanut proteins exists in children who are multi-allergic to these foods using a novel IMMULITE®-based inhibition methodology, and investigated which allergens might be responsible. In addition, we explored if an allergy to birch pollen might play a role in this co-sensitisation for cashew nut, hazelnut and peanut. Methods Serum of five children with a confirmed cashew nut allergy and suffering from allergic symptoms after eating peanut and hazelnut were subjected to inhibition immunoassays using the IMMULITE® 2000 XPi. Serum-specific IgE (sIgE) to seed storage allergens and pathogenesis-related protein 10 (PR10) allergens were determined and used for molecular multicomponent allergen correlation analyses with observed clinical symptoms and obtained inhibition data. Results IgE cross-reactivity was observed in all patients. Hazelnut extract was a strong inhibitor of cashew nut sIgE (46.8%), while cashew nut extract was less able to inhibit hazelnut extract (22.8%). Peanut extract showed the least inhibition potency. Moreover, there are strong indications that a birch pollen sensitisation to Bet v 1 might play a role in the observed symptoms provoked upon ingestion of cashew nut and hazelnut. Conclusions By applying an adjusted working protocol, the IMMULITE® technology can be used to perform inhibition assays to determine the risk of sIgE cross-reactivity between very different food components.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bastiaan-Net</LastName>
            <ForeName>Shanna</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Wageningen Food and Biobased Research, Wageningen University and Research, Wageningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Batstra</LastName>
            <ForeName>Manou R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Medische Immunologie, Reinier de Graaf Gasthuis, Delft, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aazamy</LastName>
            <ForeName>Nasrin</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Section of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Savelkoul</LastName>
            <ForeName>Huub F J</ForeName>
            <Initials>HFJ</Initials>
            <AffiliationInfo>
              <Affiliation>Cell Biology and Immunology Group, Wageningen University, Wageningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van der Valk</LastName>
            <ForeName>Johanna P M</ForeName>
            <Initials>JPM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Section of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gerth van Wijk</LastName>
            <ForeName>Roy</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Section of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schreurs</LastName>
            <ForeName>Marco W J</ForeName>
            <Initials>MWJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology, Laboratory Medical Immunology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wichers</LastName>
            <ForeName>Harry J</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Wageningen Food and Biobased Research, Wageningen University and Research, Wageningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Food Chemistry, Wageningen University, Wageningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Jong</LastName>
            <ForeName>Nicolette W</ForeName>
            <Initials>NW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Section of Allergy and Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Clin Chem Lab Med</MedlineTA>
        <NlmUniqueID>9806306</NlmUniqueID>
        <ISSNLinking>1434-6621</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IMMULITE® technology</Keyword>
        <Keyword MajorTopicYN="N">IgE cross-reactivity</Keyword>
        <Keyword MajorTopicYN="N">allergy diagnostics</Keyword>
        <Keyword MajorTopicYN="N">cashew nut</Keyword>
        <Keyword MajorTopicYN="N">hazelnut</Keyword>
        <Keyword MajorTopicYN="N">peanut</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083439</ArticleId>
        <ArticleId IdType="doi">10.1515/cclm-2019-1083</ArticleId>
        <ArticleId IdType="pii">/j/cclm.ahead-of-print/cclm-2019-1083/cclm-2019-1083.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083440</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1437-4331</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical chemistry and laboratory medicine</Title>
          <ISOAbbreviation>Clin. Chem. Lab. Med.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2019-1112</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/cclm.ahead-of-print/cclm-2019-1112/cclm-2019-1112.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Patients with cystic fibrosis (CF) have a reduced intestinal absorption of cholesterol and in a preliminary study we observed differences in plasma sterol profile between patients with pancreatic sufficiency (PS) and those with pancreatic insufficiency (PI). Therefore, we hypothesized that the sterol analysis may contribute to study the digestion and absorption state of lipids in patients with CF. To this aim we evaluated plasma sterols in a significant number of adult patients with CF in relation to the pancreatic status. Methods Beside cholesterol, we measured phytosterols and lathosterol as markers of intestinal absorption and hepatic biosynthesis, respectively, by gas-chromatography in plasma of adult CF patients with pancreatic sufficiency (PS-CF, n = 57), insufficiency (PI-CF, n = 97) and healthy subjects (control group, CT, n = 71). Results PI-CF patients had cholesterol and phytosterols levels significantly lower than PS-CF and CT (p &lt; 5 × 10-10) suggesting a reduced intestinal absorption of sterols related to PI. Instead, lathosterol was significantly higher in PI-CF patients than PS-CF and CT (p &lt; 0.0003) indicating an enhanced cholesterol biosynthesis. In PI-CF patients, phytosterols positively correlate with vitamin E (p = 0.004). Both the classes of molecules need cholesterol esterase for the intestinal digestion, thus the reduced levels of such lipids in serum from PI-CF patients may depend on a reduced enzyme activity, despite the pancreatic enzyme supplementation in all PI-CF patients. Conclusions A plasma sterols profile may be useful to evaluate the metabolic status of lipids in adult patients with CF and could help to manage the pancreatic enzyme supplementation therapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gelzo</LastName>
            <ForeName>Monica</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>CEINGE Advanced Biotechnologies s.c.a.r.l., Naples, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iacotucci</LastName>
            <ForeName>Paola</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sica</LastName>
            <ForeName>Concetta</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liguori</LastName>
            <ForeName>Renato</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Science and Technology, University of Naples Parthenope, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Comegna</LastName>
            <ForeName>Marika</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>CEINGE Advanced Biotechnologies s.c.a.r.l., Naples, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carnovale</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dello Russo</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Corso</LastName>
            <ForeName>Gaetano</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical and Experimental Medicine, University of Foggia, Viale L. Pinto 1, 71122 Foggia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castaldo</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>CEINGE Advanced Biotechnologies s.c.a.r.l., Naples, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Clin Chem Lab Med</MedlineTA>
        <NlmUniqueID>9806306</NlmUniqueID>
        <ISSNLinking>1434-6621</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cholesterol</Keyword>
        <Keyword MajorTopicYN="N">cystic fibrosis</Keyword>
        <Keyword MajorTopicYN="N">gas chromatography</Keyword>
        <Keyword MajorTopicYN="N">pancreatic insufficiency</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083440</ArticleId>
        <ArticleId IdType="doi">10.1515/cclm-2019-1112</ArticleId>
        <ArticleId IdType="pii">/j/cclm.ahead-of-print/cclm-2019-1112/cclm-2019-1112.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083441</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2194-802X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Diagnosis (Berlin, Germany)</Title>
          <ISOAbbreviation>Diagnosis (Berl)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessing the utility of a differential diagnostic generator in UK general practice: a feasibility study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/dx-2019-0033</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/dx.ahead-of-print/dx-2019-0033/dx-2019-0033.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Despite growing positive evidence supporting the potential utility of differential diagnostic generator (DDX) tools, uptake has been limited in terms of geography and settings and calls have been made to test such tools in wider routine clinical settings. This study aims to evaluate the feasibility and utility of clinical use of Isabel, an electronic DDX tool, in a United Kingdom (UK) general practice setting. Methods Mixed methods. Feasibility and utility were assessed prospectively over a 6-month period via: usage statistics, survey as well as interview data generated from clinicians before and after Isabel was available for clinical use. Normalisation process theory (NPT) was utilised as a sensitising concept in the data collection and analysis of the qualitative data. Results Usage was extremely limited (n = 18 searches). Most potential users did not utilise the program and of those that did (n = 6), usage was restricted and did not alter subsequent patient management. Baseline interview findings indicated some prior awareness of DDX tools and ambivalent views with regards to potential utility. Post-use interviews supported analytic data and indicated low usage due to a range of endogenous (professional) and exogenous (organisational) factors. Conclusions In its current form, this small exploratory study suggests that Isabel is a tool that is unlikely to be utilised on a routine basis in primary care, but may have potential utility for diagnostic support in (1) education/training and (2) rare and diagnostically complex cases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cheraghi-Sohi</LastName>
            <ForeName>Sudeh</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2863-0683</Identifier>
            <AffiliationInfo>
              <Affiliation>NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alam</LastName>
            <ForeName>Rahul</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hann</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Biostatistics, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Esmail</LastName>
            <ForeName>Aneez</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campbell</LastName>
            <ForeName>Stephen</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Riches</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>General Practitioner and Public Health Registrar, Health Education North West, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Diagnosis (Berl)</MedlineTA>
        <NlmUniqueID>101654734</NlmUniqueID>
        <ISSNLinking>2194-802X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Isabel</Keyword>
        <Keyword MajorTopicYN="N">accuracy</Keyword>
        <Keyword MajorTopicYN="N">diagnosis</Keyword>
        <Keyword MajorTopicYN="N">primary care</Keyword>
        <Keyword MajorTopicYN="N">qualitative</Keyword>
        <Keyword MajorTopicYN="N">uncertainty</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083441</ArticleId>
        <ArticleId IdType="doi">10.1515/dx-2019-0033</ArticleId>
        <ArticleId IdType="pii">/j/dx.ahead-of-print/dx-2019-0033/dx-2019-0033.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083442</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1868-1891</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hormone molecular biology and clinical investigation</Title>
          <ISOAbbreviation>Horm Mol Biol Clin Investig</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cell free DNA: revolution in molecular diagnostics - the journey so far.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/hmbci-2019-0012</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/hmbci.ahead-of-print/hmbci-2019-0012/hmbci-2019-0012.xml</ELocationID>
        <Abstract>
          <AbstractText>Cell free DNA (cf-DNA) refers to all non -ncapsulated DNA present in the blood stream which may originate from apoptotic cells as a part of the physiological cell turnover, or from cancer cells or fetal cells. Recent studies have highlighted the utility of cfDNA analysis for genetic profiling of cancer, non-invasive prenatal testing besides many other clinical applications. In our review we discuss the sources of cfDNA in the body, the techniques most commonly being used for its isolation and analysis, the applications of cfDNA testing and the associated pros-cons. We conclude that for prenatal testing, cfDNA analysis provides an effective, non-invasive and safer alternative to traditional amniocentesis and chorionic villus sampling tests. Also, in cancer patients, cfDNA analysis is useful for genetic profiling and follow-up during treatment. However, standardization of methods of isolation and analysis has become crucial for the success of widespread use of cfDNA analysis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nandi</LastName>
            <ForeName>Kajal</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, HIMSR, Mehrauli, New Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verma</LastName>
            <ForeName>Rashmi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Maulana Azad Medical College, New Delhi 110002, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dawar</LastName>
            <ForeName>Rajni</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Vardhaman Mahavir Medical College, New Delhi 110029, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goswami</LastName>
            <ForeName>Binita</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Maulana Azad Medical College, New Delhi 110002, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Horm Mol Biol Clin Investig</MedlineTA>
        <NlmUniqueID>101538885</NlmUniqueID>
        <ISSNLinking>1868-1883</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">circulating free DNA</Keyword>
        <Keyword MajorTopicYN="N">epigenetics</Keyword>
        <Keyword MajorTopicYN="N">liquid biopsy</Keyword>
        <Keyword MajorTopicYN="N">netosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>03</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083442</ArticleId>
        <ArticleId IdType="doi">10.1515/hmbci-2019-0012</ArticleId>
        <ArticleId IdType="pii">/j/hmbci.ahead-of-print/hmbci-2019-0012/hmbci-2019-0012.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083443</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1868-1891</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hormone molecular biology and clinical investigation</Title>
          <ISOAbbreviation>Horm Mol Biol Clin Investig</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of the effect of 12- and 24-week cardiac rehabilitation on physical, psychosocial and biomedical factors in ischemic heart disease patients.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/hmbci-2019-0023</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/hmbci.ahead-of-print/hmbci-2019-0023/hmbci-2019-0023.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Cardiac rehabilitation (CR) is a key component of effective care for patients with a wide spectrum of cardiac problems. It seems that the short-term provision of these services can facilitate their use and meeting of related needs for patients participating in the CR programs. Materials and methods In this interventional study on patients with ischemic heart disease (IHD) referred to the Cardiac Rehabilitation Center of Chamran Hospital, Isfahan, Iran. One-hundred and twelve patients were randomly divided into two groups of 12 and 24 weeks of CR [mean age: 59.2 ± (9.02) and 60.7 ± (9.3) years, respectively] and underwent a CR program. All information was collected in two stages, before the beginning of the program and after completion of 12- and 24-week rehabilitation programs. The data collection tools were demographics questionnaire, the International Physical Activity Questionnaires (IPAQ), McNew Quality of Life Questionnaire, Beck Depression Inventory (BDI), and Zung Self-Rating Anxiety Scale (SAS). Results The results of this study showed that in both groups, total physical activity (PA) and functional capacity increased, and the quality of life (QOL)(SF36) was statistically improved. Comparison of changes in mean differences at the end of the rehabilitation periods between the two groups, showed that only the weight, body mass index (BMI), waist circumference (WC) and high-density lipoprotein (HDL) in the 24-session group significantly decreased compared to the 12-session group and, but no significant difference in other variables was observed. Conclusion Overall, the findings of this study support the overall benefits of the CR program in both the short and the long term. Therefore it can be suggested that a short-term program can still be a valuable option for reducing the risk in cardiac patients and meeting their service needs.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sadeghi</LastName>
            <ForeName>Masoumeh</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Izadi</LastName>
            <ForeName>Abdullah</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahdi Hadavi</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rafati Fard</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roohafza</LastName>
            <ForeName>Hamidreza</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran, Phone: 0098 31 36115237, email:hroohafza@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Horm Mol Biol Clin Investig</MedlineTA>
        <NlmUniqueID>101538885</NlmUniqueID>
        <ISSNLinking>1868-1883</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anxiety</Keyword>
        <Keyword MajorTopicYN="N">cardiac rehabilitation</Keyword>
        <Keyword MajorTopicYN="N">depression</Keyword>
        <Keyword MajorTopicYN="N">functional capacity of myocardium</Keyword>
        <Keyword MajorTopicYN="N">ischemic heart disease</Keyword>
        <Keyword MajorTopicYN="N">physical activity</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083443</ArticleId>
        <ArticleId IdType="doi">10.1515/hmbci-2019-0023</ArticleId>
        <ArticleId IdType="pii">/j/hmbci.ahead-of-print/hmbci-2019-0023/hmbci-2019-0023.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083444</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1868-1891</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hormone molecular biology and clinical investigation</Title>
          <ISOAbbreviation>Horm Mol Biol Clin Investig</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/hmbci-2019-0028</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/hmbci.ahead-of-print/hmbci-2019-0028/hmbci-2019-0028.xml</ELocationID>
        <Abstract>
          <AbstractText>In the treatment of advanced-stage epithelial ovarian cancer (EOC)-associated surgery and chemotherapy with intravenous platinum/taxane-based therapy most patients had early or late recurrence. Prevention of progression and recurrence is a major objective for the management of EOC. Recently, many clinical studies have evaluated the strategy with hyperthermic intraoperative intraperitoneal (IP) drug delivery. This is an update of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in EOC and a view for future strategies. Until recently studies on HIPEC in patients with EOC were mostly retrospective and heterogeneous. Thanks to recent clinical trials, it is reasonable to conclude that surgical cytoreduction and HIPEC is an interesting approach in the management of EOC without increasing morbidity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Revaux</LastName>
            <ForeName>Aurélie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carbonnel</LastName>
            <ForeName>Marie</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanso</LastName>
            <ForeName>Frédéric</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Digestive Surgery, Foch Hospital, Suresnes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naoura</LastName>
            <ForeName>Iptissem</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asmar</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kadhel</LastName>
            <ForeName>Philippe</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Pointe-à-Pitre, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ayoubi</LastName>
            <ForeName>Jean-Marc</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Horm Mol Biol Clin Investig</MedlineTA>
        <NlmUniqueID>101538885</NlmUniqueID>
        <ISSNLinking>1868-1883</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HIPEC</Keyword>
        <Keyword MajorTopicYN="N">cytoreductive surgery</Keyword>
        <Keyword MajorTopicYN="N">hyperthermic intraoperative intraperitoneal chemotherapy</Keyword>
        <Keyword MajorTopicYN="N">ovarian cancer</Keyword>
        <Keyword MajorTopicYN="N">surgery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083444</ArticleId>
        <ArticleId IdType="doi">10.1515/hmbci-2019-0028</ArticleId>
        <ArticleId IdType="pii">/j/hmbci.ahead-of-print/hmbci-2019-0028/hmbci-2019-0028.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083445</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1868-1891</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hormone molecular biology and clinical investigation</Title>
          <ISOAbbreviation>Horm Mol Biol Clin Investig</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hepatoprotective effects of Shilajit on high fat-diet induced non-alcoholic fatty liver disease (NAFLD) in rats.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/hmbci-2019-0040</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/hmbci.ahead-of-print/hmbci-2019-0040/hmbci-2019-0040.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Non-alcoholic fatty liver disease (NAFLD) is the main common cause of chronic liver disease. The aim of this study is to evaluate the effect of Shilajit, a medicine of Ayurveda, on the liver damage caused by NAFLD. Materials and methods Forty male Wistar rats, after being established as fatty liver models by feeding a high-fat diet (HFD, 12 weeks), were divided randomly into five groups as follows: control (standard diet), vehicle (HFD + distilled water), high-dose Shilajit (HFD + 250 mg/kg Shilajit), low-dose Shilajit (HFD + 150 mg/kg Shilajit) and pioglitazone (HFD + 10 mg/kg pioglitazone). The serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), glucose and liver glutathione peroxidase (GPx), superoxide dismutase (SOD) activity, malondialdehyde (MDA) levels, liver weight, and histopathological manifestation outcomes were measured after the 2-week intervention. Results Shilajit treatment significantly reduced the values of AST and ALT, TG, TC, LDL, glucose, liver weight, and steatosis, and instead, increased high-density lipoprotein (HDL) compared with the vehicle group (p &lt; 0.05). Further, Shilajit treatment improved the adverse effects of HFD-induced histopathological changes in the liver as compared with the vehicle group (p &lt; 0.001). MDA level and GPx activity increased but SOD activity decreased in the vehicle group compared with the control group (p &lt; 0.05), while treatment with Shilajit restored the antioxidant/oxidant balance toward a significant increase in the antioxidant system in the Shilajit group (p &lt; 0.05). Conclusions These findings suggest that Shilajit improved the histopathological NAFLD changes in the liver and indicated the potential applicability of Shilajit as a potent agent for NAFLD treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ghezelbash</LastName>
            <ForeName>Baran</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shahrokhi</LastName>
            <ForeName>Nader</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Physiology Research Center, Kerman University of Medical Sciences, Kerman7616914115,Iran, Phone: +989131420391, Fax: +983433257581.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khaksari</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Endocrinology and Metabolism Research Center, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghaderi-Pakdel</LastName>
            <ForeName>Firouz</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asadikaram</LastName>
            <ForeName>Gholamreza</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Center, Institute of Neuropharmacology, Kerman, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Horm Mol Biol Clin Investig</MedlineTA>
        <NlmUniqueID>101538885</NlmUniqueID>
        <ISSNLinking>1868-1883</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Shilajit</Keyword>
        <Keyword MajorTopicYN="N">non-alcoholic fatty liver disease</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress</Keyword>
        <Keyword MajorTopicYN="N">pioglitazone</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083445</ArticleId>
        <ArticleId IdType="doi">10.1515/hmbci-2019-0040</ArticleId>
        <ArticleId IdType="pii">/j/hmbci.ahead-of-print/hmbci-2019-0040/hmbci-2019-0040.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083446</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2191-0278</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of adolescent medicine and health</Title>
          <ISOAbbreviation>Int J Adolesc Med Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The use of gadgets and their relationship to poor sleep quality and social interaction on mid-adolescents: a cross-sectional study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/ijamh-2019-0101</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/ijamh.ahead-of-print/ijamh-2019-0101/ijamh-2019-0101.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Mid-adolescents dominate the number of gadget users in Indonesia. The use of gadgets to a high intensity can cause various problems such as poor sleep quality and decreased social interaction. The purpose of this study was to analyze the relationship between the intensity of the use of gadgets and the quality of sleep and social interaction in adolescents. Method The research design used was a correlational research study with a cross-sectional approach. Through the calculation of the sample, the respondents were 250 adolescents who met the inclusion criteria, namely (1) adolescents aged 15-18 years and (2) teens who owned and used gadgets. The sampling method used simple random sampling by conducting a lottery system in each class. The independent variable was the intensity of using the gadget, while the dependent variable was the quality of sleep and social interaction. Data collection focused on the intensity of gadget use using questionnaires and it was analyzed using the Pittsburgh Sleep Quality Index (PSQI) and the Social Interaction Anxiety Scale (SIAS). The data was analyzed using Spearman's rank correlation with α = 0.05. Results The results showed that the intensity of gadget use was positively related to poor sleep quality in adolescents (p = &lt;0.001; r = 0.555). The intensity of the use of gadgets was also related to social interaction with a negative direction. The higher the intensity of the use of gadgets, the lower the social interaction in adolescents (p = 0.001; r = -293). Conclusion The use of gadgets in the mid-adolescent years is related to sleep disorders as regards the latency and duration of sleep. Adolescents are more likely to engage in social interaction and communication through gadgets than face to face.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Krisnana</LastName>
            <ForeName>Ilya</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8076-9036</Identifier>
            <AffiliationInfo>
              <Affiliation>Maternity and Pediatric Nursing Department, Faculty of Nursing, Universitas Airlangga, Surabaya, East Java60115,Indonesia, Phone: +6231-5913754.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hariani</LastName>
            <ForeName>Venni</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Nursing, Universitas Airlangga, Surabaya, East Java, Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurnia</LastName>
            <ForeName>Iqlima Dwi</ForeName>
            <Initials>ID</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6836-034X</Identifier>
            <AffiliationInfo>
              <Affiliation>Maternity and Pediatric Nursing Department, Faculty of Nursing, Universitas Airlangga, Surabaya, East Java60115,Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arief</LastName>
            <ForeName>Yuni Sufyanti</ForeName>
            <Initials>YS</Initials>
            <AffiliationInfo>
              <Affiliation>Maternity and Pediatric Nursing Department, Faculty of Nursing, Universitas Airlangga, Surabaya, East Java60115,Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Int J Adolesc Med Health</MedlineTA>
        <NlmUniqueID>8506960</NlmUniqueID>
        <ISSNLinking>0334-0139</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adolescent</Keyword>
        <Keyword MajorTopicYN="N">gadgets</Keyword>
        <Keyword MajorTopicYN="N">sleep quality</Keyword>
        <Keyword MajorTopicYN="N">smartphone</Keyword>
        <Keyword MajorTopicYN="N">social interaction</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083446</ArticleId>
        <ArticleId IdType="doi">10.1515/ijamh-2019-0101</ArticleId>
        <ArticleId IdType="pii">/j/ijamh.ahead-of-print/ijamh-2019-0101/ijamh-2019-0101.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083447</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2191-0278</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of adolescent medicine and health</Title>
          <ISOAbbreviation>Int J Adolesc Med Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Spiritual self-care in adolescents: a qualitative study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/ijamh-2019-0248</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/ijamh.ahead-of-print/ijamh-2019-0248/ijamh-2019-0248.xml</ELocationID>
        <Abstract>
          <AbstractText>One of the existential questions during adolescence concerns the ambiguity regarding spirituality. Adolescents at this age not only have spiritual, psychological and unique needs, but have spiritual requirements that help them to relax and solve problems. Therefore, this qualitative study aimed to understand the concept of spiritual self-care in Iranian adolescents in 2019. This qualitative study using a content analysis approach was conducted on 14 adolescents with an age range of 14-20 years, who were selected using the purposeful sampling method. Data were collected by semi-structured interviews which were carried out between 04 March and 20 August 2019. The interviews were transcribed immediately after the recording, and then were analyzed using direct content analysis. Two hundred and fifty-two primary codes related to the adolescents' spiritual self-care were extracted from the analysis, which determined four main aspects of spiritual self-care (spiritual belief, spiritual experience, social-religious activities and spiritual growth). The findings of this study showed that, spiritual self-care is a form of self-care by which a person uses his or her spiritual beliefs, teachings and experiences to control stress and manage crises, and their ability to cope with problems.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nafiseh</LastName>
            <ForeName>Hekmati Pour</ForeName>
            <Initials>HP</Initials>
            <AffiliationInfo>
              <Affiliation>Ph.D Student, Nursing Research Center, Faculty of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahmoodi-Shan</LastName>
            <ForeName>Gholam Reza</ForeName>
            <Initials>GR</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, Nursing Research Center, Faculty of Nursing and Midwifery, Golestan University of Medical Sciences, Initial of Shast Kola Road, Kilometer 4 Gorgan-Sari, Gorgan, P.O. BOX 4934174515, Golestan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abas</LastName>
            <ForeName>Ebadi</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Professor of Nursing, Faculty of Nursing, Baqiyatallah (a.s.) University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naser</LastName>
            <ForeName>Behnampour</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1668-8922</Identifier>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, Department of Biostatistics, Health Management and Social Development Research, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Int J Adolesc Med Health</MedlineTA>
        <NlmUniqueID>8506960</NlmUniqueID>
        <ISSNLinking>0334-0139</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adolescents</Keyword>
        <Keyword MajorTopicYN="N">qualitative study</Keyword>
        <Keyword MajorTopicYN="N">spiritual self-care</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083447</ArticleId>
        <ArticleId IdType="doi">10.1515/ijamh-2019-0248</ArticleId>
        <ArticleId IdType="pii">/j/ijamh.ahead-of-print/ijamh-2019-0248/ijamh-2019-0248.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083448</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1619-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of perinatal medicine</Title>
          <ISOAbbreviation>J Perinat Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of cerebral oxygenation and perfusion in small for gestational age neonates and neurodevelopmental outcome at 24-36 months of age.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpm-2019-0274</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/jpme.ahead-of-print/jpm-2019-0274/jpm-2019-0274.xml</ELocationID>
        <Abstract>
          <AbstractText>Objective To examine cerebral oxygenation and perfusion in small for gestational age (SGA) compared with appropriate for gestational age (AGA) neonates during the first postnatal week, and to investigate any association with neurodevelopmental outcomes at 24-36 months of age. Methods A prospective matched case-control study was conducted evaluating cerebral oxygenation and perfusion, using near-infrared spectroscopy (NIRS), between SGA and AGA neonates, during the first postnatal week. A neurodevelopmental assessment with Bayley-III was performed at 24-36 months of age. Results Forty-eight SGA and 48 AGA neonates of similar gestation (32.8 ± 2.1 vs. 32.5 ± 1.9) were enrolled. On the first postnatal day, the cerebral oxygenation was equal between SGA and AGA neonates (71 ± 7% vs. 72 ± 8%); however, in the subgroup analysis, males had higher oxygenation compared to female SGA neonates (73 ± 7% vs. 69 ± 7%, P = 0.04). Cerebral perfusion was significantly higher in SGA neonates on the first postnatal day (1.4 ± 0.6 vs. 1.1 ± 0.5, P = 0.04), but this difference was diminished on subsequent measurements. There were no significant differences between the SGA and AGA infants regarding the composite cognitive, communication and motor index scores. The length of mechanical ventilation and late-onset sepsis were significant risk factors affecting the cognitive and communication composite index scores, respectively. Conclusion Cerebral oxygenation was equal between SGA and AGA neonates, while cerebral perfusion was transiently increased in SGA neonates during the first postnatal day. There was no significant association of cerebral oxygenation and perfusion with neurodevelopmental outcomes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Milona</LastName>
            <ForeName>Eleni</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Ring Road, Thessaloniki 56403, Greece, Tel.: +966534548081.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rallis</LastName>
            <ForeName>Dimitrios</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mitsiakos</LastName>
            <ForeName>Georgios</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goutsiou</LastName>
            <ForeName>Evanthia</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hatziioannidis</LastName>
            <ForeName>Elias</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsakalidis</LastName>
            <ForeName>Christos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lithoxopoulou</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nikolaidis</LastName>
            <ForeName>Nikolaos</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karagianni</LastName>
            <ForeName>Paraskevi</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>2NICU and Neonatology Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Perinat Med</MedlineTA>
        <NlmUniqueID>0361031</NlmUniqueID>
        <ISSNLinking>0300-5577</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bayley-III</Keyword>
        <Keyword MajorTopicYN="N">intrauterine growth restriction</Keyword>
        <Keyword MajorTopicYN="N">near-infrared spectroscopy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083448</ArticleId>
        <ArticleId IdType="doi">10.1515/jpm-2019-0274</ArticleId>
        <ArticleId IdType="pii">/j/jpme.ahead-of-print/jpm-2019-0274/jpm-2019-0274.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083449</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1619-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of perinatal medicine</Title>
          <ISOAbbreviation>J Perinat Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Measurement of inotropy and systemic oxygen delivery in term, low- and very-low-birth-weight neonates using the Ultrasonic Cardiac Output Monitor (USCOM).</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpm-2019-0301</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/jpme.ahead-of-print/jpm-2019-0301/jpm-2019-0301.xml</ELocationID>
        <Abstract>
          <AbstractText>Background The aim of this study was to assess the normal values of the Smith-Madigan inotropy index (SMII) and oxygen delivery index (DO2I) in low-birth-weight (LBW) and very-low-birth-weight (VLBW) newborns on the first 3 days of life, and to identify how different degrees of maturity influence cardiovascular alterations during the transitional period compared with term neonates. Methods Twenty-eight VLBW newborns, 46 LBW newborns and 50 normal full-term newborns admitted to our department were studied. Hemodynamics of the left heart were measured in all neonates over the first 3 days using the Ultrasonic Cardiac Output Monitor (USCOM). This was combined with hemoglobin concentration and pulse oximetry to calculate DO2I. Blood pressure was combined with the hemodynamic measures and hemoglobin concentration to calculate SMII. Results SMII showed statistically significant differences among the three groups (VLBW 0.48 ± 0.11; LBW 0.54 ± 0.13; term 0.69 ± 0.17 W/m2 P &lt; 0.001), which was in line with the following myocardial parameters: stroke volume index (SVI) and cardiac index (CI) (P &lt; 0.001 and &lt;0.001). For systemic oxygen delivery (DO2) parameters, significant differences were found for DO2I (P &lt; 0.001) while hemoglobin concentration and pulse oximetry demonstrated no significant differences. In the VLBW group, SMII and DO2I showed no significant change over the 3 days. Conclusion Normal inotropy and systemic DO2I values in VLBW neonates over the first 3 days of life were assessed. SMII and DO2I were significantly lower in VLBW neonates during the first 72 h of life. With increasing birth weight, higher myocardial inotropy and DO2 were found. The addition of USCOM examination to standard neonatal echocardiography may provide further important information regarding cardiac function.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Man-Li</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>The Second School of Clinical Medicine, Southern Medical University, Guangzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Shao-Ru</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>The Second School of Clinical Medicine, Southern Medical University, Guangzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yu-Mei</ForeName>
            <Initials>YM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Perinat Med</MedlineTA>
        <NlmUniqueID>0361031</NlmUniqueID>
        <ISSNLinking>0300-5577</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">hemodynamics</Keyword>
        <Keyword MajorTopicYN="N">inotropy</Keyword>
        <Keyword MajorTopicYN="N">oxygen delivery</Keyword>
        <Keyword MajorTopicYN="N">very-low-birth-weight infant</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083449</ArticleId>
        <ArticleId IdType="doi">10.1515/jpm-2019-0301</ArticleId>
        <ArticleId IdType="pii">/j/jpme.ahead-of-print/jpm-2019-0301/jpm-2019-0301.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083450</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1619-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of perinatal medicine</Title>
          <ISOAbbreviation>J Perinat Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pregnancy outcomes among women with peptic ulcer disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpm-2019-0344</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/jpme.ahead-of-print/jpm-2019-0344/jpm-2019-0344.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Little is known about the impact of peptic ulcer disease (PUD) on pregnancy. Our objective was to evaluate the effect of PUD on pregnancy and newborn outcomes. Methods A retrospective cohort study was carried out using the Healthcare Cost and Utilization Project (HCUP)-National Inpatient Sample (NIS) from the United States. The cohort consisted of all births that took place from 1999 to 2015. PUD was classified on the basis of the International Classification of Diseases-Ninth Revision (ICD-9) coding. Multivariate logistic regression was used to evaluate the adjusted effect of PUD on maternal and neonatal outcomes. Results Of the 13,792,544 births in this cohort, 1005 were to women with PUD (7/100,000 births). Between 1999 and 2015, prevalence of PUD in pregnancy increased from 4/100,000 to 11/100,000, respectively. Women with PUD were more commonly older and more likely to have comorbid illnesses. Women with PUD were at greater risk of preeclampsia [odds ratio (OR) 2.11, 95% confidence interval (CI) 1.67-2.66], preterm premature rupture of membranes (PPROM; OR 2.16, 95% CI 1.30-3.59), cesarean delivery (OR 1.60, 95% CI 1.40-1.82), venous thromboembolism (OR 3.77, 95% CI 2.08-6.85) and maternal death (OR 24.50, 95% CI 10.12-59.32). Births to women with PUD were at increased risk of intrauterine growth restriction (IUGR; OR 1.54, 95% CI 1.11-2.14), preterm birth (OR 1.84, 95% CI 1.54-2.21), intrauterine fetal death (OR 2.18, 95% CI 1.35-3.52) and congenital anomalies (OR 2.69, 95% CI 1.59-4.56). Conclusion The prevalence of PUD in pregnancy has risen over the last several years. PUD in pregnancy should be considered a high-risk condition associated with important adverse maternal and neonatal outcomes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rosen</LastName>
            <ForeName>Charlotte</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Czuzoj-Shulman</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mishkin</LastName>
            <ForeName>Daniel S</ForeName>
            <Initials>DS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Atrius Health, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abenhaim</LastName>
            <ForeName>Haim Arie</ForeName>
            <Initials>HA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Perinat Med</MedlineTA>
        <NlmUniqueID>0361031</NlmUniqueID>
        <ISSNLinking>0300-5577</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">newborns</Keyword>
        <Keyword MajorTopicYN="N">peptic ulcer disease</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083450</ArticleId>
        <ArticleId IdType="doi">10.1515/jpm-2019-0344</ArticleId>
        <ArticleId IdType="pii">/j/jpme.ahead-of-print/jpm-2019-0344/jpm-2019-0344.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083451</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1619-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of perinatal medicine</Title>
          <ISOAbbreviation>J Perinat Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reliability of strain elastography using in vivo compression in the assessment of the uterine cervix during pregnancy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpm-2019-0370</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/jpme.ahead-of-print/jpm-2019-0370/jpm-2019-0370.xml</ELocationID>
        <Abstract>
          <AbstractText>Objective To determine the reproducibility of the mean strain value in various cervical areas and new elastographic parameters for measuring cervical stiffness evaluated by strain elastography using in vivo compression generated by internal organ movement. Methods A prospective observational study (140 singleton pregnant women; 15-33 weeks of gestation) was performed at two tertiary centers. Cervical strain was evaluated using E-cervix™ elastography. The mean strain levels of various cervical areas [internal os (IOS), external os (EOS) and endocervical area] and several new parameters [i.e. the ratio of the strain level of IOS and EOS, elasticity contrast index (ECI), and hardness ratio] were assessed twice by two independent examiners. The inter-observer and intra-observer variances were calculated using the intraclass correlation coefficient (ICC) with a 95% confidence interval (CI). Bland-Altman (B-A) analysis was also performed. Results The median gestational age was 24.0 weeks, and the mean cervical length (CL) was 3.8 cm. The intra-observer and inter-observer ICCs of the mean strain levels of the specified cervical area and new elastographic parameters were statistically significant (P &lt; 0.001, all); the intra-observer ICC was 0.639-0.725, and the inter-observer ICC was 0.538-0.718. Conclusion The reproducibility of elastographic parameter measurements using in vivo compression is improvable.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kwak</LastName>
            <ForeName>Dong Wook</ForeName>
            <Initials>DW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Seoul, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Mina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oh</LastName>
            <ForeName>Soo-Young</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Hyun Soo</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Graduate School of Medicine, Dongguk University, Seoul, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Sa Jin</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Moon Young</ForeName>
            <Initials>MY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, 569, Nonhyon-ro, Gangnam-gu, Seoul 06135, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Han Sung</ForeName>
            <Initials>HS</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0622-0701</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, The Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Perinat Med</MedlineTA>
        <NlmUniqueID>0361031</NlmUniqueID>
        <ISSNLinking>0300-5577</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cervical assessment</Keyword>
        <Keyword MajorTopicYN="N">elastography</Keyword>
        <Keyword MajorTopicYN="N">reproducibility</Keyword>
        <Keyword MajorTopicYN="N">strain</Keyword>
        <Keyword MajorTopicYN="N">ultrasonography</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083451</ArticleId>
        <ArticleId IdType="doi">10.1515/jpm-2019-0370</ArticleId>
        <ArticleId IdType="pii">/j/jpme.ahead-of-print/jpm-2019-0370/jpm-2019-0370.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083452</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1619-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of perinatal medicine</Title>
          <ISOAbbreviation>J Perinat Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Maternal obesity influences the endocrine cord blood profile of their offspring.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpm-2019-0387</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/jpme.ahead-of-print/jpm-2019-0387/jpm-2019-0387.xml</ELocationID>
        <Abstract>
          <AbstractText>Objective To compare the endocrine cord blood characteristics of offspring from obese mothers with those of offspring from healthy controls. Methods Cross-sectional case control study.</AbstractText>
          <AbstractText Label="SETTING" NlmCategory="METHODS">University medical centers.</AbstractText>
          <AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Offspring from obese mothers (n = 41) and healthy controls (n = 31).</AbstractText>
          <AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Cord blood withdrawal from neonates.</AbstractText>
          <AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Cord blood total cholesterol (TC), triglycerides (TGs), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), blood glucose (GL) and insulin (Ins). Result(s) Fetal GL and TGs were reduced in the offspring of obese women when compared to those in the offspring of the controls. The mean cord blood GL level was 47.8 mg/dL standard deviation (SD 33.1) in the offspring of the obese group vs. 57.9 mg/dL (SD 12.5) in the offspring of the control group, and the mean cord blood TG level was 26.5 (SD 33.6) in the offspring of the obese group vs. 34.6 (SD 12.3) in the offspring of the control group. Maternal obesity was also associated with reduced levels of TC and HDL-C in the pregnant women. Conclusion The observed results suggest that GL and TGs in the cord blood of the offspring of obese mothers were significantly lower than those in the offspring of the control group.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mocarzel</LastName>
            <ForeName>Carolina Carvalho</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Federal Fluminense University, Post-Graduation in Medical Sciences, Niteroi, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Velarde</LastName>
            <ForeName>Guillermo Coca</ForeName>
            <Initials>GC</Initials>
            <AffiliationInfo>
              <Affiliation>Fluminense Federal University, Niterói, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antunes</LastName>
            <ForeName>Roberto de Azevedo</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Maternity School of the Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moreira de Sá</LastName>
            <ForeName>Renato Augusto</ForeName>
            <Initials>RA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6357-7702</Identifier>
            <AffiliationInfo>
              <Affiliation>Fluminense Federal University, Niterói, Rua Cinco de Julho 232, apto 1601, Icaraí, Niterói, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurjak</LastName>
            <ForeName>Asim</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Medical School Universities of Zagreb and Sarajevo, Zagreb, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Perinat Med</MedlineTA>
        <NlmUniqueID>0361031</NlmUniqueID>
        <ISSNLinking>0300-5577</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cholesterol</Keyword>
        <Keyword MajorTopicYN="N">cord blood</Keyword>
        <Keyword MajorTopicYN="N">maternal obesity</Keyword>
        <Keyword MajorTopicYN="N">offspring obesity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083452</ArticleId>
        <ArticleId IdType="doi">10.1515/jpm-2019-0387</ArticleId>
        <ArticleId IdType="pii">/j/jpme.ahead-of-print/jpm-2019-0387/jpm-2019-0387.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083453</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1619-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of perinatal medicine</Title>
          <ISOAbbreviation>J Perinat Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cellular immune responses in amniotic fluid of women with preterm prelabor rupture of membranes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpm-2019-0395</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/jpme.ahead-of-print/jpm-2019-0395/jpm-2019-0395.xml</ELocationID>
        <Abstract>
          <AbstractText>Background Preterm birth is the leading cause of perinatal morbidity and mortality. Preterm prelabor rupture of membranes (pPROM) occurs in 30% of preterm births; thus, this complication is a major contributor to maternal and neonatal morbidity. However, the cellular immune responses in amniotic fluid of women with pPROM have not been investigated. Methods Amniotic fluid samples were obtained from women with pPROM and a positive (n = 7) or negative (n = 10) microbiological culture. Flow cytometry was performed to evaluate the phenotype and number of amniotic fluid leukocytes. The correlation between amniotic fluid immune cells and an interleukin-6 (IL-6) concentration or a white blood cell (WBC) count in amniotic fluid was calculated. Results Women with pPROM and a positive amniotic fluid culture had (1) a greater number of total leukocytes in amniotic fluid, including neutrophils and monocytes/macrophages and (2) an increased number of total T cells in amniotic fluid, namely CD4+ T cells and CD8+ T cells, but not B cells. The numbers of neutrophils and monocytes/macrophages were positively correlated with IL-6 concentrations and WBC counts in amniotic fluid of women with pPROM. Conclusion Women with pPROM and a positive amniotic fluid culture exhibit a more severe cellular immune response than those with a negative culture, which is associated with well-known markers of intra-amniotic inflammation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Galaz</LastName>
            <ForeName>Jose</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Romero</LastName>
            <ForeName>Roberto</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Detroit Medical Center, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Florida International University, Miami, FL, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hutzel Women's Hospital, 3990 John R, Box 4, Detroit, MI 48201, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Slutsky</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Motomura</LastName>
            <ForeName>Kenichiro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Para</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pacora</LastName>
            <ForeName>Percy</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panaitescu</LastName>
            <ForeName>Bogdan</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hsu</LastName>
            <ForeName>Chaur-Dong</ForeName>
            <Initials>CD</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kacerovsky</LastName>
            <ForeName>Marian</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gomez-Lopez</LastName>
            <ForeName>Nardhy</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hutzel Women's Hospital, 3990 John R, Box 4, Detroit, MI 48201, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Perinat Med</MedlineTA>
        <NlmUniqueID>0361031</NlmUniqueID>
        <ISSNLinking>0300-5577</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">acute chorioamnionitis</Keyword>
        <Keyword MajorTopicYN="N">clinical chorioamnionitis</Keyword>
        <Keyword MajorTopicYN="N">fetal inflammatory response</Keyword>
        <Keyword MajorTopicYN="N">funisitis</Keyword>
        <Keyword MajorTopicYN="N">innate immune cells</Keyword>
        <Keyword MajorTopicYN="N">interleukin-6</Keyword>
        <Keyword MajorTopicYN="N">labor</Keyword>
        <Keyword MajorTopicYN="N">microbial invasion of the amniotic cavity</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">prematurity</Keyword>
        <Keyword MajorTopicYN="N">preterm labor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083453</ArticleId>
        <ArticleId IdType="doi">10.1515/jpm-2019-0395</ArticleId>
        <ArticleId IdType="pii">/j/jpme.ahead-of-print/jpm-2019-0395/jpm-2019-0395.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083454</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0334-1763</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Reviews in the neurosciences</Title>
          <ISOAbbreviation>Rev Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pridopidine in the treatment of Huntington's disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/revneuro-2019-0085</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/revneuro.ahead-of-print/revneuro-2019-0085/revneuro-2019-0085.xml</ELocationID>
        <Abstract>
          <AbstractText>Huntington's disease (HD) is a highly common inherited monogenic neurodegenerative disease, and the gene responsible for its development is located in the 4p16.3 chromosome. The product of that gene mutation is an abnormal huntingtin (Htt) protein that disrupts the neural conduction, thus leading to motor and cognitive disorders. The disease progresses to irreversible changes in the central nervous system (CNS). Although only a few drugs are available to symptomatic treatment, 'dopamine stabilizers' (as represented by the pridopidine) may be the new treatment options. The underlying causes of HD are dopaminergic conduction disorders. Initially, the disease is hyperkinetic (chorea) until it eventually reaches the hypokinetic phase. Studies confirmed a correlation between the amount of dopamine in the CNS and the stage of the disease. Pridopidine has the capacity to be a dopamine buffer, which could increase or decrease the dopamine content depending on the disease phase. A research carried out on animal models demonstrated the protective effect of pridopidine on nerve cells thanks to its ability to alter the cortical glutamatergic signaling through the N-methyl-D-aspartate (NMDA) receptors. Studies on dopamine stabilizers also reported that pridopidine has a 100-fold greater affinity for the sigma-1 receptor than for the D2 receptor. Disturbances in the activity of sigma-1 receptors occur in neurodegenerative diseases, including HD. Their interaction with pridopidine results in the neuroprotective effect, which is manifested as an increase in the plasticity of synaptic neurons and prevention of their atrophy within the striatum. To determine the effectiveness of pridopidine in the treatment of HD, large multicenter randomized studies such as HART, MermaiHD, and PRIDE-HD were carried out.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jabłońska</LastName>
            <ForeName>Magdalena</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0204-8134</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-090 Bydgoszcz, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grzelakowska</LastName>
            <ForeName>Klaudyna</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-090 Bydgoszcz, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wiśniewski</LastName>
            <ForeName>Bartłomiej</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-090 Bydgoszcz, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazur</LastName>
            <ForeName>Ewelina</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-090 Bydgoszcz, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leis</LastName>
            <ForeName>Kamil</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-090 Bydgoszcz, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gałązka</LastName>
            <ForeName>Przemysław</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncological Pediatric Surgery, Antoni Jurasz University Hospital No. 1 in Bydgoszcz, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-090 Bydgoszcz, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Rev Neurosci</MedlineTA>
        <NlmUniqueID>8711016</NlmUniqueID>
        <ISSNLinking>0334-1763</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ACR16</Keyword>
        <Keyword MajorTopicYN="N">NMDA receptor</Keyword>
        <Keyword MajorTopicYN="N">dopamine stabilizer</Keyword>
        <Keyword MajorTopicYN="N">neurodegenerative disease</Keyword>
        <Keyword MajorTopicYN="N">sigma-1 receptor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083454</ArticleId>
        <ArticleId IdType="doi">10.1515/revneuro-2019-0085</ArticleId>
        <ArticleId IdType="pii">/j/revneuro.ahead-of-print/revneuro-2019-0085/revneuro-2019-0085.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083455</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antioxidative and Angiogenesis-Promoting Effects of Tetrahedral Framework Nucleic Acids in Diabetic wound healing with activation of the Akt/Nrf2/HO-1 pathway.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.0c00874</ELocationID>
        <Abstract>
          <AbstractText>Currently available strategies show limited effects on preventing morbidity and disability from chronic diabetic wounds. Ideal vascularization is indispensable to better restoration and prognosis of diabetic wound. This study aims to investigate the role of tetrahedral framework nucleic acids (tFNAs) in the process of angiogenesis during diabetic wound healing and the underlying mechanism. The in vitro results showed that tFNAs treatment enhanced the formation of vessel-like structure that was inhibited by advanced glycation end products (AGEs). Positive variations were detected in aspects of cell viability, migratory ability, nitric oxide (NO) level and vascular endothelial growth factor-A (VEGF-A) expression. In addition, high reactive oxygen species (ROS) level and gene expressions relevant to oxidative damage and inflammation in diabetic HUVECs were attenuated by tFNAs. As for the underlying mechanism, p-Akt/total-Akt ratio, nuclear factor erythroid 2-related factor 2 (Nrf2) level and heme oxygenase-1 (HO-1) level were higher in diabetic HUVECs treated with tFNAs. In vivo experiments showed that tFNAs facilitated diabetic wound healing by accelerating vascularization, epithelialization, collagen deposition and collagen alignment. In conclusion, tFNAs could protect endothelial cell function, reduce inflammation and impede oxidative damage through their antioxidant activity via the Akt/Nrf2/HO-1 signaling pathway. The application of tFNAs may pave the way for better healing of diabetic wound.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Shi-Yu</ForeName>
            <Initials>SY</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Songhang</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lang</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Sirong</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cai</LastName>
            <ForeName>Xiaoxiao</ForeName>
            <Initials>X</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083455</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.0c00874</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083456</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Synthesis of Sulfur Doped 2D Graphitic Carbon Nitride Nanosheets for Efficient Photocatalytic Degradation of Phenol and Hydrogen Evolution.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.9b19057</ELocationID>
        <Abstract>
          <AbstractText>Sulfur doped 2D graphitic carbon nitride nanosheets (2D-SCN) with efficient photocatalytic activity were synthesized via 1) polycondensation of thiourea to form bulk sulfur doped graphitic carbon nitride (SCN), and 2) followed by thermal oxidative treatment of the prepared SCN via an etching strategy to form 2D-SCN. Sulfur was doped in-situ into SCN by using thiourea as the precursor and the 2D nanosheet structure was obtained during the thermal oxidative etching process. The structural, morphological, and optical properties of the 2D-SCN sample were investigated in detail. Herein it is showed that the thermal oxidative etching treatment and sulfur doping induced a two-dimensional nanosheet structure (2D-SCN-3h) with a thickness of about 4.0 nm and exposure of more sulfur elements on the surface. The surface area increased from 16.6 m2/g for SCN to 226.9 m2/g. Compared to bulk SCN, a blue shift of the absorption peaks was observed for the obtained 2D-SCN-3h photocatalyst, and the absorption intensity was higher than the sulfur free counterpart (2D-CN). The successful in-situ doping of S element into SCN or 2D-SCN-3h samples is beneficial to the introduction of surface N defects and O species. The 2D-SCN-3h indicated higher efficiency in photogenerated charge carrier separation and showed the highest reductive activity in photocatalytic splitting of water at a rate of 127.4 μmol/h under simulated solar light irradiation, which was 250 times and 3 times higher than that of SCN and 2D-CN photocatalysts, respectively. The Apparent Quantum Efficiency (AQE) was estimated to be 8.35% at 420 nm irradiation. S-C-N bond formed by sulfur doping was beneficial to charge transfer process and this led to higher photocatalytic activity according to Partial Density of States (PDOS) analysis computed by first principle methods.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Haiqin</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koodali</LastName>
            <ForeName>Ranjit T</ForeName>
            <Initials>RT</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Guimei</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Yubin</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Qingguo</ForeName>
            <Initials>Q</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Mingzhe</ForeName>
            <Initials>M</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083456</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.9b19057</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083457</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>High-loading boron nitride-based bioinspired paper with plastic-like ductility and metal-like thermal conductivity.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.9b21753</ELocationID>
        <Abstract>
          <AbstractText>Although desirable in next-generation flexible electronics, fabricating hybrid film materials with excellent integration of mechanical, thermally conductive yet electrically insulating properties is still under challenge. In mollusk nacre, a small volume of chitin nanofiber framework hosts 95 vol% CaCO3 microplatelets, enabling the high-loading natural composites to exhibit ductile deformation behavior. Inspired by this, we fabricate a large-area, boron nitride-based bioinspired paper by a facile sol-gel-film conversion approach, in which BN microplatelets with a loading of 40-80 wt% are embedded into 3D poly(p-phenylene benzobisoxazole) nanofiber framework. Due to the vital role of 3D nanofiber framework, the BN-based paper exhibits plastic-like ductility (38-80%), ultrahigh toughness (10-100 MJ m-3) and good folding endurance. The high-loading BN platelets form an oriented, percolative network, and impart the paper with outstanding in-plane thermal conductivity (77.1-214.2 W m-1 K-1), comparable to some metals, such as aluminum alloys (108-230 W m-1 K-1). Using the electrically insulating BN-based paper as a flexible substrate, we demonstrate its promising application for lowering the temperature of electronic device.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yunjing</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Guang</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di</LastName>
            <ForeName>Jiangtao</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jianfeng</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083457</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.9b21753</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083458</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Novel boron doped p-type Cu2O thin film as hole selective contact in c-Si solar cell.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.9b22581</ELocationID>
        <Abstract>
          <AbstractText>P-type Cu2O thin film doped with trivalent cation Boron is demonstrated for the first time as an efficient hole selective layer for c-Si heterojunction solar cell. Cu2O and Cu2O:B films were deposited by rf- magnetron sputtering and the optical and electrical properties of the doped and undoped films were investigated. Boron doping enhanced the carrier concentration and the electrical conductivity of the Cu2O film. The band alignment of the Cu2O:B/Si heterojunction was investigated using XPS and UPS measurements. The Cu2O:B/Si interface has a valance band offset of 0.08 eV which facilitates hole transport and a conduction band offset of 1.35 eV which block the electrons. A thin SiOx tunnel oxide interlayer was also explored as the passivation layer. The initial trials of incorporating this Cu2O:B layer as hole transporting layer in a single heterojunction solar cell with the structure, ITO/Cu2O:B/n-Si/Ag, and cell area of 1 cm2 yielded an open-circuit voltage of 370 mV, short-circuit current density of 36.5 mA/cm2 and an efficiency of 5.4 %. This p-type material could find potential applications in various optoelectronic applications like organic solar cells, TFTs, LEDs etc.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>K Markose</LastName>
            <ForeName>Kurias</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaji</LastName>
            <ForeName>Manu</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhatia</LastName>
            <ForeName>Swasti</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nair</LastName>
            <ForeName>Pradeep R</ForeName>
            <Initials>PR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saji</LastName>
            <ForeName>Kachirayil J</ForeName>
            <Initials>KJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antony</LastName>
            <ForeName>Aldrin</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jayaraj</LastName>
            <ForeName>Madambi K</ForeName>
            <Initials>MK</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083458</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.9b22581</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083459</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1948-7193</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS chemical neuroscience</Title>
          <ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Underpinning the Neurobiological Intricacies Associated with Opioid Tolerance.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acschemneuro.0c00019</ELocationID>
        <Abstract>
          <AbstractText>Opioid crisis is a major threat of 21st century with a remarkable juxtaposition of use and abuse. Opioids are the most potent and efficacious class of analgesics but despite their proven therapeutic efficacy they have recently been degraded to third-line of therapy for the management of chronic pain in clinics. The reason behind is the development of potential side effects and tolerance after repeated dosing. Opioid tolerance is the major limiting factor leading to the treatment withdrawal, severe side effects due to dose escalation and sometimes even death of the patients. Every day more than 90 people die due to the overdose of opioids in America and similar trend has been seen across the globe. Researchers in past two decades are trying to dissect the neurobiological mechanism of opioid tolerance. Research on opioid tolerance shifted towards the CNS based adaptations because tolerance is much more than just being a cellular phenomenon. Thus, neurobiological adaptations associated with opioid tolerance are important to understand in order to set newer pain therapeutics. These adaptations are associated with the alterations in ascending and descending pain pathways, reward circuitry modulations, receptor desensitization and down-regulation, receptor internalization, heterodimerization and altered epigenetic regulation. The present review is focussed on novel circuitries in different brain areas such as periaqueductal gray (PAG), rostral ventromedial medulla (RVM), dorsal raphe nucleus (DRN), ventral tegmental area (VTA), and nucleus accumbens (NAc) associated with opioid tolerance. Understanding the neurobiological modulations associated with chronic opioid exposure and tolerance will pave the way for development of novel pharmacological tools for the safe and better management of chronic pain in patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Uniyal</LastName>
            <ForeName>Ankit</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gadepalli</LastName>
            <ForeName>Anagha</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>-</LastName>
            <ForeName>Akhilesh</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tiwari</LastName>
            <ForeName>Vinod</ForeName>
            <Initials>V</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Chem Neurosci</MedlineTA>
        <NlmUniqueID>101525337</NlmUniqueID>
        <ISSNLinking>1948-7193</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083459</ArticleId>
        <ArticleId IdType="doi">10.1021/acschemneuro.0c00019</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083460</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Auger Suppression of Nanotube Incandescence in Individual Suspended CNT pn-junctions.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.9b17519</ELocationID>
        <Abstract>
          <AbstractText>There are various mechanisms of light emission in carbon nanotubes (CNTs), which give rise to a wide range of spectral characteristics that provide important information. Here, we report suppression of incandescence via Auger recombination in suspended carbon nanotube pn-junctions generated from dual-gate CNT field effect transistor (FET) devices. By applying equal and opposite voltages to the gate electrodes (i.e., V<sub>g1</sub> = -V<sub>g2</sub>), we create a pn-junction within the CNT. Under these gating conditions, we observe a sharp peak in the incandescence intensity around zero applied gate voltage, where the intrinsic region has the largest spatial extent. Here, the emission occurs under high electrical power densities around 0.1MW/cm<sup>2</sup> (or 6µW) and arises from thermal emission at elevated temperatures above 800K (i.e., incandescence). It is somewhat surprising that this thermal emission intensity is so sensitive to the gating conditions, and we observe a 1000-fold suppression of light emission between V<sub>g1</sub>=0V and V<sub>g1</sub>=15V, over a range in which the electrical power dissipated in the nanotube is roughly constant. This behavior is understood on the basis of Auger recombination, which suppresses light emission by the excitation of free carriers. Based on the calculated carrier density and band profiles, the length of the intrinsic region drops by a factor of 7-25X over the range from |V<sub>g</sub>|=0V to 15V. We, therefore, conclude that the light emission intensity is significantly dependent on the free carrier density profile and the size of the intrinsic region in these CNT devices.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Sisi</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahsan</LastName>
            <ForeName>Ragib</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Xiaowei</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Younghee</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Htoon</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kapadia</LastName>
            <ForeName>Rehan</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>John</LastName>
            <ForeName>Demis D</ForeName>
            <Initials>DD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thibeault</LastName>
            <ForeName>Brian</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doorn</LastName>
            <ForeName>Stephen K</ForeName>
            <Initials>SK</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cronin</LastName>
            <ForeName>Stephen B</ForeName>
            <Initials>SB</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083460</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.9b17519</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083461</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Gold Nanobipyramid-Based Nanotheranostics for Dual-Modality Imaging Guided Phototherapy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.0c00112</ELocationID>
        <Abstract>
          <AbstractText>Multimodality imaging-guided therapy can improve the diagnostics and therapeutics efficiency of cancer. Herein, we developed a light-responsive nanotheranostic agent based on indocyanine green (ICG) conjugated mesoporous silica coated gold nanobipyramid (GNB@SiO2) (denoted as GNB@SiO2-ICG) for simultaneous fluorescence (FL)/photoacoustic (PA) imaging guided photothermal therapy (PTT). The GNB@SiO2 with excellent photostability was used for PA imaging as well as PTT. The loaded ICG promised FL imaging and PTT. The feasibility of cancer theranostic capability of GNB@SiO2-ICG were evaluated from cancer cells to mice. Under the guidance of FL/PA imaging, GNB@SiO2-ICG exhibited remarkably enhanced therapeutic efficacy, which could eliminate the tumor tissues completely without tumor recurrence. This well-defined nanotheranostic nanoplatform that intelligently integrates dual-modality imaging and phototherapy, provides an efficient nanoplatform for cancer nanotheranostics.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chunxiao</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mei</LastName>
            <ForeName>Enci</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Cunguo</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yashi</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nugasur</LastName>
            <ForeName>Bhawneeta</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hou</LastName>
            <ForeName>Liyue</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ding</LastName>
            <ForeName>Xiaoxia</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Murong</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yifan</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Zhongqian</ForeName>
            <Initials>Z</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Peng</ForeName>
            <Initials>P</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhiming</ForeName>
            <Initials>Z</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083461</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.0c00112</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083462</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1554-8937</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS chemical biology</Title>
          <ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in vitro.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.9b00454</ELocationID>
        <Abstract>
          <AbstractText>Proteolytic complexes in Mycobacterium tuberculosis (Mtb), the deadliest bacterial pathogen, are major foci in tuberculosis drug development programs. The Clp proteases, which are essential for Mtb viability, are high priority targets. These proteases function through the collaboration of ClpP1P2, a barrel-shaped heteromeric peptidase, with associated ATP-dependent chaperones like ClpX and ClpC1 that recognize and unfold specific substrates in an ATP-dependent fashion. The critical interaction of the peptidase and its unfoldase partners is blocked by the competitive binding of acyldepsipeptide antibiotics (ADEPs) to the interfaces of the ClpP2 subunits. The resulting inhibition of Clp protease activity is lethal to Mtb. Here, we report the surprising discovery that a fragment of the ADEPs retains anti-Mtb activity, yet stimulates rather than inhibits the ClpXP1P2-catalyzed degradation of proteins. Our data further suggest that the fragment stabilizes the ClpXP1P2 complex and binds ClpP1P2 in a fashion distinct from the intact ADEPs. A structure-activity relationship study of the bioactive fragment defines the pharmacophore and points the way towards the development of new drug leads for the treatment of tuberculosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schmitz</LastName>
            <ForeName>Karl R</ForeName>
            <Initials>KR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Handy</LastName>
            <ForeName>Emma L</ForeName>
            <Initials>EL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Compton</LastName>
            <ForeName>Corey L</ForeName>
            <Initials>CL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Shashank</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bishai</LastName>
            <ForeName>William R</ForeName>
            <Initials>WR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sauer</LastName>
            <ForeName>Robert T</ForeName>
            <Initials>RT</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sello</LastName>
            <ForeName>Jason K</ForeName>
            <Initials>JK</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Chem Biol</MedlineTA>
        <NlmUniqueID>101282906</NlmUniqueID>
        <ISSNLinking>1554-8929</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083462</ArticleId>
        <ArticleId IdType="doi">10.1021/acschembio.9b00454</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083463</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6882</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Analytical chemistry</Title>
          <ISOAbbreviation>Anal. Chem.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Metabolomics with <sup>15</sup>N Labeling for Characterizing Missing Monoterpene Indole Alkaloids in Plants.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.analchem.9b03860</ELocationID>
        <Abstract>
          <AbstractText>Monoterpene indole alkaloids (MIAs) in medicinal plants remain uncharacterized owing to their complicated structure by metabolomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS) despite their pharmaceutical importance. We demonstrate an untargeted metabolome analysis with <sup>15</sup>nitrogen (N) labeling to characterize MIAs having an indolic skeleton in the flowers, leaves, petioles, stems, and roots of <i>Catharanthus roseus</i>. Principal component analysis using <sup>15</sup>N- and nonlabeled metabolome data showed that N-containing metabolites (N-metabolites) are labeled with <sup>15</sup>N. Paring of the <sup>15</sup>N- and nonlabeled precursor ions were performed using the criteria of retention time, difference of <i>m</i>/<i>z</i> value, and a nonlabeled product ion at <i>m</i>/<i>z</i> 144.08 that indicates an indolic skeleton. The mass shift of the <i>m</i>/<i>z</i> value of the product and precursor ions to their <sup>15</sup>N-labeled ions identified the number of N of their ions. Finally, molecular formula of 45 MIAs was unambiguously identified using the identified N number. The alkaloid network analysis using the MS/MS similarity showed the structural commonness and uniqueness among the MIAs. Of them, antirhine was identified using an authentic standard compound. Multimetabolomics using LC-MS/MS and imaging mass spectrometry showed that antirhine accumulates considerably in the epidermis and vascular cylinder of the roots. The developed approach showed the existence of the missing MIAs. The modification of this approach will identify other MIAs that contain a hydroxylated or methoxylated indolic skeleton.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nakabayashi</LastName>
            <ForeName>Ryo</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-8674-0928</Identifier>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Sustainable Resource Science , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mori</LastName>
            <ForeName>Tetsuya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Sustainable Resource Science , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takeda</LastName>
            <ForeName>Noriko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Sustainable Resource Science , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Toyooka</LastName>
            <ForeName>Kiminori</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Sustainable Resource Science , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sudo</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medicinal Plant Garden , Hoshi University , Ebara 2-4-41 Shinagawa-ku , Tokyo , 142-8501 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsugawa</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2015-3958</Identifier>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Sustainable Resource Science , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Integrative Medical Sciences , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saito</LastName>
            <ForeName>Kazuki</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-6310-5342</Identifier>
            <AffiliationInfo>
              <Affiliation>RIKEN Center for Sustainable Resource Science , 1-7-22 Suehiro-cho, Tsurumi-ku , Yokohama 230-0045 , Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate School of Pharmaceutical Sciences , Chiba University , 1-8-1 Inohana, Chuo-ku , Chiba 260-8675 , Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anal Chem</MedlineTA>
        <NlmUniqueID>0370536</NlmUniqueID>
        <ISSNLinking>0003-2700</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083463</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.analchem.9b03860</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083464</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1948-7193</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS chemical neuroscience</Title>
          <ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Zebrafish-Based Screening of Antiseizure Plants Used in Traditional Chinese Medicine: <i>Magnolia officinalis</i> Extract and Its Constituents Magnolol and Honokiol Exhibit Potent Anticonvulsant Activity in a Therapy-Resistant Epilepsy Model.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acschemneuro.9b00610</ELocationID>
        <Abstract>
          <AbstractText>With the aim to discover interesting lead compounds that could be further developed into compounds active against pharmacoresistant epilepsies, we first collected 14 medicinal plants used in traditional Chinese medicine (TCM) against epilepsy. Of the six extracts that tested positive in a pentylenetetrazole (PTZ) behavioral zebrafish model, only the ethanol and acetone extracts from <i>Magnolia officinalis</i> (<i>M. officinalis</i>) also showed effective antiseizure activity in the ethylketopentenoate (EKP) zebrafish model. The EKP model is regarded as an interesting discovery platform to find mechanistically novel antiseizure drugs, as it responds poorly to a large number of marketed anti-epileptics. We then demonstrated that magnolol and honokiol, two major constituents of <i>M. officinalis</i>, displayed an effective behavioral and electrophysiological antiseizure activity in both the PTZ and the EKP models. Out of six structural analogues tested, only 4-<i>O</i>-methylhonokiol was active and to a lesser extent tetrahydromagnolol, whereas the other analogues (3,3'-dimethylbiphenyl, 2,2'-biphenol, 2-phenylphenol, and 3,3',5,5'-tetra-<i>tert</i>-butyl-[1,1'-biphenyl]-2,2'-diol) were not consistently active in the aforementioned assays. Finally, magnolol was also active in the 6 Hz psychomotor mouse model, an acute therapy-resistant rodent model, thereby confirming the translation of the findings from zebrafish larvae to mice in the field of epilepsy. We also developed a fast and automated power spectral density (PSD) analysis of local field potential (LFP) recordings. The PSD results are in agreement with the visual analysis of LFP recordings using Clampfit software and manually counting the epileptiform events. Taken together, screening extracts of single plants employed in TCM, using a combination of zebrafish- and mouse-based assays, allowed us to identify allyl biphenol as a chemical scaffold for the future development of compounds with potential activity against therapy-resistant epilepsies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7267-0359</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences , KU Leuven , 3000 Leuven , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Copmans</LastName>
            <ForeName>Daniëlle</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-9804-8410</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences , KU Leuven , 3000 Leuven , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Partoens</LastName>
            <ForeName>Michèle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences , KU Leuven , 3000 Leuven , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hunyadi</LastName>
            <ForeName>Borbála</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, Department of Electrical Engineering (ESAT) , KU Leuven , 3001 Leuven , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luyten</LastName>
            <ForeName>Walter</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology , KU Leuven , 3000 Leuven , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Witte</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences , KU Leuven , 3000 Leuven , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Chem Neurosci</MedlineTA>
        <NlmUniqueID>101525337</NlmUniqueID>
        <ISSNLinking>1948-7193</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antiseizure activity</Keyword>
        <Keyword MajorTopicYN="N">Antiseizure drug discovery</Keyword>
        <Keyword MajorTopicYN="N">Honokiol</Keyword>
        <Keyword MajorTopicYN="N">Magnolol</Keyword>
        <Keyword MajorTopicYN="N">Pharmacoresistant model</Keyword>
        <Keyword MajorTopicYN="N">Zebrafish</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083464</ArticleId>
        <ArticleId IdType="doi">10.1021/acschemneuro.9b00610</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083465</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hierarchical Core-Shell Structure of 2D VS2@VC@N-Doped Carbon Sheets Decorated by Ultrafine Pd Nanoparticles: Assembled in 3D Rosette-like Array on Carbon Fiber Microelectrode for Electrochemical Sensing.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.9b21436</ELocationID>
        <Abstract>
          <AbstractText>The development of two-dimension (2D) nanohybrid materials with heterogeneous component in nanoscale and three-dimension (3D) well-ordered assembly in microscale has been regarded as an effective way to improve their overall performances by synergistic coupling of the optimized structure and composition. In this work, we reported the design and synthesis of a new type of hierarchically core-shell structure of 2D VS2@VC@N-doped carbon (NC) sheets decorated by ultrafine Pd nanoparticles (PdNPs), which were vertically grown on carbon fiber (CF) and assembled into a unique 3D rosette-like array. The resultant VS2@VC@NC-PdNPs modified CF microelectrode integrated the structural and electrochemical properties of the heterogeneous hybridization of core-shell VS2@VC@NC-PdNPs sheets with unique rosette-like array structure, and gave rise to a significant improvement in terms of electron transfer ability, electrocatalytic activity, stability and biocompatibility. Under the optimized conditions, the VS2@VC@NC-PdNPs modified CF microelectrode demonstrated excellent electrochemical sensing performance towards biomarker hydrogen peroxide (H2O2) including high sensitivity of 152.7 μA cm-2 mM-1, low detection limit of 50 nM (a signal-to-noise ratio of 3:1), as well as good reproducibility and anti-interference ability, which could be used for real-time in situ electrochemical detection of H2O2 in live cancer cells and cancer tissue. The remarkable performances of the proposed nanohybrid microelectrode will have a profound impact on the design of diverse 2D layered materials as promising candidate for electrochemical biosensing applications.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Hao</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Jianquan</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qijun</ForeName>
            <Initials>Q</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manoj</LastName>
            <ForeName>Devaraj</ForeName>
            <Initials>D</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Anshun</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chi</LastName>
            <ForeName>Kai</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Jinghua</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Wenshan</ForeName>
            <Initials>W</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Yimin</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Shuai</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083465</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.9b21436</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083466</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1936-086X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS nano</Title>
          <ISOAbbreviation>ACS Nano</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsnano.9b09263</ELocationID>
        <Abstract>
          <AbstractText>Triple-negative breast cancer (TNBC) accounts for nearly one-quarter of all breast cancer cases, but effective targeted therapies for this disease remain elusive because TNBC cells lack expression of the three most common receptors seen on other subtypes of breast cancer. Here, we exploit TNBC cells' overexpression of Notch-1 receptors and Bcl-2 anti-apoptotic proteins to provide an effective targeted therapy. Prior studies have shown that the small molecule drug ABT-737, which inhibits Bcl-2 to reinstate apoptotic signaling, is a promising candidate for TNBC therapy. However, ABT-737 is poorly soluble in aqueous conditions and its orally bioavailable derivative causes severe thrombocytopenia. To enable targeted delivery of ABT-737 to TNBC and enhance its therapeutic efficacy, we encapsulated the drug in poly(lactic co-glycolic acid) nanoparticles (NPs) that were functionalized with Notch-1 antibodies to produce N1-ABT-NPs. The antibodies in this NP platform enable both TNBC cell-specific binding and suppression of Notch signaling within TNBC cells by locking the Notch-1 receptors in a ligand unresponsive state. This Notch inhibition potentiates the effect of ABT-737 by up-regulating Noxa, resulting in effective killing of TNBC cells. We present the results of in vitro studies that demonstrate N1-ABT-NPs can preferentially bind TNBC cells versus non-cancerous breast epithelial cells to effectively regulate Bcl-2 and Notch signaling to induce cell death. Further, we show that N1-ABT-NPs can accumulate in subcutaneous TNBC xenograft tumors in mice following systemic administration to reduce tumor burden and extend animal survival. Together, these findings demonstrate that nanoparticle-mediated co-delivery of Notch-1 antibodies and ABT-737 is a potent treatment strategy for TNBC that may improve patient outcomes with further development and implementation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Valcourt</LastName>
            <ForeName>Danielle M</ForeName>
            <Initials>DM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dang</LastName>
            <ForeName>Megan N</ForeName>
            <Initials>MN</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scully</LastName>
            <ForeName>Mackenzie A</ForeName>
            <Initials>MA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Day</LastName>
            <ForeName>Emily S</ForeName>
            <Initials>ES</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Nano</MedlineTA>
        <NlmUniqueID>101313589</NlmUniqueID>
        <ISSNLinking>1936-0851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083466</ArticleId>
        <ArticleId IdType="doi">10.1021/acsnano.9b09263</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083467</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6882</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Analytical chemistry</Title>
          <ISOAbbreviation>Anal. Chem.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Structural analysis of the glycoprotein complex avidin by tandem-trapped ion mobility spectrometry - mass spectrometry (tandem-TIMS/MS).</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.analchem.9b05481</ELocationID>
        <Abstract>
          <AbstractText>Glycoproteins play a central role in many biological processes including disease mechanisms. Nevertheless, because glycoproteins are heterogeneous entities, it remains unclear how glycosylation modulates the protein structure and function. Here, we assess the ability of tandem-trapped ion mobility spectrometry - mass spectrometry (tandem-TIMS/MS) to characterize the structure and sequence of the homo-tetrameric glycoprotein avidin. We show that (1) tandem-TIMS/MS retains native-like avidin tetramers with deeply buried solvent particles; (2) applying high activation voltages in the interface of tandem-TIMS results in collision-induced dissociation (CID) of avidin tetramers into compact monomers, dimers, and trimers with cross sections consistent with x-ray structures and reports from surface-induced dissociation (SID); (3) avidin oligomers are best described as heterogeneous ensembles with (essentially) random combinations of monomer glycoforms; (4) native top-down sequence analysis of the avidin tetramer is possible by CID in tandem-TIMS. Overall, our results demonstrate that tandem-TIMS/MS has the potential to correlate individual proteoforms to variations in protein structure.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Fanny C</ForeName>
            <Initials>FC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cropley</LastName>
            <ForeName>Tyler C</ForeName>
            <Initials>TC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ridgeway</LastName>
            <ForeName>Mark E</ForeName>
            <Initials>ME</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Melvin A</ForeName>
            <Initials>MA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bleiholder</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anal Chem</MedlineTA>
        <NlmUniqueID>0370536</NlmUniqueID>
        <ISSNLinking>0003-2700</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083467</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.analchem.9b05481</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083468</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6882</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Analytical chemistry</Title>
          <ISOAbbreviation>Anal. Chem.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Diaphorase-Catalyzed Formation of a Formazan Precipitate and Its Electrodissolution for Sensitive Affinity Biosensors.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.analchem.9b05430</ELocationID>
        <Abstract>
          <AbstractText>Catalytic precipitation and subsequent electrochemical oxidation or reduction of a redox-active precipitate has been widely used in electrochemical biosensors. However, such biosensors often do not allow for low detection limits due to a low rate of precipitation, nonspecific precipitation, loose binding of the precipitate to the electrode surface, and insulating behavior of the precipitate within a normal potential window. Here, we report an ultrasensitive electrochemical immunosensor for parathyroid hormone (PTH) detection based on DT-diaphorase (DT-D)-catalyzed formation of an organic precipitate and electrochemical oxidation of the precipitate. In the present study we found that DT-D can be used as a catalytic label in precipitation-based affinity biosensors because DT-D catalyzes fast reduction of 3-(4,-5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to MTT-formazan precipitate; the MTT reduction does not occur in the absence of DT-D; and a high electrochemical signal is obtained at low potentials during electrodissolution of MTT-formazan precipitate. The immunosensor is fabricated using a silane copolymer-modified ITO electrode surface that is suitable for both efficient and strong adsorption of MTT-formazan precipitate. When the enzymatic MTT-formazan precipitation and subsequent MTT-formazan electrodissolution is applied to a sandwich-type immunosensor, PTH can be detected over a wide range of concentrations with a very low detection limit (∼1 pg/mL) in artificial serum. The measured concentrations of PTH in clinical serum samples showed high similarity with those obtained using a commercial instrument.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Haque</LastName>
            <ForeName>Al-Monsur Jiaul</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Chemistry Institute for Functional Materials , Pusan National University , Busan 46241 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nandhakumar</LastName>
            <ForeName>Ponnusamy</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Chemistry Institute for Functional Materials , Pusan National University , Busan 46241 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Gyeongho</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Chemistry Institute for Functional Materials , Pusan National University , Busan 46241 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Seonhwa</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Chemistry Institute for Functional Materials , Pusan National University , Busan 46241 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Byeongjun</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences , Korea Advanced Institute of Science and Technology (KAIST) , Daejeon 34141 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Nam-Sihk</ForeName>
            <Initials>NS</Initials>
            <AffiliationInfo>
              <Affiliation>EONE Laboratories , Incheon 22014 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoon</LastName>
            <ForeName>Young Ho</ForeName>
            <Initials>YH</Initials>
            <AffiliationInfo>
              <Affiliation>EONE Laboratories , Incheon 22014 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jon</LastName>
            <ForeName>Sangyong</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-6971-586X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences , Korea Advanced Institute of Science and Technology (KAIST) , Daejeon 34141 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Haesik</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-7450-5915</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Chemistry Institute for Functional Materials , Pusan National University , Busan 46241 , Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anal Chem</MedlineTA>
        <NlmUniqueID>0370536</NlmUniqueID>
        <ISSNLinking>0003-2700</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083468</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.analchem.9b05430</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083469</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chemical Alterations of Dissolved Organic Matter by Permanganate Oxidation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b06675</ELocationID>
        <Abstract>
          <AbstractText>Dissolved organic matter (DOM) is ubiquitous in raw drinking water and can efficiently scavenge oxidants, such as permanganate. Here, changes to DOM induced by permanganate oxidation under typical drinking water treatment conditions (6 µM, 1 hr) to bulk DOM properties, DOM functional groups, and DOM chemical formulae were examined for two DOM isolate types (terrestrial and microbial). Permanganate oxidation did not mineralize DOM, rather changes were compositional in nature. Optical properties suggest that permanganate oxidation decreased DOM aromaticity (decreased SUVA-254), decreased DOM electron donating capacity, and decreased DOM average molecular weight (increased E2/E3 ratios). Fourier transform-infrared spectroscopy second derivative analyses revealed that permanganate does not oxidize DOM alkene groups, suggesting permanganate access to functional groups may be important. Four ionization techniques were used with ultrahigh resolution mass spectrometry: negative and positive ion mode electrospray ionization and negative and positive ion mode laser/desorption ionization. The results from all four techniques were combined to understand changes in DOM chemical formulae. It was concluded that nitrogen-containing aromatic compounds and alkylbenzenes were oxidized by permanganate to form nitrogen-containing aliphatic compounds and benzoic acid-containing compounds. This work highlights how multiple ionization techniques coupled with UHR-MS can enable a more detailed characterization of DOM.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Laszakovits</LastName>
            <ForeName>Juliana R</ForeName>
            <Initials>JR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Somogyi</LastName>
            <ForeName>Arpad</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>MacKay</LastName>
            <ForeName>Allison A</ForeName>
            <Initials>AA</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083469</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b06675</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083470</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5010</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemical research in toxicology</Title>
          <ISOAbbreviation>Chem. Res. Toxicol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Biotransformation Mechanism of Pesticides by Cytochrome P450: A DFT Study on Dieldrin.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.chemrestox.0c00013</ELocationID>
        <Abstract>
          <AbstractText>Pesticide biotransformation, especially by cytochrome P450 enzymes (CYPs), may produce metabolites with substantially altered toxicological and physicochemical profiles, which has drawn great attention as a basis for environmental risk assessment. CYPs are active in the metabolism of various reactions of pesticides, and there are potential different short-lived oxidant species in CYPs (Compound I vs. Compound 0), which makes elucidating their biotransformation mechanism challenging. To facilitate this task, we performed density functional theory (DFT) calculations to explore the puzzled bifurcation pathways of dieldrin by CYPs. The results show that the two-oxidant mechanism doesn't work, while the bifurcation pathways are within the mechanistic framework of two-state reactivity of Compound I. Specifically, 9-hydroxy-dieldrin as hydroxylation product is formed via H-abstraction and essentially barrierless C-9 alkyl radical rebound in doublet-state; while 3-ketone-dieldrin as dechlorination product is formed via H-abstraction, C-9 alkyl radical cyclization and C-3 cyclized radical rebound in quartet-state followed by HCl elimination, originated from a significant barrier for C-9 alkyl radical rebound in quartet-state to provide this radical sufficient lifetime for cyclization. Thus, the ratio [dechlorination]/[hydroxylation] can be estimated as 1:35, in consistent with the experimental findings. We envision that application of computational chemistry has the great potential in revealing complex biotransformation mechanisms of pesticides.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chai</LastName>
            <ForeName>Lihong</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Shujing</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shubin</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Haiying</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Meirong</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Chem Res Toxicol</MedlineTA>
        <NlmUniqueID>8807448</NlmUniqueID>
        <ISSNLinking>0893-228X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083470</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.chemrestox.0c00013</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083471</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6882</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Analytical chemistry</Title>
          <ISOAbbreviation>Anal. Chem.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analysis of the Stable Isotope Ratios (18O/16O, 17O/16O and D/H) in Glacier Water by Laser Spectrometry.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.analchem.9b05679</ELocationID>
        <Abstract>
          <AbstractText>A compact isotope ratio sensor based on laser absorption spectroscopy at 2.7 μm was developed for high precision and simultaneous measurements of the D/H, 18O/16O and 17O/16O isotope ratios in glacier water. Measurements of the oxygen and hydrogen isotope ratios in glacier water demonstrate a 1σ precision of 0.3‰ for δ18O, 0.2‰ for δ17O and 0.5‰ for δ2H respectively. The δ values of the working standard glacier water obtained by the calibrated sensor system is basically identical to the IRMS measurement results with a very high calibration accuracy from 0.17‰ to 0.75‰. Preliminary results on the reproducibility measurements display a standard deviation of 0.13‰ for δ18O, 0.13‰ for δ17O and 0.64‰ for δ2H respectively.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Xiaojuan</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Weidong</ForeName>
            <Initials>W</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sigrist</LastName>
            <ForeName>Markus Werner</ForeName>
            <Initials>MW</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fertein</LastName>
            <ForeName>Eric</ForeName>
            <Initials>E</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anal Chem</MedlineTA>
        <NlmUniqueID>0370536</NlmUniqueID>
        <ISSNLinking>0003-2700</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083471</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.analchem.9b05679</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083472</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Elucidating toxicodynamic differences at the molecular scale between ZnO NPs and ZnCl2 in Enchytraeus crypticus via non-targeted metabolomics.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.0c00663</ELocationID>
        <Abstract>
          <AbstractText>Much efforts have been devoted to clarifying the comparative toxicity of ZnO nanoparticles and Zn ions, however, little is known about their toxicodynamic processes at the metabolic level. Here, we investigated the acute (2d) and chronic (7d) effects to a soil species Enchytraeus crypticus of two sublethal doses of ZnO-NPs and ZnCl2 (10 and 30 mg/L Zn) using UHPLC-Q-TOF/MS-based metabolomics. The metabolomics analysis identified 99, 128, 121, and 183 significantly changed metabolites (SCMs) in E. crypticus exposed to ZnO-NPs for 2d, ZnCl2 for 2d, ZnO-NPs for 7d, and ZnCl2 for 7d, respectively, suggesting ZnCl2 induced stronger metabolic reprogramming than ZnO-NPs and a longer exposure time caused greater metabolite changes. Among the SCMs, 67 were shared by ZnO-NPs and ZnCl2 after 2d, and 84 after 7d. These metabolites were mainly related to oxidative stress and antioxidant defense, membrane disturbance, and energy expenditure. The targeted analysis on physiological and biochemical responses further proved the metabolic observations. Nevertheless, 32 (33%) and 37 (31%) SCMs were found only in ZnO-NPs treatments after 2d and 7d, respectively, suggesting the toxicity of ZnO-NPs cannot be solely attributed to the released Zn ions. Metabolic pathways analysis revealed significant perturbations of galactose metabolism, amino sugar and nucleotide sugar metabolism, and glycerophospholipid metabolism in all test groups. Based on involvement frequency, glucose-1-phosphate, glycerol 3-phosphate, and phosphorylcholine could serve as universal biomarkers for exposure to different Zn forms. Four pathways perturbed by ZnO-NPs were nanospecific upon acute exposure, and 3 upon chronic exposure. Our findings demonstrated that metabolomics is an effective tool for understanding the molecular toxicity mechanism and highlighted that time-series measurements are essential for discovering and comparing modes of action of metal ions and NPs.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Erkai</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiu</LastName>
            <ForeName>Rong-Liang</ForeName>
            <Initials>RL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Xinde</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Lan</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peijnenburg</LastName>
            <ForeName>Willie Jgm</ForeName>
            <Initials>WJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiu</LastName>
            <ForeName>Hao</ForeName>
            <Initials>H</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083472</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.0c00663</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083473</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4602</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biomacromolecules</Title>
          <ISOAbbreviation>Biomacromolecules</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reactive oxygen species (ROS)-responsive polymersomes with site-specific chemotherapeutic delivery into tumors via spacer design chemistry.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.biomac.9b01748</ELocationID>
        <Abstract>
          <AbstractText>The lack of cellular and tissue specificity in conventional chemotherapies along with the generation of a complex tumor microenvironment (TME) limit the dosage of active agents that reaches tumor sites thereby resulting in ineffective responses and side effects. Therefore, the development of selective TME responsive nanomedicines is of due relevance towards successful chemotherapies, albeit challenging. In this framework, we have synthesized novel, ready-to-use ROS-responsive amphiphilic block copolymers (BCs) with two different spacer chemistry designs to connect a hydrophobic boronic ester-based ROS sensor into the polymer backbone. Hydrodynamic flow focusing nanoprecipitation microfluidics (MF) was used in the preparation of well-defined ROS-responsive PSs there were further characterized by a combo of techniques (1H NMR, DLS, SLS, TEM and cryo-TEM). The reaction with hydrogen peroxide releases an amphiphilic phenol or a hydrophilic carboxylic acid which impacts polymersome (PS) stability and cargo release. Therefore, the importance of the spacer chemistry in BCs deprotection and PSs stability and cargo release is herein highlighted. We have also evaluated the impact of spacer chemistry on PS-specific release of the chemotherapeutic drug doxorubicin (DOX) into tumors in vitro and in vivo. We demonstrate that by spacer chemistry design one can enhance the efficacy of DOX treatments (decrease in tumor growth and prolonged animal survival) in mice bearing EL4 T cell lymphoma. Side effects (weight loss and cardiotoxicity) were also reduced compared to free DOX administration highlighting the potential of the well-defined ROS-responsive PSs as TME selective nanomedicines. The PSs could also find applications in other environments with high ROS-levels, such as, for instance, chronic inflammations, aging, diabetes, cardiovascular diseases and obesity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jager</LastName>
            <ForeName>Eliezer</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sincari</LastName>
            <ForeName>Vladimir</ForeName>
            <Initials>V</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Albuquerque</LastName>
            <ForeName>Lindomar J C</ForeName>
            <Initials>LJC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jager</LastName>
            <ForeName>Alessandro</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Humajova</LastName>
            <ForeName>Jana</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kucka</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pankrac</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paral</LastName>
            <ForeName>Petr</ForeName>
            <Initials>P</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Heizer</LastName>
            <ForeName>Tomas</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janoušková</LastName>
            <ForeName>Olga</ForeName>
            <Initials>O</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Konefal</LastName>
            <ForeName>Rafal</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavlova</LastName>
            <ForeName>Ewa</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sedlacek</LastName>
            <ForeName>Ondrej</ForeName>
            <Initials>O</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giacomelli</LastName>
            <ForeName>Fernando C</ForeName>
            <Initials>FC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pouckova</LastName>
            <ForeName>Pavla</ForeName>
            <Initials>P</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sefc</LastName>
            <ForeName>Ludek</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stepanek</LastName>
            <ForeName>Petr</ForeName>
            <Initials>P</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hruby</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biomacromolecules</MedlineTA>
        <NlmUniqueID>100892849</NlmUniqueID>
        <ISSNLinking>1525-7797</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083473</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.biomac.9b01748</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083474</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Enrichment of nitrogen fixing bacteria in a nitrogen deficient wastewater treatment system.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b05322</ELocationID>
        <Abstract>
          <AbstractText>Anthropogenic nitrogen fixation is essential to sustain a global population of 7.7 billion. However, there has been a long-standing desire to find cheaper and more environmentally friendly alternatives to the Haber Bosch process. In this study, we developed a new strategy of nitrogen fixation by enriching free-living N2 fixing bacteria (NFB) in reactors fed with low nitrogen wastewater, analogous to those usually found in certain industrial effluents such as paper mills. Our reactors fixed appreciable quantities of nitrogen with a rate of 11.8 mg of N per litre per day. This rate is comparable to recent "breakthrough" nitrogen fixing technologies and far higher than observed in low C:N reactors (fed with organic matter and nitrogen). NFB were quantified using qPCR of the nifH (marker gene used to identify biological nitrogen fixation) and 16S rRNA genes. The nifH gene was enriched by a factor of ten in the nitrogen fixing reactors (compared to controls) attaining 13% of the bacterial population (1:4.2 copies of nifH to 16S rRNA). Illumina MiSeq 16S rRNA gene amplicon sequencing of reactors showed that the microbial community was dominated (19%) by Clostridium pasteurianum. We envisage that nitrogen enriched biomass could potentially be used as a biofertiliser and that the treated wastewater could be released to the environment with very little post treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ospina-Betancourth</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Acharya</LastName>
            <ForeName>Kishor</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allen</LastName>
            <ForeName>Ben D</ForeName>
            <Initials>BD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Entwistle</LastName>
            <ForeName>Jim</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Head</LastName>
            <ForeName>Ian M</ForeName>
            <Initials>IM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanabria</LastName>
            <ForeName>Janeth</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Curtis</LastName>
            <ForeName>Thomas P</ForeName>
            <Initials>TP</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083474</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b05322</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083475</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cytotoxic free radicals on air-borne soot particles generated by burning wood or low-maturity coals.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b06395</ELocationID>
        <Abstract>
          <AbstractText>Traditional cookstove is a major contributor to combustion-derived soot particles, which contain various chemical species that may cause significant impact to human health and ecosystem. However, properties and toxicity associated with environmentally persistent free radicals (EPFRs) in such emissions are not well known. This paper investigated the characteristics and the cytotoxicity of soot-associated EPFRs discharged from Chinese household stoves. Our results showed that the concentrations of EPFRs were related to fuel types, and they were higher in wood-burning soot (8.9-10.5 × 1016 spins/g) than that in coal-burning soot (3.9-9.7 × 1016 spins/g). Meanwhile, EPFRs concentrations in soot decreased with an increase of coal maturity. The soot-EPFRs, especially reactive fraction, readily induced the generation of reactive oxygen species (ROS). Potential health effects of soot-EPFRs were also examined using normal human bronchial epithelial cell line 16HBE as a model. Soot particles were internalized by 16HBE cells inducing cytotoxicity. The main toxicity inducers were identified to be reactive EPFR species, which generated ROS inside human cells. Our findings provided valuable insights into potential contributions of soot-EPFRs associated with different types of fuel to health problems. This information will support regulations to end or to limit current stove usage in numerous households.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jia</LastName>
            <ForeName>Hanzhong</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Shuaishuai</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Lan</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Shiqing</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharma</LastName>
            <ForeName>Virender K</ForeName>
            <Initials>VK</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Bing</ForeName>
            <Initials>B</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083475</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b06395</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083476</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sequestration of Selenite and Selenate in Gypsum (CaSO4•2H2O): Insights from Single-Crystal EPR and Synchrotron XAS Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b05714</ELocationID>
        <Abstract>
          <AbstractText>Gypsum is the most common sulfate mineral on Earth's surface and is the dominant solid byproduct in a wide variety of mining and industrial processes, thus representing a major source for heavy metal(loid) contamination, including selenium. Gypsum crystals grown from the gel diffusion technique in 0.02 M Na2SeO4 solution at pH 7.5 and 0.02 M Na2SeO3 solutions at pH 7.5 and 9.0 contain 828, 5198 and 5955 ppm Se, respectively. Synchrotron Se K-edge X-ray absorption spectroscopic analyses show that selenite and selenate are the dominant species in Se4+- and Se6+-doped gypsum, respectively. Single-crystal EPR spectra of Se4+- and Se6+-doped gypsum after gamma-ray irradiation reveal five selenium-centered oxyradicals: SeO2-(I), SeO2-(II), SeO2-(III), SeO3- and HSeO42-. The former three radicals provide unequivocal evidence for the substitution of their paramagnetic precursor SeO32- for SO42- in the gypsum structure, while the latter two confirm the replacement of SeO42- for SO42-. These results demonstrate that gypsum has a significant capacity for sequestrating both selenite and selenate in the structure but has a marked preference for the former, thus confirming important controls on the mobility and bioavailability of selenium oxyanions and pointing to optimal applications of gypsum for remediating selenium contamination under neutral to alkaline conditions.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Jinru</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ning</ForeName>
            <Initials>N</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Renfei</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nilges</LastName>
            <ForeName>Mark J</ForeName>
            <Initials>MJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jia</LastName>
            <ForeName>Yongfeng</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Shaofeng</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Yuanming</ForeName>
            <Initials>Y</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083476</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b05714</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083477</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-510X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Inorganic chemistry</Title>
          <ISOAbbreviation>Inorg Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Combination of Charge and Energy Transfer Processes in MOFs for Efficient Photocatalytic Oxidative Coupling of Amines.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.inorgchem.9b03743</ELocationID>
        <Abstract>
          <AbstractText>Combining electron and energy transfer processes is very significant for efficient photocatalytic oxidation of organic molecules. The first synthesized MOF, Co<sub>2</sub>(L)(2,6-NDC)<sub>2</sub>·<i>x</i>guest (<b>FJI-Y10</b>, L = bis(<i>N</i>-pyridyl) tetrachloroperylene peryleneimide, 2,6-NDC = 2,6-naphthalenedicarboxylic acid, FJI = Fujian Institute), shows a 2-fold interpenetrated <i>pcu</i> net, in which the 2,6-NDC ligand connects typical Co<sub>2</sub>(COO)<sub>4</sub> paddle wheel clusters to form square lattices pillared by new PDI-type ligand L. <b>FJI-Y10</b> as a heterogeneous and recyclable photocatalyst is applied for photo-oxidation of benzylamine and its derivatives with an excellent yield of 100%, which is much higher than that (59%) of the equivalent L ligand as a homogeneous photocatalyst under the same reaction conditions. Such a high-efficiency photocatalytic activity attributes to the combination of charge and energy transfer processes in catalyst <b>FJI-Y10</b> during the catalytic process.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Feng-Juan</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Structural Chemistry , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences , Fuzhou 350002 , Fujian , China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fujian Normal University , Cangshan Campus, No. 8 Shangsan Road , Cangshan District, Fuzhou 350007 , Fujian , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Guoliang</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>School of Mechanical Engineering , Tianjin University of Technology and Education , Tianjin 300222 , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ju</LastName>
            <ForeName>Zhanfeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Structural Chemistry , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences , Fuzhou 350002 , Fujian , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Yan-Xi</ForeName>
            <Initials>YX</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Structural Chemistry , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences , Fuzhou 350002 , Fujian , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Daqiang</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4627-072X</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Structural Chemistry , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences , Fuzhou 350002 , Fujian , China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fujian Normal University , Cangshan Campus, No. 8 Shangsan Road , Cangshan District, Fuzhou 350007 , Fujian , China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Inorg Chem</MedlineTA>
        <NlmUniqueID>0366543</NlmUniqueID>
        <ISSNLinking>0020-1669</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083477</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.inorgchem.9b03743</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083478</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Colloidal Behaviors of Two-Dimensional Titanium Carbide in Natural Surface Waters: The Role of Solution Chemistry.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b05372</ELocationID>
        <Abstract>
          <AbstractText>While two-dimensional titanium carbide (Ti3C2Tx MXene) has emerged as a shining star material in various communities, its environmental behaviors and fate remain unknown. Herein, the colloidal properties and stability of Ti3C2Tx MXene were explored in aquatic systems at the first time, considering the roles of solution chemistry conditions (e.g., pH, ionic types and strength). It was found that pH had no effect on the stability of Ti3C2Tx in the range of 5.0 to 11.0, whereas ionic valence and concentration displayed significant effects on the aggregation behavior of Ti3C2Tx. By employing time-resolved dynamic light scattering measurements, the critical coagulation concentration (CCC) value of Ti3C2Tx was determined to be 12 mM for NaCl. The divalent cations Ca2+ and Mg2+ exhibited higher destabilizing capacity to Ti3C2Tx, as evidenced by the lower CCC values (0.3 and 0.4 mM for CaCl2 and MgCl2, respectively) and faster coagulation rates. Long-term stability studies implied that Ti3C2Tx MXene was less likely to be transported over long distance in the synthetic or natural waters. These findings provided significant insights into the fate and transport of Ti3C2Tx in the aquatic environment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Xuemei</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Gang</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alsaedi</LastName>
            <ForeName>Ahmed</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hayat</LastName>
            <ForeName>Tasawar</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Changlun</ForeName>
            <Initials>C</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083478</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b05372</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083479</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A regionalised life cycle assessment model to globally assess the environmental implications of soil salinisation in irrigated agriculture.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b03334</ELocationID>
        <Abstract>
          <AbstractText>We present a global, locally resolved life cycle assessment (LCA) model to assess the potential effects on soil quality due to the accumulation of water-soluble salts in the agricultural soil profile, allowing differentiation between agricultural practices. Using globally available soil and climate information and crop specific salt tolerances, the model quantifies the negative implications that salts in irrigation water have on soil quality, in terms of change in the soil electrical conductivity and the corresponding change in the amount of crops that can be grown at increasing soil salinity levels. To facilitate the use of the model, we provide a life cycle inventory tool with information on salts emitted with irrigation water per country and 160 crops. Global average soil susceptibility is 0.19 dS/m per g salt in 1 m3 soil and the average resulting relative crop diversity loss is 5.7*10-02 per g salt in 1 m3 soil. These average values vary tangibly as a function of the location. In most humid regions worldwide the characterisation factor is null, showing that in these cases soil salinisation due to irrigation does not contribute to soil degradation. We displayed how to apply the model with a case study. The model serves for guiding decision-making processes towards improving the sustainability of irrigated agriculture.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nunez</LastName>
            <ForeName>Montserrat</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finkbeiner</LastName>
            <ForeName>Matthias</ForeName>
            <Initials>M</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083479</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b03334</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083480</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-510X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Inorganic chemistry</Title>
          <ISOAbbreviation>Inorg Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Guided Ion Beam and Quantum Chemical Investigation of the Thermochemistry of Thorium Dioxide Cations: Thermodynamic Evidence for Participation of f Orbitals in Bonding.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.inorgchem.9b03488</ELocationID>
        <Abstract>
          <AbstractText>Kinetic energy dependent reactions of ThO<sup>+</sup> with O<sub>2</sub> are studied using a guided ion beam tandem mass spectrometer. The formation of ThO<sub>2</sub><sup>+</sup> in the reaction of ThO<sup>+</sup> with O<sub>2</sub> is observed to be slightly endothermic and also exhibits two obvious features in the cross section. These kinetic energy dependent cross sections were modeled to determine a 0 K bond dissociation energy of <i>D</i><sub>0</sub>(OTh<sup>+</sup>-O) = 4.94 ± 0.06 eV. This value is slightly larger but within experimental uncertainty of less precise previously reported experimental values. The higher energy feature in the ThO<sub>2</sub><sup>+</sup> cross section was also analyzed and suggests formation of an excited state of the product ion lying 3.1 ± 0.2 eV above the ground state. Additionally, the thermochemistry of ThO<sub>2</sub><sup>+</sup> was explored by quantum chemical calculations, including a full Feller-Peterson-Dixon (FPD) composite approach with correlation contributions up to CCSDT(Q) and four-component spin-orbit corrections, as well as more approximate CCSD(T) calculations including semiempirical estimates of spin-orbit energy contributions. The FPD approach predicts <i>D</i><sub>0</sub>(OTh<sup>+</sup>-O) = 4.87 ± 0.04 eV, in good agreement with the experimental value. Analogous FPD results for ThO<sup>+</sup>, ThO, and ThO<sub>2</sub> are also presented, including ionization energies for both ThO and ThO<sub>2</sub>. The ThO<sub>2</sub><sup>+</sup> bond energy is larger than those of its transition metal congeners, TiO<sub>2</sub><sup>+</sup> and ZrO<sub>2</sub><sup>+</sup>, which can be attributed partially to an actinide contraction, but also to contributions from the participation of f orbitals on thorium that are unavailable to the transition metal systems.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Armentrout</LastName>
            <ForeName>P B</ForeName>
            <Initials>PB</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2953-6039</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry , University of Utah , Salt Lake City , Utah 84112-0850 , United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peterson</LastName>
            <ForeName>Kirk A</ForeName>
            <Initials>KA</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4901-3235</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry , Washington State University , Pullman , Washington 99164-4630 , United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Inorg Chem</MedlineTA>
        <NlmUniqueID>0366543</NlmUniqueID>
        <ISSNLinking>0020-1669</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083480</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.inorgchem.9b03488</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083481</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5851</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science &amp; technology</Title>
          <ISOAbbreviation>Environ. Sci. Technol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of locational choices and consumer behaviors on personal land footprints: An exploration across the urban-rural continuum in USA.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.9b06024</ELocationID>
        <Abstract>
          <AbstractText>Land is a scarce resource. We develop consumption-based land footprints (CBLF) for urban and rural US residents to evaluate new levers for reducing land-demand by combining: 1) direct land-use for human settlements including housing, 2) indirect land-use associated with personal consumptions, e.g., food and clothing. Results show that an average urban resident's indirect land-use (199,176 ft2/capita) is ~23 times the direct land-use (8519 ft2/capita), for a total urban CBLF of 207,695 ft2/capita. Rural residents have a slightly higher (~6%) indirect land-use and ~10 times larger direct land-use compared to urban. As in both cases, indirect land-use is much larger than direct, a strategic mix of individual actions including halving food waste (-4.7%), one-day weekly plant-based diet (-3.3%), reducing clothing consumption (-2.8%), and others, can together reduce CBLF by -12.8%. Meanwhile, housing and locational choices across the urban-rural continuum evaluated for the median-density Minneapolis-St. Paul Metropolitan Statistical Area (MSP MSA) yield CBLF reductions from -1.9% (from single- to multi-family housing) to -10.6% (from rural to the urban core). The analysis demonstrates that consumer behavior changes could rival housing/locational choices in order to reduce personal CBLF. Our method of combining input-output analysis with parcel data could be applied in different regions to provide customized land conservation information.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramaswami</LastName>
            <ForeName>Anu</ForeName>
            <Initials>A</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Environ Sci Technol</MedlineTA>
        <NlmUniqueID>0213155</NlmUniqueID>
        <ISSNLinking>0013-936X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083481</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.est.9b06024</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083482</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5126</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the American Chemical Society</Title>
          <ISOAbbreviation>J. Am. Chem. Soc.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Covalent Catalysis by Cross β Amyloid Nanotubes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/jacs.9b13517</ELocationID>
        <Abstract>
          <AbstractText>The binding pockets of extant enzymes feature precise positioning of amino acid residues that facilitate multiple complex transformations exploiting covalent and non-covalent interactions. Reversible covalent anchoring is extensively used as an efficient tool by Nature for activating modern enzymes such as esterases, dehydratases and also for proteins like opsins for the complex process of visual phototransduction. Here we construct paracrystalline amyloid surfaces through the self-propagation of short peptides which offer binding pockets exposed with arrays of imidazoles and lysines. As covalent catalysis is utilized by modern-day enzymes, these homogenous amyloid nanotubes exploit Schiff imine formation via the exposed lysines to efficiently hydrolyse both activated and inactivated esters. Controls where lysines were mutated with charged residues accessed similar morphologies but did not augment rate. The designed amyloid microphases thus foreshadow the generation of binding pockets of advanced proteins and have the potential to contribute to the development of functional materials.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sarkhel</LastName>
            <ForeName>Baishakhi</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chatterjee</LastName>
            <ForeName>Ayan</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Das</LastName>
            <ForeName>Dibyendu</ForeName>
            <Initials>D</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Am Chem Soc</MedlineTA>
        <NlmUniqueID>7503056</NlmUniqueID>
        <ISSNLinking>0002-7863</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083482</ArticleId>
        <ArticleId IdType="doi">10.1021/jacs.9b13517</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083483</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1543-8392</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular pharmaceutics</Title>
          <ISOAbbreviation>Mol. Pharm.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.molpharmaceut.0c00149</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mastrotto</LastName>
            <ForeName>Francesca</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brazzale</LastName>
            <ForeName>Chiara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bellato</LastName>
            <ForeName>Federica</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Martin</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grange</LastName>
            <ForeName>Guillaume</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Drug Research Program, Faculty of Pharmacy , University of Helsinki , 00014 Helsinki , Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahmoudzadeh</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Drug Research Program, Faculty of Pharmacy , University of Helsinki , 00014 Helsinki , Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magarkar</LastName>
            <ForeName>Aniket</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-3385-964X</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Organic Chemistry and Biochemistry , Academy of the Sciences of the Czech Republic , 166 10 Prague , Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bunker</LastName>
            <ForeName>Alex</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1236-9513</Identifier>
            <AffiliationInfo>
              <Affiliation>Drug Research Program, Faculty of Pharmacy , University of Helsinki , 00014 Helsinki , Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salmaso</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4705-5909</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caliceti</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2222-9944</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Mol Pharm</MedlineTA>
        <NlmUniqueID>101197791</NlmUniqueID>
        <ISSNLinking>1543-8384</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>Mol Pharm. 2020 Feb 3;17(2):472-487</RefSource>
          <PMID Version="1">31789523</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083483</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.molpharmaceut.0c00149</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083484</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1523-7052</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Organic letters</Title>
          <ISOAbbreviation>Org. Lett.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rh(III)-Catalyzed Relay Double Carbenoid Insertion and Diannulation of Sulfoximine Benzamides with α-Diazo Carbonyl Compounds: Access to Furo[2,3-<i>c</i>]isochromenes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.orglett.9b04659</ELocationID>
        <Abstract>
          <AbstractText>An efficient rhodium-catalyzed construction of furo[2,3-<i>c</i>]isochromene scaffolds through tandem double carbenoid insertion and diannulation of sulfoximine benzamides with α-diazo carbonyl compounds has been developed. Mechanistic studies revealed that the alkyl-rhodium intermediate generated by carbenoid insertion was directly trapped with another molecule of carbene species, followed by subsequent intramolecular cyclization reactions. Sulfoximine was released in situ, featuring a traceless directing fashion. The reactions proceeded smoothly under mild conditions with wide functional group tolerance.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Chen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Chen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Shunfan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Xinwei</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1974-2464</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zuo</LastName>
            <ForeName>Youpeng</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Wangcheng</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Tongtong</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0806-9590</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shang</LastName>
            <ForeName>Yongjia</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-9873-9150</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Laboratory of Molecule-Based Materials (State Key Laboratory Cultivation Base), College of Chemistry and Materials Science , Anhui Normal University , Wuhu 241002 , P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Org Lett</MedlineTA>
        <NlmUniqueID>100890393</NlmUniqueID>
        <ISSNLinking>1523-7052</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083484</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.orglett.9b04659</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083485</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-7708</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of alternative and complementary medicine (New York, N.Y.)</Title>
          <ISOAbbreviation>J Altern Complement Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Informing the Model of Care for an Academic Integrative Health Care Center: A Qualitative Study of Primary Care Stakeholder Views.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/acm.2019.0321</ELocationID>
        <Abstract>
          <AbstractText><b><i>Objectives:</i></b> To engage with local primary care stakeholders to inform the model of care for a proposed academic integrative health care center incorporating evidence-informed traditional, complementary, and integrative medicine (TCIM) in Sydney, Australia. <b><i>Design:</i></b> In-depth semistructured interviews, informed by community-based participatory research principles, were conducted to explore primary care stakeholder preferences and service requirements regarding the proposed Western Sydney Integrative Health (WSIH) center in their local district. <b><i>Setting:</i></b> Telephone and face-to-face interviews at primary care clinics in Sydney. <b><i>Subjects:</i></b> Thirteen participants took part in the study: eight general practitioners (GPs) and five primary care practice managers (PMs). <b><i>Methods:</i></b> GPs were recruited through local GP newsletters, closed GP Facebook groups, and snowballing. PMs were recruited through a national PM newsletter. The semistructured interviews were audiorecorded and transcribed verbatim before conducting a thematic analysis. <b><i>Results:</i></b> Three main themes emerged: (1) the rationale for "why" the WSIH center should be established, (2) "what" was most important to provide, and (3) "how" the center could achieve these goals. Participants were willing to refer to the service, acknowledging the demand for TCIM, current gaps in chronic disease care, and negligible Government funding for TCIM. They endorsed a model of care that minimizes out-of-pocket costs for the underserved, incorporates medical oversight, integrates evidence-informed TCIM with conventional health care, builds trust through interprofessional communication and education, and provides sound clinical governance with a strong focus on credentialing and risk management. It was proposed that safety and quality standards are best met by a GP-led approach and evidence-based practice. <b><i>Conclusions:</i></b> Our findings demonstrate that participants acknowledged the need for a model of care that fits into the local landscape through integrating conventional health care with TCIM in a team-based environment, with medical/GP oversight to ensure sound clinical governance. Findings will be used with input from other stakeholder groups to refine the WSIH model of care.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ee</LastName>
            <ForeName>Carolyn</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Templeman</LastName>
            <ForeName>Kate</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grant</LastName>
            <ForeName>Suzanne</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Avard</LastName>
            <ForeName>Nicole</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Manincor</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reath</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hunter</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Altern Complement Med</MedlineTA>
        <NlmUniqueID>9508124</NlmUniqueID>
        <ISSNLinking>1075-5535</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">academic health center</Keyword>
        <Keyword MajorTopicYN="N">and integrative medicine</Keyword>
        <Keyword MajorTopicYN="N">community-based participatory research</Keyword>
        <Keyword MajorTopicYN="N">complementary</Keyword>
        <Keyword MajorTopicYN="N">evidence-based medicine</Keyword>
        <Keyword MajorTopicYN="N">integrative health care</Keyword>
        <Keyword MajorTopicYN="N">integrative medicine</Keyword>
        <Keyword MajorTopicYN="N">primary care</Keyword>
        <Keyword MajorTopicYN="N">stakeholder engagement</Keyword>
        <Keyword MajorTopicYN="N">traditional</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083485</ArticleId>
        <ArticleId IdType="doi">10.1089/acm.2019.0321</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083486</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1947-5543</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biopreservation and biobanking</Title>
          <ISOAbbreviation>Biopreserv Biobank</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of Vitrification Techniques on the Somatic Tissue Preservation of Agouti (<i>Dasyprocta leporina</i> Linnaeus, 1758).</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/bio.2019.0109</ELocationID>
        <Abstract>
          <AbstractText>The cryobanks of agouti somatic tissues represent a promising tool for the conservation of this species and of those that are phylogenetically related and endangered. For these purposes, one strategy to guarantee the quality of samples after warming would be to choose the appropriate tissue vitrification technique. Therefore, we evaluated the effects of two different techniques, direct vitrification in cryovials (DVC) and solid-surface vitrification (SSV), on the preservation of ear somatic tissues derived from agoutis kept in a scientific center of creation. Noncryopreserved somatic tissues were used as controls. Although SSV reduced the thickness of the dermis and cartilage (<i>p</i> &lt; 0.05), the epidermal thickness of these samples was observed to be similar to controls (<i>p</i> &gt; 0.05). Notably, the number of fibroblasts was not altered with either technique. However, both vitrification methods led to an increase in the number of perinuclear halos, with a particularly strong increase observed in DVC-derived fragments (<i>p</i> &lt; 0.05). Compared with the DVC group, SSV showed a larger number of normal chondrocytes and smaller number of degenerate chondrocytes. Furthermore, the number of empty lacunae in SSV-derived fragments remained similar to controls (<i>p</i> &gt; 0.05). In summary, SSV was found to be a more efficient method for vitrifying agouti somatic tissues compared with DVC. These results are important for the proper formation of agouti somatic banks, an essential step in the study of biological resources in this species.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Costa</LastName>
            <ForeName>Cibelle A S</ForeName>
            <Initials>CAS</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borges</LastName>
            <ForeName>Alana A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nascimento</LastName>
            <ForeName>Matheus B</ForeName>
            <Initials>MB</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aquino</LastName>
            <ForeName>Leonardo V C</ForeName>
            <Initials>LVC</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silva</LastName>
            <ForeName>Alexandre R</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oliveira</LastName>
            <ForeName>Moacir F</ForeName>
            <Initials>MF</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pereira</LastName>
            <ForeName>Alexsandra F</ForeName>
            <Initials>AF</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Animal Biotechnology, Federal Rural University of Semi-Arid, Mossoró, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biopreserv Biobank</MedlineTA>
        <NlmUniqueID>101507284</NlmUniqueID>
        <ISSNLinking>1947-5543</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cryobanking</Keyword>
        <Keyword MajorTopicYN="N">somatic tissues</Keyword>
        <Keyword MajorTopicYN="N">vitrification</Keyword>
        <Keyword MajorTopicYN="N">wild rodents</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083486</ArticleId>
        <ArticleId IdType="doi">10.1089/bio.2019.0109</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083487</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1947-5543</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biopreservation and biobanking</Title>
          <ISOAbbreviation>Biopreserv Biobank</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Feasibility Analysis of Cell-Free DNA Derived from Plasma of Lung Cancer Patients for Next-Generation Sequencing.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/bio.2019.0115</ELocationID>
        <Abstract>
          <AbstractText><b><i>Purpose:</i></b> The quality of specimens directly affects the experimental results. The stability and structural integrity of nucleic acids in samples have a decisive influence on high-throughput sequencing results. Next-generation sequencing (NGS) provides the most comprehensive criteria for evaluating the specimen quality. To test the quality of cell-free DNA (cfDNA) from lung cancer plasma samples stored in our biobank, we conducted a study to evaluate the quality in terms of the genetic level. <b><i>Methods:</i></b> A total of 189 peripheral blood samples were collected from patients from patients with EGFR-positive nonsmall cell lung cancer who were seen and treated in Jilin Provincial Cancer Hospital from August 2012 to March 2018. Twelve milliliters of peripheral blood samples were collected and centrifuged at 4°C, 2000 rpm for 15 minutes. Plasma samples were dispensed into cryotubes and stored at -80°C. Plasma cfDNA was extracted by a DNA extraction kit (Qiagen) and the DNA concentration was detected by a Qubit 3.0 fluorometer. <b><i>Results:</i></b> The total volume of cfDNA extraction at baseline was 50 μL, the median concentration according to Qubit was 0.633 ng/μL, the range was 0.331-6.09 ng/μL, and the median total DNA was 34.25 ng, ranging from 20.35 to 304.5 ng. The median value of the Qubit concentration in advanced plasma samples was 0.838 ng/μL, ranging from 0.24 to 21.9 ng/μL, and median total DNA was 41.9 ng, ranging from 12.0 to 1095.0 ng. Based on the aforementioned quality assessment factors, 4 of 189 frozen lung cancer baseline plasma samples were not included in further analyses, and for the remaining 185 cases of cfDNA &gt;20 ng, the pass rate was 97.9%. In 143 frozen lung cancer advanced stage plasma samples, 133 cases of cfDNA &gt;20 ng, the pass rate was 93%. <b><i>Conclusion:</i></b> Frozen lung cancer plasma samples stored in the biobank for 1-6 years at -80°C under certain conditions still retain a high level of cfDNA, which is suitable for NGS detection.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Xueli</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Biobank, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Biobank, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Medical Oncology Translational Research Lab, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jingjing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Biobank, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Heping</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Trial Institution, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Linna</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Biobank, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Wenxiu</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Biobank, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yao</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Biobank, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Oncology Translational Research Lab, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Thoracic Oncology, Jilin Provincial Cancer Hospital, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biopreserv Biobank</MedlineTA>
        <NlmUniqueID>101507284</NlmUniqueID>
        <ISSNLinking>1947-5543</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">NGS</Keyword>
        <Keyword MajorTopicYN="N">biobank</Keyword>
        <Keyword MajorTopicYN="N">cfDNA</Keyword>
        <Keyword MajorTopicYN="N">lung cancer</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083487</ArticleId>
        <ArticleId IdType="doi">10.1089/bio.2019.0115</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083488</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2152-2723</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cyberpsychology, behavior and social networking</Title>
          <ISOAbbreviation>Cyberpsychol Behav Soc Netw</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Engagement in a Novel Internet Intervention for Alcohol Reduction: A Qualitative Study of User Motivations and Experiences.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/cyber.2019.0289</ELocationID>
        <Abstract>
          <AbstractText>Internet interventions are effective in reducing alcohol consumption, but little is known regarding their acceptability. We aimed to inform recruitment and retention strategies by exploring users' motivations and experiences in using a novel, Internet intervention, the Hello Sunday Morning (HSM) program. We conducted one-to-one, telephone-enabled qualitative interviews with 24 adult users of HSM (50 percent female; <i>M</i><sub>age</sub> = 42.42 years), purposively selected to ensure diversity in demographics and drinking levels. Data were analyzed using thematic analysis. Two themes, each with two subthemes were identified: (1a) pathway to HSM: HSM attracted participants seeking help for alcohol-related problems, and those not yet seeking help; (1b) format and framing: the positive, nonthreatening framing and anonymous, convenient format enabled participants to join out of interest, curiosity, or desire for a challenge; (2a) support and normalization: participants gained social support from other users, and their problems with alcohol and desire to seek help were normalized; (2b) goal setting and self-monitoring: setting goals and monitoring progress provided participants with motivation and self-accountability. We conclude that evidence-based behavior change techniques, including social support, normative strategies, goal setting, and self-monitoring, were appealing to users. These aspects could be incorporated into other programs to recruit participants who might otherwise avoid or delay seeking help.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Black</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychology, Faculty of Science, University of Sydney, Camperdown, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loomes</LastName>
            <ForeName>Max</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychology, Faculty of Science, University of Sydney, Camperdown, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Juraskova</LastName>
            <ForeName>Ilona</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychology, Faculty of Science, University of Sydney, Camperdown, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Johnston</LastName>
            <ForeName>Ian</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychology, Faculty of Science, University of Sydney, Camperdown, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cyberpsychol Behav Soc Netw</MedlineTA>
        <NlmUniqueID>101528721</NlmUniqueID>
        <ISSNLinking>2152-2715</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alcohol drinking</Keyword>
        <Keyword MajorTopicYN="N">health behavior</Keyword>
        <Keyword MajorTopicYN="N">mobile applications</Keyword>
        <Keyword MajorTopicYN="N">qualitative research</Keyword>
        <Keyword MajorTopicYN="N">retention in care</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083488</ArticleId>
        <ArticleId IdType="doi">10.1089/cyber.2019.0289</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083489</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-6199</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioanalysis</Title>
          <ISOAbbreviation>Bioanalysis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of single molecule array digital immunoassay technology to quantitate neurofilament light chain.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4155/bio-2019-0221</ELocationID>
        <Abstract>
          <AbstractText><b>Aim:</b> Globally, neurodegeneration accounts for significant morbidity and mortality among the elderly. Millions of people are afflicted with neurodegenerative diseases, with the most notable cases attributed to Alzheimer's, Huntington's, Amyotrophic Later Sclerosis and Parkinson's diseases. Sensitive assays that can detect proteopathic anomalies indicative of early neurodegeneration have remained elusive. Therefore, there is an urgent need for sensitive diagnostic and prognostic biomarker assays that can guide the therapeutic regimen in the clinic. <b>Materials &amp; methods:</b> Single molecule array digital immunoassay platform has sensitivity about 1000-fold higher than traditional ligand binding assays. Consequently, we are now beginning to implement ultrasensitive techniques in bioanalysis. <b>Conclusion:</b> In the current study, we evaluated single molecule array technology and report specifications to quantitate neurofilament light chain, a bona-fide biomarker for neurodegeneration. Preliminary neurofilament light screening results from 100 human geriatric cerebrospinal fluid samples displayed huge biological variation and warrants further investigation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Midde</LastName>
            <ForeName>Krishna K</ForeName>
            <Initials>KK</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Broadnax</LastName>
            <ForeName>Alexa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Binion</LastName>
            <ForeName>Brittany</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oglesby</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harman</LastName>
            <ForeName>Jake</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edwards</LastName>
            <ForeName>Mike</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Myler</LastName>
            <ForeName>Heather</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matys</LastName>
            <ForeName>Katie</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bennett</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Bioanalysis</MedlineTA>
        <NlmUniqueID>101512484</NlmUniqueID>
        <ISSNLinking>1757-6180</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">biomarker</Keyword>
        <Keyword MajorTopicYN="N">cerebrospinal fluid (CSF)</Keyword>
        <Keyword MajorTopicYN="N">digital ELISA</Keyword>
        <Keyword MajorTopicYN="N">neurodegeneration</Keyword>
        <Keyword MajorTopicYN="N">neurofilament light (NfL) chain</Keyword>
        <Keyword MajorTopicYN="N">single molecule array (SiMoA)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083489</ArticleId>
        <ArticleId IdType="doi">10.4155/bio-2019-0221</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083491</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-6199</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioanalysis</Title>
          <ISOAbbreviation>Bioanalysis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analytical challenges and advancements in bioanalysis of therapeutic proteins.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4155/bio-2020-0006</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>K Shukla</LastName>
            <ForeName>Snehal</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy &amp; Health Sciences, 8000 Utopia Parkway, St. John's University, Queens, NY 11439, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Vivek</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy &amp; Health Sciences, 8000 Utopia Parkway, St. John's University, Queens, NY 11439, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Bioanalysis</MedlineTA>
        <NlmUniqueID>101512484</NlmUniqueID>
        <ISSNLinking>1757-6180</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">analytical</Keyword>
        <Keyword MajorTopicYN="N">biosimilars</Keyword>
        <Keyword MajorTopicYN="N">capillary electrophoresis</Keyword>
        <Keyword MajorTopicYN="N">challenges</Keyword>
        <Keyword MajorTopicYN="N">liquid chromatography</Keyword>
        <Keyword MajorTopicYN="N">therapeutic proteins</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083491</ArticleId>
        <ArticleId IdType="doi">10.4155/bio-2020-0006</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083490</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-6199</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioanalysis</Title>
          <ISOAbbreviation>Bioanalysis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development and validation of a UPLC-MS/MS method for simultaneous determination of LBPT and its metabolites in human plasma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4155/bio-2019-0289</ELocationID>
        <Abstract>
          <AbstractText><b>Aim:</b> A Ultra performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) method was developed to detfermine LBPT as well as its four metabolites in human plasma to support the clinical study aiming to evaluate the efficacy of LBPT tablet in patients undergoing hip/knee replacement. <b>Methodology:</b> Plasma samples were prepared by protein precipitation and then separated on a C<sub>18</sub> analytical column using (A) acetonitrile (B) 0.1% formic acid and 10 mM ammonium formate in water. The detection was performed on a triple quadrupole tandem mass spectrometer in positive electrospray ionization using multiple reactions monitoring mode. <b>Results &amp; conclusion:</b> The method has been validated in accordance with the US FDA guidelines and was applied to the measurement of five analytes in human plasma samples from a Phase II clinical trial.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Mengyi</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2102-7419</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100032, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Aijing</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100032, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhuang</LastName>
            <ForeName>Quankun</ForeName>
            <Initials>Q</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4577-0303</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100032, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jia</LastName>
            <ForeName>Ranran</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100032, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yinping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100032, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yali</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Beijing Shiqiao Biological Pharmaceutical Co. Ltd, Beijing 101301, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Hongyun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100032, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Bioanalysis</MedlineTA>
        <NlmUniqueID>101512484</NlmUniqueID>
        <ISSNLinking>1757-6180</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">LBPT</Keyword>
        <Keyword MajorTopicYN="N">UPLC–MS/MS</Keyword>
        <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>
        <Keyword MajorTopicYN="N">platelet-activating factor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083490</ArticleId>
        <ArticleId IdType="doi">10.4155/bio-2019-0289</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083492</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2152-2723</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cyberpsychology, behavior and social networking</Title>
          <ISOAbbreviation>Cyberpsychol Behav Soc Netw</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Personal Autonomous Car: Personality and the Driverless Car.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/cyber.2019.0544</ELocationID>
        <Abstract>
          <AbstractText>Road traffic accidents, congestion and their ensuing issues are of international concern. A recent technological development to alleviate this situation is the autonomic car. A driverless vehicle will transport its passengers to their destinations. User experience would be enhanced by adapting the workings of the vehicle in line with the personality of its user. An autonomic car information system preference questionnaire was designed, focusing on different components of a futuristic information system. Participants comprised 155 students. The results demonstrated two factors: willingness to share information and need for control. A regression analysis on the automatic car preferences, personality (the Big 5), gender, and age showed that openness, consciousnesses, and age were related to different preferences. The results are assessed, followed by a discussion on personality in relation to the autonomic car.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Amichai-Hamburger</LastName>
            <ForeName>Yair</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The Research Center for Internet Psychology (CIP), Sammy Ofer School of Communication, Interdisciplinary Center (IDC), Herzliya, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mor</LastName>
            <ForeName>Yaron</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Interdisciplinary Center Hertzlia, Hertzlia, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wellingstein</LastName>
            <ForeName>Tamar</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Interdisciplinary Center Hertzlia, Hertzlia, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Landesman</LastName>
            <ForeName>Tomer</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Computer Science, Interdisciplinary Center Hertzlia, Israel Center of Internet and Psychology (CIP), Hertzlia, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ophir</LastName>
            <ForeName>Yaakov</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The Faculty of Industrial Engineering and Management Technion, Israel Institute of Technology, Haifa, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cyberpsychol Behav Soc Netw</MedlineTA>
        <NlmUniqueID>101528721</NlmUniqueID>
        <ISSNLinking>2152-2715</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">autonomous car</Keyword>
        <Keyword MajorTopicYN="N">information system</Keyword>
        <Keyword MajorTopicYN="N">personality</Keyword>
        <Keyword MajorTopicYN="N">well-being</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083492</ArticleId>
        <ArticleId IdType="doi">10.1089/cyber.2019.0544</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083493</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1756-8927</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Future medicinal chemistry</Title>
          <ISOAbbreviation>Future Med Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Targeting anti-apoptotic BCL-2 family proteins for cancer treatment.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4155/fmc-2020-0004</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xuan</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6062-6708</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry, College of Pharmacy, University of Florida, 1333 Center Drive, Gainesville, FL 32610, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Xingui</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacodynamics, College of Pharmacy, University of Florida, 1333 Center Drive, Gainesville, FL 32610, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Daohong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacodynamics, College of Pharmacy, University of Florida, 1333 Center Drive, Gainesville, FL 32610, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Guangrong</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8106-6663</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry, College of Pharmacy, University of Florida, 1333 Center Drive, Gainesville, FL 32610, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Future Med Chem</MedlineTA>
        <NlmUniqueID>101511162</NlmUniqueID>
        <ISSNLinking>1756-8919</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BCL-2</Keyword>
        <Keyword MajorTopicYN="N">BCL-XL</Keyword>
        <Keyword MajorTopicYN="N">MCL-1</Keyword>
        <Keyword MajorTopicYN="N">apoptosis</Keyword>
        <Keyword MajorTopicYN="N">cancer treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083493</ArticleId>
        <ArticleId IdType="doi">10.4155/fmc-2020-0004</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083494</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2152-2723</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cyberpsychology, behavior and social networking</Title>
          <ISOAbbreviation>Cyberpsychol Behav Soc Netw</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Pilot Study of an Online Psychoeducational Program on Cyberbullying That Aims to Increase Confidence and Help-Seeking Behaviors Among Adolescents.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/cyber.2019.0081</ELocationID>
        <Abstract>
          <AbstractText>This pilot study obtained preliminary data on the effectiveness of an online, self-guided cognitive behavioral therapy-based psychoeducational program for coping with a potential experience of cyberbullying. The aim of the increasing resilience to cyberbullying (IRCB) program was to increase adolescents' likelihood of employing coping skills that may be helpful for a victim of cyberbullying, and to increase confidence in their ability to cope and/or help a friend cope with an experience of cyberbullying. Online questionnaires were administered to participants at baseline (preprogram, <i>n</i> = 54) and after program completion (postprogram, <i>n</i> = 54). Participants were year 9 or 10 students from Australian secondary schools (<i>M</i> = 14.70 years, <i>SD</i> = 0.57; 89% male). Results indicated significant increases in adolescents' likelihood of using the coping skills of self-compassion and challenging unhelpful thinking to cope with an experience of cyberbullying. There was also a significant increase in adolescents' help-seeking attitudes and behavioral intentions to engage with counseling services in the event of being victim of cyberbullying. There was no evidence to suggest that the IRCB program significantly increased adolescents' confidence in their ability to cope and/or help a friend cope with an experience of cyberbullying. The majority (87%) of participants (<i>n</i> = 34) described the IRCB program as helping them. Results suggest that an online intervention has the potential to provide adolescents with a free and easily accessible intervention that helps ameliorate the effect of cyberbullying, by promoting effective coping skills.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chillemi</LastName>
            <ForeName>Kerry</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health, Arts &amp; Design, Swinburne University of Technology, Hawthorn, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abbott</LastName>
            <ForeName>Jo-Anne M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health, Arts &amp; Design, Swinburne University of Technology, Hawthorn, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Austin</LastName>
            <ForeName>David W</ForeName>
            <Initials>DW</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health, Deakin University, Burwood, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Knowles</LastName>
            <ForeName>Ann</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health, Arts &amp; Design, Swinburne University of Technology, Hawthorn, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cyberpsychol Behav Soc Netw</MedlineTA>
        <NlmUniqueID>101528721</NlmUniqueID>
        <ISSNLinking>2152-2715</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">an online cognitive-behavioral therapy-based psychoeducational program for coping with a potential experience of cyberbullying</Keyword>
        <Keyword MajorTopicYN="N">an online psychoeducational program on coping with cyberbullying</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083494</ArticleId>
        <ArticleId IdType="doi">10.1089/cyber.2019.0081</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083495</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-8992</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of child and adolescent psychopharmacology</Title>
          <ISOAbbreviation>J Child Adolesc Psychopharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/cap.2019.0138</ELocationID>
        <Abstract>
          <AbstractText><b><i>Objectives:</i></b> Bipolar disorder (BD) is a debilitating illness that often starts at an early age. Prevention of first and subsequent mood episodes, which are usually preceded by a period characterized by subthreshold symptoms is important. We compared demographic and clinical characteristics including severity and duration of subsyndromal symptoms across adolescents with three different bipolar-spectrum disorders. <b><i>Methods:</i></b> Syndromal and subsyndromal psychopathology were assessed in adolescent inpatients (age = 12-18 years) with a clinical mood disorder diagnosis. Assessments included the validated Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P). We compared phenomenology across patients with a research consensus conference-confirmed DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) diagnoses of BD-I, BD-not otherwise specified (NOS), or mood disorder (MD) NOS. <b><i>Results:</i></b> Seventy-six adolescents (age = 15.6 ± 1.4 years, females = 59.2%) were included (BD-I = 24; BD-NOS = 29; MD-NOS = 23) in this study. Median baseline global assessment of functioning scale score was 21 (interquartile range = 17-40; between-group <i>p</i> = 0.31). Comorbidity was frequent, and similar across groups, including disruptive behavior disorders (55.5%, <i>p</i> = 0.27), anxiety disorders (40.8%, <i>p</i> = 0.98), and personality disorder traits (25.0%, <i>p</i> = 0.21). Mania symptoms (most frequent: irritability = 93.4%, <i>p</i> = 0.82) and depressive symptoms (most frequent: depressed mood = 81.6%, <i>p</i> = 0.14) were common in all three BD-spectrum groups. Manic and depressive symptoms were more severe in both BD-I and BD-NOS versus MD-NOS (<i>p</i> &lt; 0.0001). Median duration of subthreshold manic symptoms was shorter in MD-NOS versus BD-NOS (11.7 vs. 20.4 weeks, <i>p</i> = 0.002) and substantial in both groups. The most used psychotropics upon discharge were antipsychotics (65.8%; BD-I = 79.2%; BD-NOS = 62.1%; MD-NOS = 56.5%, <i>p</i> = 0.227), followed by mood stabilizers (43.4%; BD-I = 66.7%; BD-NOS = 31.0%; MD-NOS = 34.8%, <i>p</i> = 0.02) and antidepressants (19.7%; BD-I = 20.8%; BD-NOS = 10.3%; MD-NOS = 30.4%). <b><i>Conclusions:</i></b> Youth with BD-I, BD-NOS, and MD-NOS experience considerable symptomatology and are functionally impaired, with few differences observed in psychiatric comorbidity and clinical severity. Moreover, youth with BD-NOS and MD-NOS undergo a period with subthreshold manic symptoms, enabling identification and, possibly, preventive intervention of those at risk for developing BD or other affective episodes requiring hospitalization.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Salazar de Pablo</LastName>
            <ForeName>Gonzalo</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guinart</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cornblatt</LastName>
            <ForeName>Barbara A</ForeName>
            <Initials>BA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Psychiatric Neuroscience, The Feinstein Institutes for Medical Research, Manhasset, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Auther</LastName>
            <ForeName>Andrea M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carrión</LastName>
            <ForeName>Ricardo E</ForeName>
            <Initials>RE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Psychiatric Neuroscience, The Feinstein Institutes for Medical Research, Manhasset, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carbon</LastName>
            <ForeName>Maren</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiménez-Fernández</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Child and Adolescent Mental Health Unit, Jaén Medical Center, Jaén, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Granada, Granada, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vernal</LastName>
            <ForeName>Ditte L</ForeName>
            <Initials>DL</Initials>
            <AffiliationInfo>
              <Affiliation>Research Unit for Child- and Adolescent Psychiatry, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walitza</LastName>
            <ForeName>Susanne</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gerstenberg</LastName>
            <ForeName>Miriam</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saba</LastName>
            <ForeName>Riccardo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mental Health, ASL Roma 6, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lo Cascio</LastName>
            <ForeName>Nella</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Prevention and Early Intervention Service, Department of Mental Health, ASL Roma 1, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brandizzi</LastName>
            <ForeName>Martina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mental Health, Local Health Agency Rome 1, Inpatient Psychiatric Unit, Santo Spirito in Sassia Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arango</LastName>
            <ForeName>Celso</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moreno</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Van Meter</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Psychiatric Neuroscience, The Feinstein Institutes for Medical Research, Manhasset, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Correll</LastName>
            <ForeName>Christoph U</ForeName>
            <Initials>CU</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Psychiatric Neuroscience, The Feinstein Institutes for Medical Research, Manhasset, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Child Adolesc Psychopharmacol</MedlineTA>
        <NlmUniqueID>9105358</NlmUniqueID>
        <ISSNLinking>1044-5463</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adolescence</Keyword>
        <Keyword MajorTopicYN="N">bipolar disorder</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
        <Keyword MajorTopicYN="N">risk</Keyword>
        <Keyword MajorTopicYN="N">subsyndromal</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083495</ArticleId>
        <ArticleId IdType="doi">10.1089/cap.2019.0138</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083496</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1465-3478</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of food sciences and nutrition</Title>
          <ISOAbbreviation>Int J Food Sci Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The composition of faecal microbiota is related to the amount and variety of dietary fibres.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-11</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09637486.2020.1727864</ELocationID>
        <Abstract>
          <AbstractText>For normal gut and body function, the diet should contain variety of dietary fibres. To elucidate the links between food intake, especially the variety of dietary fibres, faecal microbiota, body mass index and content of blood lipids, 59 healthy subjects on common Estonian diet were enrolled. The dietary records were analysed at nutrient level while seven categories of fibres were characterised to differentiate variety of fibre profiles consumed. The data of the high fibre (HF) intake (&gt;15.1 g/1000 kcal) and the low fibre (LF) intake (&lt;9.4 g/1000 kcal) groups were comparatively evaluated. LF diets associated with <i>Collinsella</i>, <i>Coprococcus</i> and <i>Dorea</i>, and higher consumption of meat and white flour products while HF diet with <i>Roseburia</i>, <i>Bacteroides xylanisolvens</i> and <i>Oxalobacter formigenes</i>, and arabinoxylan and pectin rich cereals and vegetables. Based on the results, modulation of the colon microbiota can be suggested by careful variation and enrichment of dietary fibre sources.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Adamberg</LastName>
            <ForeName>Kaarel</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7203-925X</Identifier>
            <AffiliationInfo>
              <Affiliation>Center of Food and Fermentation Technologies, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaagura</LastName>
            <ForeName>Madis</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Center of Food and Fermentation Technologies, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aaspõllu</LastName>
            <ForeName>Anu</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health Development, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nurk</LastName>
            <ForeName>Eha</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health Development, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adamberg</LastName>
            <ForeName>Signe</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Food Sci Nutr</MedlineTA>
        <NlmUniqueID>9432922</NlmUniqueID>
        <ISSNLinking>0963-7486</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Faecal microbiome</Keyword>
        <Keyword MajorTopicYN="N">arabinoxylan</Keyword>
        <Keyword MajorTopicYN="N">dietary fibre</Keyword>
        <Keyword MajorTopicYN="N">pectin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083496</ArticleId>
        <ArticleId IdType="doi">10.1080/09637486.2020.1727864</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083497</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2689-3622</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Facial plastic surgery &amp; aesthetic medicine</Title>
          <ISOAbbreviation>Facial Plast Surg Aesthet Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Royal Family Heritage: The Habsburg Jaw.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/fpsam.2019.29017.mar</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zamudio Martínez</LastName>
            <ForeName>Gabriela</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Ciencias Clínicas, Instituto Tecnológico y de Estudios Superiores de Monterrey, Guadalajara, Mexico.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martínez</LastName>
            <ForeName>Adriana Zamudio</ForeName>
            <Initials>AZ</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Ciencias Clínicas, Instituto Tecnológico y de Estudios Superiores de Monterrey, Guadalajara, Mexico.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Facial Plast Surg Aesthet Med</MedlineTA>
        <NlmUniqueID>101757922</NlmUniqueID>
        <ISSNLinking>2689-3614</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083497</ArticleId>
        <ArticleId IdType="doi">10.1089/fpsam.2019.29017.mar</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083498</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-7682</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Expert opinion on biological therapy</Title>
          <ISOAbbreviation>Expert Opin Biol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fecal transplantation for ulcerative colitis: current evidence and future applications.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/14712598.2020.1733964</ELocationID>
        <Abstract>
          <AbstractText>IntroductionEstablished evidence suggests that gut microbiota plays a role in ulcerative colitis (UC). Fecal microbiota transplantation (FMT) is clearly recognized as a highly effective treatment for patients with recurrent Clostridium difficile infection, and has been investigated also in patients with UC, with promising results.Areas coveredLiterature review was performed to select publications concerning current evidence on the role of gut microbiota in the pathogenesis of UC, and on the effectiveness of FMT in this disorder.Expert OpinionThe randomized controlled trials published investigating the use of FMT suggested a potential role for FMT in the treatment of mild to moderate UC. However, given several unanswered questions regarding donor selection, dose, route of administration and duration of therapy, this is not yet recommended as a viable therapy option. FMT has allowed for more in depth investigation with regards to the role the gut microbiota may be playing in UC. This knowledge is critical to identifying where FMT may appropriately fit in the UC treatment paradigm. As our understanding of the role the microbiome plays in this chronic disease, FMT, and then eventually defined microbes, will hopefully serve in a complementary role to conventional IBD therapies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lopetuso</LastName>
            <ForeName>Loris R</ForeName>
            <Initials>LR</Initials>
            <AffiliationInfo>
              <Affiliation>UOC MEDICINA INTERNA E GASTROENTEROLOGIA, Area Medicina Interna, Gastroenterologia ed Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ianiro</LastName>
            <ForeName>Gianluca</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>UOC MEDICINA INTERNA E GASTROENTEROLOGIA, Area Medicina Interna, Gastroenterologia ed Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allegretti</LastName>
            <ForeName>Jessica R</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bibbò</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8043-4807</Identifier>
            <AffiliationInfo>
              <Affiliation>UOC MEDICINA INTERNA E GASTROENTEROLOGIA, Area Medicina Interna, Gastroenterologia ed Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gasbarrini</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6230-1779</Identifier>
            <AffiliationInfo>
              <Affiliation>UOC MEDICINA INTERNA E GASTROENTEROLOGIA, Area Medicina Interna, Gastroenterologia ed Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scaldaferri</LastName>
            <ForeName>Franco</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8334-7541</Identifier>
            <AffiliationInfo>
              <Affiliation>UOC MEDICINA INTERNA E GASTROENTEROLOGIA, Area Medicina Interna, Gastroenterologia ed Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cammarota</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>UOC MEDICINA INTERNA E GASTROENTEROLOGIA, Area Medicina Interna, Gastroenterologia ed Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Istituto di Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Expert Opin Biol Ther</MedlineTA>
        <NlmUniqueID>101125414</NlmUniqueID>
        <ISSNLinking>1471-2598</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Faecal microbiota transplantation</Keyword>
        <Keyword MajorTopicYN="N">Inflammatory bowel disease</Keyword>
        <Keyword MajorTopicYN="N">Ulcerative colitis</Keyword>
        <Keyword MajorTopicYN="N">gut microbiota</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083498</ArticleId>
        <ArticleId IdType="doi">10.1080/14712598.2020.1733964</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083499</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1464-522X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical engineering &amp; technology</Title>
          <ISOAbbreviation>J Med Eng Technol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Efficient high capacity technique to embed EPR information and to detect tampering in medical images.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-14</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/03091902.2020.1718223</ELocationID>
        <Abstract>
          <AbstractText>Reversible data hiding (RDH) is one of the well-known and highly recommended method to enhance medical data security or electronic patient record (EPR), privacy and truthfulness. In clinical images, while hiding the data, care must be taken to maintain the confidentiality of the information that is to be hidden within the clinical images because the hidden information should not bring down the original quality of the image. Mostly, the investigations carried out for medical diagnosis are usually constructed on the basis of investigation systems used for diagnosis and are grounded on the images usually used for medical study. Magnetic resonance image (MRI), CR and CT, digital format images which are acquired are related to the patient's data and information regarding their diagnosis study. In this presented approach, we introduce an RDH scheme that can also be combined with encryption and reversible watermarking techniques. Here, we use the data related to the patient diagnosis as the secret information to embed in medical images. Quality of the marked image after embedding the data is usually measured with metrics that are usually used in image processing such as PSNR and SSIM.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Geetha</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>MVJ College of Engineering, Bangalore, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>SENSE, VIT University, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Geetha</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>SCSE, VIT University, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Med Eng Technol</MedlineTA>
        <NlmUniqueID>7702125</NlmUniqueID>
        <ISSNLinking>0309-1902</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Data hiding</Keyword>
        <Keyword MajorTopicYN="N">EPR</Keyword>
        <Keyword MajorTopicYN="N">pixel to block transformation</Keyword>
        <Keyword MajorTopicYN="N">watermark</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083499</ArticleId>
        <ArticleId IdType="doi">10.1080/03091902.2020.1718223</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083500</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2161-7856</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Games for health journal</Title>
          <ISOAbbreviation>Games Health J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of Exergaming on Muscle Strength, Pain, and Functionality of Shoulders in Cancer Patients.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/g4h.2019.0113</ELocationID>
        <Abstract>
          <AbstractText><b><i>Objective:</i></b> To compare the strength of the middle deltoid muscle by means of dynamometry and the Shoulder Pain and Disability Index (SPADI) in participants in treatment for cancer after the practice of an exergaming protocol. <b><i>Materials and Methods:</i></b> We conducted a randomized controlled clinical trial. Thirty-eight voluntary participants were divided into two groups<u>:</u> cancer group (<i>n</i> = 19; age = 61.46 ± 8.79 years; body mass index [BMI] = 28.36 ± 4.94 kg/m<sup>3</sup>) and control group (<i>n</i> = 19; age = 57.62 ± 7.57 years; BMI = 28.06 ± 3.74 kg/m<sup>3</sup>), and they participated in the study. All participants performed an exergame protocol by using Xbox 360 Kinect<sup>®</sup> (Microsoft, Redmond) with the game <i>Your Shape Fitness Evolved 2012</i> two to three times per week for 20 sessions. They were evaluated through the isometric dynamometer in the middle deltoid muscle and the SPADI at three moments: preintervention (EV1), after 10 sessions (EV2), and after 20 sessions (EV3). <b><i>Results:</i></b> The cancer group scored higher on both the disability index, in all three evaluations, and the pain index, in EV2 and EV3, when compared with the control group. There was a significant reduction in the disability score in EV2 and EV3 when compared with EV1 in the cancer group, whereas pain was lower in EV2 and EV3 when compared with EV1 in the control group. There were no significant interevaluation or intergroup differences in the maximal isometric voluntary contraction of the deltoid muscle of both upper limbs. <b><i>Conclusion:</i></b> At the end of the exergaming, protocol reduced the disability of the shoulder joint of the cancer group and decreased the differences between the groups for disability and pain scores, without changing isometric force.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Oliveira</LastName>
            <ForeName>Paulo Furtado de</ForeName>
            <Initials>PF</Initials>
            <AffiliationInfo>
              <Affiliation>Motricity of Sciences Institute, and Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alves</LastName>
            <ForeName>Ricardo da Silva</ForeName>
            <Initials>RDS</Initials>
            <AffiliationInfo>
              <Affiliation>Bioscience Program, Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iunes</LastName>
            <ForeName>Denise Hollanda</ForeName>
            <Initials>DH</Initials>
            <AffiliationInfo>
              <Affiliation>Motricity of Sciences Institute, and Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carvalho</LastName>
            <ForeName>Jovana Maria de</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Motricity of Sciences Institute, and Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borges</LastName>
            <ForeName>Juliana Bassalobre Carvalho</ForeName>
            <Initials>JBC</Initials>
            <AffiliationInfo>
              <Affiliation>Motricity of Sciences Institute, and Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Menezes</LastName>
            <ForeName>Flávia da Silva</ForeName>
            <Initials>FDS</Initials>
            <AffiliationInfo>
              <Affiliation>Motricity of Sciences Institute, and Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carvalho</LastName>
            <ForeName>Leonardo César</ForeName>
            <Initials>LC</Initials>
            <AffiliationInfo>
              <Affiliation>Motricity of Sciences Institute, and Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bioscience Program, Federal University of Alfenas, Alfenas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Games Health J</MedlineTA>
        <NlmUniqueID>101583709</NlmUniqueID>
        <ISSNLinking>2161-783X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer</Keyword>
        <Keyword MajorTopicYN="N">Exergaming</Keyword>
        <Keyword MajorTopicYN="N">Rehabilitation</Keyword>
        <Keyword MajorTopicYN="N">Shoulders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083500</ArticleId>
        <ArticleId IdType="doi">10.1089/g4h.2019.0113</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083501</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1473-0782</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The European journal of contraception &amp; reproductive health care : the official journal of the European Society of Contraception</Title>
          <ISOAbbreviation>Eur J Contracept Reprod Health Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Risk of abortion within 1-2 years after childbirth in relation to contraceptive choice: a retrospective cohort study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13625187.2020.1718091</ELocationID>
        <Abstract>
          <AbstractText><b>Objectives:</b> The primary objective of the study was to investigate whether the choice of long-acting reversible contraception (LARC) was associated with the risk of abortion over a period of 24 months postpartum. The secondary objective was to analyse whether other significant factors were affecting the risk of abortion during this period.<b>Methods:</b> In this retrospective cohort study, we analysed 11,066 women who had delivered in three Swedish cities during 2013 and 2014. Demographic and medical variables were obtained from medical records. Attendance at the postpartum visit, choice of postpartum contraception and history of abortion was noted. Logistic regression analysis was performed to assess factors associated with the risk of abortion. The main outcome measure was the proportion of women with abortion up to 24 months postpartum.<b>Results:</b> Data from 11,066 women were included in the final analysis. Within 12-24 months after delivery 2.5% of women had an abortion. The choice of LARC after childbirth reduced the risk of subsequent abortion (odds ratio 0.74; 95% confidence interval [CI] 0.60, 0.91; <i>p</i> =  .005). Smoking, age &lt;25 years and have had a previous abortion significantly increased the risk of abortion during follow-up, whereas exclusive breastfeeding decreased the risk.<b>Conclusions:</b> Increasing the proportion of women who choose LARC postpartum could decrease the risk of abortion for up to 2 years after childbirth.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lichtenstein Liljeblad</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1230-5325</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, Danderyd Hospital, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kopp Kallner</LastName>
            <ForeName>Helena</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-7184-9165</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, Danderyd Hospital, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brynhildsen</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-0071-4383</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics &amp; Gynaecology, Department of Clinical &amp; Experimental Medicine, Linköping University, Linköping, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Eur J Contracept Reprod Health Care</MedlineTA>
        <NlmUniqueID>9712127</NlmUniqueID>
        <ISSNLinking>1362-5187</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Abortion</Keyword>
        <Keyword MajorTopicYN="N">childbirth</Keyword>
        <Keyword MajorTopicYN="N">contraception</Keyword>
        <Keyword MajorTopicYN="N">delivery</Keyword>
        <Keyword MajorTopicYN="N">long-acting reversible contraception</Keyword>
        <Keyword MajorTopicYN="N">termination of pregnancy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083501</ArticleId>
        <ArticleId IdType="doi">10.1080/13625187.2020.1718091</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083502</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1546-3141</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>214</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>AJR. American journal of roentgenology</Title>
          <ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Radiologists' Education in Transgender Health Care Must Include Sensitivity to Language.</ArticleTitle>
        <Pagination>
          <MedlinePgn>W69</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.19.22559</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stowell</LastName>
            <ForeName>Justin T</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Mayo Clinic in Florida, Jacksonville, FL stowell.justin@mayo.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zavaletta</LastName>
            <ForeName>Vaz A</ForeName>
            <Initials>VA</Initials>
            <AffiliationInfo>
              <Affiliation>Emory University School of Medicine, Atlanta, GA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>AJR Am J Roentgenol</MedlineTA>
        <NlmUniqueID>7708173</NlmUniqueID>
        <ISSNLinking>0361-803X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083502</ArticleId>
        <ArticleId IdType="doi">10.2214/AJR.19.22559</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083503</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1546-3141</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>214</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>AJR. American journal of roentgenology</Title>
          <ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Digital Breast Tomosynthesis Decreases the Recall Rate by Discriminating Between Superficial Breast Parenchymal Lesions and Benign Skin Lesions.</ArticleTitle>
        <Pagination>
          <MedlinePgn>W68</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.19.22149</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cohen</LastName>
            <ForeName>Yamin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Rachel Nash Breast Clinic, Jerusalem, Israel cohenyamin@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>AJR Am J Roentgenol</MedlineTA>
        <NlmUniqueID>7708173</NlmUniqueID>
        <ISSNLinking>0361-803X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083503</ArticleId>
        <ArticleId IdType="doi">10.2214/AJR.19.22149</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083504</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1546-3141</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>214</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>AJR. American journal of roentgenology</Title>
          <ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Readership Surveys and Future Direction.</ArticleTitle>
        <Pagination>
          <MedlinePgn>485-486</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.19.22601</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berquist</LastName>
            <ForeName>Thomas H</ForeName>
            <Initials>TH</Initials>
            <AffiliationInfo>
              <Affiliation>Editor in Chief ajrsubmit@arrs.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>AJR Am J Roentgenol</MedlineTA>
        <NlmUniqueID>7708173</NlmUniqueID>
        <ISSNLinking>0361-803X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083504</ArticleId>
        <ArticleId IdType="doi">10.2214/AJR.19.22601</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083505</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-5094</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ophthalmic genetics</Title>
          <ISOAbbreviation>Ophthalmic Genet.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Optical coherence tomography and fundus autofluorescence imaging in an infant with <i>RD3</i>-related leber congenital amaurosis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-4</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13816810.2020.1731837</ELocationID>
        <Abstract>
          <AbstractText><b>Background:</b> Leber congenital amaurosis (LCA) is both genetically and phenotypically heterogeneous group of retinal disorder. Mutations in retinal degeneration 3 (<i>RD3)</i> have been reported as an infrequent cause of LCA which account for less than 1% of all known LCA cases. This case report provides Optical Coherence Tomography (OCT) and Fundus Autofluorescence (FAF) findings of an infant with LCA related to a mutation in <i>RD3</i>.<b>Materials and Methods:</b> Single retrospective case report.<b>Results:</b> TruSight One Expanded Sequencing Panel was applied to the patient on the Illumina NextSeq. Homozygous pathogenic variant (c.112 C &gt; T, p.Arg38Ter) was detected in the RD3 gene. Well-demarcated central foveal atrophy was noted in the infrared imaging. FAF imaging showed perifoveal hyperautofluorescent ring and irregular hyperautofluorescence outside the vascular arcade. An arrest in foveal development and loss of outer retinal structure including outer nuclear layer, external limiting membrane, ellipsoid zone and interdigitation zone at the fovea were detected in the OCT imaging.<b>Conclusion</b>: This study indicates that RD3-related LCA has a very severe phenotype with foveal development arrest and very early loss of all photoreceptor layer and external limiting membrane at the fovea.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dikkaya</LastName>
            <ForeName>Funda</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2312-2521</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seyhan</LastName>
            <ForeName>Serhat</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetic, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Erdur</LastName>
            <ForeName>Sevil Karaman</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Şentürk</LastName>
            <ForeName>Fevzi</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aras</LastName>
            <ForeName>Cengiz</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ophthalmic Genet</MedlineTA>
        <NlmUniqueID>9436057</NlmUniqueID>
        <ISSNLinking>1381-6810</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Leber congenital amaurosis</Keyword>
        <Keyword MajorTopicYN="N">RD3 mutation</Keyword>
        <Keyword MajorTopicYN="N">fundus autofluorescence</Keyword>
        <Keyword MajorTopicYN="N">optical coherence tomography</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083505</ArticleId>
        <ArticleId IdType="doi">10.1080/13816810.2020.1731837</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083506</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2165-5987</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioengineered</Title>
          <ISOAbbreviation>Bioengineered</ISOAbbreviation>
        </Journal>
        <ArticleTitle>MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis <i>in vitro</i> and <i>in vivo</i>.</ArticleTitle>
        <Pagination>
          <MedlinePgn>219-228</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21655979.2020.1729928</ELocationID>
        <Abstract>
          <AbstractText>Neuroblastoma (NB) is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). It is well known that miR-145 functions as a tumor suppressor in several types of cancer. However, the impact of miR-145 on NB is still ambiguous. Our aim was to investigate the potential tumor suppressive role and mechanisms of miR-145 in high-risk neuroblastoma. Expression levels of miR-145 in tissues and cells were determined using RT-qPCR. The effect of miR-145 on cell viability was evaluated using MTT assays, apoptosis levels were determined using TUNEL staining, and the MTDH protein expression was determined using western blot and RT-PCR. Luciferase reporter plasmids were constructed to confirm direct targeting for MTDH. <b>The results showed</b> that miR-145 expression was significantly lower in high-risk MYCN amplified (MNA) tumors and low miR-145 expression was associated with worse EFS and OS in our cohort. Over-expression of miR-145 reduced cell viability and increased apoptosis in SH-SY-5Y cells. We identified MTDH as a direct target for miR-145 in SH-SY-5Y cells. Targeting MTDH has the similar results as miR-145 overexpression. Our findings suggest that low miR-145 expression was associated with poor prognosis in patients with NB, and the overexpression of miR-145 inhibited NB cells growth by down-regulating MTDH, thus providing a potential target for the development of microRNA-based approach for NB therapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Surgery, Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Kai</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Urology, Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Liang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Child Health Division, Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Huanyu</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3514-3699</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Surgery, Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Bioengineered</MedlineTA>
        <NlmUniqueID>101581063</NlmUniqueID>
        <ISSNLinking>2165-5979</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MTDH</Keyword>
        <Keyword MajorTopicYN="N">Neuroblastoma</Keyword>
        <Keyword MajorTopicYN="N">apoptosis</Keyword>
        <Keyword MajorTopicYN="N">miR-145</Keyword>
        <Keyword MajorTopicYN="N">tumorigenesis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083506</ArticleId>
        <ArticleId IdType="doi">10.1080/21655979.2020.1729928</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083507</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0031-949X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Phytopathology</Title>
          <ISOAbbreviation>Phytopathology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genetically distinct A<i>cidovorax citrulli</i> strains display cucurbit fruit preference under field conditions.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1094/PHYTO-10-19-0389-R</ELocationID>
        <Abstract>
          <AbstractText>Strains of <i>Acidovorax citrulli</i>, the causal agent of bacterial fruit blotch (BFB) of cucurbits, can be assigned to two groups, I and II. The natural association of group I and II strains with different cucurbit species suggests host preference; however, there are no direct data to support this hypothesis under field conditions. Hence, the objective of this study was to assess differences in the prevalence of group I and II <i>A. citrulli</i> strains on cucurbit species in the field. From 2017-2019, we used group I and II strains to initiate BFB outbreaks in field plots planted with four cucurbit species. At different times, we collected symptomatic tissues and assayed them for group I and II strains using a group-specific PCR assay. Binary distribution data analysis revealed that the odds of melon, pumpkin, and squash foliage infection by group I strains were 21.7, 11.5, and 22.1 times greater, respectively, than the odds of watermelon foliage infection by the group I strain (p &lt; 0.0001). More strikingly, the odds of melon fruit infection by the group I strain were 97.5 times greater than watermelon fruit infection by the same strain (p &lt; 0.0001). Unexpectedly, some of the group II isolates recovered from the 2017 and 2019 studies were different from the group II strains used as inocula. Overall, data from these experiments confirm that <i>A. citrulli</i> strains exhibit a preference for watermelon and melon, which is more pronounced in fruit tissues.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>University of Georgia, 1355, Plant Pathology, Athens, Georgia, United States; mzhao@uga.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dutta</LastName>
            <ForeName>Bhabesh</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>University of Georgia College of Agricultural and Environmental Sciences, 96665, Plant Pathology, Tifton, Georgia, United States; bhabesh@uga.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Xuelin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>University of Georgia College of Agricultural and Environmental Sciences, 96665, Tifton, Georgia, United States; xuelin@uga.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burdman</LastName>
            <ForeName>Saul</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The Hebrew University of Jerusalem Department of Plant Pathology and Microbiology, 549294, Plant Pathology and Microbiology, Rehovot, Central, Israel; saul.burdman@mail.huji.ac.il.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walcott</LastName>
            <ForeName>Ron Ricardo</ForeName>
            <Initials>RR</Initials>
            <Suffix>PhD</Suffix>
            <AffiliationInfo>
              <Affiliation>University of Georgia College of Agricultural and Environmental Sciences, 96665, Plant Pathology, Athens, Georgia, United States; rwalcott@uga.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Phytopathology</MedlineTA>
        <NlmUniqueID>9427222</NlmUniqueID>
        <ISSNLinking>0031-949X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bacteriology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083507</ArticleId>
        <ArticleId IdType="doi">10.1094/PHYTO-10-19-0389-R</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083508</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-7465</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of interferon &amp; cytokine research : the official journal of the International Society for Interferon and Cytokine Research</Title>
          <ISOAbbreviation>J. Interferon Cytokine Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of Melatonin and Flavonoid-Rich Fractions of <i>Chromolaena odorata</i> on the Alteration of Proinflammatory Cytokines and Nitric Oxide Induced by Aflatoxin B1 in the Gastric Mucosa of Wistar Rats.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/jir.2019.0101</ELocationID>
        <Abstract>
          <AbstractText>In this study, we investigated serum interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) after ingestion of aflatoxin B1 (AFB1) in rats. We also studied the effects of nitric oxide (NO) on the stomach after consumption of AFB1. Therefore, we hypothesized that a standard anti-inflammatory agent-melatonin (MEL), and the flavonoid-rich fractions from <i>Chromolaena odorata</i> (FRFC) could counteract the deleterious effects of IL-1β, TNF-α, and NO after consumption of AFB1. Thirty-five Wistar rats (211.86 ± 27.23 g) were randomly selected into 5 groups, with 7 rats in each group. Group A (control); all rats in groups B, C, D, and E received 2.5 mg/kg AFB1 each orally on day 5, whereas those of groups C, D, and E received oral administration of 10 mg/kg MEL, 50 mg/kg FRFC<sub>1</sub>, and 100 mg/kg FRFC<sub>2</sub>, respectively, for 7 days. All of them were killed on the 8th day, 24 h after last treatment. Serum samples were analyzed for IL-1β and TNF-α, whereas stomach tissue was evaluated for NO level. Significant (<i>P</i> &lt; 0.5) increase in serum IL-1β and TNF-α in rats given AFB1 only was recorded when compared with those in the control group. Conversely, we observed significant reduction in serum IL-1β and TNF-α in all the groups that received MEL, FRFC<sub>1</sub>, and FRFC<sub>2</sub> after pretreatment with AFB1 when compared with those that were given AFB1 only. In addition, there was a significant increase in NO in rats given AFB1 only when compared with control, whereas reduction in NO was significant in the groups C, D, and E that were given MEL, FRFC<sub>1</sub>, and FRFC<sub>2</sub>, respectively, when compared with AFB1 group. MEL and FRFC may be responsible for the prevention of increased gastric mucosal NO and inflammatory effects of proinflammatory cytokines induced by AFB1.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Amid</LastName>
            <ForeName>Adetayo Sadudeen</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery and Radiology, Faculty of Veterinary Medicine, University of Ilorin, Ilorin, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Makinde</LastName>
            <ForeName>Oludele Ayobami</ForeName>
            <Initials>OA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, Federal University of Agriculture, Abeokuta, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Akinrinmade</LastName>
            <ForeName>Fadeyemi Joseph</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery and Radiology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Interferon Cytokine Res</MedlineTA>
        <NlmUniqueID>9507088</NlmUniqueID>
        <ISSNLinking>1079-9907</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chromolaena odorata</Keyword>
        <Keyword MajorTopicYN="N">aflatoxin B1</Keyword>
        <Keyword MajorTopicYN="N">interleukin-1 beta</Keyword>
        <Keyword MajorTopicYN="N">nitric oxide</Keyword>
        <Keyword MajorTopicYN="N">stomach</Keyword>
        <Keyword MajorTopicYN="N">tumor necrosis factor alpha</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083508</ArticleId>
        <ArticleId IdType="doi">10.1089/jir.2019.0101</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083509</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2169-5180</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Soft robotics</Title>
          <ISOAbbreviation>Soft Robot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Geometric Confined Pneumatic Soft-Rigid Hybrid Actuators.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/soro.2018.0157</ELocationID>
        <Abstract>
          <AbstractText>In this work, we propose a new kind of soft-rigid hybrid actuator composed mainly of soft chambers and rigid frames. Compared with the well-known fiber-reinforced soft actuators, the hybrid actuators are able to ensure the design of noncircular cross-sectional shapes. It is demonstrated that rigid frames are capable of providing geometric constraints, reducing the ineffective deformation, and improving the energy utilization for the hybrid actuators with noncircular cross-sections. The essential characteristics of rigid constraints and flexible constraints are obtained by simulation and experiments on specimens with three different cross-sectional shapes. Furthermore, a spring-fluid film model is introduced to characterize the behavior of a representative hybrid linear actuator and a bending actuator with a rectangular cross-section, and it is also proved by the corresponding experiments. The change of the cross-sectional shape of fiber-reinforced soft actuators under pressurization is also explained theoretically as a contrast. Then, two application examples, namely, a robotic gripper and a caudal fin formed from linear actuators, are designed and demonstrated, showing the advantages and potential applications of the proposed geometric confined hybrid actuators. The proposed soft-rigid hybrid actuators combine the properties of soft and rigid materials, expand the design scope of the compliant actuators, and provide new solutions for robotics, especially for soft robots with specific requirements for their shapes or profiles.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jinhua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Institute of Design Science and Basic Components, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Institute of Design Science and Basic Components, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Microsystem &amp; Terahertz Research Center, China Academy of Engineering Physics, Chengdu &amp; China Institute of Electronic Engineering, China Academy of Engineering Physics, Mianyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Michael Yu</ForeName>
            <Initials>MY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Institute of Design Science and Basic Components, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical and Aerospace Engineering and Hong Kong University of Science and Technology, Kowloon, Hong Kong.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Electronic and Computer Engineering, Hong Kong University of Science and Technology, Kowloon, Hong Kong.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>HKUST Robotics Institute, Kowloon, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Baotong</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Institute of Design Science and Basic Components, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>John X J</ForeName>
            <Initials>JXJ</Initials>
            <AffiliationInfo>
              <Affiliation>Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Institute of Design Science and Basic Components, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Soft Robot</MedlineTA>
        <NlmUniqueID>101623819</NlmUniqueID>
        <ISSNLinking>2169-5172</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">geometric confined soft actuators</Keyword>
        <Keyword MajorTopicYN="N">soft robotics</Keyword>
        <Keyword MajorTopicYN="N">soft–rigid hybrid actuators</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083509</ArticleId>
        <ArticleId IdType="doi">10.1089/soro.2018.0157</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083510</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-0057</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Food additives &amp; contaminants. Part A, Chemistry, analysis, control, exposure &amp; risk assessment</Title>
          <ISOAbbreviation>Food Addit Contam Part A Chem Anal Control Expo Risk Assess</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Determination of color additive tartrazine (E 102) in food samples after dispersive solid phase extraction with a zirconium-based metal-organic framework (UiO-66(Zr)-(COOH)<sub>2</sub>).</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-11</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19440049.2020.1726501</ELocationID>
        <Abstract>
          <AbstractText>A new and rapid dispersive solid phase extraction method by using a green-synthesised UiO-66(Zr)-(COOH)<sub>2</sub> (Zr-BTeC) adsorbent with body-centred cubic <b>(bcu)</b> topology was developed for determination of tartrazine in food samples. Zr-BTeC was used for the first time as an adsorbent for tartrazine. It was synthesised and characterised by X-ray diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, thermogravimetric analysis, Brunauer-Emmett-Teller surface area analysis, and zeta potential measurements. Tartrazine was determined at 405 nm spectrophotometrically. Experimental conditions were optimised in order to achieve quantitative recoveries. The sample acidity was found to be 0.02 mol L<sup>-1</sup> HCl. The amount of Zr-BTeC was 10 mg. Both adsorption and elution contact times were only 5 s without the need for vortexing. Elution was with 2 mL of 0.5 mol L<sup>-1</sup> NH<sub>3</sub>. A sample volume of 45 mL was selected as optimum. The adsorption capacity for tartrazine with Zr-BTeC was found to be 185 mg g<sup>-1</sup> and the adsorbent was reusable up to 40 cycles. The tartrazine concentrations found by the developed method in food supplements were compared with the results obtained by HPLC method for the same samples. Statistical analysis results showed that there are insignificant differences between the results of the two methods (<i>p</i> = .05). The method was successfully applied to the determination of tartrazine in spiked chewing gums, lemon flavoured icing glaze, and jelly samples.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Oymak</LastName>
            <ForeName>Tülay</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Analytical Chemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tokalıoğlu</LastName>
            <ForeName>Şerife</ForeName>
            <Initials>Ş</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2944-1347</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Science, Chemistry Department, Erciyes University, Kayseri, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cam</LastName>
            <ForeName>Şafak</ForeName>
            <Initials>Ş</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Arts and Sciences, Chemistry Department, Recep Tayyip Erdogan University, Rize, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Demir</LastName>
            <ForeName>Selçuk</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5719-7145</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Arts and Sciences, Chemistry Department, Recep Tayyip Erdogan University, Rize, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Food Addit Contam Part A Chem Anal Control Expo Risk Assess</MedlineTA>
        <NlmUniqueID>101485040</NlmUniqueID>
        <ISSNLinking>1944-0057</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Tartrazine</Keyword>
        <Keyword MajorTopicYN="N">dispersive solid phase extraction</Keyword>
        <Keyword MajorTopicYN="N">green synthesis</Keyword>
        <Keyword MajorTopicYN="N">metal-organic framework</Keyword>
        <Keyword MajorTopicYN="N">spectrophotometry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083510</ArticleId>
        <ArticleId IdType="doi">10.1080/19440049.2020.1726501</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083511</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Women's understanding of immunization card and its correlation with vaccination behaviors.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-7</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2020.1726682</ELocationID>
        <Abstract>
          <AbstractText><b>Background</b>: Despite the proven effectiveness of vaccinations, vaccination uptake is limited in Nigeria. According to the Multiple Indicator Cluster Survey (MICS), one of the main barriers is the lack of accurate knowledge of the vaccination schedule. This study evaluates caregivers' knowledge of the vaccination schedule and their ability to read the immunization card.<b>Methods</b>: The study evaluated the knowledge of caregivers in 11 settlements in the Jada local government area of Adamawa State in September 2019. The change in knowledge among caregivers before and after referring to the immunization card was evaluated using a simple statistical hypothesis testing (chi-square test). We also used logistic regression analysis to evaluate the determinants of vaccination knowledge, as well as the correlation between knowledge and actual vaccination behaviors.<b>Results</b>: More than half of the women had correct knowledge of the vaccination schedule for critical vaccines. However, the knowledge of the caregivers did not improve after referring to the immunization card which contained the information. Caregivers who brought their children to the clinic for vaccination recently were more likely to know the vaccination schedule correctly. Accurate knowledge was highly correlated with the actual vaccination behaviors.<b>Conclusion</b>: Reference to the immunization card did not improve the knowledge of vaccination schedule, especially among the less-educated population. To increase the demand for vaccinations, one potential policy is to target the uneducated population and help them increase their knowledge.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sato</LastName>
            <ForeName>Ryoko</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7040-317X</Identifier>
            <AffiliationInfo>
              <Affiliation>Global Health and Population, Harvard T.H Chan School of Public Health, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fintan</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Independent.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Immunization card</Keyword>
        <Keyword MajorTopicYN="N">knowledge</Keyword>
        <Keyword MajorTopicYN="N">northern Nigeria</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083511</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2020.1726682</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083512</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1931-8448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Microbial drug resistance (Larchmont, N.Y.)</Title>
          <ISOAbbreviation>Microb. Drug Resist.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mutational Variation Analysis of <i>oprD</i> Porin Gene in Multidrug-Resistant Clinical Isolates of <i>Pseudomonas aeruginosa</i>.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/mdr.2019.0147</ELocationID>
        <Abstract>
          <AbstractText>The present study deals with the outer membrane OprD porin protein in 29 clinical bacterial isolates of multidrug-resistant <i>Pseudomonas aeruginosa</i>. <i>oprD</i> porin gene expression was investigated using real-time reverse transcription-PCR. Amplicons from <i>oprD</i> and its transcriptional regulator <i>mexT</i> gene were sequenced and analyzed for mutations. Hypothetical models of selected mutant OprD-porin proteins were predicted and refined by homology modeling approach. <i>oprD</i> ampliconic sequences were also screened for restriction fragment length polymorphism (RFLP). The <i>oprD</i> gene was found to be downregulated in 89.7% (<i>n</i> = 26) of the isolates in comparison to the transcript levels in the reference strain <i>P. aeruginosa</i>-PAO (MTCC-3541). Interestingly, all these isolates displayed the presence of a conspicuous 8-bp deletion (GGCCAGCC) at nucleotide position 235 of <i>mexT</i> regulatory gene. Based on the mutational patterns observed in <i>oprD</i> gene, the isolates were classified into categories designated as A, B1-2, C1-4, D1-6, E1-2, and F. Our hypothetical models revealed that mutations were predominantly confined to the extracellular loops emanating from the β-barrel porin protein. These protein models also enabled clear visualization of loss of substantial portions of the truncated polypeptide. Incidentally, since most of the <i>oprD</i> amplicons of the clinical isolates were found to display distinct RFLP banding patterns, our results also provide a useful diagnostic tool for detection of <i>P. aeruginosa</i> porin mutants.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Suresh</LastName>
            <ForeName>Manju</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, University of Calicut, Malappuram, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skariyachan</LastName>
            <ForeName>Sinosh</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, St. Pius X College, Kasaragod, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Narayanan</LastName>
            <ForeName>Nithya</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, University of Calicut, Malappuram, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pullampara Rajamma</LastName>
            <ForeName>Jayasree</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, University of Calicut, Malappuram, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panickassery Ramakrishnan</LastName>
            <ForeName>Manish Kumar</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, University of Calicut, Malappuram, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Microb Drug Resist</MedlineTA>
        <NlmUniqueID>9508567</NlmUniqueID>
        <ISSNLinking>1076-6294</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">OprD porin protein</Keyword>
        <Keyword MajorTopicYN="N">Pseudomonas aeruginosa</Keyword>
        <Keyword MajorTopicYN="N">homology modeling</Keyword>
        <Keyword MajorTopicYN="N">mexT regulatory gene</Keyword>
        <Keyword MajorTopicYN="N">multidrug resistant</Keyword>
        <Keyword MajorTopicYN="N">restriction fragment length polymorphism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083512</ArticleId>
        <ArticleId IdType="doi">10.1089/mdr.2019.0147</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083513</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1556-3669</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Telemedicine journal and e-health : the official journal of the American Telemedicine Association</Title>
          <ISOAbbreviation>Telemed J E Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nonmydriatic Retinal Diabetic Screening in the Primary Care Setting: Assessing Degree of Retinopathy and Incidence of Nondiabetic Ocular Diagnoses.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/tmj.2019.0206</ELocationID>
        <Abstract>
          <AbstractText><b><i>Purpose:</i></b> To study the rates and severity of diabetic retinopathy (DR), rates of nondiabetic ocular disease, and rates of referral to eye care providers in the context of nonmydriatic retinal screening performed in primary care and endocrinology clinics. <b><i>Materials and Methods:</i></b> This study is a retrospective chart review of patients who had nonmydriatic retinal imaging in the primary care setting. Presence and severity of DR as well as detection of nondiabetic ocular diseases were analyzed. Referral rates for different types of pathology were determined. <b><i>Results:</i></b> A total of 324 patients were imaged and 294 (90.7%) had gradable images. Mild DR was found in at least one eye of 71 (24.1%) patients, moderate in 20 (6.8%), severe in 3 (1.0%), and proliferative DR in 2 (0.6%). Macular edema was found in 13 (4.4%) patients. Nondiabetic ocular diseases were suspected in 106 (36.1%) patients. The most prevalent findings included glaucoma suspect (10.9%), age-related macular degeneration suspect (8.8%), and hypertensive retinopathy (5.4%). Seventy (23.8%) patients were referred to an eye care provider for DR, 66 (22.4%) were referred for nondiabetic eye disease, and 21 (7.1%) were referred for both. <b><i>Conclusion:</i></b> One-third of patients were found to have some degree of DR. Suspected nondiabetic disease or other pathologies were found in one-third of the study population. Referral for examination by an eye care provider was recommended for approximately half of the patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gu</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agron</LastName>
            <ForeName>Samantha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>May</LastName>
            <ForeName>Lauren N</ForeName>
            <Initials>LN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirza</LastName>
            <ForeName>Rukhsana G</ForeName>
            <Initials>RG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bryar</LastName>
            <ForeName>Paul J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Telemed J E Health</MedlineTA>
        <NlmUniqueID>100959949</NlmUniqueID>
        <ISSNLinking>1530-5627</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">education</Keyword>
        <Keyword MajorTopicYN="N">ophthalmology</Keyword>
        <Keyword MajorTopicYN="N">telehealth</Keyword>
        <Keyword MajorTopicYN="N">telemedicine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083513</ArticleId>
        <ArticleId IdType="doi">10.1089/tmj.2019.0206</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083514</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fear, knowledge, and vaccination behaviors among women in Northern Nigeria.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-11</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2020.1723365</ELocationID>
        <Abstract>
          <AbstractText><b>Background</b>: Although vaccine hesitancy is a global concern, the evaluation on how fear of vaccination affects vaccination-related knowledge, behaviors, and perceptions is extremely scarce in developing countries. This study contributes to the literature by filling the knowledge gap on the fear of vaccination by focusing on Nigerian caregivers.<b>Methods</b>: The study evaluates the correlation between fear of vaccination and knowledge, actual behaviors, and perception among caregivers in 11 settlements in the Jada local government area of Adamawa State, northeastern Nigeria. The data were collected in September 2019. We use logistic regression analysis to evaluate the correlation.<b>Results and Discussions</b>: About 15% of caregivers have some form of fear regarding vaccination. However, such fear is not correlated with most of the socio-demographic characteristics among caregivers. Fear is significantly correlated with the lack of accurate vaccination knowledge, with a lower likelihood of vaccination uptake for their children, and with the lack of perceptions of vaccination importance and intention to vaccinate their children. Results from our study are consistent with findings from existing studies conducted in developed countries.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sato</LastName>
            <ForeName>Ryoko</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7040-317X</Identifier>
            <AffiliationInfo>
              <Affiliation>Global Health and Population, Harvard T.H Chan School of Public Health, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fintan</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Independent, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Fear</Keyword>
        <Keyword MajorTopicYN="N">Nigeria</Keyword>
        <Keyword MajorTopicYN="N">knowledge</Keyword>
        <Keyword MajorTopicYN="N">perceptions</Keyword>
        <Keyword MajorTopicYN="N">vaccination</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083514</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2020.1723365</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083515</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1556-3669</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Telemedicine journal and e-health : the official journal of the American Telemedicine Association</Title>
          <ISOAbbreviation>Telemed J E Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Interprofessional Communication of Physicians Using WhatsApp: Physicians' Perspective.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/tmj.2019.0216</ELocationID>
        <Abstract>
          <AbstractText><b><i>Background:</i></b> Interprofessional communication using Facebook<sup>®</sup>, Snapchat<sup>®</sup>, Instagram<sup>®</sup>, and WhatsApp<sup>®</sup> has become a reality that is shaping our future. However, studies evaluating the dimensions of this use in the medical field are scarce and proper guidelines have not yet been established. This highlights the importance of exploring the wide range of using such common communication tools in the medical field. <b><i>Objective:</i></b> The aim of this study is to investigate the prevalence of WhatsApp use as an interprofessional communication tool among Lebanese physicians and explore the dimensions of its use. <b><i>Materials and Methods:</i></b> This cross-sectional study was conducted by using LimeSurvey through an e-mail-based questionnaire sent to 5,329 physicians enrolled in the Lebanese Order of Physicians. <b><i>Results:</i></b> Four hundred twenty-nine physicians completed the survey with a response rate of 8%. Most respondents (96.5%) were WhatsApp users, where 72.7% stated being consulted by colleagues via WhatsApp, and about 50% reported being members of professional WhatsApp groups that mainly share medical cases and patients' updates. Further, most physicians made sure that the shared information contained no patient identifier and kept it for future referencing without the patient's permission or consent before consulting their colleagues. Almost 75% of the respondents agreed that guidelines are needed to illustrate the medico-legal and ethical aspects of WhatsApp use by physicians and recommended using WhatsApp specifically for inter-physician communication. <b><i>Conclusion:</i></b> The findings of this study illustrate the high prevalence of WhatsApp Messenger use among Lebanese physicians. Utilizing such digital platforms is highly demanded to enhance interprofessional communication between physicians in the medical field.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shaarani</LastName>
            <ForeName>Issam</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Kantar</LastName>
            <ForeName>Aref</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hamzeh</LastName>
            <ForeName>Nour</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jounblat</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Yaman</LastName>
            <ForeName>Tala</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Habanjar</LastName>
            <ForeName>Mira</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halawi</LastName>
            <ForeName>Nourhane</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Itani</LastName>
            <ForeName>Ahmad</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Soubra</LastName>
            <ForeName>Rabih</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Telemed J E Health</MedlineTA>
        <NlmUniqueID>100959949</NlmUniqueID>
        <ISSNLinking>1530-5627</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">WhatsApp</Keyword>
        <Keyword MajorTopicYN="N">e-health</Keyword>
        <Keyword MajorTopicYN="N">legal/legislation</Keyword>
        <Keyword MajorTopicYN="N">patient communication</Keyword>
        <Keyword MajorTopicYN="N">telehealth</Keyword>
        <Keyword MajorTopicYN="N">telemedicine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083515</ArticleId>
        <ArticleId IdType="doi">10.1089/tmj.2019.0216</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083516</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1527-3792</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of urology</Title>
          <ISOAbbreviation>J. Urol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Editorial Comment.</ArticleTitle>
        <Pagination>
          <MedlinePgn>101097JU000000000000070801</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/JU.0000000000000708.01</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fossum</LastName>
            <ForeName>Magdalena</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Surgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Urol</MedlineTA>
        <NlmUniqueID>0376374</NlmUniqueID>
        <ISSNLinking>0022-5347</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083516</ArticleId>
        <ArticleId IdType="doi">10.1097/JU.0000000000000708.01</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083517</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1941-0921</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>2</Issue>
            <PubDate>
              <MedlineDate>2020 Mar/Apr</MedlineDate>
            </PubDate>
          </JournalIssue>
          <Title>Sports health</Title>
          <ISOAbbreviation>Sports Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Society News.</ArticleTitle>
        <Pagination>
          <MedlinePgn>207-208</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1941738120903293</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016433">News</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Sports Health</MedlineTA>
        <NlmUniqueID>101518422</NlmUniqueID>
        <ISSNLinking>1941-0921</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083517</ArticleId>
        <ArticleId IdType="doi">10.1177/1941738120903293</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083518</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-8898</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cognitive neuroscience</Title>
          <ISOAbbreviation>J Cogn Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Frequency-based Dissociation of Symbolic and Nonsymbolic Numerical Processing during Numerical Comparison.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-21</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1162/jocn_a_01550</ELocationID>
        <Abstract>
          <AbstractText>Recent evidence suggests that during numerical calculation, symbolic and nonsymbolic processing are functionally distinct operations. Nevertheless, both roughly recruit the same brain areas (spatially overlapping networks in the parietal cortex) and happen at the same time (roughly 250 msec poststimulus onset). We tested the hypothesis that symbolic and nonsymbolic processing are segregated by means of functionally relevant networks in different frequency ranges: high Gamma (above 50 Hz) for symbolic processing and lower Beta (12-17 Hz) for nonsymbolic processing. EEG signals were quantified as participants compared either symbolic numbers or nonsymbolic quantities. Larger EEG Gamma-band power was observed for more difficult symbolic comparisons (ratio of 0.8 between the two numbers) than for easier comparisons (ratio of 0.2) over frontocentral regions. Similarly, Beta-band power was larger for more difficult nonsymbolic comparisons than for easier ones over parietal areas. These results confirm the existence of a functional dissociation in EEG oscillatory dynamics during numerical processing that is compatible with the notion of distinct linguistic processing of symbolic numbers and approximation of nonsymbolic numerical information.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rubinsten</LastName>
            <ForeName>Orly</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>University of Haifa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Korem</LastName>
            <ForeName>Nachshon</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>University of Haifa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Levin</LastName>
            <ForeName>Naama</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>University of Haifa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Furman</LastName>
            <ForeName>Tamar</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>University of Haifa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cogn Neurosci</MedlineTA>
        <NlmUniqueID>8910747</NlmUniqueID>
        <ISSNLinking>0898-929X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083518</ArticleId>
        <ArticleId IdType="doi">10.1162/jocn_a_01550</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083519</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-8898</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cognitive neuroscience</Title>
          <ISOAbbreviation>J Cogn Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Thickness of Deep Layers in the Fusiform Face Area Predicts Face Recognition.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-14</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1162/jocn_a_01551</ELocationID>
        <Abstract>
          <AbstractText>People with superior face recognition have relatively thin cortex in face-selective brain areas, whereas those with superior vehicle recognition have relatively thick cortex in the same areas. We suggest that these opposite correlations reflect distinct mechanisms influencing cortical thickness (CT) as abilities are acquired at different points in development. We explore a new prediction regarding the specificity of these effects through the depth of the cortex: that face recognition selectively and negatively correlates with thickness of the deepest laminar subdivision in face-selective areas. With ultrahigh resolution MRI at 7T, we estimated the thickness of three laminar subdivisions, which we term "MR layers," in the right fusiform face area (FFA) in 14 adult male humans. Face recognition was negatively associated with the thickness of deep MR layers, whereas vehicle recognition was positively related to the thickness of all layers. Regression model comparisons provided overwhelming support for a model specifying that the magnitude of the association between face recognition and CT differs across MR layers (deep vs. superficial/middle) whereas the magnitude of the association between vehicle recognition and CT is invariant across layers. The total CT of right FFA accounted for 69% of the variance in face recognition, and thickness of the deep layer alone accounted for 84% of this variance. Our findings demonstrate the functional validity of MR laminar estimates in FFA. Studying the structural basis of individual differences for multiple abilities in the same cortical area can reveal effects of distinct mechanisms that are not apparent when studying average variation or development.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McGugin</LastName>
            <ForeName>Rankin W</ForeName>
            <Initials>RW</Initials>
            <AffiliationInfo>
              <Affiliation>Vanderbilt University.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Newton</LastName>
            <ForeName>Allen T</ForeName>
            <Initials>AT</Initials>
            <AffiliationInfo>
              <Affiliation>Vanderbilt University Medical Center.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vanderbilt University Institute of Imaging Science.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Monroe Carell Jr. Children's Hospital at Vanderbilt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tamber-Rosenau</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>University of Houston.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomarken</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Vanderbilt University.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gauthier</LastName>
            <ForeName>Isabel</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Vanderbilt University.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cogn Neurosci</MedlineTA>
        <NlmUniqueID>8910747</NlmUniqueID>
        <ISSNLinking>0898-929X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083519</ArticleId>
        <ArticleId IdType="doi">10.1162/jocn_a_01551</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083520</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-8898</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cognitive neuroscience</Title>
          <ISOAbbreviation>J Cogn Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The White Matter Module Hub Network of Semantics Revealed by Semantic Dementia.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-18</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1162/jocn_a_01549</ELocationID>
        <Abstract>
          <AbstractText>Cognitive neuroscience exploring the architecture of semantics has shown that coherent supramodal concepts are computed in the anterior temporal lobes (ATL), but it is unknown how/where modular information implemented by posterior cortices (word/object/face forms) is conveyed to the ATL hub. We investigated the semantic module hub network in healthy adults (<i>n</i> = 19) and in semantic dementia patients (<i>n</i> = 28) by combining semantic assessments of verbal and nonverbal stimuli and MRI-based fiber tracking using seeds in three module-related cortices implementing (i) written word forms (visual word form area), (ii) abstract lexical representations (posterior-superior temporal cortices), and (iii) face/object representations (face form area). Fiber tracking revealed three key tracts linking the ATL with the three module-related cortices. Correlation analyses between tract parameters and semantic scores indicated that the three tracts subserve semantics, transferring modular verbal or nonverbal object/face information to the left and right ATL, respectively. The module hub tracts were functionally and microstructurally damaged in semantic dementia, whereas damage to non-module-specific ATL tracts (inferior longitudinal fasciculus, uncinate fasciculus) had more limited impact on semantic failure. These findings identify major components of the white matter module hub network of semantics, and they corroborate/materialize claims of cognitive models positing direct links between modular and semantic representations. In combination with modular accounts of cognition, they also suggest that the currently prevailing "hub-and-spokes" model of semantics could be extended by incorporating an intermediate module level containing invariant representations, in addition to "spokes," which subserve the processing of a near-unlimited number of sensorimotor and speech-sound features.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sundqvist</LastName>
            <ForeName>Martina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche de Paris.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Routier</LastName>
            <ForeName>Alexandre</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche de Paris.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dubois</LastName>
            <ForeName>Bruno</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence "Démences Rares," Hôpital de la Pitié-Salpêtrière, AP-HP.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colliot</LastName>
            <ForeName>Olivier</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche de Paris.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence "Démences Rares," Hôpital de la Pitié-Salpêtrière, AP-HP.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teichmann</LastName>
            <ForeName>Marc</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence "Démences Rares," Hôpital de la Pitié-Salpêtrière, AP-HP.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cogn Neurosci</MedlineTA>
        <NlmUniqueID>8910747</NlmUniqueID>
        <ISSNLinking>0898-929X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083520</ArticleId>
        <ArticleId IdType="doi">10.1162/jocn_a_01549</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083521</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-1087</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the American College of Nutrition</Title>
          <ISOAbbreviation>J Am Coll Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Calf Circumference Is a Good Predictor of Longer Hospital Stay and Nutritional Risk in Emergency Patients: A Prospective Cohort Study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-5</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07315724.2020.1723452</ELocationID>
        <Abstract>
          <AbstractText><b>Objective:</b> This study aimed to evaluate the validity of calf circumference (CC) in identifying malnourished patients and patients at nutritional risk and determine the association between CC and clinical outcomes of hospitalized patients.<b>Methods:</b> A prospective cohort study was conducted involving patients admitted to the emergency department of a tertiary hospital in the first 48 hours of admission. Nutritional risk was determined using Nutritional Risk Screening, malnutrition was diagnosed using subjective global assessment, and CC was manually measured. Brazilian cutoff points for CC were used to identify low muscle mass. The outcomes of interest were length of emergency care and hospital stay, occurrence of infection, and death, besides nutritional risk and malnutrition.<b>Results:</b> In total, 528 patients (52.76 ± 16.18 years; 54.6% females) were followed up for 9.0 (3.0-19.0) days; 39.6% of them had reduced CC values. The accuracy of CC in identifying patients at nutritional risk and malnourished patients was 67.7% and 54.1%, respectively. The cutoff value of 36.5 cm was highly accurate in identifying nutritional risk [AUC-ROC curve = 0.764 (95% CI: 0.704-0.825) for men, and AUC-ROC curve = 0.716 (95% CI: 0.659-0.774) for women]. Patients with low CC had a 1.59-fold (95% CI: 1.07-2.36) greater likelihood of a long hospital stay than patients with normal CC.<b>Conclusions:</b> Low CC values have satisfactory validity in identifying nutritional risk and are associated with long hospital stay.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tarnowski</LastName>
            <ForeName>Micheli</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition Science, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stein</LastName>
            <ForeName>Elana</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition Science, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marcadenti</LastName>
            <ForeName>Aline</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Research of the Heart Hospital (IP-HCor), São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Postgraduate Program in Health Sciences: Cardiology, Institute of Cardiology/University Foundation of Cardiology (IC/FUC), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Postgraduate Program in Nutrition Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fink</LastName>
            <ForeName>Jaqueline</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nutrition, Dietetics of Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rabito</LastName>
            <ForeName>Estela</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition, Postgraduate Program in Food and Nutrition, Federal University of Paraná, Curitiba, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silva</LastName>
            <ForeName>Flávia Moraes</ForeName>
            <Initials>FM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition, Postgraduate Program in Nutrition, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Am Coll Nutr</MedlineTA>
        <NlmUniqueID>8215879</NlmUniqueID>
        <ISSNLinking>0731-5724</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Calf circumference</Keyword>
        <Keyword MajorTopicYN="N">length of hospital stay</Keyword>
        <Keyword MajorTopicYN="N">mortality</Keyword>
        <Keyword MajorTopicYN="N">nutritional assessment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083521</ArticleId>
        <ArticleId IdType="doi">10.1080/07315724.2020.1723452</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083522</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0300-9831</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition</Title>
          <ISOAbbreviation>Int J Vitam Nutr Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Beauty from within: Oral administration of a sulfur-containing supplement methylsulfonylmethane improves signs of skin ageing.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1024/0300-9831/a000643</ELocationID>
        <Abstract>
          <AbstractText><b/> <i>Background</i>: Methylsulfonylmethane (MSM) is an organosulfur compound with known benefits for joint health, sports nutrition, immune function, and anti-aging formulations and is gaining popularity as a nutritional supplement for the support of hair, skin and nails. <i>Methods</i>: The study was conducted in two steps; in Part I (pilot study) a panel of 20 participants ingested either 3 g a day of MSM or placebo capsules for 16 weeks. Visual and subject self assessment of wrinkles and skin texture as the predominant sign of ageing was observed. In Part II (dose-response study), 63 participants ingested either 1 g or 3 g per day of MSM for 16 weeks. Expert clinical grading, instrumental measurements and consumer perception was used to evaluate skin conditions like lines and wrinkles. Additionally, instrumentational analysis was conducted using corneometer and cutometer for investigation of skin hydration, firmness and elasticity. <i>Results</i>: Part I of the study clearly indicates that oral ingestion of MSM (3 g/d) reduces signs of ageing like facial wrinkles (<i>p</i> &lt; 0.05) and skin roughness (<i>p</i> &lt; 0.05) as compared to placebo. Detailed analysis in Part II instrumentation assessments showed a significant (<i>p</i> &lt; 0.05) improvement from baseline in the severity of facial wrinkles, as well as improved skin firmness, elasticity and hydration with MSM. Some of these parameters exhibited a good dose-response indicating that the higher (3 g/d) of the supplement was more effective than the lower dose of 1 g/d, but generally the lower dose of 1 g/d appeared to be sufficiently effective in reducing the facial signs of ageing. <i>Conclusion</i>: This study indicated that MSM is effective in reducing visual signs of skin ageing even at a low dose of 1 g/d.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Muizzuddin</LastName>
            <ForeName>Neelam</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Skin Clinical Research Consultants.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benjamin</LastName>
            <ForeName>Rodney</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7190-6788</Identifier>
            <AffiliationInfo>
              <Affiliation>Bergstrom Nutrition.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Int J Vitam Nutr Res</MedlineTA>
        <NlmUniqueID>1273304</NlmUniqueID>
        <ISSNLinking>0300-9831</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MSM; methylsulfonylmethane</Keyword>
        <Keyword MajorTopicYN="N">ageing</Keyword>
        <Keyword MajorTopicYN="N">firmness elasticity</Keyword>
        <Keyword MajorTopicYN="N">hydration</Keyword>
        <Keyword MajorTopicYN="N">skin</Keyword>
        <Keyword MajorTopicYN="N">wrinkles</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083522</ArticleId>
        <ArticleId IdType="doi">10.1024/0300-9831/a000643</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083523</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8730</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Zygote (Cambridge, England)</Title>
          <ISOAbbreviation>Zygote</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Embryonic and early larval development of two marine angelfish, <i>Centropyge bicolor</i> and <i>Centropyge bispinosa</i>.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-7</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/S0967199419000789</ELocationID>
        <Abstract>
          <AbstractText>Marine angelfish (family: Pomacanthidae) are among the most sought-after fish species in the saltwater aquarium trade. However, there is a lack of information in the literature on their early ontogeny. The objective of this study was to describe the embryonic and early larval development of two dwarf angelfish, the bicolour angelfish, Centropyge bicolor and the coral beauty angelfish, Centropyge bispinosa. The eggs of these two species were obtained from spontaneous spawning of the broodstock fish in captivity and incubated at 26.0 ± 0.2°C throughout the study. Fertilized eggs (n = 15) of both species are transparent, pelagic and spherical; the mean diameters of the eggs were measured at 703.6 ± 7.8 μm for C. bicolor and 627.6 ± 7.8 μm for C. bispinosa. The eggs of both species possessed a narrow perivitelline space, smooth and thin chorion, a homogenous and non-segmented yolk as well as a single oil globule. Overall, the observed embryonic development pattern of C. bicolor and C. bispinosa was very similar, and the main difference was the embryonic pigmentation pattern, which only became evident close to hatching. Larvae of both species started hatching at 13 h 30 min after fertilization, and the larval characteristics of both species also showed high levels of similarities. However, the mouth opening time for C. bicolor was 72 h after hatching (AH) and 96 AH for C. bispinosa. In general, the observed early ontogeny of C. bicolor and C. bispinosa also resembled that of other Centropyge species documented in the literature.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mendonça</LastName>
            <ForeName>Raoani Cruz</ForeName>
            <Initials>RC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6629-680X</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory of Marine Fishes and Ornamentals (LAPOM), Aquaculture Department, Agricultural Sciences Center (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346 Bairro Itacorubi, Florianópolis, SCCEP 88034-001, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jun Yu</ForeName>
            <Initials>JY</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Sustainable Tropical Fisheries and Aquaculture, College of Science and Engineering, James Cook University, Townsville, QLD4814, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Chaoshu</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Sustainable Tropical Fisheries and Aquaculture, College of Science and Engineering, James Cook University, Townsville, QLD4814, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsuzuki</LastName>
            <ForeName>Mônica Yumi</ForeName>
            <Initials>MY</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Marine Fishes and Ornamentals (LAPOM), Aquaculture Department, Agricultural Sciences Center (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346 Bairro Itacorubi, Florianópolis, SCCEP 88034-001, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Zygote</MedlineTA>
        <NlmUniqueID>9309124</NlmUniqueID>
        <ISSNLinking>0967-1994</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Centropyge</Keyword>
        <Keyword MajorTopicYN="N">Early larvae</Keyword>
        <Keyword MajorTopicYN="N">Embryo</Keyword>
        <Keyword MajorTopicYN="N">Ontogeny</Keyword>
        <Keyword MajorTopicYN="N">Pomacathidae</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083523</ArticleId>
        <ArticleId IdType="pii">S0967199419000789</ArticleId>
        <ArticleId IdType="doi">10.1017/S0967199419000789</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083524</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">1832-4274</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Twin research and human genetics : the official journal of the International Society for Twin Studies</Title>
          <ISOAbbreviation>Twin Res Hum Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Heritability of Curve Patterns in Oral Glucose Tolerance Test.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/thg.2020.3</ELocationID>
        <Abstract>
          <AbstractText>Type 2 diabetes, which is caused by both genetic and environmental factors, may be diagnosed using the oral glucose tolerance test (OGTT). Recent studies demonstrated specific patterns in glucose curves during OGTT associated with cardiometabolic risk profiles. As the relative contribution of genetic and environmental influences on glucose curve patterns is unknown, we aimed to investigate the heritability of these patterns. We studied twins from the Danish GEMINAKAR cohort aged 18-67 years and free from diabetes at baseline during 1997-2000; glucose concentrations were measured three times during a 2-h OGTT. Heterogeneity of the glucose response during OGTT was examined with latent class mixed-effects models, evaluating goodness of fit by Bayes information criterion. The genetic influence on curve patterns was estimated using quantitative genetic modeling based on linear structural equations. Overall, 1455 twins (41% monozygotic) had valid glucose concentrations measured from the OGTT, and four latent classes with different glucose response patterns were identified. Statistical modeling demonstrated genetic influence for belonging to a specific class or not, with heritability estimated to be between 45% and 67%. During ∼12 years of follow-up, the four classes were each associated with different incidence of type 2 diabetes. Hence, glucose response curve patterns associated with type 2 diabetes risk appear to be moderately to highly heritable.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dalgård</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, Environmental Medicine and The Danish Twin Registry, University of Southern Denmark, Odense C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Möller</LastName>
            <ForeName>Soren</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Odense Patient Data Explorative Network (OPEN), Odense University Hospital and Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kyvik</LastName>
            <ForeName>Kirsten O</ForeName>
            <Initials>KO</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Research and The Danish Twin Registry, University of Southern Denmark and Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Odense C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Twin Res Hum Genet</MedlineTA>
        <NlmUniqueID>101244624</NlmUniqueID>
        <ISSNLinking>1832-4274</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">genetic variation</Keyword>
        <Keyword MajorTopicYN="N">latent class modeling</Keyword>
        <Keyword MajorTopicYN="N">oral glucose tolerance test</Keyword>
        <Keyword MajorTopicYN="N">twins</Keyword>
        <Keyword MajorTopicYN="N">type 2 diabetes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083524</ArticleId>
        <ArticleId IdType="pii">S1832427420000031</ArticleId>
        <ArticleId IdType="doi">10.1017/thg.2020.3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083525</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Voices Raised: The NCLEX-RN Experience in Canada.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26107</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26107</ELocationID>
        <Abstract>
          <AbstractText>The journey to this issue on the National Council Licensure Examination (NCLEX) began when the CJNL editorial director received two unsolicited NCLEX-focused manuscripts for consideration to publish. Adding to the growing body of articles and news stories published about the NCLEX since its 2015 implementation in Canada, the two papers revealed that the NCLEX-RN remains a controversial and unresolved issue for our profession. CJNL has long published special issues to focus attention on specific topics. Such focused publication creates a convenient repository of knowledge and information about a given subject, facilitating deeper exploration of the issue and serving as a historical reference point for the topic going forward. This issue continues that tradition by presenting 10 papers that discuss the NCLEX from the perspectives of researchers, policy makers, educators, students and a coalition of nurses that is vigorously advocating for remedies to address the disproportionately adverse impact of the NCLEX on students and especially on francophone writers. As CJNL's editor for policy and innovation, I was asked to serve as guest editor for this issue, and it has been my privilege to do so.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mildon</LastName>
            <ForeName>Barbara</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Chief Executive Officer, Kawartha Lakes' Community Care Health &amp; Care Network, Lindsay, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083525</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26107</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26107</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083526</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Perspectives on the Need for a Nursing Entry-to-Practice Examination in Canada.</ArticleTitle>
        <Pagination>
          <MedlinePgn>12-16</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26106</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26106</ELocationID>
        <Abstract>
          <AbstractText>Whenever we approach a policy change or revision, it is important to consider the impact of mental models and path dependency on our ability to consider a full range of options. The need for an entry-to-practice (ETP) or pre-licensing nursing examination may well fit the description of an entrenched mental model that results in path dependency. In this commentary, the objectives and purpose of nursing ETP examinations are explored within Canadian historical context, jurisdictional comparisons are considered and questions raised that could inform a national discussion on why Canada may or may not need an ETP examination for nursing.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>MacMillan</LastName>
            <ForeName>Kathleen</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Adjunct (Retired)School of Nursing, Faculty of Health Professions, Dalhousie University, Halifax, NS, Adjunct, Faculty of Nursing, University of Prince Edward Island, Charlottetown, PE.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083526</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26106</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26106</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083527</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Canadian Nurses Association: Reflections on the NCLEX-RN through the Lens of Nursing History and Evolution.</ArticleTitle>
        <Pagination>
          <MedlinePgn>17-21</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26105</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26105</ELocationID>
        <Abstract>
          <AbstractText>Decades of work by professional associations, regulators and educators have produced an ethical, reliable, robustly educated and regulated nursing workforce that enjoys high levels of respect in Canada and around the world. The officers of the Canadian Nurses Association comment here on the organization's history and changing role in regulatory policy over the past decade during the introduction of the American NCLEX-RN examination as the assessment tool for entry-to-practice for Canadian registered nurses. Facing forward, to maintain a strong, trusted nursing workforce the association remains committed to meaningful collaboration among nursing's professional, regulatory, education and union sectors.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Villeneuve</LastName>
            <ForeName>Michael J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Chief Executive Officer, Canadian Nurses Association, Ottawa, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Betker</LastName>
            <ForeName>Claire</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>President, Canadian Nurses Association, Ottawa, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guest</LastName>
            <ForeName>Tim</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>President-Elect, Canadian Nurses Association, Ottawa, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083527</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26105</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26105</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083528</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Transition to NCLEX-RN: Reflections from a CASN Past President.</ArticleTitle>
        <Pagination>
          <MedlinePgn>22-29</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26104</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26104</ELocationID>
        <Abstract>
          <AbstractText>Each president of CASN has one "issue" on which he or she focuses most during the presidency - for me, it was the NCLEX. Canadian nursing graduates first wrote the NCLEX for entry to practice in 2015. Failure rates were significantly higher than for the previous exam - the CRNE. Although the pass rates have improved, this is likely a result of better practice for writing this type of test. Apprehensions remain about the negative impact of the Americanization of our Canadian nursing curriculum and the damage that this examination appears to be doing to present and future francophone nurses.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Woodend</LastName>
            <ForeName>Kirsten</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Dean, Trent/Fleming School of Nursing, Trent University, Peterborough, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083528</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26104</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26104</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083529</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Predictors of Success in the NCLEX-RN for Canadian Graduates.</ArticleTitle>
        <Pagination>
          <MedlinePgn>30-45</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26103</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26103</ELocationID>
        <Abstract>
          <AbstractText>The National Council Licensure Examination for Registered Nurses (NCLEX-RN) has been the nursing licensure exam in most Canadian jurisdictions since 2015. Nursing faculty across the country have invested considerable effort into understanding the NCLEX-RN, so they could help to prepare students to be successful in the exam. A retrospective study was conducted at one Canadian university to identify predictors of success on the NCLEX-RN. Findings revealed that the strongest predictors of success were a grade point average of &gt;3.5 and a course grade in the community development course. The strong predictive value of the community development course was unexpected, and this suggests that content specifically related to acute care may not play as heavy a role in the NCLEX-RN outcome as previously expected. It is possible that students' higher levels of cognitive abilities, such as application, analysis and synthesis of nursing knowledge, play a larger role in the exam outcome than content-specific knowledge.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McCloskey</LastName>
            <ForeName>Rose</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Professor, Department of Nursing &amp; Health Sciences, University of New Brunswick, Saint John, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stewart</LastName>
            <ForeName>Connie</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mathematics and Statistics, University of New Brunswick, Saint John, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burke</LastName>
            <ForeName>Lisa Keeping</ForeName>
            <Initials>LK</Initials>
            <AffiliationInfo>
              <Affiliation>Associate Dean of Health Research, Department of Nursing &amp; Health Sciences, University of New Brunswick, Saint John, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083529</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26103</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26103</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083530</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Closer Look at the Introduction of the NCLEX-RN in Canada.</ArticleTitle>
        <Pagination>
          <MedlinePgn>46-56</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26102</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26102</ELocationID>
        <Abstract>
          <AbstractText>In 2015, the nursing faculty across most of Canada were informed by provincial nursing regulators that the America-based National Council Licensure Examination-Registered Nurse (NCLEX-RN) was going to replace the Canadian Registered Nurse Examination for our nursing students to become registered as nurses. This change in the exam has presented a number of challenges to both faculty and students as they transitioned from a Canadian exam for the Canadian context to an exam that was originally formulated for nursing registration in the United States. This manuscript examines the differences in the Canadian and American healthcare systems; explores the variations in Canadian and American nursing practice and education; outlines concerns surrounding the use of standardized testing that panders to corporate interests, encourages "teaching to the test" and is costing nursing programs and nursing students considerable resources; and explores the controversy surrounding the validity of the NCLEX-RN in both Canada and the United States. This manuscript asks Canadian nursing leaders, educators, clinicians and researchers to question why Canadians have taken on this exam when Americans themselves state that this exam "gives a false and incomplete picture of practice readiness."</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Campbell</LastName>
            <ForeName>T Diane</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, College of Nursing, University of Saskatchewan, Regina Campus, Regina, SK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Penz</LastName>
            <ForeName>Kelly</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, College of Nursing, University of Saskatchewan, Regina Campus, Regina, SK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vandenberg</LastName>
            <ForeName>Helen</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, College of Nursing, University of Saskatchewan, Regina Campus, Regina, SK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campbell</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Student in the Baccalauréat en Education, University of Regina, Regina, SK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083530</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26102</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26102</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083531</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Adoption of NCLEX-RN in Canada: A Failure of Leadership at the Intersection of Nursing Regulation, Education and Practice.</ArticleTitle>
        <Pagination>
          <MedlinePgn>57-65</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26101</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26101</ELocationID>
        <Abstract>
          <AbstractText>This commentary presents perspectives of two senior nursing professors who have extensive faculty and leadership experience in both Canada and the United States. To understand more about how the adoption of the National Council Licensure Examination-Registered Nurses (NCLEX-RN) examination in Canada came to be, the authors conducted conversations with 29 Canadian nurse educators and nursing education and practice leaders. Based on these conversations as well as a review of published materials on the topic, the authors conclude that regulatory leaders failed to involve key leaders and stakeholders from nursing education and practice in this decision, and the resulting negative consequences have been borne primarily by the education and practice sectors. The authors argue that the NCLEX-RN adoption has introduced a misalignment into what had been a well-aligned model of education, regulation and practice in Canada and invite readers to consider the following discussion points. First, the NCLEX-RN has been designed to operate within a healthcare system that should not, by any reasonable argument, be replicated elsewhere; therefore, what are the contextual factors that led to the Canadian adoption of the NCLEX-RN? Second, American regulators stipulate that the examination must fit associate degree graduate competencies and that the additional knowledge and competencies gained at the baccalaureate level are irrelevant for licensure purposes; however, is this a fit for Canadian nursing licensure that requires the baccalaureate degree as an entry for practice? In conclusion, as American higher education in nursing now begins to move toward a competency-based model, further changes will have to be implemented to shape and frame the future of nursing education in the United States, and by extension, the future development of the NCLEX-RN within Canada's distinct historical, social, political and institutional context.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>May</LastName>
            <ForeName>Katharyn A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Emerita Professor and Dean, School of Nursing at the University of Wisconsin-Madison, Madison, WI.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Singh-Carlson</LastName>
            <ForeName>Savitri</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Professor and Fulbright Scholar, School of Nursing, San Diego State University, San Diego, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083531</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26101</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26101</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083532</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Forgotten: The Challenges Faced by Francophone Nursing Candidates following the Introduction of the NCLEX-RN in Canada.</ArticleTitle>
        <Pagination>
          <MedlinePgn>66-73</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26100</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26100</ELocationID>
        <Abstract>
          <AbstractText>In 2015, the traditional paper-and-pencil entry-to-practice exam in Canada was replaced by a computer-adaptive testing exam, the American National Council Licensure Examination for Registered Nurses (NCLEX-RN). As there are two official languages in Canada - English and French - the NCLEX-RN was translated to French. Although initially the pass rates for anglophone writers with the NCLEX-RN were lower than with the previous Canadian licensing exam, their pass rates have now increased. By contrast, francophone writers have continued to have lower pass rates, and a decreasing number of candidates are choosing to write the exam in French. A lack of access to French language preparatory resources is being reported by francophone graduates as one of the contributing factors. Canadian nursing regulators report that they are not responsible for ensuring that candidates have access to preparatory materials. However, given the bilingual culture and heritage in Canada, there is a responsibility to ensure equitable access to preparatory resources to ensure success on the licensing exam. This paper raises alarm about the decreasing number of francophone graduates writing the NCLEX-RN in French and the ongoing delivery of safe, quality nursing care to francophone patients by nurses proficient in the French language.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lalonde</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Professeure Adjointe/Assistant Professor, École des sciences infirmières/School of Nursing, Faculté des sciences de la santé/Faculty of Health Sciences, Université d'Ottawa/University of Ottawa, Ottawa, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083532</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26100</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26100</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083533</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The NCLEX-RN as an Entry-to-Practice Exam in New Brunswick: The Rocky Road Story of Francophone Candidates to the Nursing Profession.</ArticleTitle>
        <Pagination>
          <MedlinePgn>74-80</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26099</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26099</ELocationID>
        <Abstract>
          <AbstractText>This article describes the experience of adopting the NCLEX-RN as an entry-to-practice exam among francophone baccalaureate nursing students in New Brunswick, Canada. The journey between 2012 and now has been difficult, and nursing leadership was necessary to inform key stakeholders regarding the inequities faced by francophone nursing students and to bring about change. Here is a description of the arduous work done by a group of concerned nurses (active and retired) to advocate for the rights of francophone nursing students.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guerrette-Daigle</LastName>
            <ForeName>Lise</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Retired VP Réseau de santé Vitalité, Independent Nursing Consultant, Richibouctou-Village, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Landry</LastName>
            <ForeName>Véronique</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>IPSSP Responsible for the Nurse Practitioner Program, Lecturer and Clinical Instructor, Université de Moncton Dieppe, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harrison</LastName>
            <ForeName>Suzanne</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Associate Professor, Director School of Nursing, Université de Moncton Moncton, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Durocher-Hendriks</LastName>
            <ForeName>Suzie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Adjunct professor, Clinical coordinator, Université de Moncton Saint-Jacques, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marquis</LastName>
            <ForeName>France L</ForeName>
            <Initials>FL</Initials>
            <AffiliationInfo>
              <Affiliation>Retired Nursing Professor and Nursing Leader, Université de Moncton, Independent Health and Nursing Consultant, Edmundston, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Auffrey</LastName>
            <ForeName>Lucille M</ForeName>
            <Initials>LM</Initials>
            <AffiliationInfo>
              <Affiliation>MNHS, Independent Health Consultant, Retired Nursing Leader, Shédiac, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maillet</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Independent Health Consultant, Retired Nursing Leader, Moncton, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Labrie</LastName>
            <ForeName>Nicole D</ForeName>
            <Initials>ND</Initials>
            <AffiliationInfo>
              <Affiliation>Regional Chronic Disease Manager, éseau de Santé Vitalité, Saint-Quentin, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McGraw</LastName>
            <ForeName>Monica</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Lecturer and Clinical Instructor Université de Moncton, Cormier-Village, NB.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wallace</LastName>
            <ForeName>Isabelle</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Acute Care Nurse, Hôpital Montfort, Indigenous Health Consultant, Ottawa, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083533</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26099</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26099</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083534</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Promoting Quality in Nursing Education in Canada through a Canadian Examination for Baccalaureate Nurses.</ArticleTitle>
        <Pagination>
          <MedlinePgn>81-91</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26098</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26098</ELocationID>
        <Abstract>
          <AbstractText>Since its creation in 1942, the Canadian Association of Schools of Nursing's mandate has been to foster high-quality nursing education in Canada in the interest of healthier Canadians. To this end, the Canadian Examination for Baccalaureate Nurses/l'examen canadien du baccalauréat en sciences infirmières (CEBN/ECBSI) has been developed and will be launched in 2020. Its purpose, what the Canadian Examination for Baccalaureate Nurses designation signifies and the development of the examination are described.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baker</LastName>
            <ForeName>Cynthia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Executive Director, Canadian Association of Schools of Nursing, Ottawa, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083534</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26098</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26098</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083535</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Canadian Nursing Students' Association and its Advocacy for a Culturally Competent Entry-to-Practice Exam.</ArticleTitle>
        <Pagination>
          <MedlinePgn>92-96</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26097</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26097</ELocationID>
        <Abstract>
          <AbstractText>The Canadian Nursing Students' Association (CNSA) is the national voice of Canadian nursing students. Its goal is to increase the legal, ethical, professional and educational aspects of nursing, which are an integral part of the profession. The association is actively dedicated to the positive promotion of nurses and nursing as a whole. Since the implementation of the NCLEX-RN, CNSA has worked extensively to support nursing students as they write this entry-to-practice examination. On national and provincial platforms, CNSA has implored stakeholders to engage in an inclusive dialogue that results in increased support for nursing students with regard to the NCLEX-RN.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>John</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Neonatal Intensive Care Unit, The Hospital for Sick Children, Assistant Researcher, Daphne Cockwell School of Nursing, Ryerson University Toronto, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marques</LastName>
            <ForeName>Melanie</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>York University, Toronto, ON.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marchand</LastName>
            <ForeName>Victoria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>University of Ottawa, Ottawa, ON, CNSA President.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083535</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26097</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26097</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083536</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1910-622X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing leadership (Toronto, Ont.)</Title>
          <ISOAbbreviation>Nurs Leadersh (Tor Ont)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Creating a Shared Vision for Nursing.</ArticleTitle>
        <Pagination>
          <MedlinePgn>97-98</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">cjnl.2020.26096</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.12927/cjnl.2020.26096</ELocationID>
        <Abstract>
          <AbstractText>As we launch into the Year of the Nurse and Mid-wife, marking the 200th anniversary of Florence Nightingale's birth, there is much to look forward to in 2020. Numerous events and celebrations have been planned throughout the year, particularly with some schools of nursing also marking significant anniversaries. Indeed, in this country and others, there are many accomplishments to be celebrated in the context of the profession's evolution over the last two centuries. We should be proud but remain ever vigilant and appropriately responsive to circumstances that threaten our ability to sustain and effectively evolve into the future.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Longwoods Publishing.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nagle</LastName>
            <ForeName>Lynn</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor, Lawrence S. Bloomberg, Faculty of Nursing, University of Toronto.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Nurs Leadersh (Tor Ont)</MedlineTA>
        <NlmUniqueID>101470760</NlmUniqueID>
        <ISSNLinking>1910-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083536</ArticleId>
        <ArticleId IdType="pii">cjnl.2020.26096</ArticleId>
        <ArticleId IdType="doi">10.12927/cjnl.2020.26096</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083537</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Omalizumab in eosinophilic granulomatosis with polyangiitis: friend or foe? A systematic literature review.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To systematically evaluate, through a Medline search, the role of omalizumab in eosinophilic granulomatosis with polyangiitis (EGPA).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was performed with the following inclusion criteria: original articles and case reports written in English and reporting an association between omalizumab and EGPA.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found 18 papers on EGPA (14 case reports, 3 retrospective cohort studies, 1 prospective cohort study). Omalizumab showed to be effective as corticosteroid-sparing agent in EGPA patients with severe asthmatic manifestations. On the contrary, conflicting results concerned its use in refractory forms of EGPA. Plausible is the increased risk of EGPA onset among asthmatic patients treated with omalizumab, probably related to steroid reduction, even if it cannot be excluded that omalizumab might be occasionally directly involved in the pathogenesis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings support the use of omalizumab in selected forms of EGPA, but caution in the tapering of corticosteroids is also recommended. Quality of evidence is limited, as the source of information was mainly case reports. Clinical trials are required in order to evaluate the role of omalizumab in EGPA and to ascertain the risk of asthmatic patients given omalizumab to develop EGPA.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Basta</LastName>
            <ForeName>Fabio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy. fabiobasta@libero.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazzuca</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immuno-Rheumatology, Campus Bio-Medico, University of Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nucera</LastName>
            <ForeName>Eleonora</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Unit, Università Cattolica del Sacro Cuore, Policlinico "A. Gemelli", Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schiavino</LastName>
            <ForeName>Domenico</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Unit, Università Cattolica del Sacro Cuore, Policlinico "A. Gemelli", Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Afeltra</LastName>
            <ForeName>Antonella</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immuno-Rheumatology, Campus Bio-Medico, University of Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antonelli Incalzi</LastName>
            <ForeName>Raffaele</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Geriatrics, Campus Bio-Medico University, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083537</ArticleId>
        <ArticleId IdType="pii">14506</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083538</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritis.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Subclinical atherosclerosis, defined as the presence of carotid plaques, is more frequently found in patients with axial spondyloarthritis (axSpA) than in healthy individuals. We sought to determine whether axSpA patients are more commonly reclassified into the very high cardiovascular risk category than controls after performing carotid ultrasound and if this can be linked to disease characteristics.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">343 patients diagnosed with axSpA according to ASAS criteria and 177 controls were studied. Disease characteristics and Systematic Coronary Risk Evaluation (SCORE) were assessed in patients and controls. Presence of plaques and intima-media thickness (cIMT) was determined by carotid ultrasound. Multivariable regression analysis was performed to identify differences in the frequency of reclassification between patients and controls, as well as factors associated with reclassification in axSpA.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Carotid plaques (36% vs.25%, p=0.010) and higher cIMT (0.641± 0.121 vs. 0.602± 0.115 mm, p=0.001) were more common in patients than controls. Reclassification into the high-risk category was greater in patients (34% vs. 25%, p=0.037). Age (beta coefficient 2.74 [95%CI 1.34-5.62] vs. beta coef. 0.63 (95%CI 0.40-0.99) in patients, interaction p=0.001) and serum LDL-cholesterol (beta coef. 1.03 [95%CI 1.02-1.04] vs. beta coef. 1.00 [0.99-1.01], interaction p=0.029) showed a higher effect on reclassification in controls after multivariable analysis. Although reclassification in axSpA was associated with higher ASDAS-CRP, BASFI and BASMI scores, these associations were lost after adjusting for cardiovascular risk factors.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with axSpA are more likely to be reclassified into the very-high risk category after carotid ultrasound than controls. The influence of traditional cardiovascular risk factors on this reclassification differs between patients and controls.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rueda-Gotor</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quevedo-Abeledo</LastName>
            <ForeName>Juan Carlos</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Corrales</LastName>
            <ForeName>Alfonso</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Genre</LastName>
            <ForeName>Fernanda</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hernández-Hernández</LastName>
            <ForeName>Vanesa</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Delgado-Frías</LastName>
            <ForeName>Esmeralda</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>González-Gay</LastName>
            <ForeName>Miguel Ángel</ForeName>
            <Initials>MÁ</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology; Epidemiology, Genetics &amp; Atherosclerosis Res. Group on Systemic Inflammatory Diseases, Hosp. Univ. Marqués de Valdecilla, IDIVAL; School of Medicine, University of Cantabria, Santander, Spain; Faculty of Health Sciences, Univ. Witwatersrand, Johannesburg, South Africa. miguelaggay@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferraz-Amaro</LastName>
            <ForeName>Ivan</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083538</ArticleId>
        <ArticleId IdType="pii">14421</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083539</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>CYR61/TGF-β axis promotes adventitial fibrosis of Takayasu's arteritis in the IL-17 mediated inflammatory microenvironment.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Takayasu's arteritis (TAK) is characterised by inflammation and fibrosis in the aortas, but its pathogenesis remains unclear. The aim of the study is to demonstrate the role of cysteine-rich protein 61 (CYR61), a novel proinflammatory factor, in the inflammation and fibrosis of TAK vessels.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">CYR61 expression in the aortic vessel was compared between TA tissues and healthy samples by immunohistochemistry staining. The effect of CYR61 on the proliferation, migration and activation of adventitial fibroblasts (AFs) in the IL-17-mediated inflammatory microenvironment was studied in vitro.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Here we found higher expression of CYR61 in the aortic adventitia in TAK patients than in healthy donors by immunohistochemistry staining. In vitro, recombinant human CYR61 (rhCYR61) significantly upregulated the proliferation of primary human aortic adventitial fibroblasts (AFs) and their expression of extracellular matrix (ECM) proteins such as collagen I, collagen III and fibronectin at the mRNA and protein levels, but rhCYR61 partly inhibited the migration of AFs. The integrin αvβ1 was identified as a membrane receptor of CYR61 in AFs, and its downstream Erk1/2 pathway was found activated by detecting its phosphorylation level. Pretreatment with PD98059, an inhibitor of Erk1/2, down-regulated the mRNA and protein expression of ECM proteins in the rhCYR61-stimulated AFs. Furthermore, rhCYR61 up-regulated the expression of TGF-β, and TGF-β siRNA transfection obviously attenuated the profibrotic effect ofrhCYR61. Finally, to clarify the cooperation between CYR61 and classical proinflammatory factors, IL-17 was chosen as a co-stimulator in the culture of AFs. rhIL-17 promoted the mRNA and protein expression of CYR61 in AFs, and the collaboration of rhIL-17 and rhCYR61 dramatically boosted the synthesis of ECM and TGF-β.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest that CYR61 played a profibrotic role through the TGF-β pathway and it enhanced IL-17-mediated inflammation and fibrosis in the mechanism of vascular impairment in TAK.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Lili</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, and Evidence-based Medicine, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kong</LastName>
            <ForeName>Xiufang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Xiaomeng</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Sifan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yujiao</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Xiaomin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Rongyi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Chunsheng</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Lindi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Zhongshan Hospital, Fudan University, and Evidence-based Medicine, Fudan University, Shanghai, China. zsh-rheum@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083539</ArticleId>
        <ArticleId IdType="pii">14515</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083540</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional case control study.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We evaluated age at natural menopause and the prevalence of premature ovarian failure (POF) in a monocentric Caucasian cohort of patients with systemic lupus erythematosus (SLE).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this cross-sectional study, we enrolled women affected by SLE compared with healthy controls (HC) to investigate data about natural menopause (amenorrhoea for at least 12 months at ≥40 years) and POF (amenorrhoea for at least 12 months at &lt;40 years).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We enrolled 196 SLE (median age 47.0 years, IQR 16.7; median disease duration 132 months, IQR 180) and 90 HC (median age 49.9 years, IQR 15.0). Ninety-four SLE (48.0%) and 26 HC (23.4%) were menopausal: median age at onset was significantly lower in SLE than HC (47 years, IQR 8.0 vs. 50.5 years, IQR 4; p=0.0001). POF was registered in 17% of the SLE, and in none of the HC (p&lt;0.0001). POF was significantly associated with anti-Sm (p=0.0004), anti-RNP (p=0.02), anti-cardiolipin (p=0.0008), lupus anticoagulant (p=0.0002), treatment with cyclophosphamide (p=0.0001), azathioprine (p=0.0001), mycophenolate mofetil (p=0.0001), cyclosporine A (p=0.007).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SLE patients develop menopause at a younger age; moreover, a higher POF frequency was observed in SLE patients in comparison with HC. POF is associated with specific SLE-related autoantibodies and the use of immunosuppressant drugs, in particular cyclophosphamide.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ceccarelli</LastName>
            <ForeName>Fulvia</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy. fulviaceccarelli@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orefice</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perrone</LastName>
            <ForeName>Giuseppina</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Ginecologico-Ostetriche e Scienze Urologiche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pirone</LastName>
            <ForeName>Carmelo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perricone</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Truglia</LastName>
            <ForeName>Simona</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miranda</LastName>
            <ForeName>Francesca</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pacucci</LastName>
            <ForeName>Viviana Antonella</ForeName>
            <Initials>VA</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spinelli</LastName>
            <ForeName>Francesca Romana</ForeName>
            <Initials>FR</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galoppi</LastName>
            <ForeName>Paola</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Ginecologico-Ostetriche e Scienze Urologiche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alessandri</LastName>
            <ForeName>Cristiano</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valesini</LastName>
            <ForeName>Guido</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conti</LastName>
            <ForeName>Fabrizio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Lupus Clinic, Reumatologia, Dipartimento Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>03</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083540</ArticleId>
        <ArticleId IdType="pii">14151</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083541</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical features of immunoglobulin G4-related disease with central nervous system involvement: an analysis of 15 cases.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Immunoglobulin G4-related disease (IgG4-RD) is a systemic disease that affects various organs of the body. The aim of this study is to elucidate the clinical characteristics of IgG4-RD with central nervous system (CNS) involvement.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Among 589 patients with IgG4-RD in a prospective single-centre cohort study in Peking Union Medical College Hospital, 15 patients had CNS involvement. The clinical data including demographic features, symptoms, involved organs, laboratory findings, radiological results, pathology, treatment and outcome were analysed.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen patients, including nine men and six women, had IgG4-related neuropathy, with an average age of 49.8±12.3 years. IgG4 related hypophysitis was the most common manifestation, accounting for 40% (6/15) of cases, followed by hypertrophic cranial pachymeningitis (n=4), hypertrophic spinal pachymeningitis (n=2), intracranial mass (n=2), cavernous sinus and orbital disease (n=1). Most patients had multi-organ involvement, with the most common extra-CNS manifestations were Mikulicz disease (MD) and lymphadenitis in 5 (33.3%) cases. Serum IgG4 levels were elevated in 12/15(80%) patients and the median value was 438.5 (104, 2250)mg/dL. Fourteen cases underwent biopsy, of which tissue was taken directly from CNS lesions in 4 cases. All patients received treatment with glucocorticoids (GCs) combined with immunosuppressants, including cyclophosphamide, tacrolimus, mycophenolate mofetil, and tripterygium glycosides. Complete remission was achieved in 3/15 (20.0%) patients, and 11/15 cases (73.3%) achieved partial remission.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">IgG4-related CNS involvement is a rare and distinct entity of IgG4-RD. Treatment with corticosteroids combined with immunosuppressive agents yielded favourable responses.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Linyi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Panpan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xia</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jieqiong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Jiuliang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jinjin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fei</LastName>
            <ForeName>Yunyun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China. zhangwen91@sina.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>YIcheng</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Xiaofeng</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Ministry of Education, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083541</ArticleId>
        <ArticleId IdType="pii">13987</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083542</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Endothelial dysfunction and subclinical atheromatosis in patients with systemic sclerosis.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess subclinical vascular features in patients with systemic sclerosis (SSc) via carotid ultrasound, and flow-mediated vasodilation (FMD), as measures of cardiovascular risk (CVR).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Cross-sectional study over a cohort of 70 patients diagnosed with SSc (diffuse or limited forms), on whom a vascular study protocol was performed to assess angiodynamic parameters measured by FMD in brachial artery and carotid ultrasound lesions: carotid intima-media thickness (CIMT) and carotid atheroma plaques (AP). Classical CVR factors were also assessed, as well as main features of SSc regarding skin and organic involvement, laboratory parameters, presence of autoantibodies and specific treatments.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">94% of patients were women with a mean age of 50.2± 12.5 years. 84% had endothelial dysfunction (ED), being severe in 49%, statistically associated with glucocorticoid (GC) treatment (OR=8.78; CI= 1.52-50.78; p= 0.015). CIMT was pathological in 39%, 23% had AP (none had significative haemodymanic stenosis). Serum vitamin D concentration (25(OH)D3) showed a protective effect on CIMT (OR= 0.94; CI= 0.89-0.99; p= 0.025). No differences between types of SSc were obtained; neither association between SSc features and classical CVR factors.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GC treatment has implications in CVR, despite in SSc GC doses administered are lower than in other autoimmune diseases (in our cohort even prednisone ≤10 mg daily was associated with ED). GC may be associated with an early vascular damage in these patients, which could lead to changes in FMD, ED and finally AP. On the other hand, optimum levels of 25(OH)D3 seemed to be beneficial against vascular damage.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>González-Martín</LastName>
            <ForeName>Jorge Juan</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, University Hospital HM Sanchinarro, Madrid, Spain. reumatologia.hms@hmhospitales.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Novella-Navarro</LastName>
            <ForeName>Marta</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calvo-Aranda</LastName>
            <ForeName>Enrique</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cabrera-Alarcón</LastName>
            <ForeName>José Luis</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>National Cardiovascular Research Centre (CNIC), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carrión</LastName>
            <ForeName>Ofelia</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Angiology &amp; Vascular Surgery Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdelkader</LastName>
            <ForeName>Afnan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Angiology &amp; Vascular Surgery Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aramburu</LastName>
            <ForeName>Francisco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alcocer</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sainz</LastName>
            <ForeName>Felipe</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Angiology &amp; Vascular Surgery Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>García de la Peña</LastName>
            <ForeName>Paloma</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, University Hospital HM Sanchinarro, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083542</ArticleId>
        <ArticleId IdType="pii">14639</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083543</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>04</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Improvement in matrix metalloproteinase-3 independently predicts low disease activity at 52 weeks in bio-switch rheumatoid arthritis patients treated with abatacept.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To explore predictive factors including MMP-3 for achievement of low disease activity (LDA) at 52 weeks in bio-switch rheumatoid arthritis (RA) patients treated with abatacept, for whom obtaining a good clinical response can be difficult.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Participants were 423 consecutive patients with RA treated with abatacept who were observed for longer than 52 weeks and registered in the TBCR, a Japanese multicentre registry system. Multivariate logistic regression analysis was used to study factors that predict the achievement of LDA at 52 weeks in bio-naïve (n=234) and bio-switch (n=189) groups.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">ROC analysis revealed that MMP-3 improvement rates at 12 weeks in bio-switch patients had the highest AUC with a cut-off value of 20.0% for predicting LDA achievement at 52 weeks. Multivariate logistic regression analysis revealed that, in addition to DAS28-CRP at baseline, achieving 20% improvement in MMP-3 levels at 12 weeks was an independent predictive factor (adjusted OR: 4.277, p=0.003) in the bio-switch group, whereas DAS28 was the only predictor in the bio-naïve group. Patients who achieved 20% improvement in MMP-3 levels at 12 weeks had significantly higher achievement rates of LDA at 52 weeks compared to those who did not achieve 20% improvement in the bio-switch group (60.0 vs. 33.3%, p=0.001).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest that improvement in MMP-3 levels is key to predicting the clinical efficacy of abatacept. Closer attention paid not only to major clinical indices, but also changes in MMP-3 levels, could improve our ability to optimise clinical results when treating bio-switch patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Takemoto</LastName>
            <ForeName>Toki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya; and Department of Orthopaedic Surgery, Anjo Kosei Hospital, Anjo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Nobunori</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. nobunori@med.nagoya-u.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kida</LastName>
            <ForeName>Daihei</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya Medical Center, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaneko</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya Medical Center, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirano</LastName>
            <ForeName>Yuji</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Toyohashi Municipal Hospital, Toyohashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujibayashi</LastName>
            <ForeName>Takayoshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Konan Kosei Hospital, Konan, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanayama</LastName>
            <ForeName>Yasuhide</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Toyota Kosei Hospital, Toyota, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanabayashi</LastName>
            <ForeName>Masahiro</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Ichinomiya Municipal Hospital, Ichinomiya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yabe</LastName>
            <ForeName>Yuichiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Tokyo Shinjuku Medical Center, Shinjuku-ku, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takagi</LastName>
            <ForeName>Hideki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Nagoya Central Hospital, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oguchi</LastName>
            <ForeName>Takeshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Anjo Kosei Hospital, Anjo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kato</LastName>
            <ForeName>Takefumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Kato Orthopaedic Clinic, Okazaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Funahashi</LastName>
            <ForeName>Koji</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Kariya-Toyota General Hospital, Kariya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsumoto</LastName>
            <ForeName>Takuya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Shizuoka Kosei Hospital, Shizuoka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sobue</LastName>
            <ForeName>Yasumori</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishiume</LastName>
            <ForeName>Tsuyoshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Mochihito</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yokota</LastName>
            <ForeName>Yutaka</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Terabe</LastName>
            <ForeName>Kenya</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asai</LastName>
            <ForeName>Shuji</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishiguro</LastName>
            <ForeName>Naoki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kojima</LastName>
            <ForeName>Toshihisa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083543</ArticleId>
        <ArticleId IdType="pii">14466</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083544</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Immunoglobulin (Ig) A vasculitis affects children more commonly than adults and previous literature lacks any formal damage assessment. Our aim in this study is to investigate the disease course, relapse rates and prognostic factors in adult patients with IgA vasculitis and to evaluate the disease-related damage.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We assembled a retrospective cohort of adult IgA vasculitis from six tertiary Rheumatology Centres in Turkey. The demographics, clinical characteristics, treatment and outcomes of patients were abstracted from medical records.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 130 (male/female: 85/45) patients and the mean age was 42.2±17 years. Cutaneous manifestations and arthritis/arthralgia were the most common clinical manifestations. One hundred thirteen patients (86.9%) were treated with oral glucocorticoids (GC). As additional immunosuppressive (IS) agents, azathioprine was given to 44 (34.9%) and pulse cyclophosphamide to 18 (12.6%) patients. Seventy-nine patients (60%) had follow-up of median 15 (IQR 7-40) months. Twelve (15%) patients relapsed during follow-up. The mean VDI score was 0.4 in the last visit. Nineteen (24.7%) patients had at least one damage item at the end of follow-up. Most frequent damage items were renal 11 (42%), ocular 4 (15%) and cardiovascular 4 (15%).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this cohort the most frequent damage item was renal and was related to the disease itself. Damage score was higher in patients with more severe disease and treated more aggressively. Our results suggest that more effective treatment options are needed in a subgroup of patients with IgA vasculitis to prevent the damage related with the vasculitis, especially with more severe disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gazel</LastName>
            <ForeName>Ummugulsum</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Marmara University, Istanbul, Turkey. gulsumoguz@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colak</LastName>
            <ForeName>Seda</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Ankara Numune Education and Research Hospital, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sari</LastName>
            <ForeName>Alper</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cansu</LastName>
            <ForeName>Döndü Üsküdar</ForeName>
            <Initials>DÜ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yazici</LastName>
            <ForeName>Ayten</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cefle</LastName>
            <ForeName>Ayse</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bes</LastName>
            <ForeName>Cemal</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Health Sciences University Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karadag</LastName>
            <ForeName>Omer</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Omma</LastName>
            <ForeName>Ahmet</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Ankara Numune Education and Research Hospital, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Direskeneli</LastName>
            <ForeName>Haner</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alibaz-Oner</LastName>
            <ForeName>Fatma</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083544</ArticleId>
        <ArticleId IdType="pii">14770</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083545</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bioinformatics analysis of gene and microRNA targets for fibromyalgia.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Fibromyalgia (FM) is the most common chronic pain disease in middle-aged women. Patients may also complain of migraine, irritable bowel syndrome and depression, which seriously affect their work and life, causing huge economic losses to society. However, the pathogenesis of FM is still controversial and the effect of the current treatment is far from satisfactory.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Differentially expressed genes (DEGs) and miRNAs (DEMs) were found between FM and normal blood samples. The pathway and process enrichment analysis of the genes were performed. Protein-protein interaction network were constructed. Hub genes were found and analysed in The Comparative Toxicogenomics Database.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 102 genes were up-regulated and 46 down-regulated, 206 miRNAs down-regulated, and 15 up-regulated in FM. CD38, GATM, HDC, FOS were found as canditate genes. These genes were significantly associated with musculoskeletal disease, mental disorder, immune system disease. There was partial overlap between metformin therapy-related genes and FM-related genes.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found DEGs and DEMs in FM patients through bioinformatics analysis, which may be involved in the occurrence and development of FM and serve as potential targets for diagnosis and treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Qiu</LastName>
            <ForeName>Yong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Anaesthesiology Department, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Teng-Jiao</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Anaesthesiology Department, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Ling-Bing</ForeName>
            <Initials>LB</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Xu-Tao</ForeName>
            <Initials>XT</Initials>
            <AffiliationInfo>
              <Affiliation>Anaesthesiology Department, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hua</LastName>
            <ForeName>Zhen</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Anaesthesiology Department, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. huazhenbj528@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083545</ArticleId>
        <ArticleId IdType="pii">15067</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083546</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of biopsy-proven giant cell arteritis in North America and Southern Europe: a population-based study.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To compare clinical characteristics, treatment and prognosis of two population-based cohorts of patients with biopsy-proven giant cell arteritis (GCA) from Olmsted County, Minnesota, USA (Olmsted cohort) and the Reggio Emilia area, Northern Italy (Reggio cohort).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">All patients residing in Olmsted County and the Reggio Emilia area with a new diagnosis of biopsy-proven GCA in 1986-2007 were retrospectively identified. Patients were followed from GCA diagnosis to death, migration or September 2011.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 110 patients in the Olmsted and 144 in the Reggio cohort. Compared with the Olmsted cohort, patients from the Reggio cohort had longer duration of symptoms prior to diagnosis (median 1.4 months vs. 0.7, p&lt;0.001) and were younger (mean 74.6 years vs. 77.8, p=0.002), more likely to have cranial symptoms (93% vs. 86%, p=0.048), permanent vision loss (21% vs. 6%, p=0.001) and systemic symptoms (67% vs. 46%, p=0.001). ESR and CRP were higher (mean 88 mm/h vs. 73, and 89.0 mg/L vs. 35.2, both p&lt;0.001) in the Reggio cohort. Patients from the Olmsted cohort received a higher initial prednisone dose (mean 53.6 mg/day vs. 49.5, p=0.001). There were no differences in relapse rates, cumulative glucocorticoid (GC) dosages at 1, 2 and 5 years, and time to first GC discontinuation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Geographical, genetic and/or environmental factors may contribute to the different clinical features at onset of GCA observed in this study.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Muratore</LastName>
            <ForeName>Francesco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crowson</LastName>
            <ForeName>Cynthia S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, and Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boiardi</LastName>
            <ForeName>Luigi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pinelli</LastName>
            <ForeName>Ambra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Medicine, Dentistry and Morphological Sciences with interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koster</LastName>
            <ForeName>Matthew J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Restuccia</LastName>
            <ForeName>Giovanna</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kermani</LastName>
            <ForeName>Tanaz A</ForeName>
            <Initials>TA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matteson</LastName>
            <ForeName>Eric L</ForeName>
            <Initials>EL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, and Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salvarani</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Div. Rheumatology, Azienda Unità Sanitaria Locale IRCCS di Reggio Emilia, and Dept. of Surgery, Medicine, Dentistry and Morphological Sciences with interest in Transplant, Oncology and Regenerative Medicine, Univ. of Modena &amp; Reggio Emilia, Modena, Italy. salvarani.carlo@ausl.re.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Warrington</LastName>
            <ForeName>Kenneth J</ForeName>
            <Initials>KJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083546</ArticleId>
        <ArticleId IdType="pii">14808</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083547</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aims to characterise the clinical phenotype and autoantibody associations in an autoimmune population positive for anti-Ro52 and/or anti-Ro60 autoantibodies.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">508 sera of individuals tested for autoantibody presence were found positive for anti-Ro52 and/or anti-Ro60. Medical records were available for 272 of them. Correlations of clinical, laboratory and other autoantibodies as well as disease phenotypes with the presence of anti-Ro52 and/or anti-Ro60 reactivity were examined.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Combined serum anti-Ro52/anti-Ro60 reactivity was the most frequent one, mostly seen in Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) patients. In thesepatients this reactivity strongly associated with anti-La and/or anti-dsDNA autoantibodies. SS patients with combined anti-Ro52/anti-Ro60 and anti-La reactivity had clinical and/or laboratory risk factors for lymphoma development. Solo anti-Ro52 reactivity was primarily found in idiopathic inflammatory myopathies (IIM), primary biliary cholangitis (PBC), rheumatoid arthritis (RA) and SS patients. Solo anti-Ro52 also associated with anti-Jo1 and anti-M2 autoantibodies and with interstitial lung disease (ILD) in a context of IIM-related lung injury. ILD patients with combined anti-Ro52/anti-Ro-60 reactivity were diagnosed mostly as RA and/or SS. Solo anti-Ro60 reactivity strongly correlated with oral ulcers and co-existed with autoantibodies to Sm and nRNP/Sm.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Testing for autoantibodies against both Ro peptides may aim diagnosis, classify clinical manifestations in disease entities and define prognosis in certain autoimmune disorders. A distinct weight could be given to the isolated anti-Ro specificities in the SS classification criteria.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zampeli</LastName>
            <ForeName>Evangelia</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Autoimmune Systemic and Neurological Diseases, Athens, Greece. zampelieva@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mavrommati</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine and Autoimmune Diseases, Euroclinic of Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moutsopoulos</LastName>
            <ForeName>Haralampos M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Academy of Athens, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skopouli</LastName>
            <ForeName>Fotini N</ForeName>
            <Initials>FN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine and Autoimmune Diseases, Euroclinic of Athens, and Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083547</ArticleId>
        <ArticleId IdType="pii">14858</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083548</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>04</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: a 5-year prospective cohort.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the potential predictive value in patients with systemic lupus erythematous of the ankle-brachial index (ABI) for the occurrence of arterial vascular events.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">216 lupus patients from a prospective clinical cohort were evaluated using the ABI at the start of the study and then followed up for 5 years. Abnormal ABI was defined as an index ≤0.9 or &gt;1.4. Several potential vascular risk factors were also evaluated. Arterial vascular events (AVE): coronary events, cerebrovascular events, peripheral arterial disease and death related to vascular disease. Survival analysis was performed using a competitive risk regression approach, considering non-vascular death as a competitive event.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">18 arterial events and 14 deaths were identified. In the competitive risk regression analysis, independent predictors of higher risk were identified: family history of early AVE [subdistribution hazard ratio (SHR) 5.44, 95% confidence interval (CI) 1.69-17.50, p=0.004)], cumulative prednisone (grams) (SHR 1.01, 95% CI 1.01-1.03, p=0.007) and a personal history of arterial thrombosis (SHR 5.44, 95% CI 1.45-14.59, p=0.004). Female gender was a protective factor (SHR 0.22, 95% CI 0.07-0.77, p=0.017). A statistical trend was detected with abnormal ABI (SHR 2.65, 95% CI 0.86-8.14, p=0.089).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Male gender, exposure to high cumulative doses of prednisone, family history of early arterial vascular disease and occurrence of previous arterial thrombosis are independent risk predictors of arterial vascular events in patients with systemic lupus erythematosus. Abnormal ABI may be related to high risk for arterial vascular events.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Erdozain</LastName>
            <ForeName>Jose-Gabriel</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain. jgerdocas@gmail.com, jgerdocas@yahoo.es.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pijoan</LastName>
            <ForeName>Jose-Ignacio</ForeName>
            <Initials>JI</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Epidemiology Unit-Hospital Universitario Cruce, Biocruces Health Research Institute, CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villar</LastName>
            <ForeName>Irama</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nieto</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruiz-Arruza</LastName>
            <ForeName>Ioana</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruiz-Irastorza</LastName>
            <ForeName>Guillermo</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martinez-Berriotxoa</LastName>
            <ForeName>Agustin</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083548</ArticleId>
        <ArticleId IdType="pii">14655</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083549</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To identify the predictors of coronary involvement, and to determine the impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis (TAK).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study of TAK patients with coronary evaluation by angiography or computed tomography angiography was conducted in a tertiary center between 1990 and 2018. Risk factors for coronary involvement and predictors of overall survival, cardiovascular event-free survival, and relapse-free survival were investigated.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The median follow-up was 4.3 years (IQR 2.8-7.1). Out of 130 consecutive TAK patients, 71 (54.6%) had coronary involvement. Multivariate analysis revealed that age (OR: 1.537 per 10-year increase, 95% CI: 1.176-2.009, p=0.002) and type V angiographic classification (OR: 3.449, 95% CI: 1.600-7.437, p=0.002) were independent predictors of coronary involvement. Coronary involvement (HR: 8.358, 95% CI: 1.887-37.033, p=0.015), left ventricular systolic dysfunction (HR: 3.889, 95% CI: 1.467-10.311, p=0.006), and aortic regurgitation (HR: 3.373, 95% CI: 1.209-9.408, p=0.020) were independent predictors of overall survival. Furthermore, coronary involvement and baseline active disease were independently associated with increased major cardiovascular events (HR: 10.333, 95% CI: 2.326-45.906, p=0.017; HR: 7.084, 95% CI: 1.677-29.914, p=0.008, respectively) and relapse (HR: 5.186, 95% CI: 2.381-11.295, p&lt;0.001; HR: 5.694, 95% CI: 2.022-16.031, p=0.001, respectively). No immunosuppressive therapy was independently associated with increased cardiovascular events (HR: 2.560, 95% CI: 1.181-5.550, p=0.002).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Coronary involvement is an important predictor of poor long-term outcomes in patients with TAK. Increasing age and type V angiographic classification can help to identify TAK patients with coronary involvement.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Zhenyu</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. pumch_lzy@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Zhujun</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Ligang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shuyang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083549</ArticleId>
        <ArticleId IdType="pii">14878</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083550</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>04</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Performance of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in Asian patients: a single-centre retrospective cohort study in Korea.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the performance of the 2019 European League against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for systemic lupus erythematosus (SLE) in Asian patients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an electronic medical chart review of patients with SLE and defined rheumatic diseases. Classification criteria of the 1997 ACR, 2012 Systemic Lupus International Collaborating Clinics (SLICC), and 2019 EULAR/ACR were examined based on sensitivity, specificity, positive predictive value, negative predicted value, and accuracy using clinical diagnosis as the gold standard.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 335 SLE patients and 337 non-SLE patients were analysed. Non-SLE patients included rheumatoid arthritis (RA) (n=92), anti-phospholipid syndrome (APS) (n=57), mixed connective tissue disease (n=52), systemic sclerosis (n=43), primary Sjögren's syndrome (SS) (n=39), undifferentiated connective tissue disease (n=28), RA with secondary SS (n=24), dermatomyositis (n=1), and spondyloarthropathy (n=1). The sensitivity was 97.6% (95% confidence interval (CI): 0.954-0.989) for the 2019 EULAR/ACR criteria, 98.5% (95% CI: 0.966-0.995) for the 2012 SLICC criteria and 95.5% (95% CI: 0.927-0.975) for the 1997 ACR criteria. The specificity was 91.4% (95% CI: 0.879-0.942) for the 2019 EULAR/ACR criteria, 92.6% (95% CI: 0.892-0.951) for the 2012 SLICC criteria 93.8% (95% CI: 0.906-0.961) for the 1997 ACR criteria.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 2019 EULAR/ACR criteria for SLE had comparable performance to the 2012 SLICC criteria regarding diagnostic sensitivity and specificity in Korean population of SLE and other rheumatic diseases. However, the new criteria could not reach higher specificity than the 2012 SLICC criteria.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Eunyoung Emily</ForeName>
            <Initials>EE</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Eun Bong</ForeName>
            <Initials>EB</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Jin Kyun</ForeName>
            <Initials>JK</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Eun Young</ForeName>
            <Initials>EY</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Yeong Wook</ForeName>
            <Initials>YW</Initials>
            <AffiliationInfo>
              <Affiliation>Div. of Rheumatology, Dept. of Internal Medicine, and Dept. of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National Univ. Hosp., Seoul, Korea. ysong@snu.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083550</ArticleId>
        <ArticleId IdType="pii">14861</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083551</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0392-856X</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental rheumatology</Title>
          <ISOAbbreviation>Clin. Exp. Rheumatol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study.</ArticleTitle>
        <Pagination>
          <MedlinePgn/>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To clarify the efficacy and safety of calcineurin inhibitors (CNI) for treating adult-onset Still's disease (AOSD).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This multicentre historical cohort study enrolled the consecutive patients with AOSD according to Yamaguchi classification criteria. The endpoints were set as the time from the initiation of treatment to events, the persistency rate of CNI and safety. Based on the recurrent event data analysis, these endpoints were evaluated for each event. We divided the events into two groups according to the treatment that included CNI or conventional therapy without CNI.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred seventy-eight patients with 247 events were analysed. CNI were predominantly used in 72 events with a recurrent history, typical skin rash, high ferritin levels, and/or severe complications such as macrophage activation syndrome, disseminated intravascular coagulation, serositis, meningitis. CNI led to a significantly longer event-free survival (hazard ratio: 0.57, 95% confidential interval: 0.32-0.99) after adjustment of concomitant medications. Subgroup analysis showed that CNI were effective for AOSD patients with high ALT level (hazard ratio: 0.11, 95% confidential interval: 0.02-0.59) and severe complications (hazard ratio: 0.11, 95% confidential interval: 0.01-0.94). The persistency rate of CNI was 71% at 5th year. Adverse events occurred more frequently in the CNI group (18% versus 8%, p=0.02); however, CNI did not involve in increased risk of adverse events, including nephrotoxicity, after adjustment (p=0.23).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our retrospective analysis suggested that CNI could be an effective and safe option for treating AOSD.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nakamura</LastName>
            <ForeName>Hiroyuki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo,and Department of Internal Medicine, Tomakomai City Hospital, Tomakomai, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujieda</LastName>
            <ForeName>Yuichiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. edaichi@med.hokudai.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tarumi</LastName>
            <ForeName>Masato</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Tomakomai City Hospital, Tomakomai, and Department of Internal Medicine, Kushiro Red Cross Hospital, Kushiro, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kitakawa</LastName>
            <ForeName>Hirohiko</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Kushiro Red Cross Hospital, Kushiro, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hisada</LastName>
            <ForeName>Ryo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>3rd Department of Internal Medicine, Hokkaido P.W.F.A.C Obihiro-Kosei General Hospital, Obihiro, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakagawa</LastName>
            <ForeName>Ikuma</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Takikawa Municipal Hospital, Takikawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noguchi</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Japanese Red Cross Kitami Hospital, Kitami, and Department of Rheumatology, Tonan Hospital, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurita</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Japanese Red Cross Kitami Hospital, Kitami, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kataoka</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kasahara</LastName>
            <ForeName>Hideki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, NTT-East Sapporo Hospital, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amasaki</LastName>
            <ForeName>Yoshiharu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Tonan Hospital, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yokota</LastName>
            <ForeName>Isao</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Atsumi</LastName>
            <ForeName>Tatsuya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Exp Rheumatol</MedlineTA>
        <NlmUniqueID>8308521</NlmUniqueID>
        <ISSNLinking>0392-856X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083551</ArticleId>
        <ArticleId IdType="pii">14659</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083552</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2050-084X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>eLife</Title>
          <ISOAbbreviation>Elife</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rapid sex-specific adaptation to high temperature in <i>Drosophila</i>.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.53237</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">e53237</ELocationID>
        <Abstract>
          <AbstractText>The pervasive occurrence of sexual dimorphism demonstrates different adaptive strategies of males and females. While different reproductive strategies of the two sexes are well-characterized, very little is known about differential functional requirements of males and females in their natural habitats. Here, we study the impact environmental change on the selection response in both sexes. Exposing replicated <i>Drosophila</i> populations to a novel temperature regime, we demonstrate sex-specific changes in gene expression, metabolic and behavioral phenotypes in less than 100 generations. This indicates not only different functional requirements of both sexes in the new environment but also rapid sex-specific adaptation. Supported by computer simulations we propose that altered sex-biased gene regulation from standing genetic variation, rather than new mutations, is the driver of rapid sex-specific adaptation. Our discovery of environmentally driven divergent functional requirements of males and females has important implications-possibly even for gender aware medical treatments.</AbstractText>
          <CopyrightInformation>© 2020, Hsu et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hsu</LastName>
            <ForeName>Sheng-Kai</ForeName>
            <Initials>SK</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6942-7163</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vienna Graduate School of Population Genetics, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jakšić</LastName>
            <ForeName>Ana Marija</ForeName>
            <Initials>AM</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2293-255X</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vienna Graduate School of Population Genetics, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nolte</LastName>
            <ForeName>Viola</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lirakis</LastName>
            <ForeName>Manolis</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vienna Graduate School of Population Genetics, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kofler</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barghi</LastName>
            <ForeName>Neda</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3700-0971</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Versace</LastName>
            <ForeName>Elisabetta</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4578-1851</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Experimental Psychology, Queen Mary University of London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schlötterer</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4710-6526</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Populationsgenetik, Vetmeduni Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>ArchAdapt</GrantID>
            <Acronym>ERC_</Acronym>
            <Agency>European Research Council</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>W1225</GrantID>
            <Agency>Austrian Science Fund</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Elife</MedlineTA>
        <NlmUniqueID>101579614</NlmUniqueID>
        <ISSNLinking>2050-084X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="plain-language-summary" Language="eng">
        <AbstractText>Male and female animals of the same species sometimes differ in appearance and sexual behavior, a phenomenon known as sexual dimorphism. Both sexes share most of the same genes, but differences can emerge because of the way these are read by cells to create proteins – a process called gene expression. For instance, certain genes can be more expressed in males than in females, and vice-versa. Most studies into the emergence of sexual dimorphism have taken place in stable environments with few changes in climate or other factors. Therefore, the potential impact of environmental changes on sexual dimorphism has been largely overlooked. Here, Hsu et al. used genetic and computational approaches to investigate whether male and female fruit flies adapt differently to a new, hotter environment over several generations. The experiment showed that, after only 100 generations, the way that 60% of all genes were expressed evolved in a different direction in the two sexes. This led to differences in how the males and females made and broke down fat molecules, and in how their neurons operated. These expression changes also translated in differences for high-level biological processes. For instance, animals in the new settings ended up behaving differently, with the males at the end of the experiment spending more time chasing females than the ancestral flies. These findings demonstrate that male and female fruit flies adapt many biological processes (including metabolism and behaviors) differently to cope with changes in their environment, and that many different genes support these sex-specific adaptations. Ultimately, the work by Hsu et al. may inform medical strategies that take into account interactions between the patient’s sex and their environment.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drosophila simulans</Keyword>
        <Keyword MajorTopicYN="N">evolutionary biology</Keyword>
        <Keyword MajorTopicYN="N">experimental evolution</Keyword>
        <Keyword MajorTopicYN="N">genetics</Keyword>
        <Keyword MajorTopicYN="N">genomics</Keyword>
        <Keyword MajorTopicYN="N">sex-specific adaptation</Keyword>
        <Keyword MajorTopicYN="N">sexual dimorphism</Keyword>
      </KeywordList>
      <CoiStatement>SH, AJ, VN, ML, RK, NB, EV, CS No competing interests declared</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083552</ArticleId>
        <ArticleId IdType="doi">10.7554/eLife.53237</ArticleId>
        <ArticleId IdType="pii">53237</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083553</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2050-084X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>eLife</Title>
          <ISOAbbreviation>Elife</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Targeted induction of a silent fungal gene cluster encoding the bacteria-specific germination inhibitor fumigermin.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.52541</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">e52541</ELocationID>
        <Abstract>
          <AbstractText>Microorganisms produce numerous secondary metabolites (SMs) with various biological activities. Many of their encoding gene clusters are silent under standard laboratory conditions because for their activation they need the ecological context, such as the presence of other microorganisms. The true ecological function of most SMs remains obscure, but understanding of both the activation of silent gene clusters and the ecological function of the produced compounds is of importance to reveal functional interactions in microbiomes. Here, we report the identification of an as-yet uncharacterized silent gene cluster of the fungus <i>Aspergillus fumigatus</i>, which is activated by the bacterium <i>Streptomyces rapamycinicus</i> during the bacterial-fungal interaction. The resulting natural product is the novel fungal metabolite fumigermin, the biosynthesis of which requires the polyketide synthase FgnA. Fumigermin inhibits germination of spores of the inducing <i>S. rapamycinicus,</i> and thus helps the fungus to defend resources in the shared habitat against a bacterial competitor.</AbstractText>
          <CopyrightInformation>© 2020, Stroe et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stroe</LastName>
            <ForeName>Maria Cristina</ForeName>
            <Initials>MC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4049-1062</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, Friedrich Schiller University Jena, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Netzker</LastName>
            <ForeName>Tina</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4845-9366</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scherlach</LastName>
            <ForeName>Kirstin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomolecular Chemistry, HKI, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krüger</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hertweck</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, Friedrich Schiller University Jena, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomolecular Chemistry, HKI, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valiante</LastName>
            <ForeName>Vito</ForeName>
            <Initials>V</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-4405-169X</Identifier>
            <AffiliationInfo>
              <Affiliation>Leibniz Research Group - Biobricks of Microbial Natural Product Syntheses, HKI, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brakhage</LastName>
            <ForeName>Axel A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8814-4193</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, Friedrich Schiller University Jena, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Collaborative Research Center 1127 ChemBioSys (projects B01)</GrantID>
            <Agency>Deutsche Forschungsgemeinschaft</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>Collaborative Research Center 1127 ChemBioSys (projects B02)</GrantID>
            <Agency>Deutsche Forschungsgemeinschaft</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>DrugBioTune</GrantID>
            <Agency>Bundesministerium für Bildung und Forschung</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>Microbial and Biomolecular Interactions</GrantID>
            <Agency>International Leibniz Research School</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Elife</MedlineTA>
        <NlmUniqueID>101579614</NlmUniqueID>
        <ISSNLinking>2050-084X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aspergillus fumigatus</Keyword>
        <Keyword MajorTopicYN="N">Streptomyces rapamycinicus</Keyword>
        <Keyword MajorTopicYN="N">ecology</Keyword>
        <Keyword MajorTopicYN="N">germination inhibition</Keyword>
        <Keyword MajorTopicYN="N">infectious disease</Keyword>
        <Keyword MajorTopicYN="N">microbial interaction</Keyword>
        <Keyword MajorTopicYN="N">microbiology</Keyword>
        <Keyword MajorTopicYN="N">polyketide</Keyword>
        <Keyword MajorTopicYN="N">secondary metabolism</Keyword>
      </KeywordList>
      <CoiStatement>MS, TN, KS, TK, CH, VV No competing interests declared, AB Reviewing editor, eLife</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083553</ArticleId>
        <ArticleId IdType="doi">10.7554/eLife.52541</ArticleId>
        <ArticleId IdType="pii">52541</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083554</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-486X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing for women's health</Title>
          <ISOAbbreviation>Nurs Womens Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sleep Promotion for Preterm Infants in the NICU.</ArticleTitle>
        <Pagination>
          <MedlinePgn>24-35</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1751-4851(19)30230-2</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nwh.2019.11.004</ELocationID>
        <Abstract>
          <AbstractText>Sleep is a crucial human physiologic need. Preterm infants in the NICU are exposed to noxious stimuli that often disrupt and shorten their sleep periods. Sleep disruption may have a negative effect on clinical outcomes, growth, and development and may also delay hospital discharge. Increasing evidence suggests that sleep quality is critical for brain development and synaptic plasticity and is associated with long-term neurodevelopmental outcomes. The purpose of this article is to discuss the importance of sleep in preterm infants, describe tools commonly used to assess infant sleep and identify different sleep-wake states, and identify interventions that promote sleep in preterm infants in the NICU. Nurses play a vital role in implementing appropriate interventions that promote preterm infants' sleep.</AbstractText>
          <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Jinhee</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nurs Womens Health</MedlineTA>
        <NlmUniqueID>101304602</NlmUniqueID>
        <ISSNLinking>1751-4851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">NICU</Keyword>
        <Keyword MajorTopicYN="N">behavioral states</Keyword>
        <Keyword MajorTopicYN="N">neonatal intensive care unit</Keyword>
        <Keyword MajorTopicYN="N">neurodevelopment</Keyword>
        <Keyword MajorTopicYN="N">preterm infant</Keyword>
        <Keyword MajorTopicYN="N">sleep</Keyword>
        <Keyword MajorTopicYN="N">wake</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>03</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083554</ArticleId>
        <ArticleId IdType="pii">S1751-4851(19)30230-2</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nwh.2019.11.004</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083555</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-486X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing for women's health</Title>
          <ISOAbbreviation>Nurs Womens Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Standardized Practices to Address Maternal Venous Thromboembolism: AWHONN Practice Brief Number 7.</ArticleTitle>
        <Pagination>
          <MedlinePgn>58-60</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1751-4851(20)30023-4</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nwh.2020.01.002</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <CollectiveName>Association of Women’s Health, Obstetric and Neonatal Nurses</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D017065">Practice Guideline</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nurs Womens Health</MedlineTA>
        <NlmUniqueID>101304602</NlmUniqueID>
        <ISSNLinking>1751-4851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083555</ArticleId>
        <ArticleId IdType="pii">S1751-4851(20)30023-4</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nwh.2020.01.002</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083556</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-486X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing for women's health</Title>
          <ISOAbbreviation>Nurs Womens Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Health Care Decision Making for Reproductive Care.</ArticleTitle>
        <Pagination>
          <MedlinePgn>61</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1751-4851(20)30024-6</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nwh.2020.01.003</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <CollectiveName>Association of Women’s Health, Obstetric and Neonatal Nurses</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D017065">Practice Guideline</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nurs Womens Health</MedlineTA>
        <NlmUniqueID>101304602</NlmUniqueID>
        <ISSNLinking>1751-4851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083556</ArticleId>
        <ArticleId IdType="pii">S1751-4851(20)30024-6</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nwh.2020.01.003</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083557</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-486X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nursing for women's health</Title>
          <ISOAbbreviation>Nurs Womens Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analgesia and Anesthesia in the Intrapartum Period.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1-e60</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1751-4851(19)30234-X</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nwh.2019.12.002</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hale</LastName>
            <ForeName>Susan</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hill</LastName>
            <ForeName>Catherine M</ForeName>
            <Initials>CM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hermann</LastName>
            <ForeName>Melanie</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kinzig</LastName>
            <ForeName>Angel</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lawrence</LastName>
            <ForeName>Carol</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCaughin</LastName>
            <ForeName>Nicole</ForeName>
            <Initials>N</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parker</LastName>
            <ForeName>Cheryl</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abney-Roberts</LastName>
            <ForeName>Sue-Ellen</ForeName>
            <Initials>SE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>Carol Elaine</ForeName>
            <Initials>CE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>McMenemy</LastName>
            <ForeName>Nancy</ForeName>
            <Initials>N</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vincent</LastName>
            <ForeName>Jamie</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D017065">Practice Guideline</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nurs Womens Health</MedlineTA>
        <NlmUniqueID>101304602</NlmUniqueID>
        <ISSNLinking>1751-4851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083557</ArticleId>
        <ArticleId IdType="pii">S1751-4851(19)30234-X</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nwh.2019.12.002</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083558</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2213-4808</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>Multisensory research</Title>
          <ISOAbbreviation>Multisens Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cross-Modal Correspondence Between Speech Sound and Visual Shape Influencing Perceptual Representation of Shape: the Role of Articulation and Pitch.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-30</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1163/22134808-20191330</ELocationID>
        <Abstract>
          <AbstractText>Cross-modal correspondence is the tendency to systematically map stimulus features across sensory modalities. The current study explored cross-modal correspondence between speech sound and shape (Experiment 1), and whether such association can influence shape representation (Experiment 2). For the purpose of closely examining the role of the two factors - articulation and pitch - combined in speech acoustics, we generated two sets of 25 vowel stimuli - pitch-varying and pitch-constant sets. Both sets were generated by manipulating articulation - frontness and height of the tongue body's positions - but differed in terms of whether pitch varied among the sounds within the same set. In Experiment 1, participants made a forced choice between a round and a spiky shape to indicate the shape better associated with each sound. Results showed that shape choice was modulated according to both articulation and pitch, and we therefore concluded that both factors play significant roles in sound-shape correspondence. In Experiment 2, participants reported their subjective experience of shape accompanied by vowel sounds by adjusting an ambiguous shape in the response display. We found that sound-shape correspondence exerts an effect on shape representation by modulating audiovisual interaction, but only in the case of pitch-varying sounds. Therefore, pitch information within vowel acoustics plays the leading role in sound-shape correspondence influencing shape representation. Taken together, our results suggest the importance of teasing apart the roles of articulation and pitch for understanding sound-shape correspondence.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kwak</LastName>
            <ForeName>Yuna</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>1Department of Psychology, Korea University, Seoul 02841, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nam</LastName>
            <ForeName>Hosung</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>2Department of English Language and Literature, Korea University, Seoul 02841, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3Haskins Laboratories, New Haven, CT 06511, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hyun-Woong</ForeName>
            <Initials>HW</Initials>
            <AffiliationInfo>
              <Affiliation>1Department of Psychology, Korea University, Seoul 02841, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Chai-Youn</ForeName>
            <Initials>CY</Initials>
            <AffiliationInfo>
              <Affiliation>1Department of Psychology, Korea University, Seoul 02841, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Multisens Res</MedlineTA>
        <NlmUniqueID>101604290</NlmUniqueID>
        <ISSNLinking>2213-4794</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cross-modal correspondence</Keyword>
        <Keyword MajorTopicYN="N">articulation</Keyword>
        <Keyword MajorTopicYN="N">audiovisual interaction</Keyword>
        <Keyword MajorTopicYN="N">bouba–kiki effect</Keyword>
        <Keyword MajorTopicYN="N">pitch</Keyword>
        <Keyword MajorTopicYN="N">speech sound</Keyword>
        <Keyword MajorTopicYN="N">visual shape</Keyword>
        <Keyword MajorTopicYN="N">vowel sound</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083558</ArticleId>
        <ArticleId IdType="doi">10.1163/22134808-20191330</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083559</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2213-4808</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>Multisensory research</Title>
          <ISOAbbreviation>Multisens Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Book Review.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1163/22134808-bja10001</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spence</LastName>
            <ForeName>Charles</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental Psychology, Anna Watts Building, University of Oxford, Oxford, OX2 6GG, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Multisens Res</MedlineTA>
        <NlmUniqueID>101604290</NlmUniqueID>
        <ISSNLinking>2213-4794</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083559</ArticleId>
        <ArticleId IdType="doi">10.1163/22134808-bja10001</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083560</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2213-4808</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Multisensory research</Title>
          <ISOAbbreviation>Multisens Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Task-Irrelevant Sound Corrects Leftward Spatial Bias in Blindfolded Haptic Placement Task.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-28</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1163/22134808-20191387</ELocationID>
        <Abstract>
          <AbstractText>We often rely on our sense of vision for understanding the spatial location of objects around us. If vision cannot be used, one must rely on other senses, such as hearing and touch, in order to build spatial representations. Previous work has found evidence of a leftward spatial bias in visual and tactile tasks. In this study, we sought evidence of this leftward bias in a non-visual haptic object location memory task and assessed the influence of a task-irrelevant sound. In Experiment 1, blindfolded right-handed sighted participants used their non-dominant hand to haptically locate an object on the table, then used their dominant hand to place the object back in its original location. During placement, participants either heard nothing (no-sound condition) or a task-irrelevant repeating tone to the left, right, or front of the room. The results showed that participants exhibited a leftward placement bias on no-sound trials. On sound trials, this leftward bias was corrected; placements were faster and more accurate (regardless of the direction of the sound). One explanation for the leftward bias could be that participants were overcompensating their reach with the right hand during placement. Experiment 2 tested this explanation by switching the hands used for exploration and placement, but found similar results as Experiment 1. A third Experiment found evidence supporting the explanation that sound corrects the leftward bias by heightening attention. Together, these findings show that sound, even if task-irrelevant and semantically unrelated, can correct one's tendency to place objects too far to the left.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cacciamani</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>California Polytechnic State University, San Luis Obispo, CA,USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sheparovich</LastName>
            <ForeName>Larisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>California Polytechnic State University, San Luis Obispo, CA,USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gibbons</LastName>
            <ForeName>Molly</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>California Polytechnic State University, San Luis Obispo, CA,USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crowley</LastName>
            <ForeName>Brooke</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>California Polytechnic State University, San Luis Obispo, CA,USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carpenter</LastName>
            <ForeName>Kalynn E</ForeName>
            <Initials>KE</Initials>
            <AffiliationInfo>
              <Affiliation>California Polytechnic State University, San Luis Obispo, CA,USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wack</LastName>
            <ForeName>Carson</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>California Polytechnic State University, San Luis Obispo, CA,USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>01</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Multisens Res</MedlineTA>
        <NlmUniqueID>101604290</NlmUniqueID>
        <ISSNLinking>2213-4794</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Auditory perception</Keyword>
        <Keyword MajorTopicYN="N">blindness</Keyword>
        <Keyword MajorTopicYN="N">haptic exploration</Keyword>
        <Keyword MajorTopicYN="N">haptic memory</Keyword>
        <Keyword MajorTopicYN="N">spatial memory</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083560</ArticleId>
        <ArticleId IdType="doi">10.1163/22134808-20191387</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083561</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1571-8093</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of health law</Title>
          <ISOAbbreviation>Eur J Health Law</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Teaching Health and Human Rights in a Globalised Classroom.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-12</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1163/15718093-12251007</ELocationID>
        <Abstract>
          <AbstractText>This article outlines the importance of human rights in the health law curriculum. The author reflects on her experiences of teaching Health and Human Rights at the Faculty of Law, University of Copenhagen. Health and human rights, it is argued, can have important implications for students' understanding of health and the role of law. Namely, it underscores the obligations of states and the rights of individuals, as well as the need for health laws and policies to respect rights. This approach prohibits health laws that discriminate or stigmatise. Furthermore, it is put forth that the growing body of socioeconomic rights jurisprudence should be integrated into teaching. Equally, students should be prepared for the needs of the modern labour market: interdisciplinarity and digitalisation, and to assess the human rights implications. Finally, educators must acknowledge and discuss the limitations of rights so that students are equipped to address and solve challenges.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ó Cathaoir</LastName>
            <ForeName>Katharina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Assistant Professor in Health Law, Faculty of Law, University of Copenhagen Copenhagen Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Eur J Health Law</MedlineTA>
        <NlmUniqueID>9431861</NlmUniqueID>
        <ISSNLinking>0929-0273</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">health law</Keyword>
        <Keyword MajorTopicYN="N">human rights</Keyword>
        <Keyword MajorTopicYN="N">right to health</Keyword>
        <Keyword MajorTopicYN="N">socioeconomic rights</Keyword>
        <Keyword MajorTopicYN="N">teaching </Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083561</ArticleId>
        <ArticleId IdType="doi">10.1163/15718093-12251007</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083562</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2213-4808</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Multisensory research</Title>
          <ISOAbbreviation>Multisens Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Book Review.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1163/22134808-bja10002</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spence</LastName>
            <ForeName>Charles</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental Psychology, Anna Watts Building, University of Oxford, Oxford, OX2 6GG, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Multisens Res</MedlineTA>
        <NlmUniqueID>101604290</NlmUniqueID>
        <ISSNLinking>2213-4794</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083562</ArticleId>
        <ArticleId IdType="doi">10.1163/22134808-bja10002</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083563</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1558-1551</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Breast disease</Title>
          <ISOAbbreviation>Breast Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Brachial plexus schwannoma mimicking advanced breast carcinoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/BD-190432</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Schwannoma is an extremely rare benign tumour of the peripheral nervous system; its association with breast cancer is sporadic, and its association with the brachial plexus is extremely rare.</AbstractText>
          <AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">The authors report a case of a patient with breast cancer associated with nodulation in the left supraclavicular fossa, and due to the clinical and radiological features, it was considered metastatic lymph node disease. The patient underwent neoadjuvant chemotherapy, with partial response of the breast. Surgical treatment included resection of the supraclavicular nodule, which was found to be a supraclavicular fossa schwannoma. The correct diagnosis of influences the radiotherapeutic planning. The unusual presentation led to diagnostic confusion in the present case a fact that changed the breast treatment.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The best of our knowledge it is the third description of brachial plexus schwannoma associated with breast cancer and the first with a synchronous association. The knowledge of this pathology and its potential to alter treatment justify the reporting of the present case.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>da Costa Vieira</LastName>
            <ForeName>René Aloisio</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Mastologia e Reconstrução Mamária, Hospital de Câncer de Barretos, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Araujo Silva</LastName>
            <ForeName>Igor</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Mastologia e Reconstrução Mamária, Hospital de Câncer de Barretos, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Souza Coelho</LastName>
            <ForeName>Rafael Darahem</ForeName>
            <Initials>RD</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Radiologia e Diagnóstico por Imagem, Hospital de Câncer de Barretos, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Almeida Junior</LastName>
            <ForeName>Carlos Roberto</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Neurocirurgia, Hospital de Câncer de Barretos, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Almeida Santos Yamashita</LastName>
            <ForeName>Mauricio Eiji</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Patologia, Hospital de Câncer de Barretos, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Breast Dis</MedlineTA>
        <NlmUniqueID>8801277</NlmUniqueID>
        <ISSNLinking>0888-6008</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>
        <Keyword MajorTopicYN="N">brachial plexus</Keyword>
        <Keyword MajorTopicYN="N">diagnosis</Keyword>
        <Keyword MajorTopicYN="N">differential</Keyword>
        <Keyword MajorTopicYN="N">neurilemmoma</Keyword>
        <Keyword MajorTopicYN="N">scwannoma</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083563</ArticleId>
        <ArticleId IdType="pii">BD190432</ArticleId>
        <ArticleId IdType="doi">10.3233/BD-190432</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083564</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-5034</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biorheology</Title>
          <ISOAbbreviation>Biorheology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Viscoelastic behavior of cardiomyocytes carrying LMNA mutations.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/BIR-190229</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Laminopathies are genetic diseases caused by mutations in the nuclear lamina.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Given the clinical impact of laminopathies, understanding mechanical properties of cells bearing lamin mutations will lead to advancement in the treatment of heart failure.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Atomic force microscopy (AFM) was used to analyze the viscoelastic behavior of neonatal rat ventricular myocyte cells expressing three human lamin A/C gene (LMNA) mutations.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Cell storage modulus was characterized, by two plateaus, one in the low frequency range, a second one at higher frequencies. The loss modulus instead showed a "bell" shape with a relaxation toward fluid properties at lower frequencies. Mutations shifted the relaxation to higher frequencies, rendering the networks more solid-like. This increase of stiffness with mutations (solid like behavior) was at frequencies around 1 Hz, close to the human heart rate.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These features resulted from a combination of the properties of cytoskeleton filaments and their temporary cross-linker. Our results substantiate that cross-linked filaments contribute, for the most part, to the mechanical strength of the cytoskeleton of the cell studied and the relaxation time is determined by the dissociation dynamics of the cross-linking proteins. The severity of biomechanical defects due to these LMNA mutations correlated with the severity of the clinical phenotype.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Borin</LastName>
            <ForeName>Daniele</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peña</LastName>
            <ForeName>Brisa</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Institute, University of Colorado Anschutz Medical Campus - Aurora, Co., USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taylor</LastName>
            <ForeName>Matthew R G</ForeName>
            <Initials>MRG</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Institute, University of Colorado Anschutz Medical Campus - Aurora, Co., USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mestroni</LastName>
            <ForeName>Luisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Institute, University of Colorado Anschutz Medical Campus - Aurora, Co., USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lapasin</LastName>
            <ForeName>Romano</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sbaizero</LastName>
            <ForeName>Orfeo</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Biorheology</MedlineTA>
        <NlmUniqueID>0372526</NlmUniqueID>
        <ISSNLinking>0006-355X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AFM</Keyword>
        <Keyword MajorTopicYN="N">Viscoelasticity</Keyword>
        <Keyword MajorTopicYN="N">cardiomyocytes</Keyword>
        <Keyword MajorTopicYN="N">lamin A/C</Keyword>
        <Keyword MajorTopicYN="N">loss modulus</Keyword>
        <Keyword MajorTopicYN="N">storage modulus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083564</ArticleId>
        <ArticleId IdType="pii">BIR190229</ArticleId>
        <ArticleId IdType="doi">10.3233/BIR-190229</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083565</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-5034</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biorheology</Title>
          <ISOAbbreviation>Biorheology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Viscoelastic characterization of diabetic and non-diabetic human adipose tissue.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/BIR-190234</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Obesity-induced chronic inflammation and fibrosis in adipose tissue contributes to the progression of type 2 diabetes mellitus (DM). While fibrosis is known to induce mechanical stiffening of numerous tissue types, it is unknown whether DM is associated with alterations in adipose tissue mechanical properties.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was to investigate whether DM is associated with differences in bulk viscoelastic properties of adipose tissue from diabetic (DM) and non-diabetic (NDM) obese subjects.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Bulk shear rheology was performed on visceral (VAT) and subcutaneous (SAT) adipose tissue, collected from obese subjects undergoing elective bariatric surgery. Rheology was also performed on the remaining extracellular matrix (ECM) from decellularized VAT (VAT ECM). Linear mixed models were used to assess whether correlations existed between adipose tissue mechanical properties and DM status, sex, age, and body mass index (BMI).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">DM was not associated with significant differences in adipose tissue viscoelastic properties for any of the tissue types investigated. Tissue type dependent differences were however detected, with VAT having significantly lower shear storage and loss moduli than SAT and VAT ECM independent of DM status.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although DM is typically associated with adipose tissue fibrosis, it is not associated with differences in macroscopic adipose tissue mechanical properties.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Juliar</LastName>
            <ForeName>Benjamin A</ForeName>
            <Initials>BA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Strieder-Barboza</LastName>
            <ForeName>Clarissa</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karmakar</LastName>
            <ForeName>Monita</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flesher</LastName>
            <ForeName>Carmen G</ForeName>
            <Initials>CG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baker</LastName>
            <ForeName>Nicki A</ForeName>
            <Initials>NA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Varban</LastName>
            <ForeName>Oliver A</ForeName>
            <Initials>OA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lumeng</LastName>
            <ForeName>Carey N</ForeName>
            <Initials>CN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Putnam</LastName>
            <ForeName>Andrew J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Rourke</LastName>
            <ForeName>Robert W</ForeName>
            <Initials>RW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Ann Arbor Veterans Affairs Healthcare System, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Biorheology</MedlineTA>
        <NlmUniqueID>0372526</NlmUniqueID>
        <ISSNLinking>0006-355X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Rheology</Keyword>
        <Keyword MajorTopicYN="N">decellularized adipose tissue</Keyword>
        <Keyword MajorTopicYN="N">diabetes mellitus</Keyword>
        <Keyword MajorTopicYN="N">subcutaneous adipose tissue</Keyword>
        <Keyword MajorTopicYN="N">visceral adipose tissue</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083565</ArticleId>
        <ArticleId IdType="pii">BIR190234</ArticleId>
        <ArticleId IdType="doi">10.3233/BIR-190234</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083566</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-3619</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bio-medical materials and engineering</Title>
          <ISOAbbreviation>Biomed Mater Eng</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of stress distribution in partially and completely edentulous mandibles around splinted and non-splinted implant prostheses: A finite element study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/BME-201077</ELocationID>
        <Abstract>
          <AbstractText>In some treatments using multiple dental implants, the implants are inserted in the bone with splinted or non-splinted implant prostheses. There are some reports about the influence of the splinted and non-splinted implants on stress distribution in the bone using the finite element method (FEM), and a controversy in the literature regarding whether the splinted or non-splinted implants prostheses reduce the stress generated on the implant-surrounding bone more efficiently. Additionally, the simple shape of the jaw bones with limited bone area was used for FEM analysis in many studies at the expense of accurate analysis. The aim of this study was to evaluate the difference in stress distribution in the bone between the splinted and non-splinted implants, and between completely and partially edentulous mandibles. The implants were inserted in the first premolar, second premolar, and first molar regions of the partial and complete mandibles, and the splinted and non-splinted crowns were attached to the implants. Vertical load (100 N) or oblique load (70 N, 30° from its long axis towards the lingual) was applied on the first premolar. When vertical load was applied to the partially edentulous mandible model, the stress was concentrated intensively on the cortical bone around the first premolar regardless of whether splinted or non-splinted implants were used. On the other hand, the vertical load applied to the completely edentulous mandible model caused the stress to be concentrated intensively on the cortical bone around the first premolar with non-splinted implants. With respect to the oblique load, the stress was concentrated intensively on the cortical bone around the first premolar only with the non-splinted implants, in both the partial and the complete mandibles.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ozeki</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Major in Mechanical Systems Engineering, Graduate School of Science and Engineering, Ibaraki University, Nakanarusawa, Hitachi, Ibaraki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishio</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Major in Mechanical Systems Engineering, Graduate School of Science and Engineering, Ibaraki University, Nakanarusawa, Hitachi, Ibaraki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Biomed Mater Eng</MedlineTA>
        <NlmUniqueID>9104021</NlmUniqueID>
        <ISSNLinking>0959-2989</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">xx</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083566</ArticleId>
        <ArticleId IdType="pii">BME201077</ArticleId>
        <ArticleId IdType="doi">10.3233/BME-201077</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083567</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Loss of SMARCB1 expression in colon carcinoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190287</ELocationID>
        <Abstract>
          <AbstractText>SMARCB1 is a tumor suppressor gene, which is part of SWI/SNF complex involved in transcriptional regulation. Recently, loss of SMARCB1 expression has been reported in gastrointestinal carcinomas. Our purpose was to evaluate the incidence and prognostic value of SMARCB1 loss in colon carcinoma (CC). Patients with stage III CC (n= 1695), and a second cohort of 23 patients with poorly differentiated CC were analyzed. Immunohistochemistry for SMARCB1 was performed on tissue microarrays, and cases with loss of expression were controlled on whole sections. Loss of SMARCB1 was compared with the clinico-pathological and molecular characteristics, and the prognostic value was evaluated. Loss of SMARCB1 was identified in 12 of 1695 (0.7%) patients with stage III CC. Whole section controls showed a complete loss in only one of these cases, corresponding to a medullary carcinoma. SMARCB1 loss was not associated with histological grade, tumor size nor survival. In the cohort of poorly differentiated CC, we detected 2/23 (8.7%) cases with loss of SMARCB1; one was rhabdoid while the other had medullary and mucinous histology. These 2 cases were deficient for MisMatched Repair (dMMR) and mutated for BRAF. SMARCB1 loss is rare in stage III CC, but appears more frequent in poorly differentiated CC.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Melloul</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Ambroise Paré Hospital, APHP, Boulogne, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mosnier</LastName>
            <ForeName>J-F</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Hotel Dieu, Nantes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Masliah-Planchon</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Somatic Genetic Unit, Institut Curie, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Paris-Sciences-Lettres, Institut Curie Research Center, INSERMU830, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>SIREDO, Institut Curie, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lepage</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>François Mitterrand University Hospital, Dijon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche-Comté, Besançon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le Malicot</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche-Comté, Besançon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Francophone Society of Digestive Cancer, Dijon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gornet</LastName>
            <ForeName>J-M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>St Louis Hospital, APHP, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edeline</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Eugène Marquis Center, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dansette</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Hotel Dieu, Nantes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Texereau</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Layne Hospital Center, Mont-de-Marsan, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Delattre</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Somatic Genetic Unit, Institut Curie, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Paris-Sciences-Lettres, Institut Curie Research Center, INSERMU830, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>SIREDO, Institut Curie, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laurent Puig</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>G. Pompidou European Hospital, APHP, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM UMR-S1147, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taieb</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>G. Pompidou European Hospital, APHP, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM UMR-S1147, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>J-F</LastName>
            <ForeName>Emile</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Ambroise Paré Hospital, APHP, Boulogne, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Hotel Dieu, Nantes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Somatic Genetic Unit, Institut Curie, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Paris-Sciences-Lettres, Institut Curie Research Center, INSERMU830, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>SIREDO, Institut Curie, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>François Mitterrand University Hospital, Dijon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche-Comté, Besançon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Francophone Society of Digestive Cancer, Dijon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>St Louis Hospital, APHP, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Eugène Marquis Center, Rennes, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Layne Hospital Center, Mont-de-Marsan, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>G. Pompidou European Hospital, APHP, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM UMR-S1147, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>EA4340-BCOH, Versailles SQY University, Paris-Saclay University, Boulogne, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BRAF V600E</Keyword>
        <Keyword MajorTopicYN="N">SMARCB1</Keyword>
        <Keyword MajorTopicYN="N">colon carcinoma</Keyword>
        <Keyword MajorTopicYN="N">mismatch repair deficiency</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083567</ArticleId>
        <ArticleId IdType="pii">CBM190287</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190287</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083568</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The role of vesicular overexpressed in cancer pro-survival protein 1 in hepatocellular carcinoma proliferation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190574</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recently, hepatocellular carcinoma (HCC) has been ranked as the second leading cause of cancer-associated death. However, the underlying molecular mechanisms of HCC progression remain unclear. Vesicular overexpressed in cancer pro-survival protein 1 (VOPP1) could be upregulated in a quantity of human cancers, including squamous cell carcinoma (SCC), gastric cancer, and glioblastoma. However, the precise functional mechanism of VOPP1 in HCC remains poorly understood. The present study aimed to investigate the role of VOPP1 in HCC proliferation.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Immunohistochemistry (IHC), Western blot and Reverse-transcription polymerase chain reaction (RT-PCR) were used to analyze the protein and mRNA expressions of VOPP1, mitogen-activated protein kinase (MAPK) 14, ribosomal protein S6 kinase β1 (RPS6KB1), cylindromatosis (CYLD) and Twist family bHLH transcription factor 1 (TWIST1). The cell proliferation and apoptosis were tested using Celigo cell imaging analyzer and annexin V-APC apoptosis detection kit respectively. Colony formation and tumor xenograft assays were performed to understand their roles in tumorigenicity.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The expression of VOPP1 in HCC samples was higher than that in adjacent noncancerous tissues by immunohistochemistry. In addition, the down-regulation of VOPP1 using shRNA inhibited cell proliferation and tumour growth, and induced cell apoptosis in vitro and in vivo. Furthermore, VOPP1 silencing increased the expression of MAPK14 and RPS6KB1, indicating that the MAPK and mTOR signalling pathways might be involved in VOPP1-mediated cancer cell proliferation.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The present data indicate that VOPP1 may play an important role in the progression of HCC by targeting the MAPK and mTOR signalling pathways, and that VOPP1 may potentially be a candidate as a novel molecular target for HCC therapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Zheping</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Linjun</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Haojiang</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Peng</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Binfeng</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Qiuyue</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Yongfu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Shangdong</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gan</LastName>
            <ForeName>Meifu</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Enze Hospital, Wenzhou Medical University, Taizhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Weijie</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wenlong</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hepatobiliary Surgery, Enze Hospital, Wenzhou Medical University, Taizhou, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">VOPP1</Keyword>
        <Keyword MajorTopicYN="N">apoptosis</Keyword>
        <Keyword MajorTopicYN="N">hepatocellular carcinoma</Keyword>
        <Keyword MajorTopicYN="N">proliferation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083568</ArticleId>
        <ArticleId IdType="pii">CBM190574</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190574</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083569</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of a novel microRNA profile including miR-106b, miR-17, miR-20b, miR-18a and miR-93 in the metastasis of nasopharyngeal carcinoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190601</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Metastasis often leads to poor prognosis in nasopharyngeal carcinoma (NPC) patients. Evidence has indicated the important roles of microRNA (miRNA) in cancer metastasis. The aim of this study was to identify and verify the key miRNAs that might be involved in the development of NPC metastasis.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Microarray data were obtained and analyzed to screen the differentially expressed miRNAs (DEMs) between NPC tissues with metastasis and those without metastasis. The target genes of the DEMs were predicted and their functions were annotated. Then, candidate hub genes were screened out through protein-protein interaction analysis, and the key miRNAs were identified. Afterwards, the expression levels of the key miRNAs were assessed by qRT-PCR based on an in vitro model.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 22 DEMs were screened out, and 616 target genes were predicted. Gene Ontology (GO) and pathway enrichment analysis showed that the target genes may be enriched in a diversity of GO terms and signaling pathways. Among them, eleven hub genes were identified, such as PTEN, KAT2B, CCND1, STAT3, and MAP3K5. Moreover, a five-miRNA profile (miR-106b, miR-17, miR-20b, miR-18a and miR-93) was identified and their expression levels were tested to be up-regulated in high-metastatic NPC cells relative to low-metastatic ones.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The present study revealed that five miRNAs (miR-106b, miR-17, miR-20b, miR-18a and miR-93) and several hub genes such as PTEN, KAT2B, CCND1, STAT3, and MAP3K5, might play critical roles in the development of NPC metastasis. Future investigations are needed to confirm the results.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Aoshuang</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Houyu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ye</LastName>
            <ForeName>Huiping</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Dairong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhuo</LastName>
            <ForeName>Xianlu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Nasopharyngeal carcinoma</Keyword>
        <Keyword MajorTopicYN="N">metastasis</Keyword>
        <Keyword MajorTopicYN="N">microRNA</Keyword>
        <Keyword MajorTopicYN="N">microarray</Keyword>
        <Keyword MajorTopicYN="N">qRT-PCR</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083569</ArticleId>
        <ArticleId IdType="pii">CBM190601</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190601</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083570</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190988</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The majority of ovarian cancer cases are diagnosed at an advanced stage with poor prognosis. This study evaluates autoantibodies against tumor antigens to identify candidate biomarkers for early detection of ovarian cancer in women at increased risk.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the immunoreactivity of paraneoplastic antigens and tumor associated antigens with high-grade serous ovarian cancer (HGSOC) samples.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Five paraneoplastic antigens along with three tumor-associated antigens were evaluated with HGSOC patient serum samples. Validation screening was performed with n= 164 serum samples consisting of: 50 late stage HGSOC, 14 early stage HGSOC, 50 benign ovarian cyst, and 50 healthy control samples on ELISA and western blot. The four markers TRIM21, NY-ESO-1, TP53, and PAX8 were evaluated on a second validation serum set, n= 150.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">TRIM21 achieved the highest sensitivity in the first validation screening of 33% with 100% specificity. Combining TRIM21 with NY-ESO-1, TP53, and PAX8 provided 67% sensitivity with 94% specificity, and 56% sensitivity at 98% specificity. These four markers resulted in 46% sensitivity with 98% specificity in the second validation cohort; TRIM21 achieved the highest individual sensitivity of 36%.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Autoantibodies to TRIM21, NY-ESO-1, and TP53 may complement CA125 in screening of women at genetic risk for ovarian cancer.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hurley</LastName>
            <ForeName>Laura C</ForeName>
            <Initials>LC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Levin</LastName>
            <ForeName>Nancy K</ForeName>
            <Initials>NK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Molecular Therapeutics Program, Karmanos Cancer Institute, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chatterjee</LastName>
            <ForeName>Madhumita</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Molecular Therapeutics Program, Karmanos Cancer Institute, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Coles</LastName>
            <ForeName>Jasmine</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muszkat</LastName>
            <ForeName>Shlomo</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Howarth</LastName>
            <ForeName>Zachary</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dyson</LastName>
            <ForeName>Gregory</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Molecular Therapeutics Program, Karmanos Cancer Institute, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tainsky</LastName>
            <ForeName>Michael A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Molecular Medicine and Genetics, School of Medicine, Wayne State University, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Molecular Therapeutics Program, Karmanos Cancer Institute, Detroit, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Autoantibody</Keyword>
        <Keyword MajorTopicYN="N">biomarker</Keyword>
        <Keyword MajorTopicYN="N">ovarian cancer</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic antigen</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083570</ArticleId>
        <ArticleId IdType="pii">CBM190988</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190988</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083571</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-191204</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung adenocarcinoma is the most common type of lung cancer, and it is one of the most aggressive and rapidly fatal tumor types.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify a signature mutation genes for prognostic prediction of lung adenocarcinoma.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Four hundred and sixty-two lung adenocarcinoma cases were screened out and downloaded from TCGA database. Mutation data of 18 targeted genes were detected by MuTect. LASSO-COX model was used to screen gene loci, and then a prognosis model was established. Afterwards, 40 clinical patients of lung adenocarcinoma were collected to verify the mutation features and the predictive function of the above prognostic model. The mutations of above 18 genes were sequenced with targeted next generation sequencing (NGS) and analyzed with GATK and MuTect.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">TP53 (282, 32.38%), NF1 (82, 9.41%) and EGFR (80, 9.18%) were the top 3 most frequent mutation genes. A total of 7 variables were screened out after lasso-COX analysis (tumor stage, age, diagnostic type, SMARCA4, GNAS, PTCH2, TSC2). SMARCA4, GNAS and TSC2 were a gene mutation signature to predict a poor prognosis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We established a prognostic model for lung adenocarcinoma, and further concluded that SMARCA4, GNAS and TSC2 were a gene signature which plays a prognostic role.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Geng</LastName>
            <ForeName>Hua</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Tianjin Chest Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Shixiong</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Tianjin Chest Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Yixian</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Yuebin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Meilin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Tianjin Chest Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Yanzhi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Lung adenocarcinoma</Keyword>
        <Keyword MajorTopicYN="N">a risk model</Keyword>
        <Keyword MajorTopicYN="N">gene mutation signature</Keyword>
        <Keyword MajorTopicYN="N">prognosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083571</ArticleId>
        <ArticleId IdType="pii">CBM191204</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-191204</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083572</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Low OCEL1 expression is associated with poor prognosis in human non-small cell lung cancer.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-191268</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Occludin/ELL domain containing 1 (OCEL1) is a novel discovered protein with its molecular functions remaining unknown and its role in lung cancer has not been directly explored.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study focused on the role of OCEL1 in the progression and prognosis of non-small cell lung cancer (NSCLC).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A public database and tissue samples (80 NSCLC tissue samples and paired normal lung samples) were used to compare differences in OCEL1 expression and investigate its relationship with clinical characteristics and prognosis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to adjacent normal lung tissue samples, OCEL1 expression was significantly down-regulated in tumor tissues. In addition, there was a negative correlation between OCEL1 and Ki67 expression levels. Low OCEL1 expression was significantly associated with lymph node metastasis, higher TNM stage, and poor prognosis. Importantly, multivariate analysis identified OCEL1 expression as an independent predictor for unfavorable NSCLC prognosis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results indicated that OCEL1 protein may serve as a novel prognostic biomarker in NSCLC.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Mingming</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Zhe</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Bofang</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Qingjie</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hou</LastName>
            <ForeName>Kezuo</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Che</LastName>
            <ForeName>Xiaofang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qu</LastName>
            <ForeName>Xiujuan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yunpeng</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Ye</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Xuejun</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">NSCLC</Keyword>
        <Keyword MajorTopicYN="N">OCEL1</Keyword>
        <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
        <Keyword MajorTopicYN="N">prognosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083572</ArticleId>
        <ArticleId IdType="pii">CBM191268</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-191268</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083573</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>243-250</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190222</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prognostic biomarkers are promising targets for cancer prevention and treatment.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We try to filtrate survival-related genes for non-small cell lung cancer (NSCLC) via transcriptome analysis.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Transcriptome data and clinical information of Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), mainly subtypes of NSCLC, were obtained from The Cancer Genome Atlas (TCGA) program. Differentially expressed genes (DEGs) analyzed by DESeq2 package were regarded as candidate genes. For survival analysis, univariate and multivariate Cox regression were applied to select biomarkers for overall survival (OS) and progression-free survival (PFS), where univariate analysis was for preliminary filtration and multivariate analysis considering age, gender, TNM parameters and clinical stage was for ultimate determination. Gene ontology (GO) analysis and pathway enrichment were used for biological annotation.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We ultimately acquired a series of genes closely related to prognosis. For LUAD, we determined 314 OS-related genes and 275 PFS-related genes, while 54 OS-related genes and 78 PFS-related genes were chosen for LUSC. The final biological analysis indicated important function of proliferative signaling in LUAD but for LUSC, only cornification process had statistical meaning.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We strictly determined prognostic genes of NSCLC, which would contribute to its carcinogenesis investigation and therapeutic methods improvement.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xiong</LastName>
            <ForeName>Yanlu</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Yangbo</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiao</LastName>
            <ForeName>Tianyun</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Yong</ForeName>
            <Initials>Y</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Lung adenocarcinoma</Keyword>
        <Keyword MajorTopicYN="N">biomarker</Keyword>
        <Keyword MajorTopicYN="N">lung squamous cell carcinoma</Keyword>
        <Keyword MajorTopicYN="N">prognosis</Keyword>
        <Keyword MajorTopicYN="N">transcriptome</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083573</ArticleId>
        <ArticleId IdType="pii">CBM190222</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190222</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083574</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer.</ArticleTitle>
        <Pagination>
          <MedlinePgn>213-223</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190533</ELocationID>
        <Abstract>
          <AbstractText>Cervical cancer (CC) is one kind of female cancer. With the development of bioinformatics, targeted specific biomarkers therapy has become much more valuable. GSE26511 was obtained from gene expression omnibus (GEO). We utilized a package called "WGCNA" to build co-expression network and choose the hub module. Search Tool for the Retrieval of Interacting Genes Database (STRING) was used to analyze protein-protein interaction (PPI) information of those genes in the hub module. A Plug-in called MCODE was utilized to choose hub clusters of PPI network, which was visualized in Cytoscape. Clusterprofiler was used to do functional analysis. Univariate and multivariate cox proportional hazards regression analysis were both conducted to predict the risk score of CC patients. Kaplan-Meier curve analysis was done to show the overall survival. Receiver operating characteristic (ROC) curve analysis was utilized to evaluate the predictive value of the patient outcome. Validation of the hub gene in databases, Gene set enrichment analysis (GSEA) and GEPIA were completed. We built co-expression network based on GSE26511 and one CC-related module was identified. Functional analysis of this module showed that extracellular space and Signaling pathways regulating pluripotency of stem cells were most related pathways. PPI network screened GNG11 as the most valuable protein. Cox analysis showed that ACKR1 was negatively correlated with CC progression, which was validated in Gene Expression Profiling Interactive Analysis (GEPIA) and datasets. Survival analysis was performed and showed the consistent result. GSEA set enrichment analysis was also completed. This study showed hub functional terms and gene participated in CC and then speculated that ACKR1 might be tumor suppressor for CC.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jinhui</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Siyue</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Lijuan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wan</LastName>
            <ForeName>Yicong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Shulin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Wenjun</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bioinformatics analysis</Keyword>
        <Keyword MajorTopicYN="N">atypical chemokine receptor 1 (ACKR1)</Keyword>
        <Keyword MajorTopicYN="N">cervical cancer</Keyword>
        <Keyword MajorTopicYN="N">lymph node metastasis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083574</ArticleId>
        <ArticleId IdType="pii">CBM190533</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190533</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083575</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1875-8592</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biomarkers : section A of Disease markers</Title>
          <ISOAbbreviation>Cancer Biomark</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.</ArticleTitle>
        <Pagination>
          <MedlinePgn>225-242</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CBM-190575</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Deregulated microRNAs (miRNAs) in breast and gynecological cancer might contribute to improve early detection of female malignancies.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Specification of miRNA types in serum and urine as minimally-invasive biomarkers for breast (BC), endometrial (EC) and ovarian cancer (OC).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In a discovery phase, serum and urine samples from 17 BC, five EC and five OC patients vs. ten healthy controls (CTRL) were analyzed with Agilent human miRNA microarray chip. Selected miRNA types were further investigated by RT-qPCR in serum (31 BC, 13 EC, 15 OC patients, 32 CTRL) and urine (25 BC, 10 EC, 10 OC patients, 30 CTRL) applying two-sample t-tests.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Several miRNA biomarker candidates exhibited diagnostic features due to distinctive expression levels (serum: 26; urine: 22). Among these, miR-518b, -4719 and -6757-3p were found specifically deregulated in BC serum. Four, non-entity-specific, novel biomarker candidates with unknown functional roles were identified in urine (miR-3973; -4426; -5089-5p and -6841). RT-qPCR identified miR-484/-23a (all p⩽ 0.001) in serum as potential diagnostic markers for EC and OC while miR-23a may also serve as an endogenous control in BC diagnosis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Promising miRNAs as liquid biopsy-based tools in the detection of BC, EC and OC qualified for external validation in larger cohorts.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ritter</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirschfeld</LastName>
            <ForeName>Marc</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Veterinary Medicine, Georg-August-University Goettingen, Goettingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berner</LastName>
            <ForeName>Kai</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaeger</LastName>
            <ForeName>Markus</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grundner-Culemann</LastName>
            <ForeName>Franziska</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schlosser</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asberger</LastName>
            <ForeName>Jasmin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weiss</LastName>
            <ForeName>Daniela</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noethling</LastName>
            <ForeName>Claudia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mayer</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology and Obstetrics, Hospital Memmingen, Memmingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Erbes</LastName>
            <ForeName>Thalia</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Cancer Biomark</MedlineTA>
        <NlmUniqueID>101256509</NlmUniqueID>
        <ISSNLinking>1574-0153</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">breast cancer</Keyword>
        <Keyword MajorTopicYN="N">endometrial cancer</Keyword>
        <Keyword MajorTopicYN="N">liquid biopsy</Keyword>
        <Keyword MajorTopicYN="N">miR-23a-3p</Keyword>
        <Keyword MajorTopicYN="N">miR-484</Keyword>
        <Keyword MajorTopicYN="N">miRNA</Keyword>
        <Keyword MajorTopicYN="N">ovarian cancer</Keyword>
        <Keyword MajorTopicYN="N">screening</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083575</ArticleId>
        <ArticleId IdType="pii">CBM190575</ArticleId>
        <ArticleId IdType="doi">10.3233/CBM-190575</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083576</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8622</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical hemorheology and microcirculation</Title>
          <ISOAbbreviation>Clin. Hemorheol. Microcirc.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The accuracy of prostate lesion localization in cognitive fusion.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/CH-180423</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Prostate cancer (PCa) is one of the most common cancers in elderly men worldwide. Systematic biopsy guided by transrectal ultrasound remains the standard for PCa diagnosis; however, the false negative rate is 10-20%. Multiparametric magnetic resonance imaging (mpMRI) allows PCa visualization with a more precise localization and a higher accuracy and specificity for the detection of PCa. The physician can mentally relocate the most appropriate area detected on the prebiopsy mpMRI, based on its zonal topography and anatomical landmarks, called cognitive fusion. Herein, we concentrated on the accuracy of PCa localization in cognitive fusion compared with MRI-TRUS fusion and explored the applied scope of cognitive fusion.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-two eligible patients with 36 PCa lesions were recruited for our study. TRUS examinations and MRI-TRUS fusion procedures were performed by experienced operators. The cognitive fusion images were compared using the TRUS image in a MRI-TRUS fusion workstation.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Using cognitive fusion imaging, 86.1% of the lesions were accurately located by the senior sonographer and 69.4% of the lesions were accurately located by the junior sonographer. The maximum diameter and PI-RADS score of the lesions were important factors that affected the accuracy of cognitive fusion (P &lt; 0.05). Furthermore, the lesions with high PI-RADS scores and the lesions with large diameters were more accurately located using cognitive fusion (P &lt; 0.05).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cognitive fusion is a reliable technique with dependency on working experience, and its accuracy of locating suspicious lesions is consistent with MRI-TRUS fusion in patients with high PI-RADS score and large lesions.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Guang</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiang</LastName>
            <ForeName>Lihua</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shao</LastName>
            <ForeName>Hongda</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ding</LastName>
            <ForeName>Shisi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Rong</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ultrasound in Medical, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Clin Hemorheol Microcirc</MedlineTA>
        <NlmUniqueID>9709206</NlmUniqueID>
        <ISSNLinking>1386-0291</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083576</ArticleId>
        <ArticleId IdType="pii">CH180423</ArticleId>
        <ArticleId IdType="doi">10.3233/CH-180423</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083577</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-190378</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Memory troubles and hippocampal atrophy are considered more frequent and focal atrophy less severe in late-onset (&gt;65 years) than in presenile behavioral variant frontotemporal dementia (bvFTD).</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare cerebrospinal fluid (CSF) and plasma biomarkers in late-onset and presenile bvFTD.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Multicentric retrospective study (2007-2017) on patients with clinical diagnosis of bvFTD.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">This study included 44 patients (67%) with presenile and 22 (33%) with late-onset bvFTD (comparable mean disease duration; n = 11 with causal mutations). Hippocampal atrophy was more frequent (80% versus 25.8%) and severe in late-onset bvFTD (median Scheltens score: 3 [0-4] versus 1 [0-3]), without difference after adjustment for age. Lobar atrophy and focal hypometabolism/hypoperfusion were not different between groups. The median CSF Aβ1-42 and phosphorylated tau (P-tau) concentrations were in the normal range and comparable between groups. Axonal neurodegeneration biomarkers were within the normal range (CSF T-tau; plasma T-tau in late-onset bvFTD) or higher (plasma neurofilament light chain (NFL); plasma T-tau in presenile bvFTD) than the normal values, but globally not different between bvFTD groups. Plasma glial fibrillary acid protein (GFAP) was strongly increased in both bvFTD groups compared with the values in controls of the same age.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The CSF and plasma biomarker profiles did not suggest a more aggressive neurodegeneration in the presenile group (comparable T-tau, NFL, and GFAP levels) or the co-existence of Alzheimer's disease in the late-onset group (comparable and within normal range CSF Aβ1-42 and P-tau). The severity of the neurodegenerative process seems comparable in presenile and late-onset bvFTD.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marelli</LastName>
            <ForeName>Cecilia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inserm U1198 MMDN, Montpellier, France; EPHE, Paris, France, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hourregue</LastName>
            <ForeName>Claire</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gutierrez</LastName>
            <ForeName>Laure-Anne</ForeName>
            <Initials>LA</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM U1061, Univ Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paquet</LastName>
            <ForeName>Claire</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Center of Cognitive Neurology, Lariboisière Fernand-Widal Hospital, APHP, University of Paris Diderot, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Menjot de Champfleur</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Institut d'Imagerie Fonctionnelle Humaine, I2FH, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neuroradiology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Team "Plasticity of Central Nervous System, Stem Cells and Glial Tumors, " Institut National de la Santé et de la Recherche Médicale Unité 583, Institut of Neurosciences of Montpellier, Saint Eloi Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Verbizier</LastName>
            <ForeName>Delphine</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacob</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dubois</LastName>
            <ForeName>Jonathan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>INSERM U1061, Univ Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maleska</LastName>
            <ForeName>Aleksandra Maceski</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Biochimie Protéomique Clinique, INSERM-UM 1183, University Hospital Center, University of Montpellier, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirtz</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Biochimie Protéomique Clinique, INSERM-UM 1183, University Hospital Center, University of Montpellier, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Navucet</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bennys</LastName>
            <ForeName>Karim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dumurgier</LastName>
            <ForeName>Julien</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Center of Cognitive Neurology, Lariboisière Fernand-Widal Hospital, APHP, University of Paris Diderot, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cognat</LastName>
            <ForeName>Emmanuel</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Center of Cognitive Neurology, Lariboisière Fernand-Widal Hospital, APHP, University of Paris Diderot, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berr</LastName>
            <ForeName>Claudine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM U1061, Univ Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magnin</LastName>
            <ForeName>Eloi</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Centre Mémoire Ressources Recherche Besançon Franche-Comté, CHU de Besançon, Besançon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lehmann</LastName>
            <ForeName>Sylvain</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Biochimie Protéomique Clinique, INSERM-UM 1183, University Hospital Center, University of Montpellier, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gabelle</LastName>
            <ForeName>Audrey</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Memory Research and Resources Alzheimer Center, Department of Neurology, University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM U1061, Univ Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biomarkers</Keyword>
        <Keyword MajorTopicYN="N">cerebrospinal fluid</Keyword>
        <Keyword MajorTopicYN="N">frontotemporal dementia</Keyword>
        <Keyword MajorTopicYN="N">glial fibrillary 
acid protein</Keyword>
        <Keyword MajorTopicYN="N">late-onset</Keyword>
        <Keyword MajorTopicYN="N">neurofilament light chain</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083577</ArticleId>
        <ArticleId IdType="pii">JAD190378</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-190378</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083578</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of Aerobic Dance on Cognition in Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-190681</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Regular aerobic exercises could improve global cognition in older adults with mild cognitive impairment (MCI), such as aerobic dance a type of commonly practiced aerobic exercises. However, its effects remain debatable in improving the cognitive function in patients with MCI.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this systematic review and meta-analysis is to evaluate the effects of aerobic dance on cognitive function among older adults with MCI.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We searched articles in the MEDLINE, PubMed, Embase, and The Cochrane Library databases from inception to 28 February 2019, with the following criteria: 1) randomized controlled trials; 2) older adults with MCI; 3) aerobic dance intervention.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Five studies of 842 participants were identified. This meta-analysis showed that aerobic dance can significantly improve global cognition (Mini-Mental State Examination: MD = 1.43; 95% CI:[0.59, 2.27]; p = 0.0009; Alzheimer's Disease Assessment Scale-Cognitive Subscale: MD=-2.30; 95% CI:[-3.60, -1.00]; p = 0.0005), and delayed recall ability (SMD = 0.46;95% CI: [0.30, 0.62]; p &lt; 0.00001) in older adults with MCI. In addition, have positive effects on improving executive function (Trial-Making Test A: MD = -2.37;95% CI:[-4.16, -0.58]; p = 0.010; Trial-Making Test B: MD = -16.0; 95% CI: [-30.03, -2.11]; p = 0.020) and immediate recall ability (SMD = 0.24;95% CI: [0.01, 0.46]; p = 0.04).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Aerobic dance significantly improves global cognitive function and memory in older adults with MCI. In addition, it also benefits executive function. However, due to the limitations as the review states, more randomized controlled trials with better study design and larger sample sizes should be conducted in the future research to make it much clearer.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Qian</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>First Clinical Medical College, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Jinhui</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Nanjing Drum Tower Hospital, The Affiliated Hospital of the Medical School at Nanjing University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Yaxin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>First Clinical Medical College, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Nawab</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>First Clinical Medical College, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Tong</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aerobic dance</Keyword>
        <Keyword MajorTopicYN="N">cognition</Keyword>
        <Keyword MajorTopicYN="N">executive function</Keyword>
        <Keyword MajorTopicYN="N">memory</Keyword>
        <Keyword MajorTopicYN="N">meta-analysis</Keyword>
        <Keyword MajorTopicYN="N">mild cognitive function</Keyword>
        <Keyword MajorTopicYN="N">randomized controlled trials</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083578</ArticleId>
        <ArticleId IdType="pii">JAD190681</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-190681</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083579</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Advanced Glycation End Product Accumulation is Associated with Lower Cognitive Performance in an Older General Population: The Nagahama Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-190878</ELocationID>
        <Abstract>
          <AbstractText>Accumulation of advanced glycation end products (AGEs) has been linked with cognitive decline as a risk factor based on the analysis in small populations. We investigated the association between skin autofluorescence of AGEs and global cognitive function in a Japanese older (≥60 years) population (n = 4,041). The AGEs quartiles were inversely associated with the Revised Hasegawa's Dementia Scale score (Q1: reference, Q2: β= -0.011, p = 0.537, Q3: β= -0.043, p = 0.016, Q4: β= -0.064, p &lt; 0.001) independent of major risk factors. Accumulation of AGEs was associated with lower cognitive performance in older adults.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tabara</LastName>
            <ForeName>Yasuharu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamanaka</LastName>
            <ForeName>Mikihiro</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Air Water Biodesign Inc., Kobe, Hyogo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Setoh</LastName>
            <ForeName>Kazuya</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Segawa</LastName>
            <ForeName>Hiroaki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Air Water Biodesign Inc., Kobe, Hyogo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kawaguchi</LastName>
            <ForeName>Takahisa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kosugi</LastName>
            <ForeName>Shinji</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Ethics and Medical Genetics, Kyoto University School of Public Health, Sakyo-ku Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakayama</LastName>
            <ForeName>Takeo</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Informatics, Kyoto University School of Public Health, Sakyo-ku Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsuda</LastName>
            <ForeName>Fumihiko</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>Nagahama Study Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advanced glycation end products</Keyword>
        <Keyword MajorTopicYN="N">cognitive function</Keyword>
        <Keyword MajorTopicYN="N">epidemiological 
studies</Keyword>
        <Keyword MajorTopicYN="N">population at risk</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083579</ArticleId>
        <ArticleId IdType="pii">JAD190878</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-190878</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083580</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mental Demands at Work and Risk of Dementia.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-190920</ELocationID>
        <Abstract>
          <AbstractText> High mental demands at work was examined as a possible protective factor to reduce the risk of dementia in 1,277 initially dementia-free participants, aged 60 years and older. The cohort was followed for a mean of 13.6 years. During follow-up, 376 participants developed all-cause dementia (Alzheimer's disease = 199; vascular dementia = 145). The association between mental demands at work and dementia was analyzed with Cox hazard models, adjusted for a range of covariates. The results revealed no significant association between mental demands at work and incidence of dementia. Based on the measures used in this study, it was concluded that high mental demands at work may not reduce the risk of dementia later on in life.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sundström</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Umeå University, Umeå, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Demographic and Ageing Research (CEDAR), Umeå University, Umeå, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sörman</LastName>
            <ForeName>Daniel Eriksson</ForeName>
            <Initials>DE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Umeå University, Umeå, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Human Work Science, Luleå University of Technology, Luleå, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansson</LastName>
            <ForeName>Patrik</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Umeå University, Umeå, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ljungberg</LastName>
            <ForeName>Jessica Körning</ForeName>
            <Initials>JK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Umeå University, Umeå, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Human Work Science, Luleå University of Technology, Luleå, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adolfsson</LastName>
            <ForeName>Rolf</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Umeå University, Umeå, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aging</Keyword>
        <Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="N">cognitive 
reserve</Keyword>
        <Keyword MajorTopicYN="N">cognitive occupation complexity</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">mental demands at work</Keyword>
        <Keyword MajorTopicYN="N">vascular dementia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083580</ArticleId>
        <ArticleId IdType="pii">JAD190920</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-190920</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083581</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191033</ELocationID>
        <Abstract>
          <AbstractText> There is currently no effective treatment for Alzheimer's disease (AD), the most common form of dementia. It has been proposed, however, that a modest delay in onset can significantly reduce the number of cases. Thus, prevention and intervention strategies are currently the focus of much research. In the search for compounds that potentially confer benefit, the Amla fruit and its extracts have drawn attention. Amla preparations have been used for centuries in traditional Indian medicine systems such as Ayurveda, with various parts of the plant used to treat a variety of diseases. Here we review many animal-based studies, and some clinical trials, which have shown that Amla, and its extracts, exert many positive effects on dyslipidemia, hyperglycemia, inflammation, oxidative stress, apoptosis, and autophagy, that contribute to AD risk. Collectively, this evidence suggests that Amla may be of value as part of an effective disease-delaying treatment for AD.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Teimouri</LastName>
            <ForeName>Elham</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rainey-Smith</LastName>
            <ForeName>Stephanie R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bharadwaj</LastName>
            <ForeName>Prashant</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Sciences, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verdile</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Sciences, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martins</LastName>
            <ForeName>Ralph N</ForeName>
            <Initials>RN</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, Macquarie University, North Ryde, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="N">Amla</Keyword>
        <Keyword MajorTopicYN="N">anti-inflammatory</Keyword>
        <Keyword MajorTopicYN="N">antioxidant</Keyword>
        <Keyword MajorTopicYN="N">cardiovascular disease</Keyword>
        <Keyword MajorTopicYN="N">type 2 diabetes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083581</ArticleId>
        <ArticleId IdType="pii">JAD191033</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191033</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083582</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circulating Progenitor Cells and Cognitive Impairment in Men and Women with Coronary Artery Disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191063</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Circulating progenitor cells (CPC) have been associated with memory function and cognitive impairment in healthy adults. However, it is unclear whether such associations also exist in patients with coronary artery disease (CAD).</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the association between CPCs and memory performance among individuals with CAD.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We assessed cognitive function in 509 patients with CAD using the verbal and visual Memory subtests of the Wechsler memory scale-IV and the Trail Making Test parts A and B. CPCs were enumerated with flow cytometry as CD45med/CD34+ blood mononuclear cells, those co-expressing other epitopes representing populations enriched for hematopoietic and endothelial progenitors.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">After adjusting for demographic and cardiovascular risk factors, lower number of endothelial progenitor cell counts were independently associated with lower visual and verbal memory scores (p for all &lt; 0.05). There was a significant interaction in the magnitude of this association with race (p &lt; 0.01), such that the association of verbal memory scores with endothelial progenitor subsets was present in Black but not in non-Black participants. No associations were present with the hematopoietic progenitor-enriched cells or with the Trail Making Tests.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Lower numbers of circulating endothelial progenitor cells are associated with cognitive impairment in patients with CAD, suggesting a protective effect of repair/regeneration processes in the maintenance of cognitive status. Impairment of verbal memory function was more strongly associated with lower CPC counts in Black compared to non-Black participants with CAD. Whether strategies designed to improve regenerative capacity will improve cognition needs further study.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moazzami</LastName>
            <ForeName>Kasra</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wittbrodt</LastName>
            <ForeName>Matthew T</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lima</LastName>
            <ForeName>Bruno B</ForeName>
            <Initials>BB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Jeong Hwan</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hammadah</LastName>
            <ForeName>Muhammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ko</LastName>
            <ForeName>Yi-An</ForeName>
            <Initials>YA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Obideen</LastName>
            <ForeName>Malik</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdelhadi</LastName>
            <ForeName>Naser</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaseer</LastName>
            <ForeName>Belal</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gafeer</LastName>
            <ForeName>M Mazen</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nye</LastName>
            <ForeName>Jonathon A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Amit J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Atlanta VA Medical Center, Decatur, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ward</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raggi</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Mazankowski Alberta Heart Institute, University of Alberta, Alberta, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Waller</LastName>
            <ForeName>Edmund K</ForeName>
            <Initials>EK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bremner</LastName>
            <ForeName>J Douglas</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Atlanta VA Medical Center, Decatur, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quyyumi</LastName>
            <ForeName>Arshed A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vaccarino</LastName>
            <ForeName>Viola</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Circulating progenitor cells</Keyword>
        <Keyword MajorTopicYN="N">Wechsler Memory Scale</Keyword>
        <Keyword MajorTopicYN="N">cognitive impairment</Keyword>
        <Keyword MajorTopicYN="N">coronary artery 
disease</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">memory</Keyword>
        <Keyword MajorTopicYN="N">trail making tests</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083582</ArticleId>
        <ArticleId IdType="pii">JAD191063</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191063</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083583</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Carotid Stiffness is Associated with Brain Amyloid-β Burden in Amnestic Mild Cognitive Impairment.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191073</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vascular dysfunction has been implicated in the onset and progression of Alzheimer's disease (AD), yet the relationship of arterial stiffening with brain amyloid-β (Aβ) burden in at risk patients is unclear.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to determine the relationship of aortic and carotid arterial stiffening with Aβ burden in patients with amnestic mild cognitive impairment (aMCI), a proposed transitional stage between normal aging and AD.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-two older adults with aMCI underwent 18Florbetapir PET amyloid imaging to ascertain Aβ burden via standardized uptake value ratio (SUVR). Carotid-femoral pulse wave velocity (cfPWV), which reflects aortic stiffness, and carotid β stiffness index and distensibility, which reflect local cerebral arterial stiffness, thus having direct impact on the cerebral circulation, were measured using applanation tonometry and ultrasonography.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Region-of-interest based analysis showed that precuneus and mean cortex Aβ SUVR were correlated positively with carotid β stiffness index and negatively with carotid distensibility after adjusting for age, sex, mean arterial pressure (MAP), pulse pressure (PP), and APOE4 status. Whole-brain voxel-wise analysis showed that Aβ SUVR was positively correlated with carotid β stiffness index, and negatively with carotid distensibility at the precuneus/cingulate gyrus after multiple comparison correction. cfPWV was not correlated with Aβ SUVR.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Carotid rather than aortic stiffening is independently associated with brain Aβ burden in patients with aMCI after adjusting for age, sex, MAP, PP, and APOE4 status. These findings provide evidence that arterial stiffening, particularly carotid artery stiffening, may contribute to AD pathology in patients with aMCI.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pasha</LastName>
            <ForeName>Evan P</ForeName>
            <Initials>EP</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rutjes</LastName>
            <ForeName>Elmer</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Radboud University Medical Center, Nijmegen, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomoto</LastName>
            <ForeName>Tsubasa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tarumi</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stowe</LastName>
            <ForeName>Ann</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Claassen</LastName>
            <ForeName>Jurgen A H R</ForeName>
            <Initials>JAHR</Initials>
            <AffiliationInfo>
              <Affiliation>Radboud University Medical Center, Nijmegen, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Munro Cullum</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>David C</ForeName>
            <Initials>DC</Initials>
            <AffiliationInfo>
              <Affiliation>Michigan State University, East Lansing, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Rong</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Arterial stiffness</Keyword>
        <Keyword MajorTopicYN="N">amyloid</Keyword>
        <Keyword MajorTopicYN="N">mild cognitive impairment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083583</ArticleId>
        <ArticleId IdType="pii">JAD191073</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191073</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083584</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Oxytocin Alleviates MPTP-Induced Neurotoxicity in Mice by Targeting MicroRNA-26a/Death-Associated Protein Kinase 1 Pathway.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191091</ELocationID>
        <Abstract>
          <AbstractText>Neurotoxicity is one of the major pathological changes in multiple neurological disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD), the second popular neurodegenerative disease in aged people. It is known that the AD and PD share the similar neuropathological hallmarks, such as the oxidative stress, loss of specific neurons, and aggregation of specific proteins. However, there are no effective therapeutic drugs for both AD and PD yet. Oxytocin (OXT) is a small peptide with 9 amino acids that is neuroprotective to many neurological disorders. Whether OXT administration confers neuroprotection to 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine (MPTP)-induced neurotoxicity in mice are still not known. In this study, we first found that the OXT levels are decreased in MPTP mice. Supplementation with OXT effectively rescues the locomotor disabilities and anxiety-like behaviors in MPTP mice. OXT also alleviates the hyperphosphorylation of α-synuclein at S129 site and the loss of dopaminergic neurons in the substantia nigra pars compacta, as well as the oxidative stress in the MPTP mice, and alleviates both oxidative stress and cell cytotoxicity in vitro. Furthermore, we found that OXT could inhibit the miR-26a/DAPK1 signal pathway in MPTP mice. In summary, our study demonstrates protective effects of OXT in MPTP mice and that miR-26a/DAPK1 signaling pathway may play an important role in mediating the protection of OXT.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Almansoub</LastName>
            <ForeName>Hasan A M M</ForeName>
            <Initials>HAMM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Faculty of Science - Marib, Sana'a University, Marib, Yemen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Ding-Qi</ForeName>
            <Initials>DQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahaman</LastName>
            <ForeName>Yacoubou Abdoul Razak</ForeName>
            <Initials>YAR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cognitive Impairment Ward of Neurology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salissou</LastName>
            <ForeName>Maibouge Tanko Mahamane</ForeName>
            <Initials>MTM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Youming</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Fan</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Lan-Ting</ForeName>
            <Initials>LT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Almansob</LastName>
            <ForeName>Yusra A M</ForeName>
            <Initials>YAM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Dan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alpha-synuclein</Keyword>
        <Keyword MajorTopicYN="N">MPTP</Keyword>
        <Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
        <Keyword MajorTopicYN="N">behavior deficit</Keyword>
        <Keyword MajorTopicYN="N">neurotoxicity</Keyword>
        <Keyword MajorTopicYN="N">oxidative 
stress</Keyword>
        <Keyword MajorTopicYN="N">oxytocin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083584</ArticleId>
        <ArticleId IdType="pii">JAD191091</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191091</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083585</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191133</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diagnosis of Alzheimer's disease (AD) confirmed by biomarkers allows the patient to make important life decisions. However, doubt about the fleetness of symptoms progression and future cognitive decline remains. Neuropsychological measures were extensively studied in prediction of time to conversion to dementia for mild cognitive impairment (MCI) patients in the absence of biomarker information. Similar neuropsychological measures might also be useful to predict the progression to dementia in patients with MCI due to AD.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the contribution of neuropsychological measures to predict time to conversion to dementia in patients with MCI due to AD.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Patients with MCI due to AD were enrolled from a clinical cohort and the effect of neuropsychological performance on time to conversion to dementia was analyzed.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, converters scored lower than non-converters at measures of verbal initiative, non-verbal reasoning, and episodic memory. The test of non-verbal reasoning was the only statistically significant predictor in a multivariate Cox regression model. A decrease of one standard deviation was associated with 29% of increase in the risk of conversion to dementia. Approximately 50% of patients with more than one standard deviation below the mean in the z score of that test had converted to dementia after 3 years of follow-up.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In MCI due to AD, lower performance in a test of non-verbal reasoning was associated with time to conversion to dementia. This test, that reveals little decline in the earlier phases of AD, appears to convey important information concerning conversion to dementia.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Silva</LastName>
            <ForeName>Dina</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Cognitive Neuroscience Research Group, Department of Psychology and Educational Sciences and Centre for Biomedical Research (CBMR), Universidade do Algarve, Faro, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Lisbon, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cardoso</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Lisbon, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guerreiro</LastName>
            <ForeName>Manuela</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Lisbon, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maroco</LastName>
            <ForeName>João</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Superior de Psicologia Aplicada, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mendes</LastName>
            <ForeName>Tiago</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Lisbon, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Psychiatry and Mental Health Department, Santa Maria Hospital, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alves</LastName>
            <ForeName>Luísa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Chronic Diseases Research Centre, NOVA Medical School, NOVA University of Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nogueira</LastName>
            <ForeName>Joana</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Dementia Clinic, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Psychology and Educational Sciences, University of Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baldeiras</LastName>
            <ForeName>Inês</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Laboratory of Neurochemistry, Centro Hospitalar e Universitário de Coimbra.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santana</LastName>
            <ForeName>Isabel</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Dementia Clinic, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Laboratory of Neurochemistry, Centro Hospitalar e Universitário de Coimbra.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Mendonça</LastName>
            <ForeName>Alexandre</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Lisbon, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alzheimer’s disease (AD)</Keyword>
        <Keyword MajorTopicYN="N">Raven Coloured Progressive Matrices</Keyword>
        <Keyword MajorTopicYN="N">amyloid-β</Keyword>
        <Keyword MajorTopicYN="N">cognitive impairment</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">mild cognitive impairment due to AD</Keyword>
        <Keyword MajorTopicYN="N">neuropsychological assessment</Keyword>
        <Keyword MajorTopicYN="N">prodromal AD</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083585</ArticleId>
        <ArticleId IdType="pii">JAD191133</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191133</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083586</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The "Interest Game": A Ludic Application to Improve Apathy Assessment in Patients with Neurocognitive Disorders.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191282</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apathy, a highly prevalent behavioral disorder in Alzheimer's disease and other related disorders, is currently assessed using clinical scales as it is for all neuropsychiatric disorders.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to propose a new type of assessment using new technologies designed to assess loss of interest by a more implicit and indirect method.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The Interest Game is a form of interactive self-report, where categories of interests are presented in order to quantify them and identify the activities that constitute them. Two indices can be extracted, the number of categories and the number of activities selected. We compared the scores between three groups: Apathetic (A) and Non-Apathetic (NA) subjects (according to the Apathy Diagnostic Criteria) and controls with no objective cognitive impairment.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">95 subjects were included. Results showed that subjects from the A group had significantly less interests (both categories and images selected) than the NA group. As expected, the control group selected a higher number of categories than the other groups. The diagnosis (minor or major neurocognitive disorder) and level of education had also a significant effect on the number of categories selected. Furthermore, subjects with major neurocognitive disorder (NCD) had significantly less interests than minor NCD group. The number of categories measure was more sensitive than the number of images selected.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The Interest Game is a promising tool to quantify and identify subject interests and differentiate between apathetic and non-apathetic subjects. Future studies should focus on including more apathetic subjects in the minor NCD group and validating this tool with the general population.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zeghari</LastName>
            <ForeName>Radia</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Université Côte d'Azur, CoBTeK Laboratory, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Association Innovation Alzheimer, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manera</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Université Côte d'Azur, CoBTeK Laboratory, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Association Innovation Alzheimer, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fabre</LastName>
            <ForeName>Roxane</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Université Côte d'Azur, CoBTeK Laboratory, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre Hospitalier Universitaire de Nice, Département de Santé Publique, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guerchouche</LastName>
            <ForeName>Rachid</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>INRIA Sophia Antipolis, STARS team, Sophia Antipolis, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>König</LastName>
            <ForeName>Alexandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Université Côte d'Azur, CoBTeK Laboratory, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INRIA Sophia Antipolis, STARS team, Sophia Antipolis, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Phan Tran</LastName>
            <ForeName>Minh Khue</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Université Côte d'Azur, CoBTeK Laboratory, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INRIA Sophia Antipolis, STARS team, Sophia Antipolis, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robert</LastName>
            <ForeName>Philippe</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Université Côte d'Azur, CoBTeK Laboratory, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre Hospitalier Universitaire de Nice, Département de Santé Publique, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre Hospitalier Universitaire de Nice, Resource &amp; Research Memory Centre, Nice.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Apathy</Keyword>
        <Keyword MajorTopicYN="N">interest</Keyword>
        <Keyword MajorTopicYN="N">leisure activities</Keyword>
        <Keyword MajorTopicYN="N">neurocognitive disorders</Keyword>
        <Keyword MajorTopicYN="N">serious 
games</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083586</ArticleId>
        <ArticleId IdType="pii">JAD191282</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191282</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083587</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Objectively-Measured Activity Patterns are Associated with Home Blood Pressure in Memory Clinic Patients.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191310</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Physicians are cautious to prescribe antihypertensive drugs in frail older adults because of the potential adverse effects, especially in those with cognitive complaints. Lifestyle aspects might provide safe targets to lower blood pressure in older adults.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our goal was to evaluate the associations between activity patterns and blood pressure in memory clinic patients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used an observational cross-sectional study to measure activity patterns with the ActivPAL accelerometer, and simultaneous home blood pressure levels in memory clinic patients (age range 51-87 years old). Office blood pressure was assessed during routine clinical practice.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">41 patients (mean age of 74.3 (7.7) years of age, 46% female) were included. Sedentary parameters were associated with higher mean home blood pressure, with the strongest correlation between more prolonged sitting bouts and higher SBP (r = 0.58, p &lt; .0001). Physical activity parameters were negatively associated with mean home blood pressure. Adjusted regression estimates remained significant, showing, e.g., a 4.5 (95% CI = 1.6;7.4) mmHg increase in SBP for every hour of sitting per day and a -1.0 (95% CI = -1.8;-0.2) mmHg decrease in DBP for every additional 1000 steps per day. No strong correlations were found between any of the activity pattern variables and office blood pressure.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Associations between activity pattern variables and blood pressure were only found with home blood pressure measurements, not with office measurements. Longitudinal evaluations of these associations are now needed to explore if reducing prolonged sedentary bouts and increasing step count indeed serve as safe targets to lower blood pressure.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maasakkers</LastName>
            <ForeName>Carlijn M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geriatrics/Radboud Alzheimer Center, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Heus</LastName>
            <ForeName>Rianne A A</ForeName>
            <Initials>RAA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geriatrics/Radboud Alzheimer Center, Donders Institute for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thijssen</LastName>
            <ForeName>Dick H J</ForeName>
            <Initials>DHJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Melis</LastName>
            <ForeName>René J F</ForeName>
            <Initials>RJF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geriatrics/Radboud Alzheimer Center, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gardiner</LastName>
            <ForeName>Paul A</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Mater Research Institute, The University of Queensland, South Brisbane, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Claassen</LastName>
            <ForeName>Jurgen A H R</ForeName>
            <Initials>JAHR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geriatrics/Radboud Alzheimer Center, Donders Institute for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Blood pressure</Keyword>
        <Keyword MajorTopicYN="N">cognitive decline</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">hypertension</Keyword>
        <Keyword MajorTopicYN="N">physical 
activity</Keyword>
        <Keyword MajorTopicYN="N">sedentary behavior</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083587</ArticleId>
        <ArticleId IdType="pii">JAD191310</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191310</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083588</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-8908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Alzheimer's disease : JAD</Title>
          <ISOAbbreviation>J. Alzheimers Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Activation of Inflammation is Associated with Amyloid-β Accumulation Induced by Chronic Sleep Restriction in Rats.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-191317</ELocationID>
        <Abstract>
          <AbstractText>Alzheimer's disease (AD) is the most common age-associated neurodegenerative disease featured by progressive learning and memory deficit, and Aβ was identified as playing a key role in the process of AD and was theorized to be caused by the imbalance of production and clearance. Increasing evidence suggested an association between sleep deprivation and AD. Our recent study found that chronic sleep restriction (CSR) caused cognitive impairment and Aβ accumulation in rats, but the underlining mechanism was unclear. In the present study, we investigated the effects of inflammation on Aβ accumulation induced by CSR. We found that CSR significantly increased the expression of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), and nitric oxide (NO) in brain, and the inflammatory factors levels were positively correlated with Aβ42 deposition. Additionally, the inflammatory factors were correlated with BACE1, LRP-1, and RAGE levels in both the hippocampus and the prefrontal cortex. Furthermore, the plasma levels of IL-1β, TNF-α, and NO were elevated after CSR, and the concentration of plasma inflammatory mediators were correlated with plasma levels of sLRP1 and sRAGE. These results suggested that the inflammation in brain and plasma might be involved in the CSR-induced Aβ accumulation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Peng</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Beiyu</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Meng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yanbo</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Louyan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shang</LastName>
            <ForeName>Suhang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huo</LastName>
            <ForeName>Kang</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qu</LastName>
            <ForeName>Qiumin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Alzheimers Dis</MedlineTA>
        <NlmUniqueID>9814863</NlmUniqueID>
        <ISSNLinking>1387-2877</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="N">amyloid-β</Keyword>
        <Keyword MajorTopicYN="N">chronic sleep restriction</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">risk factor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083588</ArticleId>
        <ArticleId IdType="pii">JAD191317</ArticleId>
        <ArticleId IdType="doi">10.3233/JAD-191317</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083589</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2214-3602</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neuromuscular diseases</Title>
          <ISOAbbreviation>J Neuromuscul Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paramyotonia Congenita with Persistent Distal and Facial Muscle Weakness: A Case Report with Literature Review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JND-190440</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paramyotonia congenita (PC; OMIM 168300) is a non-dystrophic myotonia caused by mutations in the SCN4A gene. Transient muscle stiffness, usually induced by exposure to cold and aggravated by exercise, is the predominant clinical symptom, and interictal persistent weakness is uncommon.</AbstractText>
          <AbstractText Label="CASE REPORT" NlmCategory="METHODS">We report a family with a history of PC accompanied by persistent hand muscle weakness with masticatory muscle involvement. Persistent weakness was exacerbated with age, and MR analysis showed marked atrophy of temporal, masseter, and finger flexor muscles with fatty replacement. The PC causative mutation T1313M in the SCN4A gene was prevalent in the family. Administration of acetazolamide chloride improved clinical symptoms and the results of cold and short exercise tests. Phenotypic variation within the family was remarkable, as the two younger affected patients did not present with persistent weakness or muscle atrophy.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PC associated with the T1313M mutation is a possible cause of persistent distal hand weakness.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Taminato</LastName>
            <ForeName>Tomoya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mori-Yoshimura</LastName>
            <ForeName>Madoka</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miki</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Saku Central Hospital, Nagano Prefectural Federation of Agricultural Cooperatives for Health and Welfare, Nagano, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sasaki</LastName>
            <ForeName>Ryogen</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Mie National Hospital, Mie, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Satoh</LastName>
            <ForeName>Nosiko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oya</LastName>
            <ForeName>Yasushi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishino</LastName>
            <ForeName>Ichizo</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Yuji</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Neuromuscul Dis</MedlineTA>
        <NlmUniqueID>101649948</NlmUniqueID>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Paramyotonia congenita</Keyword>
        <Keyword MajorTopicYN="N">SCN4A</Keyword>
        <Keyword MajorTopicYN="N">T1313M</Keyword>
        <Keyword MajorTopicYN="N">acetazolamide chloride</Keyword>
        <Keyword MajorTopicYN="N">persistent distal hand weakness</Keyword>
        <Keyword MajorTopicYN="N">short exercise test</Keyword>
        <Keyword MajorTopicYN="N">strabismus</Keyword>
        <Keyword MajorTopicYN="N">temporal muscle</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083589</ArticleId>
        <ArticleId IdType="pii">JND190440</ArticleId>
        <ArticleId IdType="doi">10.3233/JND-190440</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083590</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2214-3602</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neuromuscular diseases</Title>
          <ISOAbbreviation>J Neuromuscul Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JND-190462</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Weakness affects motor performance and causes skeletal deformities in spinal muscular atrophy (SMA). Scoliosis surgery decision-making is based on curve progression, pulmonary function, and skeletal maturity. Benefits include quality of life, sitting balance, and endurance. Post-operative functional decline has not been formally assessed.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the impact of scoliosis surgery on motor function in SMA types 2 and 3.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Prospective data were acquired during a multicenter natural history study. Seventeen participants (12 type 2, 5 type 3 with 4 of the 5 having lost the ability to ambulate) had motor function assessed using the Hammersmith Functional Motor Scale Expanded (HFMSE) performed pre-operatively and at least 3 months post-operatively. Independent t-tests determined group differences based on post-operative HFMSE changes, age, and baseline HFMSE scores.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Three participants had minimal HFMSE changes (±2 points) representing stability (mean change = -0.7). Fourteen participants lost &gt;3 points, representing a clinically meaningful progressive change (mean change = -12.1, SD = 8.9). No participant improved &gt;2 points. There were no age differences between stable and progressive groups (p = 0.278), but there were significant differences between baseline HFMSE (p = 0.006) and change scores (p = 0.001). Post-operative changes were permanent over time.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Scoliosis surgery has an immediate impact on function. Baseline HFMSE scores anticipate post-operative loss as higher motor function scores were associated with worse decline. Instrumentation that includes fixation to the pelvis reduces flexibility, limiting the ability for compensatory maneuvers. These observations provide information to alert clinicians regarding surgical risk and to counsel families.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Young</LastName>
            <ForeName>Sally Dunaway</ForeName>
            <Initials>SD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montes</LastName>
            <ForeName>Jacqueline</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salazar</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Glanzman</LastName>
            <ForeName>Allan M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pasternak</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirek</LastName>
            <ForeName>Elizabeth</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martens</LastName>
            <ForeName>William</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of Rochester, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finkel</LastName>
            <ForeName>Richard S</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Neurology, Nemours Children's Hospital, Orlando, FL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Darras</LastName>
            <ForeName>Basil T</ForeName>
            <Initials>BT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Vivo</LastName>
            <ForeName>Darryl C</ForeName>
            <Initials>DC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Neuromuscul Dis</MedlineTA>
        <NlmUniqueID>101649948</NlmUniqueID>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Spinal muscular atrophy</Keyword>
        <Keyword MajorTopicYN="N">motor function</Keyword>
        <Keyword MajorTopicYN="N">scoliosis</Keyword>
        <Keyword MajorTopicYN="N">surgery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083590</ArticleId>
        <ArticleId IdType="pii">JND190462</ArticleId>
        <ArticleId IdType="doi">10.3233/JND-190462</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083591</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1877-718X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Parkinson's disease</Title>
          <ISOAbbreviation>J Parkinsons Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JPD-191793</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Well water frequently is considered a risk factor for Parkinson's disease (PD), but few studies were designed appropriately to test whether geographic factors affect PD risk.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the risk of PD in relation to residential use of private well water.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In a nationwide, population-based case-control study, we identified all incident PD cases (N = 89,790) and all comparable controls (N = 21,549,400) age 66-90 who solely relied on Medicare coverage in the U.S. in 2009. We estimated the probability of use of private well water using zip code of residence at diagnosis/reference and U.S. Census data on household water source. We modeled this exposure linearly in logistic regression to calculate the odds ratio (OR) and 95% confidence interval (CI) of PD risk in relation to well water use. We adjusted for age, sex and race/ethnicity, and verified that smoking and use of medical care did not confound results. We repeated analyses with a 2-year exposure lag and separately within each U.S. state.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Use of well water was inversely associated with PD risk (OR = 0.87, 95% CI 0.85-0.89). We confirmed this association in a Cox survival analysis in which we followed controls for 5 years, death or PD diagnosis. There was little evidence that well water use increased risk of PD in any individual state.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although it remains possible that exposures in well water in more narrow geographic regions increase PD risk, in general these results suggest that exposures more common in urban/suburban areas might also be relevant.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Silver</LastName>
            <ForeName>Maya R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Racette</LastName>
            <ForeName>Brad A</ForeName>
            <Initials>BA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dube</LastName>
            <ForeName>Umber</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Faust</LastName>
            <ForeName>Irene M</ForeName>
            <Initials>IM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Searles Nielsen</LastName>
            <ForeName>Susan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Parkinsons Dis</MedlineTA>
        <NlmUniqueID>101567362</NlmUniqueID>
        <ISSNLinking>1877-7171</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Case-control studies</Keyword>
        <Keyword MajorTopicYN="N">Medicare</Keyword>
        <Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
        <Keyword MajorTopicYN="N">drinking water</Keyword>
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">geographic factors</Keyword>
        <Keyword MajorTopicYN="N">ground water</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083591</ArticleId>
        <ArticleId IdType="pii">JPD191793</ArticleId>
        <ArticleId IdType="doi">10.3233/JPD-191793</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083592</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1877-718X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Parkinson's disease</Title>
          <ISOAbbreviation>J Parkinsons Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quantitative Profiling of Synuclein Species: Application to Transgenic Mouse Models of Parkinson's Disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/JPD-191835</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Improved analytical tools for detailed characterization of synucleins in pre-clinical models of Parkinson's disease (PD) and related synucleinopathies are needed.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Develop a multiple reaction monitoring (MRM) liquid chromatography tandem mass spectrometry (LC-MS/MS) assay to quantify species-specific sequences and structural heterogeneity in soluble α- and β-synucleins in brain tissue.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Using a proteolytic digestion workflow, the MRM LC-MS/MS method assayed six proteotypic peptides from the α-synuclein sequence; three unique to mouse or human α-synuclein and three conserved in α- and β-synuclein. For quantification, we used labeled α-synuclein as the internal standard and an external calibration curve. As proof of concept, the synuclein LC-MS/MS method was applied to brain tissue specimens from M83 transgenic PD mice, which overexpresses human α-synuclein, relative to wild-type littermate controls.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The synuclein MRM assay was linear over a wide concentration range (at least one order of magnitude). The assay had several advantages over ligand binding analytical methods, such as western blotting and enzyme-linked immunosorbent assays. These advantages included the ability to: quantify 1) total α-synuclein, 2) combined α- and β-synucleins, 3) species-specific contributions to total α-synuclein (e.g., in mice expressing both mouse and human α-synuclein), and 4) identify peptide-specific profile differences that may reflect post-translational modifications, all within a single analysis.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">With improved and expanded analytical characteristics coupled with a streamlined sample preparation workflow, the quantitative synuclein profiling LC-MS/MS assay provides a versatile and efficient platform to characterize synuclein biology in pre-clinical models and the potential for application to human tissues and fluids.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Singh</LastName>
            <ForeName>Serena</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khayachi</LastName>
            <ForeName>Anouar</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Milnerwood</LastName>
            <ForeName>Austen J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeMarco</LastName>
            <ForeName>Mari L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Providence Health Care, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Parkinsons Dis</MedlineTA>
        <NlmUniqueID>101567362</NlmUniqueID>
        <ISSNLinking>1877-7171</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
        <Keyword MajorTopicYN="N">Protein sequence</Keyword>
        <Keyword MajorTopicYN="N">mass spectrometry</Keyword>
        <Keyword MajorTopicYN="N">synucleins</Keyword>
        <Keyword MajorTopicYN="N">tandem mass 
spectrometry</Keyword>
        <Keyword MajorTopicYN="N">transgenic mice</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083592</ArticleId>
        <ArticleId IdType="pii">JPD191835</ArticleId>
        <ArticleId IdType="doi">10.3233/JPD-191835</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083593</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-4429</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neonatal-perinatal medicine</Title>
          <ISOAbbreviation>J Neonatal Perinatal Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Glycerin suppositories used prophylactically in premature infants (supp): A pilot randomized controlled trial.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NPM-190310</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Glycerin suppositories are often used to facilitate meconium evacuation in premature infants. The evidence for this practice is inconclusive. The purpose of this study was to assess the feasibility of a multicenter randomized controlled trial on the effectiveness of this treatment strategy.</AbstractText>
          <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">We conducted an external pilot study for a multicenter randomized controlled trial of premature infants randomized to glycerin suppositories or placebo procedure. Participants were included if they were gestational age of 24 weeks 0 days to 31 weeks 6 days and/or birthweight of 500 to 1500 grams. We excluded infants with life-threatening congenital anomalies, contraindications to receiving suppositories, or signs of clinical instability. Outcomes included cost, recruitment, and treatment-related adverse events.</AbstractText>
          <AbstractText Label="RESULT" NlmCategory="RESULTS">A total of 109 were screened, 79 were initially eligible, and 34 consented to participate. Four of these infants were excluded prior to randomization due to thrombocytopenia, 30 were randomized, and 26 reached full enteral feeds. Three infants (10%) experienced rectal bleeding 5 to 43 days after completing study treatments. An anal fissure was noted in two of these patients. There were no cases of rectal perforation but one infant assigned to active treatment developed necrotizing enterocolitis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Conducting a multicenter randomized controlled trial on the use of glycerin suppositories in premature infants is feasible. Minor modifications to the study protocol are needed to increase participant recruitment and simplify the administration of study treatments.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Livingston</LastName>
            <ForeName>M H</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>McMaster Pediatric Surgery Research Collaborative.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elliott</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>McMaster Pediatric Surgery Research Collaborative.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Pediatric Surgery, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Neonatology, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jones</LastName>
            <ForeName>S A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pediatric Surgery, Western University, London, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosenbaum</LastName>
            <ForeName>P L</ForeName>
            <Initials>PL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neonatology, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CanChild Center for Childhood Disability Research, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walton</LastName>
            <ForeName>J M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>McMaster Pediatric Surgery Research Collaborative.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Pediatric Surgery, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Neonatal Perinatal Med</MedlineTA>
        <NlmUniqueID>101468335</NlmUniqueID>
        <ISSNLinking>1878-4429</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Premature infants</Keyword>
        <Keyword MajorTopicYN="N">enteral feeding</Keyword>
        <Keyword MajorTopicYN="N">glycerin</Keyword>
        <Keyword MajorTopicYN="N">suppository</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083593</ArticleId>
        <ArticleId IdType="pii">NPM190310</ArticleId>
        <ArticleId IdType="doi">10.3233/NPM-190310</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083594</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-4429</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neonatal-perinatal medicine</Title>
          <ISOAbbreviation>J Neonatal Perinatal Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Safety of immediate skin-to-skin contact after vaginal birth in vigorous late preterm neonates - A pilot study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NPM-190311</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To evaluate the safety of immediate skin-to-skin contact (SSC) in vigorous late preterm neonates, where observation under radiant warmer is standard of care, in a prospective, randomized, controlled, and equivalence pilot study.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Singletons born vaginally at 35-36 6/7 weeks gestation were randomized to initiate immediate SSC or standard of care with continuous pulse oximeter monitoring for the first hour of life.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-seven dyads were randomized to SSC (n = 21) or radiant warmer (n = 26). Vitals were recorded at designated time intervals to assess tolerance of postnatal transitioning. We found no significant difference in the number of SSC interruptions, pulse oximeter readings, initial glucose level, and rates of hypoglycemia, hypothermia, or NICU admission between the two groups.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vigorous late preterm neonates transitioned to immediate SSC without additional risks compared to control counterparts. Large, multicenter, and randomized-control studies need to be conducted to establish standardized guidelines for this practice.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Walsh</LastName>
            <ForeName>R S</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>Rainbow Babies &amp; Children's Hospital, Cleveland, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Payne</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Rainbow Babies &amp; Children's Hospital, Cleveland, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cossler</LastName>
            <ForeName>N J</ForeName>
            <Initials>NJ</Initials>
            <AffiliationInfo>
              <Affiliation>University Hospitals MacDonald Women's Hospital, Cleveland, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thompson</LastName>
            <ForeName>C L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Case Western Reserve University, Cleveland, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhola</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Rainbow Babies &amp; Children's Hospital, Cleveland, OH.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Neonatal Perinatal Med</MedlineTA>
        <NlmUniqueID>101468335</NlmUniqueID>
        <ISSNLinking>1878-4429</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Late preterm</Keyword>
        <Keyword MajorTopicYN="N">pilot study</Keyword>
        <Keyword MajorTopicYN="N">safety</Keyword>
        <Keyword MajorTopicYN="N">skin-to-skin contact</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083594</ArticleId>
        <ArticleId IdType="pii">NPM190311</ArticleId>
        <ArticleId IdType="doi">10.3233/NPM-190311</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083595</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-4429</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neonatal-perinatal medicine</Title>
          <ISOAbbreviation>J Neonatal Perinatal Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of suspected neonatal herpes simplex virus infection in preterm versus term newborns in the neonatal intensive care unit.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NPM-190334</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While national guidelines are available for the evaluation and management of term infants at risk for herpes simplex virus (HSV) infection, such guidelines are lacking for preterm infants. We sought to determine the risk factors and clinical characteristics of preterm vs. term infants who were evaluated and treated empirically for HSV infection in the neonatal intensive care unit (NICU).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In a retrospective cohort study, medical records of all infants who were admitted to our NICU (2009-2016) and who were evaluated and empirically treated for HSV were reviewed for mothers' and infants' demographics, clinical characteristics, and laboratory findings.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period 4.2% (103/2,471) of all preterm infants, and 6.0% (112/1,865) of all term infants were evaluated and treated empirically for neonatal HSV. Among all infants who were evaluated and treated for HSV, 5.5% (12/215) had neonatal HSV disease, of whom 83.3% (10/12) were preterm infants. In comparison to term, preterm infants were more likely to be evaluated and treated, if they had a maternal history of HSV [OR of 2.51 (95% CI: 1.41-4.48)], prolonged rupture of membranes [2.64 (1.221-5.73)], leukopenia [3.65 (1.94-6.87)] and thrombocytopenia [2.25 (0.85-5.89)]. HSV disease was associated with a higher mortality compared to those without disease [25% (3/12) vs. 4.4% (9/203) respectively; p = &lt;0.05].</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Preterm infants evaluated and empirically treated for HSV have a higher burden of HSV infection than term infants. HSV should be considered in the management of preterm infant with a maternal history of HSV, prolonged rupture of membranes, and thrombocytopenia.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fernandes</LastName>
            <ForeName>N D</ForeName>
            <Initials>ND</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Case Western Reserve University at MetroHealth Medical Center, Cleveland OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sthapit</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Case Western Reserve University at MetroHealth Medical Center, Cleveland OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mhanna</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Case Western Reserve University at MetroHealth Medical Center, Cleveland OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neonatal Intensive Care Unit, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abughali</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Case Western Reserve University at MetroHealth Medical Center, Cleveland OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Infectious Diseases, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Neonatal Perinatal Med</MedlineTA>
        <NlmUniqueID>101468335</NlmUniqueID>
        <ISSNLinking>1878-4429</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Herpes simplex virus</Keyword>
        <Keyword MajorTopicYN="N">acyclovir</Keyword>
        <Keyword MajorTopicYN="N">infection</Keyword>
        <Keyword MajorTopicYN="N">premature infants</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083595</ArticleId>
        <ArticleId IdType="pii">NPM190334</ArticleId>
        <ArticleId IdType="doi">10.3233/NPM-190334</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083596</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuropsychology and the dementia spectrum: Differential diagnosis, clinical management, and forensic utility.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192965</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The utility of neuropsychology in the treatment and evaluation of neuropsychological disorders and neurodegenerative diseases is supported by scientific study. As a discipline, neuropsychology's value and efficacy when applied to the dementia spectrum are rooted in its inherent adaptability as a practical, cost-effective, and scientifically based resource for differential diagnosis, treatment planning, and forensic decision making.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This article provides a framework for conceptualizing dementia as a spectrum of disorders and outlines a rationale for preferential reliance upon neuropsychological tenants. The function of neuropsychology in differential diagnosis, clinical management, integrative care, and forensic applications is delineated for use as a contemporary interdisciplinary reference.</AbstractText>
          <AbstractText Label="METHODOLOGY" NlmCategory="METHODS">An overview of the literature on dementia as a spectrum of disorders has been integrated with the science and practice of neuropsychology.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The utility of neuropsychology emanates from its focus on brain functioning and the discipline's appreciation for the relationship between brain functioning on cognition, mental state, and behavior. Early and routine referral for neuropsychological assessment allows for the objective determination of normal versus abnormal neurocognitive functioning, provides a baseline for serial reassessment, and leads to the more rapid deployment of effective treatments. Beyond the hospital and clinic, neuropsychological expertise is increasingly sought after as integral to the legal system when decisions regarding eligibility for long term care and questions about capacity require objective and reliable measurement.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Begali</LastName>
            <ForeName>Vivian L</ForeName>
            <Initials>VL</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropsychology and Psychological Healthcare, Fountain Park Medical Offices, 9327 MidlothianTurnpike, Suite 1-C, Richmond, VA 23235, USA Tel.: +1 804 728 2964; E-mail: drbegali@gmail.com; Web: http://www.drvivianbegali.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Neuropsychology</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">differential diagnosis</Keyword>
        <Keyword MajorTopicYN="N">forensic</Keyword>
        <Keyword MajorTopicYN="N">long term care</Keyword>
        <Keyword MajorTopicYN="N">neuropsychological assessment</Keyword>
        <Keyword MajorTopicYN="N">testamentary</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083596</ArticleId>
        <ArticleId IdType="pii">NRE192965</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192965</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083597</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neurorehabilitation of persistent sport-related post concussion syndrome.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192966</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent Sport-Related Post-Concussion Syndrome is often diagnosed with any type of prolonged PCS symptoms. However, there are not specific diagnostic criteria for PPCS such that misdiagnosis often occurs. Further, the signs and symptoms of PCS overlap with other common illnesses such as depression, anxiety, migraines, ADHD and others. Misdiagnosis may lead to less than efficacious treatment, resulting in prolonged symptoms.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This article will review relevant evidence-based literature on PCS, pointing out the lack of a systemic diagnostic framework. It will also provide evidence that highlights the multiple conflicting findings in the literature. This article will posit the BioPsychoSocial framework as the best diagnostic framework for understanding the impact of concussions on the person and to generate individualized and personal interventions.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A narrative review of sport concussion-related articles was conducted, after extensive searches of relevant and non-relevant literature by each author, as well as articles recommended by colleagues. Articles varied from American Academy of Neurology Class I to IV for evaluation and critique. Class IV articles were reviewed, as there is much public misconception regarding sport and other concussion treatment that needed identification and discussion.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Articles reviewed varied by quality of research design and methodology. Multiple symptoms, recovery patterns and rehabilitation treatment approaches are purported in the sport-related concussion literature. Current consensus data as well as the mixed and contradictory findings were explored.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Persistent Sport-Related Post-Concussion Syndrome is a topic of great interest to both professionals and the general public. There is much misunderstanding about the etiology, causation, diagnostic formulations, symptom presentation, prolonging factors and treatment involved in this syndrome. This article posits an individualized multi-system diagnostic formulation, examining all relevant factors, as generating the best interventions for neurorehabilitation of Persistent Sport-Related Post-Concussion Syndrome.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Conder</LastName>
            <ForeName>Alanna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Carolina Neuropsychological Service, Raleigh, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conder</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Carolina Neuropsychological Service, Raleigh, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Friesen</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Niagara Neuropsychology, Grimsby, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Concussion</Keyword>
        <Keyword MajorTopicYN="N">Post-Concussion 
Syndrome</Keyword>
        <Keyword MajorTopicYN="N">biofeedback</Keyword>
        <Keyword MajorTopicYN="N">mild traumatic brain injury</Keyword>
        <Keyword MajorTopicYN="N">sport concussion</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083597</ArticleId>
        <ArticleId IdType="pii">NRE192966</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192966</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083598</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Solution-Focused Brief Therapy (SFBT) with individuals with brain injury and their families.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192967</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brain injury is considered a chronic condition and the medical model has long been the traditional paradigm underlying rehabilitation programs for people after acquired brain injury (ABI). In recent years, strengths-based approaches have been increasingly proposed, but little has been written about specific psychotherapeutic application in ABI rehabilitation.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe a strengths-based model, Solution-Focused Brief Therapy (SFBT) and its clinical application to individuals with ABI and their families.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The author describes the assumptions, tenets, and principles of SFBT, a competency-based and resource-based model that orients to the future and focuses on strengths and successes. A direct comparison is made between the traditional medical paradigm and the solution-focused paradigm.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Key ingredients of SFBT are described, including specific strategies, techniques, and its clinical application with individuals with ABI and their families. Limitations around using SFBT and the need for further research with ABI populations are reported.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SFBT is a welcome shift away from the problem-saturated stories that underlie traditional rehabilitation approaches. The strengths-based underpinning of SFBT is a promising psychotherapeutic intervention that merits further investigation with ABI populations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gan</LastName>
            <ForeName>Caron</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Advanced Practice Nurse/Family Therapist/Clinical Team Investigator, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, 150 Kilgour Road, Toronto, Ontario, Canada, ON M4 G 1R8 Tel.: +1 416 425 6220 / Ext. 3514; Fax: +1 416 424 3880; E-mail: cgan@hollandbloorview.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Solution-Focused Therapy</Keyword>
        <Keyword MajorTopicYN="N">brain injury</Keyword>
        <Keyword MajorTopicYN="N">psychotherapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083598</ArticleId>
        <ArticleId IdType="pii">NRE192967</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192967</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083599</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Community Reintegration Following Holistic Milieu-Oriented Neurorehabilitation up to 30 Years Post-Discharge.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192968</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The primary goal of neurorehabilitation for individuals with acquired brain injury (ABI) is successful community reintegration, which commonly focuses on home independence, productivity, and social engagement. Previous research has demonstrated that holistic treatment approaches have better long-term outcomes than other treatment approaches. Holistic approaches go beyond the fundamental components of neurorehabilitation and address metacognition and self-awareness, as well as interpersonal and functional skills.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The present study aimed to examine community reintegration of individuals with ABI who completed holistic milieu-oriented neurorehabilitation at the Center for Transitional Neuro-Rehabilitation (CTN), Barrow Neurological Institute (BNI) at up to 30-years post-discharge. We evaluated (a) functional independence, (b) productivity and driving status, and (c) psychosocial profiles of the brain injury survivors.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">Participants included 107 individuals with ABI with heterogeneous etiologies who attended holistic milieu-oriented neurorehabilitation between 1986 and 2016. These participants completed the Mayo-Portland Adaptability Inventory-4 (MPAI-4) and a long-term outcome questionnaire (LOQ) specifically developed for this study.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The results demonstrate that 89% of participants were productive at up to 30 years post-discharge (73% engaged in competitive work and/or school) after excluding the retired participants. Almost all of the participants who were engaged in work and/or school reported using compensatory strategies on a long-term basis. Furthermore, only 14% out of 102 study participants were driving at the time of program admission; whereas 58% out of 96 were driving at the time of discharge; and impressively, 70% out of 107 participants were driving at the time of follow-up. Regression analyses revealed that older age at the time of injury, shorter duration between injury and treatment, and better functionality indicated by lower MPAI-4 Ability Index scores significantly predicted a return to driving status at the time of study participation. Psychosocial data from the LOQ revealed positive findings with respect to patients' marital status, living situation, income, and quality of social life.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The findings from this study suggest that functional gains made during holistic neurorehabilitation have enduring effects and that patients can benefit highly from holistic milieu therapy beyond the early post-acute phases of their recovery. Additionally, they provide evidence that there is potential to return to driving, years after treatment completion.Our holistic milieu treatment approach addressing metacognition, self-awareness, social and coping skills training, and actively transitioning to community settings, is thought to have contributed to the exceptional and long-lasting outcomes in this study.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Perumparaichallai</LastName>
            <ForeName>Ramaswamy Kavitha</ForeName>
            <Initials>RK</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Transitional Neuro-Rehabilitation, Barrow Neurological Institute/St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewin</LastName>
            <ForeName>Rivian K</ForeName>
            <Initials>RK</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Transitional Neuro-Rehabilitation, Barrow Neurological Institute/St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Memphis, Memphis, TN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klonoff</LastName>
            <ForeName>Pamela S</ForeName>
            <Initials>PS</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Transitional Neuro-Rehabilitation, Barrow Neurological Institute/St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Holistic neurorehabilitation</Keyword>
        <Keyword MajorTopicYN="N">acquired brain injury</Keyword>
        <Keyword MajorTopicYN="N">community reintegration</Keyword>
        <Keyword MajorTopicYN="N">long-term outcome</Keyword>
        <Keyword MajorTopicYN="N">return to driving</Keyword>
        <Keyword MajorTopicYN="N">return to work</Keyword>
        <Keyword MajorTopicYN="N">traumatic brain injury</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083599</ArticleId>
        <ArticleId IdType="pii">NRE192968</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192968</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083600</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Biopsychosocial outcome indicators in traumatic brain injuries.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192969</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Traumatic brain injury (TBI) remains a silent and global epidemic which creates an aftermath of convoluted dynamics. Despite significant incidence rates and increasing awareness over the long-term catastrophic implications, there remain marked contrasts between acute vs. post-acute rehabilitation processes in the United States.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore existing research and highlight the complexity of TBIs to inform vital changes needed to reduce the significant differences and inconsistencies across post-acute treatment settings. To highlight how psychologists/neuropsychologists and other rehabilitation professionals maintain a prominent operational presence in post-acute settings resulting in key leadership opportunities to support a more efficient longitudinal continuation of care model.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Literature search of various health science databases was completed for articles between 1987 to 2019 to explore the range and depth of post-acute treatment, model, and outcomes research.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Despite progressive medical advancements, translation of relevant rehabilitation research and practices into post-acute treatment settings remains inconsistent.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Significant barriers remain for objective and comprehensive evaluation(s) of post-acute program quality and purported patient outcomes in the United States. There remains a lack of consensually relevant and objective metrics. Further investigation is recommended for: consensus on longitudinal post-acute brain injury outcome measures; functional relevance of program accreditations/certifications; outcome differences based on team composition and program resources; and patient/stakeholder variables/input to support optimal post-acute service access and delivery.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Parbhoo</LastName>
            <ForeName>Pritesh</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>NeuroInternational Healthcare, LLC, 1876 Barber Rd, Building A, Sarasota, FL 34240, USA Tel.: +1 (813) 401 6728; E-mail: drparbhoo@neurointernational.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Traumatic</Keyword>
        <Keyword MajorTopicYN="N">brain injury</Keyword>
        <Keyword MajorTopicYN="N">disability</Keyword>
        <Keyword MajorTopicYN="N">leadership</Keyword>
        <Keyword MajorTopicYN="N">neuropsychology</Keyword>
        <Keyword MajorTopicYN="N">outcomes</Keyword>
        <Keyword MajorTopicYN="N">post-acute</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation metrics</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation psychology</Keyword>
        <Keyword MajorTopicYN="N">silent epidemic</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083600</ArticleId>
        <ArticleId IdType="pii">NRE192969</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192969</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083601</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The role of rehabilitation psychology in stroke care described through case examples.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192970</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A stroke event, sometimes referred to as a cerebrovascular accident (CVA), is a sudden and often traumatic life event that results in life-changing consequences with which affected people must cope. There are nearly 800,000 instances of stroke annually in the U.S. (American Heart Association, 2018). Stroke is the leading cause of disability in adults, and more than one-third of people who survive a stroke will have severe disability in the U.S. (Mayo, 2005). Between 35% and 75% of stroke survivors will have significant cognitive impairment (Tatemichi et al., 1994; Nys et al., 2007). An estimated one-third of people suffer depression after stroke (Hackett et al., 2005), about one-fourth experience significant anxiety (Barker-Collo, 2007), and about one-fifth suffer from insomnia (Leppavuoria et al., 2002). These and other stroke-related psychological issues negatively influence rehabilitation and outcomes through a variety of mechanisms. For example, post-stroke depression has been shown to be related to more negative functional consequences (Kneebone et al., 2000; Matsuzaki et al., 2015). Psychological disturbances may affect rehabilitation outcomes through a reduction in adherence to home exercise programs, reduced energy level, increased fatigue, reduced frustration tolerance, and potentially less motivation and hope about the future.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This manuscript aims to identify and describe the role of rehabilitation psychology in treating these common post-stroke complaints and, ultimately, optimizing post-stroke outcomes via two case examples.</AbstractText>
          <AbstractText Label="METHODOLOGY" NlmCategory="METHODS">This manuscript describes two cases of individuals in post-acute rehabilitation who had psychological issues which were negatively affecting outcomes.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Given the abrupt and significant life-changing nature of stroke, it is often necessary to manage a diverse array of psychological issues that often cannot be simply managed via psychotropic medications. Moreover, an understanding of the patients' emotional adjustment and issues can help them maximize their rehabilitation, recovery, and community integration. For the cases discussed, psychology consultations were central in helping optimize their rehabilitation and functional outcomes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Perna</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Pate Rehabilitation, Dallas, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harik</LastName>
            <ForeName>Lindsey</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>TIRR Memorial Hermann, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Stroke/CVA</Keyword>
        <Keyword MajorTopicYN="N">interdisciplinary rehabilitation</Keyword>
        <Keyword MajorTopicYN="N">post-stroke depression</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation psychology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083601</ArticleId>
        <ArticleId IdType="pii">NRE192970</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192970</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083602</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mild TBI in interdisciplinary neurorehabilitation: Treatment challenges and insights.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192971</ELocationID>
        <Abstract>
          <AbstractText Label="BACKROUND" NlmCategory="UNASSIGNED">Traumatic brain injury (TBI) has an estimated prevalence rate of 1.7 million occurrences a year in the United States with over 75% of traumatic brain injuries classified as 'mild.' The majority of individuals with mild traumatic brain injuries resume their daily functioning fairly quickly, and many fully within the first year. However, a minority of persons with mild TBI (mTBI), with estimates ranging between 1% and 20%, develop persistent cognitive, emotional, behavioral, and physical symptoms. Clinicians vary considerably in their clinical opinions regarding these individuals and there is no consensus on the treatment protocol for this population.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This manuscript presents four case studies of mild TBI with persistent symptoms treated by a transdisciplinary team in an outpatient neurorehabilitation setting based on community reintegration. Clinical challenges and insights involved in conceptualizing and effectively treating these individuals are discussed to facilitate future direction.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Four different mild TBI cases, each with persistent symptoms, but different injury mechanisms, dynamics, and factors affecting symptom persistence, expression, course, and outcome were included in the analysis of their treatment course and outcome. The treatment protocol included: brain injury education combined with supportive counseling for cultivation of positive expectancy effects, symptom-based, graded treatment involving most disciplines, frequent treatment team consultations, collaborations, and planning, and consistent team messages about post-injury recovery and expected return to community activities. Treatment outcomes were assessed with self and family reports, as well as the Mayo Portland Adaptability Inventory (MAPI-4) at admission and at discharge.</AbstractText>
          <AbstractText Label="RESULTS AND CONCLUSIONS" NlmCategory="CONCLUSIONS">Each of the individuals made functional progress during rehabilitation, as evidenced by self and family reports and the MAPI-4. The cases posed various challenges to the treatment team, though a transdisciplinary team under the guidance of a rehabilitation physician and rehabilitation neuropsychologist was able to help patients navigate the path to their functional recovery. In addition to the specific treatment protocol, transdisciplinary team collaboration guided by rehabilitation neuropsychology contributed to treatment success.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pundlik</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>The Institute of Rehabilitation Research (TIRR), Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Pate Rehabilitation, Dallas, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perna</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Pate Rehabilitation, Dallas, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arenivas</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>The Institute of Rehabilitation Research (TIRR), Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mild TBI</Keyword>
        <Keyword MajorTopicYN="N">interdisciplinary rehabilitation</Keyword>
        <Keyword MajorTopicYN="N">neurorehabilitation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083602</ArticleId>
        <ArticleId IdType="pii">NRE192971</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192971</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083603</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Predictors of longitudinal depression trajectories after traumatic brain injury in Latin America: A multi-site study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192972</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Latin America has exceptionally high rates of traumatic brain injury (TBI), but very little research has been conducted on longitudinal TBI outcomes in this global region.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study examined whether cognitive dysfunction and social disadaptation in individuals with TBI in Latin America at hospital discharge predict longitudinal trajectories of depression at baseline, 2 months, and 4 months.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A sample of 109 people with a new TBI was recruited from three hospitals in Mexico City, Mexico, and in Cali and Neiva, Colombia. Participants completed measures of cognitive dysfunction and social disadaptation before hospital discharge and measures of depression at baseline, 2 months, and 4 months.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Results suggested that depression scores were found to decrease over time in a quadratic (or U-shaped) fashion, and more significant cognitive dysfunction at hospital discharge was associated with higher longitudinal depression trajectories. Social disadaptation did not exert a unique effect on depression trajectories after controlling for cognitive dysfunction. Depression trajectories changed differentially over time as a function of baseline cognitive dysfunction, such that for those with high cognitive impairment, depression scores started high and then dropped to a moderated range and plateaued, but for individuals with low cognitive dysfunction, depression scores started lower and decreased linearly but moderately.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results suggest a strong need for neuropsychological assessments and evidence-based cognitive rehabilitation strategies to be implemented immediately after TBI in Latin America, which could exert salubrious effects on depression trajectories over time.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cariello</LastName>
            <ForeName>Anna N</ForeName>
            <Initials>AN</Initials>
            <AffiliationInfo>
              <Affiliation>Virginia Commonwealth University, Richmond, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perrin</LastName>
            <ForeName>Paul B</ForeName>
            <Initials>PB</Initials>
            <AffiliationInfo>
              <Affiliation>Virginia Commonwealth University, Richmond, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agudelo</LastName>
            <ForeName>Yaneth Rodriguez</ForeName>
            <Initials>YR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuropsychology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olivera Plaza</LastName>
            <ForeName>Silvia Leonor</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Universidad Sur Colombiana, Neiva, Huila, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quijano</LastName>
            <ForeName>Maria Cristina</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Departartment of Social Sciencies, Pontificia University of Javeriana Cali, Cali, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trujillo</LastName>
            <ForeName>Michael A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>University of California, San Francisco, San Francisco, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arango-Lasprilla</LastName>
            <ForeName>Juan Carlos</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>BioCruces Bizkaia Health Research Institute, Cruces University Hospital Barakaldo, Barakaldo, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cell Biology and Histology, University of the Basque Country (UPV/EHU), Leioa, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Latin America</Keyword>
        <Keyword MajorTopicYN="N">Traumatic brain injury</Keyword>
        <Keyword MajorTopicYN="N">caregivers</Keyword>
        <Keyword MajorTopicYN="N">depression</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083603</ArticleId>
        <ArticleId IdType="pii">NRE192972</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192972</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083604</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Medical adjustment counseling: An evidence-based neuropsychological approach in the care of medical patients.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-192973</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Today, there exists a need for a practical counseling approach for patients with brain disorders based on an empirical measure that can be used to objectify procedural adequacy. Clinical neuropsychology, which focuses on developing knowledge about human brain-behavioral relationships and applying this information to clinical problems, is the ideal discipline to address this issue. Unlike other methods of appraisal and current counseling approaches, medical adjustment counseling (MAC) for patients with cognitive and behavioral changes due to brain disorders is based on the application of neuropsychological principles and evidence-based practices.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In this review, I discuss the neuropsychological principles underlying MAC, differentiation from conventional clinical psychology systems, and the specifics of the treatment stages. Transtheoretical analytic points of inclusion and a clinical case example are also discussed.</AbstractText>
          <AbstractText Label="METHODOLOGY" NlmCategory="METHODS">MAC involves an interactive exchange between the neuropsychologist and patient based on the neuropsychological examination (NPE). The resulting neuropsychological profile facilitates the conversion of empirical objective evidence into practical biopsychosocial adaptive strategies that can be modified according to each patient's diagnosis and level of impairment. MAC is delivered in four stages (validation, education, accommodation, and reintegration) that require an understanding of the ecological applicability of the NPE to the real-life situation of the patient, a knowledge base of the neurobehavioral consequences of the medical diagnosis, integration of medical disciplines regarding additional diagnostics, psychological crisis systems and patient/family reactions.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Without the objective neuropsychological evidence provided by the NPE and MAC, the clinical judgment of the psychologist is based on something more akin to witchcraft and magic than science.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sica</LastName>
            <ForeName>Robert B</ForeName>
            <Initials>RB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Neuroscience Division, Jersey Shore University Medical Center, Rutgers-Robert Wood Johnson Medical School, Hackensack Meridian Seton Hall Medical School, Neuropsychological Rehabilitation Services-LifeSpan, 2100 State Route 33, Suits 9 and 10, Neptune, New Brunswick, NJ 07753, USA E-mail: rsica18@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Medical adjustment counseling</Keyword>
        <Keyword MajorTopicYN="N">brain-behavioral relationships</Keyword>
        <Keyword MajorTopicYN="N">clinical neuropsychology</Keyword>
        <Keyword MajorTopicYN="N">neuropsychological examination</Keyword>
        <Keyword MajorTopicYN="N">procedural adequacy</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083604</ArticleId>
        <ArticleId IdType="pii">NRE192973</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-192973</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083605</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6448</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>NeuroRehabilitation</Title>
          <ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuropsychological and psychological applications in neurorehabilitation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-200002</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Begali</LastName>
            <ForeName>Vivian</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Guest Editor, Neuropsychology and Psychological Healthcare, 9327 Midlothian Turnpike, Suite 1-C, Richmond, VA 23235, USA E-mail: drbegali@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>NeuroRehabilitation</MedlineTA>
        <NlmUniqueID>9113791</NlmUniqueID>
        <ISSNLinking>1053-8135</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083605</ArticleId>
        <ArticleId IdType="pii">NRE200002</ArticleId>
        <ArticleId IdType="doi">10.3233/NRE-200002</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083606</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of vestibular research : equilibrium &amp; orientation</Title>
          <ISOAbbreviation>J Vestib Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuropsychological profiles of children with vestibular loss.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/VES-200689</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The impact of vestibular loss (VL) on cognition has been previously studied in experimental animal, human and adult patient studies showing links between VL, and cognitive impairments in space orientation, working memory, mental rotation and selective attention. However, few studies have been conducted on children with VL.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We investigated for the first time, the impact of a VL on children's cognition.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">13 children with VL (10 years, 5 months) and 60 average-age matched controls performed a neuropsychological assessment consisting of visuospatial working memory, selective visual attention, mental rotation and space orientation tasks.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Children with VL recalled smaller sequences for both forward and backward memory subtasks (mean±SD = 6.3±1.9 and 5.3±2.6) than controls (8.2±2.3 and 7.3±2.0), have less accurate mental rotation scores (25.4±6 versus 30.8±5.1) and greater additional distance travelled in the maze task (96.4±66.6 versus 60.4±66.3); all corrected p-values &lt;0.05. Selective visual attention measures do not show significant differences.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Children with VL show similar cognitive difficulties that adults with VL, in tasks involving dynamic cognitive processes (higher attentional load) that in tasks requiring static cognitive processes such as visual attention task.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lacroix</LastName>
            <ForeName>Emilie</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Oto-Rhino-Laryngology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroscience (IONS), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Research in Psychological Science (IPSY), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edwards</LastName>
            <ForeName>Martin Gareth</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroscience (IONS), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Research in Psychological Science (IPSY), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Volder</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroscience (IONS), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Research in Psychological Science (IPSY), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noël</LastName>
            <ForeName>Marie-Pascale</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Research in Psychological Science (IPSY), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rombaux</LastName>
            <ForeName>Philippe</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Oto-Rhino-Laryngology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Research in Psychological Science (IPSY), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deggouj</LastName>
            <ForeName>Naima</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Oto-Rhino-Laryngology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroscience (IONS), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Research in Psychological Science (IPSY), Université Catholique de Louvain, Louvain-la-Neuve, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Vestib Res</MedlineTA>
        <NlmUniqueID>9104163</NlmUniqueID>
        <ISSNLinking>0957-4271</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>S</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Vestibular</Keyword>
        <Keyword MajorTopicYN="N">children</Keyword>
        <Keyword MajorTopicYN="N">cognitive abilities</Keyword>
        <Keyword MajorTopicYN="N">neuropsychology</Keyword>
        <Keyword MajorTopicYN="N">vestibular loss</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083606</ArticleId>
        <ArticleId IdType="pii">VES200689</ArticleId>
        <ArticleId IdType="doi">10.3233/VES-200689</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083607</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of vestibular research : equilibrium &amp; orientation</Title>
          <ISOAbbreviation>J Vestib Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of vestibular symptoms and postural balance control in patients with chronic otitis media.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/VES-200691</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evidence to support potential links between chronic otitis media (COM) and vestibular impairment/postural balance control issues is lacking.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether COM associates with vestibular symptoms, balance problems, and abnormalities in vestibular function tests.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We selected patients with COM and excluded patients with any identifiable underlying causes for vestibular dysfunction. Fifty-two healthy volunteers were included as controls. All subjects underwent anamnesis, physical examination, posturography, and video-head impulse tests.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found a high prevalence of vestibular symptoms (58.4%) among patients with COM, while only 2% of the controls had vestibular symptoms. There was a positive correlation between COM activity with the presence of tinnitus and vestibular symptoms (P &lt; 0.05). Clinical vestibular tests were abnormal in 63% of patients with COM, and those positively associated with presence of vestibular symptoms. Posturography results shown worse postural balance control in patients with COM as compared with controls, especially in the limit of stability (LOS) (Mean LOS, COM = 157.56 cm2; controls = 228.98 cm2; p &lt; 0.001), and in the test with eyes closed while standing on a foam mattress (sway area, COM = 10.91 cm2; controls = 5.90 cm2; p &lt; 0.001). We did not observe differences in the average vestibuloocular reflex gains in the video-head impulse test between our COM and control groups.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results show that COM associates with a high prevalence of vestibular symptoms, worse postural control, and more severe hearing loss as compared with controls. Among patients with COM, the activity of the middle-ear inflammation seemed to positively associate with more severe hearing and balance problems.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Monsanto</LastName>
            <ForeName>Rafael da Costa</ForeName>
            <Initials>RDC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head &amp; Neck Surgery, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM) (São Paulo, SP, Brazil).</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology Head &amp; Neck Surgery, University of Minnesota (Minnesota, MN, USA).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kasemodel</LastName>
            <ForeName>Ana Luiza Papi</ForeName>
            <Initials>ALP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head &amp; Neck Surgery, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM) (São Paulo, SP, Brazil).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomaz</LastName>
            <ForeName>Andreza</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head &amp; Neck Surgery, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM) (São Paulo, SP, Brazil).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abrahão Elias</LastName>
            <ForeName>Thais Gomes</ForeName>
            <Initials>TG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head &amp; Neck Surgery, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM) (São Paulo, SP, Brazil).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paparella</LastName>
            <ForeName>Michael Mauro</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology Head &amp; Neck Surgery, University of Minnesota (Minnesota, MN, USA).</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Paparella Ear Head &amp; Neck Institute. (Minnesota, MN, USA).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Oliveira Penido</LastName>
            <ForeName>Norma</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head &amp; Neck Surgery, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM) (São Paulo, SP, Brazil).</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Vestib Res</MedlineTA>
        <NlmUniqueID>9104163</NlmUniqueID>
        <ISSNLinking>0957-4271</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>S</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Otitis media</Keyword>
        <Keyword MajorTopicYN="N">dizziness</Keyword>
        <Keyword MajorTopicYN="N">postural 
balance</Keyword>
        <Keyword MajorTopicYN="N">vertigo</Keyword>
        <Keyword MajorTopicYN="N">vestibular function tests</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083607</ArticleId>
        <ArticleId IdType="pii">VES200691</ArticleId>
        <ArticleId IdType="doi">10.3233/VES-200691</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083608</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-6464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of vestibular research : equilibrium &amp; orientation</Title>
          <ISOAbbreviation>J Vestib Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Veterans with dizziness recruit compensatory saccades in each semicircular canal plane although VOR gain is normal.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/VES-200692</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Exposure to brain injury via blast or blunt mechanisms disrupts multiple sensorimotor systems simultaneously. Large numbers of US Gulf War era and Operation Iraqi/Enduring Freedom veterans with traumatic brain injury (TBI) are suffering the symptom of dizziness - presumed due to "Multi-Sensory Impairment", a clinical pattern of damage to the auditory, visual and vestibular sensorimotor systems.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the oculomotor response to rapid head rotation in a population of veterans with dizziness. We also describe the reliability of using the video head impulse test (vHIT) in a veteran population.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used the vHIT to evaluate the vestibular-ocular reflex (VOR) gain and presence of compensatory saccades (CS) in each semicircular canal of 81 veterans (31% TBI) with dizziness. Data was collected using the GN Otometric™ vHIT. Data was processed using both the Otometric™ software and custom software written in MATLAB™. This data was evaluated through Kruskal-Wallis rank-sum test and analysis of regression.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Veterans with dizziness recruit CS in all semicircular canal planes even though their VOR gain is normal. The vHIT is a reliable clinical test to quantify the metrics of the VOR and CS in veterans.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Veterans with dizziness symptoms use compensatory saccades in all planes of semicircular canal rotation, despite having normal peripheral VOR gain during rapid head rotation. The video head impulse test is a stable measure of vestibular slow phase and metrics of compensatory saccades in veterans with dizziness.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Le Cao</LastName>
            <ForeName>Thuy Tien</ForeName>
            <Initials>TT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brewer</LastName>
            <ForeName>Kelly</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veteran Affairs, Veterans Biomedical Institute, War Related Illness and Injury Study Center, East Orange, NJ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Serrador</LastName>
            <ForeName>Jorge</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Veteran Affairs, Veterans Biomedical Institute, War Related Illness and Injury Study Center, East Orange, NJ, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Physiology and Neuroscience, Rutgers Biomedical Health Sciences, Newark, NJ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schubert</LastName>
            <ForeName>Michael C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Vestibular NeuroAdaptation, Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Vestib Res</MedlineTA>
        <NlmUniqueID>9104163</NlmUniqueID>
        <ISSNLinking>0957-4271</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>S</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Traumatic brain injury</Keyword>
        <Keyword MajorTopicYN="N">compensatory saccade</Keyword>
        <Keyword MajorTopicYN="N">vestibular-ocular reflex</Keyword>
        <Keyword MajorTopicYN="N">video head impulse test</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083608</ArticleId>
        <ArticleId IdType="pii">VES200692</ArticleId>
        <ArticleId IdType="doi">10.3233/VES-200692</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083609</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-9270</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Work (Reading, Mass.)</Title>
          <ISOAbbreviation>Work</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mouse with your arm™: Facilitating forearm support using the chair armrest to prevent and mitigate musculoskeletal disorders1.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/WOR-203103</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Musculoskeletal disorders (MSDs) can be prevented by avoiding trauma caused by poor posture, compression, force, and repetition. Neutral postures are recommended to avoid MSDs.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study introduces Mouse With Your Arm™ (MWYA) methodology which promotes sitting back in a chair, using the chair's armrest for forearm support at relaxed elbow height, matching surface and armrest height, and keeping the mouse on the surface edge. This position allows optimal task chair use, facilitates movement and neutral postures, avoids compression and contact stress, and is effective in mitigating MSDs.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">MWYA was applied and measured in the field for more 23 years providing over 3,500 individualized assessments to integrate a participant's unique characteristics, reported health concerns, tasks, tools, and environment to achieve and sustain whole-body neutral and comfortable working postures.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Previous research has consistently recommended use of forearm support by a desk, apparatus, or wrist rest, and resulted in non-neutral, static postures and measured health consequences. By using armrests for support, MWYA avoids the potential of MSDs as can be caused by these previously endorsed postures.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">By applying the five MWYA principles, computer users comprehend neutral posture and put forth the effort essential to creating healthy human computer relationships.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eggleston</LastName>
            <ForeName>Sara Taylor</ForeName>
            <Initials>ST</Initials>
            <AffiliationInfo>
              <Affiliation>MWYA Methodology and Structured Health Resources, Inc., 3153 North Wagner, Ann Arbor, MI, USA Tel.: +1 734-224-2425; E-mail: STaylor@StructuredHealth.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Work</MedlineTA>
        <NlmUniqueID>9204382</NlmUniqueID>
        <ISSNLinking>1051-9815</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Disability management</Keyword>
        <Keyword MajorTopicYN="N">ergonomics</Keyword>
        <Keyword MajorTopicYN="N">health</Keyword>
        <Keyword MajorTopicYN="N">holistic</Keyword>
        <Keyword MajorTopicYN="N">posture</Keyword>
        <Keyword MajorTopicYN="N">rehabilitation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083609</ArticleId>
        <ArticleId IdType="pii">WOR203103</ArticleId>
        <ArticleId IdType="doi">10.3233/WOR-203103</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083610</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-9114</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of X-ray science and technology</Title>
          <ISOAbbreviation>J Xray Sci Technol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A primary analysis on measuring repeatability of the maximum diameter between CT and MR imaging for lung cancers.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/XST-190613</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the measurement reproducibility of the maximum diameter on MRI routine sequence (T1WI, T2WI, DWI) and CT in peripheral and central lung cancer, and to provide reference standard for evaluating treatment responses for lung cancer.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">53 patients with lung cancer underwent CT and 3.0T MR scanning. The maximum diameter was measured according to the RECIST1.1 standard on images of CT (lung and enhanced mediastinal window), MRI T2-BLADE, axial T1-VIBE and DWIb0, DWIb300, DWIb800, respectively. The reproducibility of the diameters was analyzed with intraclass correlation coefficient (ICC), and the distribution of measurement points with the Bland-Altman method. The difference analysis was assessed by paired samples t-test and nonparametric rank sum test, P &lt; 0.05 is considered statistically significant.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Reproducibility of diameters derived from routine MRI and CT was good (ICC &gt; 0.75). For peripheral lung cancer, there was no significant difference in diameters between CT and MRI. While for central lung cancer, there was significant difference in diameters measured between using CT and each MRI sequence. However, the diameters derived from T1-VIBE and T2-BLADE were not significantly different from all DWI sequences.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For peripheral lung cancer, the measurement on CT and routine MRI sequences can potentially replace each other after comprehensive consideration of examination purposes, but for central lung cancer, alternative use of CT and MRI in evaluating treatment responses for lung cancer should needs extra attention. The diameter measurement of lung cancer on DWI is consistent with that on T1WI and T2WI, suggesting that DWI can provide functional and morphological information.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shu-Qing</LastName>
            <ForeName>Zhang</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao-Wen</LastName>
            <ForeName>Gu</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Suzhou Municipal Hospital, Suzhou, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jia</LastName>
            <ForeName>Liu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kumar Ps</LastName>
            <ForeName>Sanjeev</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Imaging, Parexel International Corporation, Billerica, Massachusetts 01821, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiang-Ming</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>The Affiliated Wuxi People's Hospital to Nanjing Medical University, Wuxi, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jian-Bin</LastName>
            <ForeName>Yin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jian-Qin</LastName>
            <ForeName>Jiang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Yancheng City No.1 People's Hospital, Tinghu District, Yancheng, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Qian</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao-Yun</LastName>
            <ForeName>Hu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>The Affiliated Wuxi People's Hospital to Nanjing Medical University, Wuxi, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lei</LastName>
            <ForeName>Cui</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Xray Sci Technol</MedlineTA>
        <NlmUniqueID>9000080</NlmUniqueID>
        <ISSNLinking>0895-3996</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Lung cancer</Keyword>
        <Keyword MajorTopicYN="N">MRI</Keyword>
        <Keyword MajorTopicYN="N">computed tomography</Keyword>
        <Keyword MajorTopicYN="N">diameter</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083610</ArticleId>
        <ArticleId IdType="pii">XST190613</ArticleId>
        <ArticleId IdType="doi">10.3233/XST-190613</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083611</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1095-9114</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Journal of X-ray science and technology</Title>
          <ISOAbbreviation>J Xray Sci Technol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Directional weighted spatial fuzzy C-means for segmentation of brain MRI images.</ArticleTitle>
        <Pagination>
          <MedlinePgn>185</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3233/XST-200001</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Sajid Ullah</ForeName>
            <Initials>SU</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Lakki Marwat, KPK, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ullah</LastName>
            <ForeName>Imran</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Harbin Engineering University, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Imran</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Management Sciences, Peshawar, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imran</LastName>
            <ForeName>Ali</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of Science and Technology, Bannu, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ullah</LastName>
            <ForeName>Najeeb</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>CECOS University of IT and Emerging Sciences, Peshawar, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Xray Sci Technol</MedlineTA>
        <NlmUniqueID>9000080</NlmUniqueID>
        <ISSNLinking>0895-3996</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083611</ArticleId>
        <ArticleId IdType="pii">XST200001</ArticleId>
        <ArticleId IdType="doi">10.3233/XST-200001</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083612</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2090-598X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>18</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Arab journal of urology</Title>
          <ISOAbbreviation>Arab J Urol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Re: Can rectal catheters be avoided during paediatric urodynamic studies? By Abhilash Cheriyan, Arun Jacob Philip George, Antony Devasia and J. Chandrasingh.</ArticleTitle>
        <Pagination>
          <MedlinePgn>47</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/2090598X.2019.1694763</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Farag</LastName>
            <ForeName>Fawzy</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Sohag University Hospital, Sohag, Egypt, ff.farag@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arab J Urol</MedlineTA>
        <NlmUniqueID>101562480</NlmUniqueID>
        <ISSNLinking>2090-598X</ISSNLinking>
      </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083612</ArticleId>
        <ArticleId IdType="doi">10.1080/2090598X.2019.1694763</ArticleId>
        <ArticleId IdType="pii">1694763</ArticleId>
        <ArticleId IdType="pmc">PMC7006662</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083613</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2048-8505</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical kidney journal</Title>
          <ISOAbbreviation>Clin Kidney J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>85-94</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ckj/sfz038</ELocationID>
        <Abstract>
          <AbstractText Label="Background" NlmCategory="UNASSIGNED">Understanding how frailty affects health-related quality of life (HRQOL) in those with chronic kidney disease (CKD) could assist in the development of management strategies to improve outcomes for this vulnerable patient group. This study aimed to evaluate the relationship between frailty and HRQOL in patients with CKD Stages 4 and 5 (G4-5) and those established on haemodialysis (G5D).</AbstractText>
          <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Ninety participants with dialysis-dependent chronic kidney disease (CKD G4-5D) were recruited between December 2016 and December 2017. Frailty was assessed using the Frailty Phenotype, which included assessments of unintentional weight loss, weakness (handgrip strength), slowness (walking speed), physical activity and self-perceived exhaustion. HRQOL was assessed using the RAND 36-Item Health Survey Version 1.0 (SF-36).</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Nineteen (21%) patients were categorized as frail. Frailty, when adjusted for age, gender, dialysis dependence and comorbidity, had a significant effect on five of the eight SF-36 domains: physical functioning, role limitations due to emotional problems, energy/fatigue, social functioning and pain. Regression modelling best explained the variation in the physical functioning domain (adj. <i>R</i> <sup>2</sup> = 0.27, P &lt; 0.001), with frailty leading to a 26-point lower score. Exhaustion was the only Frailty Phenotype component that had a significant effect on scores across all SF-36 domains.</AbstractText>
          <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Frailty is independently associated with worse HRQOL in patients with CKD G4-5D, with self-perceived exhaustion being the most significant Frailty Phenotype component contributing to HRQOL. Efforts should be made to identify frail patients with CKD so that management strategies can be offered that aim to improve morbidity, mortality and patient-reported outcomes, including HRQOL and fatigue.</AbstractText>
          <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nixon</LastName>
            <ForeName>Andrew C</ForeName>
            <Initials>AC</Initials>
            <Identifier Source="ORCID">0000-0002-4093-6204</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston,UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Health Research and Innovation, National Institute of Health Research Lancashire Clinical Research Facility, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bampouras</LastName>
            <ForeName>Theodoros M</ForeName>
            <Initials>TM</Initials>
            <AffiliationInfo>
              <Affiliation>Active Ageing Research Group, University of Cumbria, Lancaster, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Lancaster Medical School, Lancaster University, Lancaster, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pendleton</LastName>
            <ForeName>Neil</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mitra</LastName>
            <ForeName>Sandip</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Manchester Academy of Health Sciences Centre, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Devices for Dignity, National Institute of Health Research MedTech &amp; In-vitro Diagnostics Co-operative, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brady</LastName>
            <ForeName>Mark E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston,UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dhaygude</LastName>
            <ForeName>Ajay P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston,UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Kidney J</MedlineTA>
        <NlmUniqueID>101579321</NlmUniqueID>
        <ISSNLinking>2048-8505</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">chronic kidney disease</Keyword>
        <Keyword MajorTopicYN="N">end-stage kidney disease</Keyword>
        <Keyword MajorTopicYN="N">frailty</Keyword>
        <Keyword MajorTopicYN="N">geriatric nephrology</Keyword>
        <Keyword MajorTopicYN="N">haemodialysis</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>03</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083613</ArticleId>
        <ArticleId IdType="doi">10.1093/ckj/sfz038</ArticleId>
        <ArticleId IdType="pii">sfz038</ArticleId>
        <ArticleId IdType="pmc">PMC7025341</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083614</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2048-8505</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical kidney journal</Title>
          <ISOAbbreviation>Clin Kidney J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome.</ArticleTitle>
        <Pagination>
          <MedlinePgn>39-41</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ckj/sfz146</ELocationID>
        <Abstract>
          <AbstractText>Direct renin inhibitors (DRIs) block the activation of the alternative complement pathway <i>in vitro</i> and could be a treatment option for refractory hypertension in atypical hemolytic uremic syndrome (aHUS). A 20-year-old male presented with primary aHUS complicated by end-stage renal disease and refractory malignant hypertension despite being on five antihypertensive medications at maximum dose. Only a partial response was achieved with aliskiren and eculizumab, but after increasing aliskiren to a supratherapeutic dose, antihypertensive medication was reduced, platelets increased, C3 increased and epoetin alfa requirement decreased. DRI may be an adjunct treatment for malignant hypertension associated with aHUS.</AbstractText>
          <CopyrightInformation>Published by Oxford University Press on behalf of ERA-EDTA 2019. This work is written by US Government employees and is in the public domain in the US.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Plasse</LastName>
            <ForeName>Richard A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology Department, Walter Reed National Military Medical Center, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nee</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology Department, Walter Reed National Military Medical Center, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olson</LastName>
            <ForeName>Stephen W</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology Department, Walter Reed National Military Medical Center, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Kidney J</MedlineTA>
        <NlmUniqueID>101579321</NlmUniqueID>
        <ISSNLinking>2048-8505</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alternative complement pathway</Keyword>
        <Keyword MajorTopicYN="N">atypical hemolytic uremic syndrome</Keyword>
        <Keyword MajorTopicYN="N">direct renin inhibitors</Keyword>
        <Keyword MajorTopicYN="N">malignant hypertension</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083614</ArticleId>
        <ArticleId IdType="doi">10.1093/ckj/sfz146</ArticleId>
        <ArticleId IdType="pii">sfz146</ArticleId>
        <ArticleId IdType="pmc">PMC7025342</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083615</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2048-8505</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical kidney journal</Title>
          <ISOAbbreviation>Clin Kidney J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Diabetes mellitus: a single cardiorenal syndrome umbrella.</ArticleTitle>
        <Pagination>
          <MedlinePgn>14-16</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ckj/sfz161</ELocationID>
        <Abstract>
          <AbstractText>Diabetes and chronic kidney disease are among the fastest-growing causes of death worldwide. An optimized conceptual framework on the pathogenesis of diabetic kidney disease and its interplay with cardiovascular disease will facilitate the development of monitoring and therapeutic strategies to decrease the risk for severe clinical events and early mortality. In this issue of <i>ckj</i>, Pinier <i>et al</i>. provide data supporting the existence in diabetic patients of a single cardiorenal syndrome umbrella, rather than separate cardiorenal or renocardiac entities (e.g. acute cardiorenal syndrome or chronic renocardiac syndromes).</AbstractText>
          <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rodríguez</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Hospital del Mar, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut Mar for Medical Research, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arias-Cabrales</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Hospital del Mar, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut Mar for Medical Research, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pascual</LastName>
            <ForeName>Julio</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Hospital del Mar, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut Mar for Medical Research, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Kidney J</MedlineTA>
        <NlmUniqueID>101579321</NlmUniqueID>
        <ISSNLinking>2048-8505</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AKI</Keyword>
        <Keyword MajorTopicYN="N">acute tubular necrosis</Keyword>
        <Keyword MajorTopicYN="N">cardiorenal syndrome</Keyword>
        <Keyword MajorTopicYN="N">chronic renal failure</Keyword>
        <Keyword MajorTopicYN="N">chronic renal insufficiency</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083615</ArticleId>
        <ArticleId IdType="doi">10.1093/ckj/sfz161</ArticleId>
        <ArticleId IdType="pii">sfz161</ArticleId>
        <ArticleId IdType="pmc">PMC7025372</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083616</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2048-8505</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical kidney journal</Title>
          <ISOAbbreviation>Clin Kidney J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view.</ArticleTitle>
        <Pagination>
          <MedlinePgn>17-23</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ckj/sfz028</ELocationID>
        <Abstract>
          <AbstractText Label="Background" NlmCategory="UNASSIGNED">Interconnections between major cardiovascular events (MCVEs) and renal events are recognized in diabetes, however, the specific impact of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS) on the risk of end-stage renal disease (ESRD) on top of established renal risk factors is unclear in type 2 diabetes mellitus.</AbstractText>
          <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We conducted a retrospective study in 861 consecutive patients followed in a nephrology setting during the 2000-13 period.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">The mean age was 70 ± 10 years, 65.1% were men and the estimated glomerular filtration rate (eGFR) was 42.4 ± 21.0 mL/min/1.73 m<sup>2</sup>. During follow-up (median 59 months), 194 patients reached ESRD. A history of AF, HF or ACS was associated with an increased risk of reduced baseline eGFR. In turn, reduced baseline eGFR resulted in a greater risk of new MCVE (especially HF) during follow-up. Finally, all new MCVEs were risk factors for subsequent acute kidney injury (AKI) {HF: hazard ratio [HR] 8.99 [95% confidence interval (CI) 7.06-11.4]; AF: HR 5.42 (3.91-7.52); ACS: HR 8.82 (6.24-12.5); all P &lt; 0.0001} and ESRD [HF: HR 5.52 (95% CI 4.01-7.60), P &lt; 0.0001; AF: HR 3.48 (2.30-5.21), P &lt; 0.0001; ACS: HR 2.31 (1.43-3.73), P = 0.0006]. The AF- and HF-associated risks of ESRD were significant after adjustments on all renal risks of ESRD (gender, blood pressure, eGFR, albuminuria, renin-angiotensin blockers, retinopathy and AKI), but the association was less strong for ACS. Importantly, no association was noted between other major events such as stroke or infections and the risk of ESRD.</AbstractText>
          <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Past and new cardiovascular events (more HF and AF than ACS) have a strong, independent impact on the development of ESRD above and beyond established risk factors in diabetes.</AbstractText>
          <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pinier</LastName>
            <ForeName>Cédric</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gatault</LastName>
            <ForeName>Philippe</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>EA4245, François-Rabelais University, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fauchier</LastName>
            <ForeName>Laurent</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Cardiologie, Hôpital Trousseau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Angoulvant</LastName>
            <ForeName>Denis</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>EA4245, François-Rabelais University, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Cardiologie, Hôpital Trousseau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>François</LastName>
            <ForeName>Maud</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barbet</LastName>
            <ForeName>Christelle</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bailly</LastName>
            <ForeName>Elodie</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noble</LastName>
            <ForeName>Johan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chevallier</LastName>
            <ForeName>Eloi</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rabot</LastName>
            <ForeName>Nolwenn</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Büchler</LastName>
            <ForeName>Matthias</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>EA4245, François-Rabelais University, Tours, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sautenet</LastName>
            <ForeName>Bénédicte</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inserm U1246, François-Rabelais University, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halimi</LastName>
            <ForeName>Jean-Michel</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>EA4245, François-Rabelais University, Tours, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Kidney J</MedlineTA>
        <NlmUniqueID>101579321</NlmUniqueID>
        <ISSNLinking>2048-8505</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cardiovascular events</Keyword>
        <Keyword MajorTopicYN="N">diabetes mellitus</Keyword>
        <Keyword MajorTopicYN="N">end-stage renal disease</Keyword>
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">heart failure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083616</ArticleId>
        <ArticleId IdType="doi">10.1093/ckj/sfz028</ArticleId>
        <ArticleId IdType="pii">sfz028</ArticleId>
        <ArticleId IdType="pmc">PMC7025370</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083617</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2048-8505</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical kidney journal</Title>
          <ISOAbbreviation>Clin Kidney J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Aliskiren and the dual complement inhibition concept.</ArticleTitle>
        <Pagination>
          <MedlinePgn>35-38</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ckj/sfz142</ELocationID>
        <Abstract>
          <AbstractText>In this issue of <i>Clinical Kidney Journal</i>, Plasse <i>et al</i>. report on the use of high-dose aliskiren as an adjunct therapy in a patient treated with eculizumab for haemolytic uraemic syndrome (HUS). This follows the recent description of the complement factor 3 (C3) activating activity of the enzyme renin and the successful therapeutic use of the direct renin inhibitor aliskiren in three cases of C3 glomerulopathy/dense deposit disease. We discuss the potential clinical and pathophysiological implications of these reports on nephropathies linked to complement, from HUS to C3 glomerulopathy to immunoglobulin A nephropathy as well as the concept of dual complement inhibition for kidney disease.</AbstractText>
          <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Perez-Gomez</LastName>
            <ForeName>Maria Vanessa</ForeName>
            <Initials>MV</Initials>
            <AffiliationInfo>
              <Affiliation>IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>REDINREN, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ortiz</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>REDINREN, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Kidney J</MedlineTA>
        <NlmUniqueID>101579321</NlmUniqueID>
        <ISSNLinking>2048-8505</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">aliskiren</Keyword>
        <Keyword MajorTopicYN="N">complement</Keyword>
        <Keyword MajorTopicYN="N">dense deposit disease</Keyword>
        <Keyword MajorTopicYN="N">haemolytic uraemic syndrome</Keyword>
        <Keyword MajorTopicYN="N">paroxysmal nocturnal haemoglobinuria</Keyword>
        <Keyword MajorTopicYN="N">renin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083617</ArticleId>
        <ArticleId IdType="doi">10.1093/ckj/sfz142</ArticleId>
        <ArticleId IdType="pii">sfz142</ArticleId>
        <ArticleId IdType="pmc">PMC7025362</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083618</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-9084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Physical chemistry chemical physics : PCCP</Title>
          <ISOAbbreviation>Phys Chem Chem Phys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Formation of highly excited iodine atoms from multiphoton excitation of CH<sub>3</sub>I.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9cp06242d</ELocationID>
        <Abstract>
          <AbstractText>Mass resolved REMPI spectra, as well as CH3+and I+ ion and photoelectron images, were recorded for two-photon resonant excitations of CH3I via s, p and d Rydberg states (CH3I**) in the excitation region of 55 700 to 70 000 cm-1. Photoelectron (PE) and ion kinetic energy release spectra (KERs) were derived from the images. The data revealed that after the two-photon resonant excitation, an additional photon is absorbed to form one or more superexcited state(s) (CH3I#), followed by branching into three pathways. The major one is the dissociation of CH3I# to form excited Rydberg states of iodine atoms (I**) along with CH3(X), a phenomenon not commonly observed in methyl halides. The second (minor) pathway involves autoionization of CH3I# towards CH3I+(X), which absorbs another photon to form CH3+ along with I/I* and the third one (minor) is CH3I# dissociation towards the ion pair, CH3+ + I-, prior to I- electron ejection. Furthermore, one-photon non-resonant dissociation of CH3I to form CH3(X) and I/I* prior to three-photon ionization of the fragments is also detected.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Matthíasson</LastName>
            <ForeName>Kristján</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7532-3125</Identifier>
            <AffiliationInfo>
              <Affiliation>Science Institute, University of Iceland, Dunhagi 3, 107 Reykjavík, Iceland. agust@hi.is kristjm@hi.is gkoumarianou@ucsb.edu mej7@hi.is glodic.pavle@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koumarianou</LastName>
            <ForeName>Greta</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0036-4309</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Electronic Structure and Laser, Foundation for Research and Technology-Hellas, Vassilika Vouton, 71110 Heraklion, Greece. sama@iesl.forth.gr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Meng-Xu</ForeName>
            <Initials>MX</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-1989-908X</Identifier>
            <AffiliationInfo>
              <Affiliation>Science Institute, University of Iceland, Dunhagi 3, 107 Reykjavík, Iceland. agust@hi.is kristjm@hi.is gkoumarianou@ucsb.edu mej7@hi.is glodic.pavle@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Glodic</LastName>
            <ForeName>Pavle</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0510-0855</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Electronic Structure and Laser, Foundation for Research and Technology-Hellas, Vassilika Vouton, 71110 Heraklion, Greece. sama@iesl.forth.gr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samartzis</LastName>
            <ForeName>Peter C</ForeName>
            <Initials>PC</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8873-2326</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Electronic Structure and Laser, Foundation for Research and Technology-Hellas, Vassilika Vouton, 71110 Heraklion, Greece. sama@iesl.forth.gr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kvaran</LastName>
            <ForeName>Ágúst</ForeName>
            <Initials>Á</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1742-6994</Identifier>
            <AffiliationInfo>
              <Affiliation>Science Institute, University of Iceland, Dunhagi 3, 107 Reykjavík, Iceland. agust@hi.is kristjm@hi.is gkoumarianou@ucsb.edu mej7@hi.is glodic.pavle@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phys Chem Chem Phys</MedlineTA>
        <NlmUniqueID>100888160</NlmUniqueID>
        <ISSNLinking>1463-9076</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083618</ArticleId>
        <ArticleId IdType="doi">10.1039/c9cp06242d</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083619</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chemical-substitution-induced successive symmetry descent and structure-property correlation for "114" oxides CaBa<sub>1-x</sub>Sr<sub>x</sub>Zn<sub>2</sub>Al<sub>2</sub>O<sub>7</sub>.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9dt04566j</ELocationID>
        <Abstract>
          <AbstractText>The crystal structures, photoluminescence properties, and transport properties of a series of new "114" oxides CaBa1-xSrxZn2Al2O7 (x = 0-1) were investigated in detail. Careful Rietveld refinements performed on solid solution samples revealed that the structural symmetry of CaBa1-xSrxZn2Al2O7 evolves from hexagonal P63mc (x &lt; 0.2) to trigonal P31c (0.2 ≤ x ≤ 0.6) and then to orthorhombic Pna21 (x &gt; 0.6) with an increase of the Sr2+-content, which is cooperative with the rotation of T1O4 tetrahedra around the c-axis. Eu3+ was used as a local structural probe to gain an insight into the structure, which further corroborated the correctness of the observed structural symmetry descending sequence in CaBa1-xSrxZn2Al2O7. More importantly, the reduction of structural symmetry is also associated with a tendency from layered ordering to complete charge ordering transition for Zn2+/Al3+ cations, which was revealed to have a significant influence on the transport properties. These findings are expected to offer a route to manipulate the physical properties of "114" oxides containing magnetic cations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>An</LastName>
            <ForeName>Yuling</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 401331, People's Republic of China. pengfeijiang@cqu.edu.cn taoyang@cqu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Pengfei</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-6832-7462</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 401331, People's Republic of China. pengfeijiang@cqu.edu.cn taoyang@cqu.edu.cn and College of Physics, Chongqing University, Chongqing, 401331, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Wenliang</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-3131-7302</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 401331, People's Republic of China. pengfeijiang@cqu.edu.cn taoyang@cqu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cong</LastName>
            <ForeName>Rihong</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-9018-6819</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 401331, People's Republic of China. pengfeijiang@cqu.edu.cn taoyang@cqu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2276-4023</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 401331, People's Republic of China. pengfeijiang@cqu.edu.cn taoyang@cqu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083619</ArticleId>
        <ArticleId IdType="doi">10.1039/c9dt04566j</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083620</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-9084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Physical chemistry chemical physics : PCCP</Title>
          <ISOAbbreviation>Phys Chem Chem Phys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Structural interpretation of the energetic performances of a pure silica LTA-type zeolite.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9cp06760d</ELocationID>
        <Abstract>
          <AbstractText>The high pressure intrusion-extrusion process of different electrolyte aqueous solutions (NaCl and CaCl2, 2 M and 3 M) in a hydrophobic pure-silica LTA zeolite was investigated for energetic purposes by means of in situ X-ray powder diffraction, porosimeter tests, thermogravimetric analysis and NMR spectroscopy. The intrusion pressure of the saline solutions was proved to be higher than that of pure water, with the highest value measured for CaCl2, thus increasing the energetic performance of the system. The intrusion of NaCl solutions was irreversible (bumper behavior), whereas that of CaCl2 solutions is partially reversible (shock absorber behavior). The structural investigation allowed interpreting these results on the basis of the different intrusion mechanisms, in turn induced by the different nature of the cations present in the electrolyte solutions. When Si-LTA is intruded by NaCl solution, firstly H2O molecules penetrate the pores, leading to higher silanol defect formation followed by the solvated ions. With CaCl2, instead, due to a higher solvation enthalpy of Ca2+, a higher pressure is required for intrusion, and both H2O and ions penetrate at the same pressure. The structural refinements demonstrate (i) a different arrangement of the extraframework species in the two systems, (ii) the intrusion of the salt solutions occurs through strong desolvation of the ions and (iii) the salt/H2O ratios of the intruded species are higher than those of the starting electrolyte solutions.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Confalonieri</LastName>
            <ForeName>Giorgia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Chimiche e Geologiche (DSCG), Università di Modena e Reggio Emilia, Italy. rossella.arletti@unimore.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ryzhikov</LastName>
            <ForeName>Andrey</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-3775-2092</Identifier>
            <AffiliationInfo>
              <Affiliation>Université de Haute Alsace (UHA), Axe Matériaux à Porosité Contrôlée (MPC), Institut de Science des Matériaux de Mulhouse (IS2M), Mulhouse, France. andrey.ryzhikov@uha.fr and Université de Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arletti</LastName>
            <ForeName>Rossella</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-9878-8657</Identifier>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Chimiche e Geologiche (DSCG), Università di Modena e Reggio Emilia, Italy. rossella.arletti@unimore.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quartieri</LastName>
            <ForeName>Simona</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Matematiche e Informatiche, Scienze Fisiche e Scienze della Terra, Università di Messina, Messina S. Agata, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vezzalini</LastName>
            <ForeName>Giovanna</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Chimiche e Geologiche (DSCG), Università di Modena e Reggio Emilia, Italy. rossella.arletti@unimore.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isaac</LastName>
            <ForeName>Carole</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Université de Haute Alsace (UHA), Axe Matériaux à Porosité Contrôlée (MPC), Institut de Science des Matériaux de Mulhouse (IS2M), Mulhouse, France. andrey.ryzhikov@uha.fr and Université de Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paillaud</LastName>
            <ForeName>Jean-Louis</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Université de Haute Alsace (UHA), Axe Matériaux à Porosité Contrôlée (MPC), Institut de Science des Matériaux de Mulhouse (IS2M), Mulhouse, France. andrey.ryzhikov@uha.fr and Université de Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nouali</LastName>
            <ForeName>Habiba</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Université de Haute Alsace (UHA), Axe Matériaux à Porosité Contrôlée (MPC), Institut de Science des Matériaux de Mulhouse (IS2M), Mulhouse, France. andrey.ryzhikov@uha.fr and Université de Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daou</LastName>
            <ForeName>T Jean</ForeName>
            <Initials>TJ</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-9973-3372</Identifier>
            <AffiliationInfo>
              <Affiliation>Université de Haute Alsace (UHA), Axe Matériaux à Porosité Contrôlée (MPC), Institut de Science des Matériaux de Mulhouse (IS2M), Mulhouse, France. andrey.ryzhikov@uha.fr and Université de Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phys Chem Chem Phys</MedlineTA>
        <NlmUniqueID>100888160</NlmUniqueID>
        <ISSNLinking>1463-9076</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083620</ArticleId>
        <ArticleId IdType="doi">10.1039/c9cp06760d</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083621</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-9084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Physical chemistry chemical physics : PCCP</Title>
          <ISOAbbreviation>Phys Chem Chem Phys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A microfluidic study of synergic liquid-liquid extraction of rare earth elements.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9cp06569e</ELocationID>
        <Abstract>
          <AbstractText>A microfluidic technique is coupled with X-ray fluorescence in order to investigate the origin of the so-called synergy effect observed in liquid-liquid extraction of rare earth elements (REEs) when special combinations of two extractants - one solvating and one ionic - are used. The setup enables kinetic studies by varying the two phases' contact time. The results obtained are compared with those obtained using a standard batch extraction method at identical contact time. We then determine variations of free energies of transfer for five rare earth elements present in a solution together with a non-target ion (Fe3+) at different pH. Analysis of the effect of temperature and of surface charge density of the coexisting cations allows separating electrostatic effects from complexation effects. We finally show that all non-linear (synergic) effects are quadratic in mole fraction. This demonstrates that in-plane mixing entropy of the bent extractant film, in the first nanometer around rare earth ions, is the determining term in the synergy effect. Surprisingly, even when the third phase is present, free energies of transfer could still be measured in the dilute phase, which is reported for the first time, to our knowledge. We hence show that the extractive power of the dense third phase is stronger than that of conventional reverse aggregates in equilibrium with excess water.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>El Maangar</LastName>
            <ForeName>Asmae</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0561-9825</Identifier>
            <AffiliationInfo>
              <Affiliation>Univ. Grenoble Alpes, IRIG-MEM, F-38054 Grenoble, France and ICSM, CEA, Univ Montpellier, CNRS, ENSCM, Marcoule, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Theisen</LastName>
            <ForeName>Johannes</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8282-5281</Identifier>
            <AffiliationInfo>
              <Affiliation>Univ. Grenoble Alpes, IRIG-MEM, F-38054 Grenoble, France and ICSM, CEA, Univ Montpellier, CNRS, ENSCM, Marcoule, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Penisson</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Univ. Grenoble Alpes, IRIG-MEM, F-38054 Grenoble, France and ICSM, CEA, Univ Montpellier, CNRS, ENSCM, Marcoule, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zemb</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8410-6969</Identifier>
            <AffiliationInfo>
              <Affiliation>ICSM, CEA, Univ Montpellier, CNRS, ENSCM, Marcoule, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gabriel</LastName>
            <ForeName>Jean-Christophe P</ForeName>
            <Initials>JP</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-0194-683X</Identifier>
            <AffiliationInfo>
              <Affiliation>Univ. Grenoble Alpes, IRIG-MEM, F-38054 Grenoble, France and Université Paris-Saclay, CEA, CNRS, NIMBE, 91191, Gif-sur-Yvette, France. jean-christophe.gabriel@cea.fr and Nanyang Technological University, ERI@N, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phys Chem Chem Phys</MedlineTA>
        <NlmUniqueID>100888160</NlmUniqueID>
        <ISSNLinking>1463-9076</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083621</ArticleId>
        <ArticleId IdType="doi">10.1039/c9cp06569e</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083622</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2050-7895</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science. Processes &amp; impacts</Title>
          <ISOAbbreviation>Environ Sci Process Impacts</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Emerging investigator series: influence of marine emissions and atmospheric processing on individual particle composition of summertime Arctic aerosol over the Bering Strait and Chukchi Sea.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9em00495e</ELocationID>
        <Abstract>
          <AbstractText>The Arctic is rapidly transforming due to sea ice loss, increasing shipping activity, and oil and gas development. Associated marine and combustion emissions influence atmospheric aerosol composition, impacting complex aerosol-cloud-climate feedbacks. To improve understanding of the sources and processes determining Arctic aerosol composition, atmospheric particles were collected aboard the Korean icebreaker R/V Araon cruising within the Bering Strait and Chukchi Sea during August 2016. Offline analyses of individual particles by microspectroscopic techniques, including scanning electron microscopy with energy dispersive X-ray spectroscopy and atomic force microscopy with infrared spectroscopy, provided information on particle size, morphology, and chemical composition. The most commonly observed particle types were sea spray aerosol (SSA), comprising ∼60-90%, by number, of supermicron particles, and organic aerosol (OA), comprising ∼50-90%, by number, of submicron particles. Sulfate and nitrate were internally mixed within both SSA and OA particles, consistent with particle multiphase reactions during atmospheric transport. Within the Bering Strait, SSA and OA particles were more aged, with greater number fractions of particles containing sulfate and/or nitrate, compared to particles collected over the Chukchi Sea. This is indicative of greater pollution influence within the Bering Strait from coastal and inland sources, while the Chukchi Sea is primarily influenced by marine sources.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kirpes</LastName>
            <ForeName>Rachel M</ForeName>
            <Initials>RM</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2998-0108</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Michigan, 930 N University Ave, Ann Arbor, MI 48109, USA. prattka@umich.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriguez</LastName>
            <ForeName>Blanca</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Earth System Science, University of California, Irvine, CA 92697, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Saewung</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Earth System Science, University of California, Irvine, CA 92697, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>China</LastName>
            <ForeName>Swarup</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laskin</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Keyhong</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Korea Polar Research Institute, Incheon, 21990, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jung</LastName>
            <ForeName>Jinyoung</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Korea Polar Research Institute, Incheon, 21990, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ault</LastName>
            <ForeName>Andrew P</ForeName>
            <Initials>AP</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7313-8559</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Michigan, 930 N University Ave, Ann Arbor, MI 48109, USA. prattka@umich.edu and Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pratt</LastName>
            <ForeName>Kerri A</ForeName>
            <Initials>KA</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4707-2290</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Michigan, 930 N University Ave, Ann Arbor, MI 48109, USA. prattka@umich.edu and Department of Earth &amp; Environmental Sciences, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Environ Sci Process Impacts</MedlineTA>
        <NlmUniqueID>101601576</NlmUniqueID>
        <ISSNLinking>2050-7887</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083622</ArticleId>
        <ArticleId IdType="doi">10.1039/c9em00495e</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083623</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>TiO<sub>2</sub>/Cu<sub>2</sub>O nanoparticle-catalyzed direct C(sp)-P bond formation via aerobic oxidative coupling in air and visible light.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9dt04757c</ELocationID>
        <Abstract>
          <AbstractText>The synthesis of organophosphorus compounds is one of the important goals in organic chemistry. Among these compounds, alkynylphosphonates are significantly utilized as the main precursors for the synthesis of biologically active molecules in medicinal chemistry and have attracted extensive interest in the past few decades. Although few efforts have been made towards the direct and atom-economical synthesis of alkynylphosphonates, efforts towards the utilization of visible light as a green and renewable energy source have not been made to date. Here, we have promoted a strategy to construct a type of nano metal oxide composite photocatalyst (Cu2O decorated on TiO2) for the synthesis of alkynylphosphonates via direct C-P bond formation between terminal alkyne and H-phosphonate under visible light irradiation. In this p-n heterojunction photocatalyst, Cu2O acted as a visible-light absorber; moreover, the CB (conduction band) of TiO2 was favorable for accepting a photogenerated electron, and the generated electron hole (e-/h+) pair could initiate the reaction. The present study can provide a new way for the synthesis of this important class of phosphorus organic compounds.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hosseini-Sarvari</LastName>
            <ForeName>Mona</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7555-8004</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Faculty of Science, Shiraz University, Shiraz, 7194684795 I.R, Iran. hossaini@shirazu.ac.ir.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jafari</LastName>
            <ForeName>Fattaneh</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Faculty of Science, Shiraz University, Shiraz, 7194684795 I.R, Iran. hossaini@shirazu.ac.ir.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083623</ArticleId>
        <ArticleId IdType="doi">10.1039/c9dt04757c</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083624</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-9084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Physical chemistry chemical physics : PCCP</Title>
          <ISOAbbreviation>Phys Chem Chem Phys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Probing ultracold chemistry using ion spectrometry.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9cp07015j</ELocationID>
        <Abstract>
          <AbstractText>Rapid progress in atomic, molecular, and optical (AMO) physics techniques enabled the creation of ultracold samples of molecular species and opened opportunities to explore chemistry in the ultralow temperature regime. In particular, both the external and internal quantum degrees of freedom of the reactant atoms and molecules are controlled, allowing studies that explored the role of the long-range potential in ultracold reactions. The kinetics of these reactions have typically been determined using the loss of reactants as proxies. To extend such studies into the short-range, we developed an experimental apparatus that combines the production of quantum-state-selected ultracold KRb molecules with ion mass and kinetic energy spectrometry, and directly observed KRb + KRb reaction intermediates and products [M.-G. Hu and Y. Liu, et al., Science, 2019, 366, 1111]. Here, we present the apparatus in detail. For future studies that aim for detecting the quantum states of the reaction products, we demonstrate a photodissociation based scheme to calibrate the ion kinetic energy spectrometer at low energies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-5228-1997</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA. yuliu@g.harvard.edu ni@chemistry.harvard.edu and Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA and Harvard-MIT Center for Ultracold Atoms, Cambridge, Massachusetts 02138, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grimes</LastName>
            <ForeName>David D</ForeName>
            <Initials>DD</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-5567-7890</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA. yuliu@g.harvard.edu ni@chemistry.harvard.edu and Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA and Harvard-MIT Center for Ultracold Atoms, Cambridge, Massachusetts 02138, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Ming-Guang</ForeName>
            <Initials>MG</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7728-7500</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA. yuliu@g.harvard.edu ni@chemistry.harvard.edu and Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA and Harvard-MIT Center for Ultracold Atoms, Cambridge, Massachusetts 02138, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ni</LastName>
            <ForeName>Kang-Kuen</ForeName>
            <Initials>KK</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-0537-0719</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA. yuliu@g.harvard.edu ni@chemistry.harvard.edu and Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA and Harvard-MIT Center for Ultracold Atoms, Cambridge, Massachusetts 02138, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phys Chem Chem Phys</MedlineTA>
        <NlmUniqueID>100888160</NlmUniqueID>
        <ISSNLinking>1463-9076</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083624</ArticleId>
        <ArticleId IdType="doi">10.1039/c9cp07015j</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083625</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-9084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Physical chemistry chemical physics : PCCP</Title>
          <ISOAbbreviation>Phys Chem Chem Phys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The puzzling hyper-fine structure and an accurate equilibrium geometry of succinic anhydride.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9cp06775b</ELocationID>
        <Abstract>
          <AbstractText>An accurate semiexperimental equilibrium structure of succinic anhydride has been determined from a combination of experiment and theory. The cm-wave and mm-wave rotational spectra of succinic anhydride, 3,4-dihydrofuran-2,5-dione, were recorded in a pulsed supersonic jet using Fourier-transform microwave spectroscopy and in a free-jet using mm-wave absorption spectroscopy. Many lines in the cm-wave spectrum show fine structure and after eliminating all other possibilities the origin of this fine structure is determined to be from spin-spin interaction. Accurate rotational and quartic centrifugal distortion constants are determined. Assignments of 13C and 18O singly substituted isotopologues in natural abundance were used to obtain a substitution geometry for the heavy atoms of succinic anhydride. Theoretical approaches permitted the calculation of a Born-Oppenheimer ab initio structure and the determination of a semiexperimental equilibrium structure in which computed rovibrational corrections were utilized to convert vibrational ground state rotational constants into equilibrium constants. The agreement between the semiexperimental structure and the Born-Oppenheimer ab initio structure is excellent. Succinic anhydride has been shown to have a planar heavy atom equilibrium structure with the effects of a large amplitude vibration apparent in the resultant rotational constants.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jahn</LastName>
            <ForeName>Michaela K</ForeName>
            <Initials>MK</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-6238-1046</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Physikalische Chemie &amp; Elektrochemie, Gottfried-Wilhelm-Leibniz-Universität, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Obenchain</LastName>
            <ForeName>Daniel A</ForeName>
            <Initials>DA</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-5533-1163</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Physikalische Chemie &amp; Elektrochemie, Gottfried-Wilhelm-Leibniz-Universität, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nair</LastName>
            <ForeName>K P Rajappan</ForeName>
            <Initials>KPR</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Physikalische Chemie &amp; Elektrochemie, Gottfried-Wilhelm-Leibniz-Universität, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grabow</LastName>
            <ForeName>Jens-Uwe</ForeName>
            <Initials>JU</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2663-8091</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Physikalische Chemie &amp; Elektrochemie, Gottfried-Wilhelm-Leibniz-Universität, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vogt</LastName>
            <ForeName>Natalja</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-7190-5702</Identifier>
            <AffiliationInfo>
              <Affiliation>Section of Chemical Information Systems, University of Ulm, Germany and Chemistry Department, Lomonosov Moscow State University, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Demaison</LastName>
            <ForeName>Jean</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Chemical Information Systems, University of Ulm, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Godfrey</LastName>
            <ForeName>Peter D</ForeName>
            <Initials>PD</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Monash University, Wellington Rd, Clayton, Vic 3800, Australia. donald.mcnaughton@monash.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McNaughton</LastName>
            <ForeName>Don</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-5321-6468</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Monash University, Wellington Rd, Clayton, Vic 3800, Australia. donald.mcnaughton@monash.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phys Chem Chem Phys</MedlineTA>
        <NlmUniqueID>100888160</NlmUniqueID>
        <ISSNLinking>1463-9076</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083625</ArticleId>
        <ArticleId IdType="doi">10.1039/c9cp06775b</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083626</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2047-4849</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biomaterials science</Title>
          <ISOAbbreviation>Biomater Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Biomembrane induced in situ self-assembly of peptide with enhanced antimicrobial activity.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9bm01785b</ELocationID>
        <Abstract>
          <AbstractText>Antimicrobial peptides (AMPs) as biocides are of great interest because they have the ability to combat antibiotic resistance. Normally, natural AMPs need to be rationally designed or modified for practical use as an antibiotic. Here, a novel AMP, termed FF8, which is a cationic octapeptide composed of arginine, lysine, and phenylalanine, was designed. The FF8 was found to self-assemble into nanofibers when induced by a negatively charged lipid membrane or pH is above 9.4. The fibers on the membrane broke the lipid membrane, forming pores and significantly reducing its fluidity. FF8 also exhibited enhanced antibacterial activity by significantly increasing the permeability of the inner and outer membranes of Escherichia coli (E. coli) and maintaining the pores of the inner membrane of cells, which caused continuous membrane leakage. Because of its high antibacterial activity, cytocompatibility, and cost-effectiveness, FF8 is a promising antibacterial material.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Zhiwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Zhen</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Limin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China. zhangyi@sinap.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yujiao</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jinjin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China. zhangyi@sinap.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China. zhangyi@sinap.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2024-2624</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China and Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China. zhangyi@sinap.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biomater Sci</MedlineTA>
        <NlmUniqueID>101593571</NlmUniqueID>
        <ISSNLinking>2047-4830</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083626</ArticleId>
        <ArticleId IdType="doi">10.1039/c9bm01785b</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083627</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2042-650X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Food &amp; function</Title>
          <ISOAbbreviation>Food Funct</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The holistico-reductionist Siga classification according to the degree of food processing: an evaluation of ultra-processed foods in French supermarkets.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9fo02271f</ELocationID>
        <Abstract>
          <AbstractText>The qualitative NOVA classification of foods according to their degree of processing is used worldwide by researchers. NOVA defines ultra-processed foods (UPFs) by the presence of processed industrial ingredients and additives to modify the sensory properties (aroma, taste, colour and texture) of reconstituted food, named 'cosmetic' compounds, i.e., modifying food appearance. Some drastic processes directly applied to food are also markers of ultra-processing. However, with the intent to develop an elaborate tool for industries and retailers, the Siga classification was developed by combining the four holistic NOVA groups with four more new reductionist subgroups considering the impact of processing on the food/ingredient matrix; the contents of added salt, sugar and fat; the nature and number of markers of ultra-processing (MUPs); and the levels of at-risk additives (groups are unprocessed, A0; minimally processed foods, A1; culinary ingredients, A2; balanced foods, B1/C0.1; high salt, sugar and/or fat level foods, B2/C0.2; processed/ultra-processed foods; and UPFs with more than one MUP, C1). The Siga algorithm was used to characterize 24 932 packaged foods in French supermarkets (baby foods and alcohol excluded), which were representative of the packaged food assortments. The main results showed that two-thirds of the products were ultra-processed. Products with more than one MUP (C1) corresponded to the most represented category, accounting for 54% of the products. Among foods with more than five ingredients, 75% were UPFs. Considering all products, the average number of ingredients, MUPs and at-risk additives were 10.1, 2.6 and 0.5, respectively. Among food categories, some contained a high percentage of UPFs: 94, 95, 95, 81, 80, and 87% for salted meats, cooked dishes, flavoured yogurts/white cheeses, energy and gourmet bars, breakfast cereals, and vegetarian dishes, respectively. Finally, the Siga algorithm presents a useful tool for improving the health potential of packaged food and for decision-making on search engine optimization (SEO) policy and assortment management in supermarkets.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Davidou</LastName>
            <ForeName>Sylvie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-7264-3839</Identifier>
            <AffiliationInfo>
              <Affiliation>Siga, 5 Avenue du Général De Gaulle, 94160 Saint-Mandé, France. sylvie@siga.care.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Christodoulou</LastName>
            <ForeName>Aris</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-4810-5552</Identifier>
            <AffiliationInfo>
              <Affiliation>Siga, 5 Avenue du Général De Gaulle, 94160 Saint-Mandé, France. sylvie@siga.care.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fardet</LastName>
            <ForeName>Anthony</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4972-9217</Identifier>
            <AffiliationInfo>
              <Affiliation>Siga, 5 Avenue du Général De Gaulle, 94160 Saint-Mandé, France. sylvie@siga.care.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Frank</LastName>
            <ForeName>Kelly</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Siga, 5 Avenue du Général De Gaulle, 94160 Saint-Mandé, France. sylvie@siga.care.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Food Funct</MedlineTA>
        <NlmUniqueID>101549033</NlmUniqueID>
        <ISSNLinking>2042-6496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083627</ArticleId>
        <ArticleId IdType="doi">10.1039/c9fo02271f</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083628</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2050-7895</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Environmental science. Processes &amp; impacts</Title>
          <ISOAbbreviation>Environ Sci Process Impacts</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Influence of climate and biological variables on temporal trends of persistent organic pollutants in Arctic char and ringed seals from Greenland.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9em00561g</ELocationID>
        <Abstract>
          <AbstractText>Climate change may affect temporal trends of persistent organic pollutants (POPs) in Arctic wildlife. We studied how biological and climate variables influence temporal trends of selected POP groups in landlocked Arctic char muscle and in ringed seal blubber from West and East Greenland. The variables included fish length or animal age, sex, a stable nitrogen isotope, sea ice extent, air or seawater temperature, salinity and the Arctic Oscillation Index (AOI). Model selection for multiple regression showed that the most important predictors varied among POP groups, species and region. Decreasing time trends were found for all POP groups with the exception of hexachlorobenzene (HCB) concentration which remained stable in Arctic char and ringed seals from West Greenland. When retained in the most parsimonious model, the AOI was positively associated with POP concentrations for East Greenland seals, but negatively for West Greenland seals. Seawater temperature and sea ice extent were positively associated with POP concentrations. The effects of explanatory variables on the annual rates of change in POP concentrations were relatively minor relative to the decline caused by reduction in POP emissions following national and international regulations introduced since the 1970s.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rigét</LastName>
            <ForeName>Frank</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2204-2135</Identifier>
            <AffiliationInfo>
              <Affiliation>Aarhus University, Department of Bioscience, Roskilde, Denmark. ffr@bios.au.dk and Greenland Institute of Natural Resources, Nuuk, Greenland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vorkamp</LastName>
            <ForeName>Katrin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Aarhus University, Department of Environmental Science, Arctic Research Centre, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eulaers</LastName>
            <ForeName>Igor</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Aarhus University, Department of Bioscience, Roskilde, Denmark. ffr@bios.au.dk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dietz</LastName>
            <ForeName>Rune</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Aarhus University, Department of Bioscience, Roskilde, Denmark. ffr@bios.au.dk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Environ Sci Process Impacts</MedlineTA>
        <NlmUniqueID>101601576</NlmUniqueID>
        <ISSNLinking>2050-7887</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083628</ArticleId>
        <ArticleId IdType="doi">10.1039/c9em00561g</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083629</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2040-3372</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nanoscale</Title>
          <ISOAbbreviation>Nanoscale</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quantitative analysis of time-resolved RHEED during growth of vertical nanowires.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9nr09621c</ELocationID>
        <Abstract>
          <AbstractText>We present an approach for quantitative evaluation of time-resolved reflection high-energy electron diffraction (RHEED) intensity patterns measured during the growth of vertical, free-standing nanowires (NWs). The approach considers shadowing due to attenuation by absorption and extinction within the individual nanowires and estimates the time dependence of its influence on the RHEED signal of the nanowire ensemble as a function of instrumental RHEED parameters and the growth dynamics averaged over the nanowire ensemble. The developed RHEED simulation model takes into account the nanowire structure evolution related to essential growth aspects, such as axial growth, radial growth with tapering and facet growth, as well as so-called parasitic intergrowth on the substrate. It also considers the influence of the NW density, which turns out to be a sensitive parameter for the time-dependent interpretation of the intensity patterns. Finally, the application potential is demonstrated by evaluating experimental data obtained during molecular beam epitaxy (MBE) of self-catalysed GaAs nanowires. We demonstrate, how electron shadowing enables a time-resolved analysis of the crystal structure evolution at the top part of the growing NWs. The approach offers direct access to study growth dynamics of polytypism in nanowire ensembles at the growth front region under standard growth conditions.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jakob</LastName>
            <ForeName>Julian</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-4983-6533</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory for Applications of Synchrotron Radiation, Karlsruhe Institute of Technology, Kaiserstraße 12, D-76131 Karlsruhe, Germany. julian.jakob@kit.edu and Institute for Photon Science and Synchrotron Radiation, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-Leopoldshafen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schroth</LastName>
            <ForeName>Philipp</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Applications of Synchrotron Radiation, Karlsruhe Institute of Technology, Kaiserstraße 12, D-76131 Karlsruhe, Germany. julian.jakob@kit.edu and Institute for Photon Science and Synchrotron Radiation, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-Leopoldshafen, Germany and Solid State Physics, Emmy-Noether Campus, Walter-Flex Straße 3, D-57068 Siegen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feigl</LastName>
            <ForeName>Ludwig</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Photon Science and Synchrotron Radiation, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-Leopoldshafen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hauck</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-9274-4733</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute for Photon Science and Synchrotron Radiation, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-Leopoldshafen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pietsch</LastName>
            <ForeName>Ullrich</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Solid State Physics, Emmy-Noether Campus, Walter-Flex Straße 3, D-57068 Siegen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baumbach</LastName>
            <ForeName>Tilo</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Applications of Synchrotron Radiation, Karlsruhe Institute of Technology, Kaiserstraße 12, D-76131 Karlsruhe, Germany. julian.jakob@kit.edu and Institute for Photon Science and Synchrotron Radiation, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-Leopoldshafen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nanoscale</MedlineTA>
        <NlmUniqueID>101525249</NlmUniqueID>
        <ISSNLinking>2040-3364</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083629</ArticleId>
        <ArticleId IdType="doi">10.1039/c9nr09621c</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083630</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2040-3372</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nanoscale</Title>
          <ISOAbbreviation>Nanoscale</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intrinsic ferromagnetism with high temperature, strong anisotropy and controllable magnetization in the CrX (X = P, As) monolayer.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9nr10322h</ELocationID>
        <Abstract>
          <AbstractText>2D ferromagnetic (FM) materials with high temperature, large magnetocrystalline anisotropic energy (MAE), and controllable magnetization are highly desirable for novel nanoscale spintronic applications. Herein by using DFT and Monte Carlo simulations, we demonstrate the possibility of realizing intrinsic ferromagnetism in 2D monolayer CrX (X = P, As), which are stable and can be exfoliated from their bulk phase with a van der Waals layered structure. Following the Goodenough-Kanamori-Anderson (GKA) rule, the long-range ferromagnetism of CrX is caused via a 90° superexchange interaction along Cr-P(As)-Cr bonds. The Curie temperature of CrP is predicted to be 232 K based on a Heisenberg Hamiltonian model, while the Berezinskii-Kosterlitz-Thouless transition temperature of CrAs is as high as 855 K. In contrast to other 2D magnetic materials, the CrP monolayer exhibits a significant uniaxial MAE of 217 μeV per Cr atom originating from spin-orbit coupling. Analysis of MAE reveals that CrP favors easy out-of-plane magnetization, while CrAs prefers easy in-plane magnetization. Remarkably, hole and electron doping can switch the magnetization axis in between the in-plane and out-of-plane direction, allowing for the effective control of spin injection/detection in 2D structures. Our results offer an ideal platform for realizing 2D magnetoelectric devices such as spin-FETs in spintronics.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>An-Ning</ForeName>
            <Initials>AN</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2616-2345</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Physics and Technology, University of Jinan, Jinan, Shandong 250022, People's Republic of China. ss_zhangchw@ujn.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Pei-Ji</ForeName>
            <Initials>PJ</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-5009-9158</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Physics and Technology, University of Jinan, Jinan, Shandong 250022, People's Republic of China. ss_zhangchw@ujn.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Chang-Wen</ForeName>
            <Initials>CW</Initials>
            <AffiliationInfo>
              <Affiliation>School of Physics and Technology, University of Jinan, Jinan, Shandong 250022, People's Republic of China. ss_zhangchw@ujn.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nanoscale</MedlineTA>
        <NlmUniqueID>101525249</NlmUniqueID>
        <ISSNLinking>2040-3364</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083630</ArticleId>
        <ArticleId IdType="doi">10.1039/c9nr10322h</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083631</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2042-650X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Food &amp; function</Title>
          <ISOAbbreviation>Food Funct</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Immunomodulatory activity of R-phycoerythrin from Porphyra haitanensis via TLR4/NF-κB-dependent immunocyte differentiation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9fo02444a</ELocationID>
        <Abstract>
          <AbstractText>The immunomodulatory effects of R-phycoerythrin (R-PE) from Porphyra haitanensis were investigated by a hydrocortisone (HC)-induced immunosuppressive model in the present research. The results showed that R-PE had immunomodulatory potential, such as increasing spleen and thymus indexes, ameliorating spleen morphology, enhancing the phagocytic capability of macrophages, promoting spleen T lymphocyte proliferation, and strengthening serum hemolysin formation. Furthermore, R-PE elevated the CD4+/CD8+ ratio and up-regulated the levels of cytokines for Th1, Th2, and Th17 and the mRNA expression of transcription factors T-bet, GATA3, and RORγt. Besides, the levels of cytokines for Treg and transcription factor Foxp3 were down-regulated. The levels of T-bet/GATA3 and RORγt/Foxp3 were increased. R-PE activated the phosphorylation of NF-κB through the TLR4-mediated differentiation pathway. These findings suggested that R-PE exerted immunomodulatory activities in the innate and adaptive immune systems through TLR4/NF-κB mediated CD4+ T cell activation and differentiation, which facilitated the further application of R-PE as an immunomodulator.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Chun</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2127-4118</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Engineering, Ocean University of China, 5 Yushan Road, Qingdao 266003, PR China. jiangxl@ouc.edu.cn shenzp1987@ouc.edu.cn wangchun_95@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Zhaopeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266003, PR China and Qingdao Marine Biomedical Research Institute, Qingdao 266000, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Liyan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Medical School, Huanghe Scinece &amp; Technology University, Zhengzhou, 450063, PR China. liyanli0921@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yinping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao 266042, PR China. fmsboc@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Hongtao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioactive Seaweed Substances, Qingdao Brightmoon Seaweed Group Co Ltd, Qingdao 266400, PR China. htzhao101@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Xiaolu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Engineering, Ocean University of China, 5 Yushan Road, Qingdao 266003, PR China. jiangxl@ouc.edu.cn shenzp1987@ouc.edu.cn wangchun_95@163.com and Qingdao Marine Biomedical Research Institute, Qingdao 266000, PR China and State Key Laboratory of Bioactive Seaweed Substances, Qingdao Brightmoon Seaweed Group Co Ltd, Qingdao 266400, PR China. htzhao101@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Food Funct</MedlineTA>
        <NlmUniqueID>101549033</NlmUniqueID>
        <ISSNLinking>2042-6496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083631</ArticleId>
        <ArticleId IdType="doi">10.1039/c9fo02444a</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083632</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Open clamshell dinuclear palladium(ii) complexes possessing out-of-plane anisotropy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/d0dt00323a</ELocationID>
        <Abstract>
          <AbstractText>Double cyclometalation of planar, oligomeric phenylpyridines yielded dinuclear palladium(ii) complexes with novel out-of-plane anisotropy. An X-ray crystal structure analysis revealed that the complexes exhibit concave-convex geometry, and 1H NMR measurement evidenced the occurrence of stable out-of-plane anisotropy. The dipole moment and Pd-Pd interaction were investigated by theoretical calculations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yamamoto</LastName>
            <ForeName>Koji</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0866-3207</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Science and Engineering, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8503, Japan. takata.t.ab@m.titech.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Higuchi</LastName>
            <ForeName>Kazuki</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Science and Engineering, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8503, Japan. takata.t.ab@m.titech.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuwata</LastName>
            <ForeName>Shigeki</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-3165-9882</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Science and Engineering, Tokyo Institute of Technology, 2-12-1 (H-126), Ookayama, Meguro-ku, Tokyo 152-8552, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hayashi</LastName>
            <ForeName>Yoshihiro</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7650-4083</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Science and Engineering, Tokyo Institute of Technology, 2-12-1 (H-126), Ookayama, Meguro-ku, Tokyo 152-8552, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kawauchi</LastName>
            <ForeName>Susumu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Science and Engineering, Tokyo Institute of Technology, 2-12-1 (H-126), Ookayama, Meguro-ku, Tokyo 152-8552, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takata</LastName>
            <ForeName>Toshikazu</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-4601-3443</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Science and Engineering, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8503, Japan. takata.t.ab@m.titech.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083632</ArticleId>
        <ArticleId IdType="doi">10.1039/d0dt00323a</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083633</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-6848</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Soft matter</Title>
          <ISOAbbreviation>Soft Matter</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Magnetic hierarchical porous SiO<sub>2</sub> microparticles from droplet microfluidics for water decontamination.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9sm02391g</ELocationID>
        <Abstract>
          <AbstractText>A simple and flexible strategy based on droplet microfluidics is developed for controllable fabrication of uniform magnetic SiO2 microparticles with highly-interconnected hierarchical porous structures for enhanced water decontamination. Uniform precursor water droplets containing surfactants and homogenized fine oil droplets with a relatively high volume ratio are generated from microfluidics as templates for microparticle synthesis via hydrolysis/condensation reaction. The SiO2 microparticles possess hierarchical porous structures, containing both mesopores with size of several nanometers, and well-controlled and highly-interconnected macropores with size of hundreds of nanometers. The SiO2 microparticles synergistically integrate fast mass transfer and large functional surface area for enhanced adsorption. To demonstrate the enhanced adsorption performances for organic dyes and toxic heavy metal ions, the microparticles are respectively used for removal of methylene blue in water, and modified with thiol-groups for removal of Pb2+ ions in water. Meanwhile, the microparticles can be easily recycled by magnetic field for reuse.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Mao-Jie</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>College of Engineering, Sichuan Normal University, Chengdu, Sichuan 610101, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ting</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>College of Engineering, Sichuan Normal University, Chengdu, Sichuan 610101, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Ping</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>College of Engineering, Sichuan Normal University, Chengdu, Sichuan 610101, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhi-Lu</ForeName>
            <Initials>ZL</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, P. R. China. wangwei512@scu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, P. R. China. wangwei512@scu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Yao-Yao</ForeName>
            <Initials>YY</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, P. R. China. wangwei512@scu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiu</LastName>
            <ForeName>Lian-Di</ForeName>
            <Initials>LD</Initials>
            <AffiliationInfo>
              <Affiliation>College of Engineering, Sichuan Normal University, Chengdu, Sichuan 610101, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Gang</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>College of Engineering, Sichuan Normal University, Chengdu, Sichuan 610101, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2281-8706</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, P. R. China. wangwei512@scu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chu</LastName>
            <ForeName>Liang-Yin</ForeName>
            <Initials>LY</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2676-6325</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Engineering, Sichuan Normal University, Chengdu, Sichuan 610101, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Soft Matter</MedlineTA>
        <NlmUniqueID>101295070</NlmUniqueID>
        <ISSNLinking>1744-683X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083633</ArticleId>
        <ArticleId IdType="doi">10.1039/c9sm02391g</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083634</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1364-5528</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Analyst</Title>
          <ISOAbbreviation>Analyst</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Measuring temperature effects on nanobubble nucleation via a solid-state nanopore.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/d0an00041h</ELocationID>
        <Abstract>
          <AbstractText>In this study, we designed SiNX solid-state nanopores to detect the temperature effect on the hydrogen nanobubble formation. Here, we integrated a temperature controller with the highly sensitive nanopore. As the temperature decreases from 25 °C to 5 °C, the occurrence of the nanobubble nucleation inside a 12.3 nm SiNX nanopore confined space decreased from 102 s-1 to 23 s-1, and the life-time of nanobubbles increased from 1.16 ms to 4.78 ms. The results further gave the activation energy for nanobubble nucleation which was 8.1 × 10-20 J with a 12.3 nm SiNX nanopore. Our method provides an efficient analytical tool for revealing the temperature-dependent nanobubble nucleation, which further benefits the fundamental understanding of nanobubble nucleation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Qiao</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ying</LastName>
            <ForeName>Yi-Lun</ForeName>
            <Initials>YL</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-6217-256X</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China and State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China. yilunying@nju.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Shao-Chuang</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yong-Xu</ForeName>
            <Initials>YX</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Long</LastName>
            <ForeName>Yi-Tao</ForeName>
            <Initials>YT</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2571-7457</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China and State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China. yilunying@nju.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Analyst</MedlineTA>
        <NlmUniqueID>0372652</NlmUniqueID>
        <ISSNLinking>0003-2654</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083634</ArticleId>
        <ArticleId IdType="doi">10.1039/d0an00041h</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083635</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2040-3372</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nanoscale</Title>
          <ISOAbbreviation>Nanoscale</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A wet-processed, binder-free sulfur cathode integrated with a dual-functional separator for flexible Li-S batteries.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9nr10966h</ELocationID>
        <Abstract>
          <AbstractText>Developing flexible, robust and lightweight sulfur cathodes by rationally designing their structures and configurations through a viable and scalable strategy is a critical enabler for fulfilling flexible lithium-sulfur (Li-S) batteries. However, besides the requirements for cathode flexibility, intrinsic limitations from the shuttling of lithium polysulfides and the growth of Li dendrites have restricted the widespread implementations of Li-S batteries. Here, we report a wet-processed strategy by dissolving and recrystallizing S in a suitable solvent to fabricate a flexible, binder-free S cathode. Integrating the resulting S cathode with a dual-functional separator has demonstrated to be able to suppress both the shuttle effect and growth of dendritic Li. The wet-processed strategy not only enables the fabrication of flexible and binder-free S-nanomat cathodes, but also facilitates the deposition of the cathodes on the separators. Meanwhile, a dual-functional separator is fabricated by vapor-phase polymerization of polypyrrole (PPy) coating on both surfaces of the commercial separator, which leads to the reduction of the shuttle effect and the suppression of the growth of dendritic Li simultaneously. As a result, by integrating the S-nanomat and the dual-functional separator, the cathode exhibits exceptional mechanical properties and electrochemical performance. Li-S pouch cells are further demonstrated to show stable cycling performance in the bending state, indicating the feasibility of the integrated S cathode for flexible Li-S batteries.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Xuewei</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA. xuewei.fu@wsu.edu katie_zhong@wsu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dunne</LastName>
            <ForeName>Francis</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA. xuewei.fu@wsu.edu katie_zhong@wsu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA. xuewei.fu@wsu.edu katie_zhong@wsu.edu and College of Materials Science and Engineering, Chongqing University, 174 Shezhengjie, Chongqing, 400044, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Wei-Hong</ForeName>
            <Initials>WH</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-3384-6614</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA. xuewei.fu@wsu.edu katie_zhong@wsu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nanoscale</MedlineTA>
        <NlmUniqueID>101525249</NlmUniqueID>
        <ISSNLinking>2040-3364</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083635</ArticleId>
        <ArticleId IdType="doi">10.1039/c9nr10966h</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083636</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>New Cu(i) halide complexes showing TADF combined with room temperature phosphorescence: the balance tuned by halogens.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/d0dt00192a</ELocationID>
        <Abstract>
          <AbstractText>A series of Cu(i) halide complexes derived from tris(2-pyridyl)phosphine (Py3P), [Cu2(Py3P)2X2] (X = Cl, Br, I), have been synthesized by a straightforward reaction in solution or through a mechanochemical route. At room temperature, the solid complexes exhibit bright dual-mode photoluminescence (λmax = 520-550 nm, τ = 14.5-20.0 μs, and ΦPL ≈ 53%), expressed by thermally activated delayed fluorescence (TADF) combined with phosphorescence (PH), originating from 1(M + X)LCT and 3(M + X)LCT excited states, respectively. Remarkably, the balance of these radiative processes at 300 K is regulated by halogen atom nature, switching from TADF-assisted phosphorescence to PH-admixed TADF. The emission of [Cu2(Py3P)2Cl2] at 300 K is largely contributed by PH (73%) admixed with the TADF fraction (27%) and [Cu2(Py3P)2Br2] also emits mainly PH (65%) admixed with the larger TADF fraction (35%). Meanwhile, for [Cu2(Py3P)2I2], the TADF channel becomes dominating (61%) and PH contribution drops to 39%. The photophysical study corroborated by (TD)DFT computations has revealed that this effect arises mainly from the narrowing of the ΔE(S1 - T1) gap of the [Cu2(Py3P)2X2] complexes in the order Cl (1500 cm-1) &gt; Br (1250 cm-1) &gt; I (1000 cm-1) which facilitates the TADF pathway and suppresses PH in the same order.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baranov</LastName>
            <ForeName>Andrey Yu</ForeName>
            <Initials>AY</Initials>
            <AffiliationInfo>
              <Affiliation>Nikolaev Institute of Inorganic Chemistry, Siberian Branch of Russian Academy of Sciences, 3, Akad. Lavrentiev Ave., Novosibirsk 630090, Russian Federation. chemisufarm@yandex.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berezin</LastName>
            <ForeName>Alexey S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Nikolaev Institute of Inorganic Chemistry, Siberian Branch of Russian Academy of Sciences, 3, Akad. Lavrentiev Ave., Novosibirsk 630090, Russian Federation. chemisufarm@yandex.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samsonenko</LastName>
            <ForeName>Denis G</ForeName>
            <Initials>DG</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2688-4521</Identifier>
            <AffiliationInfo>
              <Affiliation>Nikolaev Institute of Inorganic Chemistry, Siberian Branch of Russian Academy of Sciences, 3, Akad. Lavrentiev Ave., Novosibirsk 630090, Russian Federation. chemisufarm@yandex.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazur</LastName>
            <ForeName>Anton S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Chemistry, St. Petersburg State University, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tolstoy</LastName>
            <ForeName>Peter M</ForeName>
            <Initials>PM</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-8426-3988</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Chemistry, St. Petersburg State University, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Plyusnin</LastName>
            <ForeName>Viktor F</ForeName>
            <Initials>VF</Initials>
            <AffiliationInfo>
              <Affiliation>Voevodsky Institute of Chemical Kinetics and Combustion, Institutskaya str. 3, 630090 Novosibirsk, Russian Federation and Novosibirsk State University (National Research University), 2, Pirogova Str., Novosibirsk 630090, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kolesnikov</LastName>
            <ForeName>Ilya E</ForeName>
            <Initials>IE</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Optical and Laser Materials Research, Saint Petersburg State University, Ulianovskaya, 5, Saint Petersburg 198504, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Artem'ev</LastName>
            <ForeName>Alexander V</ForeName>
            <Initials>AV</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1389-7078</Identifier>
            <AffiliationInfo>
              <Affiliation>Nikolaev Institute of Inorganic Chemistry, Siberian Branch of Russian Academy of Sciences, 3, Akad. Lavrentiev Ave., Novosibirsk 630090, Russian Federation. chemisufarm@yandex.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083636</ArticleId>
        <ArticleId IdType="doi">10.1039/d0dt00192a</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083637</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Correction: Solid state characterization of oxidized actinides co-crystallized with uranyl nitrate hexahydrate.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/d0dt90034f</ELocationID>
        <Abstract>
          <AbstractText>Correction for 'Solid state characterization of oxidized actinides co-crystallized with uranyl nitrate hexahydrate' by Jeffrey D. Einkauf et al., Dalton Trans., 2020, 49, 608-612.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Einkauf</LastName>
            <ForeName>Jeffrey D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Nuclear Security Science &amp; Policy Initiatives, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burns</LastName>
            <ForeName>Jonathan D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Nuclear Engineering and Science Center, Texas A&amp;M University, College Station, TX 77843, USA. burns.jon@tamu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>Dalton Trans. 2020 Jan 21;49(3):608-612</RefSource>
          <PMID Version="1">31894211</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083637</ArticleId>
        <ArticleId IdType="doi">10.1039/d0dt90034f</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083638</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1470-8728</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Biochemical journal</Title>
          <ISOAbbreviation>Biochem. J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Processing of the SARS-CoV pp1a/ab nsp7-10 region.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">BCJ20200029</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1042/BCJ20200029</ELocationID>
        <Abstract>
          <AbstractText>Severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of a respiratory disease with a high case fatality rate. During the formation of the coronaviral replication/transcription complex (RTC), essential steps include processing of the conserved polyprotein nsp7-10 region by the main protease Mpro and subsequent complex formation of the released nsp's. Here, we analyzed processing of the coronavirus nsp7-10 region using native mass spectrometry showing consumption of substrate, rise and fall of intermediate products and complexation. Importantly, there is a clear order of cleavage efficiencies, which is influenced by the polyprotein tertiary structure. Furthermore, the predominant product is an nsp7+8(2:2) hetero-tetramer with nsp8 scaffold. In conclusion, native MS, opposed to other methods, can expose the processing dynamics of viral polyproteins and the landscape of protein interactions in one set of experiments. Thereby, new insights into protein interactions, essential for generation of viral progeny, were provided, with relevance for development of antivirals.</AbstractText>
          <CopyrightInformation>Copyright 2020 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Krichel</LastName>
            <ForeName>Boris</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Heinrich Pette Institute, Leibniz Institute for Experimental Virology; European XFEL GmbH, Hamburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Falke</LastName>
            <ForeName>Sven</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Universität Hamburg, Hamburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hilgenfeld</LastName>
            <ForeName>Rolf</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>University of Lübeck, Lübeck, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Redecke</LastName>
            <ForeName>Lars</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>University of Lübeck.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uetrecht</LastName>
            <ForeName>Charlotte</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Heinrich Pette Institute, Leibniz Institute for Experimental Virology; European XFEL GmbH, Hamburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem J</MedlineTA>
        <NlmUniqueID>2984726R</NlmUniqueID>
        <ISSNLinking>0264-6021</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">coronavirus</Keyword>
        <Keyword MajorTopicYN="N">native mass spectrometry</Keyword>
        <Keyword MajorTopicYN="N">polyprotein processing</Keyword>
        <Keyword MajorTopicYN="N">structural virology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083638</ArticleId>
        <ArticleId IdType="pii">222182</ArticleId>
        <ArticleId IdType="doi">10.1042/BCJ20200029</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083639</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1367-4811</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioinformatics (Oxford, England)</Title>
          <ISOAbbreviation>Bioinformatics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>netGO: R-Shiny package for network-integrated pathway enrichment analysis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">btaa077</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btaa077</ELocationID>
        <Abstract>
          <AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">We present an R-Shiny package, netGO, for novel network-integrated pathway enrichment analysis. The conventional Fisher's exact test (FET) considers the extent of overlap between target genes and pathway gene-sets, while recent network-based analysis tools consider only network interactions between the two. netGO implements an intuitive framework to integrate both the overlap and networks into a single score, and adaptively resamples genes based on network degrees to assess the pathway enrichment. In benchmark tests for gene expression and genome-wide association study (GWAS) data, netGO captured the relevant gene-sets better than existing tools, especially when analyzing a small number of genes. Specifically, netGO provides user-interactive visualization of the target genes, enriched gene-set and their network interactions for both netGO and FET results for further analysis. For this visualization, we also developed a standalone R-Shiny package shinyCyJS to connect R-shiny and the JavaScript version of cytoscape.</AbstractText>
          <AbstractText Label="AVAILABILITY AND IMPLEMENTATION" NlmCategory="METHODS">netGO R-Shiny package is freely available from github, https://github.com/unistbig/netGO.</AbstractText>
          <AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="BACKGROUND">Supplementary data are available at Bioinformatics online.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Jinhwan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoon</LastName>
            <ForeName>Sora</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nam</LastName>
            <ForeName>Dougu</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mathematical Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Bioinformatics</MedlineTA>
        <NlmUniqueID>9808944</NlmUniqueID>
        <ISSNLinking>1367-4803</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083639</ArticleId>
        <ArticleId IdType="pii">5728635</ArticleId>
        <ArticleId IdType="doi">10.1093/bioinformatics/btaa077</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083640</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1876-4479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Crohn's &amp; colitis</Title>
          <ISOAbbreviation>J Crohns Colitis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Molecular structure and function of Janus kinases: implications for the development of inhibitors.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">jjz206</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ecco-jcc/jjz206</ELocationID>
        <Abstract>
          <AbstractText>Cytokines can trigger multiple signaling pathways, including Janus Tyrosine kinases (JAK) and signal transducers and activators of transcription (STATS) pathways. JAKs are cytoplasmic proteins that, following the binding of cytokines to their receptors, transduce the signal by phosphorylating STAT proteins, which enter the nuclei and rapidly target gene promoters to regulate gene transcription. Due to the critical involvement of JAK proteins in mediating innate and adaptive immune responses, these family of kinases have become desirable pharmacological targets in inflammatory diseases, including ulcerative colitis and Crohn's disease. In this review we provide an overview of the main cytokines that signal through the JAK/STAT pathway, the available in vivo evidence on mutant or deleted JAK proteins and discuss the implications of pharmacologically targeting this kinase family in the context of inflammatory diseases.</AbstractText>
          <CopyrightInformation>© European Crohn’s and Colitis Organisation (ECCO) 2019.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Garrido-Trigo</LastName>
            <ForeName>Alba</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salas</LastName>
            <ForeName>Azucena</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Inflammatory Bowel Disease Unit, Department of Gastroenterology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - CIBEREHD Rosselló, Barcelona SPAIN.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Crohns Colitis</MedlineTA>
        <NlmUniqueID>101318676</NlmUniqueID>
        <ISSNLinking>1873-9946</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083640</ArticleId>
        <ArticleId IdType="pii">5687783</ArticleId>
        <ArticleId IdType="doi">10.1093/ecco-jcc/jjz206</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083641</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1538-3598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA</Title>
          <ISOAbbreviation>JAMA</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preventing Surgical Site Infections: Looking Beyond the Current Guidelines.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2019.20830</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fields</LastName>
            <ForeName>Adam C</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pradarelli</LastName>
            <ForeName>Jason C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Itani</LastName>
            <ForeName>Kamal M F</ForeName>
            <Initials>KMF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Boston University School of Medicine, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA</MedlineTA>
        <NlmUniqueID>7501160</NlmUniqueID>
        <ISSNLinking>0098-7484</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083641</ArticleId>
        <ArticleId IdType="pii">2761780</ArticleId>
        <ArticleId IdType="doi">10.1001/jama.2019.20830</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083642</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-4054</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Briefings in bioinformatics</Title>
          <ISOAbbreviation>Brief. Bioinformatics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Closing the gap between formats for storing layout information in systems biology.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">bbaa030</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/bib/bbaa030</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hoksza</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, avenue du Swing L-4367 Belvaux, Luxembourg.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Mathematics and Physics, Charles University, Malostranské nám. 25, 118 00 Prague, Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gawron</LastName>
            <ForeName>Piotr</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, avenue du Swing L-4367 Belvaux, Luxembourg.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ostaszewski</LastName>
            <ForeName>Marek</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, avenue du Swing L-4367 Belvaux, Luxembourg.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hasenauer</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mathematics, Technische Universität München, München, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Mathematics and Natural Sciences, University of Bonn, Bonn, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schneider</LastName>
            <ForeName>Reinhard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, avenue du Swing L-4367 Belvaux, Luxembourg.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Brief Bioinform</MedlineTA>
        <NlmUniqueID>100912837</NlmUniqueID>
        <ISSNLinking>1467-5463</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083642</ArticleId>
        <ArticleId IdType="pii">5743395</ArticleId>
        <ArticleId IdType="doi">10.1093/bib/bbaa030</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083644</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2156</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Brain : a journal of neurology</Title>
          <ISOAbbreviation>Brain</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Corrigendum.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">awaa048</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awaa048</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Brain</MedlineTA>
        <NlmUniqueID>0372537</NlmUniqueID>
        <ISSNLinking>0006-8950</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083644</ArticleId>
        <ArticleId IdType="pii">5743441</ArticleId>
        <ArticleId IdType="doi">10.1093/brain/awaa048</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083643</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1538-3598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA</Title>
          <ISOAbbreviation>JAMA</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Presumed Asymptomatic Carrier Transmission of COVID-19.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2020.2565</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bai</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yao</LastName>
            <ForeName>Lingsheng</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Anyang Hospital of Traditional Chinese Medicine, Anyang, Henan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Interventional, the Fifth People's Hospital of Anyang, Anyang, Henan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tian</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Dong-Yan</ForeName>
            <Initials>DY</Initials>
            <AffiliationInfo>
              <Affiliation>Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Lijuan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Meiyun</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA</MedlineTA>
        <NlmUniqueID>7501160</NlmUniqueID>
        <ISSNLinking>0098-7484</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083643</ArticleId>
        <ArticleId IdType="pii">2762028</ArticleId>
        <ArticleId IdType="doi">10.1001/jama.2020.2565</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083645</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2047-2412</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>European heart journal cardiovascular Imaging</Title>
          <ISOAbbreviation>Eur Heart J Cardiovasc Imaging</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Left ventricular myocardial crypts: morphological patterns and prognostic implications.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">jeaa020</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjci/jeaa020</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS " NlmCategory="UNASSIGNED">Left ventricular (LV) myocardial crypts are considered a subtle marker of hypertrophic cardiomyopathy. However, crypts have also been observed in seemingly healthy individuals and it is unknown whether myocardial crypts are associated with adverse outcome.</AbstractText>
          <AbstractText Label="METHODS AND RESULTS " NlmCategory="UNASSIGNED">Myocardial crypts were defined as invaginations traversing &gt;50% of the myocardial wall and assessed using contrast-enhanced cardiac computed tomography in 10 097 individuals from the Copenhagen General Population Study. Number of crypts, location, shape, penetrance, and volume were assessed. The endpoint was a composite of major adverse cardiovascular events and defined as death, myocardial infarction, heart failure, or stroke. Cox regression models were adjusted for clinical variables, medical history, electrocardiographic parameters, and cardiac chamber sizes. A total of 1199 LV myocardial crypts were identified in 915 (9.1%) individuals. Seven hundred (6.9%) had one crypt and 215 (2.1%) had multiple crypts. During a median follow-up of 4.0 years (interquartile range 1.5-6.7), major adverse cardiovascular events occurred in 619 individuals. Individuals with one or multiple crypts had a hazard ratio for major adverse cardiovascular events of 1.00 [95% confidence interval (CI): 0.72-1.40; P = 0.98] and 0.90 (95% CI: 0.47-1.75; P = 0.76), respectively, compared with those with no crypts. No specific pattern of crypt location, shape, penetrance, or volume was associated to an increased hazard ratio for major adverse cardiovascular events.</AbstractText>
          <AbstractText Label="CONCLUSION " NlmCategory="UNASSIGNED">LV myocardial crypts are frequent in the general population and are not associated with intermediate-term major adverse cardiovascular events.</AbstractText>
          <CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sigvardsen</LastName>
            <ForeName>Per E</ForeName>
            <Initials>PE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pham</LastName>
            <ForeName>Michael H C</ForeName>
            <Initials>MHC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kühl</LastName>
            <ForeName>Jørgen T</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fuchs</LastName>
            <ForeName>Andreas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Afzal</LastName>
            <ForeName>Shoaib</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Biochemistry, Copenhagen General Population Study, Herlev Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Møgelvang</LastName>
            <ForeName>Rasmus</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nordestgaard</LastName>
            <ForeName>Børge G</ForeName>
            <Initials>BG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Biochemistry, Copenhagen General Population Study, Herlev Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Køber</LastName>
            <ForeName>Lars</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kofoed</LastName>
            <ForeName>Klaus F</ForeName>
            <Initials>KF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The Diagnostic Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Eur Heart J Cardiovasc Imaging</MedlineTA>
        <NlmUniqueID>101573788</NlmUniqueID>
        <ISSNLinking>2047-2404</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="N">left ventricular myocardial crypts</Keyword>
        <Keyword MajorTopicYN="N">myocardial disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083645</ArticleId>
        <ArticleId IdType="pii">5743452</ArticleId>
        <ArticleId IdType="doi">10.1093/ehjci/jeaa020</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083646</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3207</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The American journal of clinical nutrition</Title>
          <ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Exopolysaccharides from milk fermented by lactic acid bacteria enhance dietary carotenoid bioavailability in humans in a randomized crossover trial and in rats.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">nqaa020</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ajcn/nqaa020</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dietary supplementation with carotenoids can have beneficial health effects, but carotenoids are poorly absorbed.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We aimed to evaluate how milk fermented by lactic acid bacteria affects dietary carotenoid bioavailability in humans and rats and to investigate mechanisms by which active components in milk fermented by Lactobacilli enhance dietary carotenoid absorption.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Male rats (n = 8/group) were administered β-carotene or β-carotene + fermented milk. Rats (n = 6/group) were also pretreated with ezetimibe, a cholesterol absorption inhibitor, to investigate β-carotene transport mechanisms. In humans, 3 studies were conducted using a randomized crossover method. Subjects (n = 16/study) consumed a vegetable (carrot, tomato, or spinach) drink alone or with a fermented milk drink. Blood samples were collected at various time points after consumption.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In rats, the serum β-carotene area under the concentration-time curve (AUC) was significantly higher for the β-carotene + fermented milk than for β-carotene only. A significant correlation (r = 0.83, P &lt; 0.001) between the exopolysaccharide (EPS) content of fermented milk and serum β-carotene AUC was observed. Ezetimibe treatment did not suppress elevations in serum β-carotene concentrations induced by fermented milk ingestion. In humans, the incremental area under the concentration-time curve (iAUC) for β-carotene in the plasma triacylglycerol-rich lipoprotein (TRL) fraction was significantly (1.8-fold, range: 0.6-3.9) higher when carrot + fermented milk was consumed compared with carrot drink alone. A significantly (6.5-fold, range: 0.04-7.7) higher iAUC for lycopene in the plasma TRL fraction was observed for subjects who consumed tomato + fermented milk compared with tomato drink alone. A significant increase in plasma lutein in all fractions was observed after consumption of spinach + fermented milk, but not with spinach drink alone.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Co-ingestion of β-carotene and fermented milk significantly increased dietary β-carotene bioavailability in humans and rats. EPSs could affect the physical properties of fermented milk to enhance dietary β-carotene absorption mediated by simple diffusion mechanisms. These findings may be relevant for methods to increase dietary carotenoid bioavailability.This trial was registered at umin.ac.jp/ctr as UMIN000034838, UMIN000034839, and UMIN000034840.</AbstractText>
          <CopyrightInformation>Copyright © The Author(s) 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Morifuji</LastName>
            <ForeName>Masashi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Food Microbiology Research Labs, Meiji Co., Ltd., Meiji Innovation Center, Hachiouji, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ichikawa</LastName>
            <ForeName>Satomi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Food Microbiology Research Labs, Meiji Co., Ltd., Meiji Innovation Center, Hachiouji, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kitade</LastName>
            <ForeName>Masami</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Food Microbiology Research Labs, Meiji Co., Ltd., Meiji Innovation Center, Hachiouji, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fukasawa</LastName>
            <ForeName>Tomoyuki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Food Microbiology Research Labs, Meiji Co., Ltd., Meiji Innovation Center, Hachiouji, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asami</LastName>
            <ForeName>Yukio</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Food Microbiology Research Labs, Meiji Co., Ltd., Meiji Innovation Center, Hachiouji, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manabe</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sugawara</LastName>
            <ForeName>Tatsuya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Clin Nutr</MedlineTA>
        <NlmUniqueID>0376027</NlmUniqueID>
        <ISSNLinking>0002-9165</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">bioavailability</Keyword>
        <Keyword MajorTopicYN="N">carotenoids</Keyword>
        <Keyword MajorTopicYN="N">exopolysaccharide</Keyword>
        <Keyword MajorTopicYN="N">fermented milk</Keyword>
        <Keyword MajorTopicYN="N">humans</Keyword>
        <Keyword MajorTopicYN="N">lactic acid bacteria</Keyword>
        <Keyword MajorTopicYN="N">rats</Keyword>
        <Keyword MajorTopicYN="N">β-carotene</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083646</ArticleId>
        <ArticleId IdType="pii">5743410</ArticleId>
        <ArticleId IdType="doi">10.1093/ajcn/nqaa020</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083647</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2199</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cerebral cortex (New York, N.Y. : 1991)</Title>
          <ISOAbbreviation>Cereb. Cortex</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Generalizable Multivariate Brain Pattern for Interpersonal Guilt.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">bhz326</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/cercor/bhz326</ELocationID>
        <Abstract>
          <AbstractText>Feeling guilty when we have wronged another is a crucial aspect of prosociality, but its neurobiological bases are elusive. Although multivariate patterns of brain activity show promise for developing brain measures linked to specific emotions, it is less clear whether brain activity can be trained to detect more complex social emotional states such as guilt. Here, we identified a distributed guilt-related brain signature (GRBS) across two independent neuroimaging datasets that used interpersonal interactions to evoke guilt. This signature discriminated conditions associated with interpersonal guilt from closely matched control conditions in a cross-validated training sample (N = 24; Chinese population) and in an independent test sample (N = 19; Swiss population). However, it did not respond to observed or experienced pain, or recalled guilt. Moreover, the GRBS only exhibited weak spatial similarity with other brain signatures of social-affective processes, further indicating the specificity of the brain state it represents. These findings provide a step toward developing biological markers of social emotions, which could serve as important tools to investigate guilt-related brain processes in both healthy and clinical populations.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Hongbo</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychological and Cognitive Sciences, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cognitive Science, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Yale University, New Haven, CT 06520, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychological and Brain Sciences, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koban</LastName>
            <ForeName>Leonie</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Cognitive Science, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Swiss Center for Affective Sciences, University of Geneva, 1205 Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Control-Interoception-Attention Team, Brain &amp; Spine Institute, 47 bd de l'hôpital, 75013 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Luke J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH 03755, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wagner</LastName>
            <ForeName>Ullrich</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Münster, 48149 Münster, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krishnan</LastName>
            <ForeName>Anjali</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Cognitive Science, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Brooklyn College of the City University of New York, New York, NY 11210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vuilleumier</LastName>
            <ForeName>Patrik</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Swiss Center for Affective Sciences, University of Geneva, 1205 Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratory for Behavioral Neurology and Imaging of Cognition, Department of Neuroscience, University Medical Center, University of Geneva, 1205 Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Xiaolin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychological and Cognitive Sciences, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beijing Key Laboratory of Behavior and Mental Health, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Psychological and Brain Sciences, Zhejiang Normal University, Zhejiang 321004, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Applied Brain and Cognitive Sciences, School of Business and Management, Shanghai International Studies University, Shanghai 200083, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wager</LastName>
            <ForeName>Tor D</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Cognitive Science, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH 03755, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cereb Cortex</MedlineTA>
        <NlmUniqueID>9110718</NlmUniqueID>
        <ISSNLinking>1047-3211</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">brain signature</Keyword>
        <Keyword MajorTopicYN="N">cross-culture</Keyword>
        <Keyword MajorTopicYN="N">fMRI</Keyword>
        <Keyword MajorTopicYN="N">guilt</Keyword>
        <Keyword MajorTopicYN="N">multivariate pattern analysis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083647</ArticleId>
        <ArticleId IdType="pii">5735622</ArticleId>
        <ArticleId IdType="doi">10.1093/cercor/bhz326</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083648</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1537-6591</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
          <ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Contact Precautions for Methicillin-Resistant Staphylococcus aureus (MRSA) in Veterans Affairs Long-Term Care Facilities: Analysis of Policies not Practice.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">ciaa146</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciaa146</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Evans</LastName>
            <ForeName>Martin E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Veterans Health Administration, MRSA/MDRO Prevention Office, National Infectious Diseases Service, Specialty Care Services, Veterans Affairs Central Office, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Lexington Veterans Affairs Medical Center, Lexington, KY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky School of Medicine, Lexington, KY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roselle</LastName>
            <ForeName>Gary A</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>National Infectious Diseases Service, Patient Care Services, Veterans Affairs Central Office, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kralovic</LastName>
            <ForeName>Stephen M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>National Infectious Diseases Service, Patient Care Services, Veterans Affairs Central Office, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Infect Dis</MedlineTA>
        <NlmUniqueID>9203213</NlmUniqueID>
        <ISSNLinking>1058-4838</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083648</ArticleId>
        <ArticleId IdType="pii">5735667</ArticleId>
        <ArticleId IdType="doi">10.1093/cid/ciaa146</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083649</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Functional analysis reveals G/U pairs critical for replication and trafficking of an infectious non-coding viroid RNA.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa100</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa100</ELocationID>
        <Abstract>
          <AbstractText>While G/U pairs are present in many RNAs, the lack of molecular studies to characterize the roles of multiple G/U pairs within a single RNA limits our understanding of their biological significance. From known RNA 3D structures, we observed that the probability a G/U will form a Watson-Crick (WC) base pair depends on sequence context. We analyzed 17 G/U pairs in the 359-nucleotide genome of Potato spindle tuber viroid (PSTVd), a circular non-coding RNA that replicates and spreads systemically in host plants. Most putative G/U base pairs were experimentally supported by selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE). Deep sequencing PSTVd genomes from plants inoculated with a cloned master sequence revealed naturally occurring variants, and showed that G/U pairs are maintained to the same extent as canonical WC base pairs. Comprehensive mutational analysis demonstrated that nearly all G/U pairs are critical for replication and/or systemic spread. Two selected G/U pairs were found to be required for PSTVd entry into, but not for exit from, the host vascular system. This study identifies critical roles for G/U pairs in the survival of an infectious RNA, and increases understanding of structure-based regulation of replication and trafficking of pathogen and cellular RNAs.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Genetics, Center for Applied Plant Sciences, Center for RNA Biology, and Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Molecular, Cellular, and Developmental Biology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Cuiji</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Genetics, Center for Applied Plant Sciences, Center for RNA Biology, and Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>James</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Genetics, Center for Applied Plant Sciences, Center for RNA Biology, and Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chun</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tao</LastName>
            <ForeName>Xiaorong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leontis</LastName>
            <ForeName>Neocles B</ForeName>
            <Initials>NB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Bowling Green State University, Bowling Green, OH 43403, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zirbel</LastName>
            <ForeName>Craig L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mathematics and Statistics, Bowling Green State University, Bowling Green, OH 43403, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bisaro</LastName>
            <ForeName>David M</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Genetics, Center for Applied Plant Sciences, Center for RNA Biology, and Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Molecular, Cellular, and Developmental Biology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ding</LastName>
            <ForeName>Biao</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Genetics, Center for Applied Plant Sciences, Center for RNA Biology, and Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Molecular, Cellular, and Developmental Biology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083649</ArticleId>
        <ArticleId IdType="pii">5742885</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa100</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083650</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1574-6968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>FEMS microbiology letters</Title>
          <ISOAbbreviation>FEMS Microbiol. Lett.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reviewing the right papers.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">fnaa035</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/femsle/fnaa035</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gophna</LastName>
            <ForeName>Uri</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Cell Biology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>FEMS Microbiol Lett</MedlineTA>
        <NlmUniqueID>7705721</NlmUniqueID>
        <ISSNLinking>0378-1097</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083650</ArticleId>
        <ArticleId IdType="pii">5743414</ArticleId>
        <ArticleId IdType="doi">10.1093/femsle/fnaa035</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083651</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2091</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of antimicrobial chemotherapy</Title>
          <ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dkaa041</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa041</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Infections caused by vancomycin-resistant Enterococcus faecium (VREfm) represent a major public health concern due to limited treatment options. Among invasive isolates of VREfm, ST117, ST80 and ST78 represent the most frequently detected STs by MLST in Germany. In this study, we investigated the genetic diversity of isolates of VREfm recovered from different nosocomial outbreaks in Bavaria, Germany, by WGS.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Between January 2018 and April 2019, 99 non-replicate isolates of VREfm originating from nosocomial outbreaks at eight different hospitals in Bavaria were investigated for genetic diversity by WGS. In detail, complex types (CTs) were identified by core-genome MLST. Furthermore, an SNP analysis was performed for all VREfm strains.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Most of the isolates of this study (76%) belonged to three major clonal groups, which occurred in at least three hospitals: ST80/CT1065 vanB (n = 45; six hospitals), ST117/CT71 vanB (n = 11; four hospitals) and ST78/CT894like vanA (n = 19; three hospitals). Moreover, isolates of the predominant lineage ST80/CT1065 vanB showed a maximum difference of 36 SNPs as revealed by SNP analysis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Whole-genome analysis of VREfm causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavarian hospital settings, namely ST80/CT1065 vanB, ST117/CT71 vanB and ST78/CT894like vanA. Further studies are needed for a better understanding of the factors affecting the successful spread of the above-mentioned lineages.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eisenberger</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tuschak</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Werner</LastName>
            <ForeName>Markus</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bogdan</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bollinger</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Laboratoriumsmedizin, Mikrobiologie und Krankenhaushygiene (ILMH), Klinikum Bayreuth GmbH, Bayreuth, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hossain</LastName>
            <ForeName>Hamid</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Laboratoriumsmedizin und Mikrobiologie, Klinikum St Marien Amberg, Amberg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut für Laboratoriumsmedizin und Mikrobiologie, Kliniken Nordoberpfalz AG, Weiden, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Friedrich</LastName>
            <ForeName>Petra</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Deutsches Beratungszentrum für Hygiene BZH GmbH, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hussein</LastName>
            <ForeName>Ziyad</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Laboratoriumsdiagnostik und Transfusionsmedizin, DONAUISAR Klinikum, Deggendorf, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pöhlmann</LastName>
            <ForeName>Christoph</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Abteilung für Hygiene und Mikrobiologie, Klinikum Memmingen, Memmingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Würstl</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Stabsstelle Krankenhaushygiene und Infektionsprävention, München Klinik, München, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nickel</LastName>
            <ForeName>Silke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lehner-Reindl</LastName>
            <ForeName>Verena</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Höller</LastName>
            <ForeName>Christiane</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liebl</LastName>
            <ForeName>Bernhard</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valenza</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Bavarian Health and Food Safety Authority, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Antimicrob Chemother</MedlineTA>
        <NlmUniqueID>7513617</NlmUniqueID>
        <ISSNLinking>0305-7453</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083651</ArticleId>
        <ArticleId IdType="pii">5743460</ArticleId>
        <ArticleId IdType="doi">10.1093/jac/dkaa041</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083652</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1462-0332</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Rheumatology (Oxford, England)</Title>
          <ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Efficacy and safety of rituximab for autoimmune neutropenia: a French case series and literature review.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">keaa045</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/rheumatology/keaa045</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bigot</LastName>
            <ForeName>William</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department, Sorbonne Université, AP-HP, Hôpital Saint-Antoine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B), Paris.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Viallard</LastName>
            <ForeName>Jean Francois</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne et Immunologie Clinique, CHU Bordeaux, Bordeaux.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sellam</LastName>
            <ForeName>Jérémie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department, Sorbonne Université, AP-HP, Hôpital Saint-Antoine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dellal</LastName>
            <ForeName>Azeddine</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Rhumatologie, Hôpital Montfermeil, Monfermeil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Retbi</LastName>
            <ForeName>Aurélie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Hôpital Saint Antoine, Sorbonne Universités, AP-HP, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gobert</LastName>
            <ForeName>Delphine</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department, Sorbonne Université, AP-HP, Hôpital Saint-Antoine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malard</LastName>
            <ForeName>Florent</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Rhumatologie, Hôpital Montfermeil, Monfermeil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohty</LastName>
            <ForeName>Mohamad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Rhumatologie, Hôpital Montfermeil, Monfermeil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mekinian</LastName>
            <ForeName>Arsène</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department, Sorbonne Université, AP-HP, Hôpital Saint-Antoine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fain</LastName>
            <ForeName>Olivier</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department, Sorbonne Université, AP-HP, Hôpital Saint-Antoine.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Rheumatology (Oxford)</MedlineTA>
        <NlmUniqueID>100883501</NlmUniqueID>
        <ISSNLinking>1462-0324</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083652</ArticleId>
        <ArticleId IdType="pii">5743471</ArticleId>
        <ArticleId IdType="doi">10.1093/rheumatology/keaa045</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083653</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-734X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title>
          <ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intraoperative localization of cardiac conduction tissue regions using real-time fibre-optic confocal microscopy: first in human trial.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">ezaa040</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezaa040</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to evaluate the feasibility and safety of fibre-optic confocal microscopy (FCM) using fluorescein sodium dye for the intraoperative location of conduction tissue regions during paediatric heart surgery.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The pilot study included 6 patients undergoing elective surgery for the closure of isolated secundum atrial septal defect aged 30 days to 21 years. FCM imaging was integrated within the normal intraoperative protocol for atrial septal defect repair. Fluorescein sodium dye was applied on the arrested heart. FCM images were acquired at the atrioventricular node region, sinus node region and right ventricle (RV). Total imaging time was limited to 3 min. Any adverse events related to the study were recorded and analysed. Subjects received standard postoperative care. Trained reviewers (n = 9) classified, de-identified and randomized FCM images (n = 60) recorded from the patients as presenting striated, reticulated or indistinguishable microstructures. The reliability of reviewer agreement was assessed using Fleiss' kappa.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The FCM imaging instruments were integrated effectively into the cardiac surgery operating room. All adverse events found in the study were deemed expected and not related to FCM imaging. Reticulated myocardial microstructures were found during FCM imaging at atrioventricular node and sinus node regions, while striated microstructures were observed in RV. Reliability of agreement of reviewers classifying the FCM images was high (Fleiss' kappa: 0.822).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FCM using fluorescein sodium dye was found to be safe for use during paediatric heart surgery. The study demonstrates the potential for FCM to be effective in identifying conduction tissue regions during congenital heart surgery.</AbstractText>
          <AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">NCT03189134.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kaza</LastName>
            <ForeName>Aditya K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mondal</LastName>
            <ForeName>Abhijit</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Piekarski</LastName>
            <ForeName>Breanna</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sachse</LastName>
            <ForeName>Frank B</ForeName>
            <Initials>FB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hitchcock</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT03189134</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Cardiothorac Surg</MedlineTA>
        <NlmUniqueID>8804069</NlmUniqueID>
        <ISSNLinking>1010-7940</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Conduction tissue</Keyword>
        <Keyword MajorTopicYN="N">Congenital heart surgery</Keyword>
        <Keyword MajorTopicYN="N">Intraoperative confocal imaging</Keyword>
        <Keyword MajorTopicYN="N">Pilot study</Keyword>
        <Keyword MajorTopicYN="N">Tissue microstructure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083653</ArticleId>
        <ArticleId IdType="pii">5743449</ArticleId>
        <ArticleId IdType="doi">10.1093/ejcts/ezaa040</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083654</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-734X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title>
          <ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Technical aspects of uniportal video-assisted thoracoscopic double sleeve bronchovascular resections.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">ezaa037</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezaa037</ELocationID>
        <Abstract>
          <AbstractText>Double sleeve, bronchial and vascular reconstructions are challenging procedures indicated for centrally located tumours to avoid pneumonectomy. Traditionally, these resections have been performed by thoracotomy, but thanks to advances in imaging systems, better surgical instruments and the gained experience in video-assisted thoracic surgery (VATS), the scenario now is different. During the last decade, we have seen a rapid evolution of the uniportal VATS technique from simple lobectomies to advanced double sleeve bronchovascular procedures and carinal resections. The advantages of VATS over open surgery for major lung resections in terms of postoperative pain and morbidity, length of hospital stay and quality of life have prompted experienced surgeons to adopt uniportal VATS for cases requiring a sleeve resection. However, when a double bronchial and vascular sleeve resection is required, the adoption rate of minimally invasive surgery is still very low even for very experienced VATS surgeons. The difficulty of tumour mobilization, complexity of the suturing technique and the concern about possible uncontrolled massive bleeding during VATS are the main reasons for this low rate of adoption. In this article, we describe the technical aspects and tricks of this procedure when it is done by the uniportal VATS approach.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gonzalez-Rivas</LastName>
            <ForeName>Diego</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Coruña University Hospital, Coruña, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garcia</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Coruña University Hospital, Coruña, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Chang</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sekhniaidze</LastName>
            <ForeName>Dmitrii</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Regional Oncological Center, Tyumen, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Gening</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Yuming</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Cardiothorac Surg</MedlineTA>
        <NlmUniqueID>8804069</NlmUniqueID>
        <ISSNLinking>1010-7940</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advanced video-assisted thoracic surgery</Keyword>
        <Keyword MajorTopicYN="N">Bronchoplasty</Keyword>
        <Keyword MajorTopicYN="N">Bronchovascular reconstruction</Keyword>
        <Keyword MajorTopicYN="N">Double sleeve</Keyword>
        <Keyword MajorTopicYN="N">Uniportal sleeve</Keyword>
        <Keyword MajorTopicYN="N">Vascular sleeve</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083654</ArticleId>
        <ArticleId IdType="pii">5743450</ArticleId>
        <ArticleId IdType="doi">10.1093/ejcts/ezaa037</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083655</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2091</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of antimicrobial chemotherapy</Title>
          <ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of two multiplex immunochromatographic assays for the rapid detection of major carbapenemases in Enterobacterales.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dkaa043</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa043</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Two commercially available lateral flow immunochromatographic assays (ICAs) for detection of the major carbapenemases were prospectively assessed for the detection of carbapenemases in Enterobacterales: RESIST-4 O.K.N.V. (Coris BioConcept) and NG-Test CARBA 5 (NG Biotech).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">These two assays were performed prospectively on consecutive Enterobacterales suspected of producing a carbapenemase that were referred to the Belgian National Reference Center for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria between March and June 2018. The intensity of the band corresponding to a carbapenemase for each test was compared using ImageJ software.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 161 isolates tested, a carbapenemase was detected in 91 (60 OXA-48-like, 15 VIM, 9 KPC, 5 NDM, 1 IMP and 1 IMP + OXA-48); in the remaining 70, no carbapenemases were detected. For both tests, the results were 100% concordant with the results of the PCR-sequencing reference method. Two IMP producers were only detected by NG-Test CARBA 5 as IMP is not targeted by RESIST-4 O.K.N.V. The mean intensity of the OXA-48, VIM and NDM bands displayed by NG-Test CARBA 5 was 3 to 3.7 times higher than for RESIST-4 O.K.N.V., while the KPC band was on average 1.7 times more intense with RESIST-4 O.K.N.V.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RESIST-4 O.K.N.V. and NG-Test CARBA 5 are two efficient assays for identification of the major carbapenemases. NG-Test CARBA 5 offers the advantage of detecting IMP, which remains rare in Western countries.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bogaerts</LastName>
            <ForeName>Pierre</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Clinical Microbiology, National Reference Center for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berger</LastName>
            <ForeName>Anne-Sophie</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Clinical Microbiology, National Reference Center for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evrard</LastName>
            <ForeName>Stéphanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Clinical Microbiology, National Reference Center for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Te-Din</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Clinical Microbiology, National Reference Center for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Antimicrob Chemother</MedlineTA>
        <NlmUniqueID>7513617</NlmUniqueID>
        <ISSNLinking>0305-7453</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083655</ArticleId>
        <ArticleId IdType="pii">5743462</ArticleId>
        <ArticleId IdType="doi">10.1093/jac/dkaa043</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083656</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>DNA nanotechnology assisted nanopore-based analysis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa095</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa095</ELocationID>
        <Abstract>
          <AbstractText>Nanopore technology is a promising label-free detection method. However, challenges exist for its further application in sequencing, clinical diagnostics and ultra-sensitive single molecule detection. The development of DNA nanotechnology nonetheless provides possible solutions to current obstacles hindering nanopore sensing technologies. In this review, we summarize recent relevant research contributing to efforts for developing nanopore methods associated with DNA nanotechnology. For example, DNA carriers can capture specific targets at pre-designed sites and escort them from nanopores at suitable speeds, thereby greatly enhancing capability and resolution for the detection of specific target molecules. In addition, DNA origami structures can be constructed to fulfill various design specifications and one-pot assembly reactions, thus serving as functional nanopores. Moreover, based on DNA strand displacement, nanopores can also be utilized to characterize the outputs of DNA computing and to develop programmable smart diagnostic nanodevices. In summary, DNA assembly-based nanopore research can pave the way for the realization of impactful biological detection and diagnostic platforms via single-biomolecule analysis.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ding</LastName>
            <ForeName>Taoli</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Computer Science and Technology, School of Electronics Engineering and Computer Science, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, College of engineering, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Control and Computer Engineering, North China Electric Power University, Beijing 102206, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Victor</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Emory University, Atlanta, GA 30322, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Nan</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>School of Control and Computer Engineering, North China Electric Power University, Beijing 102206, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Zuhong</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, College of engineering, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ke</LastName>
            <ForeName>Yonggang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Emory University, Atlanta, GA 30322, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Cheng</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Computer Science and Technology, School of Electronics Engineering and Computer Science, Peking University, Beijing 100871, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083656</ArticleId>
        <ArticleId IdType="pii">5742838</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa095</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083657</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Broadly applicable oligonucleotide mass spectrometry for the analysis of RNA writers and erasers in vitro.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa091</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa091</ELocationID>
        <Abstract>
          <AbstractText>RNAs are post-transcriptionally modified by dedicated writer or eraser enzymes that add or remove specific modifications, respectively. Mass spectrometry (MS) of RNA is a useful tool to study the modification state of an oligonucleotide (ON) in a sensitive manner. Here, we developed an ion-pairing reagent free chromatography for positive ion detection of ONs by low- and high-resolution MS, which does not interfere with other types of small compound analyses done on the same instrument. We apply ON-MS to determine the ONs from an RNase T1 digest of in vitro transcribed tRNA, which are purified after ribozyme-fusion transcription by automated size exclusion chromatography. The thus produced tRNAValAAC is substrate of the human tRNA ADAT2/3 enzyme and we confirm the deamination of adenosine to inosine and the formation of tRNAValIACin vitro by ON-MS. Furthermore, low resolution ON-MS is used to monitor the demethylation of ONs containing 1-methyladenosine by bacterial AlkB in vitro. The power of high-resolution ON-MS is demonstrated by the detection and mapping of modified ONs from native total tRNA digested with RNase T1. Overall, we present an oligonucleotide MS method which is broadly applicable to monitor in vitro RNA (de-)modification processes and native RNA.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hagelskamp</LastName>
            <ForeName>Felix</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Ludwig Maximilians University Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borland</LastName>
            <ForeName>Kayla</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Ludwig Maximilians University Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramos</LastName>
            <ForeName>Jillian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Center for RNA Biology, University of Rochester, Rochester, NY 14627, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hendrick</LastName>
            <ForeName>Alan G</ForeName>
            <Initials>AG</Initials>
            <AffiliationInfo>
              <Affiliation>STORM Therapeutics, Moneta Building, Babraham Research Campus, Cambridge CB22 3AT UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Dragony</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Center for RNA Biology, University of Rochester, Rochester, NY 14627, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kellner</LastName>
            <ForeName>Stefanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Ludwig Maximilians University Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083657</ArticleId>
        <ArticleId IdType="pii">5742835</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa091</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083658</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hierarchical chromatin organization detected by TADpole.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa087</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa087</ELocationID>
        <Abstract>
          <AbstractText>The rapid development of Chromosome Conformation Capture (3C-based techniques), as well as imaging together with bioinformatics analyses, has been fundamental for unveiling that chromosomes are organized into the so-called topologically associating domains or TADs. While TADs appear as nested patterns in the 3C-based interaction matrices, the vast majority of available TAD callers are based on the hypothesis that TADs are individual and unrelated chromatin structures. Here we introduce TADpole, a computational tool designed to identify and analyze the entire hierarchy of TADs in intra-chromosomal interaction matrices. TADpole combines principal component analysis and constrained hierarchical clustering to provide a set of significant hierarchical chromatin levels in a genomic region of interest. TADpole is robust to data resolution, normalization strategy and sequencing depth. Domain borders defined by TADpole are enriched in main architectural proteins (CTCF and cohesin complex subunits) and in the histone mark H3K4me3, while their domain bodies, depending on their activation-state, are enriched in either H3K36me3 or H3K27me3, highlighting that TADpole is able to distinguish functional TAD units. Additionally, we demonstrate that TADpole's hierarchical annotation, together with the new DiffT score, allows for detecting significant topological differences on Capture Hi-C maps between wild-type and genetically engineered mouse.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Soler-Vila</LastName>
            <ForeName>Paula</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cuscó</LastName>
            <ForeName>Pol</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Gastrointestinal and Endocrine Tumors Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farabella</LastName>
            <ForeName>Irene</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Stefano</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marti-Renom</LastName>
            <ForeName>Marc A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Dr. Aiguader 88, Barcelona 08003, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universitat Pompeu Fabra (UPF), Pg. Lluis Companys 23, Barcelona 08003, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083658</ArticleId>
        <ArticleId IdType="pii">5742820</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa087</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083659</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2091</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of antimicrobial chemotherapy</Title>
          <ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dkaa036</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa036</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The combination of cefepime and the novel β-lactam enhancer zidebactam (WCK 5222) is under development for the treatment of difficult-to-treat Gram-negative infections. Against MBL-producing pathogens, cefepime and zidebactam induce cell elongation and spheroplast formation, indicating PBP3 and PBP2 dysfunction, respectively, having a potent bactericidal effect as a combination. The objective of the present study was to determine the mechanistic basis of the bactericidal effect of cefepime/zidebactam on MBL-expressing pathogens.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Pseudomonal PBP-binding affinities of cefepime, zidebactam and imipenem were assessed at different timepoints and also in the presence of purified VIM-1 using a Bocillin FL competition assay. The antibacterial activity of cefepime/zidebactam against three VIM-expressing Pseudomonas aeruginosa isolates was assessed by time-kill and neutropenic mouse lung/thigh infection studies.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Amidst cefepime-hydrolysing concentrations of VIM-1, substantial cefepime binding to target PBPs was observed. High-affinity binding of zidebactam to PBP2 remained unaltered in the presence of VIM-1; however, MBL addition significantly affected imipenem PBP2 binding. Furthermore, the rate of cefepime binding to the primary target PBP3 was found to be higher compared with the imipenem PBP2 binding rate. Finally, complementary PBP inhibition by cefepime/zidebactam resulted in enhanced bactericidal activity in time-kill and neutropenic mouse lung/thigh infection studies against VIM-6-, VIM-10- and VIM-11-expressing P. aeruginosa, thus revealing the mechanistic basis of β-lactam enhancer action.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For the first time ever (to the best of our knowledge), this study demonstrates that in the presence of VIM-1 MBL, β-lactamase-labile cefepime and β-lactamase-stable zidebactam produce effective inhibition of respective target PBPs. For cefepime, this seems to be a result of a faster rate of PBP binding, which helps it overcome β-lactamase-mediated hydrolysis.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moya</LastName>
            <ForeName>Bartolome</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Microbiologia and Unidad de Investigacion, Hospital Universitario Son Espases, Instituto de Investigacion Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhagwat</LastName>
            <ForeName>Sachin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Wockhardt Research Centre, Aurangabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cabot</LastName>
            <ForeName>Gabriel</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Microbiologia and Unidad de Investigacion, Hospital Universitario Son Espases, Instituto de Investigacion Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bou</LastName>
            <ForeName>German</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Microbiologia, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Mahesh</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Wockhardt Research Centre, Aurangabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oliver</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Microbiologia and Unidad de Investigacion, Hospital Universitario Son Espases, Instituto de Investigacion Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Antimicrob Chemother</MedlineTA>
        <NlmUniqueID>7513617</NlmUniqueID>
        <ISSNLinking>0305-7453</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083659</ArticleId>
        <ArticleId IdType="pii">5743461</ArticleId>
        <ArticleId IdType="doi">10.1093/jac/dkaa036</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083660</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Multiplex accurate sensitive quantitation (MASQ) with application to minimal residual disease in acute myeloid leukemia.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa090</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa090</ELocationID>
        <Abstract>
          <AbstractText>Measuring minimal residual disease in cancer has applications for prognosis, monitoring treatment and detection of recurrence. Simple sequence-based methods to detect nucleotide substitution variants have error rates (about 10-3) that limit sensitive detection. We developed and characterized the performance of MASQ (multiplex accurate sensitive quantitation), a method with an error rate below 10-6. MASQ counts variant templates accurately in the presence of millions of host genomes by using tags to identify each template and demanding consensus over multiple reads. Since the MASQ protocol multiplexes 50 target loci, we can both integrate signal from multiple variants and capture subclonal response to treatment. Compared to existing methods for variant detection, MASQ achieves an excellent combination of sensitivity, specificity and yield. We tested MASQ in a pilot study in acute myeloid leukemia (AML) patients who entered complete remission. We detect leukemic variants in the blood and bone marrow samples of all five patients, after induction therapy, at levels ranging from 10-2 to nearly 10-6. We observe evidence of sub-clonal structure and find higher target variant frequencies in patients who go on to relapse, demonstrating the potential for MASQ to quantify residual disease in AML.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moffitt</LastName>
            <ForeName>Andrea B</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spector</LastName>
            <ForeName>Mona S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andrews</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kendall</LastName>
            <ForeName>Jude</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alexander</LastName>
            <ForeName>Joan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stepansky</LastName>
            <ForeName>Asya</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>BeiCong</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kolitz</LastName>
            <ForeName>Jonathan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY 11030, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chiorazzi</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY 11030, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allen</LastName>
            <ForeName>Steven L</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY 11030, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krasnitz</LastName>
            <ForeName>Alex</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wigler</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Levy</LastName>
            <ForeName>Dan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zihua</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083660</ArticleId>
        <ArticleId IdType="pii">5742832</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa090</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083661</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2049-632X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pathogens and disease</Title>
          <ISOAbbreviation>Pathog Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ciprofloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">ftaa011</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/femspd/ftaa011</ELocationID>
        <Abstract>
          <AbstractText>Current study aims to characterize influence of sub-minimum inhibitory concentration (sub-MIC) of ciprofloxacin on Salmonella intracellular survival and host virulence. Herein, Salmonella resistance patterns to various antibiotics were in agreement with those reported in previous studies. Moreover, intracellular survival of both ciprofloxacin-sensitive and -resistant Salmonella was markedly reduced upon treatment with sub-MIC of ciprofloxacin as determined by gentamicin protection assay. These findings were further confirmed using immunostaining indicating an inhibitory effect of sub-MIC of ciprofloxacin on Salmonella intracellular survival. RT-qPCR revealed that expression of genes encoding Salmonella type three secretion system (TTSS) decreased upon bacterial exposure to sub-MIC of ciprofloxacin. Furthermore, bacterial exposure to sub-MIC of ciprofloxacin significantly reduced expression of both sifA and sifB, which are important for Salmonella filaments formation within host. Treatment of Salmonella with sub-MIC of ciprofloxacin reduced bacterial capacity to kill mice infection models. A lower mortality rate was observed in mice injected with Salmonella treated with sub-MIC of ciprofloxacin as compared to mice inoculated with untreated bacteria. Collectively, current findings indicate that, in addition to its bactericidal potential, sub-MIC of ciprofloxacin could inhibit Salmonella intracellular survival, virulence genes expression as well as host pathogenesis, providing another mechanism for ciprofloxacin in limiting Salmonella host infection.</AbstractText>
          <CopyrightInformation>© FEMS 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Askoura</LastName>
            <ForeName>Momen</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hegazy</LastName>
            <ForeName>Wael Abdel Halim</ForeName>
            <Initials>WAH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, College of Pharmacy, University of Florida (USA).</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pathog Dis</MedlineTA>
        <NlmUniqueID>101595366</NlmUniqueID>
        <ISSNLinking>2049-632X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
          Salmonella enterica
        </Keyword>
        <Keyword MajorTopicYN="N">
          Salmonella pathogenicity island-2 (SPI-2)</Keyword>
        <Keyword MajorTopicYN="N">Ciprofloxacin</Keyword>
        <Keyword MajorTopicYN="N">Immunostaining</Keyword>
        <Keyword MajorTopicYN="N">Intracellular survival</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083661</ArticleId>
        <ArticleId IdType="pii">5743416</ArticleId>
        <ArticleId IdType="doi">10.1093/femspd/ftaa011</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083662</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1574-6968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>FEMS microbiology letters</Title>
          <ISOAbbreviation>FEMS Microbiol. Lett.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dissolved organic matter stimulates N2 fixation and nifH gene expression in Trichodesmium.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">fnaa034</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/femsle/fnaa034</ELocationID>
        <Abstract>
          <AbstractText>Mixotrophy, the combination of heterotrophic and autotrophic nutrition modes, is emerging as the rule rather than the exception in marine photosynthetic plankton. Trichodesmium, a prominent diazotroph ubiquitous in the (sub)tropical oceans, is generally considered to obtain energy via autotrophy. While the ability of Trichodesmium to use dissolved organic phosphorus when deprived of inorganic phosphorus sources is well known, the extent to which this important cyanobacterium may benefit from other dissolved organic matter (DOM) sources is unknown. Here we provide evidence of carbon-, nitrogen- and phosphorus-rich DOM molecules enhancing N2 fixation rates and nifH gene expression in natural Trichodesmium colonies collected at two stations in the western tropical South Pacific. Sampling at a third station located in the oligotrophic South Pacific Gyre revealed no Trichodesmium but showed presence of UCYN-B, although no nifH expression was detected. Our results suggest that Trichodesmium may behave mixotrophically in response to certain environmental conditions, providing them with metabolic plasticity and adding up to the view that mixotrophy is widespread among marine microbes.</AbstractText>
          <CopyrightInformation>© FEMS 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Benavides</LastName>
            <ForeName>Mar</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO UM 110, 13288, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duhamel</LastName>
            <ForeName>Solange</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Lamont-Doherty Earth Observatory, Columbia University, Palisades, NY 10964, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Van Wambeke</LastName>
            <ForeName>France</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO UM 110, 13288, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shoemaker</LastName>
            <ForeName>Katyanne M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Massachusetts Dartmouth, 285 Old Westport Road, North Dartmouth, MA 02747, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moisander</LastName>
            <ForeName>Pia H</ForeName>
            <Initials>PH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Massachusetts Dartmouth, 285 Old Westport Road, North Dartmouth, MA 02747, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salamon</LastName>
            <ForeName>Ellen</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Copenhagen, Strandpromenaden 5, 3000 Helsingør, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Riemann</LastName>
            <ForeName>Lasse</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Copenhagen, Strandpromenaden 5, 3000 Helsingør, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bonnet</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO UM 110, 13288, Marseille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>FEMS Microbiol Lett</MedlineTA>
        <NlmUniqueID>7705721</NlmUniqueID>
        <ISSNLinking>0378-1097</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">DOM</Keyword>
        <Keyword MajorTopicYN="N">diazotrophs</Keyword>
        <Keyword MajorTopicYN="N">mixotrophy</Keyword>
        <Keyword MajorTopicYN="N">western tropical South Pacific</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083662</ArticleId>
        <ArticleId IdType="pii">5743415</ArticleId>
        <ArticleId IdType="doi">10.1093/femsle/fnaa034</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083663</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa111</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa111</ELocationID>
        <Abstract>
          <AbstractText>DNA methyltransferases are primary enzymes for cytosine methylation at CpG sites of epigenetic gene regulation in mammals. De novo methyltransferases DNMT3A and DNMT3B create DNA methylation patterns during development, but how they differentially implement genomic DNA methylation patterns is poorly understood. Here, we report crystal structures of the catalytic domain of human DNMT3B-3L complex, noncovalently bound with and without DNA of different sequences. Human DNMT3B uses two flexible loops to enclose DNA and employs its catalytic loop to flip out the cytosine base. As opposed to DNMT3A, DNMT3B specifically recognizes DNA with CpGpG sites via residues Asn779 and Lys777 in its more stable and well-ordered target recognition domain loop to facilitate processive methylation of tandemly repeated CpG sites. We also identify a proton wire water channel for the final deprotonation step, revealing the complete working mechanism for cytosine methylation by DNMT3B and providing the structural basis for DNMT3B mutation-induced hypomethylation in immunodeficiency, centromere instability and facial anomalies syndrome.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Chien-Chu</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yi-Ping</ForeName>
            <Initials>YP</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Wei-Zen</ForeName>
            <Initials>WZ</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>James C K</ForeName>
            <Initials>JCK</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Hanna S</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Institute of Biochemistry and Molecular Biology, National Taiwan University, Taipei 10048, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083663</ArticleId>
        <ArticleId IdType="pii">5742902</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa111</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083664</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1550-9109</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Sleep</Title>
          <ISOAbbreviation>Sleep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nighttime road traffic noise exposure at the least and most exposed façades and sleep medication prescription redemption - a Danish cohort study.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">zsaa029</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/sleep/zsaa029</ELocationID>
        <Abstract>
          <AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">Traffic noise has been associated with poor sleep quality and short sleep duration. This study investigates the association between nighttime road traffic noise at the least and most exposed façade of the residence, and redemption of sleep medication.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In a cohort of 44,438 Danes, aged 50-64 at baseline (1993-97), we identified all addresses from 1987-2015 from a national registry, and calculated nighttime road traffic noise at the most and least exposed façades. Using Cox Proportional Hazard Models we investigated the association between residential traffic noise over 1, 5 and 10 years before redemption of the first sleep medication prescription in the Danish National Prescription Registry. During a median follow-up time of 18.5 years, 13,114 persons redeemed a prescription.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that 10-year average nighttime exposure to road traffic noise at most exposed façade was associated with a hazard ratio (HR) of 1.05, 95 % confidence interval (CI) (1.00-1.10) for Ln &gt;55 as compared to ≤ 45 dB, which when stratified by sex was confined to men (HR 1.16, 95 % CI 1.08-1.25). For the least exposed façade the HR for Ln &gt; 45 vs. ≤ 35 dB was 1.00, 95 % CI (0.95-1.05). For the most exposed façade, the overall association was strongest in smokers and physically inactive.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Long-term residential nighttime noise exposure at the most exposed façade may be associated with a higher likelihood of redeeming prescriptions for sleep medication, especially among men, smokers, and physically inactive.</AbstractText>
          <CopyrightInformation>© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Roswall</LastName>
            <ForeName>Nina</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poulsen</LastName>
            <ForeName>Aslak H</ForeName>
            <Initials>AH</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thacher</LastName>
            <ForeName>Jesse D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hvidtfeldt</LastName>
            <ForeName>Ulla A</ForeName>
            <Initials>UA</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raaschou-Nielsen</LastName>
            <ForeName>Ole</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Science, Aarhus University, Frederiksborgvej, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jensen</LastName>
            <ForeName>Steen Solvang</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Science, Aarhus University, Frederiksborgvej, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Overvad</LastName>
            <ForeName>Kim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Aalborg University Hospital, Hobrovej, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, Aarhus University, Bartholins Alle, Aarhus C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tjønneland</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, University of Copenhagen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sørensen</LastName>
            <ForeName>Mette</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Danish Cancer Society Research Center, Strandboulevarden, Copenhagen Ø, Denmark (Institution where work was performed).</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Natural Science and Environment, Roskilde University, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Sleep</MedlineTA>
        <NlmUniqueID>7809084</NlmUniqueID>
        <ISSNLinking>0161-8105</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cohort study</Keyword>
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">prescription registry</Keyword>
        <Keyword MajorTopicYN="N">road traffic noise</Keyword>
        <Keyword MajorTopicYN="N">sleep medication</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083664</ArticleId>
        <ArticleId IdType="pii">5739759</ArticleId>
        <ArticleId IdType="doi">10.1093/sleep/zsaa029</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083665</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-734X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title>
          <ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preclosing of the femoral artery allows total percutaneous venoarterial extracorporeal membrane oxygenation and prevents groin wound infection after lung transplantation.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">ezaa039</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezaa039</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">In lung transplantation (LT), femoral venoarterial extracorporeal membrane oxygenation (VA-ECMO) usually requires an open approach that may be associated with severe groin wound infection. In endovascular aortic procedures, preclosing of the femoral artery (PFA) with vascular closure devices allows the percutaneous insertion and withdrawal of large-bore cannulae. We sought to evaluate whether this innovative technique could be applied in the specific setting of LT to achieve total percutaneous VA-ECMO and decrease groin wound infection.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective study of a prospective database including patients who underwent LT in our centre from January 2011 to December 2017. Patients who underwent peripheral VA-ECMO using the PFA technique after January 2014 (PFA group, n = 106) were compared to those who underwent peripheral VA-ECMO using open cannulation and/or decannulation before January 2014 (non-PFA group, n = 48). The primary end point was the rate of technical success defined as total percutaneous VA-ECMO. Secondary end points included groin wound infections and delayed vascular complications.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The PFA technique was technically successful in 98 patients (92.5%). As compared with the non-PFA group, the PFA group was characterized by a similar rate of vascular complications (16.6% vs 11.3%, P = 0.360) and a decreased rate of groin wound infection (18.9% vs 0%, P &lt; 0.001). In multivariate analysis, risk factors associated with vascular complications following PFA included female sex, peripheral arterial disease and ECMO duration.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In LT patients, PFA is associated with a high rate of total percutaneous VA-ECMO, thus preventing the occurrence of groin wound infection.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pellenc</LastName>
            <ForeName>Quentin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Girault</LastName>
            <ForeName>Antoine</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roussel</LastName>
            <ForeName>Arnaud</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aguir</LastName>
            <ForeName>Sonia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cerceau</LastName>
            <ForeName>Pierre</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Longrois</LastName>
            <ForeName>Dan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Département d'Anesthésie-Réanimation, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mal</LastName>
            <ForeName>Hervé</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Pneumologie B et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mordant</LastName>
            <ForeName>Pierre</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castier</LastName>
            <ForeName>Yves</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Vasculaire, Thoracique, et Transplantation Pulmonaire, Bichat Hospital, Paris University, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Cardiothorac Surg</MedlineTA>
        <NlmUniqueID>8804069</NlmUniqueID>
        <ISSNLinking>1010-7940</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Arterial complications</Keyword>
        <Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword>
        <Keyword MajorTopicYN="N">Lung transplantation</Keyword>
        <Keyword MajorTopicYN="N">Percutaneous arterial closure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083665</ArticleId>
        <ArticleId IdType="pii">5743448</ArticleId>
        <ArticleId IdType="doi">10.1093/ejcts/ezaa039</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083666</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The hTERT core promoter forms three parallel G-quadruplexes.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa107</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa107</ELocationID>
        <Abstract>
          <AbstractText>The structure of the 68 nt sequence with G-quadruplex forming potential within the hTERT promoter is disputed. One model features a structure with three stacked parallel G-quadruplex units, while another features an unusual duplex hairpin structure adjoined to two stacked parallel and antiparallel quadruplexes. We report here the results of an integrated structural biology study designed to distinguish between these possibilities. As part of our study, we designed a sequence with an optimized hairpin structure and show that its biophysical and biochemical properties are inconsistent with the structure formed by the hTERT wild-type sequence. By using circular dichroism, thermal denaturation, nuclear magnetic resonance spectroscopy, analytical ultracentrifugation, small-angle X-ray scattering, molecular dynamics simulations and a DNase I cleavage assay we found that the wild type hTERT core promoter folds into a stacked, three-parallel G-quadruplex structure. The hairpin structure is inconsistent with all of our experimental data obtained with the wild-type sequence. All-atom models for both structures were constructed using molecular dynamics simulations. These models accurately predicted the experimental hydrodynamic properties measured for each structure. We found with certainty that the wild-type hTERT promoter sequence does not form a hairpin structure in solution, but rather folds into a compact stacked three-G-quadruplex conformation.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Monsen</LastName>
            <ForeName>Robert C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry &amp; Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeLeeuw</LastName>
            <ForeName>Lynn</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dean</LastName>
            <ForeName>William L</ForeName>
            <Initials>WL</Initials>
            <AffiliationInfo>
              <Affiliation>James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gray</LastName>
            <ForeName>Robert D</ForeName>
            <Initials>RD</Initials>
            <AffiliationInfo>
              <Affiliation>James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sabo</LastName>
            <ForeName>T Michael</ForeName>
            <Initials>TM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry &amp; Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chakravarthy</LastName>
            <ForeName>Srinivas</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The Biophysics Collaborative Access Team (BioCAT), Department of Biological Chemical and Physical Sciences, Illinois Institute of Technology, Chicago, IL 60616, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chaires</LastName>
            <ForeName>Jonathan B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry &amp; Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trent</LastName>
            <ForeName>John O</ForeName>
            <Initials>JO</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry &amp; Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083666</ArticleId>
        <ArticleId IdType="pii">5742833</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa107</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083667</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa115</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa115</ELocationID>
        <Abstract>
          <AbstractText>Endonuclease V (EndoV) is a conserved inosine-specific ribonuclease with unknown biological function. Here, we present the first mouse model lacking EndoV, which is viable without visible abnormalities. We show that endogenous murine EndoV cleaves inosine-containing RNA in vitro, nevertheless a series of experiments fails to link an in vivo function to processing of such transcripts. As inosine levels and adenosine-to-inosine editing often are dysregulated in hepatocellular carcinoma (HCC), we chemically induced HCC in mice. All mice developed liver cancer, however, EndoV-/- tumors were significantly fewer and smaller than wild type tumors. Opposed to human HCC, adenosine deaminase mRNA expression and site-specific editing were unaltered in our model. Loss of EndoV did not affect editing levels in liver tumors, however mRNA expression of a selection of cancer related genes were reduced. Inosines are also found in certain tRNAs and tRNAs are cleaved during stress to produce signaling entities. tRNA fragmentation was dysregulated in EndoV-/- livers and apparently, inosine-independent. We speculate that the inosine-ribonuclease activity of EndoV is disabled in vivo, but RNA binding allowed to promote stabilization of transcripts or recruitment of proteins to fine-tune gene expression. The EndoV-/- tumor suppressive phenotype calls for related studies in human HCC.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kong</LastName>
            <ForeName>Xiang Yi</ForeName>
            <Initials>XY</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vik</LastName>
            <ForeName>Erik Sebastian</ForeName>
            <Initials>ES</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nawaz</LastName>
            <ForeName>Meh Sameen</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berges</LastName>
            <ForeName>Natalia</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dahl</LastName>
            <ForeName>Tuva Børresdatter</ForeName>
            <Initials>TB</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vågbø</LastName>
            <ForeName>Cathrine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suganthan</LastName>
            <ForeName>Rajikala</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Segers</LastName>
            <ForeName>Filip</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holm</LastName>
            <ForeName>Sverre</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quiles-Jiménez</LastName>
            <ForeName>Ana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, NO-0317 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gregersen</LastName>
            <ForeName>Ida</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fladeby</LastName>
            <ForeName>Cathrine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aukrust</LastName>
            <ForeName>Pål</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, NO-0317 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bjørås</LastName>
            <ForeName>Magnar</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klungland</LastName>
            <ForeName>Arne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine, Institute of Basic Medical Sciences, University ofOslo, NO-0317 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halvorsen</LastName>
            <ForeName>Bente</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, NO-0317 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alseth</LastName>
            <ForeName>Ingrun</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083667</ArticleId>
        <ArticleId IdType="pii">5742903</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa115</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083668</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1362-4962</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nucleic acids research</Title>
          <ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A memory switch for plant synthetic biology based on the phage ϕC31 integration system.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gkaa104</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa104</ELocationID>
        <Abstract>
          <AbstractText>Synthetic biology has advanced from the setup of basic genetic devices to the design of increasingly complex gene circuits to provide organisms with new functions. While many bacterial, fungal and mammalian unicellular chassis have been extensively engineered, this progress has been delayed in plants due to the lack of reliable DNA parts and devices that enable precise control over these new synthetic functions. In particular, memory switches based on DNA site-specific recombination have been the tool of choice to build long-term and stable synthetic memory in other organisms, because they enable a shift between two alternative states registering the information at the DNA level. Here we report a memory switch for whole plants based on the bacteriophage ϕC31 site-specific integrase. The switch was built as a modular device made of standard DNA parts, designed to control the transcriptional state (on or off) of two genes of interest by alternative inversion of a central DNA regulatory element. The state of the switch can be externally operated by action of the ϕC31 integrase (Int), and its recombination directionality factor (RDF). The kinetics, memory, and reversibility of the switch were extensively characterized in Nicotiana benthamiana plants.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bernabé-Orts</LastName>
            <ForeName>Joan Miquel</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quijano-Rubio</LastName>
            <ForeName>Alfredo</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vazquez-Vilar</LastName>
            <ForeName>Marta</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mancheño-Bonillo</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moles-Casas</LastName>
            <ForeName>Victor</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Selma</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gianoglio</LastName>
            <ForeName>Silvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Granell</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orzaez</LastName>
            <ForeName>Diego</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología Molecular y Celular de Plantas (IBMCP). CSIC - Universidad Politécnica de Valencia. Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nucleic Acids Res</MedlineTA>
        <NlmUniqueID>0411011</NlmUniqueID>
        <ISSNLinking>0305-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083668</ArticleId>
        <ArticleId IdType="pii">5742792</ArticleId>
        <ArticleId IdType="doi">10.1093/nar/gkaa104</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083669</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2385</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</Title>
          <ISOAbbreviation>Nephrol. Dial. Transplant.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development of a person-centered interdisciplinary plan-of-care program for dialysis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">gfaa018</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ndt/gfaa018</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dialysis care often focuses on outcomes that are of lesser importance to patients than to clinicians. There is growing international interest in individualizing care based on patient priorities, but evidence-based approaches are lacking. The objective of this study was to develop a person-centered dialysis care planning program. To achieve this objective we performed qualitative interviews, responsively developed a novel care planning program and then assessed program content and burden.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted 25 concept elicitation interviews with US hemodialysis patients, care partners and care providers, using thematic analysis to analyze transcripts. Interview findings and interdisciplinary stakeholder panel input informed the development of a new care planning program, My Dialysis Plan. We then conducted 19 cognitive debriefing interviews with patients, care partners and care providers to assess the program's content and face validities, comprehensibility and burden.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified five themes in concept elicitation interviews: feeling boxed in by the system, navigating dual lives, acknowledging an evolving identity, respecting the individual as a whole person and increasing individualization to enhance care. We then developed a person-centered care planning program and supporting materials that underwent 32 stakeholder-informed iterations. Data from subsequent cognitive interviews led to program revisions intended to improve contextualization and understanding, decrease burden and facilitate implementation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">My Dialysis Plan is a content-valid, person-centered dialysis care planning program that aims to promote care individualization. Investigation of the program's capacity to improve patient experiences and outcomes is needed.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dorough</LastName>
            <ForeName>Adeline</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina (UNC) School of Medicine, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Forfang</LastName>
            <ForeName>Derek</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>San Pablo, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murphy</LastName>
            <ForeName>Shannon L</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina (UNC) School of Medicine, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mold</LastName>
            <ForeName>James W</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kshirsagar</LastName>
            <ForeName>Abhijit V</ForeName>
            <Initials>AV</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina (UNC) School of Medicine, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeWalt</LastName>
            <ForeName>Darren A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine and Clinical Epidemiology, Department of Medicine, UNC School of Medicine, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flythe</LastName>
            <ForeName>Jennifer E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nephrol Dial Transplant</MedlineTA>
        <NlmUniqueID>8706402</NlmUniqueID>
        <ISSNLinking>0931-0509</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">care plan</Keyword>
        <Keyword MajorTopicYN="N">dialysis</Keyword>
        <Keyword MajorTopicYN="N">person-centered</Keyword>
        <Keyword MajorTopicYN="N">priorities</Keyword>
        <Keyword MajorTopicYN="N">qualitative research</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083669</ArticleId>
        <ArticleId IdType="pii">5743459</ArticleId>
        <ArticleId IdType="doi">10.1093/ndt/gfaa018</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083670</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1758-4469</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Tree physiology</Title>
          <ISOAbbreviation>Tree Physiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The PalERF109 transcription factor positively regulates salt tolerance via PalHKT1;2 in Populus alba var. pyramidalis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">tpaa018</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/treephys/tpaa018</ELocationID>
        <Abstract>
          <AbstractText>Salinity restricts the growth of trees to varying extents, but the regulatory mechanisms involved in their varying salt tolerance are largely unknown. In efforts to elucidate these mechanisms, we identified a total of 99 genes in the ERF family of transcription factors and examined their expression patterns under salt stress in Populus alba var. pyramidalis. We found that a B4 group gene, PalERF109, was rapidly induced by salt treatment, and preferentially expressed in stems and petioles, where it is probably involved in transport of ions and water in xylem. Overexpression of PalERF109 enhanced the salt tolerance of the poplar, and further analysis showed that it directly up-regulated a high-affinity K+ transporter (HKT) gene, PalHKT1;2. The results clearly indicate that PalERF109 enhances salt tolerance at least partially through direct activation of PalHKT1;2, and extend understanding of ERF genes' roles in trees' stress responses.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ningning</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tong</LastName>
            <ForeName>Shaofei</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Hu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Zhiyang</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Bao</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lou</LastName>
            <ForeName>Shangling</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jianquan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Grassland Agro-Ecosystem, Institute of Innovation Ecology &amp; College of Life Science, Lanzhou University, Lanzhou 730000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Huanhuan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Yuanzhong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Bio-resources and Eco-environment of Ministry of Education, College of Life Science, Sichuan University, Chengdu 610065, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Tree Physiol</MedlineTA>
        <NlmUniqueID>100955338</NlmUniqueID>
        <ISSNLinking>0829-318X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
          HKT
        </Keyword>
        <Keyword MajorTopicYN="N">
          PalERF109
        </Keyword>
        <Keyword MajorTopicYN="N">
          Populus alba var. pyramidalis
        </Keyword>
        <Keyword MajorTopicYN="N">salt stress</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083670</ArticleId>
        <ArticleId IdType="pii">5743165</ArticleId>
        <ArticleId IdType="doi">10.1093/treephys/tpaa018</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083671</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1758-4469</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Tree physiology</Title>
          <ISOAbbreviation>Tree Physiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differences in growth, and physiological and metabolic responses among Canadian native and hybrid willows (Salix spp.) under salinity stress.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">tpaa017</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/treephys/tpaa017</ELocationID>
        <Abstract>
          <AbstractText>Globally, soil salinization is becoming increasingly prevalent, due to local hydrogeologic phenomena, climate change, and anthropogenic activities. This has significantly curtailed current world food production, and limits future production potential. In the prairie region of North America, sulphate salts, rather than sodium chloride, are often the predominant cause of soil degradation. In order to amend soil quality, revegetate salt-affected sites and recover economic loss associated with soil salinization, the establishment of short rotation coppice plantations with willows (Salix spp.) has been suggested as a possible solution. To screen for the best candidates for such an application, 20 hybrid and 16 native willow genotypes were treated with three different salt conditions for four months. The treatments were designed to reflect the salt composition and concentrations on North American prairies. Under moderate salinity treatment (7 dS m-1), hybrid willows had better growth, as they established quickly while managing salt transport and mineral nutrition balance. However, native willows showed higher potential for long-term survival under severe salinity treatment (14 dS m-1), showing lower Na:K ratio in roots and better photosynthetic performance. Two native willow genotypes with high osmotic and salinity tolerance indices, specifically LAR-10 and MJW-9, are expected to show superior potential for remediating salt-affected sites. In addition, we observed significantly higher sulphate/sulfur concentrations in both leaf and root tissues in response to the severe salinity treatment, shedding light on the effect of sulphate salinity on sulphate uptake, and potentially sulfur metabolism in plants.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xinyi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>University of British Columbia, Department of Wood Science, Faculty of Forestry, 2424 Main Mall, Vancouver, BC, V6T 1Z4, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Soolanayakanahally</LastName>
            <ForeName>Raju Y</ForeName>
            <Initials>RY</Initials>
            <AffiliationInfo>
              <Affiliation>Indian Head Research Farm, Agriculture and Agri-Food Canada, Indian Head, SK, S0G 2K0, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guy</LastName>
            <ForeName>Robert D</ForeName>
            <Initials>RD</Initials>
            <AffiliationInfo>
              <Affiliation>University of British Columbia, Department of Forest and Conservation Sciences, Faculty of Forestry, 2424 Main Mall, Vancouver, BC, V6T 1Z4, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shunmugam</LastName>
            <ForeName>Arun S K</ForeName>
            <Initials>ASK</Initials>
            <AffiliationInfo>
              <Affiliation>Agriculture Victoria Research, Department of Jobs, Precincts and Regions, 110 Natimuk Road, Horsham, VIC, 3400, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mansfield</LastName>
            <ForeName>Shawn D</ForeName>
            <Initials>SD</Initials>
            <AffiliationInfo>
              <Affiliation>University of British Columbia, Department of Wood Science, Faculty of Forestry, 2424 Main Mall, Vancouver, BC, V6T 1Z4, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Tree Physiol</MedlineTA>
        <NlmUniqueID>100955338</NlmUniqueID>
        <ISSNLinking>0829-318X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
          Salix spp</Keyword>
        <Keyword MajorTopicYN="N">biomass production</Keyword>
        <Keyword MajorTopicYN="N">gas exchange</Keyword>
        <Keyword MajorTopicYN="N">metabolite analysis</Keyword>
        <Keyword MajorTopicYN="N">mineral nutrition</Keyword>
        <Keyword MajorTopicYN="N">soil salinity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083671</ArticleId>
        <ArticleId IdType="pii">5743164</ArticleId>
        <ArticleId IdType="doi">10.1093/treephys/tpaa017</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083672</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1758-4469</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Tree physiology</Title>
          <ISOAbbreviation>Tree Physiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Commentary on the assessment of NPP/GPP ratio.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">tpaa016</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/treephys/tpaa016</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Landsberg</LastName>
            <ForeName>J J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>'Withycombe' Church Lane, Mt Wilson, NSW 2786, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Waring</LastName>
            <ForeName>R H</ForeName>
            <Initials>RH</Initials>
            <AffiliationInfo>
              <Affiliation>College of Forestry, Oregon State University, Corvallis OR 97330 USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Sustainable Forests and Landscapes, School of GeoSciences, NCEO, University of Edinburgh, EH9 3FF, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Canada</Country>
        <MedlineTA>Tree Physiol</MedlineTA>
        <NlmUniqueID>100955338</NlmUniqueID>
        <ISSNLinking>0829-318X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083672</ArticleId>
        <ArticleId IdType="pii">5743163</ArticleId>
        <ArticleId IdType="doi">10.1093/treephys/tpaa016</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083673</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2091</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of antimicrobial chemotherapy</Title>
          <ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dkaa028</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa028</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The dosing regimen of daptomycin for critically ill patients undergoing continuous renal replacement therapy (CRRT) remains controversial. The goal of this study was to provide guidance for optimal daptomycin therapy in CRRT patients with Staphylococcus aureus infections.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Individual concentration data of 32 CRRT subjects pooled from previously published studies were used to construct the population pharmacokinetic model for daptomycin. Model-based simulations were performed to evaluate the efficacy and risk of toxicity for daptomycin doses of 4, 6 and 8 mg/kg, q24h or q48h, under CRRT doses of 25, 30 and 35 mL/h/kg. Efficacy was assessed by the bacteriostatic and bactericidal AUC/MIC targets and drug exposure-based efficacy references. Toxicity was estimated by safety exposure references and the trough concentration threshold.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A two-compartment model adequately described the pharmacokinetics of daptomycin. Efficacy analysis demonstrated that q48h dosing is associated with an extremely low probability of bactericidal target attainment on every second day after dosing and q24h dosing is preferred for a high probability of bactericidal target attainment. Toxicity evaluation showed that 8 mg/kg q24h has a high probability for reaching the toxicity-related concentration threshold, while 6 mg/kg q24h gives a satisfactory risk-benefit balance. The studied CRRT doses had a limited impact on efficacy and a CRRT dose of 30-35 mL/h/kg may lower the risk of toxicity.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The model predicted that the combination of 6 mg/kg q24h daptomycin dose and CRRT dose of 30-35 mL/h/kg would achieve the best balance of efficacy and safety.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Feifan</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Sanwang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Medical College, Hunan Normal University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Zeneng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Antimicrob Chemother</MedlineTA>
        <NlmUniqueID>7513617</NlmUniqueID>
        <ISSNLinking>0305-7453</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083673</ArticleId>
        <ArticleId IdType="pii">5743464</ArticleId>
        <ArticleId IdType="doi">10.1093/jac/dkaa028</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083674</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2091</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of antimicrobial chemotherapy</Title>
          <ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dkaa005</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa005</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pharmacokinetic (PK)-pharmacodynamic (PD) indices relate measures of drug exposure to antibacterial effect. Clinical PK-PD studies aim to correlate PK-PD indices with outcomes in patients. Optimization of dosing based on pre-clinical studies means that PK-PD relationships are difficult to establish; therefore studies need to be designed and reported carefully to validate pre-clinical findings.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe the methodological features of clinical antibacterial and antifungal PK-PD studies that reported the relationship between PK-PD indices and clinical or microbiological responses.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Studies published between 1980 and 2015 were identified through systematic searches. Methodological features of eligible studies were extracted.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 85 publications containing 97 PK-PD analyses. Most studies were small, with fewer than 100 patients. Around a quarter were performed on patients with infections due to a single specific pathogen. In approximately one-third of studies, patients received concurrent antibiotics/antifungals and in some other studies patients received other treatments that may confound the PK-PD-outcome relationship. Most studies measured antimicrobial concentrations in blood/serum and only four measured free concentrations. Most performed some form of regression, time-to-event analysis or used the Hill/Emax equation to examine the association between PK-PD index and outcome. Target values of PK-PD indices that predict outcomes were investigated in 52% of studies. Target identification was most commonly done using recursive partitioning or logistic regression.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Given the variability in conduct and reporting, we suggest that an agreed set of standards for the conduct and reporting of studies should be developed.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McAleenan</LastName>
            <ForeName>Alexandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol BS8 2PS, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ambrose</LastName>
            <ForeName>Paul G</ForeName>
            <Initials>PG</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Clinical Pharmacodynamics, 242 Broadway, Schenectady, New York 12305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhavnani</LastName>
            <ForeName>Sujata M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Clinical Pharmacodynamics, 242 Broadway, Schenectady, New York 12305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drusano</LastName>
            <ForeName>George L</ForeName>
            <Initials>GL</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Therapeutic Innovation, Department of Medicine, University of Florida, UF Research and Academic Center at Lake Nowa, 6550 Sanger Road, Orlando, Florida 32827, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hope</LastName>
            <ForeName>William W</ForeName>
            <Initials>WW</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Antimicrobial Pharmacodynamics, Institute of Translational Medicine, University of Liverpool, Liverpool L69 4BX, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mouton</LastName>
            <ForeName>Johan W</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology &amp; Infectious Diseases, Erasmus Medical Centre, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Higgins</LastName>
            <ForeName>Julian P T</ForeName>
            <Initials>JPT</Initials>
            <AffiliationInfo>
              <Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol BS8 2PS, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>MacGowan</LastName>
            <ForeName>Alasdair P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Bristol Centre for Antimicrobial Research &amp; Evaluation, Infection Sciences, Pathology Science Quarter, North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Antimicrob Chemother</MedlineTA>
        <NlmUniqueID>7513617</NlmUniqueID>
        <ISSNLinking>0305-7453</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083674</ArticleId>
        <ArticleId IdType="pii">5743463</ArticleId>
        <ArticleId IdType="doi">10.1093/jac/dkaa005</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083675</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2091</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of antimicrobial chemotherapy</Title>
          <ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pharmacokinetics of once-daily doravirine over 72 h following drug cessation.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dkaa038</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa038</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xinzhu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Imperial College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Milinkovic</LastName>
            <ForeName>Ana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pereira</LastName>
            <ForeName>Branca</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moyle</LastName>
            <ForeName>Graeme</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fedele</LastName>
            <ForeName>Serge</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Lervina</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yener</LastName>
            <ForeName>Dilek</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Connolly</LastName>
            <ForeName>Simon</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McClure</LastName>
            <ForeName>Myra</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Imperial College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boffito</LastName>
            <ForeName>Marta</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Imperial College London, London, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Antimicrob Chemother</MedlineTA>
        <NlmUniqueID>7513617</NlmUniqueID>
        <ISSNLinking>0305-7453</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083675</ArticleId>
        <ArticleId IdType="pii">5743468</ArticleId>
        <ArticleId IdType="doi">10.1093/jac/dkaa038</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083676</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1945-7197</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of clinical endocrinology and metabolism</Title>
          <ISOAbbreviation>J. Clin. Endocrinol. Metab.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Is midlife metabolic syndrome associated with cognitive function change? The Study of Women's Health Across the Nation.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dgaa067</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgaa067</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Metabolic syndrome (MetS) affects cognitive function in late-life, particularly in women. But longitudinal research is scarce on associations of MetS with cognitive function during midlife.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Objective was to determine associations between MetS exposure and cognitive function trajectories in midlife women.</AbstractText>
          <AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">This is a 17-year prospective, longitudinal study of multi-racial/ethnic women in seven US communities, with annual/biennial assessments.</AbstractText>
          <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Participants were 2,149 US women traversing menopause.</AbstractText>
          <AbstractText Label="EXPOSURE" NlmCategory="METHODS">Exposure consisted of MetS assessments (median four assessments over four years).</AbstractText>
          <AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Main outcome measures were assessments of cognitive function in 3 domains: perceptual speed (Symbol Digit Modalities Test, SDMT), episodic memory (East Boston Memory Test), and working memory (Digit Span Backward Test).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">By their first cognitive assessment (age 50.7±2.9 years), 29.5% met the criteria for MetS. Women completed a median (IQR) of 6 (IQR 4-7) follow-up cognitive assessments over 11.2 (IQR 9.2-11.5) years. Women with MetS, compared to those without, had a larger 10-year decline in SDMT z-score (estimate -0.087, 95%CI -0.150, -0.024, p=0.007), after adjustment for cognitive testing practice effects, sociodemographic, lifestyle, mood and menopause factors. As such, MetS accelerated the 10-year loss of perceptual speed by 24%. MetS did not differentially affect the rate of decline in either immediate (p=0.534) or delayed (p=0.740) episodic memory or in working memory (p=0.584).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In midlife women MetS exposure was associated with accelerated decline in perceptual speed, but not episodic or working memory.</AbstractText>
          <CopyrightInformation>© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kazlauskaite</LastName>
            <ForeName>Rasa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janssen</LastName>
            <ForeName>Imke</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Medicine, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilson</LastName>
            <ForeName>Robert S</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Appelhans</LastName>
            <ForeName>Bradley M</ForeName>
            <Initials>BM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Medicine, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evans</LastName>
            <ForeName>Denis A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arvanitakis</LastName>
            <ForeName>Zoe</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Khoudary</LastName>
            <ForeName>Samar R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kravitz</LastName>
            <ForeName>Howard M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Medicine, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Endocrinol Metab</MedlineTA>
        <NlmUniqueID>0375362</NlmUniqueID>
        <ISSNLinking>0021-972X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083676</ArticleId>
        <ArticleId IdType="pii">5735651</ArticleId>
        <ArticleId IdType="doi">10.1210/clinem/dgaa067</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083677</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1537-6613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of infectious diseases</Title>
          <ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Summer outbreak of severe RSV-B disease, Minnesota, 2017 associated with emergence of a genetically distinct viral lineage.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">jiaa075</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiaa075</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory syncytial virus (RSV) typically causes winter outbreaks in temperate climates. During summer 2017, the Minnesota Department of Health (MDH) received a report of an increased cases of severe RSV-B infection.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We compared characteristics of summer 2017 cases with those from the surrounding 4 summers (2014-2018). To understand the genetic relatedness among viruses, we performed high-throughput sequencing of RSV from patients with a spectrum of illness from multiple clinical sites in Minnesota and Wisconsin.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">From May-Sept. 2017, 58 cases of RSV (43 RSV-B) were reported compared to 20-29 cases (3-7 RSV-B) during the same time frame in other years. The median age and frequency of co-morbidities was similar, but 55% (24/43) were admitted to the ICU in 2017 compared to 12% in preceding 3 years (OR: 4.84, p&lt;0.01). Sequencing was performed on 137 specimens from March 2016-March 2018. Outbreak cases formed a unique clade sharing a single conserved non-synonymous change in the SH gene. We observed increased cases during the following winter season, during which time the new lineage was the predominant circulating strain.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identified an outbreak of severe RSV-B disease associated with a new genetic lineage among urban Minnesota children during a time of expected low RSV circulation.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thielen</LastName>
            <ForeName>Beth K</ForeName>
            <Initials>BK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Infectious Diseases and International Medicine and Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bye</LastName>
            <ForeName>Erica</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maroushek</LastName>
            <ForeName>Stacene</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Hennepin County Medical Center, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Friedlander</LastName>
            <ForeName>Hannah</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bistodeau</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Christensen</LastName>
            <ForeName>Jaime</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reisdorf</LastName>
            <ForeName>Erik</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Wisconsin State Laboratory of Hygiene, Madison, WI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shilts</LastName>
            <ForeName>Meghan H</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Karen</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Como-Sabetti</LastName>
            <ForeName>Kathryn</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Strain</LastName>
            <ForeName>Anna K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferrieri</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Medicine and Pathology and Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lynfield</LastName>
            <ForeName>Ruth</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Infect Dis</MedlineTA>
        <NlmUniqueID>0413675</NlmUniqueID>
        <ISSNLinking>0022-1899</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">molecular epidemiology</Keyword>
        <Keyword MajorTopicYN="N">respiratory infections</Keyword>
        <Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword>
        <Keyword MajorTopicYN="N">viral next generation sequencing</Keyword>
        <Keyword MajorTopicYN="N">viral pathogenesis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083677</ArticleId>
        <ArticleId IdType="pii">5741008</ArticleId>
        <ArticleId IdType="doi">10.1093/infdis/jiaa075</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083678</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-9097</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of food protection</Title>
          <ISOAbbreviation>J. Food Prot.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Research PaperCharacterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from fresh produce and agricultural environments in Korea.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4315/JFP-19-483</ELocationID>
        <Abstract>
          <AbstractText>This study characterized Escherichia coli strains from fresh produce and farm environments in Korea. To characterize Escherichia coli strains and evaluate the spread of antimicrobial resistance, we conducted phenotypic and genetic studies on antimicrobial-resistant strains in isolates from fresh produce and farm environments. We performed a genetic epidemiological characterization of isolates that produced extended-spectrum beta-lactamase (ESBL), and confirmed plasmid transfer in isolates that carried bla CTX-M-type genes. E. coli strains were isolated from eight fresh produce samples and 152 samples from the farm environment from May 2014 to June 2016. Cephalosporin resistance was the most prevalent (61.8%) among the isolates. Five ESBL-producing strains with high genetic homology to E. coli of human- or livestock-origin were identified. There was successful lateral transfer of p lasmids harboring bla CTX-M-type genes to transconjugants . Two isolates from Chinese cabbage and water from a nearby stream harboring the IS Ecp1-bla CTX-M-55 -orf477 operon were confirmed as having sequence type 1196 and the same type of plasmid replicon, suggesting that cross-contamination was highly likely. A high-risk clone ST69 (clonal complex 69) was also observed in the farm environment. This study provides genetic evidence that E. coli antimicrobial resistance factors in farm environments originate in the clinic or in livestock, and suggests that Good Agricultural Practice in farming is important to inhibit the spread of antimicrobial resistance to fresh produce.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cha</LastName>
            <ForeName>Min-Hyeok</ForeName>
            <Initials>MH</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ryu</LastName>
            <ForeName>Jae-Gee</ForeName>
            <Initials>JG</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chi</LastName>
            <ForeName>Young-Min</ForeName>
            <Initials>YM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woo</LastName>
            <ForeName>Gun-Jo</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Korea University 145 Anam-ro, Seongbuk-gu KOREA, REPUBLIC OF Seoul 02841 +82-10-8721-8704.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Food Prot</MedlineTA>
        <NlmUniqueID>7703944</NlmUniqueID>
        <ISSNLinking>0362-028X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CTX-M type genes</Keyword>
        <Keyword MajorTopicYN="N">Escherichia coli</Keyword>
        <Keyword MajorTopicYN="N">antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">extended-spectrum beta-lactamase</Keyword>
        <Keyword MajorTopicYN="N">farm environment</Keyword>
        <Keyword MajorTopicYN="N">fresh produce</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083678</ArticleId>
        <ArticleId IdType="pii">426179</ArticleId>
        <ArticleId IdType="doi">10.4315/JFP-19-483</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083679</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-9097</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of food protection</Title>
          <ISOAbbreviation>J. Food Prot.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An Observational Study of Thermometer Use by Consumers when Preparing Ground Turkey Patties.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4315/JFP-19-594</ELocationID>
        <Abstract>
          <AbstractText>The purpose of this study was to test effectiveness of an intervention on consumer thermometer use by using a randomized experimental design and direct observation of meal preparation. The study was conducted in test kitchen facilities located in two locations in North Carolina (one urban and one rural). Cameras recorded participants' actions at various locations throughout the kitchen and recorded the meal preparation from beginning to end. Before preparing the meal, a randomized treatment group watched a 3-minute United States Department of Agriculture (USDA) food safety video "The Importance of Cooking to a Safe Internal Temperature and How to Use a Food Thermometer" ( https://www.youtube.com/watch?v=-2KkV2yFiN0 ). Participants in the control and treatment groups were observed while cooking turkey burgers and preparing a salad to determine whether they used a thermometer to check the doneness of the turkey patties. Following meal preparation, all participants responded to a post-observation interview about food handling behaviors. Treatment group participants were also asked about the intervention. A total of 383 people participated in the study (201 control, 182 treatment). Participants who viewed the video were twice as likely to use a thermometer to check the doneness of the turkey patties compared with those who were not exposed to the video (75 vs. 34%) and twice as likely to place the thermometer in the correct location (52 vs. 23%). Sixty-seven percent of participants who watched the video reported that it influenced their behavior in the kitchen. This study demonstrates the importance of timing and framing of a behavioral intervention for thermometer use, and highlights considerations for the development of additional messages (e.g., proper insertion).</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Duong</LastName>
            <ForeName>Minh</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Food, Bioprocessing, and Nutrition Sciences. Raleigh, NC 27607. Virginia Polytechnic University; Department of Food Science and Technology. Blacksburg, VA 24061.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shumaker</LastName>
            <ForeName>Ellen</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>RTI International 3040 E Cornwallis Rd PO Box 12194 UNITED STATES Research Triangle Park North Carolina 27709 919-541-1282.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cates</LastName>
            <ForeName>Sheryl</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>RTI International; Research Triangle Park, NC 27709.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shelley</LastName>
            <ForeName>Lisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Agricultural and Human Sciences. Raleigh, NC 27607.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goodson</LastName>
            <ForeName>Lydia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Agricultural and Human Sciences. Raleigh, NC 27607.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bernstein</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>U.S. Department of Agriculture, Food Safety and Inspection Service, Office of Public Affairs and Consumer Education; Washington, DC. 20250.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lavallee</LastName>
            <ForeName>Aaron</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>U.S. Department of Agriculture, Food Safety and Inspection Service, Office of Public Affairs and Consumer Education; Washington, DC. 20250.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kirchner</LastName>
            <ForeName>Margaret</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Food, Bioprocessing, and Nutrition Sciences. Raleigh, NC 27607.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goulter</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Food, Bioprocessing, and Nutrition Sciences. Raleigh, NC 27607.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaykus</LastName>
            <ForeName>Lee-Ann</ForeName>
            <Initials>LA</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Food, Bioprocessing, and Nutrition Sciences. Raleigh, NC 27607.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chapman</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>North Carolina State University; Department of Agricultural and Human Sciences. Raleigh, NC 27607.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Food Prot</MedlineTA>
        <NlmUniqueID>7703944</NlmUniqueID>
        <ISSNLinking>0362-028X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">consumers</Keyword>
        <Keyword MajorTopicYN="N">meal preparation</Keyword>
        <Keyword MajorTopicYN="N">observation</Keyword>
        <Keyword MajorTopicYN="N">test kitchen</Keyword>
        <Keyword MajorTopicYN="N">thermometer use</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083679</ArticleId>
        <ArticleId IdType="pii">426199</ArticleId>
        <ArticleId IdType="doi">10.4315/JFP-19-594</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083680</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2431</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of experimental botany</Title>
          <ISOAbbreviation>J. Exp. Bot.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Photons to Food: Genetic improvement of cereal crop photosynthesis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">eraa077</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jxb/eraa077</ELocationID>
        <Abstract>
          <AbstractText>Photosynthesis has become a major trait of interest for cereal yield improvement as breeders appear to have reached the theoretical genetic limit for harvest index, the mass of grain as a proportion of crop biomass. Yield improvements afforded by the adoption of green revolution dwarfing genes to wheat and rice are becoming exhausted and improvements in biomass and radiation use efficiency are now sought in these crops. Exploring genetic diversity in photosynthesis is now possible using high throughput techniques and low cost genotyping facilitates discovery of the genetic architecture underlying this variation. Photosynthetic traits have been shown to be highly heritable and significant variation is present for these traits in available germplasm. This offers hope that breeding for improved photosynthesis and radiation use efficiency in cereal crops is tractable and a useful shorter term adjunct to genetic and genome engineering to boost yield potential.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Experimental Biology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Furbank</LastName>
            <ForeName>Robert T</ForeName>
            <Initials>RT</Initials>
            <AffiliationInfo>
              <Affiliation>ARC Centre of Excellence for Translational Photosynthesis, Research School of Biology. The Australian National University, Canberra, ACT, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CSIRO Agriculture, Canberra, ACT, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharwood</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>ARC Centre of Excellence for Translational Photosynthesis, Research School of Biology. The Australian National University, Canberra, ACT, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Estavillo</LastName>
            <ForeName>Gonzalo M</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>CSIRO Agriculture, Canberra, ACT, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silva-Perez</LastName>
            <ForeName>Viridiana</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>CSIRO Agriculture, Canberra, ACT, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Condon</LastName>
            <ForeName>Anthony G</ForeName>
            <Initials>AG</Initials>
            <AffiliationInfo>
              <Affiliation>CSIRO Agriculture, Canberra, ACT, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Exp Bot</MedlineTA>
        <NlmUniqueID>9882906</NlmUniqueID>
        <ISSNLinking>0022-0957</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CO2 assimilation</Keyword>
        <Keyword MajorTopicYN="N">Rubisco</Keyword>
        <Keyword MajorTopicYN="N">electron transport</Keyword>
        <Keyword MajorTopicYN="N">grain yield</Keyword>
        <Keyword MajorTopicYN="N">radiation use efficiency</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083680</ArticleId>
        <ArticleId IdType="pii">5739772</ArticleId>
        <ArticleId IdType="doi">10.1093/jxb/eraa077</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083681</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Alcohol-Induced Deaths Among American Indian and Alaska Native Individuals-"Drinking Was What I and Others Just Did".</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921391</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21391</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Manson</LastName>
            <ForeName>Spero M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Centers for American Indian and Alaska Native Health, Colorado School of Public Health, Anschutz Medical Campus, University of Colorado, Aurora.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083681</ArticleId>
        <ArticleId IdType="pii">2761539</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21391</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083682</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Social Determinants and Differences in Mortality by Race/Ethnicity.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921392</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21392</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pérez-Stable</LastName>
            <ForeName>Eliseo J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>Office of the Director, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriquez</LastName>
            <ForeName>Erik J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083682</ArticleId>
        <ArticleId IdType="pii">2761540</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21392</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083683</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Personalized Treatment for Finger Amputations-What Should We Do With the Thumb?</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921689</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21689</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eberlin</LastName>
            <ForeName>Kyle R</ForeName>
            <Initials>KR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083683</ArticleId>
        <ArticleId IdType="pii">2761541</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21689</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083684</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessment of a 2-Step Urine Culture Ordering Process for Detecting Asymptomatic Bacteruria Among Hospitalized Patients.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921665</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21665</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Taylor</LastName>
            <ForeName>Maureen T</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Michael Garron Hospital, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCready</LastName>
            <ForeName>Janine</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Michael Garron Hospital, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Havey</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>William Osler Health System, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaur</LastName>
            <ForeName>Sahejpreet</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Powis</LastName>
            <ForeName>Jeff</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Michael Garron Hospital, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083684</ArticleId>
        <ArticleId IdType="pii">2761542</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21665</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083685</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association of Hypertrophic Obstructive Cardiomyopathy With Outcomes Following Transcatheter Aortic Valve Replacement.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921669</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21669</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bandyopadhyay</LastName>
            <ForeName>Dhrubajyoti</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai, St Luke's Roosevelt Hospital, New York, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chakraborty</LastName>
            <ForeName>Sandipan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Interfaith Medical Center, Brooklyn, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amgai</LastName>
            <ForeName>Birendra</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Interfaith Medical Center, Brooklyn, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kapadia</LastName>
            <ForeName>Samir R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braunwald</LastName>
            <ForeName>Eugene</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naidu</LastName>
            <ForeName>Srihari S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Westchester Medical Center and New York Medical College, Valhalla, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kalra</LastName>
            <ForeName>Ankur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083685</ArticleId>
        <ArticleId IdType="pii">2761543</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21669</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083686</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of Physician Gender and Race on Simulated Patients' Ratings and Confidence in Their Physicians: A Randomized Trial.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1920511</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.20511</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Women and black physicians encounter workplace challenges because of their gender and race. It is unclear whether these individuals are assessed with lower patient satisfaction or confidence ratings compared with white male physicians.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To examine whether physician gender and race affect participant ratings in scenarios in which physician competence is challenged.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This randomized trial enrolled a geographically diverse sample of 3592 online respondents in the United States who were recruited from 2 crowdsourcing platforms: Amazon Mechanical Turk (n = 1741) and Lucid (n = 1851). A 2 × 2 factorial design for the gender and race of simulated physicians was conducted between March 9 and July 25, 2018. Participants were excluded before intervention if they were younger than 18 years, were pregnant, or had a history of cancer or abdominal surgical procedures.</AbstractText>
          <AbstractText Label="Interventions" NlmCategory="UNASSIGNED">A clinical vignette was presented to the participant with a picture of the emergency department physician. Participants were randomly assigned to physicians with different gender and race, with 823 assigned to black women, 791 to black men, 828 to white women, and 835 to white men. A contradictory diagnosis from an online symptom checker introduced doubt about the clinical diagnosis.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">A composite outcome (range, 0-100, with 0 representing low patient confidence and satisfaction and 100 representing the maximum on the composite scale) measured participant (1) confidence in the physician, (2) satisfaction with care, (3) likelihood to recommend the physician, (4) trust in the physician's diagnosis, and (5) likelihood to request additional tests.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among 3277 adult participants, complete data were available for 3215 (median age, 49 years [range, 18-89 years]; 1667 [52%] female; 2433 [76%] white). No significant differences were observed in participant satisfaction and physician confidence for the white male physician control physicians (mean composite score, 66.13 [95% CI, 64.76-67.51]) compared with white female (mean composite score, 66.50 [95% CI, 65.19-67.82]), black female (mean composite score, 67.36 [95% CI, 66.03-68.69]), and black male (mean composite score, 66.96 [95% CI, 65.55-68.36]) physicians. Machine learning with bayesian additive regression trees revealed no evidence of treatment effect heterogeneity as a function of participants' race, gender, racial prejudice, or sexism.</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">No significant differences were observed for simulated patients' evaluations of female or black physicians, suggesting that bias in favor of white male physicians is negligible in survey-based measures of patient satisfaction.</AbstractText>
          <AbstractText Label="Trial Registration" NlmCategory="UNASSIGNED">ClinicalTrials.gov Identifier: NCT04190901.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Solnick</LastName>
            <ForeName>Rachel E</ForeName>
            <Initials>RE</Initials>
            <AffiliationInfo>
              <Affiliation>National Clinical Scholars Program, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peyton</LastName>
            <ForeName>Kyle</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Yale Law School, New Haven, Connecticut.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kraft-Todd</LastName>
            <ForeName>Gordon</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Boston College, Chestnut Hill, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Safdar</LastName>
            <ForeName>Basmah</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT04190901</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083686</ArticleId>
        <ArticleId IdType="pii">2761544</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.20511</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083687</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Trends in Alcohol-Induced Deaths in the United States, 2000-2016.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921451</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21451</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Notable increases in mortality from alcohol-induced causes over the past 2 decades in the United States have been reported. However, comprehensive assessments of trends in alcohol-induced mortality by sex, age, race/ethnicity, and social and geographic factors are lacking.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To examine trends in alcohol-induced mortality rates from 2000 to 2016, comparing results by demographic characteristics including sex, race/ethnicity, age, county-level socioeconomic status, and geographic location.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This serial cross-sectional study used US national vital statistics data for years 2000 to 2016 for all US residents older than 15 years. Data analysis was conducted from January to September 2019.</AbstractText>
          <AbstractText Label="Exposures" NlmCategory="UNASSIGNED">Trends in alcohol-induced mortality by sex, race/ethnicity, age, county-level socioeconomic status (ie, median income, percentage of unemployed residents, percentage of residents with a bachelor's degree), rurality level, and US state.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Alcohol-induced mortality, ie, deaths for which alcohol holds a population-attributable fraction of 1. Deaths were expressed per 100 000 residents as absolute and age-standardized rates. Mortality trends were measured as average annual percentage changes (AAPCs) for the entire period (ie, 2000-2016) and annual percentage changes (APCs) for individual periods of change within the study period.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 425 045 alcohol-induced deaths were identified from 2000 to 2016 (2000: 19 627 deaths; 14 979 [76.3%] men; 2016: 34 857 deaths; 25 213 [73.3%] men). The rate of alcohol-induced deaths increased substantially among men (AAPC, 1.4%; 95% CI, 1.0% to 1.8%) and women (AAPC, 3.1%; 95% CI, 2.6% to 3.6%) and accelerated recently (men, 2012-2016: APC, 4.2%; 95% CI, 3.1% to 5.3%; women, 2013-2016: APC, 7.1%; 95% CI, 5.1% to 9.1%). The largest increases by race/ethnicity were observed among American Indian and Alaska Native men (AAPC, 3.3%; 95% CI, 2.6% to 4.0%), American Indian and Alaska Native women (AAPC, 4.2%; 95% CI, 3.8% to 4.6%), and white women (AAPC, 4.1%; 95% CI, 3.6% to 4.7%). Despite initial declines among black women, black men, and Latino men (eg, Latino men, 2000-2003: APC, -5.1%; 95% CI, -9.8% to -0.1%; 2003-2013: APC, -0.6%; 95% CI, -1.4% to 0.2%), increases occurred later in the study period (eg, Latino men, 2013-2016: APC, 4.1%; 95% CI, 0.3% to 8.1%). The rates of increase varied by age group and in turn by racial/ethnic group. Among white individuals, large absolute increases occurred in midlife (eg, men aged 55-59 years, 2000-2003: 25.5 deaths per 100 000 residents; 2013-2016: 43.3 deaths per 100 000 residents; women aged 50-54 years, 2000-2003: 7.4 deaths per 100 000 residents; 2013-2016: 16.5 deaths per 100 000 residents), although APCs were also large for ages 25 to 34 years, ranging from 4.6% to 6.9% per year among men and from 7.3% to 12.0% among women. Among American Indian and Alaska Native individuals, increases throughout the age range were observed, with the largest absolute increase occurring for ages 45 to 49 years among men (2000-2013: 113.6 deaths per 100 000 residents; 2013-2016: 193.1 deaths per 100 000 residents) and for ages 50 to 54 among women (2000-2013: from 56.1 deaths per 100 000 residents; 2013-2016: 105.1 deaths per 100 000 residents).</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">This study found large increases in alcohol-induced death rates across age and racial/ethnic subgroups of the US population, which have accelerated over recent years. Large increases in alcohol-induced deaths among younger age groups may be associated with future increases in alcohol-related disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spillane</LastName>
            <ForeName>Susan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shiels</LastName>
            <ForeName>Meredith S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Best</LastName>
            <ForeName>Ana F</ForeName>
            <Initials>AF</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haozous</LastName>
            <ForeName>Emily A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Pacific Institute for Research and Evaluation, Calverton, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Withrow</LastName>
            <ForeName>Diana R</ForeName>
            <Initials>DR</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yingxi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berrington de González</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freedman</LastName>
            <ForeName>Neal D</ForeName>
            <Initials>ND</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083687</ArticleId>
        <ArticleId IdType="pii">2761545</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21451</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083688</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association of Dietary Patterns With Testicular Function in Young Danish Men.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921610</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21610</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Diet may play a role in testicular function, but data on how adherence to different diet patterns influences human testicular function are scarce.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To determine whether adherence to specific dietary patterns is associated with testicular function in young men.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This cross-sectional study included 2935 young Danish men unselected regarding fertility status who were enrolled from April 1, 2008, through May 31, 2017. Data were analyzed from July 1, 2017, to January 30, 2019.</AbstractText>
          <AbstractText Label="Exposures" NlmCategory="UNASSIGNED">Dietary patterns identified with principal component analysis based on responses to a validated food frequency questionnaire.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Standard semen quality assessment; serum concentrations of testosterone, free testosterone, estradiol, inhibin B, follicle-stimulating hormone, luteinizing hormone, and sex hormone-binding globulin; and testicular volume measured with ultrasonography.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among the 2935 participants included in the analysis, median age was 19 (interquartile range, 19-20) years and 2290 (78.0%) had normal body mass index. The 4 dietary patterns identified included Western, prudent, open-sandwich (a traditional Danish eating pattern), and vegetarianlike. The greatest adherence to the prudent pattern was associated with the highest total sperm count (median, 167 [95% CI, 146-183] million), followed by adherence to vegetarianlike (median, 151 [95% CI, 134-168] million) and open-sandwich (median, 146 [95% CI, 131-163] million) patterns. Adherence to the Western pattern was associated with the lowest total sperm count (median, 122 [95% CI, 109-138] million), which was significantly lower than sperm count in the other 3 diet patterns. After adjusting for confounders, the median total sperm count for men in the highest quintile of adherence to the Western pattern was 26 million lower (95% CI, -42 to -9 million) than for men in the lowest quintile of adherence to this pattern. Conversely, the median total sperm count of men in the highest quintile of adherence to the prudent pattern was 43 million (95% CI, 23-63 million) higher than that of men in the lowest quintile. Men with the highest adherence to the Western pattern had a lower median ratio of inhibin B to follicle-stimulating hormone (-12 [95% CI, -20 to -3]) and higher median ratio of free testosterone to luteinizing hormone (10 [95% CI, 2-19]) compared with men with lowest adherence to this pattern.</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">In this cross-sectional study, adherence to generally healthy diet patterns was associated with better semen quality, with potentially more favorable fertility potential among adult men.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nassan</LastName>
            <ForeName>Feiby L</ForeName>
            <Initials>FL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jensen</LastName>
            <ForeName>Tina K</ForeName>
            <Initials>TK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Odense Patient Data Explorative Network (OPEN), Odense, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Priskorn</LastName>
            <ForeName>Lærke</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Growth and Reproduction, International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halldorsson</LastName>
            <ForeName>Thorhallur I</ForeName>
            <Initials>TI</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Foetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, Reykjavík.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chavarro</LastName>
            <ForeName>Jorge E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jørgensen</LastName>
            <ForeName>Niels</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Growth and Reproduction, International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083688</ArticleId>
        <ArticleId IdType="pii">2761546</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21610</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083689</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications: A Systematic Review and Network Meta-analysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921618</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21618</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Antihypertension medications have been associated with prevention of cardiovascular events, although less is known about the comparative effectiveness of different medication classes.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To compare contemporary aggregated first-in-trial cardiovascular events among patients with hypertension and no substantial comorbidities.</AbstractText>
          <AbstractText Label="Data Sources" NlmCategory="UNASSIGNED">The PubMed, Embase, and Cochrane Library databases were systematically searched for articles published between January 1, 1990, and October 24, 2017.</AbstractText>
          <AbstractText Label="Study Selection" NlmCategory="UNASSIGNED">Randomized clinical trials that tested commonly used antihypertension medications (angiotensin-converting enzyme inhibitors, dihydropyridine calcium channel blockers, nondihydropyridine calcium channel blockers, β-blockers, angiotensin receptor blockers, and diuretics) and that reported selected cardiovascular outcomes for at least 6 months of follow-up.</AbstractText>
          <AbstractText Label="Data Extraction and Synthesis" NlmCategory="UNASSIGNED">The analysis was conducted from October 2017 to December 2019. Two reviewers extracted the number of cardiovascular events at the end of treatment for all study groups. For each outcome, a frequentist network meta-analysis was used to compare risk reductions between medication classes (random-effects models weighted by the inverse variance). The dose-response association between a 10-mm Hg reduction of systolic blood pressure and a 5-mm Hg reduction of diastolic blood pressure and the risk of first-in-trial cardiovascular events was estimated.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">First-in-trial cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and revascularization.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">In this systematic review and network meta-analysis, data were pooled from 46 eligible clinical trials (248 887 total participants with a mean [SD] age of 65.6 [5.8] years; 52.8% men). In the network meta-analysis, compared with placebo, angiotensin-converting enzyme inhibitors, dihydropyridine calcium channel blockers, and thiazide diuretics were reported to be similarly effective in reducing overall cardiovascular events (25%), cardiovascular death (20%), and stroke (35%); angiotensin-converting enzyme inhibitors were reported to be the most effective in reducing the risk of myocardial infarction (28%); and diuretics were reported to be the most effective in reducing revascularization (33%). In the metaregression analyses, each 10-mm Hg reduction in systolic blood pressure and 5-mm Hg reduction in diastolic blood pressure was significantly associated with a lower risk of cardiovascular death, stroke, and overall cardiovascular events.</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">In this network meta-analysis of clinical trials of patients with hypertension and no substantial comorbidities, different classes of antihypertension medications were associated with similar benefits in reducing cardiovascular events. Future studies should compare the effectiveness of combinations of antihypertension medications in reducing cardiovascular events.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Jingkai</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galaviz</LastName>
            <ForeName>Karla I</ForeName>
            <Initials>KI</Initials>
            <AffiliationInfo>
              <Affiliation>Emory Global Diabetes Research Center, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kowalski</LastName>
            <ForeName>Alysse J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Health Sciences Doctoral Program, Laney Graduate School, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magee</LastName>
            <ForeName>Matthew J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Emory Global Diabetes Research Center, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haw</LastName>
            <ForeName>J Sonya</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Metabolism and Lipids, Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Narayan</LastName>
            <ForeName>K M Venkat</ForeName>
            <Initials>KMV</Initials>
            <AffiliationInfo>
              <Affiliation>Emory Global Diabetes Research Center, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Mohammed K</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Emory Global Diabetes Research Center, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083689</ArticleId>
        <ArticleId IdType="pii">2761547</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21618</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083690</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessment of Tree-Based Statistical Learning to Estimate Optimal Personalized Treatment Decision Rules for Traumatic Finger Amputations.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921626</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21626</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Optimal treatment for traumatic finger amputation is unknown to date.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To use statistical learning methods to estimate evidence-based treatment assignment rules to enhance long-term functional and patient-reported outcomes in patients after traumatic amputation of fingers distal to the metacarpophalangeal joint.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This decision analytical model used data from a retrospective cohort study of 338 consenting adult patients who underwent revision amputation or replantation at 19 centers in the United States and Asia from August 1, 2016, to April 12, 2018. Of those, data on 185 patients were included in the primary analysis.</AbstractText>
          <AbstractText Label="Exposures" NlmCategory="UNASSIGNED">Treatment with revision amputation or replantation.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Outcome measures were hand strength, dexterity, hand-related quality of life, and pain. A tree-based statistical learning method was used to derive clinical decision rules for treatment of traumatic finger amputation.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among 185 study participants (mean [SD] age, 45 [16] years; 156 [84%] male), the median number of fingers amputated per patient was 1 (range, 1-5); 115 amputations (62%) were distal to the proximal interphalangeal joint, and 110 (60%) affected the nondominant hand. On the basis of the tree-based statistical learning estimates, to maximize hand dexterity or to minimize patient-reported pain, replantation was found to be the best strategy. To maximize hand strength, revision amputation was the best strategy for patients with a single-finger amputation but replantation was preferred for all other injury patterns. To maximize patient-reported quality of life, revision amputation was the best approach for patients with dominant hand injuries, and replantation was the best strategy for patients with nondominant hand injuries.</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">The findings suggest that the approach to treating traumatic finger amputations varies based on the patient's injury characteristics and functional needs.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Speth</LastName>
            <ForeName>Kelly A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoon</LastName>
            <ForeName>Alfred P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Plastic Surgery, Michigan Medicine, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chung</LastName>
            <ForeName>Kevin C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Plastic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>FRANCHISE Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083690</ArticleId>
        <ArticleId IdType="pii">2761548</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21626</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083691</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association of Dual Decline in Memory and Gait Speed With Risk for Dementia Among Adults Older Than 60 Years: A Multicohort Individual-Level Meta-analysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921636</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21636</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Dual decline in both memory and gait speed may characterize a group of older individuals at high risk for future dementia.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To assess the risk of dementia in older persons who experience parallel declines in memory and gait speed compared with those who experience no decline or decline in either memory or gait speed only.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">A multicohort meta-analysis was performed of 6 prospective cohort studies conducted between 1997 and 2018 in the United States and Europe. Participants were 60 years or older, had an initial gait speed of more than 0.6 m/s (ie, free of overt dismobility), with repeated measures of memory and gait speed before dementia diagnosis during a mean follow-up of 6.6 to 14.5 years. Within each study, participants were divided into 4 groups: memory decline only, gait speed decline only, dual decline, or no decline (hereafter referred to as usual agers). Gait decline was defined as a loss of 0.05 m/s or more per year; memory decline was defined as being in the cohort-specific lowest tertile of annualized change.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Risk of incident dementia according to group membership was examined by Cox proportional hazards regression with usual agers as the reference, adjusted for baseline age, sex, race/ethnicity, educational level, study site, and baseline gait speed and memory.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Across the 6 studies of 8699 participants, mean age ranged between 70 and 74 years and mean gait speed ranged between 1.05 and 1.26 m/s. Incident dementia ranged from 5 to 21 per 1000 person-years. Compared with usual agers, participants with only memory decline had 2.2 to 4.6 times higher risk for developing dementia (pooled hazard ratio, 3.45 [95% CI, 2.45-4.86]). Those with only gait decline had 2.1 to 3.6 times higher risk (pooled hazard ratio, 2.24 [95% CI, 1.62-3.09]). Those with dual decline had 5.2 to 11.7 times the risk (pooled hazard ratio, 6.28 [95% CI, 4.56-8.64]).</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">In this study, dual decline of memory and gait speed was associated with increased risk of developing dementia among older individuals, which might be a potentially valuable group for preventive or therapeutic interventions. Why dual decline is associated with an elevated risk of dementia and whether these individuals progress to dementia through specific mechanisms should be investigated by future studies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tian</LastName>
            <ForeName>Qu</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Resnick</LastName>
            <ForeName>Susan M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mielke</LastName>
            <ForeName>Michelle M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yaffe</LastName>
            <ForeName>Kristine</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of California, San Francisco.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of California, San Francisco.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, University of California, San Francisco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Launer</LastName>
            <ForeName>Lenore J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Epidemiology and Population Studies, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jonsson</LastName>
            <ForeName>Palmi V</ForeName>
            <Initials>PV</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grande</LastName>
            <ForeName>Giulia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Karolinska Institutet, Aging Research Center, Department of Neurobiology, Care Sciences and Society, Stockholm University, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Welmer</LastName>
            <ForeName>Anna-Karin</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Karolinska Institutet, Aging Research Center, Department of Neurobiology, Care Sciences and Society, Stockholm University, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Karolinska University Hospital, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Stockholm Gerontology Research Center, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laukka</LastName>
            <ForeName>Erika J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>Karolinska Institutet, Aging Research Center, Department of Neurobiology, Care Sciences and Society, Stockholm University, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Stockholm Gerontology Research Center, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bandinelli</LastName>
            <ForeName>Stefania</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Unit, Azienda Sanitaria di Firenze, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cherubini</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatria, Accettazione Geriatrica e Centro di ricerca per l'invecchiamento, IRCCS Istituto Nazionale Ricovero e Cura per Anziani, Ancona, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosano</LastName>
            <ForeName>Caterina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kritchevsky</LastName>
            <ForeName>Stephen B</ForeName>
            <Initials>SB</Initials>
            <AffiliationInfo>
              <Affiliation>The Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simonsick</LastName>
            <ForeName>Eleanor M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Studenski</LastName>
            <ForeName>Stephanie A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferrucci</LastName>
            <ForeName>Luigi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083691</ArticleId>
        <ArticleId IdType="pii">2761549</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21636</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083692</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Incidence of Death From Unintentional Injury Among Patients With Cancer in the United States.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921647</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21647</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Previous studies have suggested that patients with cancer may be at an increased risk of death from unintentional injury, but to our knowledge, no large studies have examined the rates of death from unintentional injury among patients with cancer.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To characterize the incidence of death from unintentional injury among patients with cancer in the United States.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This retrospective cohort study included patients diagnosed with a first primary cancer between January 1, 1973, and December 31, 2015, identified from the Surveillance, Epidemiology, and End Results (SEER) program data. Comparisons with the general US population were based on mortality data collected by the National Center for Health Statistics. Analyses were performed from February 1, 2019, to August 15, 2019.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Rates and standardized mortality ratios (SMRs) of death from unintentional injury among patients with cancer.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 8 271 020 patients with cancer were included in this study (50.2% female; mean [SD] age, 63.0 [15.7] years). Among them, 40 599 deaths from unintentional injury were identified. The rates of death from unintentional injury were 81.90 per 100 000 person-years among patients with cancer and 51.21 per 100 000 person-years in the corresponding US general population. The SMR of death from unintentional injury was 1.60 (95% CI, 1.58-1.61). Higher rates of death from unintentional injury were associated with increasing age at diagnosis (≥80 years; rate ratio [RR], 2.91; 95% CI, 2.84-2.98; P &lt; .001), male sex (RR, 1.69; 95% CI, 1.66-1.73; P &lt; .001), American Indian or Alaskan Native population (RR, 1.48; 95% CI, 1.30-1.68; P &lt; .001), and being unmarried (RR, 1.23; 95% CI, 1.18-1.28; P &lt; .001). Rates of death from unintentional injury were the highest in patients with cancers of the liver (200.37 per 100 000 person-years), brain (175.04 per 100 000 person-years), larynx (148.78 per 100 000 person-years), and esophagus (144.98 per 100 000 person-years). The SMRs were the highest in the first month after cancer diagnosis.</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">This study found that the incidence of death from unintentional injury among patients with cancer was significantly higher than that in the general population in the United States. The rates of death from unintentional injury varied by age, sex, race/ethnicity, marital status, cancer site, disease stage, and time since diagnosis. The findings suggest that death from unintentional injury among patients with cancer requires further attention and that initiatives to identify patients at risk and to develop targeted prevention strategies should be prioritized.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Kunyu</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Yongqiang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Jiangtong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jiayuan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Huayi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Kaixu</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Wenjing</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Pengcheng</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Bian</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083692</ArticleId>
        <ArticleId IdType="pii">2761550</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21647</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083693</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development and Validation of a Machine Learning Individualized Treatment Rule in First-Episode Schizophrenia.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921660</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21660</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Little guidance exists to date on how to select antipsychotic medications for patients with first-episode schizophrenia.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To develop a preliminary individualized treatment rule (ITR) for patients with first-episode schizophrenia.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This prognostic study obtained data from Taiwan's National Health Insurance Research Database on patients with prescribed antipsychotic medications, ambulatory claims, or discharge diagnoses of a schizophrenic disorder between January 1, 2005, and December 31, 2011. An ITR was developed by applying a targeted minimum loss-based ensemble machine learning method to predict treatment success from baseline clinical and demographic data in a 70% training sample. The model was validated in the remaining 30% of the sample. The probability of treatment success was estimated for each medication for each patient under the model. The analysis was conducted between July 16, 2018, and July 15, 2019.</AbstractText>
          <AbstractText Label="Exposures" NlmCategory="UNASSIGNED">Fifteen different antipsychotic medications.</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Treatment success was defined as not switching medication and not being hospitalized for 12 months.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among the 32 277 patients in the analysis, the mean (SD) age was 36.7 (14.3) years, and 15 752 (48.8%) were male. In the validation sample, the treatment success rate (SE) was 51.7% (1.0%) under the ITR and was 44.5% (0.5%) in the observed population (Z = 7.1; P &lt; .001). The estimated treatment success if all patients were given a prescription for 1 medication was significantly lower for each of the 13 medications than under the ITR (Z = 4.2-16.8; all P &lt; .001). Aripiprazole (3088 [31.9%]) and amisulpride (2920 [30.2%]) were the medications most often recommended by the ITR. Only 1054 patients (10.9%) received ITR-recommended medications. Observed treatment success, although lower than the success under the ITR, was nonetheless significantly higher than if medications had been randomized (44.5% [SE, 0.55%] vs 41.3% [SE, 0.4%]; Z = 6.9; P &lt; .001), although only marginally higher than if medications had been randomized in their observed population proportions (44.5% [SE, 0.5%] vs 43.5% [SE, 0.4%]; Z = 2.2; P = .03]).</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">These results suggest that an ITR may be associatded with an increase in the treatment success rate among patients with first-episode schizophrenia, but experimental evaluation is needed to confirm this possibility. If confirmed, model refinement that investigates biomarkers, clinical observations, and patient reports as additional predictors in iterative pragmatic trials would be needed before clinical implementation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Chi-Shin</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, National Taiwan University Hospital &amp; College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luedtke</LastName>
            <ForeName>Alex R</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Statistics, University of Washington, Seattle.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sadikova</LastName>
            <ForeName>Ekaterina</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsai</LastName>
            <ForeName>Hui-Ju</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liao</LastName>
            <ForeName>Shih-Cheng</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, National Taiwan University Hospital &amp; College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Chen-Chung</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, National Taiwan University Hospital &amp; College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gau</LastName>
            <ForeName>Susan Shur-Fen</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, National Taiwan University Hospital &amp; College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>VanderWeele</LastName>
            <ForeName>Tyler J</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kessler</LastName>
            <ForeName>Ronald C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083693</ArticleId>
        <ArticleId IdType="pii">2761551</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21660</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083695</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Precision Health in Aging and Nursing Practice.</ArticleTitle>
        <Pagination>
          <MedlinePgn>3-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200129-03</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Martha</LastName>
            <ForeName>Sarah R</ForeName>
            <Initials>SR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Auld</LastName>
            <ForeName>Jonathan P</ForeName>
            <Initials>JP</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hash</LastName>
            <ForeName>Jonika B</ForeName>
            <Initials>JB</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Hyejeong</ForeName>
            <Initials>H</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083695</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200129-03</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083694</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2574-3805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA network open</Title>
          <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association of Variation in Consultant Use Among Hospitalist Physicians With Outcomes Among Medicare Beneficiaries.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1921750</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.21750</ELocationID>
        <Abstract>
          <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Evidence is lacking on the consequences of high rates of inpatient consultation.</AbstractText>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To examine outcomes and resource use of patients cared for by hospitalists who use more inpatient consultation than their colleagues.</AbstractText>
          <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">A retrospective cohort study of medical admissions to hospitalists among fee-for-service Medicare beneficiaries was conducted. Hospitalist consultation tendency was identified from January 1, 2013, to December 31, 2014; admissions were calculated in 2013; and outcomes were measured in 2014. Data were analyzed from January 31, 2017, to May 9, 2019. A total of 711 654 admissions with patients receiving care from 14 584 hospitalists at 737 hospitals were included.</AbstractText>
          <AbstractText Label="Exposure" NlmCategory="UNASSIGNED">Admission to high-consulting hospitalists, considered to be those who were in the top 25% of the distribution of consulting frequency at their own hospital (adjusted for patient case mix).</AbstractText>
          <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Outcomes included length of stay, Medicare Part B inpatient charges, discharge destination, all-cause 7- and 30-day readmissions, 90-day outpatient specialist visits, and 30-day mortality.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">The 711 654 hospital admissions included 408 489 women (57.4%); mean (SD) age of the population was 80 (8.5) years. Length of stay of patients cared for by high-consulting hospitalists was longer compared with other hospitalists (adjusted incidence rate ratio, 1.04; 95% CI, 1.03-1.05). The admissions resulted in a mean of $137.91 (95% CI, $118.89-$156.93) more in Medicare Part B charges and were less likely to end with the patient going home (adjusted odds ratio [aOR], 0.96; 95% CI, 0.94-0.98) compared with patients cared for by other hospitalists in the cohort. Patients cared for by high-consulting hospitalists also were 7% more likely than patients cared for by other hospitalists to see an outpatient specialist at 90 days (aOR 1.07; 95% CI, 1.05-1.09), with no significant differences in 30-day mortality (aOR 1.01, 95% CI, 0.98-1.03) or readmissions (7-day readmissions: aOR 1.01; 95% CI, 0.98-1.03; 30-day readmissions: aOR, 1.01; 95% CI, 0.99-1.03).</AbstractText>
          <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">Hospitalists who obtain consultations more than their colleagues at the same institution were associated with greater use of health care resources without apparent mortality benefit. Further investigation should identify whether reducing high rates of consultation can reduce resource use without harming patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stevens</LastName>
            <ForeName>Jennifer P</ForeName>
            <Initials>JP</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division for Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hatfield</LastName>
            <ForeName>Laura A</ForeName>
            <Initials>LA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nyweide</LastName>
            <ForeName>David J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Medicare &amp; Medicaid Innovation, Centers for Medicare &amp; Medicaid Services, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Landon</LastName>
            <ForeName>Bruce</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Netw Open</MedlineTA>
        <NlmUniqueID>101729235</NlmUniqueID>
        <ISSNLinking>2574-3805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083694</ArticleId>
        <ArticleId IdType="pii">2761552</ArticleId>
        <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.21750</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083696</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The 2019 Doris Schwartz Gerontological Nursing Research Award: Keela Herr, PhD, RN, AGSF, FGSA, FAAN-Challenges &amp; Triumphs on the Journey to Improve Pain Care for Older Adults.</ArticleTitle>
        <Pagination>
          <MedlinePgn>7-8</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200129-02</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Butcher</LastName>
            <ForeName>Howard Karl</ForeName>
            <Initials>HK</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083696</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200129-02</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083697</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Effects of Health Care Policies: LGBTQ Aging Adults.</ArticleTitle>
        <Pagination>
          <MedlinePgn>9-13</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200203-02</ELocationID>
        <Abstract>
          <AbstractText>Projected estimates for lesbian, gay, bisexual, transgender, queer (LGBTQ) populations in the United States reach 4 to 8 million older adults by 2030. Healthy People 2020 created goals to improve the health, safety, and well-being of these individuals. However, not all political agendas point to resolutions favorable for this population. Provisions under the Affordable Care Act once considered status quo protections for the LGBTQ community are now threatened as law makers are rolling back health care mandates, exposing members of the LGBTQ community to potential exacerbations of prejudice, discrimination, and stigmatization previously seen as historical violations of human rights. The purpose of this article is to identify how current health care policies have created legal windows of opportunity for persons to discriminate and create juxtaposition with goals and objectives of Healthy People 2020, promoting barriers in the health care continuum for LGBTQ aging adults. [Journal of Gerontological Nursing, 46(3), 9-13.].</AbstractText>
          <CopyrightInformation>Copyright 2020, SLACK Incorporated.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zanetos</LastName>
            <ForeName>Joanne M</ForeName>
            <Initials>JM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skipper</LastName>
            <ForeName>Alan W</ForeName>
            <Initials>AW</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083697</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200203-02</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083698</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preference Consistency: Veteran and Non-Veteran Nursing Home Resident Self-Reported Preferences for Everyday Living.</ArticleTitle>
        <Pagination>
          <MedlinePgn>15-25</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200129-06</ELocationID>
        <Abstract>
          <AbstractText>Understanding patient preferences is core to person-centered care. The consistency of everyday preference reporting was assessed comparing responses of Veteran (VA) and non-VA nursing home (NH) residents on the Preferences for Everyday Living Inventory (PELI) at baseline and 5 to 7 days later. Non-VA NH residents demonstrated higher perfect agreement than VA residents (66% vs. 56%, respectively) and higher acceptable agreement (95% vs. 88%, respectively). Multiple regression analyses examined significant predictors of reliability using demographics, cognitive functional variables, and interviewer ratings. In the VA group, higher perfect agreement was associated with residents who were less likely to have hearing deficits, better cognition, and better interviewer ratings related to energy, attention, and comprehension. In the non-VA group, higher perfect agreement was associated with residents who were younger and more independent with walking. Overall, higher agreement was associated with being female, non-VA, and having better cognition. Implications for future research and clinical practice are highlighted. [Journal of Gerontological Nursing, 46(3), 15-25.].</AbstractText>
          <CopyrightInformation>Copyright 2020, SLACK Incorporated.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Curyto</LastName>
            <ForeName>Kimberly</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dockler</LastName>
            <ForeName>Leah M</ForeName>
            <Initials>LM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Van Haitsma</LastName>
            <ForeName>Kimberly S</ForeName>
            <Initials>KS</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083698</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200129-06</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083699</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effectiveness of Electronic Medication Packaging Devices on Medication Adherence: A Scoping Review.</ArticleTitle>
        <Pagination>
          <MedlinePgn>27-36</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200129-01</ELocationID>
        <Abstract>
          <AbstractText>Poor adherence to complex medication regimens is a global problem that affects the treatment of chronic diseases, which involves polypharmacy and requires long-term administration of medications. The most significant barrier to medication adherence in older adults is patient-related factors. The purpose of this study was to find evidence from the current literature to evaluate the effectiveness of electronic medication packaging (EMP) devices on improving medication adherence in older patients. MEDLINE and EMBASE databases were searched based on inclusion/exclusion criteria, focusing on medication adherence and EMP devices with specific technological features. Search results included studies with experiences of patients with four different devices and various medical conditions. Study results indicated that EMP devices may improve medication adherence in older patients. However, due to insufficient evidence that supports their effectiveness specifically in the aging population, further clinical validation in older adults is recommended to draw strong conclusions. [Journal of Gerontological Nursing, 46(3), 27-36.].</AbstractText>
          <CopyrightInformation>Copyright 2020, SLACK Incorporated.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kurup</LastName>
            <ForeName>Rashmi</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martínez</LastName>
            <ForeName>Juan Pablo Díaz</ForeName>
            <Initials>JPD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doucet</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tyrrell</LastName>
            <ForeName>Pascal N</ForeName>
            <Initials>PN</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083699</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200129-01</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083700</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Lived Experience of Older Adults With Type 2 Diabetes Mellitus and Diabetes-Related Distress.</ArticleTitle>
        <Pagination>
          <MedlinePgn>37-44</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200129-05</ELocationID>
        <Abstract>
          <AbstractText>An older, more diverse population and longer lifespans are major contributors to the anticipated tripling of diabetes prevalence by 2050. Diabetes-related distress affects up to 40% of people with diabetes and may be a higher risk for older adults due to greater prevalence of comorbidities. The objective of the current phenomenological study was to describe how diabetes-related distress might be uniquely experienced by older adults (age ≥65) with type 2 diabetes mellitus (T2DM). Interpretive phenomenology guided the research design and analysis. Everyday life experiences of living with T2DM and elevated diabetes distress were investigated with interpretive interviews. The most prevalent lived experiences were strained relationships with health care providers, guilt, fear, loneliness, and forgetfulness. These experiences created challenges in managing diabetes and increased diabetes-related distress. Improving knowledge regarding the lived experience of older adults with diabetes-related distress may allow health care providers to tailor treatment to this population, thus improving outcomes. [Journal of Gerontological Nursing, 46(3), 37-44.].</AbstractText>
          <CopyrightInformation>Copyright 2020, SLACK Incorporated.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hernandez</LastName>
            <ForeName>Lenore</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leutwyler</LastName>
            <ForeName>Heather</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cataldo</LastName>
            <ForeName>Janine</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanaya</LastName>
            <ForeName>Alka</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Swislocki</LastName>
            <ForeName>Arthur</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chesla</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083700</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200129-05</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083701</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Family Caregiving During the Hospitalization of an Older Relative.</ArticleTitle>
        <Pagination>
          <MedlinePgn>45-50</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200129-04</ELocationID>
        <Abstract>
          <AbstractText>The purpose of the current study was to examine the role and activities of family caregivers for older relatives during hospitalization. The Family Care Actions Index was completed by 293 family caregivers of hospitalized older adults. Results indicated that the scope of caregiving activities extended beyond providing care to the patient and included working together with the health care team. Activities requiring interaction with providers, such as care coordination, planning, evaluation, and oversight, were frequently performed by family caregivers. Family caregivers are assuming a greater role during the hospital stay of older relatives. Partnering with family caregivers provides hospital staff an opportunity to improve care, outcomes, and satisfaction. [Journal of Gerontological Nursing, 46(3), 45-50.].</AbstractText>
          <CopyrightInformation>Copyright 2020, SLACK Incorporated.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Glose</LastName>
            <ForeName>Susan</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083701</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200129-04</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083702</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0098-9134</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gerontological nursing</Title>
          <ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bone and Muscle Health Can Make or Break Care as We Age: Geriatrics Experts Hope These New Insights Can Strengthen Science's Response.</ArticleTitle>
        <Pagination>
          <MedlinePgn>51-52</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20200203-01</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Linnebur</LastName>
            <ForeName>Sunny</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gerontol Nurs</MedlineTA>
        <NlmUniqueID>7510258</NlmUniqueID>
        <ISSNLinking>0098-9134</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083702</ArticleId>
        <ArticleId IdType="doi">10.3928/00989134-20200203-01</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083703</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1424-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>150</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Swiss medical weekly</Title>
          <ISOAbbreviation>Swiss Med Wkly</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Temporal work stressors and satisfaction with work, life and health among health professionals in Switzerland.</ArticleTitle>
        <Pagination>
          <MedlinePgn>w20175</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4414/smw.2020.20175</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">Swiss Med Wkly. 2020;150:w20175</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Working in a hospital can be both rewarding and stressful. Whether one or the other is dominant depends on a number of factors ranging from shift work, physical demands, responsibilities and time pressure to job autonomy, work climate and leisure time.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">This study aimed to examine associations between temporal work stressors and satisfaction with work, life and health among health professionals in general, and nurses and physicians in particular. Associations were further investigated for possible mediating and intervening factors.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Cross-sectional survey data on 1232 health professionals at three public hospitals and two rehabilitation clinics were collected in 2015/2016. Stepwise multiple linear regression analyses were used to estimate the standardised effects (beta coefficients) of temporal work stressors (overtime and time pressure), and organisational and personal resources (job autonomy, work climate, internal control belief) on general stress as the assumed mediator and finally on satisfaction with work, life and health.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Temporal work stressors were found to strongly predict general stress symptoms among health professionals (&amp;beta; = 0.25) and particularly physicians (&amp;beta; = 0.30), independently of the observed stress-buffering effects of organisational resources such as job autonomy (&amp;beta; = &amp;minus;0.09) or work climate (&amp;beta; = &amp;minus;0.22). Associations between temporal work stressors (as predictors) and satisfaction with work, life and health (as outcomes) turned out to be mostly indirect, mediated by general stress. General stress in turn was observed to be the strongest predictor of domain-specific satisfaction (&amp;beta; = &amp;minus;0.17 to &amp;minus;0.34), sometimes only surpassed by resources such as work climate or internal control belief. Explained variance of the three satisfaction outcomes in the fully specified regression or explanatory models ranged between 14% and 45% depending on the (sub-)sample (nurses, physicians, all health professionals) or the outcome. Control belief was revealed to be a strong and independent personal resource, particularly regarding satisfaction with life and health in general (&amp;beta; = 0.25/0.21).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Satisfaction and well-being of health professionals are strongly affected by job stressors such as frequent or excessive overtime work or permanent time pressure at work. Negative consequences of temporal work stressors are attenuated by organisational and personal resources such as a high level of job autonomy, a good work climate or a strong internal control belief.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Siebenhüner</LastName>
            <ForeName>Klarissa</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, University Hospital of Zurich, Switzerland / Centre of Competence Multimorbidity, University of Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Battegay</LastName>
            <ForeName>Edouard</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, University Hospital of Zurich, Switzerland / Centre of Competence Multimorbidity, University of Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hämmig</LastName>
            <ForeName>Oliver</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Swiss Med Wkly</MedlineTA>
        <NlmUniqueID>100970884</NlmUniqueID>
        <ISSNLinking>0036-7672</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083703</ArticleId>
        <ArticleId IdType="doi">10.4414/smw.2020.20175</ArticleId>
        <ArticleId IdType="pii">Swiss Med Wkly. 2020;150:w20175</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083704</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1424-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>150</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Swiss medical weekly</Title>
          <ISOAbbreviation>Swiss Med Wkly</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identifying cancer driver genes from functional genomics screens.</ArticleTitle>
        <Pagination>
          <MedlinePgn>w20195</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4414/smw.2020.20195</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">Swiss Med Wkly. 2020;150:w20195</ELocationID>
        <Abstract>
          <AbstractText>With the emerging advances made in genomics and functional genomics approaches, there is a critical and growing unmet need to integrate plural datasets in order to identify driver genes in cancer. An integrative approach, with the convergence of multiple types of genetic evidence, can limit false positives through a posterior filtering strategy and reduce the need for multiple hypothesis testing to identify true cancer vulnerabilities. We performed a pooled shRNA screen against 906 human genes in the oral cancer cell line AW13516 in triplicate. The genes that were depleted in the screen were integrated with copy number alteration and gene expression data and ranked based on ROAST analysis, using an integrative scoring system, DepRanker, to compute a Rank Impact Score (RIS) for each gene. The RIS-based ranking of candidate driver genes was used to identify the putative oncogenes AURKB and TK1 as essential for oral cancer cell proliferation. We validated the findings, showing that shRNA mediated genetic knockdown of TK1 or pharmacological inhibition of AURKB by AZD-1152 HQPA in AW13516 cells could significantly impede their proliferation. Next we analysed alterations in AURKB and TK1 genes in head and neck cancer and their association with prognosis using data on 528 patients obtained from TCGA. Patients harbouring alterations in AURKB and TK1 genes were associated with poor survival. To summarise, we present DepRanker as a simple yet robust package with no third-party dependencies for the identification of potential driver genes from a pooled shRNA functional genomic screen by integrating results from RNAi screens with gene expression and copy number data. Using DepRanker, we identify AURKB and TK1 as potential therapeutic targets in oral cancer. DepRanker is in the public domain and available for download at http://www.actrec.gov.in/pi-webpages/AmitDutt/DepRanker/DepRanker.html.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Togar</LastName>
            <ForeName>Trupti</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India / Training School Complex, Homi Bhabha National Institute, Anushakti Nagar, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Desai</LastName>
            <ForeName>Sanket</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India / Training School Complex, Homi Bhabha National Institute, Anushakti Nagar, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mishra</LastName>
            <ForeName>Rohit</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Terwadkar</LastName>
            <ForeName>Prachi</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramteke</LastName>
            <ForeName>Manoj</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ranjan</LastName>
            <ForeName>Malika</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kawle</LastName>
            <ForeName>Dhananjay</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sahoo</LastName>
            <ForeName>Bikram</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pal</LastName>
            <ForeName>Ankita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Upadhyay</LastName>
            <ForeName>Pawan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India / Training School Complex, Homi Bhabha National Institute, Anushakti Nagar, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dutt</LastName>
            <ForeName>Amit</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India / Training School Complex, Homi Bhabha National Institute, Anushakti Nagar, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Swiss Med Wkly</MedlineTA>
        <NlmUniqueID>100970884</NlmUniqueID>
        <ISSNLinking>0036-7672</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083704</ArticleId>
        <ArticleId IdType="doi">10.4414/smw.2020.20195</ArticleId>
        <ArticleId IdType="pii">Swiss Med Wkly. 2020;150:w20195</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083705</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1424-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>150</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Swiss medical weekly</Title>
          <ISOAbbreviation>Swiss Med Wkly</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A large-scale assessment of the healthcare burden of adhesive capsulitis of the shoulder joint.</ArticleTitle>
        <Pagination>
          <MedlinePgn>w20188</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4414/smw.2020.20188</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">Swiss Med Wkly. 2020;150:w20188</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND AND AIM" NlmCategory="OBJECTIVE">Frozen shoulder is a poorly understood pathological entity that is characterised by a painful and stiff shoulder. To analyse the socioeconomic impact of frozen shoulder in terms of cost generation and prolonged absence from work, we conducted a retrospective cohort study based on shoulder injuries through accidents in Switzerland.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Data were obtained from the comprehensive database of the Statistical Service for the Swiss National Accident Insurances (SSUV). Cases with shoulder injuries (ICD-10 codes S4* and M84.3*) and/or an additional code of adhesive capsulitis (M75.0) were extracted. Outcomes were work incapacity, with long-term work incapacity defined as absence from work for &amp;gt;90 days and very-long-term cases with &amp;gt;360 days lost. Healthcare and treatment costs as well as total insurance expenses were measured over a 5-year follow-up. Multivariate statistical analyses were used to quantify the effect of the frozen shoulder complication.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among all 456,926 patients with a shoulder injury, 5% or a total of 22,228 posttraumatic frozen shoulder cases were observed over the 8-year period. Patients suffering from a frozen shoulder after shoulder injury showed significantly longer sick leave periods with 30.8% long-term and 9.7% very-long-term cases compared with 9.4% and 1.3%, respectively, in the non-frozen shoulder cohort. Overall costs per case for an injured shoulder without developing a frozen shoulder was roughly CHF 8000, whereas expenses for cases with posttraumatic and postoperative frozen shoulder were CHF 34,000 per case.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Developing a frozen shoulder after a shoulder injury is associated with significant longer work incapacities (3.3&amp;ndash;7.5 times) and is responsible for costs of CHF 78 million every year. The presented numbers are for cases covered by the compulsory accident insurance only and do not include the even more frequent idiopathic frozen shoulder cases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bouaicha</LastName>
            <ForeName>Samy</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, University of Zurich, Balgrist University Hospital, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wieser</LastName>
            <ForeName>Karl</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, University of Zurich, Balgrist University Hospital, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kriechling</LastName>
            <ForeName>Philipp</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, University of Zurich, Balgrist University Hospital, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scholz-Odermatt</LastName>
            <ForeName>Stefan M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Suva (Swiss Accident Insurance Fund), Lucerne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Swiss Med Wkly</MedlineTA>
        <NlmUniqueID>100970884</NlmUniqueID>
        <ISSNLinking>0036-7672</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083705</ArticleId>
        <ArticleId IdType="doi">10.4414/smw.2020.20188</ArticleId>
        <ArticleId IdType="pii">Swiss Med Wkly. 2020;150:w20188</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083706</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1424-3997</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>150</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Swiss medical weekly</Title>
          <ISOAbbreviation>Swiss Med Wkly</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Should systemic sclerosis be recognised as an occupational disease in Switzerland?</ArticleTitle>
        <Pagination>
          <MedlinePgn>w20193</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4414/smw.2020.20193</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">Swiss Med Wkly. 2020;150:w20193</ELocationID>
        <Abstract>
          <AbstractText>Systemic sclerosis is a rare autoimmune disease characterised by a multifactorial aetiology involving a gene&amp;ndash;environment interaction. Despite the growing epidemiological arguments for odds ratio (OR) data showing an association with occupational exposure, systemic sclerosis is not currently included in the list of recognised occupational diseases in Switzerland, unlike other northern European countries. Future recognition will be conditional on the demonstration of a strong association between the disease and occupational exposure in the scientific literature. The present article&amp;rsquo;s main goal is to present five cases of systemic sclerosis investigated for possible occupational aetiologies during occupational pathology consultations at the Institute for Work and Health, in Lausanne. The occupational aetiologies of these cases are discussed against the background of a literature review of publications from the past 20 years in order to determine whether recognition as an occupational disease is possible within Switzerland&amp;rsquo;s legal framework. Epidemiological studies of systemic sclerosis have identified strong associations with occupational factors such as exposure to silica and solvents, with ORs &amp;gt;2, and weaker associations with epoxy resins and welding fumes. Other occupational exposures are also known to induce systemic sclerosis-like diseases, such as vinyl chloride disease and toxic oil syndrome. All five patients had been exposed to either silica, solvents, or both. Given their exposure and the data in the literature, four patients had their cases declared to their accident insurance companies and two of them were recognised as suffering from an occupational disease by the Swiss National Accident Insurance Fund. Our literature review enabled us to design a short questionnaire to help general practitioners and rheumatologists to identify those patients with systemic sclerosis who are likely to have their illness recognised as an occupational disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schmid</LastName>
            <ForeName>Mathilde</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland / Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grolimund Berset</LastName>
            <ForeName>Denise</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krief</LastName>
            <ForeName>Peggy</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zyska Cherix</LastName>
            <ForeName>Anja</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Danuser</LastName>
            <ForeName>Brigitta</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rinaldo</LastName>
            <ForeName>Mickaël</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Swiss Med Wkly</MedlineTA>
        <NlmUniqueID>100970884</NlmUniqueID>
        <ISSNLinking>0036-7672</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083706</ArticleId>
        <ArticleId IdType="doi">10.4414/smw.2020.20193</ArticleId>
        <ArticleId IdType="pii">Swiss Med Wkly. 2020;150:w20193</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083707</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Q&amp;amp;A: Stethoscopes and Telescopes.</ArticleTitle>
        <Pagination>
          <MedlinePgn>46-48</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Ever since he was a boy, Temple family physician John Manning, MD, has been fascinated by space. Now, Dr. Manning is also an amateur photographer. About 10 years ago, he merged his interests in photography and space into his latest obsession: astrophotography.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Doolittle</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083707</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083708</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Talk to Patients About: Why Do Some Vaccinated People Still Get Sick?</ArticleTitle>
        <Pagination>
          <MedlinePgn>45</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Every so often, physicians encounter a patient who still gets sick despite getting vaccinated against that disease. Patients naturally ask, how could this happen? There are various reasons.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Price</LastName>
            <ForeName>Sean</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083708</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083709</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reaching for the Cure: Texas Medicaid Doesn&amp;#39;t Cover Hepatitis C Drugs Until Patients Are Seriously Ill.</ArticleTitle>
        <Pagination>
          <MedlinePgn>38-42</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Infectious disease specialist Ogechika Alozie, MD, has a ready-made solution for patients diagnosed with hepatitis C now that five medications can rid patients of this deadly disease. But for Texas Medicaid patients, there's a catch. The program does not pay for the cure based just on a diagnosis. Instead, Medicaid pays only after a blood test, biopsy, or sonogram shows the liver is so badly damaged that it's on the verge of cirrhosis. At that point, patients who get the medication will be cured of their hepatitis C but more vulnerable to other deadly illnesses, like liver cancer.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Price</LastName>
            <ForeName>Sean</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083709</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083710</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Appropriate Use of Time? Medicare Rules for Advanced Imaging Orders Pose Prior-Auth Burdens.</ArticleTitle>
        <Pagination>
          <MedlinePgn>34-36</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>An effective way to cut down on overuse of potentially harmful imaging, or a prior authorization-esque burden on physicians who order needed tests? Texas physicians see Medicare's "appropriate use" system for advanced imaging both ways. As of Jan. 1, physicians ordering advanced imaging tests for Medicare patients must consult an electronic portal, which evaluates whether the test meets Medicare's own "appropriate use criteria" for whether a test should be ordered. Then when the claim is filed, physicians must document that they checked the system and its determination.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berlin</LastName>
            <ForeName>Joey</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083710</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083711</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Not Seeing Eye to Eye: Physician Employment of Optometrists Tested.</ArticleTitle>
        <Pagination>
          <MedlinePgn>25-27</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>A state board's concerns over stopping conflicts of interest and a physician's right to employ and delegate treatment to other professionals are colliding head-on. Now, it's up to Texas Attorney General Ken Paxton to sort out what, in his view, the state's optometry law allows.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berlin</LastName>
            <ForeName>Joey</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083711</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083712</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preserving Do No Harm: Supreme Court Tosses Challenge to Medical Ethics Committee Law.</ArticleTitle>
        <Pagination>
          <MedlinePgn>22-23</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Twenty years after it took effect, Texas' medical ethics committee review law has withstood challenge after challenge. The Texas Supreme Court is on the verge of ending the latest high-profile attack on the law that ensures physicians can uphold their professional obligation to "do no harm." In October 2019, the state's high court declined to take up Kelly v. Houston Methodist Hospital, in which the mother of a deceased patient attempted to overturn a provision of the Texas Advance Directives Act. Justices' action leaves intact an appeals court decision that preserves physicians' ability to use their medical judgment in end-of-life cases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berlin</LastName>
            <ForeName>Joey</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083712</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083713</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Doctor on the Set: Surgical Resident Thrives in Hollywood.</ArticleTitle>
        <Pagination>
          <MedlinePgn>4-5</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>About two years ago, Michael Metzner, MD, took a break from his San Antonio surgical residency program for what was supposed to be a year-long gig in the bright lights of Hollywood. He hasn't come back. He says he will … just not quite yet.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Levine</LastName>
            <ForeName>Steve</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083713</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083714</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Texas medicine</Title>
          <ISOAbbreviation>Tex Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clearing the Haze: Texas Physicians Demystify Vaping.</ArticleTitle>
        <Pagination>
          <MedlinePgn>16-21</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The rise in EVALI deaths and hospitalizations has changed the conversation about vaping and gives physicians an opportunity to champion tighter rules and higher taxes on an untested, unhealthy product that remains lightly regulated in both the U.S. and Texas.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Price</LastName>
            <ForeName>Sean</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Tex Med</MedlineTA>
        <NlmUniqueID>0051012</NlmUniqueID>
        <ISSNLinking>0040-4470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083714</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083715</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1473-2262</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>39</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>European cells &amp; materials</Title>
          <ISOAbbreviation>Eur Cell Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The chondrogenic differentiation potential of dental pulp stem cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>121-135</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.22203/eCM.v039a08</ELocationID>
        <Abstract>
          <AbstractText>Dental pulp stem cells (DPSCs) are particularly promising for tissue engineering (TE) due to the ease of their isolation procedure, great expansion potential and capability to differentiate towards several cell types of the mesodermal, ectodermal and endodermal lineages. Although several studies hint that DPSCs exhibit potential for cartilage tissue formation, the chondrogenic potential of DPSCs has only been marginally explored. Thus, the aim of the present study was to closely investigate the chondrogenic differentiation capacity of DPSCs for TE applications. More specifically, the potential of DPSCs for engineering hyaline and fibrous cartilage was determined. DPSCs obtained from 7 human molars were expanded and chondrogenically differentiated in a 3D pellet culture model. After 21 d of differentiation with chondrogenic stimuli, DPSCs displayed glycosaminoglycan, aggrecan and limited collagen type II deposition. Cells presented an elongated morphology and produced a collagen-rich extracellular matrix, with a predominance of collagen type I in most of the samples, a characteristic of fibrous cartilage tissue. Variations in the administration periods of several chondro-inductive growth factors, including transforming growth factor beta 3, bone morphogenetic protein-2, -6, -7 and insulin-like growth factor-1, did not increase glycosaminoglycan or collagen type II deposition, typical markers of hyaline cartilage tissue. Furthermore, DPSCs could not be stimulated to go into hypertrophic chondrogenesis. These results indicated that under a large variety of chondro-inductive culture conditions, DPSCs could form fibrocartilaginous tissues but not hyaline cartilage. Thus, DPSCs represent a valuable cell source for the regeneration of fibrocartilage in joints.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Longoni</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Utomo</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Hooijdonk</LastName>
            <ForeName>I E</ForeName>
            <Initials>IE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bittermann</LastName>
            <ForeName>G K</ForeName>
            <Initials>GK</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vetter</LastName>
            <ForeName>V C</ForeName>
            <Initials>VC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kruijt Spanjer</LastName>
            <ForeName>E C</ForeName>
            <Initials>EC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ross</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosenberg</LastName>
            <ForeName>A J</ForeName>
            <Initials>AJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gawlitta</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University Medical Centre Utrecht, Department of Oral and Maxillofacial Surgery and Special Dental Care, room G05.129, PO Box 85500, 3508 GA Utrecht, the Netherlands. d.gawlitta@umcutrecht.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Eur Cell Mater</MedlineTA>
        <NlmUniqueID>100973416</NlmUniqueID>
        <ISSNLinking>1473-2262</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083715</ArticleId>
        <ArticleId IdType="doi">10.22203/eCM.v039a08</ArticleId>
        <ArticleId IdType="pii">vol039a08</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083716</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0028-3843</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Neurologia i neurochirurgia polska</Title>
          <ISOAbbreviation>Neurol. Neurochir. Pol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.5603/PJNNS.a2020.0015</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Multiple sclerosis (MS) is the most common non-traumatic neurological cause of disability in young adults, affecting women 1-3 times more often than men. Several specific challenges arise from the fact that young women diagnosed with MS often have to make decisions related to treatment and family planning at the same time. These issues are connected with fertility, the impact of pregnancy on disease course, the choice of pregnancy timing, and the optimal mode of disease-modifying therapy in the context of a planned pregnancy, contraception, urological complaints, and sexual dysfunction.</AbstractText>
          <AbstractText Label="STATE OF THE ART" NlmCategory="BACKGROUND">While MS does not in itself adversely affect fertility, pregnancy or childbirth, pregnancy needs to be carefully planned. This requires the interdisciplinary co-operation of a neurologist, gynaecologist and psychologist. Data on the impact of disease-modifying drugs on foetal development are very limited, and none of these drugs is 100% safe during pregnancy. In the second and third trimesters, MS relapse rate decreases. Unfortunately, it increases within the first 3-6 months after delivery. Adequate disease control should be achieved before pregnancy, as relapse rate in the period of two years preceding pregnancy is one of the strongest predictive factors for post-partum relapses.</AbstractText>
          <AbstractText Label="CLINICAL IMPLICATIONS" NlmCategory="CONCLUSIONS">The following is a statement by a working group of experts in neurology, gynaecology, obstetrics and urology, convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society, addressing the issues that are specific to the female MS population. The aim of this statement is to provide guidance in pregnancy planning and disease management, both during pregnancy and post-partum.</AbstractText>
          <AbstractText Label="FUTURE DIRECTIONS" NlmCategory="CONCLUSIONS">This statement reflects expert opinion and is not intended to be read as guidelines. It rather provides up-to-date information on how to optimise care of female MS patients of childbearing age.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kalinowska</LastName>
            <ForeName>Alicja</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-0618-1637</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Division of Neurochemistry and Neuropathology, Poznan Univerisity of Medical Sciences, 49, Przybyszewskiego st., 60-355 Poznan, Poland. akalinowskalyszczarz@ump.edu.pl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kułakowska</LastName>
            <ForeName>Alina</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical University of Bialystok, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adamczyk-Sowa</LastName>
            <ForeName>Monika</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Zabrze; Medical University of Silesia, Katowice, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Czajkowski</LastName>
            <ForeName>Krzysztof</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurowska</LastName>
            <ForeName>Katarzyna</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Psychiatry and Neurology, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pietrzak</LastName>
            <ForeName>Bronisława</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>I Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Radziszewski</LastName>
            <ForeName>Piotr</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General, Oncological and Functional Urology, Medical University of Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rejdak</LastName>
            <ForeName>Konrad</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical University of Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bartosik-Psujek</LastName>
            <ForeName>Halina</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Faculty, University of Rzeszow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Poland</Country>
        <MedlineTA>Neurol Neurochir Pol</MedlineTA>
        <NlmUniqueID>0101265</NlmUniqueID>
        <ISSNLinking>0028-3843</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">childbearing age</Keyword>
        <Keyword MajorTopicYN="N">multiple sclerosis</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">women</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083716</ArticleId>
        <ArticleId IdType="pii">VM/OJS/J/65085</ArticleId>
        <ArticleId IdType="doi">10.5603/PJNNS.a2020.0015</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083717</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-7793</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of physiology</Title>
          <ISOAbbreviation>J. Physiol. (Lond.)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Widespread diversity in the transcriptomes of functionally divergent limb tendons.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1113/JP279646</ELocationID>
        <Abstract>
          <AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">Tendon is a hypocellular, matrix-rich tissue that has been excluded from comparative transcriptional atlases. These atlases have provided important knowledge about biological heterogeneity between tissues, and our manuscript addresses this important gap. We performed measures on four of the most studied tendons, the Achilles, forepaw flexor, patellar, and supraspinatus tendons of both mice and rats. These tendons are functionally distinct and are also among the most commonly injured, and therefore of important translational interest. Approximately one-third of the transcriptome was differentially regulated between Achilles, forepaw flexor, patellar, and supraspinatus tendons within either mice or rats. Nearly two thirds of the transcripts that are expressed in anatomically similar tendons were different between mice and rats. The overall findings from this study identified that although tendons across the body share a common anatomical definition based on their physical location between skeletal muscle and bone, tendon is a surprisingly genetically heterogeneous tissue.</AbstractText>
          <AbstractText Label="ABSTRACT" NlmCategory="UNASSIGNED">Tendon is a functionally important connective tissue that transmits force between skeletal muscle and bone. Previous studies have evaluated the architectural designs and mechanical properties of different tendons throughout the body. However, less is known about the underlying transcriptional differences between tendons which may dictate their designs and properties. Therefore, our objective was to develop a comprehensive atlas of the transcriptome of limb tendons in adult mice and rats using systems biology techniques. We selected the Achilles, forepaw digit flexor, patellar, and supraspinatus tendons due to their divergent functions and high rates of injury and tendinopathies in patients. Using RNA sequencing data, we generated the Comparative Tendon Transcriptional Database (CTTDb) that identified substantial diversity in the transcriptomes of tendons both within and across species. Approximately 30% of transcripts were differentially regulated between tendons of a given species, and nearly 60% of the transcripts present in anatomically similar tendons were different between species. Many of the genes that differed between tendons and across species are important in tissue specification and limb morphogenesis, tendon cell biology and tenogenesis, growth factor signalling, and production and maintenance of the extracellular matrix. This study indicates that tendon is a surprisingly heterogenous tissue with substantial genetic variation based on anatomical location and species. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Disser</LastName>
            <ForeName>Nathaniel P</ForeName>
            <Initials>NP</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghahramani</LastName>
            <ForeName>Gregory C</ForeName>
            <Initials>GC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7338-6819</Identifier>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Swanson</LastName>
            <ForeName>Jacob B</ForeName>
            <Initials>JB</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4658-2037</Identifier>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wada</LastName>
            <ForeName>Susumu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chao</LastName>
            <ForeName>Max L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodeo</LastName>
            <ForeName>Scott A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oliver</LastName>
            <ForeName>David J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mendias</LastName>
            <ForeName>Christopher L</ForeName>
            <Initials>CL</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2384-0171</Identifier>
            <AffiliationInfo>
              <Affiliation>Hospital for Special Surgery, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Physiol</MedlineTA>
        <NlmUniqueID>0266262</NlmUniqueID>
        <ISSNLinking>0022-3751</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">RNA sequencing</Keyword>
        <Keyword MajorTopicYN="N">extracellular matrix</Keyword>
        <Keyword MajorTopicYN="N">gene expression atlas</Keyword>
        <Keyword MajorTopicYN="N">tenocyte</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083717</ArticleId>
        <ArticleId IdType="doi">10.1113/JP279646</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083718</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-7793</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of physiology</Title>
          <ISOAbbreviation>J. Physiol. (Lond.)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Increased diaphragm motor unit discharge frequencies during quiet breathing in people with chronic tetraplegia.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1113/JP279220</ELocationID>
        <Abstract>
          <AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">Respiratory muscle strength is compromised in people with tetraplegia, which may be compensated for by an increase in neural drive to the diaphragm. We found that the discharge frequencies of diaphragm motor units are higher in people with chronic tetraplegia compared to able-bodied people during quiet breathing. Furthermore, we found that the area of single motor unit potentials was increased in people with tetraplegia. These results suggest an increased motoneurone output to the diaphragm and re-modelling of diaphragm motor units to maintain ventilation in tetraplegia.</AbstractText>
          <AbstractText Label="ABSTRACT" NlmCategory="UNASSIGNED">People with tetraplegia have reduced inspiratory muscle strength, ∼40% of able-bodied individuals. Paralysed or partially paralysed respiratory muscles as a result of tetraplegia compromise lung function, increase the incidence of respiratory infections and can cause dyspnoea. We hypothesised that reduced inspiratory muscle strength in tetraplegia may increase neural drive to the inspiratory muscles to maintain ventilation. We recorded the discharge properties of single motor units from the diaphragm in participants with chronic tetraplegia (8 males, 42-78 years, C3-C6 injury, AIS A-C) and able-bodied control participants (6 males matched for age and BMI). In each group, 117 and 166 single motor units, respectively, were discriminated from recordings in the costal diaphragm using a monopolar electrode. A linear mixed-effects model analysis showed higher peak discharge frequencies of motor units during quiet breathing in tetraplegia (17.8 ± 4.9 Hz; mean ± SD) compared to controls (12.4 ± 2.2 Hz) (P &lt; 0.001). There were no differences in tidal volume, inspiratory time or mean air flow between groups. Motor unit potentials in tetraplegia, compared to controls, were larger in amplitude (1.1 ± 0.7 mV and 0.5 ± 0.3 mV, respectively, P = 0.007) and area (1.83 ± 1.49 μV ms and 0.69 ± 0.52 μV ms, respectively, P = 0.003). The findings indicate that diaphragm motor unit remodelling is likely to have occurred in people with chronic tetraplegia and that there is an increase in diaphragm motor unit discharge rates during quiet breathing. These neural changes ensure that ventilation is maintained in people with chronic tetraplegia. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nguyen</LastName>
            <ForeName>D A T</ForeName>
            <Initials>DAT</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of New South Wales.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewis</LastName>
            <ForeName>R H C</ForeName>
            <Initials>RHC</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of New South Wales.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Prince of Wales Hospital, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boswell-Ruys</LastName>
            <ForeName>C L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of New South Wales.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Prince of Wales Hospital, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hudson</LastName>
            <ForeName>A L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of New South Wales.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gandevia</LastName>
            <ForeName>S C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of New South Wales.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Prince of Wales Hospital, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Butler</LastName>
            <ForeName>J E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of New South Wales.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Physiol</MedlineTA>
        <NlmUniqueID>0266262</NlmUniqueID>
        <ISSNLinking>0022-3751</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">diaphragm</Keyword>
        <Keyword MajorTopicYN="N">electromyography</Keyword>
        <Keyword MajorTopicYN="N">tetraplegia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083718</ArticleId>
        <ArticleId IdType="doi">10.1113/JP279220</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083719</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-3479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</Title>
          <ISOAbbreviation>Int J Gynaecol Obstet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Girls' attendance at school after a menstrual hygiene intervention in northern Ethiopia.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ijgo.13127</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the effect on school attendance of a menstrual hygiene intervention that distributes educational booklets to school children and menstrual hygiene kits to schoolgirls in northern Ethiopia.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Attendance was tracked for 8839 students in grades 7-12 during the 2015-2016 academic year when the intervention was implemented. Negative binomial regression was used to test whether student sex predicted post-intervention school absences when controlling for grade-level and pre-intervention absences. Similar attendance data were analyzed for 3569 students in grades 7, 9, and 11 for the 2014-2015 academic year as a historical comparison.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Over 12 211 educational booklets were distributed to students and 5991 menstrual hygiene kits were distributed to schoolgirls. After the intervention, girls had 24% fewer school absences than boys. Sex was not a predictor of absences during a similar time-period in the prior school year.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This is one of the first large studies to show a positive relationship between a menstrual hygiene intervention and girls' school attendance. These positive results suggest such interventions should be expanded to other schools in northern Ethiopia. Future research should explore whether similar interventions can also decrease the rate at which girls drop out of school around menarche.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Belay</LastName>
            <ForeName>Shewaye</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Parasitology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sebert Kuhlmann</LastName>
            <ForeName>Anne K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>College for Public Health and Social Justice, Saint Louis University, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewis Wall</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anthropology, College of Arts and Sciences, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics &amp; Gynecology, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Int J Gynaecol Obstet</MedlineTA>
        <NlmUniqueID>0210174</NlmUniqueID>
        <ISSNLinking>0020-7292</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Adolescence</Keyword>
        <Keyword MajorTopicYN="N">Ethiopia</Keyword>
        <Keyword MajorTopicYN="N">Low-resource countries</Keyword>
        <Keyword MajorTopicYN="N">Menstrual hygiene management</Keyword>
        <Keyword MajorTopicYN="N">Menstruation</Keyword>
        <Keyword MajorTopicYN="N">Program evaluation</Keyword>
        <Keyword MajorTopicYN="N">Schools</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083719</ArticleId>
        <ArticleId IdType="doi">10.1002/ijgo.13127</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083720</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pediatric Epiglottopexy Using an Endoscopic Suturing Device.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28545</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thorpe</LastName>
            <ForeName>Ryan K</ForeName>
            <Initials>RK</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8046-407X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanotra</LastName>
            <ForeName>Sohit P</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083720</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28545</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Olney DR, Greinwald JH, Smith RJH, Bauman NM. Laryngomalacia and its treatment. Laryngoscope 1999;109:1770-1775.</Citation>
        </Reference>
        <Reference>
          <Citation>Lichtenberger G, Toohill RJ. The Endo-Extralaryngeal needle carrier. Otolaryngol Neck Surg 1991;105:755-756.</Citation>
        </Reference>
        <Reference>
          <Citation>Álvarez-Neri H, Villamor P, Ortiz Hernandez E, Penchyna Grub J. Epiglottopexy by external puncture for epiglottic prolapse in severe laryngomalacia. A novel technique. Eur Ann Otorhinolaryngol Head Neck Dis 2019;136:115-117.</Citation>
        </Reference>
        <Reference>
          <Citation>Whymark AD, Clement WA, Kubba H, Geddes NK. Laser epiglottopexy for laryngomalacia. Arch Otolaryngol Neck Surg 2006;132:978.</Citation>
        </Reference>
        <Reference>
          <Citation>Werner JA, Lippert BM, Dünne AA, Ankermann T, Folz BJ, Seyberth H. Epiglottopexy for the treatment of severe laryngomalacia. Eur Arch Otorhinolaryngol 2002;259:459-464.</Citation>
        </Reference>
        <Reference>
          <Citation>Kanotra SP, Givens VB, Keith B. Swallowing outcomes after pediatric epiglottopexy. Eur Arch Otorhinolaryngol 2020;277:285-291.</Citation>
        </Reference>
        <Reference>
          <Citation>Ozgursoy OB, Dursun G. Endostitch and endostapler assisted transoral endoscopic Zenker's diverticulostomy. J Laryngol Otol 2012;126:759-759.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholas BD, Devitt S, Rosen D, Spiegel J, Boon M. Endostitch-assisted endoscopic Zenker's diverticulostomy: a tried approach for difficult cases. Dis Esophagus 2010;23:296-299.</Citation>
        </Reference>
        <Reference>
          <Citation>Kulasegarah J, Breshinan M, Walsh M. Vocal cord lateralisation in bilateral abductor cord paralysis using ENDO CLOSE TM suturing device. Clin Otolaryngol 2007;32:313-314.</Citation>
        </Reference>
        <Reference>
          <Citation>Adams JB, Schulam PG, Moore RG, Partin AW, Kavoussi LR. New laparoscopic suturing device: initial clinical experience. Urology 1995;46:242-245.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083721</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of Recording Electrode Arrays in Endotracheal Thyroid Monitoring Tubes in a Porcine Model.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28513</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Alteration in positioning or head manipulation during thyroid surgery can lead to endotracheal tube movement and potentially a change in intraoperative neural monitoring readings. We sought to study the impact of positional changes on two different commercially available recording electrode arrays.</AbstractText>
          <AbstractText Label="MATERIALS" NlmCategory="METHODS">Eight pigs divided equally into two study groups based on recording electrode arrays were used: Neurosign Lantern Laryngeal Electrode (LLE) (Neurosign_Technomed, The Netherlands) and Medtronic NIM EMG [neural integrity monitor electromyogram] endotracheal tube (ETT) (Medtronic, Jacksonville, FL). Neck movement and reposition were performed for all pigs. Signal data, including amplitude and latency, were collected for vagus nerve, recurrent laryngeal nerve (RLN), and external branch of superior laryngeal nerve (EBSLN) before and after repositioning. The differences of amplitude and latency by pre- and post-repositioning were compared for all animals.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight pigs were included in the current study. ETT group (Medtronic) had a significant decrease in amplitude of all tested nerves: for the vagus nerve on the left side by 36.30% (P = .021) and on the right by 49.29% (P = .024), for RLN on the left by 30.22% (P = .014) and on the right by 42.34% (P = .004), and for EBSLN on the left by 63.62% (P = .003) and on the right by 13.58% (P = .010). The amplitude changes in LLE group (Neurosign) repositioning were not statistically significant in all nerves.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Recording electrode array configuration can impact the stability of nerve monitoring signal during thyroid surgeries. Repositioning was associated with changes in nerve signal amplitude in ETT group (Medtronic), whereas LLE (Neurosign) did not show any significant differences. Human studies are warranted.</AbstractText>
          <AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">NA Laryngoscope, 2020.</AbstractText>
          <CopyrightInformation>© 2020 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kandil</LastName>
            <ForeName>Emad</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5895-4403</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al-Qurayshi</LastName>
            <ForeName>Zaid</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Randolph</LastName>
            <ForeName>Gregory</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Thyroid and Parathyroid Endocrine Surgery, Massachusetts Eye and Ear Infirmary, Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shama</LastName>
            <ForeName>Mohamed</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7633-4363</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Thyroid and Parathyroid Endocrine Surgery, Massachusetts Eye and Ear Infirmary, Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bamford</LastName>
            <ForeName>Jeremy</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Tulane University School of Medicine, New Orleans, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Sang-Wook</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Tulane University</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Intraoperative neural monitoring</Keyword>
        <Keyword MajorTopicYN="N">Lantern Laryngeal Electrode</Keyword>
        <Keyword MajorTopicYN="N">NIM EMG endotracheal tube</Keyword>
        <Keyword MajorTopicYN="N">thyroidectomy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083721</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28513</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Duclos A, Lifante JC, Ducarroz S, Soardo P, Colin C, Peix JL. Influence of intraoperative neuromonitoring on surgeons' technique during thyroidectomy. World J Surg 2011;35:773-778.</Citation>
        </Reference>
        <Reference>
          <Citation>Jatzko GR, Lisborg PH, Müller MG, Wette VM. Recurrent nerve palsy after thyroid operations-principal nerve identification and a literature review. Surgery 1994;115:139-144.</Citation>
        </Reference>
        <Reference>
          <Citation>Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004;136:1310-1322.</Citation>
        </Reference>
        <Reference>
          <Citation>Flisberg K, Lindholm T. Electrical stimulation of the human recurrent laryngeal nerve during thyroid operation. Acta Otolaryngol Suppl 1969;263:63-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Randolph GW. Surgical anatomy of the recurrent laryngeal nerve. In: Randolph GW, ed. Surgery of the Thyroid and Parathyroid Glands. Philadelphia, PA: W. B. Saunders; 2003:300-342.</Citation>
        </Reference>
        <Reference>
          <Citation>Snyder SK, Hendricks JC. Intraoperative neurophysiology testing of the recurrent laryngeal nerve: plaudits and pitfalls. Surgery 2005;138:1183-1191. discussion 1191-1192.</Citation>
        </Reference>
        <Reference>
          <Citation>Randolph GW, Dralle H, Abdullah H, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope 2011;121:S1-S16.</Citation>
        </Reference>
        <Reference>
          <Citation>Dralle H, Sekulla C, Lorenz K, Brauckhoff M, Machens A, German IONM Study Group. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008;32:1358-1366.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang S, Zhou L, Lu Z, Ma B, Ji Q, Wang Y. Systematic review with meta-analysis of intraoperative neuromonitoring during thyroidectomy. Int J Surg 2017;39:104-113.</Citation>
        </Reference>
        <Reference>
          <Citation>Schneider R, Randolph GW, Barczynski M, et al. Continuous intraoperative neural monitoring of the recurrent nerves in thyroid surgery: a quantum leap in technology. Gland Surg 2016;5:607-616.</Citation>
        </Reference>
        <Reference>
          <Citation>Lu IC, Chu KS, Tsai CJ, et al. Optimal depth of NIM EMG endotracheal tube for IONM of the RLN during thyroidectomy. World J Surg 2008;32:1935-1939.</Citation>
        </Reference>
        <Reference>
          <Citation>Statistical consulting. Repeated measures analysis with STATA. UCLA Institute for digital research and education website. Available at: https://stats.idre.ucla.edu/stata/seminars/repeated-measures-analysis-with-stata/. Accessed March, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Horne SK, Gal TJ, Brennan JA. Prevalence and patterns of intraoperative nerve monitoring for thyroidectomy. Otolaryngol Head Neck Surg 2007;136:952-956.</Citation>
        </Reference>
        <Reference>
          <Citation>Sturgeon C, Sturgeon T, Angelos P. Neuromonitoring in thyroid surgery: attitudes, usage patterns, and predictors of use among endocrine surgeons. World J Surg 2009;33:417-425.</Citation>
        </Reference>
        <Reference>
          <Citation>Schneider R, Randolph GW, Dionigi G, et al. International neural monitoring study group guideline 2018 part I: staging bilateral thyroid surgery with monitoring loss of signal. Laryngoscope 2018;128:S1-S17.</Citation>
        </Reference>
        <Reference>
          <Citation>Barber SR, Liddy W, Kyriazidis N, et al. Changes in electromyographic amplitudes but not latencies occur with endotracheal tube malpositioning during intraoperative monitoring for thyroid surgery: implications for guidelines. Laryngoscope 2017;127:2182-2188.</Citation>
        </Reference>
        <Reference>
          <Citation>Gorti GK, MA B, Haverson K, Macchiarini P, Bailey M. A preclinical model for laryngeal transplantation: anatomy and mucosal imunology of the porcine larynx. Transplantation 1999;68:1638-1642.</Citation>
        </Reference>
        <Reference>
          <Citation>Alajmo E, Salimbeni C. The vocal muscle. Arch Ital Anat Embriol 1983;88:15-24.</Citation>
        </Reference>
        <Reference>
          <Citation>Kurita S, Nagata K, Hirano M. A comparative study of the layer structure of the vocal fold. In: Bless DM, Abbs JH, eds. Vocal Fold Physiology: Contemporary Research and Clinical Issues. San Diego, CA: College Hill Press; 1983:3-21.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083722</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>What is the Role of Transoral Thyroidectomy?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28578</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Brent A</ForeName>
            <Initials>BA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5821-4640</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology/Head and Neck Surgery, Louisiana State University Health Sciences Center &amp; Feist-Weiller Cancer Center, Shreveport, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asarkar</LastName>
            <ForeName>Ameya A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9028-8746</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology/Head and Neck Surgery, Louisiana State University Health Sciences Center &amp; Feist-Weiller Cancer Center, Shreveport, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Overton Brooks Veterans Affairs Medical Center, Shreveport, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nathan</LastName>
            <ForeName>Cherie-Ann O</ForeName>
            <Initials>CO</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7386-318X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology/Head and Neck Surgery, Louisiana State University Health Sciences Center &amp; Feist-Weiller Cancer Center, Shreveport, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Overton Brooks Veterans Affairs Medical Center, Shreveport, Louisiana, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083722</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28578</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Anuwong A, Ketwong K, Jitpratoom P, Sasanakietkul T, Duh QY. Safety and outcomes of the transoral endoscopic thyroidectomy vestibular approach. JAMA Surg 2018;153:21-27.</Citation>
        </Reference>
        <Reference>
          <Citation>Tartaglia F, Maturo A, Di Matteo FM, et al. Transoral video assisted thyroidectomy: a systematic review. G Chir 2018;39:276-283.</Citation>
        </Reference>
        <Reference>
          <Citation>Razavi CR, Russell JO. Indications and contraindications to transoral thyroidectomy. Ann Thyroid 2017;2:12.</Citation>
        </Reference>
        <Reference>
          <Citation>Ahn JH, Yi JW. Transoral endoscopic thyroidectomy for thyroid carcinoma: outcomes and surgical completeness in 150 single-surgeon cases. Surg Endosc 2020;34:861-867.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu YJ, Chi SY, Elsarawy A, et al. What is the appropriate nodular diameter in thyroid cancer for extraction by transoral endoscopic thyroidectomy vestibular approach without breaking the specimens? A surgicopathologic study. Surg Laparosc Endosc Percutan Tech 2018;28:390-393.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083723</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ultrasound-Guided Suture Lateralization in Pediatric Bilateral Vocal Fold Immobility.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28553</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Puricelli</LastName>
            <ForeName>Michael D</ForeName>
            <Initials>MD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head and Neck Surgery, University of Iowa, Iowa, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peterson</LastName>
            <ForeName>Joseph</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5650-5871</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head and Neck Surgery, University of Iowa, Iowa, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanotra</LastName>
            <ForeName>Sohit P</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head and Neck Surgery, University of Iowa, Iowa, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Iowa Stead Family Children's Hospital, Iowa, Iowa, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Pediatric</Keyword>
        <Keyword MajorTopicYN="N">suture lateralization</Keyword>
        <Keyword MajorTopicYN="N">ultrasound, larynx, bilateral</Keyword>
        <Keyword MajorTopicYN="N">vocal fold paralysis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083723</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28553</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Lesnik M, Thierry B, Blanchard M, et al. Idiopathic bilateral vocal cord paralysis in infants: case series and literature review. Laryngoscope 2015;125:1724-1728.</Citation>
        </Reference>
        <Reference>
          <Citation>Rutter MJ, Hart CK, Alarcon A, et al. Endoscopic anterior-posterior cricoid split for pediatric bilateral vocal fold paralysis. Laryngoscope 2018;128:257-263.</Citation>
        </Reference>
        <Reference>
          <Citation>Madani S, Bach Á, Matievics V, et al. A new solution for neonatal bilateral vocal cord paralysis: endoscopic arytenoid abduction lateropexy. Laryngoscope 2017;127:1608-1614.</Citation>
        </Reference>
        <Reference>
          <Citation>DeMauro SB, Wei JL, Lin RJ. Perspectives on neonatal and infant tracheostomy. Semin Fetal Neonatal Med 2016;21:285-291.</Citation>
        </Reference>
        <Reference>
          <Citation>Howell R, Romeo S, Myer C 4th, Bowen M, Khosla S. The lasso technique for endoscopic suture lateralization in bilateral vocal fold immobility. Laryngoscope 2017;127:2604-2607.</Citation>
        </Reference>
        <Reference>
          <Citation>Sztanó B, Bach Á, Matievics V, et al. Endoscopic arytenoid abduction lateropexy for the treatment of neonatal bilateral vocal cord paralysis - Long-term results. Int J Pediatr Otorhinolaryngol 2019;119:147-150.</Citation>
        </Reference>
        <Reference>
          <Citation>Costache A, Dumitru M, Anghel I, Cergan R, Anghel AG, Sarafoleanu C. Ultrasonographic anatomy of head and neck-a pictorial for the ENT specialist. Med Ultrason. 2015;17:104-108.</Citation>
        </Reference>
        <Reference>
          <Citation>El Amrousy D, Elkashlan M, Elshmaa N, Ragab A. Ultrasound-guided laryngeal air column width difference as a new predictor for postextubation stridor in children. Crit Care Med 2018;46:e496-e501.</Citation>
        </Reference>
        <Reference>
          <Citation>Shirley F, Oshri W, Ari D, Gad F. The role of laryngeal ultrasound in the assessment of pediatric dysphonia and stridor. Int J Pediatr Otorhinolaryngol 2019;122:175-179.</Citation>
        </Reference>
        <Reference>
          <Citation>Ongkasuwan J, Devore D, Hollas S, Jones J, Tran B. Laryngeal ultrasound and pediatric vocal fold nodules. Laryngoscope 2017;127:676-678.</Citation>
        </Reference>
        <Reference>
          <Citation>Ongkasuwan J, Ocampo E, Tran B. Laryngeal ultrasound and vocal fold movement in the pediatric cardiovascular intensive care unit. Laryngoscope 2017;127:167-172.</Citation>
        </Reference>
        <Reference>
          <Citation>Benjamin B. Pediatric laryngoscopes: design and application. Ann Otol Rhinol Laryngol 2001;110:617-623.</Citation>
        </Reference>
        <Reference>
          <Citation>Lichtenberger G. Reversible lateralization of the paralyzed vocal cord without tracheostomy. Ann Otol Rhinol Laryngol 2002;111:21-26.</Citation>
        </Reference>
        <Reference>
          <Citation>Woodson BT, McFadden EA, Toohill RJ. Clinical experience with the Lichtenberger endo-extralaryngeal needle carrier. Laryngoscope 1991;101:1019-1023.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083724</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The New phytologist</Title>
          <ISOAbbreviation>New Phytol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A lack of genetically compatible mates constrains the spread of an invasive weed.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nph.16496</ELocationID>
        <Abstract>
          <AbstractText>Introduced populations often experience lag-times prior to invasion, but the mechanisms constraining rapid expansions of introduced populations are unclear. Solidago altissima is a North American native plant with highly invasive Japanese populations, and introduced Australian populations that are not invasive despite the climatic and ecological suitability of the region. By contrasting Australian with Japanese populations, we tested the hypothesis that Australian population growth is limited by a lack of long-distance dispersal via seeds due to limited number of compatible mates. In the field, Australian populations rarely produced viable seeds. A cross-pollination experiment found that Australian plants are fertile, yet lack compatible mates within Australia. Genetic analysis revealed that Australian individuals descend from a small set of self-incompatible genetic clones, which explains the negligible seed set within Australia. Our results show that low genetic diversity, leading to mate incompatibility, inhibits invasiveness of Australian S. altissima, and provides compelling evidence for genetic, rather than ecological, factors constraining invasion in Australia.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Uesugi</LastName>
            <ForeName>Akane</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3363-5312</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, Monash University, Building 18, Victoria, 3800, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baker</LastName>
            <ForeName>David J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, Monash University, Building 18, Victoria, 3800, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Silva</LastName>
            <ForeName>Nissanka</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, Monash University, Building 18, Victoria, 3800, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nurkowski</LastName>
            <ForeName>Kristin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, Monash University, Building 18, Victoria, 3800, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hodgins</LastName>
            <ForeName>Kathryn A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, Monash University, Building 18, Victoria, 3800, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>New Phytol</MedlineTA>
        <NlmUniqueID>9882884</NlmUniqueID>
        <ISSNLinking>0028-646X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Solidago altissima
</Keyword>
        <Keyword MajorTopicYN="N">Allee effect</Keyword>
        <Keyword MajorTopicYN="N">genotype-by-sequencing</Keyword>
        <Keyword MajorTopicYN="N">invasive species</Keyword>
        <Keyword MajorTopicYN="N">lag-time</Keyword>
        <Keyword MajorTopicYN="N">seed limitation</Keyword>
        <Keyword MajorTopicYN="N">self-incompatibility</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083724</ArticleId>
        <ArticleId IdType="doi">10.1111/nph.16496</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083725</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1752-7325</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of public health dentistry</Title>
          <ISOAbbreviation>J Public Health Dent</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Improving parent oral health literacy in Head Start programs.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jphd.12361</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Parental low oral health literacy is thought to contribute to child oral health disparities. Few large-scale interventions can improve oral health literacy for diverse, high-risk populations. We sought to determine whether an oral health literacy intervention aimed at parents of children attending Head Start programs improved oral health literacy and behaviors.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Staff from 29 Head Start agencies across the country were trained to deliver a parent oral health literacy intervention. Parent surveys were conducted at baseline and approximately 6 months later, following intervention completion. Surveys measured parent and child demographics, oral health knowledge, behaviors, information sources, and health care utilization. Paired t tests and mixed-effects regression models controlling for agency, child age, and race/ethnicity evaluated whether measures improved after the intervention. In addition, at follow-up, agency staff were asked to complete an open-ended survey reporting how the intervention impacted their site. Responses were coded using a grounded theory approach.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2,011 (87%) parents completed both the baseline and follow-up surveys. All oral health knowledge and behaviors improved significantly from baseline to follow-up. In addition, parents reported using more oral health information sources, using more preventative oral health care, and less emergency room (ER) use for child dental problems. Head Start staff perceived that the intervention increased parental oral health literacy, enhanced parental oral health engagement, improved child oral health behaviors, and facilitated health communication with parents.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings suggest that this intervention successfully improved oral health literacy for diverse parents of children at high risk for dental caries.</AbstractText>
          <CopyrightInformation>© 2020 American Association of Public Health Dentistry.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dudovitz</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9457-0562</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Children's Discovery and Innovations Institute, UCLA Mattel Children's Hospital, David Geffen School of Medicine, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teutsch</LastName>
            <ForeName>Carol</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>UCLA Health Care Institute, Anderson School of Management, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holt</LastName>
            <ForeName>Katrina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>National Maternal and Child Oral Health Resource Center, Georgetown University, Washington, DC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Herman</LastName>
            <ForeName>Ariella</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>UCLA Health Care Institute, Anderson School of Management, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Public Health Dent</MedlineTA>
        <NlmUniqueID>0014207</NlmUniqueID>
        <ISSNLinking>0022-4006</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>D</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">child</Keyword>
        <Keyword MajorTopicYN="N">health literacy</Keyword>
        <Keyword MajorTopicYN="N">oral health</Keyword>
        <Keyword MajorTopicYN="N">parents</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083725</ArticleId>
        <ArticleId IdType="doi">10.1111/jphd.12361</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>U.S Department of Health and Human Services. Healthy People 2020. Available from: http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx. Accessed in December, 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Health UDo, Committee HSOHC. US Department of Health and Human Services Oral Health Strategic Framework, 2014-2017. Public Health Rep. 2016;131(2):242-57.</Citation>
        </Reference>
        <Reference>
          <Citation>Thomson WM, Poulton R, Milne BJ, Caspi A, Broughton JR, Ayers KMS. Socioeconomic inequalities in oral health in childhood and adulthood in a birth cohort. Community Dent Oral Epidemiol. 2004;32(5):345-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Detty AMR, Oza-Frank R. Oral health status and academic performance among Ohio third-graders, 2009-2010. J Public Health Dent. 2014;74(4):336-42.</Citation>
        </Reference>
        <Reference>
          <Citation>Seirawan H, Faust S, Mulligan R. The impact of oral health on the academic performance of disadvantaged children. Am J Public Health. 2012;102(9):1729-34.</Citation>
        </Reference>
        <Reference>
          <Citation>Benyamini Y, Leventhal H, Leventhal EA. Self-rated oral health as an independent predictor of self-rated general health, self-esteem and life satisfaction. Soc Sci Med. 2004;59(5):1109-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Jokovic A, Locker D, Stephens M, Kenny D, Tompson B, Guyatt G. Validity and reliability of a questionnaire for measuring child oral-health-related quality of life. J Dent Res. 2002;81(7):459-63.</Citation>
        </Reference>
        <Reference>
          <Citation>Jin LJ, Lamster IB, Greenspan JS, Pitts NB, Scully C, Warnakulasuriya S. Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis. 2016;22(7):609-19.</Citation>
        </Reference>
        <Reference>
          <Citation>Anil S, Anand PS. Early childhood caries: prevalence, risk factors, and prevention. Front Pediatr. 2017;5(157). https://doi.org/10.3389/fped.2017.00157.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson AR, Brega AG, Campagna EJ, Braun PA, Henderson WG, Bryant LL, Batliner TS, Quissell DO, Albino J. Validation and impact of caregivers' oral health knowledge and behavior on children's oral health status. Pediatr Dent. 2016;38(1):47-54.</Citation>
        </Reference>
        <Reference>
          <Citation>Skafida V, Chambers S. Positive association between sugar consumption and dental decay prevalence independent of oral hygiene in pre-school children: a longitudinal prospective study. J Public Health (Oxf). 2018;40(3):e275-e83.</Citation>
        </Reference>
        <Reference>
          <Citation>Moynihan P, Tanner LM, Holmes RD, Hillier-Brown F, Mashayekhi A, Kelly SAM, Craig D. Systematic review of evidence pertaining to factors that modify risk of early childhood caries. JDR Clin Transl Res. 2019;4(3):202-16.</Citation>
        </Reference>
        <Reference>
          <Citation>The invisible barrier: literacy and its relationship with oral health. J Public Health Dent. 2005;65(3):174-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Firmino RT, Martins CC, LdS F, Martins Paiva S, Granville-Garcia AF, Fraiz FC et al. Association of oral health literacy with oral health behaviors, perception, knowledge, and dental treatment related outcomes: a systematic review and meta-analysis. J Public Health Dent. 2018;78(3):231-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Vann WF, Lee JY, Baker D, Divaris K. Oral health literacy among female caregivers:impact on oral health outcomes in early childhood. J Dent Res. 2010;89(12):1395-400.</Citation>
        </Reference>
        <Reference>
          <Citation>Miller E, Lee JY, DeWalt DA, Vann WF Jr. Impact of caregiver literacy on children's oral health outcomes. Pediatrics. 2010;126(1):107-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Brega AG, Thomas JF, Henderson WG, Batliner TS, Quissell DO, Braun PA et al. Association of parental health literacy with oral health of Navajo nation preschoolers. Health Educ Res. 2016;31(1):70-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee JY, Divaris K, Baker AD, Rozier RG, Lee S-YD, Vann WF Jr. Oral health literacy levels among a low-income WIC population. J Public Health Dent. 2011;71(2):152-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoeft KS, Barker JC, Shiboski S, Pantoja-Guzman E, Hiatt RA. Effectiveness evaluation of contra caries oral health education program for improving Spanish-speaking parents' preventive oral health knowledge and behaviors for their young children. Community Dent Oral Epidemiol. 2016;44(6):564-76.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson LB, Debaryshe B, Singh M, Taba S. Evaluating two oral health video interventions with early head start families. Int J Dent. 2013;2013:437830.</Citation>
        </Reference>
        <Reference>
          <Citation>Edelstein BL. Pediatric dental-focused interprofessional interventions: rethinking early childhood oral health management. Dent Clin N Am. 2017;61(3):589-606.</Citation>
        </Reference>
        <Reference>
          <Citation>Bryant LL, Quissell DO, Braun PA, Henderson WG, Johs N, George C, Smith V, Toledo N, Thomas J, Albino JE. A community-based oral health intervention in Navajo nation head start: participation factors and contextual challenges. J Community Health. 2016;41(2):340-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Quissell DO, Bryant LL, Braun PA, Cudeii D, Johs N, Smith VL, George C, Henderson WG, Albino J. Preventing caries in preschoolers: successful initiation of an innovative community-based clinical trial in Navajo nation head start. Contemp Clin Trials. 2014;37(2):242-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Administration for Children and Families. Head Start Program Facts: Fiscal Year 2018. Washington, DC, 2019. Available from: https://eclkc.ohs.acf.hhs.gov/about-us/article/head-start-program-facts-fiscal-year-2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Sivanand B, Herman A, Teutsch C, Teutsch S. Building health literacy and family engagement in Head Start communities: a case study [Internet]. Washington, DC: National Academy of Medicine; 2017 [cited 2020 Feb 18]. Available from: https://nam.edu/wp-content/uploads/2017/04/Building-Health-Literacy-and-Family-Engagement-in-Head-Start-Communities.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Herman A, Nelson BB, Teutsch C, Chung PJ. “Eat healthy, stay active!”: a coordinated intervention to improve nutrition and physical activity among head start parents, staff, and children. Am J Health Promot. 2012;27(1):e27-36.</Citation>
        </Reference>
        <Reference>
          <Citation>Teutsch SM, Herman A, Teutsch CB. How a population health approach improves health and reduces disparities: the case of head start. Prev Chronic Dis. 2016;13:E11.</Citation>
        </Reference>
        <Reference>
          <Citation>Herman A, Nelson BB, Teutsch C, Chung PJ. A structured management approach to implementation of health promotion interventions in head start. Prev Chronic Dis. 2013;10:E155.</Citation>
        </Reference>
        <Reference>
          <Citation>Nelson BB, Teutsch C, Chung PJ, Herman A. Predictors of sustained implementation of low-literacy health education programs. J Commun Med Health Educ. 2014;4(5):1-5.</Citation>
        </Reference>
        <Reference>
          <Citation>Collins CC, Villa-Torres L, Sams LD, Zeldin LP, Divaris K. Framing young childrens oral health: a participatory action research project. PLoS One. 2016;11(8):e0161728-e.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083726</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The New phytologist</Title>
          <ISOAbbreviation>New Phytol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Systemin-mediated long-distance systemic defense responses.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nph.16495</ELocationID>
        <Abstract>
          <AbstractText>Systemin, a peptide plant hormone of 18 amino acids coordinates local and systemic immune responses. The activation of the canonical systemin-mediated systemic signaling pathway involves systemin release from its precursor prosystemin, systemin binding to its membrane receptor SYSTEMIN RECEPTOR1 (SYR1), and the transport of long-distance signaling molecules, including jasmonic acid, the prosystemin mRNA, volatile organic compounds and possibly systemin itself. Here, we review emerging evidence that the disordered structure and unconventional processing and secretion of systemin contribute to regulation of systemin-mediated signaling during plant defense. We highlight recent advances in systemin research, which elucidated how cells integrates multiple long-distance signals in the systemic defense response. In addition, we discuss the perception of systemin by SYR1 and its mediation of downstream defense responses.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Haiyan</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4803-9655</Identifier>
            <AffiliationInfo>
              <Affiliation>Tianjin Key Laboratory of Animal and Plant Resistance, College of Life Sciences, Tianjin Normal University, Tianjin, 300387, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Plant Molecular Physiology, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Jinxing</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9338-1356</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Plant Molecular Physiology, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Biological Sciences, Beijing Forestry University, Beijing, 100083, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>New Phytol</MedlineTA>
        <NlmUniqueID>9882884</NlmUniqueID>
        <ISSNLinking>0028-646X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">jasmonic acid</Keyword>
        <Keyword MajorTopicYN="N">protein processing</Keyword>
        <Keyword MajorTopicYN="N">receptor-like kinase</Keyword>
        <Keyword MajorTopicYN="N">systemic defense</Keyword>
        <Keyword MajorTopicYN="N">systemin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083726</ArticleId>
        <ArticleId IdType="doi">10.1111/nph.16495</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083727</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1466-7657</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>67</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International nursing review</Title>
          <ISOAbbreviation>Int Nurs Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nursing Now 2020: the Nightingale Challenge.</ArticleTitle>
        <Pagination>
          <MedlinePgn>7-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/inr.12579</ELocationID>
        <Abstract>
          <AbstractText>Global healthcare expenditure is increasing, along with the numbers of older patients with multiple comorbidities, while the numbers of health workers are hugely decreasing, and many nursing and midwifery vacancies remain unfilled. With the World Health Organization declaring 2020 the Year of the Nurse and Midwife, and commencing the Nursing Now campaign with partners including the International Council of Nurses and the International Confederation of Midwives, has allowed these professions to unite, encourage advocacy and the call for global investment in nursing and midwifery. These actions will permit these professions to address universal health coverage, global inconsistencies of professional practice, and recruitment and retention. The Nightingale Challenge seeks to place early career nurses and midwives at the forefront of transformation, calling on employers worldwide to invest and provide nursing leadership development, and to become a key part of the solution to address the issues of providing universal health coverage, promoting gender equality and supporting economic growth. This will help place them at the heart of tackling 21st century health challenges.</AbstractText>
          <CopyrightInformation>© 2020 International Council of Nurses.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bayliss-Pratt</LastName>
            <ForeName>Lisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>The Nightingale Challenge.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daley</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>The Nightingale Challenge.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhattacharya-Craven</LastName>
            <ForeName>Adrita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>The Nightingale Challenge.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Nurs Rev</MedlineTA>
        <NlmUniqueID>7808754</NlmUniqueID>
        <ISSNLinking>0020-8132</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advocacy</Keyword>
        <Keyword MajorTopicYN="N">Global Health Care</Keyword>
        <Keyword MajorTopicYN="N">Midwives</Keyword>
        <Keyword MajorTopicYN="N">Nightingale Challenge</Keyword>
        <Keyword MajorTopicYN="N">Nurses</Keyword>
        <Keyword MajorTopicYN="N">Nursing Leadership</Keyword>
        <Keyword MajorTopicYN="N">Universal Health Coverage</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083727</ArticleId>
        <ArticleId IdType="doi">10.1111/inr.12579</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>All-Party Parliamentary Group on Global Health (2016) Triple Impact: How developing nursing will improve health, promote gender equality and support economic growth. London: All-Party Parliamentary Group on Global Health, p. 4. Available from: https://www.who.int/hrh/com-heeg/digital-APPG_triple-impact.pdf?ua=1 (accessed 12 Jan 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Casey, M., et al. (2018) Enablers and challenges to advanced nursing and midwifery practice roles. Journal of Nursing Management. 27(2):271-277.</Citation>
        </Reference>
        <Reference>
          <Citation>Charlesworth, A., Gershlick, B., Firth, Z., Kraidler, J. &amp; Watt, T. (2019) Briefing: Investing in The NHS Long Term Plan. June. The Health Foundation. Available from: https://www.health.org.uk/publications/reports/investing-in-the-nhs-long-term-plan (accessed 31 Jan 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Commonwealthfund.org. (2020) Brazil’s family health strategy: Using community health care workers to provide primary care|Commonwealth Fund. Available at: https://www.commonwealthfund.org/publications/case-study/2016/dec/brazils-family-health-strategy-using-community-health-care-workers (accessed 15 Jan 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Global Burden of Disease Health Financing Collaborator Network (2018) Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. The Lancet, 389, 2005-2030.</Citation>
        </Reference>
        <Reference>
          <Citation>Gunn, V., et al. (2019) Nursing professionalization and welfare state policies: A critical review of structural factors influencing the development of nursing and the nursing workforce. Nurs Inq, 26 (1), e12263. https://doi.org/10.1111/nin.12263.</Citation>
        </Reference>
        <Reference>
          <Citation>Limb, M. (2016) World will lack 18 million health workers by 2030 without adequate investment, warns UN. BMJ, 354, i5169. https://doi.org/10.1136/bmj.i5169.</Citation>
        </Reference>
        <Reference>
          <Citation>McDonald, K. M., et al. (2019) Incorporating theory into practice: Reconceptualizing exemplary care coordination initiatives from the US Veterans Health Delivery System. Journal of General Internal Medicine, 34 (S1), 24-29. https://doi.org/10.1007/s11606-019-04969-w.</Citation>
        </Reference>
        <Reference>
          <Citation>Nelson-Brantley, H., et al. (2019) Grassroots to global: The future of nursing leadership. The Journal of Nursing Administration, 49(3), pp. 118-120. Available at: https://journals.lww.com/jonajournal/Abstract/2019/03000/Grassroots_to_Global The_Future_of_Nursing. 4.aspx (accessed 12 Jan 2020). https://doi.org/10.1097/NNA.0000000000000723.</Citation>
        </Reference>
        <Reference>
          <Citation>NHS England (2020) South Coast Medical Group Primary Care Network: Supporting the demand on primary care. Available at: https://www.england.nhs.uk/gp/case-studies/south-coast-medical-group-primary-care-network-supporting-the-demand-on-primary-care/ accessed 15 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Nursing Now (2020) Nursing Now: Vision. Available at: https://www.nursingnow.org/vision/ accessed 12 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Nursing Now (2020) Participating organisations. Available at: https://www.nursingnow.org/participating-organisations/ accessed 12 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Nursing Now (2020) About the Nightingale Challenge. Available at: https://www.nursingnow.org/about-nightingale/ accessed 15 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>UHC2030, (2020) International Council of Nurses: Why nurses are so important for UHC. Available at: https://www.uhc2030.org/news-events/partner-insights/international-council-of-nurses-why-nurses-are-so-important-for-uhc-555297/ accessed 15 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations (2019) World population prospects 2019. Accessed from https://population.un.org/wpp/Publications/Files/WPP2019_Highlights.pdf (accessed 12 Jan 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2016) Global strategic directions for strengthening nursing and midwifery 2016-2020 Available from: https://www.who.int/hrh/nursing_midwifery/global-strategic-midwifery2016-2020.pdf?ua=1 (accessed 10 Jan 2020).</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083728</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1466-7657</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>67</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International nursing review</Title>
          <ISOAbbreviation>Int Nurs Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global challenges in health and health care for nurses and midwives everywhere.</ArticleTitle>
        <Pagination>
          <MedlinePgn>4-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/inr.12578</ELocationID>
        <Abstract>
          <AbstractText>The next decade is likely to produce any number of global challenges that will affect health and health care, including pan-national infections such as the new coronavirus COVID-19 and others that will be related to global warming. Nurses will be required to react to these events, even though they will also be affected as ordinary citizens. The future resilience of healthcare services will depend on having sufficient numbers of nurses who are adequately resourced to face the coming challenges.</AbstractText>
          <CopyrightInformation>© 2020 International Council of Nurses.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Catton</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>International Council of Nurses, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Nurs Rev</MedlineTA>
        <NlmUniqueID>7808754</NlmUniqueID>
        <ISSNLinking>0020-8132</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19 recruitment and retention</Keyword>
        <Keyword MajorTopicYN="N">Year of the Nurse and Midwife</Keyword>
        <Keyword MajorTopicYN="N">climate change</Keyword>
        <Keyword MajorTopicYN="N">coronavirus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083728</ArticleId>
        <ArticleId IdType="doi">10.1111/inr.12578</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>International Council of Nurses (2018) Nurses, Climate Change and Health. Revised. Available from: https://www.icn.ch/sites/default/files/inline-files/ICN%20PS%20Nurses%252c%20climate%20change%20and%20health%20FINAL%20.pdf (accessed 31 Jan 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>International Council of Nurses. (2019). Core Competencies in Disaster Nursing. Version 2.0. Available from: https://www.icn.ch/sites/default/files/inline-files/ICN_Disaster-Comp-Report_WEB.pdf (accessed 31 Jan 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>International Council of Nurses (2020) Pope acknowledges the International Year of the Nurse and Midwife, praising ‘the noblest of professions’. Available at: https://www.icn.ch/news/pope-acknowledges-international-year-nurse-and-midwife-praising-noblest-professions accessed 31 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Watts, N. (2019) The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate. The Lancet, 394 (10211), 1836-1878. https://doi.org/10.1016/S0140-6736(19)32596-6.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2020a) Year of the Nurse and Midwife 2020. Available from: https://www.who.int/news-room/campaigns/year-of-the-nurse-and-the-midwife-2020 accessed 31 Jan 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2020b) Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) accessed 31 Jan 2020.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083729</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1466-7657</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>67</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International nursing review</Title>
          <ISOAbbreviation>Int Nurs Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nursing science and health policy - opportunities in the year of the nurse and the midwife.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-3</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/inr.12577</ELocationID>
        <Abstract>
          <AbstractText>The 2020 International Year of the Nurse and the Midwife is an important opportunity to marry nursing science and health policy globally. Nurses and midwives are demonstrating strong intent towards evidence-based practice but often feel they lack the skills to implement it. Examples are provided of ways in which general and advanced practice nurses have succeeded in bringing evidence into practice and then into local and global policy.</AbstractText>
          <CopyrightInformation>© 2020 International Council of Nurses.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mitchell</LastName>
            <ForeName>Pamela H</ForeName>
            <Initials>PH</Initials>
            <AffiliationInfo>
              <Affiliation>International Nursing Review.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Nurs Rev</MedlineTA>
        <NlmUniqueID>7808754</NlmUniqueID>
        <ISSNLinking>0020-8132</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Academic-practice partnerships</Keyword>
        <Keyword MajorTopicYN="N">Evidence-based practice</Keyword>
        <Keyword MajorTopicYN="N">Nursing Research</Keyword>
        <Keyword MajorTopicYN="N">Nursing Science</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083729</ArticleId>
        <ArticleId IdType="doi">10.1111/inr.12577</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Anderson, C. (2019) Here’s What Happens When School Starts Later. http://neatoday.org/2019/02/27/what-happens-when-schools-start-later/ last accessed January 17, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Bridges, E.J. (2015) Research at the bedside: It makes a difference. American Journal of Critical Care, 24 (4), 283-289. doi: 10.4037/ajcc2015586.</Citation>
        </Reference>
        <Reference>
          <Citation>El Ansari, W., et al. (2007) Nurses’ involvement in international research collaborations. Nursing Standard, 21 (26), 35-40. DOI: 10.7748/ns.21.26.35.s50</Citation>
        </Reference>
        <Reference>
          <Citation>Hauser, C. &amp; Kwai, I. (2019) November 1, 2019, New York Times. California Tells Schools to Start Later, Giving Teenagers More Sleep https://www.nytimes.com/2019/10/14/us/school-sleep-start.html. Last accessed January 1, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Heydari, A., Mazlom, S.R., Ranjbar, H. &amp; Scurlock-Evans, L. (2014) A study of Iranian nurses’ and midwives’ knowledge, attitudes and implementation of evidence-based practice: The time for change has arrived. Worldviews on Evidence Based Nursing, 11 (5), 325-331. doi: 10.1111/wvn.12052.</Citation>
        </Reference>
        <Reference>
          <Citation>Lewis, C.L. &amp; Oster, C.A. (2019) Research outcomes of implementing CEASE: An innovative, nurse-driven, evidence-based, patient-customized monitoring bundle to decrease alarm fatigue in the intensive care unit/step-down unit. Dimensions of Critical Care Nursing, 38 (3), 160-173. doi: 10.1097/DCC.0000000000000357</Citation>
        </Reference>
        <Reference>
          <Citation>Nursing Now. (2019) Nursing Now programmes. https://www.nursingnow.org/nursing-now-programmes/ last accessed January 17, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Plumer, B. &amp; Davenport, C. (2019) New York Times. A version of this article appears in print on Dec. 29, 2019, Section A, Page 1 of the New York edition with the headline: Trump Eroding Role of Science In Government.</Citation>
        </Reference>
        <Reference>
          <Citation>Powell, T.L., et al. (2019) Nursing understanding and perceptions of delirium: assessing current knowledge, attitudes, and beliefs in a burn ICU. Burn Care Research, 40 (4), 471-477. doi: 10.1093/jbcr/irz040</Citation>
        </Reference>
        <Reference>
          <Citation>Seattle Nursing Research Consortium. https://seattlenursingresearch.org/ last accessed January 14, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Thomas, K.A. (2019) Nursing research at Seattle Children's: Grassroots inquiry. Journal of Pediatric Nursing, 47, 165-166. doi: 10.1016/j.pedn.2019.04.005</Citation>
        </Reference>
        <Reference>
          <Citation>Thorsteinsson, H.S. (2013) Icelandic nurses' beliefs, skills, and resources associated with evidence-based practice and related factors: a national survey. Worldviews on Evidence Based Nursing, 10 (2), 116-126. doi: 10.1111/j.1741-6787.2012.00260.x</Citation>
        </Reference>
        <Reference>
          <Citation>Varney, E.J., et al. (2019) Blood pressure measurement error in children: Lessons in measurement reliability. Journal of Nursing Measurement, 27 (1), 114-125. doi: 10.1891/1061-3749.27.1.114</Citation>
        </Reference>
        <Reference>
          <Citation>Wagner, W., Fisher, E. &amp; Pascual, P. (2018) Whose science? A new era in regulatory “science wars”. Science, 362 (6415), 636-639. doi: 10.1126/science.aau3205</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083730</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Correlation Between Endolymphatic Hydrops and Clinical Features of Meniere Disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28576</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to investigate the grades of endolymphatic hydrops determined by gadolinium-contrast magnetic resonance (MR) and correlation to the clinical features in patients with Meniere disease.</AbstractText>
          <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective study.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A total of 24 patients suffering from unilateral Meniere disease with either definite or probable clinical diagnosis were included. The duration of vertigo, duration of tinnitus, duration of vertigo attacks, hearing thresholds, and canal paresis (CP) value of caloric tests were assessed. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging (MRI) was performed 4 hours after intravenous injection of double dose of gadobutrol (Gd) to show endolymph and perilymph, and the grades of endolymphatic hydrops were measured. Additionally, the correlation between clinical features and the grades of endolymphatic hydrops of cochlea and vestibular were evaluated.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Different grades of the endolymphatic hydrops in the impaired ear were revealed by MRI. The Spearman correlation showed a strong correlation between the hearing thresholds of low, middle, and high tone and the grades of cochlea and vestibular hydrops (P &lt; .05); However, no significant correlation between the duration of vertigo, duration of tinnitus, duration of vertigo attacks, CP value, and endolymphatic hydrops was determined (P &gt; .05).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">By visualizing the endolymph and perilymph of inner ear in patients with Meniere disease assisted with intravenous injection of double doses of Gd, the grades of endolymphatic hydrops could be assessed. As a result, the grades of endolymphatic hydrops in patients with Meniere disease can be used to predict the level of hearing impairment.</AbstractText>
          <AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">4 Laryngoscope, 2020.</AbstractText>
          <CopyrightInformation>© 2020 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Weidong</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3323-6952</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hui</LastName>
            <ForeName>Lian</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Ling</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Jingyi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Songbai</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, First Hospital of China Medical University, Shenyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MRI</Keyword>
        <Keyword MajorTopicYN="N">Meniere disease</Keyword>
        <Keyword MajorTopicYN="N">clinical features</Keyword>
        <Keyword MajorTopicYN="N">endolymphatic hydrops</Keyword>
        <Keyword MajorTopicYN="N">gadobutrol</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083730</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28576</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Nakashima T, Pyykkö I, Arroll MA, et al. Meniere's disease. Nat Rev Dis Primers 2016;2:16028.</Citation>
        </Reference>
        <Reference>
          <Citation>Havia M, Kentala E. Prevalence of Meniere's disease in general population of southern Finland. Otolaryngol Head Neck Surg 2005;133:762-768.</Citation>
        </Reference>
        <Reference>
          <Citation>Hallpike CS, Cairns C. Observations on the pathology of Ménière's syndrome. Proc R Soc Med 1938;31:1317-1336.</Citation>
        </Reference>
        <Reference>
          <Citation>Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Meniere's disease. J Vestib Res 2015;25:1-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Brantberg K, Baloh RW. Similarity of vertigo attacks due to Meniere's disease and benign recurrent vertigo, both with and without migraine. Acta Otolaryngol 2011;131:722-727.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117:415-420.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakashima T, Naganawa S, Teranishi M. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meniere's disease. Acta Otolaryngol 2010;130:338-343.</Citation>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Kawai H, Sone M, Ikeda M. Ratio of vestibular endolymph in patients with isolated lateral semicircular canal dysplasia. Magn Reson Med Sci 2015;14:203-210.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen X, Zhang XD, Gu X, Fang ZM, Zhang R. Endolymphatic space imaging in idiopathic sudden sensorineural hearing loss with vertigo. Laryngoscope 2012;122:2265-2268.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakashima T, Naganawa S, Pyykko I. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009;129:5-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Pyykko I, Zou J, Poe D, Nakashima T, Naganawa S. Magnetic resonance imaging of the inner ear in Meniere's disease. Otolaryngol Clin North Am 2010;43:1059-1080.</Citation>
        </Reference>
        <Reference>
          <Citation>Gurkov R, Flatz W, Louza J, Strupp M, Krause E. In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol 2011;268:1743-1748.</Citation>
        </Reference>
        <Reference>
          <Citation>Salt AN, King EB, Hartsock JJ, Gill RM, O'Leary SJ. Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs. Hear Res 2012;283:14-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30:645-648.</Citation>
        </Reference>
        <Reference>
          <Citation>Iida T, Teranishi M, Yoshida T, et al. Magnetic resonance imaging of the inner ear after both intratympanic and intravenous gadolinium injections. Acta Otolaryngol 2013;133:434-438.</Citation>
        </Reference>
        <Reference>
          <Citation>Fiorino F, Pizzini FB, Beltramello A, Mattellini B, Barbieri F. Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Meniere's disease. Otol Neurotol 2011;32:472-477.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamazaki M, Naganawa S, Kawai H, Sone M, Nakashima T. Gadolinium distribution in cochlear perilymph: differences between intratympanic and intravenous gadolinium injection. Neuroradiology 2012;54:1161-1169.</Citation>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Nakashima T. Visualization of endolymphatic hydrops with MR imaging in patients with Meniere's disease and related pathologies: current status of its methods and clinical significance. Jpn J Radiol 2014;32:191-204.</Citation>
        </Reference>
        <Reference>
          <Citation>Shi S, Guo P, Wang W. Magnetic resonance imaging of Meniere's disease after intravenous administration of gadolinium. Ann Otol Rhinol Laryngol 2018;127:777-782.</Citation>
        </Reference>
        <Reference>
          <Citation>Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003;114:563-572.</Citation>
        </Reference>
        <Reference>
          <Citation>Sieber MA, Lengsfeld P, Frenzel T, et al. Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol 2008;18:2164-2173.</Citation>
        </Reference>
        <Reference>
          <Citation>Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.</Citation>
        </Reference>
        <Reference>
          <Citation>Kimura RS. Animal models of endolymphatic hydrops. Am J Otolaryngol 1982;3:447-451.</Citation>
        </Reference>
        <Reference>
          <Citation>Horner KC. Functional changes associated with experimentally induced endolymphatic hydrops. Hear Res 1993;68:1-18.</Citation>
        </Reference>
        <Reference>
          <Citation>Shi S, Guo P, Li W, Wang W. Clinical features and endolymphatic hydrops in patients with MRI evidence of hydrops. Ann Otol Rhinol Laryngol 2019;128:286-292.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu Q, Dai C, Zhao M, Sha Y. The correlation between symptoms of definite Meniere's disease and endolymphatic hydrops visualized by magnetic resonance imaging. Laryngoscope 2016;126:974-979.</Citation>
        </Reference>
        <Reference>
          <Citation>Albera R, Canale A, Cassandro C, Albera A, Sammartano AM, Dagna F. Relationship between hearing threshold at the affected and unaffected ear in unilateral Meniere's disease. Eur Arch Otorhinolaryngol 2016;273:51-56.</Citation>
        </Reference>
        <Reference>
          <Citation>Merchant SN, Adams JC. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;25:74-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Kato M, Teranishi M, Katayama N. Association between endolymphatic hydrops as revealed by magnetic resonance imaging and caloric response. Otol Neurotol 2011;32:1480-1485.</Citation>
        </Reference>
        <Reference>
          <Citation>Guo P, Sun W, Shi S, Zhang F, Wang J, Wang W. Quantitative evaluation of endolymphatic hydrops with MRI through intravenous gadolinium administration and VEMP in unilateral definite Meniere's disease. Eur Arch Otorhinolaryngol 2019;276:993-1000.</Citation>
        </Reference>
        <Reference>
          <Citation>Park M, Lee HS, Kim H, Oh SH, Lee JH, Suh MW. Differences in perilymphatic space enhancement and adverse inflammatory reaction after intratympanic injection of two different gadolinium agents: a 9.4-T magnetic resonance imaging study. Hear Res 2016;333:118-126.</Citation>
        </Reference>
        <Reference>
          <Citation>Choi, JE, et al., Morphological correlation between caloric tests and vestibular hydrops in Meniere's disease using intravenous Gd enhanced inner ear MRI. PLoS One 2017;12:1-12.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083731</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Geriatric Nutritional Risk Index as a Prognostic Factor in Patients with Advanced Head and Neck Cancer.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28587</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The Geriatric Nutritional Risk Index (GNRI) is a simple and well-established nutritional assessment tool and is a significant prognostic factor in various cancers. However, the role of the GNRI in predicting clinical outcomes in patients with advanced head and neck cancer (AHNC) has not been investigated. The aim of the present study was to examine the association between the GNRI and prognosis in patients with AHNC.</AbstractText>
          <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Data collected between 2002 and 2013 from Tsukuba University Hospital were reviewed. The GNRI was calculated according to the equation, 1.489 × serum albumin (g/l) + 41.7 × (body weight/ideal body weight). Characteristics and prognosis were compared among three risk groups: high (GNRI &lt;82); intermediate (GNRI 82-98); and normal (GNRI &gt;98). The primary endpoint was overall survival.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 248 AHNC patients were enrolled, among whom 134 (54%) exhibited no nutritional risk, 53 (21%) had an intermediate risk for malnutrition, and 61 (25%) exhibited a high risk for malnutrition. Three-year survival rates according to the three-group GNRI scores for normal, intermediate, and high risk were 76.6%, 56.3%, and 19.5%, respectively. As the three-group GNRI score increased, the risk for mortality significantly increased (adjusted hazard ratio [HR] for intermediate to normal, 1.73 [95% CI, 1.02-2.92]; adjusted HR for high to normal, 4.31 [95% CI, 2.71-6.84]).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The GNRI could be considered a useful prognostic factor in patients with AHNC.</AbstractText>
          <AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">4 Laryngoscope, 2020.</AbstractText>
          <CopyrightInformation>© 2020 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nakayama</LastName>
            <ForeName>Masahiro</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9285-7877</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gosho</LastName>
            <ForeName>Masahiko</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics , Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adachi</LastName>
            <ForeName>Masahiro</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ii</LastName>
            <ForeName>Rieko</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsumoto</LastName>
            <ForeName>Shin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miyamoto</LastName>
            <ForeName>Hidetaka</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirose</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishimura</LastName>
            <ForeName>Bungo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tanaka</LastName>
            <ForeName>Shuho</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wada</LastName>
            <ForeName>Tetsuro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tabuchi</LastName>
            <ForeName>Keiji</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advanced head and neck cancer, GNRI, hazard ratio, overall survival, prognostic factor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083731</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28587</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 2016;375:1856-1867.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakayama M, Tabuchi K, Hara A. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer. Head Neck 2015;37:1745-1749.</Citation>
        </Reference>
        <Reference>
          <Citation>Matsumura T, Mitani Y, Oki Y, et al. Comparison of geriatric nutritional risk index scores on physical performance among elderly patients with chronic obstructive pulmonary disease. Heart Lung 2015;44:534-538.</Citation>
        </Reference>
        <Reference>
          <Citation>Komatsu M, Okazaki M, Tsuchiya K, Kawaguchi H, Nitta K. Geriatric nutritional risk index is a simple predictor of mortality in chronic hemodialysis patients. Blood Purif 2015;39:281-287.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaneko H, Suzuki S, Goto M, et al. Geriatric nutritional risk index in hospitalized heart failure patients. Int J Cardiol 2015;181:213-215.</Citation>
        </Reference>
        <Reference>
          <Citation>Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005;82:777-783.</Citation>
        </Reference>
        <Reference>
          <Citation>Wada H, Dohi T, Miyauchi K, et al. Prognostic impact of nutritional status assessed by the controlling nutritional status score in patients with stable coronary artery disease undergoing percutaneous coronary intervention. Clin Res Cardiol 2017;106:875-883.</Citation>
        </Reference>
        <Reference>
          <Citation>Shoji F, Matsubara T, Kozuma Y, et al. Preoperative geriatric nutritional risk index: a predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer. Surg Oncol 2017;26:483-488.</Citation>
        </Reference>
        <Reference>
          <Citation>Kanemasa Y, Shimoyama T, Sasaki Y, Hishima T, Omuro Y. Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma. Ann Hematol 2018;97:999-1007.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamada K, Furuya R, Takita T, et al. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008;87:106-113.</Citation>
        </Reference>
        <Reference>
          <Citation>Shah B, Sucher K, Hollenbeck CB. Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract 2006;21:312-319.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakayama M, Gosho M, Hirose Y, et al. Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer. Head Neck 2018;40:1138-1146.</Citation>
        </Reference>
        <Reference>
          <Citation>McMillan DC. The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev 2013;39:534-540.</Citation>
        </Reference>
        <Reference>
          <Citation>Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974;19:716-723.</Citation>
        </Reference>
        <Reference>
          <Citation>Wada H, Dohi T, Miyauchi K, et al. Prognostic impact of the geriatric nutritional risk index on long-term outcomes in patients who underwent percutaneous coronary intervention. Am J Cardiol 2017;119:1740-1745.</Citation>
        </Reference>
        <Reference>
          <Citation>Pressoir M, Desne S, Berchery D, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 2010;102:966-971.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamana I, Takeno S, Shimaoka H, et al. Geriatric nutritional risk index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study. Int J Surg 2018;56:44-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Bo Y, Wang K, Liu Y, et al. The geriatric nutritional risk index predicts survival in elderly esophageal squamous cell carcinoma patients with radiotherapy. PLoS One 2016;11:e0155903.</Citation>
        </Reference>
        <Reference>
          <Citation>Miyake H, Tei H, Fujisawa M. Geriatric nutrition risk index is an important predictor of cancer-specific survival, but not recurrence-free survival, in patients undergoing surgical resection for non-metastatic renal cell carcinoma. Curr Urol 2017;10:26-31.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083732</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Treatment of Vestibular Migraine: A Systematic Review and Meta-analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28546</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the efficacy of the various therapies used for the prevention of vestibular migraine (VM).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Primary studies were identified though PubMed, Scopus, PsycINFO, and Cochrane Library by two independent investigators for articles published through April 2019. The search identified randomized comparison or observational studies pertaining to vestibular migraine treatment. Meta-analysis was performed on pre- and posttreatment Dizziness Handicap Inventory, vertigo frequency, and percentage of perceived improvement.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Literature search identified 13 studies that reported sufficient outcome measures to be included in the analysis. Patients with VM had a mean age of 43.3 years with female-to-male gender ratio of 2.1:1. Classes of therapeutic agents included antiepileptic drugs, calcium channel blockers, tricyclic antidepressants, β-blockers, serotonin and norepinephrine reuptake inhibitors, and vestibular rehabilitation. All treatment options that were analyzed demonstrated improvement in all of the outcome parameters, but due to significant heterogeneity and lack of standardized reporting on outcomes, establishment of preferred treatment modality could not be determined.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Various treatment modalities have been evaluated for preventative treatment of VM. Physician familiarity, patient comorbidities, and the side-effect profiles of various interventions likely influence the selection of intervention. Future randomized controlled trials with restrictive inclusion criteria and generalizable standardized outcome measures will allow for more robust meta-analyses and for more evidence-based treatment of vestibular migraines. Laryngoscope, 2020.</AbstractText>
          <CopyrightInformation>© 2020 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Byun</LastName>
            <ForeName>Young Jae</ForeName>
            <Initials>YJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2485-4089</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Central Florida College of Medicine, Orlando, Florida.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Levy</LastName>
            <ForeName>Dylan A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Quinnipiac University Frank H. Netter MD School of Medicine, North Haven, Connecticut.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nguyen</LastName>
            <ForeName>Shaun A</ForeName>
            <Initials>SA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0664-4571</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brennan</LastName>
            <ForeName>Emily</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Research and Education Services, Medical University of South Carolina Library, Charleston, South Carolina, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rizk</LastName>
            <ForeName>Habib G</ForeName>
            <Initials>HG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Vestibular migraine</Keyword>
        <Keyword MajorTopicYN="N">dizziness</Keyword>
        <Keyword MajorTopicYN="N">headache</Keyword>
        <Keyword MajorTopicYN="N">migraine</Keyword>
        <Keyword MajorTopicYN="N">treatment</Keyword>
        <Keyword MajorTopicYN="N">vertigo</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083732</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28546</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol 2018;39:1037-1044.</Citation>
        </Reference>
        <Reference>
          <Citation>Sohn JH. Recent advances in the understanding of vestibular migraine. Behav Neurol 2016;2016:1801845.</Citation>
        </Reference>
        <Reference>
          <Citation>Geser R, Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol 2012;3:169.</Citation>
        </Reference>
        <Reference>
          <Citation>Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001;56:436-441.</Citation>
        </Reference>
        <Reference>
          <Citation>Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res 2012;22:167-172.</Citation>
        </Reference>
        <Reference>
          <Citation>Cha YH, Baloh RW. Migraine associated vertigo. J Clin Neurol 2007;3:121-126.</Citation>
        </Reference>
        <Reference>
          <Citation>Baloh RW, Jen JC. Genetics of familial episodic vertigo and ataxia. Ann N Y Acad Sci 2002;956:338-345.</Citation>
        </Reference>
        <Reference>
          <Citation>Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 1997;106:182-189.</Citation>
        </Reference>
        <Reference>
          <Citation>Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992;32:300-304.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998;108:1-28.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee SH, Jeong SH, Kim JS, et al. Effect of prophylactic medication on associated dizziness and motion sickness in migraine. Otol Neurotol 2018;39:e45-e51.</Citation>
        </Reference>
        <Reference>
          <Citation>Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013;6:CD010609.</Citation>
        </Reference>
        <Reference>
          <Citation>Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 2006;116:1782-1786.</Citation>
        </Reference>
        <Reference>
          <Citation>Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002;23:364-371.</Citation>
        </Reference>
        <Reference>
          <Citation>Maldonado Fernandez M, Birdi JS, Irving GJ, Murdin L, Kivekas I, Strupp M. Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev 2015;6:CD010600.</Citation>
        </Reference>
        <Reference>
          <Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.</Citation>
        </Reference>
        <Reference>
          <Citation>Oxford Centre for Evidence-Based Medicine. The Oxford Levels of Evidence 2. Available at: http://www.cebm.net/index.aspx?o=5653. Published 2016. Accessed June 21, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Higgns JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Chichester, United Kingdom: The Cochrane Collaboration; 2011. Available at: www.handbook.cochrane.org. Accessed June 21, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Borenstein M, Hedges LV, JPT H, Rothstein HR. Introduction to Meta-analysis. Chichester, United Kingdom: John Wiley &amp; Sons; 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat 1950;21:607-611.</Citation>
        </Reference>
        <Reference>
          <Citation>Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb 2004;2:103-108.</Citation>
        </Reference>
        <Reference>
          <Citation>Iwasaki S, Ushio M, Chihara Y, Ito K, Sugasawa K, Murofushi T. Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. Acta Otolaryngol Suppl 2007;559:45-49.</Citation>
        </Reference>
        <Reference>
          <Citation>Jay-du Preez T, van Papendorp D. Migraine-associated vertigo and dizziness as presenting complaint in a private general medical practice. S Afr Fam Pract 2011;53:165-169.</Citation>
        </Reference>
        <Reference>
          <Citation>Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol 2014;271:2931-2936.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu F, Ma T, Che X, Wang Q, Yu S. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 2017;8:524.</Citation>
        </Reference>
        <Reference>
          <Citation>Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol 2012;33:121-127.</Citation>
        </Reference>
        <Reference>
          <Citation>Salviz M, Yuce T, Acar H, Karatas A, Acikalin RM. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope 2016;126:169-174.</Citation>
        </Reference>
        <Reference>
          <Citation>Sugaya N, Arai M, Goto F. Is the headache in patients with vestibular migraine attenuated by vestibular rehabilitation? Front Neurol 2017;8:124.</Citation>
        </Reference>
        <Reference>
          <Citation>Taghdiri F, Togha M, Razeghi Jahromi S, Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus 2014;3:231.</Citation>
        </Reference>
        <Reference>
          <Citation>Teggi R, Colombo B, Gatti O, Comi G, Bussi M. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci 2015;36:1869-1873.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Ombergen A, Van Rompaey V, Van de Heyning P, Wuyts F. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol 2015;36:133-138.</Citation>
        </Reference>
        <Reference>
          <Citation>Vitkovic J, Winoto A, Rance G, Dowell R, Paine M. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol 2013;260:3039-3048.</Citation>
        </Reference>
        <Reference>
          <Citation>Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 1990;116:424-427.</Citation>
        </Reference>
        <Reference>
          <Citation>Best C, Tschan R, Eckhardt-Henn A, Dieterich M. Who is at risk for ongoing dizziness and psychological strain after a vestibular disorder? Neuroscience 2009;164:1579-1587.</Citation>
        </Reference>
        <Reference>
          <Citation>Hong SM, Kim BG, Lee BC, et al. Analysis of psychological distress after management of dizziness in old patients: multicenter study. Eur Arch Otorhinolaryngol 2012;269:39-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope 2000;110:1528-1534.</Citation>
        </Reference>
        <Reference>
          <Citation>Wrisley DM, Whitney SL, Furman JM. Vestibular rehabilitation outcomes in patients with a history of migraine. Otol Neurotol 2002;23:483-487.</Citation>
        </Reference>
        <Reference>
          <Citation>Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003;17:85-100.</Citation>
        </Reference>
        <Reference>
          <Citation>Waterston J. Neurology. 3: dizziness. Med J Aust 2000;172:506-511.</Citation>
        </Reference>
        <Reference>
          <Citation>Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-552.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim JS, Yue Q, Jen JC, Nelson SF, Baloh RW. Familial migraine with vertigo: no mutations found in CACNA1A. Am J Med Genet 1998;79:148-151.</Citation>
        </Reference>
        <Reference>
          <Citation>von Brevern M, Ta N, Shankar A, et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 2006;46:1136-1141.</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta P, Singh S, Goyal V, Shukla G, Behari M. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache 2007;47:402-412.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffmann J, Akerman S, Goadsby PJ. Efficacy and mechanism of anticonvulsant drugs in migraine. Expert Rev Clin Pharmacol 2014;7:191-201.</Citation>
        </Reference>
        <Reference>
          <Citation>Young WB, Siow HC, Silberstein SD. Anticonvulsants in migraine. Curr Pain Headache Rep 2004;8:244-250.</Citation>
        </Reference>
        <Reference>
          <Citation>Gode S, Celebisoy N, Kirazli T, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache 2010;50:77-84.</Citation>
        </Reference>
        <Reference>
          <Citation>Baier B, Winkenwerder E, Dieterich M. "Vestibular migraine": effects of prophylactic therapy with various drugs. A retrospective study. J Neurol 2009;256:436-442.</Citation>
        </Reference>
        <Reference>
          <Citation>Brodsky JR, Cusick BA, Zhou G. Evaluation and management of vestibular migraine in children: experience from a pediatric vestibular clinic. Eur J Paediatr Neurol 2016;20:85-92.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083733</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-0420</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biometrics</Title>
          <ISOAbbreviation>Biometrics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nonparametric estimation of distributions and diagnostic accuracy based on group-tested results with differential misclassification.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/biom.13236</ELocationID>
        <Abstract>
          <AbstractText>This article concerns the problem of estimating a continuous distribution in a diseased or nondiseased population when only group-based test results on the disease status are available. The problem is challenging in that individual disease statuses are not observed and testing results are often subject to misclassification, with further complication that the misclassification may be differential as the group size and the number of the diseased individuals in the group vary. We propose a method to construct nonparametric estimation of the distribution and obtain its asymptotic properties. The performance of the distribution estimator is evaluated under various design considerations concerning group sizes and classification errors. The method is exemplified with data from the National Health and Nutrition Examination Survey study to estimate the distribution and diagnostic accuracy of C-reactive protein in blood samples in predicting chlamydia incidence. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>LSC, NCMIS, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Aiyi</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6618-5082</Identifier>
            <AffiliationInfo>
              <Affiliation>Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Qizhai</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>LSC, NCMIS, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Albert</LastName>
            <ForeName>Paul S</ForeName>
            <Initials>PS</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1658-1068</Identifier>
            <AffiliationInfo>
              <Affiliation>Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biometrics</MedlineTA>
        <NlmUniqueID>0370625</NlmUniqueID>
        <ISSNLinking>0006-341X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ROC curves</Keyword>
        <Keyword MajorTopicYN="N">coverage probability</Keyword>
        <Keyword MajorTopicYN="N">diagnostic accuracy</Keyword>
        <Keyword MajorTopicYN="N">differential misclassification</Keyword>
        <Keyword MajorTopicYN="N">group testing</Keyword>
        <Keyword MajorTopicYN="N">integrated absolute bias</Keyword>
        <Keyword MajorTopicYN="N">integrated mean squared error</Keyword>
        <Keyword MajorTopicYN="N">rare disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083733</ArticleId>
        <ArticleId IdType="doi">10.1111/biom.13236</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083735</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-9170</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecology</Title>
          <ISOAbbreviation>Ecology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Variation in individual reproductive performance amplified with population size in a long-lived carnivore.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e03024</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ecy.3024</ELocationID>
        <Abstract>
          <AbstractText>Individual variation in reproductive ability is a key component of natural selection within populations, driving the evolution of life histories and population responses to changing environmental conditions. Evidence that population density affects individual-level fitness in wild populations is limited, particularly for long-lived animals which are difficult to observe on a biologically relevant scales. We tested for individual heterogeneity in reproductive performance in female grey seals (Halichoerus 16 grypus) using 35 years of mark-resighting data at Sable Island, Canada (43.93N 59.91W).We used Bayesian generalized linear mixed-effect models and multi-state open robust design mark-resight models to investigate whether population size negatively influences individual reproductive performance. We measured reproductive performance in two ways: reproductive frequency (the probability of returning to the island to breed) and annual provisioning performance (the probability of successfully weaning a pup given a female bred). Sighting histories of 1655 known-aged females with a total of 22961 pupping events were used for analysis. After accounting for effects of female age, parity, and random year effects, we found that both provisioning performance and reproductive frequency demonstrated a strong, positive correlation with population size. Among-individual variance in reproductive traits and responses to population size indicated considerable heterogeneity in overall reproductive performance. As population size grew, "robust" females increased their reproductive performance more than their more "frail" conspecifics in both reproductive traits, resulting in an amplification of differences among individuals. Consequently, simulations from posterior distributions revealed a large fitness consequence of heterogeneity in this population, with "frail" individuals having 47.1% fewer successful pups than more "robust" females (mean reproductive output ± SD: 9.12 ± 3.77 pups for frail individuals, 16.97 ± 2.94 for robust individuals). Repeatability of overall reproductive performance across environments indicates individual quality may be more influential to lifetime reproductive success than costs associated with reproductive investment. This quantification of relative fitness and its dynamics is crucial to understanding broad evolutionary processes in natural populations.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Badger</LastName>
            <ForeName>Janelle J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Wildlife, University of Alaska Fairbanks, Fairbanks, Alaska, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bowen</LastName>
            <ForeName>W Don</ForeName>
            <Initials>WD</Initials>
            <AffiliationInfo>
              <Affiliation>Bedford Institute of Oceanography, Department of Fisheries and Oceans Canada, Dartmouth, Nova Scotia, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>den Heyer</LastName>
            <ForeName>Cornelia E</ForeName>
            <Initials>CE</Initials>
            <AffiliationInfo>
              <Affiliation>Bedford Institute of Oceanography, Department of Fisheries and Oceans Canada, Dartmouth, Nova Scotia, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Breed</LastName>
            <ForeName>Greg A</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Wildlife, University of Alaska Fairbanks, Fairbanks, Alaska, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, Alaska, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecology</MedlineTA>
        <NlmUniqueID>0043541</NlmUniqueID>
        <ISSNLinking>0012-9658</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Halichoerus grypus
</Keyword>
        <Keyword MajorTopicYN="N">Bayesian statistics</Keyword>
        <Keyword MajorTopicYN="N">Individual heterogeneity</Keyword>
        <Keyword MajorTopicYN="N">grey seal</Keyword>
        <Keyword MajorTopicYN="N">life history theory</Keyword>
        <Keyword MajorTopicYN="N">mark-resight</Keyword>
        <Keyword MajorTopicYN="N">pinnipeds</Keyword>
        <Keyword MajorTopicYN="N">quality</Keyword>
        <Keyword MajorTopicYN="N">reproductive performance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083735</ArticleId>
        <ArticleId IdType="doi">10.1002/ecy.3024</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083734</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-9170</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecology</Title>
          <ISOAbbreviation>Ecology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A morphological, reproductive, and molt phenology database for 379 bird species from the Colombian Tropical Andes.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e03016</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ecy.3016</ELocationID>
        <Abstract>
          <AbstractText>The Colombian Tropical Andes are one of the regions with highest bird diversity on Earth. However, information on bird morphology, reproductive phenology, and molt is particularly scarce in this region. Also, this region is heavily impacted by deforestation, and it is vulnerable to climate change. Hence, providing baseline information on life history and morphological traits will be essential to support future research on functional diversity, climate change effects, conservation, evolution, and phenology. To fill this gap, we have compiled information on bird distribution, morphology, molt, and reproductive phenology at 52 localities of the Department of Caldas, covering an elevation range between 148 and 3845 m. This compilation comprises a wide range of habitats, including native forests, forestry plantations, croplands, and paramo. Our database presents information for 3398 records belonging to 379 bird species (representing 23 orders, 53 families, and 258 genera). From those records, 2843 correspond to information collected in the field between 2008 and 2019, and the remaining 555 records correspond to specimens deposited in the Natural History Museum of the Caldas University, collected between 1969 and 2014. We measured nine morphological traits from all specimens: total culmen, gape, bill width, bill depth, tarsus, wing length, tail length, total length, and weight. We also have reproductive condition information for 257 species and molt information available for 378 species. The information contained in this dataset represents ~20% of the Colombian avifauna and ~11% of the bird species richness in South America. This data set is released for non-commercial use only. Credits should be given to this paper (i.e., proper citation), and the products generated with this database should be shared under the same license terms (CC BY-NC-SA).</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cardona-Salazar</LastName>
            <ForeName>Leydy J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benavides-Ossa</LastName>
            <ForeName>Yeny A</ForeName>
            <Initials>YA</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vargas-Daza</LastName>
            <ForeName>Ángela M</ForeName>
            <Initials>ÁM</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Betancurt-Grisales</LastName>
            <ForeName>Juan F</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bohada-Murillo</LastName>
            <ForeName>Mauricio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martínez-Sánchez</LastName>
            <ForeName>Estefani T</ForeName>
            <Initials>ET</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cardona-Romero</LastName>
            <ForeName>Marelid</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Busi</LastName>
            <ForeName>Ana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tobón-Escobar</LastName>
            <ForeName>William D</ForeName>
            <Initials>WD</Initials>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ortíz-Giraldo</LastName>
            <ForeName>Mateo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gómez Castillo</LastName>
            <ForeName>Daniela</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alvarez-Londoño</LastName>
            <ForeName>Johnathan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Molina-Marin</LastName>
            <ForeName>Dimas A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodas-Rua</LastName>
            <ForeName>Juan C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grisales-Muñoz</LastName>
            <ForeName>Laura D</ForeName>
            <Initials>LD</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Velásquez-Trujillo</LastName>
            <ForeName>Vanessa</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salazar-Ramírez</LastName>
            <ForeName>Luisa F</ForeName>
            <Initials>LF</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pineda-Gómez</LastName>
            <ForeName>Diana M</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoyos-Jaramillo</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santisteban-Arenas</LastName>
            <ForeName>Rafael R</ForeName>
            <Initials>RR</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salazar-Ramírez</LastName>
            <ForeName>Juan G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orozco-Montoya</LastName>
            <ForeName>Gloria Patricia</ForeName>
            <Initials>GP</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramos-Valencia</LastName>
            <ForeName>Santiago A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gómez-Londoño</LastName>
            <ForeName>Germán</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de Producción Agropecuaria, Facultad de Ciencias Agropecuarias, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ospina-Bautista</LastName>
            <ForeName>Fabiola</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología, Facultad de Ciencias Exactas y Naturales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Estévez-Varón</LastName>
            <ForeName>Jaime V</ForeName>
            <Initials>JV</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología, Facultad de Ciencias Exactas y Naturales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ossa-López</LastName>
            <ForeName>Paula A</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología, Facultad de Ciencias Exactas y Naturales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rivera-Páez</LastName>
            <ForeName>Fredy A</ForeName>
            <Initials>FA</Initials>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología, Facultad de Ciencias Exactas y Naturales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pérez Cárdenas</LastName>
            <ForeName>Jorge E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación Biosalud, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de, Ciencias Básicas para la Salud, Universidad de Caldas, Facultad de Ciencias para la Salud, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fontúrbel</LastName>
            <ForeName>Francisco E</ForeName>
            <Initials>FE</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biología, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castaño-Villa</LastName>
            <ForeName>Gabriel J</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Investigación en Ecosistemas Tropicales, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genética, Biodiversidad y Manejo de Ecosistemas - GEBIOME, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de Desarrollo Rural y Recursos Naturales, Facultad de Ciencias Agropecuarias, Universidad de Caldas, Manizales, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecology</MedlineTA>
        <NlmUniqueID>0043541</NlmUniqueID>
        <ISSNLinking>0012-9658</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Avifauna</Keyword>
        <Keyword MajorTopicYN="N">Crops</Keyword>
        <Keyword MajorTopicYN="N">Endemic species</Keyword>
        <Keyword MajorTopicYN="N">Morphological traits</Keyword>
        <Keyword MajorTopicYN="N">Museum specimens</Keyword>
        <Keyword MajorTopicYN="N">Native forests</Keyword>
        <Keyword MajorTopicYN="N">Neotropical resident and migratory species</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083734</ArticleId>
        <ArticleId IdType="doi">10.1002/ecy.3016</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083736</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-9170</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecology</Title>
          <ISOAbbreviation>Ecology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Plant-soil feedback effects altered by aboveground herbivory explain plant species abundance in the landscape.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e03023</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ecy.3023</ELocationID>
        <Abstract>
          <AbstractText>Relatively little is known about how plant soil feedbacks (PSFs) may affect plant growth in field conditions where factors such as herbivory may be important. Using a potted experiment in a grassland, we measured PSFs with and without aboveground insect herbivory for 20 plant species. We then compared PSF values to plant landscape abundance. Aboveground herbivory had a large negative effect on PSF values. For 15 of 20 species, PSFs were more negative with herbivory than without. This occurred because plant biomass on 'home' soils was smaller with herbivory than without. PSF values with herbivory were correlated with plant landscape abundance while PSF values without herbivory were not. Shoot nitrogen concentrations suggested that plants create soils that increase nitrogen uptake, but that greater shoot nitrogen values increase herbivory and that the net effect of positive PSF and greater aboveground herbivory is less aboveground biomass. Results provided clear evidence that PSFs alone have limited power in explaining species abundances and that herbivory have stronger effects on plant biomass and growth on the landscape. Our results provide a potential explanation for observed differences between greenhouse and field PSF experiments and suggest that PSF experiments need to consider important biotic interactions, like aboveground herbivory, particularly when the goal of PSF research is to understand plant growth in field conditions.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Heinze</LastName>
            <ForeName>Johannes</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3556-5883</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Potsdam, Institute of Biochemistry and Biology, Maulbeerallee 1, 14469, Potsdam, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), 14195 Berlin, Germany, Altensteinstr. 6, 14195, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wacker</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9687-6477</Identifier>
            <AffiliationInfo>
              <Affiliation>Zoological Institute and Museum, University of Greifswald, Loitzer Straße 26, 17489, Greifswald, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kulmatiski</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Wildland Resources and the Ecology Center, Utah State University, Logan, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecology</MedlineTA>
        <NlmUniqueID>0043541</NlmUniqueID>
        <ISSNLinking>0012-9658</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">aboveground herbivory</Keyword>
        <Keyword MajorTopicYN="N">biotic interactions</Keyword>
        <Keyword MajorTopicYN="N">field experiment</Keyword>
        <Keyword MajorTopicYN="N">grassland</Keyword>
        <Keyword MajorTopicYN="N">landscape abundance</Keyword>
        <Keyword MajorTopicYN="N">plant-soil feedback</Keyword>
        <Keyword MajorTopicYN="N">shoot nitrogen content</Keyword>
        <Keyword MajorTopicYN="N">soil legacy effects</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083736</ArticleId>
        <ArticleId IdType="doi">10.1002/ecy.3023</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083737</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-9170</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecology</Title>
          <ISOAbbreviation>Ecology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Climate warming and heat waves alter harmful cyanobacterial blooms along the benthic-pelagic interface.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e03025</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ecy.3025</ELocationID>
        <Abstract>
          <AbstractText>In addition to a rise in mean air and water temperatures, more frequent and intense extreme climate events (such as heat waves) have been recorded around the globe during the past decades. These environmental changes are projected to further intensify in the future, and we still know little on how they will affect ecological processes driving harmful cyanobacterial bloom formation. Therefore, we conducted a long-term experiment in 400L shallow freshwater mesocosms, where we evaluated the effects of a constant +4°C increase in mean water temperatures and compared it with a fluctuating warming scenario ranging from 0 to +8°C in the short-term (i.e., including heat waves) but with the same +4°C long-term elevation in mean water temperatures. We focused on investigating not only warming effects on cyanobacterial pelagic dynamics (phenology and biomass levels), but also on their recruitment from sediments - a fundamental part of their life-history and whose response to warming remains largely unexplored. Our results demonstrate that (1) a warmer environment not only induces a seasonal advancement and boosts biomass levels of specific cyanobacterial species in the pelagic environment, but also increases their recruitment rates from the sediments, and (2) these species-specific benthic and pelagic processes respond differently depending on whether climate warming is expressed only as an increase in mean water temperatures or, in addition, through an increased warming variability (including heat waves). These results are important because they show, for the first time, that climate warming can affect cyanobacterial dynamics at different life-history stages, all the way from benthic recruitment up to their establishment in the pelagic community. Furthermore, it also highlights that both cyanobacterial benthic recruitment and pelagic biomass dynamics may be different as a result of changes in the variability of warming conditions. We argue that these findings are a critical first step to further our understanding of the relative importance of increased recruitment rates for harmful cyanobacterial bloom formation under different climate change scenarios.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Urrutia-Cordero</LastName>
            <ForeName>Pablo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9560-8374</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology/Aquatic Ecology, Lund University, Ecology building, SE-223 62, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Ecology and Genetics/Limnology, Evolutionary Biology Center, Uppsala University, Uppsala, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Helmholtz Institute for Functional Marine Biodiversity (HIFMB), Ammerländer Heerstraße 231, 26129, Oldenburg, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Chemistry and Biology of Marine Environments (ICBM), Carl-von-Ossietzky University Oldenburg, Schleusenstrasse 1, 26382, Wilhelmshaven.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Huan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology/Aquatic Ecology, Lund University, Ecology building, SE-223 62, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chaguaceda</LastName>
            <ForeName>Fernando</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0827-2110</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology/Aquatic Ecology, Lund University, Ecology building, SE-223 62, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Ecology and Genetics/Limnology, Evolutionary Biology Center, Uppsala University, Uppsala, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Geng</LastName>
            <ForeName>Hong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology/Aquatic Ecology, Lund University, Ecology building, SE-223 62, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratory for Microoganism and Bio-transformation, College of Life Science, South-Central University for Nationalities, 430074, Chima.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansson</LastName>
            <ForeName>Lars-Anders</ForeName>
            <Initials>LA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3035-1317</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology/Aquatic Ecology, Lund University, Ecology building, SE-223 62, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecology</MedlineTA>
        <NlmUniqueID>0043541</NlmUniqueID>
        <ISSNLinking>0012-9658</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Climate change</Keyword>
        <Keyword MajorTopicYN="N">climate warming</Keyword>
        <Keyword MajorTopicYN="N">cyanobacteria</Keyword>
        <Keyword MajorTopicYN="N">cyanobacterial blooms</Keyword>
        <Keyword MajorTopicYN="N">heat waves</Keyword>
        <Keyword MajorTopicYN="N">lakes</Keyword>
        <Keyword MajorTopicYN="N">mesocosms</Keyword>
        <Keyword MajorTopicYN="N">recruitment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083737</ArticleId>
        <ArticleId IdType="doi">10.1002/ecy.3025</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083738</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-9170</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecology</Title>
          <ISOAbbreviation>Ecology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The role of omnivory in mediating metacommunity robustness to habitat destruction.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e03026</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ecy.3026</ELocationID>
        <Abstract>
          <AbstractText>Omnivores have long been known to play an important role in determining the stability of ecological communities. Recent theoretical studies have suggested that they may also increase the resilience of their communities to habitat destruction, one of the major drivers of species extinctions globally. However, these outcomes were obtained for minimal food webs consisting of only a single omnivore and its prey species, while much more complex communities can be anticipated in nature. In this study, we undertake a systematic comparative analysis of the robustness of metacommunities containing various omnivory structures to habitat loss and fragmentation using a mathematical model. We observe that, in general, omnivores are better able to survive facing habitat destruction than specialist predators of similar trophic level. However, the community as a whole does not always benefit from the presence of omnivores, as they may drive their intraguild prey to extinction. We also analyze the frequency with which these modules occur in a set of empirical food webs, and demonstrate that variation in their rate of occurrence is consistent with our model predictions. Our findings demonstrate the importance of considering the complete food web in which an omnivore is embedded, suggesting that future study should focus on more holistic community analysis.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liao</LastName>
            <ForeName>Jinbao</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9520-3235</Identifier>
            <AffiliationInfo>
              <Affiliation>Ministry of Education's Key Laboratory of Poyang Lake Wetland and Watershed Research, School of Geography and Environment, Jiangxi Normal University, Ziyang Road 99, Nanchang, 330022, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bearup</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University of Kent, School of Mathematics, Statistics and Actuarial Sciences, Parkwood Road, Canterbury, CT2 7FS, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fagan</LastName>
            <ForeName>William F</ForeName>
            <Initials>WF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Maryland, College Park, MD, 20742, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecology</MedlineTA>
        <NlmUniqueID>0043541</NlmUniqueID>
        <ISSNLinking>0012-9658</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Omnivory</Keyword>
        <Keyword MajorTopicYN="N">competition capability</Keyword>
        <Keyword MajorTopicYN="N">food web persistence</Keyword>
        <Keyword MajorTopicYN="N">patch loss and fragmentation</Keyword>
        <Keyword MajorTopicYN="N">patch-dynamic model</Keyword>
        <Keyword MajorTopicYN="N">trophic-dependent dispersal</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083738</ArticleId>
        <ArticleId IdType="doi">10.1002/ecy.3026</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083739</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0215</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of cancer</Title>
          <ISOAbbreviation>Int. J. Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Efficacy of late concurrent hypo-fractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.32934</ELocationID>
        <Abstract>
          <AbstractText>Advanced melanoma patients who failed anti-PD-1 therapy have limited options. We analyzed a cohort of 133 advanced melanoma patients receiving anti-PD-1 monotherapy in a referral center between April 2015 and December 2017 and included the 26 patients with confirmed progressive (PD) or stable disease who received additional radiotherapy with an unmodified anti-PD-1 mAb regimen. Tumor evaluations were done on radiated and non-radiated (RECIST1.1) lesions, with abscopal effect defined as a partial (PR) or complete response (CR) outside radiated fields. Primary endpoint was the CR + PR rate in radiated + non-radiated lesions. Secondary endpoints were progression-free survival (PFS), melanoma-specific survival (MSS), and safety. First late radiotherapy, consisting of hypo-fractionated radiotherapy (3-5 sessions, 20-26 Gy), standard palliative radiotherapy, or brain radiosurgery was begun after a median of 6.3 months of anti-PD-1 in 23, 2, and 1 patient(s), respectively. Best response was 8 (31%) CR, 2 (8%) profound PR allowing surgical resection of remaining metastases, and 16 (62%) PD. Abscopal effect was seen in 35% of patients. Median PFS and MSS since anti-PD-1 initiation was 15.2 [95%CI: 8.0-not achieved (na)] and 35.3 [95%CI: 18.5-na] months, respectively. PFS curves seemed to achieve a plateau. We discontinued anti-PD-1 therapy in 9/10 of patients with no residual evaluable disease and observed one relapse after a median of 10 months off anti-PD1-therapy. No unusual adverse event was recorded. Limitations of the study include its retrospective nature and limited size. Hypo-fractionated radiotherapy may enhance anti-PD1 monotherapy efficacy in patients who previously failed anti-PD-1 therapy. Controlled studies are needed. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Funck-Brentano</LastName>
            <ForeName>Elisa</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baghad</LastName>
            <ForeName>Bouchra</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fort</LastName>
            <ForeName>Magali</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aouidad</LastName>
            <ForeName>Iman</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roger</LastName>
            <ForeName>Anissa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beauchet</LastName>
            <ForeName>Alain</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, Ambroise Paré hospital, APHP &amp; UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Otmezguine</LastName>
            <ForeName>Yves</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology centre, Porte de Saint-Cloud Clinic, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blom</LastName>
            <ForeName>Astrid</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Longvert</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boru</LastName>
            <ForeName>Blandine</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Ambroise-Paré hospital, APHP, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saiag</LastName>
            <ForeName>Philippe</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6500-3507</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, &amp; EA 4340 "Biomarkers in cancerology and hemato-oncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Int J Cancer</MedlineTA>
        <NlmUniqueID>0042124</NlmUniqueID>
        <ISSNLinking>0020-7136</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">abscopal effect</Keyword>
        <Keyword MajorTopicYN="N">anti-PD-1 antibody</Keyword>
        <Keyword MajorTopicYN="N">melanoma</Keyword>
        <Keyword MajorTopicYN="N">nivolumab</Keyword>
        <Keyword MajorTopicYN="N">pembrolizumab</Keyword>
        <Keyword MajorTopicYN="N">radiotherapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083739</ArticleId>
        <ArticleId IdType="doi">10.1002/ijc.32934</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083740</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The New phytologist</Title>
          <ISOAbbreviation>New Phytol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Autocrine regulation of root hair size by the RALF-FERONIA-RSL4 signaling pathway.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nph.16497</ELocationID>
        <Abstract>
          <AbstractText>Root hair (RH) size has vital physiological implications, since it influences the surface area of the root and thus the ability of the plant to absorb water and nutrients from the soil. Arabidopsis thaliana ROOT HAIR DEFECTIVE 6-LIKE 4 (RSL4), a bHLH transcription factor, controls the expression of hundreds of RH genes and RSL4 expression itself can trigger ectopic RH growth. Recent studies reveal an autocrine mechanism governing plant RH cell growth in which the extracellular peptide RAPID ALKALINIZATION FACTOR 1 (RALF1) and receptor FERONIA (FER) act at a central hub between the cell surface and downstream signaling events. RALF1-FER promotes the phosphorylation of eIF4E1. Then, phosphorylated eIF4E1 further regulates the synthesis of RH proteins, including RSL4, to promote RH growth. High levels of RSL4 exert a negative feedback on RALF1 expression via directly binding to the RALF1 gene promoter, slowing RH growth and determining final RH cell size.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Sirui</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, and Hunan Key Laboratory of Plant Functional Genomics and Developmental Regulation, Hunan University, Changsha, 410082, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martínez Pacheco</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Fundación Instituto Leloir and Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA-CONICET), Av. Patricias Argentinas 435, Buenos Aires, CP, C1405BWE, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Estevez</LastName>
            <ForeName>José M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Fundación Instituto Leloir and Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA-CONICET), Av. Patricias Argentinas 435, Buenos Aires, CP, C1405BWE, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro de Biotecnología Vegetal (CBV), Facultad de Ciencias de la Vida, Universidad Andrés Bello Santiago, 8370186, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Millennium Institute for Integrative Biology (iBio), Santiago, 8331150, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Feng</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, and Hunan Key Laboratory of Plant Functional Genomics and Developmental Regulation, Hunan University, Changsha, 410082, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Hybrid Rice, Hunan Hybrid Rice Research Center, Changsha, 410125, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>New Phytol</MedlineTA>
        <NlmUniqueID>9882884</NlmUniqueID>
        <ISSNLinking>0028-646X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Arabidopsis
</Keyword>
        <Keyword MajorTopicYN="N">FERONIA</Keyword>
        <Keyword MajorTopicYN="N">RALF1</Keyword>
        <Keyword MajorTopicYN="N">RSL4</Keyword>
        <Keyword MajorTopicYN="N">eIF4E1</Keyword>
        <Keyword MajorTopicYN="N">root hair size</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083740</ArticleId>
        <ArticleId IdType="doi">10.1111/nph.16497</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083741</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32742</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">After surgery for head and neck squamous cell carcinoma (HNSCC), decisions regarding adjuvant radiotherapy (RT) or chemoradiotherapy (CRT) are based on staging and the presence of high-risk pathology. Because higher mutant allele tumor heterogeneity (MATH; a measure of intratumor genetic heterogeneity) is associated with shorter overall survival (OS) in patients with HNSCC, the authors sought to determine whether MATH analysis might further inform these decisions.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Adjuvant therapy-associated relationships between MATH and OS were analyzed for 389 patients with HNSCC who were treated surgically. Data were obtained from The Cancer Genome Atlas and analyzed with Cox proportional hazards multiple regression accounting for 7 other patient characteristics.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The relationship between MATH and OS differed with adjuvant therapy in a way that could inform therapy decisions. Adjuvant RT alone was found to provide substantial benefit for patients having high-MATH tumors (RT vs no adjuvant therapy: hazard ratio, 0.29 [95% CI, 0.17-0.51]) but no benefit for those having low-MATH tumors. In contrast, adjuvant CRT provided no benefit beyond that of adjuvant RT for patients with high-MATH tumors but substantially improved OS among patients with low-MATH tumors (CRT vs no adjuvant therapy: hazard ratio, 0.34 [95% CI, 0.15-0.78]).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of the current analysis suggested that patients with HNSCC with high-MATH tumors who underwent surgical treatment could benefit from adjuvant RT, even when current clinical guidelines indicate otherwise. The addition of adjuvant chemotherapy for patients with high-MATH tumors would not be indicated. Adding chemotherapy might be necessary to radiosensitize low-MATH tumors to adjuvant RT. This potential predictive role of tumor MATH analysis should be evaluated in prospective clinical trials.</AbstractText>
          <CopyrightInformation>© 2020 American Cancer Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mroz</LastName>
            <ForeName>Edmund A</ForeName>
            <Initials>EA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1014-7853</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Krupal B</ForeName>
            <Initials>KB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rocco</LastName>
            <ForeName>James W</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>The Joan Levy Bisesi Foundation for Head and Neck Oncology Research</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>The Mary E. and John W. Alford Research Chair in Head and Neck Cancer at The Ohio State University</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>DE022087</GrantID>
            <Acronym>DE</Acronym>
            <Agency>NIDCR NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>Department of Otolaryngology-Head and Neck Surgery of The Ohio State University</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adjuvant radiotherapy</Keyword>
        <Keyword MajorTopicYN="N">cancer biomarkers</Keyword>
        <Keyword MajorTopicYN="N">chemoradiotherapy</Keyword>
        <Keyword MajorTopicYN="N">genetic variation</Keyword>
        <Keyword MajorTopicYN="N">intratumor heterogeneity</Keyword>
        <Keyword MajorTopicYN="N">neoplasm staging</Keyword>
        <Keyword MajorTopicYN="N">proportional hazards models</Keyword>
        <Keyword MajorTopicYN="N">squamous cell carcinoma of the head and neck</Keyword>
        <Keyword MajorTopicYN="N">surgery</Keyword>
        <Keyword MajorTopicYN="N">treatment resistance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083741</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32742</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Colevas AD, Yom SS, Pfister DG, et al. NCCN Guidelines Insights: head and neck cancers, Version 1.2018. J Natl Compr Canc Netw. 2018;16:479-490.</Citation>
        </Reference>
        <Reference>
          <Citation>Maghami E, Koyfman SA, Weiss J. Personalizing postoperative treatment of head and neck cancers. Am Soc Clin Oncol Educ Book. 2018;38:515-522.</Citation>
        </Reference>
        <Reference>
          <Citation>Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198-1205.</Citation>
        </Reference>
        <Reference>
          <Citation>Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer. 2013;119:3034-3042.</Citation>
        </Reference>
        <Reference>
          <Citation>Mroz EA, Tward AD, Hammon RJ, Ren Y, Rocco JW. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med. 2015;12:e1001786.</Citation>
        </Reference>
        <Reference>
          <Citation>Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479.</Citation>
        </Reference>
        <Reference>
          <Citation>Espiritu SMG, Liu LY, Rubanova Y, et al. The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell. 2018;173:1003-1013.e15.</Citation>
        </Reference>
        <Reference>
          <Citation>Venkatesan S, Swanton C. Tumor evolutionary principles: how intratumor heterogeneity influences cancer treatment and outcome. Am Soc Clin Oncol Educ Book. 2016;35:e141-149.</Citation>
        </Reference>
        <Reference>
          <Citation>Mroz EA, Rocco JW. The challenges of tumor genetic diversity. Cancer. 2017;123:917-927.</Citation>
        </Reference>
        <Reference>
          <Citation>Mroz EA, Rocco JW. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. Oral Oncol. 2013;49:211-215.</Citation>
        </Reference>
        <Reference>
          <Citation>Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45:1113-1120.</Citation>
        </Reference>
        <Reference>
          <Citation>National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: head and neck cancers. Accessed October 2018. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>R Development Core Team. The R Project for Statistical Computing. Accessed January 27, 2020. https://www.r-project.org</Citation>
        </Reference>
        <Reference>
          <Citation>Therneau TM. A Package for Survival Analysis in S. Accessed January 27, 2020. https://CRAN.R-project.org/package=survival</Citation>
        </Reference>
        <Reference>
          <Citation>Harrell FE Jr. rms: Regression Modeling Strategies. Accessed January 27, 2020. https://CRAN.R-project.org/package=rms</Citation>
        </Reference>
        <Reference>
          <Citation>Chen MM, Roman SA, Yarbrough WG, Burtness BA, Sosa JA, Judson BL. Trends and variations in the use of adjuvant therapy for patients with head and neck cancer. Cancer. 2014;120:3353-3360.</Citation>
        </Reference>
        <Reference>
          <Citation>Trifiletti DM, Smith A, Mitra N, et al. Beyond positive margins and extracapsular extension: evaluating the utilization and clinical impact of postoperative chemoradiotherapy in resected locally advanced head and neck cancer. J Clin Oncol. 2017;35:1550-1560.</Citation>
        </Reference>
        <Reference>
          <Citation>Lewis CM, Hessel AC, Roberts DB, et al. Prereferral head and neck cancer treatment: compliance with National Comprehensive Cancer Network treatment guidelines. Arch Otolaryngol Head Neck Surg. 2010;136:1205-1211.</Citation>
        </Reference>
        <Reference>
          <Citation>Hall SF, Irish JC, Gregg RW, Groome PA, Rohland S. Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer. Curr Oncol. 2015;22:e61-e68.</Citation>
        </Reference>
        <Reference>
          <Citation>Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW. Biological response of cancer cells to radiation treatment. Front Molec Biosci. 2014;1:24.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083742</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-9170</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ecology</Title>
          <ISOAbbreviation>Ecology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Invasive species interact with climatic variability to reduce success of natives.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e03022</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ecy.3022</ELocationID>
        <Abstract>
          <AbstractText>Plants have evolved resource-conservative and resource-acquisitive strategies to deal with variability in rainfall, but interactions with dominant invasive species may undermine these adaptations. To investigate the relative effect of invaders on species with these two strategies, we manipulated rainfall and invasive grass presence and measured demographic rates in three resource-acquisitive and three resource-conservative native annual forbs. We found that invasive grasses were harmful to all of the target species, but especially the resource-acquisitive ones, and that these effects were stronger under experimental drought. Invasive grass presence under drought lowered per capita population growth rates of acquisitive natives through increased mortality and decreased seed set. While invasive grasses also decreased per capita growth rates of resource-conservative natives, they did so by increasing mortality under experimental watering and by limiting the production of seed under experimental drought. Invasive species can thus interact with climatic fluctuations to make bad years worse for resource-acquisitive natives and good years less good for resource-conservative natives, and they may generally tend to undermine the acquisitive strategy more than the conservative one.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>LaForgia</LastName>
            <ForeName>Marina L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Plant Sciences, University of California, Davis, One Shields Drive, Davis, CA, 95616.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harrison</LastName>
            <ForeName>Susan P</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Environmental Science and Policy, University of California, Davis, One Shields Drive, Davis, CA, 95616.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Latimer</LastName>
            <ForeName>Andrew M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Plant Sciences, University of California, Davis, One Shields Drive, Davis, CA, 95616.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecology</MedlineTA>
        <NlmUniqueID>0043541</NlmUniqueID>
        <ISSNLinking>0012-9658</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">annual grassland</Keyword>
        <Keyword MajorTopicYN="N">climate change</Keyword>
        <Keyword MajorTopicYN="N">drought</Keyword>
        <Keyword MajorTopicYN="N">drought tolerance</Keyword>
        <Keyword MajorTopicYN="N">invasive species</Keyword>
        <Keyword MajorTopicYN="N">relative growth rate</Keyword>
        <Keyword MajorTopicYN="N">water use efficiency</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083742</ArticleId>
        <ArticleId IdType="doi">10.1002/ecy.3022</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083743</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2923</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Medical education</Title>
          <ISOAbbreviation>Med Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lessons From the Implementation of Developmental Progress Assessment: A Scoping Review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/medu.14136</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND/PURPOSE" NlmCategory="OBJECTIVE">Educators and researchers recently implemented developmental progress assessment (DPA) in the context of competency-based education. To reap its anticipated benefits, much still remains to be understood about its implementation. In this study, we aimed to determine the nature and extent of the current evidence on DPA, in an effort to broaden our understanding of the major goals and intended outcomes of DPA as well as the lessons learned from how it has been executed in, or applied across, educational contexts.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a scoping study informed by Arksey and O'Malley's methodology. Our search strategy yielded 2494 articles. Two team members screened them for inclusion/exclusion (90% agreement), and extracted numerical and qualitative data from 56 articles based on a pre-defined set of charting categories. The thematic analysis of the qualitative data was completed with iterative consultations and discussions until consensus was achieved for the interpretation of the results.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Tools used to document DPA include scales, milestones, and portfolios. Performances were observed in clinical or standardized contexts. We identified seven major themes in our qualitative thematic analysis: 1- Underlying aims of DPA, 2- Sources of information, 3- Barriers, 4- Contextual factors that can act as barriers or facilitators to the implementation of DPA, 5- Facilitators, 6- Observed outcomes, and 7- Documented validity evidences.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Developmental progress assessment seems to fill a need in the training of future competent health professionals. However, moving forward with a widespread implementation of DPA, factors such as lack of access to user-friendly technology and time to observe performance may render its operationalisation burdensome in the context of CBME.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>St-Onge</LastName>
            <ForeName>Christina</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5313-0456</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vachon Lachiver</LastName>
            <ForeName>Élise</ForeName>
            <Initials>É</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6934-6913</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Langevin</LastName>
            <ForeName>Serge</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boileau</LastName>
            <ForeName>Elisabeth</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8667-8012</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Family and Emergency Medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bernier</LastName>
            <ForeName>Frédéric</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre de recherche-CHUS, CIUSSS de l'Estrie-CHUS, Sherbrooke, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Aliki</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9807-6609</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Physical &amp; Occupational Therapy, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Med Educ</MedlineTA>
        <NlmUniqueID>7605655</NlmUniqueID>
        <ISSNLinking>0308-0110</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083743</ArticleId>
        <ArticleId IdType="doi">10.1111/medu.14136</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083744</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2923</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Medical education</Title>
          <ISOAbbreviation>Med Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The student is key: a realist review of educational interventions to develop analytical and non-analytical clinical reasoning ability.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/medu.14137</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Clinical reasoning refers to the cognitive processes used by individuals as they formulate a diagnosis or treatment plan. Clinical reasoning is dependent on formal and experiential knowledge. Developing the ability to acquire and recall knowledge effectively for both analytical and non-analytical cognitive processing has patient safety implications. This realist review examines the way educational interventions develop analytical and non-analytical reasoning ability in undergraduate education. A realist review is theory-driven, seeking not only to identify if an intervention works, but also understand the reasons why, for whom, and in what circumstances.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To develop understanding about the way educational interventions develop effective analytical and non-analytical clinical reasoning ability, when they do, for whom and in what circumstances.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Literature from a scoping search, combined with expert opinion and researcher experience was synthesised to generate an initial programme theory (IPT). Four databases were searched and articles relevant to the developing theory were selected as appropriate. Factors affecting educational outcomes at the individual student, teacher and wider organisational levels were investigated in order to further refine the IPT.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">28 papers contributed to the overall programme theory. The review predominantly identified evidence of mechanisms for interventions at the individual student level. Key student level factors influencing the effectiveness of interventions included an individual's self-confidence, self-efficacy and pre-existing level of knowledge. These contexts influenced a variety of educational interventions, impacting both positively and negatively on educational outcomes.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Development of analytical and non-analytical clinical reasoning ability requires activities that enhance knowledge acquisition and recall alongside the accumulation of clinical experience and opportunities to practise reasoning in real or simulated clinical environments. However, factors such as pre-existing knowledge and self-confidence influence their effectiveness, especially among individuals with 'low knowledge'. Promoting non-analytical reasoning once novices acquire more clinical knowledge is important for the development of clinical reasoning in undergraduate education.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Richmond</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2791-4294</Identifier>
            <AffiliationInfo>
              <Affiliation>Education Centre, School of Medicine, University of Nottingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cooper</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2261-7143</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Acute Medicine, University Hospitals of Derby, Burton NHS Foundation Trust, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gay</LastName>
            <ForeName>Simon</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1743-9824</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Medicine, University of Leicester, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Atiomo</LastName>
            <ForeName>William</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Education Centre, School of Medicine, University of Nottingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Rakesh</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5770-328X</Identifier>
            <AffiliationInfo>
              <Affiliation>Education Centre, School of Medicine, University of Nottingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Med Educ</MedlineTA>
        <NlmUniqueID>7605655</NlmUniqueID>
        <ISSNLinking>0308-0110</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083744</ArticleId>
        <ArticleId IdType="doi">10.1111/medu.14137</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083745</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2990</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Neuropathology and applied neurobiology</Title>
          <ISOAbbreviation>Neuropathol. Appl. Neurobiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Childhood brain tumours as epigenetic diseases.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nan.12611</ELocationID>
        <Abstract>
          <AbstractText>The study of childhood brain tumours has undergone a revolution in the past decade. A concerted, collaborative effort by researchers and clinicians worldwide, strongly supported by parent groups, has led to a remarkable over-representation of molecular data in the public domain relative to the incidence of these tumours.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jones</LastName>
            <ForeName>Chris</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8118-2296</Identifier>
            <AffiliationInfo>
              <Affiliation>CRUK Childhood Brain Tumour Centre of Excellence, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Neuropathol Appl Neurobiol</MedlineTA>
        <NlmUniqueID>7609829</NlmUniqueID>
        <ISSNLinking>0305-1846</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083745</ArticleId>
        <ArticleId IdType="doi">10.1111/nan.12611</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083746</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1472-8206</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Fundamental &amp; clinical pharmacology</Title>
          <ISOAbbreviation>Fundam Clin Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Activation of RAW264.7 macrophage by Exopolysaccharide from Aphanothece halaphytica (EPSAH) and the underlying mechanisms.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/fcp.12550</ELocationID>
        <Abstract>
          <AbstractText>Exopolysaccharide from Aphanothece halophytica (EPSAH), a potent antitumor agent and immunological adjuvant, was investigated for the activation effect on RAW264.7 macrophages and the underlying mechanisms. EPSAH could significantly enhance macrophage phagocytosis and the secretion of nitric oxide, increase the mRNA expression levels of the pro-inflammatory cytokines (IL-1β, IL-6, IL-12 and TNF-α), anti-inflammatory cytokine IL-10, and chemokines (MCP-1 and MIP-1α). When RAW264.7 cells were treated with EPSAH, the mRNA expression of TLR4 and its downstream molecules TRAF6 and MyD88 were upregulated. When TLR4 was blocked using a TLR4-specific neutralizing antibody, nitric oxide secretion from the macrophages was significantly inhibited. EPSAH was further shown to induce phosphorylation of the mitogen-activated protein kinases (MAPKs) ERK, JNK and p38, and promote cytoplasmic IκB phosphorylation and increase nuclear NF-κB p65 levels remarkably in RAW264.7 cells. These data demonstrate the capacity of EPSAH to induce macrophage activation possibly via TLR4/MyD88 pathway, which leads to the activation of its main signaling downstream molecules MAPKs and NF-κB.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ou</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1794-7861</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Shuya</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Qingfang</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Fundam Clin Pharmacol</MedlineTA>
        <NlmUniqueID>8710411</NlmUniqueID>
        <ISSNLinking>0767-3981</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Exopolysaccharide from Aphanothece halophytica (EPSAH)</Keyword>
        <Keyword MajorTopicYN="N">Macrophage activation</Keyword>
        <Keyword MajorTopicYN="N">Mitogen-activated protein kinases</Keyword>
        <Keyword MajorTopicYN="N">Nuclear factor-κB</Keyword>
        <Keyword MajorTopicYN="N">Toll-like receptor 4</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083746</ArticleId>
        <ArticleId IdType="doi">10.1111/fcp.12550</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083747</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2923</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Medical education</Title>
          <ISOAbbreviation>Med Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Empathy as Related to Gender, Age, Race/Ethnicity, Academic Background, and Career Interest: A Nationwide Study of Osteopathic Medical Students in the United States.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/medu.14138</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Research on associations between medical student empathy and demographics, academic background, and career interest is limited in number, lacks representative samples, and suffers from single institutional feature. This study was designed to fill the gap by examining associations between empathy in patient care, and gender, age, race/ethnicity, academic background, and career interest in nationwide, multi-institutional samples of medical students in the United States and to provide more definitive answers to the aforementioned associations with more confidence in the internal and external validity of the findings.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Four nationwide samples participated in this study (n=10,751). Samples 1, 2, 3, and 4 included 3,616 first-year; 2,764 second-year; 2,413 third-year; and 1,958 fourth-year students who completed a web-based survey at the end of the 2017-2018 academic year. The survey included questions on demographics, academic background, and career interest, the Jefferson Scale of Empathy, and the Infrequency Scale of the Zuckerman-Kuhlman Personality Questionnaire to control for the effect of "good impression" response bias.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Statistically significant and practically important associations were found between empathy scores and gender (in favor of women), race/ethnicity (in favor of African-American and Hispanic/Latino/Spanish), academic background (in favor of "Social/Behavioral Sciences" and "Arts &amp; Humanities" in Samples 1 and 2), and career interest (in favor of "People-Oriented" and "Psychiatry" specialties).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Special features of this study (e.g., nationwide representative samples; use of a validated instrument for measuring empathy in patient care; statistical control for the effect of "good impression" response bias; and consistency of findings in different samples from multiple institutions) provide more definitive answers to the issue of correlates of empathy in medical studentsand increase our confidence in the validity, reliability, and generalizability of the results. Findings have implications for career counselling, and targeting students who need more guidance to enhance their empathic orientation.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hojat</LastName>
            <ForeName>Mohammadreza</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8841-3269</Identifier>
            <AffiliationInfo>
              <Affiliation>Asano-Gonnella Center for Research in Medical Education and Healthcare, Sidney Kimmel Medical College at Jefferson at Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeSantis</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Asano-Gonnella Center for Research in Medical Education and Healthcare, Sidney Kimmel Medical College at Jefferson at Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shannon</LastName>
            <ForeName>Stephen</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>American Association of Colleges of Osteopathic Medicine, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Speicher</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>American Association of Colleges of Osteopathic Medicine, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bragan</LastName>
            <ForeName>Lynn</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>American Association of Colleges of Osteopathic Medicine, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calabrese</LastName>
            <ForeName>Leonard H</ForeName>
            <Initials>LH</Initials>
            <AffiliationInfo>
              <Affiliation>Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Med Educ</MedlineTA>
        <NlmUniqueID>7605655</NlmUniqueID>
        <ISSNLinking>0308-0110</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083747</ArticleId>
        <ArticleId IdType="doi">10.1111/medu.14138</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083748</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-474X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience</Title>
          <ISOAbbreviation>Int. J. Dev. Neurosci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Early weaning modulates eating behavior and promotes hypofunction of the serotonergic (5HT) system in juvenile male rats.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jdn.10018</ELocationID>
        <Abstract>
          <AbstractText>Early life stress (ELS) has been associated with developmental impairments. Early weaning is a postnatal stress model consisting of interruption of lactation and maternal care. The 5HT-system has been associated with neurobehavioral modulations promoted by ELS. Thus, the present work aims to investigate the effects of early weaning on feeding behavior and serotonergic system of juvenile male rats. For this, rats were submitted to early (PND15) or natural (PND30) weaning and had the body weight, food intake in circadian phases and food intake in response to fenfluramine assessed. mRNA expression of serotoninergic receptors (5HT1A and 5HT2C) and transporter (SERT) was assessed in the hypothalamus and brainstem, as well as NPY and POMC mRNA expression in hypothalamus. The results show that early weaning promoted changes in the percentage of weight gain during lactation period and increase in body weight at PND40. It was also observed increase of food intake in light phase but decrease in dark phase and reduction of serotonin inhibitory action on food intake. In addition, early weaning promoted increased NPY and SERT mRNA expression in the hypothalamus and 5HT2C in the brainstem. Together, the data indicate that the stress caused by early weaning impairs the eating behavior of juvenile male rats through hypofunction of the 5HT-system.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tavares</LastName>
            <ForeName>Gabriel Araújo</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Nutrition, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Nantes Université, INRAE, UMR 1280, PhAN, F-44000, Nantes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cavalcanti do Amaral Almeida</LastName>
            <ForeName>Larissa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Neuropsychiatry and Behavioral Sciences, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Araújo de Souza</LastName>
            <ForeName>Julliet</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Nutrition, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leitão de Souza</LastName>
            <ForeName>Felipe</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Nutrition, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feitosa Braz</LastName>
            <ForeName>Glauber Rudá</ForeName>
            <Initials>GR</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Neuropsychiatry and Behavioral Sciences, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Times Silva</LastName>
            <ForeName>Bruna</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Nutrition, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mayara da Silva Santos</LastName>
            <ForeName>Andresa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Nutrition, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacques Lagranha</LastName>
            <ForeName>Cláudia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Neuropsychiatry and Behavioral Sciences, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Academic Center of Vitória-CAV, Federal University of Pernambuco, Rua Alto do Reservatório, s/n - Bela Vista - Vitória de Santo Antão, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lopes de Souza</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Nutrition, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program of Neuropsychiatry and Behavioral Sciences, Federal University of Pernambuco. Av. Prof. Moraes Rego, 1235 Cidade Universitária, Recife, PE, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Int J Dev Neurosci</MedlineTA>
        <NlmUniqueID>8401784</NlmUniqueID>
        <ISSNLinking>0736-5748</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Early weaning</Keyword>
        <Keyword MajorTopicYN="N">feeding behavior</Keyword>
        <Keyword MajorTopicYN="N">fenfluramine</Keyword>
        <Keyword MajorTopicYN="N">serotonin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083748</ArticleId>
        <ArticleId IdType="doi">10.1002/jdn.10018</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083749</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1440-1681</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental pharmacology &amp; physiology</Title>
          <ISOAbbreviation>Clin. Exp. Pharmacol. Physiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1440-1681.13290</ELocationID>
        <Abstract>
          <AbstractText>B-type natriuretic peptide (BNP) exhibits roles in natriuresis and diuresis, making it an ideal drug that may aid in diuresing a fluid-overloaded patient with poor or worsening renal function. Several randomized clinical trials have tested the hypothesis that infusions of pharmacological doses of BNP to acute heart failure (HF) patients may enhance decongestion and preserve renal function in this clinical setting. Unfortunately, none of these have demonstrated beneficial outcomes. The current challenge for BNP research in acute HF lies in addressing a failure-of-concept and a reluctance to abandon an ineffective research model. Future success will necessitate a detailed understanding of the mechanism of action of BNP, as well as better integration of basic and clinical science.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Caprnda</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zulli</LastName>
            <ForeName>Anthony</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Health and Sport, Victoria University, Footscray, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shiwani</LastName>
            <ForeName>Haaris A</ForeName>
            <Initials>HA</Initials>
            <AffiliationInfo>
              <Affiliation>Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kubatka</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Experimental Carcinogenesis, Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Filipova</LastName>
            <ForeName>Slavomira</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, National Institute of Cardiovascular Diseases and Slovak Medical University, Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valentova</LastName>
            <ForeName>Vanda</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental Carcinogenesis, Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Independent Researcher, Mosjøen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gazdikova</LastName>
            <ForeName>Katarina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Bratislava, Slovak Republic.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of General Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovak Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mozos</LastName>
            <ForeName>Ioana</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Translational Research and Systems Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berukstis</LastName>
            <ForeName>Andrius</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic of Heart and Vessel Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laucevicius</LastName>
            <ForeName>Aleksandras</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic of Heart and Vessel Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rihacek</LastName>
            <ForeName>Ivan</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>2nd Department of Internal Medicine, Faculty of Medicine, Masaryk University and St, Anne´s University Hospital, Brno, Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dragasek</LastName>
            <ForeName>Jozef</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1st Department of Psychiatry, Faculty of Medicine, Pavol Jozef Safarik University and Luis Pasteur University Hospital, Kosice, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prosecky</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Brothers of Mercy Hospital, Brno, Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Egom</LastName>
            <ForeName>Emmanuel E</ForeName>
            <Initials>EE</Initials>
            <AffiliationInfo>
              <Affiliation>Egom Clinical &amp; Translational Research Services Ltd, Dartmouth, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jewish General Hospital and Lady Davis Research Institute, Montreal, Quebec, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Staffa</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>2nd Department of Surgery, Faculty of Medicine, Masaryk University and St, Anne´s University Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kruzliak</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7069-3784</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Brothers of Mercy Hospital, Brno, Czech Republic.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2nd Department of Surgery, Faculty of Medicine, Masaryk University and St, Anne´s University Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krasnik</LastName>
            <ForeName>Vladimir</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Clin Exp Pharmacol Physiol</MedlineTA>
        <NlmUniqueID>0425076</NlmUniqueID>
        <ISSNLinking>0305-1870</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">B-type natriuretic peptide</Keyword>
        <Keyword MajorTopicYN="N">clinical effectiveness</Keyword>
        <Keyword MajorTopicYN="N">heart failure</Keyword>
        <Keyword MajorTopicYN="N">pharmacotherapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083749</ArticleId>
        <ArticleId IdType="doi">10.1111/1440-1681.13290</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083750</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1344</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of labelled compounds &amp; radiopharmaceuticals</Title>
          <ISOAbbreviation>J Labelled Comp Radiopharm</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A <sup>64</sup> Cu-porphyrin based dual-modal molecular probe with integrin α<sub>v</sub> β<sub>3</sub> targeting function for tumor imaging.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jlcr.3833</ELocationID>
        <Abstract>
          <AbstractText>Pyropheophorbide-a (Pyro) is a promising multifunctional molecule for multimodal tumor imaging and tumor photodynamic therapy (PDT), but its clinical applications are seriously restricted by the limited tumor accumulation capability. Here, we designed and synthesized a small-molecule probe that achieved specific dual-modal tumor imaging based on Pyro. Briefly, a novel molecule combining Pyro, an RGD dimer peptide (3PRGD<sub>2</sub> ) and <sup>64</sup> Cu was designed and synthesized, and the obtained molecule, <sup>64</sup> Cu-Pyro-3PRGD<sub>2</sub> exhibited high tumor specificity in both positron emission tomography (PET) and optical imaging in vivo. c (RGDfk) peptide blocking significantly reduced the efficacy of the probe, which confirmed the integrin α<sub>V</sub> β<sub>3</sub> targeting of this molecular probe. <sup>64</sup> Cu-Pyro-3PRGD<sub>2</sub> had very low accumulation in normal organs and could be rapidly cleared through kidney metabolism, which prevented the potential damage to adjacent normal tissues. Overall, combining tumor targeting, dual-modal imaging and biosafety, <sup>64</sup> Cu-Pyro-3PRGD<sub>2</sub> has the potential for clinical use as a molecular imaging probe for tumor diagnosis.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Di</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8629-1739</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Kai</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Hannan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Isotopes Research Center, Peking University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biophysics, Chinese Academy of Sciences (CAS), Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xiaotong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tong</LastName>
            <ForeName>Wu</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Isotopes Research Center, Peking University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Chuangwei</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Isotopes Research Center, Peking University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Guangjie</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Isotopes Research Center, Peking University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ai</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Jiyun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biophysics, Chinese Academy of Sciences (CAS), Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Labelled Comp Radiopharm</MedlineTA>
        <NlmUniqueID>7610510</NlmUniqueID>
        <ISSNLinking>0362-4803</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Integrin αvβ3</Keyword>
        <Keyword MajorTopicYN="N">Molecular probe</Keyword>
        <Keyword MajorTopicYN="N">Optical imaging</Keyword>
        <Keyword MajorTopicYN="N">PET imaging</Keyword>
        <Keyword MajorTopicYN="N">Pyropheophorbide-a</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083750</ArticleId>
        <ArticleId IdType="doi">10.1002/jlcr.3833</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083751</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2214</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Child: care, health and development</Title>
          <ISOAbbreviation>Child Care Health Dev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Putting Positive Weight-Related Conversations into Practice: The Pilot Implementation of a Knowledge Translation Casebook.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cch.12762</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Healthcare professionals (HCPs) play an important role in discussing weight with children and their parents, but report barriers such as lack of training and supports. These barriers are especially prevalent within specialized populations such as children with Autism Spectrum Disorder (ASD). To address this, a Knowledge Translation Casebook on positive weight-related conversations was developed by a research team at a Canadian pediatric hospital. The purpose of the current pre-implementation pilot study was to explore initial acceptability and adoption of the Casebook into clinical settings.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">An interactive, multi-modal education workshop was created to provide HCPs with knowledge and training on how to have positive weight-related conversations with children and parents. Two workshops were conducted using the same curriculum, but delivered either in-person or online. Participants were drawn from a team of clinicians at a teaching hospital whose care focuses on medication management for clients with ASD, and clinicians participating in a distance-learning program on best-practice care for clients with ASD. Participants completed a demographic questionnaire, workshop evaluation, and a pre- and post-workshop questionnaire. Descriptive statistics were used to summarize demographic, questionnaire, and survey data. Answers to open-ended questions were analyzed using content analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants agreed that the workshop gave them a clear understanding of the Casebook's content, and helped them easily navigate the Casebook. Based on raw scores, self-efficacy in having weight-related conversations seemed to increase from pre- to post-workshop, but reported weight-management clinical practice scores did not change over time. However, the small sample precluded in-depth statistical analysis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The Casebook was acceptable and appeared to increase self-efficacy about having weight-related conversations with children with ASD and parents. More robust implementation strategies are needed to foster the uptake of best-practices in weight-related conversations into clinical practice. (289 words).</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bonder</LastName>
            <ForeName>Revi</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9711-851X</Identifier>
            <AffiliationInfo>
              <Affiliation>Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Institute, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Provvidenza</LastName>
            <ForeName>Christine F</ForeName>
            <Initials>CF</Initials>
            <AffiliationInfo>
              <Affiliation>Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Institute, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hubley</LastName>
            <ForeName>Darlene</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McPherson</LastName>
            <ForeName>Amy C</ForeName>
            <Initials>AC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4186-3200</Identifier>
            <AffiliationInfo>
              <Affiliation>Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Institute, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rehabilitation Sciences Institute, University of Toronto, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Child Care Health Dev</MedlineTA>
        <NlmUniqueID>7602632</NlmUniqueID>
        <ISSNLinking>0305-1862</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">casebook</Keyword>
        <Keyword MajorTopicYN="N">communication</Keyword>
        <Keyword MajorTopicYN="N">healthcare professionals</Keyword>
        <Keyword MajorTopicYN="N">knowledge translation</Keyword>
        <Keyword MajorTopicYN="N">obesity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083751</ArticleId>
        <ArticleId IdType="doi">10.1111/cch.12762</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083752</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2559</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Histopathology</Title>
          <ISOAbbreviation>Histopathology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Systematic Use of Fluorescence in situ Hybridization (FISH) and Clinicopathological Features in the Screening of PDGFRB Rearrangements of Patients with Myeloid/Lymphoid Neoplasms.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/his.14097</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">PDGFRB rearrangement defines a unique group of myeloid/lymphoid neoplasms with frequent eosinophilia and high sensitivity to tyrosine kinase inhibitors. This genetic abnormality is also rarely reported in Philadelphia-like B-lymphoblastic leukemia (B-ALL). PDGFRB rearrangement was initially thought to only occur in cases with 5q31-33 rearrangement by conventional cytogenetics; however, there are reported cases with cryptic rearrangements, suggesting the need for a broader screening strategy.</AbstractText>
          <AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We performed FISH for PDGFRB rearrangement in 197 patients, including 70 B-ALL, 10 myeloid neoplasms with 5q31-33 rearrangements, and 117 with eosinophilia (≥0.5 x 10<sup>9</sup> /L in peripheral blood or ≥ 5% in bone marrow), and identified PDGFRB rearrangement in 4/197 (2.0%) cases. In an attempt to identify clinicopathologic and genetic features that may have a stronger association with PDGFRB rearrangement, we analyzed 13 patients with confirmed PDGFRB rearrangements, including 10 myeloid neoplasms and 3 B-ALL. Of the 10 patients with myeloid neoplasms, eosinophilia was present in 8, monocytosis in 2, 5q31-33 rearrangement in 7, and abnormal bone marrow morphology in all. All patients with myeloid neoplasms showed an excellent response to imatinib including a patient in blast crisis. The three B-ALL patients presented de novo, showed no eosinophilia, had complex karyotype including 5q31-33 rearrangement, and had clinically aggressive courses with ultimate patient demise.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest a higher yield for the identification of PDGFRB rearrangement may result from an index of suspicion on patients with eosinophilia, monocytosis, bone marrow features of a myeloid neoplasm, 5q31-33 rearrangement, and patients with Philadelphia-like B-ALL.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Hong</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1780-5959</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Guilin</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loghavi</LastName>
            <ForeName>Sanam</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8980-3202</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Greipp</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Laboratory Genetics, Mayo Clinic, Rochester, Minnesota, 55905, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6821-4556</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verstovsek</LastName>
            <ForeName>Srdan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Medeiros</LastName>
            <ForeName>L Jeffrey</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reichard</LastName>
            <ForeName>Kaaren</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, 55905, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miranda</LastName>
            <ForeName>Roberto N</ForeName>
            <Initials>RN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Sa A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Histopathology</MedlineTA>
        <NlmUniqueID>7704136</NlmUniqueID>
        <ISSNLinking>0309-0167</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PDGFRB rearrangement</Keyword>
        <Keyword MajorTopicYN="N">lymphoid neoplasms</Keyword>
        <Keyword MajorTopicYN="N">myeloid neoplasms</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083752</ArticleId>
        <ArticleId IdType="doi">10.1111/his.14097</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083753</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The New phytologist</Title>
          <ISOAbbreviation>New Phytol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Convergent recruitment of 5´-hydroxylase activities by CYP75B flavonoid B-ring hydroxylases for tricin biosynthesis in Medicago legumes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nph.16498</ELocationID>
        <Abstract>
          <AbstractText>Tricin (3´,5´-dimethoxylated flavone) is a predominant flavonoid amongst monocots but occurs only in isolated and unrelated dicot lineages. Although tricin biosynthesis has been intensively studied in monocots, it remained largely elusive in tricin-accumulating dicots. We investigated a subgroup of cytochrome P450 (CYP) 75B subfamily flavonoid B-ring hydroxylases (FBHs) from two tricin-accumulating legumes, Medicago truncatula and alfalfa (M. sativa), by phylogenetic, molecular, biochemical and mutant analyses. Five Medicago cytochrome P450 CYP75B FBHs are phylogenetically distant from other legume CYP75B members. Among them, MtFBH-4, MsFBH-4 and MsFBH-10 were expressed in tricin-accumulating vegetative tissues. In vitro and in planta analyses demonstrated that these proteins catalyze 3´- and 5´-hydroxylations critical to tricin biosynthesis. A key amino acid polymorphism, T492G, at their Substrate Recognition Site 6 domain is required for the novel 5´-hydroxylation activities. M. truncatula mtfbh-4 mutants were tricin-deficient, indicating that MtFBH-4 is indispensable for tricin biosynthesis. Our results revealed that these Medicago legumes had acquired the tricin pathway through molecular evolution of CYP75B FBHs subsequent to speciation from other non-tricin-accumulating legumes. Moreover, their evolution is independent from that of grass-specific CYP75B apigenin 3´-hydroxylases/chrysoeriol 5´-hydroxylases dedicated to tricin production and Asteraceae CYP75B flavonoid 3´,5´-hydroxylases catalyzing the production of delphinidin-based pigments.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lui</LastName>
            <ForeName>Andy C W</ForeName>
            <Initials>ACW</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lam</LastName>
            <ForeName>Pui Ying</ForeName>
            <Initials>PY</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute for Sustainable Humanosphere, Kyoto University, Uji, Kyoto, 611-0011, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwun Ho</LastName>
            <ForeName>Chan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lanxiang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tobimatsu</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute for Sustainable Humanosphere, Kyoto University, Uji, Kyoto, 611-0011, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lo</LastName>
            <ForeName>Clive</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1995-3843</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, The University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>New Phytol</MedlineTA>
        <NlmUniqueID>9882884</NlmUniqueID>
        <ISSNLinking>0028-646X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Medicago truncatula
</Keyword>
        <Keyword MajorTopicYN="N">Alfalfa (Medicago sativa)</Keyword>
        <Keyword MajorTopicYN="N">dicot</Keyword>
        <Keyword MajorTopicYN="N">legume</Keyword>
        <Keyword MajorTopicYN="N">pathway evolution</Keyword>
        <Keyword MajorTopicYN="N">tricin biosynthesis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083753</ArticleId>
        <ArticleId IdType="doi">10.1111/nph.16498</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083754</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The New phytologist</Title>
          <ISOAbbreviation>New Phytol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Auxin-activated MdARF5 induces the expression of ethylene biosynthetic genes to initiate apple fruit ripening.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nph.16500</ELocationID>
        <Abstract>
          <AbstractText>The gaseous plant hormone ethylene induces the ripening of climacteric fruit, including apple (Malus domestica). Another phytohormone, auxin, is known to promote ethylene production in many horticultural crops, but the regulatory mechanism remains unclear. Here, we found that auxin application induces ethylene production in apple fruit prior to the stage of commercial harvest, when they are not otherwise capable of ripening naturally. The expression of MdARF5, a member of the auxin response factor transcription factor (TF) family involved in the auxin signaling pathway, was enhanced by treatment with the synthetic auxin naphthaleneacetic acid (NAA). Further studies revealed that MdARF5 binds to the promoter of MdERF2, encoding a TF in the ethylene signaling pathway, as well as the promoters of two 1-aminocyclopropane-1-carboxylic acid synthase (ACS) genes (MdACS3a and MdACS1) and an ACC oxidase (ACO) gene, MdACO1, all of which encode key steps in ethylene biosynthesis, thereby inducing their expression. We also observed that auxin-induced ethylene production was dependent on the methylation of the MdACS3a promoter. Our findings reveal that auxin induces ethylene biosynthesis in apple fruit through activation of MdARF5 expression.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yue</LastName>
            <ForeName>Pengtao</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Qian</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Liaoning Institute of Pomology, Xiongyue, 115009, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lyu</LastName>
            <ForeName>Tianxing</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Liaoning Institute of Pomology, Xiongyue, 115009, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xinyue</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bu</LastName>
            <ForeName>Haidong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Weiting</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Yaxiu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Aide</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7034-7021</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Horticulture, Shenyang Agricultural University, Shenyang, 110866, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>New Phytol</MedlineTA>
        <NlmUniqueID>9882884</NlmUniqueID>
        <ISSNLinking>0028-646X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ARF5</Keyword>
        <Keyword MajorTopicYN="N">DNA methylation</Keyword>
        <Keyword MajorTopicYN="N">apple</Keyword>
        <Keyword MajorTopicYN="N">auxin</Keyword>
        <Keyword MajorTopicYN="N">ethylene</Keyword>
        <Keyword MajorTopicYN="N">fruit ripening</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083754</ArticleId>
        <ArticleId IdType="doi">10.1111/nph.16500</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083755</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Muscle &amp; nerve</Title>
          <ISOAbbreviation>Muscle Nerve</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mechanisms underlying immobilization-induced muscle pain in rats.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.26840</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We investigated the mechanisms underlying immobilization-induced muscle pain in rats.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In rat skeletal muscle, pressure pain threshold (PPT) of the gastrocnemius muscle was measured, and NGF level, peripheral nerve fiber density, macrophage number, and IL-1β mRNA expression were examined. An NGF receptor inhibitor was injected intramuscularly to assess the relationship between PPT and NGF levels.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Immobilization resulted in a decrease in PPT and increases in NGF level, C fiber density, M1 macrophage number, and IL-1β mRNA expression. Injection of NGF receptor inhibitor reversed the decrease in PPT.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">NGF upregulation may be a dominant contributor to immobilization-induced muscle pain. The increases in C fiber density, M1 macrophage number, and IL-1β mRNA expression may be related to immobilization-induced muscle pain. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Oga</LastName>
            <ForeName>Satoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Locomotive Rehabilitation Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goto</LastName>
            <ForeName>Kyo</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Nagasaki Memorial Hospital, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sakamoto</LastName>
            <ForeName>Junya</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Honda</LastName>
            <ForeName>Yuichiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Nagasaki University Hospital, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sasaki</LastName>
            <ForeName>Ryo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Locomotive Rehabilitation Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Juzenkai Hospital, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishikawa</LastName>
            <ForeName>Kumiko</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Nagasaki University Hospital, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kataoka</LastName>
            <ForeName>Hideki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rehabilitation, Nagasaki Memorial Hospital, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakano</LastName>
            <ForeName>Jiro</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Origuchi</LastName>
            <ForeName>Tomoki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Locomotive Rehabilitation Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okita</LastName>
            <ForeName>Minoru</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Locomotive Rehabilitation Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Muscle Nerve</MedlineTA>
        <NlmUniqueID>7803146</NlmUniqueID>
        <ISSNLinking>0148-639X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">C fiber</Keyword>
        <Keyword MajorTopicYN="N">M1 macrophage</Keyword>
        <Keyword MajorTopicYN="N">NGF</Keyword>
        <Keyword MajorTopicYN="N">immobilization</Keyword>
        <Keyword MajorTopicYN="N">muscle pain</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083755</ArticleId>
        <ArticleId IdType="doi">10.1002/mus.26840</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083756</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1527-3350</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hepatology (Baltimore, Md.)</Title>
          <ISOAbbreviation>Hepatology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inflammation-induced LINC00665 increases the malignancy through activating PKR/NF-κB pathway in hepatocellular carcinoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.31195</ELocationID>
        <Abstract>
          <AbstractText>NF-κB signaling pathway is important for linking inflammation and tumorigenesis. Here, we characterized a NF-κB-signaling-activation induced long intergenic non-coding RNA in hepatocellular carcinoma (HCC), LINC00665 that contributes to the enhanced cell proliferation of HCC cells both in vitro and in vivo. LINC00665 physically interacts with the double-stranded RNA (dsRNA)-activated protein kinase (PKR) and enhances its activation, and maintains PKR protein stability by blocking ubiquitin/proteasome-dependent degradation, thus resulting in a positive feedback regulation of NF-κB signaling in HCC cells. Notably, HCC patients with higher LINC00665 have poorer outcomes in clinic CONCLUSION: Our findings indicate that LINC00665 is involved in the NF-κB signaling activation in HCC cells and inflammatory LINC00665/PKR/NF-κB loop plays important oncogenic roles in hepatic cancer progression and may be a potential therapeutic target.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ding</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Jingjing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huan</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yizhe</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiao</LastName>
            <ForeName>Yejun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zhen</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Zhiao</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shenglin</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9424-5073</Identifier>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yingjun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Xianghuo</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8872-668X</Identifier>
            <AffiliationInfo>
              <Affiliation>Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hepatology</MedlineTA>
        <NlmUniqueID>8302946</NlmUniqueID>
        <ISSNLinking>0270-9139</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
        <Keyword MajorTopicYN="N">Inflammation</Keyword>
        <Keyword MajorTopicYN="N">LINC00665</Keyword>
        <Keyword MajorTopicYN="N">NF-κB</Keyword>
        <Keyword MajorTopicYN="N">PKR</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083756</ArticleId>
        <ArticleId IdType="doi">10.1002/hep.31195</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083757</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1472-8206</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Fundamental &amp; clinical pharmacology</Title>
          <ISOAbbreviation>Fundam Clin Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Urolithin C increases glucose-induced ERK activation which contributes to insulin secretion.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/fcp.12551</ELocationID>
        <Abstract>
          <AbstractText>Polyphenols exert pharmacological actions through protein-mediated mechanisms and by modulating intracellular signalling pathways. We recently showed that a gut-microbial metabolite of ellagic acid named urolithin C is a glucose-dependent activator of insulin secretion acting by facilitating L-type Ca<sup>2+</sup> channel opening and Ca<sup>2+</sup> influx into pancreatic β-cells. However, it is still unknown whether urolithin C regulates key intracellular signalling proteins in β-cells. Here we report that urolithin C enhanced glucose-induced Extracellular Signal-Regulated Kinases 1/2 (ERK1/2) activation as shown by higher phosphorylation levels in INS-1 β-cells. Interestingly, inhibition of ERK1/2 with two structurally-distinct inhibitors led to a reduction of urolithin C effect on insulin secretion. Finally, we provide data to suggest that urolithin C-mediated ERK1/2 phosphorylation involved insulin signalling in INS-1 cells. Together, these data indicate that the pharmacological action of urolithin C on insulin secretion relies, in part, on its capacity to enhance glucose-induced ERK1/2 activation. Therefore, our study extends our understanding of the pharmacological action of urolithin C in β-cells. More generally, our findings revealed that urolithin C modulated the activation of key multifunctional intracellular signalling kinases which participate in the regulation of numerous biological processes.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Toubal</LastName>
            <ForeName>Slimane</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oiry</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bayle</LastName>
            <ForeName>Morgane</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cros</LastName>
            <ForeName>Gérard</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Neasta</LastName>
            <ForeName>Jérémie</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7801-4176</Identifier>
            <AffiliationInfo>
              <Affiliation>IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Fundam Clin Pharmacol</MedlineTA>
        <NlmUniqueID>8710411</NlmUniqueID>
        <ISSNLinking>0767-3981</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ERK</Keyword>
        <Keyword MajorTopicYN="N">INS-1</Keyword>
        <Keyword MajorTopicYN="N">Urolithin</Keyword>
        <Keyword MajorTopicYN="N">insulin secretion</Keyword>
        <Keyword MajorTopicYN="N">polyphenol metabolite</Keyword>
        <Keyword MajorTopicYN="N">β-cell</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083757</ArticleId>
        <ArticleId IdType="doi">10.1111/fcp.12551</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083758</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1069</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hematological oncology</Title>
          <ISOAbbreviation>Hematol Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The efficacy and safety of Epstein-Barr virus specific antigen peptide-activated cytotoxic T cells treatment for refractory or recurrent angioimmunoblastic T cell lymphoma: A prospective clinical observational study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hon.2726</ELocationID>
        <Abstract>
          <AbstractText>The efficacy and safety of Epstein-Barr virus (EBV) specific antigen peptide-activated cytotoxic T cells (CTLs) in the treatment of refractory or recurrent angioimmunoblastic T cell lymphoma(AITL)was determined in this prospective one-arm clinical study. 7 males and 2 females were enrolled with a median age of 70 years. The tumor stages were all stage III-IV. All patients had group B symptoms and IPI scores of 3-5 points. All patients received chemotherapy before CTLs infusion which the median chemotherapy cycle was 3. The diseases states before CTLs included 5 cases of disease progression (PD), 2 cases of recurrence (R), and 2 cases with residual lesions after chemotherapy. 8 patients received HLA-haploidentical EBV-specific CTLs, one patient chose autologous CTLs. The number of transfused cells was 1.67-2.38*10<sup>10</sup> for one course of CTLs therapy. 1 patient was treated with 3 courses of CTLs, 3 patients were treated with 2 courses of CTLs, and 5 patients were treated with 1 course of CTLs. During the infusion, 8 patients had fever, 1 patient had rash, and no graft-versus-host diseases were observed. The EBV-DNA decreased by more than 2 orders of magnitude in 6 patients, and the response rate was 66.7%. Two patients of PD status achieved completer remission (CR), one patient of PD status achieved partial remission (PR), two patients with residual lesions after chemotherapy achieved CR, and 4 patients had no response. The objective remission rate(ORR )was 55.6%. After the median follow-up of 14.5 months, 5 patients died, and 3 patients were completely relieved while 1 patient was lost during follow-up. The 3-year overall survival (OS) was 44.4% and 3-year progression-free survival (PFS) was 33.3%. EBV-specific antigen peptide-activated CTLs showed positive effect in certain patients with refractory and recurrent angioimmunoblastic T cell lymphoma with high clinical safety. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bingjie</LastName>
            <ForeName>Wang</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4426-5863</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Peking University First Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lihong</LastName>
            <ForeName>Wang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Peking University First Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yongjin</LastName>
            <ForeName>Shi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Peking University First Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huihui</LastName>
            <ForeName>Liu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Peking University First Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jinping</LastName>
            <ForeName>Ou</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Peking University First Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xi'nan</LastName>
            <ForeName>Cen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Peking University First Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Hematol Oncol</MedlineTA>
        <NlmUniqueID>8307268</NlmUniqueID>
        <ISSNLinking>0278-0232</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083758</ArticleId>
        <ArticleId IdType="doi">10.1002/hon.2726</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083759</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1527-3350</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hepatology (Baltimore, Md.)</Title>
          <ISOAbbreviation>Hepatology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.31198</ELocationID>
        <Abstract>
          <AbstractText>Glycogen storage disease type Ia (GSD Ia) is an inborn error of metabolism caused by defective glucose-6-phosphatase (G6PC) activity. GSD Ia patients exhibit severe hepatomegaly due to glycogen and triglyceride (TG) accumulation in the liver. We have previously shown that the activity of Carbohydrate Response Element Binding Protein (ChREBP), a key regulator of glycolysis and de novo lipogenesis, is increased in GSD Ia. In the current study we assessed the contribution of ChREBP to non-alcoholic fatty liver disease (NAFLD) development in a mouse model for hepatic GSD Ia. Liver-specific G6pc knockout (L-G6pc<sup>-/-</sup> ) mice were treated with AAV2/8-shChREBP to normalize hepatic ChREBP activity to levels observed in wildtype (L-G6pc<sup>+/+</sup> ) mice receiving AAV8-shScramble. Hepatic ChREBP knockdown markedly increased liver weight and hepatocyte size in L-G6pc<sup>-/-</sup> mice. This was associated with hepatic accumulation of G6P, glycogen and lipids, while the expression of glycolytic and lipogenic genes was reduced. Enzyme activities, flux measurements, hepatic metabolite analysis and VLDL-TG secretion assays revealed that hepatic ChREBP knockdown reduced downstream glycolysis and de novo lipogenesis, but also strongly suppressed hepatic VLDL lipidation hence promoting the storage of 'old fat'. Interestingly, enhanced VLDL-TG secretion in shScramble-treated L-G6pc<sup>-/-</sup> mice associated with a ChREBP-dependent induction of the VLDL lipidation proteins MTTP and TM6SF2, the latter being confirmed by ChIP-PCR. CONCLUSION: Attenuation of hepatic ChREBP induction in GSD Ia liver aggravates hepatomegaly due to further accumulation of glycogen and lipids as a result of reduced glycolysis and suppressed VLDL-TG secretion. TM6SF2, critical for VLDL formation, was identified as a novel ChREBP target in mouse liver. Altogether, our data show that enhanced ChREBP activity limits NAFLD development in GSD Ia by balancing hepatic TG production and -secretion.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lei</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoogerland</LastName>
            <ForeName>Joanne A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bloks</LastName>
            <ForeName>Vincent W</ForeName>
            <Initials>VW</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bos</LastName>
            <ForeName>Trijnie</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Laboratory Medicine, University of Groningen, University Medical Center Groningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bleeker</LastName>
            <ForeName>Aycha</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wolters</LastName>
            <ForeName>Henk</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wolters</LastName>
            <ForeName>Justina C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hijmans</LastName>
            <ForeName>Brenda S</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Dijk</LastName>
            <ForeName>Theo H</ForeName>
            <Initials>TH</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Laboratory Medicine, University of Groningen, University Medical Center Groningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Dutch Molecular Pathology Center, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Weeghel</LastName>
            <ForeName>Michel</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4916-2866</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Core Facility Metabolomics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mithieux</LastName>
            <ForeName>Gilles</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Institut National de la Santé et de la Recherche Médicale, U1213, Lyon, F-69008, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université de Lyon, Lyon, F-69008, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université Lyon 1, Villeurbanne, F-69622, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Houtkooper</LastName>
            <ForeName>Riekelt H</ForeName>
            <Initials>RH</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Bruin</LastName>
            <ForeName>Alain</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dutch Molecular Pathology Center, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rajas</LastName>
            <ForeName>Fabienne</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institut National de la Santé et de la Recherche Médicale, U1213, Lyon, F-69008, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université de Lyon, Lyon, F-69008, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université Lyon 1, Villeurbanne, F-69622, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuipers</LastName>
            <ForeName>Folkert</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Laboratory Medicine, University of Groningen, University Medical Center Groningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oosterveer</LastName>
            <ForeName>Maaike H</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and University of Groningen, University Medical Center Groningen, The Netherlands, Groningen.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hepatology</MedlineTA>
        <NlmUniqueID>8302946</NlmUniqueID>
        <ISSNLinking>0270-9139</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ChREBP</Keyword>
        <Keyword MajorTopicYN="N">Glycogen Storage Disease type Ia</Keyword>
        <Keyword MajorTopicYN="N">Non-Alcoholic Fatty Liver Disease</Keyword>
        <Keyword MajorTopicYN="N">TM6SF2</Keyword>
        <Keyword MajorTopicYN="N">VLDL-TG secretion</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083759</ArticleId>
        <ArticleId IdType="doi">10.1002/hep.31198</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083760</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-8137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The New phytologist</Title>
          <ISOAbbreviation>New Phytol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Phosphorus facilitation and covariation of root traits in steppe species.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nph.16499</ELocationID>
        <Abstract>
          <AbstractText>Different phosphorus (P)-acquisition strategies may be relevant for species coexistence and plant performance in terrestrial communities on P-deficient soils. However, how interspecific P facilitation functions in natural systems is largely unknown. We investigated the root physiological activities for P mobilization across 19 co-existing plant species in steppe vegetation, and then grew plants with various abilities to mobilize sorbed P in a microcosm in a glasshouse. We show that P facilitation mediated by rhizosphere processes of P-mobilizing species promoted growth and increased P content of neighbors in a species-specific manner. When roots interacted with a facilitating neighbor, Cleistogenes squarrosa and Bromus inermis tended to express greater plasticity of root proliferation or rhizosheath acid phosphatase activity than other non-P-mobilizing species did. Greater variation of these root traits was strongly correlated with increased performance in the presence of a facilitator. The results also show, for the first time, that P facilitation was an important mechanism underlying a positive complementarity effect. Our study highlights that interspecific P-acquisition facilitation requires that facilitated neighbors exhibit a better match of root traits with a facilitating species which help us better understand species coexistence in P-limited communities.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Rui-Peng</ForeName>
            <Initials>RP</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Plant-Soil Interactions, Ministry of Education, Beijing Key Laboratory of Biodiversity and Organic Farming, College of Resources and Environmental Sciences, China Agricultural University, 100193, Beijing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xiao-Xi</ForeName>
            <Initials>XX</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Plant-Soil Interactions, Ministry of Education, Beijing Key Laboratory of Biodiversity and Organic Farming, College of Resources and Environmental Sciences, China Agricultural University, 100193, Beijing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Zhi-Hua</ForeName>
            <Initials>ZH</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Plant-Soil Interactions, Ministry of Education, Beijing Key Laboratory of Biodiversity and Organic Farming, College of Resources and Environmental Sciences, China Agricultural University, 100193, Beijing, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, 410128, Hunan, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lambers</LastName>
            <ForeName>Hans</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4118-2272</Identifier>
            <AffiliationInfo>
              <Affiliation>National Academy of Agriculture Green Development, China Agricultural University, 100193, Beijing, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences and Institute of Agriculture, The University of Western Australia, 35 Stirling Highway, Crawley (Perth), WA, 6009, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Long</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0523-3308</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Plant-Soil Interactions, Ministry of Education, Beijing Key Laboratory of Biodiversity and Organic Farming, College of Resources and Environmental Sciences, China Agricultural University, 100193, Beijing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>New Phytol</MedlineTA>
        <NlmUniqueID>9882884</NlmUniqueID>
        <ISSNLinking>0028-646X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">diversity effect</Keyword>
        <Keyword MajorTopicYN="N">interspecific phosphorus facilitation</Keyword>
        <Keyword MajorTopicYN="N">phosphorus-impoverished soil</Keyword>
        <Keyword MajorTopicYN="N">phosphorus-mobilizing species</Keyword>
        <Keyword MajorTopicYN="N">plasticity</Keyword>
        <Keyword MajorTopicYN="N">rhizosphere process</Keyword>
        <Keyword MajorTopicYN="N">species coexistence</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083760</ArticleId>
        <ArticleId IdType="doi">10.1111/nph.16499</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083761</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1527-3350</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hepatology (Baltimore, Md.)</Title>
          <ISOAbbreviation>Hepatology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Model for End-stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients with Chronic Liver Disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.31199</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">As compared to other chronic diseases, patients with chronic liver disease (CLD) have significantly higher inpatient mortality; accurate models to predict inpatient mortality are lacking. Serum lactate (LA) may be elevated in patients with CLD due to both tissue hypoperfusion as well as decreased lactate clearance. We hypothesized that a parsimonious model consisting of Model for End-stage Liver Disease (MELD) and LA at admission may predict inpatient mortality in patients with CLD.</AbstractText>
          <AbstractText Label="APPROACH &amp; RESULTS" NlmCategory="UNASSIGNED">We examined all CLD patients in two large and diverse healthcare systems in Texas (North Texas, NTX and Central Texas, CTX) between 2010-2015. We developed (n=3,588) and validated (n=1,804) a model containing MELD and LA measured at time of hospitalization. We further validated the model in a second cohort of 14 tertiary care hepatology centers that prospectively enrolled non-elective hospitalized patients with cirrhosis (n=726). MELD-LA was an excellent predictor of inpatient mortality in development (c-statistic =0.81, 95% CI 0.79-0.82) and both validation cohorts (CTX cohort, c=0.85, 95% CI 0.78-0.87; multicenter cohort c=0.82, 95% CI 0.74-0.88). MELD-LA performed especially well in patients with specific cirrhosis diagnoses (c=0.84, 95% CI 0.81-0.86) or sepsis (c=0.80, 95% CI 0.78-0.82). For MELD score 25, inpatient mortality was 11.2% (LA=1 mmol/L), 19.4% (LA=3 mmol/L), 34.3% (LA=5 mmol/L) and &gt;50% (LA &gt;8 mmol/L). A linear increase (p&lt;0.01) was seen in MELD-LA and increasing number of organ failures. Overall, use of MELD-LA improved the risk prediction in 23.5% of the patients as compared to MELD model alone.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MELD-LA is an early and objective predictor of inpatient mortality and may serve as a novel model for risk assessment and guide therapeutic options.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sarmast</LastName>
            <ForeName>Naveed</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogola</LastName>
            <ForeName>Gerald O</ForeName>
            <Initials>GO</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Clinical Effectiveness, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kouznetsova</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Clinical Effectiveness, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leise</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Mayo Clinic, Rochester, MN, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bahirwani</LastName>
            <ForeName>Ranjeeta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maiwall</LastName>
            <ForeName>Rakhi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Liver and Biliary Sciences, New Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tapper</LastName>
            <ForeName>Elliot</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>University of Michigan, Ann Arbor, Michigan, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trotter</LastName>
            <ForeName>James</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bajaj</LastName>
            <ForeName>Jasmohan</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4928-3681</Identifier>
            <AffiliationInfo>
              <Affiliation>Virginia Commonwealth University, Richmond, Virginia, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thacker</LastName>
            <ForeName>Leroy R</ForeName>
            <Initials>LR</Initials>
            <AffiliationInfo>
              <Affiliation>Virginia Commonwealth University, Richmond, Virginia, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tandon</LastName>
            <ForeName>Puneeta</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>University of Alberta, Canada, Edmonton, Alberta.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wong</LastName>
            <ForeName>Florence</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9263-8869</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reddy</LastName>
            <ForeName>Rajender</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4898-7778</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Pennsylvania, Pennsylvania, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Leary</LastName>
            <ForeName>Jacqueline G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>Dallas VA Medical Center, Dallas, TX, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Masica</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Clinical Effectiveness, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Modrykamien</LastName>
            <ForeName>Ariel M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamath</LastName>
            <ForeName>Patrick S</ForeName>
            <Initials>PS</Initials>
            <AffiliationInfo>
              <Affiliation>Mayo Clinic, Rochester, MN, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asrani</LastName>
            <ForeName>Sumeet K</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hepatology</MedlineTA>
        <NlmUniqueID>8302946</NlmUniqueID>
        <ISSNLinking>0270-9139</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ACLF</Keyword>
        <Keyword MajorTopicYN="N">Alcoholic Hepatitis</Keyword>
        <Keyword MajorTopicYN="N">Cirrhosis</Keyword>
        <Keyword MajorTopicYN="N">MELD</Keyword>
        <Keyword MajorTopicYN="N">Prognosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083761</ArticleId>
        <ArticleId IdType="doi">10.1002/hep.31199</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083762</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-1097</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Photochemistry and photobiology</Title>
          <ISOAbbreviation>Photochem. Photobiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Anionic Conjugated Polyelectrolytes for FRET-based Imaging of Cellular Membrane Potential.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/php.13233</ELocationID>
        <Abstract>
          <AbstractText>We report a Förster resonance energy transfer (FRET)-based imaging ensemble for the visualization of membrane potential in living cells. A water-soluble poly(fluorene-co-phenylene) conjugated polyelectrolyte (FsPFc10) serves as a FRET donor to a voltage-sensitive dye acceptor (FluoVolt<sup>TM</sup> ). We observe FRET between FsPFc10 and FluoVolt<sup>TM</sup> , where the enhancement in FRET-sensitized emission from FluoVolt<sup>TM</sup> is measured at various donor/acceptor ratios. At a donor/acceptor ratio of 1, the excitation of FluoVolt<sup>TM</sup> in a FRET configuration results in a 3-fold enhancement in its fluorescence emission (compared to when it is excited directly). FsPFc10 efficiently labels the plasma membrane of HEK 293T/17 cells and remains resident with minimal cellular internalization for ~1.5 h. The successful plasma membrane-associated co-labeling of the cells with the FsPFc10-FluoVolt<sup>TM</sup> donor-acceptor pair is confirmed by dual channel confocal imaging. Importantly, cells labeled with FsPFc10 show excellent cellular viability with no adverse effect on cell membrane depolarization. During depolarization of membrane potential, HEK 293T/17 cells labeled with the donor-acceptor FRET pair exhibit a greater fluorescence response in FluoVolt<sup>TM</sup> emission relative to when FluoVolt<sup>TM</sup> is used as the sole imaging probe. These results demonstrate the conjugated polyelectrolyte to be a new class of membrane-labeling fluorophore for use in voltage sensing schemes.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nag</LastName>
            <ForeName>Okhil K</ForeName>
            <Initials>OK</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Bio/Molecular Science and Engineering, Naval Research Laboratory, Code 6900, 4555 Overlook Avenue. SW, Washington, DC, 20375, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jeong</LastName>
            <ForeName>Ji-Eun</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le</LastName>
            <ForeName>Van Sang</ForeName>
            <Initials>VS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oh</LastName>
            <ForeName>Eunkeu</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Optical Sciences Division, Naval Research Laboratory, Code 5600, 4555 Overlook Avenue. SW, Washington, DC, 20375, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woo</LastName>
            <ForeName>Han Young</ForeName>
            <Initials>HY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Delehanty</LastName>
            <ForeName>James B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Bio/Molecular Science and Engineering, Naval Research Laboratory, Code 6900, 4555 Overlook Avenue. SW, Washington, DC, 20375, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Photochem Photobiol</MedlineTA>
        <NlmUniqueID>0376425</NlmUniqueID>
        <ISSNLinking>0031-8655</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083762</ArticleId>
        <ArticleId IdType="doi">10.1111/php.13233</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083763</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1549-4918</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Stem cells (Dayton, Ohio)</Title>
          <ISOAbbreviation>Stem Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/stem.3163</ELocationID>
        <Abstract>
          <AbstractText>Recent studies have demonstrated the generation of midbrain-like organoids (MOs) from human pluripotent stem cells. However, the low efficiency of MO generation and the relatively immature and heterogeneous structures of the MOs hinder the translation of these organoids from the bench to the clinic. Here we describe the robust generation of MOs with homogeneous distribution of midbrain dopaminergic (mDA) neurons. Our MOs contain not only mDA neurons but also other neuronal subtypes as well as functional glial cells including astrocytes and oligodendrocytes. Furthermore, our MOs exhibit mDA neuron-specific cell death upon treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), indicating that MOs could be a proper human model system for studying the in vivo pathology of Parkinson's disease (PD). Our optimized conditions for producing homogeneous and mature MOs might provide an advanced patient-specific platform for in vitro disease modeling as well as for drug screening for PD. © AlphaMed Press 2020 SIGNIFICANCE STATEMENT: Although recent studies have demonstrated the generation of human PSC-derived MOs which display structural and functional features of midbrain, a few issues including the low generation efficiency and reproducibility of MOs, heterogeneous and immature structures of MOs, and physiologically irrelevant cellular composition of MOs hinder the clinical translation of organoid technology. This study described the novel strategy for the robust generation of homogeneous MOs using specific combination of dual SMAD inhibitors and in vitro WNT gradient. MOs generated by our optimized protocol with in vivo-like cellular composition are as structurally and functionally mature as the developing midbrain. DAC3.0 MOs with functional glial cells facilitate MPTP-based in vitro disease modeling of PD.</AbstractText>
          <CopyrightInformation>© 2020 AlphaMed Press.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kwak</LastName>
            <ForeName>Tae Hwan</ForeName>
            <Initials>TH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell Biology, School of Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Ji Hyun</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell Biology, School of Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hali</LastName>
            <ForeName>Sai</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell Biology, School of Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Jonghun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell Biology, School of Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Kee-Pyo</ForeName>
            <Initials>KP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Röntgenstrasse 20, 48149, Münster, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Chanhyeok</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell &amp; Regenerative Biotechnology, Humanized Pig Research Center (SRC), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Ju-Hyun</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ryu</LastName>
            <ForeName>Ha Kyun</ForeName>
            <Initials>HK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, College of Bioscience and Biotechnology, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Na</LastName>
            <ForeName>Ji Eun</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jo</LastName>
            <ForeName>Junghyun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Genome Institute of Singapore, 60 Biopolis Street, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna-son, Kunigami-gun, Okinawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Je</LastName>
            <ForeName>Hyunsoo Shawn</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Signature Program in Neuroscience and Behavioral Disorders, Duke-NUS Medical School, 8 College Road, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ng</LastName>
            <ForeName>Huck-Hui</ForeName>
            <Initials>HH</Initials>
            <AffiliationInfo>
              <Affiliation>Genome Institute of Singapore, 60 Biopolis Street, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwon</LastName>
            <ForeName>Jeongwoo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, Chungbuk National University, Naesudong-ro, Seowon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Nam-Hyung</ForeName>
            <Initials>NH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, Chungbuk National University, Naesudong-ro, Seowon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Kwon Ho</ForeName>
            <Initials>KH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell &amp; Regenerative Biotechnology, Humanized Pig Research Center (SRC), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Woong</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chung</LastName>
            <ForeName>Chi Hye</ForeName>
            <Initials>CH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, College of Bioscience and Biotechnology, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rhyu</LastName>
            <ForeName>Im Joo</ForeName>
            <Initials>IJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Dong Wook</ForeName>
            <Initials>DW</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6915-8090</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biotechnology and Healthcare, Wuyi University, Jiangmen, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratory of Stem Cells and Organoids, Organ-Tech Co., Ltd., Naesudong-ro, Seowon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Stem Cells</MedlineTA>
        <NlmUniqueID>9304532</NlmUniqueID>
        <ISSNLinking>1066-5099</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083763</ArticleId>
        <ArticleId IdType="doi">10.1002/stem.3163</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083764</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1549-4918</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Stem cells (Dayton, Ohio)</Title>
          <ISOAbbreviation>Stem Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cell immaturity and white/beige adipocyte-potential of primary human adipose-derived stromal cells are restrained by culture-medium TGFβ1.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/stem.3164</ELocationID>
        <Abstract>
          <AbstractText>Human adipose-derived stem/stromal cells (hASCs) can differentiate into specialized cell types and thereby contribute to tissue regeneration. As such, hASCs have drawn increasing attention in cell therapy and regenerative medicine, not to mention the ease to isolate them from donors. Culture conditions are critical for expanding hASCs while maintaining optimal therapeutic capabilities. Here, we identified a role for transforming growth factor β1 (TGFβ1) in culture medium in influencing the fate of hASCs during in vitro cell expansion. Human ASCs obtained after expansion in standard culture medium (Standard-hASCs) and in endothelial cell growth medium 2 (EGM2-hASCs) were characterized by high-throughput transcriptional studies, Gene Set Enrichment Analysis and functional properties. EGM2-hASCs exhibited enhanced multipotency capabilities and an immature phenotype as compared with Standard-hASCs. Moreover, the adipogenic potential of EGM2-hASCs was enhanced, including toward beige adipogenesis, as compared with Standard-hASCs. In these conditions TGFβ1 acts as a critical factor affecting the immaturity and multipotency of Standard-hASCs, as suggested by SMAD3 nuclear localization and phosphorylation in Standard-hASCs vs EGM2-hASCs. Finally, the typical priming of Standard-hASCs into osteoblast, chondroblast and vascular smooth muscle cell (VSMC) lineages was counteracted by pharmacological inhibition of the TGFβ1 receptor, which allowed retention of SMAD3 into the cytoplasm and a decrease in expression of osteoblast and VSMC lineage markers. Overall, the TGFβ1 pathway appears critical in influencing the commitment of hASCs toward osteoblast, chondroblast and VSMC lineages, thus reducing their adipogenic potential. These effects can be counteracted by using EGM2 culture medium or chemical inhibition of the TGFβ1 pathway. © AlphaMed Press 2020 SIGNIFICANCE STATEMENT: Human adipose-derived stem/stromal cells (hASCs) are typically expanded in serum-containing media. Here, we show that the TGFβ1 contained in serum induces the commitment of hASCs toward osteoblast, chondroblast and vascular smooth muscle cell lineages. This commitment impedes the immaturity of hASCs and their adipogenic potential during in vitro cell expansion, including toward the beige adipocyte. Standard culture medium affects the cell multipotency of hASCs, a crucial feature to consider when improving methods of hASC expansion to obtain clinical-grade hASCs. Here, we detail the effect of TGFβ1 on hASC culture and propose alternative culture methods to expand hASCs with optimal therapeutic interests.</AbstractText>
          <CopyrightInformation>© 2020 AlphaMed Press.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Leménager</LastName>
            <ForeName>Hélène</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8829-3386</Identifier>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fiévet</LastName>
            <ForeName>Loïc M A</ForeName>
            <Initials>LMA</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guilloton</LastName>
            <ForeName>Fabien</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naji</LastName>
            <ForeName>Abderrahim</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Medicine, Cooperative Medicine Unit, Research and Education Faculty, Medicine Science Cluster, Kochi Medical School (KMS), Kochi University, Kohasu, Oko-Cho, Nankoku City, Kochi Prefecture, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Descamps</LastName>
            <ForeName>Jean-Gérard</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chaput</LastName>
            <ForeName>Benoît</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plastic, Reconstructive and Aesthetic Surgery, Rangueil University Hospital, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suganuma</LastName>
            <ForeName>Narufumi</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Medicine, Cooperative Medicine Unit, Research and Education Faculty, Medicine Science Cluster, Kochi Medical School (KMS), Kochi University, Kohasu, Oko-Cho, Nankoku City, Kochi Prefecture, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pagès</LastName>
            <ForeName>Jean-Christophe</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sensebé</LastName>
            <ForeName>Luc</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carrière</LastName>
            <ForeName>Audrey</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Casteilla</LastName>
            <ForeName>Louis</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deschaseaux</LastName>
            <ForeName>Frédéric</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>STROMALab, Etablissement Français du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, National Veterinary School of Toulouse (ENVT), ERL5311 CNRS, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Stem Cells</MedlineTA>
        <NlmUniqueID>9304532</NlmUniqueID>
        <ISSNLinking>1066-5099</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mesenchymal stem/stromal cells</Keyword>
        <Keyword MajorTopicYN="N">adipose-derived stromal cells</Keyword>
        <Keyword MajorTopicYN="N">chondroblast, vascular smooth muscle cell</Keyword>
        <Keyword MajorTopicYN="N">osteoblast</Keyword>
        <Keyword MajorTopicYN="N">transforming growth factor-beta 1</Keyword>
        <Keyword MajorTopicYN="N">white adipocyte, beige adipocyte</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083764</ArticleId>
        <ArticleId IdType="doi">10.1002/stem.3164</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083765</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-9071</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical &amp; experimental ophthalmology</Title>
          <ISOAbbreviation>Clin. Experiment. Ophthalmol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intra-articular spine injections of steroid as a contributing factor to glaucoma.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ceo.13735</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Queena</ForeName>
            <Initials>Q</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8161-0780</Identifier>
            <AffiliationInfo>
              <Affiliation>The University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Casson</LastName>
            <ForeName>Robert J</ForeName>
            <Initials>RJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2822-4076</Identifier>
            <AffiliationInfo>
              <Affiliation>The University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Royal Adelaide Hospital, Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Myers</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Royal Adelaide Hospital, Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cugati</LastName>
            <ForeName>Sudha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Clin Exp Ophthalmol</MedlineTA>
        <NlmUniqueID>100896531</NlmUniqueID>
        <ISSNLinking>1442-6404</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083765</ArticleId>
        <ArticleId IdType="doi">10.1111/ceo.13735</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083766</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1549-490X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The oncologist</Title>
          <ISOAbbreviation>Oncologist</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2019-0276</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of postoperative radiotherapy in pathological T2-3N0M0 esophageal squamous cell carcinoma is unknown. We aimed to evaluate the efficacy and safety of postoperative radiotherapy in patients with pathological T2-3N0M0 thoracic esophageal squamous cell carcinoma.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Patients aged 18-72 years with pathological stage T2-3N0M0 esophageal squamous cell carcinoma after radical surgery and without neoadjuvant therapy were eligible. Patients were randomly assigned to surgery alone or to receive postoperative radiotherapy of 50.4 Gy in supraclavicular field and 56 Gy in mediastinal field in 28 fractions over 6 weeks. The primary endpoint was disease-free survival. The secondary endpoints were local-regional recurrence rate, overall survival, and radiation-related toxicities.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">From October 2012 to February 2018, 167 patients were enrolled in this study. We analyzed 157 patients whose follow-up time was more than 1 year or who had died. The median follow-up time was 45.6 months. The 3-year disease-free survival rates were 75.1% (95% confidence interval [CI] 65.9-85.5) in the postoperative radiotherapy group and 58.7% (95% CI 48.2-71.5) in the surgery group (hazard ratio 0.53, 95% CI 0.30-0.94, p = .030). Local-regional recurrence rate decreased significantly in the radiotherapy group (10.0% vs. 32.5% in the surgery group, p = .001). The overall survival and distant metastasis rates were not significantly different between two groups. Grade 3 toxicity rate related to radiotherapy was 12.5%.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Postoperative radiotherapy significantly increased disease-free survival and decreased local regional recurrence rate in patients with pathological T2-3N0M0 thoracic esophageal squamous cell carcinoma with acceptable toxicities in this interim analysis. Further enrollment and follow-up are warranted to validate these findings in this ongoing trial.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">The value of adjuvant radiotherapy for patients with node-negative esophageal cancer is not clear. The interim results of this phase III study indicated that postoperative radiotherapy significantly improved disease-free survival and decreased local-regional recurrence rate in patients with pathological T2-3N0M0 thoracic esophageal squamous cell carcinoma compared with surgery alone with acceptable toxicities. The distant metastasis rates and overall survival rates were not different between the two groups. Adjuvant radiotherapy should be considered for pathologic T2-3N0M0 thoracic esophageal squamous cell carcinoma. Prospective trials to identify high-risk subgroups are needed.</AbstractText>
          <CopyrightInformation>© AlphaMed Press 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1778-2013</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital &amp; Institute, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Jinsong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ni</LastName>
            <ForeName>Wenjie</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Xiao</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Weiming</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Zongmei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Dongfu</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Qinfu</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Jima</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiaozhen</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Wenqing</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bi</LastName>
            <ForeName>Nan</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yexiong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Shugeng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xue</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mao</LastName>
            <ForeName>Yousheng</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Kelin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Xiangyang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Dekang</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Dali</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shao</LastName>
            <ForeName>Kang</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhishan</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xinjie</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Affiliated Hospital of Jining Medical College, Jining, Shandong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lifang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Affiliated Hospital of Jining Medical College, Jining, Shandong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Zefen</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Z121107001012004</GrantID>
            <Agency>Capital Clinical Characteristic Application Research of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2016-2-4021</GrantID>
            <Agency>Capital Health Research and Development of Special of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2016YFC0904600</GrantID>
            <Agency>National Key Projects of Research and Development of China</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Oncologist</MedlineTA>
        <NlmUniqueID>9607837</NlmUniqueID>
        <ISSNLinking>1083-7159</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Esophageal cancer</Keyword>
        <Keyword MajorTopicYN="N">Randomized controlled trial</Keyword>
        <Keyword MajorTopicYN="N">Treatment modality</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083766</ArticleId>
        <ArticleId IdType="doi">10.1634/theoncologist.2019-0276</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083767</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3773</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Angewandte Chemie (International ed. in English)</Title>
          <ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Poly(2-Oxazoline) Based Functional Mimics of Peptides to Eradicate MRSA Infections and Persisters While Alleviating Antimicrobial Resistance.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.202000505</ELocationID>
        <Abstract>
          <AbstractText>Peptides have important biological functions. However, peptides' susceptibility to proteolysis is a big hurdle to their application. We demonstrated, for the first time, that poly(2-oxazoline) can work as functional mimics of peptides. Using host defense peptide as a model, we showed poly(2-oxazoline) based glycine pseudopeptides can mimic host defense peptide and have potent in vitro and in vivo activities against methicillin-resistant Staphylococcus aureus that cause formidable infections. The poly(2-oxazoline) showed potent activity against persister cells that are highly resistant to antibiotics. S taphylococcus aureus were unable to acquire resistance upon poly(2-oxazoline), owning to the reactive oxygen species related antimicrobial mechanism. Poly(2-oxazoline) treated Staphylococcus aureus were still sensitive to common antibiotics, demonstrating no observable antimicrobial pressure or cross-resistance in using antimicrobial poly(2-oxazoline). Our study highlighted poly(2-oxazoline) as a new type of functional mimics of peptides and opened up new avenues in designing and exploring peptide mimetics for biological functions and applications.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qian</LastName>
            <ForeName>Yuxin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Jiayang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wenjing</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Weinan</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Ximian</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Sheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Chengzhi</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cong</LastName>
            <ForeName>Zihao</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Zhemin</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shao</LastName>
            <ForeName>Ning</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Longqiang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Yuequn</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, School of Materials Science and Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Runhui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>East China University of Science and Technology, Materials Science and Engineering, 130 Meilong Road, 200237, Shanghai, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
        <NlmUniqueID>0370543</NlmUniqueID>
        <ISSNLinking>1433-7851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Poly(2-Oxzoline)；Peptide mimics；antibacterial；persister cell；antimicrobial resistance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083767</ArticleId>
        <ArticleId IdType="doi">10.1002/anie.202000505</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083768</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2753</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of evaluation in clinical practice</Title>
          <ISOAbbreviation>J Eval Clin Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Using outcome harvesting: Assessing the efficacy of CBME implementation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jep.13359</ELocationID>
        <Abstract>
          <AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">In 2015, Queen's University embarked on an institution-wide transition to a competency-based medical education (CBME) curriculum for all 29 postgraduate medical education programmes. On 1 July 2017, this goal was accomplished. With this mass transition came the requirement to assess the efficacy of implementation through a programme evaluation process, which included the use of outcome harvesting (Wilson-Grau). Outcome harvesting identified the intended and unintended outcomes of CBME implementation, which helped us understand how the intervention was achieved and how the relationship between behaviours and stakeholders contributed to the successful transition.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic approach to document analysis was used to categorize the eight identified areas of implementation: governance, scholarship, faculty development, resident leadership, curriculum, assessment, communications, and technology. Documents (N = 443) were organized per project area and then coded thematically. Documents were then categorized for attribution to outcomes using the outcome harvesting approach. Outcomes were validated via interrater reliability and substantiated by stakeholders to verify accuracy of formulation and plausibility of its influence on the outcome.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The harvest produced 38 outcomes, either intended or unintended, that can be attributed to CBME implementation at Queen's University.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Using outcome harvesting to assess the efficacy of CBME implementation produced a robust set of themes and resultant outcomes that can be categorized as requirements for success of implementation of any curricular innovation. Emergent themes included collaboration, community of practice, and stakeholder commitment. More unique observations noted through the harvest process included new policy development, creation of learner ownership, and an increase in the output of scholarly activity involving CBME.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Railer</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stockley</LastName>
            <ForeName>Denise</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9541-0376</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flynn</LastName>
            <ForeName>Leslie</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hastings-Truelove</LastName>
            <ForeName>Amber</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hussain</LastName>
            <ForeName>Alicia</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Eval Clin Pract</MedlineTA>
        <NlmUniqueID>9609066</NlmUniqueID>
        <ISSNLinking>1356-1294</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">evaluation</Keyword>
        <Keyword MajorTopicYN="N">medical education</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083768</ArticleId>
        <ArticleId IdType="doi">10.1111/jep.13359</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Schultz K, Griffiths J. Implementing competency-based medical education in a postgraduate family medicine residency training program. Academic Medicine. 2016;685-689.</Citation>
        </Reference>
        <Reference>
          <Citation>Hall GE, Hord SM. Implementing change: patterns, principles and potholes. fourth ed. Upper Saddle River, NJ: Pearson; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Carraccio C et al. Shifting paradigms: from Flexner to competencies. Academic Medicine. 2002;77:361-367.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson-Grau R, Britt H. 2012. Outcome harvesting. Ford Foundation. Available at: http://www.outcomemapping.ca/resource/outcome-harvesting retrieved: September 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Craig P., Dieppe P., Macintyre S., Michie S., Nazarath I., Petticrew M. Developing and evaluating complex interventions. Medical Research Council. Retrieved from Available at: http://www.mrc.ac.uk/documents/pdf/developing-and-evaluating-complexinterventions/</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson-Grau, R. Outcome harvesting. Better evaluation. 2015. Retrieved from http://betterevaluation.org/plan/approach/outcome_harvesting</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson-Grau R. Outcome Harvesting: Principles, Steps, and Evaluation Applications. Charlotte, NC: Information Age Publishing; 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Holmboe ES, Sherbino J, Long D, Swing S, Frank J, the International CBME Collaborators. The role of assessment in competency-based medical education. Medical Teacher. 2010;32(8):676-682.</Citation>
        </Reference>
        <Reference>
          <Citation>Flexner A. Medical Education in the United States and Canada. New York: Carnegie Foundation; 1910.</Citation>
        </Reference>
        <Reference>
          <Citation>Steinert Y, Mann KV. Faculty development: principles and practices. J Vet Med Educ. 2006;33(3):317.</Citation>
        </Reference>
        <Reference>
          <Citation>Cilliers P. What can we Learn from a Theory of Complexity? Emergence 2.1. 2000;23-33. Web. 5 Nov. 2019.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083769</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2516</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Haemophilia : the official journal of the World Federation of Hemophilia</Title>
          <ISOAbbreviation>Haemophilia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A single centre retrospective study of low dose prophylaxis with extended half-life factor IX for severe haemophilia B.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/hae.13936</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Extended half-life factor IX concentrates (EHL-FIX) can be administered weekly to prevent bleeding for persons with severe haemophilia B. We report the experience of a large UK haemophilia comprehensive care centre using low dose EHL-FIX for persons with severe haemophilia B.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">The low doses used in real world are approximately half of the doses used in clinical trials. We aim to assess the efficacy and safety of low dose EHL-FIX.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Data from a cohort of 13 patients who were switched from standard half-life factor IX (SHL-FIX) to Alprolix<sup>®</sup> (mean dose 31.5 IU/kg) and seven patients who switched from standard half-life factor IX to Idelvion<sup>®</sup> (mean dose 20.2 IU/kg) were included.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The median annualized bleeding rate was similar for SHL-FIX (median 3, interquartile range [IQR] 1-5) and EHL-FIX (median 3, IQR 1-5.25). Quality of life scores, measured using the European Quality of Life 5 Dimensions assessment were similar for SHL-FIX (median 0.76, IQR: 0.63-0.84) and EHL-FIX (median 0.79, IQR: 0.58-0.88).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study shows that EHL-FIX given at low doses can be effective for prevention of bleeding for persons with severe haemophilia B.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rampotas</LastName>
            <ForeName>Alexandros</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2681-5860</Identifier>
            <AffiliationInfo>
              <Affiliation>NIHR Academic Clinic Fellow in Haematology, Haematology Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Desborough</LastName>
            <ForeName>Michael J R</ForeName>
            <Initials>MJR</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1951-5616</Identifier>
            <AffiliationInfo>
              <Affiliation>Oxford Biomedical Research Centre, Oxford Haemophilia and Thrombosis Centre, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Nuffield Division of Clinical Laboratory Sciences, Oxford Clinical Research in Transfusion Medicine, University of Oxford, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Haemophilia and Thrombosis Centre, St Thomas' Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raza-Burton</LastName>
            <ForeName>Sayma</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR BRC Blood Theme, Oxford Centre for Haematology, Oxford University, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taylor</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2689-1780</Identifier>
            <AffiliationInfo>
              <Affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR BRC Blood Theme, Oxford Centre for Haematology, Oxford University, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilkinson</LastName>
            <ForeName>Alice</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Paediatric Haemophilia centre, Children's Hospital, John Radcliffe hospital, Headington, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hall</LastName>
            <ForeName>Georgina W</ForeName>
            <Initials>GW</Initials>
            <AffiliationInfo>
              <Affiliation>Paediatric Haemophilia centre, Children's Hospital, John Radcliffe hospital, Headington, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shapiro</LastName>
            <ForeName>Susan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR BRC Blood Theme, Oxford Centre for Haematology, Oxford University, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Curry</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3849-0688</Identifier>
            <AffiliationInfo>
              <Affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR BRC Blood Theme, Oxford Centre for Haematology, Oxford University, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Haemophilia</MedlineTA>
        <NlmUniqueID>9442916</NlmUniqueID>
        <ISSNLinking>1351-8216</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">annual bleeding rate</Keyword>
        <Keyword MajorTopicYN="N">bleeding disorders</Keyword>
        <Keyword MajorTopicYN="N">extended half-life factors</Keyword>
        <Keyword MajorTopicYN="N">factor IX</Keyword>
        <Keyword MajorTopicYN="N">haemophilia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083769</ArticleId>
        <ArticleId IdType="doi">10.1111/hae.13936</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935-1939.</Citation>
        </Reference>
        <Reference>
          <Citation>Castaman G. The benefits of prophylaxis in patients with hemophilia B. Expert Rev Hematol. 2018;11(8):673-683.</Citation>
        </Reference>
        <Reference>
          <Citation>Franchini M. Current management of hemophilia B: recommendations, complications and emerging issues. Expert Rev Hematol. 2014;7(5):573-581.</Citation>
        </Reference>
        <Reference>
          <Citation>Shapiro AD, Ragni MV, Valentino LA, et al. Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood. 2012;119(3):666-672.</Citation>
        </Reference>
        <Reference>
          <Citation>Santagostino E, Negrier C, Klamroth R, et al. Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients. Blood. 2012;120(12):2405-2411.</Citation>
        </Reference>
        <Reference>
          <Citation>Santagostino E, Martinowitz U, Lissitchkov T, et al. Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 2016;127(14):1761-1769.</Citation>
        </Reference>
        <Reference>
          <Citation>Powell JS, Pasi KJ, Ragni MV, et al. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013;369(24):2313-2323.</Citation>
        </Reference>
        <Reference>
          <Citation>Kenet G, Chambost H, Male C, et al. Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial. Thromb Haemost. 2016;116(4):659-668.</Citation>
        </Reference>
        <Reference>
          <Citation>Fischer K, Kulkarni R, Nolan B, et al. Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study. Lancet Haematol. 2017;4(2):e75-e82.</Citation>
        </Reference>
        <Reference>
          <Citation>Peyvandi F, Garagiola I, Boscarino M, Ryan A, Hermans C, Makris M. Real-life experience in switching to new extended half-life products at European haemophilia centres. Haemophilia. 2019;25(6):946-952.</Citation>
        </Reference>
        <Reference>
          <Citation>Lynn M, Malec SEC, Callaghan M, et al. Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: a survey of select US and canadian hemophilia treatment centers. Blood. 2019;134:2407-2407</Citation>
        </Reference>
        <Reference>
          <Citation>Johannes Oldenburg SY, Maro G, Krishnarajah G, Tiede A. Assessing bleeding rates, related clinical impact and factor utilization in German hemophilia B patients treated with extended half-life rIX-FP compared to prior drug therapy. Curr Med Res Opin. 2020;36(1):9-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Iorio A, Fischer K, Blanchette V, et al. Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates. Thromb Haemost. 2017;117(6):1023-1030.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083770</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1529-8019</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dermatologic therapy</Title>
          <ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Alopecia areata Due to Isotretinoin Treatment.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13280</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.13280</ELocationID>
        <Abstract>
          <AbstractText>Isotretinoin is a safe and useful medication for acne management. Adverse effects are mostly related to cutaneous and mucous membranes. We present a case of a 24-year-old female patient who was on treatment with Isotretinoin for acne vulgaris grade 4. After 6 months of treatment, the patient presented with localized patch of hair loss. Beginning of alopecia areata (AA) in patients with acne vulgaris could be regarded as a side effect of retinoids due to anti-acne therapy. The exact mechanism by which retinoids cause hair loss is not known. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Mrinal</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Treatwell Skin Centre, Jammu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lotti</LastName>
            <ForeName>Torello</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0840-1936</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Studies Guglielmo Marconi, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goldust</LastName>
            <ForeName>Mohamad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9615-1246</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University of Rome G. Marconi, Rome, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Medical Center Mainz, Mainz, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dermatol Ther</MedlineTA>
        <NlmUniqueID>9700070</NlmUniqueID>
        <ISSNLinking>1396-0296</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acne vulgaris</Keyword>
        <Keyword MajorTopicYN="N">Alopecia areata</Keyword>
        <Keyword MajorTopicYN="N">Isotretinoin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083770</ArticleId>
        <ArticleId IdType="doi">10.1111/dth.13280</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083771</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3765</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Chemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>DMT1 Inhibitors Kill Cancer Stem Cells by Blocking Lysosomal Iron Translocation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chem.202000159</ELocationID>
        <Abstract>
          <AbstractText>Cancer stem cells (CSC) constitute a subpopulation of cells in solid tumors that is responsible for resistance to conventional chemotherapy, metastasis and cancer relapse. The natural product Salinomycin can selectively target this cell niche by directly interacting with lysosomal iron, taking advantage of upregulated iron homeostasis in CSC. Here, we identify inhibitors of the divalent metal transporter 1 (DMT1) that selectively target CSC by blocking lysosomal iron translocation. This leads to lysosomal iron accumulation, production of reactive oxygen species and cell death with features of ferroptosis. DMT1 inhibitors selectively target CSC in primary cancer cells and circulating tumor cells, demonstrating the physiological relevance of this strategy. Taken together, this opens up opportunities to tackle unmet needs in anti-cancer therapy.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Turcu</LastName>
            <ForeName>Andreea L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Universitat de Barcelona, Pharmacy, SPAIN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Versini</LastName>
            <ForeName>Antoine</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie, Chemical Biology of Cancer, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khene</LastName>
            <ForeName>Nadjib</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie, Chemical Biology of Cancer, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gaillet</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie, Chemical Biology of Cancer, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cañeque</LastName>
            <ForeName>Tatiana</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie, Chemical Biology of Cancer, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Müller</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie, Chemical Biology of Cancer, 26 rue d'Ulm, 75005, France, Paris, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriguez</LastName>
            <ForeName>Raphaël</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, Organic Synthesis and Cell Biology Group, 26 rue d'Ulm, 75248, Paris, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chemistry</MedlineTA>
        <NlmUniqueID>9513783</NlmUniqueID>
        <ISSNLinking>0947-6539</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer stem cells, therapeutics, DMT1 inhibitor, iron, lysosomes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083771</ArticleId>
        <ArticleId IdType="doi">10.1002/chem.202000159</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083772</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3765</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Chemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chiral Bent-shaped Molecules Exhibiting Unusually Wide Range of Blue Liquid Crystalline Phases and Multi Stimuli-Responsive Behavior.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chem.201905707</ELocationID>
        <Abstract>
          <AbstractText>In this paper, chloro (-Cl) group was substituted for methyl (-CH 3 ) moiety at the kink position and witnessed a drastic modification in the phase structure of a bent-shaped molecule ( 1-4 to 1-18 ).  An unusual stabilization of cubic blue phase (BP) over a wide range of 16.4 °C has been observed. The two homologues in this series ( 1-12 and 1-14 ) exhibits an interesting phase sequence consisting of BPI/II, N*, TGBA, SmA and SmX. The higher homologues ( 1-16 and 1-18 ) stabilize the SmX phase enantiotropically in the entire temperature range. Crystal structure analysis approved the bent molecular architecture with a bent angle of 148° and revealed the presence of two different molecular conformations in an asymmetric unit of compound 1-4 . DFT study corroborated that the -Cl moiety at the central core of the molecule leads to an increase in the dipole moment along the transverse direction which in turn facilitates the unusual stabilization of frustrated structures. Crystal polymorphism has been evidenced in three homologues ( 1-10 , 1-12 and 1-14 ) of the series. On the application of mechanical pressure via grinding, the compound 1-10 transforms from bright yellow crystalline solid to dark orange-green amorphous solid which reversed upon dropwise addition of dichloromethane indicating reversible mechanochromism  of compounds. Excellent thermochromic behaviour has been observed for compound 1-10 with a controlled temperature-color combination.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Punjani</LastName>
            <ForeName>Vidhika</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Indian Institute of Science Education and Research Mohali, chemical sciences, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohiuddin</LastName>
            <ForeName>Golam</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Indian Institute of Science Education and Research Mohali, chemical sciences, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaur</LastName>
            <ForeName>Supreet</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Indian Institute of Science Education and Research Mohali, chemical sciences, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choudhury</LastName>
            <ForeName>Angshuman Roy</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>Indian Institute of Science Education and Research Mohali, chemical sciences, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paladugu</LastName>
            <ForeName>Sathyanarayana</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Hyderabad, School of Physics, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dhara</LastName>
            <ForeName>Surajit</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Hyderabad, School of Physics, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghosh</LastName>
            <ForeName>Sharmistha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Calcutta, Physics, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pal</LastName>
            <ForeName>Santanu Kumar</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Indian Institute of Science Education and Research, Chemical Scienecs, Knowledge city, Sector 81, SAS Nagar, Manauli PO, 140306, Mohali, INDIA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chemistry</MedlineTA>
        <NlmUniqueID>9513783</NlmUniqueID>
        <ISSNLinking>0947-6539</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bent shaped liquid crystals</Keyword>
        <Keyword MajorTopicYN="N">Blue Phase</Keyword>
        <Keyword MajorTopicYN="N">Cholesterol</Keyword>
        <Keyword MajorTopicYN="N">Mechanochromism</Keyword>
        <Keyword MajorTopicYN="N">Thermochromism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083772</ArticleId>
        <ArticleId IdType="doi">10.1002/chem.201905707</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083773</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3765</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Chemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Salinomycin Derivatives Kill Breast Cancer Stem Cells via Lysosomal Iron Targeting.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chem.202000335</ELocationID>
        <Abstract>
          <AbstractText>Salinomycin ( 1 ) exhibits a large spectrum of biological activities including the capacity to selectively eradicate cancer stem cells (CSC), making it and its derivatives promising candidates for the development of drug leads against CSC. We have previously shown that salinomycin and its C20-propargylamine derivative (Ironomycin, 2 ) accumulate in lysosomes and sequester iron in this organelle. We hereby report a library of salinomycin derivatives, including products of C20-amination, C1-esterification, C9-oxidation and C28-dehydration. We have evaluated the biological activity of these compounds against transformed human mammary epithelial HMLER CD24 low /CD44 high cells, a well-established model of breast CSC, and HMLER CD24 high /CD44 low cells deprived of CSC properties. Unlike other structural alterations, derivative 4 , which displays a cyclopropylamine at position C20, showed a strikingly low IC 50 value of 23 nM against HMLER CD24 low /CD44 high cells. This study provides highly selective molecules to target the CSC niche, a potential interesting advance for drug development to prevent cancer resistance.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Versini</LastName>
            <ForeName>Antoine</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie research center, organic synthesis and cell biology group, 26 rue d'Ulm, 75248, Paris CEDEX 05, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colombeau</LastName>
            <ForeName>Ludovic</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, organic synthesis and cell biology group, 26 rue d'Ulm, 75248, Paris CEDEX 05, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hienzsch</LastName>
            <ForeName>Antje</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>ABX advanced biochemical compounds, chemistry, 10-14 Heinrich-Glaeser-Str, 01454, Radeberg, GERMANY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gaillet</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, organic synthesis and cell biology, 26 rue d'Ulm, 75248, Paris CEDEX 05, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Retailleau</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Institut de Chimie des Substances Naturelles, Christallographie Structurale, 1 av. de la Terrasse, 91198, Gif-sur-Yvette, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Debieu</LastName>
            <ForeName>Sylvain</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, organic synthesis and cell biology, 26 rue d'Ulm, 75248, Paris CEDEX 05, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Müller</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, organic synthesis and cell biology, 26 rue d'Ulm, 75248, Paris CEDEX 05, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cañeque</LastName>
            <ForeName>Tatiana</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, organic synthesis and cell biology, 26 rue d'Ulm, 75248, Paris CEDEX 05, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriguez</LastName>
            <ForeName>Raphaël</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Curie Research Center, Organic Synthesis and Cell Biology Group, 26 rue d'Ulm, 75248, Paris, FRANCE.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chemistry</MedlineTA>
        <NlmUniqueID>9513783</NlmUniqueID>
        <ISSNLinking>0947-6539</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer Stem Cells</Keyword>
        <Keyword MajorTopicYN="N">ROS</Keyword>
        <Keyword MajorTopicYN="N">chemoselective oxidation</Keyword>
        <Keyword MajorTopicYN="N">stereoselective reductive amination</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083773</ArticleId>
        <ArticleId IdType="doi">10.1002/chem.202000335</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083774</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-9071</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical &amp; experimental ophthalmology</Title>
          <ISOAbbreviation>Clin. Experiment. Ophthalmol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Are topical antibiotics needed following routine phacoemulsification cataract surgery?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ceo.13737</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Michael</LastName>
            <ForeName>Eugene</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4383-6508</Identifier>
            <AffiliationInfo>
              <Affiliation>Greenlane Clinical Centre Ophthalmology Department, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Clin Exp Ophthalmol</MedlineTA>
        <NlmUniqueID>100896531</NlmUniqueID>
        <ISSNLinking>1442-6404</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083774</ArticleId>
        <ArticleId IdType="doi">10.1111/ceo.13737</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083775</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-294X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular ecology</Title>
          <ISOAbbreviation>Mol. Ecol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Parallel adaptation to climate above the 35th parallel.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/mec.15391</ELocationID>
        <Abstract>
          <AbstractText>Independent or parallel evolution of similar traits is key to understanding the genetics and limitations of adaptation. Adaptation from the same genetic changes in different populations defines parallel evolution. Such genetic changes can derive from standing ancestral variation or de novo mutations and excludes instances of adaptive introgression. In this issue of Molecular Ecology, (Walden et al. 2020) investigate the scale of parallel climate adaptation from standing genetic variation between two North American Arabidopsis lyrata lineages, each formed by a distinct evolutionary history during the last glacial cycle. By identifying adaptive variants correlated with three ecologically significant climatic gradients, they show that instead of the same genetic variants or even genes, parallel evolution is only observed at the level of biological processes. The evolution of independent adaptive variants to climate in two genetically close lineages is explained by their different post-glacial demographic histories. Separate glacial refugia and strong population bottlenecks likely were sufficient to change the landscape of shared allele frequencies, hindering the possibility of parallel evolution.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Burns</LastName>
            <ForeName>Robin</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Gregor Mendel Institute of Plant Biology, Austrian Academy of Sciences, Vienna BioCenter, 1030, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu Novikova</LastName>
            <ForeName>Polina</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Ghent University, Department of Plant Biotechnology and Bioinformatics, 9052, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>VIB Center for Plant Systems Biology, 9052, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Mol Ecol</MedlineTA>
        <NlmUniqueID>9214478</NlmUniqueID>
        <ISSNLinking>0962-1083</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Arabidopsis
</Keyword>
        <Keyword MajorTopicYN="N">climate adaptation</Keyword>
        <Keyword MajorTopicYN="N">parallel evolution</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083775</ArticleId>
        <ArticleId IdType="doi">10.1111/mec.15391</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083776</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2850</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of psychiatric and mental health nursing</Title>
          <ISOAbbreviation>J Psychiatr Ment Health Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Experiences of acute care by persons with mental health problems: an integrative literature review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jpm.12624</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">The provision of acute care to persons with mental health problems is challenging due to difficulties in encountering this group and the vulnerability of these persons. Understanding this group's experiences with acute care is thus an important endeavor. The purpose of this review was to critically and systematically identify and assess previous research on experiences of acute care by persons with mental health problems, guided by Donabedian's structure-process-outcome framework (Prospero ID: CRD42019116652).</AbstractText>
          <AbstractText Label="METHOD AND RESULTS" NlmCategory="RESULTS">An integrative literature review was performed, resulting in the identification of 43 studies. The search was conducted using five electronic databases: Web of Science Core, PubMed, Medline, Cinahl, and PsycInfo.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The review revealed that patients experienced structure components such as setting, staff, and resources in a predominantly negative way. A predominately negative picture also emerged of the process components, where for example communication and interpersonal relations were represented by negative experiences, with limited positive experiences reported. The outcome components, related to patients' satisfaction and their well-being after discharge, were also negatively experienced.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">Using Donabedian's framework of structure, process, and outcome allowed us to systematize the literature reviewed, to identify the research gaps, and to suggest ways forward for the field's development.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schmidt</LastName>
            <ForeName>Manuela</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3113-6432</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Science, Kristianstad University, 291 88, Kristianstad, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Lund University, 221 00, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uman</LastName>
            <ForeName>Timur</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8938-2150</Identifier>
            <AffiliationInfo>
              <Affiliation>Jönköping International Business School, Jönköping University, 551 11, Jönköping, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Psychiatr Ment Health Nurs</MedlineTA>
        <NlmUniqueID>9439514</NlmUniqueID>
        <ISSNLinking>1351-0126</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Patient experience</Keyword>
        <Keyword MajorTopicYN="N">acute mental health</Keyword>
        <Keyword MajorTopicYN="N">emergency psychiatry</Keyword>
        <Keyword MajorTopicYN="N">integrative review</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083776</ArticleId>
        <ArticleId IdType="doi">10.1111/jpm.12624</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083777</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3773</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Angewandte Chemie (International ed. in English)</Title>
          <ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Spiderweb-like metal-organic framework multifunctional foam.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201916211</ELocationID>
        <Abstract>
          <AbstractText>Processing metal-organic-frameworks (MOFs) into hierarchical macroscopic materials can greatly extend their practical applications. However, current strategies suffer from severe aggregation of MOFs and limited tuning of the hierarchical porous network. Here, we report a controlled strategy that can simultaneously tune the MOF loading, composition, spatial distribution, and confinement within various bio-originated macroscopic supports, as well as control the accessibility, robustness, and formability of the support itself. Our methodology enables the good dispersion of individual MOF nanoparticles on a spiderweb-like network within each macrovoid even at high loadings (up to 86 wt%), ensuring the foam pores are highly accessible for excellent adsorption and catalytic capacity. Additionally, this approach allows the direct pre-incorporation of other functional components into the framework . Our strategy provides a general toolbox for precise control over the properties of both the hierarchical support and MOF, opening new possibilities to construct tunable multi-scale porous platforms with desired functionalities .</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Chen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Cornell University College of Agriculture and Life Sciences, department of food science, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cornell University College of Agriculture and Life Sciences, Department of food science, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arshadi</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cornell University College of Agriculture and Life Sciences, Department of food science, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azizi</LastName>
            <ForeName>Morteza</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cornell University College of Agriculture and Life Sciences, department of food science, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abbaspourrad</LastName>
            <ForeName>Alireza</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Cornell University College of Agriculture and Life Sciences, Food Science, 243 Stocking Hall, 14853, Ithaca, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
        <NlmUniqueID>0370543</NlmUniqueID>
        <ISSNLinking>1433-7851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Metal-Organic Frameworks</Keyword>
        <Keyword MajorTopicYN="N">foam</Keyword>
        <Keyword MajorTopicYN="N">high internal phase emulsion</Keyword>
        <Keyword MajorTopicYN="N">oil-water separation</Keyword>
        <Keyword MajorTopicYN="N">organic-inorganic hybrid composites</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083777</ArticleId>
        <ArticleId IdType="doi">10.1002/anie.201916211</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083778</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1050</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Health economics</Title>
          <ISOAbbreviation>Health Econ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An empirical investigation of time-varying cost-effectiveness across the product life cycle.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hec.4004</ELocationID>
        <Abstract>
          <AbstractText>Cost-effectiveness is traditionally treated as a static estimate driven by clinical trial efficacy and drug price at launch. Prior studies suggest that cost-effectiveness varies over the drug's lifetime. We examined the impact of "learning by doing," one of the least studied drivers of changes in cost-effectiveness across the product life cycle. We combined time-series trends in effectiveness over time by cancer regimen using the Surveillance, Epidemiology, and End Results-Medicare database. We estimated the time-varying effects of treatments in colorectal and pancreatic cancer over their life cycle, including FOLFOX (leucovorin, 5-fluorouracil, and oxaliplatin) and gemcitabine, on survival of patients. Mean prices over time by strength and dosage form were calculated using historical wholesale acquisition costs. We found consistent downward trends in the mortality hazard ratios, which suggest that effectiveness improves over time. In the case of first-line FOLFOX for colorectal cancer, the implied incremental cost-effectiveness ratio based on the observational data fell from $610,000 per life year gained in 2004 to $27,000 per life year gained in 2011. Cost-effectiveness estimated at launch is unlikely to be representative of cost-effectiveness over the drug's lifetime. In the drugs studied, the impact of time-varying clinical effectiveness dominated the impact of changing prices overtime.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stevens</LastName>
            <ForeName>Warren</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8844-4746</Identifier>
            <AffiliationInfo>
              <Affiliation>Precision Global Health, Hillsborough, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Incerti</LastName>
            <ForeName>Devin</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4479-8750</Identifier>
            <AffiliationInfo>
              <Affiliation>Personalized Healthcare, Genentech, San Francisco, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peneva</LastName>
            <ForeName>Desi</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8637-2558</Identifier>
            <AffiliationInfo>
              <Affiliation>Health Policy and Economics, Precision Health Economics, Los Angeles, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shrestha</LastName>
            <ForeName>Anshu</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1065-3198</Identifier>
            <AffiliationInfo>
              <Affiliation>Health Policy and Economics, Precision Health Economics, Los Angeles, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Gregory</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1886-5550</Identifier>
            <AffiliationInfo>
              <Affiliation>Velocita Consulting, Hopkins, MN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramaswamy</LastName>
            <ForeName>Krishnan</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6140-3618</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Oncology, Pfizer Inc., New York, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Pfizer</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Health Econ</MedlineTA>
        <NlmUniqueID>9306780</NlmUniqueID>
        <ISSNLinking>1057-9230</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cost-benefit analysis (D61)</Keyword>
        <Keyword MajorTopicYN="N">dynamic treatment effect models (C32)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083778</ArticleId>
        <ArticleId IdType="doi">10.1002/hec.4004</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., … Mark, D. B. (2014). ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures. Circulation, 129(22), 2329-2345. https://doi.org/10.1161/CIR.0000000000000042</Citation>
        </Reference>
        <Reference>
          <Citation>Austin, P. C. (2014). The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments. Statistics in Medicine, 33(7), 1242-1258. https://doi.org/10.1002/sim.5984</Citation>
        </Reference>
        <Reference>
          <Citation>Basu, A., Grieve, R., Pritchard, D., &amp; Stevens, W. (2009). One size does not always fit all in value assessment. The American journal of managed care, 25(11), 540-542.</Citation>
        </Reference>
        <Reference>
          <Citation>Berwick, D. M., Nolan, T. W., &amp; Whittington, J. (2008). The triple aim: Care, health, and cost. Health Aff (Millwood), 27(3), 759-769. https://doi.org/10.1377/hlthaff.27.3.759</Citation>
        </Reference>
        <Reference>
          <Citation>Burris 3, H., Moore, MJ., Andersen, J., Green, MR., Rothenberg, ML., Modiano, MR., … Tarassoff, P.. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of clinical oncology. 1997 1;15(6): 2403-2413.</Citation>
        </Reference>
        <Reference>
          <Citation>Claxton, K., Briggs, A., Buxton, M. J., Culyer, A. J., McCabe, C., Walker, S., &amp; Sculpher, M. J. (2008). Value based pricing for NHS drugs: An opportunity not to be missed? BMJ, 336(7638), 251-254. https://doi.org/10.1136/bmj.39434.500185.25</Citation>
        </Reference>
        <Reference>
          <Citation>Cookson, R., &amp; Maynard, A. (2000). Health technology assessment in Europe. International Journal of Technology Assessment in Health Care, 16(02), 639-650. https://doi.org/10.1017/S0266462300101199</Citation>
        </Reference>
        <Reference>
          <Citation>Danzon, P., Towse, A., &amp; Mestre-Ferrandiz, J. (2015). Value-based differential pricing: Efficient prices for drugs in a global context. Health Economics, 24(3), 294-301. https://doi.org/10.1002/hec.3021</Citation>
        </Reference>
        <Reference>
          <Citation>de Gramont, A D, Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., … Papamichael, D. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology. 2000 16;18(16): 2938-2947.</Citation>
        </Reference>
        <Reference>
          <Citation>DiJulio, B., Firth, J., &amp; Brodie, M. (2015). Kaiser health tracking poll: August 2015. Menlo Park, CA, The Henry J. Kaiser Family Foundation.</Citation>
        </Reference>
        <Reference>
          <Citation>Experts in Chronic Myeloid Leukemia (2013). The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: From the perspective of a large group of CML experts. Blood, 121(22), 4439-4442. https://doi.org/10.1182/blood-2013-03-490003</Citation>
        </Reference>
        <Reference>
          <Citation>Figlin, R., Hutson, T., Tomczak, P., Michaelson, M., Bukowski, R., Negrier, S., … Motzer, R. (2008). Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology, 26(90150), 5024-5024. https://doi.org/10.1200/jco.2008.26.15_suppl.5024</Citation>
        </Reference>
        <Reference>
          <Citation>First Databank. (1981-2017). http://www.fdbhealth.com/</Citation>
        </Reference>
        <Reference>
          <Citation>Garrison, L. P., &amp; Veenstra, D. L. (2009). The economic value of innovative treatments over the product life cycle: The case of targeted trastuzumab therapy for breast cancer. Value in Health, 12(8), 1118-1123. https://doi.org/10.1111/j.1524-4733.2009.00572.x</Citation>
        </Reference>
        <Reference>
          <Citation>Gaynor, M., Seider, H., &amp; Vogt, W. B. (2005). The volume-outcome effect, scale economies, and learning-by-doing. The American Economic Review, 95, 243-247. https://doi.org/10.1257/000282805774670329</Citation>
        </Reference>
        <Reference>
          <Citation>Grabner, M., Johnson, W., Abdulhalim, A. M., Kuznik, A., &amp; Mullins, C. D. (2011). The value of atorvastatin over the product life cycle in the United States. Clinical Therapeutics, 33(10), 1433-1443. https://doi.org/10.1016/j.clinthera.2011.08.014</Citation>
        </Reference>
        <Reference>
          <Citation>Heng, D., Chi, K., Murray, N., Jin, T., Garcia, J., Bukowski, P., … Kollmannsberger, C. (2009). A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer. Cancer, 115(4), 776-783. https://doi.org/10.1002/cncr.24051</Citation>
        </Reference>
        <Reference>
          <Citation>Kenneth, J. (1962). The economic implications of learning by doing.</Citation>
        </Reference>
        <Reference>
          <Citation>Kolb, D. A., Boyatzis, R. E., &amp; Mainemelis, C. (2001). Experiential learning theory: Previous research and new directions. Perspectives on Thinking, Learning, and Cognitive Styles, 1(8), 227-247.</Citation>
        </Reference>
        <Reference>
          <Citation>Kristensen, F. B., Lampe, K., Chase, D. L., Lee-Robin, S. H., Wild, C., Moharra, M., … Neikter, S. A. (2009). Practical tools and methods for health technology assessment in Europe: Structures, methodologies, and tools developed by the European network for Health Technology Assessment, EUnetHTA. International Journal of Technology Assessment in Health Care, 25(S2), 1-8. https://doi.org/10.1017/S0266462309990626</Citation>
        </Reference>
        <Reference>
          <Citation>Lichtenberg, F. R., &amp; Duflos, G. (2009). The effect of patent expiration on US drug prices, marketing, and utilization by the public. Manhattan Institute for Policy Research.</Citation>
        </Reference>
        <Reference>
          <Citation>Lin, D. Y., &amp; Wei, L.-J. (1989). The robust inference for the Cox proportional hazards model. Journal of the American Statistical Association, 84(408), 1074-1078. https://doi.org/10.1080/01621459.1989.10478874</Citation>
        </Reference>
        <Reference>
          <Citation>Linley, W. G., &amp; Hughes, D. A. (2013). Societal views on NICE, cancer drugs fund and value-based pricing criteria for prioritising medicines: A cross-sectional survey of 4118 adults in Great Britain. Health Economics, 22(8), 948-964. https://doi.org/10.1002/hec.2872</Citation>
        </Reference>
        <Reference>
          <Citation>Lu, Y., Penrod, J. R., Sood, N., Woodby, S., &amp; Philipson, T. (2012). Dynamic cost-effectiveness of oncology drugs. The American Journal of Managed Care, 18(11 Suppl), S249-S256.</Citation>
        </Reference>
        <Reference>
          <Citation>Lundin, D., &amp; Ramsberg, J. (2008). Dynamic cost-effectiveness: A more efficient reimbursement criterion. Forum for Health Economics &amp; Policy, 11(2), 1-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Philipson, T. J., Kamal-Bahl, S., &amp; Jena, A. B. (2017). Defining value: The need for a longer, broader view. PharmacoEconomics, 35(7), 669-672. https://doi.org/10.1007/s40273-017-0503-7</Citation>
        </Reference>
        <Reference>
          <Citation>Pizzi, L. T. (2016). The institute for clinical and economic review and its growing influence on the US healthcare. American Health &amp; Drug Benefits, 9(1), 9-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Rawlins, M. (2008). De testimonio: On the evidence for decisions about the use of therapeutic interventions. Clinical Medicine, 8(6), 579-588. https://doi.org/10.7861/clinmedicine.8-6-579</Citation>
        </Reference>
        <Reference>
          <Citation>Rothenberg, ML., Oza, AM., Bigelow, RH., Berlin, JD., Marshall, JL., Ramanathan, RK., … Le Bail N. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. Journal of Clinical Oncology. 2003, 1;21(11): 2059-2069.</Citation>
        </Reference>
        <Reference>
          <Citation>Sanson-Fisher, R. W., Bonevski, B., Green, L. W., &amp; D'Este, C. (2007). Limitations of the randomized controlled trial in evaluating population-based health interventions. American Journal of Preventive Medicine, 33(2), 155-161. https://doi.org/10.1016/j.amepre.2007.04.007</Citation>
        </Reference>
        <Reference>
          <Citation>Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., … Langdon, R. (2015). American Society of Clinical Oncology statement: A conceptual framework to assess the value of cancer treatment options. Journal of Clinical Oncology, 33(23), 2563-2577. https://doi.org/10.1200/JCO.2015.61.6706</Citation>
        </Reference>
        <Reference>
          <Citation>Stokey, N. L. (1988). Learning by doing and the introduction of new goods. Journal of Political Economy, 96(4), 701-717. https://doi.org/10.1086/261559</Citation>
        </Reference>
        <Reference>
          <Citation>Thornton, S. (2007). Drug price reform in the UK: Debunking the myths. Health Economics, 16(10), 981-992. https://doi.org/10.1002/hec.1300</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083779</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-896X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Protein science : a publication of the Protein Society</Title>
          <ISOAbbreviation>Protein Sci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Biochemical Analysis of a Sugar 4,6-Dehydratase from Acanthamoeba polyphaga Mimivirus.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pro.3843</ELocationID>
        <Abstract>
          <AbstractText>The exciting discovery of the giant DNA Mimivirus in 2003 challenged the conventional description of viruses in a radical way, and since then, dozens of additional giant viruses have been identified. It has now been demonstrated that the Mimivirus genome encodes for the two enzymes required for the production of the unusual sugar 4-amino-4,6-dideoxy-d-glucose, namely a 4,6-dehydratase and an aminotransferase. In light of our long-standing interest in the bacterial 4,6-dehydratases and in unusual sugars in general, we conducted a combined structural and functional analysis of the Mimivirus 4,6-dehydratase referred to as R141. For this investigation, the three-dimensional X-ray structure of R141 was determined to 2.05 å resolution and refined to an R-factor of 18.3%. The overall fold of R141 places it into the short-chain dehydrogenase/reductase (SDR) superfamily of proteins. Whereas its molecular architecture is similar to that observed for the bacterial 4,6-dehydratases, there are two key regions where the polypeptide chain adopts different conformations. In particular, the conserved tyrosine that has been implicated as a catalytic acid or base in SDR superfamily members is splayed away from the active site by nearly 12 å, thereby suggesting that a major conformational change must occur upon substrate binding. In addition to the structural analysis, the kinetic parameters for R141 using either dTDP-d-glucose or UDP-d-glucose as substrates were determined. Contrary to a previous report, R141 demonstrates nearly identical catalytic efficiency with either nucleotide-linked sugar. The data presented herein represent the first three-dimensional model for a viral 4,6-dehydratase and thus expands our understanding of these fascinating enzymes. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>© 2020 The Protein Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ferek</LastName>
            <ForeName>Justin D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, University of Wisconsin, Madison, Wisconsin.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thoden</LastName>
            <ForeName>James B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, University of Wisconsin, Madison, Wisconsin.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holden</LastName>
            <ForeName>Hazel M</ForeName>
            <Initials>HM</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6214-3638</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, University of Wisconsin, Madison, Wisconsin.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Protein Sci</MedlineTA>
        <NlmUniqueID>9211750</NlmUniqueID>
        <ISSNLinking>0961-8368</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acanthamoeba polyphaga Mimivirus</Keyword>
        <Keyword MajorTopicYN="N">UDP-d-glucose 4,6-dehydratase</Keyword>
        <Keyword MajorTopicYN="N">UDP-d-viosamine</Keyword>
        <Keyword MajorTopicYN="N">X-ray structure</Keyword>
        <Keyword MajorTopicYN="N">dideoxysugar</Keyword>
        <Keyword MajorTopicYN="N">giant viruses</Keyword>
        <Keyword MajorTopicYN="N">viral glycans</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083779</ArticleId>
        <ArticleId IdType="doi">10.1002/pro.3843</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083780</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1529-8019</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dermatologic therapy</Title>
          <ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Landscape of current and future therapies of Merkel cell carcinoma.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13281</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.13281</ELocationID>
        <Abstract>
          <AbstractText>Merkel cell carcinoma is rare and aggressive skin cancer, which occurrence is linked to exposure to ultraviolet light and the Merkel-cell polyomavirus. In recent years, significant progress in understanding the mechanism of Merkel cell carcinoma pathogenesis has been observed. This neoplasm often expresses PD-L1, and MCPyV-specific T-cells can express PD-1 thus PD-1 / PD-L1 checkpoint therapies seem to be remarkably interesting treatment options. Many clinical trials are currently being conducted to confirm their effectiveness and safety for this group of patients. However, only about half of advanced Merkel cell carcinoma patients could achieve remission or disease stabilization through PD-1 / PD-L1 checkpoint therapies thus innovative treatments are still needed. In this paper, we have presented current and future directions in the development of Merkel cell carcinoma therapy. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kwiatkowska</LastName>
            <ForeName>Dominika</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University of Rzeszow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reich</LastName>
            <ForeName>Adam</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5573-1754</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University of Rzeszow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dermatol Ther</MedlineTA>
        <NlmUniqueID>9700070</NlmUniqueID>
        <ISSNLinking>1396-0296</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PD-1 inhibitors</Keyword>
        <Keyword MajorTopicYN="N">Skin malignancy</Keyword>
        <Keyword MajorTopicYN="N">treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083780</ArticleId>
        <ArticleId IdType="doi">10.1111/dth.13281</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083781</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2753</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of evaluation in clinical practice</Title>
          <ISOAbbreviation>J Eval Clin Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jep.13374</ELocationID>
        <Abstract>
          <AbstractText Label="RATIONALE, AIMS, AND OBJECTIVES" NlmCategory="UNASSIGNED">Clinical practice guidelines (CPGs) have become a common feature in the health and social care fields, as they promote evidence-based practice and aim to improve quality of care and patient outcome. However, the benefits of the recommendations reported in CPGs are only as good as the quality of the CPGs themselves. Indeed, rigorous development and strategies for reporting are significant precursors to successful implementation of the recommendations that are proposed. Unfortunately, research has demonstrated that there is much variability in their level of quality. Furthermore, the quality of many CPGs has yet to be examined. The aim of the present study was to assess the quality of seven CPGs from four Quebec professional regulatory bodies pertaining to clinical evaluations in the fields of medicine, psychoeducation, psychotherapy, and social work.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The seven Quebec CPGs were assessed by four trained appraisers using the Appraisal of Guidelines for Research and Evaluation II guideline evaluation tool.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Results suggest that while some quality criteria were met, most were not, denoting that these CPGs are of sub-optimal quality.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings highlight that there is still a lot to be done in order to improve the rigour and transparency with which scientific evidence is assessed and applied when developing CPGs. Impacts regarding the implementation of these CPGs are discussed in light of their use in clinical practice.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ciquier</LastName>
            <ForeName>Gabrielle</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5096-8907</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Counselling Psychology, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azzi</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Counselling Psychology, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hébert</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Counselling Psychology, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watkins-Martin</LastName>
            <ForeName>Kia</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Counselling Psychology, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drapeau</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Counselling Psychology, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, McGill University, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Social Sciences and Humanities Research Council of Canada</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Eval Clin Pract</MedlineTA>
        <NlmUniqueID>9609066</NlmUniqueID>
        <ISSNLinking>1356-1294</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AGREE II</Keyword>
        <Keyword MajorTopicYN="N">best practice</Keyword>
        <Keyword MajorTopicYN="N">clinical practice guidelines</Keyword>
        <Keyword MajorTopicYN="N">guideline development</Keyword>
        <Keyword MajorTopicYN="N">guidelines</Keyword>
        <Keyword MajorTopicYN="N">quality improvement</Keyword>
        <Keyword MajorTopicYN="N">quality measurement</Keyword>
        <Keyword MajorTopicYN="N">standards</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083781</ArticleId>
        <ArticleId IdType="doi">10.1111/jep.13374</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Middleton JC, Kalogeropoulos C, Middleton JA, Drapeau M. Assessing the methodological quality of the Canadian Psychiatric Association's anxiety and depression clinical practice guidelines. J Eval Clin Pract. 2018;25(4):613-621. https://doi.org/10.1111/jep.13026.</Citation>
        </Reference>
        <Reference>
          <Citation>Girlanda F, Fiedler I, Ay E, Barbui C, Koesters M. Guideline implementation strategies for specialist mental healthcare. Curr Opin Psychiatry. 2013;26(4):369-375. https://doi.org/10.1097/YCO.0b013e328361e7ae.</Citation>
        </Reference>
        <Reference>
          <Citation>Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. The Lancet. 1993;342(8883):1317-1322. https://doi.org/10.1016/0140-6736(93)92244-N.</Citation>
        </Reference>
        <Reference>
          <Citation>Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530. https://doi.org/10.1136/bmj.318.7182.527.</Citation>
        </Reference>
        <Reference>
          <Citation>Wiseman R, Cohen K, Gray A, et al. AGREE to disagree: critical appraisal and the publication of practice guidelines. S Afr Med J. 2014;104(5):345-346. https://doi.org/10.7196/SAMJ.8215.</Citation>
        </Reference>
        <Reference>
          <Citation>AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12(1):18-23. https://doi.org/10.1136/qhc.12.1.18.</Citation>
        </Reference>
        <Reference>
          <Citation>Alonso-Coello P, Irfan A, Sola I, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. BMJ Qual Saf. 2010;19(6):e58-e58. https://doi.org/10.1136/qshc.2010.042077.</Citation>
        </Reference>
        <Reference>
          <Citation>Blozik E, Nothacker M, Bunk T, Szecsenyi J, Ollenschläger G, Scherer M. Simultaneous development of guidelines and quality indicators-how do guideline groups act? A worldwide survey. Int J Health Care Qual Assur. 2012;25(8):712-729. https://doi.org/10.1108/09526861211270659.</Citation>
        </Reference>
        <Reference>
          <Citation>Cahill NE, Heyland DK. Bridging the guideline-practice gap in critical care nutrition: a review of guideline implementation studies. J Parenter Enter Nutr. 2010;34(6):653-659. https://doi.org/10.1177/0148607110361907.</Citation>
        </Reference>
        <Reference>
          <Citation>Gordon J, Cooper B. Talking knowledge-practising knowledge: a critical best practice approach to how social workers understand and use knowledge in practice. Practice. 2010;22(4):245-257. https://doi.org/10.1080/09503153.2010.495768.</Citation>
        </Reference>
        <Reference>
          <Citation>Norris SL, Holmer HK, Ogden LA, Burda BU. Conflict of interest in clinical practice guideline development: a systematic review. PLoS One. 2011;6(10):e25153. https://doi.org/10.1371/journal.pone.0025153.</Citation>
        </Reference>
        <Reference>
          <Citation>Burgers JS, Cluzeau FA, Hanna SE, Hunt C, Grol R. Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada. Int J Technol Assess Health Care. 2003;19(1):148-157. https://doi.org/10.1017/S026646230300014X.</Citation>
        </Reference>
        <Reference>
          <Citation>Ansari S, Rashidian A. Guidelines for guidelines: are they up to the task? A comparative assessment of clinical practice guideline development handbooks. PLoS One. 2012;7(11):e49864. https://doi.org/10.1371/journal.pone.0049864.</Citation>
        </Reference>
        <Reference>
          <Citation>Steinert T, Richter D, Bergk J. Sources of bias in guideline development. Psychiatr Serv. 2010;61:946-947.</Citation>
        </Reference>
        <Reference>
          <Citation>Burgers JS, Fervers B, Haugh M, et al. International assessment of the quality of clinical practice guidelines in oncology using the appraisal of guidelines and research and evaluation instrument. J Clin Oncol. 2004;22(10):2000-2007. https://doi.org/10.1200/JCO.2004.06.157.</Citation>
        </Reference>
        <Reference>
          <Citation>AGREE II. The AGREE next steps consortium. Appraisal of Guidelines for Research Evaluation II, 2009. http://www.agreetrust.org/wp-content/uploads/2013/10/AGREE-II-Users-Manual-and-23-item-Instrument_2009_UPDATE_2013.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. Can Med Assoc J. 2010;182(10):1045-1052. https://doi.org/10.1503/cmaj.091714.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Ansary LA, Tricco AC, Adi Y, et al. A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. PLoS One. 2013;8(1):e53744. https://doi.org/10.1371/journal.pone.0053744.</Citation>
        </Reference>
        <Reference>
          <Citation>Alarcon JD, Rubiano AM, Chirinos MS, et al. Clinical practice guidelines for the care of patients with severe traumatic brain injury: a systematic evaluation of their quality. J Trauma Acute Care Surg. 2013;75(2):311-319. https://doi.org/10.1097/TA.0b013e3182924bf8.</Citation>
        </Reference>
        <Reference>
          <Citation>Berrigan L, Marshall S, McCullagh S, Velikonja D, Bayley M. Quality of clinical practice guidelines for persons who have sustained mild traumatic brain injury. Brain Inj. 2011;25(7-8):742-751. https://doi.org/10.3109/02699052.2011.580317.</Citation>
        </Reference>
        <Reference>
          <Citation>Irani S, Rashidian A, Yousefi-Nooraie R, Soltani A. Evaluating clinical practice guidelines developed for the management of thyroid nodules and thyroid cancers and assessing the reliability and validity of the AGREE instrument: evaluating thyroid guidelines by AGREE. J Eval Clin Pract. 2011;17(4):729-736. https://doi.org/10.1111/j.1365-2753.2010.01561.x.</Citation>
        </Reference>
        <Reference>
          <Citation>Lambert E, Carey S. Practice guideline recommendations on perioperative fasting: a systematic review. J Parenter Enteral Nutr. 2016;40(8):1158-1165. https://doi.org/10.1177/0148607114567713.</Citation>
        </Reference>
        <Reference>
          <Citation>Tudor KI, Kozina PN, Marušić A. Methodological rigour and transparency of clinical practice guidelines developed by neurology professional societies in Croatia. PLoS One. 2013;8(7):e69877. https://doi.org/10.1371/journal.pone.0069877.</Citation>
        </Reference>
        <Reference>
          <Citation>Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839-E842. https://doi.org/10.1503/cmaj.090449.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin Ginis KA, van der Scheer JW, Latimer-Cheung AE, et al. Evidence-based scientific exercise guidelines for adults with spinal cord injury: an update and a new guideline. Spinal Cord. 2018;56(4):308-321. https://doi.org/10.1038/s41393-017-0017-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Rios E, Seron P, Lanas F, Bonfill X, Quigley E, Alonso-Coello P. Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol. 2014;26(4):422-431.</Citation>
        </Reference>
        <Reference>
          <Citation>Sabharwal S, Patel NK, Gauher S, Holloway I, Athansiou T. High Methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument. Clin Orthop Relat Res. 2014;472(6):1982-1988. https://doi.org/10.1007/s11999-014-3530-0.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosenfeld RM, Shiffman RN, Robertson P. Clinical practice guideline development manual, third edition: a quality-driven approach for translating evidence into action. Otolaryngol-Head Neck Surg. 2013;148(1_suppl):S1-S55. https://doi.org/10.1177/0194599812467004.</Citation>
        </Reference>
        <Reference>
          <Citation>Stamoulos C, Reyes A, Trepanier L, Drapeau M. The methodological quality of clinical practice guidelines in psychology: a pilot study of the guidelines developed by the ordre des Psychologues du Québec. Can Psychol. 2014;55(3):177-186. https://doi.org/10.1037/a0037287.</Citation>
        </Reference>
        <Reference>
          <Citation>Trepanier L, Stamoulos C, Reyes A. Assessing the quality of the OPQ's guidelines for the evaluation of dyslexia in children using the appraisal of guidelines for research and evaluation (AGREE) II: a brief report. Can Psychol. 2017;58(3):211-217. https://doi.org/10.1037/cap0000121.</Citation>
        </Reference>
        <Reference>
          <Citation>Collège des médecins du Québec. L'évaluation Médicale de l'aptitude à Conduire Un Véhicule Automobile. 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>Ordre des psychoéducateurs et psychoéducatrices du Québec. Évaluer Un Adolescent Dans Le Cadre d'une Décision Du Tribunal En Application de La Loi Sur Le Système de Justice Pénale Pour Les Adolescents. 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Ordre des psychoéducateurs et psychoéducatrices du Québec. L'évaluation Psychoéducative de La Personne En Difficulté d'adaptation. Lignes Directrices. Montréal; 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Bourque S, Ordre des travailleurs sociaux et des thérapeutes conjugaux et familieux du Québec. Évaluer Une Personne Ayant Un Trouble Mental Ou Neuropsychologique Attesté Par Un Diagnostic Ou Par Une Évaluation Effectuée Par Un Professionnel Habilité. Montréal; 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Gauthier L, Ordre des travailleurs sociaux et des thérapeutes conjugaux et familiaux du Québec. L'évaluation psychosociale dans le contexte des régimes de protection, du mandat donné en prévision de l'inaptitude et des autres mesures de protection au majeur. Montréal: Ordre des travailleurs sociaux et des thérapeutes conjugaux et familiaux du Québec; 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Hébert A, Ordre des travailleurs sociaux et des thérapeutes conjugaux et familieux du Québec. Évaluer Un Enfant Qui n'est Pas Encore Admissible à l'éducation Préscolaire et Qui Présente Des Indices de Retard de Développement Dans Le but de Déterminer Des Services de Réadaptation et d'adaptation Répondant à Ses Besoins. 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Ordre des travailleurs sociaux et des thérapeutes conjugaux et familieux du Québec et Ordre des psychologues du Québec. Guidelines for Expert Assessment Concerning Child Custody and Access Rights. 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Barriocanal AM, López A, Monreal M, Montané E. Quality assessment of peripheral artery disease clinical guidelines. J Vasc Surg. 2016;63(4):1091-1098. https://doi.org/10.1016/j.jvs.2015.12.040.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang S-G, Kim D-I, Shin E-S, Jang J-E, Yeon J-Y, Lee Y-S. Methodological quality appraisal of 27 Korean guidelines using a scoring guide based on the AGREE II instrument and a web-based evaluation. J Korean Med Sci. 2016;31(5):682-687. https://doi.org/10.3346/jkms.2016.31.5.682.</Citation>
        </Reference>
        <Reference>
          <Citation>MacQueen G, Santaguida P, Keshavarz H, et al. Systematic review of clinical practice guidelines for failed antidepressant treatment response in major depressive disorder, dysthymia, and subthreshold depression in adults. Can J Psychiatry. 2017;62(1):11-23. https://doi.org/10.1177/0706743716664885.</Citation>
        </Reference>
        <Reference>
          <Citation>Ye Z-K, Liu Y, Cui X-L, Liu L-H. Critical appraisal of the quality of clinical practice guidelines for stress ulcer prophylaxis. PLoS One. 2016;11(5):e0155020. https://doi.org/10.1371/journal.pone.0155020 (Green J, ed).</Citation>
        </Reference>
        <Reference>
          <Citation>Tasca GA, Sylvestre J, Balfour L, et al. What clinicians want: findings from a psychotherapy practice research network survey. Psychotherapy. 2015;52(1):1-11. https://doi.org/10.1037/a0038252.</Citation>
        </Reference>
        <Reference>
          <Citation>Vernooij RWM, Alonso-Coello P, Brouwers M, Martínez García L. CheckUp panel. Reporting items for updated clinical guidelines: checklist for the reporting of updated guidelines (CheckUp). PLoS Med. 2017;14(1):e1002207. https://doi.org/10.1371/journal.pmed.1002207.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083783</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1439-0531</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Reproduction in domestic animals = Zuchthygiene</Title>
          <ISOAbbreviation>Reprod. Domest. Anim.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>MiR-142-5P Regulates triglyceride by Targeting CTNNB1 in Goat Mammary Epithelial Cells.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/rda.13660</ELocationID>
        <Abstract>
          <AbstractText>MicroRNAs (miRNAs) regulate genes through posttranscriptional regulation by targeting the 3'-UTR of mRNA to downregulate gene expression. Several reports have indicated that miRNA regulation can affect many physiological processes, including immune function, apoptosis, cell proliferation and differentiation, and milk fat metabolism. In this study, miR-142-5P promoted milk fat metabolism, and inhibition of miR-142-5P suppressed milk fat metabolism both in vivo and in vitro. The luciferase and Western blot assays indicated that Catenin beta-1 (CTNNB1) is a potential target for miR-142-5P. In addition, CTNNB1 inhibited milk fat metabolism. In summary, miR-142-5P may promote milk fat metabolism by inhibiting CTNNB1 expression.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sui</LastName>
            <ForeName>MeiXia</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6431-5085</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Biological and Agricultural Engineering, Weifang University, Weifang, 261061, Shandong, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shandong Key Laboratory of Biochemistry and Molecular Biology in Universities, Weifang University, Weifang, 261061, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>ZongWei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Administrative Examination and Approval Service Bureau of Shouguang, Weifang, 262700, Shandong, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xi</LastName>
            <ForeName>Dan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>College of Biological and Agricultural Engineering, Weifang University, Weifang, 261061, Shandong, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shandong Key Laboratory of Biochemistry and Molecular Biology in Universities, Weifang University, Weifang, 261061, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>HanHai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>College of Biological and Agricultural Engineering, Weifang University, Weifang, 261061, Shandong, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shandong Key Laboratory of Biochemistry and Molecular Biology in Universities, Weifang University, Weifang, 261061, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Reprod Domest Anim</MedlineTA>
        <NlmUniqueID>9015668</NlmUniqueID>
        <ISSNLinking>0936-6768</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
CTNNB1
</Keyword>
        <Keyword MajorTopicYN="N">goat</Keyword>
        <Keyword MajorTopicYN="N">miR-142-5P</Keyword>
        <Keyword MajorTopicYN="N">milk fat metabolism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083783</ArticleId>
        <ArticleId IdType="doi">10.1111/rda.13660</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083782</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2753</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of evaluation in clinical practice</Title>
          <ISOAbbreviation>J Eval Clin Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Do stroke clinical practice guideline recommendations for the intervention of thickened liquids for aspiration support evidence based decision making? A systematic review and narrative synthesis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jep.13372</ELocationID>
        <Abstract>
          <AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Aspiration is a common sequela post stroke as a result of oropharyngeal dysphagia. It is primarily managed using the poorly empirically supported intervention of thickened liquids. Where evidence is limited, clinicians may rely on clinical practice guidelines to support decision making. The purpose of this systematic review and narrative synthesis was to evaluate the evidentiary bases of recommendations made by stroke clinical practice guidelines regarding the thickened liquids intervention.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was conducted on stroke clinical guidelines retrieved via searches conducted across a range of databases including Academic Search Complete, CINAHL, MEDLINE, and the Cochrane Library as well as through association websites. Guidelines were eligible for inclusion if they focused on adult stroke populations, made recommendations relating to the thickened liquid intervention and were published between January 2010 and December 2018. Four independent reviewers rated methodological quality using the AGREE-II instrument. Intervention recommendations were extracted and analysed using the Criteria for Levels of Evidence Reported from the Canadian Stroke Best Practice Recommendations and a novel framework examining the appropriateness of the supporting evidence.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen clinical guidelines were included in the review. Methodological quality was variable with seven rating as good-excellent overall. Thirty recommendations regarding the intervention were extracted. Of these, 16 recommendations were classed as a recommendation to use the treatment and all guidelines made this recommendation. Much of the evidence used to scaffold recommendations did not directly support the intervention.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite the limited evidence base for the thickened liquid intervention, there was consensus among stroke guidelines in recommending it. This is despite limited empirical support. Furthermore, much of the evidence used to support recommendations was not appropriate, suggesting less than satisfactory evidence-based practices in formulating recommendations. In this case, clinical guidelines may not be reliable decision-support tools for facilitating clinical decision making.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Journal of Evaluation in Clinical Practice published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McCurtin</LastName>
            <ForeName>Arlene</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0649-0448</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Allied Health, Health Sciences Building, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Health Research Institute, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boland</LastName>
            <ForeName>Pauline</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>School of Allied Health, Health Sciences Building, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kavanagh</LastName>
            <ForeName>Maeve</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Allied Health, Health Sciences Building, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lisiecka</LastName>
            <ForeName>Dominika</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing and Midwifery, University College Cork, Cork, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Nursing and Healthcare Sciences, Institute of Technology, Tralee, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roche</LastName>
            <ForeName>Caoimhe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Allied Health, Health Sciences Building, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galvin</LastName>
            <ForeName>Rose</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>School of Allied Health, Health Sciences Building, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Health Research Institute, University of Limerick, Limerick, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Eval Clin Pract</MedlineTA>
        <NlmUniqueID>9609066</NlmUniqueID>
        <ISSNLinking>1356-1294</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">clinical guidelines</Keyword>
        <Keyword MajorTopicYN="N">evidence-based medicine</Keyword>
        <Keyword MajorTopicYN="N">medical informatics</Keyword>
        <Keyword MajorTopicYN="N">systematic reviews</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083782</ArticleId>
        <ArticleId IdType="doi">10.1111/jep.13372</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Altman KW, Yu G, Schaefer SD. Consequences of dysphagia in the hospitalized patient, impact on prognosis and hospital resources. Arch Otolaryngol. 2010;136:784-789.</Citation>
        </Reference>
        <Reference>
          <Citation>Arnold M, Liesirova K, Broeg-Morvay A, et al. Dysphagia in acute stroke: incidence, burden and impact on clinical outcome. PLoS One. 2016. https://doi.org/10.1371/journal.pone.0148424.</Citation>
        </Reference>
        <Reference>
          <Citation>Doggett DL, Tappe KA, Mitchell MD, Chapell VC, Turkelson CM. Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence based comprehensive analysis of the literature. Dysphagia. 2001;16:279-295.</Citation>
        </Reference>
        <Reference>
          <Citation>Armstrong JR, Mosher BD. Aspiration pneumonia after stroke intervention and prevention. Neurohospitalist. 2011;1(2):85-93.</Citation>
        </Reference>
        <Reference>
          <Citation>Martino R, Foley N, Bhoghal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke; incidence, diagnosis, and pulmonary complications. Stroke. 2005;36:2756-2763.</Citation>
        </Reference>
        <Reference>
          <Citation>Clavé P, de Kraa M, Arreola V, et al. The effect of bolus viscosity on swallowing function in neurogenic dysphagia'. Aliment Pharmacol. 2006;24(9):1385-1394.</Citation>
        </Reference>
        <Reference>
          <Citation>McCurtin A, Healy C, Kelly L, Murphy F, Ryan J, Walsh J. Plugging the patient evidence gap: what patients with swallowing disorders post-stroke say about thickened liquids. Int J Lang Commun Disord. 2018;53(1):30-39.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones O, Cartwright J, Whitworth A, Cocks N. Dysphagia therapy post stroke: an exploration of the practices and clinical decision-making of speech-language pathologists in Australia. Int J Speech Lang Pathol. 2017. https://doi.org/10.1080/17549507.2016.1265588.</Citation>
        </Reference>
        <Reference>
          <Citation>McCurtin A, Healy C. Why do clinicians choose the therapies and techniques they do? Exploring clinical decision making via treatment selections in dysphagia practice. J Speech Lang Pathol. 2017;19(1):69-76.</Citation>
        </Reference>
        <Reference>
          <Citation>Smithard DG, Fairfield C, Roffe C, Enderby P. European Society for Swallowing Disorders Position Statements and Meeting Abstracts 2012: dysphagia management in the acute phase of stroke. Dysphagia. 2007;28(2):307.</Citation>
        </Reference>
        <Reference>
          <Citation>Andersen UT, Beck AM, Kjaersgaard A, Hansen T, Poulsen I. Systematic review and evidence based recommendations on texture modified foods and thickened fluids for adults (≥18 years) with oropharyngeal dysphagia. e-SPEN J. 2013;8(4):127-134.</Citation>
        </Reference>
        <Reference>
          <Citation>Newman R, Vilardell N, Clave P, Speyer R. Effect of bolus viscosity on the safety and efficacy of swallowing and the kinematics of the swallow response in patients with oropharyngeal dysphagia: white paper by the European Society for Swallowing Disorders. Dysphagia. 2016;31:232-249.</Citation>
        </Reference>
        <Reference>
          <Citation>Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012. https://doi.org/10.1002/14651858.CD000323.pub2.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaneoka A, Pisegna JM, Saito H, et al. A systematic review and meta-analysis of pneumonia associated with thin liquid vs. thickened liquid intake in patients who aspirate. Clin Rehabil. 2016. https://doi.org/10.1177/0269215516677739.</Citation>
        </Reference>
        <Reference>
          <Citation>Steele CM, Alsanei WA, Ayanikalath S, Brabon CE, Chen J, et al. The influence of food texture and liquid consistency modification on swallowing physiology and function: a systematic review. Dysphagia. 2015;30:2-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Beck AM, Kjaersgaard A, Hansen T, Poulsen I. Systematic review and evidence based recommendations on texture modified foods and thickened liquids for adults (above 17 years) with oropharyngeal dysphagia - an updated clinical guideline. Clin Nutr. 2017;37:1980-1991. https://doi.org/10.1016/j.clnu.2017.09.002.</Citation>
        </Reference>
        <Reference>
          <Citation>Hurdowar A, Graham ID, Bayley M, Harrison M, Wood-Dauphinee S, Bhogal S. Quality of stroke rehabilitation clinical practice guidelines. J Eval Clin Pract. 2007;13:657-664.</Citation>
        </Reference>
        <Reference>
          <Citation>Kredo T, Bernhardsson S, Machingaidze S, et al. Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care. 2016;28(1):122-128.</Citation>
        </Reference>
        <Reference>
          <Citation>Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530.</Citation>
        </Reference>
        <Reference>
          <Citation>Heiwe S, Kajermo KN, Tyni-Lenné R, et al. Evidence-based practice: attitudes, knowledge, and behaviour among allied health care professionals. Int J Qual Health Care. 2011;23(2):198-209.</Citation>
        </Reference>
        <Reference>
          <Citation>Management of Stroke Rehabilitation Working Group. VA/DOD clinical practice guideline for the management of stroke rehabilitation. J Rehabil Res Dev. 2010;47(9):1-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Wainberg SK, Santos NCL, Gabriel FC, et al. Clinical practice guidelines for surgical antimicrobial prophylaxis: qualitative appraisals and synthesis of recommendations. J Eval Clin Pract. 2018. https://doi.org/10.1111/jep.12992.</Citation>
        </Reference>
        <Reference>
          <Citation>Clifford AM, Ryan J, Walsh C, McCurtin A. What information is used in treatment decision aids? A systematic review of the types of evidence populating health decision aids. BMC Med Inform Decis. 2017. https://doi.org/10.1186/s12911-017-0415-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Murray J, Miller M, Doeltgen S, Scholten I. Intake of thickened liquids by hospitalized adults with dysphagia after stroke. Int J Speech Lang Pathol. 2014;16(5):486-494.</Citation>
        </Reference>
        <Reference>
          <Citation>Alonso-Coello P, Irfan A, Solà I, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care. 2010;19(6):e58.</Citation>
        </Reference>
        <Reference>
          <Citation>Siering U, Eikermann M, Hausner E, Hoffmann-Eßer W, Neugebauer EA. Appraisal tools for clinical practice guidelines: a systematic review. PLoS One. 2013. https://doi.org/10.1371/journal.pone.0082915.</Citation>
        </Reference>
        <Reference>
          <Citation>Navarro Puerto MA, Ibarluzea IG, Ruiz OG, et al. Analysis of the quality of clinical practice guidelines on established ischemic stroke. Int J Technol Assess. 2008;24(3):333-341.</Citation>
        </Reference>
        <Reference>
          <Citation>Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF. Conflicts of interest and the quality of recommendations in clinical guidelines. J Eval Clin Pract. 2012;19(4):674-681.</Citation>
        </Reference>
        <Reference>
          <Citation>Royal College of Physicians in London &amp; Intercollegiate Stroke Working Party. National clinical guideline for stroke. 5th ed.; 2016 https://www.rcplondon.ac.uk/guidelines-policy/stroke-guidelines. Accessed June 21, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Gandhi S, Verma S, Ethier JL, Simmons CE, Burnett H, Alibhai SM. A systemic review and quality appraisal of international guidelines for early breast cancer systemic therapy: are recommendations sensitive to different global resources? Breast. 2015;24:309-317.</Citation>
        </Reference>
        <Reference>
          <Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009. https://doi.org/10.1371/journal.pmed.1000097.</Citation>
        </Reference>
        <Reference>
          <Citation>Martínez García L, Arévalo-Rodríguez I, Solà I, et al. Guidelines for monitoring and updating clinical practice guidelines: a systematic review. Implement Sci. 2012. https://doi.org/10.1186/1748-5908-7-109.</Citation>
        </Reference>
        <Reference>
          <Citation>Silagy C, Rubin G, Henderson-Smart D, Gross P. A guide to the development, implementation and evaluation of clinical practice guidelines. National Health and Medical Research Council. Canberra: Commonwealth of Australia; 1998:1-79.</Citation>
        </Reference>
        <Reference>
          <Citation>RWM V, Sanabria AJ, Solà I, Alonso-Coello P, Martínez García L. Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks. Implement Sci. 2014. https://doi.org/10.1186/1748-5908-9-3.</Citation>
        </Reference>
        <Reference>
          <Citation>AGREE Next Steps Consortium. The AGREE II Instrument [online]; 2009. http://www.agreetrust.org/wp-content/uploads/2013/10/AGREE-II-Users-Manual-and-23-item-Instrument_2009_UPDATE_2013.pdf. Accessed June 20, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. Can Med Assoc J. 2010a;182(10):1045-1052.</Citation>
        </Reference>
        <Reference>
          <Citation>Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. Can Med Assoc J. 2010b;182(10):472-478.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang TW, Lai JH, Wu MY, Chen SL, Wu CH, Tam KW. Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC Med. 2013. https://doi.org/10.1186/1741-7015-11-191.</Citation>
        </Reference>
        <Reference>
          <Citation>Teasell R, Foley N, Salter K, Bhogal S, Jutai J, Speechley M. Evidence-based review of stroke rehabilitation: executive summary, 12th edition. Top Stroke Rehabil. 2009;16(6):463-488.</Citation>
        </Reference>
        <Reference>
          <Citation>Stroke Foundation of Australia. National Stroke Foundation: Clinical Guidelines for Stroke Management. Melbourne: National Stroke Foundation; 2017 https://informme.org.au/Guidelines/Clinical-Guidelines-for-Stroke-Management-2017. Accessed December 20, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>NWR Best Practices in Stroke Rehabilitation Group Best Practice Guidelines for the Management and Rehabilitation of Stroke in the North West Region of Cameroon; 2013. http://icdr.utoronto.ca/wp-content/uploads/2015/05/Best-Practice-Guideline-Stroke-rehabilitation-for-NWR-Final-.pdf. Accessed December 20, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Cockburn L, Fanfon TN, Bramall A, et al. Best practice guidelines for stroke in Cameroon: an innovative and participatory knowledge translation project. Afr J Disabil. 2014. https://doi.org/10.4102/ajod.v3i1.92.</Citation>
        </Reference>
        <Reference>
          <Citation>Hebert D, Lindsay MP, McIntyre A, et al. Canadian stroke best practice recommendations: stroke rehabilitation practice guidelines, update 2015. Int J Stroke. 2016;11(4):459-484.</Citation>
        </Reference>
        <Reference>
          <Citation>Boulanger JM, Lindsay MP, Stotts G, et al. Canadian stroke best practice recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018. Int J Stroke. 2018;13(9):949-984.</Citation>
        </Reference>
        <Reference>
          <Citation>Wirth R, Smoliner C, Jäger M, Warnecke T, Leischker AH, Dziewas R. Guideline clinical nutrition in patients with stroke'. Exp Transl Stroke Med. 2014. https://doi.org/10.1186/2040-7378-5-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Irish Heart Foundation: Council for Stroke. National Clinical Guidelines and Recommendations for the Care of People with Stroke and Transient Ischaemic Attack. Dublin: Irish Heart Foundation; 2010 http://irishheart.ie/wp-content/uploads/2017/04/guidelines.pdf. Accessed December 20, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Stroke Society of the Philippines. Guidelines for the Prevention, Treatment and Rehabilitation of Stroke. 5th ed. Manila: The Stroke Society of the Philippines; 2010 http://www.strokesocietyphil.org/files/2011.pdf. Accessed January 2, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Scottish Intercollegiate Guideline Network. Management of Patients with Stroke; Rehabilitation, Prevention and Management of Complications, and Discharge Planning. Edinburgh: Scottish Intercollegiate Guideline Network; 2010 (SIGN Publication no. 118). www.sign.ac.uk. Accessed January 2, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Scottish Intercollegiate Guideline Network. Management of Patients with Stroke: Identification and Management of Dysphagia. Edinburgh: Scottish Intercollegiate Guideline Network; 2010 (SIGN Publication no. 119). www.sign.ac.uk. Accessed January 2, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>National Institute for Clinical Excellence &amp; National Clinical Guideline Centre. Stroke rehabilitation: Long term rehabilitation after stroke. Clinical guideline 162; 2013. https://www.nice.org.uk/guidance/cg162/resources/cg162-stroke-rehabilitation-full-guideline3. Accessed January 2, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>VA/DoD Clinical Practice Guideline. Management of Stroke Rehabilitation; 2010. Washington: Department of Veterans Affairs, Department of Defense and The American Heart Association/American Stroke Association. https://www.healthquality.va.gov/guidelines/rehab/stroke. Accessed January 4, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47. https://doi.org/10.1161/STR.0000000000000098.</Citation>
        </Reference>
        <Reference>
          <Citation>Bakhtiyari J, Sarraf P, Nakhostin-Ansari N, et al. Effects of early intervention of swallowing therapy on recovery from dysphagia following stroke. Iran J Neurol. 2015;14(3):119-124.</Citation>
        </Reference>
        <Reference>
          <Citation>Cichero JAY, Lam P, Steele CM, et al. Development of international terminology and definitions for texture-modified foods and thickened fluids use in dysphagia management. Dysphagia. 2017. https://doi.org/10.1007/s00455-016-9758-y.</Citation>
        </Reference>
        <Reference>
          <Citation>Bayley M, Lindsay P, Teasell R, et al. Canadian Stroke Quality of Care Study: quality indicators for stroke rehabilitation (in collaboration with SCORE). Toronto, ON: Canadian Stroke Network, Ontario Ministry of Health and Long-Term Care and Institute for Clinical Evaluative Sciences; 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Lindsay MP, Gubitz G, Bayley M, et al. Canadian Best Practice Recommendations for Stroke Care (Update 2010). Ottawa, ON, Canadian Stroke Network; 2010 http://strokebestpractices.ca/wp-content/uploads/2010/12/2010_BP_ENG.pdf. Accessed August 31, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>SCORE (Stroke Canada Optimization of Rehabilitation through Evidence). Evidence-based Recommendations for the Upper and Lower Extremities and Risk Assessment Post-stroke. Ottawa, ON: Canadian Stroke Network; 2007, 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>Carnaby G, Hankey GJ, Pizzi J. Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol. 2006;5(1):31-37.</Citation>
        </Reference>
        <Reference>
          <Citation>DePippo KL, Holas MA, Reding MJ, Mandel FS, Lesser ML. Dysphagia therapy following stroke: a controlled trial. Neurology. 1994;44(9):1655-1660.</Citation>
        </Reference>
        <Reference>
          <Citation>Stroke Foundation of Australia. National Stroke Foundation: Clinical Guidelines for Stroke Management. Melbourne: National Stroke Foundation; 2010 https://www.pedro.org.au/wp-content/uploads/CPG_stroke.pdf. Accessed March 23, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke. 4th ed. London: Royal College of Physicians; 2012 https://www.strokeaudit.org/Guideline/Historical-Guideline/National-Clinical-Guidelines-for-Stroke-fourth-edi.aspx. Accessed March 24, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Scottish Intercollegiate Guideline Network. Management of Patients with Stroke. Edinburgh: Scottish Intercollegiate Guideline Network; 2004 (SIGN Publication no. 119). www.sign.ac.uk/sign-119-management-of-patients-with-stroke-identification-and-management-of-dysphagia.html. Accessed March 30, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>AHRQ Evidence Report Summaries; 1999. Rockville, MD: Agency for Healthcare Research and Quality (US); 1998-2005. https://www.ncbi.nlm.nih.gov/books/NBK11926/#A130265. Accessed March 30, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Cook IJ, Kahrilas PJ. AGA technical review on management of oropharyngeal dysphagia. Gastroenterology. 1999;116:455-478.</Citation>
        </Reference>
        <Reference>
          <Citation>Logemann JA, Rademaker AW, Pauloski BR, Ohmae Y, Kahrilas PJ. Normal swallowing physiology as viewed by videofluoroscopy and videoendoscopy. Folia Phoniatr Logop. 1998;50(6):311-319.</Citation>
        </Reference>
        <Reference>
          <Citation>Elmstahl S, Bulow M, Ekberg O, Petersson M, Tegner H. Treatment of dysphagia improves nutritional conditions in stroke patients. Dysphagia. 1999;14(2):61-66.</Citation>
        </Reference>
        <Reference>
          <Citation>Huckabee ML, Cannito MP. Outcomes of swallowing rehabilitation in chronic brainstem dysphagia: a retrospective evaluation. Dysphagia. 1999;14:93-109.</Citation>
        </Reference>
        <Reference>
          <Citation>Klor BM, Militani FJ. Rehabilitation of neurogenic dysphagia with percutaneous endoscopic gastrostomy. Dysphagia. 1999;14:162-164.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosenbek JC, Roecker EB, Wood JL, Robbins J. Thermal application reduces the duration of stage transition in dysphagia after stroke. Dysphagia. 1996;11(4):225-233.</Citation>
        </Reference>
        <Reference>
          <Citation>Ramritu P, Finlayson K, Mitchell A, Croft G. Identification and Nursing Management of Dysphagia in Individuals with Neurological Impairment: A Systematic Review. No. 8. Adelaide: Joanna Briggs Institute for Evidence Based Nursing and Midwifery; 2000.</Citation>
        </Reference>
        <Reference>
          <Citation>National Institute for Health and Clinical Excellence (NICE). Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. Clinical Guideline 32. London: National Institute for Health and Clinical Excellence; 2006 https://www.ncbi.nlm.nih.gov/pubmed/21309138. Accessed April 3, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>National Institute for Health and Clinical Excellence (NICE). Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). Clinical Guideline 68. London: National Institute for Health and Clinical Excellence; 2008 https://www.niceorguk/guidance/cg68 Accessed April 3, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>British Dietetic Association and the Royal College of Speech and Language Therapists joint document. National Descriptors for Texture Modification in Adults; 2002. http://www.bda.uk.com/Downloads/dysphagia.pdf. Accessed April 4, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>NHS National Patient Safety Agency, Royal College of Speech and Language Therapists, The British Dietetic Association, National Nurses Nutrition Group and Hospital Caterers Association. Dysphagia Diet Food Texture Descriptors; 2011. https://www.rcslt.org/members/publications/dysphagia_diet_texture_descriptions. Accessed April 4, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Kertscher B, Speyer R, Palmieri M, Plant C. Bedside screening to detect oropharyngeal dysphagia in patients with neurological disorders: an updated systematic review. Dysphagia. 2014;29:204-212.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson RD, Howe EC. A cost-effectiveness analysis of screening methods for dysphagia after stroke. PM R. 2014;4:273-282.</Citation>
        </Reference>
        <Reference>
          <Citation>Bax L, McFarlane M, Green E, Miles A. Speech-language pathologist-led fiberoptic endoscopic evaluation of swallowing: functional outcomes for patients after stroke. J Stroke Cerebrovasc Dis. 2014;23:e195-e200.</Citation>
        </Reference>
        <Reference>
          <Citation>Foley N, Teasell R, Salter K, Kruger E, Martino R. Dysphagia treatment post stroke: a systematic review of randomised controlled trials. Age Ageing. 2008;37(3):258-264.</Citation>
        </Reference>
        <Reference>
          <Citation>Speyer R, Baijens L, Heijnen M, Zwijnenberg I. Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review. Dysphagia. 2010;25(1):40-65.</Citation>
        </Reference>
        <Reference>
          <Citation>Rofes L, Arreola V, Mukherjee R, et al. The effects of a xanthan gum-based thickener on the swallowing function of patients with dysphagia. Aliment Pharmacol. 2014;39:1169-1170.</Citation>
        </Reference>
        <Reference>
          <Citation>Bath PM, Bath-Hextall FJ, Smithard D. Interventions for dysphagia in acute stroke. Cochrane Database Syst Rev. 2009;4:CD00w0323.</Citation>
        </Reference>
        <Reference>
          <Citation>Ashford J, McCabe D, Wheeler-Hegland K, et al. Evidence-based systematic review: oropharyngeal dysphagia behavioral treatments, part III: impact of dysphagia treatments on populations with neurological disorders. J Rehabil Res Dev. 2009;46:195-204.</Citation>
        </Reference>
        <Reference>
          <Citation>Garon BR, Engle M, Ormiston C. A randomized control study to determine the effects of unlimited oral intake of water in patients with identified aspiration. Neurorehabil Neural Repair. 1997;11(3):139-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh S, Hamdy S. Dysphagia in stroke patients. Postgrad Med J. 2006;82(968):383-391.</Citation>
        </Reference>
        <Reference>
          <Citation>ADAPTE Collaboration. The ADAPTE process: resource toolkit for guideline adaptation. Version 2.0; 2009. http://www.g-i-n.net/document-store/working-groups-documents/adaptation/adapte-resource-toolkit-guideline-adaptation-2-0.pdf. Accessed August 7, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Rohde A, Worrall L, Le Dorze G. Systematic review of the quality of clinical guidelines for aphasia in stroke management: clinical guidelines for aphasia. J Eval Clin Pract. 2013;19(6):994-1003.</Citation>
        </Reference>
        <Reference>
          <Citation>Martínez García L, Sanabria AJ, García Álvarez E, et al. The validity of recommendations from clinical guidelines: a survival analysis. Can Med Assoc J. 2014;186(16):1211-1219.</Citation>
        </Reference>
        <Reference>
          <Citation>McCurtin A, Clifford A. What are the primary influences on treatment decisions? How does this reflect on evidence-based practice? Indications from the discipline of Speech &amp; Language Therapy. J Eval Clin Pract. 2015;21:1178-1189.</Citation>
        </Reference>
        <Reference>
          <Citation>Parahoo K. Barriers to, and facilitators of, research utilization among nurses in Northern Ireland. J Adv Nurs. 2000;31(1):89-98.</Citation>
        </Reference>
        <Reference>
          <Citation>McCurtin A, Murphy CA, Roddam H. Moving beyond traditional understandings of evidence based practice: a total evidence and knowledge approach (TEKA) to treatment evaluation and clinical decision-making in speech-language pathology. Semin Speech Lang. 2019;40(5):370-393.</Citation>
        </Reference>
        <Reference>
          <Citation>Elwyn E, Wieringa S, Greenhalgh T. Clinical encounters in the post-guidelines era. BMJ. 2016. https://doi.org/10.1136/bmj.i3200.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083784</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-4095</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Advanced materials (Deerfield Beach, Fla.)</Title>
          <ISOAbbreviation>Adv. Mater. Weinheim</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dendronized-Polymer Disturbing Cells' Stress Protection by Targeting Metabolism Leads to Tumor Vulnerability.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1907490</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/adma.201907490</ELocationID>
        <Abstract>
          <AbstractText>Metabolic demand of cancer is quite unique compared to normal tissues and this is an emerging hallmark of cancer, which brings a potential opportunity to discover drugs that target cancer cell metabolism. Herein, the development of a dendronized pyropheophorbide a (Ppa)-conjugated polymer (DPP) is reported, and a linear Ppa-conjugated polymer (LPP) is reported as a control. DPP is found to disturb cellular metabolism including increased energy depletion, dysfunctional H<sup>+</sup> regulation, and decreased antioxidation, resulting in deficiency in protecting cells from stresses. These vulnerable cells are subjected to photodynamic therapy (PDT) treatment in the presence of DPP, resulting in attenuated cancer cell growth and eventually cell death. The in vivo anticancer efficacy is also ascribed to significantly prolonged blood circulation and enhanced tumor accumulation of DPP due to its unique molecular structure. This study presents a new platform using dendronized polymers for tumor suppression by targeting cancer cell metabolism.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Dayi</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Xiuli</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Qianfeng</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhiqian</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duan</LastName>
            <ForeName>Zhenyu</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Wen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Meng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Hongyan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Hu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA, 91711, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Qiyong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gu</LastName>
            <ForeName>Zhongwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Kui</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3536-1485</Identifier>
            <AffiliationInfo>
              <Affiliation>Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>51673127</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>51873120</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81621003</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81801820</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2018HH0006</GrantID>
            <Agency>Department of Science and Technology of Sichuan Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2015DFE52780</GrantID>
            <Agency>Ministry of Science and Technology of the People's Republic of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2018M643493</GrantID>
            <Agency>China Postdoctoral Science Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2018SCU12032</GrantID>
            <Agency>Fundamental Research Funds for the Central Universities</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>ZYGD18028</GrantID>
            <Agency>West China Hospital, Sichuan University</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Adv Mater</MedlineTA>
        <NlmUniqueID>9885358</NlmUniqueID>
        <ISSNLinking>0935-9648</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dendrimers</Keyword>
        <Keyword MajorTopicYN="N">photodynamic therapy</Keyword>
        <Keyword MajorTopicYN="N">polymers</Keyword>
        <Keyword MajorTopicYN="N">stress protection</Keyword>
        <Keyword MajorTopicYN="N">tumor metabolism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083784</ArticleId>
        <ArticleId IdType="doi">10.1002/adma.201907490</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>H. Cheong, C. Lu, T. Lindsten, C. B. Thompson, Nat. Biotechnol. 2012, 30, 671.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Li, S. Ning, M. Ghandi, G. V. Kryukov, S. Gopal, A. Deik, A. Souza, K. Pierce, P. Keskula, D. Hernandez, J. Ann, D. Shkoza, V. Apfel, Y. Zou, F. Vazquez, J. Barretina, R. A. Pagliarini, G. G. Galli, D. E. Root, W. C. Hahn, A. Tsherniak, M. Giannakis, S. L. Schreiber, C. B. Clish, L. A. Garraway, W. R. Sellers, Nat. Med. 2019, 25, 850.</Citation>
        </Reference>
        <Reference>
          <Citation>M. V. Liberti, J. W. Locasale, Trends Biochem. Sci. 2016, 41, 211.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Stransky, K. Cotter, M. Forgac, Physiol. Rev. 2016, 96, 1071.</Citation>
        </Reference>
        <Reference>
          <Citation>B. J. Altman, Z. E. Stine, C. V. Dang, Nat. Rev. Cancer 2016, 16, 619.</Citation>
        </Reference>
        <Reference>
          <Citation>a) J. Shi, P. W. Kantoff, R. Wooster, O. C. Farokhzad, Nat. Rev. Cancer 2016, 17, 20;</Citation>
        </Reference>
        <Reference>
          <Citation>b) X. Liu, C. Liu, Z. Zheng, S. Chen, X. Pang, X. Xiang, J. Tang, E. Ren, Y. Chen, M. You, X. Wang, X. Chen, W. Luo, G. Liu, N. Xia, Adv. Mater. 2019, 31, 1808294;</Citation>
        </Reference>
        <Reference>
          <Citation>c) G. Yang, S. Z. F. Phua, W. Q. Lim, R. Zhang, L. Feng, G. Liu, H. Wu, A. K. Bindra, D. Jana, Z. Liu, Y. Zhao, Adv. Mater. 2019, 31, 1901513;</Citation>
        </Reference>
        <Reference>
          <Citation>d) Q. Zhou, S. Shao, J. Wang, C. Xu, J. Xiang, Y. Piao, Z. Zhou, Q. Yu, J. Tang, X. Liu, Z. Gan, R. Mo, Z. Gu, Y. Shen, Nat. Nanotechnol. 2019, 14, 799.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Lammers, F. Kiessling, M. Ashford, W. Hennink, D. Crommelin, G. Storm, Nat. Rev. Mater. 2016, 1, 16069.</Citation>
        </Reference>
        <Reference>
          <Citation>a) F. Gao, Y. Tang, W.-L. Liu, M.-Z. Zou, C. Huang, C.-J. Liu, X.-Z. Zhang, Adv. Mater. 2019, 31, 1904639;</Citation>
        </Reference>
        <Reference>
          <Citation>b) C. Chu, H. Lin, H. Liu, X. Wang, J. Wang, P. Zhang, H. Gao, C. Huang, Y. Zeng, Y. Tan, G. Liu, X. Chen, Adv. Mater. 2017, 29, 1605928.</Citation>
        </Reference>
        <Reference>
          <Citation>a) P. Zhang, J. Wang, H. Chen, L. Zhao, B. Chen, C. Chu, H. Liu, Z. Qin, J. Liu, Y. Tan, X. Chen, G. Liu, J. Am. Chem. Soc. 2018, 140, 14980;</Citation>
        </Reference>
        <Reference>
          <Citation>b) R. Zhang, L. Feng, Z. Dong, L. Wang, C. Liang, J. Chen, Q. Ma, R. Zhang, Q. Chen, Y. Wang, Z. Liu, Biomaterials 2018, 162, 123.</Citation>
        </Reference>
        <Reference>
          <Citation>a) Z. Tang, Y. Liu, M. He, W. Bu, Angew. Chem., Int. Ed. 2019, 58, 946;</Citation>
        </Reference>
        <Reference>
          <Citation>b) C. Chen, W. Su, Y. Liu, J. Zhang, C. Zuo, Z. Yao, W. Bu, Biomaterials 2019, 200, 48.</Citation>
        </Reference>
        <Reference>
          <Citation>a) K. Chen, H. Cai, H. Zhang, H. Zhu, Z. Gu, Q. Gong, K. Luo, Acta Biomater. 2019, 84, 339;</Citation>
        </Reference>
        <Reference>
          <Citation>b) S. Guo, X. Xiao, X. Wang, Q. Luo, H. Zhu, H. Zhang, H. Li, Q. Gong, K. Luo, Biomater. Sci. 2019, 7, 1919.</Citation>
        </Reference>
        <Reference>
          <Citation>S. L. Cramer, A. Saha, J. Liu, S. Tadi, S. Tiziani, W. Yan, K. Triplett, C. Lamb, S. E. Alters, S. Rowlinson, Y. J. Zhang, M. J. Keating, P. Huang, J. DiGiovanni, G. Georgiou, E. Stone, Nat. Med. 2016, 23, 120.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Gorrini, T. W. Mak, Cancer Cell 2019, 35, 161.</Citation>
        </Reference>
        <Reference>
          <Citation>L. S. Schneider, K. von Schwarzenberg, T. Lehr, M. Ulrich, R. Kubisch-Dohmen, J. Liebl, D. Trauner, D. Menche, A. M. Vollmar, Cancer Res. 2015, 75, 2863.</Citation>
        </Reference>
        <Reference>
          <Citation>a) A. De Milito, E. Iessi, M. Logozzi, F. Lozupone, M. Spada, M. L. Marino, C. Federici, M. Perdicchio, P. Matarrese, L. Lugini, A. Nilsson, S. Fais, Cancer Res. 2007, 67, 5408;</Citation>
        </Reference>
        <Reference>
          <Citation>b) K. von Schwarzenberg, R. M. Wiedmann, P. Oak, S. Schulz, H. Zischka, G. Wanner, T. Efferth, D. Trauner, A. M. Vollmar, J. Biol. Chem. 2013, 288, 1385.</Citation>
        </Reference>
        <Reference>
          <Citation>a) Z. Wang, L. Y. Yip, J. H. J. Lee, Z. Wu, H. Y. Chew, P. K. W. Chong, C. C. Teo, H. Y.-K. Ang, K. L. E. Peh, J. Yuan, S. Ma, L. S. K. Choo, N. Basri, X. Jiang, Q. Yu, A. M. Hillmer, W. T. Lim, T. K. H. Lim, A. Takano, E. H. Tan, D. S. W. Tan, Y. S. Ho, B. Lim, W. L. Tam, Nat. Med. 2019, 25, 825;</Citation>
        </Reference>
        <Reference>
          <Citation>b) X. Gao, S. M. Sanderson, Z. Dai, M. A. Reid, D. E. Cooper, M. Lu, J. P. Richie, A. Ciccarella, A. Calcagnotto, P. G. Mikhael, S. J. Mentch, J. Liu, G. Ables, D. G. Kirsch, D. S. Hsu, S. N. Nichenametla, J. W. Locasale, Nature 2019, 572, 397.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Zhan, N. Rindtorff, M. Boutros, Oncogene 2017, 36, 1461.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083785</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1613-6829</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Small</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Facilitate Gas Transport through Metal-Organic Polyhedra Constructed Porous Liquid Membrane.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1907016</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/smll.201907016</ELocationID>
        <Abstract>
          <AbstractText>Type II porous liquids are demonstrated to be promise porous materials. However, the category of porous hosts is very limited. Here, a porous host metal-organic polyhedra (MOP-18) is reported to construct type II porous liquids. MOP-18 is dissolved into 15-crown-5 as an individual cage (5 nm). Both the molecular dynamics simulations and experimental gravimetric CO<sub>2</sub> solubility test indicate that the inner cavity of MOP-18 in porous liquids is unoccupied by 15-crown-5 and is accessible to CO<sub>2</sub> . Thus, the prepared porous liquids show enhanced gas solubility. Furthermore, the prepared porous liquid is encapsulated into graphene oxide (GO) nanoslits to form a GO-supported porous liquid membrane (GO-SPLM). Owing to the empty cavity of MOP-18 unit cages in porous liquids that reduces the gas diffusion barrier, GO-SPLM significantly enhances the permeability of gas.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Zheng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shenzhen Key Laboratory of Laser Engineering, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ying</LastName>
            <ForeName>Wen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Ke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>College of Science, China University of Petroleum (East China), Qingdao, 266580, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Yu-Jia</ForeName>
            <Initials>YJ</Initials>
            <AffiliationInfo>
              <Affiliation>Shenzhen Key Laboratory of Laser Engineering, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Youguo</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Science, China University of Petroleum (East China), Qingdao, 266580, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Xinsheng</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5355-4854</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>21671171</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>21875212</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>51632008</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2016YFA0200204</GrantID>
            <Agency>National Key Research and Development Program</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>LD18E02001</GrantID>
            <Agency>Zhejiang Natural Science Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2018M643148</GrantID>
            <Agency>China Postdoctoral Science Foundation</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Small</MedlineTA>
        <NlmUniqueID>101235338</NlmUniqueID>
        <ISSNLinking>1613-6810</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MOP-18</Keyword>
        <Keyword MajorTopicYN="N">gas transportation</Keyword>
        <Keyword MajorTopicYN="N">liquid membrane</Keyword>
        <Keyword MajorTopicYN="N">metal-organic polyhedra</Keyword>
        <Keyword MajorTopicYN="N">porous liquid</Keyword>
        <Keyword MajorTopicYN="N">type II porous liquids</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083785</ArticleId>
        <ArticleId IdType="doi">10.1002/smll.201907016</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>S. L. James, Adv. Mater. 2016, 28, 5712.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Stein, Z. Wang, M. A. Fierke, Adv. Mater. 2009, 21, 265.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Deng, H. Yu, L. Wang, J. Liu, K. J. Shea, J. Mater. Chem. A 2019, 7, 15975.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Dusselier, M. E. Davis, Chem. Rev. 2018, 118, 5265.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Giri, M. G. Del Popolo, G. Melaugh, R. L. Greenaway, K. Raetzke, T. Koschine, L. Pison, M. F. C. Gomes, A. I. Cooper, S. L. James, Nature 2015, 527, 216.</Citation>
        </Reference>
        <Reference>
          <Citation>R. L. Greenaway, D. Holden, E. G. B. Eden, A. Stephenson, C. W. Yong, M. J. Bennison, T. Hasell, M. E. Briggs, S. L. James, A. I. Cooper, Chem. Sci. 2017, 8, 2640.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Zhang, S.-H. Chai, Z.-A. Qiao, S. M. Mahurin, J. Chen, Y. Fang, S. Wan, K. Nelson, P. Zhang, S. Dai, Angew. Chem., Int. Ed. 2015, 54, 932.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Li, H. Chen, J. A. Schott, B. Li, Y. Zheng, S. M. Mahurin, D.-e. Jiang, G. Cui, X. Hu, Y. Wang, L. Li, S. Dai, Nanoscale 2019, 11, 1515.</Citation>
        </Reference>
        <Reference>
          <Citation>N. O'Reilly, N. Giri, S. L. James, Chem. - Eur. J. 2007, 13, 3020.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Melaugh, N. Giri, C. E. Davidson, S. L. James, M. G. Del Popolo, Phys. Chem. Chem. Phys. 2014, 16, 9422.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Zhang, F. Yang, J. Huang, B. G. Sumpter, R. Qiao, J. Phys. Chem. B 2016, 120, 7195.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Shan, P. F. Fulyio, L. Kong, J. A. Schott, C.-L. Do-Thanh, T. Tian, X. Hu, S. M. Mahurin, H. Xing, S. Dai, ACS Appl. Mater. Interfaces 2018, 10, 32.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Liu, J. Liu, X. Hou, T. Xu, J. Tong, J. Zhang, B. Ye, B. Liu, Langmuir 2018, 34, 3654.</Citation>
        </Reference>
        <Reference>
          <Citation>M. C. Gomes, L. Pison, C. Cervinka, A. Padua, Angew. Chem., Int. Ed. 2018, 57, 11909.</Citation>
        </Reference>
        <Reference>
          <Citation>S. He, L. Chen, J. Cui, B. Yuan, H. Wang, F. Wang, Y. Yu, Y. Lee, T. Li, J. Am. Chem. Soc. 2019, 141, 19708.</Citation>
        </Reference>
        <Reference>
          <Citation>D. J. L. Tranchemontagne, Z. Ni, M. O'Keeffe, O. M. Yaghi, Angew. Chem., Int. Ed. 2008, 47, 5136.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Ahmad, A. H. Chughtai, H. A. Younus, F. Verpoort, Coord. Chem. Rev. 2014, 280, 1.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Carne-Sanchez, G. A. Craig, P. Larpent, T. Hirose, M. Higuchi, S. Kitagawa, K. Matsuda, K. Urayama, S. Furukawa, Nat. Commun. 2018, 9, 2506.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Hosono, S. Kitagawa, Acc. Chem. Res. 2018, 51, 2437.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Vardhan, M. Yusubov, F. Verpoort, Coord. Chem. Rev. 2016, 306, 171.</Citation>
        </Reference>
        <Reference>
          <Citation>G. A. Craig, P. Larpent, S. Kusaka, R. Matsuda, S. Kitagawa, S. Furukawa, Chem. Sci. 2018, 9, 6463.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Hosono, M. Gochomori, R. Matsuda, H. Sato, S. Kitagawa, J. Am. Chem. Soc. 2016, 138, 6525.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Jung, H. Kim, K. Baek, K. Kim, Angew. Chem., Int. Ed. 2008, 47, 5755.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Furukawa, J. Kim, K. E. Plass, O. M. Yaghi, J. Am. Chem. Soc. 2006, 128, 8398.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Bavykina, A. Cadiau, J. Gascon, Coord. Chem. Rev. 2019, 386, 85.</Citation>
        </Reference>
        <Reference>
          <Citation>T. F. Willems, C. Rycroft, M. Kazi, J. C. Meza, M. Haranczyk, Microporous Mesoporous Mater. 2012, 149, 134.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083786</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-636X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chirality</Title>
          <ISOAbbreviation>Chirality</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Determination of protein binding for novel 2-(2-hydroxypropanamido)-5-trifluoromethyl benzoic acid enantiomers to rats, dogs, and humans plasma by UPLC-MS/MS.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chir.23192</ELocationID>
        <Abstract>
          <AbstractText>R-/S-2-(2-hydroxypropanamido)-5-trifluoromethyl benzoic acid (R-/S-HFBA) is a novel COX inhibitor with remarkable anti-inflammatory and antiplatelet aggregation activities, but no gastrointestinal toxicity. In our previous study, the different pharmacokinetic profiles of the two enantiomers in rats were observed after administration of R-HFBA and S-HFBA. Stereoselective protein binding of the two enantiomers may be a reason for the different pharmacokinetic behaviors. In this study, we developed and validated an UPLC-MS/MS method for determining stereoselective binding of HFBA enantiomers to rat, dog, and human plasma in vitro. Chromatographic separation was achieved by gradient elution with a flow rate of 0.4 mL/min. MS/MS detection was operated in positive electrospray using multiple reaction monitoring (MRM) mode. The method was proved to be linear over the concentration range of 0.005 to 10 μg/mL with a lower limit of quantification of 0.005 μg/mL. The developed method was successfully employed to the plasma protein binding study of HFBA enantiomers. Equilibrium dialysis method was applied to assess drug-plasma protein interactions. The results showed that the enantiomers were both extensively bound to three species plasma and protein binding of R-/S-HFBA was concentration dependent. R-HFBA and S-HFBA showed significant species difference among rat, dog, and human plasma and stereoselective plasma protein binding.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rong</LastName>
            <ForeName>Rong</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dan</LastName>
            <ForeName>Yuhan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Ruizhen</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yunli</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Zhiguo</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1493-8932</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Chirality</MedlineTA>
        <NlmUniqueID>8914261</NlmUniqueID>
        <ISSNLinking>0899-0042</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">R-/S-2-(2-hydroxypropanamido)-5-trifluoromethyl benzoic acid</Keyword>
        <Keyword MajorTopicYN="N">UPLC-MS/MS</Keyword>
        <Keyword MajorTopicYN="N">plasma protein binding</Keyword>
        <Keyword MajorTopicYN="N">species difference</Keyword>
        <Keyword MajorTopicYN="N">stereoselectivity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083786</ArticleId>
        <ArticleId IdType="doi">10.1002/chir.23192</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Buscher B, Laakso S, Mascher H, et al. Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum. Bioanalysis. 2014;6(5):673-682.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun JA, Kong DZ, Zhen YQ, et al. Stereoselective binding of doxazosin enantiomers to plasma proteins from rats, dogs and humans in vitro. Acta Pharmacol Sin. 2013;34(12):1568-1574.</Citation>
        </Reference>
        <Reference>
          <Citation>Vuignier K, Schappler J, Veuthey JL, Carrupt PA, Martel S. Drug-protein binding: a critical review of analytical tools. Anal Bioanal Chem. 2010;398(1):53-66.</Citation>
        </Reference>
        <Reference>
          <Citation>Kamble S, Loadman P, Abraham MH, Liu X. Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method. J Pharm Biomed Anal. 2018;149:16-21.</Citation>
        </Reference>
        <Reference>
          <Citation>Hong Y, Tang Y, Zeng S. Enantioselective plasma protein binding of propafenone: mechanism, drug interaction, and species difference. Chirality. 2009;21(7):692-698.</Citation>
        </Reference>
        <Reference>
          <Citation>Maddi S, Yamsani MR, Seeling A, Scriba GK. Stereoselective plasma protein binding of amlodipine. Chirality. 2010;22(2):262-266.</Citation>
        </Reference>
        <Reference>
          <Citation>Chuang VTG, Otagiri M. Stereoselective binding of human serum albumin. Chirality. 2010;18:159-166.</Citation>
        </Reference>
        <Reference>
          <Citation>Radwan MA, Aboul-Enein HY. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats. Chirality. 2010;16:119-125.</Citation>
        </Reference>
        <Reference>
          <Citation>Jin YX, Tang YH, Zeng S. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma. J Pharm Biomed Anal. 2008;46(5):953-958.</Citation>
        </Reference>
        <Reference>
          <Citation>Ye ZQ, Zetterberg C, Gao H. Automation of plasma protein binding assay using rapid equilibrium dialysis device and Tecan workstation. J Pharm Biomed Anal. 2017;140:210-214.</Citation>
        </Reference>
        <Reference>
          <Citation>Van LS, Morrison D, Sysmans L, Nelis P, Mortishire-smith R. Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding. J Lab Autom. 2011;16:56-57.</Citation>
        </Reference>
        <Reference>
          <Citation>Howard ML, Hill JJ, Galluppi GR, Mclean MA. Plasma protein binding in drug discovery and development. Comb Chem High Throughput Screen. 2010;13(2):170-187.</Citation>
        </Reference>
        <Reference>
          <Citation>Trainor GL. The importance of plasma protein binding in drug discovery. Expert Opin Drug Discovery. 2007;2(1):51-64.</Citation>
        </Reference>
        <Reference>
          <Citation>Rong R, Zhang RZ, Wang X, Dan YH, Zhao YL, Yu ZG. Synthesis, pharmacological evaluation and molecular docking of novel R-/S-2-(2-hydroxypropanamido)-5-trifluoromethyl benzoic acid as dual anti-inflammatory anti-platelet aggregation agents. N-S Arch Pharmacol. 2019;5:1-2. https://doi.org/10.1007/s00210-019-01753-9</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang QL, Li SS, Wang DL, Zhao YL, Yu ZG. Stereoselective protein binding studies of 2-(2-hydroxypropanamido) benzoic acid enantiomers in rat, beagle dog and human plasma. J Chromatogr B. 2017;1061-1062:169-175.</Citation>
        </Reference>
        <Reference>
          <Citation>US-FDA Guidance for Industry: Bioanalytical Method Validation. Guidance for Industry: Bioanalytical Method Validation 2018; https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Gewirtz DA, Holt SA. Protein binding as a component of drug interaction in cellular pharmacokinetic studies: effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro. Biochem Pharmacol. 1985;34(6):747-754.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu H, Wu PP, Yang MJ, et al. Application of a UPLC-MS/MS method to the protein binding study of tm-2 in rat, human and beagle dog plasma. J Pharm Anal. 2016;6(1):32-38.</Citation>
        </Reference>
        <Reference>
          <Citation>Zou P, Yu YK, Zheng N, et al. Applications of human pharmacokinetic prediction in first-in-human dose estimation. AAPS Journal. 2012;14(2):262-281.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083788</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1529-8019</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dermatologic therapy</Title>
          <ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Surgical and post-surgical wound care in hidradenitis suppurativa.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.13282</ELocationID>
        <Abstract>
          <AbstractText>Hidradenitis suppurativa (HS) is a chronic inflammatory disorder. Several medical treatments, with varying degree of efficacy, have been developed. However, in most cases of advanced (HS), the definitive treatment option is often represented by surgical excisions. Surgical techniques, reconstructive approach and local wound care should be accurately designed in order to obtain the best result. In this review we analysed the possible surgical treatments and local wound care. A Medline search was performed on the various surgical treatments, reconstructive techniques and local wound care. Surgical treatment is a common therapeutic modality for HS. Different surgical reconstructive techniques and postsurgical wound care approaches are described for the management of HS patients. There were few high-quality evidence-based studies evaluating the surgical management of HS. Many disparate HS severity scores were used in these studies making comparison between them difficult. Nonetheless research into different surgical approaches and wound care management has increased substantially in the past decade and has given patients more surgical therapeutic strategies. The description of the best combinations and timing of surgery, wound care and medical therapies, will be a matter of future research for the definition of the optimal management of HS patient. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Manfredini</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3601-655X</Identifier>
            <AffiliationInfo>
              <Affiliation>Section of Dermatology. Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garbarino</LastName>
            <ForeName>Federico</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3958-5718</Identifier>
            <AffiliationInfo>
              <Affiliation>Section of Dermatology. Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bigi</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Dermatology. Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pellacani</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Dermatology. Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magnoni</LastName>
            <ForeName>Cristina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Dermatology. Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dermatol Ther</MedlineTA>
        <NlmUniqueID>9700070</NlmUniqueID>
        <ISSNLinking>1396-0296</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083788</ArticleId>
        <ArticleId IdType="doi">10.1111/dth.13282</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083787</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-3156</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Tropical medicine &amp; international health : TM &amp; IH</Title>
          <ISOAbbreviation>Trop. Med. Int. Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/tmi.13384</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area, and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000-2016.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">(N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians, and a search for relevant "International Statistical Classification of Diseases and Related Health Problems" (ICD)-based data.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3,489 cases (N)CC cases were coded: 832 in Italy, 8 in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abraham</LastName>
            <ForeName>Annette</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, School of Medicine, Technical University Munich, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmidt</LastName>
            <ForeName>Veronika</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, School of Medicine, Technical University Munich, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaminski</LastName>
            <ForeName>Miriam</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Charité-Universitätsmedizin Berlin, Klinik für Psychiatrie und Psychotherapie, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stelzle</LastName>
            <ForeName>Dominik</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, School of Medicine, Technical University Munich, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chair of Epidemiology, Department of Sport and Health Sciences, Technical University of Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Meijere</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, School of Medicine, Technical University Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bustos</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Soumyaranjan Sahu</LastName>
            <ForeName>Priyadarshi</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Medical University of the Americas, Nevis, West Indies.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hugo Garcia</LastName>
            <ForeName>Hector</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bobić</LastName>
            <ForeName>Branko</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Food- and Vector-borne Zoonoses, University of Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cretu</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Parasitology, Carol Davila University of Medicine, Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chiodini</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Tropical Diseases, University College Hospital, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deksne</LastName>
            <ForeName>Gunita</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Food Safety, Animal Health and Environment "BIOR", Riga, Latvia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Biology, University of Latvia, Riga, Latvia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dermauw</LastName>
            <ForeName>Veronique</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Devleesschauwer</LastName>
            <ForeName>Brecht</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Public Health and Food Safety, Ghent University, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dorny</LastName>
            <ForeName>Pierre</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fonseca</LastName>
            <ForeName>Ana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Public Health Department, NOVA University of Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gabriël</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Public Health and Food Safety, Ghent University, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ángeles Gómez Morales</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>European Union Reference Laboratory for Parasites, Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kucsera</LastName>
            <ForeName>István</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>National Public Health Center, Budapest, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laranjo-González</LastName>
            <ForeName>Minerva</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recerca en Sanitat Animal, Campus de la Universitat Autònoma de Barcelona, Bellaterra, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trevisan</LastName>
            <ForeName>Chiara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vilhena</LastName>
            <ForeName>Manuela</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Ciências Agrárias e Ambientais Mediterrânicas, Universidade de Évora, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walker</LastName>
            <ForeName>Naomi F</ForeName>
            <Initials>NF</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital for Tropical Diseases, University College Hospital, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zammarchi</LastName>
            <ForeName>Lorenzo</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Medicine, University of Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sylvia Winkler</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, School of Medicine, Technical University Munich, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Trop Med Int Health</MedlineTA>
        <NlmUniqueID>9610576</NlmUniqueID>
        <ISSNLinking>1360-2276</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Europe</Keyword>
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">neurocysticercosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083787</ArticleId>
        <ArticleId IdType="doi">10.1111/tmi.13384</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083789</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1573</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Phytotherapy research : PTR</Title>
          <ISOAbbreviation>Phytother Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ptr.6639</ELocationID>
        <Abstract>
          <AbstractText>The number of patients using cannabis for therapeutic purposes is growing worldwide. While research regarding the treatment of certain diseases/disorders with cannabis and cannabinoids is also expanding, only a few longitudinal studies have assessed the mid-term impacts of medical cannabis use on psychological variables and quality of life (QoL). The aim of the study was to assess the psychological safety and QoL of patients with chronic diseases who self-medicate with cannabis over time. We recruited patients with various chronic diseases who use cannabis and collected data regarding patterns of cannabis use as well as mental health, personality and QoL. Participants were followed-up at baseline, 4, 8 and 12 months. Hair analysis was conducted to confirm the presence of cannabinoids. Personality assessment showed a consistent decrease in self-transcendence and self-directedness scores. Neither cognitive nor psychopathological deterioration was found. There were also no variations in QoL. Mid-term use of medical cannabis seems to show adequate tolerability regarding cognitive and psychopathological abilities, and it may help patients with chronic diseases to maintain an acceptable QoL.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bouso</LastName>
            <ForeName>José C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>ICEERS-International Center for Ethnobotanical Education, Research and Service, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiménez-Garrido</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>ICEERS-International Center for Ethnobotanical Education, Research and Service, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ona</LastName>
            <ForeName>Genís</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>ICEERS-International Center for Ethnobotanical Education, Research and Service, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anthropology, Philosophy and Social Work, Universitat Rovira i Virgili, Medical Anthropology Research Center, Tarragona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woźnica</LastName>
            <ForeName>Damian</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>ICEERS-International Center for Ethnobotanical Education, Research and Service, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dos Santos</LastName>
            <ForeName>Rafael G</ForeName>
            <Initials>RG</Initials>
            <AffiliationInfo>
              <Affiliation>ICEERS-International Center for Ethnobotanical Education, Research and Service, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences and Behavior, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute for Translational Medicine (INCT-TM), CNPq, Ribeirão Preto, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hallak</LastName>
            <ForeName>Jaime E C</ForeName>
            <Initials>JEC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences and Behavior, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute for Translational Medicine (INCT-TM), CNPq, Ribeirão Preto, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paranhos</LastName>
            <ForeName>Beatriz A P B</ForeName>
            <Initials>BAPB</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, Sao Paulo University, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Almeida Mendes</LastName>
            <ForeName>Felipe</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, Sao Paulo University, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yonamine</LastName>
            <ForeName>Mauricio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, Sao Paulo University, Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alcázar-Córcoles</LastName>
            <ForeName>Miguel Á</ForeName>
            <Initials>MÁ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Health Psychology, School of Psychology, Madrid Autonomous University, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farré</LastName>
            <ForeName>Magí</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Fundació Alchimia Solidària</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Fundación Canna</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phytother Res</MedlineTA>
        <NlmUniqueID>8904486</NlmUniqueID>
        <ISSNLinking>0951-418X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cannabis</Keyword>
        <Keyword MajorTopicYN="N">chronic disease</Keyword>
        <Keyword MajorTopicYN="N">medical cannabis</Keyword>
        <Keyword MajorTopicYN="N">mental health</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083789</ArticleId>
        <ArticleId IdType="doi">10.1002/ptr.6639</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Aixalà, M., Ona, G., Parés, Ò., &amp; Bouso, J. C. (2019). Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users. Drugs Educ Prevent Policy, 1-8. https://doi.org/10.1080/09687637.2019.1611739</Citation>
        </Reference>
        <Reference>
          <Citation>Alonso, J., Prieto, L., &amp; Anto, J. M. (1995). La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clín (Barc), 104, 771.</Citation>
        </Reference>
        <Reference>
          <Citation>Amin, M. R., &amp; Ali, D. W. (2019). Pharmacology of medical cannabis. Adv Exp Med Biol, 1162, 151-165.</Citation>
        </Reference>
        <Reference>
          <Citation>Bakas, T., McLennon, S. M., Carpenter, J. S., Buelow, J. M., Otte, J. L., Hanna, K. M., … Welch, J. L. (2012). Systematic review of health-related quality of life models. Health Qual Life Outcomes, 10(1), 1-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Borras, R., Modamio, P., Lastra, C. F., &amp; Marino, E. L. (2011). Medicinal use of cannabis in Spain. Altern Ther Health Med, 17(5), 52-54.</Citation>
        </Reference>
        <Reference>
          <Citation>Bridgeman, M. B., &amp; Abazia, D. T. (2017). Medicinal cannabis: History, pharmacology, and implications for the acute care setting. PT, 42(3), 180-188.</Citation>
        </Reference>
        <Reference>
          <Citation>Corroon, J. M., Mischley, L. K., &amp; Sexton, M. (2017). Cannabis as a substitute for prescription drugs: a cross-sectional study. J Pain Res, 10, 989-998.</Citation>
        </Reference>
        <Reference>
          <Citation>de Hoop, B., Heerdink, E. R., &amp; Hazekamp, A. (2018). Medicinal cannabis on prescription in The Netherlands: Statistics for 2003-2016. Cannabis Cannabinoid Res, 3, 54-55.</Citation>
        </Reference>
        <Reference>
          <Citation>de Ridder, D., Geenen, R., Kuijer, R., &amp; van Middendorp, H. (2008). Psychological adjustment to chronic disease. Lancet, 372, 246-255.</Citation>
        </Reference>
        <Reference>
          <Citation>Derogatis, L. R. (1994). SCL-90-R. Symptom Checklist-90-R. Administration, Scoring and Procedures Manual. Minneapolis: National Computer System.</Citation>
        </Reference>
        <Reference>
          <Citation>Ebbert, J. O., Scharf, E. L., &amp; Hurt, R. T. (2018). Medical Cannabis. Mayo Clin Proc, 93(12), 1842-1847.</Citation>
        </Reference>
        <Reference>
          <Citation>Fernández, Ó. (2016). THC:CBD in daily practice: Available Data from UK, Germany and Spain. Eur Neurol, 75(Suppl 1), 1-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Fisher, E., Eccleston, C., Degenhardt, L., Finn, D. P., Finnerup, N. B., Gilron, I., … Moore, R. A. (2019). Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials. Pain Rep, 4(3), e741. https://doi.org/10.1097/PR9.0000000000000741</Citation>
        </Reference>
        <Reference>
          <Citation>Fonseca-Pedrero, E., Paino, M., Lemos-Giráldez, S., &amp; Muñiz, J. (2012). Validation of the community assessment psychic Experiences-42 (CAPE-42) in Spanish college students and patients with psychosis. Actas Esp Psiquiatr, 40, 169-176.</Citation>
        </Reference>
        <Reference>
          <Citation>Fraguas-Sánchez, A. I., &amp; Torres-Suárez, A. I. (2018). Medical use of cannabis. Drugs, 78(16), 1665-1703.</Citation>
        </Reference>
        <Reference>
          <Citation>García Martínez, J., &amp; Sánchez-Cánovas, J. (1994). Adaptación del cuestionario de fallos cognitivos de Broadbent, Cooper, Fitzgerald y Parkes. Análisis y Modificación de Conducta, 20(73), 727-750.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldenberg, M., Reid, M. W., IsHak, W. W., &amp; Danovitch, I. (2017). The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug Alcohol Depend, 174, 80-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Goulet-Stock, S., Rueda, S., Vafaei, A., Ialomiteanu, A., Manthey, J., Rehm, J., &amp; Fischer, B. (2017). Comparing medical and recreational cannabis users on socio-demographic substance and medication use, and health and disability characteristics. Eur Addict Res, 23, 129-135.</Citation>
        </Reference>
        <Reference>
          <Citation>Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Gonenc, A., Smith, R. T., Lambros, A. M., … Lukas, S. E. (2018). The grass might be greener: medical marijuana patients exhibit altered brain activity and improved executive function after 3 months of treatment. Front Pharmacol, 8, 983.</Citation>
        </Reference>
        <Reference>
          <Citation>Hakkarainen P., Frank V.A., Barratt M.J., Dahl H.V., Decorte T., Karjalainen K., … Werse B. (2014). Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries. Int J Drug Policy, 26, 250-256.</Citation>
        </Reference>
        <Reference>
          <Citation>Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D., &amp; Grotenhermen, F. (2013). The medicinal use of cannabis and cannabinoids-An international cross-sectional survey on administration forms. J Psychoactive Drugs, 45, 199-210.</Citation>
        </Reference>
        <Reference>
          <Citation>Hindocha, C., Freeman, T. P., Schafer, G., Gardener, C., Das, R. K., Morgan, C. J. A., &amp; Curran, H. V. (2015). Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo controlled study in cannabis users. Eur Neuropsychopharmacol, 25(3), 325-334.</Citation>
        </Reference>
        <Reference>
          <Citation>Ilgen, M. A., Bohnert, K., Kleinberg, F., Jannausch, M., Bohnert, A. S. B., Walton, M., &amp; Blow, F. C. (2013). Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend, 132(3), 654-659.</Citation>
        </Reference>
        <Reference>
          <Citation>International Narcotics Control Board. Report. https://www.incb.org/documents/Publications/AnnualReports/AR2014/English/AR_2014.pdf. Accessed June 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Khan, S. P., Pickens, T. A., &amp; Berlau, D. J. (2019). Perspectives on cannabis as a substitute for opioid analgesics. Pain Manag, 9(2), 191-203.</Citation>
        </Reference>
        <Reference>
          <Citation>Klieve H., Beamish W., Bryer F., Rebollo R., Perret H., &amp; van den Muyzenberg, J. (2010). Accessing practitioner expertise through online survey tool LimeSurvey. Retrieved from: https://research-repository.griffith.edu.au/handle/10072/36611</Citation>
        </Reference>
        <Reference>
          <Citation>MacCallum, C. A., &amp; Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. Eur J Intern Med, 49, 12-19.</Citation>
        </Reference>
        <Reference>
          <Citation>Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., di Marzo, V., … Zimmer, A. (2015). Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci, 36(5), 277-296.</Citation>
        </Reference>
        <Reference>
          <Citation>McCabe, C. J., Louie, K. A., &amp; King, K. M. (2015). Premeditation moderates the relation between sensation seeking and risky substance use among young adults. Psychol Addict Behav, 29(3), 753-765.</Citation>
        </Reference>
        <Reference>
          <Citation>McCabe, S. E., Boyd, C. J., &amp; Teter, C. J. (2009). Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend, 102(1-3), 63-70.</Citation>
        </Reference>
        <Reference>
          <Citation>Megari, K. (2013). Quality of life in chronic disease patients. Health Psychol Res, 1(3), e27.</Citation>
        </Reference>
        <Reference>
          <Citation>Oliveira, C. D. R., Yonamine, M., &amp; Moreau, R. L. M. (2007). Headspace solid-phase microextraction of cannabinoids in human head hair samples. J Sep Sci, 30, 128-134.</Citation>
        </Reference>
        <Reference>
          <Citation>Owen, K. P., Sutter, M. E., &amp; Albertson, T. E. (2014). Marijuana: Respiratory tract effects. Clin Rev Allergy Immunol, 46, 65-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Palmieri, B., Laurino, C., &amp; Vadalà, M. (2019). Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan). Int J Pharm Pract, 27(3), 264-270.</Citation>
        </Reference>
        <Reference>
          <Citation>Park, J., &amp; Wu, L. (2017). Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug Alcohol Depend, 177, 1-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Pedrero-Pérez, E. J. (2009). TCI-R-67: versión abreviada del TCI-R de Cloninger. Proceso de creación y administración a una muestra de adictos a sustancias en tratamiento. Trastornos Adictivos, 11, 12-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Piomelli, D., &amp; Russo, E. B. (2016). The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD. Cannabis Cannabinoid Res, 1, 44-46.</Citation>
        </Reference>
        <Reference>
          <Citation>ProCon. 33 legal medical marijuana states and DC. https://medicalmarijuana.procon.org/view.resource.php?resourceID=000881 Accessed June 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Reed P.G. (2008). Nursing time: Research, practice, and theory dimensions. Nursing Science Quarterly, 21(3), 222-223.</Citation>
        </Reference>
        <Reference>
          <Citation>Reinarman, C., Nunberg, H., Lanthier, F., &amp; Heddleston, T. (2011). Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs, 43, 128-135.</Citation>
        </Reference>
        <Reference>
          <Citation>Royuela, A., &amp; Macías, J. A. (1997). Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburgh. Vigilia-Sueño, 9, 81-94.</Citation>
        </Reference>
        <Reference>
          <Citation>Russo, E. B. (2019). The case for the entourage effect and conventional breeding of clinical cannabis: No “strain,” no gain. Front Plant Sci, 9. https://doi.org/10.3389/fpls.2018.01969</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations. Single Convention on Narcotic Drugs. https://www.unodc.org/pdf/convention_1961_en.pdf. Accessed June 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor, M., Lees, R., Henderson, G., Lingford-Hughes, A., Macleod, J., Sullivan, J., &amp; Hickman, M. (2017). Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users. Drug Alcohol Rev, 36, 220-226.</Citation>
        </Reference>
        <Reference>
          <Citation>Vasconcelos S.C., Silva A.O., Moreira M.A.S.P., Correia A.S.B., Guerra A.L.A.G., Santos A.R.D., &amp; Frazão I.D.S. (2017). Bioethical analysis to the therapeutic use of cannabis: Integrative review. Nurs Ethics, 26, 96-104.</Citation>
        </Reference>
        <Reference>
          <Citation>Vilagut, G., Ferrer, M., Rajmil, L., Rebollo, P., Permanyer-Miralda, G., Quintana, J. M., … Alonso, J. (2005). El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit, 19, 135-150.</Citation>
        </Reference>
        <Reference>
          <Citation>Walsh, Z., Callaway, R., Belle-Isle, L., Capler, R., Kay, R., Lucas, P., &amp; Holtzman, S. (2013). Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. Int J Drug Policy, 24, 511-516.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083790</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-4095</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Advanced materials (Deerfield Beach, Fla.)</Title>
          <ISOAbbreviation>Adv. Mater. Weinheim</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Nontoxic Bifunctional (Anti)Solvent as Digestive-Ripening Agent for High-Performance Perovskite Solar Cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1907123</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/adma.201907123</ELocationID>
        <Abstract>
          <AbstractText>The preparation of high-quality perovskite films is important for achieving high-performance perovskite solar cells (PSCs). The effective balance between solvent and antisolvent is an essential factor for regulating high-quality perovskite film during the spin-coating and thermal-annealing steps. In this work, a greener, nonhalogenated, nontoxic bifunctional (anti)solvent, methyl benzoate (MB), is developed not only as an antisolvent to rapidly generate crystal seeds at the perovskite spin-coating step, but also as a digestive-ripening solvent for the perovskite precursors, which can prevent the loss of organic components during the thermal-annealing stage and effectively suppress the formation of miscellaneous lead halide phases. As a result, this novel bifunctional (anti)solvent is employed in planar n-i-p PSCs for engineering high-quality perovskite layers and thus achieving a power conversion efficiency up to 22.37% with negligible hysteresis and &gt;1300 h stability. Moreover, due to the high boiling point and low-volatility characteristic of MB, high-performance PSCs are achieved reproducibly at different operating temperatures (22-34 °C). Therefore, this developed bifunctional solvent system can provide a promising platform toward globally upscaling and commercializing PSCs in all seasons and regions.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yun</LastName>
            <ForeName>Yikai</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Fangfang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hongyan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ian Wark Laboratory, CSIRO Materials Science and Engineering, Victoria, Clayton South, 3169, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Yinyu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Sizhou</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Wenchao</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Materials Science and Engineering, Monash University, Victoria, Clayton, 3800, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Zhengchun</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>You</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Yezhou</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Ian Wark Laboratory, CSIRO Materials Science and Engineering, Victoria, Clayton South, 3169, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Tianshi</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2084-3537</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NJ Tech), 5 Xinmofan Road, Nanjing, 210009, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Key Shaanxi Institute of Flexible Electronics (SIFE), Northwestern Polytechnical University (NPU), 127 West Youyi Road, Xi'an, 710072, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2017YFE0131900</GrantID>
            <Agency>National Key Research and Development Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017YFB0404500</GrantID>
            <Agency>National Key Research and Development Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>91833306</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>91733302</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>21601085</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Adv Mater</MedlineTA>
        <NlmUniqueID>9885358</NlmUniqueID>
        <ISSNLinking>0935-9648</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antisolvents</Keyword>
        <Keyword MajorTopicYN="N">digestive ripening</Keyword>
        <Keyword MajorTopicYN="N">methyl benzoate</Keyword>
        <Keyword MajorTopicYN="N">perovskites</Keyword>
        <Keyword MajorTopicYN="N">solvents</Keyword>
        <Keyword MajorTopicYN="N">thermal annealing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083790</ArticleId>
        <ArticleId IdType="doi">10.1002/adma.201907123</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>A. Kojima, K. Teshima, Y. Shirai, T. Miyasaka, J. Am. Chem. Soc. 2009, 131, 6050.</Citation>
        </Reference>
        <Reference>
          <Citation>H. S. Kim, C. R. Lee, J. H. Im, K. B. Lee, T. Moehl, A. Marchioro, S. J. Moon, R. Humphry-Baker, J. H. Yum, J. E. Moser, M. Grätzel, N. G. Park, Sci. Rep. 2012, 2, 591.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Burschka, N. Pellet, S. J. Moon, R. Humphry-Baker, P. Gao, M. K. Nazeeruddin, M. Grätzel, Nature 2013, 499, 316.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Wang, Y. Cao, C. Chen, Q. Chen, X. Wu, X. Li, T. Qin, W. Huang, Adv. Funct. Mater. 2018, 28, 52.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Rong, Y. Hu, A. Mei, H. Tan, M. I. Saidaminov, S. Il Seok, M. D. McGehee, E. H. Sargent, H. Han, Science 2018, 361, 6408.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Saliba, T. Matsui, J.-Y. Seo, K. Domanski, J.-P. Correa-Baena, M. K. Nazeeruddin, S. M. Zakeeruddin, W. Tress, A. Abate, A. Hagfeldt, M. Grätzel, Energy Environ. Sci. 2016, 9, 1989.</Citation>
        </Reference>
        <Reference>
          <Citation>G. E. Eperon, T. Leijtens, K. A. Bush, R. Prasanna, T. Green, J. T. Wang, D. P. Mcmeekin, G. Volonakis, R. L. Milot, R. May, A. Palmstrom, J. Daniel, R. A. Belisle, J. B. Patel, E. S. Parrott, R. J. Sutton, W. Ma, B. Conings, A. Babayigit, H. Boyen, S. Bent, F. Giustino, M. Herz, M. B. Johnston, M. D. Mcgehee, H. J. Snaith, Science 2016, 354, 861.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Nie, H. Tsai, R. Asadpour, J.-C. Blancon, A. J. Neukirch, G. Gupta, J. J. Crochet, M. Chhowalla, S. Tretiak, M. A. Alam, H.-L. Wang, A. D. Mohite, Science 2015, 347, 522.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Niu, J. Lu, R. Munir, J. Li, D. Barrit, X. Zhang, H. Hu, Z. Yang, A. Amassian, K. Zhao, S. Z. Liu, Adv. Mater. 2018, 30, 16.</Citation>
        </Reference>
        <Reference>
          <Citation>M. S. Jamal, M. S. Bashar, A. K. M. Hasan, Z. A. Almutairi, H. F. Alharbi, N. H. Alharthi, M. R. Karim, H. Misran, N. Amin, K. B. Sopian, M. Akhtaruzzaman, Renewable Sustainable Energy Rev. 2018, 98, 469.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Li, T. R. Klein, D. H. Kim, M. Yang, J. J. Berry, M. F. A. M. van Hest, K. Zhu, Nat. Rev. Mater. 2018, 3, 18017.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Wu, X. Xu, Y. Zhao, J. Shi, Y. Xu, Y. Luo, D. Li, H. Wu, Q. Meng, ACS Appl. Mater. Interfaces 2017, 9, 26937.</Citation>
        </Reference>
        <Reference>
          <Citation>W. S. Yang, B.-W. Park, E. H. Jung, N. J. Jeon, Y. C. Kim, D. U. Lee, S. S. Shin, J. Seo, E. K. Kim, J. H. Noh, S. Seok, Science 2017, 356, 1376.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Liu, M. B. Johnston, H. J. Snaith, Nature 2013, 501, 395.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Li, D. Q. Bi, C. Y. Yi, J.-D. Décoppet, J. S. Luo, S. M. Zakeeruddin, A. Hagfeldt, M. Grätzel, Science 2016, 353, 58.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Zhou, Z. Wang, Y. Zhou, S. Pang, D. Wang, H. Xu, Z. Liu, N. P. Padture, G. Cui, Angew. Chem., Int. Ed. 2015, 54, 9705.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Luo, W. Yang, Z. Wang, A. Sadhanala, Q. Hu, R. Su, R. Shivanna, G. F. Trindade, J. F. Watts, Z. Xu, T. Liu, K. Chen, F. Ye, P. Wu, L. Zhao, J. Wu, Y. Tu, Y. Zhang, X. Yang, W. Zhang, R. H. Friend, Q. Gong, H. J. Snaith, R. Zhu, Science 2018, 360, 1442.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Zheng, B. Chen, C. Wu, S. Priya, Nano Energy 2015, 17, 269.</Citation>
        </Reference>
        <Reference>
          <Citation>S. K. Bhangu, M. Ashokkumar, J. Lee, Cryst. Growth Des. 2016, 16, 1934.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Zhang, C. Xiao, X. Chen, B. W. Larson, S. P. Harvey, J. J. Berry, K. Zhu, Joule 2019, 3, 1452.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Paek, P. Schouwink, E. N. Athanasopoulou, K. T. Cho, G. Grancini, Y. Lee, Y. Zhang, F. Stellacci, M. K. Nazeeruddin, P. Gao, Chem. Mater. 2017, 29, 3490.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Xiao, F. Huang, W. Huang, Y. Dkhissi, Y. Zhu, J. Etheridge, A. Gray-Weale, U. Bach, Y. B. Cheng, L. Spiccia, Angew. Chem., Int. Ed. 2014, 53, 9898.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Capello, U. Fischer, K. Hungerbühler, Green Chem. 2007, 9, 927.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Prat, J. Hayler, A. Wells, Green Chem. 2014, 16, 4546.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Bu, L. Wu, X. Liu, X. Yang, P. Zhou, X. Yu, T. Qin, J. Shi, S. Wang, S. Li, Z. Ku, Y. Peng, F. Huang, Q. Meng, Y.-B. Cheng, J. Zhong, Adv. Energy Mater. 2017, 7, 1700576.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Bu, X. Liu, Y. Zhou, J. Yi, X. Huang, L. Luo, J. Xiao, Z. Ku, Y. Peng, F. Huang, Y.-B. Cheng, J. Zhong, Energy Environ. Sci. 2017, 10, 2509.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Bu, J. Li, F. Zheng, W. Chen, X. Wen, Z. Ku, Y. Peng, J. Zhong, Y. B. Cheng, F. Huang, Nat. Commun. 2018, 9, 4609.</Citation>
        </Reference>
        <Reference>
          <Citation>S. H. Turren-Cruz, A. Hagfeldt, M. Saliba, Science 2018, 362, 449.</Citation>
        </Reference>
        <Reference>
          <Citation>E. J. Juarez-Perez, Z. Hawash, S. R. Raga, L. K. Ono, Y. Qi, Energy Environ. Sci. 2016, 9, 3406.</Citation>
        </Reference>
        <Reference>
          <Citation>T. A. Berhe, W.-N. Su, C.-H. Chen, C.-J. Pan, J.-H. Cheng, H.-M. Chen, M.-C. Tsai, L.-Y. Chen, A. A. Dubale, B.-J. Hwang, Energy Environ. Sci. 2016, 9, 323.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Dualeh, P. Gao, S. I. Seok, M. K. Nazeeruddin, M. Grätzel, Chem. Mater. 2014, 26, 6160.</Citation>
        </Reference>
        <Reference>
          <Citation>D. P. Nenon, J. A. Christians, L. M. Wheeler, J. L. Blackburn, E. M. Sanehira, B. Dou, M. L. Olsen, K. Zhu, J. J. Berry, J. M. Luther, Energy Environ. Sci. 2016, 9, 2072.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Wang, J. Wu, P. Zhang, D. Liu, T. Zhang, L. Ji, X. Gu, Z. D. Chen, S. Li, Nano Energy 2017, 39, 616.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Gedamu, I. M. Asuo, D. Benetti, M. Basti, I. Ka, S. G. Cloutier, F. Rosei, R. Nechache, Sci. Rep. 2018, 8, 12885.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Li, Y. Xia, C. Wang, G. Wang, Y. Chen, L. Guo, D. Luo, S. Wen, ACS Appl. Mater. Interfaces 2019, 11, 34989.</Citation>
        </Reference>
        <Reference>
          <Citation>H. B. Lee, M. K. Jeon, N. Kumar, B. Tyagi, J. W. Kang, Adv. Funct. Mater. 2019, 29, 1903213.</Citation>
        </Reference>
        <Reference>
          <Citation>T. B. Adams, S. M. Cohen, J. Doull, V. J. Feron, J. I. Goodman, L. J. Marnett, I. C. Munro, P. S. Portoghese, R. L. Smith, W. J. Waddell, B. M. Wagner, Food Chem. Toxicol. 2005, 43, 1207.</Citation>
        </Reference>
        <Reference>
          <Citation>N. J. Jeon, J. H. Noh, Y. C. Kim, W. S. Yang, S. Ryu, S. I. Seok, Nat. Mater. 2014, 13, 897.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Li, Y. Chen, Z. Liu, Q. Chen, X. Wang, H. Zhou, Adv. Mater. 2016, 28, 9862.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Sun, C. Zhang, J. Chang, H. Yang, H. Xi, G. Lu, D. Chen, Z. Lin, X. Lu, J. Zhang, Y. Hao, Nano Energy 2016, 28, 417.</Citation>
        </Reference>
        <Reference>
          <Citation>T. J. Jacobsson, J. P. Correa-Baena, E. H. Anaraki, B. Philippe, S. D. Stranks, M. E. Bouduban, W. Tress, K. Schenk, J. Teuscher, J. E. Moser, H. Rensmo, A. Hagfeldt, J. Am. Chem. Soc. 2016, 138, 10331.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Huang, F. Huang, E. Gann, Y. B. Cheng, C. R. McNeill, Adv. Funct. Mater. 2015, 25, 5529.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Meng, C. Sun, R. Wang, W. Huang, Z. Zhao, P. Sun, T. Huang, J. Xue, J. W. Lee, C. Zhu, Y. Huang, Y. Li, Y. Yang, J. Am. Chem. Soc. 2018, 140, 17255.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Zhang, S. Pathak, N. Sakai, T. Stergiopoulos, P. K. Nayak, N. K. Noel, A. A. Haghighirad, V. M. Burlakov, D. W. deQuilettes, A. Sadhanala, W. Li, L. Wang, D. S. Ginger, R. H. Friend, H. J. Snaith, Nat. Commun. 2015, 6, 10030.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Yang, L. Zhang, Y. Cao, Y. Miao, Y. Ke, Y. Wei, Q. Guo, Y. Wang, Z. Rong, N. Wang, R. Li, J. Wang, W. Huang, F. Gao, Appl. Phys. Lett. 2017, 111, 073302.</Citation>
        </Reference>
        <Reference>
          <Citation>S.-M. Yoo, S. J. Yoon, J. A. Anta, H. J. Lee, P. P. Boix, I. Mora-Seró, Joule 2019, 3, 2535.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Li, Z. K. Wang, Y. G. Yang, Y. Hu, S. L. Feng, J. M. Wang, X. Y. Gao, L. S. Liao, Adv. Energy Mater. 2016, 6, 1601156.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083791</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The FEBS journal</Title>
          <ISOAbbreviation>FEBS J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Arabidopsis (ASHH2) CW domain binds monomethylated K4 of the histone H3 tail through conformational selection.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/febs.15256</ELocationID>
        <Abstract>
          <AbstractText>Chromatin post-translational modifications are thought to be important for epigenetic effects on gene expression. Methylation of histone N-terminal tail lysine residues constitutes one of many such modifications, executed by families of Histone Lysine Methyltransferase (HKMTase). One such protein is ASHH2 from the flowering plant Arabidopsis thaliana, equipped with the interaction domain CW and the HKMTase domain, SET. The CW domain of ASHH2 is a selective binder of monomethylation at Lysine 4 on histone H3 (H3K4me1) and likely helps the enzyme dock correctly onto chromatin sites. The study of CW and related interaction domains have so far been emphasizing lock-key models, missing important aspects of histone-tail CW interactions. We here present an analysis of the ASHH2 CW-H3K4me1 complex using NMR and molecular dynamics, as well as mutation and affinity studies of flexible coils. β-augmentation and rearrangement of coils coincide with changes in the flexibility of the complex, in particular the η1, η3 and C-terminal coils, but also in the β1 and β2 strands and the C-terminal part of the ligand. Furthermore, we show that mutating residues with outlier dynamic behaviour affects the complex binding affinity despite these not being in direct contact with the ligand. Overall, the binding process is consistent with conformational selection. We propose that this binding mechanism presents an advantage when searching for the correct PTM state among the highly modified and flexible histone tails, and also that the binding shifts the catalytic SET domain towards the nucleosome.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dobrovolska</LastName>
            <ForeName>Olena</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brilkov</LastName>
            <ForeName>Maxim</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Madeleine</LastName>
            <ForeName>Noelly</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomedicine, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ødegård-Fougner</LastName>
            <ForeName>Øyvind</ForeName>
            <Initials>Ø</Initials>
            <AffiliationInfo>
              <Affiliation>Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, 69117, Heidelberg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Strømland</LastName>
            <ForeName>Øyvind</ForeName>
            <Initials>Ø</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedicine, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Stephen R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Structural Biology Science Technology Platform, Francis Crick Institute, NW1 1AT, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Marco</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>King's College London, Strand, London, WC2R 2LS, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Christodoulou</LastName>
            <ForeName>Evangelos</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Structural Biology Science Technology Platform, Francis Crick Institute, NW1 1AT, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teigen</LastName>
            <ForeName>Knut</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedicine, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isaksson</LastName>
            <ForeName>Johan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, The Arctic University of Tromsø, N-9037, Tromsø, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Underhaug</LastName>
            <ForeName>Jarl</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reuter</LastName>
            <ForeName>Nathalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aalen</LastName>
            <ForeName>Reidunn B</ForeName>
            <Initials>RB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, The Arctic University of Tromsø, N-9037, Tromsø, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aasland</LastName>
            <ForeName>Rein</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, The Arctic University of Tromsø, N-9037, Tromsø, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halskau</LastName>
            <ForeName>Øyvind</ForeName>
            <Initials>Ø</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2517-1060</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, University of Bergen, N-5020, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>FEBS J</MedlineTA>
        <NlmUniqueID>101229646</NlmUniqueID>
        <ISSNLinking>1742-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CW</Keyword>
        <Keyword MajorTopicYN="N">conformational selection</Keyword>
        <Keyword MajorTopicYN="N">dynamics</Keyword>
        <Keyword MajorTopicYN="N">histone-tail binding</Keyword>
        <Keyword MajorTopicYN="N">induced fit</Keyword>
        <Keyword MajorTopicYN="N">methylation</Keyword>
        <Keyword MajorTopicYN="N">structure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083791</ArticleId>
        <ArticleId IdType="doi">10.1111/febs.15256</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083792</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1613-6829</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Small</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mild-Temperature Solution-Assisted Encapsulation of Phosphorus into ZIF-8 Derived Porous Carbon as Lithium-Ion Battery Anode.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1907141</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/smll.201907141</ELocationID>
        <Abstract>
          <AbstractText>The high theoretical capacity of red phosphorus (RP) makes it a promising anode material for lithium-ion batteries. However, the large volume change of RP during charging/discharging imposes an adverse effect on the cyclability and the rate performance suffers from its low conductivity. Herein, a facile solution-based strategy is exploited to incorporate phosphorus into the pores of zeolitic imidazole framework (ZIF-8) derived carbon hosts under a mild temperature. With this method, the blocky RP is etched into the form of polyphosphides anions (PP, mainly P<sub>5</sub> <sup>-</sup> ) so that it can easily diffuse into the pores of porous carbon hosts. Especially, the indelible crystalline surface phosphorus can be effectively avoided, which usually generates in the conventional vapor-condensation encapsulation method. Moreover, highly-conductive ZIF-8 derived carbon hosts with any pore smaller than 3 nm are efficient for loading PP and these pores can alleviate the volume change well. Finally, the composite of phosphorus encapsulated into ZIF-8 derived porous carbon exhibits a significantly improved electrochemical performance as lithium-ion battery anode with a high capacity of 786 mAh g<sup>-1</sup> after 100 cycles at 0.1 A g<sup>-1</sup> , a good stability within 700 cycles at 1 A g<sup>-1</sup> , and an excellent rate performance.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Published by WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Chengzhan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carbon Materials of Zhejiang Province, Institute of New Materials and Industrial Technologies, College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, Zhejiang, 325035, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Huaping</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Physics and IMN MacroNano, Ilmenau University of Technology, Ilmenau, 98693, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carbon Materials of Zhejiang Province, Institute of New Materials and Industrial Technologies, College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, Zhejiang, 325035, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, N9B3P4, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Huile</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carbon Materials of Zhejiang Province, Institute of New Materials and Industrial Technologies, College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, Zhejiang, 325035, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Long</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Physics and IMN MacroNano, Ilmenau University of Technology, Ilmenau, 98693, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Wanyi</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carbon Materials of Zhejiang Province, Institute of New Materials and Industrial Technologies, College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, Zhejiang, 325035, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jichang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, N9B3P4, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lei</LastName>
            <ForeName>Yong</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5048-7433</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Physics and IMN MacroNano, Ilmenau University of Technology, Ilmenau, 98693, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Shun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carbon Materials of Zhejiang Province, Institute of New Materials and Industrial Technologies, College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, Zhejiang, 325035, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>51972239</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>51872209</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>LZ17E020002</GrantID>
            <Agency>Zhejiang Provincial Natural Science Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>LZ20E010001</GrantID>
            <Agency>Zhejiang Provincial Natural Science Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>LE2249/5-1</GrantID>
            <Agency>German Research Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>China Scholarship Council</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Small</MedlineTA>
        <NlmUniqueID>101235338</NlmUniqueID>
        <ISSNLinking>1613-6810</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anodes</Keyword>
        <Keyword MajorTopicYN="N">lithium-ion batteries</Keyword>
        <Keyword MajorTopicYN="N">metal-organic framework derived carbon</Keyword>
        <Keyword MajorTopicYN="N">physical confinement</Keyword>
        <Keyword MajorTopicYN="N">red phosphorus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083792</ArticleId>
        <ArticleId IdType="doi">10.1002/smll.201907141</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Y. Fu, Q. Wei, G. Zhang, S. Sun, Adv. Energy Mater. 2018, 8, 1703058.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Liu, H. Zhi, X. Yu, Energy Storage Mater. 2019, 16, 290.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Li, H. Zhao, J. Mater. Chem. A 2018, 6, 24013.</Citation>
        </Reference>
        <Reference>
          <Citation>S. S. Zhang, InfoMat 2019, https://doi.org/10.1002/inf2.12058.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Zhao, J. Zhang, C. Fu, J. Huang, D. Xiao, M. M. F. Yuen, C. Niu, J. Mater. Chem. A 2018, 6, 2540.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Zhang, D. Zhao, D. Xiao, C. Ma, H. Du, X. Li, L. Zhang, J. Huang, H. Huang, C. L. Jia, D. Tomanek, C. Niu, Angew. Chem., Int. Ed. 2017, 56, 1850.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Xu, J. Ding, W. Zhu, X. Zhou, S. Ge, N. Yuan, Sci. China Mater. 2017, 61, 371.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Zhu, Y. Wen, X. Fan, T. Gao, F. Han, C. Luo, S. Lion, C. Wang, ACS Nano 2015, 9, 3254.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Zhou, Z. Jiang, S. Niu, S. Zhu, J. Zhou, Y. Zhu, J. Liang, D. Han, K. Xu, L. Zhu, X. Liu, G. Wang, Y. Qian, Chem 2018, 4, 372.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Gao, T. Zhou, Y. Zheng, Y. Liu, J. Chen, H. Liu, Z. Guo, Adv. Energy Mater. 2016, 6, 1601037.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Zhao, B. Li, J. Zhang, X. Li, D. Xiao, C. Fu, L. Zhang, Z. Li, J. Li, D. Cao, C. Niu, Nano Lett. 2017, 17, 3376.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Liu, A. Zhang, C. Shen, Q. Liu, X. Cao, Y. Ma, L. Chen, C. Lau, T. C. Chen, F. Wei, C. Zhou, ACS Nano 2017, 11, 5530.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Wu, Z. Liu, X. Zhong, X. Cheng, Z. Fan, Y. Yu, Small 2018, 14, 1703472.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Ma, L. Chen, X. Ren, G. Hou, L. Chen, L. Zhang, B. Liu, Q. Ai, L. Zhang, P. Si, J. Lou, J. Feng, L. Ci, J. Mater. Chem. A 2018, 6, 1574.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Ruan, J. Wang, D. Shi, Y. Xu, S. Chou, H. Liu, J. Wang, J. Mater. Chem. A 2015, 3, 19011.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Sun, L. Wang, Y. Li, Y. Li, H. R. Lee, A. Pei, X. He, Y. Cui, Joule 2019, 3, 1080.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Li, Z. Yang, M. Li, Y. Jiang, X. Wei, X. Zhong, L. Gu, Y. Yu, Nano Lett. 2016, 16, 1546.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Yao, J. Cui, J. Huang, J.-Q. Huang, W. G. Chong, L. Qin, Y.-W. Mai, J.-K. Kim, Adv. Energy Mater. 2018, 8, 1702267.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Li, S. Hu, X. Luo, Z. Li, X. Sun, M. Li, F. Liu, Y. Yu, Adv. Mater. 2017, 29, 1700253.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Li, H. Jin, Y. Yuan, H. Lu, C. Su, D. Fan, Y. Li, J. Wang, J. Lu, S. Wang, Nano Energy 2019, 58, 23.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Cao, C. Tan, M. Sindoro, H. Zhang, Chem. Soc. Rev. 2017, 46, 2660.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. V. Kaneti, J. Tang, R. R. Salunkhe, X. Jiang, A. Yu, K. C. Wu, Y. Yamauchi, Adv. Mater. 2017, 29, 1700213.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Zhang, A. Chen, M. Zhong, Z. Zhang, X. Zhang, Z. Zhou, X.-H. Bu, Electrochem. Energy Rev. 2018, 2, 29.</Citation>
        </Reference>
        <Reference>
          <Citation>X. C. Xie, K.-J. Huang, X. Wu, J. Mater. Chem. A 2018, 6, 6754.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Zhang, M. Huang, B. Xi, K. Mi, A. Yuan, S. Xiong, Adv. Energy Mater. 2018, 8, 1701330.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Liu, X. Huang, J. Wang, H. Song, Y. Yang, Y. Liu, J. Li, L. Wang, C. Yu, Adv. Funct. Mater. 2018, 28, 1705253.</Citation>
        </Reference>
        <Reference>
          <Citation>J. He, W. Lv, Y. Chen, K. Wen, C. Xu, W. Zhang, Y. Li, W. Qin, W. He, ACS Nano 2017, 11, 8144.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Zhang, Z. Su, F. Jiang, L. Yang, J. Qian, Y. Zhou, W. Li, M. Hong, Nanoscale 2014, 6, 6590.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Zhou, X. Yu, X. Fan, X. Wang, H. Li, Y. Zhang, W. Li, J. Zheng, B. Wang, X. Li, J. Mater. Chem. A 2015, 3, 8272.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Dragulescu-Andrasi, L. Z. Miller, B. Chen, D. T. McQuade, M. Shatruk, Angew. Chem., Int. Ed. 2016, 55, 3904.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Thommes, K. Kaneko, A. V. Neimark, J. P. Olivier, F. Rodriguez-Reinoso, J. Rouquerol, K. S. W. Sing, Pure Appl. Chem. 2015, 87, 1051.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Liu, Y. Zou, L. Tao, Z. Ma, D. Liu, P. Zhou, H. Liu, S. Wang, Small 2017, 13, 1700758.</Citation>
        </Reference>
        <Reference>
          <Citation>H. X. Zhong, J. Wang, Y. W. Zhang, W. L. Xu, W. Xing, D. Xu, Y. F. Zhang, X. B. Zhang, Angew. Chem., Int. Ed. 2014, 53, 14235.</Citation>
        </Reference>
        <Reference>
          <Citation>Q. Zhao, L. Liu, R. Liu, L. Zhu, Chem. Eng. J. 2018, 353, 311.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Zheng, Y. Yang, Q. Chen, Nat. Commun. 2014, 5, 5261.</Citation>
        </Reference>
        <Reference>
          <Citation>U. Elrod, M. Ch. Lux-Steiner, M. Obergfell, E. Bucher, L. Schlapbach, Appl. Phys. B: Photophys. Laser Chem. 1987, 43, 197.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Wu, Y. Cao, H. Zhao, J. Mao, Z. Guo, Carbon Energy 2019, 1, 57.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Yuan, J. Lu, Carbon Energy 2019, 1, 8.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Yan, H. Jin, J. Guo, Carbon Energy 2019, 1, 246.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Fan, X. Liu, W. Hu, C. Zhong, J. Lu, InfoMat. 2019, 1, 130.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. X. Yao, X. Q. Zhang, B. Q. Li, C. Yan, P. Y. Chen, J. Q. Huang, Q. Zhang, InfoMat. 2019, https://doi.org/10.1002/inf2.12046.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Q. Li, L. Kong, C. X. Zhao, Q. Jin, X. Chen, H. J. Peng, J. L. Qin, J. X. Chen, H. Yuan, Q. Zhang, J. Q. Huang, InfoMat. 2019, 1, 533.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Zhao, Y. Zhu, X. Zhang, InfoMat. 2019, https://doi.org/10.1002/inf2.12042.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Lin, Q. Xia, W. Wang, W. Li, S. Chou, InfoMat. 2019, 1, 376.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Chen, H. Tan, X. Rui, Q. Zhang, Y. Feng, H. Geng, C. Li, S. Huang, Y. Yu, InfoMat. 2019, 1, 251.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Liang, C. Z. Zhao, H. Yuan, Y. Chen, W. Zhang, J. Q. Huang, D. Yu, Y. Liu, M. M. Titirici, Y. L. Chueh, H. Yu, Q. Zhang, InfoMat. 2019, 1, 6.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083793</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2040-1124</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of diabetes investigation</Title>
          <ISOAbbreviation>J Diabetes Investig</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Time Course of Metabolic Status in Pregnant Women: the Japan Environment and Children's Study (JECS).</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jdi.13238</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aimed to evaluate the metabolic status of pregnant women by assessing metabolic biomarkers in participants in the Japan Environment and Children's Study (JECS), a nationwide, multicenter, pregnancy and birth cohort.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Pregnant women aged 14-50 years were studied in 15 centers across Japan. Clinical information was obtained using self-administered questionnaires. Blood samples were taken during the first two trimesters to measure metabolic biomarkers. Samples were divided into seven groups according to the weeks of pregnancy.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 82,972 pregnant women, 43 had only type 1 diabetes, 78 had only type 2 diabetes, 2,315 had only gestational diabetes and 354 had only dyslipidemia. HbA1c, total cholesterol, low-density lipoprotein cholesterol, and triglyceride across all the percentiles increased as pre-pregnancy body mass index increased, while high-density lipoprotein cholesterol levels across all the percentiles decreased as body mass index increased. HbA1c was high in participants with type 1 diabetes or type 2 diabetes only but not in those with gestational diabetes or hyperlipidemia only. Participants with type 2 diabetes or dyslipidemia only had high triglyceride in the first trimester, which then decreased in the second trimester. Participants with type 2 diabetes only also showed low high-density lipoprotein cholesterol, while participants with dyslipidemia only showed high total cholesterol and low-density lipoprotein cholesterol throughout.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Metabolic biomarkers were affected by blood sample timing and underlying metabolic disease. The JECS will clarify the influences of metabolic status during pregnancy on the health and development of the offspring in future studies.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sasaki</LastName>
            <ForeName>Hatoko</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5785-0482</Identifier>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arata</LastName>
            <ForeName>Naoko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomotaki</LastName>
            <ForeName>Ai</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Center for Global Health and Medicine, National College of Nursing, 1-2-1, Umezono, Kiyose-shi, Tokyo, 204-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamamoto-Hanada</LastName>
            <ForeName>Kiwako</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mezawa</LastName>
            <ForeName>Hidetoshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Konishi</LastName>
            <ForeName>Mizuho</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishitsuka</LastName>
            <ForeName>Kazue</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saito-Abe</LastName>
            <ForeName>Mayako</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sato</LastName>
            <ForeName>Miori</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishizato</LastName>
            <ForeName>Minaho</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saito</LastName>
            <ForeName>Hirohisa</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohya</LastName>
            <ForeName>Yukihiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>Japan Environment, Children’s Study (JECS) Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Japan</Country>
        <MedlineTA>J Diabetes Investig</MedlineTA>
        <NlmUniqueID>101520702</NlmUniqueID>
        <ISSNLinking>2040-1116</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cohort</Keyword>
        <Keyword MajorTopicYN="N">diabetes</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
      </KeywordList>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Kamijima</LastName>
          <ForeName>Michihiro</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Yamazaki</LastName>
          <ForeName>Shin</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ohya</LastName>
          <ForeName>Yukihiro</ForeName>
          <Initials>Y</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kishi</LastName>
          <ForeName>Reiko</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Yaegashi</LastName>
          <ForeName>Nobuo</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hashimoto</LastName>
          <ForeName>Koichi</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mori</LastName>
          <ForeName>Chisato</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ito</LastName>
          <ForeName>Shuichi</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Yamagata</LastName>
          <ForeName>Zentaro</ForeName>
          <Initials>Z</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Inadera</LastName>
          <ForeName>Hidekuni</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kamijima</LastName>
          <ForeName>Michihiro</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Nakayama</LastName>
          <ForeName>Takeo</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Iso</LastName>
          <ForeName>Hiroyasu</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Shima</LastName>
          <ForeName>Masayuki</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kurosawa</LastName>
          <ForeName>Youichi</ForeName>
          <Initials>Y</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Suganuma</LastName>
          <ForeName>Narufumi</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kusuhara</LastName>
          <ForeName>Koichi</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Katoh</LastName>
          <ForeName>Takahiko</ForeName>
          <Initials>T</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083793</ArticleId>
        <ArticleId IdType="doi">10.1111/jdi.13238</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083794</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1861-471X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry, an Asian journal</Title>
          <ISOAbbreviation>Chem Asian J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recent Advances in the Synthesis, Surface Modifications and Applications of Core-shell Magnetic Mesoporous Silica Nanospheres.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/asia.202000045</ELocationID>
        <Abstract>
          <AbstractText>The hierarchically structured core-shell magnetic mesoporous silica nanospheres (Mag-MSNs) have attracted extensive attention, particularly in the studies of reliable preparation methods of the multifunctional materials and the diverse applications of these nanomaterials across a wide range of multidisciplinary researches. These Mag-MSNs have been prepared with well-designed synthesis strategies and used as adsorbent materials, biomedicine and catalysis due to their excellent magnetic responsiveness, large specific surface area and readiness in their surface modification. The surface functionalization of the core-shell Mag-MSNs bridges the gap between heterogeneous and homogeneous phases and greatly extends the properties and application prospects of the materials. The introduction of various molecular matrices into the shell of Mag-MSNs enables the combination of functionalization and magnetic separation technology. In some cases, it is an important feature in the sustainable development process to recover the functionalized core-shell Mag-MSNs after the reaction and reuse them without losing activity. In this review, the design strategies and the construction of the core-shell Mag-MSNs are discussed. Various surface functionalization methods of core-shell Mag-MSNs are summarized and the latest applications of these functionalized nanomaterials in the fields of biomedicine, catalysis and wastewater treatment are demonstrated.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zuo</LastName>
            <ForeName>Bin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>University of Shanghai for Science and Technology, College of Science, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Wanfang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>University of Shanghai for Science and Technology, College of Science, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiaoqiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>University of Shanghai for Science and Technology, College of Science, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Shige</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Shanghai for Science and Technology, College of Science, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Qinyue</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>University of Shanghai for Science and Technology, College of Science, No. 334 Jungong Road, 200093, Shanghai, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Mingxian</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>University of Shanghai for Science and Technology, College of Science, UNITED STATES.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chem Asian J</MedlineTA>
        <NlmUniqueID>101294643</NlmUniqueID>
        <ISSNLinking>1861-471X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">core-shell magnetic mesoporous silica nanospheres (Mag-MSNs) * the preparation methods * surface modifications * multi-functionality</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083794</ArticleId>
        <ArticleId IdType="doi">10.1002/asia.202000045</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083795</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1462-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cellular microbiology</Title>
          <ISOAbbreviation>Cell. Microbiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cleavage and degradation of EDEM1 promotes coxsackievirus B3 replication via ATF6a-mediated unfolded protein response signaling.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13198</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cmi.13198</ELocationID>
        <Abstract>
          <AbstractText>Our previous study of coxsackievirus B3 (CVB3)-induced unfolded protein responses (UPR) found that overexpression of ATF6a enhances CVB3 VP1 capsid protein production and increases viral particle formation. These findings implicate that ATF6a signaling benefits CVB3 replication. However, the mechanism by which ATF6a signaling is transduced to promote virus replication is unclear. In this study, using a Tet-On inducible ATF6a HeLa cell line, we found that ATF6a signaling downregulated the protein expression of the ER degradation-enhancing α-mannosidase-like protein 1 (EDEM1), resulting in accumulation of CVB3 VP1 protein; in contrast, expression of a dominant negative ATF6a had the opposite effect. Furthermore, we found that EDEM1 was cleaved by both CVB3 protease 3C and virus-activated caspase and subsequently degraded via the ubiquitin-proteasome pathway. However, overexpression of EDEM1 caused VP1 degradation, likely via a glycosylation-independent and ubiquitin-lysosome pathway. Finally, we demonstrated that CRISPR/Cas9-mediated knockout of EDEM1 increased VP1 accumulation and thus CVB3 replication. This is the first study to report the ER protein quality control of non-enveloped RNA virus and reveals a novel mechanism by which CVB3 evades host ER quality control pathways through cleavage and degradation of the UPR target gene EDEM1, to ultimately benefit its own replication. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Huifang M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiu</LastName>
            <ForeName>Ye</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Biology, Hunan University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Guangze</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Hua</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yankuan T</ForeName>
            <Initials>YT</Initials>
            <AffiliationInfo>
              <Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aghakeshmiri</LastName>
            <ForeName>Sana</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanson</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Decheng</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3177-0070</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Cell Microbiol</MedlineTA>
        <NlmUniqueID>100883691</NlmUniqueID>
        <ISSNLinking>1462-5814</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083795</ArticleId>
        <ArticleId IdType="doi">10.1111/cmi.13198</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083797</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>The FEBS journal</Title>
          <ISOAbbreviation>FEBS J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cell cycle dependence of transcriptome gene modules: comparison of regression lines.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/febs.15257</ELocationID>
        <Abstract>
          <AbstractText>The transcriptome consists of various gene modules that can be mutually dependent and ignoring these dependencies may lead to misinterpretation. The most important problem is module dependence on cell-cycle activity. Using meta-analysis of over 30,000 single-cell transcriptomes, we show gene module dependencies on cell-cycle signature, which can be consistently observed in various normal and cancer cells. Transcript levels of receptors, plasma membrane and differentiation-related genes are negatively regressed on cell-cycle signature. Pluripotency, stress response, DNA repair, chromatin remodeling, proteasomal protein degradation, protein network connectivity and unicellular evolutionary origin are regressed positively. These effects cannot be explained by partial overlap of corresponding gene sets because they remain if the overlapped genes were removed. We propose a visual analysis of gene module-specific regression lines as complement to an uncurated enrichment analysis. The different lines for a same gene module indicate different cell conditions. The approach is tested on several problems (polyploidy, pluripotency, cancer, phylostratigraphy). Intriguingly, we found variation in cell-cycle activity, which is independent of cell progression through the cycle. The upregulation of G2/M checkpoint genes with downregulation of G2/M transition and cytokinesis is revealed in polyploid cells. A temporal increase in cell-cycle activity at transition from pluripotent to more differentiated state is found in human embryonic stem cells. The upregulation of unicellular interactome cluster in human cancers is shown in single cells with control for cell-cycle activity. The greater scatter around regression line in cancer cells suggests greater heterogeneity caused by deviation from a line of normal cells.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vinogradov</LastName>
            <ForeName>A E</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anatskaya</LastName>
            <ForeName>O V</ForeName>
            <Initials>OV</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>FEBS J</MedlineTA>
        <NlmUniqueID>101229646</NlmUniqueID>
        <ISSNLinking>1742-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">cell cycle</Keyword>
        <Keyword MajorTopicYN="N">human</Keyword>
        <Keyword MajorTopicYN="N">polyploidy</Keyword>
        <Keyword MajorTopicYN="N">stem cells</Keyword>
        <Keyword MajorTopicYN="N">transcriptome</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083797</ArticleId>
        <ArticleId IdType="doi">10.1111/febs.15257</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083796</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2045-8827</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>MicrobiologyOpen</Title>
          <ISOAbbreviation>Microbiologyopen</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Transposon mutagenesis in Mycobacterium kansasii links a small RNA gene to colony morphology and biofilm formation and identifies 9,885 intragenic insertions that do not compromise colony outgrowth.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e988</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/mbo3.988</ELocationID>
        <Abstract>
          <AbstractText>Mycobacterium kansasii (Mk) is a resilient opportunistic human pathogen that causes tuberculosis-like chronic pulmonary disease and mortality stemming from comorbidities and treatment failure. The standard treatment of Mk infections requires costly, long-term, multidrug courses with adverse side effects. The emergence of drug-resistant isolates further complicates the already challenging drug therapy regimens and threatens to compromise the future control of Mk infections. Despite the increasingly recognized global burden of Mk infections, the biology of this opportunistic pathogen remains essentially unexplored. In particular, studies reporting gene function or generation of defined mutants are scarce. Moreover, no transposon (Tn) mutagenesis tool has been validated for use in Mk, a situation limiting the repertoire of genetic approaches available to accelerate the dissection of gene function and the generation of gene knockout mutants in this poorly characterized pathogen. In this study, we validated the functionality of a powerful Tn mutagenesis tool in Mk and used this tool in conjunction with a forward genetic screen to establish a previously unrecognized role of a conserved mycobacterial small RNA gene of unknown function in colony morphology features and biofilm formation. We also combined Tn mutagenesis with next-generation sequencing to identify 12,071 Tn insertions that do not compromise viability in vitro. Finally, we demonstrated the susceptibility of the Galleria mellonella larva to Mk, setting the stage for further exploration of this simple and economical infection model system to the study of this pathogen.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. MicrobiologyOpen published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Budell</LastName>
            <ForeName>William C</ForeName>
            <Initials>WC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Brooklyn College, City University of New York, Brooklyn, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biology Ph.D. Program, Graduate Center, City University of New York, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Germain</LastName>
            <ForeName>Gabrielle A</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Brooklyn College, City University of New York, Brooklyn, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biology Ph.D. Program, Graduate Center, City University of New York, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janisch</LastName>
            <ForeName>Niklas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Brooklyn College, City University of New York, Brooklyn, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biology Ph.D. Program, Graduate Center, City University of New York, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McKie-Krisberg</LastName>
            <ForeName>Zaid</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Brooklyn College, City University of New York, Brooklyn, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jayaprakash</LastName>
            <ForeName>Anitha D</ForeName>
            <Initials>AD</Initials>
            <AffiliationInfo>
              <Affiliation>Girihlet Inc., Oakland Genome Center, Oakland, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Resnick</LastName>
            <ForeName>Andrew E</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Brooklyn College, City University of New York, Brooklyn, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quadri</LastName>
            <ForeName>Luis E N</ForeName>
            <Initials>LEN</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7723-1187</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Brooklyn College, City University of New York, Brooklyn, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biology Ph.D. Program, Graduate Center, City University of New York, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biochemistry Ph.D. Program, Graduate Center, City University of New York, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R03 AI 128314</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R03 AI 135755</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Microbiologyopen</MedlineTA>
        <NlmUniqueID>101588314</NlmUniqueID>
        <ISSNLinking>2045-8827</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Galleria mellonella
</Keyword>
        <Keyword MajorTopicYN="N">
Mycobacterium kansasii
</Keyword>
        <Keyword MajorTopicYN="N">biofilm</Keyword>
        <Keyword MajorTopicYN="N">gene essentiality</Keyword>
        <Keyword MajorTopicYN="N">nontuberculous mycobacteria</Keyword>
        <Keyword MajorTopicYN="N">small noncoding RNA</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083796</ArticleId>
        <ArticleId IdType="doi">10.1002/mbo3.988</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Aldridge, B. B., Keren, I., &amp; Fortune, S. M. (2014). The spectrum of drug susceptibility in mycobacteria. Microbiology Spectrum, 2(5), MGM2-0031-2013. https://doi.org/10.1128/microbiolspec.MGM2-0031-2013</Citation>
        </Reference>
        <Reference>
          <Citation>Arnvig, K. B., Cortes, T., &amp; Young, D. B. (2014). Noncoding RNA in mycobacteria. Microbiology Spectrum, 2(2), MGM2-0029-2013. https://doi.org/10.1128/microbiolspec.MGM2-0029-2013</Citation>
        </Reference>
        <Reference>
          <Citation>Arnvig, K. B., &amp; Young, D. B. (2009). Identification of small RNAs in Mycobacterium tuberculosis. Molecular Microbiology, 73(3), 397-408. https://doi.org/10.1111/j.1365-2958.2009.06777.x</Citation>
        </Reference>
        <Reference>
          <Citation>Bakula, Z., Safianowska, A., Nowacka-Mazurek, M., Bielecki, J., &amp; Jagielski, T. (2013). Short communication: Subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene. BioMed Research International, 2013, 178725. https://doi.org/10.1155/2013/178725</Citation>
        </Reference>
        <Reference>
          <Citation>Bardarov, S., Kriakov, J., Carriere, C., Yu, S., Vaamonde, C., McAdam, R. A., … Jacobs, W. R. (1997). Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 94(20), 10961-10966. https://doi.org/10.1073/pnas.94.20.10961</Citation>
        </Reference>
        <Reference>
          <Citation>Belisle, J. T., &amp; Brennan, P. J. (1989). Chemical basis of rough and smooth variation in mycobacteria. Journal of Bacteriology, 171(6), 3465-3470. https://doi.org/10.1128/jb.171.6.3465-3470.1989</Citation>
        </Reference>
        <Reference>
          <Citation>Brown-Elliott, B. A., Nash, K. A., &amp; Wallace, R. J. Jr (2012). Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clinical Microbiology Reviews, 25(3), 545-582. https://doi.org/10.1128/CMR.05030-11</Citation>
        </Reference>
        <Reference>
          <Citation>Chakraborty, P., &amp; Kumar, A. (2019). The extracellular matrix of mycobacterial biofilms: Could we shorten the treatment of mycobacterial infections? Microbial Cell, 6(2), 105-122. https://doi.org/10.15698/mic2019.02.667</Citation>
        </Reference>
        <Reference>
          <Citation>Chapelais-Baron, M., Goubet, I., Peteri, R., Pereira, M. F., Mignot, T., Jabveneau, A., &amp; Rosenfeld, E. (2018). Colony analysis and deep learning uncover 5-hydroxyindole as an inhibitor of gliding motility and iridescence in Cellulophaga lytica. Microbiology, 164(3), 308-321. https://doi.org/10.1099/mic.0.000617</Citation>
        </Reference>
        <Reference>
          <Citation>Chavadi, S. S., Edupuganti, U. R., Vergnolle, O., Fatima, I., Singh, S. M., Soll, C. E., &amp; Quadri, L. E. (2011). Inactivation of tesA reduces cell-wall lipid production and increases drug susceptibility in mycobacteria. Journal of Biological Chemistry, 286, 24616-24625.</Citation>
        </Reference>
        <Reference>
          <Citation>Chavadi, S. S., Stirrett, K. L., Edupuganti, U. R., Vergnolle, O., Sadhanandan, G., Marchiano, E., … Quadri, L. E. N. (2011). Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster. Journal of Bacteriology, 193(21), 5905-5913. https://doi.org/10.1128/JB.05811-11</Citation>
        </Reference>
        <Reference>
          <Citation>Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., … Barrell, B. G. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393(6685), 537-544. https://doi.org/10.1038/31159</Citation>
        </Reference>
        <Reference>
          <Citation>Daley, C. L., &amp; Griffith, D. E. (2010). Pulmonary non-tuberculous mycobacterial infections. International Journal of Tuberculosis and Lung Disease, 14(6), 665-671.</Citation>
        </Reference>
        <Reference>
          <Citation>Dalton, J. P., Uy, B., Swift, S., &amp; Wiles, S. (2017). A novel restraint device for injection of Galleria mellonella larvae that minimizes the risk of accidental operator needle stick injury. Frontiers in Cellular and Infection Microbiology, 7, 99. https://doi.org/10.3389/fcimb.2017.00099</Citation>
        </Reference>
        <Reference>
          <Citation>Davies, B. S., Roberts, C. H., Kaul, S., Klein, J. L., &amp; Milburn, H. J. (2012). Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London. Scandinavian Journal of Infectious Diseases, 44(11), 815-819. https://doi.org/10.3109/00365548.2012.694469</Citation>
        </Reference>
        <Reference>
          <Citation>DeJesus, M. A., Ambadipudi, C., Baker, R., Sassetti, C., &amp; Ioerger, T. R. (2015). TRANSIT - A software tool for Himar1 TnSeq analysis. PLoS Computational Biology, 11(10), e1004401. https://doi.org/10.1371/journal.pcbi.1004401</Citation>
        </Reference>
        <Reference>
          <Citation>DeJesus, M. A., Gerrick, E. R., Xu, W., Park, S. W., Long, J. E., Boutte, C. C., … Ioerger, T. R. (2017). Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. Mbio, 8(1), e02133-16. https://doi.org/10.1128/mBio.02133-16</Citation>
        </Reference>
        <Reference>
          <Citation>DeJesus, M. A., &amp; Ioerger, T. R. (2013). A Hidden Markov Model for identifying essential and growth-defect regions in bacterial genomes from transposon insertion sequencing data. BMC Bioinformatics, 14, 303. https://doi.org/10.1186/1471-2105-14-303</Citation>
        </Reference>
        <Reference>
          <Citation>DeJesus, M. A., Zhang, Y. J., Sassetti, C. M., Rubin, E. J., Sacchettini, J. C., &amp; Ioerger, T. R. (2013). Bayesian analysis of gene essentiality based on sequencing of transposon insertion libraries. Bioinformatics, 29, 695-703. https://doi.org/10.1093/bioinformatics/btt043</Citation>
        </Reference>
        <Reference>
          <Citation>DiChiara, J. M., Contreras-Martinez, L. M., Livny, J., Smith, D., McDonough, K. A., &amp; Belfort, M. (2010). Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis. Nucleic Acids Research, 38(12), 4067-4078. https://doi.org/10.1093/nar/gkq101</Citation>
        </Reference>
        <Reference>
          <Citation>Driessen, N. N., Stoop, E. J. M., Ummels, R., Gurcha, S. S., Mishra, A. K., Larrouy-Maumus, G., … Appelmelk, B. J. (2010). Mycobacterium marinum MMAR_2380, a predicted transmembrane acyltransferase, is essential for the presence of the mannose cap on lipoarabinomannan. Microbiology, 156(Pt 11), 3492-3502. https://doi.org/10.1099/mic.0.037507-0</Citation>
        </Reference>
        <Reference>
          <Citation>Dubnau, E., Fontan, P., Manganelli, R., Soares-Appel, S., &amp; Smith, I. (2002). Mycobacterium tuberculosis genes induced during infection of human macrophages. Infection and Immunity, 70(6), 2787-2795.</Citation>
        </Reference>
        <Reference>
          <Citation>Ehsani, L., Reddy, S. C., Mosunjac, M., Kraft, C. S., &amp; Guarner, J. (2015). Fatal aortic pseudoaneurysm from disseminated Mycobacterium kansasii infection: Case report. Human Pathology, 46(3), 467-470. https://doi.org/10.1016/j.humpath.2014.11.005</Citation>
        </Reference>
        <Reference>
          <Citation>Entwistle, F. M., &amp; Coote, P. J. (2018). Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis mycobacteria infections and antibiotic treatments. Journal of Medical Microbiology, 67(4), 585-597. https://doi.org/10.1099/jmm.0.000696</Citation>
        </Reference>
        <Reference>
          <Citation>Evans, A. J., Crisp, A. J., Hubbard, R. B., Colville, A., Evans, S. A., &amp; Johnston, I. D. (1996). Pulmonary Mycobacterium kansasii infection: Comparison of radiological appearances with pulmonary tuberculosis. Thorax, 51(12), 1243-1247. https://doi.org/10.1136/thx.51.12.1243</Citation>
        </Reference>
        <Reference>
          <Citation>Fan, P. D., Narzisi, G., Jayaprakash, A. D., Venturini, E., Robine, N., Smibert, P., … Ladanyi, M. (2018). YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proceedings of the National Academy of Sciences of the United States of America, 115(26), E6030-E6038. https://doi.org/10.1073/pnas.1717782115</Citation>
        </Reference>
        <Reference>
          <Citation>Flor, A., Capdevila, J. A., Martin, N., Gavalda, J., &amp; Pahissa, A. (1996). Nontuberculous mycobacterial meningitis: Report of two cases and review. Clinical Infectious Diseases, 23(6), 1266-1273. https://doi.org/10.1093/clinids/23.6.1266</Citation>
        </Reference>
        <Reference>
          <Citation>Griffin, J. E., Gawronski, J. D., Dejesus, M. A., Ioerger, T. R., Akerley, B. J., &amp; Sassetti, C. M. (2011). High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathogens, 7(9), e1002251. https://doi.org/10.1371/journal.ppat.1002251</Citation>
        </Reference>
        <Reference>
          <Citation>Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., … Winthrop, K. (2007). An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine, 175(4), 367-416. https://doi.org/10.1164/rccm.200604-571ST</Citation>
        </Reference>
        <Reference>
          <Citation>Henkle, E., &amp; Winthrop, K. L. (2015). Nontuberculous mycobacteria infections in immunosuppressed hosts. Clinics in Chest Medicine, 36(1), 91-99. https://doi.org/10.1016/j.ccm.2014.11.002</Citation>
        </Reference>
        <Reference>
          <Citation>Hirashima, T., Nagai, T., Shigeoka, H., Tamura, Y., Yoshida, H., Kawahara, K., … Kawase, I. (2014). Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: A retrospective study. BMC Cancer, 14, 770. https://doi.org/10.1186/1471-2407-14-770</Citation>
        </Reference>
        <Reference>
          <Citation>Hoefsloot, W., van Ingen, J., Andrejak, C., Ängeby, K., Bauriaud, R., Bemer, P., … Wagner, D. (2013). The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: An NTM-NET collaborative study. European Respiratory Journal, 42(6), 1604-1613. https://doi.org/10.1183/09031936.00149212</Citation>
        </Reference>
        <Reference>
          <Citation>Huff, J., Czyz, A., Landick, R., &amp; Niederweis, M. (2010). Taking phage integration to the next level as a genetic tool for mycobacteria. Gene, 468(1-2), 8-19. https://doi.org/10.1016/j.gene.2010.07.012</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston, J. C., &amp; Elwood, K. (2011). Mycobacterium kansasii. In D. Schlossberg (Ed.), Tuberculosis and nontuberculous mycobacterial infections (6th ed., pp. 578-585). Washington, DC: ASM Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Kempes, C. P., Okegbe, C., Mears-Clarke, Z., Follows, M. J., &amp; Dietrich, L. E. (2014). Morphological optimization for access to dual oxidants in biofilms. Proceedings of the National Academy of Sciences of the United States of America, 111(1), 208-213. https://doi.org/10.1073/pnas.1315521110</Citation>
        </Reference>
        <Reference>
          <Citation>Kendall, B. A., &amp; Winthrop, K. L. (2013). Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Seminars in Respiratory and Critical Care Medicine, 34(1), 87-94. https://doi.org/10.1055/s-0033-1333567</Citation>
        </Reference>
        <Reference>
          <Citation>Klein, J. L., Brown, T. J., &amp; French, G. L. (2001). Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations. Antimicrobial Agents and Chemotherapy, 45(11), 3056-3058. https://doi.org/10.1128/AAC.45.11.3056-3058.2001</Citation>
        </Reference>
        <Reference>
          <Citation>Kwenda, G., Churchyard, G. J., Thorrold, C., Heron, I., Stevenson, K., Duse, A. G., &amp; Marais, E. (2015). Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines. Journal of Water and Health, 13(1), 190-202. https://doi.org/10.2166/wh.2014.161</Citation>
        </Reference>
        <Reference>
          <Citation>Lamichhane, G., Arnvig, K. B., &amp; McDonough, K. A. (2013). Definition and annotation of (myco)bacterial non-coding RNA. Tuberculosis (Edinburgh, Scotland), 93(1), 26-29. https://doi.org/10.1016/j.tube.2012.11.010</Citation>
        </Reference>
        <Reference>
          <Citation>Langridge, G. C., Phan, M.-D., Turner, D. J., Perkins, T. T., Parts, L., Haase, J., … Turner, A. K. (2009). Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Research, 19(12), 2308-2316. https://doi.org/10.1101/gr.097097.109</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, M. H., Pascopella, L., Jacobs, W. R. Jr, &amp; Hatfull, G. F. (1991). Site-specific integration of mycobacteriophage L5: Integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. Proceedings of the National Academy of Sciences of the United States of America, 88(8), 3111-3115. https://doi.org/10.1073/pnas.88.8.3111</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Y., Spiropoulos, J., Cooley, W., Khara, J. S., Gladstone, C. A., Asai, M., … Langford, P. R. (2018). Galleria mellonella - A novel infection model for the Mycobacterium tuberculosis complex. Virulence, 9(1), 1126-1137. https://doi.org/10.1080/21505594.2018.1491255</Citation>
        </Reference>
        <Reference>
          <Citation>Livak, K. J., &amp; Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25(4), 402-408. https://doi.org/10.1006/meth.2001.1262</Citation>
        </Reference>
        <Reference>
          <Citation>Long, J. E., DeJesus, M., Ward, D., Baker, R. E., Ioerger, T., &amp; Sassetti, C. M. (2015). Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. Methods in Molecular Biology, 1279, 79-95. https://doi.org/10.1007/978-1-4939-2398-4_6</Citation>
        </Reference>
        <Reference>
          <Citation>Lyons, J., Vandenberghe, E., Fahy, R., McDonnell, C., Keane, J., &amp; McLaughlin, A. M. (2014). An unusual lung mass post stem cell transplantation. Transplant Infectious Disease, 16(4), 672-675. https://doi.org/10.1111/tid.12257</Citation>
        </Reference>
        <Reference>
          <Citation>Mai, J., Rao, C., Watt, J., Sun, X., Lin, C., Zhang, L., &amp; Liu, J. (2019). Mycobacterium tuberculosis 6C sRNA binds multiple mRNA targets via C-rich loops independent of RNA chaperones. Nucleic Acids Research, 47(8), 4292-4307. https://doi.org/10.1093/nar/gkz149</Citation>
        </Reference>
        <Reference>
          <Citation>Maliwan, N., &amp; Zvetina, J. R. (2005). Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: A 50 year experience. Postgraduate Medical Journal, 81(958), 530-533. https://doi.org/10.1136/pgmj.2004.026229</Citation>
        </Reference>
        <Reference>
          <Citation>Meir, M., Grosfeld, T., &amp; Barkan, D. (2018). Establishment and validation of Galleria mellonella as a novel model organism to study Mycobacterium abscessus Infection, pathogenesis, and treatment. Antimicrobial Agents and Chemotherapy, 62(4), e2539-17. https://doi.org/10.1128/AAC.02539-17</Citation>
        </Reference>
        <Reference>
          <Citation>Minnikin, D. E., Lee, O. Y., Wu, H. H., Besra, G. S., Bhatt, A., Nataraj, V., … Donoghue, H. D. (2015). Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis. Tuberculosis (Edinburgh, Scotland), 95(Suppl 1), S133-S139. https://doi.org/10.1016/j.tube.2015.02.009</Citation>
        </Reference>
        <Reference>
          <Citation>Mirsaeidi, M., Farshidpour, M., Allen, M. B., Ebrahimi, G., &amp; Falkinham, J. O. (2014). Highlight on advances in nontuberculous mycobacterial disease in North America. BioMed Research International, 2014, 1-10. https://doi.org/10.1155/2014/919474</Citation>
        </Reference>
        <Reference>
          <Citation>Mohandas, P., Budell, W. C., Mueller, E., Au, A., Bythrow, G. V., &amp; Quadri, L. E. (2016). Pleiotropic consequences of gene knockouts in the phthiocerol dimycocerosate and phenolic glycolipid biosynthetic gene cluster of the opportunistic human pathogen Mycobacterium marinum. FEMS Microbiology Letters, 363, fnw016. https://doi.org/10.1093/femsle/fnw016</Citation>
        </Reference>
        <Reference>
          <Citation>Nataraj, V., Pang, P.-C., Haslam, S. M., Veerapen, N., Minnikin, D. E., Dell, A., … Bhatt, A. (2015). MKAN27435 is required for the biosynthesis of higher subclasses of lipooligosaccharides in Mycobacterium kansasii. PLoS ONE, 10(3), e0122804. https://doi.org/10.1371/journal.pone.0122804</Citation>
        </Reference>
        <Reference>
          <Citation>Onwueme, K. C., Vos, C. J., Zurita, J., Soll, C. E., &amp; Quadri, L. E. (2005). Identification of phthiodiolone ketoreductase, an enzyme required for production of mycobacterial diacyl phthiocerol virulence factors. Journal of Bacteriology, 187(14), 4760-4766. https://doi.org/10.1128/jb.187.14.4760-4766.2005</Citation>
        </Reference>
        <Reference>
          <Citation>Philley, J. V., &amp; Griffith, D. E. (2015). Treatment of slowly growing mycobacteria. Clinics in Chest Medicine, 36(1), 79-90. https://doi.org/10.1016/j.ccm.2014.10.005</Citation>
        </Reference>
        <Reference>
          <Citation>Picardeau, M., Prod'Hom, G., Raskine, L., LePennec, M. P., &amp; Vincent, V. (1997). Genotypic characterization of five subspecies of Mycobacterium kansasii. Journal of Clinical Microbiology, 35(1), 25-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Prevots, D. R., &amp; Marras, T. K. (2015). Epidemiology of human pulmonary infection with nontuberculous mycobacteria: A review. Clinics in Chest Medicine, 36(1), 13-34. https://doi.org/10.1016/j.ccm.2014.10.002</Citation>
        </Reference>
        <Reference>
          <Citation>Quadri, L. E., Sailer, M., Roy, K. L., Vederas, J. C., &amp; Stiles, M. E. (1994). Chemical and genetic characterization of bacteriocins produced by Carnobacterium piscicola LV17B. Journal of Biological Chemistry, 269(16), 12204-12211.</Citation>
        </Reference>
        <Reference>
          <Citation>Ren, H., Dover, L. G., Islam, S. T., Alexander, D. C., Chen, J. M., Besra, G. S., &amp; Liu, J. (2007). Identification of the lipooligosaccharide biosynthetic gene cluster from Mycobacterium marinum. Molecular Microbiology, 63(5), 1345-1359. https://doi.org/10.1111/j.1365-2958.2007.05603.x</Citation>
        </Reference>
        <Reference>
          <Citation>Ricketts, W. M., O'Shaughnessy, T. C., &amp; van Ingen, J. (2014). Human-to-human transmission of Mycobacterium kansasii or victims of a shared source? European Respiratory Journal, 44(4), 1085-1087. https://doi.org/10.1183/09031936.00066614</Citation>
        </Reference>
        <Reference>
          <Citation>Rubin, E. J., Akerley, B. J., Novik, V. N., Lampe, D. J., Husson, R. N., &amp; Mekalanos, J. J. (1999). In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proceedings of the National Academy of Sciences of the United States of America, 96(4), 1645-1650. https://doi.org/10.1073/pnas.96.4.1645</Citation>
        </Reference>
        <Reference>
          <Citation>Rwegasila, E., Mubofu, E. B., Nyandoro, S. S., Erasto, P., &amp; Munissi, J. J. (2016). Preparation, characterization and in vivo antimycobacterial studies of panchovillin-chitosan nanocomposites. International Journal of Molecular Sciences, 17(10), 1559. https://doi.org/10.3390/ijms17101559</Citation>
        </Reference>
        <Reference>
          <Citation>Rybniker, J., Kramme, S., &amp; Small, P. L. (2006). Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis - Application for identification and susceptibility testing. Journal of Medical Microbiology, 55(Pt 1), 37-42. https://doi.org/10.1099/jmm.0.46238-0</Citation>
        </Reference>
        <Reference>
          <Citation>Sambrook, J. F., &amp; Russell, D. W. (2001). Molecular cloning: A laboratory manual (3rd ed.). Cold Spring Harbour, NY: Cold Spring Harbour Laboratory Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Santin, M., Dorca, J., Alcaide, F., Gonzalez, L., Casas, S., Lopez, M., &amp; Guerra, M. R. (2009). Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. European Respiratory Journal, 33(1), 148-152. https://doi.org/10.1183/09031936.00024008</Citation>
        </Reference>
        <Reference>
          <Citation>Sassetti, C. M., Boyd, D. H., &amp; Rubin, E. J. (2001). Comprehensive identification of conditionally essential genes in mycobacteria. Proceedings of the National Academy of Sciences of the United States of America, 98(22), 12712-12717. https://doi.org/10.1073/pnas.231275498</Citation>
        </Reference>
        <Reference>
          <Citation>Siegrist, M. S., &amp; Rubin, E. J. (2009). Phage transposon mutagenesis. Methods in Molecular Biology, 465, 311-323. https://doi.org/10.1007/978-1-59745-207-6_21</Citation>
        </Reference>
        <Reference>
          <Citation>Sun, Z., &amp; Zhang, Y. (1999). Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Antimicrobial Agents and Chemotherapy, 43(3), 537-542.</Citation>
        </Reference>
        <Reference>
          <Citation>Taillard, C., Greub, G., Weber, R., Pfyffer, G. E., Bodmer, T., Zimmerli, S., … Prod'hom, G. (2003). Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. Journal of Clinical Microbiology, 41(3), 1240-1244. https://doi.org/10.1128/JCM.41.3.1240-1244.2003</Citation>
        </Reference>
        <Reference>
          <Citation>Tatham, E., Chavadi, S., Mohandas, P., Edupuganti, U., Angala, S., Chatterjee, D., &amp; Quadri, L. E. (2012). Production of mycobacterial cell wall glycopeptidolipids requires a member of the MbtH-like protein family. BMC Microbiology, 12(1), 118. https://doi.org/10.1186/1471-2180-12-118</Citation>
        </Reference>
        <Reference>
          <Citation>Tortoli, E. (2003). Mycobacterium kansasii, species or complex? Biomolecular and epidemiological insights. Kekkaku, 78(11), 705-709.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsai, C. J., Loh, J. M., &amp; Proft, T. (2016). Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence, 7(3), 214-229. https://doi.org/10.1080/21505594.2015.1135289</Citation>
        </Reference>
        <Reference>
          <Citation>Vaerewijck, M. J., Huys, G., Palomino, J. C., Swings, J., &amp; Portaels, F. (2005). Mycobacteria in drinking water distribution systems: Ecology and significance for human health. FEMS Microbiology Reviews, 29(5), 911-934. https://doi.org/10.1016/j.femsre.2005.02.001</Citation>
        </Reference>
        <Reference>
          <Citation>van Opijnen, T., &amp; Camilli, A. (2013). Transposon insertion sequencing: A new tool for systems-level analysis of microorganisms. Nature Reviews Microbiology, 11(7), 435-442. https://doi.org/10.1038/nrmicro3033</Citation>
        </Reference>
        <Reference>
          <Citation>Veyrier, F., Pletzer, D., Turenne, C., &amp; Behr, M. A. (2009). Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis. BMC Evolutionary Biology, 9, 196. https://doi.org/10.1186/1471-2148-9-196</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, H. X., Yue, J., Han, M., Yang, J. H., Gao, R. L., Jing, L. J., … Zhao, Y. L. (2010). Nontuberculous mycobacteria: Susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008. Chinese Medical Journal, 123(2), 184-187.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, J., McIntosh, F., Radomski, N., Dewar, K., Simeone, R., Enninga, J., … Behr, M. A. (2015). Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii. Genome Biology and Evolution, 7(3), 856-870. https://doi.org/10.1093/gbe/evv035</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, J., Pritchard, J. R., Kreitmann, L., Montpetit, A., &amp; Behr, M. A. (2014). Disruption of Mycobacterium avium subsp. paratuberculosis-specific genes impairs in vivo fitness. BMC Genomics, 15, 415. https://doi.org/10.1186/1471-2164-15-415</Citation>
        </Reference>
        <Reference>
          <Citation>Weinberg, Z., Barrick, J. E., Yao, Z., Roth, A., Kim, J. N., Gore, J., … Breaker, R. R. (2007). Identification of 22 candidate structured RNAs in bacteria using the CMfinder comparative genomics pipeline. Nucleic Acids Research, 35(14), 4809-4819. https://doi.org/10.1093/nar/gkm487</Citation>
        </Reference>
        <Reference>
          <Citation>Wu, T.-S., Leu, H.-S., Chiu, C.-H., Lee, M.-H., Chiang, P.-C., Wu, T.-L., … Lai, H.-C. (2009). Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan. Journal of Antimicrobial Chemotherapy, 64(3), 511-514. https://doi.org/10.1093/jac/dkp238</Citation>
        </Reference>
        <Reference>
          <Citation>Yamada, H., Kohyama, T., Terashi, K., Mori, H., Yamaguchi, A., Arima, N., &amp; Tanaka, H. (1997). Fatal pulmonary infection due to multidrug-resistant Mycobacterium kansasii which developed in an immunocompetent young man. Internal Medicine, 36(4), 298-300. https://doi.org/10.2169/internalmedicine.36.298</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, J., Tran, V., Li, M., Huang, X., Niu, C., Wang, D., … Liu, J. (2012). Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum. Infection and Immunity, 80(4), 1381-1389. https://doi.org/10.1128/iai.06370-11</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, Y. J., Ioerger, T. R., Huttenhower, C., Long, J. E., Sassetti, C. M., Sacchettini, J. C., &amp; Rubin, E. J. (2012). Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathogens, 8(9), e1002946. https://doi.org/10.1371/journal.ppat.1002946</Citation>
        </Reference>
        <Reference>
          <Citation>Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research, 31(13), 3406-3415. https://doi.org/10.1093/nar/gkg595</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083798</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2040-1124</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of diabetes investigation</Title>
          <ISOAbbreviation>J Diabetes Investig</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of SGLT2 Inhibitors on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jdi.13237</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND/OBJECTIVE" NlmCategory="OBJECTIVE">Non-alcoholic fatty liver disease (NAFLD) is more and more common in patients with type 2diabetes mellitus (T2DM). Currently, some researches have found that Sodium glucose co- transporter2 (SGLT2) inhibitors, a new hypoglycemic drug, can improve nonalcoholic fatty liver besides hypoglycemic effect. Thus, we undertook a meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of SGLT2 inhibitors on the treatment of NAFLD METHODS: PubMed, Embase and the Cochrane Library were searched for RCTs of SGLT2 inhibitors in patients with NAFLD and T2DM up to Oct1, 2019. Differences were expressed as weight mean difference (WMD) with 95% CI for continuous outcomes. I<sup>2</sup> statistic was applied to evaluate the heterogeneity of studies.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of six trials including 309 patients were selected into our meta-analysis. SGLT2 inhibitors could reduce alanine amino- transferase (ALT) (WMD (95% CI): -11.05IU/L (-19.85, -2.25); P=0.01) and MRI-PDFF (WMD (95% CI): -2.07% (-3.86,-0.28); P=0.02). However, SGLT2 inhibitors didn't reduce aspartate aminotransferas (AST) (WMD (95% CI): -1.11IU/L (-2.39, 0.17); P=0.09). Besides, secondary outcomes such as body weight and visceral fat area (VFA), were also reduced (WMD (95% CI): -1.62Kg (-2.02, -1.23), P &lt; 0.00001, WMD (95% CI): -19.98cm<sup>2</sup> (-27.18, -12.79), P&lt;0.00001, respectively).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SGLT2 inhibitors can significantly decrease ALT and liver fat, accompanying with weight loss, which may have a positive effect on fatty liver in patients with T2DM. The limitation is that the sample size of the studies is small. Therefore, more large RCTs specified on NAFLD are needed to evaluate these results.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xing</LastName>
            <ForeName>Baodi</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8735-2505</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Endocrine and Metabolic Diseases, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yuhang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrine and Metabolic Diseases, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Bingzi</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrine and Metabolic Diseases, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yue</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrine and Metabolic Diseases, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Wenshan</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrine and Metabolic Diseases, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Wenjuan</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrine and Metabolic Diseases, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Japan</Country>
        <MedlineTA>J Diabetes Investig</MedlineTA>
        <NlmUniqueID>101520702</NlmUniqueID>
        <ISSNLinking>2040-1116</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Non-alcoholic Fatty Liver Disease</Keyword>
        <Keyword MajorTopicYN="N">Sodium-glucose Co-transporter2 Inhibitors</Keyword>
        <Keyword MajorTopicYN="N">Type2 Diabetes Mellitus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083798</ArticleId>
        <ArticleId IdType="doi">10.1111/jdi.13237</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083799</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1860-7187</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>ChemMedChem</Title>
          <ISOAbbreviation>ChemMedChem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Discovery of a novel Class of potent and selective non-competitive Sentrin-specific Protease 1 Inhibitors.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cmdc.202000067</ELocationID>
        <Abstract>
          <AbstractText>Sentrin-specific proteases (SENPs) are responsible for the maturation of small ubiquitin-like modifiers (SUMOs) and the deconjugation of SUMOs from their substrate proteins. Studies on prostate cancer revealed an overexpression of SENP1, which promotes prostate cancer progression as well as metastasis. Therefore, SENP1 has been identified as a novel drug target against prostate cancer. Herein, we report the discovery and biological evaluation of potent and selective SENP1 inhibitors. A structure-activity relationship (SAR) of the newly identified pyridone scaffold revealed allosteric inhibitors with very attractive in vitro ADMET properties regarding plasma binding and plasma stability for this challenging target. This study also emphasizes the importance of biochemical mode of inhibition studies for de novo designed inhibitors.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lindenmann</LastName>
            <ForeName>Urs</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Zurcher Hochschule fur Angewandte Wissenschaften, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brand</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>ZHAW Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gall</LastName>
            <ForeName>Flavio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>ZHAW Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Frasson</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>ZHAW Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hunziker</LastName>
            <ForeName>Lukas</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>ZHAW Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kroslakova</LastName>
            <ForeName>Ivana</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Zurcher Hochschule fur Angewandte Wissenschaften, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sievers</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>ZHAW Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Riedl</LastName>
            <ForeName>Rainer</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>ZHAW Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Einsiedlerstrasse 31, 8820, Wädenswil, SWITZERLAND.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>ChemMedChem</MedlineTA>
        <NlmUniqueID>101259013</NlmUniqueID>
        <ISSNLinking>1860-7179</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drug Discovery</Keyword>
        <Keyword MajorTopicYN="N">Structure-activity relationships</Keyword>
        <Keyword MajorTopicYN="N">drug design</Keyword>
        <Keyword MajorTopicYN="N">inhibitors</Keyword>
        <Keyword MajorTopicYN="N">medicinal chemistry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083799</ArticleId>
        <ArticleId IdType="doi">10.1002/cmdc.202000067</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083800</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-553X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of laboratory hematology</Title>
          <ISOAbbreviation>Int J Lab Hematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Upregulation of long noncoding RNA Lnc-IRF2-3 and Lnc-ZNF667-AS1 is associated with poor survival in B-chronic lymphocytic leukemia.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijlh.13167</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lnc-IRF2-3 and Lnc-ZNF667-AS1 were recently studied as a positive biomarker for many tumor cells. However, experimental studies found that they are associated with worse outcomes in B-CLL.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A prospective case study was conducted on 135 B-CLL patients that were compared to thirty healthy controls. The patients were followed up for 40 months and quantitative measurements of Lnc-IRF2-3 and Lnc-ZNF667-AS1 were measured and compared between the two groups as well as high-risk and low low-risk B-CLL.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Lnc-IRF2-3 and Lnc-ZNF667-AS1 had a high specificity (94% and 85%) and sensitivity (85%, 87%), respectively, to differentiate B-CLL from healthy controls. Furthermore, they showed high expression levels in high-risk CLL groups. For survival analysis, there was a negative correlation between overall survival (OS) and progression-free survival (PFS) and both biomarkers. However, it was not evident in multivariate Cox regression analysis; in patients with Lnc-IRF2-3 expression level, &gt;67 had a significant decrease in OS and PFS. However, there is no significant effect for high expression levels of Lnc-ZNF667-AS1 on OS (P = .16) or PFS (P = .48).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The Lnc-IRF2-3 and Lnc-ZNF667-AS1 are promising prognostic biomarkers in B-CLL.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>El-Khazragy</LastName>
            <ForeName>Nashwa</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6646-4674</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Pathology/Hematology and Biomedical Research Departments, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Global Research Labs, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Esmaiel</LastName>
            <ForeName>Marwa A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Faculty of Science, Ain shams University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohamed</LastName>
            <ForeName>Magdy M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Faculty of Science, Ain shams University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hassan</LastName>
            <ForeName>Nahla S</ForeName>
            <Initials>NS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Faculty of Science, Ain shams University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Lab Hematol</MedlineTA>
        <NlmUniqueID>101300213</NlmUniqueID>
        <ISSNLinking>1751-5521</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Lnc-IRF2-3</Keyword>
        <Keyword MajorTopicYN="N">Lnc-ZNF667-AS1</Keyword>
        <Keyword MajorTopicYN="N">chronic lymphocytic Leukemia.</Keyword>
        <Keyword MajorTopicYN="N">leukemia</Keyword>
        <Keyword MajorTopicYN="N">zinc finger proteins</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083800</ArticleId>
        <ArticleId IdType="doi">10.1111/ijlh.13167</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Rosenquist R, Porwit A. CHAPTER 28 - The chronic lymphoid leukemias. In: Porwit A, McCullough J, Erber WN eds, Blood and Bone Marrow Pathology. Edinburgh: Churchill Livingstone; 2011:407-418.</Citation>
        </Reference>
        <Reference>
          <Citation>Wierda WG, Brien SO, Gribben J, Rai K. Chronic lymphocytic leukaemia. Nat Rev Dis Primers 2017;3:16096.</Citation>
        </Reference>
        <Reference>
          <Citation>Pulte D, Castro FA, Jansen L, et al. Trends in the survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 2016;9(1):28.</Citation>
        </Reference>
        <Reference>
          <Citation>Redaelli A, Laskin B, Stephens J, Botteman M, Pashos C. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care. 2004;13(3):279-287.</Citation>
        </Reference>
        <Reference>
          <Citation>Lewandowska AM, Rudzki M, Rudzki S, Lewandowski T, Laskowska B. Environmental risk factors for cancer - a review paper. Ann Agric Environ Med. 2019;26(1):1-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Puiggros A, Blanco G, Espinet B. Genetic abnormalities in chronic lymphocytic leukemia : where we are and where. BioMed Res Int. 2014;2014:1-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Amin NA, Malek SN. Gene mutations in chronic lymphocytic leukemia. Semin Oncol. 2016;43(2):215-221.</Citation>
        </Reference>
        <Reference>
          <Citation>Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012;2012:1-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Rai KR, Jain P. Advances in the clinical staging of chronic lymphocytic leukemia. Clin Chem. 2011;57(12):1771-1772.</Citation>
        </Reference>
        <Reference>
          <Citation>Muñoz-Novas C, Poza-Santaella M, González-Gascón y Marín I, et al. The International prognostic index for patients with chronic lymphocytic leukemia has the higher value in predicting overall outcome compared with the Barcelona-Brno biomarkers only prognostic model and the MD Anderson Cancer Center Prognostic Index. BioMed Res Int. 2018;2018:1-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Soini E, Hautala A, Poikonen E, Becker U, Kyttälä M, Martikainen J. Cost-effectiveness of first-line chronic lymphocytic leukemia treatments when full-dose fludarabine is unsuitable. Clin Ther. 2016;38(4):889-904.</Citation>
        </Reference>
        <Reference>
          <Citation>Redaelli A, Corporation P, Redaelli A, et al. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care. 2004;10:279-287.</Citation>
        </Reference>
        <Reference>
          <Citation>El Rouby S, Thomas A, Costin D, et al. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood. 1993;82(11):3452-3459.</Citation>
        </Reference>
        <Reference>
          <Citation>Zenz T, Ha S, Denzel T, et al. Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia ( CLL ): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood. 2019;114(13):2589-2598.</Citation>
        </Reference>
        <Reference>
          <Citation>Blume CJ, Hüllein J, Sellner L, et al. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia. 2015;29:2015-2023.</Citation>
        </Reference>
        <Reference>
          <Citation>Cornet E, Debliquis A, Rimelen V, Civic N. Developing molecular signatures for chronic lymphocytic. Leukemia. 2015;10:1-19.</Citation>
        </Reference>
        <Reference>
          <Citation>Fabbri M, Bottoni A, Shimizu M, et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011;305(1):59-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Physiology C. ZNF667 serves as a putative oncogene in human hepatocellular. Carcinoma. 2017;41:2523-2533.</Citation>
        </Reference>
        <Reference>
          <Citation>Heller G, Altenberger C, Schmid B, et al. DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers. Oncotarget. 2015;6(1):394-408.</Citation>
        </Reference>
        <Reference>
          <Citation>Cells H, Jiang L, Wang H, et al. ZNF667 / Mipu1 is a novel anti-apoptotic factor that directly regulates the expression of the Rat Bax gene in H9c2 cells. PLoS ONE 2014;9(11):e111653.</Citation>
        </Reference>
        <Reference>
          <Citation>Li Y, Wang D, Wang L, et al. Distinct genomic aberrations between low-grade and high-grade gliomas of Chinese patients. PLoS ONE. 2013;8(2):e57168.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao L, Li R, Han D, Zhang X, Nian G, Wu M. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer. Eur Rev Med Pharmacol Sci 2017;21:5353-5360.</Citation>
        </Reference>
        <Reference>
          <Citation>Vrba L, Garbe JC, Stampfer MR, Futscher BW. A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers. Epigenetics. 2015;10(11):1074-1083.</Citation>
        </Reference>
        <Reference>
          <Citation>Ferreira PG, Jares P, Rico D, et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 2014;24(2):212-226.</Citation>
        </Reference>
        <Reference>
          <Citation>Meng W, Cui W, Zhao L, Chi W, Cao H, Wang B. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma. J Biomed Sci. 2019;26(1):13.</Citation>
        </Reference>
        <Reference>
          <Citation>Mei Z-B, Wang G, Liang Z, et al. Prognostic value of IRF-2 expression in colorectal cancer. Oncotarget. 2017;8:38969-38977</Citation>
        </Reference>
        <Reference>
          <Citation>Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.</Citation>
        </Reference>
        <Reference>
          <Citation>Gentile M, Shanafelt TD, Cutrona G, et al. A progression-risk score to predict treatment-free survival for early early-stage chronic lymphocytic leukemia patients. Leukemia. 2016;30:1440-1443.</Citation>
        </Reference>
        <Reference>
          <Citation>Ronchetti D, Manzoni M, Agnelli L, et al. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomes. Blood Cancer J. 2016;6(9):e468.</Citation>
        </Reference>
        <Reference>
          <Citation>Ronchetti D, Agnelli L, Taiana E, et al. Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. Oncotarget. 2016;7(12):14814-14830.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083801</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1462-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cellular microbiology</Title>
          <ISOAbbreviation>Cell. Microbiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fungal biotin homeostasis is essential for immune evasion after macrophage phagocytosis and virulence.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cmi.13197</ELocationID>
        <Abstract>
          <AbstractText>Biotin is an important cofactor for multiple enzymes in central metabolic processes. While many bacteria and most fungi are able to synthesize biotin de novo, Candida spp. are auxotrophic for this vitamin and thus require efficient uptake systems to facilitate biotin acquisition during infection. Here we show that C. glabrata and C. albicans use a largely conserved system for biotin uptake and regulation, consisting of the high-affinity biotin transporter Vht1 and the transcription factor Vhr1. Both species induce expression of biotin-metabolic genes upon in vitro biotin depletion and following phagocytosis by macrophages, indicating low biotin levels in the Candida-containing phagosome. In line with this, we observed reduced intracellular proliferation of both Candida cells pre-starved of biotin and deletion mutants lacking VHR1 or VHT1 genes. VHT1 was essential for the full virulence of C. albicans during systemic mouse infections, and the lack of VHT1 led to reduced fungal burden in C. glabrata-infected brains and C. albicans-infected brains and kidneys. Together, our data suggest a critical role of Vht1-mediated biotin acquisition for C. glabrata and C. albicans during intracellular growth in macrophages and systemic infections. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sprenger</LastName>
            <ForeName>Marcel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hartung</LastName>
            <ForeName>Teresa Sofie</ForeName>
            <Initials>TS</Initials>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allert</LastName>
            <ForeName>Stefanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wisgott</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Niemiec</LastName>
            <ForeName>Maria Joanna</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Graf</LastName>
            <ForeName>Katja</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacobsen</LastName>
            <ForeName>Ilse D</ForeName>
            <Initials>ID</Initials>
            <AffiliationInfo>
              <Affiliation>Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, Friedrich Schiller University, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kasper</LastName>
            <ForeName>Lydia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hube</LastName>
            <ForeName>Bernhard</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6028-0425</Identifier>
            <AffiliationInfo>
              <Affiliation>Department Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology, Friedrich Schiller University, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Cell Microbiol</MedlineTA>
        <NlmUniqueID>100883691</NlmUniqueID>
        <ISSNLinking>1462-5814</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Candida albicans</Keyword>
        <Keyword MajorTopicYN="N">Candida glabrata</Keyword>
        <Keyword MajorTopicYN="N">biotin</Keyword>
        <Keyword MajorTopicYN="N">macrophage</Keyword>
        <Keyword MajorTopicYN="N">metabolism</Keyword>
        <Keyword MajorTopicYN="N">virulence</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083801</ArticleId>
        <ArticleId IdType="doi">10.1111/cmi.13197</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083802</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1462-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cellular microbiology</Title>
          <ISOAbbreviation>Cell. Microbiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Matrix stiffness regulates endosomal escape of uropathogenic E. coli.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cmi.13196</ELocationID>
        <Abstract>
          <AbstractText>Uropathogenic E. coli (UPEC) infection in vivo is characterized by invasion of bladder umbrella epithelial cells followed by endosomal escape and proliferation in the cytoplasm to form intracellular bacterial communities (IBCs). By contrast, UPEC infection in tissue culture models results in bacteria being trapped within Lamp1-positive endosomes where proliferation is limited. Pharmacological disruption of the actin cytoskeleton has been shown to facilitate UPEC endosomal escape in vitro and extracellular matrix stiffness is a well characterized physiological regulator of actin dynamics; therefore, we hypothesized that substrate stiffness may play a role in UPEC endosomal escape. Using functionalized polyacrylamide substrates, we found that at physiological stiffness, UPEC escaped the endosome and proliferated rapidly in the cytoplasm of bladder epithelial cells. Dissection of the cytoskeletal signaling pathway demonstrated that inhibition of the Rho GTPase RhoB or its effector PRK1 was sufficient to increase cytoplasmic bacterial growth and that RhoB protein level was significantly reduced at physiological stiffness. Our data suggest that tissue stiffness is a critical regulator of intracellular bacterial growth. Due to the ease of doing genetic and pharmacological manipulations in cell culture, this model system may provide a useful tool for performing mechanistic studies on the intracellular life cycle of uropathogens. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moorthy</LastName>
            <ForeName>Sudha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Rutgers University-Camden, Camden, NJ.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Byfield</LastName>
            <ForeName>Fitzroy J</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janmey</LastName>
            <ForeName>Paul A</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, University of Pennsylvania, Philadelphia, PA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klein</LastName>
            <ForeName>Eric A</ForeName>
            <Initials>EA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3941-6233</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Rutgers University-Camden, Camden, NJ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Computational and Integrative Biology, Rutgers University-Camden, Camden, NJ.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Cell Microbiol</MedlineTA>
        <NlmUniqueID>100883691</NlmUniqueID>
        <ISSNLinking>1462-5814</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083802</ArticleId>
        <ArticleId IdType="doi">10.1111/cmi.13196</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083803</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-9071</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical &amp; experimental ophthalmology</Title>
          <ISOAbbreviation>Clin. Experiment. Ophthalmol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The role of topical antibiotics in endophthalmitis prophylaxis in routine phacoemulsification cataract surgery?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ceo.13739</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Jina V</ForeName>
            <Initials>JV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freundlich</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Dipika V</ForeName>
            <Initials>DV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McGhee</LastName>
            <ForeName>Charles N J</ForeName>
            <Initials>CNJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Clin Exp Ophthalmol</MedlineTA>
        <NlmUniqueID>100896531</NlmUniqueID>
        <ISSNLinking>1442-6404</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083803</ArticleId>
        <ArticleId IdType="doi">10.1111/ceo.13739</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083804</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1861-471X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry, an Asian journal</Title>
          <ISOAbbreviation>Chem Asian J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Columnar Stacking of Partially Fluorinated [4]Helicenes: C-H···F Interactions Change the Stacking Orientation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/asia.202000037</ELocationID>
        <Abstract>
          <AbstractText>The partial fluorination of polycyclic aromatic hydrocarbons often produces a layered crystal packing, where fluorinated aromatic surfaces are stacked over nonfluorinated aromatic surfaces. Herein, we report the synthesis and crystal packing of partially fluorinated [4]helicenes with steric congestion resulting from H and F atoms in the fjord region. F6-[4]Helicene forms head-to-tail columnar stacks consisting of an alternate arrangement of perfluorinated and nonfluorinated naphthalene moieties. With decreasing fluorine content, aromatic stacking switched from arene-fluoroarene (ArH-ArF) hetero-stacking to ArH-ArH/ArF-ArF homo-stacking with the help of intermolecular C-H···F contacts in the fjord region. As a result, head-to-head columnar stacks appear. Therefore, the conventional ArH-ArF stacking motif is not always applicable to Fn-[4]helicenes with twisted π-surfaces.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Risa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Yamagata University, Faculty of Science, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uziie</LastName>
            <ForeName>Yuto</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Yamagata University, Faculty of Science, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujiwara</LastName>
            <ForeName>Wataru</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Yamagata University, Graduate School of Science and Engineering, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Katagiri</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Yamagata University, Graduate School of Science and Engineering, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murase</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Yamagata University, Department of Material and Biological Chemistry, Faculty of Science, 1-4-12 Kojirakawa-machi, 990-8560, Yamagata, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chem Asian J</MedlineTA>
        <NlmUniqueID>101294643</NlmUniqueID>
        <ISSNLinking>1861-471X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Arene</Keyword>
        <Keyword MajorTopicYN="N">Fluorine</Keyword>
        <Keyword MajorTopicYN="N">Helical structures</Keyword>
        <Keyword MajorTopicYN="N">Noncovalent interactions</Keyword>
        <Keyword MajorTopicYN="N">pi interactions</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083804</ArticleId>
        <ArticleId IdType="doi">10.1002/asia.202000037</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083805</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-0261</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular oncology</Title>
          <ISOAbbreviation>Mol Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genetic alterations of malignant pleural mesothelioma: association to tumor heterogeneity and overall survival.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/1878-0261.12651</ELocationID>
        <Abstract>
          <AbstractText>Development of precision medicine for malignant pleural mesothelioma (MPM) requires a deep knowledge of tumor heterogeneity. Histologic and molecular classifications and histo-molecular gradients have been proposed to describe heterogeneity, but a deeper understanding of gene mutations in the context of MPM heterogeneity is required and the associations between mutations and clinical data need to be refined. We characterized genetic alterations on one of the largest MPM series (266 tumor samples), well-annotated with histologic, molecular and clinical data of patients. Targeted next generation sequencing was performed focusing on the major MPM mutated genes and the TERT promoter. Molecular heterogeneity was characterized using predictors allowing classification of each tumor into the previously described molecular subtypes and the determination of the proportion of epithelioïd-like and sarcomatoïd-like components (E/S.scores). The mutation frequencies are consistent with literature data, but this study emphasized that TERT promoter, not considered by previous large sequencing studies, was the third locus most affected by mutations in MPM. Mutations in TERT promoter, NF2 and LATS2 were more frequent in non-epithelioid MPM and positively associated to the S.score. BAP1, NF2, TERT promoter, TP53 and SETD2 mutations were enriched in some molecular subtypes. NF2 mutation rate was higher in asbestos unexposed patient. TERT promoter, NF2 and TP53 mutations were associated with a poorer overall survival. Our findings lead to a better characterization of MPM heterogeneity by identifying new significant associations between mutational status and histologic and molecular heterogeneity. Strikingly, we highlight the strong association between new mutations and overall survival.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Quetel</LastName>
            <ForeName>Lisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meiller</LastName>
            <ForeName>Clément</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Assié</LastName>
            <ForeName>Jean-Baptiste</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blum</LastName>
            <ForeName>Yuna</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imbeaud</LastName>
            <ForeName>Sandrine</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montagne</LastName>
            <ForeName>François</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Générale et Thoracique, CHU de Rouen, F-76000, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tranchant</LastName>
            <ForeName>Robin</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5789-0153</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS, UMR8231 Chimie Biologie Innovation, F-75005, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Wolf</LastName>
            <ForeName>Julien</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Thoracique et Transplantation Pulmonaire, Hôpital Foch, Suresnes, F-92150, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caruso</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Copin</LastName>
            <ForeName>Marie-Christine</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Institut de Pathologie, Centre de Biologie-Pathologie, CHRU de Lille, F-59037, Lille, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université de Lille, F-59045, Lille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hofman</LastName>
            <ForeName>Véronique</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Pathologie Clinique et Expérimentale (LPCE) et Biobanque (BB-0033-00025), CHRU de Nice, F-06003, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>FHU OncoAge, Université Côte d'Azur, F-06108, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gibault</LastName>
            <ForeName>Laure</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service d'Anatomopathologie et cytologie, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Badoual</LastName>
            <ForeName>Cécile</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service d'Anatomopathologie et cytologie, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pintilie</LastName>
            <ForeName>Ecaterina</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Thoracique, Hôpital Calmette - CHRU de Lille, F-59000, Lille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hofman</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Pathologie Clinique et Expérimentale (LPCE) et Biobanque (BB-0033-00025), CHRU de Nice, F-06003, Nice, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>FHU OncoAge, Université Côte d'Azur, F-06108, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Monnet</LastName>
            <ForeName>Isabelle</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Pneumologie et Pathologie Professionnelle, Centre Hospitalier Intercommunal de Créteil, F-94010, Créteil, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scherpereel</LastName>
            <ForeName>Arnaud</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Université de Lille, F-59045, Lille, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Pneumologie et d'Oncologie Thoracique, Hôpital Calmette - CHRU de Lille, F-59000, Lille, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Réseau National Expert pour le Mésothéliome Pleural Malin (MESOCLIN), F-59000, Lille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le Pimpec-Barthes</LastName>
            <ForeName>Françoise</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Thoracique, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zucman-Rossi</LastName>
            <ForeName>Jessica</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaurand</LastName>
            <ForeName>Marie-Claude</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jean</LastName>
            <ForeName>Didier</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, F-75006, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Mol Oncol</MedlineTA>
        <NlmUniqueID>101308230</NlmUniqueID>
        <ISSNLinking>1574-7891</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Thoracic cancer</Keyword>
        <Keyword MajorTopicYN="N">gene mutations</Keyword>
        <Keyword MajorTopicYN="N">prognosis</Keyword>
        <Keyword MajorTopicYN="N">tumor heterogeneity</Keyword>
        <Keyword MajorTopicYN="N">tumor molecular classification</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083805</ArticleId>
        <ArticleId IdType="doi">10.1002/1878-0261.12651</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083806</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-6551</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>IUBMB life</Title>
          <ISOAbbreviation>IUBMB Life</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Thermodynamic contribution of iodine atom to the binding of heterogeneously polyhalogenated benzotriazoles by the catalytic subunit of human protein kinase CK2.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/iub.2257</ELocationID>
        <Abstract>
          <AbstractText>A series of novel benzotriazole derivatives containing iodine atom(s) were synthesized. The binding of these compounds to the catalytic subunit of human protein kinase CK2 was evaluated using differential scanning fluorimetry. The obtained thermodynamic data were compared with those determined previously for the brominated and chlorinated benzotriazole analogues to get a deeper insight into the thermodynamic contribution of iodine substitution to the free energy of ligand binding. We have shown that iodine atom(s) attached to the benzene ring of benzotriazole enhance(s) its binding by the target protein. This effect is the strongest when two iodine atoms are attached at positions peripheral to the triazole ring, which according to the structures deposited in protein data bank may be indicative for the formation of the halogen bond between iodine and carbonyl groups of residues located in the hinge region of the protein. Finally, quantitative structure-activity relationship analysis pointed the solute hydrophobicity as the main factor contributing to the binding affinity.</AbstractText>
          <CopyrightInformation>© 2020 International Union of Biochemistry and Molecular Biology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marzec</LastName>
            <ForeName>Ewa</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poznański</LastName>
            <ForeName>Jarosław</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2684-1775</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paprocki</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2144-7317</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2017/25/B/ST4/01613</GrantID>
            <Agency>Narodowe Centrum Nauki</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>IUBMB Life</MedlineTA>
        <NlmUniqueID>100888706</NlmUniqueID>
        <ISSNLinking>1521-6543</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">differential scanning fluorimetry</Keyword>
        <Keyword MajorTopicYN="N">halogen bonding</Keyword>
        <Keyword MajorTopicYN="N">halogenated benzotirazoles</Keyword>
        <Keyword MajorTopicYN="N">iodinated benzotirazoles</Keyword>
        <Keyword MajorTopicYN="N">protein kinase CK2</Keyword>
        <Keyword MajorTopicYN="N">protein-ligand interactions.</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083806</ArticleId>
        <ArticleId IdType="doi">10.1002/iub.2257</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Cozza G, Pinna LA, Moro S. Kinase CK2 inhibition: An update. Curr Med Chem. 2013;20:671-693.</Citation>
        </Reference>
        <Reference>
          <Citation>Meggio F, Pinna LA. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 2003;17:349-368.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldberg JM, Manning G, Liu A, Fey P, Pilcher KE, et al. The Dictyostelium kinome-Analysis of the protein kinases from a simple model organism. PLoS Genet. 2006;2:291-303.</Citation>
        </Reference>
        <Reference>
          <Citation>Salvi M, Sarno S, Cesaro L, Nakamura H, Pinna LA. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis. Biochim Biophys Acta. 2009;1793:847-859.</Citation>
        </Reference>
        <Reference>
          <Citation>Ahmed K, Gerber DA, Cochet C. Joining the cell survival squad: An emerging role for protein kinase CK2. Trends Cell Biol. 2002;12:226-230.</Citation>
        </Reference>
        <Reference>
          <Citation>Pagano MA, Bain J, Kazimierczuk Z, et al. The selectivity of inhibitors of protein kinase CK2: An update. Biochem J. 2008;415:353-365.</Citation>
        </Reference>
        <Reference>
          <Citation>Zandomeni R, Zandomeni MC, Shugar D, Weinmann R. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. J Biol Chem. 1986;261:3414-3419.</Citation>
        </Reference>
        <Reference>
          <Citation>Hernandes MZ, Cavalcanti SM, Moreira DR, de Azevedo Junior WF, Leite AC. Halogen atoms in the modern medicinal chemistry: Hints for the drug design. Curr Drug Targets. 2010;11:303-314.</Citation>
        </Reference>
        <Reference>
          <Citation>Poznanski J, Winiewska M, Czapinska H, Poznanska A, Shugar D. Halogen bonds involved in binding of halogenated ligands by protein kinases. Acta Biochim Pol. 2016;63:203-214.</Citation>
        </Reference>
        <Reference>
          <Citation>Govindaraj V, Ungati H, Jakka SR, Bose S, Mugesh G. Directing traffic: Halogen-bond-mediated membrane transport. Chem A Eur J. 2019;25:11180-11192.</Citation>
        </Reference>
        <Reference>
          <Citation>Ungati H, Govindaraj V, Mugesh G. The remarkable effect of halogen substitution on the membrane transport of fluorescent molecules in living cells. Angewandte Chemie-International Edition. 2018;57:8989-8993.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang T, Yin P, Yang Y, Yin WD, Zhang SX, et al. Effect of element iodine on the cell membrane transportability of fluorescent polymers and lysosome-targeted cell imaging. ACS Sustainable Chem Eng. 2019;7:6295-6303.</Citation>
        </Reference>
        <Reference>
          <Citation>Janeczko M, Orzeszko A, Kazimierczuk Z, Szyszka R, Baier A. CK2 alpha and CK2 alpha ' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012;47:345-350.</Citation>
        </Reference>
        <Reference>
          <Citation>Gianoncelli A, Cozza G, Orzeszko A, Meggio F, Kazimierczuk Z, Pinna LA. Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2. Bioorg Med Chem. 2009;17:7281-7289.</Citation>
        </Reference>
        <Reference>
          <Citation>Winiewska M, Kucinska K, Makowska M, Poznanski J, Shugar D. Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2 alpha. Biochim Biophys Acta. 2015;1854:1708-1717.</Citation>
        </Reference>
        <Reference>
          <Citation>Eftink MR. The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys J. 1994;66:482-501.</Citation>
        </Reference>
        <Reference>
          <Citation>Price DW, Dirk SM, Maya F, Tour JM. Improved and new syntheses of potential molecular electronics devices. Tetrahedron. 2003;59:2497-2518.</Citation>
        </Reference>
        <Reference>
          <Citation>Youngblood WJ. Synthesis of a new trans-a(2)B(2) phthalocyanine motif as a building block for rodlike phthalocyanine polymers. J Org Chem. 2006;71:3345-3356.</Citation>
        </Reference>
        <Reference>
          <Citation>Arotsky J, Butler R, Darby AC. Iodination and iodo-compounds. Part III. Iodination of some aromatic nitro-compounds with iodine in 20% oleum. J Chem Soc C. 1970;1480-1485. Available from: https://pubs.rsc.org/en/content/articlelanding/1970/J3/j39700001480#!divAbstract.</Citation>
        </Reference>
        <Reference>
          <Citation>Szymaniec-Rutkowska A, Bugajska E, Kasperowicz S, Mieczkowska K, Maciejewska AM, Poznański J. Does the partial molar volume of a solute reflect the free energy of hydrophobic solvation? J Mol Liq. 2019;293:111527.</Citation>
        </Reference>
        <Reference>
          <Citation>Borowiecki P, Winska P, Bretner M, Gizinska M, Koronkiewicz M, et al. Synthesis of novel proxyphylline derivatives with dual anti-Candida albicans and anticancer activity. Eur J Med Chem. 2018;150:307-333.</Citation>
        </Reference>
        <Reference>
          <Citation>Wasik R, Lebska M, Felczak K, Poznanski J, Shugar D. Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2alpha by tetrabromobenzotriazole and some C(5)-substituted analogues. J Phys Chem B. 2010;114:10601-10611.</Citation>
        </Reference>
        <Reference>
          <Citation>Wasik R, Winska P, Poznanski J, Shugar D. Synthesis and Physico-chemical properties in aqueous medium of all possible isomeric Bromo analogues of benzo-1H-Triazole, potential inhibitors of protein kinases. J Phys Chem B. 2012;116:7259-7268.</Citation>
        </Reference>
        <Reference>
          <Citation>Battistutta R, De Moliner E, Sarno S, Zanotti G, Pinna LA. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole. Protein Sci. 2001;10:2200-2206.</Citation>
        </Reference>
        <Reference>
          <Citation>Wasik R, Winska P, Poznanski J, Shugar D. Isomeric mono-, Di-, and tri-Bromobenzo-1H-Triazoles as inhibitors of human protein kinase CK2 alpha. Plos One. 2012;7:e48898.</Citation>
        </Reference>
        <Reference>
          <Citation>Ibrahim MAA, Hasb AAM, Mekhemer GAH. Role and nature of halogen bonding in inhibitor(…)receptor complexes for drug discovery: Casein kinase-2 (CK2) inhibition as a case study. Theor Chem Acc. 2018;137:38. Available from: https://link.springer.com/article/10.1007/s00214-018-2207-2.</Citation>
        </Reference>
        <Reference>
          <Citation>Battistutta R, Mazzorana M, Cendron L, et al. The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules. Chembiochem. 2007;8:1804-1809.</Citation>
        </Reference>
        <Reference>
          <Citation>Winiewska M, Makowska M, Maj P, et al. Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2. Biochem Biophys Res Commun. 2015;456:282-287.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083807</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1462-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cellular microbiology</Title>
          <ISOAbbreviation>Cell. Microbiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Histoplasma capsulatum-induced extracellular DNA trap release in human neutrophils.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13195</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cmi.13195</ELocationID>
        <Abstract>
          <AbstractText>Neutrophils are leukocytes that are capable of eliminating both intra- and extracellular pathogens by mechanisms such as phagocytosis, degranulation and release of neutrophil extracellular traps (NETs). Histoplasma capsulatum var. capsulatum (H. capsulatum) is a dimorphic fungus with a global distribution that causes histoplasmosis, a disease that is endemic in different geographic areas and is spreading worldwide. The release of NETs has been described as an important host defense mechanism against different fungi; however, there are no reports demonstrating that this process is implicated in neutrophil response to H. capsulatum infection. Therefore, the aim of this work is to investigate whether isolated human neutrophils release NETs in response to H. capsulatum and the potential mechanisms involved, as well as delineate the NETs antifungal activity. Using both confocal fluorescence and scanning electron microscopy techniques, we determined that NETs are released in vitro in response to H. capsulatum via an oxidative mechanism that is downstream of activation of the Syk and Src kinase pathways and is also dependent on CD18. NETs released in response to H. capsulatum yeasts involve the loss of neutrophil viability and are associated with elastase and citrullinated histones, however also can occur in a PAD4 histone citrullination independent pathway. This NETs also presented fungicidal activity against H. capsulatum yeasts. Our findings may contribute to the understanding of how neutrophils recognize and respond as immune effector cells to H. capsulatum, which may lead to better knowledge of histoplasmosis pathophysiology and treatment. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thompson-Souza</LastName>
            <ForeName>Glaucia A</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>Giulia M P</ForeName>
            <Initials>GMP</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Institute, Fluminense Federal University, Niterói, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silva</LastName>
            <ForeName>Juliana C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Sciences/Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muniz</LastName>
            <ForeName>Valdirene S</ForeName>
            <Initials>VS</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braga</LastName>
            <ForeName>Yasmim A V</ForeName>
            <Initials>YAV</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Sciences/Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Figueiredo</LastName>
            <ForeName>Rodrigo T</ForeName>
            <Initials>RT</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Sciences/Campus of Duque de Caxias, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Melo</LastName>
            <ForeName>Rossana C N</ForeName>
            <Initials>RCN</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Cellular Biology, Department of Biology, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>André L S</ForeName>
            <Initials>ALS</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Neves</LastName>
            <ForeName>Josiane S</ForeName>
            <Initials>JS</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6645-1715</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Cell Microbiol</MedlineTA>
        <NlmUniqueID>100883691</NlmUniqueID>
        <ISSNLinking>1462-5814</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">DNA extracellular trap</Keyword>
        <Keyword MajorTopicYN="N">H. capsulatum</Keyword>
        <Keyword MajorTopicYN="N">histoplasmosis</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">neutrophil</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083807</ArticleId>
        <ArticleId IdType="doi">10.1111/cmi.13195</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083808</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-6551</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>IUBMB life</Title>
          <ISOAbbreviation>IUBMB Life</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/iub.2250</ELocationID>
        <Abstract>
          <AbstractText>This study aimed to investigate the renal protective effect of atorvastatin (ATV) on the kidney inflammation induced by calcium oxalate (CaOx) crystals. A cell model of cell-crystal interactions and a rat model of CaOx kidney stone were established. The expressions of TLR4, NF-κB, NLRP3, and cleaved caspase-1 in cells and rat kidney tissues were detected using Western blot, immunohistochemical, and/or immunofluorescence. The concentrations of malondialdehyde (MDA), superoxide dismutase (SOD), reactive oxygen species (ROS) in cells, and lactic acid dehydrogenase (LDH) in the culture medium were measured. The secreted levels of interleukin (IL)-1β, IL-18, IL-6, and tumor necrosis factor-α (TNF-α) were examined by ELISA. The serum levels of creatinine (CRE) and blood urea nitrogen (BUN) were measured. von Kossa staining was used for the evaluation of renal lens deposition. The CaOx model group showed significantly decreased SOD level; increased concentrations of MDA; ROS and LDH; elevated expressions of TLR4, NF-κB, NLRP3, and cleaved caspase-1; and the elevated release of IL-1β, IL-18, IL-6, and TNF- α as compared to the control group. The treatment with ATV significantly inhibited the formation of CaOx kidney stone by increasing the level of SOD; downregulating MDA, ROS, and LDH; inhibiting the expressions of TLR4, NF-κB, NLRP3 and cleaved caspase-1; and blocking the secretion of inflammatory cytokines. In addition, the serum levels of CRE and BUN, and the intrarenal crystal deposition were also significantly decreased in ATV-treated rats. In summary, oxidative stress, TLR4/NF-κB, and NLRP3 inflammasome pathways are involved in renal inflammatory responses induced by CaOx crystals. ATV treatment significantly suppressed oxidative stress, inhibited the activation of TLR4/NF-κB and NLRP3 inflammasome pathways, and decreased the release of inflammatory mediators, thereby ameliorating CaOx crystal-induced damage and crystal deposition in HK-2 cells and rat kidney tissues.</AbstractText>
          <CopyrightInformation>© 2020 International Union of Biochemistry and Molecular Biology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6616-8784</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Langdong Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yunlong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Xiaofeng</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Juening</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Langdong Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Langdong Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Quan</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Derong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Hua</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tao</LastName>
            <ForeName>Zhiwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Langdong Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Yaoliang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Langdong Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>81760127</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81960138</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017GXNSFAA198070</GrantID>
            <Agency>Natural Science Foundation of Guangxi Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017GXNSFAA198158</GrantID>
            <Agency>Natural Science Foundation of Guangxi Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2018GXNSFBA138011</GrantID>
            <Agency>Natural Science Foundation of Guangxi Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>AB16380225</GrantID>
            <Agency>Scientific Research and Technology Development Program of Guangxi</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>IUBMB Life</MedlineTA>
        <NlmUniqueID>100888706</NlmUniqueID>
        <ISSNLinking>1521-6543</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">atorvastatin</Keyword>
        <Keyword MajorTopicYN="N">calcium oxalate</Keyword>
        <Keyword MajorTopicYN="N">cytokines</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083808</ArticleId>
        <ArticleId IdType="doi">10.1002/iub.2250</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Hernandez JD, Ellison JS, Lendvay TS. Current trends, evaluation, and Management of Pediatric Nephrolithiasis. JAMA Pediatr. 2015;169:964-970.</Citation>
        </Reference>
        <Reference>
          <Citation>Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35:1301-1320.</Citation>
        </Reference>
        <Reference>
          <Citation>Deng YL, Liu YL, Tao ZW, Wang X. The role of cell-crystal reaction mediated inflammation in the formation of intrarenal calcium oxalate crystals. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 2018;56:733-736.</Citation>
        </Reference>
        <Reference>
          <Citation>Jonassen JA, Kohjimoto Y, Scheid CR, Schmidt M. Oxalate toxicity in renal cells. Urol Res. 2005;33:329-339.</Citation>
        </Reference>
        <Reference>
          <Citation>Moryama MT, Domiki C, Miyazawa K, Tanaka T, Suzuki K. Effects of oxalate exposure on Madin-Darby canine kidney cells in culture: Renal prothrombin fragment-1 mRNA expression. Urol Res. 2005;33:470-475.</Citation>
        </Reference>
        <Reference>
          <Citation>Khan SR. Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies. J Clinic Experiment Nephrol. 2004;8:75-88.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu Q, Liu Y, Guan X, Wu J, He Z, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals. Kidney Blood Press Res. 2019;44:777-791.</Citation>
        </Reference>
        <Reference>
          <Citation>Hayden MS, West AP, Ghosh S. NF-κB and the immune response. Oncogene. 2006;25:6758-6780.</Citation>
        </Reference>
        <Reference>
          <Citation>Lawrence T. The nuclear factor NF- B pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.</Citation>
        </Reference>
        <Reference>
          <Citation>Nair AR, Masson GS, Ebenezer PJ, Del Piero F, Francis J. Role of TLR4 in lipopolysaccharide-induced acute kidney injury: Protection by blueberry. Free Radical Biol Med. 2014;71:16-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Korkmaz A, Kolankaya D. Protective effect of Rutin on the ischemia/reperfusion induced damage in rat kidney. J Surgical Res. 2010;164:309-315.</Citation>
        </Reference>
        <Reference>
          <Citation>Mulay SR, Kulkarni OP, Rupanagudi KV, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Investig. 2013;123:236-246.</Citation>
        </Reference>
        <Reference>
          <Citation>Song Z, Zhang Y, Gong B, Xu H, Hao Z, Liang C. Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR-22-3p/NLRP3 axis in calcium oxalate-induced kidney stone. J Cell Biochem. 2019;120:10452-10462.</Citation>
        </Reference>
        <Reference>
          <Citation>Joshi S, Wang W, Peck AB, Khan SR. Activation of the NLRP3 Inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys. J Urol. 2015;193:1684-1691.</Citation>
        </Reference>
        <Reference>
          <Citation>Schroder K, Tschopp J. The Inflammasomes. Cell. 2010;140:821-832.</Citation>
        </Reference>
        <Reference>
          <Citation>Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137-161.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A. Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol. 2008;180:2212-2217.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamaguchi S, Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, et al. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol. 2005;12:290-298.</Citation>
        </Reference>
        <Reference>
          <Citation>He Z, Guan X, Liu Y, et al. Alteration of exosomes secreted from renal tubular epithelial cells exposed to high-concentration oxalate. Oncotarget. 2017;8:92635-92642.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu Y, Li D, He Z, Liu Q, Wu J, et al. Inhibition of autophagy-attenuated calcium oxalate crystal-induced renal tubular epithelial cell injury in vivo and in vitro. Oncotarget. 2018;9:4571-4582.</Citation>
        </Reference>
        <Reference>
          <Citation>Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res. 2005;33:349-357.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao J, Cheng J, Li C, et al. Ethyl pyruvate attenuates CaCl2-induced tubular epithelial cell injury by inhibiting autophagy and inflammatory responses. Kidney Blood Pressure Res. 2018;43:1585-1595.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu L, Gan X, Liu X, An R. Calcium oxalate crystals induces tight junction disruption in distal renal tubular epithelial cells by activating ROS/Akt/p38 MAPK signaling pathway. Ren Fail. 2017;39:440-451.</Citation>
        </Reference>
        <Reference>
          <Citation>Zan J, Zhang H, Lu M, et al. Isosteviol sodium injection improves outcomes by modulating TLRs/NF-κB-dependent inflammatory responses following experimental traumatic brain injury in rats. Neuroreport. 2018;29:794-803.</Citation>
        </Reference>
        <Reference>
          <Citation>Eleftheriadis, T., Pissas, G., Liakopoulos, V., Stefanidis, I., and R. Lawson, B. (2012) Toll-like receptors and their role in renal pathologies. Inflamm Allergy Drug Targets 11, 464-477.</Citation>
        </Reference>
        <Reference>
          <Citation>Kayagaki N, Wong MT, Stowe IB, et al. Noncanonical Inflammasome activation by intracellular LPS independent of TLR4. Science. 2013;341:1246-1249.</Citation>
        </Reference>
        <Reference>
          <Citation>Menu P, Vince JE. The NLRP3 inflammasome in health and disease: The good, the bad and the ugly: Inflammasomes: The good, the bad and the ugly. Clinic Experiment Immunol. 2011;166:1-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Martinon F. Dangerous liaisons: Mitochondrial DNA meets the NLRP3 Inflammasome. Immunity. 2012;36:313-315.</Citation>
        </Reference>
        <Reference>
          <Citation>Davis BK, Ting JP-Y. NLRP3 has a sweet tooth. Nat Immunol. 2010;11:105-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Koenen TB, Stienstra R, van Tits LJ, et al. Hyperglycemia activates Caspase-1 and TXNIP-mediated IL-1 transcription in human adipose tissue. Diabetes. 2011;60:517-524.</Citation>
        </Reference>
        <Reference>
          <Citation>Dhanasekar C, Kalaiselvan S, Rasool M. Morin, a bioflavonoid suppresses monosodium Urate crystal-induced inflammatory immune response in RAW 264.7 macrophages through the inhibition of inflammatory mediators, intracellular ROS levels and NF-κB activation. PLoS One. 2015;10:e0145093.</Citation>
        </Reference>
        <Reference>
          <Citation>Kang J, Sun Y, Deng Y, et al. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones. Biomed Pharmacother. 2020;121:109649.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu L-Y, Liu Y, Wu M-Y, Sun Y-Y, Ma F-Z. Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: A meta-analysis. Drug Des Devel Ther. 2018;12:437-444.</Citation>
        </Reference>
        <Reference>
          <Citation>Fuentes-Orozco C, Garcia-Salazar SJ, Gómez-Navarro B, et al. Anti-inflammatory effect of atorvastatin on the kidney graft of living donor transplants. Ann Transplant. 2018;23:442-449.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang H, Yin J, Guo Y. Atorvastatin might resist tobacco smoking-induced endothelial inflammation through the inhibition of NF-κB signal pathway. Clin Exp Hypertens. 2019;41:1-4.</Citation>
        </Reference>
        <Reference>
          <Citation>Kong F, Ye B, Lin L, Cai X, Huang W, Huang Z. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes. Biomed Pharmacother. 2016;82:167-172.</Citation>
        </Reference>
        <Reference>
          <Citation>Satoh M, Tabuchi T, Itoh T, Nakamura M. NLRP3 inflammasome activation in coronary artery disease: Results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Clin Sci. 2014;126:233-241.</Citation>
        </Reference>
        <Reference>
          <Citation>Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, et al. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol. 2005;173:271-275.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083809</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1613-6829</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Small</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Non-Preheating Processed Quasi-2D Perovskites for Efficient and Stable Solar Cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1906997</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/smll.201906997</ELocationID>
        <Abstract>
          <AbstractText>Although the hot-casting (HC) technique is prevalent in developing preferred crystal orientation of quasi-2D perovskite films, the difficulty of accurately controlling the thermal homogeneity of substrate is unfavorable for the reproducibility of device fabrication. Herein, a facile and effective non-preheating (NP) film-casting method is proposed to realize highly oriented quasi-2D perovskite films by replacing the butylammonium (BA<sup>+</sup> ) spacer partially with methylammonium (MA<sup>+</sup> ) cation as (BA)<sub>2-</sub> <sub>x</sub> (MA)<sub>3+</sub> <sub>x</sub> Pb<sub>4</sub> I<sub>13</sub> (x = 0, 0.2, 0.4, and 0.6). At the optimal x-value of 0.4, the resultant quasi-2D perovskite film possesses highly orientated crystals, associated with a dense morphology and uniform grain-size distribution. Consequently, the (BA)<sub>1.6</sub> (MA)<sub>3.4</sub> Pb<sub>4</sub> I<sub>13</sub> -based solar cells yield champion efficiencies of 15.44% with NP processing and 16.29% with HC processing, respectively. As expected, the HC-processed device shows a poor performance reproducibility compared with that of the NP film-casting method. Moreover, the unsealed device (x = 0.4) displays a better moisture stability with respect to the x = 0 stored in a 65% ± 5% relative humility chamber.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xing</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Beijing Advanced Innovation, Center for Biomedical Engineering, Beihang University, Beijing, 100191, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Guangbao</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Beijing Advanced Innovation, Center for Biomedical Engineering, Beihang University, Beijing, 100191, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Jiyu</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Beijing Advanced Innovation, Center for Biomedical Engineering, Beihang University, Beijing, 100191, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jianqi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xuning</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Beijing Advanced Innovation, Center for Biomedical Engineering, Beihang University, Beijing, 100191, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Boxin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Haoran</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Beijing Advanced Innovation, Center for Biomedical Engineering, Beihang University, Beijing, 100191, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Huiqiong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yuan</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0670-2428</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, Beijing Advanced Innovation, Center for Biomedical Engineering, Beihang University, Beijing, 100191, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>21875012</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>21674006</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>21773045</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2019M650403</GrantID>
            <Agency>China Postdoctoral Science Foundation</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017YFA0206600</GrantID>
            <Agency>National Key Research and Development Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Chinese Academy of Sciences</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Small</MedlineTA>
        <NlmUniqueID>101235338</NlmUniqueID>
        <ISSNLinking>1613-6810</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">crystal orientation</Keyword>
        <Keyword MajorTopicYN="N">film casting</Keyword>
        <Keyword MajorTopicYN="N">quasi-2D perovskites</Keyword>
        <Keyword MajorTopicYN="N">solar cells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083809</ArticleId>
        <ArticleId IdType="doi">10.1002/smll.201906997</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>L. K. Ono, Y. Qi, S. F. Liu, Joule 2018, 10, 1961.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Chen, Y. Sun, J. Peng, J. Tang, K. Zheng, Z. Liang, Adv. Mater. 2018, 30, 1703487.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Krishna, S. Gottis, M. K. Nazeeruddin, F. Sauvage, Adv. Funct. Mater. 2019, 29, 1806482.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Grancini, M. K. Nazeeruddin, Nat. Rev. Mater. 2019, 4, 4.</Citation>
        </Reference>
        <Reference>
          <Citation>I. Spanopoulos, I. Hadar, W. Ke, Q. Tu, M. Chen, H. Tsai, Y. He, G. Shekhawat, V. P. Dravid, M. R. Wasielewski, A. D. Mohite, C. C. Stoumpos, M. G. Kanatzidis, J. Am. Chem. Soc. 2019, 141, 5518.</Citation>
        </Reference>
        <Reference>
          <Citation>I. C. Smith, E. T. Hoke, D. Solis-Ibarra, M. D. McGehee, H. I. Karunadasa, Angew. Chem., Int. Ed. 2014, 53, 11232.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Tsai, W. Nie, J. Blancon, C. C. Stoumpos, R. Asadpour, B. Harutyunyan, A. J. Neukirch, R. Verduzco, J. J. Crochet, S. Tretiak, L. Pedesseau, J. Even, M. A. Alam, G. Gupta, J. Lou, P. M. Ajayan, M. J. Bedzyk, M. G. Kanatzidis, A. D. Mohite, Nature 2016, 536, 312.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Yang, R. Li, Y. Cao, Y. Wei, Y. Miao, W. L. Tan, X. Jiao, H. Chen, L. Zhang, Q. Chen, H. Zhang, W. Zou, Y. Wang, M. Yang, C. Yi, N. Wang, F. Gao, C. R. McNeill, T. Qin, J. Wang, W. Huang, Adv. Mater. 2018, 30, 1804771.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Chen, Y. Sun, J. Peng, W. Zhang, X. Su, K. Zheng, T. Pullerits, Z. Liang, Adv. Energy Mater. 2017, 7, 1700162.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Lai, B. Kan, T. Liu, N. Zheng, Z. Xie, T. Zhou, X. Wan, X. Zhang, Y. Liu, Y. Chen, J. Am. Chem. Soc. 2018, 140, 11639.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Tsai, R. Asadpour, J.-C. Blancon, C. C. Stoumpos, J. Even, P. M. Ajayan, M. G. Kanatzidis, M. A. Alam, A. D. Mohite, W. Nie, Nat. Commun. 2018, 9, 2130.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Lin, Y. Fang, J. Zhao, Y. Shao, S. J. Stuard, M. M. Nahid, H. Ade, Q. Wang, J. E. Shield, N. Zhou, A. M. Moran, J. Huang, Nat. Commun. 2019, 10, 1008.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Wu, J. Zhou, J. Zhang, R. Meng, B. Wang, B. Xue, X. Leng, D. Zhang, X. Zhang, S. Bi, Q. Zhou, Z. Wei, H. Zhou, Y. Zhang, Nano Energy 2019, 58, 706.</Citation>
        </Reference>
        <Reference>
          <Citation>D. H. Cao, C. C. Stoumpos, O. K. Farha, J. T. Hupp, M. G. Kanatzidis, J. Am. Chem. Soc. 2015, 137, 7843.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Yuan, L. N. Quan, R. Comin, G. Walters, R. Sabatini, O. Voznyy, S. Hoogland, Y. Zhao, E. M. Beauregard, P. Kanjanaboos, Z. Lu, D. H. Kim, E. H. Sargent, Nat. Nanotechnol. 2016, 11, 872.</Citation>
        </Reference>
        <Reference>
          <Citation>A. H. Proppe, R. Quintero-Bermudez, H. Tan, O. Voznyy, S. O. Kelley, E. H. Sargent, J. Am. Chem. Soc. 2018, 140, 2890.</Citation>
        </Reference>
        <Reference>
          <Citation>L. N. Quan, M. Yuan, R. Comin, O. Voznyy, E. M. Beauregard, S. Hoogland, A. Buin, A. R. Kirmani, K. Zhao, A. Amassian, D. H. Kim, E. H. Sargent, J. Am. Chem. Soc. 2016, 138, 2649.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Zhou, Y. Shen, L. Li, S. Tan, N. Liu, G. Zheng, Q. Chen, H. Zhou, J. Am. Chem. Soc. 2018, 140, 459.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Zhang, R. Munir, Z. Xu, Y. Liu, H. Tsai, W. Nie, J. Li, T. Niu, D.-M. Smilgies, M. G. Kanatzidis, A. D. Mohite, K. Zhao, A. Amassian, S. F. Liu, Adv. Mater. 2018, 30, 1707166.</Citation>
        </Reference>
        <Reference>
          <Citation>C. M. M. Soe, W. Nie, C. C. Stoumpos, H. Tsai, J.-C. Blancon, F. Liu, J. Even, T. J. Marks, A. D. Mohite, M. G. Kanatzidis, Adv. Energy Mater. 2018, 8, 1700979.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Li, N. Zhou, Q. Chen, Q. Shang, Q. Zhang, X. Wang, H. Zhou, J. Phys. Chem. Lett. 2018, 9, 1124.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Liu, J. Leng, K. Wu, J. Zhang, S. Jin, J. Am. Chem. Soc. 2017, 139, 1432.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Li, C.-C. Chen, M. Cai, X. Hua, F. Xie, X. Liu, J. Hua, Y.-T. Long, H. Tian, L. Han, Adv. Energy Mater. 2018, 8, 1800715.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Zheng, B. Chen, J. Dai, Y. Fang, Y. Bai, Y. Lin, H. Wei, X. C. Zeng, J. Huang, Nat. Energy 2017, 2, 17102.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Xie, C.-C. Chen, Y. Wu, X. Li, M. Cai, X. Liu, X. Yang, L. Han, Energy Environ. Sci. 2017, 10, 1942.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Wu, F. Xie, H. Chen, X. Yang, H. Su, M. Cai, Z. Zhou, T. Noda, L Han, Adv. Mater. 2017, 29, 1701073.</Citation>
        </Reference>
        <Reference>
          <Citation>N. R. Venkatesan, J. G. Labram, M. L. Chabinyc, ACS Energy Lett. 2018, 3, 380.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Luo, W. Yang, Z. Wang, A. Sadhanala, Q. Hu, R. Su, R. Shivanna, G. F. Trindade, J. F. Watts, Z. Xu, T. Liu, K. Chen, F. Ye, P. Wu, L. Zhao, J. Wu, Y. Tu, Y. Zhang, X. Yang, W. Zhang, R. H. Friend, Q. Gong, H. J. Snaith, R. Zhu, Science 2018, 360, 1442.</Citation>
        </Reference>
        <Reference>
          <Citation>Q. Jiang, Y. Zhao, X. Zhang , X. Yang, Y. Chen, Z. Chu, Q. Ye, X. Li, Z. Yin, J. You, Nat. Photonics 2019, 13, 460.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Gan, J. Li, Z. Fang, H. He, Z. Ye, J. Phys. Chem. Lett. 2017, 8, 5177.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Wetzelaer, M. Kuik, M. Lenes, P. Blom, Appl. Phys. Lett. 2011, 99, 153506.</Citation>
        </Reference>
        <Reference>
          <Citation>S. R. Cowan, A. Roy, A. J. Heeger, Phys. Rev. B 2010, 82, 245207.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Ortiz-Cervantes, P. Carmona-Monroy, D. Solis-Ibarra, ChemSusChem 2019, 12, 1560.</Citation>
        </Reference>
        <Reference>
          <Citation>J. C. Blancon, A. V. Stier, H. Tsai, W. Nie, C. C. Stoumpos, B. Traoré, L. Pedesseau, M. Kepenekian, F. Katsutani, G. T. Noe, J. Kono, S. Tretiak, S. A. Crooker, C. Katan, M. G. Kanatzidis, J. J. Crochet, J. Even, A. D. Mohite, Nat. Commun. 2018, 9, 2254.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Zhang, D. Zhang, Q. Zhou, R. Wang, J. Zhou, J. Wang, H. Zhou, Y. Zhang, Nano Energy 2019, 56, 494.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Tress, N. Marinova, T. Moehl, S. M. Zakeeruddin, M. K. Nazeeruddina, M. Grätzel, Energy Environ. Sci. 2015, 8, 995.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Li, C. Liang, X. Liu, F. Li, Y. Zhang, X. Liu, H. Gu, X. Hu, G. Xing, X. Tao, Y. Song, Adv. Mater. 2019, 31, 1901966.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Zhu, Z. Xu, S. Zuo, J. Feng, Z. Wang, X. Zhang, K. Zhao, J. Zhang, H. Liu, S. Priya, S. F. Liu, D. Yang, Energy Environ. Sci. 2018, 11, 3349.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083811</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1527-6473</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</Title>
          <ISOAbbreviation>Liver Transpl.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Erratum.</ArticleTitle>
        <Pagination>
          <MedlinePgn>469</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lt.25706</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Liver Transpl</MedlineTA>
        <NlmUniqueID>100909185</NlmUniqueID>
        <ISSNLinking>1527-6465</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>Liver Transpl. 2011 Jul;17(7):866-74</RefSource>
          <PMID Version="1">21542129</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083811</ArticleId>
        <ArticleId IdType="doi">10.1002/lt.25706</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083810</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1934-6638</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer cytopathology</Title>
          <ISOAbbreviation>Cancer Cytopathol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncy.22252</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Urine cytology results that are suspicious for urothelial carcinoma (UC) are challenging. The objective of this study was to elucidate the clinical significance of such results in patients who have a negative cystoscopy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective study, 83 patients who had urine cytology that was suspicious of UC and a negative cystoscopy underwent a second cystoscopy and urine evaluation by cytology, UroVysion fluorescence in situ hybridization (FISH) assay, FGFR3 (fibroblast growth factor receptor 3) and TERT (telomerase reverse transcriptase) mutations and an 8-gene expression classifier (GEC). Results from all techniques were compared with patients' clinical outcomes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The presence of tumor was identified in 41% of patients; of these, 82% had tumors identified at their second evaluation (76% high-grade [HG] tumors), and 18% had tumors identified at a later follow-up (50% were HG tumors). After The Paris System for Reporting urinary Cytology (TPS) reclassification, 53 cytology results still had an indeterminate diagnosis (13 were suspicious for HGUC, and 40 had atypical urothelial cells (AUCs)]. Complete results from second evaluations using urine cytology, cytology-TPS, FISH, and GEC were available for 6 cases that were suspicious for HGUC and 34 cases that had AUCs. The sensitivity of these techniques to detect HG tumors in cases that were suspicious for HGUC was 100%, except for cytology-TPS, for which the sensitivity was 50%. The sensitivity of cytology and cytology-TPS to detect HG tumors in cases with AUCs was 33%, whereas the sensitivity of fluorescence in situ hybridization and GEC in these cases was 83% and 75%, respectively, to detect HG tumors at the second evaluation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The current results indicate the relevant clinical significance of indeterminate urine cytology findings and strongly suggest the use of complementary evaluations by urine biomarker-based, ancillary techniques to elucidate their significance.</AbstractText>
          <CopyrightInformation>© 2020 American Cancer Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Montalbo</LastName>
            <ForeName>Ruth</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Izquierdo</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ingelmo-Torres</LastName>
            <ForeName>Mercedes</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galve</LastName>
            <ForeName>Pilar</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Solé</LastName>
            <ForeName>Manel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Hospital Clínic, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Franco</LastName>
            <ForeName>Agustín</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ribal</LastName>
            <ForeName>María José</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alcaraz</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mengual</LastName>
            <ForeName>Lourdes</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7418-9422</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory and Department of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>PI17/01343</GrantID>
            <Agency>Instituto de Salud Carlos III (ISCIII)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Plan Estatal de Investigación Científica y Técnica y de Innovación</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>European Regional Development Fund</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>CERCA Programme</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Generalitat de Catalunya</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer Cytopathol</MedlineTA>
        <NlmUniqueID>101499453</NlmUniqueID>
        <ISSNLinking>1934-662X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">bladder cancer</Keyword>
        <Keyword MajorTopicYN="N">cytology</Keyword>
        <Keyword MajorTopicYN="N">fluorescence in situ hybridization (FISH) technique</Keyword>
        <Keyword MajorTopicYN="N">gene expression</Keyword>
        <Keyword MajorTopicYN="N">patient monitoring</Keyword>
        <Keyword MajorTopicYN="N">tumor biomarkers</Keyword>
        <Keyword MajorTopicYN="N">urine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083810</ArticleId>
        <ArticleId IdType="doi">10.1002/cncy.22252</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447-461.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith ZL, Guzzo TJ. Urinary markers for bladder cancer. F1000Prime Rep. 2013;5:21.</Citation>
        </Reference>
        <Reference>
          <Citation>Goh AC, Lerner SP. Application of new technology in bladder cancer diagnosis and treatment. World J Urol. 2009;27:301-307.</Citation>
        </Reference>
        <Reference>
          <Citation>Hajdinjak T. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol Oncol. 2008;26:646-651.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosenthal DL, Wojcik EM, Kurtycz DFI, eds. The Paris System for Reporting Urinary Cytology. Springer International Publishing; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Bertsch EC, Siddiqui MT, Ellis CL. The Paris System for Reporting Urinary Cytology improves correlation with surgical pathology biopsy diagnoses of the lower urinary tract. Diagn Cytopathol. 2018;46:221-227.</Citation>
        </Reference>
        <Reference>
          <Citation>Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2017;125:427-434.</Citation>
        </Reference>
        <Reference>
          <Citation>Mowatt G, Zhu S, Kilonzo M, et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess. 2010;14:1-133, iii-iv.</Citation>
        </Reference>
        <Reference>
          <Citation>Bell MD, Yafi FA, Brimo F, et al. Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study. World J Urol. 2016;34:1405-1409.</Citation>
        </Reference>
        <Reference>
          <Citation>Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015;33:66-31.</Citation>
        </Reference>
        <Reference>
          <Citation>Marin-Aguilera M, Mengual L, Ribal MJ, et al. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol. 2007;51:409-415.</Citation>
        </Reference>
        <Reference>
          <Citation>Allory Y, Beukers W, Sagrera A, et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol. 2014;65:360-366.</Citation>
        </Reference>
        <Reference>
          <Citation>Hurst CD, Platt FM, Knowles MA. Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. Eur Urol. 2014;65:367-369.</Citation>
        </Reference>
        <Reference>
          <Citation>Zuiverloon TC, Tjin SS, Busstra M, Bangma CH, Boeve ER, Zwarthoff EC. Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay. J Urol. 2011;186:707-712.</Citation>
        </Reference>
        <Reference>
          <Citation>Kavalieris L, O'Sullivan P, Frampton C, et al. Performance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter study. J Urol. 2017;197:1419-1426.</Citation>
        </Reference>
        <Reference>
          <Citation>Lotan Y, O'Sullivan P, Raman JD, et al. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma. Urol Oncol. 2017;35:531.</Citation>
        </Reference>
        <Reference>
          <Citation>Pichler R, Fritz J, Tulchiner G, et al. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance. BJU Int. 2018;121:29-37.</Citation>
        </Reference>
        <Reference>
          <Citation>Mengual L, Burset M, Ribal MJ, et al. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res. 2010;16:2624-2633.</Citation>
        </Reference>
        <Reference>
          <Citation>Mengual L, Ribal MJ, Lozano JJ, et al. Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models. J Urol. 2014;191:261-269.</Citation>
        </Reference>
        <Reference>
          <Citation>Ribal MJ, Mengual L, Lozano JJ, et al. Gene expression test for the non-invasive diagnosis of bladder cancer: a prospective, blinded, international and multicenter validation study. Eur J Cancer. 2016;54:131-138.</Citation>
        </Reference>
        <Reference>
          <Citation>Montalbo R, Lozano JJ, Izquierdo L, et al. Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients. Transl Res. 2019;208:73-84.</Citation>
        </Reference>
        <Reference>
          <Citation>Halling KC. Vysis UroVysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn. 2003;3:507-519.</Citation>
        </Reference>
        <Reference>
          <Citation>Kandimalla R, Masius R, Beukers W, et al. A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine. Clin Cancer Res. 2013;19:4760-4769.</Citation>
        </Reference>
        <Reference>
          <Citation>Zuiverloon TC, van der Aa MN, van der Kwast TH, et al. Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer. Clin Cancer Res. 2010;16:3011-3018.</Citation>
        </Reference>
        <Reference>
          <Citation>R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2019. Accessed January 30, 2020. https://www.R-project.org/</Citation>
        </Reference>
        <Reference>
          <Citation>Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research. 2015;43:e47.</Citation>
        </Reference>
        <Reference>
          <Citation>Barkan GA, Wojcik EM, Nayar R, et al. The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology. J Am Soc Cytopathol. 2016;5:177-188.</Citation>
        </Reference>
        <Reference>
          <Citation>Sataa S, Yassine N, Ghassen HH, et al. Contemporary management of stage T1 transitional cell carcinoma of the bladder. Tunis Med. 2005;83(suppl 12):87-89.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196:1021-1029.</Citation>
        </Reference>
        <Reference>
          <Citation>Schlomer BJ, Ho R, Sagalowsky A, Ashfaq R, Lotan Y. Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. J Urol. 2010;183:62-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim PH, Sukhu R, Cordon BH, et al. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy. BJU Int. 2014;114:354-359.</Citation>
        </Reference>
        <Reference>
          <Citation>Raab SS, Grzybicki DM, Vrbin CM, Geisinger KR. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol. 2007;127:946-953.</Citation>
        </Reference>
        <Reference>
          <Citation>Brimo F, Vollmer RT, Case B, Aprikian A, Kassouf W, Auger M. Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol. 2009;132:785-793.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083812</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6033</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biotechnology progress</Title>
          <ISOAbbreviation>Biotechnol. Prog.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Microbial β-Galactosidases of industrial importance: Computational studies on the effects of point mutations on the lactose hydrolysis reaction.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/btpr.2982</ELocationID>
        <Abstract>
          <AbstractText>Hydrolysis efficiency of β-galactosidases is affected due to a strong inhibition by galactose, hampering the complete lactose hydrolysis. One alternative to reduce this inhibition is to perform mutations in the enzyme's active site. The aim of this study was to evaluate the effect of point mutations on the active site of different microbial β-galactosidases, using computational techniques. The enzymes of Aspergillus niger (AnβGal), Aspergillus oryzae (AoβGal), Bacillus circulans (BcβGal), Bifidobacterium bifidum (BbβGal), and Kluyveromyces lactis (KlβGal) were used. The mutations were carried out in all residues that were up to 4.5 å from the galactose/lactose molecules and binding energy was computed. The mutants Tyr96Ala (AnβGal), Asn140Ala and Asn199Ala (AoβGal), Arg111Ala and Glu355Ala (BcβGal), Arg122Ala and Phe358Ala (BbβGal), Tyr523Ala, Phe620Ala, and Trp582Ala (KlβGal) had the best results, with higher effect on galactose binding energy and lower effect on lactose affinity. To maximize enzyme reactions by reducing galactose affinity, double mutations were proposed for BcβGal, BbβGal, and KlβGal. The double mutations in BcβGal and BbβGal caused the highest reduction in galactose affinity, while no satisfactory results were observed to KlβGal. Using computational tools, mutants that reduced galactose affinity without significantly affecting lactose binding were proposed. The mutations proposed can be used to reduce the negative feedback process, improving the catalytic characteristics of β-galactosidases and rendering them promising for industrial applications. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>© 2020 American Institute of Chemical Engineers.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Coelho de Andrade</LastName>
            <ForeName>Bruna</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Biotecnologia de Alimentos, Universidade do Vale do Taquari - Univates, Lajeado, RS, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Programa de Pós-Graduação em Biotecnologia, Universidade do Vale do Taquari - Univates, Lajeado, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saraiva Macedo Timmers</LastName>
            <ForeName>Luis Fernando</ForeName>
            <Initials>LF</Initials>
            <AffiliationInfo>
              <Affiliation>Programa de Pós-Graduação em Biotecnologia, Universidade do Vale do Taquari - Univates, Lajeado, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Renard</LastName>
            <ForeName>Gaby</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose, Centro de Pesquisas em Biologia Molecular e Funcional, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Volpato</LastName>
            <ForeName>Giandra</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Curso de Biotecnologia, Instituto Federal de Educação, Ciência e Tecnologia do Rio Grande do Sul - IFRS, Campus Porto Alegre, Porto Alegre, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Volken de Souza</LastName>
            <ForeName>Claucia Fernanda</ForeName>
            <Initials>CF</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7708-3762</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratório de Biotecnologia de Alimentos, Universidade do Vale do Taquari - Univates, Lajeado, RS, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Programa de Pós-Graduação em Biotecnologia, Universidade do Vale do Taquari - Univates, Lajeado, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biotechnol Prog</MedlineTA>
        <NlmUniqueID>8506292</NlmUniqueID>
        <ISSNLinking>1520-6033</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">binding free energy</Keyword>
        <Keyword MajorTopicYN="N">computational alanine scanning</Keyword>
        <Keyword MajorTopicYN="N">galactose competitive inhibition</Keyword>
        <Keyword MajorTopicYN="N">molecular docking</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083812</ArticleId>
        <ArticleId IdType="doi">10.1002/btpr.2982</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083814</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6033</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biotechnology progress</Title>
          <ISOAbbreviation>Biotechnol. Prog.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of mono-rhamnolipids and di-rhamnolipids on Microbial Enhanced Oil Recovery (MEOR) applications.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e2981</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/btpr.2981</ELocationID>
        <Abstract>
          <AbstractText>Rhamnolipids (RML) have more effectiveness for specific uses according to their homologue proportions. Thus, the novelty of this work was to compare mono-rhamnolipids and di-rhamnolipids physicochemical properties on Microbial enhanced oil recovery (MEOR) applications. For this, RML produced by three strains of Pseudomonas aeruginosa containing different homologues proportion were used: a mainly mono-rhamnolipids producer (mono-RML); a mainly di-rhamnolipids producer (di-RML), and the other one that produces relatively balanced amounts of mono-RML and di-RML homologues (mono/di-RML). For mono-RML, the most abundant molecules were Rha-C<sub>10</sub> C<sub>10</sub> (m/z 503.3), for di-RML were RhaRha-C<sub>10</sub> C<sub>10</sub> (m/z 649.4) and for Mono/di-RML were Rha-C<sub>10</sub> C<sub>10</sub> (m/z 503.3) and RhaRha-C<sub>10</sub> C<sub>10</sub> (m/z 649.4). All rhamnolipids types presented robustness under high temperature and variation of salinity and pH, and high ability for oil displacement, foam stability, wettability reversal and were classified as safe for environment according to the European Union Directive No. 67/548/EEC. For all these properties, it was observed a highlight for mono-RML. Mono-RML presented the lowest surface tension (ST 26.40 mN/m), interfacial tension (IFT 1.14 mN/m) and critical micellar concentration (CMC 27.04 mg/L), the highest emulsification index (EI<sub>24</sub> 100%) and the best wettability reversal (100% with 25 ppm). In addition, mono-RML showed the best acute toxicity value (454 mg/L), making its application potential even more attractive. Based on the results, it was concluded that all rhamnolipids homologues studied have potential for MEOR applications. However, results showed that mono-RML stood out and have the best mechanism of oil incorporation in micelles due the their most effective surface-active physicochemical features. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>© 2020 American Institute of Chemical Engineers.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rocha</LastName>
            <ForeName>Vanessa Alves Lima</ForeName>
            <Initials>VAL</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2764-352X</Identifier>
            <AffiliationInfo>
              <Affiliation>Biochemical Department, Laboratory of Microbial Biotechnology, Federal University of Rio de Janeiro - Institute of Chemistry, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Castilho</LastName>
            <ForeName>Lívia Vieira Araujo</ForeName>
            <Initials>LVA</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemical Department, Laboratory of Microbial Biotechnology, Federal University of Rio de Janeiro - Institute of Chemistry, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ocean Engineering Department, Subsea Technology Laboratory, Federal University of Rio de Janeiro - COPPE Institute, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Castro</LastName>
            <ForeName>Rui de Paula Vieira</ForeName>
            <Initials>RPV</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemical Department, Laboratory of Microbial Biotechnology, Federal University of Rio de Janeiro - Institute of Chemistry, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teixeira</LastName>
            <ForeName>Douglas Braga</ForeName>
            <Initials>DB</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemical Department, Laboratory of Microbial Biotechnology, Federal University of Rio de Janeiro - Institute of Chemistry, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magalhães</LastName>
            <ForeName>Augusto Vieira</ForeName>
            <Initials>AV</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemical Department, Laboratory of Microbial Biotechnology, Federal University of Rio de Janeiro - Institute of Chemistry, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gomez</LastName>
            <ForeName>José Gregório Cabrera</ForeName>
            <Initials>JGC</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Bioproducts, University of São Paulo - Institute of Biomedical Sciences, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freire</LastName>
            <ForeName>Denise Maria Guimarães</ForeName>
            <Initials>DMG</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemical Department, Laboratory of Microbial Biotechnology, Federal University of Rio de Janeiro - Institute of Chemistry, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biotechnol Prog</MedlineTA>
        <NlmUniqueID>8506292</NlmUniqueID>
        <ISSNLinking>1520-6033</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Microbial Enhanced Oil Recovery (MEOR)</Keyword>
        <Keyword MajorTopicYN="N">Pseudomonas aeruginosa</Keyword>
        <Keyword MajorTopicYN="N">biosurfactant</Keyword>
        <Keyword MajorTopicYN="N">rhamnolipid</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083814</ArticleId>
        <ArticleId IdType="doi">10.1002/btpr.2981</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083813</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1474-9726</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Aging cell</Title>
          <ISOAbbreviation>Aging Cell</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Loss of tenomodulin expression is a risk factor for age-related intervertebral disc degeneration.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13091</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/acel.13091</ELocationID>
        <Abstract>
          <AbstractText>The intervertebral disc (IVD) degeneration is thought to be closely related to ingrowth of new blood vessels. However, the impact of anti-angiogenic factors in the maintenance of IVD avascularity remains unknown. Tenomodulin (Tnmd) is a tendon/ligament-specific marker and anti-angiogenic factor with abundant expression in the IVD. It is still unclear whether Tnmd contributes to the maintenance of IVD homeostasis, acting to inhibit vascular ingrowth into this normally avascular tissue. Herein, we investigated whether IVD degeneration could be induced spontaneously by the absence of Tnmd. Our results showed that Tnmd was expressed in an age-dependent manner primarily in the outer annulus fibrous (OAF) and it was downregulated at 6 months of age corresponding to the early IVD degeneration stage in mice. Tnmd knockout (Tnmd<sup>-</sup> <sup>/</sup> <sup>-</sup> ) mice exhibited more rapid progression of age-related IVD degeneration. These signs include smaller collagen fibril diameter, markedly lower compressive stiffness, reduced multiple IVD- and tendon/ligament-related gene expression, induced angiogenesis, and macrophage infiltration in OAF, as well as more hypertrophic-like chondrocytes in the nucleus pulposus. In addition, Tnmd and chondromodulin I (Chm1, the only homologous gene to Tnmd) double knockout (Tnmd<sup>-</sup> <sup>/</sup> <sup>-</sup> Chm1<sup>-</sup> <sup>/</sup> <sup>-</sup> ) mice displayed not only accelerated IVD degeneration, but also ectopic bone formation of IVD. Lastly, the absence of Tnmd in OAF-derived cells promoted p65 and matrix metalloproteinases upregulation, and increased migratory capacity of human umbilical vein endothelial cells. In sum, our data provide clear evidences that Tnmd acts as an angiogenic inhibitor in the IVD homeostasis and protects against age-related IVD degeneration. Targeting Tnmd may represent a novel therapeutic strategy for attenuating age-related IVD degeneration.</AbstractText>
          <CopyrightInformation>© 2019 The Authors. Aging Cell published by the Anatomical Society and John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Dasheng</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Surgery and Regenerative Medicine, Clinic for General, Trauma and Reconstructive Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Orthopaedic Center of People's Liberation Army, The Affiliated Southeast Hospital of Xiamen University, Zhangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alberton</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Surgery and Regenerative Medicine, Clinic for General, Trauma and Reconstructive Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Delgado Caceres</LastName>
            <ForeName>Manuel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prein</LastName>
            <ForeName>Carina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Applied Tissue Engineering and Regenerative Medicine (CANTER), Munich University of Applied Sciences and Center for Nanoscience (CeNS), Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clausen-Schaumann</LastName>
            <ForeName>Hauke</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Applied Tissue Engineering and Regenerative Medicine (CANTER), Munich University of Applied Sciences and Center for Nanoscience (CeNS), Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aszodi</LastName>
            <ForeName>Attila</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Surgery and Regenerative Medicine, Clinic for General, Trauma and Reconstructive Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shukunami</LastName>
            <ForeName>Chisa</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Biology and Biochemistry, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iatridis</LastName>
            <ForeName>James C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Leni and Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Docheva</LastName>
            <ForeName>Denitsa</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7588-1290</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DO1414/3-1</GrantID>
            <Agency>Deutsche Forschungsgemeinschaft</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>810850</GrantID>
            <Agency>EU H2020-WIDESPREAD-Twinning Grant Achilles</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81600696</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>GM089820</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Aging Cell</MedlineTA>
        <NlmUniqueID>101130839</NlmUniqueID>
        <ISSNLinking>1474-9718</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">angiogenesis</Keyword>
        <Keyword MajorTopicYN="N">annulus fibrous</Keyword>
        <Keyword MajorTopicYN="N">intervertebral disc degeneration</Keyword>
        <Keyword MajorTopicYN="N">knockout mice</Keyword>
        <Keyword MajorTopicYN="N">nucleus pulposus</Keyword>
        <Keyword MajorTopicYN="N">tenomodulin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083813</ArticleId>
        <ArticleId IdType="doi">10.1111/acel.13091</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Alberton, P., Dex, S., Popov, C., Shukunami, C., Schieker, M., &amp; Docheva, D. (2015). Loss of tenomodulin results in reduced self-renewal and augmented senescence of tendon stem/progenitor cells. Stem Cells and Development, 24(5), 597-609. https://doi.org/10.1089/scd.2014.0314</Citation>
        </Reference>
        <Reference>
          <Citation>Annunen, S., Paassilta, P., Lohiniva, J., Perälä, M., Pihlajamaa, T., Karppinen, J., … Ala-Kokko, L. (1999). An allele of COL9A2 associated with intervertebral disc disease. Science, 285(5426), 409-412. https://doi.org/10.1126/science.285.5426.409</Citation>
        </Reference>
        <Reference>
          <Citation>Attia, M., Santerre, J. P., &amp; Kandel, R. A. (2011). The response of annulus fibrosus cell to fibronectin-coated nanofibrous polyurethane-anionic dihydroxyoligomer scaffolds. Biomaterials, 32(2), 450-460. https://doi.org/10.1016/j.biomaterials.2010.09.010</Citation>
        </Reference>
        <Reference>
          <Citation>Bedore, J., Sha, W., McCann, M. R., Liu, S., Leask, A., &amp; Séguin, C. A. (2013). Impaired intervertebral disc development and premature disc degeneration in mice with notochord-specific deletion of CCN2. Arthritis &amp; Rheumatology, 65(10), 2634-2644. https://doi.org/10.1002/art.38075</Citation>
        </Reference>
        <Reference>
          <Citation>Brandau, O., Meindl, A., Fässler, R., &amp; Aszódi, A. (2001). A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Developmental Dynamics, 221(1), 72-80. https://doi.org/10.1002/dvdy.1126</Citation>
        </Reference>
        <Reference>
          <Citation>Cornejo, M. C., Cho, S. K., Giannarelli, C., Iatridis, J. C., &amp; Purmessur, D. (2015). Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines. Osteoarthritis and Cartilage, 23(3), 487-496. https://doi.org/10.1016/j.joca.2014.12.010</Citation>
        </Reference>
        <Reference>
          <Citation>Cs-Szabo, G., Ragasa-San Juan, D., Turumella, V., Masuda, K., Thonar, E. J., &amp; An, H. S. (2002). Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. Spine, 27(20), 2212-2219. https://doi.org/10.1097/00007632-200210150-00006</Citation>
        </Reference>
        <Reference>
          <Citation>de Vries, S. A. H., van Doeselaar, M., Meij, B. P., Tryfonidou, M. A., &amp; Ito, K. (2018). Notochordal cell matrix: An inhibitor of neurite and blood vessel growth? Journal of Orthopaedic Research, 36(12), 3188-3195. https://doi.org/10.1002/jor.24114</Citation>
        </Reference>
        <Reference>
          <Citation>Dex, S., Alberton, P., Willkomm, L., Söllradl, T., Bago, S., Milz, S., … Docheva, D. (2017). Tenomodulin is required for tendon endurance running and collagen I fibril adaptation to mechanical load. EBioMedicine, 20, 240-254. https://doi.org/10.1016/j.ebiom.2017.05.003</Citation>
        </Reference>
        <Reference>
          <Citation>Dex, S., Lin, D., Shukunami, C., &amp; Docheva, D. (2016). Tenogenic modulating insider factor: Systematic assessment on the functions of tenomodulin gene. Gene, 587(1), 1-17. https://doi.org/10.1016/j.gene.2016.04.051</Citation>
        </Reference>
        <Reference>
          <Citation>Docheva, D., Hunziker, E. B., Fässler, R., &amp; Brandau, O. (2005). Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Molecular and Cellular Biology, 25(2), 699-705. https://doi.org/10.1128/MCB.25.2.699-705.2005</Citation>
        </Reference>
        <Reference>
          <Citation>Feng, C., Liu, H., Yang, M., Zhang, Y., Huang, B., &amp; Zhou, Y. (2016). Disc cell senescence in intervertebral disc degeneration: Causes and molecular pathways. Cell Cycle, 15(13), 1674-1684. https://doi.org/10.1080/15384101.2016.1152433</Citation>
        </Reference>
        <Reference>
          <Citation>Feng, H., Danfelter, M., Strömqvist, B., &amp; Heinegård, D. (2006). Extracellular matrix in disc degeneration. The Journal of Bone and Joint Surgery-American, 88(Suppl 2), 25-29. https://doi.org/10.2106/JBJS.E.01341</Citation>
        </Reference>
        <Reference>
          <Citation>Fontana, G., See, E., &amp; Pandit, A. (2015). Current trends in biologics delivery to restore intervertebral disc anabolism. Advanced Drug Delivery Reviews, 84, 146-158. https://doi.org/10.1016/j.addr.2014.08.008</Citation>
        </Reference>
        <Reference>
          <Citation>Freemont, A. J., Peacock, T. E., Goupille, P., Hoyland, J. A., O'Brien, J., &amp; Jayson, M. I. (1997). Nerve ingrowth into diseased intervertebral disc in chronic back pain. The Lancet, 350(9072), 178-181. https://doi.org/10.1016/S0140-6736(97)02135-1</Citation>
        </Reference>
        <Reference>
          <Citation>Gronau, T., Krüger, K., Prein, C., Aszodi, A., Gronau, I., Iozzo, R. V., … Dreier, R. (2017). Forced exercise-induced osteoarthritis is attenuated in mice lacking the small leucine-rich proteoglycan decorin. Annals of the Rheumatic Diseases, 76(2), 442-449. https://doi.org/10.1136/annrheumdis-2016-209319</Citation>
        </Reference>
        <Reference>
          <Citation>Gruber, H. E., &amp; Hanley, E. N. Jr. (1998). Analysis of aging and degeneration of the human intervertebral disc. Spine, 23(7), 751-757. https://doi.org/10.1097/00007632-199804010-00001</Citation>
        </Reference>
        <Reference>
          <Citation>Guterl, C. C., See, E. Y., Blanquer, S., Pandit, A., Ferguson, S. J., Benneker, L. M., … Grad, S. (2013). Challenges and strategies in the repair of ruptured annulus fibrosus. European Cells and Materials, 25, 1-21. https://doi.org/10.22203/eCM.v025a01</Citation>
        </Reference>
        <Reference>
          <Citation>Hiraki, Y., Inoue, H., Iyama, K.-I., Kamizono, A., Ochiai, M., Shukunami, C., … Kondo, J. (1997). Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. Journal of Biological Chemistry, 272(51), 32419-32426. https://doi.org/10.1074/jbc.272.51.32419</Citation>
        </Reference>
        <Reference>
          <Citation>Hoogendoorn, R., Doulabi, B. Z., Huang, C. L., Wuisman, P. I., Bank, R. A., &amp; Helder, M. N. (2008). Molecular changes in the degenerated goat intervertebral disc. Spine, 33(16), 1714-1721. https://doi.org/10.1097/BRS.0b013e31817d2468</Citation>
        </Reference>
        <Reference>
          <Citation>Hristova, G. I., Jarzem, P., Ouellet, J. A., Roughley, P. J., Epure, L. M., Antoniou, J., &amp; Mwale, F. (2011). Calcification in human intervertebral disc degeneration and scoliosis. Journal of Orthopaedic Research, 29(12), 1888-1895. https://doi.org/10.1002/jor.21456</Citation>
        </Reference>
        <Reference>
          <Citation>Hsieh, C.-F., Alberton, P., Loffredo-Verde, E., Volkmer, E., Pietschmann, M., Müller, P. E., … Docheva, D. (2016). Periodontal ligament cells as alternative source for cell-based therapy of tendon injuries: In vivo study of full-size Achilles tendon defect in a rat model. European Cells and Materials, 32, 228-240. https://doi.org/10.22203/eCM.v032a15</Citation>
        </Reference>
        <Reference>
          <Citation>Huang, Y. C., Urban, J. P., &amp; Luk, K. D. (2014). Intervertebral disc regeneration: Do nutrients lead the way? Nature Reviews Rheumatology, 10(9), 561-566. https://doi.org/10.1038/nrrheum.2014.91</Citation>
        </Reference>
        <Reference>
          <Citation>Iatridis, J. C., Nicoll, S. B., Michalek, A. J., Walter, B. A., &amp; Gupta, M. S. (2013). Role of biomechanics in intervertebral disc degeneration and regenerative therapies: What needs repairing in the disc and what are promising biomaterials for its repair? The Spine Journal, 13(3), 243-262. https://doi.org/10.1016/j.spinee.2012.12.002</Citation>
        </Reference>
        <Reference>
          <Citation>Illien-Jünger, S., Torre, O. M., Kindschuh, W. F., Chen, X., Laudier, D. M., &amp; Iatridis, J. C. (2016). AGEs induce ectopic endochondral ossification in intervertebral discs. European Cells and Materials, 32, 257-270. https://doi.org/10.22203/eCM.v032a17</Citation>
        </Reference>
        <Reference>
          <Citation>Ito, Y., Toriuchi, N., Yoshitaka, T., Ueno-Kudoh, H., Sato, T., Yokoyama, S., … Asahara, H. (2010). The Mohawk homeobox gene is a critical regulator of tendon differentiation. Proceedings of the National Academy of Sciences, 107, 10538-10542. https://doi.org/10.1073/pnas.1000525107</Citation>
        </Reference>
        <Reference>
          <Citation>Kamper, M., Hamann, N., Prein, C., Clausen-Schaumann, H., Farkas, Z., Aszodi, A., … Zaucke, F. (2016). Early changes in morphology, bone mineral density and matrix composition of vertebrae lead to disc degeneration in aged collagen IX -/- mice. Matrix Biology, 49, 132-143. https://doi.org/10.1016/j.matbio.2015.09.005</Citation>
        </Reference>
        <Reference>
          <Citation>Kimura, N., Shukunami, C., Hakuno, D., Yoshioka, M., Miura, S., Docheva, D., … Fukuda, K. (2008). Local tenomodulin absence, angiogenesis, and matrix metalloproteinase activation are associated with the rupture of the chordae tendineae cordis. Circulation, 118(17), 1737-1747. https://doi.org/10.1161/CIRCULATIONAHA.108.780031</Citation>
        </Reference>
        <Reference>
          <Citation>Kwon, W. K., Moon, H. J., Kwon, T. H., Park, Y. K., &amp; Kim, J. H. (2017). The role of hypoxia in angiogenesis and extracellular matrix regulation of intervertebral disc cells during inflammatory reactions. Neurosurgery, 81(5), 867-875. https://doi.org/10.1093/neuros/nyx149</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, J. M., Song, J. Y., Baek, M. J., Jung, H.-Y., Kang, H., Han, I. B., … Shin, D. E. (2011). Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration. Journal of Orthopaedic Research, 29(2), 265-269. https://doi.org/10.1002/jor.21210</Citation>
        </Reference>
        <Reference>
          <Citation>Leung, V. Y., Tam, V., Chan, D., Chan, B. P., &amp; Cheung, K. M. (2011). Tissue engineering for intervertebral disk degeneration. Orthopedic Clinics of North America, 42(4), 575-583. https://doi.org/10.1016/j.ocl.2011.07.003</Citation>
        </Reference>
        <Reference>
          <Citation>Lin, D., Alberton, P., Caceres, M. D., Volkmer, E., Schieker, M., &amp; Docheva, D. (2017). Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing. Cell Death and Disease, 8(10), e3116. https://doi.org/10.1038/cddis.2017.510</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, W., Liu, D., Zheng, J., Shi, P., Chou, P.-H., Oh, C., … Chee, A. (2017). Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration. The Spine Journal, 17(5), 720-726. https://doi.org/10.1016/j.spinee.2017.01.010</Citation>
        </Reference>
        <Reference>
          <Citation>Masuda, K., Aota, Y., Muehleman, C., Imai, Y., Okuma, M., Thonar, E. J., An, H. S. (2005). A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine, 30(1), 5-14. https://doi.org/10.1097/01.brs.0000148152.04401.20</Citation>
        </Reference>
        <Reference>
          <Citation>McCann, M. R., &amp; Séguin, C. A. (2016). Notochord cells in intervertebral disc development and degeneration. Journal of Developmental Biology, 4(1), 1-18. https://doi.org/10.3390/jdb4010003</Citation>
        </Reference>
        <Reference>
          <Citation>Minogue, B. M., Richardson, S. M., Zeef, L. A., Freemont, A. J., &amp; Hoyland, J. A. (2010). Transcriptional profiling of bovine intervertebral disc cells: Implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Research &amp; Therapy, 12(1), R22. https://doi.org/10.1186/ar2929</Citation>
        </Reference>
        <Reference>
          <Citation>Mwale, F., Roughley, P., &amp; Antoniou, J. (2004). Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: A requisite for tissue engineering of intervertebral disc. European Cells and Materials, 8, 58-63. https://doi.org/10.22203/eCM.v008a06</Citation>
        </Reference>
        <Reference>
          <Citation>Nakamichi, R., Ito, Y., Inui, M., Onizuka, N., Kayama, T., Kataoka, K., … Asahara, H. (2016). Mohawk promotes the maintenance and regeneration of the outer annulus fibrosus of intervertebral discs. Nature Communications, 7, 12503. https://doi.org/10.1038/ncomms12503</Citation>
        </Reference>
        <Reference>
          <Citation>Nakazawa, K. R., Walter, B. A., Laudier, D. M., Krishnamoorthy, D., Mosley, G. E., Spiller, K. L., &amp; Iatridis, J. C. (2018). Accumulation and localization of macrophage phenotypes with human intervertebral disc degeneration. The Spine Journal, 18(2), 343-356. https://doi.org/10.1016/j.spinee.2017.09.018</Citation>
        </Reference>
        <Reference>
          <Citation>Nguyen, C., Poiraudeau, S., &amp; Rannou, F. (2015). From Modic 1 vertebral-endplate subchondral bone signal changes detected by MRI to the concept of 'active discopathy'. Annals of the Rheumatic Diseases, 74(8), 1488-1494. https://doi.org/10.1136/annrheumdis-2015-207317</Citation>
        </Reference>
        <Reference>
          <Citation>Oshima, Y., Sato, K., Tashiro, F., Miyazaki, J., Nishida, K., Hiraki, Y., … Shukunami, C. (2004). Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. Journal of Cell Science, 117(Pt 13), 2731-2744. https://doi.org/10.1242/jcs.01112</Citation>
        </Reference>
        <Reference>
          <Citation>Phillips, K. L., Jordan-Mahy, N., Nicklin, M. J., &amp; Le Maitre, C. L. (2013). Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Annals of the Rheumatic Diseases, 72(11), 1860-1867. https://doi.org/10.1136/annrheumdis-2012-202266</Citation>
        </Reference>
        <Reference>
          <Citation>Popov, C., Kohler, J., &amp; Docheva, D. (2016). Activation of EphA4 and EphB2 reverse signaling restores the age-associated reduction of self-renewal, migration, and actin turnover in human tendon stem/progenitor cells. Frontiers in Aging Neuroscience, 7, 246. https://doi.org/10.3389/fnagi.2015.00246</Citation>
        </Reference>
        <Reference>
          <Citation>Purmessur, D., Freemont, A. J., &amp; Hoyland, J. A. (2008). Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Research &amp; Therapy, 10(4), R99. https://doi.org/10.1186/ar2487</Citation>
        </Reference>
        <Reference>
          <Citation>Pye, S. R., Reid, D. M., Adams, J. E., Silman, A. J., &amp; O'Neill, T. W. (2007). Influence of weight, body mass index and lifestyle factors on radiographic features of lumbar disc degeneration. Annals of the Rheumatic Diseases, 66(3), 426-427. https://doi.org/10.1136/ard.2006.057166</Citation>
        </Reference>
        <Reference>
          <Citation>Risbud, M. V., &amp; Shapiro, I. M. (2014). Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nature Reviews Rheumatology, 10(1), 44-56. https://doi.org/10.1038/nrrheum.2013.160</Citation>
        </Reference>
        <Reference>
          <Citation>Roberts, S., Evans, H., Trivedi, J., &amp; Menage, J. (2008). Histology and pathology of the human intervertebral disc. The Journal of Bone and Joint Surgery-American, 88(Suppl 2), 10-14. https://doi.org/10.2106/JBJS.F.00019</Citation>
        </Reference>
        <Reference>
          <Citation>Shukunami, C., Oshima, Y., &amp; Hiraki, Y. (2001). Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochemical and Biophysical Research Communications, 280(5), 1323-1327. https://doi.org/10.1006/bbrc.2001.4271</Citation>
        </Reference>
        <Reference>
          <Citation>Shukunami, C., Takimoto, A., Nishizaki, Y., Yoshimoto, Y., Tanaka, S., Miura, S., … Hiraki, Y. (2018). Scleraxis is a transcriptional activator that regulates the expression of tenomodulin, a marker of mature tenocytes and ligamentocytes. Scientific Reports, 8(1), 3155. https://doi.org/10.1038/s41598-018-21194-3</Citation>
        </Reference>
        <Reference>
          <Citation>Smits, P., &amp; Lefebvre, V. (2003). Sox5 and Sox6 are required for notochord extracellular matrix sheath formation, notochord cell survival and development of the nucleus pulposus of intervertebral discs. Development, 130(6), 1135-1148. https://doi.org/10.1242/dev.00331</Citation>
        </Reference>
        <Reference>
          <Citation>Song, Y.-Q., Karasugi, T., Cheung, K. M. C., Chiba, K., Ho, D. W. H., Miyake, A., … Chan, D. (2013). Lumbar disc degeneration is linked to a carbohydrate sulfotransferase 3 variant. Journal of Clinical Investigation, 123(11), 4909-4917. https://doi.org/10.1172/JCI69277</Citation>
        </Reference>
        <Reference>
          <Citation>Stokes, I. A., &amp; Iatridis, J. C. (2004). Mechanical conditions that accelerate intervertebral disc degeneration: overload versus immobilization. Spine, 29(23), 2724-2732. https://doi.org/10.1097/01.brs.0000146049.52152.da</Citation>
        </Reference>
        <Reference>
          <Citation>Sztrolovics, R., Alini, M., Mort, J. S., &amp; Roughley, P. J. (1999). Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine, 24(17), 1765-1771. https://doi.org/10.1097/00007632-199909010-00003</Citation>
        </Reference>
        <Reference>
          <Citation>Takao, T., Iwaki, T., Kondo, J., &amp; Hiraki, Y. (2000). Immunohistochemistry of chondromodulin-I in the human intervertebral discs with special reference to the degenerative changes. The Histochemical Journal, 32(9), 545-550. https://doi.org/10.1023/A:1004150211097</Citation>
        </Reference>
        <Reference>
          <Citation>Takimoto, A., Oro, M., Hiraki, Y., &amp; Shukunami, C. (2012). Direct conversion of tenocytes into chondrocytes by Sox9. Experimental Cell Research, 318(13), 1492-1507. https://doi.org/10.1016/j.yexcr.2012.04.002</Citation>
        </Reference>
        <Reference>
          <Citation>Tam, V., Chan, W. C. W., Leung, V. Y. L., Cheah, K. S. E., Cheung, K. M. C., Sakai, D., … Chan, D. (2018). Histological and reference system for the analysis of mouse intervertebral disc. Journal of Orthopaedic Research, 36(1), 233-243. https://doi.org/10.1002/jor.23637</Citation>
        </Reference>
        <Reference>
          <Citation>van der Kraan, P. M., &amp; van den Berg, W. B. (2012). Chondrocyte hypertrophy and osteoarthritis: Role in initiation and progression of cartilage degeneration? Osteoarthritis and Cartilage, 20(3), 223-232. https://doi.org/10.1016/j.joca.2011.12.003</Citation>
        </Reference>
        <Reference>
          <Citation>Walker, M. H., &amp; Anderson, D. G. (2004). Molecular basis of intervertebral disc degeneration. The Spine Journal, 4(6 Suppl), 158S-166S. https://doi.org/10.1016/j.spinee.2004.07.010</Citation>
        </Reference>
        <Reference>
          <Citation>Williams, F. M. K., Bansal, A. T., van Meurs, J. B., Bell, J. T., Meulenbelt, I., Suri, P., … Spector, T. D. (2013). Novel genetic variants associated with lumbar disc degeneration in northern Europeans: A meta-analysis of 4600 subjects. Annals of the Rheumatic Diseases, 72(7), 1141-1148. https://doi.org/10.1136/annrheumdis-2012-201551</Citation>
        </Reference>
        <Reference>
          <Citation>Williams, F. M., Popham, M., Sambrook, P. N., Jones, A. F., Spector, T. D., &amp; MacGregor, A. J. (2011). Progression of lumbar disc degeneration over a decade: A heritability study. Annals of the Rheumatic Diseases, 70(7), 1203-1207. https://doi.org/10.1136/ard.2010.146001</Citation>
        </Reference>
        <Reference>
          <Citation>Yoshimoto, Y., Takimoto, A., Watanabe, H., Hiraki, Y., Kondoh, G., &amp; Shukunami, C. (2017). Scleraxis is required for maturation of tissue domains for proper integration of the musculoskeletal system. Scientific Reports, 7, 45010. https://doi.org/10.1038/srep45010</Citation>
        </Reference>
        <Reference>
          <Citation>Yoshioka, M., Yuasa, S., Matsumura, K., Kimura, K., Shiomi, T., Kimura, N., … Fukuda, K. (2006). Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nature Medicine, 12(10), 1151-1159. https://doi.org/10.1038/nm1476</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, D., Jin, L., Reames, D. L., Shen, F. H., Shimer, A. L., &amp; Li, X. (2013). Intervertebral disc degeneration and ectopic bone formation in apolipoprotein E knockout mice. Journal of Orthopaedic Research, 31(2), 210-217. https://doi.org/10.1002/jor.22216</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083815</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2328-9503</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>7</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of clinical and translational neurology</Title>
          <ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients.</ArticleTitle>
        <Pagination>
          <MedlinePgn>266</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.50996</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ann Clin Transl Neurol</MedlineTA>
        <NlmUniqueID>101623278</NlmUniqueID>
        <ISSNLinking>2328-9503</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>Ann Clin Transl Neurol. 2019 Sep;6(9):1872-1876</RefSource>
          <PMID Version="1">31386270</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083815</ArticleId>
        <ArticleId IdType="doi">10.1002/acn3.50996</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Reference</Title>
        <Reference>
          <Citation>Antelmi E, Pizza F, Donadio V, et al. Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients. Ann Clin Transl Neurol 2019;6:1872-1876.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083816</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2300-9020</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dental and medical problems</Title>
          <ISOAbbreviation>Dent Med Probl</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sagittal mandibular osteotomy in a patient with Eisenmenger's syndrome: A case report.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.17219/dmp/113206</ELocationID>
        <Abstract>
          <AbstractText>The various abnormalities of occlusion cause significant discomfort to the patient suffering from them. Currently, the surgical treatment of malocclusion in healthy patients is a routine process. The situation is completely different when the patient has a serious disease of the respiratory or cardiovascular system - a condition which may contraindicate such treatment. A 30-year-old female patient, with a class III skeletal defect (open bite and progeny) and Eisenmenger's syndrome was chosen as a clinical case. The DDS-Pro software was selected to plan the operation. The bilateral sagittal split osteotomy of the mandible was selected as the method of surgery. At the time of the initial examination, the patient had been denied surgical treatment several times in several other clinics. Before the treatment began, the patient underwent intensive preparation in the cardiac surgery unit for 2.5 months. Using the software, a surgical intervention was planned with the production of a surgical template. The operation was then performed; the treatment period was unremarkable. The resulting occlusion and changes in the shape of the face fully met the patient's psychological and esthetic expectations. In conclusion, a complicated cardiovascular pathology does not always deprive patients with malocclusion of the possibility to undergo surgical treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Filipskyi</LastName>
            <ForeName>Anton</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oral and Maxillofacial Surgery, Danylo Halytsky Lviv National Medical University, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vares</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oral and Maxillofacial Surgery, Danylo Halytsky Lviv National Medical University, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Filipska</LastName>
            <ForeName>Tetyana</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Ward of Maxillofacial Surgery, Lviv Regional Clinical Hospital, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kulinchenko</LastName>
            <ForeName>Ruslan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Prosthetic Dentistry, Danylo Halytsky Lviv National Medical University, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Poland</Country>
        <MedlineTA>Dent Med Probl</MedlineTA>
        <NlmUniqueID>101205669</NlmUniqueID>
        <ISSNLinking>1644-387X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>D</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Eisenmenger’s syndrome</Keyword>
        <Keyword MajorTopicYN="N">malocclusion</Keyword>
        <Keyword MajorTopicYN="N">orthognathic surgery</Keyword>
        <Keyword MajorTopicYN="N">osteotomy of the mandible</Keyword>
        <Keyword MajorTopicYN="N">progeny</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083816</ArticleId>
        <ArticleId IdType="doi">10.17219/dmp/113206</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083817</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2155-7780</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>The primary care companion for CNS disorders</Title>
          <ISOAbbreviation>Prim Care Companion CNS Disord</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Tapentadol: An Opioid of Abuse Acquired Online.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4088/PCC.19l02432</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">19l02432</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ansley</LastName>
            <ForeName>Brant S</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Kansas University School of Medicine, Kansas City, Kansas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sethi</LastName>
            <ForeName>Roopa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Southwest Network, 3640 W Osborn Rd, Phoenix, AZ 85019. roopasethimd@gmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Southwest Network, Phoenix, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Prim Care Companion CNS Disord</MedlineTA>
        <NlmUniqueID>101547532</NlmUniqueID>
        <ISSNLinking>2155-7780</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083817</ArticleId>
        <ArticleId IdType="doi">10.4088/PCC.19l02432</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083818</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2155-7780</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>The primary care companion for CNS disorders</Title>
          <ISOAbbreviation>Prim Care Companion CNS Disord</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Case of Vitamin B12 Deficiency With Various Psychiatric Symptoms and Cognitive Impairment.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4088/PCC.19l02490</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">19l02490</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kimoto</LastName>
            <ForeName>Keitaro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shibasaki</LastName>
            <ForeName>Bunta</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tamura</LastName>
            <ForeName>Norio</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Keyaki-no-Mori Hospital, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maehara</LastName>
            <ForeName>Mizuki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Natsuru</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mikami</LastName>
            <ForeName>Katsunaka</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsumoto</LastName>
            <ForeName>Hideo</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamamoto</LastName>
            <ForeName>Kenji</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. key@is.icc.u-tokai.ac.jp.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Prim Care Companion CNS Disord</MedlineTA>
        <NlmUniqueID>101547532</NlmUniqueID>
        <ISSNLinking>2155-7780</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083818</ArticleId>
        <ArticleId IdType="doi">10.4088/PCC.19l02490</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083819</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2155-7780</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>The primary care companion for CNS disorders</Title>
          <ISOAbbreviation>Prim Care Companion CNS Disord</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association of Excessive Daytime Sleepiness With Psychological Distress in Medical Students.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.4088/PCC.19m02531</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">19m02531</ELocationID>
        <Abstract>
          <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To determine the prevalence of excessive daytime sleepiness among medical students and establish a relationship between self-perceived sleepiness and psychological distress.</AbstractText>
          <AbstractText Label="Methods" NlmCategory="UNASSIGNED">In a cross-sectional study, 441 medical students from a public-sector university in Pakistan completed a questionnaire from August to December 2018. The questionnaire included the Epworth Sleepiness Scale (ESS), which measured daytime sleepiness, and the 12-item General Health Questionnaire (GHQ-12), which measured mental health. Pearson correlations and student t tests were used for comparisons with a significance level of P &lt; .05.</AbstractText>
          <AbstractText Label="Results" NlmCategory="UNASSIGNED">Many of the students (44.9%) obtained a high score (≥ 10) on the ESS (ie, experience excessive daytime sleepiness). On average, higher scores on the ESS correlated with higher scores on the GHQ-12. A statistically significant correlation (P &lt; .05) between ESS scores and GHQ-12 scores was obtained when the students with higher (≥ 10) ESS scores were compared with students with lower (&lt; 10) ESS scores.</AbstractText>
          <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Excessive daytime sleepiness is frequent among medical students and significantly associated with psychological distress. Thus, careful investment in planning appropriate university policies and class schedules is required to encourage healthy and adequate sleep among students, which could have a significant impact on learning, academic performance, and health of medical students.</AbstractText>
          <CopyrightInformation>© Copyright 2020 Physicians Postgraduate Press, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sameer</LastName>
            <ForeName>Hafiz M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>King Edward Medical University/Mayo Hospital, Nelagumbad, Anarkali, Lahore, Pakistan 54000. sameer2376@hotmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>King Edward Medical University/Mayo Hospital, Lahore, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imran</LastName>
            <ForeName>Nazish</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child and Family Psychiatry, King Edward Medical University/Mayo Hospital, Lahore, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tarar</LastName>
            <ForeName>Taliah N</ForeName>
            <Initials>TN</Initials>
            <AffiliationInfo>
              <Affiliation>King Edward Medical University/Mayo Hospital, Lahore, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khawaja</LastName>
            <ForeName>Imran S</ForeName>
            <Initials>IS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, UT Southwestern Medical Center, Dallas, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Sleep Medicine, VA Medical Center, Dallas, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Oklahoma, Norman, Oklahoma, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Prim Care Companion CNS Disord</MedlineTA>
        <NlmUniqueID>101547532</NlmUniqueID>
        <ISSNLinking>2155-7780</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083819</ArticleId>
        <ArticleId IdType="doi">10.4088/PCC.19m02531</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083820</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Empirical dietary patterns and their influence on health in epidemiological studies].</ArticleTitle>
        <Pagination>
          <MedlinePgn>6-18</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10001</ELocationID>
        <Abstract>
          <AbstractText>The last two or three decades in the epidemiology of nutrition empirical approaches to assessing the diet of the population are increasingly being used. However, in Russian studies, these approaches are used extremely rarely, which may be due to insufficient knowledge of the essence, methodological aspects and the field of application of posterior dietary patterns. In this regard, the aim of this review was to highlight the essence, methods and main results of using empirical approaches to assessing the diet of the population. Results. This review discusses the main methodological features of multivariate analysis methods - factor analysis (principal component analysis) and cluster analysis. The main trends of dietary patterns characteristic of the epidemiology of nutrition, and various in different countries and regions are shown. The results of studies of the impact of dietary patterns on some indicators of health status (cardiovascular and oncological diseases, diseases of the musculoskeletal system, diabetes mellitus, metabolic syndrome and its components, mortality) are considered. A brief description of the few Russian studies that used the principal component method in identifying empirical dietary patterns of population is given. In general, this review indicates that the use of multidimensional statistics to highlight population dietary patterns as part of an empirical assessment is nowadays one of the most important components of nutrition epidemiology in different countries. An empirical assessment allows us to consider the diets of the population from a factual point of view and significantly supplements the scientific knowledge obtained using other epidemiological approaches. Currently, considerable experience in the development of methodological approaches to dietary patterns, as well as in the analysis of their associations with various indicators of health status has been accumulated. Conclusion. All this testifies to the high relevance of the considered epidemiological approaches and the need for their testing in Russian conditions, which, perhaps, will give new knowledge about the dietary patterns formation and its impact on the health status of Russians.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maksimov</LastName>
            <ForeName>S A</ForeName>
            <Initials>SA</Initials>
            <Identifier Source="ORCID">0000-0003-0545-2586</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, 101990, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karamnova</LastName>
            <ForeName>N S</ForeName>
            <Initials>NS</Initials>
            <Identifier Source="ORCID">0000-0002-8604-712X</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, 101990, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shalnova</LastName>
            <ForeName>S A</ForeName>
            <Initials>SA</Initials>
            <Identifier Source="ORCID">0000-0003-2087-6483</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, 101990, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drapkina</LastName>
            <ForeName>O M</ForeName>
            <Initials>OM</Initials>
            <Identifier Source="ORCID">0000-0002-4453-8430</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, 101990, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cluster analysis</Keyword>
        <Keyword MajorTopicYN="N">dietary patterns</Keyword>
        <Keyword MajorTopicYN="N">epidemiological studies</Keyword>
        <Keyword MajorTopicYN="N">factor analysis</Keyword>
        <Keyword MajorTopicYN="N">principal
component analysis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083820</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10001</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083821</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[The role of nutritional factors and food allergy in the development of psoriasis].</ArticleTitle>
        <Pagination>
          <MedlinePgn>19-27</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10002</ELocationID>
        <Abstract>
          <AbstractText>Psoriasis is a chronic relapsing disease that affects about 2% of the world's population and leads to medical and social losses. There is evidence of the effect of nutritional factors on the course of psoriasis in modern literature. The aim of the research was to analyze modern domestic and foreign literature on the role of nutritional factors, food allergies and the state of the gastrointestinal tract in the etiopathogenesis of psoriasis Material and methods. The electronic resources were used in preparing the article: the PubMed/MEDLINE portal, "Scientific Electronic Library eLIBRARY.RU". The following filters and keywords were requested: psoriasis and nutrition, food allergies and psoriasis, gastrointestinal manifestations and psoriasis, diet and psoriasis, obesity and psoriasis. Results and discussion. The role of nutrition as a predictor of the development of psoriatic skin rashes and exacerbation of the disease has been discussed. The mechanisms of the positive influence of the correction of metabolic disorders on skin processes in patients with psoriasis have been analyzed. It has been noted that further studies are needed to study the effectiveness of a lowcalorie diet for psoriasis treatment. Particular attention has been paid to the role of food allergy and pathology of the gastrointestinal tract in the etiopathogenesis of psoriatic disease. It is noted that in patients with psoriasis, structural and functional disorders in the gastrointestinal tract are observed, which lead to metabolic changes, endotoxinemia and autosensitization of the body. The role of intolerance to certain foods in the development of psoriasis has been discussed. Most of the available data indicate a high incidence of celiac disease and gluten intolerance in patients with psoriasis, however, information about the effectiveness of a gluten-free diet is controversial. Attention is drawn to the "non-celiac gluten sensitivity" associated with psoriasis, which represents a syndrome of neither allergic nor autoimmune genesis, which is manifested by gluten intolerance and characterized by symptoms similar to celiac disease. An increase in the frequency of occurrence of a high concentration of specific IgE to potato and carrot allergens in patients with psoriasis is noted, which most likely reflects cross-reactions with pollen allergens. An interesting hypothesis is the discussion of a lesion of the gastrointestinal tract in the presence of food allergies in patients with psoriasis, which may be a reflection of the systemic dermatogastrointestinal process and manifest psoriatic rashes on the skin. The mechanism of the anti-inflammatory effect associated with adhering to the Mediterranean diet for psoriasis is described in detail. Conclusion. The data presented allow us to consider the role of nutrition in the etiopathogenesis of psoriasis as significant, both from the point of view of the influence of nutritional factors and food allergens, that must be taken into account when prescribing therapeutic nutrition and elimination diet in combination with standard systemic therapy.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Barilo</LastName>
            <ForeName>A A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0001-5349-9122</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660022, Krasnoyarsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smirnova</LastName>
            <ForeName>S V</ForeName>
            <Initials>SV</Initials>
            <Identifier Source="ORCID">0000-0002-1197-1481</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660022, Krasnoyarsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">celiac disease</Keyword>
        <Keyword MajorTopicYN="N">food allergy</Keyword>
        <Keyword MajorTopicYN="N">gastrointestinal tract</Keyword>
        <Keyword MajorTopicYN="N">low-calorie diet</Keyword>
        <Keyword MajorTopicYN="N">nutrition</Keyword>
        <Keyword MajorTopicYN="N">psoriasis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083821</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10002</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083822</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Dietary intake of children with cystic fibrosis].</ArticleTitle>
        <Pagination>
          <MedlinePgn>28-36</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10003</ELocationID>
        <Abstract>
          <AbstractText>The high incidence of nutritional deficiency in cystic fibrosis continues to be an urgent problem in pediatrics. This is due to the multifactorial nature of these violations, one of which is the lack of effectiveness of nutritional correction. The aim of the research was to assess the actual diet of children and adolescents suffering from cystic fibrosis in order to develop an algorithm for individual approaches to correcting nutritional status.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">150 children (boys - 85, girls - 65) aged 1 year to 18 years (average age 6.4±5.2 years) with a confirmed diagnosis of cystic fibrosis have been examined. Depending on age, the children were divided into groups: the 1st group consisted of 40 children from 1 year to 2 years (average age 1.9±0.7 years); 2nd group - from 3 to 5 years (n=41, 4.4±1.0 years); 3rd group - from 6 to 9 years (n=43, 7.7±1.1 years); 4th group - from 10 to 18 years old (n=26, 13.1±2.5). The actual nutrition was evaluated by questionnaire for 3 days, including one day off. Body mass, height have been measured, and body mass index (BMI) have been calculated.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">Only children of the first three years of life had an optimal diet for this disease in terms of energy value. At the age of 3 years and older, the deficit of energy intake increased, reaching 32% of the individual requirement in adolescence (10-18 years). The structure of nutrition revealed an imbalance of the main nutrients in the direction of the predominance of the lipid component (more than 40% of the energy value) and increased intake of saturated fatty acids, with a reduced proportion of protein and carbohydrates. There was a lack of dietary intake of a number of vitamins (C, B1, B2, A, E, D) and mineral substances (iron, potassium).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study showed the need for an individual approach to the correction of diet energy value and macronutrient intake in children with cystic fibrosis.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maksimycheva</LastName>
            <ForeName>T Yu</ForeName>
            <Initials>TY</Initials>
            <Identifier Source="ORCID">0000-0003-4029-7921</Identifier>
            <AffiliationInfo>
              <Affiliation>Research Centre for Medical Genetics, 115478, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, 125993, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kondratyeva</LastName>
            <ForeName>E I</ForeName>
            <Initials>EI</Initials>
            <Identifier Source="ORCID">0000-0001-6395-0407</Identifier>
            <AffiliationInfo>
              <Affiliation>Research Centre for Medical Genetics, 115478, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sorvacheva</LastName>
            <ForeName>T N</ForeName>
            <Initials>TN</Initials>
            <Identifier Source="ORCID">0000-0001-0003-3482-0616</Identifier>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, 125993, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pyrieva</LastName>
            <ForeName>E A</ForeName>
            <Initials>EA</Initials>
            <Identifier Source="ORCID">0000-0002-9110-6753</Identifier>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, 125993, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evdokimova</LastName>
            <ForeName>T A</ForeName>
            <Initials>TA</Initials>
            <Identifier Source="ORCID">0000-0001-9178-6659</Identifier>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, 125993, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">actual nutrition</Keyword>
        <Keyword MajorTopicYN="N">children</Keyword>
        <Keyword MajorTopicYN="N">cystic fibrosis</Keyword>
        <Keyword MajorTopicYN="N">diet</Keyword>
        <Keyword MajorTopicYN="N">energy value</Keyword>
        <Keyword MajorTopicYN="N">macronutrients</Keyword>
        <Keyword MajorTopicYN="N">nutritional status</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083822</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10003</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083823</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[The study of biological effects of different geographical origin goji berries in rats with alimentary hypercholesterolemia].</ArticleTitle>
        <Pagination>
          <MedlinePgn>37-45</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10004</ELocationID>
        <Abstract>
          <AbstractText>Food and medicinal plants as well as its' fruits, used in traditional medicine, are now widely used as sources of bioactive phytochemical compounds to impart functional properties to products. Due to the significant variation in phytonutrient content depending on geoclimatic conditions, a comparative study of goji berries collected in different regions seems to be relevant. The aim - comparative study of L. barbarum and L. chinense berries and its biological effects when inclusion in the diet of rats with experimental hyperlipidemia.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">In the berries of L. barbarum (China) and L. chinense (Kazakhstan), the composition of monosaccharides, the content of vitamins (D, E, C), minerals (Mg, Ca, Se), phenolic compounds and steroid substances as well as catalase and superoxide dismutase activity and total antioxidant activity was determined. Biological experiment lasted 186 days, it was carried out on Wistar rats, divided into intact (n=10) and experimental animals (n=48), in which alimentary hyperlipidemia was reproduced for 100 days (diet containing animal fats 5.0-19.0% and cholesterol 0.5-2.0%), further animals were divided in control rats with hyperlipidemia, consuming a standard diet (group 1) and experimental rats, which were supplemented for 86 days with L. barbarum (group 2) and L. chinense (group 3) in an amount of 20% of the diet carbohydrate component. On the 128th and 186th days of the experiment, rats' blood serum was analyzed for total protein, albumin, creatinine and urea, triacylglycerides, total cholesterol, high and low density lipoprotein cholesterol, malondialdehyde and the total antioxidant activity of blood serum was measured.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">L. chinense berries, which are characterized by a high content of phenolic compounds (20% higher than in L. barbarum berries), when administered to rats with alimentary hyperlipidemia on the 28th day, reduced the concentration of total cholesterol by 44.1% and low-density lipoproteins by 35.8% relative to control animals, on day 86 contributed to an increase in the concentration of high density lipoproteins to 79.6%. The effect of L. barbarum berries, characterized by an increase in high density lipoproteins in rat blood (by 62.3%), may be due to a higher content of vitamins C, E and selenium (35, 11 and 22% more than in L. chinense), the presence of phytosterols and phytostanols, in particular dodecanoic acid.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The data obtained indicate a pronounced antioxidant effect of L. barbarum and L. chinense berries and the possibility of their use in the diet to correct lipid metabolism disorders.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chernukha</LastName>
            <ForeName>I M</ForeName>
            <Initials>IM</Initials>
            <Identifier Source="ORCID">0000-0003-4298-0927</Identifier>
            <AffiliationInfo>
              <Affiliation>V.M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, 109316, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kotenkova</LastName>
            <ForeName>E A</ForeName>
            <Initials>EA</Initials>
            <Identifier Source="ORCID">0000-0003-1864-8115</Identifier>
            <AffiliationInfo>
              <Affiliation>V.M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, 109316, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vasilevskaya</LastName>
            <ForeName>E R</ForeName>
            <Initials>ER</Initials>
            <Identifier Source="ORCID">0000-0002-4752-3939</Identifier>
            <AffiliationInfo>
              <Affiliation>V.M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, 109316, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ivankin</LastName>
            <ForeName>A N</ForeName>
            <Initials>AN</Initials>
            <Identifier Source="ORCID">0000-0002-6557-2697</Identifier>
            <AffiliationInfo>
              <Affiliation>V.M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, 109316, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lisitsyn</LastName>
            <ForeName>A B</ForeName>
            <Initials>AB</Initials>
            <Identifier Source="ORCID">0000-0002-4079-6950</Identifier>
            <AffiliationInfo>
              <Affiliation>V.M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, 109316, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fedulova</LastName>
            <ForeName>L V</ForeName>
            <Initials>LV</Initials>
            <Identifier Source="ORCID">0000-0003-3573-930X</Identifier>
            <AffiliationInfo>
              <Affiliation>V.M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, 109316, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Goji berries</Keyword>
        <Keyword MajorTopicYN="N">Lycium barbarum</Keyword>
        <Keyword MajorTopicYN="N">Lycium chinense</Keyword>
        <Keyword MajorTopicYN="N">alimentary
hyperlipidemia</Keyword>
        <Keyword MajorTopicYN="N">antioxidants</Keyword>
        <Keyword MajorTopicYN="N">lipid profile</Keyword>
        <Keyword MajorTopicYN="N">rats</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083823</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10004</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083824</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[The effect of agar-pectin gels on the eating behaviour of fasted and fed mice].</ArticleTitle>
        <Pagination>
          <MedlinePgn>46-53</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10005</ELocationID>
        <Abstract>
          <AbstractText>A diet rich in non-digestible plant polysaccharides (dietary fibers) leads to effective appetite suppression and reduces food intake. The mechanical properties of food contribute to the satiating effect of food. It is known that solid food satiates to a greater extent than liquid, as the duration of food processing in the oral cavity increases. The aim of the study was to assess the effect of mechanical properties of agar-pectin gels on the feeding behaviour of mice Material and methods. The gels were prepared by dissolving the corresponding weights of agar, pectin and sucrose in 100 ml of water: gel 1 contained 6 g of agar, 3 g of pectin, gel 2 - 20 g of agar, 1 g of pectin and 0.03 M CaCl<sub>2</sub>, gel 3 - 20 g of agar, 1 g of pectin (without the addition of calcium ions). All gels contained an equal amount of sucrose (15 g per 100 ml of water). The mechanical properties of the gels (strength, Young's modulus and elasticity) were determined on a texture analyzer. Mice with an initial body weight of 32.9±0.5 g (n=8 in each group) received gels once a day for four days. Each day, animals were individually placed in experimental cages for 60 minutes: in the first 30 min, they were given test gels and for the next 30 min standard rodent food. The first two days were training. Before the third gel presentation, the animals were previously completely restricted in food for 14 hr (fasted mice), and before the fourth gel presentation, the mice received food ad libitum (fed mice). The eating behaviour of the mice, the amount of gel eaten and standard feed eaten were determined. Mice that were not exposed to gels were used as control. Results and discussion. Gel 3 was the hardest (251±3 kPa) in comparison with gel 1 (44±1 kPa) and 2 (141±3 kPa). Fasted mice that received gel 3 ate 36% less food (p&lt;0.05), and the total energy intake was 19% lower (p&lt;0.05) compared to the control. Fasted mice that received gels 1 and 2 ate the same amount of food as the control animals. Gel 3 significantly reduced feeding time by 19% (p&lt;0.05) in fasted mice. Gels 1 and 2 did not alter the eating behaviour of fasted mice. Fed mice that received gels ate as much food as in the control. Gels failed to affect the eating behaviour of fed mice. Conclusion. Overall, solid gel 3 reduced food intake and time spent on feeding after 14 h of complete food restriction. The effect of the gel on the feeding behaviour of animals and the amount of food eaten is determined by the hardness of the gel and does not depend on the ratio of the components of the gel and its resistance to in vitro simulated gastric and intestinal fluids.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Paderin</LastName>
            <ForeName>N M</ForeName>
            <Initials>NM</Initials>
            <Identifier Source="ORCID">0000-0001-5313-7105</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Physiology of Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences, Federal Research Centre "Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences", 167982, Syktyvkar, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Markov</LastName>
            <ForeName>P A</ForeName>
            <Initials>PA</Initials>
            <Identifier Source="ORCID">0000-0002-4803-4803</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Physiology of Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences, Federal Research Centre "Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences", 167982, Syktyvkar, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Popov</LastName>
            <ForeName>S V</ForeName>
            <Initials>SV</Initials>
            <Identifier Source="ORCID">0000-0003-1763-8898</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Physiology of Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences, Federal Research Centre "Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences", 167982, Syktyvkar, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">agar-pectin gels</Keyword>
        <Keyword MajorTopicYN="N">eating behaviour</Keyword>
        <Keyword MajorTopicYN="N">mice</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083824</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10005</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083825</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[The role of dietary diversity in the formation of syndrome intestinal bacterial overgrowth].</ArticleTitle>
        <Pagination>
          <MedlinePgn>54-63</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10006</ELocationID>
        <Abstract>
          <AbstractText>Small intestinal bacterial overgrowth (SIBO) is a widespread disease characterized by a significant decrease of the quality of life. Antibiotic treatment of SIBO is usually effective, however, the recurrence rate is high. Microbiota is dependent on dietary pattern of the patient and specific nutrients, therefore the diversity of dietary patterns may be one of the major factor promoting SIBO or its relapses after treatment. The aim of the study was to compare nutritional diversity in patients with SIBО-H<sub>2</sub> and in healthy controls.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Оne thousand twenty three patients with suspected SIBО were examined. Hydrogen-methane breath test with lactulose was performed in 973 patients, the results of which identified groups with SIBO-H<sub>2</sub> (n=522), with SIBO-CH<sub>4</sub> (n=340) and without signs of SIBO (n=108). Data on food intake was collected with 24 h recall from all participants. Dietary diversity was assessed using method of calculation of unique values (count base diversity) for 11 groups of food: cereals, meat and eggs, fish and non-fish seafood, fat containing products, dairy products, nuts, vegetables, fruits and berries, confectionery, drinks, sauces and spices. The pattern of food diversity for each patient was obtained by counting the items in each of the studied food groups. Comparison of the mean values of the number of items in each of the studied food groups was used to compare food diversity in patients with and without SIBО-H<sub>2</sub>.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">A comparison of nutritional diversity in patients with SIBO-H<sub>2</sub> revealed a lower count base diversity in the groups of dairy products (2.70±1.37 vs 3.19±1.34, p&lt;0.001), vegetables (5.50±2.22 vs 6.29±1.90, p&lt;0.001), fruits (1.54± 1.38 vs 1.99±1.69, p=0.018) in compare with controls. Count base diversity in grains, meats, fishes, fat products, nuts and legumes and sweets did not demonstrate significant differences.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Significant differences in the diversity of dietary patterns in patients with SIBО were found in dairy products, vegetables and fruits and berries. The obtained data may be used to develop diet for SIBO patients additionally to the treatment and prevention of its relapses.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pilipenko</LastName>
            <ForeName>V I</ForeName>
            <Initials>VI</Initials>
            <Identifier Source="ORCID">0000-0001-5632-1880</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 115446, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isakov</LastName>
            <ForeName>V A</ForeName>
            <Initials>VA</Initials>
            <Identifier Source="ORCID">0000-0002-4417-8076</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 115446, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vlasova</LastName>
            <ForeName>A V</ForeName>
            <Initials>AV</Initials>
            <Identifier Source="ORCID">0000-0003-2966-1171</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 115446, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naidenova</LastName>
            <ForeName>M A</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0002-6654-8234</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 115446, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morozov</LastName>
            <ForeName>S V</ForeName>
            <Initials>SV</Initials>
            <Identifier Source="ORCID">0000-0001-6816-3058</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 115446, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">breath test with lactulose</Keyword>
        <Keyword MajorTopicYN="N">food diversity</Keyword>
        <Keyword MajorTopicYN="N">nutrition
assessment</Keyword>
        <Keyword MajorTopicYN="N">small intestinal bacterial overgrowth</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083825</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10006</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083826</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Enzymatic hydrolysates of whey protein and chicken egg ppotein: production, physical-chemical and immunochemical characteristics].</ArticleTitle>
        <Pagination>
          <MedlinePgn>64-68</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10007</ELocationID>
        <Abstract>
          <AbstractText>Reducing the manifestations of food allergy by the inclusion of specialized foods in the nutrition of children and adults suffering from this disease is an important problem. The aim was to obtain and characterize in vitro food protein hydrolysates to evaluate their use in specialized foods with reduced potential allergenicity.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Whey protein concentrate (WPC) and chicken egg protein (CEP) and enzymes such as pancreatin and alkalase have been used. Proteolysis of proteins was carried out in an FA-10 fermenter for 3 hours at an enzyme : substrate ratio of 1:50 in dry matter, at optimal pH and temperature for pancreatin and alkalase. Enzymes were inactivated at +75 °C and fermentolizate was ultrafiltered. The solutions were concentrated by reverse osmosis and freeze-dried. The molecular weight distribution of the peptide fractions was evaluated by HPLC. Residual antigenicity was determined by the method of indirect enzyme-linked immunosorbent assay and expressed as the fold of antigenicity reduction relative to the original protein.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">During WPC proteolysis with pancreatin the hydrolyzate was obtained with a fold reduction of antigenicity of 2.3×10<sup>3</sup> relative to the initial WPC. A decrease in antigenicity of 4.7×10<sup>4</sup> times was achieved with proteolysis of WPC by alkalase. The combination of WPC fermentolysis with pancreatin or alkalase followed by ultrafiltration reduced the content of high molecular weight peptides with a mass more than 8.7 kDa. The multiplicity of decrease in antigenicity with respect to the starting protein was 1.64×10<sup>5</sup> and 1.90×10<sup>5</sup>, respectively. After repeated ultrafiltration the reduction in antigenicity of the obtained WPC alkalase or pancreatin hydrolysate was more than 1.0×10<sup>6</sup> and more than 5.0×10<sup>5</sup>, respectively. The decrease in antigenicity of the CEP hydrolyzate obtained with proteolysis by alkalase and ultrafiltration compared to the initial CEP was 1.0×10<sup>5</sup> times, and 5.0×10<sup>5</sup> times when we used repeated ultrafiltration.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A significant decrease in the content of high molecular weight peptides and a decrease in the antigenicity of peptide mixtures based on WPC and CEP to the values that permit their use in hypoallergenic products is achieved by combining proteolysis and double ultrafiltration through a UF10 membrane.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zorin</LastName>
            <ForeName>S N</ForeName>
            <Initials>SN</Initials>
            <Identifier Source="ORCID">0000-0003-2689-6098</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sidorova</LastName>
            <ForeName>Yu S</ForeName>
            <Initials>YS</Initials>
            <Identifier Source="ORCID">0000-0002-2168-2659</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazo</LastName>
            <ForeName>V K</ForeName>
            <Initials>VK</Initials>
            <Identifier Source="ORCID">0000-0002-3237-7967</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alkalase</Keyword>
        <Keyword MajorTopicYN="N">antigenicity</Keyword>
        <Keyword MajorTopicYN="N">chicken egg protein</Keyword>
        <Keyword MajorTopicYN="N">enzymatic hydrolyzate</Keyword>
        <Keyword MajorTopicYN="N">molecular weight distribution</Keyword>
        <Keyword MajorTopicYN="N">pancreatin</Keyword>
        <Keyword MajorTopicYN="N">whey protein</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083826</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10007</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083827</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Oral nutrition supplements: applied classification of formulas and basic rules of their prescribing in oncology].</ArticleTitle>
        <Pagination>
          <MedlinePgn>69-76</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10008</ELocationID>
        <Abstract>
          <AbstractText>The analysis of current data concerning the use of oral nutrition supplements (ONS) in cancer patients has been performed. The aim of the research is improving the effectiveness of medical nutrition in cancer patients by clarifying terms, definitions, developing an applied classification of ONS formulas and outlining the basic approaches for their use.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Using the keywords «cancer», «oral nutritional supplements», and «siping», the literature was searched in such databases as eLIBRARY (elibrary.ru) and MEDLINE (ncbi.nlm.nih.gov) in Russian and English.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">The definition of this type of nutritional support has been given. The applied classification of ONS formulas has been made. Depending on the energy and protein content, presence of some specific nutrients, osmolarity, nitrogen/non-protein kilocalories ratio and viscosity, they were divided into 3 groups. For the initial assessment of nutritional status of the cancer patient, the European society for medical oncology scale (ESMO, 2008) is the most appropriate. Emphasis is placed on the importance of maintaining physical activity.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An approximate algorithm of ONS prescribing in oncology has been formulated.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Potapov</LastName>
            <ForeName>A L</ForeName>
            <Initials>AL</Initials>
            <Identifier Source="ORCID">0000-0003-3752-3107</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khoronenko</LastName>
            <ForeName>V E</ForeName>
            <Initials>VE</Initials>
            <Identifier Source="ORCID">0000-0001-8845-9913</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gameeva</LastName>
            <ForeName>E V</ForeName>
            <Initials>EV</Initials>
            <Identifier Source="ORCID">0000-0002-8509-4338</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khailova</LastName>
            <ForeName>Zh V</ForeName>
            <Initials>ZV</Initials>
            <Identifier Source="ORCID">0000-0003-3258-0954</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boiarkina</LastName>
            <ForeName>A V</ForeName>
            <Initials>AV</Initials>
            <Identifier Source="ORCID">0000-0003-0220-4261</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ivanov</LastName>
            <ForeName>S A</ForeName>
            <Initials>SA</Initials>
            <Identifier Source="ORCID">0000-0001-7689-6032</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaprin</LastName>
            <ForeName>A D</ForeName>
            <Initials>AD</Initials>
            <Identifier Source="ORCID">0000-0001-8784-8415</Identifier>
            <AffiliationInfo>
              <Affiliation>National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249036, Obninsk, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cancers</Keyword>
        <Keyword MajorTopicYN="N">oral nutrition supplements</Keyword>
        <Keyword MajorTopicYN="N">sip feeding</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083827</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10008</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083828</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Modern approaches to the development of gluten-free bakery formulations].</ArticleTitle>
        <Pagination>
          <MedlinePgn>77-85</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10009</ELocationID>
        <Abstract>
          <AbstractText>According to WHO, currently about 1% of the world's population suffers from celiac disease, a disease associated with a deficiency of enzymes that break down gluten and proteins close to it. In celiac disease, there is a malabsorption of disaccharides, fats, vitamins and amino acids, which imposes restrictions on food formulations that can be used in the diet of people with celiac disease. Analysis of the market of gluten-free bakery products showed a lack in this segment of products, including the complete absence of products with ω-3 polyunsaturated fatty acids (PUFAs), the total deficit of which is noted in the diet of Russians and around the world. The aim of the study was to develop recipes for gluten-free bakery products enriched with ω-3 PUFAs, dietary fibers and protein.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The quality of the resulting bread was evaluated by conventional methods including the determination of the content of protein, dietary fiber, fat and its fatty acid composition.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">To achieve this goal, we used approaches that combined both traditional and non-traditional food raw materials, namely gluten-free flour of chia seeds (a source of PUFA and dietary fiber), lupin flour (a source of protein), as well as enzyme transesterificated milk fat substitute containing ω-3 PUFAs. A protein-polysaccharide mixture was used as a thickener and structure-forming agent. The developed formulations allowed to obtain finished products characterized by the content of ω-3 fatty acids - 0.4-0.6 g/100 g, while maintaining a balance between essential ω-6 and ω-3 fatty acids at the level (2.5-3.5):1, recommended for therapeutic nutrition, dietary fiber - 11.1-12.4 g/100 g, and protein content - 5.2-6.7 g/100 g, while maintaining good organoleptic properties. The achieved level of enrichment in accordance with the current legislation allows labeling the resulting products as «high in ω-3 fatty acids and dietary fibers». According to the available data on the biological effect of the components of the developed product, it can affect lipid metabolism, contributing to the reduction of atherogenic lipids in the blood.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The implementation of the results of this work in the industry will expand the range of gluten-free products through the production of specialized bakery products with the strengthening of their dietary therapeutic and preventive orientation due to the high content of ω-3 fatty PUFAs and dietary fibers.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zaytseva</LastName>
            <ForeName>L V</ForeName>
            <Initials>LV</Initials>
            <Identifier Source="ORCID">0000-0001-8176-1650</Identifier>
            <AffiliationInfo>
              <Affiliation>Central Scientific-Research Institute of Modern Fat Technology, 196608, Saint Petersburg, Pushkin, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yudina</LastName>
            <ForeName>T A</ForeName>
            <Initials>TA</Initials>
            <Identifier Source="ORCID">0000-0001-7618-596X</Identifier>
            <AffiliationInfo>
              <Affiliation>Moscow State University of Food Production, 125080, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruban</LastName>
            <ForeName>N V</ForeName>
            <Initials>NV</Initials>
            <Identifier Source="ORCID">0000-0003-2511-172X</Identifier>
            <AffiliationInfo>
              <Affiliation>Moscow State University of Food Production, 125080, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bessonov</LastName>
            <ForeName>V V</ForeName>
            <Initials>VV</Initials>
            <Identifier Source="ORCID">0000-0002-3587-5347</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mekhtiev</LastName>
            <ForeName>V S</ForeName>
            <Initials>VS</Initials>
            <Identifier Source="ORCID">0000-0003-2133-6024</Identifier>
            <AffiliationInfo>
              <Affiliation>LLC «Protein Plus», 199004, Saint Petersburg, Russian Federation.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">celiac disease</Keyword>
        <Keyword MajorTopicYN="N">dietary fibers</Keyword>
        <Keyword MajorTopicYN="N">enrichment with PUFAs</Keyword>
        <Keyword MajorTopicYN="N">gluten-free bakery products</Keyword>
        <Keyword MajorTopicYN="N">protein</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083828</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10009</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083829</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Carrot juice nutritional profile].</ArticleTitle>
        <Pagination>
          <MedlinePgn>86-95</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10010</ELocationID>
        <Abstract>
          <AbstractText>Carrot juice is one of the main products of carrot processing and the second most popular vegetable juice after tomato. Due to the presence of a complex of various nutritive and biologically active substances (BAS) carrot juice can make a significant contribution to maintaining human healthy diet. The aim of the study was to establish the nutrient profile of carrot juice.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A study of parameters of carrot juice of industrial production, characterizing its nutritional and biological value was carried out. The results of these experiments were compared with the data of BAS profiles of carrot juice from reference books and scientific publications.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">The established nutrient profile includes data about content of more than 30 nutritients and BAS. The sucrose is the predominant carbohydrate in carrot juice; glucose and fructose concentrations are substantially lower. Among organic acids predominates L-malic acid whereas content of citric acid is usually 5-10 fold lower than that of L-malic acid. The total acidity of carrot juice is low, on average 0.25 mg of organic acids is present in 100 cm<sup>3</sup> of juice. Carrot juice is a relatively rich source of a number of vitamins and minerals. A serving (200-250 cm<sup>3</sup>) of industrial carrot juice on average contains around 18% of the recommended daily intake (RDI) for potassium, 9% for magnesium, 8% for iron, 12% for copper and 14% for manganese. Vitamins are represented to a large extent by β-carotene and other carotenoids (more than 400% of the RDI in a serving), as well as niacin, biotin and pantothenic acid - about 7% of the RDI in a serving for each of these vitamins. The content of vitamins E and K in serving averages 17 and 10% of the RDI respectively. Not clarified carrot juice contains about 1.1 g of dietary fiber in 100 cm<sup>3</sup>, including pectins - about 0.2 g/100 cm<sup>3</sup>.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on the results of this investigation the carrot juice might be considered as a substantial source of minor BAS mostly carotenoids, vitamins E and K, group B vitamins: niacin, biotin, pantothenic acid, mineral substances: potassium, magnesium, iron, copper, manganese, as well as dietary fiber.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Khomich</LastName>
            <ForeName>L M</ForeName>
            <Initials>LM</Initials>
            <Identifier Source="ORCID">0000-0002-4312-3559</Identifier>
            <AffiliationInfo>
              <Affiliation>Non-Commercial Organization "Russian Union of Juice Producers" (RSPS), Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perova</LastName>
            <ForeName>I B</ForeName>
            <Initials>IB</Initials>
            <Identifier Source="ORCID">0000-0001-5975-1376</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eller</LastName>
            <ForeName>K I</ForeName>
            <Initials>KI</Initials>
            <Identifier Source="ORCID">0000-0003-1046-4442</Identifier>
            <AffiliationInfo>
              <Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">biologically active substances</Keyword>
        <Keyword MajorTopicYN="N">carotenoids</Keyword>
        <Keyword MajorTopicYN="N">carrot juice</Keyword>
        <Keyword MajorTopicYN="N">dietary fiber</Keyword>
        <Keyword MajorTopicYN="N">micronutrients</Keyword>
        <Keyword MajorTopicYN="N">nutrient profile</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083829</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10010</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083830</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0042-8833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Voprosy pitaniia</Title>
          <ISOAbbreviation>Vopr Pitan</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Lipid profile of the black sea shrimp Palaemon adspersus Rathke, 1837].</ArticleTitle>
        <Pagination>
          <MedlinePgn>96-100</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.24411/0042-8833-2020-10011</ELocationID>
        <Abstract>
          <AbstractText>Lipids play one of the leading roles in ensuring the physiological needs and quality of human life. Therefore, assessment of traditional and new types of aquatic organisms from the standpoint of nutritional value of lipids is an urgent task nowadays. The aim of the work was to study the lipid profile of one of the most mass commercial species of crustaceans - the Black Sea grass shrimp Palaemon adspersus Rathke, 1837.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The collection of material was carried out in May in the Hadzhibey Lyman of Odessa region. Prawn catching was carried out by a trap net with a mesh size of 2.8 up to 8 mm. The total number of individuals analyzed was 250 specimens. In the average sample of prawn, the content of total lipids have been determined by the Soxhlet method, the fatty acid composition of lipids has been studied using gas chromatography, and the fractional composition - by a thin layer chromatography on silica gel plates method. All the studies have been performed in 3 replicates.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">Lipid profile of hepatopancreas of the Black Sea shrimp was represented by the content of total lipids 10±1.8, among them triglycerides - 35.2±5.3%, phospholipids - 16.8±3.6%, free fatty acids - 12.5±2.1%, sterols - 6.5±1.4%, sterol esters 6.5±1.3%, mono- and diglycerides - 1.5-2.7% of total lipids. The nutritive value of lipids was characterized both by a high content of phospholipids, and fatty acids such as oleic one belonging to the ω-9 family (18:1) - 15.7%, and eicosapentaenoic (20:5) - 18.30% and docosahexaenoic (22:6) - 14.70% acids of the ω-3 family. The biological significance coefficient of lipids of the Black Sea grass prawn was 3.3, which was adjusted with the value of this indicator of other aquatic organisms. The ratio of fatty acids ω-6 to ω-3 was 1:19.5 which indicated a high nutritional value of hepatopancreas lipids of this prawn species.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of the study allow recommending the hepatopancreas lipids of the Black Sea grass shrimp for the enrichment of foods with ω-3 polyunsaturated fatty acids, the formation of multicomponent products with desired properties, as well as for the drug development.</AbstractText>
          <CopyrightInformation>Copyright© GEOTAR-Media Publishing Group.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lebskaya</LastName>
            <ForeName>T K</ForeName>
            <Initials>TK</Initials>
            <Identifier Source="ORCID">0000-0003-0875-2875</Identifier>
            <AffiliationInfo>
              <Affiliation>National University of Life and Environmental Sciences of Ukraine, 03041, Kiev, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bal-Prylypko</LastName>
            <ForeName>L V</ForeName>
            <Initials>LV</Initials>
            <Identifier Source="ORCID">0000-0002-9489-8610</Identifier>
            <AffiliationInfo>
              <Affiliation>National University of Life and Environmental Sciences of Ukraine, 03041, Kiev, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Menchinskaya</LastName>
            <ForeName>A A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0001-8593-3325</Identifier>
            <AffiliationInfo>
              <Affiliation>National University of Life and Environmental Sciences of Ukraine, 03041, Kiev, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lebsky</LastName>
            <ForeName>S O</ForeName>
            <Initials>SO</Initials>
            <Identifier Source="ORCID">0000-0002-0062-3473</Identifier>
            <AffiliationInfo>
              <Affiliation>National University of Life and Environmental Sciences of Ukraine, 03041, Kiev, Ukraine.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vopr Pitan</MedlineTA>
        <NlmUniqueID>2984870R</NlmUniqueID>
        <ISSNLinking>0042-8833</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">fatty acids</Keyword>
        <Keyword MajorTopicYN="N">lipids</Keyword>
        <Keyword MajorTopicYN="N">nutritional value</Keyword>
        <Keyword MajorTopicYN="N">shrimp</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083830</ArticleId>
        <ArticleId IdType="doi">10.24411/0042-8833-2020-10011</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">32083831</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2194-802X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>28</Day>
            </PubDate>
          </JournalIssue>
          <Title>Diagnosis (Berlin, Germany)</Title>
          <ISOAbbreviation>Diagnosis (Berl)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/dx-2020-0015</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">/j/dx.ahead-of-print/dx-2020-0015/dx-2020-0015.xml</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lippi</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Associate Editor of Diagnosis, Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University Hospital of Verona, Piazzale L.A. Scuro, 10, 37134 Verona, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Plebani</LastName>
            <ForeName>Mario</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Editor-in-Chief of Diagnosis, Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Diagnosis (Berl)</MedlineTA>
        <NlmUniqueID>101654734</NlmUniqueID>
        <ISSNLinking>2194-802X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32083831</ArticleId>
        <ArticleId IdType="doi">10.1515/dx-2020-0015</ArticleId>
        <ArticleId IdType="pii">/j/dx.ahead-of-print/dx-2020-0015/dx-2020-0015.xml</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
